PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Maley, J; Giresse, P; Doumenge, C; Favier, C				Maley, Jean; Giresse, Pierre; Doumenge, Charles; Favier, Charly			Comment on "Intensifying Weathering and Land Use in Iron Age Central Africa"	SCIENCE			English	Editorial Material							CONGO; SEDIMENTS; FAN		[Maley, Jean; Favier, Charly] Univ Montpellier 2, Dept Paleoenvironm & Paleoclimatol, Inst Sci Evolut Montpellier, CNRS,UMR 5554, F-34095 Montpellier, France; [Giresse, Pierre] Univ Perpignan, CNRS, Ctr Format & Rech Environm Mediterraneens, F-66860 Perpignan, France; [Doumenge, Charles] TA, Ctr Int Rech Agron Dev, F-34398 Montpellier, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Universite Perpignan Via Domitia; CIRAD; Universite de Montpellier	Maley, J (corresponding author), Univ Montpellier 2, Dept Paleoenvironm & Paleoclimatol, Inst Sci Evolut Montpellier, CNRS,UMR 5554, F-34095 Montpellier, France.	jean.maley@univ-montp2.fr	FAVIER, Charly/J-9900-2014; Favier, Charly/A-7516-2012; Höhn, Alexa/ABC-5771-2020; Salzmann, Ulrich/H-9929-2017; Bostoen, Koen/D-5447-2011	Favier, Charly/0000-0002-1126-6950; Höhn, Alexa/0000-0003-2943-7858; Salzmann, Ulrich/0000-0001-5598-5327; Bostoen, Koen/0000-0003-2284-6165; CLIST, Bernard/0000-0001-8521-6588; Denham, Tim/0000-0002-8164-2990	European Research Council [284126] Funding Source: Medline	European Research Council(European Research Council (ERC)European Commission)		Bayon G, 2012, SCIENCE, V335, P1219, DOI 10.1126/science.1215400; Gaillardet J, 1999, GEOCHIM COSMOCHIM AC, V63, P4037, DOI 10.1016/S0016-7037(99)00307-5; Gingele FX, 1998, PALAEOGEOGR PALAEOCL, V138, P17, DOI 10.1016/S0031-0182(97)00121-1; Giresse P, 2005, PALAEOGEOGR PALAEOCL, V218, P257, DOI 10.1016/j.palaeo.2004.12.018; GIRESSE P, 1982, B SOC GEOL FR, V24, P803; Lespez L, 2011, QUATERNARY SCI REV, V30, P737, DOI 10.1016/j.quascirev.2010.12.021; Maley J, 2002, IDS BULL-I DEV STUD, V33, P13, DOI 10.1111/j.1759-5436.2002.tb00003.x; Maley J, 2011, PALAEOECO A, V30, P227; Neumann K, 2012, QUATERN INT, V249, P53, DOI 10.1016/j.quaint.2011.03.024; PINCON B, 1995, CR ACAD SCI II A, V320, P1241; PINCON B, 1991, CR ACAD SCI II, V312, P1393; Pincon B., 1990, PAYSAGES QUATERNAIRE, P479; Schneider RR, 1997, PALEOCEANOGRAPHY, V12, P463, DOI 10.1029/96PA03640	13	47	48	0	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 31	2012	337	6098								10.1126/science.1221820	http://dx.doi.org/10.1126/science.1221820			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	996WP	22936758				2022-12-28	WOS:000308125800024
J	Neumann, K; Eggert, MKH; Oslisly, R; Clist, B; Denham, T; de Maret, P; Ozainne, S; Hildebrand, E; Bostoen, K; Salzmann, U; Schwartz, D; Eichhorn, B; Tchiengue, B; Hohn, A				Neumann, K.; Eggert, M. K. H.; Oslisly, R.; Clist, B.; Denham, T.; de Maret, P.; Ozainne, S.; Hildebrand, E.; Bostoen, K.; Salzmann, U.; Schwartz, D.; Eichhorn, B.; Tchiengue, B.; Hoehn, A.			Comment on "Intensifying Weathering and Land Use in Iron Age Central Africa"	SCIENCE			English	Editorial Material							RAIN-FOREST; FARMERS		[Neumann, K.; Eichhorn, B.; Hoehn, A.] Goethe Univ Frankfurt, Inst Archaeol Sci, D-60323 Frankfurt, Germany; [Eggert, M. K. H.] Univ Tubingen, Inst Ur & Fruhgeschichte & Archaol Mittelalters, D-72070 Tubingen, Germany; [Oslisly, R.] IRD, UMR IRD MN HN Patrimoines Locaux 208, Yaounde, Cameroon; [Clist, B.; Bostoen, K.] Univ Ghent, Dept African Languages & Cultures, B-9000 Ghent, Belgium; [Denham, T.] La Trobe Univ, Archaeol Program, Melbourne, Vic 2086, Australia; [de Maret, P.] Univ Libre Bruxelles, Ctr Anthropol Culturelle, B-1050 Brussels, Belgium; [Ozainne, S.] Univ Geneva, Dept Genet & Evolut, Unite Anthropol, Lab Archeol & Peuplement Afrique APA, CH-1211 Geneva 4, Switzerland; [Hildebrand, E.] SUNY Stony Brook, Dept Anthropol, Stony Brook, NY 11794 USA; [Salzmann, U.] Northumbria Univ, Sch Built & Nat Environm, Newcastle Upon Tyne NE1 8ST, Tyne & Wear, England; [Schwartz, D.] ERL 7230 UDS CNRS, Fac Geog & Amenagement, F-67083 Strasbourg, France; [Tchiengue, B.] Herbier Natl Cameroon, Yaounde, Cameroon	Goethe University Frankfurt; Eberhard Karls University of Tubingen; Institut de Recherche pour le Developpement (IRD); Ghent University; La Trobe University; Universite Libre de Bruxelles; University of Geneva; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Northumbria University; Centre National de la Recherche Scientifique (CNRS)	Neumann, K (corresponding author), Goethe Univ Frankfurt, Inst Archaeol Sci, Grueneburgweg 1, D-60323 Frankfurt, Germany.	k.neumann@em.uni-frankfurt.de	FAVIER, Charly/J-9900-2014; Favier, Charly/A-7516-2012; Höhn, Alexa/ABC-5771-2020; Salzmann, Ulrich/H-9929-2017; Bostoen, Koen/D-5447-2011	Favier, Charly/0000-0002-1126-6950; Höhn, Alexa/0000-0003-2943-7858; Salzmann, Ulrich/0000-0001-5598-5327; Bostoen, Koen/0000-0003-2284-6165; CLIST, Bernard/0000-0001-8521-6588; Denham, Tim/0000-0002-8164-2990	European Research Council [284126] Funding Source: Medline	European Research Council(European Research Council (ERC)European Commission)		Barton H, 2012, QUATERN INT, V249, P1, DOI 10.1016/j.quaint.2011.07.044; Bayon G, 2012, SCIENCE, V335, P1219, DOI 10.1126/science.1215400; Brncic TM, 2009, HOLOCENE, V19, P79, DOI 10.1177/0959683608098954; Clist B., 2005, THESIS U LIBRE BRUXE; De Maret P., 1990, PAYSAGES QUATERNAIRE, P447; Diamond J, 2003, SCIENCE, V300, P597, DOI 10.1126/science.1078208; Eggert MK., 2006, J AFR ARCHAEOL, V4, P273, DOI [10.3213/1612-1651-10076, DOI 10.3213/1612-1651-10076]; Maley J, 2002, IDS BULL-I DEV STUD, V33, P13, DOI 10.1111/j.1759-5436.2002.tb00003.x; Neumann K, 2012, QUATERN INT, V249, P53, DOI 10.1016/j.quaint.2011.03.024; Ngomanda A, 2009, CLIM PAST, V5, P647, DOI 10.5194/cp-5-647-2009; Oslisly R., 2007, RETHINKING AGR ARCHA, P347; Pincon B., 1990, PAYSAGES QUATERNAIRE, P479; Salzmann U, 2005, HOLOCENE, V15, P190, DOI 10.1191/0959683605hl799rp; SCHWARTZ D, 1992, B SOC GEOL FR, V163, P353; Wotzka H.-P., 2006, GRUNDLEGUNGEN BEITRA, P271	15	47	48	0	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 31	2012	337	6098								10.1126/science.1221747	http://dx.doi.org/10.1126/science.1221747			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	996WP	22936758	Green Accepted			2022-12-28	WOS:000308125800023
J	Lupp, C; Skipper, M; Weiss, U				Lupp, Claudia; Skipper, Magdalena; Weiss, Ursula			GUT MICROBES AND HEALTH	NATURE			English	Editorial Material																			0	43	45	1	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 13	2012	489	7415					219	219		10.1038/489219a	http://dx.doi.org/10.1038/489219a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003UC	22972294	Bronze			2022-12-28	WOS:000308635900029
J	Howan, K; Smith, AJ; Westblade, LF; Joly, N; Grange, W; Zorman, S; Darst, SA; Savery, NJ; Strick, TR				Howan, Kevin; Smith, Abigail J.; Westblade, Lars F.; Joly, Nicolas; Grange, Wilfried; Zorman, Sylvain; Darst, Seth A.; Savery, Nigel J.; Strick, Terence R.			Initiation of transcription-coupled repair characterized at single-molecule resolution	NATURE			English	Article							RNA-POLYMERASE; DNA-REPAIR; STRUCTURAL BASIS; MECHANISM; MFD; NANOMANIPULATION; TRANSLOCATION; TERMINATION; MUTATION; STRAND	Transcription-coupled DNA repair uses components of the transcription machinery to identify DNA lesions and initiate their repair. These repair pathways are complex, so their mechanistic features remain poorly understood. Bacterial transcription-coupled repair is initiated when RNA polymerase stalled at a DNA lesion is removed by Mfd, an ATP-dependent DNA translocase(1-3). Here we use single-molecule DNA nanomanipulation to observe the dynamic interactions of Escherichia coli Mfd with RNA polymerase elongation complexes stalled by a cyclopyrimidine dimer or by nucleotide starvation. We show that Mfd acts by catalysing two irreversible, ATP-dependent transitions with different structural, kinetic and mechanistic features. Mfd remains bound to the DNA in a long-lived complex that could act as a marker for sites of DNA damage, directing assembly of subsequent DNA repair factors. These results provide a framework for considering the kinetics of transcription-coupled repair in vivo, and open the way to reconstruction of complete DNA repair pathways at single-molecule resolution.	[Howan, Kevin; Joly, Nicolas; Grange, Wilfried; Zorman, Sylvain; Strick, Terence R.] Univ Paris Diderot, CNRS, Inst Jacques Monod, UMR 7592, F-75205 Paris, France; [Smith, Abigail J.; Savery, Nigel J.] Univ Bristol, Sch Biochem, DNA Prot Interact Unit, Bristol BS8 1TD, Avon, England; [Westblade, Lars F.; Darst, Seth A.] Rockefeller Univ, New York, NY 10065 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; University of Bristol; Rockefeller University	Strick, TR (corresponding author), Univ Paris Diderot, CNRS, Inst Jacques Monod, UMR 7592, F-75205 Paris, France.	strick.terence@ijm.univ-paris-diderot.fr	Joly, Nicolas/H-6851-2018	Joly, Nicolas/0000-0003-2731-3827; Savery, Nigel/0000-0002-0803-4075; Strick, Terence/0000-0003-1744-3679	Frontieres Interdisciplinaires du Vivant Doctoral Program; Fondation pour la Recherche Medicale; BBSRC [BB/I003142/1]; National Institutes of Health [GM073829]; EURYI grant; CNRS; University of Paris Diderot; BBSRC [BB/I001859/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I001859/1, BB/I003142/1] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073829] Funding Source: NIH RePORTER	Frontieres Interdisciplinaires du Vivant Doctoral Program; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EURYI grant; CNRS(Centre National de la Recherche Scientifique (CNRS)); University of Paris Diderot; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank K. Neumann for showing us how to perform global fitting with the Igor software package. K.H. was supported by a PhD scholarship from the Frontieres Interdisciplinaires du Vivant Doctoral Program and the Fondation pour la Recherche Medicale. Work in the laboratory of N.J.S. was supported by BBSRC grant BB/I003142/1, and work in the laboratory of S.A.D. was supported by National Institutes of Health grant GM073829. This work was also made possible by a EURYI grant, in addition to CNRS and University of Paris Diderot core funding, to T.R.S.	Brueckner F, 2007, SCIENCE, V315, P859, DOI 10.1126/science.1135400; Chambers AL, 2003, NUCLEIC ACIDS RES, V31, P6409, DOI 10.1093/nar/gkg868; Deaconescu AM, 2007, CURR OPIN STRUC BIOL, V17, P96, DOI 10.1016/j.sbi.2007.01.005; Deaconescu AM, 2012, P NATL ACAD SCI USA, V109, P3353, DOI 10.1073/pnas.1115105109; Deaconescu AM, 2006, CELL, V124, P507, DOI 10.1016/j.cell.2005.11.045; Deaconescu AM, 2005, ACTA CRYSTALLOGR F, V61, P1062, DOI 10.1107/S1744309105035876; Hanawalt PC, 2008, NAT REV MOL CELL BIO, V9, P958, DOI 10.1038/nrm2549; Komissarova N, 2002, MOL CELL, V10, P1151, DOI 10.1016/S1097-2765(02)00738-4; Kou SC, 2005, J PHYS CHEM B, V109, P19068, DOI 10.1021/jp051490q; Landick R, 2006, BIOCHEM SOC T, V34, P1062, DOI 10.1042/BST0341062; Manelyte L, 2010, MOL CELL, V40, P714, DOI 10.1016/j.molcel.2010.11.012; MELLON I, 1989, NATURE, V342, P95, DOI 10.1038/342095a0; Park JS, 2006, P NATL ACAD SCI USA, V103, P4870, DOI 10.1073/pnas.0600145103; Park JS, 2002, CELL, V109, P757, DOI 10.1016/S0092-8674(02)00769-9; Revyakin A, 2004, P NATL ACAD SCI USA, V101, P4776, DOI 10.1073/pnas.0307241101; Revyakin A, 2003, METHOD ENZYMOL, V370, P577; Revyakin A, 2006, SCIENCE, V314, P1139, DOI 10.1126/science.1131398; Savery NJ, 2007, TRENDS MICROBIOL, V15, P326, DOI 10.1016/j.tim.2007.05.005; SELBY CP, 1993, J BACTERIOL, V175, P7509, DOI 10.1128/JB.175.23.7509-7514.1993; SELBY CP, 1991, P NATL ACAD SCI USA, V88, P8232, DOI 10.1073/pnas.88.18.8232; SELBY CP, 1993, SCIENCE, V260, P53, DOI 10.1126/science.8465200; SELBY CP, 1995, J BIOL CHEM, V270, P4882, DOI 10.1074/jbc.270.9.4882; Smith AJ, 2008, DNA REPAIR, V7, P1670, DOI 10.1016/j.dnarep.2008.06.020; Smith AJ, 2007, NUCLEIC ACIDS RES, V35, P1802, DOI 10.1093/nar/gkm019; Smith AJ, 2005, NUCLEIC ACIDS RES, V33, P755, DOI 10.1093/nar/gki225; Srivastava DB, 2011, J MOL BIOL, V406, P275, DOI 10.1016/j.jmb.2010.12.004; Westblade LF, 2010, NUCLEIC ACIDS RES, V38, P8357, DOI 10.1093/nar/gkq692; WITKIN EM, 1956, COLD SPRING HARB SYM, V21, P123, DOI 10.1101/SQB.1956.021.01.011	28	65	66	1	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 18	2012	490	7420					431	434		10.1038/nature11430	http://dx.doi.org/10.1038/nature11430			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	021XI	22960746	Green Accepted			2022-12-28	WOS:000309918500052
J	Popovich, PG				Popovich, Phillip G.			Building Bridges for Spinal Cord Repair	CELL			English	Editorial Material									Ohio State Univ, Wexner Med Ctr, Dept Neurosci, Columbus, OH 43210 USA; [Popovich, Phillip G.] Ohio State Univ, Wexner Med Ctr, Ctr Brain & Spinal Cord Repair, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Popovich, PG (corresponding author), Ohio State Univ, Wexner Med Ctr, Dept Neurosci, Columbus, OH 43210 USA.	phillip.popovich@osumc.edu						Brown A, 2012, EXP NEUROL, V235, P133, DOI 10.1016/j.expneurol.2011.11.004; Deshpande DM, 2006, ANN NEUROL, V60, P32, DOI 10.1002/ana.20901; Josephson A, 2002, J COMP NEUROL, V453, P292, DOI 10.1002/cne.10408; Ketschek AR, 2012, EXP NEUROL, V235, P627, DOI 10.1016/j.expneurol.2012.03.017; Liu K, 2010, NAT NEUROSCI, V13, P1075, DOI 10.1038/nn.2603; Lu P, 2012, CELL, V150, P1264, DOI 10.1016/j.cell.2012.08.020; Lu P, 2012, J NEUROSCI, V32, P8208, DOI 10.1523/JNEUROSCI.0308-12.2012; Reier Paul J, 2004, NeuroRx, V1, P424, DOI 10.1007/BF03206629; Sahni V, 2010, NAT REV NEUROL, V6, P363, DOI 10.1038/nrneurol.2010.73	9	10	9	0	21	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 14	2012	150	6					1105	1106		10.1016/j.cell.2012.08.025	http://dx.doi.org/10.1016/j.cell.2012.08.025			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	007ZY	22980974	Bronze			2022-12-28	WOS:000308928100005
J	Mascre, G; Dekoninck, S; Drogat, B; Youssef, KK; Brohee, S; Sotiropoulou, PA; Simons, BD; Blanpain, C				Mascre, Guilhem; Dekoninck, Sophie; Drogat, Benjamin; Youssef, Khalil Kass; Brohee, Sylvain; Sotiropoulou, Panagiota A.; Simons, Benjamin D.; Blanpain, Cedric			Distinct contribution of stem and progenitor cells to epidermal maintenance	NATURE			English	Article							HAIR FOLLICLE; MOUSE SKIN; IN-VIVO; LINEAGE; PROLIFERATION; HOMEOSTASIS; POPULATIONS; EXPRESSION; MODEL; UNITS	The skin interfollicular epidermis (IFE) is the first barrier against the external environment and its maintenance is critical for survival. Two seemingly opposite theories have been proposed to explain IFE homeostasis. One posits that IFE is maintained by long-lived slow-cycling stem cells that give rise to transit-amplifying cell progeny, whereas the other suggests that homeostasis is achieved by a single committed progenitor population that balances stochastic fate. Here we probe the cellular heterogeneity within the IFE using two different inducible Cre recombinase-oestrogen receptor constructs targeting IFE progenitors in mice. Quantitative analysis of clonal fate data and proliferation dynamics demonstrate the existence of two distinct proliferative cell compartments arranged in a hierarchy involving slow-cycling stem cells and committed progenitor cells. After wounding, only stem cells contribute substantially to the repair and long-term regeneration of the tissue, whereas committed progenitor cells make a limited contribution.	[Mascre, Guilhem; Dekoninck, Sophie; Drogat, Benjamin; Youssef, Khalil Kass; Brohee, Sylvain; Sotiropoulou, Panagiota A.; Blanpain, Cedric] Univ Libre Brussels, IRIBHM, B-1070 Brussels, Belgium; [Brohee, Sylvain] Univ Libre Brussels, Machine Learning Grp, B-1050 Brussels, Belgium; [Simons, Benjamin D.] Univ Cambridge, Cavendish Lab, Dept Phys, Cambridge CB3 0HE, England; [Simons, Benjamin D.] Univ Cambridge, Wellcome Trust, Canc Res UK Gurdon Inst, Cambridge CB2 1QN, England; [Blanpain, Cedric] Univ Libre Brussels, WELBIO, B-1070 Brussels, Belgium	Universite Libre de Bruxelles; Universite Libre de Bruxelles; University of Cambridge; Cancer Research UK; University of Cambridge; Wellcome Trust Sanger Institute; Universite Libre de Bruxelles; WELBIO	Blanpain, C (corresponding author), Univ Libre Brussels, IRIBHM, B-1070 Brussels, Belgium.	bds10@cam.ac.uk; cedric.blanpain@ulb.ac.be	Simons, Benjamin/AAY-8920-2020; Blanpain, Cedric/ABD-8392-2021; Youssef, Khalil Kass/AAB-6528-2021	Simons, Benjamin/0000-0002-3875-7071; Youssef, Khalil Kass/0000-0002-4572-3160; benjamin, Drogat/0000-0002-0020-4826	FRS/FNRS; TELEVIE; FNRS; program d'excellence CIBLES of the Wallonia Region; Fondation Contre le Cancer; ULB fondation; Gaston Ithier; European Research Council (ERC); EMBO Young Investigator Program; EPSRC [EP/F032773/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/F032773/1] Funding Source: researchfish	FRS/FNRS(Fonds de la Recherche Scientifique - FNRS); TELEVIE; FNRS(Fonds de la Recherche Scientifique - FNRS); program d'excellence CIBLES of the Wallonia Region; Fondation Contre le Cancer; ULB fondation; Gaston Ithier; European Research Council (ERC)(European Research Council (ERC)); EMBO Young Investigator Program(European Molecular Biology Organization (EMBO)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We thank F. Bollet-Quivogne and J.-M. Vanderwinden for their help with confocal imaging. C. B. and P. A. S. are chercheur qualifie, G. M. and S. B. are supported by fellowship of the FRS/FNRS. B. D. is supported by TELEVIE. C. B. is an investigator of WELBIO. This work was supported by the FNRS, the program d'excellence CIBLES of the Wallonia Region, a research grant from the Fondation Contre le Cancer, the ULB fondation, the fond Gaston Ithier, the European Research Council (ERC) and the EMBO Young Investigator Program.	Blanpain C, 2006, GENE DEV, V20, P3022, DOI 10.1101/gad.1477606; Blanpain C, 2009, NAT REV MOL CELL BIO, V10, P207, DOI 10.1038/nrm2636; Bonaguidi MA, 2011, CELL, V145, P1142, DOI 10.1016/j.cell.2011.05.024; Candi E, 2005, NAT REV MOL CELL BIO, V6, P328, DOI 10.1038/nrm1619; Clayton E, 2007, NATURE, V446, P185, DOI 10.1038/nature05574; COTSARELIS G, 1990, CELL, V61, P1329, DOI 10.1016/0092-8674(90)90696-C; COTSARELIS G, 1989, CELL, V57, P201, DOI 10.1016/0092-8674(89)90958-6; Diamond I, 2000, J INVEST DERMATOL, V115, P788, DOI 10.1046/j.1523-1747.2000.00144.x; Doupe DP, 2010, DEV CELL, V18, P317, DOI 10.1016/j.devcel.2009.12.016; Essers MAG, 2009, NATURE, V458, P904, DOI 10.1038/nature07815; Foudi A, 2009, NAT BIOTECHNOL, V27, P84, DOI 10.1038/nbt.1517; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Ghazizadeh S, 2001, EMBO J, V20, P1215, DOI 10.1093/emboj/20.6.1215; Ghazizadeh S, 2005, J INVEST DERMATOL, V124, P367, DOI 10.1111/j.0022-202X.2004.23599.x; Ito M, 2005, NAT MED, V11, P1351, DOI 10.1038/nm1328; JONES PH, 1995, CELL, V80, P83, DOI 10.1016/0092-8674(95)90453-0; JONES PH, 1993, CELL, V73, P713, DOI 10.1016/0092-8674(93)90251-K; Jones P, 2008, NAT REV MOL CELL BIO, V9, P82, DOI 10.1038/nrm2292x; Klein AM, 2011, DEVELOPMENT, V138, P3103, DOI 10.1242/dev.060103; Kolodka TM, 1998, P NATL ACAD SCI USA, V95, P4356, DOI 10.1073/pnas.95.8.4356; Langton AK, 2008, J INVEST DERMATOL, V128, P1311, DOI 10.1038/sj.jid.5701178; Lapouge G, 2011, P NATL ACAD SCI USA, V108, P7431, DOI 10.1073/pnas.1012720108; LAVKER RM, 1982, SCIENCE, V215, P1239, DOI 10.1126/science.7058342; Legg J, 2003, DEVELOPMENT, V130, P6049, DOI 10.1242/dev.00837; Levy V, 2007, FASEB J, V21, P1358, DOI 10.1096/fj.06-6926com; LOEFFLER M, 1987, VIRCHOWS ARCH B, V53, P286, DOI 10.1007/BF02890255; Mackenzie IC, 1997, J INVEST DERMATOL, V109, P377, DOI 10.1111/1523-1747.ep12336255; Mansson R, 2007, IMMUNITY, V26, P407, DOI 10.1016/j.immuni.2007.02.013; McCall MN, 2010, BIOSTATISTICS, V11, P242, DOI 10.1093/biostatistics/kxp059; MORRIS RJ, 1985, J INVEST DERMATOL, V84, P277, DOI 10.1111/1523-1747.ep12265358; Pina C, 2012, NAT CELL BIOL, V14, P287, DOI 10.1038/ncb2442; Potten C S, 1981, Int Rev Cytol, V69, P271; POTTEN CS, 1987, CELL TISSUE KINET, V20, P461, DOI 10.1111/j.1365-2184.1987.tb01355.x; POTTEN CS, 1987, VIRCHOWS ARCH B, V53, P279, DOI 10.1007/BF02890254; POTTEN CS, 1982, CELL TISSUE KINET, V15, P305, DOI 10.1111/j.1365-2184.1982.tb01050.x; Rangarajan A, 2001, EMBO J, V20, P3427, DOI 10.1093/emboj/20.13.3427; Ro S, 2005, EXP DERMATOL, V14, P838, DOI 10.1111/j.1600-0625.2005.00366.x; Ro S, 2004, EMBO REP, V5, P914, DOI 10.1038/sj.embor.7400218; Rocheteau P, 2012, CELL, V148, P112, DOI 10.1016/j.cell.2011.11.049; Snippert HJ, 2010, SCIENCE, V327, P1385, DOI 10.1126/science.1184733; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Takeda N, 2011, SCIENCE, V334, P1420, DOI 10.1126/science.1213214; Tani H, 2000, P NATL ACAD SCI USA, V97, P10960, DOI 10.1073/pnas.97.20.10960; Ting SB, 2005, SCIENCE, V308, P411, DOI 10.1126/science.1107511; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; Vasioukhin V, 1999, P NATL ACAD SCI USA, V96, P8551, DOI 10.1073/pnas.96.15.8551; Waghmare SK, 2008, EMBO J, V27, P1309, DOI 10.1038/emboj.2008.72; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Youssef KK, 2010, NAT CELL BIOL, V12, P299, DOI 10.1038/ncb2031; Zhang YV, 2010, CELL CYCLE, V9, P1504, DOI 10.4161/cc.9.8.11252; Zhang YV, 2009, CELL STEM CELL, V5, P267, DOI 10.1016/j.stem.2009.06.004	51	381	389	1	72	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 13	2012	489	7415					257	+		10.1038/nature11393	http://dx.doi.org/10.1038/nature11393			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003UC	22940863				2022-12-28	WOS:000308635900034
J	Wiersinga, WJ; Currie, BJ; Peacock, SJ				Wiersinga, W. Joost; Currie, Bart J.; Peacock, Sharon J.			Melioidosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							BURKHOLDERIA-PSEUDOMALLEI INFECTION; INTRACELLULAR LIFE-CYCLE; ANTIMICROBIAL RESISTANCE; SECRETION SYSTEM; T-CELLS; SUSCEPTIBILITY; EPIDEMIOLOGY; DISEASE; CEFTAZIDIME; ACTIVATION		[Wiersinga, W. Joost] Univ Amsterdam, Acad Med Ctr, Dept Med, Div Infect Dis, NL-1105 AZ Amsterdam, Netherlands; [Wiersinga, W. Joost] Univ Amsterdam, Acad Med Ctr, Ctr Expt & Mol Med, NL-1105 AZ Amsterdam, Netherlands; [Currie, Bart J.] Royal Darwin Hosp, Dept Infect Dis, Darwin, NT, Australia; [Currie, Bart J.] Royal Darwin Hosp, No Terr Med Program, Darwin, NT, Australia; [Currie, Bart J.] Menzies Sch Hlth Res, Global & Trop Hlth Div, Darwin, NT, Australia; [Peacock, Sharon J.] Mahidol Univ, Fac Trop Med, Bangkok, Thailand; [Peacock, Sharon J.] Univ Cambridge, Addenbrookes Hosp, Dept Med, Cambridge CB2 2QQ, England	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Charles Darwin University; Menzies School of Health Research; Mahidol University; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Wiersinga, WJ (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Med, Div Infect Dis, Meibergdreef 9,Rm G2-132, NL-1105 AZ Amsterdam, Netherlands.	w.j.wiersinga@amc.uva.nl	Peacock, Sharon J/ABE-6331-2020	Peacock, Sharon/0000-0002-1718-2782	Pfizer	Pfizer(Pfizer)	Dr. Peacock reports receiving consulting fees from Pfizer. No other potential conflict of interest relevant to this article was reported.	Allwood EM, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00170; [Anonymous], 2005, MMWR-MORBID MORTAL W, V55, P873; [Anonymous], 2012, MEL; Boddey JA, 2007, CELL MICROBIOL, V9, P514, DOI 10.1111/j.1462-5822.2006.00807.x; Burtnick MN, 2011, INFECT IMMUN, V79, P1512, DOI 10.1128/IAI.01218-10; Ceballos-Olvera I, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002452; Chantratita N, 2007, AM J TROP MED HYG, V77, P814, DOI 10.4269/ajtmh.2007.77.814; Chantratita N, 2011, P NATL ACAD SCI USA, V108, P17165, DOI 10.1073/pnas.1111020108; Chaowagul W, 1999, CLIN INFECT DIS, V29, P375, DOI 10.1086/520218; Cheng AC, 2008, AM J TROP MED HYG, V78, P208, DOI 10.4269/ajtmh.2008.78.208; Cheng AC, 2007, CLIN MICROBIOL REV, V20, P533, DOI 10.1128/CMR.00018-07; Chetchotisakd P, 2010, 6 WORLD MEL C TOWNSV; Chierakul W, 2005, AM J TROP MED HYG, V73, P1165, DOI 10.4269/ajtmh.2005.73.1165; Chierakul W, 2005, CLIN INFECT DIS, V41, P982, DOI 10.1086/432942; Christenson Bernard, 2003, Bol Asoc Med P R, V95, P17; Cruz-Migoni A, 2011, SCIENCE, V334, P821, DOI 10.1126/science.1211915; Cuadros J, 2011, AM J TROP MED HYG, V85, P282, DOI 10.4269/ajtmh.2011.11-0207; Currie Bart J, 2008, Trans R Soc Trop Med Hyg, V102 Suppl 1, pS1, DOI 10.1016/S0035-9203(08)70002-6; Currie BJ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000900; Currie BJ, 2000, T ROY SOC TROP MED H, V94, P301, DOI 10.1016/S0035-9203(00)90333-X; DANCE DAB, 1991, CLIN MICROBIOL REV, V4, P52, DOI 10.1128/CMR.4.1.52-60.1991; DeShazer D, 2007, FEMS MICROBIOL LETT, V277, P64, DOI 10.1111/j.1574-6968.2007.00946.x; Dorman SE, 1998, CLIN INFECT DIS, V26, P889, DOI 10.1086/513928; Easton A, 2007, J INFECT DIS, V195, P99, DOI 10.1086/509810; Estes DM, 2010, EXPERT REV ANTI-INFE, V8, P325, DOI [10.1586/eri.10.4, 10.1586/ERI.10.4]; French CT, 2011, P NATL ACAD SCI USA, V108, P12095, DOI 10.1073/pnas.1107183108; Gamage AM, 2011, MICROBIOL-SGM, V157, P1176, DOI 10.1099/mic.0.046540-0; Haque A, 2006, J INFECT DIS, V193, P370, DOI 10.1086/498983; Haque A, 2006, J INFECT DIS, V194, P1241, DOI 10.1086/508217; Harris P, 2011, INT J ANTIMICROB AG, V37, P547, DOI 10.1016/j.ijantimicag.2011.02.001; Holden MTG, 2004, P NATL ACAD SCI USA, V101, P14240, DOI 10.1073/pnas.0403302101; Inglis TJJ, 2006, AM J TROP MED HYG, V75, P947, DOI 10.4269/ajtmh.2006.75.947; Kaestli M, 2011, ENV MICROBIOL; Limmathurotsakul D, 2006, CLIN INFECT DIS, V43, P979, DOI 10.1086/507632; Limmathurotsakul D, 2010, AM J TROP MED HYG, V82, P1113, DOI 10.4269/ajtmh.2010.10-0038; Meumann EM, 2012, CLIN INFECT DIS, V54, P362, DOI 10.1093/cid/cir808; Miao EA, 2010, P NATL ACAD SCI USA, V107, P3076, DOI 10.1073/pnas.0913087107; Nandi T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000845; Ngauy V, 2005, J CLIN MICROBIOL, V43, P970, DOI 10.1128/JCM.43.2.970-972.2005; O'Sullivan BP, 2011, CHEST, V140, P239, DOI 10.1378/chest.10-3336; Pagnarith Y, 2010, AM J TROP MED HYG, V82, P1106, DOI 10.4269/ajtmh.2010.10-0030; Patel N, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00198; Peacock SJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001488; Pilatz S, 2006, INFECT IMMUN, V74, P3576, DOI 10.1128/IAI.01262-05; Price EP, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000725; Rholl DA, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00139; Richardson LJ, 2012, J MICROBIOL METH, V88, P179, DOI 10.1016/j.mimet.2011.10.023; Salam AP, 2011, EMERG INFECT DIS, V17, P1296, DOI [10.3201/eid1707.110502, 10.3201/eid1707.100502]; Schwarz S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001068; Schweizer HP, 2008, EMERG INFECT DIS, V14, P1689, DOI [10.3201/eid1411.080431, 10.3201/eid1407.071501]; Sim SH, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000178; Simpson AJH, 1999, CLIN INFECT DIS, V29, P381, DOI 10.1086/520219; Stevens MP, 2002, MOL MICROBIOL, V46, P649, DOI 10.1046/j.1365-2958.2002.03190.x; Stewart T, 2011, EMERG INFECT DIS, V17, P1286, DOI 10.3201/eid1707.100661; Sun GW, 2005, CELL MICROBIOL, V7, P1447, DOI 10.1111/j.1462-5822.2005.00569.x; SUTMO'LLER P., 1957, JOUR AMER VET MED ASSOC, V130, P415; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Trunck LA, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000519; Tumapa S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-190; Varughese S, 2011, TRANSPL INFECT DIS, V13, P95, DOI 10.1111/j.1399-3062.2010.00553.x; Werts C, 2001, NAT IMMUNOL, V2, P346, DOI 10.1038/86354; West TE, 2012, GENES IMMUN, V13, P38, DOI 10.1038/gene.2011.49; West TE, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-46; White NJ, 2003, LANCET, V361, P1715, DOI 10.1016/S0140-6736(03)13374-0; Wiersinga WJ, 2008, J THROMB HAEMOST, V6, P32; Wiersinga WJ, 2008, J INFECT DIS, V198, P1388, DOI 10.1086/592220; Wiersinga WJ, 2007, PLOS MED, V4, P1268, DOI 10.1371/journal.pmed.0040248; Wiersinga WJ, 2007, INFECT IMMUN, V75, P3739, DOI 10.1128/IAI.00080-07; Wiersinga WJ, 2006, NAT REV MICROBIOL, V4, P272, DOI 10.1038/nrmicro1385; Wuthiekanun V, 2006, AM J TROP MED HYG, V74, P1074, DOI 10.4269/ajtmh.2006.74.1074; Wuthiekanun V, 2011, ANTIMICROB AGENTS CH, V55, P5388, DOI 10.1128/AAC.05517-11	71	522	557	2	64	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 13	2012	367	11					1035	1044		10.1056/NEJMra1204699	http://dx.doi.org/10.1056/NEJMra1204699			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	003ZE	22970946				2022-12-28	WOS:000308649100010
J	Kelly, HW; Sternberg, AL; Lescher, R; Fuhlbrigge, AL; Williams, P; Zeiger, RS; Raissy, HH; Van Natta, ML; Tonascia, J; Strunk, RC				Kelly, H. William; Sternberg, Alice L.; Lescher, Rachel; Fuhlbrigge, Anne L.; Williams, Paul; Zeiger, Robert S.; Raissy, Hengameh H.; Van Natta, Mark L.; Tonascia, James; Strunk, Robert C.		CAMP Res Grp	Effect of Inhaled Glucocorticoids in Childhood on Adult Height	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LONG-TERM TREATMENT; ASTHMATIC-CHILDREN; FLUTICASONE PROPIONATE; BECLOMETHASONE DIPROPIONATE; LINEAR GROWTH; BONE-AGE; BUDESONIDE; CORTICOSTEROIDS; MILD; ADOLESCENTS	BACKGROUND The use of inhaled glucocorticoids for persistent asthma causes a temporary reduction in growth velocity in prepubertal children. The resulting decrease in attained height 1 to 4 years after the initiation of inhaled glucocorticoids is thought not to decrease attained adult height. METHODS We measured adult height in 943 of 1041 participants (90.6%) in the Childhood Asthma Management Program; adult height was determined at a mean (+/- SD) age of 24.9 +/- 2.7 years. Starting at the age of 5 to 13 years, the participants had been randomly assigned to receive 400 mu g of budesonide, 16 mg of nedocromil, or placebo daily for 4 to 6 years. We calculated differences in adult height for each active treatment group, as compared with placebo, using multiple linear regression with adjustment for demographic characteristics, asthma features, and height at trial entry. RESULTS Mean adult height was 1.2 cm lower (95% confidence interval [CI], -1.9 to -0.5) in the budesonide group than in the placebo group (P = 0.001) and was 0.2 cm lower (95% CI, -0.9 to 0.5) in the nedocromil group than in the placebo group (P = 0.61). A larger daily dose of inhaled glucocorticoid in the first 2 years was associated with a lower adult height (-0.1 cm for each microgram per kilogram of body weight) (P = 0.007). The reduction in adult height in the budesonide group as compared with the placebo group was similar to that seen after 2 years of treatment (-1.3 cm; 95% CI, -1.7 to -0.9). During the first 2 years, decreased growth velocity in the budesonide group occurred primarily in prepubertal participants. CONCLUSIONS The initial decrease in attained height associated with the use of inhaled glucocorticoids in prepubertal children persisted as a reduction in adult height, although the decrease was not progressive or cumulative. (Funded by the National Heart, Lung, and Blood Institute and the National Center for Research Resources; CAMP ClinicalTrials.gov number, NCT00000575.)	[Kelly, H. William; Raissy, Hengameh H.] Univ New Mexico, Albuquerque, NM 87131 USA; [Sternberg, Alice L.; Van Natta, Mark L.; Tonascia, James] Johns Hopkins Univ, Baltimore, MD USA; [Lescher, Rachel; Strunk, Robert C.] Washington Univ, St Louis, MO USA; [Lescher, Rachel] Alaska Native Med Ctr, Anchorage, AK USA; [Fuhlbrigge, Anne L.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Williams, Paul] Univ Washington, Seattle, WA 98195 USA; [Zeiger, Robert S.] Univ Calif San Diego, San Diego, CA 92103 USA; [Zeiger, Robert S.] Kaiser Permanente So Calif Reg, San Diego, CA USA	University of New Mexico; Johns Hopkins University; Washington University (WUSTL); Alaska Native Medical Center; Harvard University; Brigham & Women's Hospital; University of Washington; University of Washington Seattle; University of California System; University of California San Diego; Kaiser Permanente	Kelly, HW (corresponding author), 9828 Guadalupe Trail NW, Albuquerque, NM 87114 USA.	hwkelly@salud.unm.edu	; Menendez, Rosario/G-9723-2016	Williams, Paul/0000-0003-3300-1328; Menendez, Rosario/0000-0002-3592-3839; Zeiger, Robert/0000-0001-5788-5063	National Center for Research Resources [M01RR00051, M01RR0099718-24, M01RR02719-14, RR00036]; National Heart, Lung, and Blood Institute [NO1-HR-16044, 16045, 16046, 16047, 16048, 16049, 16050, 16051, 16052, U01HL075232, U01HL075407, U01HL075408, U01HL075409, U01HL075415, U01HL075416, U01HL075417, U01HL075419, U01HL075420]; AstraZeneca; GlaxoSmithKline; Merck; Novartis; Dmagi; Lovelace Respiratory Research Institute; Sunovion; Aerocrine; Genentech; MedImmune; Schering-Plough; Thermo- fisher; DIVISION OF LUNG DISEASES [N01HR016049, N01HR016051, N01HR016050, N01HR016052, N01HR016047, N01HR016044, N01HR016046, N01HR016045, N01HR016048] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000041] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR002719, M01RR000036, M01RR000051] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL075416, U01HL075409, U01HL075419, U01HL075408, U01HL075420, U01HL075232, U01HL075415, U01HL075407, U01HL075417] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); AstraZeneca(AstraZeneca); GlaxoSmithKline(GlaxoSmithKline); Merck(Merck & Company); Novartis(Novartis); Dmagi; Lovelace Respiratory Research Institute; Sunovion; Aerocrine; Genentech(Roche HoldingGenentech); MedImmune(AstraZenecaMedimmune); Schering-Plough(Merck & CompanySchering Plough Corporation); Thermo- fisher; DIVISION OF LUNG DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by contracts with the National Heart, Lung, and Blood Institute (NO1-HR-16044, 16045, 16046, 16047, 16048, 16049, 16050, 16051, and 16052) and General Clinical Research Center grants from the National Center for Research Resources (M01RR00051, M01RR0099718-24, M01RR02719-14, and RR00036). Phases 2 and 3 of the CAMP Continuation Study were supported by grants from the National Heart, Lung, and Blood Institute (U01HL075232, U01HL075407, U01HL075408, U01HL075409, U01HL075415, U01HL075416, U01HL075417, U01HL075419, U01HL075420, and U01HL075408).; Dr. Kelly reports serving on steering committees for and receiving consulting fees from AstraZeneca, GlaxoSmithKline, Merck, and Novartis; Dr. Fuhlbrigge, receiving consulting fees from Merck, GlaxoSmithKline, Dmagi, Lovelace Respiratory Research Institute, and Sunovion and serving as a member of an adjudication committee for studies sponsored by AstraZeneca, GlaxoSmithKline, Merck, and Novartis; Dr. Williams, receiving lecture fees from GlaxoSmithKline; and Dr. Zeiger, serving on a steering committee for a study sponsored by GlaxoSmithKline and receiving consulting fees from Aerocrine, AstraZeneca, Genentech, GlaxoSmithKline, MedImmune, Novartis, Schering-Plough, and Sunovion and grant support from Aerocrine, Genentech, GlaxoSmithKline, MedImmune, Merck, and Thermo- fisher. No other potential conflict of interest relevant to this article was reported.	Acun C, 2005, ALLERGY ASTHMA PROC, V26, P204; Agertoft L, 2000, NEW ENGL J MED, V343, P1064, DOI 10.1056/NEJM200010123431502; Allen DB, 1998, J PEDIATR-US, V132, P472, DOI 10.1016/S0022-3476(98)70023-X; [Anonymous], 2011, STAT MULT IMP REF MA; [Anonymous], 2007, EPR3 NAT I HLTH NAT; Cherniack R, 1999, CONTROL CLIN TRIALS, V20, P91; de Benedictis FM, 2001, ARCH PEDIAT ADOL MED, V155, P1248; Diggle P., 2002, ANAL LONGITUDINAL DA, DOI DOI 10.2307/2983303; FERGUSON AC, 1982, J ALLERGY CLIN IMMUN, V69, P461, DOI 10.1016/0091-6749(82)90122-1; Ferguson AC, 2007, RESP MED, V101, P118, DOI 10.1016/j.rmed.2006.04.009; Fine RN, 2000, PEDIATR NEPHROL, V14, P679, DOI 10.1007/s004670000383; Guilbert TW, 2006, NEW ENGL J MED, V354, P1985, DOI 10.1056/NEJMoa051378; Inoue T, 1999, J ASTHMA, V36, P159, DOI 10.3109/02770909909056312; Kelly HW, 2009, ANN PHARMACOTHER, V43, P519, DOI 10.1345/aph.1L546; Larsson L, 2002, PHARMACOEPIDEM DR S, V11, P715, DOI 10.1002/pds.762; Lee JJ, 2010, INFLAMM BOWEL DIS, V16, P1669, DOI 10.1002/ibd.21214; MURRAY AB, 1976, LANCET, V2, P197; Patel L, 1998, ARCH DIS CHILD, V79, P169, DOI 10.1136/adc.79.2.169; Pauwels RA, 2003, LANCET, V361, P1071, DOI 10.1016/S0140-6736(03)12891-7; Pedersen S, 2006, DRUG SAFETY, V29, P599, DOI 10.2165/00002018-200629070-00005; SEARLE SR, 1980, AM STAT, V34, P216, DOI 10.2307/2684063; Sharek PJ, 2000, PEDIATRICS, V106, DOI 10.1542/peds.106.1.e8; Silverstein MD, 1997, J ALLERGY CLIN IMMUN, V99, P466, DOI 10.1016/S0091-6749(97)70072-1; Skoner DP, 2011, J ASTHMA, V48, P848, DOI 10.3109/02770903.2011.604883; SNYDER RD, 1967, CLIN PEDIATR, V6, P389, DOI 10.1177/000992286700600705; Strunk RC, 2009, J PEDIATR-US, V154, P682, DOI 10.1016/j.jpeds.2008.11.036; Szefler S, 2000, NEW ENGL J MED, V343, P1054; TANNER JM, 1983, ARCH DIS CHILD, V58, P767, DOI 10.1136/adc.58.10.767; TANNER JM, 1975, ARCH DIS CHILD, V50, P14, DOI 10.1136/adc.50.1.14; TINKELMAN DG, 1993, PEDIATRICS, V92, P64; Tukey J. W., 1977, EXPLORATORY DATA ANA; Van Bever HP, 1999, PEDIATR PULM, V27, P369, DOI 10.1002/(SICI)1099-0496(199906)27:6<369::AID-PPUL2>3.3.CO;2-S; Verberne AAPH, 1997, AM J RESP CRIT CARE, V156, P688, DOI 10.1164/ajrccm.156.3.9611067	33	259	283	1	41	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 6	2012	367	10					904	912		10.1056/NEJMoa1203229	http://dx.doi.org/10.1056/NEJMoa1203229			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	999VO	22938716	Green Accepted, Green Published			2022-12-28	WOS:000308343300007
J	Kim, YH; Heo, JS; Kim, TH; Park, S; Yoon, MH; Kim, J; Oh, MS; Yi, GR; Noh, YY; Park, SK				Kim, Yong-Hoon; Heo, Jae-Sang; Kim, Tae-Hyeong; Park, Sungjun; Yoon, Myung-Han; Kim, Jiwan; Oh, Min Suk; Yi, Gi-Ra; Noh, Yong-Young; Park, Sung Kyu			Flexible metal-oxide devices made by room-temperature photochemical activation of sol-gel films	NATURE			English	Article							HIGH-PERFORMANCE; TRANSISTORS; FABRICATION; ELECTRONICS; STABILITY; CIRCUITS; ZNO	Amorphous metal-oxide semiconductors have emerged as potential replacements for organic and silicon materials in thin-film electronics. The high carrier mobility in the amorphous state, and excellent large-area uniformity, have extended their applications to active-matrix electronics, including displays, sensor arrays and X-ray detectors(1-7). Moreover, their solution processability and optical transparency have opened new horizons for low-cost printable and transparent electronics on plastic substrates(8-13). But metal-oxide formation by the sol-gel route requires an annealing step at relatively high temperature(2,14-19), which has prevented the incorporation of these materials with the polymer substrates used in high-performance flexible electronics. Here we report a general method for forming high-performance and operationally stable metal-oxide semiconductors at room temperature, by deep-ultraviolet photochemical activation of sol-gel films. Deep-ultraviolet irradiation induces efficient condensation and densification of oxide semicon-ducting films by photochemical activation at low temperature. This photochemical activation is applicable to numerous metal-oxide semiconductors, and the performance (in terms of transistor mobility and operational stability) of thin-film transistors fabricated by this route compares favourably with that of thin-film transistors based on thermally annealed materials. The field-effect mobilities of the photo-activated metal-oxide semiconductors are as high as 14 and 7 cm(2) V-1 s(-1) (with an Al2O3 gate insulator) on glass and polymer substrates, respectively; and seven-stage ring oscillators fabricated on polymer substrates operate with an oscillation frequency of more than 340 kHz, corresponding to a propagation delay of less than 210 nanoseconds per stage.	[Heo, Jae-Sang; Park, Sung Kyu] Chung Ang Univ, Sch Elect & Elect Engn, Seoul 156756, South Korea; [Kim, Yong-Hoon; Kim, Tae-Hyeong; Kim, Jiwan; Oh, Min Suk] Korea Elect Technol Inst, Flexible Display Res Ctr, Songnam 463816, South Korea; [Park, Sungjun; Yoon, Myung-Han] Gwangju Inst Sci & Technol, Sch Mat Sci & Engn, Kwangju 500712, South Korea; [Yoon, Myung-Han] World Class Univ, Gwangju Inst Sci & Technol, Dept Nanobio Mat & Elect, Kwangju 500712, South Korea; [Yi, Gi-Ra] Sungkyunkwan Univ, Dept Polymer Sci & Engn, Suwon 440746, South Korea; [Noh, Yong-Young] Hanbat Natl Univ, Dept Chem Engn, Taejon 305719, South Korea	Chung Ang University; Korea Electronics Technology Institute (KETI); Gwangju Institute of Science & Technology (GIST); Gwangju Institute of Science & Technology (GIST); Sungkyunkwan University (SKKU); Hanbat National University	Park, SK (corresponding author), Chung Ang Univ, Sch Elect & Elect Engn, Seoul 156756, South Korea.	skpark@cau.ac.kr	Noh, Yong-Young/C-4423-2008; Kim, Jiwan/AAL-2162-2021; Kim, Yong-Hoon/AAC-5500-2022; Noh, Yong-Young/C-7210-2014; park, sung kyu/H-5338-2011; NOH, YONG-YOUNG/AHB-1910-2022; Yi, Gi-Ra/E-5592-2010	Noh, Yong-Young/0000-0001-7222-2401; Kim, Jiwan/0000-0002-1727-5786; park, sung kyu/0000-0001-9617-2541; Yi, Gi-Ra/0000-0003-1353-8988; Park, Sungjun/0000-0001-9603-902X	Basic Science Research Program [2010-0002623]; World-Class University Program through a National Research Foundation of Korea (NRF) [R31-10026]; Ministry of Education, Science, and Technology	Basic Science Research Program; World-Class University Program through a National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	We acknowledge discussions with C.-I. Kim, S.-H. Song, H.-I. Kwon, B.-S. Bae, Y. Hong, S. Lim, J.-I. Han, M. J. Lee, A. Fenoglio and K.-H. Kim. This work was partially supported by Basic Science Research Program (no. 2010-0002623) and World-Class University Program (no. R31-10026) through a National Research Foundation of Korea (NRF) grant funded by the Ministry of Education, Science, and Technology.	Adamopoulos G, 2011, ADV MATER, V23, P1894, DOI 10.1002/adma.201003935; Briseno AL, 2006, NATURE, V444, P913, DOI 10.1038/nature05427; Cao Q, 2008, NATURE, V454, P495, DOI 10.1038/nature07110; Cho EN, 2011, IEEE T DEVICE MAT RE, V11, P112, DOI 10.1109/TDMR.2010.2096508; Choi HS, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3658460; Clark T, 2000, CHEM MATER, V12, P3879, DOI 10.1021/cm000456f; Dusastre V, 2010, MAT SUSTAINABLE ENER; Facchetti A., 2010, TRANSPARENT ELECT; Han SY, 2011, J AM CHEM SOC, V133, P5166, DOI 10.1021/ja104864j; Hwang S, 2011, THIN SOLID FILMS, V519, P5146, DOI 10.1016/j.tsf.2011.01.074; Imai H, 1999, J APPL PHYS, V85, P203, DOI 10.1063/1.369471; Imai H, 2005, HANDBOOK OF SOL-GEL SCIENCE AND TECHNOLOGY: PROCESSING CHARACTERIZATION AND APPLICATIONS, VOL. I: SOL-GEL PROCESSING, P639; Jeon S, 2011, ACS APPL MATER INTER, V3, P1, DOI 10.1021/am1009088; Jeong S, 2010, ADV MATER, V22, P1346, DOI 10.1002/adma.200902450; Kamiya T, 2010, SCI TECHNOL ADV MAT, V11, DOI 10.1088/1468-6996/11/4/044305; Kim KM, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3665912; Kim MG, 2011, NAT MATER, V10, P382, DOI [10.1038/nmat3011, 10.1038/NMAT3011]; Kim YH, 2012, IEEE ELECTR DEVICE L, V33, P50, DOI 10.1109/LED.2011.2171913; Kim YH, 2010, IEEE T ELECTRON DEV, V57, P1009, DOI 10.1109/TED.2010.2043179; Klauk H., 2006, ORGANIC ELECT MAT MA; Lim W, 2010, J VAC SCI TECHNOL B, V28, P116, DOI 10.1116/1.3276774; Meyers ST, 2008, J AM CHEM SOC, V130, P17603, DOI 10.1021/ja808243k; Nomura K, 2004, NATURE, V432, P488, DOI 10.1038/nature03090; Park YM, 2011, ADV MATER, V23, P971, DOI 10.1002/adma.201003641; Sekitani T, 2010, NAT MATER, V9, P1015, DOI 10.1038/NMAT2896; Son KS, 2010, IEEE ELECTR DEVICE L, V31, P812, DOI 10.1109/LED.2010.2050294; VANDELEEST RE, 1995, APPL SURF SCI, V86, P278, DOI 10.1016/0169-4332(94)00398-X; Wager JF, 2003, SCIENCE, V300, P1245, DOI 10.1126/science.1085276; Yang S, 2011, IEEE ELECTR DEVICE L, V32, P1692, DOI 10.1109/LED.2011.2167122	29	846	861	28	1139	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 6	2012	489	7414					128	U191		10.1038/nature11434	http://dx.doi.org/10.1038/nature11434			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999WW	22955624				2022-12-28	WOS:000308347000048
J	Yang, LC; Rieves, D; Ganley, C				Yang, Lucie; Rieves, Dwaine; Ganley, Charles			Brain Amyloid Imaging - FDA Approval of Florbetapir F18 Injection	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Yang, Lucie; Rieves, Dwaine] Food & Drug Adm, Ctr Drug Evaluat & Res, Div Med Imaging Prod, Silver Spring, MD USA; [Ganley, Charles] Food & Drug Adm, Ctr Drug Evaluat & Res, Off New Drugs, Silver Spring, MD USA; [Ganley, Charles] Food & Drug Adm, Ctr Drug Evaluat & Res, Off Drug Evaluat 4, Silver Spring, MD USA	US Food & Drug Administration (FDA); US Food & Drug Administration (FDA); US Food & Drug Administration (FDA)	Yang, LC (corresponding author), Food & Drug Adm, Ctr Drug Evaluat & Res, Div Med Imaging Prod, Silver Spring, MD USA.							[Anonymous], 2011, PROM BRAIN HLTH; [Anonymous], HIGHL PRESCR INF AM; Department of Energy National Energy Technology Laboratory, 2004, GUID US ANT AG HIV 1, P2; Lister-James J, 2011, SEMIN NUCL MED, V41, P300, DOI 10.1053/j.semnuclmed.2011.03.001; Okie S, 2011, NEW ENGL J MED, V365, P1069, DOI 10.1056/NEJMp1107288	5	125	127	0	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 6	2012	367	10					885	887		10.1056/NEJMp1208061	http://dx.doi.org/10.1056/NEJMp1208061			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	999VO	22931256	Bronze			2022-12-28	WOS:000308343300002
J	Althoff, KN; Buchacz, K; Hall, HI; Zhang, JB; Hanna, DB; Rebeiro, P; Gange, SJ; Moore, RD; Kitahata, MM; Gebo, KA; Martin, J; Justice, AC; Horberg, MA; Hogg, RS; Sterling, TR; Cescon, A; Klein, MB; Thorne, JE; Crane, HM; Mugavero, MJ; Napravnik, S; Kirk, GD; Jacobson, LP; Brooks, JT				Althoff, Keri N.; Buchacz, Kate; Hall, H. Irene; Zhang, Jinbing; Hanna, David B.; Rebeiro, Peter; Gange, Stephen J.; Moore, Richard D.; Kitahata, Mari M.; Gebo, Kelly A.; Martin, Jeffrey; Justice, Amy C.; Horberg, Michael A.; Hogg, Robert S.; Sterling, Timothy R.; Cescon, Angela; Klein, Marina B.; Thorne, Jennifer E.; Crane, Heidi M.; Mugavero, Michael J.; Napravnik, Sonia; Kirk, Gregory D.; Jacobson, Lisa P.; Brooks, John T.		N Amer AIDS Cohort Collaboration	US Trends in Antiretroviral Therapy Use, HIV RNA Plasma Viral Loads, and CD4 T-Lymphocyte Cell Counts Among HIV-Infected Persons, 2000 to 2008	ANNALS OF INTERNAL MEDICINE			English	Article							UNITED-STATES; VIROLOGICAL RESPONSES; CLINICAL COHORT; MEDICAL-CARE; AIDS; ADULTS; IMMUNODEFICIENCY; MORTALITY; HAART; DEATH	Background: The U.S. National HIV/AIDS Strategy targets for 2015 include "increasing access to care and improving health outcomes for persons living with HIV in the United States" (PLWH-US). Objective: To demonstrate the utility of the NA-ACCORD (North American AIDS Cohort Collaboration on Research and Design) for monitoring trends in the HIV epidemic in the United States and to present trends in HIV treatment and related health outcomes. Design: Trends from annual cross-sectional analyses comparing patients from pooled, multicenter, prospective, clinical HIV cohort studies with PLWH-US, as reported to national surveillance systems in 40 states. Setting: U.S. HIV outpatient clinics. Patients: HIV-infected adults with 1 or more HIV RNA plasma viral load (HIV VL) or CD4 T-lymphocyte (CD4) cell count measured in any calendar year from 1 January 2000 to 31 December 2008. Measurements: Annual rates of antiretroviral therapy use, HIV VL, and CD4 cell count at death. Results: 45 529 HIV-infected persons received care in an NA-ACCORD-participating U.S. clinical cohort from 2000 to 2008. In 2008, the 26 030 NA-ACCORD participants in care and the 655 966 PLWH-US had qualitatively similar demographic characteristics. From 2000 to 2008, the proportion of participants prescribed highly active antiretroviral therapy increased by 9 percentage points to 83% (P < 0.001), whereas the proportion with suppressed HIV VL (<= 2.7 log(10) copies/mL) increased by 26 percentage points to 72% (P < 0.001). Median CD4 cell count at death more than tripled to 0.209 x 10(9) cells/L (P < 0.001). Limitation: The usual limitations of observational data apply. Conclusion: The NA-ACCORD is the largest cohort of HIV-infected adults in clinical care in the United States that is demographically similar to PLWH-US in 2008. From 2000 to 2008, increases were observed in the percentage of prescribed HAART, the percentage who achieved a suppressed HIV VL, and the median CD4 cell count at death. Primary Funding Source: National Institutes of Health; Centers for Disease Control and Prevention; Canadian Institutes of Health Research; Canadian HIV Trials Network; and the government of British Columbia, Canada.	Johns Hopkins Univ, Baltimore, MD USA; Ctr Dis Control & Prevent, Atlanta, GA 30333 USA; Univ Washington, Seattle, WA 98104 USA; Univ Calif San Francisco, San Francisco, CA 94143 USA; Yale Univ, New Haven, CT USA; Vet Affairs Connecticut Healthcare Syst, New Haven, CT USA; Mid Atlantic Permanente Res Inst, Rockville, MD 20852 USA; British Columbia Ctr Excellence HIV AIDS, Vancouver, BC, Canada; Simon Fraser Univ, Vancouver, BC, Canada; Vanderbilt Univ, Nashville, TN 37232 USA; McGill Univ, Montreal, PQ H2X 2P4, Canada; Univ Alabama Birmingham, Birmingham, AL 35294 USA; Univ N Carolina, Chapel Hill, NC 27599 USA	Johns Hopkins University; Centers for Disease Control & Prevention - USA; University of Washington; University of Washington Seattle; University of California System; University of California San Francisco; Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; B.C. Centre for Excellence in HIV/AIDS; Simon Fraser University; Vanderbilt University; McGill University; University of Alabama System; University of Alabama Birmingham; University of North Carolina; University of North Carolina Chapel Hill	Althoff, KN (corresponding author), 615 N Wolfe St,Room E-7142, Baltimore, MD 21231 USA.	kalthoff@jhsph.edu	Althoff, Keri N/HGC-5595-2022; Gange, Stephen/AGY-5004-2022; Gebo, Kelly/AHA-7533-2022	Gange, Stephen/0000-0001-7842-512X; Gebo, Kelly/0000-0003-4010-398X; Hogg, Robert/0000-0003-3463-5488; Althoff, Keri/0000-0002-5068-6595; Jacobson, Lisa P./0000-0003-1722-6826; Klein, Marina/0000-0002-3063-8430; Rebeiro, Peter/0000-0003-1951-9104	National Institutes of Health [M01-RR025747, P30-AI27757, P30-AI27767, P30-AI27763, P30-AI50410, P30-AI54999, R01-DA04334, R01-DA12568, R01-DA11602, R01-AA16893, R24-AI067039, Z01-CP010176, AHQ290-01-0012, N02-CP55504, AI-69432, AI-69434, K01-AI071725]; CDC [CDC200-2006-18797]; Canadian Institutes of Health Research [TGF-96118, HCP-97105, CBR-86906, CBR-94036, KRS-86251, 169621]; Canadian HIV Trials Network [24]; government of British Columbia; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U01HD032632] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [Z01CP010176] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025747, M01RR000071, M01RR000079, M01RR000083, M01RR000052, UL1RR024131, M01RR000722] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [U10EY008052, U10EY008067, U10EY008057, K23EY013707] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI069432, U01AI035040, U01AI034994, P30AI094189, P30AI050410, U01AI035039, U01AI068634, U01AI034989, U01AI034993, U01AI042590, UM1AI069432, U01AI035041, P30AI027763, U01AI037613, U01AI035043, U01AI038855, U01AI031834, U01AI038858, U01AI035004, P30AI027757, P30AI054999, U01AI037984, U01AI069918, P30AI027767, K01AI071725, UM1AI069434, U01AI035042, U01AI068636, U01AI069434, R24AI067039, K01AI093197] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA016893, U10AA013566, R21AA015032] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA012568, F31DA030254, R01DA011602, K24DA000432, R01DA004334] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CDC(Centre National de la Recherche Scientifique (CNRS)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian HIV Trials Network; government of British Columbia; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	By grants U01-AI069918, U10-AA13566, U01-AI31834, U01-AI34989, U01-AI34993, U01-AI34994, U01-AI35004, U01-AI35039, U01-AI35040, U01-AI35041, U01-AI35042, U01AI35043, U01-AI37613, U01-AI37984, U01-AI38855, U01-AI38858, U01-AI42590, U01-AI68634, U01-AI68636, U01-HD32632, U10-EY08057, U10-EY08052, U10-EY08067, UL1-RR024131, UL1-RR024131, M01-RR-00052, M01-RR00071, M01-RR00079, M01-RR00083, M01-RR00722, M01-RR025747, P30-AI27757, P30-AI27767, P30-AI27763, P30-AI50410, P30-AI54999, R01-DA04334, R01-DA12568, R01-DA11602, R01-AA16893, R24-AI067039, Z01-CP010176, AHQ290-01-0012, N02-CP55504, AI-69432, AI-69434, K01-AI071725, K23-AI610320, K23-EY013707, K24-DA00432, K01-AI093197 (Dr. Althoff) and F31-DA30254 (Mr. Hanna) from the National Institutes of Health; contract CDC200-2006-18797 from the CDC; grants TGF-96118, HCP-97105, CBR-86906, CBR-94036, KRS-86251, and 169621 from the Canadian Institutes of Health Research; the Canadian HIV Trials Network, project 24; and the government of British Columbia. The CDC funds all U.S. states and the District of Columbia to conduct HIV surveillance and provides technical assistance to all funded areas. Participating investigators and contributors are CDC employees. Employees of the CDC conducted the surveillance data analyses, and the report was reviewed and approved by the CDC.	Althoff KN, 2010, CLIN INFECT DIS, V50, P1512, DOI 10.1086/652650; [Anonymous], 2010, NAT HIV AIDS STRAT U; Baeten JM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001888; Belperio PS, 2010, HIV MED, V11, P209, DOI 10.1111/j.1468-1293.2009.00764.x; Blair Janet M., 2011, Morbidity and Mortality Weekly Report, V60, P1; Bozzette SA, 1998, NEW ENGL J MED, V339, P1897, DOI 10.1056/NEJM199812243392606; *CDCP, 2005, HIV AIDS SURVEILLA S, V11, P1; Centers for Disease Control and Prevention, 2011, HIV SURV REP 2009, V21; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Cole SR, 2010, AM J EPIDEMIOL, V172, P107, DOI 10.1093/aje/kwq084; Das M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011068; Gandhi NR, 2007, MED CARE, V45, P1105, DOI 10.1097/MLR.0b013e3181271476; Gange SJ, 2007, INT J EPIDEMIOL, V36, P294, DOI 10.1093/ije/dyl286; Gardner EM, 2011, CLIN INFECT DIS, V52, P793, DOI 10.1093/cid/ciq243; Gay CL, 2006, AIDS, V20, P775, DOI 10.1097/01.aids.0000216380.30055.4a; Hall HI, 2012, JAIDS-J ACQ IMM DEF, V60, P77, DOI 10.1097/QAI.0b013e318249fe90; Henrich TJ, 2008, J COMMUN HEALTH, V33, P69, DOI 10.1007/s10900-007-9069-1; Hogg R, 2008, LANCET, V372, P293, DOI 10.1016/S0140-6736(08)61113-7; HOLFORD TR, 1991, ANNU REV PUBL HEALTH, V12, P425, DOI 10.1146/annurev.pu.12.050191.002233; Howe CJ, 2010, AIDS RES HUM RETROV, V26, P875, DOI 10.1089/aid.2009.0282; Hughes JP, 1999, BIOMETRICS, V55, P625, DOI 10.1111/j.0006-341X.1999.00625.x; Kelley CF, 2009, CLIN INFECT DIS, V48, P787, DOI 10.1086/597093; Keruly JC, 2007, CLIN INFECT DIS, V45, P1369, DOI 10.1086/522759; Lau B, 2007, AIDS RES HUM RETROV, V23, P769, DOI 10.1089/aid.2006.0171; Lau B, 2007, JAIDS-J ACQ IMM DEF, V44, P179, DOI 10.1097/01.qai.0000247229.68246.c5; Leone S, 2011, INFECTION, V39, P13, DOI 10.1007/s15010-010-0079-z; Lifson AR, 2011, AIDS RES THER, V8, DOI 10.1186/1742-6405-8-2; Lok JJ, 2010, AIDS, V24, P1867, DOI 10.1097/QAD.0b013e32833adbcf; Losina E, 2009, CLIN INFECT DIS, V49, P1570, DOI 10.1086/644772; Marin B, 2009, AIDS, V23, P1743, DOI 10.1097/QAD.0b013e32832e9b78; McGowan CC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018462; McNaghten AD, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000550; Mehta SH, 2007, AIDS CARE, V19, P637, DOI 10.1080/09540120701235644; Montaner JSG, 2010, LANCET, V376, P532, DOI 10.1016/S0140-6736(10)60936-1; Moore RD, 2007, CLIN INFECT DIS, V44, P441, DOI 10.1086/510746; Pacheco AG, 2009, JAIDS-J ACQ IMM DEF, V51, P624, DOI 10.1097/QAI.0b013e3181a4ecf5; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Prejean J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017502; Sackoff JE, 2006, ANN INTERN MED, V145, P397, DOI 10.7326/0003-4819-145-6-200609190-00003; Scott JD, 2009, AIDS PATIENT CARE ST, V23, P925, DOI 10.1089/apc.2009.0099; Seal PS, 2011, J GEN INTERN MED, V26, P745, DOI 10.1007/s11606-011-1693-x; Shapiro MF, 1999, JAMA-J AM MED ASSOC, V281, P2305, DOI 10.1001/jama.281.24.2305; Silverberg MJ, 2009, J GEN INTERN MED, V24, P1065, DOI 10.1007/s11606-009-1049-y; Thiebaut R, 2004, COMPUT METH PROG BIO, V74, P255, DOI 10.1016/j.cmpb.2003.08.004; Torian Lucia, 2011, Morbidity and Mortality Weekly Report, V60, P689; Wood E, 2003, CAN MED ASSOC J, V169, P656; Worm SW, 2010, AIDS, V24, P1537, DOI 10.1097/QAD.0b013e32833a0918	47	91	91	0	18	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 4	2012	157	5					325	U63		10.7326/0003-4819-157-5-201209040-00005	http://dx.doi.org/10.7326/0003-4819-157-5-201209040-00005			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	000BM	22944874	Green Accepted, Green Submitted			2022-12-28	WOS:000308361500003
J	Einstein, DJ				Einstein, David J.			ON BEING A DOCTOR Knot	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Tufts Med Ctr, Boston, MA 02111 USA	Tufts Medical Center	Einstein, DJ (corresponding author), Tufts Med Ctr, 800 Washington St, Boston, MA 02111 USA.	deinstein@tuftsmedicalcenter.org	Einstein, David/ABB-3748-2020						0	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 4	2012	157	5					381	382		10.7326/0003-4819-157-5-201209040-00012	http://dx.doi.org/10.7326/0003-4819-157-5-201209040-00012			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	000BM	22944877				2022-12-28	WOS:000308361500009
J	Cheng, L; Booker, FL; Tu, C; Burkey, KO; Zhou, LS; Shew, HD; Rufty, TW; Hu, SJ				Cheng, Lei; Booker, Fitzgerald L.; Tu, Cong; Burkey, Kent O.; Zhou, Lishi; Shew, H. David; Rufty, Thomas W.; Hu, Shuijin			Arbuscular Mycorrhizal Fungi Increase Organic Carbon Decomposition Under Elevated CO2	SCIENCE			English	Article							SOIL MICROBIAL COMMUNITY; RESIDUE DECOMPOSITION; NITROGEN LIMITATION; EXTERNAL HYPHAE; ASSIMILATION; AGGREGATION; ACQUISITION; GRASSLAND; FEEDBACKS; BACTERIA	The extent to which terrestrial ecosystems can sequester carbon to mitigate climate change is a matter of debate. The stimulation of arbuscular mycorrhizal fungi (AMF) by elevated atmospheric carbon dioxide (CO2) has been assumed to be a major mechanism facilitating soil carbon sequestration by increasing carbon inputs to soil and by protecting organic carbon from decomposition via aggregation. We present evidence from four independent microcosm and field experiments demonstrating that CO2 enhancement of AMF results in considerable soil carbon losses. Our findings challenge the assumption that AMF protect against degradation of organic carbon in soil and raise questions about the current prediction of terrestrial ecosystem carbon balance under future climate-change scenarios.	[Cheng, Lei; Tu, Cong; Zhou, Lishi; Shew, H. David; Hu, Shuijin] N Carolina State Univ, Dept Plant Pathol, Raleigh, NC 27695 USA; [Booker, Fitzgerald L.; Burkey, Kent O.] ARS, USDA, Plant Sci Res Unit, Raleigh, NC 27607 USA; [Booker, Fitzgerald L.; Burkey, Kent O.; Rufty, Thomas W.] N Carolina State Univ, Dept Crop Sci, Raleigh, NC 27695 USA; [Zhou, Lishi] Chinese Acad Sci, State Key Lab Vegetat & Environm Change, Inst Bot, Beijing 100093, Peoples R China	University of North Carolina; North Carolina State University; United States Department of Agriculture (USDA); University of North Carolina; North Carolina State University; Chinese Academy of Sciences; Institute of Botany, CAS	Hu, SJ (corresponding author), N Carolina State Univ, Dept Plant Pathol, Box 7616, Raleigh, NC 27695 USA.	shuijin_hu@ncsu.edu	Cheng, lei/E-6307-2013; Tu, Cong/H-9750-2013	Hu, Shuijin/0000-0002-3225-5126; Cheng, Lei/0000-0002-5486-3632	U.S. Department of Agriculture (USDA)-Agricultural Research Service Plant Science Research Unit (Raleigh, NC); USDA [2009-35101-05351]	U.S. Department of Agriculture (USDA)-Agricultural Research Service Plant Science Research Unit (Raleigh, NC); USDA(United States Department of Agriculture (USDA))	We thank F. Chapin III, D. Coleman, Y. Luo, R. Miller, and M. Rillig for valuable comments; M. Gumpertz for advice on statistical analyses; J. Barton, W. Pursley, and E. Silva for technical assistance; and D. Watson and J. Morton for providing mycorrhizal inoculum. L. C. was primarily supported by a fellowship from U.S. Department of Agriculture (USDA)-Agricultural Research Service Plant Science Research Unit (Raleigh, NC) and in part by a USDA grant to S. H. (2009-35101-05351). S. H., L. C. and C. T. conceived experiments 1 to 4. K.O.B. and F. L. B. designed and maintained the long-term CO<INF>2</INF> and O<INF>3</INF> study. H. D. S and T. W. R. contributed to design of experiments 1 and 2. L. C. performed experiments 1 to 3 and the meta-analysis study; and C. T., F. L. B., and L.Z. performed experiment 4. L. C. and S. H. analyzed the data and mainly wrote the manuscript with inputs from all coauthors. The data reported in this paper are deposited in the Dryad Repository (http://dx.doi.org/10.5061/dryad.b7f53).	Alberton O, 2005, NEW PHYTOL, V167, P859, DOI 10.1111/j.1469-8137.2005.01458.x; Bloom AJ, 2002, P NATL ACAD SCI USA, V99, P1730, DOI 10.1073/pnas.022627299; Bloom AJ, 2010, SCIENCE, V328, P899, DOI 10.1126/science.1186440; Bonfante P, 2009, ANNU REV MICROBIOL, V63, P363, DOI 10.1146/annurev.micro.091208.073504; Carney KM, 2007, P NATL ACAD SCI USA, V104, P4990, DOI 10.1073/pnas.0610045104; Cheng L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021377; Davidson EA, 2006, NATURE, V440, P165, DOI 10.1038/nature04514; de Graaff MA, 2010, NEW PHYTOL, V188, P1055, DOI 10.1111/j.1469-8137.2010.03427.x; Di HJ, 2009, NAT GEOSCI, V2, P621, DOI 10.1038/NGEO613; Drigo B, 2010, P NATL ACAD SCI USA, V107, P10938, DOI 10.1073/pnas.0912421107; Fellbaum CR, 2012, P NATL ACAD SCI USA, V109, P2666, DOI 10.1073/pnas.1118650109; Geisseler D, 2010, SOIL BIOL BIOCHEM, V42, P2058, DOI 10.1016/j.soilbio.2010.08.021; Govindarajulu M, 2005, NATURE, V435, P819, DOI 10.1038/nature03610; Hodge A, 2001, NATURE, V413, P297, DOI 10.1038/35095041; Hodge A, 2010, P NATL ACAD SCI USA, V107, P13754, DOI 10.1073/pnas.1005874107; Hu S, 2001, NATURE, V409, P188, DOI 10.1038/35051576; JAKOBSEN I, 1990, NEW PHYTOL, V115, P77, DOI 10.1111/j.1469-8137.1990.tb00924.x; Kiers ET, 2011, SCIENCE, V333, P880, DOI 10.1126/science.1208473; Orwin KH, 2011, ECOL LETT, V14, P493, DOI 10.1111/j.1461-0248.2011.01611.x; Phillips RP, 2011, ECOL LETT, V14, P187, DOI 10.1111/j.1461-0248.2010.01570.x; Reich PB, 2006, NATURE, V440, P922, DOI 10.1038/nature04486; Rillig MC, 1999, NATURE, V400, P628, DOI 10.1038/23168; Sanders IR, 1998, OECOLOGIA, V117, P496, DOI 10.1007/s004420050685; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Tisdall JM, 1997, AUST J SOIL RES, V35, P55, DOI 10.1071/S96065; Treseder KK, 2000, NEW PHYTOL, V147, P189, DOI 10.1046/j.1469-8137.2000.00690.x; Tu C, 2006, GLOBAL CHANGE BIOL, V12, P793, DOI 10.1111/j.1365-2486.2006.01149.x; van Groenigen KJ, 2011, NATURE, V475, P214, DOI 10.1038/nature10176; Wilson GWT, 2009, ECOL LETT, V12, P452, DOI 10.1111/j.1461-0248.2009.01303.x	30	315	365	44	970	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 31	2012	337	6098					1084	1087		10.1126/science.1224304	http://dx.doi.org/10.1126/science.1224304			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996WP	22936776				2022-12-28	WOS:000308125800044
J	Dong, N; Zhu, YQ; Lu, QH; Hu, LY; Zheng, YQ; Shao, F				Dong, Na; Zhu, Yongqun; Lu, Qiuhe; Hu, Liyan; Zheng, Yuqing; Shao, Feng			Structurally Distinct Bacterial TBC-like GAPs Link Arf GTPase to Rab1 Inactivation to Counteract Host Defenses	CELL			English	Article							ENTEROPATHOGENIC ESCHERICHIA-COLI; MATRIX PROTEIN GM130; ENDOPLASMIC-RETICULUM; ACTIVATING PROTEIN; EFFECTOR PROTEIN; SHIGELLA; VIRA; COMPLEX; DOMAIN; IDENTIFICATION	Rab GTPases are frequent targets of vacuole-living bacterial pathogens for appropriate trafficking of the vacuole. Here we discover that bacterial effectors including VirA from nonvacuole Shigella flexneri and EspG from extracellular Enteropathogenic Escherichia coli (EPEC) harbor TBC-like dual-finger motifs and exhibits potent RabGAP activities. Specific inactivation of Rab1 by VirA/EspG disrupts ER-to-Golgi trafficking. S. flexneri intracellular persistence requires VirA TBC-like GAP activity that mediates bacterial escape from autophagy-mediated host defense. Rab1 inactivation by EspG severely blocks host secretory pathway, resulting in inhibited interleukin-8 secretion from infected cells. Crystal structures of VirA/EspG-Rab1-GDP-aluminum fluoride complexes highlight TBC-like catalytic role for the arginine and glutamine finger residues and reveal a 3D architecture distinct from that of the TBC domain. Structure of Arf6-EspG-Rab1 ternary complex illustrates a pathogenic signaling complex that rewires host Arf signaling to Rab1 inactivation. Structural distinctions of VirA/EspG further predict a possible extensive presence of TBC-like RabGAP effectors in counteracting various host defenses.	[Zhu, Yongqun] Zhejiang Univ, Inst Life Sci, Hangzhou 310058, Zhejiang, Peoples R China; [Dong, Na; Lu, Qiuhe; Hu, Liyan; Zheng, Yuqing; Shao, Feng] Natl Inst Biol Sci, Beijing 102206, Peoples R China	Zhejiang University; National Institute of Biological Sciences, Beijing	Zhu, YQ (corresponding author), Zhejiang Univ, Inst Life Sci, Hangzhou 310058, Zhejiang, Peoples R China.	zhuyongqun@zju.edu.cn; shaofeng@nibs.ac.cn	Zheng, Yuqing/AAO-6891-2020	Lu, Qiuhe/0000-0002-0202-7448	Howard Hughes Medical Institute; Zhejiang University; National Basic Research Program of China (973 Programs) [2010CB835400, 2012CB518700]	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Zhejiang University; National Basic Research Program of China (973 Programs)(National Basic Research Program of China)	We thank Dr. David G. Lambright for kindly providing bacterial expression constructs for 30 Rabs. We thank the staff at the KEK Synchrotron Facility (Tsukuba, Japan) and Argonne Advanced Photon Source (Chicago, IL) for assistances with data collection. We also thank Yan Zhou, Jieling Yang, Yin Xu, and Jianjin Shi for technical assistance. The research was supported in part by an International Early Career Scientist grant from the Howard Hughes Medical Institute to F.S. Y.Z. was supported by new faculty start-up funds from Zhejiang University. This work was also supported by the National Basic Research Program of China (973 Programs 2010CB835400 and 2012CB518700) to F.S.	Albert S, 1999, EMBO J, V18, P5216, DOI 10.1093/emboj/18.19.5216; Ashida H, 2011, CURR OPIN MICROBIOL, V14, P16, DOI 10.1016/j.mib.2010.08.014; Barr F, 2010, CURR OPIN CELL BIOL, V22, P461, DOI 10.1016/j.ceb.2010.04.007; Brurnell JH, 2007, MICROBIOL MOL BIOL R, V71, P636, DOI 10.1128/MMBR.00023-07; Chen H, 2005, P NATL ACAD SCI USA, V102, P2766, DOI 10.1073/pnas.0409719102; Clements A, 2011, CELL MICROBIOL, V13, P1429, DOI 10.1111/j.1462-5822.2011.01631.x; Davis J, 2008, PROTEIN SCI, V17, P2167, DOI 10.1110/ps.037978.108; De Antoni A, 2002, J BIOL CHEM, V277, P41023, DOI 10.1074/jbc.M205783200; Dong N, 2010, EMBO J, V29, P1363, DOI 10.1038/emboj.2010.33; DONNENBERG MS, 1991, INFECT IMMUN, V59, P4310, DOI 10.1128/IAI.59.12.4310-4317.1991; Elliott SJ, 2001, INFECT IMMUN, V69, P4027, DOI 10.1128/IAI.69.6.4027-4033.2001; Germane KL, 2008, BIOCHEMISTRY-US, V47, P10241, DOI 10.1021/bi801533k; Germane KL, 2011, BIOCHEMISTRY-US, V50, P917, DOI 10.1021/bi1020138; Hardwidge PR, 2005, INFECT IMMUN, V73, P2586, DOI 10.1128/IAI.73.5.2586-2594.2005; Huang J, 2011, AUTOPHAGY, V7, P17, DOI 10.4161/auto.7.1.13840; Hutagalung AH, 2011, PHYSIOL REV, V91, P119, DOI 10.1152/physrev.00059.2009; Ingmundson A, 2007, NATURE, V450, P365, DOI 10.1038/nature06336; Zoppino FCM, 2010, TRAFFIC, V11, P1246, DOI 10.1111/j.1600-0854.2010.01086.x; Masuda ES, 2000, FEBS LETT, V470, P61, DOI 10.1016/S0014-5793(00)01288-6; Nottingham RM, 2009, P NATL ACAD SCI USA, V106, P14185, DOI 10.1073/pnas.0907725106; Ogawa M, 2005, SCIENCE, V307, P727, DOI 10.1126/science.1106036; Pan XJ, 2006, NATURE, V442, P303, DOI 10.1038/nature04847; Pfeffer S, 2004, NAT REV MOL CELL BIO, V5, P886, DOI 10.1038/nrm1500; Pfeffer SR, 2007, ANNU REV BIOCHEM, V76, P629, DOI 10.1146/annurev.biochem.76.061705.130002; Rak A, 2000, EMBO J, V19, P5105, DOI 10.1093/emboj/19.19.5105; Rittinger K, 1997, NATURE, V389, P758, DOI 10.1038/39651; Rivera VM, 2000, SCIENCE, V287, P826, DOI 10.1126/science.287.5454.826; Rivera-Molina FE, 2009, P NATL ACAD SCI USA, V106, P14408, DOI 10.1073/pnas.0906536106; Salcedo SP, 2005, CURR OPIN MICROBIOL, V8, P92, DOI 10.1016/j.mib.2004.12.007; Scheffzek K, 1997, SCIENCE, V277, P333, DOI 10.1126/science.277.5324.333; Selyunin AS, 2011, NATURE, V469, P107, DOI 10.1038/nature09593; Shao F, 2002, CELL, V109, P575, DOI 10.1016/S0092-8674(02)00766-3; Slagowski NL, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040009; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; STROM M, 1993, NATURE, V361, P736, DOI 10.1038/361736a0; UCHIYA KI, 1995, MOL MICROBIOL, V17, P241, DOI 10.1111/j.1365-2958.1995.mmi_17020241.x; Volpicelli-Daley LA, 2005, MOL BIOL CELL, V16, P4495, DOI 10.1091/mbc.E04-12-1042; Weide T, 2001, EMBO REP, V2, P336, DOI 10.1093/embo-reports/kve065; Yoshida S, 2006, SCIENCE, V314, P985, DOI 10.1126/science.1133174	39	158	164	6	82	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 31	2012	150	5					1029	1041		10.1016/j.cell.2012.06.050	http://dx.doi.org/10.1016/j.cell.2012.06.050			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	001ZU	22939626	Bronze			2022-12-28	WOS:000308500200016
J	Tyndall, G				Tyndall, Geoffrey			Vibrational Excitation Can Control Tropospheric Chemistry	SCIENCE			English	Editorial Material							RADICALS; ISOMERIZATION; KINETICS		Natl Ctr Atmospher Res, Boulder, CO 80301 USA	National Center Atmospheric Research (NCAR) - USA	Tyndall, G (corresponding author), Natl Ctr Atmospher Res, 3090 Ctr Green Dr, Boulder, CO 80301 USA.	tyndall@ucar.edu						Bohn B, 1996, J CHEM SOC FARADAY T, V92, P1459, DOI 10.1039/ft9969201459; Dibble TS, 2012, J PHYS CHEM A, V116, P7603, DOI 10.1021/jp303652x; Dibble TS, 2002, J PHYS CHEM A, V106, P6643, DOI 10.1021/jp025682m; Glowacki DR, 2012, SCIENCE, V337, P1066, DOI 10.1126/science.1224106; Sorensen M, 2003, INT J CHEM KINET, V35, P191, DOI 10.1002/kin.10119; Wallington TJ, 1996, J PHYS CHEM-US, V100, P18116, DOI 10.1021/jp9624764	6	1	1	1	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 31	2012	337	6098					1046	1047		10.1126/science.1227528	http://dx.doi.org/10.1126/science.1227528			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996WP	22936763				2022-12-28	WOS:000308125800030
J	Vargas-Parada, L				Vargas-Parada, Laura			PATHOLOGY Three questions	NATURE			English	Editorial Material							CANCER											Gravitt PE, 2011, J CLIN INVEST, V121, P4593, DOI 10.1172/JCI57149; Herfs M, 2012, P NATL ACAD SCI USA, V109, P10516, DOI 10.1073/pnas.1202684109; Maglennon GA, 2011, VIROLOGY, V414, P153, DOI 10.1016/j.virol.2011.03.019; Woo YL, 2010, INT J CANCER, V126, P133, DOI 10.1002/ijc.24804; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798	5	7	7	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 30	2012	488	7413					S14	S15		10.1038/488S14a	http://dx.doi.org/10.1038/488S14a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	996NC	22932435				2022-12-28	WOS:000308095100010
J	Plante, J; Turgeon, AF; Zarychanski, R; Lauzier, F; Vigneault, L; Moore, L; Boutin, A; Fergusson, DA				Plante, Jennifer; Turgeon, Alexis F.; Zarychanski, Ryan; Lauzier, Francois; Vigneault, Louise; Moore, Lynne; Boutin, Amelie; Fergusson, Dean A.			Effect of systemic steroids on post-tonsillectomy bleeding and reinterventions: systematic review and meta-analysis of randomised controlled trials	BMJ-BRITISH MEDICAL JOURNAL			English	Article							POSTOPERATIVE NAUSEA; DOUBLE-BLIND; DEXAMETHASONE; PAIN; CHILDREN; ONDANSETRON; PREVENTION; EMESIS; ADENOTONSILLECTOMY; METOCLOPRAMIDE	Objective To evaluate the risk of postoperative bleeding and reintervention with the use of systemic steroids in patients undergoing tonsillectomy. Design Systematic review and meta-analysis of randomised controlled trials. Data sources Medline, Embase, Cochrane Library, Scopus, Web of Science, Intute, Biosis, OpenSIGLE, National Technical Information Service, and Google Scholar were searched. References from reviews identified in the search and from included studies were scanned. Review methods Randomised controlled trials comparing the administration of systemic steroids during tonsillectomy with any other comparator were eligible. Primary outcome was postoperative bleeding. Secondary outcomes were the rate of admission for a bleeding episode, reintervention for a bleeding episode, blood transfusion, and mortality. Results Of 1387 citations identified, 29 randomised controlled trials (n=2674) met all eligibility criteria. Seven studies presented a low risk of bias, but none was specifically designed to systematically identify postoperative bleeding. Administration of systemic steroids did not significantly increase the incidence of post-tonsillectomy bleeding (29 studies, n=2674 patients, odds ratio 0.96 (95% confidence interval 0.66 to 1.40), I-2=0%). We observed a significant increase in the incidence of operative reinterventions for bleeding episodes in patients who received systemic steroids (12, n=1178, 2.27 (1.03 to 4.99), I-2=0%). No deaths were reported. Sensitivity analyses were consistent with the findings. Conclusions Although systemic steroids do not appear to increase bleeding events after tonsillectomy, their use is associated with a raised incidence of operative reinterventions for bleeding episodes, which may be related to increased severity of bleeding events. Systemic steroids should be used with caution, and the risks and benefits weighed, for the prevention of postoperative nausea and vomiting after tonsillectomy before further research is performed to clarify their condition of use.	[Plante, Jennifer; Turgeon, Alexis F.; Lauzier, Francois; Vigneault, Louise] Univ Laval, Ctr Hospr Affilie Univ Quebec CHA, Dept Anesthesiol, Enfant Jesus Hosp,Div Crit Care Med, Quebec City, PQ G1J 1Z4, Canada; [Turgeon, Alexis F.; Lauzier, Francois; Moore, Lynne; Boutin, Amelie] Univ Laval, CHA Res Ctr, Enfant Jesus Hosp, Trauma Emergency Crit Care Med Unit, Quebec City, PQ G1J 1Z4, Canada; [Zarychanski, Ryan] CancerCare Manitoba, Dept Hematol & Med Oncol, Winnipeg, MB, Canada; [Zarychanski, Ryan] Univ Manitoba, Dept Internal Med, Winnipeg, MB, Canada; [Zarychanski, Ryan] Univ Manitoba, Dept Community Hlth Sci, Winnipeg, MB R3T 2N2, Canada; [Lauzier, Francois] Univ Laval, Dept Med, Quebec City, PQ G1J 1Z4, Canada; [Moore, Lynne] Univ Laval, Dept Social & Prevent Med, Quebec City, PQ G1J 1Z4, Canada; [Fergusson, Dean A.] Ottawa Hosp Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada	Laval University; Laval University; CancerCare Manitoba Foundation; University of Manitoba; University of Manitoba; Laval University; Laval University; University of Ottawa; Ottawa Hospital Research Institute	Turgeon, AF (corresponding author), Univ Laval, Ctr Hospr Affilie Univ Quebec CHA, Dept Anesthesiol, Enfant Jesus Hosp,Div Crit Care Med, Quebec City, PQ G1J 1Z4, Canada.	alexis.turgeon@fmed.ulaval.ca	Lauzier, Francois/B-9237-2015; Zarychanski, Ryan/AAB-6369-2022	Lauzier, Francois/0000-0002-6530-5513; Fergusson, Dean/0000-0002-3389-2485; Zarychanski, Ryan/0000-0001-9455-6138; Boutin, Amelie/0000-0003-1907-2920	Fonds de Recherche Quebec-Sante; Traumatology Research Consortium of the Fonds de Recherche Quebec-Sante; Canadian Institutes for Health Research	Fonds de Recherche Quebec-Sante; Traumatology Research Consortium of the Fonds de Recherche Quebec-Sante; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	This study was funded by personal funds. AFT and FL are recipients of a research career award from the Fonds de Recherche Quebec-Sante. AFT and FL are supported by the Traumatology Research Consortium of the Fonds de Recherche Quebec-Sante. LM and DAF are recipients of New Investigator Awards from the Canadian Institutes for Health Research. RZ is a recipient of a randomised controlled trials mentorship award from the Canadian Institutes for Health Research.	Alajmi MA, 2008, KUWAIT MED J, V40, P211; Ammar Gaber, 2009, Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, V23, P936; Apfel CC, 2004, NEW ENGL J MED, V350, P2441, DOI 10.1056/NEJMoa032196; April MM, 1996, ARCH OTOLARYNGOL, V122, P117; Atkins D, 2004, BMJ-BRIT MED J, V328, P1490; Baugh RF, 2011, OTOLARYNG HEAD NECK, V144, pS1, DOI 10.1177/0194599810389949; Bolton CM, 2006, BRIT J ANAESTH, V97, P593, DOI 10.1093/bja/ael256; British Association of Otorhinolaryngologists-Head and Neck Surgeons Comparative Audit Group and the Clinical Effectiveness Unit of the Royal College of Surgeons of England, 2005, NAT PROSP TONS AUD; Carr MM, 1999, ARCH OTOLARYNGOL, V125, P1361, DOI 10.1001/archotol.125.12.1361; CATLIN FI, 1991, ARCH OTOLARYNGOL, V117, P649; Collison P J, 2000, Ear Nose Throat J, V79, P640; Czarnetzki C, 2008, JAMA-J AM MED ASSOC, V300, P2621, DOI 10.1001/jama.2008.794; FERRARI LR, 1992, ANESTH ANALG, V75, P351; Fujii Y, 1996, CAN J ANAESTH, V43, P1229, DOI 10.1007/BF03013430; FURST SR, 1994, ANESTHESIOLOGY, V81, P799, DOI 10.1097/00000542-199410000-00005; Gan TJ, 2007, ANESTH ANALG, V105, P1615, DOI 10.1213/01.ane.0000295230.55439.f4; Geva A, 2011, OTOLARYNG HEAD NECK, V144, P838, DOI 10.1177/0194599811399538; Giannoni C, 2002, OTOLARYNG HEAD NECK, V126, P307, DOI 10.1067/mhn.2002.122700; Goldman AC, 2000, OTOLARYNG HEAD NECK, V123, P682, DOI 10.1067/mhn.2000.111354; Gune Y, 2002, CUKUROVA U TIP FAKUL, V27, P13; Gunter JB, 2006, PEDIATR ANESTH, V16, P1153, DOI 10.1111/j.1460-9592.2006.01952.x; Hanasono MM, 2004, ARCH OTOLARYNGOL, V130, P917, DOI 10.1001/archotol.130.8.917; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Holt R, 2000, PAEDIATR ANAESTH, V10, P181, DOI 10.1046/j.1460-9592.2000.00475.x; Inci Nusret, 2009, Kulak Burun Bogaz Ihtis Derg, V19, P1; Johnson LB, 2002, LARYNGOSCOPE, V112, P35; Kaan MN, 2006, INT J PEDIATR OTORHI, V70, P73, DOI 10.1016/j.ijporl.2005.05.013; Kaufmann Michal, 2006, Harefuah, V145, P577; Kim MW, 1998, KOREAN J OTOLARYNGOL, V41, P783; Lachance M, 2008, LARYNGOSCOPE, V118, P232, DOI 10.1097/MLG.0b013e318159a5cc; Lee MSW, 2004, OTOLARYNG HEAD NECK, V131, P833, DOI 10.1016/j.otohns.2004.08.008; Liechti M, 2007, J ANESTH, V21, P311, DOI 10.1007/s00540-007-0523-0; LITMAN RS, 1994, ANESTH ANALG, V78, P478; Macassey EA, 2007, ANZ J SURG, V77, P579, DOI 10.1111/j.1445-2197.2007.04154.x; Malde AD, 2005, INDIAN J ANAESTH, V49, P202; Mathiesen O, 2011, ACTA ANAESTH SCAND, V55, P297, DOI 10.1111/j.1399-6576.2010.02389.x; McAuliffe JJ, 2001, AM SOC AN ANN M 2001; McKean S, 2006, CLIN OTOLARYNGOL, V31, P36, DOI 10.1111/j.1749-4486.2006.01141.x; Mohamed SK, 2009, EUR ARCH OTO-RHINO-L, V266, P1815, DOI 10.1007/s00405-009-0937-4; Mohammad L, 2006, INDIAN J OTOLARYNGOL, V58, P141, DOI 10.1007/BF03050769; Nawasreh O, 2000, J BAHRAIN MED SOC, V12, P130; O'Leary S, 2005, LARYNGOSCOPE, V115, P591, DOI 10.1097/01.mlg.0000161361.66191.60; OHLMS LA, 1995, ARCH OTOLARYNGOL, V121, P737; Palme CE, 2000, LARYNGOSCOPE, V110, P2000, DOI 10.1097/00005537-200012000-00003; Rabbani MZ, 2010, J PAK MED ASSOC, V60, P559; Randall DA, 1998, OTOLARYNG HEAD NECK, V118, P61, DOI 10.1016/S0194-5998(98)70376-6; Raut V, 2001, LARYNGOSCOPE, V111, P2178, DOI 10.1097/00005537-200112000-00020; Rujirojindakul P, 2008, THAI J ANESTHESIOL, V34, P1; Samarkandi AH, 2004, SAUDI MED J, V25, P1636; Steward DL, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003997.pub2; Stewart R, 2002, CLIN OTOLARYNGOL, V27, P321, DOI 10.1046/j.1365-2273.2002.00588.x; Tom LWC, 1996, INT J PEDIATR OTORHI, V37, P115, DOI 10.1016/0165-5876(96)01388-2; Trujillo M, 2005, AN ORL MEX, V50, P61; VOLK MS, 1993, OTOLARYNG HEAD NECK, V109, P726, DOI 10.1177/019459989310900415; Windfuhr Jochen P, 2002, Ear Nose Throat J, V81, P626; Wong SSL, 2006, J MED LIBR ASSOC, V94, P41; YUSUF S, 1985, PROG CARDIOVASC DIS, V27, P335, DOI 10.1016/S0033-0620(85)80003-7	58	58	59	0	16	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 28	2012	345								e5389	10.1136/bmj.e5389	http://dx.doi.org/10.1136/bmj.e5389			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	036SJ	22930703	Green Published, hybrid			2022-12-28	WOS:000311050500008
J	Button, B; Cai, LH; Ehre, C; Kesimer, M; Hill, DB; Sheehan, JK; Boucher, RC; Rubinstein, M				Button, Brian; Cai, Li-Heng; Ehre, Camille; Kesimer, Mehmet; Hill, David B.; Sheehan, John K.; Boucher, Richard C.; Rubinstein, Michael			A Periciliary Brush Promotes the Lung Health by Separating the Mucus Layer from Airway Epithelia	SCIENCE			English	Article							CYSTIC-FIBROSIS; SURFACE LIQUID; PSEUDOMONAS-AERUGINOSA; MUCOCILIARY CLEARANCE; RESPIRATORY-TRACT; IN-VIVO; MUCIN; TRANSPORT; DISEASE; IDENTIFICATION	Mucus clearance is the primary defense mechanism that protects airways from inhaled infectious and toxic agents. In the current gel-on-liquid mucus clearance model, a mucus gel is propelled on top of a "watery" periciliary layer surrounding the cilia. However, this model fails to explain the formation of a distinct mucus layer in health or why mucus clearance fails in disease. We propose a gel-on-brush model in which the periciliary layer is occupied by membrane-spanning mucins and mucopolysaccharides densely tethered to the airway surface. This brush prevents mucus penetration into the periciliary space and causes mucus to form a distinct layer. The relative osmotic moduli of the mucus and periciliary brush layers explain both the stability of mucus clearance in health and its failure in airway disease.	[Cai, Li-Heng; Rubinstein, Michael] Univ N Carolina, Curriculum Appl Sci & Engn, Chapel Hill, NC 27599 USA; [Button, Brian; Ehre, Camille; Kesimer, Mehmet; Hill, David B.; Boucher, Richard C.] Univ N Carolina, Cyst Fibrosis Res & Treatment Ctr, Chapel Hill, NC 27599 USA; [Kesimer, Mehmet; Sheehan, John K.] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Rubinstein, Michael] Univ N Carolina, Dept Chem, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Rubinstein, M (corresponding author), Univ N Carolina, Curriculum Appl Sci & Engn, Chapel Hill, NC 27599 USA.	mr@unc.edu	Cai, Li-Heng/A-1602-2009; , Mehmet Kesimer/AHB-9223-2022; Cai, Liheng/O-2834-2013	Cai, Liheng/0000-0002-6806-0566	Cystic Fibrosis Foundation [BUTTON07XX0, BUTTON11G0, RUBIN09XX0, R026-CRII]; NSF [CHE-0911588, DMR-0907515, DMR-1121107, DMR-1122483, PHY11-25915, CBET-0609087]; NIH [K01DK080847, R01HL077546, P50HL107168, P01HL34322, P01HL108808, P01HL110873-01, P50HL107168-01, P30DK065988, HHSN268200900020, UL1-RR025747, R01HL103940]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025747] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL103940, R01HL077546, P50HL107168, P01HL034322, P01HL108808, P01HL110873] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK080847, P30DK065988] Funding Source: NIH RePORTER; Direct For Mathematical & Physical Scien [0911588] Funding Source: National Science Foundation; Division Of Materials Research [0907515] Funding Source: National Science Foundation	Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Division Of Materials Research(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	Funding for this work was provided by Cystic Fibrosis Foundation grants BUTTON07XX0 (to B. B.), BUTTON11G0 (to B. B.), RUBIN09XX0 (to M. R.), and R026-CRII (to R. C. B.); NSF grants CHE-0911588, DMR-0907515, DMR-1121107, DMR-1122483, PHY11-25915 (in part), and CBET-0609087 (to M. R.); and NIH grants K01DK080847 (to B. B.), R01HL077546 (in part to M. R.), P50HL107168, P01HL34322, P01HL108808, P01HL110873-01, P50HL107168-01, P30DK065988, HHSN268200900020, and UL1-RR025747 (to R. C. B.), and R01HL103940 (to M. K.). We thank S. Panyukov and E. B. Zhulina for illuminating discussions, L. Brown for graphical and editorial assistance, S. Randell for the human airway epithelial cells, K. Burns for histology assistance, and R. Tarran for use of the Leica SP5 confocal microscope. M. R. conceived the study, and B. B., L.-H. C., R. C. B., and M. R. designed the experiments. B. B. developed experimental approaches for the osmotic pressure measurements and the PCL permeability and osmotic compression experiments. L.-H. C. prepared regents and, along with B. B., performed the PCL permeability and osmotic compression experiments. C. E. conducted the transmission electron microscopy and immunological experiments. M. K., D. B. H., and J.K.S. provided technical assistance in preparing reagents. M. R., L.-H. C., B. B., and R. C. B. discussed and analyzed the results. M. R. and R. C. B. supervised the whole study. B. B., L.-H. C., R. C. B., and M. R. wrote the paper. The authors declare that they have no competing financial interests.	ARFKEN GB, 1999, MATH METHODS PHYS; BALTIMORE RS, 1989, AM REV RESPIR DIS, V140, P1650, DOI 10.1164/ajrccm/140.6.1650; Boucher RC, 2004, EUR RESPIR J, V23, P146, DOI 10.1183/09031936.03.00057003; Boucher RC, 2007, ANNU REV MED, V58, P157, DOI 10.1146/annurev.med.58.071905.105316; Clunes LA, 2012, FASEB J, V26, P533, DOI 10.1096/fj.11-192377; Colby R.H., 2003, POLYM PHYS; Fahy JV, 2010, NEW ENGL J MED, V363, P2233, DOI 10.1056/NEJMra0910061; Finkbeiner WE, 2011, AM J PHYSIOL-LUNG C, V301, pL402, DOI 10.1152/ajplung.00210.2010; Hattrup CL, 2008, ANNU REV PHYSIOL, V70, P431, DOI 10.1146/annurev.physiol.70.113006.100659; Hilding A C, 1967, Minn Med, V50, P915; Hogg JC, 2004, NEW ENGL J MED, V350, P2645, DOI 10.1056/NEJMoa032158; Houtmeyers E, 1999, EUR RESPIR J, V13, P1177, DOI 10.1034/j.1399-3003.1999.13e39.x; Hovenberg HW, 1996, BIOCHEM J, V318, P319, DOI 10.1042/bj3180319; IRAVANI J, 1972, J PATHOL, V106, P81, DOI 10.1002/path.1711060204; Jachimska B, 2008, LANGMUIR, V24, P6866, DOI 10.1021/la800548p; KALINER M, 1984, J ALLERGY CLIN IMMUN, V73, P318, DOI 10.1016/0091-6749(84)90403-2; Kesimer M, 2010, AM J PHYSIOL-LUNG C, V298, pL15, DOI 10.1152/ajplung.00194.2009; Kinsky MP, 2000, J TRAUMA, V49, P844, DOI 10.1097/00005373-200011000-00009; Knowles MR, 2002, J CLIN INVEST, V109, P571, DOI 10.1172/JCI200215217; Lai SK, 2007, P NATL ACAD SCI USA, V104, P1482, DOI 10.1073/pnas.0608611104; Lai SK, 2009, ADV DRUG DELIVER REV, V61, P158, DOI 10.1016/j.addr.2008.11.002; Lucas AM, 1934, ARCHIV OTOLARYNGOL, V20, P518; Mall M, 2004, NAT MED, V10, P487, DOI 10.1038/nm1028; Matsui H, 2006, P NATL ACAD SCI USA, V103, P18131, DOI 10.1073/pnas.0606428103; MATTHEWS LW, 1963, AM REV RESPIR DIS, V88, P199; Monzon ME, 2006, AM J RESP CELL MOL, V34, P135, DOI 10.1165/rcmb.2005-0256OC; Pattison J.R., 2000, PRINCIPLES PRACTICE, P645; Quinton Paul M., 1999, Physiological Reviews, V79, pS3; Raphael JH, 1996, BRIT J ANAESTH, V76, P116, DOI 10.1093/bja/76.1.116; Raynal BDE, 2002, BIOCHEM J, V362, P289, DOI 10.1042/0264-6021:3620289; ROSE MC, 1992, AM J PHYSIOL, V263, pL413, DOI 10.1152/ajplung.1992.263.4.L413; Schwab U, 2002, INFECT IMMUN, V70, P4547, DOI 10.1128/IAI.70.8.4547-4555.2002; Sheehan JK, 2000, BIOCHEM J, V347, P37, DOI 10.1042/0264-6021:3470037; Smith DJ, 2007, B MATH BIOL, V69, P817, DOI 10.1007/s11538-006-9163-z; Tang BC, 2009, P NATL ACAD SCI USA, V106, P19268, DOI 10.1073/pnas.0905998106; Tarran R, 2001, J GEN PHYSIOL, V118, P223, DOI 10.1085/jgp.118.2.223; Tarran R, 2001, MOL CELL, V8, P149, DOI 10.1016/S1097-2765(01)00286-6; Tarran Robert, 2004, Proc Am Thorac Soc, V1, P42, DOI 10.1513/pats.2306014; Thornton DJ, 2008, ANNU REV PHYSIOL, V70, P459, DOI 10.1146/annurev.physiol.70.113006.100702; Wanner A, 1996, AM J RESP CRIT CARE, V154, P1868, DOI 10.1164/ajrccm.154.6.8970383; Wickstrom C, 1998, BIOCHEM J, V334, P685, DOI 10.1042/bj3340685; WIDDICOMBE JH, 1995, RESP PHYSIOL, V99, P3, DOI 10.1016/0034-5687(94)00095-H; Wine Jeffrey J, 2004, Proc Am Thorac Soc, V1, P47, DOI 10.1513/pats.2306015; Worlitzsch D, 2002, J CLIN INVEST, V109, P317, DOI 10.1172/JCI0213870	44	516	522	13	190	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 24	2012	337	6097					937	941		10.1126/science.1223012	http://dx.doi.org/10.1126/science.1223012			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992VI	22923574	Green Accepted, Green Submitted			2022-12-28	WOS:000307807600037
J	Simpson, IJ; Andersen, MPS; Meinardi, S; Bruhwiler, L; Blake, NJ; Helmig, D; Rowland, FS; Blake, DR				Simpson, Isobel J.; Andersen, Mads P. Sulbaek; Meinardi, Simone; Bruhwiler, Lori; Blake, Nicola J.; Helmig, Detlev; Rowland, F. Sherwood; Blake, Donald R.			Long-term decline of global atmospheric ethane concentrations and implications for methane	NATURE			English	Article							EMISSIONS; GROWTH; BUDGET; GASES; MODEL	After methane, ethane is the most abundant hydrocarbon in the remote atmosphere. It is a precursor to tropospheric ozone and it influences the atmosphere's oxidative capacity through its reaction with the hydroxyl radical, ethane's primary atmospheric sink(1-3). Here we present the longest continuous record of global atmospheric ethane levels. We show that global ethane emission rates decreased from 14.3 to 11.3 teragrams per year, or by 21 per cent, from 1984 to 2010. We attribute this to decreasing fugitive emissions from ethane's fossil fuel source-most probably decreased venting and flaring of natural gas in oil fields-rather than a decline in its other major sources, biofuel use and biomass burning. Ethane's major emission sources are shared with methane, and recent studies have disagreed on whether reduced fossil fuel or microbial emissions have caused methane's atmospheric growth rate to slow(4,5). Our findings suggest that reduced fugitive fossil fuel emissions account for at least 10-21 teragrams per year (30-70 per cent) of the decrease in methane's global emissions, significantly contributing to methane's slowing atmospheric growth rate since the mid-1980s.	[Simpson, Isobel J.; Andersen, Mads P. Sulbaek; Meinardi, Simone; Blake, Nicola J.; Rowland, F. Sherwood; Blake, Donald R.] Univ Calif Irvine, Dept Chem, Irvine, CA 92697 USA; [Andersen, Mads P. Sulbaek] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Bruhwiler, Lori] NOAA, ESRL, Boulder, CO 80305 USA; [Helmig, Detlev] Univ Colorado, Inst Arctic & Alpine Res INSTAAR, Boulder, CO 80309 USA	University of California System; University of California Irvine; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); National Oceanic Atmospheric Admin (NOAA) - USA; University of Colorado System; University of Colorado Boulder	Simpson, IJ (corresponding author), Univ Calif Irvine, Dept Chem, Irvine, CA 92697 USA.	isimpson@uci.edu	Sulbaek Andersen, Mads/C-4708-2008; Bruhwiler, Lori/AAQ-8502-2020	Sulbaek Andersen, Mads/0000-0002-7976-5852; Bruhwiler, Lori/0000-0002-3554-9250; Blake, Donald/0000-0002-8283-5014	NASA [NAG5-8935]; Gary Comer Abrupt Climate Change Fellowship; Directorate For Geosciences [1108391] Funding Source: National Science Foundation	NASA(National Aeronautics & Space Administration (NASA)); Gary Comer Abrupt Climate Change Fellowship; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This research was funded by NASA (grant NAG5-8935), with contributions from the Gary Comer Abrupt Climate Change Fellowship. We acknowledge discussions with many colleagues, especially M. Aydin and C. Wiedinmyer. We thank colleagues at the Norfolk Island Bureau of Meteorology and the NOAA research stations in Samoa and Barrow for sample collection; the UCI team for sample collection and analysis, especially B. Chisholm, R. Day, G. Liu, B. Love and M. McEachern; and K. Masarie for work with the NOAA/INSTAAR data. M.P.S.A. is supported at JPL by an appointment to the NASA Postdoctoral Program, administered by Oak Ridge Associated Universities through a contract with NASA.	Andreae MO, 2001, GLOBAL BIOGEOCHEM CY, V15, P955, DOI 10.1029/2000GB001382; Aydin M, 2011, NATURE, V476, P198, DOI 10.1038/nature10352; BLAKE DR, 1986, NATURE, V321, P231, DOI 10.1038/321231a0; Bousquet P, 2006, NATURE, V443, P439, DOI 10.1038/nature05132; Dlugokencky EJ, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL018126; Elvidge CD, 2009, ENERGIES, V2, P595, DOI 10.3390/en20300595; Etiope G, 2009, SCIENCE, V323, P478, DOI 10.1126/science.1165904; Fernandes SD, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2006GB002836; Gupta ML, 1998, J GEOPHYS RES-ATMOS, V103, P28219, DOI 10.1029/98JD02645; Johnson MR, 2011, J AIR WASTE MANAGE, V61, P190, DOI 10.3155/1047-3289.61.2.190; Jones V.T., 2000, HAND EXPL G, P133; Kai FM, 2011, NATURE, V476, P194, DOI 10.1038/nature10259; Katzenstein AS, 2003, P NATL ACAD SCI USA, V100, P11975, DOI 10.1073/pnas.1635258100; Krol M, 2005, ATMOS CHEM PHYS, V5, P417, DOI 10.5194/acp-5-417-2005; Levin I, 2012, NATURE, V486, pE3, DOI 10.1038/nature11175; Montzka SA, 2011, SCIENCE, V331, P67, DOI 10.1126/science.1197640; Pozzer A, 2010, ATMOS CHEM PHYS, V10, P4403, DOI 10.5194/acp-10-4403-2010; Rinsland CP, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD001150; RUDOLPH J, 1995, J GEOPHYS RES-ATMOS, V100, P11369, DOI 10.1029/95JD00693; Sander S.P, 2011, JPL PUBLICATION; Schultz MG, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB003031; Simpson IJ, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027330; Spivakovsky CM, 2000, J GEOPHYS RES-ATMOS, V105, P8931, DOI 10.1029/1999JD901006; Stein O, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD008062; Stern DI, 1996, CHEMOSPHERE, V33, P159, DOI 10.1016/0045-6535(96)00157-9; Strapoc D, 2007, ORG GEOCHEM, V38, P267, DOI 10.1016/j.orggeochem.2006.09.005; van der Werf GR, 2010, ATMOS CHEM PHYS, V10, P11707, DOI 10.5194/acp-10-11707-2010; Wiedinmyer C, 2011, GEOSCI MODEL DEV, V4, P625, DOI 10.5194/gmd-4-625-2011; Xiao YP, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009415; Yevich R, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB001952	30	130	133	3	150	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 23	2012	488	7412					490	494		10.1038/nature11342	http://dx.doi.org/10.1038/nature11342			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992FS	22914166	Green Published			2022-12-28	WOS:000307761600032
J	Baxter, JM; Patel, AN; Varma, S				Baxter, Julia M.; Patel, Anand N.; Varma, Sandeep			Facial basal cell carcinoma	BMJ-BRITISH MEDICAL JOURNAL			English	Review							NONMELANOMA SKIN-CANCER; TRENDS; EPIDEMIOLOGY; PREVENTION; AUSTRALIA; SUBTYPES; NMSC		[Baxter, Julia M.; Patel, Anand N.; Varma, Sandeep] Nottingham Univ Hosp NHS Trust, Queens Med Ctr, Nottingham NG7 2UH, England	Nottingham University Hospital NHS Trust; University of Nottingham	Varma, S (corresponding author), Nottingham Univ Hosp NHS Trust, Queens Med Ctr, Nottingham NG7 2UH, England.	sandeep.varma@nuh.nhs.uk						Alam M, 2011, J AM ACAD DERMATOL, V64, P839, DOI 10.1016/j.jaad.2010.06.028; Batra RS, 2002, ARCH DERMATOL, V138, P1043, DOI 10.1001/archderm.138.8.1043; Brewster DH, 2007, BRIT J DERMATOL, V156, P1295, DOI 10.1111/j.1365-2133.2007.07892.x; Camp WL, 2011, SEMIN CUTAN MED SURG, V30, P6, DOI 10.1016/j.sder.2011.01.003; Cancer Research UK, 2011, SKIN CANC RISKS CAUS; Chinem VP, 2011, AN BRAS DERMATOL, V86, P292, DOI 10.1590/S0365-05962011000200013; CHUANG TY, 1990, J AM ACAD DERMATOL, V22, P413, DOI 10.1016/0190-9622(90)70056-N; Custodio G, 2010, AN BRAS DERMATOL, V85, P819, DOI 10.1590/S0365-05962010000600007; de Vries E, 2004, J INVEST DERMATOL, V123, P634, DOI 10.1111/j.0022-202X.2004.23306.x; Diffey BL, 2005, BRIT J DERMATOL, V153, P679, DOI 10.1111/j.1365-2133.2005.06799.x; Donaldson MR, 2011, SEMIN CUTAN MED SURG, V30, P3, DOI 10.1016/j.sder.2011.01.002; Flohil SC, 2011, ACTA DERM-VENEREOL, V91, P24, DOI 10.2340/00015555-1009; Hannuksela-Svahn A, 1999, ARCH DERMATOL, V135, P781, DOI 10.1001/archderm.135.7.781; Hoey SEH, 2007, BRIT J DERMATOL, V156, P1301, DOI 10.1111/j.1365-2133.2007.07936.x; Holme SA, 2000, BRIT J DERMATOL, V143, P1224, DOI 10.1046/j.1365-2133.2000.03892.x; Jung GW, 2010, BRIT J DERMATOL, V163, P146, DOI 10.1111/j.1365-2133.2010.09809.x; Katalinic A, 2003, BRIT J DERMATOL, V149, P1200, DOI 10.1111/j.1365-2133.2003.05554.x; Kopke LFF, 2002, AN BRAS DERMATOL, V77, P249; Lear JT, 1998, J ROY SOC MED, V91, P585, DOI 10.1177/014107689809101110; Lear JT, 1997, POSTGRAD MED J, V73, P538, DOI 10.1136/pgmj.73.863.538; Madan V, 2010, LANCET, V375, P673, DOI 10.1016/S0140-6736(09)61196-X; Mantese Sônia Antunes Oliveira, 2006, An. Bras. Dermatol., V81, P136, DOI 10.1590/S0365-05962006000200004; MARGO CE, 1993, SURV OPHTHALMOL, V38, P169, DOI 10.1016/0039-6257(93)90100-L; McCormack CJ, 1997, ARCH DERMATOL, V133, P593, DOI 10.1001/archderm.133.5.593; Nakayama M, 2011, J SKIN CANCER, V2011, DOI 10.1155/2011/496910; Richmond-Sinclair NM, 2009, J INVEST DERMATOL, V129, P323, DOI 10.1038/jid.2008.234; Roewert-Huber J, 2007, BRIT J DERMATOL, V157, P47, DOI 10.1111/j.1365-2133.2007.08273.x; Rubin AI, 2005, NEW ENGL J MED, V353, P2262, DOI 10.1056/NEJMra044151; Staples M, 1998, INT J CANCER, V78, P144, DOI 10.1002/(SICI)1097-0215(19981005)78:2<144::AID-IJC3>3.0.CO;2-Z; Staples MP, 2006, MED J AUSTRALIA, V184, P6, DOI 10.5694/j.1326-5377.2006.tb00086.x; Takenouchi T, 2001, DERMATOL SURG, V27, P393, DOI 10.1046/j.1524-4725.2001.27401.x; Telfer NR, 2008, BRIT J DERMATOL, V159, P35, DOI 10.1111/j.1365-2133.2008.08666.x; Trakatelli M, 2007, BRIT J DERMATOL, V156, P1, DOI 10.1111/j.1365-2133.2007.07861.x; Vico P, 1995, Eur J Surg Oncol, V21, P490, DOI 10.1016/S0748-7983(95)96861-X	34	40	42	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 21	2012	345								e5342	10.1136/bmj.e5342	http://dx.doi.org/10.1136/bmj.e5342			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	996GP	22915688				2022-12-28	WOS:000308073200012
J	Dalton, T; Cegielski, P; Akksilp, S; Asencios, L; Caoili, JC; Cho, SN; Erokhin, VV; Ershova, J; Gler, MT; Kazennyy, BY; Kim, HJ; Kliiman, K; Kurbatova, E; Kvasnovsky, C; Leimane, V; van der Walt, M; Via, LE; Volchenkov, GV; Yagui, MA; Kang, H				Dalton, Tracy; Cegielski, Peter; Akksilp, Somsak; Asencios, Luis; Campos Caoili, Janice; Cho, Sang-Nae; Erokhin, Vladislav V.; Ershova, Julia; Tarcela Gler, Ma; Kazennyy, Boris Y.; Kim, Hee Jin; Kliiman, Kai; Kurbatova, Ekaterina; Kvasnovsky, Charlotte; Leimane, Vaira; van der Walt, Martie; Via, Laura E.; Volchenkov, Grigory V.; Yagui, Martin A.; Kang, Hyungseok		Global PETTS Investigators	Prevalence of and risk factors for resistance to second-line drugs in people with multidrug-resistant tuberculosis in eight countries: a prospective cohort study	LANCET			English	Article							MYCOBACTERIUM-TUBERCULOSIS; INDIA; TB	Background The prevalence of extensively drug-resistant (XDR) tuberculosis is increasing due to the expanded use of second-line drugs in people with multidrug-resistant (MDR) disease. We prospectively assessed resistance to second-line antituberculosis drugs in eight countries. Methods From Jan 1, 2005, to Dec 31, 2008, we enrolled consecutive adults with locally confirmed pulmonary MDR tuberculosis at the start of second-line treatment in Estonia, Latvia, Peru, Philippines, Russia, South Africa, South Korea, and Thailand. Drug-susceptibility testing for study purposes was done centrally at the Centers for Disease Control and Prevention for 11 first-line and second-line drugs. We compared the results with clinical and epidemiological data to identify risk factors for resistance to second-line drugs and XDR tuberculosis. Findings Among 1278 patients, 43.7% showed resistance to at least one second-line drug, 20.0% to at least one second-line injectable drug, and 12.9% to at least one fluoroquinolone. 6.7% of patients had XDR tuberculosis (range across study sites 0.8-15.2%). Previous treatment with second-line drugs was consistently the strongest risk factor for resistance to these drugs, which increased the risk of XDR tuberculosis by more than four times. Fluoroquinolone resistance and XDR tuberculosis were more frequent in women than in men. Unemployment, alcohol abuse, and smoking were associated with resistance to second-line injectable drugs across countries. Other risk factors differed between drugs and countries. Interpretation Previous treatment with second-line drugs is a strong, consistent risk factor for resistance to these drugs, including XDR tuberculosis. Representative drug-susceptibility results could guide in-country policies for laboratory capacity and diagnostic strategies.	[Dalton, Tracy; Cegielski, Peter; Ershova, Julia; Kurbatova, Ekaterina; Kvasnovsky, Charlotte] Ctr Dis Control & Prevent, Div TB Eliminat, Atlanta, GA 30333 USA; [Akksilp, Somsak] Off Dis Prevent & Control Reg 7, Ubon Ratchathani, Thailand; [Asencios, Luis] Natl TB Reference Lab, Lima, Peru; [Campos Caoili, Janice; Tarcela Gler, Ma] Trop Dis Fdn, Manila, Philippines; [Cho, Sang-Nae] Int TB Res Ctr, Masan, South Korea; [Cho, Sang-Nae] Yonsei Univ, Coll Med, Seoul, South Korea; [Erokhin, Vladislav V.] Russian Acad Med Sci, Cent TB Res Inst, Moscow, Russia; [Kazennyy, Boris Y.] Orel Oblast TB Dispensary, Oryol, Russia; [Kim, Hee Jin] Korean Inst TB, Seoul, South Korea; [Kliiman, Kai] Tartu Univ Hosp, Tartu, Estonia; [Leimane, Vaira] State Agcy, Infectol Ctr Latvia, TB & Lung Dis Clin, Riga, Latvia; [van der Walt, Martie] MRC, Pretoria, South Africa; [Via, Laura E.] NIAID, NIH, Bethesda, MD 20892 USA; [Volchenkov, Grigory V.] Vladimir Oblast TB Dispensary, Vladimir, Russia; [Yagui, Martin A.] Natl Inst Hlth, Lima, Peru; [Kang, Hyungseok] Natl Masan TB Hosp, Masan, South Korea	Centers for Disease Control & Prevention - USA; Yonsei University; Yonsei University Health System; Russian Academy of Medical Sciences; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Instituto Nacional de Salud - Peru	Dalton, T (corresponding author), Ctr Dis Control & Prevent, Div TB Eliminat, 1600 Clifton Rd NE,Mailstop F08, Atlanta, GA 30333 USA.	tldalton@cdc.gov	Barry, III, Clifton/H-3839-2012; BONILLA-ASALDE, CÉSAR ANTONIO/AHH-6777-2022; Via, Laura/AAD-3917-2021; Kim, Heejin/HII-8568-2022; Kuznetsova, Tatiana/I-6882-2013; van der Walt, Martie/CAH-0101-2022	Barry, III, Clifton/0000-0002-2927-270X; BONILLA-ASALDE, CÉSAR ANTONIO/0000-0002-4470-1939; Via, Laura/0000-0001-6074-9521; Kuznetsova, Tatiana/0000-0003-3564-7405; van der Walt, Martie/0000-0001-9987-3167; Shamputa, Isdore Chola/0000-0003-1888-8936	US Agency for International Development; Centers for Disease Control and Prevention; National Institutes of Health/National Institute of Allergy and Infectious Diseases; Korean Ministry of Health and Welfare; Centers for Disease Control and Prevention Division of Tuberculosis Elimination; National Institute of Allergy and Infectious Diseases; North Estonia Regional Hospital; Tartu University Hospital, Estonia National Tuberculosis Registry; Estonia National Institute for Health Development; State Agency Infectology Centre of Latvia; Riga Tuberculosis and Lung Disease Clinic; Lima Ciudad and Lima Este Health Districts and reference laboratories; Philippines Tropical Disease Foundation; Orel and Vladimir Oblast Tuberculosis Dispensaries; Central Tuberculosis Research Institute of the Russian Academy of Medical Sciences; South Africa Medical Research Council; KwaZulu-Natal King George V Hospital; Klerksdorp Hospital; Witbank Specialised Tuberculosis Hospital; Jose Pearson Hospital; Korean Institute of Tuberculosis; National Masan Tuberculosis Hospital; Thai Office of Disease Prevention and Control; WHO in Switzerland, Denmark, Peru, and Russia; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001067] Funding Source: NIH RePORTER	US Agency for International Development(United States Agency for International Development (USAID)); Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Institutes of Health/National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Korean Ministry of Health and Welfare(Ministry of Health & Welfare (MOHW), Republic of Korea); Centers for Disease Control and Prevention Division of Tuberculosis Elimination(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); North Estonia Regional Hospital; Tartu University Hospital, Estonia National Tuberculosis Registry; Estonia National Institute for Health Development; State Agency Infectology Centre of Latvia; Riga Tuberculosis and Lung Disease Clinic; Lima Ciudad and Lima Este Health Districts and reference laboratories; Philippines Tropical Disease Foundation; Orel and Vladimir Oblast Tuberculosis Dispensaries; Central Tuberculosis Research Institute of the Russian Academy of Medical Sciences; South Africa Medical Research Council; KwaZulu-Natal King George V Hospital; Klerksdorp Hospital; Witbank Specialised Tuberculosis Hospital; Jose Pearson Hospital; Korean Institute of Tuberculosis; National Masan Tuberculosis Hospital; Thai Office of Disease Prevention and Control; WHO in Switzerland, Denmark, Peru, and Russia; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	US Agency for International Development, Centers for Disease Control and Prevention, National Institutes of Health/National Institute of Allergy and Infectious Diseases, and Korean Ministry of Health and Welfare.; The findings and conclusions in this Article are those of the authors and do not necessarily represent the views of the US CDC. We thank the patients who gave their time and energy to contribute to this study and the doctors, nurses, and microbiologists at each of the enrolment sites for their contributions to this work. We thank the people in the following countries and organisations for support and contributions: Centers for Disease Control and Prevention Division of Tuberculosis Elimination, US Agency for International Development, National Institute of Allergy and Infectious Diseases, North Estonia Regional Hospital, Tartu University Hospital, Estonia National Tuberculosis Registry, Estonia National Institute for Health Development, State Agency Infectology Centre of Latvia, Riga Tuberculosis and Lung Disease Clinic, Lima Ciudad and Lima Este Health Districts and reference laboratories, Philippines Tropical Disease Foundation, Orel and Vladimir Oblast Tuberculosis Dispensaries, Central Tuberculosis Research Institute of the Russian Academy of Medical Sciences, South Africa Medical Research Council, KwaZulu-Natal King George V Hospital, Klerksdorp Hospital, Witbank Specialised Tuberculosis Hospital, Jose Pearson Hospital, Korean Institute of Tuberculosis, National Masan Tuberculosis Hospital, Thai Office of Disease Prevention and Control, and WHO in Switzerland, Denmark, Peru, and Russia. We also thank medical and nursing staff in the Ubon Ratchathani, Srisaket, Sakon Nakon, Yasothon Provinces, Thailand.	Andrews JR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015735; [Anonymous], 2010, MULTIDRUG EXTENSIVEL; [Anonymous], 2008, 4 WHO; [Anonymous], 2006, WKLY EPIDEMIOL REC, V81, P430; Bonilla Cesar A, 2008, PLoS One, V3, pe2957, DOI 10.1371/journal.pone.0002957; Clinical and Laboratory Standars Insistute (CLSI), 2011, SUSC TEST MYC NOC OT; Fleiss JL., 2003, STAT METHODS RATES P; Gupta R, 2002, TROP MED INT HEALTH, V7, P970, DOI 10.1046/j.1365-3156.2002.00960.x; Han LL, 2005, INT J TUBERC LUNG D, V9, P818; James P, 2011, CLIN RESPIR J, V5, P19, DOI 10.1111/j.1752-699X.2009.00184.x; Jeon CY, 2008, CLIN INFECT DIS, V46, P42, DOI 10.1086/524017; Kent PT, 1985, GUIDE LEVEL 3 LAB; Kliiman K, 2009, EUR RESPIR J, V33, P1085, DOI 10.1183/09031936.00155708; Liu CH, 2011, RESPIROLOGY, V16, P918, DOI 10.1111/j.1440-1843.2011.01990.x; Paramasivan CN, 2010, INT J TUBERC LUNG D, V14, P243; Post FA, 2004, J INFECT DIS, V190, P99, DOI 10.1086/421501; Prammananan T, 2005, INT J TUBERC LUNG D, V9, P216; Shah NS, 2007, EMERG INFECT DIS, V13, P380, DOI 10.3201/eid1303.061400; Stokes ME, 2009, CATEGORICAL DATA ANA; WHO, 2006, WKLY EPIDEMIOL REC, V81, P386; WHO, 2011, WHO GLOBAL TUBERCULO; Wright A, 2009, LANCET, V373, P1861, DOI 10.1016/S0140-6736(09)60331-7; Yu HT, 2012, J MED MICROBIOL, V61, P960, DOI 10.1099/jmm.0.042655-0	23	146	151	0	53	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 20	2012	380	9851					1406	1417		10.1016/S0140-6736(12)60734-X	http://dx.doi.org/10.1016/S0140-6736(12)60734-X			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	025NM	22938757				2022-12-28	WOS:000310196500030
J	Hoffner, S				Hoffner, Sven			Unexpected high levels of multidrug-resistant tuberculosis present new challenges for tuberculosis control	LANCET			English	Editorial Material							MYCOBACTERIUM-TUBERCULOSIS; DRUG		Swedish Inst Communicable Dis Control, Dept Preparedness, SE-17182 Solna, Sweden	Swedish Institute for Infectious Disease Control	Hoffner, S (corresponding author), Swedish Inst Communicable Dis Control, Dept Preparedness, SE-17182 Solna, Sweden.	sven.hoffner@smi.se						Chang KC, 2011, ANTIMICROB AGENTS CH, V55, P4499, DOI 10.1128/AAC.00630-11; Dalton T, 2012, LANCET; Diacon AH, 2012, LANCET; Ignatyeva O, 2012, J CLIN MICROBIOL, V50, P1593, DOI 10.1128/JCM.00039-12; Kruuner A, 2001, J CLIN MICROBIOL, V39, P3339, DOI 10.1128/JCM.39.9.3339-3345.2001; Nodieva A, 2010, INT J TUBERC LUNG D, V14, P427; Skrahina A, 2012, EUR RESPIR J, V39, P1425, DOI 10.1183/09031936.00145411; Udwadia ZF, 2012, CLIN INFECT DIS, V54, P579, DOI 10.1093/cid/cir889; Van Deun A, 2011, INT J TUBERC LUNG D, V15, P116; Velayati AA, 2009, CHEST, V136, P420, DOI 10.1378/chest.08-2427; World Health Organization, 2008, ORGANIZATION; Wright A, 2009, LANCET, V373, P1861, DOI 10.1016/S0140-6736(09)60331-7; Zignol M, 2012, B WORLD HEALTH ORGAN, V90, P111, DOI 10.2471/BLT.11.092585	13	19	19	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 20	2012	380	9851					1367	1369		10.1016/S0140-6736(12)61069-1	http://dx.doi.org/10.1016/S0140-6736(12)61069-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	025NM	22938756				2022-12-28	WOS:000310196500008
J	Bollen, G				Bollen, Georg			Measuring the Heaviest Atoms	SCIENCE			English	Editorial Material							DIRECT MASS MEASUREMENTS; SPECTROMETRY; ELEMENTS; SHIPTRAP; ISLAND		Michigan State Univ, Facil Rare Isotope Beams, E Lansing, MI 48824 USA	Michigan State University	Bollen, G (corresponding author), Michigan State Univ, Facil Rare Isotope Beams, E Lansing, MI 48824 USA.	bollen@frib.msu.edu	Bollen, Georg/GWQ-5595-2022					Blaum K, 2006, PHYS REP, V425, P1, DOI 10.1016/j.physrep.2005.10.011; Block M, 2007, EUR PHYS J D, V45, P39, DOI 10.1140/epjd/e2007-00189-2; Block M, 2010, NATURE, V463, P785, DOI 10.1038/nature08774; Bollen G, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.152501; Clery D, 2011, SCIENCE, V333, P1377, DOI 10.1126/science.333.6048.1377; Ferrer R, 2007, EUR PHYS J-SPEC TOP, V150, P347, DOI 10.1140/epjst/e2007-00342-1; Hofmann S, 2000, REV MOD PHYS, V72, P733, DOI 10.1103/RevModPhys.72.733; Morita K, 2004, J PHYS SOC JPN, V73, P2593, DOI 10.1143/JPSJ.73.2593; Mukherjee M, 2008, EUR PHYS J A, V35, P1, DOI 10.1140/epja/i2007-10528-9; Oganessian Y, 2007, J PHYS G NUCL PARTIC, V34, pR165, DOI 10.1088/0954-3899/34/4/R01; Ramirez EM, 2012, SCIENCE, V337, P1207, DOI 10.1126/science.1225636; Stavsetra L, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.132502	12	0	0	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 7	2012	337	6099					1183	1184		10.1126/science.1228467	http://dx.doi.org/10.1126/science.1228467			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	000UJ	22955825				2022-12-28	WOS:000308414000025
J	Moore, W				Moore, Wendy			The eccentricities of osteopathy	BRITISH MEDICAL JOURNAL			English	Editorial Material												wendymoore@ntlworld.com						Gevitz N, 2007, DICT MED BIOGRAPHY, V5, P118; Still AT, 1897, AUTOBIOGRAPHY; Trowbridge C., 1991, AT STILL 1828 1917	3	0	0	0	5	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	SEP 3	2012	345								e5890	10.1136/bmj.e5890	http://dx.doi.org/10.1136/bmj.e5890			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	003TH	22945956				2022-12-28	WOS:000308633700008
J	Aldy, JE; Stavins, RN				Aldy, Joseph E.; Stavins, Robert N.			Climate Negotiators Create an Opportunity for Scholars	SCIENCE			English	Editorial Material									[Stavins, Robert N.] Harvard Univ, John F Kennedy Sch Govt, Cambridge, MA 02138 USA; Resources Future Inc, Washington, DC 20036 USA; Natl Bur Econ Res, Cambridge, MA 02138 USA	Harvard University; Resources for the Future; National Bureau of Economic Research	Stavins, RN (corresponding author), Harvard Univ, John F Kennedy Sch Govt, Cambridge, MA 02138 USA.	robert_stavins@harvard.edu						Aldy J. E., 2012, DESIGNING BRETTON WO; Bosetti V., 2011, 201146 HARV KENN SCH; Jaffe J, 2009, ECOL LAW QUART, V36, P789; Newell R. G., 2010, POSTKYOTO INT CLIMAT; Nordhaus WD., 2008, QUESTION BALANCE; United States Energy Information Administration, 2012, INT EN STAT; World Resources Institute, 2012, CLIM AN IND TOOL	7	28	28	1	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 31	2012	337	6098					1043	1044		10.1126/science.1223836	http://dx.doi.org/10.1126/science.1223836			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	996WP	22936761				2022-12-28	WOS:000308125800028
J	Lewis, MA; Steel, KP				Lewis, Morag A.; Steel, Karen P.			A Cornucopia of Candidates for Deafness	CELL			English	Editorial Material							HAIR CELL-DIFFERENTIATION; TRANSCRIPTION FACTOR; EAR; DROSOPHILA; HEARING; ORGAN; CHANNEL; SYSTEM; GENE	Many genes involved in deafness are yet to be discovered. Here, Senthilan et al. focus on the Drosophila Johnston's organ to uncover a wide variety of genes, including several unexpected candidates as well as those already known to underlie deafness in mice and humans.	[Lewis, Morag A.; Steel, Karen P.] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England	Wellcome Trust Sanger Institute	Steel, KP (corresponding author), Wellcome Trust Sanger Inst, Genome Campus, Cambridge CB10 1SA, England.	kps@sanger.ac.uk		Lewis, Morag/0000-0002-1846-8600	MRC [G0300212, MC_qA137918] Funding Source: UKRI; Medical Research Council [MC_qA137918] Funding Source: researchfish; Medical Research Council [G0300212, MC_QA137918] Funding Source: Medline; Wellcome Trust [098051] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Bechstedt S, 2008, CURR BIOL, V18, pR869, DOI 10.1016/j.cub.2008.07.069; Bermingham NA, 1999, SCIENCE, V284, P1837, DOI 10.1126/science.284.5421.1837; Boekhoff-Falk G, 2005, DEV DYNAM, V232, P550, DOI 10.1002/dvdy.20207; Corey DP, 2006, J PHYSIOL-LONDON, V576, P23, DOI 10.1113/jphysiol.2006.116582; Effertz T, 2011, CURR BIOL, V21, P592, DOI 10.1016/j.cub.2011.02.048; Hertzano R, 2007, EUR J NEUROSCI, V25, P999, DOI 10.1111/j.1460-9568.2007.05332.x; JARMAN AP, 1993, CELL, V73, P1307, DOI 10.1016/0092-8674(93)90358-W; Senthilan PR, 2012, CELL, V150, P1042, DOI 10.1016/j.cell.2012.06.043; Wallis D, 2003, DEVELOPMENT, V130, P221, DOI 10.1242/dev.00190; Zheng JL, 2000, DEVELOPMENT, V127, P4551	10	3	3	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 31	2012	150	5					879	881		10.1016/j.cell.2012.08.007	http://dx.doi.org/10.1016/j.cell.2012.08.007			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	001ZU	22939617	Bronze			2022-12-28	WOS:000308500200004
J	Benavente, OR; Hart, RG; McClure, LA; Szychowski, JM; Coffey, CS; Pearce, LA				Benavente, Oscar R.; Hart, Robert G.; McClure, Leslie A.; Szychowski, Jeffrey M.; Coffey, Christopher S.; Pearce, Lesly A.		SPS3 Investigators	Effects of Clopidogrel Added to Aspirin in Patients with Recent Lacunar Stroke	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TRANSIENT ISCHEMIC ATTACK; RISK-FACTORS; SECONDARY PREVENTION; DOUBLE-BLIND; SUBTYPES; POPULATION; RECURRENCE; PROGNOSIS; DEMENTIA; SURVIVAL	BACKGROUND Lacunar infarcts are a frequent type of stroke caused mainly by cerebral small-vessel disease. The effectiveness of antiplatelet therapy for secondary prevention has not been defined. METHODS We conducted a double-blind, multicenter trial involving 3020 patients with recent symptomatic lacunar infarcts identified by magnetic resonance imaging. Patients were randomly assigned to receive 75 mg of clopidogrel or placebo daily; patients in both groups received 325 mg of aspirin daily. The primary outcome was any recurrent stroke, including ischemic stroke and intracranial hemorrhage. RESULTS The participants had a mean age of 63 years, and 63% were men. After a mean follow-up of 3.4 years, the risk of recurrent stroke was not significantly reduced with aspirin and clopidogrel (dual antiplatelet therapy) (125 strokes; rate, 2.5% per year) as compared with aspirin alone (138 strokes, 2.7% per year) (hazard ratio, 0.92; 95% confidence interval [CI], 0.72 to 1.16), nor was the risk of recurrent ischemic stroke (hazard ratio, 0.82; 95% CI, 0.63 to 1.09) or disabling or fatal stroke (hazard ratio, 1.06; 95% CI, 0.69 to 1.64). The risk of major hemorrhage was almost doubled with dual antiplatelet therapy (105 hemorrhages, 2.1% per year) as compared with aspirin alone (56, 1.1% per year) (hazard ratio, 1.97; 95% CI, 1.41 to 2.71; P<0.001). Among classifiable recurrent ischemic strokes, 71% (133 of 187) were lacunar strokes. All-cause mortality was increased among patients assigned to receive dual antiplatelet therapy (77 deaths in the group receiving aspirin alone vs. 113 in the group receiving dual antiplatelet therapy) (hazard ratio, 1.52; 95% CI, 1.14 to 2.04; P = 0.004); this difference was not accounted for by fatal hemorrhages (9 in the group receiving dual antiplatelet therapy vs. 4 in the group receiving aspirin alone). CONCLUSIONS Among patients with recent lacunar strokes, the addition of clopidogrel to aspirin did not significantly reduce the risk of recurrent stroke and did significantly increase the risk of bleeding and death. (Funded by the National Institute of Neurological Disorders and Stroke and others; SPS3 ClinicalTrials.gov number, NCT00059306.)	[Benavente, Oscar R.] Univ British Columbia, Brain Res Ctr, Dept Med, Div Neurol, Vancouver, BC V6T 2B5, Canada; [Hart, Robert G.] Populat Hlth Res Inst, Hamilton, ON, Canada; [McClure, Leslie A.; Szychowski, Jeffrey M.] Univ Alabama Birmingham, Birmingham, AL USA; [Coffey, Christopher S.] Univ Iowa, Iowa City, IA USA	University of British Columbia; Population Health Research Institute; University of Alabama System; University of Alabama Birmingham; University of Iowa	Benavente, OR (corresponding author), Univ British Columbia, Brain Res Ctr, Dept Med, Div Neurol, S169-2211 Wesbrook Mall, Vancouver, BC V6T 2B5, Canada.	oscar.benavente@ubc.ca	Roquer, Jaume/G-8919-2017; Fuentes, Blanca/I-2114-2019; Sánchez, Patricia Martínez/O-5687-2016; Hill, Michael D/C-9073-2012; JIMENEZ-CONDE, JORDI/C-1941-2012; Reverté Villarroya, Silvia/AAX-7360-2020; Arboix, Adrià/E-2067-2018; McClure, Leslie/P-2929-2015	Roquer, Jaume/0000-0001-5992-2606; Fuentes, Blanca/0000-0002-0363-862X; Sánchez, Patricia Martínez/0000-0003-1945-4435; Hill, Michael D/0000-0002-6269-1543; Reverté Villarroya, Silvia/0000-0002-2052-9978; Arboix, Adrià/0000-0002-8512-7881; Szychowski, Jeff/0000-0002-1727-1662; Tirschwell, David/0000-0002-8059-2901; Diez Tejedor, Exuperio/0000-0003-2295-1707; Cantu-Brito, Carlos/0000-0001-7494-2015; Pearce, Lesly/0000-0002-0838-1739; Castellanos, Maria del Mar/0000-0003-3116-1352	National Institute of Neurological Disorders and Stroke [U01 NS38529-04A1]; Sanofi-Aventis; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS038529] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Sanofi-Aventis(Sanofi-Aventis); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funded by the National Institute of Neurological Disorders and Stroke and others; SPS3 ClinicalTrials.gov number, NCT00059306.); Supported by a grant from the National Institute of Neurological Disorders and Stroke (U01 NS38529-04A1) and by Sanofi-Aventis and Bristol-Myers Squibb, which donated the clopidogrel and matching placebo used in the study.	Benavente OR, 2011, INT J STROKE, V6, P164, DOI 10.1111/j.1747-4949.2010.00573.x; Berger PB, 2010, CIRCULATION, V121, P2575, DOI 10.1161/CIRCULATIONAHA.109.895342; Bhatt DL, 2006, NEW ENGL J MED, V354, P1706, DOI 10.1056/NEJMoa060989; BOGOUSSLAVSKY J, 1988, STROKE, V19, P1083, DOI 10.1161/01.STR.19.9.1083; BOITEN J, 1993, CEREBROVASC DIS, V3, P221, DOI 10.1159/000108704; Bousser MG, 2011, LANCET, V377, P2013, DOI 10.1016/S0140-6736(11)60600-4; Connolly SJ, 2009, NEW ENGL J MED, V360, P2066, DOI 10.1056/NEJMoa0901301; Delaney JA, 2007, CAN MED ASSOC J, V177, P347, DOI 10.1503/cmaj.070186; DELBRUTTO OH, 1993, STROKE, V24, P1833, DOI 10.1161/01.STR.24.12.1833; Diener HC, 2004, LANCET, V364, P331, DOI 10.1016/S0140-6736(04)16721-4; Furie KL, 2011, STROKE, V42, P227, DOI 10.1161/STR.0b013e3181f7d043; Hart RG, 2005, STROKE, V36, P1588, DOI 10.1161/01.STR.0000170642.39876.f2; HAZUDA HP, 1986, AM J EPIDEMIOL, V123, P96, DOI 10.1093/oxfordjournals.aje.a114228; Kolominsky-Rabas PL, 2001, STROKE, V32, P2735, DOI 10.1161/hs1201.100209; Lavados PM, 2005, LANCET, V365, P2206, DOI 10.1016/S0140-6736(05)66779-7; McClure LA, 2012, CONTEMP CLIN TRIALS, V33, P1088, DOI 10.1016/j.cct.2012.06.007; Mehta SR, 2010, NEW ENGL J MED, V363, P1585; Mehta SR, 2010, NEW ENGL J MED, V363, P930, DOI 10.1056/NEJMoa0909475; Palacio S, 2012, STROKE, V43, P2157, DOI 10.1161/STROKEAHA.112.656173; Peters RJG, 2003, CIRCULATION, V108, P1682, DOI 10.1161/01.CIR.0000091201.39590.CB; Ross GW, 1999, NEUROLOGY, V53, P337, DOI 10.1212/WNL.53.2.337; Sacco RL, 2008, NEW ENGL J MED, V359, P1238, DOI 10.1056/NEJMoa0805002; SACCO RL, 1995, NEUROLOGY, V45, P659, DOI 10.1212/WNL.45.4.659; Saposnik G, 2003, STROKE, V34, P2103, DOI 10.1161/01.STR.0000088063.74250.DB; Steinhubl SR, 2009, ANN INTERN MED, V150, P379, DOI 10.7326/0003-4819-150-6-200903170-00006; TATEMICHI TK, 1993, ANN NEUROL, V33, P568, DOI 10.1002/ana.410330603; Usman MHU, 2009, AM J CARDIOL, V103, P1107, DOI 10.1016/j.amjcard.2009.01.003; Wardlaw JM, 2005, J NEUROL NEUROSUR PS, V76, P617, DOI 10.1136/jnnp.2004.039982; White CL, 2012, J STROKE CEREBROVASC; Wolfe CDA, 2002, J NEUROL NEUROSUR PS, V72, P211, DOI 10.1136/jnnp.72.2.211; Worley K L, 1998, Tex Med, V94, P62; Yusuf S, 2001, NEW ENGL J MED, V345, P494; ZWEIFLER RM, 1995, STROKE, V26, P245, DOI 10.1161/01.STR.26.2.245; 2001, N ENGL J MED, V345, P1506; 2001, N ENGL J MED, V345, P1716	35	426	446	2	41	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 30	2012	367	9					817	825		10.1056/NEJMoa1204133	http://dx.doi.org/10.1056/NEJMoa1204133			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	996EN	22931315	Green Accepted			2022-12-28	WOS:000308067400003
J	Browne, SK; Burbelo, PD; Chetchotisakd, P; Suputtamongkol, Y; Kiertiburanakul, S; Shaw, PA; Kirk, JL; Jutivorakool, K; Zaman, R; Ding, L; Hsu, AP; Patel, SY; Olivier, KN; Lulitanond, V; Mootsikapun, P; Anunnatsiri, S; Angkasekwinai, N; Sathapatayavongs, B; Hsueh, PR; Shieh, CC; Brown, MR; Thongnoppakhun, W; Claypool, R; Sampaio, EP; Thepthai, C; Waywa, D; Dacombe, C; Reizes, Y; Zelazny, AM; Saleeb, P; Rosen, LB; Mo, A; Iadarola, M; Holland, SM				Browne, Sarah K.; Burbelo, Peter D.; Chetchotisakd, Ploenchan; Suputtamongkol, Yupin; Kiertiburanakul, Sasisopin; Shaw, Pamela A.; Kirk, Jennifer L.; Jutivorakool, Kamonwan; Zaman, Rifat; Ding, Li; Hsu, Amy P.; Patel, Smita Y.; Olivier, Kenneth N.; Lulitanond, Viraphong; Mootsikapun, Piroon; Anunnatsiri, Siriluck; Angkasekwinai, Nasikarn; Sathapatayavongs, Boonmee; Hsueh, Po-Ren; Shieh, Chi-Chang; Brown, Margaret R.; Thongnoppakhun, Wanna; Claypool, Reginald; Sampaio, Elizabeth P.; Thepthai, Charin; Waywa, Duangdao; Dacombe, Camilla; Reizes, Yona; Zelazny, Adrian M.; Saleeb, Paul; Rosen, Lindsey B.; Mo, Allen; Iadarola, Michael; Holland, Steven M.			Adult-Onset Immunodeficiency in Thailand and Taiwan	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NONTUBERCULOUS MYCOBACTERIAL INFECTION; INTERFERON-GAMMA AUTOANTIBODY; IFN-GAMMA; AVIUM COMPLEX; PATIENT; DISEASES; SUSCEPTIBILITY; RECURRENT; HIV	BACKGROUND Autoantibodies against interferon-gamma are associated with severe disseminated opportunistic infection, but their importance and prevalence are unknown. METHODS We enrolled 203 persons from sites in Thailand and Taiwan in five groups: 52 patients with disseminated, rapidly or slowly growing, nontuberculous mycobacterial infection (group 1); 45 patients with another opportunistic infection, with or without nontuberculous mycobacterial infection (group 2); 9 patients with disseminated tuberculosis (group 3); 49 patients with pulmonary tuberculosis (group 4); and 48 healthy controls (group 5). Clinical histories were recorded, and blood specimens were obtained. RESULTS Patients in groups 1 and 2 had CD4+ T-lymphocyte counts that were similar to those in patients in groups 4 and 5, and they were not infected with the human immunodeficiency virus (HIV). Washed cells obtained from patients in groups 1 and 2 had intact cytokine production and a response to cytokine stimulation. In contrast, plasma obtained from these patients inhibited the activity of interferon-gamma in normal cells. High-titer anti-interferon-gamma autoantibodies were detected in 81% of patients in group 1, 96% of patients in group 2, 11% of patients in group 3, 2% of patients in group 4, and 2% of controls (group 5). Forty other anticytokine autoantibodies were assayed. One patient with cryptococcal meningitis had autoantibodies only against granulocyte-macrophage colony-stimulating factor. No other anticytokine autoantibodies or genetic defects correlated with infections. There was no familial clustering. CONCLUSIONS Neutralizing anti-interferon-gamma autoantibodies were detected in 88% of Asian adults with multiple opportunistic infections and were associated with an adult-onset immunodeficiency akin to that of advanced HIV infection. (Funded by the National Institute of Allergy and Infectious Diseases and the National Institute of Dental and Craniofacial Research; ClinicalTrials.gov number, NCT00814827.)	[Browne, Sarah K.; Jutivorakool, Kamonwan; Zaman, Rifat; Ding, Li; Hsu, Amy P.; Olivier, Kenneth N.; Brown, Margaret R.; Claypool, Reginald; Sampaio, Elizabeth P.; Saleeb, Paul; Rosen, Lindsey B.; Mo, Allen; Holland, Steven M.] NIAID, Lab Clin Infect Dis, NIH, Bethesda, MD 20892 USA; [Shaw, Pamela A.; Kirk, Jennifer L.] NIAID, Biostat Res Branch, NIH, Bethesda, MD 20892 USA; [Burbelo, Peter D.; Iadarola, Michael] Natl Inst Dent & Craniofacial Res, Lab Sensory Biol, NIH, Bethesda, MD USA; [Zelazny, Adrian M.] NIH, Microbiol Serv, Dept Lab Med, Ctr Clin, Bethesda, MD 20892 USA; [Dacombe, Camilla; Reizes, Yona] Systex, Rockville, MD USA; [Chetchotisakd, Ploenchan; Lulitanond, Viraphong; Mootsikapun, Piroon; Anunnatsiri, Siriluck] Khon Kaen Univ, Srinagarind Hosp, Khon Kaen, Thailand; [Suputtamongkol, Yupin; Angkasekwinai, Nasikarn; Thongnoppakhun, Wanna; Thepthai, Charin; Waywa, Duangdao] Mahidol Univ, Siriraj Hosp, Bangkok 10700, Thailand; [Browne, Sarah K.; Sathapatayavongs, Boonmee] Mahidol Univ, Ramathibodi Hosp, Fac Med, Bangkok 10400, Thailand; [Jutivorakool, Kamonwan] Chulalongkorn Univ, Fac Med, Dept Med, Bangkok 10330, Thailand; [Jutivorakool, Kamonwan] Thai Red Cross Soc, King Chulalongkorn Mem Hosp, Bangkok, Thailand; [Patel, Smita Y.] Univ Oxford, John Radcliffe Hosp, Oxford OX3 9DU, England; [Hsueh, Po-Ren] Natl Taiwan Univ, Taipei 10764, Taiwan; [Shieh, Chi-Chang] Natl Cheng Kung Univ, Tainan 70101, Taiwan; [Sampaio, Elizabeth P.] Inst Oswaldo Cruz, Leprosy Lab, BR-20001 Rio De Janeiro, Brazil; [Mo, Allen] Colgate Univ, Hamilton, NY 13346 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); Khon Kaen University; Mahidol University; Mahidol University; Chulalongkorn University; Chulalongkorn University; Thai Red Cross Society; University of Oxford; National Taiwan University; National Cheng Kung University; Fundacao Oswaldo Cruz; Colgate University	Browne, SK (corresponding author), CRC B3-4141,MSC 1684,9000 Rockville Pike, Bethesda, MD 20892 USA.	brownesa@niaid.nih.gov	Angkasekwinai, Nasikarn/AAS-3199-2020; Hsueh, Po-Ren/ABE-1594-2021	HSUEH, PO-REN/0000-0002-7502-9225; Patel, Smita/0000-0002-6207-2208	Division of Intramural Research, National Institute of Allergy and Infectious Diseases; Division of Intramural Research, National Institute of Dental and Craniofacial Research, National Institutes of Health; National Institute of Allergy and Infectious Diseases; National Institute of Dental and Craniofacial Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001069] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000724] Funding Source: NIH RePORTER; CLINICAL CENTER [ZIACL080013, ZIACL090034] Funding Source: NIH RePORTER	Division of Intramural Research, National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Division of Intramural Research, National Institute of Dental and Craniofacial Research, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); CLINICAL CENTER	Supported by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, and the Division of Intramural Research, National Institute of Dental and Craniofacial Research, National Institutes of Health.; Funded by the National Institute of Allergy and Infectious Diseases and the National Institute of Dental and Craniofacial Research	Al-Muhsen S, 2008, J ALLERGY CLIN IMMUN, V122, P1043, DOI 10.1016/j.jaci.2008.10.037; Anekthananon Thanomsak, 2004, Journal of the Medical Association of Thailand, V87, P173; Baerlecken N, 2009, CLIN INFECT DIS, V49, pE76, DOI 10.1086/605581; Browne SK, 2012, BLOOD, V119, P3933, DOI 10.1182/blood-2011-12-395707; Browne SK, 2010, LANCET INFECT DIS, V10, P875, DOI 10.1016/S1473-3099(10)70196-1; Burbelo PD, 2010, BLOOD, V116, P4848, DOI 10.1182/blood-2010-05-286161; Burbelo Peter D, 2009, J Vis Exp, DOI 10.3791/1549; Carey B, 2010, CLIN IMMUNOL, V135, P223, DOI 10.1016/j.clim.2010.02.017; *CDCP, 2003, GUID APPR EV HIV TES; Chen YP, 2008, APMIS, V116, P850, DOI 10.1111/j.1600-0463.2008.00935.x; Chetchotisakd P, 2000, CLIN INFECT DIS, V30, P29, DOI 10.1086/313589; Chetchotisakd P, 2007, CLIN INFECT DIS, V45, P421, DOI 10.1086/520030; Clark S, 2011, J ALLERGY CLIN IMMUN, V128, P838, DOI 10.1016/j.jaci.2011.05.025; Crum NF, 2005, MEDICINE, V84, P291, DOI 10.1097/01.md.0000180044.19285.9a; Ding LW, 2006, EPIDEMIOL INFECT, V134, P1060, DOI 10.1017/S0950268805005698; Ding L, 2012, J CLIN IMMUNOL, V32, P238, DOI 10.1007/s10875-011-9621-8; Doffinger R, 2004, CLIN INFECT DIS, V38, pE10, DOI 10.1086/380453; Dorman SE, 2000, CYTOKINE GROWTH F R, V11, P321, DOI 10.1016/S1359-6101(00)00010-1; Hoflich C, 2004, BLOOD, V103, P673, DOI 10.1182/blood-2003-04-1065; Kampitak T, 2011, INFECTION, V39, P65, DOI 10.1007/s15010-010-0067-3; Kampmann B, 2005, J CLIN INVEST, V115, P2480, DOI 10.1172/JCI19316; Kony SJ, 2000, J INFECTION, V41, P167, DOI 10.1053/jinf.2000.0721; Koya T, 2009, J INFECT CHEMOTHER, V15, P118, DOI 10.1007/s10156-008-0662-8; Patel SY, 2005, J IMMUNOL, V175, P4769, DOI 10.4049/jimmunol.175.7.4769; Sungkanuparph Somnuek, 2003, International Journal of Infectious Diseases, V7, P198, DOI 10.1016/S1201-9712(03)90052-X; SUTHERLAND R, 2006, 17 INT AIDS C MEX CI, V20, P821; Tanaka Y, 2007, INTERNAL MED, V46, P1005, DOI 10.2169/internalmedicine.46.6452; Tang BSF, 2010, CLIN VACCINE IMMUNOL, V17, P1132, DOI 10.1128/CVI.00053-10; van de Vosse E, 2004, LANCET INFECT DIS, V4, P739, DOI 10.1016/S1473-3099(04)01203-4; World Health Organization, 2010, WHO GLOB TUB CONTR	30	319	326	3	35	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 23	2012	367	8					725	734		10.1056/NEJMoa1111160	http://dx.doi.org/10.1056/NEJMoa1111160			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	992CX	22913682	Green Accepted, Bronze			2022-12-28	WOS:000307754200007
J	Spence, D				Spence, Des			Methadone is no panacea	BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk						[Anonymous], 2012, BBC NEWS	1	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	AUG 22	2012	345								e5670	10.1136/bmj.e5670	http://dx.doi.org/10.1136/bmj.e5670			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	996GV	22915733				2022-12-28	WOS:000308073800004
J	Zenon, A; Krauzlis, RJ				Zenon, Alexandre; Krauzlis, Richard J.			Attention deficits without cortical neuronal deficits	NATURE			English	Article							AREAS MT; MODULATION; MICROSTIMULATION; INACTIVATION; SELECTION; SIGNALS	The ability to process relevant stimuli selectively is a fundamental function of the primate visual system. The best-understood correlate of this function is the enhanced response of neurons in the visual cortex to attended stimuli(1,2). However, recent results show that the superior colliculus (SC), a midbrain structure, also has a crucial role in visual attention(3-5). It has been assumed that the SC acts through the same well-known mechanisms in the visual cortex(3,5). Here we tested this hypothesis by transiently inactivating the SC during a motion-change-detection task and measuring responses in two visual cortical areas. We found that despite large deficits in visual attention, the enhanced responses of neurons in the visual cortex to attended stimuli were unchanged. These results show that the SC contributes to visual attention through mechanisms that are independent of the classic effects in the visual cortex, demonstrating that other processes must have key roles in visual attention.	[Zenon, Alexandre; Krauzlis, Richard J.] Salk Inst Biol Studies, Syst Neurobiol Lab, La Jolla, CA 92037 USA; [Zenon, Alexandre] Catholic Univ Louvain, Inst Neurosci, B-1200 Brussels, Belgium; [Krauzlis, Richard J.] NEI, Lab Sensorimotor Res, Bethesda, MD 20892 USA	Salk Institute; Universite Catholique Louvain; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Krauzlis, RJ (corresponding author), Salk Inst Biol Studies, Syst Neurobiol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	richard.krauzlis@nih.gov	Zénon, Alexandre/AGN-7203-2022	Zénon, Alexandre/0000-0001-7989-1261; Richard, Krauzlis/0000-0002-1826-0447	F.M. Kirby Foundation; National Eye Institute Intramural Research Program at the National Institutes of Health; NATIONAL EYE INSTITUTE [ZIAEY000511] Funding Source: NIH RePORTER	F.M. Kirby Foundation; National Eye Institute Intramural Research Program at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank E. Boehle, N. Dill and A. Karnik for technical assistance, and R. Wurtz for discussions and reading of the manuscript. This work was supported by the F.M. Kirby Foundation and the National Eye Institute Intramural Research Program at the National Institutes of Health.	Bair W, 2001, J NEUROSCI, V21, P1676, DOI 10.1523/JNEUROSCI.21-05-01676.2001; Bender DB, 2001, J NEUROPHYSIOL, V85, P219, DOI 10.1152/jn.2001.85.1.219; Berger J. O., 2001, MONOGRAPH SERIES, V38, P135; Carrasco M, 2004, NAT NEUROSCI, V7, P308, DOI 10.1038/nn1194; Cavanaugh J, 2004, J NEUROSCI, V24, P11236, DOI 10.1523/JNEUROSCI.3724-04.2004; Cohen MR, 2009, NAT NEUROSCI, V12, P1594, DOI 10.1038/nn.2439; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Dickey AS, 2009, J NEUROPHYSIOL, V102, P1331, DOI 10.1152/jn.90920.2008; Hafed ZM, 2008, J NEUROSCI, V28, P8124, DOI 10.1523/JNEUROSCI.1317-08.2008; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Harris KD, 2000, J NEUROPHYSIOL, V84, P401, DOI 10.1152/jn.2000.84.1.401; Ignashchenkova A, 2004, NAT NEUROSCI, V7, P56, DOI 10.1038/nn1169; Kustov AA, 1996, NATURE, V384, P74, DOI 10.1038/384074a0; Lovejoy LP, 2010, NAT NEUROSCI, V13, P261, DOI 10.1038/nn.2470; Mitchell JF, 2007, NEURON, V55, P131, DOI 10.1016/j.neuron.2007.06.018; Mitchell JF, 2009, NEURON, V63, P879, DOI 10.1016/j.neuron.2009.09.013; Moore T, 2006, CURR OPIN NEUROBIOL, V16, P159, DOI 10.1016/j.conb.2006.03.009; Moore T, 2003, NATURE, V421, P370, DOI 10.1038/nature01341; MORAN J, 1985, SCIENCE, V229, P782, DOI 10.1126/science.4023713; Muller JR, 2005, P NATL ACAD SCI USA, V102, P524, DOI 10.1073/pnas.0408311101; O'Connor DH, 2002, NAT NEUROSCI, V5, P1203, DOI 10.1038/nn957; Palmer J, 2009, VISION RES, V49, P1045, DOI 10.1016/j.visres.2008.02.022; Redgrave P, 1999, NEUROSCIENCE, V89, P1009, DOI 10.1016/S0306-4522(98)00319-4; Rensink RA, 1997, PSYCHOL SCI, V8, P368, DOI 10.1111/j.1467-9280.1997.tb00427.x; Reynolds JH, 2004, ANNU REV NEUROSCI, V27, P611, DOI 10.1146/annurev.neuro.26.041002.131039; ROBINSON DL, 1992, TRENDS NEUROSCI, V15, P127, DOI 10.1016/0166-2236(92)90354-B; Roelfsema PR, 1998, NATURE, V395, P376, DOI 10.1038/26475; Ross TD, 2003, COMPUT BIOL MED, V33, P509, DOI 10.1016/S0010-4825(03)00019-2; Rudolph K, 1999, CEREB CORTEX, V9, P90, DOI 10.1093/cercor/9.1.90; SCHOPPMANN A, 1976, NEUROSCI LETT, V2, P177, DOI 10.1016/0304-3940(76)90011-2; Treue S, 1999, NATURE, V399, P575, DOI 10.1038/21176; Treue S, 1996, NATURE, V382, P539, DOI 10.1038/382539a0; Treue S, 2001, TRENDS NEUROSCI, V24, P295, DOI 10.1016/S0166-2236(00)01814-2; Wagenmakers EJ, 2007, PSYCHON B REV, V14, P779, DOI 10.3758/BF03194105; Wardak C, 2006, J NEUROSCI, V26, P4228, DOI 10.1523/JNEUROSCI.3336-05.2006; Wetzels R, 2009, PSYCHON B REV, V16, P752, DOI 10.3758/PBR.16.4.752	37	146	147	0	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 20	2012	489	7416					434	U124		10.1038/nature11497	http://dx.doi.org/10.1038/nature11497			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AK	22972195	Green Accepted			2022-12-28	WOS:000308860900046
J	Gao, Y; Zorman, S; Gundersen, G; Xi, ZQ; Ma, L; Sirinakis, G; Rothman, JE; Zhang, YL				Gao, Ying; Zorman, Sylvain; Gundersen, Gregory; Xi, Zhiqun; Ma, Lu; Sirinakis, George; Rothman, James E.; Zhang, Yongli			Single Reconstituted Neuronal SNARE Complexes Zipper in Three Distinct Stages	SCIENCE			English	Article							MEMBRANE-FUSION; NEUROTRANSMITTER RELEASE; SYNAPTOBREVIN; PROTEINS; EXOCYTOSIS; MOLECULE; COIL; ENERGETICS; MECHANISM; BINDING	Soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) proteins drive membrane fusion by assembling into a four-helix bundle in a zippering process. Here, we used optical tweezers to observe in a cell-free reconstitution experiment in real time a long-sought SNARE assembly intermediate in which only the membrane-distal amino-terminal half of the bundle is assembled. Our findings support the zippering hypothesis, but suggest that zippering proceeds through three sequential binary switches, not continuously, in the amino-and carboxyl-terminal halves of the bundle and the linker domain. The half-zippered intermediate was stabilized by externally applied force that mimicked the repulsion between apposed membranes being forced to fuse. This intermediate then rapidly and forcefully zippered, delivering free energy of 36 k(B)T (where k(B) is Boltzmann's constant and T is temperature) to mediate fusion.	[Gao, Ying; Zorman, Sylvain; Gundersen, Gregory; Xi, Zhiqun; Ma, Lu; Sirinakis, George; Rothman, James E.; Zhang, Yongli] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06520 USA	Yale University	Rothman, JE (corresponding author), Yale Univ, Sch Med, Dept Cell Biol, 333 Cedar St, New Haven, CT 06520 USA.	james.rothman@yale.edu; yongli.zhang@yale.edu			NIH [GM093341, DK027044]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK027044, R01DK027044] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM093341] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank H. Ji and W. Xu for technical assistance and F. Pincet, T. Melia, and E. Karatekin for valuable discussion. This work is supported by NIH grants GM093341 to Y.Z. and DK027044 to J.E.R. Y.Z. designed the experiments; Y.G., S.Z., G. G., Z.X., L. M., and G. S. performed the experiments; Y.Z. and Y.G. analyzed the data; and Y.Z. and J.E.R. wrote the paper. The data and Matlab codes are in the paper and the supplementary materials.	Cecconi C, 2005, SCIENCE, V309, P2057, DOI 10.1126/science.1116702; Cohen FS, 2004, J MEMBRANE BIOL, V199, P1, DOI 10.1007/s00232-004-0669-8; Ellena JF, 2009, P NATL ACAD SCI USA, V106, P20306, DOI 10.1073/pnas.0908317106; Fasshauer D, 1998, P NATL ACAD SCI USA, V95, P15781, DOI 10.1073/pnas.95.26.15781; Li F, 2007, NAT STRUCT MOL BIOL, V14, P890, DOI 10.1038/nsmb1310; Gao Y, 2011, J AM CHEM SOC, V133, P12749, DOI 10.1021/ja204005r; Hanson PI, 1997, CELL, V90, P523, DOI 10.1016/S0092-8674(00)80512-7; Hua SY, 1999, NAT NEUROSCI, V2, P1078, DOI 10.1038/16005; Karatekin E, 2010, P NATL ACAD SCI USA, V107, P3517, DOI 10.1073/pnas.0914723107; Kubelka J, 2004, CURR OPIN STRUC BIOL, V14, P76, DOI 10.1016/j.sbi.2004.01.013; Kummel D, 2011, NAT STRUCT MOL BIOL, V18, P927, DOI 10.1038/nsmb.2101; Kyoung M, 2011, P NATL ACAD SCI USA, V108, pE304, DOI 10.1073/pnas.1107900108; Li F, 2011, NAT STRUCT MOL BIOL, V18, P941, DOI 10.1038/nsmb.2102; Liu W, 2009, J Nanoneurosci, V1, P120; Melia TJ, 2002, J CELL BIOL, V158, P929, DOI 10.1083/jcb.200112081; Pobbati AV, 2006, SCIENCE, V313, P673, DOI 10.1126/science.1129486; Sabatini BL, 1996, NATURE, V384, P170, DOI 10.1038/384170a0; Shi L, 2012, SCIENCE, V335, P1355, DOI 10.1126/science.1214984; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Stein A, 2009, NATURE, V460, P525, DOI 10.1038/nature08156; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Walter AM, 2010, J CELL BIOL, V188, P401, DOI 10.1083/jcb.200907018; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Weninger K, 2003, P NATL ACAD SCI USA, V100, P14800, DOI 10.1073/pnas.2036428100; Weninger K, 2008, STRUCTURE, V16, P308, DOI 10.1016/j.str.2007.12.010; Wiederhold K, 2009, J BIOL CHEM, V284, P13143, DOI 10.1074/jbc.M900703200; Woodside MT, 2006, SCIENCE, V314, P1001, DOI 10.1126/science.1133601; Xi ZQ, 2012, P NATL ACAD SCI USA, V109, P5711, DOI 10.1073/pnas.1116784109; Xu T, 1999, CELL, V99, P713, DOI 10.1016/S0092-8674(00)81669-4; Xu Y, 2010, BIOCHEMISTRY-US, V49, P1568, DOI 10.1021/bi9021878	31	265	269	1	134	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 14	2012	337	6100					1340	1343		10.1126/science.1224492	http://dx.doi.org/10.1126/science.1224492			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	004TW	22903523	Green Accepted			2022-12-28	WOS:000308705000042
J	Greene, JA; Choudhry, NK; Kesselheim, AS; Brennan, TA; Shrank, W				Greene, Jeremy A.; Choudhry, Niteesh K.; Kesselheim, Aaron S.; Brennan, Troyen A.; Shrank, William			Changes in Direct-to-Consumer Pharmaceutical Advertising Following Shifts From Prescription-Only to Over-the-Counter Status	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							DRUGS		[Greene, Jeremy A.; Choudhry, Niteesh K.; Kesselheim, Aaron S.; Shrank, William] Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital	Greene, JA (corresponding author), Johns Hopkins Univ, Baltimore, MD 21218 USA.	greene@jhmi.edu	Kesselheim, Aaron/R-6793-2017	Kesselheim, Aaron/0000-0002-8867-2666				Donohue JM, 2007, NEW ENGL J MED, V357, P673, DOI 10.1056/NEJMsa070502; Faerber AE, 2012, HEALTH COMMUN, V27, P66, DOI 10.1080/10410236.2011.569001; *IMS HLTH, TOT US PROM SPEND TY; Sharfstein JM, 2007, NEW ENGL J MED, V357, P2321, DOI 10.1056/NEJMp0707400; VMS, 2010, ADS PROD SHEET; World Health Organization, ETH CRIT MED DRUG PR	6	11	11	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 12	2012	308	10					973	975		10.1001/2012.jama.10647	http://dx.doi.org/10.1001/2012.jama.10647			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	003AA	22968881				2022-12-28	WOS:000308579300015
J	Moreno-Serra, R; Smith, PC				Moreno-Serra, Rodrigo; Smith, Peter C.			Does progress towards universal health coverage improve population health?	LANCET			English	Article							CARE; INSURANCE; MORTALITY; IMPACT; OUTCOMES; SERVICE; CHINA	Many commentators, including WHO, have advocated progress towards universal health coverage on the grounds that it leads to improvements in population health. In this report we review the most robust cross-country empirical evidence on the links between expansions in coverage and population health outcomes, with a focus on the health effects of extended risk pooling and prepayment as key indicators of progress towards universal coverage across health systems. The evidence suggests that broader health coverage generally leads to better access to necessary care and improved population health, particularly for poor people. However, the available evidence base is limited by data and methodological constraints, and further research is needed to understand better the ways in which the effectiveness of extended health coverage can be maximised, including the effects of factors such as the quality of institutions and governance.	[Moreno-Serra, Rodrigo; Smith, Peter C.] Univ London Imperial Coll Sci Technol & Med, Sch Business, London SW7 2AZ, England; [Moreno-Serra, Rodrigo; Smith, Peter C.] Univ London Imperial Coll Sci Technol & Med, Ctr Hlth Policy, London SW7 2AZ, England	Imperial College London; Imperial College London	Smith, PC (corresponding author), Univ London Imperial Coll Sci Technol & Med, Sch Business, Tanaka Bldg,S Kensington Campus, London SW7 2AZ, England.	peter.smith@imperial.ac.uk		Smith, Peter/0000-0003-0058-7588	UK Medical Research Council; European Observatory for Health Systems and Policy; Rockefeller Foundation; Medical Research Council [G1002338] Funding Source: researchfish; MRC [G1002338] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Observatory for Health Systems and Policy; Rockefeller Foundation; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	RM-S was supported by a fellowship grant from the UK Medical Research Council. PCS was partly supported by a grant from the European Observatory for Health Systems and Policy. This report is part of a Series funded by the Rockefeller Foundation. We thank the foundation for convening various author meetings and workshops, and their participants (and five anonymous referees) for very helpful suggestions. The sponsor had no role in study design, database search, analysis, interpretation, or writing of the report. The corresponding author had final responsibility for the decision to submit for publication.	[Anonymous], 2010, LANCET, V376, P1799, DOI 10.1016/S0140-6736(10)62148-4; [Anonymous], 2001, MACR HLTH INV HLTH E; [Anonymous], EFFECT SUPPLEMENTAL; Asawanuchit S., 2003, 03227 IMF; Baeza CC., 2006, SURVIVAL PROTECTING; Baldacci E., 2003, J INT DEV, V15, P709, DOI DOI 10.1002/JID.1025; Bidani B, 1997, J ECONOMETRICS, V77, P125, DOI 10.1016/S0304-4076(95)01809-3; Bloom DE, 2004, WORLD DEV, V32, P1, DOI 10.1016/j.worlddev.2003.07.002; Bokhari FAS, 2007, HEALTH ECON, V16, P257, DOI 10.1002/hec.1157; Buchmueller TC, 2005, MED CARE RES REV, V62, P3, DOI 10.1177/1077558704271718; COCHRANE AL, 1978, J EPIDEMIOL COMMUN H, V32, P200, DOI 10.1136/jech.32.3.200; Escobar ML, 2010, IMPACT OF HEALTH INSURANCE IN LOW- AND MIDDLE-INCOME COUNTRIES, P1; Farahani M, 2010, HEALTH ECON, V19, P1361, DOI 10.1002/hec.1557; Filmer D, 1999, SOC SCI MED, V49, P1309, DOI 10.1016/S0277-9536(99)00150-1; Finkelstein A, 2008, J PUBLIC ECON, V92, P1644, DOI 10.1016/j.jpubeco.2007.10.005; Garrett L, 2009, LANCET, V374, P1294, DOI 10.1016/S0140-6736(09)61503-8; Giedion U, 2010, IMPACT OF HEALTH INSURANCE IN LOW- AND MIDDLE-INCOME COUNTRIES, P13; Gruber J, 2008, J ECON LIT, V46, P571, DOI 10.1257/jel.46.3.571; Gupta S, 2003, HEALTH ECON, V12, P685, DOI 10.1002/hec.759; Hadley J, 2003, MED CARE RES REV, V60, p3S, DOI 10.1177/1077558703254101; Hu SL, 2008, LANCET, V372, P1846, DOI 10.1016/S0140-6736(08)61368-9; Jack W, 2011, OXFORD HDB HLTH EC, P78; King G, 2009, LANCET, V373, P1447, DOI 10.1016/S0140-6736(09)60239-7; Knaul FM, 2012, LANCET; Lei XY, 2009, HEALTH ECON, V18, pS25, DOI 10.1002/hec.1501; Levy H., 2004, HLTH POLICY UNINSURE, P179; Lozano R, 2006, LANCET, V368, P1729, DOI 10.1016/S0140-6736(06)69566-4; Lu CL, 2010, LANCET, V375, P1375, DOI 10.1016/S0140-6736(10)60233-4; Martin S, 2008, J HEALTH ECON, V27, P826, DOI 10.1016/j.jhealeco.2007.12.002; Mishra P, 2009, J HEALTH ECON, V28, P855, DOI 10.1016/j.jhealeco.2009.05.004; Moreno-Serra R, 2011, EFFECTS HLTH COVERAG; Moreno-Serra R, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001087; Moreno-Serra R, 2010, J HEALTH ECON, V29, P585, DOI 10.1016/j.jhealeco.2010.05.007; Musgrove P, 1996, 29290 HNP WORLD BANK; Nordhaus WD, 2003, MEASURING THE GAINS FROM MEDICAL RESEARCH, P9; Nyman JA, 2008, EUR J HEALTH ECON, V9, P369, DOI 10.1007/s10198-007-0084-z; O'Donnell O, 2005, 02 EQ; O'Donnell O, 2007, WORLD BANK ECON REV, V21, P93, DOI 10.1093/wber/lhl009; Or Z, 2001, OECD LABOUR MARKET S, V46; Rajkumar AS, 2008, J DEV ECON, V86, P96, DOI 10.1016/j.jdeveco.2007.08.003; ruber J, 2012, 17739 NBER; Sachs J. D., 2005, END POVERTY EC POSSI; Savedoff WD, 2012, LANCET, V380, P924, DOI 10.1016/S0140-6736(12)61083-6; Sosa-Rubi SG, 2009, J HEALTH ECON, V28, P20, DOI 10.1016/j.jhealeco.2008.08.002; Tolmie C, 2007, PUBLIC SPENDING GOVE; Wagstaff A, 2004, MILLENNIUM DEV GOALS; Wagstaff A, 2007, J HEALTH ECON, V26, P505, DOI 10.1016/j.jhealeco.2006.10.006; Wagstaff A, 2009, J HEALTH ECON, V28, P1, DOI 10.1016/j.jhealeco.2008.10.007; WHO, 2010, WORLD MALARIA REPORT 2010, P1; WHO, 2008, PHARMAFORUM 0121; World Bank, CHILD MORT DEV COUNT; World Health Organization, GLOB HLTH OBS; Xu K, 2007, HEALTH AFFAIR, V26, P972, DOI 10.1377/hlthaff.26.4.972	53	136	142	2	52	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 8	2012	380	9845					917	923		10.1016/S0140-6736(12)61039-3	http://dx.doi.org/10.1016/S0140-6736(12)61039-3			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	002QL	22959388				2022-12-28	WOS:000308547300035
J	Rodin, J; de Ferranti, D				Rodin, Judith; de Ferranti, David			Universal health coverage: the third global health transition?	LANCET			English	Editorial Material									[de Ferranti, David] Results Dev Inst, Washington, DC 20005 USA; [Rodin, Judith] Rockefeller Fdn, New York, NY USA		de Ferranti, D (corresponding author), Results Dev Inst, Washington, DC 20005 USA.	ddeferranti@resultsfordevelopment.org						Bang A, 2011, PLANNING; Chan M., 2012, 65 WORLD HLTH ASS GE; Garrett L, 2009, LANCET, V374, P1294, DOI 10.1016/S0140-6736(09)61503-8; Lagomarsino G, 2012, LANCET, V380, P933, DOI 10.1016/S0140-6736(12)61147-7; Liptak Adam, 2012, NY TIMES        0829; Moreno-Serra R, 2012, LANCET, V380, P917, DOI 10.1016/S0140-6736(12)61039-3; Sachs JD, 2012, LANCET, V380, P944, DOI 10.1016/S0140-6736(12)61149-0; Savedoff WD, 2012, LANCET, V380, P924, DOI 10.1016/S0140-6736(12)61083-6; WHO, 2010, WOR HEALT REP, P1; World Health Assembly, 2011, SUST HLTH FIN STRUCT	10	81	85	2	21	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 8	2012	380	9845					861	862		10.1016/S0140-6736(12)61340-3	http://dx.doi.org/10.1016/S0140-6736(12)61340-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	002QL	22959371				2022-12-28	WOS:000308547300004
J	Maurano, MT; Humbert, R; Rynes, E; Thurman, RE; Haugen, E; Wang, H; Reynolds, AP; Sandstrom, R; Qu, HZ; Brody, J; Shafer, A; Neri, F; Lee, K; Kutyavin, T; Stehling-Sun, S; Johnson, AK; Canfield, TK; Giste, E; Diegel, M; Bates, D; Hansen, RS; Neph, S; Sabo, PJ; Heimfeld, S; Raubitschek, A; Ziegler, S; Cotsapas, C; Sotoodehnia, N; Glass, I; Sunyaev, SR; Kaul, R; Stamatoyannopoulos, JA				Maurano, Matthew T.; Humbert, Richard; Rynes, Eric; Thurman, Robert E.; Haugen, Eric; Wang, Hao; Reynolds, Alex P.; Sandstrom, Richard; Qu, Hongzhu; Brody, Jennifer; Shafer, Anthony; Neri, Fidencio; Lee, Kristen; Kutyavin, Tanya; Stehling-Sun, Sandra; Johnson, Audra K.; Canfield, Theresa K.; Giste, Erika; Diegel, Morgan; Bates, Daniel; Hansen, R. Scott; Neph, Shane; Sabo, Peter J.; Heimfeld, Shelly; Raubitschek, Antony; Ziegler, Steven; Cotsapas, Chris; Sotoodehnia, Nona; Glass, Ian; Sunyaev, Shamil R.; Kaul, Rajinder; Stamatoyannopoulos, John A.			Systematic Localization of Common Disease-Associated Variation in Regulatory DNA	SCIENCE			English	Article							CROHNS-DISEASE; 22 LOCI; VARIANTS; EVOLUTION; PROMOTER; CELLS	Genome-wide association studies have identified many noncoding variants associated with common diseases and traits. We show that these variants are concentrated in regulatory DNA marked by deoxyribonuclease I (DNase I) hypersensitive sites (DHSs). Eighty-eight percent of such DHSs are active during fetal development and are enriched in variants associated with gestational exposure-related phenotypes. We identified distant gene targets for hundreds of variant-containing DHSs that may explain phenotype associations. Disease-associated variants systematically perturb transcription factor recognition sequences, frequently alter allelic chromatin states, and form regulatory networks. We also demonstrated tissue-selective enrichment of more weakly disease-associated variants within DHSs and the de novo identification of pathogenic cell types for Crohn's disease, multiple sclerosis, and an electrocardiogram trait, without prior knowledge of physiological mechanisms. Our results suggest pervasive involvement of regulatory DNA variation in common human disease and provide pathogenic insights into diverse disorders.	[Maurano, Matthew T.; Humbert, Richard; Rynes, Eric; Thurman, Robert E.; Haugen, Eric; Wang, Hao; Reynolds, Alex P.; Sandstrom, Richard; Qu, Hongzhu; Shafer, Anthony; Neri, Fidencio; Lee, Kristen; Kutyavin, Tanya; Stehling-Sun, Sandra; Johnson, Audra K.; Canfield, Theresa K.; Giste, Erika; Diegel, Morgan; Bates, Daniel; Neph, Shane; Sabo, Peter J.; Stamatoyannopoulos, John A.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Qu, Hongzhu] Chinese Acad Sci, Beijing Inst Genom, Lab Dis Genom & Individualized Med, Beijing 100029, Peoples R China; [Brody, Jennifer; Sotoodehnia, Nona] Univ Washington, Dept Med, Cardiovasc Hlth Res Unit, Seattle, WA 98195 USA; [Hansen, R. Scott; Kaul, Rajinder] Univ Washington, Dept Med, Div Med Genet, Seattle, WA 98195 USA; [Heimfeld, Shelly] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98109 USA; [Raubitschek, Antony; Ziegler, Steven] Benaroya Res Inst, Program Immunol, Seattle, WA 98101 USA; [Cotsapas, Chris] Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06520 USA; [Cotsapas, Chris] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06520 USA; [Sotoodehnia, Nona] Univ Washington, Dept Med, Div Cardiol, Seattle, WA 98195 USA; [Glass, Ian] Univ Washington, Dept Pediat, Div Med Genet, Seattle, WA 98195 USA; [Sunyaev, Shamil R.] Brigham & Womens Hosp, Div Genet, Boston, MA 02115 USA; [Sunyaev, Shamil R.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Stamatoyannopoulos, John A.] Univ Washington, Dept Med, Div Oncol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; Benaroya Research Institute; Yale University; Yale University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Washington; University of Washington Seattle	Stamatoyannopoulos, JA (corresponding author), Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.	jstam@uw.edu		Kaul, Rajinder/0000-0002-7895-9284; Cotsapas, Chris/0000-0002-7772-5910; Sandstrom, Richard/0000-0002-3356-1547; Haugen, Eric/0000-0001-7444-8981	NIH [U54HG004592, U01ES01156, P30 DK056465, R01HL088456, R24HD000836-47]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD000836] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088456] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG004592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056465] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U01ES017156] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [F31MH094073] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank many colleagues for their insightful comments and critical readings of the manuscript. We also thank many colleagues who provided individual cell samples for DNase I analysis. This work was supported by NIH grants U54HG004592 and U01ES01156 (J.A.S.), P30 DK056465 (S. H.), R01HL088456 (N.S.), and R24HD000836-47 (I. G.). We acknowledge the generous sharing of results from the International MS Genetics, International IBD Genetics, and CHARGE QRS Consortia. DNase I data have been deposited in Gene Expression Omnibus (GEO) under accession nos. GSE29692 and GSE18927 and can be viewed and downloaded at genome.ucsc.edu, www.uwencode.org/data, and www.epigenomebrowser.org.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; BARKER DJP, 1993, LANCET, V341, P938, DOI 10.1016/0140-6736(93)91224-A; Bernstein BE, 2010, NAT BIOTECHNOL, V28, P1045, DOI 10.1038/nbt1010-1045; Booth DR, 2010, NAT GENET, V42, P469, DOI 10.1038/ng0610-469; Brand S, 2009, GUT, V58, P1152, DOI 10.1136/gut.2008.163667; COLLINS FS, 1985, NATURE, V313, P325, DOI 10.1038/313325a0; Cookson W, 2009, NAT REV GENET, V10, P184, DOI 10.1038/nrg2537; Cotsapas C, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002254; Degner JF, 2012, NATURE, V482, P390, DOI 10.1038/nature10808; Fajans SS, 2001, NEW ENGL J MED, V345, P971, DOI 10.1056/NEJMra002168; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Gibson G, 2012, NAT REV GENET, V13, P135, DOI 10.1038/nrg3118; GROSS DS, 1988, ANNU REV BIOCHEM, V57, P159, DOI 10.1146/annurev.bi.57.070188.001111; Harismendy O, 2011, NATURE, V470, P264, DOI 10.1038/nature09753; Hindorff LA, CATALOG PUBLISHED GE; International Multiple Sclerosis Genetics Consortium (IMSGC), 2010, NAT GENET       0527, V42, P470; John S, 2011, NAT GENET, V43, P264, DOI 10.1038/ng.759; KING MC, 1975, SCIENCE, V188, P107, DOI 10.1126/science.1090005; Knight JC, 2003, NAT GENET, V33, P469, DOI 10.1038/ng1124; Lettice LA, 2002, P NATL ACAD SCI USA, V99, P7548, DOI 10.1073/pnas.112212199; Li GL, 2012, CELL, V148, P84, DOI 10.1016/j.cell.2011.12.014; Maston GA, 2006, ANNU REV GENOM HUM G, V7, P29, DOI 10.1146/annurev.genom.7.080505.115623; Maurano MT, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002599; Musunuru K, 2010, NATURE, V466, P714, DOI 10.1038/nature09266; Nicolae DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000888; Patsopoulos NA, 2011, ANN NEUROL, V70, P897, DOI 10.1002/ana.22609; Pomerantz MM, 2009, NAT GENET, V41, P882, DOI 10.1038/ng.403; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Rockman MV, 2002, MOL BIOL EVOL, V19, P1991, DOI 10.1093/oxfordjournals.molbev.a004023; Soranzo N, 2009, NAT GENET, V41, P1182, DOI 10.1038/ng.467; Sotoodehnia N, 2010, NAT GENET, V42, P1068, DOI 10.1038/ng.716; Stranger BE, 2011, GENETICS, V187, P367, DOI 10.1534/genetics.110.120907; Symonds ME, 2009, NAT REV ENDOCRINOL, V5, P604, DOI 10.1038/nrendo.2009.195; Tamura T, 2008, ANNU REV IMMUNOL, V26, P535, DOI 10.1146/annurev.immunol.26.021607.090400; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; von Budingen HC, 2011, CURR OPIN IMMUNOL, V23, P713, DOI 10.1016/j.coi.2011.09.003	36	2106	2161	15	191	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 7	2012	337	6099					1190	1195		10.1126/science.1222794	http://dx.doi.org/10.1126/science.1222794			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	000UJ	22955828	Green Accepted			2022-12-28	WOS:000308414000028
J	Howk, JC; Lehner, N; Fields, BD; Mathews, GJ				Howk, J. Christopher; Lehner, Nicolas; Fields, Brian D.; Mathews, Grant J.			Observation of interstellar lithium in the low-metallicity Small Magellanic Cloud	NATURE			English	Article							HIGH-RESOLUTION SURVEY; SPITE PLATEAU; DIFFUSE BANDS; WMAP DATA; GALAXY; NUCLEOSYNTHESIS; ABSORPTION; ABUNDANCES; PARAMETERS; EVOLUTION	The primordial abundances of light elements produced in the standard theory of Big Bang nucleosynthesis (BBN) depend only on the cosmic ratio of baryons to photons, a quantity inferred from observations of the microwave background(1). The predicted(2-4) primordial Li-7 abundance is four times that measured in the atmospheres of Galactic halo stars(5-7). This discrepancy could be caused by modification of surface lithium abundances during the stars' lifetimes(8) or by physics beyond the Standard Model that affects early nucleosynthesis(9,10). The lithium abundance of low-metallicity gas provides an alternative constraint on the primordial abundance and cosmic evolution of lithium(11) that is not susceptible to the in situ modifications that may affect stellar atmospheres. Here we report observations of interstellar Li-7 in the low-metallicity gas of the Small Magellanic Cloud, a nearby galaxy with a quarter the Sun's metallicity. The present-day Li-7 abundance of the Small Magellanic Cloud is nearly equal to the BBN predictions, severely constraining the amount of possible subsequent enrichment of the gas by stellar and cosmic-ray nucleosynthesis. Our measurements can be reconciled with standard BBN with an extremely fine-tuned depletion of stellar Li with metallicity. They are also consistent with non-standard BBN.	[Howk, J. Christopher; Lehner, Nicolas; Mathews, Grant J.] Univ Notre Dame, Dept Phys, Ctr Astrophys, Notre Dame, IN 46556 USA; [Fields, Brian D.] Univ Illinois, Dept Astron, Urbana, IL 61801 USA; [Fields, Brian D.] Univ Illinois, Dept Phys, Urbana, IL 61801 USA	University of Notre Dame; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Howk, JC (corresponding author), Univ Notre Dame, Dept Phys, Ctr Astrophys, Notre Dame, IN 46556 USA.	jhowk@nd.edu	Howk, Jay/D-2577-2013	Fields, Brian/0000-0002-4188-7141; Lehner, Nicolas/0000-0001-9158-0829; Howk, J. Christopher/0000-0002-2591-3792	European Southern Observatory [382.B-0556]	European Southern Observatory	We thank the European Southern Observatory for granting us time for this project as part of proposal 382.B-0556. We also thank A. Fox and H. Sana for discussions about the UVES data and A. Korn, P. Molaro, T. Prodanovic, D. Romano, and D. Welty for input on the project that improved the paper.	Asplund M, 2009, ANNU REV ASTRON ASTR, V47, P481, DOI 10.1146/annurev.astro.46.060407.145222; Cartledge SIB, 2005, ASTROPHYS J, V630, P355, DOI 10.1086/431922; Cox NLJ, 2007, ASTRON ASTROPHYS, V470, P941, DOI 10.1051/0004-6361:20065261; Cyburt RH, 2008, J COSMOL ASTROPART P, DOI 10.1088/1475-7516/2008/11/012; Dekker H, 2000, P SOC PHOTO-OPT INS, V4008, P534, DOI 10.1117/12.395512; Dunkley J, 2009, ASTROPHYS J SUPPL S, V180, P306, DOI 10.1088/0067-0049/180/2/306; Fields BD, 2011, ANNU REV NUCL PART S, V61, P47, DOI 10.1146/annurev-nucl-102010-130445; Iocco F, 2009, PHYS REP, V472, P1, DOI 10.1016/j.physrep.2009.02.002; Jedamzik K, 2004, PHYS REV D, V70, DOI 10.1103/PhysRevD.70.063524; Kawanomoto S, 2009, ASTROPHYS J, V701, P1506, DOI 10.1088/0004-637X/701/2/1506; Knauth DC, 2003, ASTROPHYS J, V586, P268, DOI 10.1086/346264; Korn AJ, 2006, NATURE, V442, P657, DOI 10.1038/nature05011; Lambert DL, 2004, MON NOT R ASTRON SOC, V349, P757, DOI 10.1111/j.1365-2966.2004.07557.x; Pospelov M, 2010, ANNU REV NUCL PART S, V60, P539, DOI 10.1146/annurev.nucl.012809.104521; Prantzos N, 2012, ASTRON ASTROPHYS, V542, DOI 10.1051/0004-6361/201219043; Prodanovic T, 2004, ASTROPHYS J, V616, pL115, DOI 10.1086/426814; Romano D, 2003, MON NOT R ASTRON SOC, V346, P295, DOI 10.1046/j.1365-2966.2003.07083.x; Sbordone L, 2010, ASTRON ASTROPHYS, V522, DOI 10.1051/0004-6361/200913282; SPITE M, 1982, NATURE, V297, P483, DOI 10.1038/297483a0; Steigman G, 1996, ASTROPHYS J, V457, P737, DOI 10.1086/176768; Steigman G, 2007, ANNU REV NUCL PART S, V57, P463, DOI 10.1146/annurev.nucl.56.080805.140437; Suzuki TK, 2002, ASTROPHYS J, V573, P168, DOI 10.1086/340487; Weingartner JC, 2001, ASTROPHYS J, V563, P842, DOI 10.1086/324035; Welty DE, 2006, ASTROPHYS J SUPPL S, V165, P138, DOI 10.1086/504153; Welty DE, 2003, ASTROPHYS J SUPPL S, V147, P61, DOI 10.1086/374587; Welty DE, 2001, ASTROPHYS J SUPPL S, V133, P345, DOI 10.1086/320354	27	61	61	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 6	2012	489	7414					121	123		10.1038/nature11407	http://dx.doi.org/10.1038/nature11407			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999WW	22955622	Green Submitted			2022-12-28	WOS:000308347000046
J	Zikherman, J; Parameswaran, R; Weiss, A				Zikherman, Julie; Parameswaran, Ramya; Weiss, Arthur			Endogenous antigen tunes the responsiveness of naive B cells but not T cells	NATURE			English	Article							SELF-TOLERANCE; EXPRESSION; CD45; ACTIVATION; RESOLUTION; SELECTION; ANERGY; MOUSE	In humans, up to 75% of newly generated B cells and about 30% of mature B cells show some degree of autoreactivity(1). Yet, how B cells establish and maintain tolerance in the face of autoantigen exposure during and after development is not certain. Studies of model B-cell antigen receptor (BCR) transgenic systems have highlighted the critical role of functional unresponsiveness or 'anergy'(2,3). Unlike T cells, evidence suggests that receptor editing and anergy, rather than deletion, account for much of B-cell tolerance(4,5). However, it remains unclear whether the mature diverse B-cell repertoire of mice contains anergic autoreactive B cells, and if so, whether antigen was encountered during or after their development. By taking advantage of a reporter mouse in which BCR signalling rapidly and robustly induces green fluorescent protein expression under the control of the Nur77 regulatory region, antigen-dependent and antigen-independent BCR signalling events in vivo during B-cell maturation were visualized. Here we show that B cells encounter antigen during development in the spleen, and that this antigen exposure, in turn, tunes the responsiveness of BCR signalling in B cells at least partly by downmodulating expression of surface IgM but not IgD BCRs, and by modifying basal calcium levels. By contrast, no analogous process occurs in naive mature T cells. Our data demonstrate not only that autoreactive B cells persist in the mature repertoire, but that functional unresponsiveness or anergy exists in the mature B-cell repertoire along a continuum, a fact that has long been suspected, but never yet shown. These results have important implications for understanding how tolerance in T and B cells is differently imposed, and how these processes might go awry in disease.	[Zikherman, Julie; Parameswaran, Ramya; Weiss, Arthur] Univ Calif San Francisco, Rosalind Russell Med Res Ctr Arthrit, Dept Med, Div Rheumatol, San Francisco, CA 94143 USA; [Weiss, Arthur] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Weiss, A (corresponding author), Univ Calif San Francisco, Rosalind Russell Med Res Ctr Arthrit, Dept Med, Div Rheumatol, San Francisco, CA 94143 USA.	aweiss@medicine.ucsf.edu	Parameswaran, Ramya/AAH-5791-2019	Zikherman, Julie/0000-0002-0873-192X	Rosalind Russell Medical Research Foundation Bechtel Award; American College of Rheumatology REF Rheumatology Investigator Award; Arthritis National Research Foundation; National Institutes of Health [K08 AR059723]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K08AR059723] Funding Source: NIH RePORTER	Rosalind Russell Medical Research Foundation Bechtel Award; American College of Rheumatology REF Rheumatology Investigator Award; Arthritis National Research Foundation(National Research Foundation of Korea); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank A. Roque for assisting with animal husbandry and Z. Wang and J. Paw for help with cell sorting. This work was supported by the Rosalind Russell Medical Research Foundation Bechtel Award (J. Z.), an American College of Rheumatology REF Rheumatology Investigator Award (J. Z.), an Arthritis National Research Foundation grant (J. Z.) and National Institutes of Health Grant K08 AR059723 (J. Z.), as well as the Howard Hughes Medical Institute (A.W.).	Allman D, 2001, J IMMUNOL, V167, P6834, DOI 10.4049/jimmunol.167.12.6834; Benschop RJ, 2001, IMMUNITY, V14, P33, DOI 10.1016/S1074-7613(01)00087-5; Cambier JC, 2007, NAT REV IMMUNOL, V7, P633, DOI 10.1038/nri2133; Chung JB, 2003, TRENDS IMMUNOL, V24, P343, DOI 10.1016/S1471-4906(03)00119-4; COOKE MP, 1994, J EXP MED, V179, P425, DOI 10.1084/jem.179.2.425; Cornall RJ, 1998, IMMUNITY, V8, P497, DOI 10.1016/S1074-7613(00)80554-3; Duty JA, 2009, J EXP MED, V206, P139, DOI 10.1084/jem.20080611; Fields ML, 2003, CURR OPIN IMMUNOL, V15, P709, DOI 10.1016/j.coi.2003.09.016; Glynne R, 2000, IMMUNOL REV, V176, P216; Glynne R, 2000, NATURE, V403, P672, DOI 10.1038/35001102; Goodnow CC, 2005, NATURE, V435, P590, DOI 10.1038/nature03724; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; Halverson R, 2004, NAT IMMUNOL, V5, P645, DOI 10.1038/ni1076; HARDY RR, 1991, J EXP MED, V173, P1213, DOI 10.1084/jem.173.5.1213; Hermiston ML, 2005, IMMUNITY, V23, P635, DOI 10.1016/j.immuni.2005.11.001; Lang J, 1997, J EXP MED, V186, P1513, DOI 10.1084/jem.186.9.1513; Loder F, 1999, J EXP MED, V190, P75, DOI 10.1084/jem.190.1.75; Merrell KT, 2006, IMMUNITY, V25, P953, DOI 10.1016/j.immuni.2006.10.017; MITTELSTADT PR, 1993, J IMMUNOL, V150, P4822; Moran AE, 2011, J EXP MED, V208, P1279, DOI 10.1084/jem.20110308; Teague BN, 2007, J IMMUNOL, V178, P7511, DOI 10.4049/jimmunol.178.12.7511; The Gene Expression Nervous System Atlas (GENSAT) Project, N01NS02331 GENSAT PR; Virts EL, 2003, BLOOD, V101, P849, DOI 10.1182/blood-2002-07-1969; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907; Winoto A, 2002, CELL, V109, pS57, DOI 10.1016/S0092-8674(02)00710-9; Yarkoni Y, 2010, IMMUNOL REV, V237, P249, DOI 10.1111/j.1600-065X.2010.00936.x; Zikherman J, 2012, P NATL ACAD SCI USA, V109, pE3, DOI 10.1073/pnas.1117374108; Zikherman J, 2010, IMMUNITY, V32, P342, DOI 10.1016/j.immuni.2010.03.006; Zikherman J, 2009, J IMMUNOL, V182, P4093, DOI 10.4049/jimmunol.0803317	29	205	206	1	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 6	2012	489	7414					160	U185		10.1038/nature11311	http://dx.doi.org/10.1038/nature11311			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999WW	22902503	Green Accepted, Green Submitted			2022-12-28	WOS:000308347000055
J	Skinner, L				Skinner, Luke			A Long View on Climate Sensitivity	SCIENCE			English	Editorial Material							EARTHS TEMPERATURE		Univ Cambridge, Dept Earth Sci, Godwin Lab Palaeoclimate Res, Cambridge CB2 3EQ, England	University of Cambridge	Skinner, L (corresponding author), Univ Cambridge, Dept Earth Sci, Godwin Lab Palaeoclimate Res, Cambridge CB2 3EQ, England.	lcs32@cam.ac.uk						Arrhenius S., 1896, LOND EDINB DUBLIN PH, V41, P237, DOI [10.1080/14786449608620846, DOI 10.1080/14786449608620846]; Callendar GS, 1938, Q J ROY METEOR SOC, V64, P223, DOI 10.1002/qj.49706427503; Crucifix M, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027137; Denton GH, 2010, SCIENCE, V328, P1652, DOI 10.1126/science.1184119; Hansen J., 2008, Open Atmosphere Science Journal, V2, P217, DOI 10.2174/1874282300802010217; Held IM, 2005, B AM METEOROL SOC, V86, P1609, DOI 10.1175/BAMS-86-11-1609; Higgins JA, 2006, EARTH PLANET SC LETT, V245, P523, DOI 10.1016/j.epsl.2006.03.009; HOFFERT MI, 1992, NATURE, V360, P573, DOI 10.1038/360573a0; Knutti R, 2008, NAT GEOSCI, V1, P735, DOI 10.1038/ngeo337; Kohler P, 2010, QUATERNARY SCI REV, V29, P129, DOI 10.1016/j.quascirev.2009.09.026; LORENZ EN, 1976, QUATERNARY RES, V6, P495, DOI 10.1016/0033-5894(76)90022-3; Pagani M, 2006, SCIENCE, V314, P1556, DOI 10.1126/science.1136110; Pagani M, 2010, NAT GEOSCI, V3, P27, DOI 10.1038/NGEO724; Paillard D, 2001, REV GEOPHYS, V39, P325, DOI 10.1029/2000RG000091; Rogelj J, 2012, NAT CLIM CHANGE, V2, P248, DOI [10.1038/NCLIMATE1385, 10.1038/nclimate1385]; Solomon S., 2007, PHYS SCI BASIS WORKI; WISSEL C, 1984, OECOLOGIA, V65, P101, DOI 10.1007/BF00384470	17	16	16	2	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 24	2012	337	6097					917	919		10.1126/science.1224011	http://dx.doi.org/10.1126/science.1224011			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	992VI	22923566				2022-12-28	WOS:000307807600029
J	Moughty, AM; O'Connor, G				Moughty, Adrian M.; O'Connor, Gerard			Bilateral Anterior Shoulder Dislocation	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Moughty, Adrian M.; O'Connor, Gerard] Mater Misericordiae Univ Hosp, Dublin, Ireland	Mater Misericordiae University Hospital; University College Dublin	Moughty, AM (corresponding author), Mater Misericordiae Univ Hosp, Dublin, Ireland.	amoughty@hotmail.com		O'Connor, Gerard/0000-0002-4584-3760					0	2	2	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 23	2012	367	8					E12	E12		10.1056/NEJMicm1106207	http://dx.doi.org/10.1056/NEJMicm1106207			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	992CX	22913706				2022-12-28	WOS:000307754200011
J	Ropper, AH				Ropper, Allan H.			Hyperosmolar Therapy for Raised Intracranial Pressure	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TRAUMATIC BRAIN-INJURY; CEREBROSPINAL-FLUID PRESSURE; SEVERE HEAD-INJURY; HYPERTONIC SALINE; MANNITOL; HYPERTENSION; CHILDREN; DEATH; CARE	A 49-year-old female passenger was thrown against the doorframe during an automobile accident. After being pulled from the car, she opened her eyes intermittently, moaned, and had flexion withdrawal of her limbs (Glasgow Coma Scale score, 8). Her pupils were 5 mm in diameter and reactive to light. Her blood pressure was 165/85 mm Hg, her heart rate 112 beats per minute, and her breathing regular. After her spine was stabilized, she was conveyed to an intensive care unit (ICU). In the ICU, she no longer opened her eyes, had flexion posturing of her arms, and made no verbal responses (Glasgow Coma Scale score, 5). There was a contusion on her right frontal scalp but no sign of other organ injury. Computed tomography showed large regions of frontal brain contusion with surrounding edema (Fig. 1). The patient was intubated, and an external ventricular drain was placed in order to measure intracranial pressure, which was 29 mm Hg with periodic elevations to 36 mm Hg. After drainage of cerebrospinal fluid, the intracranial pressure transiently decreased to 26 mm Hg. The serum sodium concentration was 139 mmol per liter. The neurointensivist recommended an intravenous bolus infusion of 23% saline to reduce intracranial pressure and attain a serum sodium concentration of 150 mmol per liter. The patient's weight was 55 kg.	Brigham & Womens Hosp, Dept Neurol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital	Ropper, AH (corresponding author), Brigham & Womens Hosp, Dept Neurol, 75 Francis St, Boston, MA 02115 USA.	aropper@partners.org						Adrogue HJ, 2000, NEW ENGL J MED, V342, P1493, DOI 10.1056/NEJM200005183422006; Baker A, 2006, CAN J ANAESTH, V53, P722, DOI 10.1007/BF03021632; Better OS, 1997, KIDNEY INT, V52, P886, DOI 10.1038/ki.1997.409; Bullock MR, 2007, J NEUROTRAUMA S1, V24, pS14; Bullock MR, 2007, J NEUROTRAUM, V24, pvii; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Diringer MN, 2004, NEUROCRIT CARE, V1, P219, DOI 10.1385/NCC:1:2:219; FISHER B, 1992, J NEUROSURG ANESTH, V4, P4, DOI 10.1097/00008506-199201000-00002; Francony G, 2008, CRIT CARE MED, V36, P795, DOI 10.1097/CCM.0B013E3181643B41; Horn P, 1999, NEUROL RES, V21, P758, DOI 10.1080/01616412.1999.11741010; JAMES HE, 1977, ACTA NEUROCHIR, V36, P189, DOI 10.1007/BF01405391; JAVID M, 1956, JAMA-J AM MED ASSOC, V160, P943, DOI 10.1001/jama.1956.02960460021006; Juul N, 2000, J NEUROSURG, V92, P1, DOI 10.3171/jns.2000.92.1.0001; Kellie George, 1824, Trans Med Chir Soc Edinb, V1, P84; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Koenig MA, 2008, NEUROLOGY, V70, P1023, DOI 10.1212/01.wnl.0000304042.05557.60; Langlois J.A., 2006, TRAUMATIC BRAIN INJU; MCDOWELL ME, 1955, AM J PHYSIOL, V180, P545, DOI 10.1152/ajplegacy.1955.180.3.545; Monro A., 1835, OBSERVATIONS STRUCTU, V1835, P5; MUIZELAAR JP, 1983, J NEUROSURG, V59, P822, DOI 10.3171/jns.1983.59.5.0822; Muzha I, 2004, LANCET, V364, P1321, DOI 10.1016/S0140-6736(04)17188-2; Paczynski RP, 1997, CRIT CARE CLIN, V13, P105, DOI 10.1016/S0749-0704(05)70298-0; Palo J, 1999, LANCET, V354, P1909, DOI 10.1016/S0140-6736(05)76879-3; Simma B, 1998, CRIT CARE MED, V26, P1265, DOI 10.1097/00003246-199807000-00032; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Treggiari MM, 2007, NEUROCRIT CARE, V6, P104, DOI 10.1007/s12028-007-0012-1; Vialet R, 2003, CRIT CARE MED, V31, P1683, DOI 10.1097/01.CCM.0000063268.91710.DF; Videen TO, 2001, NEUROLOGY, V57, P2120, DOI 10.1212/WNL.57.11.2120; Weed LH, 1919, AM J PHYSIOL, V48, P512, DOI 10.1152/ajplegacy.1919.48.4.512; WISE BL, 1962, J NEUROSURG, V19, P1038, DOI 10.3171/jns.1962.19.12.1038	30	111	119	0	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 23	2012	367	8					746	752		10.1056/NEJMct1206321	http://dx.doi.org/10.1056/NEJMct1206321			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	992CX	22913684				2022-12-28	WOS:000307754200009
J	Schuster, MA; Elliott, MN; Kanouse, DE; Wallander, JL; Tortolero, SR; Ratner, JA; Klein, DJ; Cuccaro, PM; Davies, SL; Banspach, SW				Schuster, Mark A.; Elliott, Marc N.; Kanouse, David E.; Wallander, Jan L.; Tortolero, Susan R.; Ratner, Jessica A.; Klein, David J.; Cuccaro, Paula M.; Davies, Susan L.; Banspach, Stephen W.			Racial and Ethnic Health Disparities among Fifth-Graders in Three Cities	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NATIONAL-SURVEY; UNITED-STATES; US CHILDREN; ADOLESCENT; SMOKING; OBESITY; RACE; CONSEQUENCES; RACE/ETHNICITY; DETERMINANTS	BACKGROUND For many health-related behaviors and outcomes, racial and ethnic disparities among adolescents are well documented, but less is known about health-related disparities during preadolescence. METHODS We studied 5119 randomly selected public-school fifth-graders and their parents in three metropolitan areas in the United States. We examined differences among black, Latino, and white children on 16 measures, including witnessing of violence, peer victimization, perpetration of aggression, seat-belt use, bike-helmet use, substance use, discrimination, terrorism worries, vigorous exercise, obesity, and self-rated health status and psychological and physical quality of life. We tested potential mediators of racial and ethnic disparities (i.e., sociodemographic characteristics and the child's school) using partially adjusted models. RESULTS There were significant differences between black children and white children for all 16 measures and between Latino children and white children for 12 of 16 measures, although adjusted analyses reduced many of these disparities. For example, in un-adjusted analysis, the rate of witnessing a threat or injury with a gun was higher among blacks (20%) and Latinos (11%) than among whites (5%), and the number of days per week on which the student performed vigorous exercise was lower among blacks (3.56 days) and Latinos (3.77 days) than among whites (4.33 days) (P<0.001 for all comparisons). After statistical adjustment, these differences were reduced by about half between blacks and whites and were eliminated between Latinos and whites. Household income, household highest education level, and the child's school were the most substantial mediators of racial and ethnic disparities. CONCLUSIONS We found that harmful health behaviors, experiences, and outcomes were more common among black children and Latino children than among white children. Adjustment for socioeconomic status and the child's school substantially reduced most of these differences. Interventions that address potentially detrimental consequences of low socioeconomic status and adverse school environments may help reduce racial and ethnic differences in child health. (Funded by the Centers for Disease Control and Prevention.)	[Schuster, Mark A.; Ratner, Jessica A.; Klein, David J.] Boston Childrens Hosp, Div Gen Pediat, Dept Med, Boston, MA 02115 USA; [Schuster, Mark A.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Schuster, Mark A.; Elliott, Marc N.; Kanouse, David E.] RAND Corp, Santa Monica, CA USA; [Wallander, Jan L.] Univ Calif Merced, Ctr Excellence Hlth Dispar, Merced, CA USA; [Wallander, Jan L.] Univ Calif Merced, Hlth Sci Res Inst, Merced, CA USA; [Tortolero, Susan R.; Cuccaro, Paula M.] Univ Texas Hlth Sci Ctr, Ctr Hlth Promot & Prevent Res, Houston, TX USA; [Davies, Susan L.] Univ Alabama Birmingham, Sch Publ Hlth, Dept Hlth Behav, Birmingham, AL 35294 USA; [Banspach, Stephen W.] Ctr Dis Control & Prevent, Natl Ctr Chron Dis Prevent & Hlth Promot, Div Adolescent & Sch Hlth, Atlanta, GA USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; RAND Corporation; University of California System; University of California Merced; University of California System; University of California Merced; University of Texas System; University of Texas Health Science Center Houston; University of Alabama System; University of Alabama Birmingham; Centers for Disease Control & Prevention - USA	Schuster, MA (corresponding author), Boston Childrens Hosp, Div Gen Pediat, Dept Med, 300 Longwood Ave, Boston, MA 02115 USA.	mark.schuster@childrens.harvard.edu		Cuccaro, Paula/0000-0002-9551-4789	Centers for Disease Control and Prevention [CCU409679, CCU609653, CCU915773, U48DP000046, U48DP000057, U48DP000056, U19DP002663, U19DP002664, U19DP002665]; NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO [U48DP000057, U19DP002664, U19DP002663, U48DP000046, U19DP002665, U48DP000056] Funding Source: NIH RePORTER	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	Supported by cooperative agreements (CCU409679, CCU609653, CCU915773, U48DP000046, U48DP000057, U48DP000056, U19DP002663, U19DP002664, and U19DP002665) with the Centers for Disease Control and Prevention.	Adler NE, 2008, ANNU REV PUBL HEALTH, V29, P235, DOI 10.1146/annurev.publhealth.29.020907.090852; Anderson SE, 2009, ARCH PEDIAT ADOL MED, V163, P344, DOI 10.1001/archpediatrics.2009.18; Bernard Stephanie J., 2007, Morbidity and Mortality Weekly Report, V56, P1; Braveman PA, 2011, AM J PREV MED, V40, pS4, DOI 10.1016/j.amepre.2010.10.002; Braveman PA, 2010, AM J PUBLIC HEALTH, V100, pS186, DOI 10.2105/AJPH.2009.166082; Brook DW, 2008, NICOTINE TOB RES, V10, P1283, DOI 10.1080/14622200802238993; CAMPAIGNE BN, 1994, J PEDIATR-US, V124, P675, DOI 10.1016/S0022-3476(05)81354-X; Centers for Disease Control and Prevention (CDC), 2009, HIGH SCH YOUTH RISK; Chen E, 2006, AM J PUBLIC HEALTH, V96, P702, DOI 10.2105/AJPH.2004.048124; Cooley-Quille M, 2001, J CLIN CHILD PSYCHOL, V30, P199, DOI 10.1207/S15374424JCCP3002_7; Crouch JL, 2000, J COMMUNITY PSYCHOL, V28, P625, DOI 10.1002/1520-6629(200011)28:6<625::AID-JCOP6>3.0.CO;2-R; David RJ, 1997, NEW ENGL J MED, V337, P1209, DOI 10.1056/NEJM199710233371706; Dietz WH, 1998, AM J CLIN NUTR BETHE, V101, P518; Eisenman DP, 2009, AM J PUBLIC HEALTH, V99, P168, DOI 10.2105/AJPH.2007.124206; Fiscella K, 2009, PEDIATRICS, V123, P1073, DOI 10.1542/peds.2008-0533; Flores G, 2009, PEDIATRICS, V124, P999, DOI 10.1542/peds.2009-1724; Flores G, 2010, PEDIATRICS, V125, pE979, DOI 10.1542/peds.2010-0188; Gordon-Larsen P, 2003, OBES RES, V11, P121, DOI 10.1038/oby.2003.20; Graubard BI, 1999, BIOMETRICS, V55, P652, DOI 10.1111/j.0006-341X.1999.00652.x; Harrell JS, 1998, J ADOLESCENT HEALTH, V23, P271, DOI 10.1016/S1054-139X(98)00078-0; Harris KM, 2006, ARCH PEDIAT ADOL MED, V160, P74, DOI 10.1001/archpedi.160.1.74; Hedley AA, 2004, JAMA-J AM MED ASSOC, V291, P2847, DOI 10.1001/jama.291.23.2847; Heron HP, 2008, DEATH PRELIMINARY DA; Knack JM, 2011, BRAIN COGNITION, V77, P183, DOI 10.1016/j.bandc.2011.06.011; LaVeist T, 2011, HEALTH AFFAIR, V30, P1880, DOI 10.1377/hlthaff.2011.0640; Lu Michael C, 2003, Matern Child Health J, V7, P13, DOI 10.1023/A:1022537516969; Lynch JL, 2011, SOCIOL INQ, V81, P499, DOI 10.1111/j.1475-682X.2011.00390.x; McDermott RJ, 1999, J SCHOOL HEALTH, V69, P356, DOI 10.1111/j.1746-1561.1999.tb06429.x; Mulye TP, 2009, J ADOLESCENT HEALTH, V45, P8, DOI 10.1016/j.jadohealth.2009.03.013; Oberg Charles N, 2006, Curr Probl Pediatr Adolesc Health Care, V36, P251, DOI 10.1016/j.cppeds.2006.03.001; Reijntjes A, 2010, CHILD ABUSE NEGLECT, V34, P244, DOI 10.1016/j.chiabu.2009.07.009; Rigby K, 2003, CAN J PSYCHIAT, V48, P583, DOI 10.1177/070674370304800904; Riggs NR, 2007, NICOTINE TOB RES, V9, P1147, DOI 10.1080/14622200701648359; Sampson RJ, 2006, AM J PUBLIC HEALTH, V96, P591, DOI 10.2105/AJPH.2004.037705; Sampson RJ, 2005, AM J PUBLIC HEALTH, V95, P224, DOI 10.2105/AJPH.2004.037705; Sanders-Phillips Kathy, 2009, Pediatrics, V124 Suppl 3, pS176, DOI 10.1542/peds.2009-1100E; Simons-Morton BG, 2003, AM J HEALTH BEHAV, V27, P592, DOI 10.5993/AJHB.27.6.2; Singh GK, 2008, J COMMUN HEALTH, V33, P206, DOI 10.1007/s10900-008-9094-8; Singh GK, 2010, ANN EPIDEMIOL, V20, P40, DOI 10.1016/j.annepidem.2009.09.008; Stein B.D., 2004, APPL DEV SCI, V8, P184, DOI [DOI 10.1207/S1532480XADS0804_2, 10.1207/s1532480xads0804_2]; Stein BD, 2004, PSYCHIATRY, V67, P105, DOI 10.1521/psyc.67.2.105.35964; Suglia SF, 2010, INT J BEHAV MED, V17, P43, DOI 10.1007/s12529-009-9044-6; Vaillancourt T, 2011, BRAIN COGNITION, V77, P191, DOI 10.1016/j.bandc.2011.06.012; VEGA WA, 1993, AM J PUBLIC HEALTH, V83, P185, DOI 10.2105/AJPH.83.2.185; Wen M, 2007, ETHNIC HEALTH, V12, P401, DOI 10.1080/13557850701300657; Williams DR, 2010, J HEALTH SOC BEHAV, V51, pS15, DOI 10.1177/0022146510383838; Williams DR, 2005, HEALTH AFFAIR, V24, P325, DOI 10.1377/hlthaff.24.2.325; Windle M, 2004, AM J PREV MED, V27, P164, DOI 10.1016/j.amepre.2004.04.007; Woolf SH, 2011, HEALTH AFFAIR, V30, P1852, DOI 10.1377/hlthaff.2011.0685	49	119	119	0	34	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 23	2012	367	8					735	745		10.1056/NEJMsa1114353	http://dx.doi.org/10.1056/NEJMsa1114353			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	992CX	22913683	Green Published			2022-12-28	WOS:000307754200008
J	van Ee, E; Kleber, RJ				van Ee, Elisa; Kleber, Rolf J.			The art of medicine Child in the shadowlands	LANCET			English	Editorial Material									[van Ee, Elisa; Kleber, Rolf J.] Fdn Ctr 45, NL-1112 XE Diemen, Netherlands; [Kleber, Rolf J.] Univ Utrecht, Dept Clin & Hlth Psychol, Utrecht, Netherlands	Utrecht University	van Ee, E (corresponding author), Fdn Ctr 45, NL-1112 XE Diemen, Netherlands.	e.van.ee@centrum45.nl			Arts and Humanities Research Council [AH/J001554/1] Funding Source: researchfish; AHRC [AH/J001554/1] Funding Source: UKRI	Arts and Humanities Research Council(UK Research & Innovation (UKRI)Arts & Humanities Research Council (AHRC)); AHRC(UK Research & Innovation (UKRI)Arts & Humanities Research Council (AHRC))			0	9	9	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG 18	2012	380	9842					642	643		10.1016/S0140-6736(12)61360-9	http://dx.doi.org/10.1016/S0140-6736(12)61360-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	991SE	22908379				2022-12-28	WOS:000307721000015
J	Aspinwall, LG; Brown, TR; Tabery, J				Aspinwall, Lisa G.; Brown, Teneille R.; Tabery, James			The Double-Edged Sword: Does Biomechanism Increase or Decrease Judges' Sentencing of Psychopaths?	SCIENCE			English	Article							LAW; GENOTYPE; IMPACT; MAOA	We tested whether expert testimony concerning a biomechanism of psychopathy increases or decreases punishment. In a nationwide experiment, U.S. state trial judges (N = 181) read a hypothetical case (based on an actual case) where the convict was diagnosed with psychopathy. Evidence presented at sentencing in support of a biomechanical cause of the convict's psychopathy significantly reduced the extent to which psychopathy was rated as aggravating and significantly reduced sentencing (from 13.93 years to 12.83 years). Content analysis of judges' reasoning indicated that even though the majority of judges listed aggravating factors (86.7%), the biomechanical evidence increased the proportion of judges listing mitigating factors (from 29.7 to 47.8%). Our results contribute to the literature on how biological explanations of behavior figure into theories of culpability and punishment.	[Tabery, James] Univ Utah, Dept Philosophy, Salt Lake City, UT 84112 USA; [Aspinwall, Lisa G.] Univ Utah, Dept Psychol, Salt Lake City, UT 84112 USA; [Brown, Teneille R.] Univ Utah, SJ Quinney Coll Law, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Tabery, J (corresponding author), Univ Utah, Dept Philosophy, Salt Lake City, UT 84112 USA.	tabery@philosophy.utah.edu	Brown, Teneille/AAN-3496-2020		University of Utah	University of Utah	The research was supported by a University of Utah Interdisciplinary Research Seed Grant. We are grateful to J. Taber for assistance with statistical analyses, G. Cash and A. Spivey for coding qualitative data, P. Burrows and Media Solutions for constructing the online survey, A. Newman for formatting assistance, and to two anonymous reviewers for their helpful comments on a prior version of this article. Finally, we thank the judges for their time and participation. Authors' names are listed alphabetically.	Bernet W, 2007, J FORENSIC SCI, V52, P1362, DOI 10.1111/j.1556-4029.2007.00562.x; Blair RJR, 2006, COGNITION, V101, P414, DOI 10.1016/j.cognition.2006.04.005; Brown T, 2010, STANFORD LAW REV, V62, P1119; Dar-Nimrod I, 2011, PSYCHOL BULL, V137, P800, DOI 10.1037/a0021860; DeMatteo D, 2006, PSYCHOL PUBLIC POL L, V12, P214, DOI 10.1037/1076-8971.12.2.214; Dodge K. A., 2011, GENE ENV INTERACTION, P207; Dodge KA, 2009, PERSPECT PSYCHOL SCI, V4, P408, DOI 10.1111/j.1745-6924.2009.01147.x; Edens JF, 2005, BEHAV SCI LAW, V23, P603, DOI 10.1002/bsl.660; Evansburg AR, 2001, AM CRIM LAW REV, V38, P1565; Farahany N. A., 2006, LAW CONTEMP PROBL, V69, P115; Feresin Emiliano, 2009, NATURE, DOI [10.1038/news.2009.1050, DOI 10.1038/NEWS.2009.1050]; Glenn AL, 2009, MOL PSYCHIATR, V14, P5, DOI 10.1038/mp.2008.104; Greene J, 2004, PHILOS T R SOC B, V359, P1775, DOI 10.1098/rstb.2004.1546; Gurley JR, 2008, BEHAV SCI LAW, V26, P85, DOI 10.1002/bsl.797; Haslam N, 2011, PSYCHOL BULL, V137, P819, DOI 10.1037/a0022386; Hoffman Diane E., 2007, MARYLAND LAW REV, V66, P858; Hughes V, 2010, NATURE, V464, P340, DOI 10.1038/464340a; Jones M, 2003, DUKE LAW J, V52, P1031; Monterosso J, 2005, ETHICS BEHAV, V15, P139, DOI 10.1207/s15327019eb1502_4; Morse Stephen J., 2008, MINN JL SCI TECH, V9, p[1, 14]; Nahmias E, 2006, MIDWEST STUD PHILOS, V31, P214; Schopp R. F., 2006, LAW PSYCHOL REV, V30, P57; Skeem JL, 2011, PSYCHOL SCI PUBL INT, V12, P95, DOI 10.1177/1529100611426706; Snead OC, 2007, NEW YORK U LAW REV, V82, P1265; Tikkanen R, 2011, PSYCHIAT RES, V185, P382, DOI 10.1016/j.psychres.2010.08.026; Viding E, 2008, PHILOS T R SOC B, V363, P2519, DOI 10.1098/rstb.2008.0037; WEINER B, 1988, J PERS SOC PSYCHOL, V55, P738, DOI 10.1037/0022-3514.55.5.738	28	169	170	1	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 17	2012	337	6096					846	849		10.1126/science.1219569	http://dx.doi.org/10.1126/science.1219569			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	989BQ	22904010				2022-12-28	WOS:000307535600044
J	Wilding, J				Wilding, John			Are the causes of obesity primarily environmental? Yes	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							BODY-MASS INDEX; CHILDHOOD OBESITY		Univ Liverpool, Dept Obes & Endocrinol, Ctr Clin Sci, Univ Hosp Aintree, Liverpool L9 7AL, Merseyside, England	University of Liverpool	Wilding, J (corresponding author), Univ Liverpool, Dept Obes & Endocrinol, Ctr Clin Sci, Univ Hosp Aintree, Liverpool L9 7AL, Merseyside, England.	j.p.h.wilding@liv.ac.uk	Wilding, John PH/A-7106-2008; Wilding, John/ABB-6443-2020	Wilding, John PH/0000-0003-2839-8404; Wilding, John/0000-0003-2839-8404				Allison DB, 1996, INT J OBESITY, V20, P501; Borys JM, 2012, OBES REV, V13, P299, DOI 10.1111/j.1467-789X.2011.00950.x; Farooqi IS, 2007, OBES REV, V8, P37, DOI 10.1111/j.1467-789X.2007.00315.x; Foresight, 2007, TACKL OB FUT CHOIC P; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Gilmore AB, 2011, J PUBLIC HEALTH-UK, V33, P2, DOI 10.1093/pubmed/fdr008; Harris JL, 2009, ANNU REV PUBL HEALTH, V30, P211, DOI 10.1146/annurev.publhealth.031308.100304; Marmot M, 2005, LANCET, V365, P1099, DOI 10.1016/S0140-6736(05)74234-3; Mayor S, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d6688; Organization WH, 2009, GLOB HLTH RISKS MORT; Romon M, 2009, PUBLIC HEALTH NUTR, V12, P1735, DOI 10.1017/S1368980008004278; ROTHWELL NJ, 1982, BRIT J NUTR, V47, P461, DOI 10.1079/BJN19820058	12	17	17	0	24	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 11	2012	345								e5843	10.1136/bmj.e5843	http://dx.doi.org/10.1136/bmj.e5843			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	007BG	22968528				2022-12-28	WOS:000308863200005
J	Davis, RJ				Davis, Roger J.			A Scaffold Switch to Insulate	SCIENCE			English	Editorial Material							MAP KINASE; SACCHAROMYCES-CEREVISIAE; SIGNALING SPECIFICITY; PHEROMONE RESPONSE; STE5; YEAST; PROTEIN; DOMAIN; ACTIVATION; PATHWAY		[Davis, Roger J.] Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Worcester, MA 01605 USA; [Davis, Roger J.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA	Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Davis, RJ (corresponding author), Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Worcester, MA 01605 USA.	roger.davis@umassmed.edu		Davis, Roger/0000-0002-0130-1652	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Bao MZ, 2004, CELL, V119, P991, DOI 10.1016/j.cell.2004.11.052; Bhattacharyya RP, 2006, SCIENCE, V311, P822, DOI 10.1126/science.1120941; Chen RE, 2007, BBA-MOL CELL RES, V1773, P1311, DOI 10.1016/j.bbamcr.2007.05.003; CHOI KY, 1994, CELL, V78, P499; Chou S, 2004, CELL, V119, P981, DOI 10.1016/j.cell.2004.11.053; Garrenton LS, 2006, GENE DEV, V20, P1946, DOI 10.1101/gad.1413706; Garrenton LS, 2010, P NATL ACAD SCI USA, V107, P11805, DOI 10.1073/pnas.1005817107; Good M, 2009, CELL, V136, P1085, DOI 10.1016/j.cell.2009.01.049; Inouye C, 1997, SCIENCE, V278, P103, DOI 10.1126/science.278.5335.103; MARCUS S, 1994, P NATL ACAD SCI USA, V91, P7762, DOI 10.1073/pnas.91.16.7762; Morrison DK, 2003, ANNU REV CELL DEV BI, V19, P91, DOI 10.1146/annurev.cellbio.19.111401.091942; Sette C, 2000, MOL BIOL CELL, V11, P4033, DOI 10.1091/mbc.11.11.4033; Winters MJ, 2005, MOL CELL, V20, P21, DOI 10.1016/j.molcel.2005.08.020; Zalatan JG, 2012, SCIENCE, V337, P1218, DOI 10.1126/science.1220683	14	0	2	1	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 7	2012	337	6099					1178	1179		10.1126/science.1227747	http://dx.doi.org/10.1126/science.1227747			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	000UJ	22955821				2022-12-28	WOS:000308414000021
J	Decker, RB; Krimigis, SM; Roelof, EC; Hill, ME				Decker, Robert B.; Krimigis, Stamatios M.; Roelof, Edmond C.; Hill, Matthew E.			No meridional plasma flow in the heliosheath transition region	NATURE			English	Article								Over a two-year period, Voyager 1 observed a gradual slowing-down of radial plasma flow in the heliosheath to near-zero velocity(1) after April 2010 at a distance of 113.5 astronomical units from the Sun (1 astronomical unit equals 1.5x10(8) kilometres). Voyager 1 was then about 20 astronomical units beyond the shock that terminates the free expansion of the solar wind and was immersed in the heated non-thermal plasma region called the heliosheath. The expectation from contemporary simulations(2,3) was that the heliosheath plasma would be deflected from radial flow to meridional flow (in solar heliospheric coordinates), which at Voyager 1 would lie mainly on the (locally spherical) surface called the heliopause. This surface is supposed to separate the heliosheath plasma, which is of solar origin, from the interstellar plasma, which is of local Galactic origin. In 2011, the Voyager project began occasional temporary re-orientations of the spacecraft (totalling about 10-25 hours every 2 months) to re-align the Low-Energy Charged Particle instrument on board Voyager 1 so that it could measure meridional flow. Here we report that, contrary to expectations, these observations yielded a meridional flow velocity of +3 +/- 11 km s(-1), that is, one consistent with zero within statistical uncertainties. [GRAPHICS] .	[Decker, Robert B.; Krimigis, Stamatios M.; Roelof, Edmond C.; Hill, Matthew E.] Johns Hopkins Univ, Appl Phys Lab, Laurel, MD 20707 USA; [Krimigis, Stamatios M.] Acad Athens, Athens 11527, Greece	Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; Academy of Athens	Decker, RB (corresponding author), Johns Hopkins Univ, Appl Phys Lab, Johns Hopkins Rd, Laurel, MD 20707 USA.	robert.decker@jhuapl.edu	Hill, Matthew/H-4312-2016; Krimigis, Stamatios/G-4591-2019; Roelof, Edmond/G-6654-2019	Hill, Matthew/0000-0002-5674-4936; Krimigis, Stamatios/0000-0003-2781-2386; Roelof, Edmond/0000-0002-2270-0652	Johns Hopkins University Applied Physics Laboratory by NASA [NNN06AA01C]	Johns Hopkins University Applied Physics Laboratory by NASA	This work was supported at The Johns Hopkins University Applied Physics Laboratory by NASA contract NNN06AA01C. We thank J. Aiello for his assistance with our graphical presentation. We are grateful to the staff of the Voyager project for performing the Voyager 1 roll manoeuvres that made our analyses possible.	Borovikov SN, 2011, ASTROPHYS J LETT, V728, DOI 10.1088/2041-8205/728/1/L21; GLEESON LJ, 1968, ASTROPHYS SPACE SCI, V2, P431, DOI 10.1007/BF02175919; Krimigis SM, 2011, NATURE, V474, P359, DOI 10.1038/nature10115; Pogorelov NV, 2009, ASTROPHYS J, V696, P1478, DOI 10.1088/0004-637X/696/2/1478; Richardson JD, 2011, ASTROPHYS J LETT, V734, DOI 10.1088/2041-8205/734/1/L21	5	64	64	2	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 6	2012	489	7414					124	127		10.1038/nature11441	http://dx.doi.org/10.1038/nature11441			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999WW	22955623				2022-12-28	WOS:000308347000047
J	Gray, GM; Cohen, JT				Gray, George M.; Cohen, Joshua T.			Rethink chemical risk assessments	NATURE			English	Editorial Material									[Gray, George M.] George Washington Univ, Ctr Risk Sci & Publ Hlth, Washington, DC 20037 USA; [Cohen, Joshua T.] Tufts Med Ctr, Ctr Evaluat Value & Risk Hlth, Boston, MA 02111 USA	George Washington University; Tufts Medical Center	Gray, GM (corresponding author), George Washington Univ, Ctr Risk Sci & Publ Hlth, Washington, DC 20037 USA.	gmgray@gwu.edu; jcohen@tuftsmedicalcenter.org		Cohen, Joshua/0000-0003-1737-0991				Carter TR, 2007, AR4 CLIMATE CHANGE 2007: IMPACTS, ADAPTATION, AND VULNERABILITY, P133; Collins FS, 2008, SCIENCE, V319, P906, DOI 10.1126/science.1154619; Finkel A. M., 2010, INCREASED TOXICITY S; National Research Council, 2011, REV ENV PROT AG DRAF; National Research Council, 2006, HLTH RISKS DIOX REL; Sunstein C.R., 2002, RISK REASON SAFETY L; US Environmental Protection Agency, 2012, US FEDERAL REGISTER, V77, P26751; US EPA, 2012, EPAS INT RISK INF SY; World Health Organization, 2010, FACT SHEET 225 DIOX	9	16	18	1	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 6	2012	489	7414					27	28		10.1038/489027a	http://dx.doi.org/10.1038/489027a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999WW	22955594	Bronze			2022-12-28	WOS:000308347000015
J	Zhuang, ZP; Yang, CZ; Lorenzo, F; Merino, M; Fojo, T; Kebebew, E; Popovic, V; Stratakis, CA; Prchal, JT; Pacak, K				Zhuang, Zhengping; Yang, Chunzhang; Lorenzo, Felipe; Merino, Maria; Fojo, Tito; Kebebew, Electron; Popovic, Vera; Stratakis, Constantine A.; Prchal, Josef T.; Pacak, Karel			Somatic HIF2A Gain-of-Function Mutations in Paraganglioma with Polycythemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HYPOXIA-INDUCIBLE FACTORS; PHEOCHROMOCYTOMA; HIF-1-ALPHA; CANCER; ERYTHROCYTOSIS; TUMORIGENESIS; HIF-2-ALPHA; INHIBITION; GENE	Hypoxia-inducible factors are transcription factors controlling energy, iron metabolism, erythropoiesis, and development. When these proteins are dysregulated, they contribute to tumorigenesis and cancer progression. However, mutations in genes encoding a subunits of hypoxia-inducible factors (HIF-alpha) have not previously been identified in any cancer. Here we report two novel somatic gain-of-function mutations in the gene encoding hypoxia-inducible factor 2 alpha (HIF2A) in two patients, one presenting with paraganglioma and the other with paraganglioma and somatostatinoma, both of whom had polycythemia. The two mutations were associated with increased HIF-2 alpha activity and increased protein half-life.	[Pacak, Karel] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Med Neuroendocrinol, Program Reprod & Adult Endocrinol, NIH, Bethesda, MD 20892 USA; [Zhuang, Zhengping; Yang, Chunzhang] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Surg Neurol Branch, NINDS, NIH, Bethesda, MD 20892 USA; [Merino, Maria] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Pathol Lab, NIH, Bethesda, MD 20892 USA; [Fojo, Tito] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Med Oncol Branch, NIH, Bethesda, MD 20892 USA; [Kebebew, Electron] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Endocrine Oncol Branch, NIH, Bethesda, MD 20892 USA; [Stratakis, Constantine A.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, NCI, NIH, Bethesda, MD 20892 USA; [Stratakis, Constantine A.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Program Dev Endocrinol & Genet, NIH, Bethesda, MD 20892 USA; [Lorenzo, Felipe; Prchal, Josef T.] Univ Utah, Div Hematol, Associated Reg & Univ Pathologists Labs, Sch Med, Salt Lake City, UT USA; [Lorenzo, Felipe; Prchal, Josef T.] Univ Utah, Sch Med, Vet Affairs Med Ctr, Salt Lake City, UT USA; [Prchal, Josef T.] Univ Utah, Sch Med, Eccles Inst Human Genet, Salt Lake City, UT USA; [Popovic, Vera] Univ Belgrade, Fac Med, Belgrade, Serbia; [Popovic, Vera] Clin Ctr Serbia, Dept Neuroendocrinol, Belgrade, Serbia	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Utah System of Higher Education; University of Utah; US Department of Veterans Affairs; Veterans Health Administration (VHA); Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; University of Belgrade; Clinical Centre of Serbia	Pacak, K (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Med Neuroendocrinol, Program Reprod & Adult Endocrinol, NIH, Bldg 10,CRC Rm 1E-3140,10 Ctr Dr, MSC 1109, Bethesda, MD 20892 USA.	karel@mail.nih.gov	Stratakis, Constantine/AAP-4745-2020	Yang, Chunzhang/0000-0001-6433-0867	National Institute of Neurological Disorders and Stroke; Eunice Kennedy Shriver National Institute of Child Health and Human Development; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008920, ZIAHD008735] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [ZIESC000853, P01CA108671] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003053] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported in part by the Intramural Research Program of the National Institute of Neurological Disorders and Stroke and the Eunice Kennedy Shriver National Institute of Child Health and Human Development.	Bertout JA, 2008, NAT REV CANCER, V8, P967, DOI 10.1038/nrc2540; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Clifford SC, 2001, HUM MOL GENET, V10, P1029, DOI 10.1093/hmg/10.10.1029; Favier J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007094; Gimenez-Roqueplo AP, 2012, HORM METAB RES, V44, P328, DOI 10.1055/s-0031-1301302; Hu CJ, 2003, MOL CELL BIOL, V23, P9361, DOI 10.1128/MCB.23.24.9361-9374.2003; Ivan M, 2002, P NATL ACAD SCI USA, V99, P13459, DOI 10.1073/pnas.192342099; Kaelin WG, 2011, COLD SH Q B, V76, P335, DOI 10.1101/sqb.2011.76.010975; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Keith B, 2012, NAT REV CANCER, V12, P9, DOI 10.1038/nrc3183; Koivunen P, 2012, NATURE, V483, P485, DOI 10.1038/nature10898; Kondo K, 2002, CANCER CELL, V1, P237, DOI 10.1016/S1535-6108(02)00043-0; Ladroue C, 2008, NEW ENGL J MED, V359, P2685, DOI 10.1056/NEJMoa0806277; Lenders JWM, 2005, LANCET, V366, P665, DOI 10.1016/S0140-6736(05)67139-5; Mastrogiannaki M, 2009, J CLIN INVEST, V119, P1159, DOI 10.1172/JCI38499; Morris MR, 2009, ANTICANCER RES, V29, P4337; Neumann HPH, 2002, NEW ENGL J MED, V346, P1459, DOI 10.1056/NEJMoa020152; Okamoto H, 2006, CANCER RES, V66, P10199, DOI 10.1158/0008-5472.CAN-06-0955; Percy MJ, 2008, NEW ENGL J MED, V358, P162, DOI 10.1056/NEJMoa073123; Perrotta S, 2008, NEW ENGL J MED, V358, P1966; Prchal JT, 2010, WILLIAMS HEMATOLOGY, P823; Rankin EB, 2008, CELL DEATH DIFFER, V15, P678, DOI 10.1038/cdd.2008.21; Semenza GL, 2012, TRENDS PHARMACOL SCI, V33, P207, DOI 10.1016/j.tips.2012.01.005; VINIK AI, 1987, SEMIN ONCOL, V14, P263; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510	25	272	288	1	27	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 6	2012	367	10					922	930		10.1056/NEJMoa1205119	http://dx.doi.org/10.1056/NEJMoa1205119			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	999VO	22931260	Green Accepted, Bronze			2022-12-28	WOS:000308343300009
J	Lopez-Olivo, MA; Tayar, JH; Martinez-Lopez, JA; Pollono, EN; Cueto, JP; Gonzales-Crespo, MR; Fulton, S; Suarez-Almazor, ME				Lopez-Olivo, Maria A.; Tayar, Jean H.; Martinez-Lopez, Juan A.; Pollono, Eduardo N.; Polo Cueto, Jose; Rosa Gonzales-Crespo, M.; Fulton, Stephanie; Suarez-Almazor, Maria E.			Risk of Malignancies in Patients With Rheumatoid Arthritis Treated With Biologic Therapy A Meta-analysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							ANTITUMOR NECROSIS FACTOR; PLACEBO-CONTROLLED TRIAL; INTERLEUKIN-1 RECEPTOR ANTAGONIST; RANDOMIZED CONTROLLED-TRIALS; ALPHA MONOCLONAL-ANTIBODY; MODIFYING ANTIRHEUMATIC DRUGS; RECEIVING CONCOMITANT METHOTREXATE; RITUXIMAB PLUS METHOTREXATE; PHASE-III TRIAL; EVERY 4 WEEKS	Context Concerns exist regarding the potential development of malignancies in patients with rheumatoid arthritis (RA) who are receiving biologic response modifiers (BRMs). Objective To assess the risk of malignancy in patients with RA enrolled in randomized controlled trials (RCTs) of BRMs. Data Sources Electronic databases, conference proceedings, and websites of regulatory agencies were searched for RCTs evaluating abatacept, adalimumab, anakinra, certolizumab, etanercept, golimumab, infliximab, rituximab, and tocilizumab in RA from inception through July 9, 2012. Study Selection Independent selection of studies included RCTs that compared the safety of any BRMs used in RA patients with placebo and/or any traditional disease-modifying antirheumatic drugs with a minimum of 24 weeks of follow-up. Data Extraction Independent reviewers selected studies and extracted data on quality and outcomes. Pooled estimates and 95% confidence intervals were calculated for each BRM. Results Sixty-three RCTs with 29 423 patients were analyzed. No statistically significant increased risk of developing malignancy was observed. Of the 29 423 patients, 211 developed a malignancy during the trial (118 solid tumors, 48 skin cancers, 14 lymphomas, 5 hematologic nonlymphomas, and 26 not specified). The incidence rate for any malignancy during the first year of therapy was very low in the BRM plus methotrexate group (0.77%; 95% CI, 0.65%-0.92%), the BRM monotherapy group (0.64%; 95% CI, 0.42%-0.95%), and the controls (0.66%; 95% CI, 0.52%-0.84%). Anakinra plus methotrexate showed lower odds compared with methotrexate alone (Peto odds ratio, 0.11; 95% CI, 0.03-0.45). No statistically significant risk was observed for specific cancer sites, although the Peto odds ratio for lymphoma was 2.1 (95% CI, 0.55-8.4) in patients receiving tumor necrosis factor inhibitors compared with controls. Conclusion The use of BRMs among patients with RA included in RCTs of at least 6 months' duration was not significantly associated with an increased risk of malignancy compared with other disease-modifying antirheumatic drugs or with placebo. JAMA. 2012;308(9):898-908	[Lopez-Olivo, Maria A.; Tayar, Jean H.; Fulton, Stephanie; Suarez-Almazor, Maria E.] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Martinez-Lopez, Juan A.] Spanish Soc Rheumatol, Madrid, Spain; [Rosa Gonzales-Crespo, M.] Hosp 12 Octubre, E-28041 Madrid, Spain; [Pollono, Eduardo N.] Texas Tech Univ, Hlth Sci Ctr, Paul Foster Sch Med, El Paso, TX USA; [Polo Cueto, Jose] Manati Med Ctr, Manati, PR USA	University of Texas System; UTMD Anderson Cancer Center; Hospital Universitario 12 de Octubre; Texas Tech University System; Texas Tech University	Suarez-Almazor, ME (corresponding author), Univ Texas MD Anderson Canc Ctr, 1515 Holcombe Blvd,Unit 1465, Houston, TX 77030 USA.	msalmazor@mdanderson.org	Lopez-Olivo, Maria/AAD-6510-2019	Lopez-Olivo, Maria/0000-0002-5165-8393; Tayar, Jean/0000-0002-9018-3802; Fulton, Stephanie/0000-0001-7543-3546	National Institute of Arthritis and Musculoskeletal and Skin Diseases [AR053593]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K24AR053593] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This study was not funded or supported by any organization. Dr Suarez-Almazor has a K24 career award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (grant AR053593).	Askling J, 2008, CURR OPIN RHEUMATOL, V20, P334, DOI 10.1097/BOR.0b013e3282f7c706; Askling J, 2011, PHARMACOEPIDEM DR S, V20, P119, DOI 10.1002/pds.2046; Badley E M, 1987, Int Rehabil Med, V8, P118; Bathon JM, 2000, NEW ENGL J MED, V343, P1586, DOI 10.1056/NEJM200011303432201; Bejarano V, 2008, ARTHRIT RHEUM-ARTHR, V59, P1467, DOI 10.1002/art.24106; Berlin JA, 1997, LANCET, V350, P185, DOI 10.1016/S0140-6736(05)62352-5; Bhandari M, 2004, CAN MED ASSOC J, V170, P477; Bingham CO, 2010, ARTHRITIS RHEUM-US, V62, P64, DOI 10.1002/art.25034; Bongartz T, 2006, JAMA-J AM MED ASSOC, V295, P2275, DOI 10.1001/jama.295.19.2275; Bongartz T, 2009, ANN RHEUM DIS, V68, P1177, DOI 10.1136/ard.2008.094904; Bradburn MJ, 2007, STAT MED, V26, P53, DOI 10.1002/sim.2528; Breedveld FC, 2006, ARTHRITIS RHEUM-US, V54, P26, DOI 10.1002/art.21519; Bresnihan B, 1998, ARTHRITIS RHEUM, V41, P2196, DOI 10.1002/1529-0131(199812)41:12<2196::AID-ART15>3.3.CO;2-U; Brown SL, 2002, ARTHRITIS RHEUM-US, V46, P3151, DOI 10.1002/art.10679; Buscemi N, 2006, J CLIN EPIDEMIOL, V59, P697, DOI 10.1016/j.jclinepi.2005.11.010; Carmona L, 2011, SEMIN ARTHRITIS RHEU, V41, P71, DOI 10.1016/j.semarthrit.2010.08.005; Chakravarty EF, 2008, EXPERT OPIN DRUG SAF, V7, P539, DOI 10.1517/14740338.7.5.539 ; Chen MF, 2012, J MOL MED, V90, P89, DOI 10.1007/s00109-011-0809-4; Choy E, 2012, RHEUMATOLOGY, V51, P1226, DOI 10.1093/rheumatology/ker519; Clair EWS, 2004, ARTHRITIS RHEUM-US, V50, P3432, DOI 10.1002/art.20568; Cohen S, 2002, ARTHRITIS RHEUM, V46, P614, DOI 10.1002/art.10141; Cohen SB, 2004, ANN RHEUM DIS, V63, P1062, DOI 10.1136/ard.2003.016014; Cohen SB, 2008, J RHEUMATOL, V35, P4; Cohen SB, 2006, ARTHRITIS RHEUM-US, V54, P2793, DOI 10.1002/art.22025; Combe B, 2006, ANN RHEUM DIS, V65, P1357, DOI 10.1136/ard.2005.049650; Combe B, 2009, ANN RHEUM DIS, V68, P1146, DOI 10.1136/ard.2007.087106; Curtis JR, 2010, SEMIN ARTHRITIS RHEU, V40, P2, DOI 10.1016/j.semarthrit.2010.03.003; Diamond GA, 2007, ANN INTERN MED, V147, P578, DOI 10.7326/0003-4819-147-8-200710160-00182; Dinarello CA, 2010, CANCER METAST REV, V29, P317, DOI 10.1007/s10555-010-9229-0; Durez P, 2007, ARTHRITIS RHEUM-US, V56, P3919, DOI 10.1002/art.23055; Edwards JCW, 2004, NEW ENGL J MED, V350, P2572, DOI 10.1056/NEJMoa032534; Emery P, 2008, ANN RHEUM DIS, V67, P1516, DOI 10.1136/ard.2008.092932; Emery P, 2006, ARTHRITIS RHEUM, V54, P1390, DOI 10.1002/art.21778; Emery P, 2010, ANN RHEUM DIS, V69, P1629, DOI 10.1136/ard.2009.119933; Emery P, 2010, ANN RHEUM DIS, V69, P510, DOI 10.1136/ard.2009.119016; Emery P, 2008, LANCET, V372, P375, DOI 10.1016/S0140-6736(08)61000-4; Emery P, 2009, ARTHRITIS RHEUM-US, V60, P2272, DOI 10.1002/art.24638; Fleischmann R, 2009, ANN RHEUM DIS, V68, P805, DOI 10.1136/ard.2008.099291; Fleischmann RM, 2003, ARTHRITIS RHEUM-US, V48, P927, DOI 10.1002/art.10870; Furst DE, 2003, J RHEUMATOL, V30, P2563; Geborek P, 2005, ANN RHEUM DIS, V64, P699, DOI 10.1136/ard.2004.030528; Genovese MC, 2008, ARTHRITIS RHEUM-US, V58, P2968, DOI 10.1002/art.23940; Genovese MC, 2005, NEW ENGL J MED, V353, P1114, DOI 10.1056/NEJMoa050524; Genovese MC, 2004, ARTHRITIS RHEUM-US, V50, P1412, DOI 10.1002/art.20221; Goekoop-Ruiterman YPM, 2005, ARTHRITIS RHEUM-US, V52, P3381, DOI [10.1002/art.21405, 10.1002/art.23364]; Goekoop-Ruiterman YPM, 2007, ANN INTERN MED, V146, P406, DOI 10.7326/0003-4819-146-6-200703200-00005; Greenwald MW, 2011, ARTHRITIS RHEUM-US, V63, P622, DOI 10.1002/art.30194; Harnack U, 2010, ANTICANCER RES, V30, P3959; Heikkila K, 2009, CANCER CAUSE CONTROL, V20, P15, DOI 10.1007/s10552-008-9212-z; Higgins JPT, COCHRANE HDB SYSTEMA, P4; Hu DW, 2009, RHEUMATOL INT, V29, P297, DOI 10.1007/s00296-008-0681-x; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Jones G, 2010, ANN RHEUM DIS, V69, P88, DOI 10.1136/ard.2008.105197; Kaiser R, 2008, CLIN LYMPHOMA MYELOM, V8, P87, DOI 10.3816/CLM.2008.n.009; Kay J, 2008, ARTHRITIS RHEUM-US, V58, P964, DOI 10.1002/art.23383; Keystone EC, 2009, ANN RHEUM DIS, V68, P789, DOI 10.1136/ard.2008.099010; Keystone EC, 2004, ARTHRITIS RHEUM, V50, P1400, DOI 10.1002/art.20217; Keystone E, 2008, ARTHRITIS RHEUM, V58, P3319, DOI 10.1002/art.23964; KIM HY, 2007, APLAR J RHEUMATOL, V10, P9, DOI DOI 10.1111/J.1479-8077.2007.00248.X; Klareskog L, 2004, LANCET, V363, P675, DOI 10.1016/S0140-6736(04)15640-7; Kremer JM, 2003, NEW ENGL J MED, V349, P1907, DOI 10.1056/NEJMoa035075; Kremer J, 2010, ARTHRITIS RHEUM-US, V62, P917, DOI 10.1002/art.27348; Kremer JM, 2006, ANN INTERN MED, V144, P865, DOI 10.7326/0003-4819-144-12-200606200-00003; Kremer JM, 2011, ARTHRITIS RHEUM-US, V63, P609, DOI 10.1002/art.30158; Le Blay P, 2012, J RHEUMATOL, V39, P712, DOI 10.3899/jrheum.110982; Leombruno JP, 2009, ANN RHEUM DIS, V68, P1136, DOI 10.1136/ard.2008.091025; Lipsky PE, 2000, NEW ENGL J MED, V343, P1594, DOI 10.1056/NEJM200011303432202; Maini R, 1999, LANCET, V354, P1932, DOI 10.1016/S0140-6736(99)05246-0; Maini RN, 1998, ARTHRITIS RHEUM, V41, P1552, DOI 10.1002/1529-0131(199809)41:9<1552::AID-ART5>3.0.CO;2-W; Maini RN, 2004, ARTHRITIS RHEUM-US, V50, P1051, DOI 10.1002/art.20159; Mease PJ, 2010, J RHEUMATOL, V37, P917, DOI 10.3899/jrheum.090442; Miyasaka N, 2008, MOD RHEUMATOL, V18, P252, DOI 10.1007/s10165-008-0045-0; Moreland LW, 1999, ANN INTERN MED, V130, P478, DOI 10.7326/0003-4819-130-6-199903160-00004; Nannini C, 2009, ARTHRIT RHEUM-ARTHR, V61, P801, DOI 10.1002/art.24506; Nishimoto N, 2007, ANN RHEUM DIS, V66, P1162, DOI 10.1136/ard.2006.068064; Nishimoto N, 2009, MOD RHEUMATOL, V19, P12, DOI 10.1007/s10165-008-0125-1; Parakkal D, 2011, EUR J GASTROEN HEPAT, V23, P1150, DOI 10.1097/MEG.0b013e32834bb90a; Quinn MA, 2005, ARTHRITIS RHEUM-US, V52, P27, DOI 10.1002/art.20712; Schiff M, 2008, ANN RHEUM DIS, V67, P1096, DOI 10.1136/ard.2007.080002; Setoguchi S, 2006, ARTHRITIS RHEUM-US, V54, P2757, DOI 10.1002/art.22056; Singh JA, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008794.pub2; Smitten AL, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2404; Smolen J, 2009, ANN RHEUM DIS, V68, P797, DOI 10.1136/ard.2008.101659; Smolen JS, 2008, LANCET, V371, P987, DOI 10.1016/S0140-6736(08)60453-5; Smolen JS, 2009, LANCET, V374, P210, DOI 10.1016/S0140-6736(09)60506-7; Soubrier M, 2009, RHEUMATOLOGY, V48, P1429, DOI 10.1093/rheumatology/kep261; Tak PP, 2011, ANN RHEUM DIS, V70, P39, DOI 10.1136/ard.2010.137703; Tak PP, 2012, ANN RHEUM DIS, V71, P351, DOI 10.1136/annrheumdis-2011-200170; van de Putte BA, 2004, ANN RHEUM DIS, V63, P508, DOI 10.1136/ard.2003.013052; van der Heijde D, 2007, ARTHRITIS RHEUM, V56, P3928, DOI 10.1002/art.23141; van der Heijde D, 2006, ARTHRITIS RHEUM-US, V54, P1063, DOI 10.1002/art.21655; van Vollenhoven RF, 2011, ARTHRITIS RHEUM-US, V63, P1782, DOI 10.1002/art.30372; van Vollenhoven RF, 2009, LANCET, V374, P459, DOI 10.1016/S0140-6736(09)60944-2; van Vollenhoven RF, 2012, LANCET, V379, P1712, DOI 10.1016/S0140-6736(12)60027-0; Weinblatt M, 2006, ARTHRITIS RHEUM, V54, P2807, DOI 10.1002/art.22070; Weinblatt ME, 1999, NEW ENGL J MED, V340, P253, DOI 10.1056/NEJM199901283400401; Weinblatt ME, 2003, ARTHRITIS RHEUM-US, V48, P35, DOI 10.1002/art.10697; Weinblatt M, 2007, ANN RHEUM DIS, V66, P228, DOI 10.1136/ard.2006.055111; Weisberg HI, 2009, CLIN TRIALS, V6, P109, DOI 10.1177/1740774509102563; Westhovens R, 2006, ARTHRITIS RHEUM-US, V54, P1075, DOI 10.1002/art.21734; Westhovens R, 2009, ANN RHEUM DIS, V68, P1870, DOI 10.1136/ard.2008.101121; Wiens A, 2010, RHEUMATOL INT, V30, P1063, DOI 10.1007/s00296-009-1111-4; Wiens A, 2010, PHARMACOTHERAPY, V30, P339, DOI 10.1592/phco.30.4.339; Wiens A, 2009, CLIN RHEUMATOL, V28, P1365, DOI 10.1007/s10067-009-1233-9; Wiens A, 2009, SCAND J IMMUNOL, V70, P337, DOI 10.1111/j.1365-3083.2009.02296.x; Wolfe F, 2004, ARTHRITIS RHEUM-US, V50, P1740, DOI 10.1002/art.20311; Wolfe F, 2007, ARTHRITIS RHEUM, V56, P2886, DOI 10.1002/art.22864; Wong AK, 2012, CLIN RHEUMATOL, V31, P631, DOI 10.1007/s10067-011-1895-y; Yazici Y, 2012, ANN RHEUM DIS, V71, P198, DOI 10.1136/ard.2010.148700	109	219	226	0	23	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 5	2012	308	9					898	908		10.1001/2012.jama.10857	http://dx.doi.org/10.1001/2012.jama.10857			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	999ET	22948700				2022-12-28	WOS:000308292900020
J	Lima, WF; Prakash, TP; Murray, HM; Kinberger, GA; Li, WY; Chappell, AE; Li, CS; Murray, SF; Gaus, H; Seth, PP; Swayze, EE; Crooke, ST				Lima, Walt F.; Prakash, Thazha P.; Murray, Heather M.; Kinberger, Garth A.; Li, Wenyu; Chappell, Alfred E.; Li, Cheryl S.; Murray, Susan F.; Gaus, Hans; Seth, Punit P.; Swayze, Eric E.; Crooke, Stanley T.			Single-Stranded siRNAs Activate RNAi in Animals	CELL			English	Article							SMALL INTERFERING RNA; MAMMALIAN-CELLS; CHEMICAL-MODIFICATIONS; HUMAN DICER; OLIGONUCLEOTIDE; IDENTIFICATION; ARGONAUTE2; STABILITY; CLEAVAGE; DUPLEXES	The therapeutic utility of siRNAs is limited by the requirement for complex formulations to deliver them to tissues. If potent single-stranded RNAs could be identified, they would provide a simpler path to pharmacological agents. Here, we describe single-stranded siRNAs (ss-siRNAs) that silence gene expression in animals absent lipid formulation. Effective ss-siRNAs were identified by iterative design by determining structure-activity relationships correlating chemically modified single strands and Argonaute 2 (AGO2) activities, potency in cells, nuclease stability, and pharmacokinetics. We find that the passenger strand is not necessary for potent gene silencing. The guide-strand activity requires AGO2, demonstrating action through the RNAi pathway. ss-siRNA action requires a 5' phosphate to achieve activity in vivo, and we developed a metabolically stable 5'-(E)-vinylphosphonate (5'-VP) with conformation and sterioelectronic properties similar to the natural phosphate. Identification of potent ss-siRNAs offers an additional option for RNAi therapeutics and an alternate perspective on RNAi mechanism.	[Lima, Walt F.; Murray, Heather M.; Li, Cheryl S.; Crooke, Stanley T.] Isis Pharmaceut Inc, Core Antisense Res, Carlsbad, CA 92010 USA; [Prakash, Thazha P.; Kinberger, Garth A.; Li, Wenyu; Seth, Punit P.; Swayze, Eric E.] Isis Pharmaceut Inc, Med Chem, Carlsbad, CA 92010 USA; [Chappell, Alfred E.; Gaus, Hans] Isis Pharmaceut Inc, Struct Biol, Carlsbad, CA 92010 USA; [Murray, Susan F.] Isis Pharmaceut Inc, Mol Pharmacol, Carlsbad, CA 92010 USA	Isis Pharmaceuticals Inc; Isis Pharmaceuticals Inc; Isis Pharmaceuticals Inc; Isis Pharmaceuticals Inc	Lima, WF (corresponding author), Isis Pharmaceut Inc, Core Antisense Res, Carlsbad, CA 92010 USA.	wlima@isisph.com	Murray, Heather/GQY-8016-2022; Seth, Punit/M-2205-2019	Seth, Punit/0000-0002-1783-7806; Gaus, Hans/0000-0002-7471-8619; Swayze, Eric/0000-0001-6430-6576				Allerson CR, 2005, J MED CHEM, V48, P901, DOI 10.1021/jm049167j; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Braasch DA, 2003, BIOCHEMISTRY-US, V42, P7967, DOI 10.1021/bi0343774; Caplen NJ, 2003, EXPERT OPIN BIOL TH, V3, P575, DOI 10.1517/14712598.3.4.575; Chen PY, 2008, RNA, V14, P263, DOI 10.1261/rna.789808; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Crooke S. T., 2008, ANTISENSE DRUG TECHN; Dande P, 2006, J MED CHEM, V49, P1624, DOI 10.1021/jm050822c; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Graham MJ, 1998, J PHARMACOL EXP THER, V286, P447; Graham MJ, 2001, BIOCHEM PHARMACOL, V62, P297, DOI 10.1016/S0006-2952(01)00669-4; Guzaev AP, 2003, J AM CHEM SOC, V125, P2380, DOI 10.1021/ja0284613; Hall AHS, 2004, NUCLEIC ACIDS RES, V32, P5991, DOI 10.1093/nar/gkh936; Haringsma HJ, 2012, NUCLEIC ACIDS RES, V40, P4125, DOI 10.1093/nar/gkr1301; Holen T, 2003, NUCLEIC ACIDS RES, V31, P2401, DOI 10.1093/nar/gkg338; Kini HK, 2007, FEBS LETT, V581, P5611, DOI 10.1016/j.febslet.2007.11.010; Lima WF, 2009, J BIOL CHEM, V284, P26017, DOI 10.1074/jbc.M109.010835; Lima WF, 2009, J BIOL CHEM, V284, P2535, DOI 10.1074/jbc.M803748200; MacRae IJ, 2006, SCIENCE, V311, P195, DOI 10.1126/science.1121638; Martinez J, 2002, CELL, V110, P563, DOI 10.1016/S0092-8674(02)00908-X; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Nykanen A, 2001, CELL, V107, P309, DOI 10.1016/S0092-8674(01)00547-5; Prakash TP, 2005, J MED CHEM, V48, P4247, DOI 10.1021/jm050044o; Rand TA, 2004, P NATL ACAD SCI USA, V101, P14385, DOI 10.1073/pnas.0405913101; Rivas FV, 2005, NAT STRUCT MOL BIOL, V12, P340, DOI 10.1038/nsmb918; Rose SD, 2005, NUCLEIC ACIDS RES, V33, P4140, DOI 10.1093/nar/gki732; Schwarz DS, 2002, MOL CELL, V10, P537, DOI 10.1016/S1097-2765(02)00651-2; Song JJ, 2004, SCIENCE, V305, P1434, DOI 10.1126/science.1102514; Tao WK, 2011, MOL THER, V19, P567, DOI 10.1038/mt.2010.282; Tomari Y, 2004, SCIENCE, V306, P1377, DOI 10.1126/science.1102755; Vaishnaw Akshay K, 2010, Silence, V1, P14, DOI 10.1186/1758-907X-1-14; Wu HJ, 1998, J BIOL CHEM, V273, P2532, DOI 10.1074/jbc.273.5.2532; Yu DB, 2012, CELL, V150, P895, DOI 10.1016/j.cell.2012.08.002	34	185	246	1	64	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 31	2012	150	5					883	894		10.1016/j.cell.2012.08.014	http://dx.doi.org/10.1016/j.cell.2012.08.014			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	001ZU	22939618	Bronze			2022-12-28	WOS:000308500200005
J	Rapley, C				Rapley, Chris			Time to raft up	NATURE			English	Editorial Material							CLIMATE		UCL, Dept Earth Sci, London WC1E 6BT, England	University of London; University College London	Rapley, C (corresponding author), UCL, Dept Earth Sci, London WC1E 6BT, England.	christopher.rapley@ucl.ac.uk						Festinger L., 1957, THEORY COGNITIVE DIS, V2; Grundmann R., 2012, SCI TECHNOL HUM VALU; International Council for Science, 2012, FUT EARTH RES GLOB S; Kahan D, 2012, NATURE CLIM CHANGE; McCallie E, 2007, MUS SOC ISS, V2, P165, DOI 10.1179/msi.2007.2.2.165; Poortinga W, 2011, GLOBAL ENVIRON CHANG, V21, P1015, DOI 10.1016/j.gloenvcha.2011.03.001; Sarewitz D., 2012, WORKSH AAAS SCI RESP; Shuckburgh E., CLIMATE SCI IN PRESS; Weintrobe S., ENGAGING CL IN PRESS	10	11	11	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 30	2012	488	7413					583	585		10.1038/488583a	http://dx.doi.org/10.1038/488583a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996NC	22932363				2022-12-28	WOS:000308095100025
J	Yi, W; Clark, PM; Mason, DE; Keenan, MC; Hill, C; Goddard, WA; Peters, EC; Driggers, EM; Hsieh-Wilson, LC				Yi, Wen; Clark, Peter M.; Mason, Daniel E.; Keenan, Marie C.; Hill, Collin; Goddard, William A., III; Peters, Eric C.; Driggers, Edward M.; Hsieh-Wilson, Linda C.			Phosphofructokinase 1 Glycosylation Regulates Cell Growth and Metabolism	SCIENCE			English	Article							O-GLCNAC MODIFICATION; BETA-N-ACETYLGLUCOSAMINE; NUCLEOCYTOPLASMIC PROTEINS; GLUCOSE-METABOLISM; BREAST-CANCER; TRANSFERASE; INHIBITION; PATHWAY; STRESS	Cancer cells must satisfy the metabolic demands of rapid cell growth within a continually changing microenvironment. We demonstrated that the dynamic posttranslational modification of proteins by O-linked beta-N-acetylglucosamine (O-GlcNAcylation) is a key metabolic regulator of glucose metabolism. O-GlcNAcylation was induced at serine 529 of phosphofructokinase 1 (PFK1) in response to hypoxia. Glycosylation inhibited PFK1 activity and redirected glucose flux through the pentose phosphate pathway, thereby conferring a selective growth advantage on cancer cells. Blocking glycosylation of PFK1 at serine 529 reduced cancer cell proliferation in vitro and impaired tumor formation in vivo. These studies reveal a previously uncharacterized mechanism for the regulation of metabolic pathways in cancer and a possible target for therapeutic intervention.	[Goddard, William A., III; Hsieh-Wilson, Linda C.] CALTECH, Div Chem & Chem Engn, Mat & Proc Simulat Ctr, Pasadena, CA 91125 USA; [Yi, Wen; Clark, Peter M.; Hsieh-Wilson, Linda C.] CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA; [Mason, Daniel E.; Peters, Eric C.] Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA; [Keenan, Marie C.; Hill, Collin; Driggers, Edward M.] Agios Pharmaceut, Cambridge, MA 02139 USA	California Institute of Technology; California Institute of Technology; Howard Hughes Medical Institute; Novartis; Agios Pharmaceuticals	Hsieh-Wilson, LC (corresponding author), CALTECH, Div Chem & Chem Engn, Mat & Proc Simulat Ctr, Pasadena, CA 91125 USA.	lhw@caltech.edu	Yi, Wen/M-5905-2014; Peters, Eric/W-2739-2019		National Institutes of Health [R01 GM084724]; Department of Defense Breast Cancer Research Program [W81XWH-10-1-0988]; Tobacco-Related Disease Research Program Postdoctoral Fellowship [19FT-0078]; Agios Pharmaceuticals; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084724] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense Breast Cancer Research Program(United States Department of Defense); Tobacco-Related Disease Research Program Postdoctoral Fellowship(University of California System); Agios Pharmaceuticals; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank P. Qasba for the Y289L GalT construct, R. Abrol for computational modeling advice, R. Diamond for cell cycle analysis, and L. Cantley and M. Vander Heiden for useful discussions. This work was supported by the National Institutes of Health (grant R01 GM084724 to L. C. H-W), the Department of Defense Breast Cancer Research Program (grant W81XWH-10-1-0988 to W.Y), and a Tobacco-Related Disease Research Program Postdoctoral Fellowship (19FT-0078 to W.Y). We also thank Agios Pharmaceuticals for financial support in providing patient tumor and matched tissue samples.	Anastasiou D, 2011, SCIENCE, V334, P1278, DOI 10.1126/science.1211485; Bensaad K, 2006, CELL, V126, P107, DOI 10.1016/j.cell.2006.05.036; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Caldwell SA, 2010, ONCOGENE, V29, P2831, DOI 10.1038/onc.2010.41; Clark PM, 2008, J AM CHEM SOC, V130, P11576, DOI 10.1021/ja8030467; Dentin R, 2008, SCIENCE, V319, P1402, DOI 10.1126/science.1151363; Ferreras C, 2009, J BIOL CHEM, V284, P9124, DOI 10.1074/jbc.M807737200; Fuhrer T, 2011, ANAL CHEM, V83, P7074, DOI 10.1021/ac201267k; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Herrero-Mendez A, 2009, NAT CELL BIOL, V11, P747, DOI 10.1038/ncb1881; Levine AJ, 2010, SCIENCE, V330, P1340, DOI 10.1126/science.1193494; Lu XH, 2000, CLIN CANCER RES, V6, P271; Lynch TP, 2012, J BIOL CHEM, V287, P11070, DOI 10.1074/jbc.M111.302547; Moseley HNB, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-37; PANDOLFI PP, 1995, EMBO J, V14, P5209, DOI 10.1002/j.1460-2075.1995.tb00205.x; Possemato R, 2011, NATURE, V476, P346, DOI 10.1038/nature10350; Ramakrishnan B, 2002, J BIOL CHEM, V277, P20833, DOI 10.1074/jbc.M111183200; Rexach JE, 2012, NAT CHEM BIOL, V8, P253, DOI [10.1038/NCHEMBIO.770, 10.1038/nchembio.770]; Rexach JE, 2010, NAT CHEM BIOL, V6, P645, DOI [10.1038/NCHEMBIO.412, 10.1038/nchembio.412]; Sidorenko Y, 2008, BIOTECHNOL PROGR, V24, P311, DOI 10.1021/bp0702673; Slawson C, 2011, NAT REV CANCER, V11, P678, DOI 10.1038/nrc3114; Sola-Penna M, 2010, IUBMB LIFE, V62, P791, DOI 10.1002/iub.393; Taylor RP, 2008, J BIOL CHEM, V283, P6050, DOI 10.1074/jbc.M707328200; Tong XM, 2009, CURR OPIN GENET DEV, V19, P32, DOI 10.1016/j.gde.2009.01.002; Wellen KE, 2010, GENE DEV, V24, P2784, DOI 10.1101/gad.1985910; Yalcin A, 2009, EXP MOL PATHOL, V86, P174, DOI 10.1016/j.yexmp.2009.01.003; Yang XY, 2008, NATURE, V451, P964, DOI 10.1038/nature06668; Zachara NE, 2004, J BIOL CHEM, V279, P30133, DOI 10.1074/jbc.M403773200	29	394	424	9	213	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 24	2012	337	6097					975	980		10.1126/science.1222278	http://dx.doi.org/10.1126/science.1222278			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992VI	22923583	Green Accepted			2022-12-28	WOS:000307807600048
J	Badgett, R; Massey, A				Badgett, Robert; Massey, Andrew			Review: Prophylactic botulinum toxin A reduces frequency of chronic migraine headaches in adults	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Badgett, Robert; Massey, Andrew] Univ Kansas, Sch Med, Wichita, KS 67214 USA	University of Kansas; University of Kansas Medical Center	Badgett, R (corresponding author), Univ Kansas, Sch Med, Wichita, KS 67214 USA.			Badgett, Robert/0000-0003-2888-3303				Colosimo C, 2012, NEUROTOX RES; Olesen J, 2010, LANCET, V376, P1825, DOI 10.1016/S0140-6736(10)62165-4; Singer N., 2010, NY TIMES        0829	3	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 21	2012	157	4							JC4-10	10.7326/0003-4819-157-4-201208210-02010	http://dx.doi.org/10.7326/0003-4819-157-4-201208210-02010			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	992XG	22910964				2022-12-28	WOS:000307813200009
J	Stevens, SM				Stevens, Scott M.			Review: Fondaparinux reduces VTE and recurrence in superficial thrombophlebitis of the leg	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Stevens, Scott M.] Intermt Med Ctr, Murray, UT USA; [Stevens, Scott M.] Univ Utah, Murray, UT USA	Intermountain Healthcare; Intermountain Medical Center; Utah System of Higher Education; University of Utah	Stevens, SM (corresponding author), Intermt Med Ctr, Murray, UT USA.							Cosmi B, 2012, J THROMB HAEMOST, V10, P1026, DOI 10.1111/j.1538-7836.2012.04727.x	1	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 21	2012	157	4							JC4-4	10.7326/0003-4819-157-4-201208210-02004	http://dx.doi.org/10.7326/0003-4819-157-4-201208210-02004			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	992XG	22910958				2022-12-28	WOS:000307813200003
J	Haley, RW				Haley, Robert W.			Controlling Urban Epidemics of West Nile Virus Infection	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							COUNTY		Univ Texas SW Med Ctr Dallas, Dept Internal Med, Div Epidemiol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Haley, RW (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Internal Med, Div Epidemiol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	Robert.Haley@UTSouthwestern.edu	Haley, Robert/P-9026-2014	Haley, Robert/0000-0001-8849-9579				Centers for Disease Control and Prevention, 2012, W NIL VIR INF GUID C; Centers for Disease Control and Prevention, 2012, MOSQ STUD; Chung W, 2012, W NILE VIRUS OUTBREA; Dallas County Medical Society, 2012, DCMS PHYS D MCCOY MD; Goodman Denise M, 2012, JAMA, V308, P1052, DOI 10.1001/2012.jama.11678; Macedo PA, 2010, J AM MOSQUITO CONTR, V26, P57, DOI 10.2987/09-5961.1; National Pesticide Telecommunications Network, 1998, PYR PYR; Petersen LR, 2003, JAMA-J AM MED ASSOC, V290, P524, DOI 10.1001/jama.290.4.524; Savage HM, 2008, J MED ENTOMOL, V45, P276, DOI 10.1603/0022-2585(2008)45[276:HHHAPA]2.0.CO;2	9	9	10	2	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 3	2012	308	13					1325	1326		10.1001/2012.jama.11930	http://dx.doi.org/10.1001/2012.jama.11930			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	014IV	22922679	Bronze			2022-12-28	WOS:000309369300023
J	Hand, TW; Dos Santos, LM; Bouladoux, N; Molloy, MJ; Pagan, AJ; Pepper, M; Maynard, CL; Elson, CO; Belkaid, Y				Hand, Timothy W.; Dos Santos, Liliane M.; Bouladoux, Nicolas; Molloy, Michael J.; Pagan, Antonio J.; Pepper, Marion; Maynard, Craig L.; Elson, Charles O., III; Belkaid, Yasmine			Acute Gastrointestinal Infection Induces Long-Lived Microbiota-Specific T Cell Responses	SCIENCE			English	Article							GUT COMMENSAL BACTERIA; TOXOPLASMA-GONDII; CROHNS-DISEASE; INDUCTION; DOMINANT; EFFECTOR; IMMUNITY; NAIVE; IGA	The mammalian gastrointestinal tract contains a large and diverse population of commensal bacteria and is also one of the primary sites of exposure to pathogens. How the immune system perceives commensals in the context of mucosal infection is unclear. Here, we show that during a gastrointestinal infection, tolerance to commensals is lost, and microbiota-specific T cells are activated and differentiate to inflammatory effector cells. Furthermore, these T cells go on to form memory cells that are phenotypically and functionally consistent with pathogen-specific T cells. Our results suggest that during a gastrointestinal infection, the immune response to commensals parallels the immune response against pathogenic microbes and that adaptive responses against commensals are an integral component of mucosal immunity.	[Hand, Timothy W.; Dos Santos, Liliane M.; Bouladoux, Nicolas; Molloy, Michael J.; Belkaid, Yasmine] NIAID, Mucosal Immun Sect, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA; [Dos Santos, Liliane M.] Univ Fed Minas Gerais, Lab Gnotobiol & Immunol, BR-31270901 Belo Horizonte, MG, Brazil; [Pagan, Antonio J.; Pepper, Marion] Univ Minnesota, Microbiol Immunol & Canc Biol Program, Minneapolis, MN 55455 USA; [Pepper, Marion] Univ Washington, Dept Immunol, Seattle, WA 98195 USA; [Maynard, Craig L.] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Elson, Charles O., III] Univ Alabama Birmingham, Mucosal HIV & Immunobiol Ctr, Birmingham, AL 35294 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Universidade Federal de Minas Gerais; University of Minnesota System; University of Minnesota Twin Cities; University of Washington; University of Washington Seattle; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Belkaid, Y (corresponding author), NIAID, Mucosal Immun Sect, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA.	ybelkaid@niaid.nih.gov	Pagan, Antonio/AAB-1604-2019; Hand, Timothy W/AAH-1216-2021; Santos, Liliane Martins dos/AAR-9220-2020	Hand, Timothy W/0000-0002-2684-9462; Santos, Liliane Martins dos/0000-0002-4466-8868; Bouladoux, Nicolas/0000-0003-1593-671X; Belkaid, Yasmine/0000-0001-9962-3571	Division of Intramural Research, National Institute of Allergy and Infectious Diseases (NIAID); CNPq-Brazil; NIH [DK071176, DK64400]; Crohn's and Colitis Foundation of America Career Development Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001115, T32AI007051] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R24DK064400, P01DK071176] Funding Source: NIH RePORTER	Division of Intramural Research, National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); CNPq-Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's and Colitis Foundation of America Career Development Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases (NIAID) (T. W. H., L. M. D., N.B., M.J.M., and Y.B.), CNPq-Brazil (L. M. D.), NIH grants DK071176 and DK64400 (C.O.E.) and The Crohn's and Colitis Foundation of America Career Development Award (C. L. M.). The authors thank M. Jenkins, A. Poholek, S. Kaech, N. Peters, J. Monteiro and the members of the Belkaid Lab for critical discussion and reading of the manuscript; the NIH Tetramer Core Facility for the T. gondii Me49 hypothetical protein tetramers; C. Eigsti, T. Moyer, E. Stregevsky, K. Holmes, and the NIAID Flow Cytometry Core for assistance with sorting; L. Koo and the NIAID Microscopy Core for assistance with 16S fluorescence in situ hybridization (FISH) images; and the NIAID Protein Biochemistry Core for CBir1 peptide. We thank the University of Alabama-Birmingham for sharing the CBir1 Tg mice by material transfer agreement. The data reported in this paper are tabulated in the main text and in the supplementary materials. The authors declare that they have no conflict of interest.	Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Benson A, 2009, CELL HOST MICROBE, V6, P187, DOI 10.1016/j.chom.2009.06.005; Cadwell K, 2010, CELL, V141, P1135, DOI 10.1016/j.cell.2010.05.009; Cong YZ, 2009, P NATL ACAD SCI USA, V106, P19256, DOI 10.1073/pnas.0812681106; Duck LW, 2007, INFLAMM BOWEL DIS, V13, P1191, DOI 10.1002/ibd.20237; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Gaboriau-Routhiau V, 2009, IMMUNITY, V31, P677, DOI 10.1016/j.immuni.2009.08.020; Geuking MB, 2011, IMMUNITY, V34, P794, DOI 10.1016/j.immuni.2011.03.021; Haas A, 2011, GUT, V60, P1506, DOI 10.1136/gut.2010.224774; Harrington LE, 2008, NATURE, V452, P356, DOI 10.1038/nature06672; Hataye J, 2006, SCIENCE, V312, P114, DOI 10.1126/science.1124228; Heimesaat MM, 2006, J IMMUNOL, V177, P8785, DOI 10.4049/jimmunol.177.12.8785; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Kaser A, 2010, ANNU REV IMMUNOL, V28, P573, DOI 10.1146/annurev-immunol-030409-101225; Kau AL, 2011, NATURE, V474, P327, DOI 10.1038/nature10213; Kosek M, 2003, B WORLD HEALTH ORGAN, V81, P197; Lathrop SK, 2011, NATURE, V478, P250, DOI 10.1038/nature10434; Lochner M, 2011, J IMMUNOL, V186, P1531, DOI 10.4049/jimmunol.1001723; Lodes MJ, 2004, J CLIN INVEST, V113, P1296, DOI 10.1172/JCI200420295; Macpherson AJ, 2004, SCIENCE, V303, P1662, DOI 10.1126/science.1091334; Macpherson AJ, 2009, SEMIN IMMUNOPATHOL, V31, P145, DOI 10.1007/s00281-009-0174-3; Marshall HD, 2011, IMMUNITY, V35, P633, DOI 10.1016/j.immuni.2011.08.016; Moon JJ, 2007, IMMUNITY, V27, P203, DOI 10.1016/j.immuni.2007.07.007; Munoz M, 2011, IMMUNOL REV, V240, P269, DOI 10.1111/j.1600-065X.2010.00992.x; Oldenhove G, 2009, IMMUNITY, V31, P772, DOI 10.1016/j.immuni.2009.10.001; Pepper M, 2010, NAT IMMUNOL, V11, P83, DOI 10.1038/ni.1826; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Sallusto F, 2009, EUR J IMMUNOL, V39, P2076, DOI 10.1002/eji.200939722; Slack E, 2009, SCIENCE, V325, P617, DOI 10.1126/science.1172747; Vernacchio L, 2006, PEDIATR INFECT DIS J, V25, P2, DOI 10.1097/01.inf.0000195623.57945.87	31	263	272	3	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 21	2012	337	6101					1553	1556		10.1126/science.1220961	http://dx.doi.org/10.1126/science.1220961			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007UC	22923434	Green Accepted			2022-12-28	WOS:000308912900055
J	Andreux, PA; Williams, EG; Koutnikova, H; Houtkooper, RH; Champy, MF; Henry, H; Schoonjans, K; Williams, RW; Auwerx, J				Andreux, Penelope A.; Williams, Evan G.; Koutnikova, Hana; Houtkooper, Riekelt H.; Champy, Marie-France; Henry, Hugues; Schoonjans, Kristina; Williams, Robert W.; Auwerx, Johan			Systems Genetics of Metabolism: The Use of the BXD Murine Reference Panel for Multiscalar Integration of Traits	CELL			English	Article							INNATE IMMUNITY; COMPLEX TRAITS; DISSECTION; SUBSTITUTION; ASSOCIATION; REGULATOR; GENOMICS; VARIANT; LOCI; MASS	Metabolic homeostasis is achieved by complex molecular and cellular networks that differ significantly among individuals and are difficult to model with genetically engineered lines of mice optimized to study single gene function. Here, we systematically acquired metabolic phenotypes by using the EUMODIC EMPReSS protocols across a large panel of isogenic but diverse strains of mice (BXD type) to study the genetic control of metabolism. We generated and analyzed 140 classical phenotypes and deposited these in an open-access web service for systems genetics (www.genenetwork.org). Heritability, influence of sex, and genetic modifiers of traits were examined singly and jointly by using quantitative-trait locus (QTL) and expression QTL-mapping methods. Traits and networks were linked to loci encompassing both known variants and novel candidate genes, including alkaline phosphatase (ALPL), here linked to hypophosphatasia. The assembled and curated phenotypes provide key resources and exemplars that can be used to dissect complex metabolic traits and disorders.	[Williams, Robert W.] Univ Tennessee, Hlth Sci Ctr, Ctr Integrat & Translat Genom, Dept Anat & Neurobiol, Memphis, TN 38163 USA; [Andreux, Penelope A.; Williams, Evan G.; Houtkooper, Riekelt H.; Schoonjans, Kristina; Auwerx, Johan] Ecole Polytech Fed Lausanne, Sch Life Sci, Lab Integrat & Syst Physiol, CH-1015 Lausanne, Switzerland; [Koutnikova, Hana; Champy, Marie-France; Auwerx, Johan] Inst Clin Souris, F-67404 Illkirch Graffenstaden, France; [Henry, Hugues] CHU Vaudois, CH-1011 Lausanne, Switzerland	University of Tennessee System; University of Tennessee Health Science Center; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Williams, RW (corresponding author), Univ Tennessee, Hlth Sci Ctr, Ctr Integrat & Translat Genom, Dept Anat & Neurobiol, Memphis, TN 38163 USA.	rwilliams@uthsc.edu; admin.auwerx@epfl.ch	Koutnikova, Hana/I-7758-2017; Auwerx, Johan/ABE-9307-2021; Houtkooper, Riekelt H/E-1602-2011; Houtkooper, Riekelt/P-5001-2019; Williams, Robert W./H-8789-2016	Houtkooper, Riekelt H/0000-0001-9961-0842; Auwerx, Johan/0000-0002-5065-5393; Williams, Evan/0000-0002-9746-376X; Williams, Robert W./0000-0001-8924-4447; Schoonjans, Kristina/0000-0003-1247-4265	Rubicon fellowship of the NWO; Ecole Polytechnique Federale de Lausanne; EU Ideas program [ERC-2008-AdG-23118]; Velux Stiftung; Swiss National Science Foundation [31003A-124713, 31003A-125487, CSRII3-136201]; NIH [P20-DA 21131, UO1AA13499, U01AA14425]; UT Center for Integrative and Translational Genomics; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U01AA014425, U01AA016662, U01AA017590, U01AA013499] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P20DA021131] Funding Source: NIH RePORTER	Rubicon fellowship of the NWO; Ecole Polytechnique Federale de Lausanne; EU Ideas program; Velux Stiftung; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UT Center for Integrative and Translational Genomics; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We would like to thank Laurent Pouilly, Tania Sorg, Hongbo Zhang, and Ulrike Kettenberger for technical assistance with various aspects of mouse phenotyping. Discussions with Thomas Vogt (Merck Research Laboratories), Carmen Argmann and Sander Houten (University of Amsterdam), Vincent Mooser (CHUV), Stephan Morgenthaler (EPFL), Dominique Pioletti (EPFL), Bernard Thorens (UNIL), Paul Franken (UNIL), and Ioannis Xenarios (UNIL) and the team members of the Auwerx lab are acknowledged. R.H.H. is supported by a Rubicon fellowship of the NWO. J.A. is the Nestle Chair in Energy Metabolism and the J.A./K.S. laboratory is supported by grants of the Ecole Polytechnique Federale de Lausanne, the EU Ideas program (ERC-2008-AdG-23118), the Velux Stiftung, the Swiss National Science Foundation (31003A-124713, 31003A-125487, and the Sinergia grant CSRII3-136201). R.W.W. and GeneNetwork are supported by NIH (P20-DA 21131 UO1AA13499 and U01AA14425) and the UT Center for Integrative and Translational Genomics.	Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Andersen EC, 2012, NAT GENET, V44, P285, DOI 10.1038/ng.1050; Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981; Astner I, 2005, EMBO J, V24, P3166, DOI 10.1038/sj.emboj.7600792; Auwerx J, 2006, NAT MED, V12, P44, DOI 10.1038/nm0106-44; Auwerx J, 2004, NAT GENET, V36, P925, DOI 10.1038/ng0904-925; Bai P, 2011, CELL METAB, V13, P461, DOI 10.1016/j.cmet.2011.03.004; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Brem RB, 2002, SCIENCE, V296, P752, DOI 10.1126/science.1069516; Bystrykh L, 2005, NAT GENET, V37, P225, DOI 10.1038/ng1497; Champy MF, 2008, MAMM GENOME, V19, P318, DOI 10.1007/s00335-008-9107-z; Champy MF, 2004, MAMM GENOME, V15, P768, DOI 10.1007/s00335-004-2393-1; Chen HN, 2005, DIABETES, V54, P1437, DOI 10.2337/diabetes.54.5.1437; Chesler EJ, 2005, NAT GENET, V37, P233, DOI 10.1038/ng1518; Chesler EJ, 2004, NAT NEUROSCI, V7, P485, DOI 10.1038/nn0504-485; Deeb SS, 1998, NAT GENET, V20, P284, DOI 10.1038/3099; Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048; Ehrenreich IM, 2010, NATURE, V464, P1039, DOI 10.1038/nature08923; Fossey SC, 2001, GENOMICS, V76, P45, DOI 10.1006/geno.2001.6584; Gaglani SM, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-44; Gatti D, 2007, HEPATOLOGY, V46, P548, DOI 10.1002/hep.21682; Haack TB, 2010, NAT GENET, V42, P1131, DOI 10.1038/ng.706; Houtkooper RH, 2010, ENDOCR REV, V31, P194, DOI 10.1210/er.2009-0026; Jiang DH, 2011, PHYSIOL REV, V91, P221, DOI 10.1152/physrev.00052.2009; Joshi MA, 2006, BIOCHEM J, V400, P153, DOI 10.1042/BJ20060869; Kelsall IR, 2009, CELL SIGNAL, V21, P1123, DOI 10.1016/j.cellsig.2009.03.001; King EG, 2012, GENETICS, V191, P935, DOI 10.1534/genetics.112.138537; Konheim YL, 2003, HUM GENET, V113, P377, DOI 10.1007/s00439-003-1000-y; Koutnikova H, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000591; Laughlin RE, 2011, BIOL PSYCHIAT, V69, P1109, DOI 10.1016/j.biopsych.2011.01.014; Leitges M, 2002, MOL ENDOCRINOL, V16, P1203; Lynch M., 1998, GENETICS ANAL QUANTI; Lyssenko V, 2011, DIABETES, V60, P2424, DOI 10.2337/db10-1532; McCarthy MI, 2010, NEW ENGL J MED, V363, P2339, DOI 10.1056/NEJMra0906948; Mehrabian M, 1998, J CLIN INVEST, V101, P2485, DOI 10.1172/JCI1748; Midorikawa R, 2006, CELL, V125, P371, DOI 10.1016/j.cell.2006.02.039; Mitchell Joyce A, 2003, AMIA Annu Symp Proc, P460; Mitchell KJ, 2004, DIABETES, V53, P393, DOI 10.2337/diabetes.53.2.393; Miyairi I, 2007, J IMMUNOL, V179, P1814, DOI 10.4049/jimmunol.179.3.1814; Mornet E, 2008, BEST PRACT RES CL RH, V22, P113, DOI 10.1016/j.berh.2007.11.003; Mozhui K, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000260; Nelson D. L., 2008, LEHNINGER PRINCIPLES, V5th, P926; Nielson CM, 2012, J BONE MINER RES, V27, P93, DOI 10.1002/jbmr.527; Nouws J, 2010, CELL METAB, V12, P283, DOI 10.1016/j.cmet.2010.08.002; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Philip VM, 2010, GENES BRAIN BEHAV, V9, P129, DOI 10.1111/j.1601-183X.2009.00540.x; POPP RA, 1962, J HERED, V53, P73, DOI 10.1093/oxfordjournals.jhered.a107127; Riu E, 1996, P NATL ACAD SCI USA, V93, P2198, DOI 10.1073/pnas.93.5.2198; Seo J, 2009, DIABETES, V58, P2565, DOI 10.2337/db09-0335; Singer JB, 2004, SCIENCE, V304, P445, DOI 10.1126/science.1093139; Thomas C, 2009, CELL METAB, V10, P167, DOI 10.1016/j.cmet.2009.08.001; Tschop MH, 2012, NAT METHODS, V9, P57, DOI [10.1038/NMETH.1806, 10.1038/nmeth.1806]; Wang XS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S4-O7; Weigert J, 2008, FEBS LETT, V582, P2965, DOI 10.1016/j.febslet.2008.07.034; Wen JH, 2009, DIABETOLOGIA, V52, P504, DOI 10.1007/s00125-008-1210-x; Whyte M., 2000, METABOLIC MOL BASES, P5313; Williams RW, 2001, GENOME BIOL, V2; Windahl SH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021402; Wolford JK, 2003, MOL GENET METAB, V79, P61, DOI 10.1016/S1096-7192(03)00051-9; Xie QF, 2007, MOL IMMUNOL, V44, P3453, DOI 10.1016/j.molimm.2007.03.018; Yamamoto H, 2011, CELL, V147, P827, DOI 10.1016/j.cell.2011.10.017; Zu LY, 2011, EUR J PHARMACOL, V650, P298, DOI 10.1016/j.ejphar.2010.09.069	62	145	148	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 14	2012	150	6					1287	1299		10.1016/j.cell.2012.08.012	http://dx.doi.org/10.1016/j.cell.2012.08.012			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	007ZY	22939713	Green Submitted, Green Accepted, Green Published, Bronze			2022-12-28	WOS:000308928100020
J	Ferreira, ML; Herbert, RD; Crowther, MJ; Verhagen, A; Sutton, AJ				Ferreira, Manuela L.; Herbert, Robert D.; Crowther, Michael J.; Verhagen, Arianne; Sutton, Alex J.			When is a further clinical trial justified?	BMJ-BRITISH MEDICAL JOURNAL			English	Article							LOW-BACK-PAIN; EXERCISE; PROGRAMS		[Ferreira, Manuela L.] Univ Sydney, George Inst Global Hlth, Camperdown, NSW 2050, Australia; [Herbert, Robert D.] Neurosci Res Australia, Sydney, NSW, Australia; [Crowther, Michael J.; Sutton, Alex J.] Univ Leicester, Dept Hlth Sci, Leicester LE1 7RH, Leics, England; [Verhagen, Arianne] Erasmus Med Ctr Univ, Dept Gen Practice, Rotterdam, Netherlands	George Institute for Global Health; University of Sydney; Neuroscience Research Australia; University of Leicester; Erasmus University Rotterdam; Erasmus MC	Ferreira, ML (corresponding author), Univ Sydney, George Inst Global Hlth, POB M201,Missenden Rd, Camperdown, NSW 2050, Australia.	mferreira@georgeinstitute.org.au	Ferreira, Manuela L/B-9880-2014; Crowther, Michael/AAL-9932-2021; Ferreira, Manuela/AAQ-5446-2020; Herbert, Rob/E-9442-2012	Ferreira, Manuela/0000-0002-3479-0683; Herbert, Rob/0000-0003-4188-9195; Crowther, Michael/0000-0001-8378-8259; Sutton, Alexander/0000-0002-8934-9940; Verhagen, Arianne/0000-0002-6195-0128	National Institute for Health Research Methods Fellowship [RP-PG-0407-10314]; NHMRC; National Institute for Health Research [MET-08-42-101] Funding Source: researchfish	National Institute for Health Research Methods Fellowship; NHMRC(National Health and Medical Research Council (NHMRC) of Australia); National Institute for Health Research(National Institute for Health Research (NIHR))	MJC is funded by a National Institute for Health Research Methods Fellowship (RP-PG-0407-10314). RDH is supported by an NHMRC research fellowship.	Albaladejo C, 2010, SPINE, V35, P483, DOI 10.1097/BRS.0b013e3181b9c9a7; Bakhtiary AH, 2007, BRIT J SPORT MED, V41, P145, DOI 10.1136/bjsm.2006.031278; Barrett B, 2005, MED DECIS MAKING, V25, P47, DOI 10.1177/0272989X04273147; Silva-Aycaguer LC, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-44; Crowther M, 2012, STATA J IN PRESS; Djavid GE, 2007, AUST J PHYSIOTHER, V53, P155, DOI 10.1016/S0004-9514(07)70022-3; Ferreira ML, 2012, J CLIN EPIDEMIOL, V65, P253, DOI 10.1016/j.jclinepi.2011.06.018; Ferreira ML, 2010, PHYS THER, V90, P1383, DOI 10.2522/ptj.20090332; Higgins JPT, 2009, J R STAT SOC A STAT, V172, P137, DOI 10.1111/j.1467-985X.2008.00552.x; Julious SA, 2004, STAT MED, V23, P1921, DOI 10.1002/sim.1783; Kell RT, 2009, J STRENGTH COND RES, V23, P513, DOI 10.1519/JSC.0b013e3181918a6e; Kofotolis N, 2006, PHYS THER, V86, P1001, DOI 10.1093/ptj/86.7.1001; Langan D, 2012, J CLIN EPIDEMIOL, V65, P511, DOI 10.1016/j.jclinepi.2011.10.009; Riley RD, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d549; Saper RB, 2009, ALTERN THER HEALTH M, V15, P18; Smeets RJEM, 2008, PAIN, V134, P263, DOI 10.1016/j.pain.2007.04.021; Sutton AJ, 2007, STAT MED, V26, P2479, DOI 10.1002/sim.2704; Sutton AJ, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-29; Willan AR, 2005, STAT MED, V24, P1791, DOI 10.1002/sim.2069	19	32	32	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 13	2012	345								e5913	10.1136/bmj.e5913	http://dx.doi.org/10.1136/bmj.e5913			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	007BS	22977141	Bronze			2022-12-28	WOS:000308864400001
J	Lozupone, CA; Stombaugh, JI; Gordon, JI; Jansson, JK; Knight, R				Lozupone, Catherine A.; Stombaugh, Jesse I.; Gordon, Jeffrey I.; Jansson, Janet K.; Knight, Rob			Diversity, stability and resilience of the human gut microbiota	NATURE			English	Review							INFLAMMATORY-BOWEL-DISEASE; INTESTINAL MICROBIOTA; CLOSTRIDIUM-DIFFICILE; CROHNS-DISEASE; ANTIBIOTIC-TREATMENT; MOLECULAR ANALYSIS; FECAL MICROBIOTA; BODY HABITATS; SEQUENCE DATA; HUMAN COLON	Trillions of microbes inhabit the human intestine, forming a complex ecological community that influences normal physiology and susceptibility to disease through its collective metabolic activities and host interactions. Understanding the factors that underlie changes in the composition and function of the gut microbiota will aid in the design of therapies that target it. This goal is formidable. The gut microbiota is immensely diverse, varies between individuals and can fluctuate over time - especially during disease and early development. Viewing the microbiota from an ecological perspective could provide insight into how to promote health by targeting this microbial community in clinical treatments.	[Lozupone, Catherine A.; Stombaugh, Jesse I.; Knight, Rob] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA; [Gordon, Jeffrey I.] Washington Univ, Ctr Genome Sci & Syst Biol, St Louis, MO USA; [Jansson, Janet K.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Earth Sci, Berkeley, CA 94720 USA; [Jansson, Janet K.] Lawrence Berkeley Natl Lab, Joint Genome Inst, Walnut Creek, CA USA; [Knight, Rob] Univ Colorado, Howard Hughes Med Inst, Boulder, CO 80309 USA; [Knight, Rob] Univ Colorado, Biofrontiers Inst, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder; Washington University (WUSTL); United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; Lawrence Berkeley National Laboratory; Howard Hughes Medical Institute; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	Knight, R (corresponding author), Univ Colorado, Dept Chem & Biochem, Campus Box 215, Boulder, CO 80309 USA.	rob.knight@colorado.edu	Lozupone, Catherine/AAD-9317-2020; Jansson, Janet/H-5478-2018; Knight, Rob/D-1299-2010	Jansson, Janet/0000-0002-5487-4315; Stombaugh, Jesse/0000-0001-9631-0748; Knight, Rob/0000-0002-0975-9019	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK090285, R37DK030292] Funding Source: NIH RePORTER; NIDDK NIH HHS [K01 DK090285, R37 DK030292] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Bach JF, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007799; Beisner BE, 2003, FRONT ECOL ENVIRON, V1, P376, DOI 10.2307/3868190; Bever JD, 1997, J ECOL, V85, P561, DOI 10.2307/2960528; Biagi E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010667; Borenstein E, 2008, P NATL ACAD SCI USA, V105, P14482, DOI 10.1073/pnas.0806162105; Candela M, 2008, INT J FOOD MICROBIOL, V125, P286, DOI 10.1016/j.ijfoodmicro.2008.04.012; Cann HM, 2002, SCIENCE, V296, P261; Caporaso JG, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-r50; Carroll IM, 2011, AM J PHYSIOL-GASTR L, V301, pG799, DOI 10.1152/ajpgi.00154.2011; Chaffron S, 2010, GENOME RES, V20, P947, DOI 10.1101/gr.104521.109; Chang JY, 2008, J INFECT DIS, V197, P435, DOI 10.1086/525047; Claesson MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006669; Clayton TA, 2009, P NATL ACAD SCI USA, V106, P14728, DOI 10.1073/pnas.0904489106; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; Dethlefsen L, 2011, P NATL ACAD SCI USA, V108, P4554, DOI 10.1073/pnas.1000087107; Dicksved J, 2008, ISME J, V2, P716, DOI 10.1038/ismej.2008.37; Dominguez-Bello MG, 2010, P NATL ACAD SCI USA, V107, P11971, DOI 10.1073/pnas.1002601107; DuPont HL, 2011, CURR OPIN INFECT DIS, V24, P503, DOI 10.1097/QCO.0b013e32834a962d; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Elmqvist T, 2003, FRONT ECOL ENVIRON, V1, P488, DOI 10.1890/1540-9295(2003)001[0488:RDECAR]2.0.CO;2; Flint HJ, 2007, ENVIRON MICROBIOL, V9, P1101, DOI 10.1111/j.1462-2920.2007.01281.x; Folke C, 2004, ANNU REV ECOL EVOL S, V35, P557, DOI 10.1146/annurev.ecolsys.35.021103.105711; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Freilich S, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r61; Fukuda S, 2011, NATURE, V469, P543, DOI 10.1038/nature09646; Glover LE, 2011, GASTROENTEROLOGY, V140, P1748, DOI 10.1053/j.gastro.2011.01.056; Gonzalez Antonio, 2011, Dialogues Clin Neurosci, V13, P55; Goodman AL, 2011, P NATL ACAD SCI USA, V108, P6252, DOI 10.1073/pnas.1102938108; Gough E, 2011, CLIN INFECT DIS, V53, P994, DOI 10.1093/cid/cir632; Hansen EE, 2011, P NATL ACAD SCI USA, V108, P4599, DOI 10.1073/pnas.1000071108; Hautier Y, 2009, SCIENCE, V324, P636, DOI 10.1126/science.1169640; Hazen TC, 2010, SCIENCE, V330, P204, DOI 10.1126/science.1195979; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Jackson RL, 2011, NUTR REV, V69, P432, DOI 10.1111/j.1753-4887.2011.00400.x; Jakobsson HE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009836; Jansson J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006386; Jernberg C, 2007, ISME J, V1, P56, DOI 10.1038/ismej.2007.3; Kau AL, 2011, NATURE, V474, P327, DOI 10.1038/nature10213; Khoruts A, 2010, J CLIN GASTROENTEROL, V44, P354, DOI 10.1097/MCG.0b013e3181c87e02; Knights D, 2011, CELL HOST MICROBE, V10, P292, DOI 10.1016/j.chom.2011.09.003; Koenig JE, 2011, P NATL ACAD SCI USA, V108, P4578, DOI 10.1073/pnas.1000081107; Kozyrskyj AL, 2011, CURR OPIN ALLERGY CL, V11, P400, DOI 10.1097/ACI.0b013e328349b166; Levine JM, 1999, OIKOS, V87, P15, DOI 10.2307/3546992; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; LIBBY JM, 1983, J INFECT DIS, V148, P606, DOI 10.1093/infdis/148.3.606; Loftus EV, 2004, GASTROENTEROLOGY, V126, P1504, DOI 10.1053/j.gastro.2004.01.063; Louis P, 2004, J BACTERIOL, V186, P2099, DOI 10.1128/JB.186.7.2099-2106.2004; Lozupone C, 2012, GENOME RES; Lupton JR, 2004, J NUTR, V134, P479, DOI 10.1093/jn/134.2.479; Manichanh C, 2010, GENOME RES, V20, P1411, DOI 10.1101/gr.107987.110; McNulty NP, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002701; Muegge BD, 2011, SCIENCE, V332, P970, DOI 10.1126/science.1198719; Nelson KE, 2010, SCIENCE, V328, P994, DOI 10.1126/science.1183605; Olszak T, 2012, SCIENCE, V336, P489, DOI 10.1126/science.1219328; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Reyes A, 2010, NATURE, V466, P334, DOI 10.1038/nature09199; Scheffer M, 2003, P NATL ACAD SCI USA, V100, P4040, DOI 10.1073/pnas.0737918100; Setchell KDR, 2010, J NUTR, V140, p1355S, DOI 10.3945/jn.109.119776; Sonnenburg JL, 2005, SCIENCE, V307, P1955, DOI 10.1126/science.1109051; STARK PL, 1982, J MED MICROBIOL, V15, P189, DOI 10.1099/00222615-15-2-189; Stecher B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000711; Sun YJ, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq872; Swidsinski A, 2009, J PHYSIOL PHARMACOL, V60, P61; Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Valentine D. L., 2012, P NATL ACAD SCI US; VANDERWAAIJ D, 1972, J HYG-CAMBRIDGE, V70, P605, DOI 10.1017/S0022172400022464; Verberkmoes NC, 2009, ISME J, V3, P179, DOI 10.1038/ismej.2008.108; Walker B. H., 2004, ECOL SOC, V9; Willing BP, 2010, GASTROENTEROLOGY, V139, P1844, DOI 10.1053/j.gastro.2010.08.049; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; YAMAMOTOOSAKI T, 1994, J MED MICROBIOL, V40, P179, DOI 10.1099/00222615-40-3-179; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Young VB, 2004, J CLIN MICROBIOL, V42, P1203, DOI 10.1128/JCM.42.3.1203-1206.2004	78	2823	2999	89	1319	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 13	2012	489	7415					220	230		10.1038/nature11550	http://dx.doi.org/10.1038/nature11550			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003UC	22972295	Green Submitted, Green Accepted			2022-12-28	WOS:000308635900030
J	Ma, XS; Herbst, T; Scheidl, T; Wang, DQ; Kropatschek, S; Naylor, W; Wittmann, B; Mech, A; Kofler, J; Anisimova, E; Makarov, V; Jennewein, T; Ursin, R; Zeilinger, A				Ma, Xiao-Song; Herbst, Thomas; Scheidl, Thomas; Wang, Daqing; Kropatschek, Sebastian; Naylor, William; Wittmann, Bernhard; Mech, Alexandra; Kofler, Johannes; Anisimova, Elena; Makarov, Vadim; Jennewein, Thomas; Ursin, Rupert; Zeilinger, Anton			Quantum teleportation over 143 kilometres using active feed-forward	NATURE			English	Article							ENTANGLEMENT; STATE; COMMUNICATION	The quantum internet(1) is predicted to be the next-generation information processing platform, promising secure communication(2,3) and an exponential speed-up in distributed computation(2,4). The distribution of single qubits over large distances via quantum teleportation(5) is a key ingredient for realizing such a global platform. By using quantum teleportation, unknown quantum states can be transferred over arbitrary distances to a party whose location is unknown. Since the first experimental demonstrations of quantum teleportation of independent external qubits(6), an internal qubit(7) and squeezed states(8), researchers have progressively extended the communication distance. Usually this occurs without active feed-forward of the classical Bell-state measurement result, which is an essential ingredient in future applications such as communication between quantum computers. The benchmark for a global quantum internet is quantum teleportation of independent qubits over a free-space link whose attenuation corresponds to the path between a satellite and a ground station. Here we report such an experiment, using active feed-forward in real time. The experiment uses two free-space optical links, quantum and classical, over 143 kilometres between the two Canary Islands of La Palma and Tenerife. To achieve this, we combine advanced techniques involving a frequency-uncorrelated polarization-entangled photon pair source, ultra-low-noise single-photon detectors and entanglement-assisted clock synchronization. The average teleported state fidelity is well beyond the classical limit(9) of two-thirds. Furthermore, we confirm the quality of the quantum teleportation procedure without feed-forward by complete quantum process tomography. Our experiment verifies the maturity and applicability of such technologies in real-world scenarios, in particular for future satellite-based quantum teleportation.	[Ma, Xiao-Song; Herbst, Thomas; Scheidl, Thomas; Wang, Daqing; Kropatschek, Sebastian; Naylor, William; Wittmann, Bernhard; Mech, Alexandra; Kofler, Johannes; Jennewein, Thomas; Ursin, Rupert; Zeilinger, Anton] Austrian Acad Sci, Inst Quantum Opt & Quantum Informat IQOQI, A-1090 Vienna, Austria; [Ma, Xiao-Song; Herbst, Thomas; Wittmann, Bernhard; Mech, Alexandra; Zeilinger, Anton] Univ Vienna, Fac Phys, Vienna Ctr Quantum Sci & Technol, A-1090 Vienna, Austria; [Kofler, Johannes] Max Planck Inst Quantum Opt, D-85748 Garching, Germany; [Anisimova, Elena; Makarov, Vadim; Jennewein, Thomas] Univ Waterloo, Inst Quantum Comp, Waterloo, ON N2L 3G1, Canada; [Anisimova, Elena; Makarov, Vadim; Jennewein, Thomas] Univ Waterloo, Dept Phys & Astron, Waterloo, ON N2L 3G1, Canada	Austrian Academy of Sciences; University of Vienna; Max Planck Society; University of Waterloo; University of Waterloo	Ma, XS (corresponding author), Yale Univ, Dept Elect Engn, New Haven, CT 06520 USA.	Xiaosong.Ma@Univie.ac.at; Anton.Zeilinger@Univie.ac.at	Zeilinger, Anton/A-1170-2011; Ursin, Rupert/E-9548-2012; Wang, Daqing/AAI-7656-2021; Ma, Xiaosong/A-6824-2011	Ursin, Rupert/0000-0002-9403-269X; Wang, Daqing/0000-0001-9300-5326; 	EU project MALICIA; Research Council of Norway [180439/V30]; Industry Canada; European Space Agency [4000104180/11/NL/AF]; Austrian Science Foundation (FWF) [SFB F4008]; CoQuS; FFG for the QTS project within the ASAP 7 program [828316]; European Commission; Q-ESSENCE [248095]; John Templeton Foundation	EU project MALICIA; Research Council of Norway(Research Council of Norway); Industry Canada; European Space Agency(European Space AgencyEuropean Commission); Austrian Science Foundation (FWF)(Austrian Science Fund (FWF)); CoQuS; FFG for the QTS project within the ASAP 7 program; European Commission(European CommissionEuropean Commission Joint Research Centre); Q-ESSENCE; John Templeton Foundation	We thank the staff of IAC: F. Sanchez-Martinez, A. Alonso, C. Warden, M. Serra and J. Carlos; and the staff of ING: M. Balcells, C. Benn, J. Rey, O. Vaduvescu, A. Chopping, D. Gonzalez, S. Rodriguez, M. Abreu, L. Gonzalez; J. Kuusela, E. Wille and Z. Sodnik; and J. Perdigues of the OGS and ESA. X.-S.M., T. J., R. U. and A. Z. thank S. Ramelow for discussions, P. Kolenderski for discussions on the SPDC source with the Bell-state synthesizer, S. Zotter for help during the early stages of the experiment, and R. Steinacker for meteorological advice. J. K. was supported by the EU project MALICIA. E. A. and V. M. thank C. Kurtsiefer and Y.-S. Kim for detector electronics design, J. Skaar for support, and the Research Council of Norway (grant No. 180439/V30) and Industry Canada for support. This work was made possible by grants from the European Space Agency (contract 4000104180/11/NL/AF), the Austrian Science Foundation (FWF) under projects SFB F4008 and CoQuS, and the FFG for the QTS project (no. 828316) within the ASAP 7 program. We also acknowledge support by the European Commission, grant Q-ESSENCE (no. 248095) and the John Templeton Foundation.	Aspelmeyer M, 2003, IEEE J SEL TOP QUANT, V9, P1541, DOI 10.1109/jstqe.2003.820918; Aspelmeyer M, 2003, SCIENCE, V301, P621, DOI 10.1126/science.1085593; BENNETT CH, 1993, PHYS REV LETT, V70, P1895, DOI 10.1103/PhysRevLett.70.1895; Boschi D, 1998, PHYS REV LETT, V80, P1121, DOI 10.1103/PhysRevLett.80.1121; Bouwmeester D, 1997, NATURE, V390, P575, DOI 10.1038/37539; Briegel HJ, 1998, PHYS REV LETT, V81, P5932, DOI 10.1103/PhysRevLett.81.5932; Calsamiglia J, 2001, APPL PHYS B-LASERS O, V72, P67, DOI 10.1007/s003400000484; Einstein A, 1935, PHYS REV, V47, P0777, DOI 10.1103/PhysRev.47.777; Fedrizzi A, 2009, NAT PHYS, V5, P389, DOI 10.1038/NPHYS1255; Furusawa A, 1998, SCIENCE, V282, P706, DOI 10.1126/science.282.5389.706; Gisin N, 2007, NAT PHOTONICS, V1, P165, DOI 10.1038/nphoton.2007.22; Hughes RJ, 2000, J MOD OPTIC, V47, P549, DOI 10.1080/095003400148376; Jin XM, 2010, NAT PHOTONICS, V4, P376, DOI 10.1038/NPHOTON.2010.87; Kim YH, 2003, PHYS REV A, V67, DOI [10.1103/PhysRevA.67.010301, 10.1103/PhysRevA.67.040301]; Kim YS, 2011, REV SCI INSTRUM, V82, DOI 10.1063/1.3641294; Kimble HJ, 2008, NATURE, V453, P1023, DOI 10.1038/nature07127; KWIAT PG, 1995, PHYS REV LETT, V75, P4337, DOI 10.1103/PhysRevLett.75.4337; Ladd TD, 2010, NATURE, V464, P45, DOI 10.1038/nature08812; Marcikic I, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2348775; MASSAR S, 1995, PHYS REV LETT, V74, P1259, DOI 10.1103/PhysRevLett.74.1259; Nielsen Michael A., 2002, QUANTUM COMPUTATION; Poh HS, 2009, PHYS REV A, V80, DOI 10.1103/PhysRevA.80.043815; Rarity JG, 2002, NEW J PHYS, V4, DOI 10.1088/1367-2630/4/1/382; Scheidl T, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/8/085002; Ursin R, 2007, NAT PHYS, V3, P481, DOI 10.1038/nphys629; Ursin R, 2004, NATURE, V430, P849, DOI 10.1038/430849a; Villoresi P, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/3/033038; White AG, 1999, PHYS REV LETT, V83, P3103, DOI 10.1103/PhysRevLett.83.3103; Yao XC, 2012, NAT PHOTONICS, V6, P225, DOI 10.1038/nphoton.2011.354; Yin J, 2012, NATURE, V488, P185, DOI 10.1038/nature11332; ZUKOWSKI M, 1993, PHYS REV LETT, V71, P4287, DOI 10.1103/PhysRevLett.71.4287	33	375	387	11	207	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 13	2012	489	7415					269	273		10.1038/nature11472	http://dx.doi.org/10.1038/nature11472			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003UC	22951967	Green Submitted			2022-12-28	WOS:000308635900036
J	Hesketh, T; Wu, D; Mao, LN; Ma, N				Hesketh, Therese; Wu, Dan; Mao, Linan; Ma, Nan			Violence against doctors in China	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							EMERGENCY-DEPARTMENT; NATIONAL-SURVEY; CARE; AGGRESSION; PHYSICIANS		[Hesketh, Therese; Wu, Dan] UCL Inst Global Hlth, London WC1N 1EH, England; [Mao, Linan] Zhejaing Ctr Int Med & Hlth Cooperat, Hangzhou, Zhejiang, Peoples R China; [Ma, Nan] UCL, London, England	University of London; University College London; University of London; University College London	Hesketh, T (corresponding author), UCL Inst Global Hlth, London WC1N 1EH, England.	t.hesketh@ucl.ac.uk		Wu, Dan/0000-0003-0415-5467; Hesketh, Therese/0000-0002-7564-9221				Al-Sahlawi K S, 1999, Eur J Emerg Med, V6, P301; Algwaiz WM, 2012, SAUDI MED J, V33, P76; Behnam M, 2011, J EMERG MED, V40, P565, DOI 10.1016/j.jemermed.2009.11.007; Blumenthal D, 2005, NEW ENGL J MED, V353, P1165, DOI 10.1056/NEJMhpr051133; *BRIT MED ASS HLTH, 2003, VIOL WORK EXP UK DOC; Cai WZ, 2011, J INTERPERS VIOLENCE, V26, P312, DOI 10.1177/0886260510362885; Chen ZH, 2004, CHINA PUBLIC HLTH, V20, P1316; Chen Zu-hui, 2003, Zhonghua Yufang Yixue Zazhi, V37, P358; Chen Zu-hui, 2004, Zhonghua Liu Xing Bing Xue Za Zhi, V25, P3; Ding XY., 2012, NOTES SERIOUS PATIEN; Forrest LE, 2011, MED J AUSTRALIA, V194, P605, DOI 10.5694/j.1326-5377.2011.tb03117.x; Harris DM, 2005, J LAW MED ETHICS, V33, P456, DOI 10.1111/j.1748-720X.2005.tb00512.x; Huang Y, 2011, FOREIGN AFF, V90, P119; Jiang NJ, 2011, PEOPLE; Joa TS, 2012, SCAND J PRIM HEALTH, V30, P55, DOI 10.3109/02813432.2012.651570; Magnavita N, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-108; Meng Q, 2012, LANCET, V379, P805, DOI 10.1016/S0140-6736(12)60278-5; Ministry of Health, 2008, RES REL YI HUAN CHIN; Minter A, 2012, BLOOMBERG       0529; Mirza NM, 2012, J EMERG MED, V42, P727, DOI 10.1016/j.jemermed.2011.01.029; Saeki K, 2011, J OCCUP HEALTH, V53, P356, DOI 10.1539/joh.11-0108-OA; Shan J., 2012, CHINA DAILY; United Nations Office on Drugs and Crime, 2011, GLOB STUD HOM; Xin HW, 2012, PEOPLES DAILY   0503; Xiong C., 2006, CHINESE HOSP ASS GUI; Yan ZH, 2011, INT J QUAL HEALTH C, V23, P384, DOI 10.1093/intqhc/mzr034; Yip WCM, 2012, LANCET, V379, P833, DOI 10.1016/S0140-6736(11)61880-1; Zheng PG, 2006, J LAW MED, V13, P465; Zhong GW, 2012, YI NAO INCIDENTS INC	29	148	152	2	22	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 7	2012	345								e5730	10.1136/bmj.e5730	http://dx.doi.org/10.1136/bmj.e5730			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	003TM	22960376				2022-12-28	WOS:000308634200001
J	Ecker, JR				Ecker, Joseph R.			FORUM: Genomics ENCODE explained	NATURE			English	Editorial Material									[Ecker, Joseph R.] Howard Hughes Med Inst, La Jolla, CA 92037 USA; [Ecker, Joseph R.] Salk Inst Biol Studies, La Jolla, CA 92037 USA	Howard Hughes Medical Institute; Salk Institute	Ecker, JR (corresponding author), Howard Hughes Med Inst, La Jolla, CA 92037 USA.	ecker@salk.edu	Ecker, Joseph R/B-9144-2008; Bickmore, Wendy A/C-7314-2013	Ecker, Joseph R/0000-0001-5799-5895; Bickmore, Wendy A/0000-0001-6660-7735; Barroso, Ines/0000-0001-5800-4520; Segal, Eran/0000-0002-6859-1164	MRC [MC_PC_U127527202] Funding Source: UKRI; Medical Research Council [MC_PC_U127527202] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)			0	164	176	1	92	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 6	2012	489	7414					52	53		10.1038/489052a	http://dx.doi.org/10.1038/489052a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999WW	22955614	Bronze			2022-12-28	WOS:000308347000034
J	Wells, JM; Washko, GR; Han, MK; Abbas, N; Nath, H; Mamary, AJ; Regan, E; Bailey, WC; Martinez, FJ; Westfall, E; Beaty, TH; Curran-Everett, D; Curtis, JL; Hokanson, JE; Lynch, DA; Make, BJ; Crapo, JD; Silverman, EK; Bowler, RP; Dransfield, MT				Wells, J. Michael; Washko, George R.; Han, MeiLan K.; Abbas, Naseer; Nath, Hrudaya; Mamary, A. James; Regan, Elizabeth; Bailey, William C.; Martinez, Fernando J.; Westfall, Elizabeth; Beaty, Terri H.; Curran-Everett, Douglas; Curtis, Jeffrey L.; Hokanson, John E.; Lynch, David A.; Make, Barry J.; Crapo, James D.; Silverman, Edwin K.; Bowler, Russell P.; Dransfield, Mark T.		COPDGene & ECLIPSE Study Invest	Pulmonary Arterial Enlargement and Acute Exacerbations of COPD	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DISEASE; HYPERTENSION; EMPHYSEMA; EPIDEMIOLOGY; PREVALENCE; PREVENTION; PHENOTYPE; PERFUSION; SMOKERS; DEATH	BACKGROUND Exacerbations of chronic obstructive pulmonary disease (COPD) are associated with accelerated loss of lung function and death. Identification of patients at risk for these events, particularly those requiring hospitalization, is of major importance. Severe pulmonary hypertension is an important complication of advanced COPD and predicts acute exacerbations, though pulmonary vascular abnormalities also occur early in the course of the disease. We hypothesized that a computed tomographic (CT) metric of pulmonary vascular disease (pulmonary artery enlargement, as determined by a ratio of the diameter of the pulmonary artery to the diameter of the aorta [PA:A ratio] of >1) would be associated with severe COPD exacerbations. METHODS We conducted a multicenter, observational trial that enrolled current and former smokers with COPD. We determined the association between a PA: A ratio of more than 1 and a history at enrollment of severe exacerbations requiring hospitalization and then examined the usefulness of the ratio as a predictor of these events in a longitudinal follow-up of this cohort, as well as in an external validation cohort. We used logistic-regression and zero-inflated negative binomial regression analyses and adjusted for known risk factors for exacerbation. RESULTS Multivariate logistic-regression analysis showed a significant association between a PA: A ratio of more than 1 and a history of severe exacerbations at the time of enrollment in the trial (odds ratio, 4.78; 95% confidence interval [CI], 3.43 to 6.65; P<0.001). A PA: A ratio of more than 1 was also independently associated with an increased risk of future severe exacerbations in both the trial cohort (odds ratio, 3.44; 95% CI, 2.78 to 4.25; P<0.001) and the external validation cohort (odds ratio, 2.80; 95% CI, 2.11 to 3.71; P<0.001). In both cohorts, among all the variables analyzed, a PA: A ratio of more than 1 had the strongest association with severe exacerbations. CONCLUSIONS Pulmonary artery enlargement (a PA: A ratio of > 1), as detected by CT, was associated with severe exacerbations of COPD. (Funded by the National Heart, Lung, and Blood Institute; ClinicalTrials.gov numbers, NCT00608764 and NCT00292552.)	[Wells, J. Michael; Abbas, Naseer; Bailey, William C.; Westfall, Elizabeth; Dransfield, Mark T.] Univ Alabama Birmingham, Lung Hlth Ctr, Div Pulm Allergy & Crit Care, Birmingham, AL 35294 USA; [Nath, Hrudaya] Univ Alabama Birmingham, Dept Radiol, Birmingham, AL 35294 USA; [Dransfield, Mark T.] Birmingham Vet Affairs Med Ctr, Birmingham, AL USA; [Washko, George R.; Silverman, Edwin K.] Brigham & Womens Hosp, Div Pulm & Crit Care, Boston, MA 02115 USA; [Silverman, Edwin K.] Brigham & Womens Hosp, Channing Lab, Div Network Med, Boston, MA 02115 USA; [Han, MeiLan K.; Martinez, Fernando J.; Curtis, Jeffrey L.] Univ Michigan Hlth Syst, Div Pulm & Crit Care Med, Ann Arbor, MI USA; [Curtis, Jeffrey L.] Vet Affairs Hlth Syst, Med Serv, Pulm & Crit Care Med Sect, Ann Arbor, MI USA; [Mamary, A. James] Temple Univ, Sch Med, Div Pulm & Crit Care, Philadelphia, PA 19122 USA; [Regan, Elizabeth; Lynch, David A.; Make, Barry J.; Crapo, James D.; Bowler, Russell P.] Natl Jewish Hlth, Div Pulm & Crit Care, Denver, CO USA; [Curran-Everett, Douglas] Natl Jewish Hlth, Div Biostat & Bioinformat, Denver, CO USA; [Hokanson, John E.] Univ Colorado, Colorado Sch Publ Hlth, Dept Epidemiol, Aurora, CO USA; [Beaty, Terri H.] Johns Hopkins Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Birmingham; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; University of Michigan System; University of Michigan; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; National Jewish Health; National Jewish Health; Colorado School of Public Health; University of Colorado System; University of Colorado Anschutz Medical Campus; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Wells, JM (corresponding author), Univ Alabama Birmingham, Lung Hlth Ctr, Div Pulm Allergy & Crit Care, 422 THT,1900 Univ Blvd, Birmingham, AL 35294 USA.	jmwells@uab.edu	Wells, James Michael/ABA-2755-2021; Reilly, John/H-8755-2012; Coxson, Harvey O/A-9861-2017	Coxson, Harvey O/0000-0001-5750-9711; Curran-Everett, Douglas/0000-0001-5992-4839; Curtis, Jeffrey/0000-0001-5191-4847; Vestbo, Jorgen/0000-0001-6355-6362; MacNee, William/0000-0002-3692-1448	National Heart, Lung, and Blood Institute [U01 HL089856, U01 HL089897, 1T32HL105346-1]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454, UL1TR000124] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL089856, R01HL116473, U01HL089897, R01HL089856, T32HL105346] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by grants (U01 HL089856, U01 HL089897, and 1T32HL105346-1) from the National Heart, Lung, and Blood Institute.	Albert RK, 2011, NEW ENGL J MED, V365, P689, DOI 10.1056/NEJMoa1104623; Alford SK, 2010, P NATL ACAD SCI USA, V107, P7485, DOI 10.1073/pnas.0913880107; Anzueto Antonio, 2007, Proc Am Thorac Soc, V4, P554, DOI 10.1513/pats.200701-003FM; BARBERA JA, 1994, AM J RESP CRIT CARE, V149, P423, DOI 10.1164/ajrccm.149.2.8306040; Barr RG, 2010, NEW ENGL J MED, V362, P217, DOI 10.1056/NEJMoa0808836; Christensen CC, 2004, EUR RESPIR J, V24, P580, DOI 10.1183/09031936.04.00118303; Devaraj A, 2010, RADIOLOGY, V254, P609, DOI 10.1148/radiol.09090548; Fabbri LM, 2009, LANCET, V374, P695, DOI 10.1016/S0140-6736(09)61252-6; FERRIS BG, 1978, AM REV RESPIR DIS, V118, P1; Gordon C, 2011, AM J RESP CRIT CARE, V184, P224, DOI 10.1164/rccm.201012-2061OC; Han MLK, 2011, RADIOLOGY, V261, P274, DOI 10.1148/radiol.11110173; Hurst JR, 2010, NEW ENGL J MED, V363, P1128, DOI 10.1056/NEJMoa0909883; Kessler R, 1999, AM J RESP CRIT CARE, V159, P158, DOI 10.1164/ajrccm.159.1.9803117; Kim V, 2011, CHEST, V140, P626, DOI 10.1378/chest.10-2948; Mannino DM, 2007, LANCET, V370, P765, DOI 10.1016/S0140-6736(07)61380-4; Matsuoka S, 2010, AM J RESP CRIT CARE, V181, P218, DOI 10.1164/rccm.200908-1189OC; Matsuoka S, 2010, ACAD RADIOL, V17, P93, DOI 10.1016/j.acra.2009.07.022; McGhan R, 2007, CHEST, V132, P1748, DOI 10.1378/chest.06-3018; Ng CS, 1999, J THORAC IMAG, V14, P270, DOI 10.1097/00005382-199910000-00007; Perez-Enguix D, 2007, TRANSPL P, V39, P2405, DOI 10.1016/j.transproceed.2007.07.055; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Reed RM, 2011, COPD, V8, P96, DOI 10.3109/15412555.2011.558545; Regan EA, 2010, COPD, V7, P32, DOI 10.3109/15412550903499522; Rizkallah J, 2009, CHEST, V135, P786, DOI 10.1378/chest.08-1516; Sethi S, 2002, NEW ENGL J MED, V347, P465, DOI 10.1056/NEJMoa012561; Smeeth L, 2004, NEW ENGL J MED, V351, P2611, DOI 10.1056/NEJMoa041747; Stewart JI, 2012, COPD            0607; Terzano C, 2010, LUNG, V188, P321, DOI 10.1007/s00408-009-9222-y; Vassaux C, 2008, EUR RESPIR J, V32, P1275, DOI 10.1183/09031936.00151707; Vestbo J, 2008, EUR RESPIR J, V31, P869, DOI 10.1183/09031936.00111707; Wright JL, 2011, AM J RESP CRIT CARE, V183, P50, DOI 10.1164/rccm.201003-0399OC; Yanbaeva DG, 2007, CHEST, V131, P1557, DOI 10.1378/chest.06-2179; Zvezdin B, 2009, CHEST, V136, P376, DOI 10.1378/chest.08-2918	33	336	345	0	42	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 6	2012	367	10					913	921		10.1056/NEJMoa1203830	http://dx.doi.org/10.1056/NEJMoa1203830			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	999VO	22938715	Green Accepted, Bronze, Green Published			2022-12-28	WOS:000308343300008
J	Brody, H				Brody, Herb			HUMAN PAPILLOMAVIRUS	NATURE			English	Editorial Material																			0	4	4	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 30	2012	488	7413					CP20	CP20		10.1038/488S1a	http://dx.doi.org/10.1038/488S1a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996NC	22932432	Bronze			2022-12-28	WOS:000308095100003
J	Rizzuto, D; Orsini, N; Qiu, CX; Wang, HX; Fratiglioni, L				Rizzuto, Debora; Orsini, Nicola; Qiu, Chengxuan; Wang, Hui-Xin; Fratiglioni, Laura			Lifestyle, social factors, and survival after age 75: population based study	BRITISH MEDICAL JOURNAL			English	Article							ALL-CAUSE MORTALITY; KUNGSHOLMEN-PROJECT; ALZHEIMERS-DISEASE; MULTIPLE IMPUTATION; ALCOHOL-CONSUMPTION; 5-YEAR MORTALITY; OLDER-ADULTS; RISK-FACTORS; DEMENTIA; LONGEVITY	Objective To identify modifiable factors associated with longevity among adults aged 75 and older. Design Population based cohort study. Setting Kungsholmen, Stockholm, Sweden. Participants 1810 adults aged 75 or more participating in the Kungsholmen Project, with follow-up for 18 years. Main outcome measure Median age at death. Vital status from 1987 to 2005. Results During follow-up 1661 (91.8%) participants died. Half of the participants lived longer than 90 years. Half of the current smokers died 1.0 year (95% confidence interval 0.0 to 1.9 years) earlier than non-smokers. Of the leisure activities, physical activity was most strongly associated with survival; the median age at death of participants who regularly swam, walked, or did gymnastics was 2.0 years (0.7 to 3.3 years) greater than those who did not. The median survival of people with a low risk profile (healthy lifestyle behaviours, participation in at least one leisure activity, and a rich or moderate social network) was 5.4 years longer than those with a high risk profile (unhealthy lifestyle behaviours, no participation in leisure activities, and a limited or poor social network). Even among the oldest old (85 years or older) and people with chronic conditions, the median age at death was four years higher for those with a low risk profile compared with those with a high risk profile. Conclusion Even after age 75 lifestyle behaviours such as not smoking and physical activity are associated with longer survival. A low risk profile can add five years to women's lives and six years to men's. These associations, although attenuated, were also present among the oldest old (>= 85 years) and in people with chronic conditions.	[Rizzuto, Debora; Qiu, Chengxuan; Wang, Hui-Xin; Fratiglioni, Laura] Karolinska Inst, Dept Neurobiol Hlth Care Sci & Soc, Aging Res Ctr, S-11330 Stockholm, Sweden; [Rizzuto, Debora; Qiu, Chengxuan; Wang, Hui-Xin; Fratiglioni, Laura] Stockholm Univ, S-11330 Stockholm, Sweden; [Orsini, Nicola] Karolinska Inst, Natl Inst Environm Med, Unit Nutr Epidemiol, S-11330 Stockholm, Sweden; [Orsini, Nicola] Karolinska Inst, Natl Inst Environm Med, Biostat Unit, S-11330 Stockholm, Sweden; [Fratiglioni, Laura] Stockholm Gerontol Res Ctr, Stockholm, Sweden	Karolinska Institutet; Stockholm University; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet	Rizzuto, D (corresponding author), Karolinska Inst, Dept Neurobiol Hlth Care Sci & Soc, Aging Res Ctr, S-11330 Stockholm, Sweden.	debora.rizzuto@ki.se	Rizzuto, Debora/X-7065-2019; Rizzuto, Debora/V-1890-2018; Orsini, Nicola/A-3602-2012	Rizzuto, Debora/0000-0001-6199-9629; Orsini, Nicola/0000-0002-2210-5634; Qiu, Chengxuan/0000-0003-1922-4912; Wang, Hui-Xin/0000-0002-5051-4929	Swedish Council for Working Life and Social Research; Swedish Research Council for Medicine; Swedish Brain Power; Karolinska Institutet's Faculty; Stiftelsen Ragnhild och Einar Lundstroms Minne	Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Swedish Research Council for Medicine; Swedish Brain Power; Karolinska Institutet's Faculty; Stiftelsen Ragnhild och Einar Lundstroms Minne	This study was funded by the Swedish Council for Working Life and Social Research, Swedish Research Council for Medicine, Swedish Brain Power, Karolinska Institutet's Faculty funding for postgraduate students, and the Stiftelsen Ragnhild och Einar Lundstroms Minne. The sponsor had no role in study design, data collection, data analysis, data interpretation, the writing of the report, or in the decision to submit the paper for publication. The corresponding author had full access to all the data in the study and had final responsibility for the decision to submit for publication.	Benetos A, 2005, J HYPERTENS, V23, P1803, DOI 10.1097/01.hjh.0000179512.71018.40; Bottai M, BIOM J, V52, P487; Candore G, 2006, ANN NY ACAD SCI, V1089, P516, DOI 10.1196/annals.1386.051; de Groot LCPMG, 2004, J GERONTOL A-BIOL, V59, P1277, DOI 10.1093/gerona/59.12.1277; Demissie S, 2003, STAT MED, V22, P545, DOI 10.1002/sim.1340; Diehr P, 2002, CURR CONTR TRIALS C, V3, DOI 10.1186/1468-6708-3-1; Dupre ME, 2008, AM J PUBLIC HEALTH, V98, P1203, DOI 10.2105/AJPH.2007.113886; Fratiglioni L, 2000, LANCET, V355, P1315, DOI 10.1016/S0140-6736(00)02113-9; Fratiglioni L, 1997, NEUROLOGY, V48, P132, DOI 10.1212/WNL.48.1.132; FRATIGLIONI L, 1992, NEUROEPIDEMIOLOGY, V11, P29, DOI 10.1159/000110958; Fried LP, 1998, JAMA-J AM MED ASSOC, V279, P585, DOI 10.1001/jama.279.8.585; Glymour MM, 2008, NEUROPSYCHOL REV, V18, P194, DOI 10.1007/s11065-008-9066-x; Hagberg B, 2008, J GERONTOL A-BIOL, V63, P1219, DOI 10.1093/gerona/63.11.1219; Halme JT, 2010, DRUG ALCOHOL DEPEN, V106, P212, DOI 10.1016/j.drugalcdep.2009.08.017; Haveman-Nies A, 2002, AM J EPIDEMIOL, V156, P962, DOI 10.1093/aje/kwf144; Holt-Lunstad J, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000316; Huang WY, 2002, J CLIN EPIDEMIOL, V55, P959, DOI 10.1016/S0895-4356(02)00462-6; Karp A, 2004, AM J EPIDEMIOL, V159, P175, DOI 10.1093/aje/kwh018; Knoops KTB, 2004, JAMA-J AM MED ASSOC, V292, P1433, DOI 10.1001/jama.292.12.1433; Marengoni A, 2011, AGEING RES REV, V10, P430, DOI 10.1016/j.arr.2011.03.003; Menotti A, 1996, PREV MED, V25, P319, DOI 10.1006/pmed.1996.0062; Newson RS, 2010, AGE, V32, P521, DOI 10.1007/s11357-010-9154-8; Nybo H, 2003, J AM GERIATR SOC, V51, P1365, DOI 10.1046/j.1532-5415.2003.51453.x; Orsini N, 2012, EPIDEMIOLOGY, V23, P770, DOI 10.1097/EDE.0b013e3182625eff; Rodriguez-Laso A., 2007, BMC GERIATR, V1, P7; Rousson V, 2010, POPUL HEALTH METR, V8, DOI 10.1186/1478-7954-8-18; RUBIN DB, 1986, J AM STAT ASSOC, V81, P366, DOI 10.2307/2289225; RUIGOMEZ A, 1995, AGE AGEING, V24, P113, DOI 10.1093/ageing/24.2.113; Spencer CA, 2005, PREV MED, V40, P712, DOI 10.1016/j.ypmed.2004.09.012; Timmreck T C, 1987, Health Educ, V18, P23; Van Buuren S, 1999, STAT MED, V18, P681, DOI 10.1002/(SICI)1097-0258(19990330)18:6<681::AID-SIM71>3.0.CO;2-R; Wang HX, 1999, AM J EPIDEMIOL, V149, P640; Wang HX, 2002, AM J EPIDEMIOL, V155, P1081, DOI 10.1093/aje/155.12.1081; Yates LB, 2008, ARCH INTERN MED, V168, P284, DOI 10.1001/archinternmed.2007.77	34	89	91	1	31	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	AUG 30	2012	345								e5568	10.1136/bmj.e5568	http://dx.doi.org/10.1136/bmj.e5568			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	036SM	22936786	Green Published, hybrid			2022-12-28	WOS:000311050800003
J	Dilday, B; Howell, DA; Cenko, SB; Silverman, JM; Nugent, PE; Sullivan, M; Ben-Ami, S; Bildsten, L; Bolte, M; Endl, M; Filippenko, AV; Gnat, O; Horesh, A; Hsiao, E; Kasliwal, MM; Kirkman, D; Maguire, K; Marcy, GW; Moore, K; Pan, Y; Parrent, JT; Podsiadlowski, P; Quimby, RM; Sternberg, A; Suzuki, N; Tytler, DR; Xu, D; Bloom, JS; Gal-Yam, A; Hook, IM; Kulkarni, SR; Law, NM; Ofek, EO; Polishook, D; Poznanski, D				Dilday, B.; Howell, D. A.; Cenko, S. B.; Silverman, J. M.; Nugent, P. E.; Sullivan, M.; Ben-Ami, S.; Bildsten, L.; Bolte, M.; Endl, M.; Filippenko, A. V.; Gnat, O.; Horesh, A.; Hsiao, E.; Kasliwal, M. M.; Kirkman, D.; Maguire, K.; Marcy, G. W.; Moore, K.; Pan, Y.; Parrent, J. T.; Podsiadlowski, P.; Quimby, R. M.; Sternberg, A.; Suzuki, N.; Tytler, D. R.; Xu, D.; Bloom, J. S.; Gal-Yam, A.; Hook, I. M.; Kulkarni, S. R.; Law, N. M.; Ofek, E. O.; Polishook, D.; Poznanski, D.			PTF 11kx: A Type Ia Supernova with a Symbiotic Nova Progenitor	SCIENCE			English	Article							WHITE-DWARF STAR; SN 2011FE; CIRCUMSTELLAR MATERIAL; SODIUM-ABSORPTION; COMPANION STAR; RS-OPHIUCHI; MASS; EVOLUTION; REMNANT; CHANNEL	There is a consensus that type Ia supernovae (SNe Ia) arise from the thermonuclear explosion of white dwarf stars that accrete matter from a binary companion. However, direct observation of SN Ia progenitors is lacking, and the precise nature of the binary companion remains uncertain. A temporal series of high-resolution optical spectra of the SN Ia PTF 11kx reveals a complex circumstellar environment that provides an unprecedentedly detailed view of the progenitor system. Multiple shells of circumstellar material are detected, and the SN ejecta are seen to interact with circumstellar material starting 59 days after the explosion. These features are best described by a symbiotic nova progenitor, similar to RS Ophiuchi.	[Dilday, B.; Howell, D. A.; Parrent, J. T.] Global Telescope Network, Las Cumbres Observ, Goleta, CA 93117 USA; [Dilday, B.; Howell, D. A.; Bildsten, L.; Moore, K.] Univ Calif Santa Barbara, Dept Phys, Santa Barbara, CA 93106 USA; [Cenko, S. B.; Silverman, J. M.; Nugent, P. E.; Filippenko, A. V.; Marcy, G. W.; Bloom, J. S.] Univ Calif Berkeley, Dept Astron, Berkeley, CA 94720 USA; [Nugent, P. E.; Hsiao, E.; Suzuki, N.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA; [Sullivan, M.; Maguire, K.; Pan, Y.; Podsiadlowski, P.; Hook, I. M.] Univ Oxford, Dept Phys Astrophys, Oxford OX1 3RH, England; [Ben-Ami, S.; Xu, D.] Weizmann Inst Sci, Dept Particle Phys & Astrophys, IL-76100 Rehovot, Israel; [Bildsten, L.] Univ Calif Santa Barbara, Kavli Inst Theoret Phys, Santa Barbara, CA 93106 USA; [Bolte, M.] Univ Calif Santa Cruz, Lick Observ, Univ Calif Observ, Santa Cruz, CA 95064 USA; [Endl, M.] Univ Texas Austin, McDonald Observ, Austin, TX 78712 USA; [Gnat, O.] Hebrew Univ Jerusalem, Racah Inst Phys, IL-91904 Jerusalem, Israel; [Hsiao, E.] Carnegie Inst Sci, Las Campanas Observ, Colina El Pino, Chile; [Horesh, A.; Kasliwal, M. M.; Kulkarni, S. R.] CALTECH, Cahill Ctr Astrophys, Pasadena, CA 91125 USA; [Kasliwal, M. M.] Observ Carnegie Inst Sci, Pasadena, CA 91101 USA; [Kirkman, D.; Tytler, D. R.] Univ Calif San Diego, Ctr Astrophys & Space Sci, La Jolla, CA 92093 USA; [Parrent, J. T.] Dartmouth Coll, Dept Phys & Astron, Hanover, NH 03755 USA; [Quimby, R. M.] Univ Tokyo, Inst Phys & Math Universe, Kashiwa, Chiba 2778583, Japan; [Sternberg, A.] Max Planck Inst Astrophys, D-85741 Garching, Germany; [Gal-Yam, A.; Ofek, E. O.] Weizmann Inst Sci, Benoziyo Ctr Astrophys, IL-76100 Rehovot, Israel; [Law, N. M.] Univ Toronto, Toronto, ON M5S 3H4, Canada; [Polishook, D.] MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA; [Poznanski, D.] Tel Aviv Univ, Sch Phys & Astron, IL-69978 Tel Aviv, Israel	University of California System; University of California Santa Barbara; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of Oxford; Weizmann Institute of Science; University of California System; University of California Santa Barbara; University of California System; University of California Santa Cruz; University of Texas System; University of Texas Austin; Hebrew University of Jerusalem; California Institute of Technology; Carnegie Institution for Science; University of California System; University of California San Diego; Dartmouth College; University of Tokyo; Max Planck Society; Weizmann Institute of Science; University of Toronto; Massachusetts Institute of Technology (MIT); Tel Aviv University	Dilday, B (corresponding author), Global Telescope Network, Las Cumbres Observ, 6740 Cortona Dr,Suite 102, Goleta, CA 93117 USA.	bdilday@lcogt.net	Maguire, Kate/HHN-6122-2022; Gnat, Orly/AAN-1665-2021; Horesh, Assaf/O-9873-2016; Marcy, Geoff/AAC-6050-2019; Howell, Andy/ABE-6446-2020; Hook, Isobel M/S-8590-2017; Nugent, Peter Edward/AGG-8472-2022	Maguire, Kate/0000-0002-9770-3508; Gnat, Orly/0000-0002-4244-0237; Horesh, Assaf/0000-0002-5936-1156; Hook, Isobel M/0000-0002-2960-978X; Bloom, Joshua/0000-0002-7777-216X; Sullivan, Mark/0000-0001-9053-4820; Nugent, Peter/0000-0002-3389-0586; Polishook, David/0000-0002-6977-3146; Hsiao, Eric Y./0000-0003-1039-2928; Kasliwal, Tamay/0000-0001-5634-7167; Poznanski, Dovi/0000-0003-1470-7173	Office of Science of the U.S. Department of Energy; W. M. Keck Foundation; NSF; TABASGO Foundation; Richard and Rhoda Goldman Fund; Hubble Fellowship; Carnegie-Princeton Fellowship; Israel Science Foundation; U.S.-Israel Binational Foundation; Bundesministerium fur Bildung und Forschung; Lord Seiff of Brimpton Fund; STFC [PP/E003427/1, ST/G004331/1, ST/H002456/1, ST/I003673/1] Funding Source: UKRI; Direct For Mathematical & Physical Scien [1109174] Funding Source: National Science Foundation; Division Of Astronomical Sciences [1009991, 0908886, 1009987] Funding Source: National Science Foundation; Office of Integrative Activities [0941742] Funding Source: National Science Foundation; Science and Technology Facilities Council [PP/E003427/1, ST/I003673/1, ST/H002456/1, ST/G004331/1] Funding Source: researchfish	Office of Science of the U.S. Department of Energy(United States Department of Energy (DOE)); W. M. Keck Foundation(W.M. Keck Foundation); NSF(National Science Foundation (NSF)); TABASGO Foundation; Richard and Rhoda Goldman Fund; Hubble Fellowship; Carnegie-Princeton Fellowship; Israel Science Foundation(Israel Science Foundation); U.S.-Israel Binational Foundation(US-Israel Binational Science Foundation); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Lord Seiff of Brimpton Fund; STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Division Of Astronomical Sciences(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Office of Integrative Activities(National Science Foundation (NSF)NSF - Office of the Director (OD)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	The Palomar Transient Factory project is a scientific collaboration between the California Institute of Technology, Columbia University, Las Cumbres Observatory, the Lawrence Berkeley National Laboratory, the National Energy Research Scientific Computing Center, the University of Oxford, and the Weizmann Institute of Science. The National Energy Research Scientific Computing Center, supported by the Office of Science of the U.S. Department of Energy, provided staff, computational resources, and data storage for this project. Some of the data presented herein were obtained at the W. M. Keck Observatory, which is operated as a scientific partnership among the California Institute of Technology, the University of California, and NASA; the observatory was made possible by the generous financial support of the W. M. Keck Foundation. The authors wish to recognize and acknowledge the very important cultural role and reverence that the summit of Mauna Kea has always had within the indigenous Hawaiian community. We are most fortunate to have the opportunity to conduct observations from this mountain. We are grateful to the staffs of the Lick, Keck, and other observatories for their assistance. We thank D. Kasen for insightful discussions on the analysis presented here, and we thank M. Auger for assistance in using his spectroscopic reduction pipeline. The research of A.V.F.'s group was supported by grants from the NSF, the TABASGO Foundation, Gary and Cynthia Bengier, and the Richard and Rhoda Goldman Fund. M. M. K. acknowledges generous support from the Hubble Fellowship and Carnegie-Princeton Fellowship. A.G.-Y. is supported by grants from the Israel Science Foundation and the U.S.-Israel Binational Foundation, an Award for Research Cooperation and High Excellence in Science from the Bundesministerium fur Bildung und Forschung, and the Lord Seiff of Brimpton Fund. The data presented in this paper are available from the Weizmann Interactive Supernova Data Repository (www.weizmann.ac.il/astrophysics/wiserep).	Aihara H, 2011, ASTROPHYS J SUPPL S, V193, DOI 10.1088/0067-0049/193/2/29; Aldering G, 2006, ASTROPHYS J, V650, P510, DOI 10.1086/507020; BRANCH D, 1995, PUBL ASTRON SOC PAC, V107, P1019, DOI 10.1086/133657; Chiotellis A, 2012, ASTRON ASTROPHYS, V537, DOI 10.1051/0004-6361/201014754; Chugai NN, 2008, ASTRON LETT+, V34, P389, DOI 10.1134/S1063773708060030; Chugai NN, 2004, ASTRON LETT+, V30, P65, DOI 10.1134/1.1646691; Garavini G, 2004, ASTRON J, V128, P387, DOI 10.1086/421747; Hamuy M, 2003, NATURE, V424, P651, DOI 10.1038/nature01854; Han Z, 2004, MON NOT R ASTRON SOC, V350, P1301, DOI 10.1111/j.1365-2966.2004.07713.x; Horesh A, 2012, ASTROPHYS J, V746, DOI 10.1088/0004-637X/746/1/21; Howell DA, 2006, NATURE, V443, P308, DOI 10.1038/nature05103; IBEN I, 1984, ASTROPHYS J SUPPL S, V54, P335, DOI 10.1086/190932; Kasen D, 2010, ASTROPHYS J, V708, P1025, DOI 10.1088/0004-637X/708/2/1025; Li WD, 2001, ASTROPHYS J, V546, P734, DOI 10.1086/318299; Li WD, 2011, NATURE, V480, P348, DOI 10.1038/nature10646; Li WD, 2011, MON NOT R ASTRON SOC, V412, P1441, DOI 10.1111/j.1365-2966.2011.18160.x; Lu GL, 2009, MON NOT R ASTRON SOC, V396, P1086, DOI 10.1111/j.1365-2966.2009.14777.x; Maoz D, 2010, ASTROPHYS J, V722, P1879, DOI 10.1088/0004-637X/722/2/1879; NUGENT P, 1995, ASTROPHYS J, V455, pL147, DOI 10.1086/309846; Nugent PE, 2011, NATURE, V480, P344, DOI 10.1038/nature10644; Patat F, 2007, SCIENCE, V317, P924, DOI 10.1126/science.1143005; Pskovskii I. P., 1977, SVA, V21, P675; Schaefer BE, 2012, NATURE, V481, P164, DOI 10.1038/nature10692; Shen KJ, 2012, ASTROPHYS J, V748, DOI 10.1088/0004-637X/748/1/35; Silverman JM, 2011, MON NOT R ASTRON SOC, V410, P585, DOI 10.1111/j.1365-2966.2010.17474.x; Simon JD, 2009, ASTROPHYS J, V702, P1157, DOI 10.1088/0004-637X/702/2/1157; Sternberg A, 2011, SCIENCE, V333, P856, DOI 10.1126/science.1203836; Walder R, 2008, ASTRON ASTROPHYS, V484, pL9, DOI 10.1051/0004-6361:200809703; Welty DE, 1996, ASTROPHYS J SUPPL S, V106, P533, DOI 10.1086/192347; Wood-Vasey WM, 2006, ASTROPHYS J, V645, pL53, DOI 10.1086/506179	34	256	258	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 24	2012	337	6097					942	945		10.1126/science.1219164	http://dx.doi.org/10.1126/science.1219164			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992VI	22923575	Green Submitted, Green Accepted			2022-12-28	WOS:000307807600038
J	Pirrotta, V				Pirrotta, Vincenzo			How to Read the Chromatin Past	SCIENCE			English	Editorial Material							REPRESSIVE COMPLEX 2; HISTONE MARKS; PRC2; METHYLATION		Rutgers State Univ, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick	Pirrotta, V (corresponding author), Rutgers State Univ, 604 Allison Rd, Piscataway, NJ 08854 USA.	pirrotta@dls.rutgers.edu	li, ran/K-1896-2012					Hansen KH, 2008, NAT CELL BIOL, V10, P1291, DOI 10.1038/ncb1787; Ketel CS, 2005, MOL CELL BIOL, V25, P6857, DOI 10.1128/MCB.25.16.6857-6868.2005; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Margueron R, 2009, NATURE, V461, P762, DOI 10.1038/nature08398; Schmitges FW, 2011, MOL CELL, V42, P330, DOI 10.1016/j.molcel.2011.03.025; Xu C, 2010, P NATL ACAD SCI USA, V107, P19266, DOI 10.1073/pnas.1008937107; Yuan W, 2012, SCIENCE, V337, P971, DOI 10.1126/science.1225237; Yuan W, 2011, J BIOL CHEM, V286, P7983, DOI 10.1074/jbc.M110.194027	8	3	3	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 24	2012	337	6097					919	920		10.1126/science.1227684	http://dx.doi.org/10.1126/science.1227684			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	992VI	22923567				2022-12-28	WOS:000307807600030
J	Preiss, D; Tikkanen, MJ; Welsh, P; Ford, I; Lovato, LC; Elam, MB; LaRosa, JC; DeMicco, DA; Colhoun, HM; Goldenberg, I; Murphy, MJ; MacDonald, TM; Pedersen, TR; Keech, AC; Ridker, PM; Kjekshus, J; Sattar, N; McMurray, JJV				Preiss, David; Tikkanen, Matti J.; Welsh, Paul; Ford, Ian; Lovato, Laura C.; Elam, Marshall B.; LaRosa, John C.; DeMicco, David A.; Colhoun, Helen M.; Goldenberg, Ilan; Murphy, Michael J.; MacDonald, Thomas M.; Pedersen, Terje R.; Keech, Anthony C.; Ridker, Paul M.; Kjekshus, John; Sattar, Naveed; McMurray, John J. V.			Lipid-Modifying Therapies and Risk of Pancreatitis A Meta-analysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							CORONARY-HEART-DISEASE; HMG-COA REDUCTASE; PRIMARY-PREVENTION; MYOCARDIAL-INFARCTION; LDL CHOLESTEROL; SEVERE HYPERTRIGLYCERIDEMIA; CARDIOVASCULAR-DISEASE; SECONDARY PREVENTION; DIABETES-MELLITUS; DOUBLE-BLIND	Context Statin therapy has been associated with pancreatitis in observational studies. Although lipid guidelines recommend fibrate therapy to reduce pancreatitis risk in persons with hypertriglyceridemia, fibrates may lead to the development of gallstones, a risk factor for pancreatitis. Objective To investigate associations between statin or fibrate therapy and incident pancreatitis in large randomized trials. Data Sources Relevant trials were identified in literature searches of MEDLINE, EMBASE, and Web of Science (January 1, 1994, for statin trials and January 1, 1972, for fibrate trials, through June 9, 2012). Published pancreatitis data were tabulated where available (6 trials). Unpublished data were obtained from investigators (22 trials). Study Selection We included randomized controlled cardiovascular end-point trials investigating effects of statin therapy or fibrate therapy. Studies with more than 1000 participants followed up for more than 1 year were included. Data Extraction Trial-specific data described numbers of participants developing pancreatitis and change in triglyceride levels at 1 year. Trial-specific risk ratios (RRs) were calculated and combined using random-effects model meta-analysis. Between-study heterogeneity was assessed using the I-2 statistic. Results In 16 placebo-and standard care-controlled statin trials with 113 800 participants conducted over a weighted mean follow-up of 4.1 (SD, 1.5) years, 309 participants developed pancreatitis (134 assigned to statin, 175 assigned to control) (RR, 0.77 [95% CI, 0.62-0.97; P=.03; I-2=0%]). In 5 dose-comparison statin trials with 39 614 participants conducted over 4.8 (SD, 1.7) years, 156 participants developed pancreatitis (70 assigned to intensive dose, 86 assigned to moderate dose) (RR, 0.82 [95% CI, 0.59-1.12; P=.21; I-2=0%]). Combined results for all 21 statin trials provided RR 0.79 (95% CI, 0.65-0.95; P=.01; I-2=0%). In 7 fibrate trials with 40 162 participants conducted over 5.3 (SD, 0.5) years, 144 participants developed pancreatitis (84 assigned to fibrate therapy, 60 assigned to placebo) (RR, 1.39 [95% CI, 1.00-1.95; P=.053; I-2=0%]). Conclusion In a pooled analysis of randomized trial data, use of statin therapy was associated with a lower risk of pancreatitis in patients with normal or mildly elevated triglyceride levels. JAMA. 2012;308(8):804-811 www.jama.com	[Preiss, David; Welsh, Paul; Sattar, Naveed; McMurray, John J. V.] Univ Glasgow, BHF Glasgow Cardiovasc Res Ctr, Glasgow G12 8TA, Lanark, Scotland; [Ford, Ian] Univ Glasgow, Robertson Ctr Biostat, Glasgow G12 8TA, Lanark, Scotland; [Tikkanen, Matti J.] Univ Helsinki, Helsinki, Finland; [Tikkanen, Matti J.] Helsinki Univ Hosp, Div Cardiol, Helsinki, Finland; [Tikkanen, Matti J.] Folkhalsan Res Ctr, Helsinki, Finland; [Lovato, Laura C.] Wake Forest Univ, Sch Med, Div Publ Hlth Sci, Dept Biostat Sci, Winston Salem, NC 27109 USA; [Elam, Marshall B.] Memphis Vet Affairs Med Ctr, Memphis, TN USA; [LaRosa, John C.] SUNY Hlth Sci Ctr Brooklyn, New York, NY USA; [DeMicco, David A.] Pfizer Global Pharmaceut, New York, NY USA; [Colhoun, Helen M.] Univ Dundee, Med Res Inst, Dundee, Scotland; [Murphy, Michael J.] Univ Dundee, Dept Biochem Med, Dundee, Scotland; [MacDonald, Thomas M.] Univ Dundee, Div Med Sci, Med Monitoring Unit, Dundee, Scotland; [Goldenberg, Ilan] Chaim Sheba Med Ctr, Cardiac Rehabil Inst, IL-52621 Tel Hashomer, Israel; [Goldenberg, Ilan] Chaim Sheba Med Ctr, Israeli Soc Prevent Heart Attacks, Leviev Heart Ctr, IL-52621 Tel Hashomer, Israel; [Pedersen, Terje R.] Univ Oslo, Oslo, Norway; [Pedersen, Terje R.] Oslo Univ Hosp, Ctr Preventat Med, Oslo, Norway; [Keech, Anthony C.] Univ Sydney, NHMRC Clin Trials Ctr, Sydney, NSW 2006, Australia; [Ridker, Paul M.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA; [Kjekshus, John] Univ Oslo, Rikshosp, Dept Cardiol, Oslo Univ Hosp, N-0027 Oslo, Norway	University of Glasgow; University of Glasgow; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Folkhalsan Research Center; Wake Forest University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Memphis VA Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; Pfizer; University of Dundee; University of Dundee; University of Dundee; Chaim Sheba Medical Center; Chaim Sheba Medical Center; University of Oslo; University of Oslo; University of Sydney; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Oslo; National Hospital Norway	Preiss, D (corresponding author), Univ Glasgow, BHF Glasgow Cardiovasc Res Ctr, 126 Univ Pl, Glasgow G12 8TA, Lanark, Scotland.	david.preiss@glasgow.ac.uk	mcmurray, John/B-2467-2013; Murphy, Michael J/K-4008-2012; Ford, Ian/ABE-6145-2020; Welsh, Paul/H-5249-2019	mcmurray, John/0000-0002-6317-3975; Murphy, Michael J/0000-0001-6735-125X; Welsh, Paul/0000-0002-7970-3643; Colhoun, Helen/0000-0002-8345-3288; Preiss, David/0000-0003-3139-1836; MacDonald, Thomas/0000-0001-5189-6669	Amgen Inc; Pfizer; AstraZeneca; Merck; AMGEN; Roche; Novartis; Merck Sharpe Dohme; Bristol-Myers Squibb; Eli Lilly; Roche Diagnostics; Solvay; Genzyme; Vascular Biogenics; ISIS; Boston Diagnostics; British Heart Foundation [FS/10/005/28147]	Amgen Inc(Amgen); Pfizer(Pfizer); AstraZeneca(AstraZeneca); Merck(Merck & Company); AMGEN(Amgen); Roche(Roche Holding); Novartis(Novartis); Merck Sharpe Dohme(Merck & Company); Bristol-Myers Squibb(Bristol-Myers Squibb); Eli Lilly(Eli Lilly); Roche Diagnostics; Solvay(Solvay SA); Genzyme(Sanofi-AventisGenzyme Corporation); Vascular Biogenics; ISIS; Boston Diagnostics; British Heart Foundation(British Heart Foundation)	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. The majority of trials discussed in this article were funded partly or wholly by industry, and Drs Tikkanen, Ford, Elam, LaRosa, DeMicco, Colhoun, Goldenberg, Pedersen, Keech, Ridker, Kjekshus, and McMurray and Ms Lovato each reported serving as an investigator in at least 1 of the trials. Dr Tikkanen reported receiving honoraria from Pfizer and consultant fees from Amgen Inc. Dr Elam reporting serving as a consultant, speaker, or both for Abbott/Solvay, Merck Schering Plough, and Pfizer Canada. Dr LaRosa reported receiving consultancy fees from Pfizer and AstraZeneca and participating in clinical trials funded by Pfizer. Dr Colhoun reported receiving honoraria for advisory board participation and speaker fees from Pfizer. Dr Pedersen reported receiving speakers honoraria, consulting fees, or research grants from Merck, AstraZeneca, AMGEN, Roche, and Novartis. Dr Keech reported receiving honoraria and research or travel grants from Abbott, Merck Sharpe & Dohme, Bristol-Myers Squibb, Novartis, Eli Lilly, Pfizer, Roche Diagnostics, Solvay, and AstraZeneca. Dr Ridker reported receiving research grant support from AstraZeneca and Novartis; receiving consultancy fees from Merck, Genzyme, Vascular Biogenics, ISIS, and Boston Diagnostics; and being listed as a co-inventor on patents held by the Brigham and Women's Hospital that relate to the use of inflammatory biomarkers in cardiovascular disease and diabetes that have been licensed to AstraZeneca and Siemens. Dr Sattar reported consulting for and receiving lecture fees from Merck, Pfizer, and AstraZeneca and receiving research grant support from Pfizer. No other authors reported disclosures.; This project was not supported by external funding. Dr Welsh is supported by British Heart Foundation fellowship grant FS/10/005/28147.	[Anonymous], 1975, JAMA-J AM MED ASSOC, V231, P360; [Anonymous], 2000, Ital Heart J, V1, P810; Armitage J, 2010, LANCET, V376, P1658, DOI 10.1016/S0140-6736(10)60310-8; Athyros VG, 2002, CURR MED RES OPIN, V18, P220, DOI 10.1185/030079902125000787; Athyros VG, 2002, J CLIN GASTROENTEROL, V34, P472, DOI 10.1097/00004836-200204000-00020; Badalov N, 2007, CLIN GASTROENTEROL H, V5, P648, DOI 10.1016/j.cgh.2006.11.023; Baigent C, 2010, LANCET, V376, P1670, DOI 10.1016/S0140-6736(10)61350-5; Baigent C, 2011, LANCET, V377, P2181, DOI 10.1016/S0140-6736(11)60739-3; Bodmer M, 2009, JAMA-J AM MED ASSOC, V302, P2001, DOI 10.1001/jama.2009.1601; CANNER PL, 1986, J AM COLL CARDIOL, V8, P1245, DOI 10.1016/S0735-1097(86)80293-5; Cannon CP, 2004, NEW ENGL J MED, V350, P1495, DOI 10.1056/NEJMoa040583; Choi OS, 2005, BIOL PHARM BULL, V28, P1394, DOI 10.1248/bpb.28.1394; Colhoun HM, 2004, LANCET, V364, P685, DOI 10.1016/S0140-6736(04)16895-5; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; de Lemos JA, 2004, JAMA-J AM MED ASSOC, V292, P1307, DOI 10.1001/jama.292.11.1307; Downs JR, 1998, JAMA-J AM MED ASSOC, V279, P1615, DOI 10.1001/jama.279.20.1615; DUANE WC, 1988, HEPATOLOGY, V8, P1147, DOI 10.1002/hep.1840080531; Ewald N, 2009, CURR OPIN LIPIDOL, V20, P497, DOI 10.1097/MOL.0b013e3283319a1d; Experience in the Coronary Drug Project, 1977, NEW ENGL J MED, V296, P1185; FRICK MH, 1993, ANN MED, V25, P41, DOI 10.3109/07853899309147855; FRICK MH, 1987, NEW ENGL J MED, V317, P1237, DOI 10.1056/NEJM198711123172001; Ginsberg HN, 2010, NEW ENGL J MED, V362, P1563, DOI 10.1056/NEJMoa1001282; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Keech A, 2005, LANCET, V366, P1849, DOI 10.1016/S0140-6736(05)67667-2; Kjekshus J, 2007, NEW ENGL J MED, V357, P2248, DOI 10.1056/NEJMoa0706201; Knopp RH, 2006, DIABETES CARE, V29, P1478, DOI 10.2337/dc05-2415; LaRosa JC, 2005, NEW ENGL J MED, V352, P1425, DOI 10.1056/NEJMoa050461; Almeida JL, 2008, J PANCREAS, V9, P431; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1016/j.ijsu.2010.02.007, 10.1136/bmj.b2535]; Nakamura H, 2006, LANCET, V368, P1155, DOI 10.1016/S0140-6736(06)69472-5; National Cholesterol Education Program, 2004, 3 NAT CHOL ED PROGR; National Institute for Health and Clinical Excellence, 2009, MAN TYP 2 DIAB; OLIVER M F, 1978, British Heart Journal, V40, P1069, DOI 10.1136/hrt.40.10.1069; PALMER RH, 1985, ARTERIOSCLEROSIS, V5, P631, DOI 10.1161/01.ATV.5.6.631; PEDERSEN TR, 1994, LANCET, V344, P1383; Pedersen TR, 2005, JAMA-J AM MED ASSOC, V294, P2437, DOI 10.1001/jama.294.19.2437; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Rubins HB, 1999, NEW ENGL J MED, V341, P410, DOI 10.1056/NEJM199908053410604; Sacks FM, 1996, NEW ENGL J MED, V335, P1001, DOI 10.1056/NEJM199610033351401; Sandhu S, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-157; Schlesinger Z, 2000, CIRCULATION, V102, P21, DOI 10.1161/01.CIR.102.1.21; Sever PS, 2003, LANCET, V361, P1149, DOI 10.1016/S0140-6736(03)12948-0; Shepherd J, 2002, LANCET, V360, P1623, DOI 10.1016/S0140-6736(02)11600-X; SHEPHERD J, 1995, NEW ENGL J MED, V333, P1301, DOI 10.1056/NEJM199511163332001; Singh S, 2006, DRUG SAFETY, V29, P1123, DOI 10.2165/00002018-200629120-00004; Tavazzi L, 2008, LANCET, V372, P1231, DOI 10.1016/S0140-6736(08)61240-4; Tonkin A, 1998, NEW ENGL J MED, V339, P1349; Tsigrelis C, 2006, WORLD J GASTROENTERO, V12, P7055, DOI 10.3748/wjg.v12.i43.7055; USFood and Drug Administration (FDA), 2011, END MET DRUGS ADV CO; Van Woerkom RC, 2010, J CLIN LIPIDOL, V4, P314, DOI 10.1016/j.jacl.2010.03.075; VONBERGMANN K, 1984, EUR J CLIN INVEST, V14, P150; Wei LM, 2011, LAB INVEST, V91, P872, DOI 10.1038/labinvest.2011.41	53	104	112	1	15	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 22	2012	308	8					804	811		10.1001/jama.2012.8439	http://dx.doi.org/10.1001/jama.2012.8439			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	991ML	22910758	Green Accepted			2022-12-28	WOS:000307705300024
J	Moyer, VA				Moyer, Virginia A.		US Preventive Serv Task Force	Screening for Ovarian Cancer: US Preventive Services Task Force Reaffirmation Recommendation Statement	ANNALS OF INTERNAL MEDICINE			English	Article							SYMPTOMS; TRIAL; WOMEN	Description: Reaffirmation of the 2004 U. S. Preventive Services Task Force (USPSTF) recommendation statement on screening for ovarian cancer. Methods: A 2008 review of the literature commissioned by the USPSTF revealed no new evidence about the benefits of screening for ovarian cancer but provided some new data about observed harms of screening. A bridge search to 2011 focused on evidence from randomized, controlled trials. Population: This recommendation applies to asymptomatic women. It does not apply to women with known genetic mutations that increase their risk for ovarian cancer (for example, BRCA mutations). Recommendation: The USPSTF recommends against screening for ovarian cancer in women (D recommendation). Ann Intern Med. 2012;157:900-904.	US Prevent Serv Task Force, Rockville, MD USA		Moyer, VA (corresponding author), US Prevent Serv Task Force, Rockville, MD USA.							American Cancer Society, 2012, CANC FACTS FIG 2012; American College of O, 2011, OBSTET GYNECOL, V117, P742; [Anonymous], 2010, GLOBE NEWSWIRE  0823; Barton M, 2012, AHRQ PUBLICATION; Buys SS, 2011, JAMA-J AM MED ASSOC, V305, P2295, DOI 10.1001/jama.2011.766; Danforth KN, 2012, AHRQ PUBLICATION, V12-05165-EF4; Gilbert L, 2012, LANCET ONCOL, V13, P285, DOI 10.1016/S1470-2045(11)70333-3; Goff BA, 2004, JAMA-J AM MED ASSOC, V291, P2705, DOI 10.1001/jama.291.22.2705; Kobayashi H, 2008, INT J GYNECOL CANCER, V18, P414, DOI 10.1111/j.1525-1438.2007.01035.x; Menon U, 2005, J CLIN ONCOL, V23, P7919, DOI 10.1200/JCO.2005.01.6642; Menon U, 2009, LANCET ONCOL, V10, P327, DOI 10.1016/S1470-2045(09)70026-9; Nelson H, 2004, AHRQ PUBLICATION; Partridge E, 2009, OBSTET GYNECOL, V113, P775, DOI 10.1097/AOG.0b013e31819cda77; Rufford BD, 2007, BJOG-INT J OBSTET GY, V114, P59, DOI 10.1111/j.1471-0528.2006.01153.x	14	137	142	0	11	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 18	2012	157	12					900	U118		10.7326/0003-4819-157-11-201212040-00539	http://dx.doi.org/10.7326/0003-4819-157-11-201212040-00539			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	057SB	22964825				2022-12-28	WOS:000312583200019
J	Garaycoechea, JI; Crossan, GP; Langevin, F; Daly, M; Arends, MJ; Patel, KJ				Garaycoechea, Juan I.; Crossan, Gerry P.; Langevin, Frederic; Daly, Maria; Arends, Mark J.; Patel, Ketan J.			Genotoxic consequences of endogenous aldehydes on mouse haematopoietic stem cell function	NATURE			English	Article							FANCONI-ANEMIA; DEHYDROGENASE-ACTIVITY; PROGENITOR CELLS; DNA-REPAIR; MARROW-CELLS; MICE; TRANSPLANTATION; SUPPRESSION; PATHWAY; ASSAYS	Haematopoietic stem cells (HSCs) regenerate blood cells throughout the lifespan of an organism. With age, the functional quality of HSCs declines, partly owing to the accumulation of damaged DNA(1-3). However, the factors that damage DNA and the protective mechanisms that operate in these cells are poorly understood. We have recently shown that the Fanconi anaemia DNA-repair pathway counteracts the genotoxic effects of reactive aldehydes(4,5). Mice with combined inactivation of aldehyde catabolism (through Aldh2 knockout) and the Fanconi anaemia DNA-repair pathway (Fancd2 knockout) display developmental defects, a predisposition to leukaemia, and are susceptible to the toxic effects of ethanol-an exogenous source of acetaldehyde(4). Here we report that aged Aldh2(-/-) Fancd2(-/-) mutant mice that do not develop leukaemia spontaneously develop aplastic anaemia, with the concomitant accumulation of damaged DNA within the haematopoietic stem and progenitor cell (HSPC) pool. Unexpectedly, we find that only HSPCs, and not more mature blood precursors, require Aldh2 for protection against acetaldehyde toxicity. Additionally, the aldehyde-oxidizing activity of HSPCs, as measured by Aldefluor stain, is due to Aldh2 and correlates with this protection. Finally, there is more than a 600-fold reduction in the HSC pool of mice deficient in both Fanconi anaemia pathway-mediated DNA repair and acetaldehyde detoxification. Therefore, the emergence of bone marrow failure in Fanconi anaemia is probably due to aldehyde-mediated genotoxicity restricted to the HSPC pool. These findings identify a new link between endogenous reactive metabolites and DNA damage in HSCs, and define the protective mechanisms that counteract this threat.	[Garaycoechea, Juan I.; Crossan, Gerry P.; Langevin, Frederic; Daly, Maria; Patel, Ketan J.] MRC, Mol Biol Lab, Cambridge CB2 0QH, England; [Arends, Mark J.] Univ Cambridge, Addenbrookes Hosp, Dept Pathol, Cambridge CB2 2QQ, England; [Patel, Ketan J.] Univ Cambridge, Addenbrookes Hosp, Dept Med, Cambridge CB2 0QQ, England	MRC Laboratory Molecular Biology; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Patel, KJ (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 0QH, England.	kjp@mrc-lmb.cam.ac.uk		Crossan, Gerry/0000-0002-7974-009X	CRUK; Homerton College, Cambridge; Milstein Fund; Darwin Trust of Edinburgh; March of Dimes Foundation; MRC [MC_U105178811] Funding Source: UKRI; Cancer Research UK [13647] Funding Source: researchfish; Medical Research Council [MC_U105178811] Funding Source: researchfish	CRUK(Cancer Research UK); Homerton College, Cambridge; Milstein Fund; Darwin Trust of Edinburgh; March of Dimes Foundation(March of Dimes); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank M. Grompe for Fancd2-deficient mice and M. Milsom and D. Walter for technical advice. We are grateful to T. Langford, R. Berks, A. Middleton, C. Knox and J. Wiles for their help with mouse experimental work. We would also like to thank the Biomed services and ARES staff for animal husbandry and assistance. We thank N. Grant for photography. We thank the Human Research Tissue Bank (NIHR Cambridge Biomedical Research Centre) for processing histology. We also thank F. Zhang for help with FACS. G. P. C. is supported by CRUK and Homerton College, Cambridge. J. I. G. is supported by the Milstein Fund and the Darwin Trust of Edinburgh. F. L. is supported by the March of Dimes Foundation.	Amrani YM, 2011, J EXP MED, V208, P1757, DOI 10.1084/jem.20102170; Armstrong L, 2004, STEM CELLS, V22, P1142, DOI 10.1634/stemcells.2004-0170; Balber AE, 2011, STEM CELLS, V29, P570, DOI 10.1002/stem.613; BECKER AJ, 1963, NATURE, V197, P452, DOI 10.1038/197452a0; Crossan GP, 2012, J PATHOL, V226, P326, DOI 10.1002/path.3002; Crossan GP, 2011, NAT GENET, V43, P147, DOI 10.1038/ng.752; Drost R, 2011, CANCER CELL, V20, P797, DOI 10.1016/j.ccr.2011.11.014; Ema H, 2006, NAT PROTOC, V1, P2979, DOI 10.1038/nprot.2006.447; Hess DA, 2006, BLOOD, V107, P2162, DOI 10.1182/blood-2005-06-2284; Houghtaling S, 2003, GENE DEV, V17, P2021, DOI 10.1101/gad.1103403; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kutler DI, 2003, BLOOD, V101, P1249, DOI 10.1182/blood-2002-07-2170; Langevin F, 2011, NATURE, V475, P53, DOI 10.1038/nature10192; Levi BP, 2009, BLOOD, V113, P1670, DOI 10.1182/blood-2008-05-156752; Lo Celso C, 2007, CURR PROTOC STEM CEL; MCCULLOCH EA, 1960, RADIAT RES, V13, P115, DOI 10.2307/3570877; MEAGHER RC, 1982, NEW ENGL J MED, V307, P845, DOI 10.1056/NEJM198209303071402; Milyavsky M, 2010, CELL STEM CELL, V7, P186, DOI 10.1016/j.stem.2010.05.016; Mohrin M, 2010, CELL STEM CELL, V7, P174, DOI 10.1016/j.stem.2010.06.014; Niedernhofer LJ, 2008, DNA REPAIR, V7, P523, DOI 10.1016/j.dnarep.2007.11.012; Nijnik A, 2007, NATURE, V447, P686, DOI 10.1038/nature05875; Purton LE, 2007, CELL STEM CELL, V1, P263, DOI 10.1016/j.stem.2007.08.016; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Rosado IV, 2011, NAT STRUCT MOL BIOL, V18, P1432, DOI 10.1038/nsmb.2173; Rossi DJ, 2007, NATURE, V447, P725, DOI 10.1038/nature05862; Rossi DJ, 2005, P NATL ACAD SCI USA, V102, P9194, DOI 10.1073/pnas.0503280102; Seita J, 2010, CELL STEM CELL, V7, P145, DOI 10.1016/j.stem.2010.07.006; Storms RW, 1999, P NATL ACAD SCI USA, V96, P9118, DOI 10.1073/pnas.96.16.9118; Storms RW, 2005, BLOOD, V106, P95, DOI 10.1182/blood-2004-09-3652; Sudo K, 2000, J EXP MED, V192, P1273, DOI 10.1084/jem.192.9.1273; SZILVASSY SJ, 1990, P NATL ACAD SCI USA, V87, P8736, DOI 10.1073/pnas.87.22.8736; Wang LJ, 2002, LIVER TRANSPLANT, V8, P822, DOI 10.1053/jlts.2002.34891; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Zhang QS, 2010, BLOOD, V116, P5140, DOI 10.1182/blood-2010-04-278226	34	265	271	0	71	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 27	2012	489	7417					571	+		10.1038/nature11368	http://dx.doi.org/10.1038/nature11368			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	046RG	22922648				2022-12-28	WOS:000311781500005
J	Govindan, R; Ding, L; Griffith, M; Subramanian, J; Dees, ND; Kanchi, KL; Maher, CA; Fulton, R; Fulton, L; Wallis, J; Chen, K; Walker, J; McDonald, S; Bose, R; Ornitz, D; Xiong, DH; You, M; Dooling, DJ; Watson, M; Mardis, ER; Wilson, RK				Govindan, Ramaswamy; Ding, Li; Griffith, Malachi; Subramanian, Janakiraman; Dees, Nathan D.; Kanchi, Krishna L.; Maher, Christopher A.; Fulton, Robert; Fulton, Lucinda; Wallis, John; Chen, Ken; Walker, Jason; McDonald, Sandra; Bose, Ron; Ornitz, David; Xiong, Donghai; You, Ming; Dooling, David J.; Watson, Mark; Mardis, Elaine R.; Wilson, Richard K.			Genomic Landscape of Non-Small Cell Lung Cancer in Smokers and Never-Smokers	CELL			English	Article							MUTATIONAL SIGNIFICANCE; SOMATIC MUTATIONS; GENE FUSIONS; IDENTIFICATION; REARRANGEMENTS; HETEROGENEITY; TRANSCRIPTION; EXPRESSION; EVOLUTION; ARID1A	We report the results of whole-genome and transcriptome sequencing of tumor and adjacent normal tissue samples from 17 patients with non-small cell lung carcinoma (NSCLC). We identified 3,726 point mutations and more than 90 indels in the coding sequence, with an average mutation frequency more than 10-fold higher in smokers than in never-smokers. Novel alterations in genes involved in chromatin modification and DNA repair pathways were identified, along with DACH1, CFTR, RELN, ABCB5, and HGF. Deep digital sequencing revealed diverse clonality patterns in both never-smokers and smokers. All validated EFGR and KRAS mutations were present in the founder clones, suggesting possible roles in cancer initiation. Analysis revealed 14 fusions, including ROS1 and ALK, as well as novel metabolic enzymes. Cell-cycle and JAK-STAT pathways are significantly altered in lung cancer, along with perturbations in 54 genes that are potentially targetable with currently available drugs.	[Govindan, Ramaswamy; Subramanian, Janakiraman; Maher, Christopher A.; McDonald, Sandra; Bose, Ron; Watson, Mark; Mardis, Elaine R.; Wilson, Richard K.] Washington Univ, Sch Med, Siteman Canc Ctr, St Louis, MO 63110 USA; [Govindan, Ramaswamy; Ding, Li; Subramanian, Janakiraman; Maher, Christopher A.; Bose, Ron] Washington Univ, Sch Med, Dept Internal Med, Div Oncol, St Louis, MO 63110 USA; [Ding, Li; Griffith, Malachi; Dees, Nathan D.; Kanchi, Krishna L.; Maher, Christopher A.; Fulton, Robert; Fulton, Lucinda; Wallis, John; Walker, Jason; Dooling, David J.; Mardis, Elaine R.; Wilson, Richard K.] Washington Univ, Sch Med, Genome Inst, St Louis, MO 63110 USA; [Ding, Li; Griffith, Malachi; Fulton, Robert; Fulton, Lucinda; Wallis, John; Dooling, David J.; Mardis, Elaine R.; Wilson, Richard K.] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; [Ornitz, David] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO 63110 USA; [McDonald, Sandra; Watson, Mark] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Xiong, Donghai; You, Ming] Med Coll Wisconsin, Dept Pharmacol & Toxicol, Milwaukee, WI 53226 USA; [Chen, Ken] Univ Texas MD Anderson Canc Ctr, Div Quantitat Sci, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA	Siteman Cancer Center; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Medical College of Wisconsin; University of Texas System; UTMD Anderson Cancer Center	Wilson, RK (corresponding author), Washington Univ, Sch Med, Siteman Canc Ctr, St Louis, MO 63110 USA.	rwilson@wustl.edu	Griffith, Malachi/P-1285-2014; Mardis, Elaine/W-2202-2019; Walker, Jason/A-9702-2013; Chen, Ken/AAU-1432-2021; Wilson, Richard K./AAF-4139-2019	Griffith, Malachi/0000-0002-6388-446X; Walker, Jason/0000-0001-7547-5789; Chen, Ken/0000-0003-4013-5279; Wilson, Richard K./0000-0002-1992-1358; Ornitz, David/0000-0003-1592-7629	Washington University in St. Louis; National Human Genome Research Institute [NHGRI U54 HG003079]; Washington University Cancer Genome Initiative; Siteman Cancer Center; NATIONAL CANCER INSTITUTE [R00CA149182, P30CA016672] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003079] Funding Source: NIH RePORTER	Washington University in St. Louis; National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Washington University Cancer Genome Initiative; Siteman Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank the following groups at The Genome Institute for their dedicated efforts in this work: the Production group for sequence data production and processing, the Technology Development group for formulation of methods and troubleshooting, the Analysis Pipeline group for developing the automated sequence analysis pipelines, the LIMS group for developing tools and software to manage samples and sequencing, and the Systems group for providing the IT infrastructure and HPC solutions required for sequencing and analysis. We thank Daniel C. Koboldt for his help on tumor clonality analysis, Mike Wendl for help with pathway analysis, Josh Peck for help with manuscript preparation, and Joshua McMichael for help with figure preparation. We also thank the Washington University Cancer Genome Initiative and Siteman Cancer Center for their support. This work was funded by grants to R.K.W. from Washington University in St. Louis and the National Human Genome Research Institute (NHGRI U54 HG003079).	Bergethon K, 2012, J CLIN ONCOL, V30, P863, DOI 10.1200/JCO.2011.35.6345; Chen K, 2012, BIOINFORMATICS, V28, P1923, DOI 10.1093/bioinformatics/bts272; Chen K, 2009, NAT METHODS, V6, P677, DOI [10.1038/NMETH.1363, 10.1038/nmeth.1363]; Dees ND, 2012, GENOME RES, V22, P1589, DOI 10.1101/gr.134635.111; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Ding L, 2012, NATURE, V481, P506, DOI 10.1038/nature10738; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Gu TL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015640; Hopkins AL, 2002, NAT REV DRUG DISCOV, V1, P727, DOI 10.1038/nrd892; Iyer MK, 2011, BIOINFORMATICS, V27, P2903, DOI 10.1093/bioinformatics/btr467; Jones S, 2010, SCIENCE, V330, P228, DOI 10.1126/science.1196333; Jones SJM, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r82; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kendall J, 2007, P NATL ACAD SCI USA, V104, P16663, DOI 10.1073/pnas.0708286104; Kohno T, 2012, NAT MED, V18, P375, DOI 10.1038/nm.2644; Koukourakis MI, 2003, CANCER RES, V63, P5376; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Larson DE, 2012, BIOINFORMATICS, V28, P311, DOI 10.1093/bioinformatics/btr665; Lee W, 2010, NATURE, V465, P473, DOI 10.1038/nature09004; Li M, 2011, NAT GENET, V43, P828, DOI 10.1038/ng.903; Lipson D, 2012, NAT MED, V18, P382, DOI 10.1038/nm.2673; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McPherson A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001138; Ng Tze Pin, 1994, Annals Academy of Medicine Singapore, V23, P752; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Pleasance ED, 2010, NATURE, V463, P184, DOI 10.1038/nature08629; Ramsey BW, 2011, NEW ENGL J MED, V365, P1663, DOI 10.1056/NEJMoa1105185; Rausch T, 2012, CELL, V148, P59, DOI 10.1016/j.cell.2011.12.013; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Rodig SJ, 1998, CELL, V93, P373, DOI 10.1016/S0092-8674(00)81166-6; Russ AP, 2005, DRUG DISCOV TODAY, V10, P1607, DOI 10.1016/S1359-6446(05)03666-4; SELLERS TA, 1990, J NATL CANCER I, V82, P1272, DOI 10.1093/jnci/82.15.1272; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Somaiah N, 2011, J THORAC ONCOL, V6, pS1758, DOI 10.1097/01.JTO.0000407557.30793.a6; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Subramanian J, 2007, J CLIN ONCOL, V25, P561, DOI 10.1200/JCO.2006.06.8015; Takeuchi K, 2012, NAT MED, V18, P378, DOI 10.1038/nm.2658; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Watanabe A, 2011, P NATL ACAD SCI USA, V108, P12384, DOI 10.1073/pnas.0906930108; Weir BA, 2007, NATURE, V450, P893, DOI 10.1038/nature06358; Wendl MC, 2011, BIOINFORMATICS, V27, P1595, DOI 10.1093/bioinformatics/btr193; Wiegand KC, 2010, NEW ENGL J MED, V363, P1532, DOI 10.1056/NEJMoa1008433; Wood RD, 2001, SCIENCE, V291, P1284, DOI 10.1126/science.1056154; Wu KM, 2006, MOL CELL BIOL, V26, P7116, DOI 10.1128/MCB.00268-06; Yang P, 1999, GENET EPIDEMIOL, V17, P253, DOI 10.1002/(SICI)1098-2272(199911)17:4<253::AID-GEPI2>3.0.CO;2-K; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394; Zhang JH, 2012, NATURE, V481, P157, DOI 10.1038/nature10725	51	834	874	20	185	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 14	2012	150	6					1121	1134		10.1016/j.cell.2012.08.024	http://dx.doi.org/10.1016/j.cell.2012.08.024			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	007ZY	22980976	Green Accepted, Bronze			2022-12-28	WOS:000308928100007
J	Imielinski, M; Berger, AH; Hammerman, PS; Hernandez, B; Pugh, TJ; Hodis, E; Cho, J; Suh, J; Capelletti, M; Sivachenko, A; Sougnez, C; Auclair, D; Lawrence, MS; Stojanov, P; Cibulskis, K; Choi, K; de Waal, L; Sharifnia, T; Brooks, A; Greulich, H; Banerji, S; Zander, T; Seidel, D; Leenders, F; Ansen, S; Ludwig, C; Engel-Riedel, W; Stoelben, E; Wolf, J; Goparju, C; Thompson, K; Winckler, W; Kwiatkowski, D; Johnson, BE; Janne, PA; Miller, VA; Pao, W; Travis, WD; Pass, HI; Gabriel, SB; Lander, ES; Thomas, RK; Garraway, LA; Getz, G; Meyerson, M				Imielinski, Marcin; Berger, Alice H.; Hammerman, Peter S.; Hernandez, Bryan; Pugh, Trevor J.; Hodis, Eran; Cho, Jeonghee; Suh, James; Capelletti, Marzia; Sivachenko, Andrey; Sougnez, Carrie; Auclair, Daniel; Lawrence, Michael S.; Stojanov, Petar; Cibulskis, Kristian; Choi, Kyusam; de Waal, Luc; Sharifnia, Tanaz; Brooks, Angela; Greulich, Heidi; Banerji, Shantanu; Zander, Thomas; Seidel, Danila; Leenders, Frauke; Ansen, Sascha; Ludwig, Corinna; Engel-Riedel, Walburga; Stoelben, Erich; Wolf, Juergen; Goparju, Chandra; Thompson, Kristin; Winckler, Wendy; Kwiatkowski, David; Johnson, Bruce E.; Jaenne, Pasi A.; Miller, Vincent A.; Pao, William; Travis, William D.; Pass, Harvey I.; Gabriel, Stacey B.; Lander, Eric S.; Thomas, Roman K.; Garraway, Levi A.; Getz, Gad; Meyerson, Matthew			Mapping the Hallmarks of Lung Adenocarcinoma with Massively Parallel Sequencing	CELL			English	Article							GROWTH-FACTOR RECEPTOR; SOMATIC MUTATIONS; GENE-MUTATIONS; CANCER; GENOME; EGFR; LANDSCAPE; GEFITINIB; PATTERNS; REVEALS	Lung adenocarcinoma, the most common subtype of non-small cell lung cancer, is responsible for more than 500,000 deaths per year worldwide. Here, we report exome and genome sequences of 183 lung adenocarcinoma tumor/normal DNA pairs. These analyses revealed a mean exonic somatic mutation rate of 12.0 events/megabase and identified the majority of genes previously reported as significantly mutated in lung adenocarcinoma. In addition, we identified statistically recurrent somatic mutations in the splicing factor gene U2AF1 and truncating mutations affecting RBM10 and ARID1A. Analysis of nucleotide context-specific mutation signatures grouped the sample set into distinct clusters that correlated with smoking history and alterations of reported lung adenocarcinoma genes. Whole-genome sequence analysis revealed frequent structural rearrangements, including in-frame exonic alterations within EGFR and SIK2 kinases. The candidate genes identified in this study are attractive targets for biological characterization and therapeutic targeting of lung adenocarcinoma.	[Imielinski, Marcin; Berger, Alice H.; Hammerman, Peter S.; Hernandez, Bryan; Pugh, Trevor J.; Hodis, Eran; Sivachenko, Andrey; Sougnez, Carrie; Auclair, Daniel; Lawrence, Michael S.; Stojanov, Petar; Cibulskis, Kristian; de Waal, Luc; Sharifnia, Tanaz; Brooks, Angela; Greulich, Heidi; Banerji, Shantanu; Thompson, Kristin; Winckler, Wendy; Gabriel, Stacey B.; Lander, Eric S.; Garraway, Levi A.; Getz, Gad; Meyerson, Matthew] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA; [Imielinski, Marcin] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Imielinski, Marcin; Meyerson, Matthew] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Lander, Eric S.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Imielinski, Marcin; Berger, Alice H.; Hammerman, Peter S.; Pugh, Trevor J.; Capelletti, Marzia; Stojanov, Petar; de Waal, Luc; Sharifnia, Tanaz; Brooks, Angela; Greulich, Heidi; Banerji, Shantanu; Kwiatkowski, David; Johnson, Bruce E.; Jaenne, Pasi A.; Garraway, Levi A.; Meyerson, Matthew] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Cho, Jeonghee; Choi, Kyusam] Samsung Med Ctr, Samsung Res Inst, Seoul 135967, South Korea; [Suh, James] NYU, Langone Med Ctr, Dept Pathol, New York, NY 10016 USA; [Goparju, Chandra; Pass, Harvey I.] NYU, Langone Med Ctr, Dept Cardiothorac Surg, New York, NY 10016 USA; [Zander, Thomas; Seidel, Danila; Leenders, Frauke; Ansen, Sascha; Ludwig, Corinna; Engel-Riedel, Walburga; Stoelben, Erich; Wolf, Juergen; Thomas, Roman K.] Univ Cologne, Dept Internal Med, D-50924 Cologne, Germany; [Zander, Thomas; Seidel, Danila; Leenders, Frauke; Ansen, Sascha; Ludwig, Corinna; Engel-Riedel, Walburga; Stoelben, Erich; Wolf, Juergen; Thomas, Roman K.] Univ Cologne, Ctr Integrated Oncol, D-50924 Cologne, Germany; [Thomas, Roman K.] Univ Cologne, Lab Translat Canc Genom Koln Bonn, D-50924 Cologne, Germany; [Zander, Thomas; Thomas, Roman K.] Max Planck Inst Neurol Res, D-50924 Cologne, Germany; [Miller, Vincent A.] Mem Sloan Kettering Canc Ctr, Dept Med, Thorac Oncol Serv, New York, NY 10065 USA; [Travis, William D.] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10065 USA; [Pao, William] Vanderbilt Ingram Canc Ctr, Div Hematol Oncol, Nashville, TN 37232 USA; [Lander, Eric S.] MIT, Dept Biol, Cambridge, MA 02142 USA; [Thomas, Roman K.] Univ Cologne, Dept Translat Genom, D-50931 Cologne, Germany; [Thomas, Roman K.] Univ Cologne, Dept Pathol, D-50937 Cologne, Germany	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Sungkyunkwan University (SKKU); Samsung Medical Center; New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center; University of Cologne; University of Cologne; University of Cologne; Max Planck Society; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Vanderbilt University; Massachusetts Institute of Technology (MIT); University of Cologne; University of Cologne	Meyerson, M (corresponding author), Broad Inst Harvard & MIT, 7 Cambridge Ctr, Cambridge, MA 02142 USA.	matthew_meyerson@dfci.harvard.edu	Stojanov, Petar/GQI-4462-2022; Lawrence, Michael/AAC-8202-2020; Seidel, Danila/Y-6795-2018; Cibulskis, Kristian/AAC-7380-2019; Pugh, Trevor/Y-2535-2019; Capelletti, Marzia/L-6317-2016	Stojanov, Petar/0000-0001-7815-776X; Seidel, Danila/0000-0003-4388-3117; Pugh, Trevor/0000-0002-8073-5888; Cibulskis, Kristian/0000-0003-1343-1582; Capelletti, Marzia/0000-0001-5095-7060; Meyerson, Matthew/0000-0002-9133-8108; Pass, Harvey/0000-0003-3222-3471	NCI [T32 CA9216]; Canadian Institutes of Health; American Cancer Society; National Lung Cancer Partnership; Dana-Farber/Harvard Cancer Center Lung Cancer SPORE [P50 CA090578]; NIGMS [T32GM07753]; German Ministry of Science and Education (BMBF) [01GS08100]; Max Planck Society [M.I.F.A.NEUR8061]; Deutsche Forschungsgemeinschaft (DFG) [SFB832 (TP6), TH1386/3-1]; EU-Framework Programme CURELUNG [HEALTH-F2-2010-258677]; American Association for Cancer Research [SU2C-AACR-IR60109]; Behrens-Weise Foundation; National Human Genome Research Institute; National Cancer Institute; Uniting Against Lung Cancer, the Lung Cancer Research Foundation; American Lung Association; NATIONAL CANCER INSTITUTE [T32CA009216, P50CA090578, R01CA116020, R01CA109038] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Canadian Institutes of Health(Canadian Institutes of Health Research (CIHR)); American Cancer Society(American Cancer Society); National Lung Cancer Partnership; Dana-Farber/Harvard Cancer Center Lung Cancer SPORE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); German Ministry of Science and Education (BMBF)(Federal Ministry of Education & Research (BMBF)); Max Planck Society(Max Planck SocietyFoundation CELLEX); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); EU-Framework Programme CURELUNG; American Association for Cancer Research; Behrens-Weise Foundation; National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Uniting Against Lung Cancer, the Lung Cancer Research Foundation; American Lung Association; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank all members of the Biological Samples Platform, DNA Sequencing Platform, and Genetic Analysis Platforms of the Broad Institute, without whose work this sequencing project could not have occurred. M.I. is supported by NCI Training Grant T32 CA9216. T.J.P. is supported by a Canadian Institutes of Health Research Fellowship. A.H.B. is supported by a postdoctoral fellowship from the American Cancer Society. P.S.H. is supported by a Young Investigator Award from the National Lung Cancer Partnership and a Career Development Award from the Dana-Farber/Harvard Cancer Center Lung Cancer SPORE P50 CA090578. E.H. is supported by NIGMS training grant T32GM07753. R.K.T. is supported by the German Ministry of Science and Education (BMBF) as a member of the NGFN-Plus program (grant 01GS08100), by the Max Planck Society (M.I.F.A.NEUR8061), by the Deutsche Forschungsgemeinschaft (DFG) through SFB832 (TP6) and grant TH1386/3-1, by the EU-Framework Programme CURELUNG (HEALTH-F2-2010-258677), by Stand Up To Cancer-American Association for Cancer Research Innovative Research Grant (SU2C-AACR-IR60109), by the Behrens-Weise Foundation, and by an anonymous foundation. This work was supported by the National Human Genome Research Institute (E.S.L.) and by the National Cancer Institute, Uniting Against Lung Cancer, the Lung Cancer Research Foundation, and the American Lung Association (M.M.). M.M., E.L., and L.A.G. are founders and equity holders of Foundation Medicine, a for-profit company that provides next-generation sequencing diagnostic services. V.A.M. is an employee of Foundation Medicine.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Banerji S, 2012, NATURE, V486, P405, DOI 10.1038/nature11154; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bass AJ, 2011, NAT GENET, V43, P964, DOI 10.1038/ng.936; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Berger MF, 2012, NATURE, V485, P502, DOI 10.1038/nature11071; Berger MF, 2011, NATURE, V470, P214, DOI 10.1038/nature09744; Bergethon K, 2012, J CLIN ONCOL, V30, P863, DOI 10.1200/JCO.2011.35.6345; Cancer Genome Atlas Research Network, 2012, NATURE; Chapman MA, 2011, NATURE, V471, P467, DOI 10.1038/nature09837; Cho J, 2011, CANCER RES, V71, P7587, DOI 10.1158/0008-5472.CAN-11-0821; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; EKSTRAND AJ, 1992, P NATL ACAD SCI USA, V89, P4309, DOI 10.1073/pnas.89.10.4309; Elsasser SJ, 2011, SCIENCE, V331, P1145, DOI 10.1126/science.1203280; Fisher S, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r1; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Graubert TA, 2012, NAT GENET, V44, P53, DOI 10.1038/ng.1031; Grovdal LM, 2004, EXP CELL RES, V300, P388, DOI 10.1016/j.yexcr.2004.07.003; Hainaut P, 2001, CARCINOGENESIS, V22, P367, DOI 10.1093/carcin/22.3.367; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hashimoto YK, 2008, J CELL BIOCHEM, V104, P1724, DOI 10.1002/jcb.21737; Hodis E, 2012, CELL, V150, P251, DOI 10.1016/j.cell.2012.06.024; Ju YS, 2012, GENOME RES, V22, P436, DOI 10.1101/gr.133645.111; Kan ZY, 2010, NATURE, V466, P869, DOI 10.1038/nature09208; Kosaka T, 2009, J THORAC ONCOL, V4, P22, DOI 10.1097/JTO.0b013e3181914111; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Lee W, 2010, NATURE, V465, P473, DOI 10.1038/nature09004; Medvedev P, 2009, NAT METHODS, V6, pS13, DOI [10.1038/NMETH.1374, 10.1038/nmeth.1374]; Minna J.D., 2008, HARRISONS PRINCIPLES, P551; MITSUDOMI T, 1993, JNCI-J NATL CANCER I, V85, P2018, DOI 10.1093/jnci/85.24.2018; Nikolaev SI, 2012, NAT GENET, V44, P133, DOI 10.1038/ng.1026; Pao W, 2005, PLOS MED, V2, P57, DOI 10.1371/journal.pmed.0020017; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Pao W, 2012, NAT MED, V18, P349, DOI 10.1038/nm.2697; Pao W, 2010, NAT REV CANCER, V10, P760, DOI 10.1038/nrc2947; Pearce LR, 2010, NAT REV MOL CELL BIO, V11, P9, DOI 10.1038/nrm2822; Pines G, 2010, ONCOGENE, V29, P5850, DOI 10.1038/onc.2010.313; Sanchez-Cespedes M, 2002, CANCER RES, V62, P3659; Schuster-Bockler B, 2012, NATURE, V488, P504, DOI 10.1038/nature11273; SLEBOS RJC, 1991, J NATL CANCER I, V83, P1024, DOI 10.1093/jnci/83.14.1024; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; Takeuchi K, 2012, NAT MED, V18, P378, DOI 10.1038/nm.2658; Tanaka H, 2007, CANCER RES, V67, P6007, DOI 10.1158/0008-5472.CAN-06-4774; Totoki Y, 2011, NAT GENET, V43, P464, DOI 10.1038/ng.804; Travis WD, 2002, CLIN CHEST MED, V23, P65, DOI 10.1016/S0272-5231(03)00061-3; Weir BA, 2007, NATURE, V450, P893, DOI 10.1038/nature06358; Wheeler M, 2001, MOL CELL BIOL, V21, P6660, DOI 10.1128/MCB.21.19.6660-6667.2001; World Health Organization, 2012, CANCER; Yoshida K, 2011, NATURE, V478, P64, DOI 10.1038/nature10496; Yuza Y, 2007, CANCER BIOL THER, V6, P661, DOI 10.4161/cbt.6.5.4003; Zang ZJ, 2012, NAT GENET, V44, P570, DOI 10.1038/ng.2246	56	1294	1338	5	150	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 14	2012	150	6					1107	1120		10.1016/j.cell.2012.08.029	http://dx.doi.org/10.1016/j.cell.2012.08.029			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	007ZY	22980975	Green Accepted, Bronze, Green Published			2022-12-28	WOS:000308928100006
J	Birney, E				Birney, Ewan			Lessons for big-data projects	NATURE			English	Editorial Material									European Bioinformat Inst, European Mol Biol Labs, Hinxton, England	European Molecular Biology Laboratory (EMBL)	Birney, E (corresponding author), European Bioinformat Inst, European Mol Biol Labs, Hinxton, England.	birney@ebi.ac.uk		Birney, Ewan/0000-0001-8314-8497					0	66	71	0	250	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 6	2012	489	7414					49	51		10.1038/489049a	http://dx.doi.org/10.1038/489049a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999WW	22955613	Bronze			2022-12-28	WOS:000308347000033
J	Meddings, JA; Reichert, H; Rogers, MAM; Saint, S; Stephansky, J; McMahon, LF				Meddings, Jennifer A.; Reichert, Heidi; Rogers, Mary A. M.; Saint, Sanjay; Stephansky, Joe; McMahon, Laurence F., Jr.			Effect of Nonpayment for Hospital-Acquired, Catheter-Associated Urinary Tract Infection	ANNALS OF INTERNAL MEDICINE			English	Article							SAFETY-NET; MEDICARE POLICY; CARE; PREVENTION; PAYMENT; IMPACT; RISK	Background: Most (59% to 86%) hospital-acquired urinary tract infections (UTIs) are catheter-associated urinary tract infections (CAUTIs). As of 2008, claims data are used to deny payment for certain hospital-acquired conditions, including CAUTIs, and publicly report hospital performance. Objective: To examine rates of UTIs in adults that are coded in claims data as hospital-acquired and catheter-associated events and evaluate how often nonpayment for CAUTI lowers hospital payment. Design: Before-and-after study of all-payer cross-sectional claims data. Setting: 96 nonfederal acute care Michigan hospitals. Patients: Nonobstetric adults discharged in 2007 (n = 767 531) and 2009 (n = 781 343). Measurements: Hospital rates of UTIs (categorized as catheter-associated or hospital-acquired) and frequency of reduced payment for hospital-acquired CAUTIs. Results: Hospitals frequently requested payment for non-CAUTIs as secondary diagnoses: 10.0% (95% CI, 9.5% to 10.5%) of discharges in 2007 and 10.3% (CI, 9.8% to 10.9%) in 2009. Hospital rates of CAUTI were very low: 0.09% (CI, 0.06% to 0.12%) in 2007 and 0.14% (CI, 0.11% to 0.17%) in 2009. In 2009, 2.6% (CI, 1.6% to 3.6%) of hospital-acquired UTIs were described as CAUTIs. Nonpayment for hospital-acquired CAUTIs reduced payment for 25 of 781 343 (0.003%) hospitalizations in 2009. Limitations: Data are from only 1 state and involved only 1 year before and after nonpayment for complications. Hospital prevention practices were not examined. Conclusion: Catheter-associated UTI rates determined by claims data seem to be inaccurate and are much lower than expected from epidemiologic surveillance data. The financial impact of current nonpayment policy for hospital-acquired CAUTI is low. Claims data are currently not valid data sets for comparing hospital-acquired CAUTI rates for the purpose of public reporting or imposing financial incentives or penalties. Primary Funding Source: Blue Cross Blue Shield of Michigan Foundation.	Univ Michigan, Sch Med, Hosp Outcomes Program Excellence, Ann Arbor Vet Affairs Med Ctr, Ann Arbor, MI USA; Univ Michigan, Sch Publ Hlth, Ann Arbor, MI 48109 USA; Michigan Hlth & Hosp Assoc, Lansing, MI 48933 USA	University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; University of Michigan System; University of Michigan	Meddings, JA (corresponding author), Div Gen Med, N Campus Res Complex,2800 Plymouth Rd,Bldg 16,Roo, Ann Arbor, MI 48109 USA.	meddings@umich.edu	Saint, Sanjay/AAF-5126-2019	Rogers, Mary/0000-0001-5519-3223; Meddings, Jennifer/0000-0001-9503-0293	Blue Cross Blue Shield of Michigan Foundation [1452.11]; Agency for Healthcare Research and Quality [1R010HS018344-01A1, 1K08-HS019767- 01]; National Institute of Diabetes and Digestive and Kidney Diseases [R21-DK078717]; National Institute of Nursing Research [R01-NR010700]; National Institutes of Health Clinical Loan Repayment Program; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K08HS019767] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK078717] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCH [R01NR010700] Funding Source: NIH RePORTER	Blue Cross Blue Shield of Michigan Foundation; Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute of Nursing Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); National Institutes of Health Clinical Loan Repayment Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))	The study was funded by grant 1452.11 from the Blue Cross Blue Shield of Michigan Foundation. The authors were also supported by awards 1R010HS018344-01A1 (Dr. McMahon) and 1K08-HS019767- 01 (Dr. Meddings) from the Agency for Healthcare Research and Quality; award R21-DK078717 (Dr. Saint) from the National Institute of Diabetes and Digestive and Kidney Diseases; and award R01-NR010700 (Dr. Saint) from the National Institute of Nursing Research. Dr. Meddings is also a recipient of the National Institutes of Health Clinical Loan Repayment Program for 2009 to 2012.	[Anonymous], 2010, BLUE CROSS BLUE SHIE; [Anonymous], 2008, FED REGISTER, V73; Centers for Medicare and Medicaid Services (CMS) HHS, 2007, Fed Regist, V72, P47129; Centers for Medicare and Medicaid Services (CMS) HHS, 2011, Fed Regist, V76, P32816; Centers for Medicare & Medicaid Services (CMS) National Center for Health Statistics (NCHS), 2009, ICD 9 CM OFF GUID CO; Edwards JR, 2007, AM J INFECT CONTROL, V35, P290, DOI 10.1016/j.ajic.2007.04.001; Foxman B, 2002, AM J MED, V113, p5S; GARIBALDI RA, 1982, INFECT CONT HOSP EP, V3, P466, DOI 10.1017/S0195941700056599; Gaskin DJ, 2001, HEALTH SERV RES, V36, P25; Gould CV, 2010, INFECT CONT HOSP EP, V31, P319, DOI 10.1086/651091; Hadley J, 2004, HEALTH SERV RES, V39, P1527, DOI 10.1111/j.1475-6773.2004.00302.x; HALEY RW, 1981, AM J MED, V70, P947, DOI 10.1016/0002-9343(81)90561-1; Healthcare Cost and Utilization Project, 2012, OV STAT INP DAT SID; Hooton TM, 2010, CLIN INFECT DIS, V50, P625, DOI 10.1086/650482; Klevens RM, 2007, PUBLIC HEALTH REP, V122, P160, DOI 10.1177/003335490712200205; KRIEGER JN, 1983, J INFECT DIS, V148, P57, DOI 10.1093/infdis/148.1.57; Maki DG, 2001, EMERG INFECT DIS, V7, P342, DOI 10.3201/eid0702.010240; McHugh M, 2011, J HEALTH CARE POOR U, V22, P638, DOI 10.1353/hpu.2011.0058; McNair PD, 2009, HEALTH AFFAIR, V28, P1485, DOI 10.1377/hlthaff.28.5.1485; Meddings J, 2010, INFECT CONT HOSP EP, V31, P627, DOI 10.1086/652523; Pennsylvania Health Care Cost Containment Council, 2012, IMP HEALTHC ASS INF; Saint S, 1999, J AM GERIATR SOC, V47, P1453, DOI 10.1111/j.1532-5415.1999.tb01567.x; Saint S, 2002, ANN INTERN MED, V137, P125, DOI 10.7326/0003-4819-137-2-200207160-00012; Saint S, 2009, ANN INTERN MED, V150, P877, DOI 10.7326/0003-4819-150-12-200906160-00013; Stone Patricia W, 2011, Policy Polit Nurs Pract, V12, P73, DOI 10.1177/1527154411416129; Werner RM, 2008, JAMA-J AM MED ASSOC, V299, P2180, DOI 10.1001/jama.299.18.2180; 2008, FED REG, V73, P23547	27	53	52	0	12	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 4	2012	157	5					305	U33		10.7326/0003-4819-157-5-201209040-00003	http://dx.doi.org/10.7326/0003-4819-157-5-201209040-00003			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	000BM	22944872	Green Accepted			2022-12-28	WOS:000308361500001
J	Naidoo, K; Yende-Zuma, N; Padayatchi, N; Naidoo, K; Jithoo, N; Nair, G; Bamber, S; Gengiah, S; El-Sadr, WM; Friedland, G; Karim, SA				Naidoo, Kogieleum; Yende-Zuma, Nonhlanhla; Padayatchi, Nesri; Naidoo, Kasavan; Jithoo, Niraksha; Nair, Gonasagrie; Bamber, Sheila; Gengiah, Santhana; El-Sadr, Wafaa M.; Friedland, Gerald; Karim, Salim Abdool			The Immune Reconstitution Inflammatory Syndrome After Antiretroviral Therapy Initiation in Patients With Tuberculosis: Findings From the SAPiT Trial	ANNALS OF INTERNAL MEDICINE			English	Article							RISK-FACTORS; PARADOXICAL REACTIONS; SOUTH-AFRICA; HIV; INFECTIONS; DISEASE; DRUGS; AIDS	Background: Concerns about the immune reconstitution inflammatory syndrome (IRIS) remain a barrier to antiretroviral therapy (ART) initiation during antituberculosis treatment in co-infected patients. Objective: To assess IRIS incidence, severity, and outcomes relative to the timing of ART initiation in patients with HIV-related tuberculosis. Design: Randomized, open-label clinical trial. (ClinicalTrials. gov registration number: NCT00398996) Setting: An outpatient clinic in Durban, South Africa. Patients: 642 patients co-infected with HIV and tuberculosis. Measurements: In a secondary analysis of the SAPiT (Starting Antiretroviral Therapy at Three Points in Tuberculosis) trial, IRIS was assessed in patients randomly assigned to initiate ART within 4 weeks of tuberculosis treatment initiation (early integrated treatment group), within 4 weeks of completion of the intensive phase of tuberculosis treatment (late integrated treatment group), or within 4 weeks after tuberculosis therapy completion (sequential treatment group). The syndrome was defined as new-onset or worsening symptoms, signs, or radiographic manifestations temporally related to treatment initiation, accompanied by a treatment response. Severity of IRIS, hospitalization, and time to resolution were monitored. Results: Incidence of IRIS was 19.5 (n = 43), 7.5 (n = 18), and 8.1 (n = 19) per 100 person-years in the early integrated, late integrated, and sequential treatment groups, respectively. Among patients with a baseline CD4(+) count less than 0.050 x 10(9) cells/L, IRIS incidence was 45.5, 9.7, and 19.7 per 100 person-years in the early integrated, late integrated, and sequential treatment groups, respectively. Incidence of IRIS was higher in the early integrated treatment group than in the late integrated (incidence rate ratio, 2.6 [95% CI, 1.5 to 4.8]; P < 0.001) or sequential (incidence rate ratio, 2.4 [CI, 1.4 to 4.4]; P < 0.001) treatment groups. More severe IRIS cases occurred in the early integrated treatment group than in the other 2 groups (35% vs. 19%; P = 0.179), and patients in the early integrated treatment group had significantly higher hospitalization rates (42% vs. 14%; P = 0.007) and longer time to resolution (70.5 vs. 29.0 days; P = 0.001) than patients in the other 2 groups. Limitations: It was not possible to assess IRIS in more patients in the sequential treatment group (n = 74) than in the late integrated (n = 50) and early integrated (n = 32) treatment groups because of loss to follow-up, withdrawal, or death within 6 months of scheduled ART initiation. This study did not assess IRIS risk in nonambulatory patients or in those with extrapulmonary and smear-negative tuberculosis. Conclusion: Initiation of ART in early stages of tuberculosis treatment resulted in significantly higher IRIS rates, longer time to resolution, and more severe cases of IRIS requiring hospitalization. These findings are particularly relevant to patients initiating ART with a CD4(+) count less than 0.050 x 10(9) cells/L, given the increased survival benefit of early ART initiation in this group. Primary Funding Source: Comprehensive International Program of Research on AIDS.	[Naidoo, Kogieleum] Univ KwaZulu Natal, Doris Duke Med Res Inst, ZA-4013 Durban, South Africa; eThekwini Res Clin, ZA-4000 Durban, South Africa; Columbia Univ, New York, NY 10032 USA; Yale Univ, Sch Med, New Haven, CT 06510 USA	University of Kwazulu Natal; Columbia University; Yale University	Naidoo, K (corresponding author), Univ KwaZulu Natal, Doris Duke Med Res Inst, 2nd Floor,719 Umbilo Rd,Private Bag X7, ZA-4013 Durban, South Africa.	yende@ukzn.ac.za	Karim, Salim Abdool/P-3117-2019; Karim, Salim Safurdeen Abdool/N-5947-2013; Karim, Salim Abdool/AAE-7118-2019; padayatchi, nesri/Q-2780-2019; Gengiah, Santhana/AAH-6484-2019	Karim, Salim Abdool/0000-0002-4986-2133; Karim, Salim Safurdeen Abdool/0000-0002-4986-2133; padayatchi, nesri/0000-0003-2543-9071; Gengiah, Santhana/0000-0003-2890-7248; Naidoo, Kogieleum/0000-0002-8874-6661	National Institutes of Health [AI51794]; U.S. President's Emergency Plan for AIDS; CIPRA; Columbia University-Southern Africa Fogarty AIDS International Training and Research Program; Fogarty International Center of the National Institutes of Health [D43TW00231]; FOGARTY INTERNATIONAL CENTER [D43TW000231] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI051794] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. President's Emergency Plan for AIDS; CIPRA; Columbia University-Southern Africa Fogarty AIDS International Training and Research Program; Fogarty International Center of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The Centre for the AIDS Programme of Research in South Africa was established as part of the Comprehensive International Program of Research on AIDS (CIPRA) (grant AI51794) from the National Institutes of Health. The U.S. President's Emergency Plan for AIDS Relief funded the care of all of the participants in the trial. The Global Fund to Fight AIDS, Tuberculosis and Malaria funded the cost of the drugs used in the trial. The research infrastructure to conduct the trial, including the data management, laboratory, and pharmacy cores, was established through the CIPRA grant. Drs. Naidoo and Padayatchi were supported by the Columbia University-Southern Africa Fogarty AIDS International Training and Research Program, which is funded by the Fogarty International Center of the National Institutes of Health (grant D43TW00231).	Abdool-Karim SS, 2004, 17 INT AIDS C MEX CI, V18, P975; Blanc FX, 2011, NEW ENGL J MED, V365, P1471, DOI 10.1056/NEJMoa1013911; Breton G, 2004, CLIN INFECT DIS, V39, P1709, DOI 10.1086/425742; Burman W, 2007, INT J TUBERC LUNG D, V11, P1282; Calligaro G, 2011, CURR OPIN PULM MED, V17, P180, DOI 10.1097/MCP.0b013e328344f692; Chien JW, 1998, CHEST, V114, P933, DOI 10.1378/chest.114.3.933; Colebunders R, 2006, INT J TUBERC LUNG D, V10, P946; Department of Health Republic of South Africa, 2008, NAT TUB MAN GUID 200; Elston JWT, 2009, INT J STD AIDS, V20, P221, DOI 10.1258/ijsa.2008.008449; Fishman JE, 2000, AM J ROENTGENOL, V174, P43, DOI 10.2214/ajr.174.1.1740043; French M A, 2000, HIV Med, V1, P107, DOI 10.1046/j.1468-1293.2000.00012.x; French MA, 2009, CLIN INFECT DIS, V48, P101, DOI 10.1086/595006; Girardi E, 2001, J ACQ IMMUN DEF SYND, V26, P326, DOI 10.1097/00126334-200104010-00006; Havlir DV, 2011, NEW ENGL J MED, V365, P1482, DOI 10.1056/NEJMoa1013607; Huruy K, 2008, JPN J INFECT DIS, V61, P205; Karim SSA, 2011, NEW ENGL J MED, V365, P1492, DOI 10.1056/NEJMoa1014181; Karim SSA, 2010, NEW ENGL J MED, V362, P697, DOI 10.1056/NEJMoa0905848; Lawn SD, 2005, LANCET INFECT DIS, V5, P361, DOI 10.1016/S1473-3099(05)70140-7; Lawn SD, 2007, AIDS, V21, P335, DOI 10.1097/QAD.0b013e328011efac; Meintjes G, 2008, LANCET INFECT DIS, V8, P516, DOI 10.1016/S1473-3099(08)70184-1; Meintjes G, 2010, AIDS, V24, P2381, DOI 10.1097/QAD.0b013e32833dfc68; Murdoch DA, 2008, AIDS, V22, P601, DOI 10.1097/QAD.0b013e3282f4a607; Narita M, 1998, AM J RESP CRIT CARE, V158, P157, DOI 10.1164/ajrccm.158.1.9712001; Navas E, 2002, ARCH INTERN MED, V162, P97, DOI 10.1001/archinte.162.1.97; Piscitelli SC, 2001, NEW ENGL J MED, V344, P984, DOI 10.1056/NEJM200103293441307; Ratnam I, 2006, CLIN INFECT DIS, V42, P418, DOI 10.1086/499356; Shelburne SA, 2006, J ANTIMICROB CHEMOTH, V57, P167, DOI 10.1093/jac/dki444; Shelburne SA, 2005, AIDS, V19, P399, DOI 10.1097/01.aids.0000161769.06158.8a; Wendel KA, 2001, CHEST, V120, P193, DOI 10.1378/chest.120.1.193; World Health Organization, 2009, GLOB TUB CONTR EP ST	30	83	83	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 4	2012	157	5					313	U48		10.7326/0003-4819-157-5-201209040-00004	http://dx.doi.org/10.7326/0003-4819-157-5-201209040-00004			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	000BM	22944873	Green Accepted, Green Published			2022-12-28	WOS:000308361500002
J	Senthilan, PR; Piepenbrock, D; Ovezmyradov, G; Nadrowski, B; Bechstedt, S; Pauls, S; Winkler, M; Mobius, W; Howard, J; Gopfert, MC				Senthilan, Pingkalai R.; Piepenbrock, David; Ovezmyradov, Guvanch; Nadrowski, Bjoern; Bechstedt, Susanne; Pauls, Stephanie; Winkler, Margret; Moebius, Wiebke; Howard, Jonathon; Goepfert, Martin C.			Drosophila Auditory Organ Genes and Genetic Hearing Defects	CELL			English	Article							NOMPC TRP CHANNEL; OUTER HAIR-CELLS; PRONEURAL GENE; MECHANOSENSORY TRANSDUCTION; PHOTORECEPTOR CELLS; SIGNALING COMPLEX; COMPOUND EYE; PROTEIN; MELANOGASTER; EXPRESSION	The Drosophila auditory organ shares equivalent transduction mechanisms with vertebrate hair cells, and both are specified by atonal family genes. Using a whole-organ knockout strategy based on atonal, we have identified 274 Drosophila auditory organ genes. Only four of these genes had previously been associated with fly hearing, yet one in five of the genes that we identified has a human cognate that is implicated in hearing disorders. Mutant analysis of 42 genes shows that more than half of them contribute to auditory organ function, with phenotypes including hearing loss, auditory hypersusceptibility, and ringing ears. We not only discover ion channels and motors important for hearing, but also show that auditory stimulus processing involves chemoreceptor proteins as well as phototransducer components. Our findings demonstrate mechanosensory roles for ionotropic receptors and visual rhodopsins and indicate that different sensory modalities utilize common signaling cascades.	[Senthilan, Pingkalai R.; Piepenbrock, David; Ovezmyradov, Guvanch; Nadrowski, Bjoern; Pauls, Stephanie; Winkler, Margret; Goepfert, Martin C.] Univ Gottingen, Dept Cellular Neurobiol, D-37077 Gottingen, Germany; [Bechstedt, Susanne; Howard, Jonathon] Max Planck Inst Cell Biol & Genet, D-01307 Dresden, Germany; [Moebius, Wiebke] Max Planck Inst Expt Med, D-37075 Gottingen, Germany	University of Gottingen; Max Planck Society; Max Planck Society	Gopfert, MC (corresponding author), Univ Gottingen, Dept Cellular Neurobiol, Julia Lermontowa Weg 3, D-37077 Gottingen, Germany.	mgoepfe@gwdg.de	Senthilan, Pingkalai/A-9387-2019; 889, CRC/L-1607-2018; Howard, Jonathon/J-7492-2016; Senthilan, Pingkalai R/A-3466-2013; Howard, Jonathon/D-4229-2011	Senthilan, Pingkalai/0000-0003-3921-8886; 889, CRC/0000-0002-6678-3138; Howard, Jonathon/0000-0003-0086-1196; Senthilan, Pingkalai R/0000-0003-3921-8886; Howard, Jonathon/0000-0003-0086-1196; Kok, Kivanc/0000-0002-1502-1600; /0000-0002-2902-7165; Gopfert, Martin/0000-0001-8201-5334	International Graduate School in Genetics and Functional Genomics; German National Academic Foundation; Volkswagen Foundation; DFG [Go1092/1-1];  [SFB 889]	International Graduate School in Genetics and Functional Genomics; German National Academic Foundation; Volkswagen Foundation(Volkswagen); DFG(German Research Foundation (DFG)); 	We thank Claude Desplan, Roger Hardy, Charlotte Helfrich-Forster, Andrew Jarman, Bloomington Stock Centre, Exelixis Collection at Harvard Medical School, the Nippon Consortium, and Fly-Till for fly lines; BestGene, Inc. for fly injections; Steve Britt for antibodies; Thomas Effertz and Swantje Gratsch for help with physiology; and Matthias Schink and Torben Ruhwedel for technical support. This work was supported by the International Graduate School in Genetics and Functional Genomics (to P.R.S. and G.O.), the German National Academic Foundation (to D.P.), the Volkswagen Foundation (to B.N. and M.C.G.), the SFB 889 (A1 to M.C.G.) and a research grant from the DFG (Go1092/1-1, to M.C.G.).	Albert JT, 2007, CURR BIOL, V17, P1000, DOI 10.1016/j.cub.2007.05.004; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baker DA, 2007, J COMP NEUROL, V501, P756, DOI 10.1002/cne.21257; Bechstedt S, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1007; Bechstedt S, 2008, CURR BIOL, V18, pR869, DOI 10.1016/j.cub.2008.07.069; Bellen HJ, 2011, GENETICS, V188, P731, DOI 10.1534/genetics.111.126995; Benton R, 2009, CELL, V136, P149, DOI 10.1016/j.cell.2008.12.001; Bermingham NA, 1999, SCIENCE, V284, P1837, DOI 10.1126/science.284.5421.1837; BLOOMQUIST BT, 1988, CELL, V54, P723, DOI 10.1016/S0092-8674(88)80017-5; Cachero S, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000568; Carbon S, 2009, BIOINFORMATICS, V25, P288, DOI 10.1093/bioinformatics/btn615; Chevesich J, 1997, NEURON, V18, P95, DOI 10.1016/S0896-6273(01)80049-0; Chien S, 2002, NUCLEIC ACIDS RES, V30, P149, DOI 10.1093/nar/30.1.149; Chou WH, 1999, DEVELOPMENT, V126, P607; Cook B, 2008, NATURE, V452, P361, DOI 10.1038/nature06603; Cooper JL, 2008, FLY, V2, P300, DOI 10.4161/fly.7366; Dror AA, 2009, ANNU REV GENET, V43, P411, DOI 10.1146/annurev-genet-102108-134135; Eberl DF, 2007, INT J DEV BIOL, V51, P679, DOI 10.1387/ijdb.072364de; Eberl DF, 1997, P NATL ACAD SCI USA, V94, P14837, DOI 10.1073/pnas.94.26.14837; Eberl DF, 2000, J NEUROSCI, V20, P5981, DOI 10.1523/JNEUROSCI.20-16-05981.2000; Effertz T, 2011, CURR BIOL, V21, P592, DOI 10.1016/j.cub.2011.02.048; Fritzsch B, 2007, INT J DEV BIOL, V51, P663, DOI 10.1387/ijdb.072367bf; Gillespie PG, 2009, CELL, V139, P33, DOI 10.1016/j.cell.2009.09.010; Gopfert MC, 2006, NAT NEUROSCI, V9, P999, DOI 10.1038/nn1735; Gong ZF, 2004, J NEUROSCI, V24, P9059, DOI 10.1523/JNEUROSCI.1645-04.2004; Gopfert MC, 2001, NATURE, V411, P908, DOI 10.1038/35082144; Gupta BP, 1997, GENES CELLS, V2, P225, DOI 10.1046/j.1365-2443.1997.d01-312.x; Haeberle H, 2004, P NATL ACAD SCI USA, V101, P14503, DOI 10.1073/pnas.0406308101; HARDIE RC, 1992, NEURON, V8, P643, DOI 10.1016/0896-6273(92)90086-S; HARRIS WA, 1977, J GEN PHYSIOL, V69, P261, DOI 10.1085/jgp.69.3.261; Herrero J, 2003, NUCLEIC ACIDS RES, V31, P3461, DOI 10.1093/nar/gkg591; Hildebrand MS, 2008, MOL THER, V16, P224, DOI 10.1038/sj.mt.6300351; Hudspeth AJ, 2008, NEURON, V59, P530, DOI 10.1016/j.neuron.2008.07.012; JARMAN AP, 1995, DEVELOPMENT, V121, P2019; JARMAN AP, 1993, CELL, V73, P1307, DOI 10.1016/0092-8674(93)90358-W; JARMAN AP, 1994, NATURE, V369, P398, DOI 10.1038/369398a0; Kamikouchi A, 2009, NATURE, V458, P165, DOI 10.1038/nature07810; Kang LJ, 2010, NEURON, V67, P381, DOI 10.1016/j.neuron.2010.06.032; Kapushesky M, 2004, NUCLEIC ACIDS RES, V32, pW465, DOI 10.1093/nar/gkh470; Kavlie RG, 2010, GENETICS, V185, P177, DOI 10.1534/genetics.110.114009; KERNAN M, 1994, NEURON, V12, P1195, DOI 10.1016/0896-6273(94)90437-5; Kim J, 2003, NATURE, V424, P81, DOI 10.1038/nature01733; Laurencon A, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r195; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; Liu L, 2007, NATURE, V450, P294, DOI 10.1038/nature06223; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu QH, 2009, INTEGR COMP BIOL, V49, P674, DOI 10.1093/icb/icp072; Ma L, 2011, J CELL SCI, V124, P2622, DOI 10.1242/jcs.084798; McDermott BM, 2007, P NATL ACAD SCI USA, V104, P11820, DOI 10.1073/pnas.0704476104; MCKENNA MP, 1994, J BIOL CHEM, V269, P16340; Miron M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-333; MONTELL C, 1985, SCIENCE, V230, P1040, DOI 10.1126/science.3933112; Nadrowski B, 2008, CURR BIOL, V18, P1365, DOI 10.1016/j.cub.2008.07.095; Nelson HB, 1997, GENETICS, V147, P1783; Niemeyer BA, 1996, CELL, V85, P651, DOI 10.1016/S0092-8674(00)81232-5; Niwa N, 2004, NAT GENET, V36, P293, DOI 10.1038/ng1308; Okazaki Y, 2002, NATURE, V420, P563, DOI 10.1038/nature01266; Petit C, 2006, TRENDS MOL MED, V12, P57, DOI 10.1016/j.molmed.2005.12.006; Raybould NP, 2007, J PHYSIOL-LONDON, V579, P101, DOI 10.1113/jphysiol.2006.122929; Roche JP, 2005, AUDIOL NEURO-OTOL, V10, P310, DOI 10.1159/000087348; Rosenzweig M, 2008, P NATL ACAD SCI USA, V105, P14668, DOI 10.1073/pnas.0805041105; Sarpal R, 2003, CURR BIOL, V13, P1687, DOI 10.1016/j.cub.2003.09.025; Savary E, 2007, STEM CELLS, V25, P332, DOI 10.1634/stemcells.2006-0303; SCHAEFFER E, 1989, CELL, V57, P403, DOI 10.1016/0092-8674(89)90915-X; Schulz S, 1999, J BIOL CHEM, V274, P37605, DOI 10.1074/jbc.274.53.37605; Scott K, 1998, NATURE, V395, P805, DOI 10.1038/27448; Sharma Y, 2002, GENESIS, V34, P115, DOI 10.1002/gene.10127; Shen WL, 2011, SCIENCE, V331, P1333, DOI 10.1126/science.1198904; SHIEH BH, 1995, NEURON, V14, P201, DOI 10.1016/0896-6273(95)90255-4; Sidi S, 2003, SCIENCE, V301, P96, DOI 10.1126/science.1084370; Thisse B, 2004, ZFIN DIRECT DATA SUB; Tinevez JY, 2007, BIOPHYS J, V93, P4053, DOI 10.1529/biophysj.107.108498; Todi SV, 2005, CURR BIOL, V15, P862, DOI 10.1016/j.cub.2005.03.050; Vasiliauskas D, 2011, NATURE, V479, P108, DOI 10.1038/nature10451; Walker RG, 1996, P NATL ACAD SCI USA, V93, P2203, DOI 10.1073/pnas.93.5.2203; Walker RG, 2000, SCIENCE, V287, P2229, DOI 10.1126/science.287.5461.2229; Wang T, 2007, J CELL BIOL, V177, P305, DOI 10.1083/jcb.200610081; Weber T, 2003, P NATL ACAD SCI USA, V100, P7690, DOI 10.1073/pnas.1330557100; WELL D, 1995, NATURE, V374, P60, DOI 10.1038/374060a0; YAMADA T, 1990, SCIENCE, V248, P483, DOI 10.1126/science.2158671; YARFITZ S, 1991, NEURON, V7, P429, DOI 10.1016/0896-6273(91)90295-B; Yorozu S, 2009, NATURE, V458, P201, DOI 10.1038/nature07843; Zheng J, 2000, NATURE, V405, P149, DOI 10.1038/35012009	83	132	135	1	49	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 31	2012	150	5					1042	1054		10.1016/j.cell.2012.06.043	http://dx.doi.org/10.1016/j.cell.2012.06.043			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	001ZU	22939627	Bronze			2022-12-28	WOS:000308500200017
J	Palike, H; Lyle, MW; Nishi, H; Raffi, I; Ridgwell, A; Gamage, K; Klaus, A; Acton, G; Anderson, L; Backman, J; Baldauf, J; Beltran, C; Bohaty, SM; Bown, P; Busch, W; Channell, JET; Chun, COJ; Delaney, M; Dewangan, P; Dunkley Jones, T; Edgar, KM; Evans, H; Fitch, P; Foster, GL; Gussone, N; Hasegawa, H; Hathorne, EC; Hayashi, H; Herrle, JO; Holbourn, A; Hovan, S; Hyeong, K; Iijima, K; Ito, T; Kamikuri, S; Kimoto, K; Kuroda, J; Leon-Rodriguez, L; Malinverno, A; Moore, TC; Murphy, BH; Murphy, DP; Nakamura, H; Ogane, K; Ohneiser, C; Richter, C; Robinson, R; Rohling, EJ; Romero, O; Sawada, K; Scher, H; Schneider, L; Sluijs, A; Takata, H; Tian, J; Tsujimoto, A; Wade, BS; Westerhold, T; Wilkens, R; Williams, T; Wilson, PA; Yamamoto, Y; Yamamoto, S; Yamazaki, T; Zeebe, RE				Paelike, Heiko; Lyle, Mitchell W.; Nishi, Hiroshi; Raffi, Isabella; Ridgwell, Andy; Gamage, Kusali; Klaus, Adam; Acton, Gary; Anderson, Louise; Backman, Jan; Baldauf, Jack; Beltran, Catherine; Bohaty, Steven M.; Bown, Paul; Busch, William; Channell, Jim E. T.; Chun, Cecily O. J.; Delaney, Margaret; Dewangan, Pawan; Dunkley Jones, Tom; Edgar, Kirsty M.; Evans, Helen; Fitch, Peter; Foster, Gavin L.; Gussone, Nikolaus; Hasegawa, Hitoshi; Hathorne, Ed C.; Hayashi, Hiroki; Herrle, Jens O.; Holbourn, Ann; Hovan, Steve; Hyeong, Kiseong; Iijima, Koichi; Ito, Takashi; Kamikuri, Shin-ichi; Kimoto, Katsunori; Kuroda, Junichiro; Leon-Rodriguez, Lizette; Malinverno, Alberto; Moore, Ted C., Jr.; Murphy, Brandon H.; Murphy, Daniel P.; Nakamura, Hideto; Ogane, Kaoru; Ohneiser, Christian; Richter, Carl; Robinson, Rebecca; Rohling, Eelco J.; Romero, Oscar; Sawada, Ken; Scher, Howie; Schneider, Leah; Sluijs, Appy; Takata, Hiroyuki; Tian, Jun; Tsujimoto, Akira; Wade, Bridget S.; Westerhold, Thomas; Wilkens, Roy; Williams, Trevor; Wilson, Paul A.; Yamamoto, Yuhji; Yamamoto, Shinya; Yamazaki, Toshitsugu; Zeebe, Richard E.			A Cenozoic record of the equatorial Pacific carbonate compensation depth	NATURE			English	Article							ANTARCTIC GLACIATION; CALCITE COMPENSATION; ORGANIC-CARBON; MODEL; OCEAN; CYCLE; DIOXIDE; HISTORY; SR/CA; ONSET	Atmospheric carbon dioxide concentrations and climate are regulated on geological timescales by the balance between carbon input from volcanic and metamorphic outgassing and its removal by weathering feedbacks; these feedbacks involve the erosion of silicate rocks and organic-carbon-bearing rocks. The integrated effect of these processes is reflected in the calcium carbonate compensation depth, which is the oceanic depth at which calcium carbonate is dissolved. Here we present a carbonate accumulation record that covers the past 53 million years from a depth transect in the equatorial Pacific Ocean. The carbonate compensation depth tracks long-term ocean cooling, deepening from 3.0-3.5 kilometres during the early Cenozoic (approximately 55 million years ago) to 4.6 kilometres at present, consistent with an overall Cenozoic increase in weathering. We find large superimposed fluctuations in carbonate compensation depth during the middle and late Eocene. Using Earth system models, we identify changes in weathering and the mode of organic-carbon delivery as two key processes to explain these large-scale Eocene fluctuations of the carbonate compensation depth.	[Paelike, Heiko; Bohaty, Steven M.; Chun, Cecily O. J.; Edgar, Kirsty M.; Foster, Gavin L.; Murphy, Daniel P.; Rohling, Eelco J.; Wilson, Paul A.] Univ Southampton, Natl Oceanog Ctr Southampton, Southampton SO14 3ZH, Hants, England; [Lyle, Mitchell W.; Baldauf, Jack; Murphy, Daniel P.] Texas A&M Univ, Dept Oceanog, College Stn, TX 77840 USA; [Nishi, Hiroshi] Tohoku Univ, Tohoku Univ Museum, Ctr Acad Resources & Arch, Aoba Ku, Sendai, Miyagi 9808578, Japan; [Raffi, Isabella] Univ G DAnnunzio, DiGAT CeRS Geo, Dipartimento Geotecnol Ambiente & Terr, Chieti, Italy; [Ridgwell, Andy] Univ Bristol, Sch Geog Sci, Bristol BS8 1SS, Avon, England; [Gamage, Kusali; Klaus, Adam] Texas A&M Univ, Integrated Ocean Drilling Program, College Stn, TX 77845 USA; [Acton, Gary] Univ Calif Davis, Dept Geol, Davis, CA 95616 USA; [Anderson, Louise] Univ Leicester, Dept Geol, Leicester LE1 7RH, Leics, England; [Backman, Jan] Stockholm Univ, Dept Geol Sci, SE-10691 Stockholm, Sweden; [Beltran, Catherine] Univ Paris 06, ISTeP, UMR 7193, F-75252 Paris 05, France; [Bown, Paul] UCL, London WC1E 6BT, England; [Busch, William] Univ New Orleans, New Orleans, LA 70148 USA; [Channell, Jim E. T.] Univ Florida, Dept Geol Sci, Gainesville, FL 32611 USA; [Chun, Cecily O. J.; Herrle, Jens O.] Goethe Univ Frankfurt, Inst Geosci, D-60438 Frankfurt, Germany; [Chun, Cecily O. J.; Herrle, Jens O.] Biodivers & Climate Res Ctr BIK F, D-60325 Frankfurt, Germany; [Chun, Cecily O. J.; Herrle, Jens O.] Senckenberg Gesell Nat Forsch, D-60325 Frankfurt, Germany; [Delaney, Margaret; Murphy, Brandon H.] Univ Calif Santa Cruz, Santa Cruz, CA 95064 USA; [Dewangan, Pawan] Natl Inst Oceanog, Panaji 403004, Goa, India; [Dunkley Jones, Tom; Fitch, Peter] Univ London Imperial Coll Sci Technol & Med, Dept Earth Sci & Engn, London SW7 2AZ, England; [Dunkley Jones, Tom] Univ Birmingham, Sch Geog Earth & Environm Sci, Birmingham B15 2TT, W Midlands, England; [Edgar, Kirsty M.] Cardiff Univ, Sch Earth & Ocean Sci, Cardiff CF10 3AT, S Glam, Wales; [Evans, Helen; Malinverno, Alberto; Williams, Trevor] Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA; [Gussone, Nikolaus] Univ Munster, Inst Mineral, D-48149 Munster, Germany; [Hasegawa, Hitoshi] Hokkaido Univ, Grad Sch Sci, Dept Nat Hist Sci, Kita Ku, Sapporo, Hokkaido 0600810, Japan; [Hathorne, Ed C.] Helmholtz Ctr Ocean Res Kiel, GEOMAR, D-24148 Kiel, Germany; [Hayashi, Hiroki] Shimane Univ, Interdisciplinary Fac Sci & Engn, Matsue, Shimane 6908504, Japan; [Holbourn, Ann] Univ Kiel, Inst Geowissensch, D-24098 Kiel, Germany; [Hovan, Steve] Indiana Univ Penn, Dept Geosci, Indiana, PA 15705 USA; [Hyeong, Kiseong] Korea Ocean Res & Dev Inst, Deep Sea Resources Res Ctr, Seoul 425600, South Korea; [Iijima, Koichi] Japan Agcy Marine Earth Sci & Technol, Inst Biogeosci, Yokosuka, Kanagawa 2370061, Japan; [Ito, Takashi] Ibaraki Univ, Fac Educ, Mito, Ibaraki 3108512, Japan; [Kamikuri, Shin-ichi; Nakamura, Hideto; Sawada, Ken] Hokkaido Univ, Div Nat Hist Sci, Fac Sci, Kita Ku, Sapporo, Hokkaido 0600810, Japan; [Kamikuri, Shin-ichi; Yamamoto, Yuhji] Kochi Univ, Ctr Adv Marine Core Res, Kochi 7838502, Japan; [Kimoto, Katsunori] JAMSTEC, RIGC, Yokosuka, Kanagawa 2370061, Japan; [Kuroda, Junichiro] JAMSTEC, IFREE, Yokosuka, Kanagawa 2370061, Japan; [Leon-Rodriguez, Lizette] Rice Univ, Dept Earth Sci, Houston, TX 77005 USA; [Moore, Ted C., Jr.] Univ Michigan, Dept Geol Sci, Ann Arbor, MI 48109 USA; [Ogane, Kaoru] Tohoku Univ, Inst Geol & Paleontol, Aoba Ku, Sendai, Miyagi 9808578, Japan; [Ohneiser, Christian] Univ Otago, Dept Geol, Dunedin, New Zealand; [Richter, Carl] Univ Louisiana, Sch Geosci, Lafayette, LA 70504 USA; [Robinson, Rebecca] Univ Rhode Isl, Grad Sch Oceanog, Narragansett, RI 02882 USA; [Romero, Oscar] Univ Granada, Inst Andaluz Ciencias Tierra, Granada 18002, Spain; [Scher, Howie] Univ S Carolina, Dept Earth & Ocean Sci, Columbia, SC 29208 USA; [Schneider, Leah] Penn State Univ, Dept Geosci, University Pk, PA 16802 USA; [Sluijs, Appy] Univ Utrecht, Palaeobot & Palynol Lab, Fac Geosci, Dept Earth Sci, NL-3584 CD Utrecht, Netherlands; [Takata, Hiroyuki] Pusan Natl Univ, Div Earth Environm Syst, Coastal Environm Syst Sch BK21, Pusan 609735, South Korea; [Tian, Jun] Tongji Univ, State Key Lab Marine Geol, Shanghai 200092, Peoples R China; [Tsujimoto, Akira] Shimane Univ, Fac Educ, Matsue, Shimane 6908504, Japan; [Wade, Bridget S.] Texas A&M Univ, Dept Geol & Geophys, College Stn, TX 77843 USA; [Wade, Bridget S.] Univ Leeds, Sch Earth & Environm, Leeds LS2 9JT, W Yorkshire, England; [Westerhold, Thomas] Univ Bremen, Ctr Marine Environm Sci MARUM, D-28359 Bremen, Germany; [Wilkens, Roy] Univ Hawaii Manoa, Hawaii Inst Geophys & Planetol, Honolulu, HI 96822 USA; [Yamamoto, Shinya] Yamanashi Inst Environm Sci, Fujiyoshida, Yamanashi 4030005, Japan; [Yamazaki, Toshitsugu] AIST, Geol Survey Japan, Tsukuba, Ibaraki 3058567, Japan; [Zeebe, Richard E.] Univ Hawaii Manoa, Dept Oceanog, Sch Ocean & Earth Sci & Technol, Honolulu, HI 96822 USA	NERC National Oceanography Centre; University of Southampton; Texas A&M University System; Texas A&M University College Station; Tohoku University; G d'Annunzio University of Chieti-Pescara; University of Bristol; Texas A&M University System; Texas A&M University College Station; University of California System; University of California Davis; University of Leicester; Stockholm University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Sorbonne Universite; University of London; University College London; University of Louisiana System; University of New Orleans; State University System of Florida; University of Florida; Goethe University Frankfurt; Senckenberg Biodiversitat & Klima- Forschungszentrum (BiK-F); Senckenberg Gesellschaft fur Naturforschung (SGN); Senckenberg Gesellschaft fur Naturforschung (SGN); University of California System; University of California Santa Cruz; Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Institute of Oceanography (NIO); Imperial College London; University of Birmingham; Cardiff University; Columbia University; University of Munster; Hokkaido University; Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; Shimane University; University of Kiel; Pennsylvania State System of Higher Education (PASSHE); Indiana University of Pennsylvania; Korea Institute of Ocean Science & Technology (KIOST); Japan Agency for Marine-Earth Science & Technology (JAMSTEC); Ibaraki University; Hokkaido University; Kochi University; Japan Agency for Marine-Earth Science & Technology (JAMSTEC); Japan Agency for Marine-Earth Science & Technology (JAMSTEC); Rice University; University of Michigan System; University of Michigan; Tohoku University; University of Otago; University of Louisiana Lafayette; University of Rhode Island; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Andaluz de Ciencias de la Tierra (IACT); University of Granada; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Utrecht University; Pusan National University; Tongji University; Shimane University; Texas A&M University System; Texas A&M University College Station; University of Leeds; University of Bremen; University of Hawaii System; University of Hawaii Manoa; National Institute of Advanced Industrial Science & Technology (AIST); University of Hawaii System; University of Hawaii Manoa	Palike, H (corresponding author), Univ Southampton, Natl Oceanog Ctr Southampton, Waterfront Campus,European Way, Southampton SO14 3ZH, Hants, England.	hpaelike@marum.de	Murphy, Daniel/B-3156-2012; Ridgwell, Andy/AAD-9487-2021; Nakamura, Hideto/J-8400-2012; Wade, Bridget S/F-4987-2014; Moore, Theodore/N-8848-2014; Gamage, Kusali/ABE-8426-2021; Sluijs, Appy/B-3726-2009; Bown, Paul/C-5235-2011; Ohneiser, Christian/B-5797-2018; Raffi, Isabella/AAY-5505-2020; Westerhold, Thomas/D-4581-2011; Herrle, Jens O/B-9088-2008; Foster, Gavin/CAF-4654-2022; Kuroda, Junichiro/A-3007-2016; Jones, Tom Dunkley/A-8441-2008; Palike, Heiko/A-6560-2008; Sawada, Ken/AAL-2645-2021; Edgar, Kirsty/AAR-9052-2021; Foster, Gavin/W-5968-2019; Rohling, Eelco J/B-9736-2008; Yamamoto, Shinya/C-5134-2011; Hathorne, Ed/AAC-6315-2020; Acton, Gary/B-6108-2016; Scher, Howie/C-4927-2013	Ridgwell, Andy/0000-0003-2333-0128; Nakamura, Hideto/0000-0002-4450-2411; Wade, Bridget S/0000-0002-7245-8614; Moore, Theodore/0000-0003-4121-1325; Gamage, Kusali/0000-0002-9259-5165; Sluijs, Appy/0000-0003-2382-0215; Bown, Paul/0000-0001-6777-4463; Raffi, Isabella/0000-0002-5192-7477; Westerhold, Thomas/0000-0001-8151-4684; Foster, Gavin/0000-0003-3688-9668; Kuroda, Junichiro/0000-0002-2218-4854; Jones, Tom Dunkley/0000-0002-9518-8143; Palike, Heiko/0000-0003-3386-0923; Sawada, Ken/0000-0003-3298-5716; Edgar, Kirsty/0000-0001-7587-9951; Rohling, Eelco J/0000-0001-5349-2158; Yamamoto, Shinya/0000-0001-7938-1106; Hathorne, Ed/0000-0002-7813-2455; Scher, Howie/0000-0002-7778-6772; Robinson, Rebecca/0000-0002-8072-1603; Acton, Gary/0000-0002-3285-4022; , Nikolaus/0000-0002-3390-1118; Wilson, Paul/0000-0001-6425-8906; Malinverno, Alberto/0000-0003-4442-9055; Holbourn, Ann/0000-0002-3167-0862; Iijima, Koichi/0000-0001-9285-9143; Ohneiser, Christian/0000-0002-2781-2522; Yamamoto, Yuhji/0000-0001-9163-0339; Hayashi, Hiroki/0000-0002-7080-0885	Philip Leverhulme Prize; BIK-F; NERC [NE/H000089/1, NE/H020136/1, NE/G003270/1, NE/F003641/1, NE/H022554/1, NE/I006168/1]; NERC [NE/I000011/1, NE/G014817/1, NE/I005595/1, NE/H016457/1, NE/H001298/1, NE/H023852/1] Funding Source: UKRI; STFC [PP/D002176/1] Funding Source: UKRI; Natural Environment Research Council [NE/G003270/1, NE/H023852/1, NE/H000089/1, NE/H001298/1, NE/F003641/1, NE/I000011/1, NE/H020136/1, NE/I005595/1, NE/G014817/1, NE/H022554/1, NE/H016457/1, NE/I006168/1] Funding Source: researchfish; Science and Technology Facilities Council [PP/D002176/1] Funding Source: researchfish; Division Of Ocean Sciences [0960999, 0961412] Funding Source: National Science Foundation; Grants-in-Aid for Scientific Research [23740377] Funding Source: KAKEN	Philip Leverhulme Prize; BIK-F; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research used samples and data provided by IODP. We thank the masters and crew of IODP Expeditions 320 and 321. H. P. acknowledges support from the Philip Leverhulme Prize, the BIK-F, and NERC grants NE/H000089/1, NE/H020136/1, NE/G003270/1, NE/F003641/1, NE/H022554/1 and NE/I006168/1. We acknowledge the use of the IRIDIS High Performance Computing Facility, and associated support services at the University of Southampton, in the completion of this work. We thank M. Palmer and D. Teagle for discussions. E.J.R. is a Visiting Fellow at the Research School of Earth Sciences, The Australian National University.	[Anonymous], 2005, OCEAN DRILL PROG SCI; ARCHER D, 1991, J GEOPHYS RES-OCEANS, V96, P17037, DOI 10.1029/91JC01812; ARCHER D, 1994, NATURE, V367, P260, DOI 10.1038/367260a0; Armstrong RA, 2001, DEEP-SEA RES PT II, V49, P219, DOI 10.1016/S0967-0645(01)00101-1; Beerling DJ, 2011, NAT GEOSCI, V4, P418, DOI 10.1038/ngeo1186; BERNER RA, 1983, AM J SCI, V283, P641, DOI 10.2475/ajs.283.7.641; Bohaty SM, 2009, PALEOCEANOGRAPHY, V24, DOI 10.1029/2008PA001676; Broecker WS, 1987, GLOBAL BIOGEOCHEM CY, V1, P15, DOI 10.1029/GB001i001p00015; Coggon RM, 2010, SCIENCE, V327, P1114, DOI 10.1126/science.1182252; Coxall HK, 2005, NATURE, V433, P53, DOI 10.1038/nature03135; Edgar KM, 2007, NATURE, V448, P908, DOI 10.1038/nature06053; EDMOND JM, 1992, SCIENCE, V258, P1594, DOI 10.1126/science.258.5088.1594; Heath G. R., 1975, GEOL SOC AM MEM, V143, P1, DOI [10.1130/MEM143-p1, DOI 10.1130/MEM143-P1]; Lear CH, 2003, EARTH PLANET SC LETT, V208, P69, DOI 10.1016/S0012-821X(02)01156-1; Leon-Rodriguez L, 2010, PALAEOGEOGR PALAEOCL, V298, P409, DOI 10.1016/j.palaeo.2010.10.029; LYLE AO, 2005, P OC DRILL PROGR SCI, V0199; Lyle AO, 2006, PALEOCEANOGRAPHY, V21, DOI 10.1029/2005PA001230; Lyle M, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2002PA000777; Lyle M., 1995, 1995 P OC DRILL PROG, V138, DOI [DOI 10.2973/0DP.PR0C.SR.138.157.1995, 10.2973/odp.proc.sr.138.157.1995]; Lyle M, 2008, REV GEOPHYS, V46, DOI 10.1029/2005RG000190; Merico A, 2008, NATURE, V452, P979, DOI 10.1038/nature06853; Misra S, 2012, SCIENCE, V335, P818, DOI 10.1126/science.1214697; Moore TC, 2008, PALEOCEANOGRAPHY, V23, DOI 10.1029/2007PA001514; Pagani M, 2011, SCIENCE, V334, P1261, DOI 10.1126/science.1203909; Palike H., 2010, P INTEGR OCEAN DRILL, V320, P1, DOI [10.2204/iodp.proc.320321.101.2010, DOI 10.2204/IODP.PROC.320321.101]; Panchuk K, 2008, GEOLOGY, V36, P315, DOI 10.1130/G24474A.1; PETERSON LS, 1990, P OCEAN DRILLING PRO, V0115; Peucker-Ehrenbrink B, 2000, TERRA NOVA, V12, P205, DOI 10.1046/j.1365-3121.2000.00295.x; Ridgwell A, 2007, BIOGEOSCIENCES, V4, P87, DOI 10.5194/bg-4-87-2007; Ridgwell A, 2005, EARTH PLANET SC LETT, V234, P299, DOI 10.1016/j.epsl.2005.03.006; Ridgwell AJ, 2003, GEOCHEM GEOPHY GEOSY, V4, DOI 10.1029/2003GC000512; Ridgwell A, 2010, NAT GEOSCI, V3, P196, DOI 10.1038/NGEO755; Spofforth DJA, 2010, PALEOCEANOGRAPHY, V25, DOI 10.1029/2009PA001738; Stuecker MF, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2009GL041436; Tyrrell T, 2004, GEOCHIM COSMOCHIM AC, V68, P3521, DOI 10.1016/j.gca.2004.02.018; Uchikawa J, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL035963; Westerhold T, 2012, IODP P, V320/321, P1, DOI DOI 10.2204/IODP.PROC.320321; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412; Zachos JC, 2008, NATURE, V451, P279, DOI 10.1038/nature06588; Zeebe RE, 2012, GEOSCI MODEL DEV, V5, P149, DOI 10.5194/gmd-5-149-2012	40	233	244	14	320	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 30	2012	488	7413					609	+		10.1038/nature11360	http://dx.doi.org/10.1038/nature11360			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996NC	22932385	Green Published, Green Submitted			2022-12-28	WOS:000308095100047
J	Stanley, M				Stanley, Margaret			PERSPECTIVE Vaccinate boys too	NATURE			English	Editorial Material									Univ Cambridge, Dept Pathol, Cambridge CB2 1TN, England	University of Cambridge	Stanley, M (corresponding author), Univ Cambridge, Dept Pathol, Cambridge CB2 1TN, England.	mas1001@cam.ac.uk						Chaturvedi AK, 2011, J CLIN ONCOL, V29, P4294, DOI 10.1200/JCO.2011.36.4596; de Martel C, 2012, LANCET ONCOL, V13, DOI 10.1016/S1470-2045(12)70137-7; Frisch M, 2002, DAN MED BULL, V49, P194; Garnett GP, 2005, J INFECT DIS, V191, pS97, DOI 10.1086/425271; Hartwig S, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-30; Kim JJ, 2011, NEW ENGL J MED, V364, P393, DOI 10.1056/NEJMp1012246	6	34	37	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 30	2012	488	7413					S10	S10		10.1038/488S10a	http://dx.doi.org/10.1038/488S10a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	996NC	22932433	Bronze			2022-12-28	WOS:000308095100008
J	Yeboah, J; McClelland, RL; Polonsky, TS; Burke, GL; Sibley, CT; O'Leary, D; Carr, JJ; Goff, DC; Greenland, P; Herrington, DM				Yeboah, Joseph; McClelland, Robyn L.; Polonsky, Tamar S.; Burke, Gregory L.; Sibley, Christopher T.; O'Leary, Daniel; Carr, Jeffery J.; Goff, David C., Jr.; Greenland, Philip; Herrington, David M.			Comparison of Novel Risk Markers for Improvement in Cardiovascular Risk Assessment in Intermediate-Risk Individuals	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORONARY-HEART-DISEASE; INTIMA-MEDIA THICKNESS; ANKLE-BRACHIAL INDEX; C-REACTIVE PROTEIN; ATHEROSCLEROSIS; PREDICTION; EVENTS; ADULTS; SCORE; CLASSIFICATION	Context Risk markers including coronary artery calcium, carotid intima-media thickness, ankle-brachial index, brachial flow-mediated dilation, high-sensitivity C-reactive protein (CRP), and family history of coronary heart disease (CHD) have been reported to improve on the Framingham Risk Score (FRS) for prediction of CHD, but there are no direct comparisons of these markers for risk prediction in a single cohort. Objective We compared improvement in prediction of incident CHD/cardiovascular disease (CVD) of these 6 risk markers within intermediate-risk participants (FRS >5%-<20%) in the Multi-Ethnic Study of Atherosclerosis (MESA). Design, Setting, and Participants Of 6814 MESA participants from 6 US field centers, 1330 were intermediate risk, without diabetes mellitus, and had complete data on all 6 markers. Recruitment spanned July 2000 to September 2002, with follow-up through May 2011. Probability-weighted Cox proportional hazard models were used to estimate hazard ratios (HRs). Area under the receiver operator characteristic curve (AUC) and net reclassification improvement were used to compare incremental contributions of each marker when added to the FRS, plus race/ethnicity. Main Outcome Measures Incident CHD defined as myocardial infarction, angina followed by revascularization, resuscitated cardiac arrest, or CHD death. Incident CVD additionally included stroke or CVD death. Results After 7.6-year median follow-up (IQR, 7.3-7.8), 94 CHD and 123 CVD events occurred. Coronary artery calcium, ankle-brachial index, high-sensitivity CRP, and family history were independently associated with incident CHD in multivariable analyses (HR, 2.60 [95% CI, 1.94-3.50]; HR, 0.79 [95% CI, 0.66-0.95]; HR, 1.28 [95% CI, 1.00-1.64]; and HR, 2.18 [95% CI, 1.38-3.42], respectively). Carotid intima-media thickness and brachial flow-mediated dilation were not associated with incident CHD in multivariable analyses (HR, 1.17 [95% CI, 0.95-1.45] and HR, 0.95 [95% CI, 0.78-1.14]). Although addition of the markers individually to the FRS plus race/ethnicity improved AUC, coronary artery calcium afforded the highest increment (0.623 vs 0.784), while brachial flow-mediated dilation had the least (0.623 vs 0.639). For incident CHD, the net reclassification improvement with coronary artery calcium was 0.659, brachial flow-mediated dilation was 0.024, ankle-brachial index was 0.036, carotid intima-media thickness was 0.102, family history was 0.160 and high-sensitivity CRP was 0.079. Similar results were obtained for incident CVD. Conclusions Coronary artery calcium, ankle-brachial index, high-sensitivity CRP, and family history were independent predictors of incident CHD/CVD in intermediate-risk individuals. Coronary artery calcium provided superior discrimination and risk reclassification compared with other risk markers. JAMA. 2012;308(8):788-795 www.jama.com	[Yeboah, Joseph] Wake Forest Univ, Wake Forest Baptist Hlth, Dept Internal Med Cardiol, Sch Med, Winston Salem, NC 27157 USA; [Carr, Jeffery J.] Wake Forest Univ, Sch Med, Dept Radiol, Winston Salem, NC 27157 USA; [Burke, Gregory L.; Carr, Jeffery J.] Wake Forest Univ, Sch Med, Div Publ Hlth Sci, Winston Salem, NC 27157 USA; [McClelland, Robyn L.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Polonsky, Tamar S.] Univ Chicago, Cardiol Sect, Dept Internal Med, Chicago, IL 60637 USA; [Sibley, Christopher T.] NIH, Bethesda, MD 20892 USA; [O'Leary, Daniel] Tufts Med Ctr, Brookline, MA USA; [Goff, David C., Jr.] Univ Colorado, Sch Publ Hlth, Aurora, CO USA; [Greenland, Philip] Northwestern Univ, Dept Prevent Med, Feinberg Sch Med, Chicago, IL 60611 USA	Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest University; University of Washington; University of Washington Seattle; University of Chicago; National Institutes of Health (NIH) - USA; Tufts Medical Center; Colorado School of Public Health; University of Colorado System; University of Colorado Anschutz Medical Campus; Northwestern University; Feinberg School of Medicine	Yeboah, J (corresponding author), Wake Forest Univ, Wake Forest Baptist Hlth, Dept Internal Med Cardiol, Sch Med, Med Ctr Blvd, Winston Salem, NC 27157 USA.	jyeboah@wakehealth.edu	Carr, John Jeffrey/A-1938-2012; Greenland, Philip/ABD-5528-2021; Sibley, Christopher T/C-9900-2013; Carr, John/AAN-7531-2021	Carr, John Jeffrey/0000-0002-4398-8237; Carr, John/0000-0002-4398-8237	National Institutes of Health (NIH); National Heart, Lung, and Blood Institute (NHLBI); NIH/NHLBI; Merck Co; NIH;  [N01-HC-95159];  [N01-HC-95160];  [N01-HC-95161];  [N01-HC-95162];  [N01-HC-95163];  [N01-HC-95164];  [N01-HC-95165];  [N01-HC-95166];  [N01-HC-95167];  [R01HL098445]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC095160, N01HC095161, N01HC095166, N01HC095165, N01HC095159, N01HC095164, N01HC095167, N01HC095162, N01HC095163] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL098445, R21HL095165, R43HL095167] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Merck Co(Merck & Company); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; ; ; ; ; ; ; ; ; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Dr McClelland reports receipt of an institutional grant or pending grant from the National Institutes of Health (NIH) for contracts that fund the Multi-Ethnic Study of Atherosclerosis (MESA) study. Dr Burke reports receipt of an institutional grant from the National Heart, Lung, and Blood Institute (NHLBI). Dr O'Leary reports receipt of an institutional grant and support (to the institution) for travel to meetings for the study or other purposes from NIH. Dr Carr reports receiptof an institutional grant from NIH/NHLBI and receipt of consultancy fees from Merck & Co. Dr Goff reports receipt of an institutional grant and support (to the institution) for travel to meetings for the study or other purposes from NHLBI, board membership on the data and safety monitoring committee for a clinical trial from Takeda, and receipt of consultancy (operations committee member for a clinical trial) fees from Merck & Co. Dr Greenland reports receipt of an institutional grant and support (to the institution) for travel to meetings for the study or other purposes) from NHLBI, receipt of a grant or pending grant from NIH, and payment for lectures including service on speakers bureaus from univeristies and NIH, Dr Herrington reports receipt of an institutional grant from NIH. Drs Yeboah, Polonsky, and Sibley report no disclosures. All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest.; This research was supported by contracts N01-HC-95159. 60, 61, 62, 63, 64, 65, 66, and N01-HC-95167 and Diversity Supplement R01HL098445 (primary investigator, Dr Carr). A full list of participating MESA investigators and institutions can be found at http://www.mesa-nhlbi.org.	AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; Bild DE, 2002, AM J EPIDEMIOL, V156, P871, DOI 10.1093/aje/kwf113; Carr JJ, 2005, RADIOLOGY, V234, P35, DOI 10.1148/radiol.2341040439; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Collins GS, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2584; Criqui MH, 2010, J AM COLL CARDIOL, V56, P1506, DOI 10.1016/j.jacc.2010.04.060; de Gonzalez AB, 2009, ARCH INTERN MED, V169, P2071, DOI 10.1001/archinternmed.2009.440; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Ford ES, 2004, J AM COLL CARDIOL, V43, P1791, DOI 10.1016/j.jacc.2003.11.061; Fowkes FGR, 2008, JAMA-J AM MED ASSOC, V300, P197, DOI 10.1001/jama.300.2.197; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Greenland P, 2010, CIRCULATION, V122, pE584, DOI 10.1161/CIR.0b013e3182051b4c; Hayward RA, 2010, ANN INTERN MED, V152, P69, DOI 10.7326/0003-4819-152-2-201001190-00004; Hlatky Mark A, 2009, Circulation, V119, P2408, DOI 10.1161/CIRCULATIONAHA.109.192278; Kavousi M, 2012, ANN INTERN MED, V156, P438, DOI 10.7326/0003-4819-156-6-201203200-00006; Kim KP, 2009, ARCH INTERN MED, V169, P1188, DOI 10.1001/archinternmed.2009.162; Nambi V, 2010, J AM COLL CARDIOL, V55, P1600, DOI 10.1016/j.jacc.2009.11.075; Pencina MJ, 2010, CLIN CHEM LAB MED, V48, P1703, DOI 10.1515/CCLM.2010.340; Polak JF, 2011, STROKE, V42, P3017, DOI 10.1161/STROKEAHA.111.625186; Polonsky TS, 2010, JAMA-J AM MED ASSOC, V303, P1610, DOI 10.1001/jama.2010.461; Ridker PM, 2007, JAMA-J AM MED ASSOC, V297, P611, DOI 10.1001/jama.297.6.611; Ridker PM, 2008, CIRCULATION, V118, P2243, DOI 10.1161/CIRCULATIONAHA.108.814251; Sivapalaratnam S, 2010, HEART, V96, P1985, DOI 10.1136/hrt.2010.210740; Voros S, 2011, J CARDIOVASC COMPUT, V5, P75, DOI 10.1016/j.jcct.2011.01.003; Wilson PWF, 2008, CIRC-CARDIOVASC QUAL, V1, P92, DOI 10.1161/CIRCOUTCOMES.108.831198; Yeboah J, 2009, CIRCULATION, V120, P502, DOI 10.1161/CIRCULATIONAHA.109.864801	26	757	774	1	53	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 22	2012	308	8					788	795		10.1001/jama.2012.9624	http://dx.doi.org/10.1001/jama.2012.9624			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	991ML	22910756	Green Accepted			2022-12-28	WOS:000307705300022
J	Bhatt, DL				Bhatt, Deepak L.			EXAMINATION of new drug-eluting stents-top of the class!	LANCET			English	Editorial Material							METAL CORONARY STENTS; RANDOMIZED-TRIALS; LATE THROMBOSIS; FOLLOW-UP; RESTENOSIS; METAANALYSIS; OUTCOMES; THERAPY		[Bhatt, Deepak L.] Brigham & Womens Hosp, VA Boston Healthcare Syst, Boston, MA 02132 USA; [Bhatt, Deepak L.] Harvard Univ, Sch Med, Boston, MA 02132 USA	Harvard University; Brigham & Women's Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Boston Healthcare System; Harvard University; Harvard Medical School	Bhatt, DL (corresponding author), Brigham & Womens Hosp, VA Boston Healthcare Syst, Boston, MA 02132 USA.	dlbhattmd@post.harvard.edu						Bangalore S, 2012, CIRCULATION, V125, P2873, DOI 10.1161/CIRCULATIONAHA.112.097014; Bavry AA, 2008, LANCET, V371, P2134, DOI 10.1016/S0140-6736(08)60922-8; Bavry AA, 2006, AM J MED, V119, P1056, DOI 10.1016/j.amjmed.2006.01.023; Boden WE, 2007, NEW ENGL J MED, V356, P1503, DOI 10.1056/NEJMoa070829; Chen MS, 2006, AM HEART J, V151, P1260, DOI 10.1016/j.ahj.2005.08.011; De Luca G, 2012, ARCH INTERN MED, V172, P611, DOI 10.1001/archinternmed.2012.758; Doyle B, 2007, CIRCULATION, V116, P2391, DOI 10.1161/CIRCULATIONAHA.107.707331; McFadden EP, 2004, LANCET, V364, P1519, DOI 10.1016/S0140-6736(04)17275-9; Palmerini T, 2012, LANCET, V379, P1393, DOI 10.1016/S0140-6736(12)60324-9; Sabate M, 2012, LANCET; Sarkees ML, 2009, CARDIOVASC REVASCULA, V10, P58, DOI 10.1016/j.carrev.2008.04.003; Sarno G, 2012, EUR HEART J, V33, P606, DOI 10.1093/eurheartj/ehr479; Walters DL, 2002, AM J CARDIOL, V89, P491, DOI 10.1016/S0002-9149(01)02285-8	13	27	28	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 27	2012	380	9852					1453	1455		10.1016/S0140-6736(12)61021-6	http://dx.doi.org/10.1016/S0140-6736(12)61021-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	026JJ	22951304				2022-12-28	WOS:000310272000007
J	Taylor, CM; de Jeu, RAM; Guichard, F; Harris, PP; Dorigo, WA				Taylor, Christopher M.; de Jeu, Richard A. M.; Guichard, Francoise; Harris, Phil P.; Dorigo, Wouter A.			Afternoon rain more likely over drier soils	NATURE			English	Article							BOUNDARY LAYER INTERACTIONS; PART II; ATMOSPHERIC CONTROLS; DIURNAL CYCLE; UNITED-STATES; MOISTURE; PRECIPITATION; LAND; CONVECTION; FEEDBACK	Land surface properties, such as vegetation cover and soil moisture, influence the partitioning of radiative energy between latent and sensible heat fluxes in daytime hours. During dry periods, soil-water deficit can limit evapotranspiration, leading to warmer and drier conditions in the lower atmosphere(1,2). Soil moisture can influence the development of convective storms through such modifications of low-level atmospheric temperature and humidity(1,3), which in turn feeds back on soil moisture. Yet there is considerable uncertainty in how soil moisture affects convective storms across the world, owing to a lack of observational evidence and uncertainty in large-scale models(4). Here we present a global-scale observational analysis of the coupling between soil moisture and precipitation. We show that across all six continents studied, afternoon rain falls preferentially over soils that are relatively dry compared to the surrounding area. The signal emerges most clearly in the observations over semi-arid regions, where surface fluxes are sensitive to soil moisture, and convective events are frequent. Mechanistically, our results are consistent with enhanced afternoon moist convection driven by increased sensible heat flux over drier soils, and/or mesoscale variability in soil moisture. We find no evidence in our analysis of a positive feedback-that is, a preference for rain over wetter soils-at the spatial scale (50-100 kilometres) studied. In contrast, we find that a positive feedback of soil moisture on simulated precipitation does dominate in six state-of-the-art global weather and climate models-a difference that may contribute to excessive simulated droughts in large-scale models.	[Taylor, Christopher M.; Harris, Phil P.] NERC Ctr Ecol & Hydrol, Wallingford OX10 8BB, Oxon, England; [de Jeu, Richard A. M.] Vrije Univ Amsterdam, Dept Earth Sci, Fac Earth & Life Sci, NL-1081 HV Amsterdam, Netherlands; [Guichard, Francoise] CNRM GAME CNRS, F-31057 Toulouse, France; [Guichard, Francoise] Meteo France, F-31057 Toulouse, France; [Dorigo, Wouter A.] Vienna Univ Technol, Inst Photogrammetry & Remote Sensing IPF, A-1040 Vienna, Austria	UK Centre for Ecology & Hydrology (UKCEH); Vrije Universiteit Amsterdam; Centre National de la Recherche Scientifique (CNRS); Technische Universitat Wien	Taylor, CM (corresponding author), NERC Ctr Ecol & Hydrol, Maclean Bldg,Benson Lane, Wallingford OX10 8BB, Oxon, England.	cmt@ceh.ac.uk	Taylor, Christopher/Y-7529-2019; Taylor, Chris/K-2319-2012; Dorigo, Wouter A/C-7794-2014; de Jeu, Richard/AAE-6922-2019; Harris, Phil P/A-1933-2010	Taylor, Chris/0000-0002-0120-3198; Dorigo, Wouter A/0000-0001-8054-7572; Harris, Phil P/0000-0002-4834-7746	European Union (FP6) WATCH Integrated Project [036946]; UK National Centre for Earth Observation; European Space Agency STSE Water Cycle Multi-mission Observation Strategy (WACMOS) project (ESRIN) [22086/08/I-EC]; NERC [NE/G018499/1, earth010002] Funding Source: UKRI; Natural Environment Research Council [earth010002, NE/G018499/1, NE/B505538/1, ceh010023] Funding Source: researchfish	European Union (FP6) WATCH Integrated Project; UK National Centre for Earth Observation; European Space Agency STSE Water Cycle Multi-mission Observation Strategy (WACMOS) project (ESRIN); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This research was partly funded by the European Union (FP6) WATCH Integrated Project (contract 036946), the UK National Centre for Earth Observation and the European Space Agency STSE Water Cycle Multi-mission Observation Strategy (WACMOS) project (ESRIN/contract number 22086/08/I-EC. We thank A. Beljaars, S. Seneviratne and D. Parker for discussions on this topic. We also thank the CMORPH, TRMM, PERSIANN and GPROF teams for the provision of their precipitation data, the World Climate Research Programme's Working Group on Coupled Modelling, and the centres who provided modelling data in Figure 3.	ANTHES RA, 1984, J CLIM APPL METEOROL, V23, P541, DOI 10.1175/1520-0450(1984)023<0541:EOCPBM>2.0.CO;2; Bartalis Z, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL031088; Betts AK, 1998, J ATMOS SCI, V55, P1091, DOI 10.1175/1520-0469(1998)055<1091:FSCASA>2.0.CO;2; Carleton AM, 2008, J CLIMATE, V21, P3617, DOI 10.1175/2007JCLI1584.1; Cheng WYY, 2004, J HYDROMETEOROL, V5, P934, DOI 10.1175/1525-7541(2004)005<0934:SOACSO>2.0.CO;2; Dai A, 2006, J CLIMATE, V19, P4605, DOI 10.1175/JCLI3884.1; Ek MB, 2004, J HYDROMETEOROL, V5, P86, DOI 10.1175/1525-7541(2004)005<0086:IOSMOB>2.0.CO;2; Eltahir EAB, 1998, WATER RESOUR RES, V34, P765, DOI 10.1029/97WR03499; Ferguson CR, 2011, J HYDROMETEOROL, V12, P1221, DOI 10.1175/2011JHM1380.1; Findell KL, 2011, NAT GEOSCI, V4, P434, DOI [10.1038/NGEO1174, 10.1038/ngeo1174]; Findell KL, 1997, WATER RESOUR RES, V33, P725, DOI 10.1029/96WR03756; Findell KL, 2003, J HYDROMETEOROL, V4, P570, DOI 10.1175/1525-7541(2003)004<0570:ACOSML>2.0.CO;2; Findell KL, 2003, J HYDROMETEOROL, V4, P552, DOI 10.1175/1525-7541(2003)004<0552:ACOSML>2.0.CO;2; Fischer EM, 2007, J CLIMATE, V20, P5081, DOI 10.1175/JCLI4288.1; Goessling HF, 2011, HYDROL EARTH SYST SC, V15, P3217, DOI 10.5194/hess-15-3217-2011; Guichard F, 2004, Q J ROY METEOR SOC, V130, P3139, DOI 10.1256/qj.03.145; Guo ZC, 2006, J HYDROMETEOROL, V7, P611, DOI 10.1175/JHM511.1; Hohenegger C, 2009, J CLIMATE, V22, P5003, DOI 10.1175/2009JCLI2604.1; Joyce RJ, 2004, J HYDROMETEOROL, V5, P487, DOI 10.1175/1525-7541(2004)005<0487:CAMTPG>2.0.CO;2; Koster RD, 2004, SCIENCE, V305, P1138, DOI 10.1126/science.1100217; McCrary RR, 2010, J CLIMATE, V23, P2178, DOI 10.1175/2009JCLI3061.1; OOKOUCHI Y, 1984, MON WEATHER REV, V112, P2281, DOI 10.1175/1520-0493(1984)112<2281:EOSMEO>2.0.CO;2; Owe M, 2008, J GEOPHYS RES-EARTH, V113, DOI 10.1029/2007JF000769; Santanello JA, 2011, J HYDROMETEOROL, V12, P766, DOI 10.1175/JHM-D-10-05014.1; Taylor CM, 2011, NAT GEOSCI, V4, P430, DOI 10.1038/ngeo1173; Taylor CM, 1998, MON WEATHER REV, V126, P1597, DOI 10.1175/1520-0493(1998)126<1597:OEOPCS>2.0.CO;2; van der Ent RJ, 2010, WATER RESOUR RES, V46, DOI 10.1029/2010WR009127; Wang JF, 2009, P NATL ACAD SCI USA, V106, P3670, DOI 10.1073/pnas.0810156106; WEBSTER PJ, 1983, J ATMOS SCI, V40, P2110, DOI 10.1175/1520-0469(1983)040<2110:MOMLFV>2.0.CO;2; Zhang YY, 2010, J ATMOS SCI, V67, P2943, DOI 10.1175/2010JAS3366.1	30	393	405	20	251	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 20	2012	489	7416					423	426		10.1038/nature11377	http://dx.doi.org/10.1038/nature11377			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AK	22972193	Green Accepted			2022-12-28	WOS:000308860900043
J	Colla, CH; Wennberg, DE; Meara, E; Skinner, JS; Gottlieb, D; Lewis, VA; Snyder, CM; Fisher, ES				Colla, Carrie H.; Wennberg, David E.; Meara, Ellen; Skinner, Jonathan S.; Gottlieb, Daniel; Lewis, Valerie A.; Snyder, Christopher M.; Fisher, Elliott S.			Spending Differences Associated With the Medicare Physician Group Practice Demonstration	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DUAL ELIGIBLES; REGIONAL-VARIATIONS; DISEASE MANAGEMENT; NEW-HAVEN; CARE; BENEFICIARIES; QUALITY; HOSPITALIZATION; DISPARITIES; INVESTMENT	Context The Centers for Medicare & Medicaid Services (CMS) recently launched accountable care organization (ACO) programs designed to improve quality and slow cost growth. The ACOs resemble an earlier pilot, the Medicare Physician Group Practice Demonstration (PGPD), in which participating physician groups received bonus payments if they achieved lower cost growth than local controls and met quality targets. Although evidence indicates the PGPD improved quality, uncertainty remains about its effect on costs. Objective To estimate cost savings associated with the PGPD overall and for beneficiaries dually eligible for Medicare and Medicaid. Design Quasi-experimental analyses comparing preintervention (2001-2004) and post-intervention (2005-2009) trends in spending of PGPD participants to local control groups. We compared estimates using several alternative approaches to adjust for case mix. Setting Ten physician groups from across the United States. Patients and Participants The intervention group was composed of fee-for-service Medicare beneficiaries (n = 990 177) receiving care primarily from the physicians in the participating medical groups. Controls were Medicare beneficiaries (n = 7 514 453) from the same regions who received care largely from non-PGPD physicians. Overall, 15% of beneficiaries were dually eligible for Medicare and Medicaid. Main Outcome Measure Annual spending per Medicare fee-for-service beneficiary. Results Annual savings per beneficiary were modest overall (adjusted mean $114,95% CI, $12-$216). Annual savings were significant in dually eligible beneficiaries (adjusted mean $532, 95% CI, $277-$786), but were not significant among nondually eligible beneficiaries (adjusted mean $59, 95% CI, $166 in savings to $47 in additional spending). The adjusted mean spending reductions were concentrated in acute care (overall, $118, 95% CI, $65-$170; dually eligible: $381, 95% CI, $247-$515; nondually eligible: $85, 95% CI,$32-$138). There was significant variation in savings across practice groups, ranging from an overall mean per-capita annual saving of $866 (95% CI, $815-$918) to an increase in expenditures of $749 (95% CI, $698-$799). Thirty-day medical readmissions decreased overall (-0.67%, 95% CI, -1.11% to -0.23%) and in the dually eligible (-1.07%, 95% CI, -1.73% to -0.41%), while surgical readmissions decreased only for the dually eligible (-2.21%, 95% CI, -3.07% to -1.34%). Estimates were sensitive to the risk-adjustment method. Conclusions Substantial PGPD savings achieved by some participating institutions were offset by a lack of saving at other participating institutions. Most of the savings were concentrated among dually eligible beneficiaries. JAMA. 2012;308(10):1015-1023 www.jama.com	[Colla, Carrie H.; Wennberg, David E.; Meara, Ellen; Skinner, Jonathan S.; Gottlieb, Daniel; Lewis, Valerie A.; Fisher, Elliott S.] Dartmouth Inst Hlth Policy & Clin Practice, Geisel Sch Med Dartmouth, Lebanon, NH 03766 USA; [Colla, Carrie H.] Norris Cotton Canc Ctr, Manchester, NH USA; [Skinner, Jonathan S.; Snyder, Christopher M.] Dartmouth Coll, Dept Econ, Hanover, NH 03755 USA; [Meara, Ellen; Skinner, Jonathan S.; Snyder, Christopher M.] Natl Bur Econ Res, Hanover, NH USA	Dartmouth College; Norris Cotton Cancer Center; Dartmouth College; National Bureau of Economic Research	Colla, CH (corresponding author), Dartmouth Inst Hlth Policy & Clin Practice, Geisel Sch Med Dartmouth, 35 Centerra Pkwy, Lebanon, NH 03766 USA.	Carrie.H.Colla@Dartmouth.edu		Meara, Ellen/0000-0003-0211-1970	National Institute on Aging [NIA P01AG19783]; Dartmouth Atlas Project; Robert Wood Johnson Foundation; Commonwealth Fund; NATIONAL INSTITUTE ON AGING [R21AG044251, R33AG044251, P01AG019783] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Dartmouth Atlas Project; Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); Commonwealth Fund; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was funded by grant NIA P01AG19783 from the National Institute on Aging, the Dartmouth Atlas Project (supported by a consortium led by the Robert Wood Johnson Foundation), and the Commonwealth Fund.	Berwick DM, 2011, NEW ENGL J MED, V365, P1753, DOI 10.1056/NEJMp1111671; Bubolz T, 2012, HEALTH AFFAIR, V31, P939, DOI 10.1377/hlthaff.2011.0921; Buntin MB, 2010, MED CARE, V48, P776, DOI 10.1097/MLR.0b013e3181e359df; Cameron AC, 2011, J BUS ECON STAT, V29, P238, DOI 10.1198/jbes.2010.07136; Centers for Medicare and Medicaid Innovation, 2012, MED PHYS GROUP PRACT; Centers for Medicare & Medicaid Services, PION ACC CAR ORG MOD; Centers for Medicare & Medicaid Services, CMS HCC RISK ADJ MOD; Congressional Budget Office, BUDG OPT, VI; Coughlin TA, 2012, HEALTH AFFAIR, V31, P1083, DOI 10.1377/hlthaff.2011.0729; Fisher ES, 2009, HEALTH AFFAIR, V28, pW219, DOI 10.1377/hlthaff.28.2.w219; Fisher ES, 2003, ANN INTERN MED, V138, P273, DOI 10.7326/0003-4819-138-4-200302180-00006; FISHER ES, 1994, NEW ENGL J MED, V331, P989, DOI 10.1056/NEJM199410133311506; Goetzel RZ, 2005, HEALTH CARE FINANC R, V26, P1; Grabowski DC, 2007, MILBANK Q, V85, P579, DOI 10.1111/j.1468-0009.2007.00502.x; HUSKAMP HA, 1994, HEALTH AFFAIR, V13, P32, DOI 10.1377/hlthaff.13.5.32; Jacobson G, 2012, MEDICARES ROLE DUAL; Kasper J., 2010, CHRONIC DIS COMORBID; Kautter J, 2004, PHYS GROUP PRACTICE; Kautter J, 2007, HEALTH CARE FINANC R, V29, P15; Konetzka RT, 2004, MED CARE, V42, P1001, DOI 10.1097/00005650-200410000-00009; Kronick RG, 2009, FACES MEDICAID; Mattke S, 2007, AM J MANAG CARE, V13, P670; Medicare Payment Advisory Commission (MedPAC), 2011, COORD CAR DUAL EL BE; Medicare Payment Advisory Commission The (MedPac), 2009, REP C IMPR INC MED P; Moon S, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-88; Peikes D, 2009, JAMA-J AM MED ASSOC, V301, P603, DOI 10.1001/jama.2009.126; Pollack CE, 2011, JAMA-J AM MED ASSOC, V305, P1706, DOI 10.1001/jama.2011.533; Pope GC, 2004, HEALTH CARE FINANC R, V25, P119; Rousseau D, 2010, DUAL ELIGIBLES MEDIC; Schore JL, 1999, HEALTH CARE FINANC R, V20, P87; Sebelius K, 2009, REP C PHYS GROUP PRA; Skinner J, 2000, FRONTIERS HLTH EC; Song YJ, 2010, NEW ENGL J MED, V363, P45, DOI 10.1056/NEJMsa0910881; Song Z, 2011, NEW ENGL J MED, V365, P909, DOI 10.1056/NEJMsa1101416; Starfield B, 2012, ANNU REV PUBL HEALTH, V33, P89, DOI 10.1146/annurev-publhealth-031811-124528; The World Bank, 2011, WORLD DEV IND GDP DE; Trisolini M, 2008, MEDICARE PHYS GROUP; Trisolini M, 2005, PHYS GROUP PRACTICE; U.S. Government Accountability Office, 2012, MED ADV CMS SHOULD I; Welch HG, 2011, JAMA-J AM MED ASSOC, V305, P1113, DOI 10.1001/jama.2011.307; WENNBERG JE, 1989, NEW ENGL J MED, V321, P1168, DOI 10.1056/NEJM198910263211706; WHITE H, 1980, ECONOMETRICA, V48, P817, DOI 10.2307/1912934; Wilensky GR, 2011, NEW ENGL J MED, V365, P1659, DOI 10.1056/NEJMp1110185; Young K., 2012, MEDICAIDS ROLE DUAL	45	122	123	0	15	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 12	2012	308	10					1015	1023		10.1001/2012.jama.10812	http://dx.doi.org/10.1001/2012.jama.10812			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	003AA	22968890	Bronze, Green Accepted			2022-12-28	WOS:000308579300025
J	Bultitude, M; Rees, J				Bultitude, Matthew; Rees, Jonathan			Management of renal colic	BMJ-BRITISH MEDICAL JOURNAL			English	Review							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; SPONTANEOUS PASSAGE; URETERAL CALCULI; STONE PASSAGE; UROLITHIASIS; DIAGNOSIS; OPIOIDS; PAIN; CT		[Bultitude, Matthew] Guys & St Thomas NHS Fdn Trust, Urol Ctr, London SE1 9RT, England; [Rees, Jonathan] Backwell & Nailsea Med Grp, Bristol, Avon, England	Guy's & St Thomas' NHS Foundation Trust	Bultitude, M (corresponding author), Guys & St Thomas NHS Fdn Trust, Urol Ctr, London SE1 9RT, England.	matthew.bultitude@gstt.nhs.uk						Aboumarzouk OM, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006029.pub4; Argyropoulos A, 2004, UROL RES, V32, P294, DOI 10.1007/s00240-004-0413-y; BAUS section of endourology, 2012, GUID AC MAN 1 PRES R; Borghi L, 1996, J UROLOGY, V155, P839, DOI 10.1016/S0022-5347(01)66321-3; Borley NC, 2007, BJU INT, V99, P494, DOI 10.1111/j.1464-410X.2007.06553.x; Catalano O, 2002, AM J ROENTGENOL, V178, P379, DOI 10.2214/ajr.178.2.1780379; Clinical effectiveness committee of the College of Emergency Medicine, 2010, CLIN STAND EM DEP; Coll DM, 2002, AM J ROENTGENOL, V178, P101, DOI 10.2214/ajr.178.1.1780101; Curhan GC, 2007, UROL CLIN N AM, V34, P287, DOI 10.1016/j.ucl.2007.04.003; Eisner BH, 2009, J UROLOGY, V182, P165, DOI 10.1016/j.juro.2009.02.131; Fulgham PF, 2012, CLIN EFFECTIVENESS P; Heidenreich A, 2002, EUR UROL, V41, P351, DOI 10.1016/S0302-2838(02)00064-7; Holdgate A, 2004, BRIT MED J, V328, P1401, DOI 10.1136/bmj.38119.581991.55; Holdgate A, 2004, COCHRANE DB SYST REV, V1; Hollingsworth JM, 2006, LANCET, V368, P1171, DOI 10.1016/S0140-6736(06)69474-9; Kober A, 2003, J UROLOGY, V170, P741, DOI 10.1097/01.ju.0000080570.83834.ad; LEE YH, 1992, J UROLOGY, V147, P16, DOI 10.1016/S0022-5347(17)37121-5; Lindqvist K, 2006, SCAND J UROL NEPHROL, V40, P119, DOI 10.1080/00365590600688203; Miller OF, 1999, J UROLOGY, V162, P688, DOI 10.1097/00005392-199909010-00014; Niemann T, 2008, AM J ROENTGENOL, V191, P396, DOI 10.2214/AJR.07.3414; Pearle MS, 1998, J UROLOGY, V160, P1260, DOI 10.1016/S0022-5347(01)62511-4; Pearle MS, 2012, CAMPBELL WALSH UROLO; Pichler R, 2012, BJU INT, V109, P770, DOI 10.1111/j.1464-410X.2011.10372.x; Preminger, 2011, CLIN EVID, V2011, P2003; Preminger GM, 2007, EUR UROL, V52, P1610, DOI 10.1016/j.eururo.2007.09.039; Scales CD, 2007, J UROLOGY, V177, P979, DOI 10.1016/j.juro.2006.10.069; Taylor EN, 2005, JAMA-J AM MED ASSOC, V293, P455, DOI 10.1001/jama.293.4.455; Tchey DU, 2011, KOREAN J UROL, V52, P847, DOI 10.4111/kju.2011.52.12.847; VAUGHAN ED, 1971, J UROLOGY, V106, P27, DOI 10.1016/S0022-5347(17)61219-9; Worster A, 2002, ANN EMERG MED, V40, P280, DOI 10.1067/mem.2002.126170; Worster AS, 2012, COCHRANE DB SYST REV, V2; Wright PJ, 2002, BMJ-BRIT MED J, V325, P1408, DOI 10.1136/bmj.325.7377.1408; Yencilek F, 2010, UROL RES, V38, P195, DOI 10.1007/s00240-010-0257-6	33	64	65	0	15	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 29	2012	345								e5499	10.1136/bmj.e5499	http://dx.doi.org/10.1136/bmj.e5499			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	036SK	22932919				2022-12-28	WOS:000311050600004
J	Langille, MR; Zhang, J; Personick, ML; Li, SY; Mirkin, CA				Langille, Mark R.; Zhang, Jian; Personick, Michelle L.; Li, Shuyou; Mirkin, Chad A.			Stepwise Evolution of Spherical Seeds into 20-Fold Twinned Icosahedra	SCIENCE			English	Article							SILVER NANOCRYSTALS; GOLD NANOPARTICLES; METAL NANOCRYSTALS; AQUEOUS-SOLUTION; GROWTH; NANOPRISMS; PARTICLES; CONVERSION; MECHANISM; SHAPES	Understanding the factors that influence the growth and final shape of noble metal nanostructures is important for controlling their properties. However, relative to their single-crystalline counterparts, the growth of nanoparticles that contain twin defects can be difficult to control because multiple competitive growth pathways can yield such structures. We used spherical, cubic, and octahedral single-crystalline gold nanoparticles as dual electron microscopy labels and plasmonic seeds to track the growth of multiply twinned silver nanostructures. As the bimetallic nanostructures grew, they successively developed twin planes to ultimately form multiply twinned nanoparticles from single-crystalline seeds. Collectively, these data demonstrate how a series of nanoparticles of different shapes and internal crystal structures are interrelated and develop from one another.	[Langille, Mark R.; Zhang, Jian; Personick, Michelle L.; Mirkin, Chad A.] Northwestern Univ, Dept Chem, Evanston, IL 60208 USA; [Langille, Mark R.; Zhang, Jian; Personick, Michelle L.; Mirkin, Chad A.] Northwestern Univ, Int Inst Nanotechnol, Evanston, IL 60208 USA; [Li, Shuyou; Mirkin, Chad A.] Northwestern Univ, Dept Mat Sci & Engn, Evanston, IL 60208 USA	Northwestern University; Northwestern University; Northwestern University	Mirkin, CA (corresponding author), Northwestern Univ, Dept Chem, 2145 Sheridan Rd, Evanston, IL 60208 USA.	chadnano@northwestern.edu	Mirkin, Chad A/E-3911-2010; Zhang, Jian/A-5133-2010; Zhang, Jian/M-9978-2019	Zhang, Jian/0000-0003-0274-0814; Personick, Michelle/0000-0003-4747-9429; Mirkin, Chad/0000-0002-6634-7627	U.S. Air Force Office of Scientific Research; U.S. Department of Defense National Security Science and Engineering Faculty Fellowships Program/Naval Postgraduate School [N00244-09-1-0012]; Non-equilibrium Energy Research Center, an Energy Frontier Research Center; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-SC0000989]; NSF Materials Research Science and Engineering Center (MRSEC) at the Materials Research Center of Northwestern University [DMR-1121262]; NSF Nanoscale Science and Engineering Center; NSF MRSEC; Keck Foundation; State of Illinois; Northwestern University; U.S. Air Force Office of Scientific Research through National Defense Science and Engineering graduate fellowship [32 CFR 168a]	U.S. Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); U.S. Department of Defense National Security Science and Engineering Faculty Fellowships Program/Naval Postgraduate School; Non-equilibrium Energy Research Center, an Energy Frontier Research Center; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NSF Materials Research Science and Engineering Center (MRSEC) at the Materials Research Center of Northwestern University; NSF Nanoscale Science and Engineering Center(National Science Foundation (NSF)); NSF MRSEC(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Keck Foundation(W.M. Keck Foundation); State of Illinois; Northwestern University; U.S. Air Force Office of Scientific Research through National Defense Science and Engineering graduate fellowship	This material is based on work supported by the U.S. Air Force Office of Scientific Research; the U.S. Department of Defense National Security Science and Engineering Faculty Fellowships Program/Naval Postgraduate School (award N00244-09-1-0012); the Non-equilibrium Energy Research Center, an Energy Frontier Research Center funded by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences under award DE-SC0000989; and the NSF Materials Research Science and Engineering Center (MRSEC) program (DMR-1121262) at the Materials Research Center of Northwestern University. The microscopy work was performed in the EPIC facility of the NUANCE Center at Northwestern University, which is supported by NSF Nanoscale Science and Engineering Center, NSF MRSEC, the Keck Foundation, the State of Illinois, and Northwestern University. This work was also supported by the U.S. Air Force Office of Scientific Research through National Defense Science and Engineering graduate fellowship 32 CFR 168a (M. L. P.). Any opinions, findings, and conclusions or recommendations expressed in this publication are those of the authors and do not necessarily reflect the views of the agency sponsors.	ALLPRESS JG, 1967, SURF SCI, V7, P1, DOI 10.1016/0039-6028(67)90062-3; Baletto F, 2005, REV MOD PHYS, V77, P371, DOI 10.1103/RevModPhys.77.371; de Jonge N, 2011, NAT NANOTECHNOL, V6, P695, DOI [10.1038/NNANO.2011.161, 10.1038/nnano.2011.161]; HOFMEISTER H, 1984, THIN SOLID FILMS, V116, P151, DOI 10.1016/0040-6090(84)90416-4; Hofmeister H, 2009, Z KRISTALLOGR, V224, P528, DOI 10.1524/zkri.2009.1034; Jin RC, 2003, NATURE, V425, P487, DOI 10.1038/nature02020; Jin RC, 2001, SCIENCE, V294, P1901, DOI 10.1126/science.1066541; Kim F, 2004, ANGEW CHEM INT EDIT, V43, P3673, DOI 10.1002/anie.200454216; Langille MR, 2011, ANGEW CHEM INT EDIT, V50, P3543, DOI 10.1002/anie.201007755; Elechiguerra JL, 2006, J MATER CHEM, V16, P3906, DOI 10.1039/b607128g; Nikoobakht B, 2003, CHEM MATER, V15, P1957, DOI 10.1021/cm0207321; Niu WX, 2011, NANO TODAY, V6, P265, DOI 10.1016/j.nantod.2011.04.006; Niu WX, 2009, J AM CHEM SOC, V131, P697, DOI 10.1021/ja804115r; Personick ML, 2011, NANO LETT, V11, P3394, DOI 10.1021/nl201796s; Pietrobon B, 2008, CHEM MATER, V20, P5186, DOI 10.1021/cm800926u; Sau TK, 2004, J AM CHEM SOC, V126, P8648, DOI 10.1021/ja047846d; SMITH DJ, 1986, SCIENCE, V233, P872, DOI 10.1126/science.233.4766.872; Tsuji M, 2010, CRYST GROWTH DES, V10, P296, DOI 10.1021/cg9009042; Wiley B, 2004, NANO LETT, V4, P1733, DOI 10.1021/nl048912c; Wu XM, 2008, J AM CHEM SOC, V130, P9500, DOI 10.1021/ja8018669; Xia YN, 2009, ANGEW CHEM INT EDIT, V48, P60, DOI 10.1002/anie.200802248; Xue C, 2008, J AM CHEM SOC, V130, P8337, DOI 10.1021/ja8005258; Xue C, 2007, ANGEW CHEM INT EDIT, V46, P8436, DOI 10.1002/anie.200703185; YAGI K, 1975, J CRYST GROWTH, V28, P117, DOI 10.1016/0022-0248(75)90033-0; Yuk JM, 2012, SCIENCE, V336, P61, DOI 10.1126/science.1217654; Zeng J, 2010, J AM CHEM SOC, V132, P8552, DOI 10.1021/ja103655f; Zhang J, 2010, J AM CHEM SOC, V132, P12502, DOI 10.1021/ja106008b; Zhang QB, 2010, SMALL, V6, P523, DOI 10.1002/smll.200902033; Zheng HM, 2009, SCIENCE, V324, P1309, DOI 10.1126/science.1172104; Zhou J, 2008, LANGMUIR, V24, P10407, DOI 10.1021/la800961j	30	155	159	3	264	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 24	2012	337	6097					954	957		10.1126/science.1225653	http://dx.doi.org/10.1126/science.1225653			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992VI	22923578				2022-12-28	WOS:000307807600042
J	Adams, B; Sisson, C				Adams, Bruce; Sisson, Craig			Review: Bedside ultrasonography has 82% sensitivity and 99% specificity for blunt intraabdominal injury	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Adams, Bruce; Sisson, Craig] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio	Adams, B (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA.							Akhtar S, 2009, ACAD EMERG MED, V16, pS32, DOI 10.1111/j.1553-2712.2009.00589.x; Silen W., 2010, COPES EARLY DIAGNOSI	2	3	3	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 21	2012	157	4							JC4-12	10.7326/0003-4819-157-4-201208210-02012	http://dx.doi.org/10.7326/0003-4819-157-4-201208210-02012			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	992XG	22910966				2022-12-28	WOS:000307813200011
J	Wang, DB; Fernandez-Martinez, A				Wang, Dongbo; Fernandez-Martinez, Alejandro			Order from Disorder	SCIENCE			English	Editorial Material							ORIENTED ATTACHMENT		[Wang, Dongbo] NIST, Div Polymers, Gaithersburg, MD 20899 USA; [Fernandez-Martinez, Alejandro] Univ Grenoble 1, Inst Sci Terre, F-38041 Grenoble 9, France; [Fernandez-Martinez, Alejandro] Ctr Natl Rech Sci, F-38041 Grenoble 9, France	National Institute of Standards & Technology (NIST) - USA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite Gustave-Eiffel; Universite de Savoie; Centre National de la Recherche Scientifique (CNRS)	Wang, DB (corresponding author), NIST, Div Polymers, Gaithersburg, MD 20899 USA.	dongbo.wang@nist.gov; alex.fernandez-martinez@obs.ujf-grenoble.fr	Fernandez-Martinez, Alejandro/I-4101-2019; Fernandez-Martinez, Alejandro/B-4042-2010	Fernandez-Martinez, Alejandro/0000-0001-5073-9629; Fernandez-Martinez, Alejandro/0000-0001-5073-9629				Billinge SJL, 2004, CHEM COMMUN, P749, DOI 10.1039/b309577k; Blanton T, 2011, POWDER DIFFR, V26, P114, DOI 10.1154/1.3583564; Cu┬lfen H., 2008, MESOCRYSTALS NONCLAS, P113; DAVID WIF, 1992, EUROPHYS LETT, V18, P219, DOI 10.1209/0295-5075/18/3/006; ELLIOTT SR, 1991, NATURE, V354, P445, DOI 10.1038/354445a0; Li DS, 2012, SCIENCE, V336, P1014, DOI 10.1126/science.1219643; Penn RL, 1998, SCIENCE, V281, P969, DOI 10.1126/science.281.5379.969; Sposito G, 1999, P NATL ACAD SCI USA, V96, P3358, DOI 10.1073/pnas.96.7.3358; TANIGAKI K, 1991, NATURE, V352, P222, DOI 10.1038/352222a0; Wang L, 2012, SCIENCE, V337, P825, DOI 10.1126/science.1220522; Yamanaka S, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.076602; Zaug JM, 2008, NAT MATER, V7, P890, DOI 10.1038/nmat2290	12	14	14	2	92	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 17	2012	337	6096					812	813		10.1126/science.1226048	http://dx.doi.org/10.1126/science.1226048			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	989BQ	22904005				2022-12-28	WOS:000307535600033
J	James, S; Held, C				James, Stefan; Held, Claes			Improving long-term outcome after myocardial infarction	LANCET			English	Editorial Material							ACUTE CORONARY SYNDROMES; ATHEROTHROMBOTIC EVENTS; CLOPIDOGREL; PREVENTION; VORAPAXAR; SAFETY		[James, Stefan] Uppsala Univ, Dept Med Sci, S-75185 Uppsala, Sweden; Uppsala Univ, Dept Cardiol, S-75185 Uppsala, Sweden; Uppsala Univ, Uppsala Clin Res Ctr, S-75185 Uppsala, Sweden	Uppsala University; Uppsala University; Uppsala University	James, S (corresponding author), Uppsala Univ, Dept Med Sci, S-75185 Uppsala, Sweden.	stefan.james@ucr.uu.se	James, Stefan K/J-4554-2014; Held, Claes/AAA-3973-2021	Held, Claes/0000-0001-9402-7404				Becker RC, 2009, LANCET, V373, P919, DOI 10.1016/S0140-6736(09)60230-0; Bhatt DL, 2006, NEW ENGL J MED, V354, P1706, DOI 10.1056/NEJMoa060989; ClinicalTrials.gov: NCT01225562, 2011, PREV CARD EV EG DEAT; Goto S, 2010, J ATHEROSCLER THROMB, V17, P156, DOI 10.5551/jat.3038; Hamm CW, 2011, EUR HEART J, V32, P2999, DOI 10.1093/eurheartj/ehr236; Mega JL, 2012, NEW ENGL J MED, V366, P9, DOI 10.1056/NEJMoa1112277; Morrow DA, 2012, NEW ENGL J MED, V366, P1404, DOI 10.1056/NEJMoa1200933; Scirica BM, 2012, LANCET; Tricoci P, 2012, NEW ENGL J MED, V366, P20, DOI 10.1056/NEJMoa1109719; Wallentin L, 2009, NEW ENGL J MED, V361, P1045, DOI 10.1056/NEJMoa0904327; Wiviott SD, 2007, NEW ENGL J MED, V357, P2001, DOI 10.1056/NEJMoa0706482	11	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 13	2012	380	9850					1290	1291		10.1016/S0140-6736(12)61383-X	http://dx.doi.org/10.1016/S0140-6736(12)61383-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	022BZ	22932713				2022-12-28	WOS:000309931400007
J	Saver, JL; Jahan, R; Levy, EI; Jovin, TG; Baxter, B; Nogueira, RG; Clark, W; Budzik, R; Zaidat, OO				Saver, Jeffrey L.; Jahan, Reza; Levy, Elad I.; Jovin, Tudor G.; Baxter, Blaise; Nogueira, Raul G.; Clark, Wayne; Budzik, Ronald; Zaidat, Osama O.		SWIFT Trialists	Solitaire flow restoration device versus the Merci Retriever in patients with acute ischaemic stroke (SWIFT): a randomised, parallel-group, non-inferiority trial	LANCET			English	Article							MECHANICAL THROMBECTOMY; ARTERIAL-OCCLUSION; RECANALIZATION; REPERFUSION; EMBOLECTOMY; ANGIOGRAPHY; MANAGEMENT; EFFICACY; OUTCOMES; THERAPY	Background The Solitaire Flow Restoration Device is a novel, self-expanding stent retriever designed to yield rapid flow restoration in acute cerebral ischaemia. We compared the efficacy and safety of Solitaire with the standard, predicate mechanical thrombectomy device, the Merci Retrieval System. Methods In this randomised, parallel-group, non-inferiority trial, we enrolled patients from 18 sites (17 in the USA and one in France). Patients were eligible for inclusion if they had acute ischaemic stroke with moderate to severe neurological deficits and were treatable by thrombectomy within 8 h of stroke symptom onset. We used a computer-generated randomisation sequence to randomly allocate patients to receive thrombectomy treatment with either Solitaire or Merci (1: 1; block sizes of four and stratified by centre and stroke severity). The primary endpoint was Thrombolysis In Myocardial Ischemia (TIMI) scale 2 or 3 flow in all treatable vessels without symptomatic intracranial haemorrhage, after up to three passes of the assigned device, as assessed by an independent core laboratory, which was masked to study assignment. Primary analysis was done by intention to treat. A prespecified efficacy stopping rule triggered an early halt to the trial. The study is registered with ClinicalTrials.gov, number NCT 01054560. Results Between February, 2010, and February, 2011, we randomly allocated 58 patients to the Solitaire group and 55 patients to the Merci group. The primary efficacy outcome was achieved more often in the Solitaire group than it was in the Merci group (61% vs 24%; difference 37% [95% CI 19-53], odds ratio [OR] 4.87 [95% CI 2.14-11.10]; p(non-inferiority)<0.0001, p(superiority)=0.0001). More patients had good 3-month neurological outcome with Solitaire than with Merci (58% vs 33%; difference 25% [6-43], OR 2.78 [1.25-6.22]; p(non-inferiority)=0.0001, p(superiority)=0.02). 90-day mortality was lower in the Solitaire group than it was in the Merci group (17 vs 38; difference -21% [-39 to -3], OR 0.34 [0.14-0.81]; p(non-inferiority)=0.0001, p(superiority)=0.02). Interpretation The Solitaire Flow Restoration Device achieved substantially better angiographic, safety, and clinical outcomes than did the Merci Retrieval System. The Solitaire device might be a future treatment of choice for endovascular recanalisation in acute ischaemic stroke.	[Saver, Jeffrey L.; Jahan, Reza] Univ Calif Los Angeles, Stroke Ctr, Los Angeles, CA 90095 USA; [Saver, Jeffrey L.] Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90095 USA; [Jahan, Reza] Univ Calif Los Angeles, Dept Radiol, Los Angeles, CA 90095 USA; [Levy, Elad I.] Millard Fillmore Hosp, Dept Neurosurg, Buffalo, NY USA; [Jovin, Tudor G.] Univ Pittsburgh, Dept Neurol, Pittsburgh, PA 15260 USA; [Baxter, Blaise] Erlanger Hosp, Dept Radiol, Chattanooga, TN USA; [Nogueira, Raul G.] Emory Univ, Dept Neurol, Atlanta, GA 30322 USA; [Clark, Wayne] Oregon Hlth & Sci Univ, Dept Neurol, Portland, OR USA; [Budzik, Ronald] Riverside Methodist Hosp, Dept Radiol, Columbus, OH 43214 USA; [Zaidat, Osama O.] Med Coll Wisconsin, Dept Neurol, Milwaukee, WI 53226 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; State University of New York (SUNY) System; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Emory University; Oregon Health & Science University; Medical College of Wisconsin	Saver, JL (corresponding author), Univ Calif Los Angeles, Stroke Ctr, 710 Westwood Plaza, Los Angeles, CA 90095 USA.	jsaver@ucla.edu	Demchuk, Andrew M/E-1103-2012	Demchuk, Andrew M/0000-0002-4930-7789; Saver, Jeffrey/0000-0001-9141-2251	Covidien/ev3; BrainsGate; CoAxia; Grifols/Talecris; Ferrer; Mitsubishi; Genervon; Benechill; Asubio; Sygnis; Chestnut Medical; Abbott Vascular	Covidien/ev3; BrainsGate; CoAxia; Grifols/Talecris; Ferrer; Mitsubishi; Genervon; Benechill; Asubio; Sygnis; Chestnut Medical; Abbott Vascular(Abbott Laboratories)	The University of California (The Regents) receive funding for JLS's services as a scientific consultant regarding trial design and conduct from Covidien/ev3, BrainsGate, CoAxia, Grifols/Talecris, Ferrer, Mitsubishi, Genervon, Benechill, Asubio, and Sygnis. JLS is an investigator in the NIH FAST-MAG, MR RESCUE, ICES, CUFFS, CLEAR-ER, and IMS 3 multicenter clinical trials for which the UC Regents receive payments based on clinical trial performance. JLS has also served as an unpaid site investigator in multicenter trials run by Covidien/ev3, Genervon, Lundbeck, and Mitsubishi for which the UC Regents received payments based on the clinical trial contracts for the number of participants enrolled. JLS and RS are employees of the University of California, which holds a patent on retriever devices for stroke. The University of California, Regents receive funding for RJ's services as a scientific consultant regarding trial design and conduct from Covidien/ev3 and Chestnut Medical. EIL serves as a scientific consultant for Covidien/ev3, Codman and Shurtleff Inc, and TheraSyn Sensors Inc; and receives fees for carotid stent training from Covidien/ev3, and Abbott Vascular. TGJ has served as a scientific consultant to Covidien/ev3, CoAxia, Concentric Medical, and Micrus. RGN has served as a scientific consultant to Covidien/ev3, CoAxia, and Concentric Medical. WC and RB have served as scientific consultants to Covidien/ev3. OOZ serves as a scientific consultant to Talecris Biotherapeutics, Stryker, Codman, and MicroVention.	Adams HP, 2007, STROKE, V38, P1655, DOI 10.1161/STROKEAHA.107.181486; BLACKWELDER WC, 1982, CONTROL CLIN TRIALS, V3, P345, DOI 10.1016/0197-2456(82)90024-1; Castano C, 2010, STROKE, V41, P1836, DOI 10.1161/STROKEAHA.110.584904; Chueh JY, 2012, AM J NEURORADIOL, V33, P1998, DOI 10.3174/ajnr.A3103; Derex L, 2002, CEREBROVASC DIS, V13, P225, DOI 10.1159/000057847; Furlan A, 1999, JAMA-J AM MED ASSOC, V282, P2003, DOI 10.1001/jama.282.21.2003; Hong KS, 2009, STROKE, V40, P3828, DOI 10.1161/STROKEAHA.109.561365; Jahan R, 2010, AM J NEURORADIOL, V31, P1938, DOI 10.3174/ajnr.A2169; Josephson SA, 2009, NEUROCRIT CARE, V10, P43, DOI 10.1007/s12028-008-9167-7; Khatri P, 2008, INT J STROKE, V3, P130, DOI 10.1111/j.1747-4949.2008.00151.x; Langer D, 2009, STROKE, V40, P2761, DOI 10.1161/STROKEAHA.108.544957; Machi P, 2012, J NEUROINTERV SURG, V4, P62, DOI 10.1136/jnis.2010.004051; Mancini GBJ, 1999, CIRCULATION, V99, P377, DOI 10.1161/01.CIR.99.3.377; Mechanical retrieval and recanalization of stroke clots using embolectomy (MR RESCUE), 2011, MECH RETRIEVAL RECAN; Mehra M, 2012, STROKE, V43, pA139; Mendonca N, 2012, STROKE, V43, P417, DOI 10.1161/STROKEAHA.111.632653; Miteff F, 2011, AM J NEURORADIOL, V32, P1078, DOI 10.3174/ajnr.A2447; Mpotsaris A, 2012, J NEUROL NEUROSUR PS, V83, P117, DOI 10.1136/jnnp.2010.225573; Noorian AR, 2012, TECH VASC INTERV RAD, V15, P47, DOI 10.1053/j.tvir.2011.12.008; Rha JH, 2007, STROKE, V38, P967, DOI 10.1161/01.STR.0000258112.14918.24; Rivero-Arias O, 2010, MED DECIS MAKING, V30, P341, DOI 10.1177/0272989X09349961; Roth C, 2010, STROKE, V41, P2559, DOI 10.1161/STROKEAHA.110.592071; Saver J, INT J STROK IN PRESS; Saver JL, 2011, J THROMB HAEMOST, V9, P333, DOI 10.1111/j.1538-7836.2011.04371.x; Sims JR, 2005, AM J NEURORADIOL, V26, P246; Smith WS, 2008, STROKE, V39, P1205, DOI 10.1161/STROKEAHA.107.497115; Smith WS, 2006, NEUROCRIT CARE, V4, P14, DOI 10.1385/NCC:4:1:014; Smith WS, 2005, STROKE, V36, P1432, DOI 10.1161/01.STR.0000171066.25248.1d; Soares BP, 2009, STROKE, V40, pS24, DOI 10.1161/STROKEAHA.108.526814	29	968	1021	6	89	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 6	2012	380	9849					1241	1249		10.1016/S0140-6736(12)61384-1	http://dx.doi.org/10.1016/S0140-6736(12)61384-1			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	020NG	22932715				2022-12-28	WOS:000309817500031
J	Papadopoulos, F; Kitsak, M; Serrano, MA; Boguna, M; Krioukov, D				Papadopoulos, Fragkiskos; Kitsak, Maksim; Angeles Serrano, M.; Boguna, Marian; Krioukov, Dmitri			Popularity versus similarity in growing networks	NATURE			English	Article							PREFERENTIAL ATTACHMENT; EMERGENCE; EVOLUTION; PAPER	The principle(1) that 'popularity is attractive' underlies preferential attachment(2), which is a common explanation for the emergence of scaling in growing networks. If new connections are made preferentially to more popular nodes, then the resulting distribution of the number of connections possessed by nodes follows power laws(3,4), as observed in many real networks(5,6). Preferential attachment has been directly validated for some real networks (including the Internet(7,8)), and can be a consequence of different underlying processes based on node fitness, ranking, optimization, random walks or duplication(9-16). Here we show that popularity is just one dimension of attractiveness; another dimension is similarity(17-24). We develop a framework in which new connections optimize certain trade-offs between popularity and similarity, instead of simply preferring popular nodes. The framework has a geometric interpretation in which popularity preference emerges from local optimization. As opposed to preferential attachment, our optimization framework accurately describes the large-scale evolution of technological (the Internet), social (trust relationships between people) and biological (Escherichia coli metabolic) networks, predicting the probability of new links with high precision. The framework that we have developed can thus be used for predicting new links in evolving networks, and provides a different perspective on preferential attachment as an emergent phenomenon.	[Papadopoulos, Fragkiskos] Cyprus Univ Technol, Dept Elect Engn Comp Engn & Informat, CY-3036 Limassol, Cyprus; [Kitsak, Maksim; Krioukov, Dmitri] Univ Calif San Diego, CAIDA, La Jolla, CA 92093 USA; [Angeles Serrano, M.; Boguna, Marian] Univ Barcelona, Dept Fis Fonamental, E-08028 Barcelona, Spain	Cyprus University of Technology; University of California System; University of California San Diego; University of Barcelona	Papadopoulos, F (corresponding author), Cyprus Univ Technol, Dept Elect Engn Comp Engn & Informat, 33 Saripolou St, CY-3036 Limassol, Cyprus.	f.papadopoulos@cut.ac.cy; dima@ucsd.edu	Boguna, Marian/B-7795-2011; Serrano, M. Angeles/A-4198-2013; Serrano, M. Ángeles/AAS-8246-2020; Papadopoulos, Fragkiskos/B-6391-2014; Krioukov, Dmitri/K-7035-2017	Boguna, Marian/0000-0001-7833-3487; Serrano, M. Angeles/0000-0001-8779-5931; Papadopoulos, Fragkiskos/0000-0002-4072-5781; Krioukov, Dmitri/0000-0001-9478-8182; Kitsak, Maksim/0000-0002-6862-6021	Marie Curie International Reintegration Grant within the 7th European Community Framework Programme; MICINN [FIS2010-21781-C02-02, BFU2010-21847-C02-02]; Generalitat de Catalunya [2009SGR838]; Ramon y Cajal programme of the Spanish Ministry of Science; ICREA Academia; Generalitat de Catalunya; NSF [CNS-0964236, CNS-1039646, CNS-0722070]; DHS [N66001-08-C-2029]; DARPA [HR0011-12-1-0012]; Cisco Systems; Direct For Computer & Info Scie & Enginr [0964236, 1039646] Funding Source: National Science Foundation	Marie Curie International Reintegration Grant within the 7th European Community Framework Programme(European Commission); MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); Generalitat de Catalunya(Generalitat de Catalunya); Ramon y Cajal programme of the Spanish Ministry of Science; ICREA Academia(ICREA); Generalitat de Catalunya(Generalitat de Catalunya); NSF(National Science Foundation (NSF)); DHS(United States Department of Homeland Security (DHS)); DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Cisco Systems; Direct For Computer & Info Scie & Enginr(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	We thank C. Elkan, G. Bianconi, P. Krapivsky, S. Redner, S. Havlin, E. Stanley and A.-L. Barabasi for discussions and suggestions. This work was supported by a Marie Curie International Reintegration Grant within the 7th European Community Framework Programme; MICINN Projects FIS2010-21781-C02-02 and BFU2010-21847-C02-02; Generalitat de Catalunya grant 2009SGR838; the Ramon y Cajal programme of the Spanish Ministry of Science; ICREA Academia prize 2010, funded by the Generalitat de Catalunya; NSF grants CNS-0964236, CNS-1039646, CNS-0722070; DHS grant N66001-08-C-2029; DARPA grant HR0011-12-1-0012; and Cisco Systems.	Adamic LA, 2000, SCIENCE, V287, DOI 10.1126/science.287.5461.2115a; [Anonymous], WWW INTERNET MODELS; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Bianconi G, 2001, PHYS REV LETT, V86, P5632, DOI 10.1103/PhysRevLett.86.5632; Bollobas B, 2003, HANDBOOK OF GRAPHS AND NETWORKS: FROM THE GENOME TO THE INTERNET, P1; Bonahon F., 2009, LOW DIMENSIONAL GEOM; Borner K, 2004, P NATL ACAD SCI USA, V101, P5266, DOI 10.1073/pnas.0307625100; Caldarelli G, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.258702; Clauset A, 2008, NATURE, V453, P98, DOI 10.1038/nature06830; Crandall David, 2008, P 14 ACM SIGKDD INT, P160, DOI DOI 10.1145/1401890.1401914; D'Souza RM, 2007, P NATL ACAD SCI USA, V104, P6112, DOI 10.1073/pnas.0606779104; Dorogovtsev S, 2010, COMPLEX NETWORKS; Dorogovtsev SN, 2000, PHYS REV LETT, V85, P4633, DOI 10.1103/PhysRevLett.85.4633; Dorogovtsev SN, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.062101; Fortunato S, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.218701; Jeong H, 2003, EUROPHYS LETT, V61, P567, DOI 10.1209/epl/i2003-00166-9; Krapivsky PL, 2000, PHYS REV LETT, V85, P4629, DOI 10.1103/PhysRevLett.85.4629; McPherson M, 2001, ANNU REV SOCIOL, V27, P415, DOI 10.1146/annurev.soc.27.1.415; Menczer F, 2004, P NATL ACAD SCI USA, V101, P5261, DOI 10.1073/pnas.0307554100; Menczer F, 2002, P NATL ACAD SCI USA, V99, P14014, DOI 10.1073/pnas.212348399; Menon AK, 2011, LECT NOTES ARTIF INT, V6912, P437, DOI 10.1007/978-3-642-23783-6_28; Motter AE, 2007, CHAOS, V17, DOI 10.1063/1.2751266; Pastor-Satorras R, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.258701; Pastor-Satorras R, 2003, J THEOR BIOL, V222, P199, DOI 10.1016/S0022-5193(03)00028-6; Redner S, 1998, EUR PHYS J B, V4, P131, DOI 10.1007/s100510050359; Simsek O, 2008, P NATL ACAD SCI USA, V105, P12758, DOI 10.1073/pnas.0800497105; van Raan AFJ, 2000, SCIENTOMETRICS, V47, P347, DOI 10.1023/A:1005647328460; Vazquez A, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.056104; Watts DJ, 2002, SCIENCE, V296, P1302, DOI 10.1126/science.1070120	30	336	354	7	140	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 27	2012	489	7417					537	540		10.1038/nature11459	http://dx.doi.org/10.1038/nature11459			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	011LT	22972194	Green Submitted			2022-12-28	WOS:000309167100044
J	van Werven, FJ; Neuert, G; Hendrick, N; Lardenois, A; Buratowski, S; van Oudenaarden, A; Primig, M; Amon, A				van Werven, Folkert J.; Neuert, Gregor; Hendrick, Natalie; Lardenois, Aurelie; Buratowski, Stephen; van Oudenaarden, Alexander; Primig, Michael; Amon, Angelika			Transcription of Two Long Noncoding RNAs Mediates Mating-Type Control of Gametogenesis in Budding Yeast	CELL			English	Article							ZINC-FINGER PROTEIN; SACCHAROMYCES-CEREVISIAE; MESSENGER-RNA; INTERGENIC TRANSCRIPTION; GENE-EXPRESSION; REPRESSION; MEIOSIS; METHYLATION; SPORULATION; ACTIVATOR	The cell-fate decision leading to gametogenesis is essential for sexual reproduction. In S. cerevisiae, only diploid MATa/alpha but not haploid MATa or MAT alpha cells undergo gametogenesis, known as sporulation. We find that transcription of two long noncoding RNAs (lncRNAs) mediates mating-type control of sporulation. In MATa or MAT alpha haploids, expression of IME1, the central inducer of gametogenesis, is inhibited in cis by transcription of the lncRNA IRT1, located in the IME1 promoter. IRT1 transcription recruits the Set2 histone methyltransferase and the Set3 histone deacetylase complex to establish repressive chromatin at the IME1 promoter. Inhibiting expression of IRT1 and an antisense transcript that antagonizes the expression of the meiotic regulator IME4 allows cells expressing the haploid mating type to sporulate with kinetics that are indistinguishable from that of MATa/alpha diploids. Conversely, expression of the two lncRNAs abolishes sporulation in MATa/alpha diploids. Thus, transcription of two lncRNAs governs mating-type control of gametogenesis in yeast.	[van Werven, Folkert J.; Hendrick, Natalie; Amon, Angelika] MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [van Werven, Folkert J.; Hendrick, Natalie; Amon, Angelika] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Neuert, Gregor; van Oudenaarden, Alexander] MIT, Dept Biol, Cambridge, MA 02139 USA; [van Oudenaarden, Alexander] Royal Netherlands Acad Arts & Sci, Hubrecht Inst, NL-3584 CT Utrecht, Netherlands; [van Oudenaarden, Alexander] Univ Med Ctr Utrecht, NL-3584 CT Utrecht, Netherlands; [Lardenois, Aurelie; Primig, Michael] Univ Rennes 1, Inst Natl Sante & Rech Med, Irset U1085, F-35042 Rennes, France; [Buratowski, Stephen] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes; Harvard University; Harvard Medical School	Amon, A (corresponding author), MIT, David H Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	angelika@mit.edu	Primig, Michael/G-3175-2013; van Oudenaarden, Alexander/AAA-1705-2019; Lardenois, Aurélie/AAA-8961-2020	Primig, Michael/0000-0002-2061-0119; Amon, Angelika/0000-0001-9837-0314; van Werven, Folkert/0000-0002-6685-2084	Netherlands Organization for Scientific Research [GM62207, 825.09.004]; National Science Foundation [ECCS-0835623]; NIH/NCI Physical Sciences Oncology Center at MIT [U54CA143874]; Inserm Avenir [R07216NS]; CREATE [NR11016NN]; NATIONAL CANCER INSTITUTE [U54CA143874] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046498, R01GM056663, R01GM062207] Funding Source: NIH RePORTER	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); National Science Foundation(National Science Foundation (NSF)); NIH/NCI Physical Sciences Oncology Center at MIT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Inserm Avenir(Institut National de la Sante et de la Recherche Medicale (Inserm)); CREATE; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to Sudeep Agarwala, Gerald Fink, and Vincent Guacci for reagents, Stacie Bumgardner for suggestions, and Stephen Bell, Frank Solomon, Gerald Fink, and members of the Amon lab for their critical reading of this manuscript. This work was supported by a grant GM62207 to A.A., by a Rubicon-grant (825.09.004) from the Netherlands Organization for Scientific Research to F.W., by grants from the National Science Foundation (ECCS-0835623) and NIH/NCI Physical Sciences Oncology Center at MIT (U54CA143874) to A.v.O. and G.N., and by the grants Inserm Avenir (R07216NS) and CREATE (NR11016NN) to M.P. A.A. is also an Investigator of the Howard Hughes Medical Institute.	Belli G, 1998, NUCLEIC ACIDS RES, V26, P942, DOI 10.1093/nar/26.4.942; Blumental-Perry A, 2002, MOL BIOL CELL, V13, P1709, DOI 10.1091/mbc.01-09-0468; Bumgarner SL, 2012, MOL CELL, V45, P470, DOI 10.1016/j.molcel.2011.11.029; Bumgarner SL, 2009, P NATL ACAD SCI USA, V106, P18321, DOI 10.1073/pnas.0909641106; Cairns BR, 2009, NATURE, V461, P193, DOI 10.1038/nature08450; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Clancy MJ, 2002, NUCLEIC ACIDS RES, V30, P4509, DOI 10.1093/nar/gkf573; COVITZ PA, 1991, GENE DEV, V5, P1982, DOI 10.1101/gad.5.11.1982; COVITZ PA, 1993, GENE DEV, V7, P1598, DOI 10.1101/gad.7.8.1598; COVITZ PA, 1994, GENETICS, V138, P577; Deng C, 2001, MOL GENET GENOMICS, V266, P497, DOI 10.1007/s004380100571; Deutschbauer AM, 2002, P NATL ACAD SCI USA, V99, P15530, DOI 10.1073/pnas.202604399; Ding DQ, 2012, SCIENCE, V336, P732, DOI 10.1126/science.1219518; Falk JE, 2010, DEV CELL, V19, P599, DOI 10.1016/j.devcel.2010.09.006; Gelfand B, 2011, MOL CELL BIOL, V31, P1701, DOI 10.1128/MCB.01071-10; Granovskaia MV, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r24; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Hainer SJ, 2011, GENE DEV, V25, P29, DOI 10.1101/gad.1975011; Hirota K, 2008, NATURE, V456, P130, DOI 10.1038/nature07348; Hochwagen A, 2005, MOL CELL BIOL, V25, P4767, DOI 10.1128/MCB.25.11.4767-4781.2005; Hongay CF, 2006, CELL, V127, P735, DOI 10.1016/j.cell.2006.09.038; Horak CE, 2002, GENE DEV, V16, P3017, DOI 10.1101/gad.1039602; Houseley J, 2008, MOL CELL, V32, P685, DOI 10.1016/j.molcel.2008.09.027; Jambhekar A, 2008, CURR BIOL, V18, P969, DOI 10.1016/j.cub.2008.05.047; KASSIR Y, 1988, CELL, V52, P853, DOI 10.1016/0092-8674(88)90427-8; Keogh MC, 2005, CELL, V123, P593, DOI 10.1016/j.cell.2005.10.025; Kim T, 2012, CELL, V150, P1158, DOI 10.1016/j.cell.2012.08.016; Kim T, 2009, CELL, V137, P259, DOI 10.1016/j.cell.2009.02.045; Krogan NJ, 2003, MOL CELL BIOL, V23, P4207, DOI 10.1128/MCB.23.12.4207-4218.2003; Lardenois A, 2011, P NATL ACAD SCI USA, V108, P1058, DOI 10.1073/pnas.1016459108; Leza MA, 1999, GENETICS, V151, P531; Li B, 2007, GENE DEV, V21, P1422, DOI 10.1101/gad.1539307; Martens JA, 2004, NATURE, V429, P571, DOI 10.1038/nature02538; MITCHELL AP, 1992, GENETICS, V131, P65; MITCHELL AP, 1986, NATURE, V319, P738, DOI 10.1038/319738a0; Pijnappel WWMP, 2001, GENE DEV, V15, P2991, DOI 10.1101/gad.207401; Pinskaya M, 2009, EMBO J, V28, P1697, DOI 10.1038/emboj.2009.108; Raj A, 2008, NAT METHODS, V5, P877, DOI 10.1038/NMETH.1253; SHAH JC, 1992, MOL CELL BIOL, V12, P1078, DOI 10.1128/MCB.12.3.1078; Shimizu M, 1998, NUCLEIC ACIDS RES, V26, P2329, DOI 10.1093/nar/26.10.2329; Shimizu M, 1997, P NATL ACAD SCI USA, V94, P790, DOI 10.1073/pnas.94.3.790; Thebault P, 2011, MOL CELL BIOL, V31, P1288, DOI 10.1128/MCB.01083-10; TOONE WM, 1995, EMBO J, V14, P5824, DOI 10.1002/j.1460-2075.1995.tb00270.x; Uhler JP, 2007, P NATL ACAD SCI USA, V104, P8011, DOI 10.1073/pnas.0702431104; van Dijk EL, 2011, NATURE, V475, P114, DOI 10.1038/nature10118; van Werven FJ, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl003; van Werven FJ, 2011, PHILOS T R SOC B, V366, P3521, DOI 10.1098/rstb.2011.0081; Xiao TJ, 2003, GENE DEV, V17, P654, DOI 10.1101/gad.1055503; Xu ZY, 2009, NATURE, V457, P1033, DOI 10.1038/nature07728; Zhang LY, 2011, GENOME RES, V21, P875, DOI 10.1101/gr.117465.110; Zofall M, 2012, SCIENCE, V335, P96, DOI 10.1126/science.1211651	51	184	186	2	53	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 14	2012	150	6					1170	1181		10.1016/j.cell.2012.06.049	http://dx.doi.org/10.1016/j.cell.2012.06.049			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	007ZY	22959267	Green Accepted, Bronze			2022-12-28	WOS:000308928100011
J	Bond, RM; Fariss, CJ; Jones, JJ; Kramer, AI; Marlow, C; Settle, JE; Fowler, JH				Bond, Robert M.; Fariss, Christopher J.; Jones, Jason J.; Kramer, Adamd. I.; Marlow, Cameron; Settle, Jaime E.; Fowler, James H.			A 61-million-person experiment in social influence and political mobilization	NATURE			English	Article							VOTER TURNOUT; NETWORK; SPREAD; COOPERATION; DYNAMICS; BEHAVIOR; ADOPTION	Human behaviour is thought to spread through face-to-face social networks, but it is difficult to identify social influence effects in observational studies(9-13), and it is unknown whether online social networks operate in the same way(14-19). Here we report results from a randomized controlled trial of political mobilization messages delivered to 61 million Facebook users during the 2010 US congressional elections. The results show that the messages directly influenced political self-expression, information seeking and real-world voting behaviour of millions of people. Furthermore, the messages not only influenced the users who received them but also the users' friends, and friends of friends. The effect of social transmission on real-world voting was greater than the direct effect of the messages themselves, and nearly all the transmission occurred between 'close friends' who were more likely to have a face-to-face relationship. These results suggest that strong ties are instrumental for spreading both online and real-world behaviour in human social networks.	[Bond, Robert M.; Fariss, Christopher J.; Settle, Jaime E.; Fowler, James H.] Univ Calif San Diego, Dept Polit Sci, La Jolla, CA 92093 USA; [Jones, Jason J.] Univ Calif San Diego, Dept Psychol, La Jolla, CA 92093 USA; [Kramer, Adamd. I.; Marlow, Cameron] Facebook Inc, Data Sci, Menlo Pk, CA 94025 USA; [Fowler, James H.] Univ Calif San Diego, Div Med Genet, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Facebook Inc; University of California System; University of California San Diego	Fowler, JH (corresponding author), Univ Calif San Diego, Dept Polit Sci, La Jolla, CA 92093 USA.	jhfowler@ucsd.edu	Bond, Robert Meade/A-1561-2014; Fariss, Christopher/A-2244-2010; Fowler, James H/C-2750-2008; Edgar, William D/J-8792-2013; Fariss, Christopher/AAN-9494-2020; Jones, Jason J/I-3350-2012; Fariss, Christopher J/AAG-9477-2021	Fowler, James H/0000-0001-7795-1638; Edgar, William D/0000-0002-7996-9273; Jones, Jason J/0000-0002-4140-0268; Fariss, Christopher J/0000-0001-9837-186X	James S. McDonnell Foundation; University of Notre Dame; John Templeton Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103504] Funding Source: NIH RePORTER	James S. McDonnell Foundation; University of Notre Dame; John Templeton Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to S. Aral, J. Berger, M. Cebrian, D. Centola, N. Christakis, C. Dawes, L. Gee, D. Green, C. Kam, P. Loewen, P. Mucha, J. P. Onnela, M. Porter, O. Smirnov and C. Volden for comments on early drafts. This work was supported in part by the James S. McDonnell Foundation, and the University of Notre Dame and the John Templeton Foundation as part of the Science of Generosity Initiative.	Apicella CL, 2012, NATURE, V481, P497, DOI 10.1038/nature10736; Aral S, 2012, SCIENCE, V337, P337, DOI 10.1126/science.1215842; Aral S, 2009, P NATL ACAD SCI USA, V106, P21544, DOI 10.1073/pnas.0908800106; Berger J, 2009, P NATL ACAD SCI USA, V106, P8146, DOI 10.1073/pnas.0812647106; Borgatti SP, 2009, SCIENCE, V323, P892, DOI 10.1126/science.1165821; Bryan CJ, 2011, P NATL ACAD SCI USA, V108, P12653, DOI 10.1073/pnas.1103343108; Centola D, 2011, SCIENCE, V334, P1269, DOI 10.1126/science.1207055; Centola D, 2010, SCIENCE, V329, P1194, DOI 10.1126/science.1185231; Christakis N. A., 2011, SOCIAL CONTAGION THE; Christakis N.A., 2009, CONNECTED SURPRISING; Christakis NA, 2008, NEW ENGL J MED, V358, P2249, DOI 10.1056/NEJMsa0706154; Christakis NA, 2007, NEW ENGL J MED, V357, P370, DOI 10.1056/NEJMsa066082; Ellison NB, 2007, J COMPUT-MEDIAT COMM, V12, P1143, DOI 10.1111/j.1083-6101.2007.00367.x; Fowler J. H., 2005, SOCIAL LOGIC POLITIC; Fowler JH, 2010, P NATL ACAD SCI USA, V107, P5334, DOI 10.1073/pnas.0913149107; Fowler JH, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2338; Gerber AS, 2008, AM POLIT SCI REV, V102, P33, DOI 10.1017/S000305540808009X; Gerber AS, 1999, P NATL ACAD SCI USA, V96, P10939, DOI 10.1073/pnas.96.19.10939; Gonzalez-Bailon S, 2011, SCI REP-UK, V1, DOI 10.1038/srep00197; GRANOVETTER MS, 1973, AM J SOCIOL, V78, P1360, DOI 10.1086/225469; Huckfeldt R.R., 1995, CITIZENS POLITICS SO; KENNY CB, 1992, AM J POLIT SCI, V36, P259, DOI 10.2307/2111432; Lazer D, 2009, SCIENCE, V323, P721, DOI 10.1126/science.1167742; Nickerson DW, 2007, Q J POLIT SCI, V2, P369, DOI 10.1561/100.00007032; Nickerson DW, 2008, AM POLIT SCI REV, V102, P49, DOI 10.1017/S0003055408080039; Ohtsuki H, 2006, NATURE, V441, P502, DOI 10.1038/nature04605; Onnela JP, 2010, P NATL ACAD SCI USA, V107, P18375, DOI 10.1073/pnas.0914572107; Red V, 2011, SIAM REV, V53, P526, DOI 10.1137/080734315; Salganik MJ, 2006, SCIENCE, V311, P854, DOI 10.1126/science.1121066; Vitak J, 2011, CYBERPSYCH BEH SOC N, V14, P107, DOI 10.1089/cyber.2009.0226	30	1169	1197	21	511	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 13	2012	489	7415					295	298		10.1038/nature11421	http://dx.doi.org/10.1038/nature11421			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	003UC	22972300	Green Accepted			2022-12-28	WOS:000308635900042
J	Hartzband, P; Groopman, J				Hartzband, Pamela; Groopman, Jerome			There Is More to Life Than Death	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Hartzband, Pamela; Groopman, Jerome] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Hartzband, Pamela; Groopman, Jerome] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Hartzband, P (corresponding author), Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA.							Catalona WJ, 2012, ANN INTERN MED, V157, P137, DOI 10.7326/0003-4819-157-2-201207170-00463; Groopman J, 2011, YOUR MED MIND DECIDE; Harris G, 2011, NY TIMES        1121; Owens DK, 2011, ANN INTERN MED, V154, P174, DOI 10.7326/0003-4819-154-3-201102010-00007; SLOVIC P, 1987, SCIENCE, V236, P280, DOI 10.1126/science.3563507	5	23	23	1	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 13	2012	367	11					987	989		10.1056/NEJMp1207052	http://dx.doi.org/10.1056/NEJMp1207052			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	003ZE	22970943				2022-12-28	WOS:000308649100004
J	Rizos, EC; Ntzani, EE; Bika, E; Kostapanos, MS; Elisaf, MS				Rizos, Evangelos C.; Ntzani, Evangelia E.; Bika, Eftychia; Kostapanos, Michael S.; Elisaf, Moses S.			Association Between Omega-3 Fatty Acid Supplementation and Risk of Major Cardiovascular Disease Events A Systematic Review and Meta-analysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							POLYUNSATURATED FATTY-ACIDS; ACUTE MYOCARDIAL-INFARCTION; PLACEBO-CONTROLLED TRIAL; CORONARY-HEART-DISEASE; FISH-OIL; DOUBLE-BLIND; EICOSAPENTAENOIC ACID; SECONDARY PREVENTION; DEATH; DEFIBRILLATORS	Context Considerable controversy exists regarding the association of omega-3 polyunsaturated fatty acids (PUFAs) and major cardiovascular end points. Objective To assess the role of omega-3 supplementation on major cardiovascular outcomes. Data Sources MEDLINE, EMBASE, and the Cochrane Central Register of Controlled Trials through August 2012. Study Selection Randomized clinical trials evaluating the effect of omega-3 on all-cause mortality, cardiac death, sudden death, myocardial infarction, and stroke. Data Extraction Descriptive and quantitative information was extracted; absolute and relative risk (RR) estimates were synthesized under a random-effects model. Heterogeneity was assessed using the Q statistic and I-2. Subgroup analyses were performed for the presence of blinding, the prevention settings, and patients with implantable cardioverter-defibrillators, and meta-regression analyses were performed for the omega-3 dose. A statistical significance threshold of .0063 was assumed after adjustment for multiple comparisons. Data Synthesis Of the 3635 citations retrieved, 20 studies of 68 680 patients were included, reporting 7044 deaths, 3993 cardiac deaths, 1150 sudden deaths, 1837 myocardial infarctions, and 1490 strokes. No statistically significant association was observed with all-cause mortality (RR, 0.96; 95% CI, 0.91 to 1.02; risk reduction [RD] -0.004, 95% CI, -0.01 to 0.02), cardiac death (RR, 0.91; 95% CI, 0.85 to 0.98; RD, -0.01; 95% CI, -0.02 to 0.00), sudden death (RR, 0.87; 95% CI, 0.75 to 1.01; RD, -0.003; 95% CI, -0.012 to 0.006), myocardial infarction (RR, 0.89; 95% CI, 0.76 to 1.04; RD, -0.002; 95% CI, -0.007 to 0.002), and stroke (RR, 1.05; 95% CI, 0.93 to 1.18; RD, 0.001; 95% CI, -0.002 to 0.004) when all supplement studies were considered. Conclusion Overall, omega-3 PUFA supplementation was not associated with a lower risk of all-cause mortality, cardiac death, sudden death, myocardial infarction, or stroke based on relative and absolute measures of association. JAMA. 2012; 308(10): 1024-1033 www.jama.com	[Rizos, Evangelos C.; Bika, Eftychia; Kostapanos, Michael S.; Elisaf, Moses S.] Univ Hosp Ioannina, Dept Internal Med, Lipid Disorders Clin, Ioannina 45110, Greece; [Ntzani, Evangelia E.] Univ Ioannina, Sch Med, Dept Hyg & Epidemiol, Clin & Mol Epidemiol Unit, GR-45110 Ioannina, Greece	University Hospital Ioannina; University of Ioannina	Elisaf, MS (corresponding author), Univ Hosp Ioannina, Dept Internal Med, Lipid Disorders Clin, Ioannina 45110, Greece.	egepi@cc.uoi.gr	Kostapanos, Michalis/AAB-2411-2020; Ntzani, Evangelina E./K-1565-2019	Kostapanos, Michalis/0000-0002-7513-5319; ELISAF, MOSES/0000-0003-0505-078X; Ntzani, Evangelia/0000-0003-3712-4181				ASSMANN G, 1992, AM J CARDIOL, V70, pH10, DOI 10.1016/0002-9149(92)91084-H; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Bosch J, 2012, NEW ENGL J MED, V367, P309, DOI 10.1056/NEJMoa1203859; Brouwer IA, 2006, JAMA-J AM MED ASSOC, V295, P2613, DOI 10.1001/jama.295.22.2613; Bucher HC, 2002, AM J MED, V112, P298, DOI 10.1016/S0002-9343(01)01114-7; BURR ML, 1989, LANCET, V2, P757; Burr ML, 2003, EUR J CLIN NUTR, V57, P193, DOI 10.1038/sj.ejcn.1601539; Cappelleri JC, 1996, JAMA-J AM MED ASSOC, V276, P1332, DOI 10.1001/jama.276.16.1332; Castelli W P, 1992, Ann Epidemiol, V2, P23, DOI 10.1016/1047-2797(92)90033-M; Conroy RM, 2003, EUR HEART J, V24, P987, DOI 10.1016/S0195-668X(03)00114-3; Einvik G, 2010, EUR J CARDIOV PREV R, V17, P588, DOI 10.1097/HJR.0b013e328339cc70; Filion KB, 2010, BMC CARDIOVASC DISOR, V10, DOI 10.1186/1471-2261-10-24; Galan P, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c6273; Garbagnati F, 2009, CEREBROVASC DIS, V27, P375, DOI 10.1159/000207441; Guyatt G., 2008, USERS GUIDES MEDICAL; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928; Hooper L, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003177.PUB2; Kris-Etherton PM, 2002, CIRCULATION, V106, P2747, DOI 10.1161/01.CIR.0000038493.65177.94; Kromhout D, 2010, NEW ENGL J MED, V363, P2015, DOI 10.1056/NEJMoa1003603; Kwak SM, 2012, ARCH INTERN MED, V172, P686, DOI 10.1001/archinternmed.2012.262; Lau J, 1997, ANN INTERN MED, V127, P820, DOI 10.7326/0003-4819-127-9-199711010-00008; LAU J, 1992, NEW ENGL J MED, V327, P248, DOI 10.1056/NEJM199207233270406; Lavie CJ, 2009, J AM COLL CARDIOL, V54, P585, DOI 10.1016/j.jacc.2009.02.084; Leaf A, 2005, CIRCULATION, V112, P2762, DOI 10.1161/CIRCULATIONAHA.105.549527; Leng GC, 1998, CLIN NUTR, V17, P265, DOI 10.1016/S0261-5614(98)80318-X; Marchioli R, 2002, CIRCULATION, V105, P1897, DOI 10.1161/01.CIR.0000014682.14181.F2; Marik PE, 2009, CLIN CARDIOL, V32, P365, DOI 10.1002/clc.20604; Moher D, 2009, J CLIN EPIDEMIOL, V62, P1006, DOI 10.1016/j.jclinepi.2009.06.005; MORRIS MC, 1993, CIRCULATION, V88, P523, DOI 10.1161/01.CIR.88.2.523; Nilsen DWT, 2001, AM J CLIN NUTR, V74, P50; Podrid PJ, 2005, CLIN CARDIOL, V28, pI3; Raitt MH, 2005, JAMA-J AM MED ASSOC, V293, P2884, DOI 10.1001/jama.293.23.2884; Rauch B, 2010, CIRCULATION, V122, P2152, DOI 10.1161/CIRCULATIONAHA.110.948562; SACKS FM, 1995, J AM COLL CARDIOL, V25, P1492, DOI 10.1016/0735-1097(95)00095-L; Saravanan P, 2010, LANCET, V376, P540, DOI 10.1016/S0140-6736(10)60445-X; Singh RB, 1997, CARDIOVASC DRUG THER, V11, P485, DOI 10.1023/A:1007757724505; Svensson M, 2006, CLIN J AM SOC NEPHRO, V1, P780, DOI 10.2215/CJN.00630206; Tavazzi L, 2008, LANCET, V372, P1223, DOI 10.1016/S0140-6736(08)61239-8; Trikalinos TA, EFFECTS EICOSAPENTAN; Van de Werf F, 2008, EUR HEART J, V29, P2909, DOI 10.1093/eurheartj/ehn416; von Schacky C, 1999, ANN INTERN MED, V130, P554, DOI 10.7326/0003-4819-130-7-199904060-00003; Yokoyama M, 2007, LANCET, V369, P1090, DOI 10.1016/S0140-6736(07)60527-3; Zhao YT, 2009, ANN MED, V41, P301, DOI 10.1080/07853890802698834	44	732	760	3	200	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 12	2012	308	10					1024	1033		10.1001/2012.jama.11374	http://dx.doi.org/10.1001/2012.jama.11374			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	003AA	22968891				2022-12-28	WOS:000308579300026
J	Chan, YHM; Marshall, WF				Chan, Yee-Hung M.; Marshall, Wallace F.			How Cells Know the Size of Their Organelles	SCIENCE			English	Review							FLAGELLAR LENGTH CONTROL; SPINDLE LENGTH; INTRAFLAGELLAR TRANSPORT; CHLAMYDOMONAS-REINHARDTII; BACTERIAL INJECTISOMES; MITOTIC SPINDLE; TELOMERE LENGTH; NEEDLE LENGTH; YEAST; PROTEINS	Cells have developed ways to sense and control the size of their organelles. Size-sensing mechanisms range from direct measurements provided by dedicated reporters to indirect functional readouts, and they are used to modify organelle size under both normal and stress conditions. Organelle size can also be controlled in the absence of an identifiable size sensor. Studies on flagella have dissected principles of size sensing and control, and it will be exciting to see how these principles apply to other organelles.	[Chan, Yee-Hung M.; Marshall, Wallace F.] Univ Calif San Francisco, UCSF Ctr Syst & Synthet Biol, Dept Biochem & Biophys, San Francisco, CA 94158 USA	University of California System; University of California San Francisco	Chan, YHM (corresponding author), Univ Calif San Francisco, UCSF Ctr Syst & Synthet Biol, Dept Biochem & Biophys, San Francisco, CA 94158 USA.	yhmchan@ucsf.edu; wallace.marshall@ucsf.edu			Herbert Boyer Postdoctoral Fellowship; NIH National Research Service Award [1F32GM090442-01A1]; NIH [R01GM097017, P50GM081879]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM081879, F32GM090442, R01GM097017] Funding Source: NIH RePORTER	Herbert Boyer Postdoctoral Fellowship; NIH National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Y.-H.M.C. acknowledges the support of the Herbert Boyer Postdoctoral Fellowship and NIH National Research Service Award no. 1F32GM090442-01A1. W. F. M. acknowledges the support of NIH grants R01GM097017 and P50GM081879.	Avasthi P, 2009, J NEUROSCI, V29, P14287, DOI 10.1523/JNEUROSCI.3976-09.2009; BARSEL SE, 1988, GENETICS, V118, P637; Bastiaens P, 2006, TRENDS CELL BIOL, V16, P125, DOI 10.1016/j.tcb.2006.01.005; Berciano MT, 2007, J STRUCT BIOL, V158, P410, DOI 10.1016/j.jsb.2006.12.008; Blaineau C, 2007, CURR BIOL, V17, P778, DOI 10.1016/j.cub.2007.03.048; Brust-Mascher I, 2009, MOL BIOL CELL, V20, P1749, DOI 10.1091/mbc.E08-10-1033; Chan YHM, 2012, PROC SPIE, V8225, DOI 10.1117/12.909278; Chan YHM, 2010, ORGANOGENESIS, V6, P88, DOI 10.4161/org.6.2.11464; Dumont S, 2009, CURR BIOL, V19, P1086, DOI 10.1016/j.cub.2009.05.056; Egner A, 2002, P NATL ACAD SCI USA, V99, P3370, DOI 10.1073/pnas.052545099; Engel BD, 2009, J CELL BIOL, V187, P81, DOI 10.1083/jcb.200812084; Federovitch CM, 2005, CURR OPIN CELL BIOL, V17, P409, DOI 10.1016/j.ceb.2005.06.010; Goehring NW, 2012, CURR BIOL, V22, pR330, DOI 10.1016/j.cub.2012.03.046; Goshima G, 1999, GENE DEV, V13, P1664, DOI 10.1101/gad.13.13.1664; Hao LM, 2011, NAT CELL BIOL, V13, P790, DOI 10.1038/ncb2268; Jorgensen P, 2007, MOL BIOL CELL, V18, P3523, DOI 10.1091/mbc.E06-10-0973; Journet L, 2003, SCIENCE, V302, P1757, DOI 10.1126/science.1091422; KATSURA I, 1987, NATURE, V327, P73, DOI 10.1038/327073a0; KUCHKA MR, 1987, GENETICS, V115, P685; Lopez-Huertas E, 2000, EMBO J, V19, P6770, DOI 10.1093/emboj/19.24.6770; Loughlin R, 2011, CELL, V147, P1397, DOI 10.1016/j.cell.2011.11.014; Luo MN, 2011, CURR BIOL, V21, P586, DOI 10.1016/j.cub.2011.02.046; Makishima S, 2001, SCIENCE, V291, P2411, DOI 10.1126/science.1058366; Marcand S, 1997, SCIENCE, V275, P986, DOI 10.1126/science.275.5302.986; Marshall WF, 2005, MOL BIOL CELL, V16, P270, DOI 10.1091/mbc.E04-07-0586; Marshall WF, 2001, J CELL BIOL, V155, P405, DOI 10.1083/jcb.200106141; McNally K, 2006, J CELL BIOL, V175, P881, DOI 10.1083/jcb.200608117; Mitchison TJ, 2005, MOL BIOL CELL, V16, P3064, DOI 10.1091/mbc.E05-02-0174; Mota LJ, 2005, SCIENCE, V307, P1278, DOI 10.1126/science.1107679; Neumann FR, 2007, J CELL BIOL, V179, P593, DOI 10.1083/jcb.200708054; Pan JM, 2004, DEV CELL, V6, P445, DOI 10.1016/S1534-5807(04)00064-4; ROSENBAU.JL, 1969, J CELL BIOL, V41, P600, DOI 10.1083/jcb.41.2.600; Schuck S, 2009, J CELL BIOL, V187, P525, DOI 10.1083/jcb.200907074; Smogorzewska A, 2000, MOL CELL BIOL, V20, P1659, DOI 10.1128/MCB.20.5.1659-1668.2000; Stolc V, 2005, P NATL ACAD SCI USA, V102, P3703, DOI 10.1073/pnas.0408358102; Toriyama M, 2006, J CELL BIOL, V175, P147, DOI 10.1083/jcb.200604160; Turner L, 2012, J BACTERIOL, V194, P2437, DOI 10.1128/JB.06735-11; Uchida M, 2011, YEAST, V28, P227, DOI 10.1002/yea.1834; Varga V, 2006, NAT CELL BIOL, V8, P957, DOI 10.1038/ncb1462; Weaver LN, 2011, CURR BIOL, V21, P1500, DOI 10.1016/j.cub.2011.08.005; Welihinda AA, 1999, GENE EXPRESSION, V7, P293; YAMAMOTO A, 1995, MOL BIOL CELL, V6, P525, DOI 10.1091/mbc.6.5.525; Zucker-Franklin D., 1998, ATLAS BLOOD CELLS FU	43	76	77	0	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 7	2012	337	6099					1186	1189		10.1126/science.1223539	http://dx.doi.org/10.1126/science.1223539			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	000UJ	22955827	Green Accepted			2022-12-28	WOS:000308414000027
J	Cloud, V; Chan, YL; Grubb, J; Budke, B; Bishop, DK				Cloud, Veronica; Chan, Yuen-Ling; Grubb, Jennifer; Budke, Brian; Bishop, Douglas K.			Rad51 Is an Accessory Factor for Dmc1-Mediated Joint Molecule Formation During Meiosis	SCIENCE			English	Article							MEIOTIC RECOMBINATION; PROTEIN COMPLEX; SACCHAROMYCES-CEREVISIAE; DNA-BINDING; DMC1; HOMOLOG; ROLES	Meiotic recombination in budding yeast requires two RecA-related proteins, Rad51 and Dmc1, both of which form filaments on DNA capable of directing homology search and catalyzing formation of homologous joint molecules (JMs) and strand exchange. With use of a separation-of-function mutant form of Rad51 that retains filament-forming but not JM-forming activity, we show that the JM activity of Rad51 is fully dispensable for meiotic recombination. The corresponding mutation in Dmc1 causes a profound recombination defect, demonstrating Dmc1's JM activity alone is responsible for meiotic recombination. We further provide biochemical evidence that Rad51 acts with Mei5-Sae3 as a Dmc1 accessory factor. Thus, Rad51 is a multifunctional protein that catalyzes recombination directly in mitosis and indirectly, via Dmc1, during meiosis.	[Cloud, Veronica; Bishop, Douglas K.] Univ Chicago, Cummings Life Sci Ctr, Comm Genet, Chicago, IL 60637 USA; [Cloud, Veronica; Chan, Yuen-Ling; Grubb, Jennifer; Budke, Brian; Bishop, Douglas K.] Univ Chicago, Cummings Life Sci Ctr, Dept Radiat & Cellular Oncol, Chicago, IL 60637 USA; [Bishop, Douglas K.] Univ Chicago, Cummings Life Sci Ctr, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago	Bishop, DK (corresponding author), Univ Chicago, Cummings Life Sci Ctr, Comm Genet, 920 E 58th St, Chicago, IL 60637 USA.	dbishop@uchicago.edu		Budke, Brian/0000-0001-6051-8416	National Institute for General Medical Sciences [GM50936]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050936] Funding Source: NIH RePORTER	National Institute for General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to A. Zhang and P. Rice for structural alignments, N. Hunter for critical reading of the manuscript and strains, P. Sung for plasmid pET11d-ScRad52, and W. Heyer for Rad54 protein. This work was supported by National Institute for General Medical Sciences grant GM50936.	BISHOP DK, 1994, CELL, V79, P1081, DOI 10.1016/0092-8674(94)90038-8; BISHOP DK, 1992, CELL, V69, P439, DOI 10.1016/0092-8674(92)90446-J; Chi P, 2006, DNA REPAIR, V5, P381, DOI 10.1016/j.dnarep.2005.11.005; Ferrari SR, 2009, J BIOL CHEM, V284, P11766, DOI 10.1074/jbc.C900023200; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; Gasior SL, 1998, GENE DEV, V12, P2208, DOI 10.1101/gad.12.14.2208; Hayase A, 2004, CELL, V119, P927, DOI 10.1016/j.cell.2004.10.031; Hunter N, 2001, CELL, V106, P59, DOI 10.1016/S0092-8674(01)00430-5; Kokabu Y, 2011, J BIOL CHEM, V286, P43569, DOI 10.1074/jbc.M111.303339; Kurumizaka H, 1999, ARCH BIOCHEM BIOPHYS, V365, P83, DOI 10.1006/abbi.1999.1166; MULLER B, 1990, J MOL BIOL, V212, P97, DOI 10.1016/0022-2836(90)90307-8; Oh SD, 2007, CELL, V130, P259, DOI 10.1016/j.cell.2007.05.035; Say AF, 2011, DNA REPAIR, V10, P586, DOI 10.1016/j.dnarep.2011.03.006; Schwacha A, 1997, CELL, V90, P1123, DOI 10.1016/S0092-8674(00)80378-5; Sheridan S, 2006, GENE DEV, V20, P1685, DOI 10.1101/gad.1447606; Shinohara A, 1997, GENES CELLS, V2, P615, DOI 10.1046/j.1365-2443.1997.1480347.x; SHINOHARA A, 1992, CELL, V69, P457, DOI 10.1016/0092-8674(92)90447-K; Tsubouchi H, 2006, GENE DEV, V20, P1766, DOI 10.1101/gad.1422506	18	186	190	2	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 7	2012	337	6099					1222	1225		10.1126/science.1219379	http://dx.doi.org/10.1126/science.1219379			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	000UJ	22955832	Green Accepted			2022-12-28	WOS:000308414000037
J	Marvasti, FF; Stafford, RS				Marvasti, Farshad Fani; Stafford, Randall S.			From Sick Care to Health Care - Reengineering Prevention into the U.S. System	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Marvasti, Farshad Fani] Stanford Univ Med Sch, Stanford Prevent Res Ctr, Stanford, CA USA; Stanford Univ Med Sch, Dept Med, Stanford, CA USA	Stanford University	Marvasti, FF (corresponding author), Stanford Univ Med Sch, Stanford Prevent Res Ctr, Stanford, CA USA.		Stafford, Randall/F-3974-2017	Stafford, Randall/0000-0003-1805-1271	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K24HL086703] Funding Source: NIH RePORTER; NHLBI NIH HHS [K24 HL086703] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Department of Health and Human Services, 2010, HLTH PEOPL 2020; FLEMING DW, 1954, WELCH RISE MODERN ME; FRIES JF, 1980, NEW ENGL J MED, V303, P130, DOI 10.1056/NEJM198007173030304; Fuster, 2010, PROMOTING CARDIOVASC; Mokdad AH, 2005, JAMA-J AM MED ASSOC, V293, P293, DOI 10.1001/jama.293.3.293	5	68	68	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 6	2012	367	10					889	891		10.1056/NEJMp1206230	http://dx.doi.org/10.1056/NEJMp1206230			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	999VO	22931257	Green Accepted			2022-12-28	WOS:000308343300004
J	Blair, AC; Fisher, ER; Rickey, D				Blair, A. Colin; Fisher, Ellen R.; Rickey, Dawn			Discovering Nanoscience	SCIENCE			English	Editorial Material							GOLD NANOPARTICLE; ALTERNATIVE TOOL		[Blair, A. Colin; Fisher, Ellen R.; Rickey, Dawn] Colorado State Univ, Dept Chem, Ft Collins, CO 80523 USA	Colorado State University	Blair, AC (corresponding author), Colorado State Univ, Dept Chem, Ft Collins, CO 80523 USA.	dawn.rickey@colostate.edu						Mattox AC, 2006, J CHEM EDUC, V83, P622, DOI 10.1021/ed083p622; McFarland A.D., 2004, J CHEM EDUC, V81, P544, DOI DOI 10.1021/ED081P544A; Olson S., 2012, ENG EXC PROD ON MILL; Rickey D., 1999, THESIS U CALIFORNIA; Rojanathanes R, 2008, TAIWAN J OBSTET GYNE, V47, P296, DOI 10.1016/S1028-4559(08)60127-8; Schwartz DL, 2011, J EDUC PSYCHOL, V103, P759, DOI 10.1037/a0025140; Tien L. T., 1998, THESIS U CALIFORNIA; Tien L. T., 1999, J COLL SCI TEACH, V28, P318; Wiwanitkit V, 2007, RENAL FAILURE, V29, P1047, DOI 10.1080/08860220701643575	9	3	4	0	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 31	2012	337	6098					1056	1057		10.1126/science.1215151	http://dx.doi.org/10.1126/science.1215151			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996WP	22936769				2022-12-28	WOS:000308125800036
J	Towbin, BD; Gonzalez-Aguilera, C; Sack, R; Gaidatzis, D; Kalck, V; Meister, P; Askjaer, P; Gasser, SM				Towbin, Benjamin D.; Gonzalez-Aguilera, Cristina; Sack, Ragna; Gaidatzis, Dimos; Kalck, Veronique; Meister, Peter; Askjaer, Peter; Gasser, Susan M.			Step-Wise Methylation of Histone H3K9 Positions Heterochromatin at the Nuclear Periphery	CELL			English	Article							CAENORHABDITIS-ELEGANS; C-ELEGANS; LAMINA INTERACTIONS; LYSINE 9; HP1 PROTEINS; GERM-LINE; GENOME; CHROMATIN; COMPLEX; METHYLTRANSFERASES	The factors that sequester transcriptionally repressed heterochromatin at the nuclear periphery are currently unknown. In a genome-wide RNAi screen, we found that depletion of S-adenosylmethionine (SAM) synthetase reduces histone methylation globally and causes derepression and release of heterochromatin from the nuclear periphery in Caenorhabditis elegans embryos. Analysis of histone methyltransferases (HMTs) showed that elimination of two HMTs, MET-2 and SET-25, mimics the loss of SAM synthetase, abrogating the perinuclear attachment of heterochromatic transgenes and of native chromosomal arms rich in histone H3 lysine 9 methylation. The two HMTs target H3K9 in a consecutive fashion: MET-2, a SETDB1 homolog, mediates mono-and dimethylation, and SET-25, a previously uncharacterized HMT, deposits H3K9me3. SET-25 colocalizes with its own product in perinuclear foci, in a manner dependent on H3K9me3, but not on its catalytic domain. This colocalization suggests an autonomous, self-reinforcing mechanism for the establishment and propagation of repeat-rich heterochromatin.	[Towbin, Benjamin D.; Sack, Ragna; Gaidatzis, Dimos; Kalck, Veronique; Meister, Peter; Gasser, Susan M.] Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland; [Towbin, Benjamin D.; Gasser, Susan M.] Univ Basel, Fac Sci, CH-4056 Basel, Switzerland; [Gonzalez-Aguilera, Cristina; Askjaer, Peter] Univ Pablo de Olavide, CABD, CSIC, Seville 41013, Spain	Friedrich Miescher Institute for Biomedical Research; University of Basel; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; CSIC - Andalusian Center for Developmental Biology (CABD)	Gasser, SM (corresponding author), Friedrich Miescher Inst Biomed Res, Maulbeerstr 66, CH-4058 Basel, Switzerland.	susan.gasser@fmi.ch	Towbin, Benjamin D/C-8545-2018; Meister, Peter/B-4770-2010; Towbin, Benjamin D/AAO-8064-2021; Askjaer, Peter/I-3316-2012	Meister, Peter/0000-0002-6230-4216; Towbin, Benjamin D/0000-0001-7046-1257; Askjaer, Peter/0000-0003-3192-4428; Gonzalez- Aguilera, Cristina/0000-0003-4845-5744; Gasser, Susan/0000-0003-3610-9123	European Union Network of Excellence "Epigenome"; Novartis Research Foundation; Fondation Suisse de recherche sur les maladies musculaires; Spanish Ministry of Science and Innovation [BFU2010-15478]; EMBO [ASTF 478-2011]	European Union Network of Excellence "Epigenome"(European Commission); Novartis Research Foundation; Fondation Suisse de recherche sur les maladies musculaires; Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); EMBO(European Molecular Biology Organization (EMBO))	We thank Y. Gruenbaum and T. Jenuwein for antibodies; M. Thomas, R. Arpagaus, R. Son, and T. Sakuragi for excellent technical assistance; I. Katic for help with injections; the Caenorhabditis Genetics Center; R. Horvitz, M. Tijsterman and F. Palladino for strains; D. Schubeler, A. Peters, and H. Ferreira for critical reading of the manuscript; and L. Hoerner for help with array hybridization. This work was supported by the European Union Network of Excellence "Epigenome", the Novartis Research Foundation, the "Fondation Suisse de recherche sur les maladies musculaires", the Spanish Ministry of Science and Innovation (BFU2010-15478 to P.A.), and EMBO (ASTF 478-2011 to C.G.A.).	Akhtar A, 2007, NAT REV GENET, V8, P507, DOI 10.1038/nrg2122; Andersen EC, 2007, DEVELOPMENT, V134, P2991, DOI 10.1242/dev.009373; Azzaria M, 1996, DEV BIOL, V178, P289, DOI 10.1006/dbio.1996.0219; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Bender LB, 2006, DEVELOPMENT, V133, P3907, DOI 10.1242/dev.02584; Bender LB, 2004, CURR BIOL, V14, P1639, DOI 10.1016/j.cub.2004.08.062; Bessler JB, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000830; Black JC, 2011, EPIGENETICS-US, V6, P13, DOI 10.4161/epi.6.1.13331; CAPOWSKI EE, 1991, GENETICS, V129, P1061; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Frokjaer-Jensen C, 2008, NAT GENET, V40, P1375, DOI 10.1038/ng.248; Goldman RD, 2002, GENE DEV, V16, P533, DOI 10.1101/gad.960502; Guelen L, 2008, NATURE, V453, P948, DOI 10.1038/nature06947; Hansen KH, 2008, NAT CELL BIOL, V10, P1291, DOI 10.1038/ncb1787; Hsieh J, 2000, ANNU REV GENET, V34, P187, DOI 10.1146/annurev.genet.34.1.187; Ikegami K, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-12-r120; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kind J, 2010, CURR OPIN CELL BIOL, V22, P320, DOI 10.1016/j.ceb.2010.04.002; Koester-Eiserfunke N, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002017; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Lehner B, 2006, NAT PROTOC, V1, P1617, DOI 10.1038/nprot.2006.245; Liu T, 2011, GENOME RES, V21, P227, DOI 10.1101/gr.115519.110; Loyola A, 2006, MOL CELL, V24, P309, DOI 10.1016/j.molcel.2006.08.019; Loyola A, 2009, EMBO REP, V10, P769, DOI 10.1038/embor.2009.90; Luo L, 2009, J CELL SCI, V122, P3729, DOI 10.1242/jcs.052555; Margalit A, 2007, TRENDS CELL BIOL, V17, P202, DOI 10.1016/j.tcb.2007.02.004; Martin David I. K., 1996, Bioessays, V18, P919, DOI 10.1002/bies.950181111; Mattout A, 2011, CURR BIOL, V21, P1603, DOI 10.1016/j.cub.2011.08.030; Meister P, 2010, GENE DEV, V24, P766, DOI 10.1101/gad.559610; Peric-Hupkes D, 2010, MOL CELL, V38, P603, DOI 10.1016/j.molcel.2010.03.016; Peters AHFM, 2003, MOL CELL, V12, P1577, DOI 10.1016/S1097-2765(03)00477-5; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Pickersgill H, 2006, NAT GENET, V38, P1005, DOI 10.1038/ng1852; Pinheiro I, 2012, CELL, V150, P948, DOI 10.1016/j.cell.2012.06.048; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Sassi HE, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni164; Schott S, 2006, DEV BIOL, V298, P176, DOI 10.1016/j.ydbio.2006.06.039; Shevelyov YY, 2009, P NATL ACAD SCI USA, V106, P3282, DOI 10.1073/pnas.0811933106; Tachibana M, 2002, GENE DEV, V16, P1779, DOI 10.1101/gad.989402; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; Wen B, 2009, NAT GENET, V41, P246, DOI 10.1038/ng.297; Ye Q, 1996, J BIOL CHEM, V271, P14653, DOI 10.1074/jbc.271.25.14653; Yuzyuk T, 2009, DEV CELL, V16, P699, DOI 10.1016/j.devcel.2009.03.008; Zhang K, 2008, NAT STRUCT MOL BIOL, V15, P381, DOI 10.1038/nsmb.1406	44	377	386	3	38	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 31	2012	150	5					934	947		10.1016/j.cell.2012.06.051	http://dx.doi.org/10.1016/j.cell.2012.06.051			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	001ZU	22939621	Bronze, Green Submitted			2022-12-28	WOS:000308500200009
J	Eisenstein, M				Eisenstein, Michael			PUBLIC HEALTH Prevention comes of age	NATURE			English	Editorial Material																		LaMontagne DS, 2011, B WORLD HEALTH ORGAN, V89, P821, DOI [10.2471/BLT.11.089862, 10.2471/BLT.11.08986]; Ovedraogo N, 2011, LANCET, V378, P315, DOI 10.1016/S0140-6736(11)61164-1; Sauvaget C, 2011, INT J GYNECOL OBSTET, V113, P14, DOI 10.1016/j.ijgo.2010.10.012	3	1	1	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 30	2012	488	7413					S11	S13		10.1038/488S11a	http://dx.doi.org/10.1038/488S11a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	996NC	22932434				2022-12-28	WOS:000308095100009
J	Mbizvo, MT; d'Arcangues, C; Van Look, PFA; Benagiano, G				Mbizvo, Michael T.; d'Arcangues, Catherine; Van Look, Paul F. A.; Benagiano, Giuseppe			40 years of innovation in sexual and reproductive health	LANCET			English	Editorial Material							RANDOMIZED TRIAL; MIFEPRISTONE; PREGNANCY; REGIMENS; CARE		[Mbizvo, Michael T.] WHO, Dept Reprod Hlth & Res, CH-1211 Geneva 27, Switzerland; [Benagiano, Giuseppe] Univ Roma La Sapienza, Rome, Italy	World Health Organization; Sapienza University Rome	Mbizvo, MT (corresponding author), WHO, Dept Reprod Hlth & Res, CH-1211 Geneva 27, Switzerland.	mbizvom@who.int						BAHZAD C, 1989, HUM REPROD, V4, P718, DOI 10.1093/oxfordjournals.humrep.a136973; Banks E, 2006, LANCET, V367, P1835, DOI 10.1016/S0140-6736(06)68805-3; CRABBE P, 1983, STEROIDS, V41, P243, DOI 10.1016/0039-128X(83)90095-8; DICZFALUSY E, 1986, CONTRACEPTION, V34, P1, DOI 10.1016/0010-7824(86)90003-X; Meda N, 2011, LANCET INFECT DIS, V11, P171, DOI 10.1016/S1473-3099(10)70288-7; Skegg DCG, 1999, B WORLD HEALTH ORGAN, V77, P713; United Nations Population Fund (UNFPA), 1995, INT C POP DEV ICPD P; Villar J, 2001, LANCET, V357, P1551, DOI 10.1016/S0140-6736(00)04722-X; von Hertzen H, 2002, LANCET, V360, P1803, DOI 10.1016/S0140-6736(02)11767-3; Warriner IK, 2006, LANCET, V368, P1965, DOI 10.1016/S0140-6736(06)69742-0; Warriner IK, 2011, LANCET, V377, P1155, DOI 10.1016/S0140-6736(10)62229-5; World Health Organization, 2004, REPR HLTH STRAT ACC	12	2	2	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 25	2012	380	9843					705	706		10.1016/S0140-6736(12)61025-3	http://dx.doi.org/10.1016/S0140-6736(12)61025-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	995IK	22920740				2022-12-28	WOS:000308001300004
J	Dickey, BF				Dickey, B. F.			Walking on Solid Ground	SCIENCE			English	Editorial Material							CYSTIC-FIBROSIS; MUCIN SECRETION; MUCUS; BICARBONATE		Univ Texas MD Anderson Canc Ctr, Dept Pulm Med, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Dickey, BF (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Pulm Med, Houston, TX 77030 USA.	bdickey@mdanderson.org			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL097000] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL097000] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Button B, 2012, SCIENCE, V337, P937, DOI 10.1126/science.1223012; Chen EYT, 2010, AM J PHYSIOL-LUNG C, V299, pL542, DOI 10.1152/ajplung.00180.2010; Davis CW, 2008, ANNU REV PHYSIOL, V70, P487, DOI 10.1146/annurev.physiol.70.113006.100638; Evans CM, 2009, CURR OPIN PULM MED, V15, P4, DOI 10.1097/MCP.0b013e32831da8d3; Fahy JV, 2010, NEW ENGL J MED, V363, P2233, DOI 10.1056/NEJMra0910061; Gustafsson JK, 2012, J EXP MED, V209, P1263, DOI 10.1084/jem.20120562; Hattrup CL, 2008, ANNU REV PHYSIOL, V70, P431, DOI 10.1146/annurev.physiol.70.113006.100659; Kesimer M, 2013, MUCOSAL IMMUNOL, V6, P379, DOI 10.1038/mi.2012.81; Lai SK, 2009, ADV DRUG DELIVER REV, V61, P86, DOI 10.1016/j.addr.2008.09.012; Raviv U, 2003, NATURE, V425, P163, DOI 10.1038/nature01970; Raynal BDE, 2003, J BIOL CHEM, V278, P28703, DOI 10.1074/jbc.M304632200; Smart JD, 2005, ADV DRUG DELIVER REV, V57, P1556, DOI 10.1016/j.addr.2005.07.001; Tarran R, 2007, SEMIN RESP CRIT CARE, V28, P295, DOI 10.1055/s-2007-981650	13	17	18	1	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 24	2012	337	6097					924	925		10.1126/science.1227091	http://dx.doi.org/10.1126/science.1227091			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992VI	22923570	Green Accepted			2022-12-28	WOS:000307807600033
J	Southwood, D				Southwood, David			When international partnerships go wrong	NATURE			English	Editorial Material									[Southwood, David] Univ London Imperial Coll Sci Technol & Med, London SW7 2AZ, England; [Southwood, David] European Space Agcy, F-75738 Paris 15, France	Imperial College London; European Space Agency	Southwood, D (corresponding author), Univ London Imperial Coll Sci Technol & Med, London SW7 2AZ, England.	d.southwood@imperial.ac.uk							0	2	2	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 23	2012	488	7412					451	453		10.1038/488451a	http://dx.doi.org/10.1038/488451a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	992FS	22914150				2022-12-28	WOS:000307761600015
J	Qiao, JJ; Fang, H				Qiao, Jianjun; Fang, Hong			Cutaneous Nodule in a Young Man	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							INTERNAL MALIGNANCIES; METASTASES; APPRAISAL		[Qiao, Jianjun; Fang, Hong] Zhejiang Univ, Coll Med, Affiliated Hosp 1, Dept Dermatol, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University	Fang, H (corresponding author), Zhejiang Univ, Coll Med, Affiliated Hosp 1, Dept Dermatol, 79 Qingchun Rd, Hangzhou 310003, Zhejiang, Peoples R China.	fanghongzy@sina.com	Qiao, Jianjun/AAE-7199-2022	Qiao, Jianjun/0000-0003-3386-297X; Fang, Hong/0000-0002-5917-2283				Chopra R, 2010, INDIAN J DERMATOL VE, V76, P125, DOI 10.4103/0378-6323.60548; Hu SS, 2008, J EUR ACAD DERMATOL, V22, P735, DOI 10.1111/j.1468-3083.2008.02590.x; Hu SCS, 2009, J AM ACAD DERMATOL, V60, P379, DOI 10.1016/j.jaad.2008.10.007; LOOKINGBILL DP, 1993, J AM ACAD DERMATOL, V29, P228, DOI 10.1016/0190-9622(93)70173-Q; Nashan D, 2010, DERMATOL THER, V23, P567, DOI 10.1111/j.1529-8019.2010.01364.x; Nashan D, 2009, J CANCER RES CLIN, V135, P1, DOI 10.1007/s00432-008-0432-0; Saeed S, 2004, J CUTAN PATHOL, V31, P419, DOI 10.1111/j.0303-6987.2004.00207.x; Sariya D, 2007, ARCH DERMATOL, V143, P613, DOI 10.1001/archderm.143.5.613; Torpy Janet M, 2010, JAMA, V303, P1771, DOI 10.1001/jama.303.17.1771	9	2	2	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 22	2012	308	8					812	813		10.1001/jama.2012.9637	http://dx.doi.org/10.1001/jama.2012.9637			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	991ML	22910759				2022-12-28	WOS:000307705300025
J	Thomas, L; Peterson, ED				Thomas, Laine; Peterson, Eric D.			The Value of Statistical Analysis Plans in Observational Research Defining High-Quality Research From the Start	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Peterson, Eric D.] Duke Clin Res Inst, Durham, NC 27705 USA; [Thomas, Laine] Duke Univ, Sch Med, Dept Biostat & Bioinformat, Durham, NC USA	Duke University; Duke University	Peterson, ED (corresponding author), Duke Clin Res Inst, 2400 Pratt St, Durham, NC 27705 USA.	eric.peterson@dm.duke.edu	Peterson, Eric David/ABF-5033-2021					Dreyer NA, 2010, AM J MANAG CARE, V16, P467; Ioannidis JPA, 2012, JAMA-J AM MED ASSOC, V308, P575, DOI 10.1001/jama.2012.8144; Lauer MS, 2011, ACAD MED, V86, P671, DOI 10.1097/ACM.0b013e318217d6e6; Pearce N, 2011, OCCUP ENVIRON MED, V68, P86, DOI 10.1136/oem.2010.058917; Sox HC, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000269; Vandenbroucke JP, 2008, PLOS MED, V5, P339, DOI 10.1371/journal.pmed.0050067; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Williams Rebecca J, 2010, CMAJ, V182, P1638, DOI 10.1503/cmaj.092252	8	78	78	0	17	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 22	2012	308	8					773	774		10.1001/jama.2012.9502	http://dx.doi.org/10.1001/jama.2012.9502			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	991ML	22910753				2022-12-28	WOS:000307705300019
J	Krebs, P; Sherman, SE				Krebs, Paul; Sherman, Scott E.			Review: Varenicline for tobacco cessation does not increase CV serious adverse events	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Krebs, Paul; Sherman, Scott E.] NYU, Sch Med, VA New York Harbor Healthcare Syst, New York, NY 10003 USA	New York University	Krebs, P (corresponding author), NYU, Sch Med, VA New York Harbor Healthcare Syst, New York, NY 10003 USA.			Sherman, Scott/0000-0003-1752-7303; Krebs, Paul/0000-0003-3380-1763				Fiore MC, TREATING TOBACCO USE	1	2	2	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 21	2012	157	4							JC4-2	10.7326/0003-4819-157-4-201208210-02002	http://dx.doi.org/10.7326/0003-4819-157-4-201208210-02002			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	992XG	22910956				2022-12-28	WOS:000307813200001
J	Upadhyay, A; Earley, A; Lamont, JL; Haynes, S; Wanner, C; Balk, EM				Upadhyay, Ashish; Earley, Amy; Lamont, Jenny L.; Haynes, Shana; Wanner, Christoph; Balk, Ethan M.			Lipid-Lowering Therapy in Persons With Chronic Kidney Disease A Systematic Review and Meta-analysis	ANNALS OF INTERNAL MEDICINE			English	Review							CORONARY-HEART-DISEASE; RENAL-TRANSPLANT RECIPIENTS; CARDIOVASCULAR-DISEASE; SUBGROUP ANALYSES; ARTERY-DISEASE; RISK-FACTORS; ATORVASTATIN; PRAVASTATIN; SIMVASTATIN; EVENTS	Background: Lipid-lowering therapy is not widely used in persons with chronic kidney disease (CKD) despite a high burden of dyslipidemia and cardiovascular disease in this population. Purpose: To synthesize evidence examining the effect of lipid-lowering therapy on clinical outcomes in persons with CKD. Data Sources: MEDLINE, the Cochrane Central Register of Controlled Trials, and the Cochrane Database of Systematic Reviews from January 2000 through November 2011. Study Selection: Randomized, controlled trials (RCTs) comparing lipid-lowering therapy with control treatment in persons with CKD, including subgroup analyses of trials in the general population. Data Extraction: Abstracts were screened and data were extracted on study methodology, population, interventions, cardiovascular and kidney outcomes, and adverse events. Data were extracted by one author and confirmed by another. Study quality was determined by consensus. Random-effects model meta-analyses were performed. Data Synthesis: 18 RCTs, all in adults, met the eligibility criteria. Five RCTs involved CKD populations, and 13 were CKD subgroup analyses from trials in the general population. Sixteen RCTs examined statins, and 2 examined statins plus ezetimibe. Lipid-lowering therapy does not improve kidney outcomes but decreases the risk for cardiac mortality (pooled risk ratio [RR] from 6 trials, 0.82 [95% CI, 0.74 to 0.91]; P < 0.001), cardiovascular events (including revascularization) (pooled RR from 9 trials, 0.78 [CI, 0.71 to 0.86]; P < 0.001), and myocardial infarction (pooled RR from 9 trials, 0.74 [CI, 0.67 to 0.81]; P < 0.001). Significant benefit was also seen for all-cause mortality but was limited by a high degree of heterogeneity. No benefit was found for other cardiovascular outcomes. Rates of adverse events were similar between intervention and comparator groups. Limitations: Lack of data in children, heterogeneity among reviewed studies, and the possibility of selective reporting of outcomes and adverse events. Conclusion: Lipid-lowering therapy decreases cardiac death and atherosclerosis-mediated cardiovascular events in persons with CKD.	[Upadhyay, Ashish] Boston Med Ctr, Dept Med, Renal Sect, Boston, MA 02118 USA; Boston Univ, Sch Med, Boston, MA 02118 USA; Tufts Univ, Sch Med, Ctr Clin Evidence Synth, Boston, MA 02111 USA; Univ Wurzburg, Wurzburg, Germany	Boston Medical Center; Boston University; Tufts University; University of Wurzburg	Upadhyay, A (corresponding author), Boston Med Ctr, Dept Med, Renal Sect, 72 E Concord St,Evans 124, Boston, MA 02118 USA.	ashishu@bu.edu	Balk, Ethan/AAJ-2547-2020	Upadhyay, Ashish/0000-0002-0536-5776	KDIGO; National Kidney Foundation; Genzyme	KDIGO; National Kidney Foundation; Genzyme(Sanofi-AventisGenzyme Corporation)	Dr. Upadhyay, Ms. Earley, Ms. Lamont, Dr. Haynes, and Dr. Balk were supported by KDIGO.; Dr. Upadhyay: Grant (money to institution): National Kidney Foundation. Ms. Earley: Grant (money to institution): National Kidney Foundation. Ms. Lamont: Grant (money to institution): National Kidney Foundation. Dr. Haynes: Grant (money to institution): National Kidney Foundation. Dr. Wanner: Support for travel to meetings for the study or other purposes: National Kidney Foundation; Board membership: Boehringer Ingelheim; Grants/grants pending (money to institution): Genzyme; Payment for lectures including service on speakers bureaus: Genzyme, Abbott, Amgen. Dr. Balk: Grant (money to institution): KDIGO, National Kidney Foundation. Disclosures can be also viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M11-2984.	Amarenco P, 2006, NEW ENGL J MED, V355, P549; Asselbergs FW, 2004, CIRCULATION, V110, P2809, DOI 10.1161/01.CIR.0000146378.65439.7A; Atkins D, 2004, BMJ-BRIT MED J, V328, P1490; Baigent C, 2011, LANCET, V377, P2181, DOI 10.1016/S0140-6736(11)60739-3; Charytan D, 2006, KIDNEY INT, V70, P2021, DOI 10.1038/sj.ki.5001934; Chonchol M, 2007, AM J KIDNEY DIS, V49, P373, DOI 10.1053/j.ajkd.2006.11.043; Colhoun HM, 2009, AM J KIDNEY DIS, V54, P810, DOI 10.1053/j.ajkd.2009.03.022; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; Eckardt KU, 2009, AM J TRANSPLANT, V9, pS1, DOI 10.1111/j.1600-6143.2009.02834.x; Edwards NC, 2006, QJM-INT J MED, V99, P723, DOI 10.1093/qjmed/hcl101; Eknoyan G, 2003, AM J KIDNEY DIS, V41, pS1, DOI 10.1016/S0272-6386(03)00111-2; Fellstrom BC, 2009, NEW ENGL J MED, V360, P1395, DOI 10.1056/NEJMoa0810177; Foley RN, 1998, J AM SOC NEPHROL, V9, P267; Foley RN, 1998, AM J KIDNEY DIS, V32, pS112, DOI 10.1053/ajkd.1998.v32.pm9820470; Goldfarb-Rumyantzev AS, 2007, AM J KIDNEY DIS, V50, P791, DOI 10.1053/j.ajkd.2007.07.023; Holdaas H, 2005, NEPHROL DIAL TRANSPL, V20, P974, DOI 10.1093/ndt/gfh735; Holdaas H, 2003, LANCET, V361, P2024, DOI 10.1016/S0140-6736(03)13638-0; Holdaas H, 2011, J AM SOC NEPHROL, V22, P1335, DOI 10.1681/ASN.2010090987; Ioannidis JPA, 1998, JAMA-J AM MED ASSOC, V279, P281, DOI 10.1001/jama.279.4.281; Jardine AG, 2004, AM J TRANSPLANT, V4, P988, DOI 10.1111/j.1600-6143.2004.00445.x; Kasiske BL, 1998, AM J KIDNEY DIS, V32, pS142, DOI 10.1053/ajkd.1998.v32.pm9820472; Kendrick J, 2010, AM J KIDNEY DIS, V55, P42, DOI 10.1053/j.ajkd.2009.09.020; Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group, 2009, Kidney Int Suppl, pS1, DOI 10.1038/ki.2009.188; Koren MJ, 2009, AM J KIDNEY DIS, V53, P741, DOI 10.1053/j.ajkd.2008.11.025; Landray M, 2006, AM J KIDNEY DIS, V47, P385, DOI 10.1053/j.ajkd.2005.11.018; Lemos PA, 2005, AM J CARDIOL, V95, P445, DOI 10.1016/j.amjcard.2004.10.008; Levey AS, 1998, AM J KIDNEY DIS, V32, P853, DOI 10.1016/S0272-6386(98)70145-3; Nakamura H, 2009, ATHEROSCLEROSIS, V206, P512, DOI 10.1016/j.atherosclerosis.2009.03.031; Navaneethan SD, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005019.pub3; Navaneethan SD, 2009, COCHRANE DATABASE SY; Nogueira J, 2007, CLIN J AM SOC NEPHRO, V2, P766, DOI 10.2215/CJN.04131206; Owens DK, 2010, J CLIN EPIDEMIOL, V63, P513, DOI 10.1016/j.jclinepi.2009.03.009; Parikh NI, 2006, ARCH INTERN MED, V166, P1884, DOI 10.1001/archinte.166.17.1884; Pedersen TR, 2004, ATHEROSCLEROSIS SUPP, V5, P81, DOI 10.1016/j.atherosclerosissup.2004.08.027; Rahman M, 2008, AM J KIDNEY DIS, V52, P412, DOI 10.1053/j.ajkd.2008.05.027; Ridker PM, 2010, J AM COLL CARDIOL, V55, P1266, DOI 10.1016/j.jacc.2010.01.020; Schoenhagen P, 2006, CIRCULATION, V113, P2826, DOI 10.1161/CIRCULATIONAHA.105.585703; Shepherd J, 2008, MAYO CLIN PROC, V83, P870; Shepherd J, 2008, J AM COLL CARDIOL, V51, P1448, DOI 10.1016/j.jacc.2007.11.072; Strippoli GFM, 2008, BMJ-BRIT MED J, V336, P645, DOI 10.1136/bmj.39472.580984.AE; Tonelli M, 2005, J AM SOC NEPHROL, V16, P3748, DOI 10.1681/ASN.2005070779; Tonelli M, 2005, CIRCULATION, V112, P171, DOI 10.1161/CIRCULATIONAHA.104.517565; Tonelli M, 2004, CIRCULATION, V110, P1557, DOI 10.1161/01.CIR.0000143892.84582.60; Tonelli M, 2001, AM J KIDNEY DIS, V37, P484, DOI 10.1053/ajkd.2001.22070; Trikalinos, 2012, 2 ACM SIGHIT INT HLT, P819, DOI [DOI 10.1145/2110363, DOI 10.1145/2110363.2110464]; Uhlig K, 2006, KIDNEY INT, V70, P2058, DOI 10.1038/sj.ki.5001875; von Birgelen C, 2003, CIRCULATION, V108, P2757, DOI 10.1161/01.CIR.0000103664.47406.49; Wang R, 2007, NEW ENGL J MED, V357, P2189, DOI 10.1056/NEJMsr077003; Wanner C, 2005, NEW ENGL J MED, V353, P238, DOI 10.1056/NEJMoa043545; Weiner DE, 2004, J GEN INTERN MED, V19, P1045, DOI 10.1111/j.1525-1497.2004.40049.x	50	133	140	0	22	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 21	2012	157	4					251	+		10.7326/0003-4819-157-4-201208210-00005	http://dx.doi.org/10.7326/0003-4819-157-4-201208210-00005			20	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	992XG	22910936				2022-12-28	WOS:000307813200016
J	Ayaz, P; Ye, XC; Huddleston, P; Brautigam, CA; Rice, LM				Ayaz, Pelin; Ye, Xuecheng; Huddleston, Patrick; Brautigam, Chad A.; Rice, Luke M.			A TOG:alpha beta-tubulin Complex Structure Reveals Conformation-Based Mechanisms for a Microtubule Polymerase	SCIENCE			English	Article							CRYSTAL-STRUCTURE; GAMMA-TUBULIN; PLUS-END; BINDING; XMAP215; YEAST; STU2P; DYNAMICS; MUTANTS; PROTEIN	Stu2p/XMAP215/Dis1 family proteins are evolutionarily conserved regulatory factors that use alpha beta-tubulin-interacting tumor overexpressed gene (TOG) domains to catalyze fast microtubule growth. Catalysis requires that these polymerases discriminate between unpolymerized and polymerized forms of alpha beta-tubulin, but the mechanism by which they do so has remained unclear. Here, we report the structure of the TOG1 domain from Stu2p bound to yeast alpha beta-tubulin. TOG1 binds alpha beta-tubulin in a way that excludes equivalent binding of a second TOG domain. Furthermore, TOG1 preferentially binds a curved conformation of alpha beta-tubulin that cannot be incorporated into microtubules, contacting alpha- and beta-tubulin surfaces that do not participate in microtubule assembly. Conformation-selective interactions with alpha beta-tubulin explain how TOG-containing polymerases discriminate between unpolymerized and polymerized forms of alpha beta-tubulin and how they selectively recognize the growing end of the microtubule.	[Rice, Luke M.] Univ Texas SW Med Ctr Dallas, Dept Biophys, Dallas, TX 75390 USA; Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Rice, LM (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Biophys, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	luke.rice@utsouthwestern.edu		Rice, Luke/0000-0001-6551-3307; Brautigam, Chad/0000-0001-6563-1338	U.S. Department of Energy, Office of Biological and Environmental Research [DE-AC02-06CH11357]; Robert A. Welch Foundation [I-1692]; NIH [GM-098543]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098543] Funding Source: NIH RePORTER	U.S. Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); Robert A. Welch Foundation(The Welch Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. Borek for assistance with diffraction data processing; D. Tomchick in the Univ. of Texas Southwestern Structural Biology Core Facility for advice and assistance; M. Rosen, Y. Jiang, and M. Moritz for sharing equipment/reagents; and S. Padrick for help with fluorescence anisotropy. H. Yu, X. Zhang, and M. Rosen gave critical comments on the manuscript. L.M.R. is the Thomas O. Hicks Scholar in Medical Research. Results shown in this report are derived from work performed at Argonne National Laboratory, Structural Biology Center at the Advanced Photon Source, beamline 19-ID. Argonne is operated by UChicago Argonne, LLC, for the U.S. Department of Energy, Office of Biological and Environmental Research under contract DE-AC02-06CH11357. This work was supported by grants I-1692 (from the Robert A. Welch Foundation) and GM-098543 (from the NIH). Coordinates have been deposited in the Protein Data Bank with accession code 4FFB.	Al-Bassam J, 2006, J CELL BIOL, V172, P1009, DOI 10.1083/jcb.200511010; Al-Bassam J, 2007, STRUCTURE, V15, P355, DOI 10.1016/j.str.2007.01.012; Aldaz H, 2005, NATURE, V435, P523, DOI 10.1038/nature03586; Brouhard GJ, 2008, CELL, V132, P79, DOI 10.1016/j.cell.2007.11.043; Buey RM, 2006, BIOCHEMISTRY-US, V45, P5933, DOI 10.1021/bi060334m; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; GARD DL, 1987, J CELL BIOL, V105, P2203, DOI 10.1083/jcb.105.5.2203; Johnson V, 2011, BIOCHEMISTRY-US, V50, P8636, DOI 10.1021/bi2005174; Kosco KA, 2001, MOL BIOL CELL, V12, P2870, DOI 10.1091/mbc.12.9.2870; Lowe J, 2001, J MOL BIOL, V313, P1045, DOI 10.1006/jmbi.2001.5077; OHKURA H, 1988, EMBO J, V7, P1465, DOI 10.1002/j.1460-2075.1988.tb02964.x; Ravelli RBG, 2004, NATURE, V428, P198, DOI 10.1038/nature02393; Rice LM, 2008, P NATL ACAD SCI USA, V105, P5378, DOI 10.1073/pnas.0801155105; Slep KC, 2007, MOL CELL, V27, P976, DOI 10.1016/j.molcel.2007.07.023; Wang PJJ, 1997, J CELL BIOL, V139, P1271, DOI 10.1083/jcb.139.5.1271; Widlund PO, 2011, P NATL ACAD SCI USA, V108, P2741, DOI 10.1073/pnas.1016498108	16	153	154	3	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 17	2012	337	6096					857	860		10.1126/science.1221698	http://dx.doi.org/10.1126/science.1221698			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	989BQ	22904013	Green Accepted			2022-12-28	WOS:000307535600047
J	Baumgart, DC; Sandborn, WJ				Baumgart, Daniel C.; Sandborn, William J.			Crohn's disease	LANCET			English	Article							INFLAMMATORY-BOWEL-DISEASE; AVIUM SUBSP PARATUBERCULOSIS; DENDRITIC CELLS; RISK-FACTORS; ENVIRONMENTAL-FACTORS; BARRIER DYSFUNCTION; MONOCLONAL-ANTIBODY; ULCERATIVE-COLITIS; SERIOUS INFECTIONS; GENE ATG16L1	Crohn's disease is a relapsing systemic inflammatory disease, mainly affecting the gastrointestinal tract with extraintestinal manifestations and associated immune disorders. Genome wide association studies identified susceptibility loci that-triggered by environmental factors-result in a disturbed innate (ie, disturbed intestinal barrier, Paneth cell dysfunction, endoplasmic reticulum stress, defective unfolded protein response and autophagy, impaired recognition of microbes by pattern recognition receptors, such as nucleotide binding domain and Toll like receptors on dendritic cells and macrophages) and adaptive (ie, imbalance of effector and regulatory T cells and cytokines, migration and retention of leukocytes) immune response towards a diminished diversity of commensal microbiota. We discuss the epidemiology, immunobiology, amd natural history of Crohn's disease; describe new treatment goals and risk stratifi cation of patients; and provide an evidence based rational approach to diagnosis (ie, work-up algorithm, new imaging methods [ie, enhanced endoscopy, ultrasound, MRI and CT] and biomarkers), management, evolving therapeutic targets (ie, integrins, chemokine receptors, cell-based and stem-cell-based therapies), prevention, and surveillance.	[Baumgart, Daniel C.] Humboldt Univ, Sch Med, Virchow Hosp,Dept Med, Charite Med Ctr,Div Gastroenterol & Hepatol, D-13344 Berlin, Germany; [Sandborn, William J.] Univ Calif San Diego, Dept Med, Div Gastroenterol & Hepatol, San Diego, CA 92103 USA	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of California System; University of California San Diego	Baumgart, DC (corresponding author), Humboldt Univ, Sch Med, Virchow Hosp,Dept Med, Charite Med Ctr,Div Gastroenterol & Hepatol, D-13344 Berlin, Germany.	daniel.baumgart@charite.de	Sandborn, William/ABE-8342-2020; Baumgart, Daniel C./AAU-2930-2021	Baumgart, Daniel C./0000-0003-2146-507X	Abbott; Astellas; Biocodex; Facet Biotech; Shire; AstraZeneca; Bristol-Myers Squibb; Genentech; GlaxoSmithKline; Janssen; Millennium Pharmaceuticals; Novartis; Pfizer; Procter and Gamble Pharmaceuticals; Shire Pharmaceuticals; UCB; Abbott Laboratories	Abbott(Abbott Laboratories); Astellas(Astellas Pharmaceuticals); Biocodex; Facet Biotech; Shire; AstraZeneca(AstraZeneca); Bristol-Myers Squibb(Bristol-Myers Squibb); Genentech(Roche HoldingGenentech); GlaxoSmithKline(GlaxoSmithKline); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Millennium Pharmaceuticals(Takeda Pharmaceutical Company Ltd); Novartis(Novartis); Pfizer(Pfizer); Procter and Gamble Pharmaceuticals(Procter & Gamble); Shire Pharmaceuticals; UCB(UCB Pharma SA); Abbott Laboratories(Abbott Laboratories)	DCB receives research support from Abbott, Astellas, Biocodex, Facet Biotech, and Shire; is a consultant for Abbott, AstraZeneca, Bayer Schering Pharma, Cellerix, (TiGenix), Genentech (Roche group), medac autoimmun, MSD, Otsuka, Facet Biotech, (formerly Protein Design Labs), and UCB; has received speaker's fees from Abbott, AstraZeneca, Dr Falk Pharma, Ferring, MSD, Otsuka, Shire, and UCB. All of his activities and contracts are in conformity with the "FSA-Kodex Fachkreise" (voluntary self-monitoring code for expert consultants to the pharmaceutical industry), have been checked by the legal Department of Charite Universit tsmedizin, Berlin, and have been approved by the directorate of the Faculty of Medicine Charite Universit tsmedizin Berlin. WJS has receives research support from Abbott, Bristol-Myers Squibb, Genentech, GlaxoSmithKline, Janssen, Millennium Pharmaceuticals, Novartis, Pfizer, Procter and Gamble Pharmaceuticals, Shire Pharmaceuticals, and UCB; is a consultant for Abbott, ActoGeniX NV, AGI Therapeutics, Alba Therapeutics Corporation, Albireo, Alfa Wasserman, Amgen, AM-Pharma BV, Anaphore, Astellas Pharma, Athersys, Atlantic Healthcare, Axcan Pharma, BioBalance Corporation, Boehringer-Ingelheim, Bristol-Myers Squibb, Celegene, Celek Pharmaceuticals, Cellerix SL, Cerimon Pharmaceuticals, ChemoCentryx, CoMentis, Cosmo Technologies, Coronado Biosciences, Cytokine Pharmasciences, Eagle Pharmaceuticals, Eisai Medical Research, Elan Pharmaceuticals, EnGene, Eli Lilly, Enteromedics, Exagen Diagnostics, Ferring Pharmaceuticals, Flexion Therapeutics, Funxional Therapeutics, Genzyme Corporation, Genentech, Gilead Sciences, Given Imaging, GlaxoSmithKline, Human Genome Sciences, Ironwood Pharmaceuticals, Janssen, KaloBios Pharmaceuticals, Lexicon Pharmaceuticals, Lycera Corporation, Meda Pharmaceuticals, Merck Research Laboratories, MerckSerono, Millennium Pharmaceuticals, Nisshin Kyorin Pharmaceuticals, Novo Nordisk A/S, NPS Pharmaceuticals, Optimer Pharmaceuticals, Orexigen Therapeutics, PDL Biopharma, Pfizer, Procter and Gamble, Prometheus Laboratories, ProtAb Limited, Purgenesis Technologies, Relypsa, Salient Pharmaceuticals, Salix Pharmaceuticals, Santarus, Schering Plough Corporation, Shire Pharmaceuticals, Sigmoid Pharma Limited, Sirtris Pharmaceuticals, SLA Pharma (UK), Targacept, Teva Pharmaceuticals, Therakos, Tillotts Pharma AG, TxCell SA, UCB Pharma, Viamet Pharmaceuticals, Vascular Biogenics, Warner Chilcott, Wyeth; and has received speaker's fees from Abbott Laboratories, Bristol-Myers Squibb, Janssen.	Aamodt G, 2008, AM J EPIDEMIOL, V168, P1065, DOI 10.1093/aje/kwn218; Aamodt G, 2008, INFLAMM BOWEL DIS, V14, P984, DOI 10.1002/ibd.20417; Abakar-Mahamat A, 2007, GASTROEN CLIN BIOL, V31, P1098, DOI 10.1016/S0399-8320(07)78343-4; Alberto L, 2006, GASTROENTEROLOGY, V130, P1588, DOI 10.1053/j.gastro.2006.02.004; Anderson CA, 2011, NAT GENET, V43, P246, DOI 10.1038/ng.764; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Baert F, 2010, GASTROENTEROLOGY, V138, P463, DOI 10.1053/j.gastro.2009.09.056; Barclay AR, 2009, J PEDIATR-US, V155, P421, DOI 10.1016/j.jpeds.2009.03.017; Barreau F, 2010, GUT, V59, P207, DOI 10.1136/gut.2008.171546; Baumgart DC, 2011, CLIN EXP IMMUNOL, V166, P46, DOI 10.1111/j.1365-2249.2011.04439.x; Baumgart DC, 2009, CLIN EXP IMMUNOL, V157, P423, DOI 10.1111/j.1365-2249.2009.03981.x; Baumgart DC, 2011, INFLAMM BOWEL DIS, V17, P2512, DOI 10.1002/ibd.21643; Baumgart DC, 2011, INFLAMM BOWEL DIS, V17, P639, DOI 10.1002/ibd.21409; Baumgart DC, 2009, AM J GASTROENTEROL, V104, P868, DOI 10.1038/ajg.2008.138; Baumgart DC, 2005, GUT, V54, P228, DOI 10.1136/gut.2004.040360; Baumgart DC, 2012, CROHNS DIS ULC COL E; Beaugerie L, 2006, GASTROENTEROLOGY, V130, P650, DOI 10.1053/j.gastro.2005.12.019; Beaugerie L, 2009, LANCET, V374, P1617, DOI 10.1016/S0140-6736(09)61302-7; Bengtson MB, 2009, INFLAMM BOWEL DIS, V15, P1867, DOI 10.1002/ibd.20978; Bengtson MB, 2009, J CROHNS COLITIS, V3, P92, DOI 10.1016/j.crohns.2008.11.002; Bernstein CN, 2007, INFLAMM BOWEL DIS, V13, P759, DOI 10.1002/ibd.20089; Bernstein CN, 2005, GASTROENTEROLOGY, V129, P827, DOI 10.1053/j.gastro.2005.06.021; Bernstein CN, 2001, AM J GASTROENTEROL, V96, P2117, DOI 10.1111/j.1572-0241.2001.03946.x; Biswas A, 2010, P NATL ACAD SCI USA, V107, P14739, DOI 10.1073/pnas.1003363107; Bloom SM, 2011, CELL HOST MICROBE, V9, P390, DOI 10.1016/j.chom.2011.04.009; Bongartz T, 2006, JAMA-J AM MED ASSOC, V295, P2275, DOI 10.1001/jama.295.19.2275; Brest P, 2011, NAT GENET, V43, P242, DOI 10.1038/ng.762; Buhner S, 2006, GUT, V55, P342, DOI 10.1136/gut.2005.065557; Buisine MP, 1999, INFLAMM BOWEL DIS, V5, P24, DOI 10.1097/00054725-199902000-00004; Burt RK, 2010, BLOOD, V116, P6123, DOI 10.1182/blood-2010-06-292391; Cadwell K, 2008, NATURE, V456, P259, DOI 10.1038/nature07416; Cadwell K, 2010, CELL, V141, P1135, DOI 10.1016/j.cell.2010.05.009; Canavan C, 2006, ALIMENT PHARM THER, V23, P1097, DOI 10.1111/j.1365-2036.2006.02854.x; Claesson MJ, 2011, P NATL ACAD SCI USA, V108, P4586, DOI 10.1073/pnas.1000097107; Clayburgh DR, 2005, J CLIN INVEST, V115, P2702, DOI 10.1172/JCI24970; Collison LW, 2010, NAT IMMUNOL, V11, P1093, DOI 10.1038/ni.1952; Colombel JF, 2010, NEW ENGL J MED, V362, P1383, DOI 10.1056/NEJMoa0904492; Cooney R, 2010, NAT MED, V16, P90, DOI 10.1038/nm.2069; Cornish JA, 2008, AM J GASTROENTEROL, V103, P2394, DOI 10.1111/j.1572-0241.2008.02064.x; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; D'Haens G, 2008, LANCET, V371, P660, DOI 10.1016/S0140-6736(08)60304-9; D'Haens GR, 2009, INFLAMM BOWEL DIS, V15, P1599, DOI 10.1002/ibd.21034; Darfeuille-Michaud A, 2004, GASTROENTEROLOGY, V127, P412, DOI 10.1053/j.gastro.2004.04.061; Declercq C, 2010, INFLAMM BOWEL DIS, V16, P807, DOI 10.1002/ibd.21111; Dethlefsen L, 2011, P NATL ACAD SCI USA, V108, P4554, DOI 10.1073/pnas.1000087107; Di Sabatino A, 2011, INFLAMM BOWEL DIS, V17, P1254, DOI 10.1002/ibd.21461; Dignass A, 2010, J CROHNS COLITIS, V4, P28, DOI 10.1016/j.crohns.2009.12.002; Dionisio PM, 2010, AM J GASTROENTEROL, V105, P1240, DOI 10.1038/ajg.2009.713; Duijvestein M, 2010, GUT, V59, P1662, DOI 10.1136/gut.2010.215152; Farraye FA, 2010, GASTROENTEROLOGY, V138, P746, DOI [10.1053/j.gastro.2009.12.037, 10.1053/j.gastro.2009.12.035]; Ferreira RC, 2010, NAT GENET, V42, P777, DOI 10.1038/ng.644; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Garcia-Olmo D, 2009, DIS COLON RECTUM, V52, P79, DOI 10.1007/DCR.0b013e3181973487; GENT AE, 1994, LANCET, V343, P766, DOI 10.1016/S0140-6736(94)91841-4; Georges M, 2011, NAT GENET, V43, P180, DOI 10.1038/ng0311-180; Gill CO, 2011, J FOOD PROTECT, V74, P480, DOI 10.4315/0362-028X.JFP-10-301; Glocker EO, 2009, NEW ENGL J MED, V361, P2033, DOI 10.1056/NEJMoa0907206; Hart AL, 2005, GASTROENTEROLOGY, V129, P50, DOI 10.1053/j.gastro.2005.05.013; Hou JK, 2011, AM J GASTROENTEROL, V106, P563, DOI 10.1038/ajg.2011.44; Hou JK, 2009, AM J GASTROENTEROL, V104, P2100, DOI 10.1038/ajg.2009.190; Iliev ID, 2009, GUT, V58, P1481, DOI 10.1136/gut.2008.175166; Jones DT, 2008, AM J GASTROENTEROL, V103, P2382, DOI 10.1111/j.1572-0241.2008.01999.x; Joossens M, 2007, INFLAMM BOWEL DIS, V13, P580, DOI 10.1002/ibd.20086; Joossens M, 2011, GUT, V60, P631, DOI 10.1136/gut.2010.223263; Kane S, 2008, AM J GASTROENTEROL, V103, P631, DOI 10.1111/j.1572-0241.2007.01582.x; Kaplan GG, 2008, AM J GASTROENTEROL, V103, P2925, DOI 10.1111/j.1572-0241.2008.02118.x; Kaplan GG, 2010, AM J GASTROENTEROL, V105, P2412, DOI 10.1038/ajg.2010.252; Kaser A, 2010, MUCOSAL IMMUNOL, V3, P11, DOI 10.1038/mi.2009.122; Kaser A, 2008, CELL, V134, P743, DOI 10.1016/j.cell.2008.07.021; Klaus J, 2011, AM J GASTROENTEROL, V106, P786, DOI 10.1038/ajg.2011.59; Kotlyar DS, 2011, CLIN GASTROENTEROL H, V9, P36, DOI 10.1016/j.cgh.2010.09.016; Larson DW, 2004, GASTROENTEROLOGY, V126, P1611, DOI 10.1053/j.gastro.2004.03.063; Lee A, 2011, J PEDIATR GASTR NUTR, V52, P170, DOI 10.1097/MPG.0b013e3181ef37ba; Lee JS, 2009, INFECT IMMUN, V77, P2979, DOI 10.1128/IAI.01411-08; Lee SK, 2009, ENDOSCOPY, V41, P9, DOI 10.1055/s-0028-1103481; Lerebours E, 2007, AM J GASTROENTEROL, V102, P122, DOI 10.1111/j.1572-0241.2006.00931.x; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; Lewis JD, 2011, GASTROENTEROLOGY, V140, P1817, DOI 10.1053/j.gastro.2010.11.058; Lichtenstein GR, 2006, CLIN GASTROENTEROL H, V4, P621, DOI 10.1016/j.cgh.2006.03.002; Loftus EV, 2004, GASTROENTEROLOGY, V126, P1504, DOI 10.1053/j.gastro.2004.01.063; Louis E, 2012, GASTROENTEROLOGY, V142, P63, DOI 10.1053/j.gastro.2011.09.034; Lutgens MWMD, 2008, GUT, V57, P1246, DOI 10.1136/gut.2007.143453; Maartens G, 2007, LANCET, V370, P2030, DOI 10.1016/S0140-6736(07)61262-8; Mahadevan U, 2011, AM J GASTROENTEROL, V106, P214, DOI 10.1038/ajg.2010.464; Mannon PJ, 2004, NEW ENGL J MED, V351, P2069, DOI 10.1056/NEJMoa033402; Marchiando AM, 2010, J CELL BIOL, V189, P111, DOI 10.1083/jcb.200902153; Marion JF, 2008, AM J GASTROENTEROL, V103, P2342, DOI 10.1111/j.1572-0241.2008.01934.x; Moussata D, 2011, GUT, V60, P26, DOI 10.1136/gut.2010.213264; Muegge BD, 2011, SCIENCE, V332, P970, DOI 10.1126/science.1198719; Ng SC, 2012, INFLAMM BOWEL DIS, V18, P725, DOI 10.1002/ibd.21747; Niess JH, 2005, SCIENCE, V307, P254, DOI 10.1126/science.1102901; Noguchi E, 2009, NAT IMMUNOL, V10, P471, DOI 10.1038/ni.1722; Panes J, 2011, ALIMENT PHARM THER, V34, P125, DOI 10.1111/j.1365-2036.2011.04710.x; Pariente B, 2011, INFLAMM BOWEL DIS, V17, P1415, DOI 10.1002/ibd.21506; Park JH, 2010, NAT GENET, V42, P570, DOI 10.1038/ng.610; Pawlowski SW, 2009, GASTROENTEROLOGY, V136, P1874, DOI 10.1053/j.gastro.2009.02.072; Pellise M, 2011, GASTROINTEST ENDOSC, V74, P840, DOI 10.1016/j.gie.2011.05.013; Peloquin JM, 2008, AM J GASTROENTEROL, V103, P2015, DOI 10.1111/j.1572-0241.2008.01920.x; Peyrin-Biroulet L, 2011, GASTROENTEROLOGY, V141, P1621, DOI 10.1053/j.gastro.2011.06.050; Peyrin-Biroulet L, 2010, AM J GASTROENTEROL, V105, P289, DOI 10.1038/ajg.2009.579; Peyrin-Biroulet L, 2009, AM J GASTROENTEROL, V104, P2089, DOI 10.1038/ajg.2009.301; Pullen N, 2009, BRIT J PHARMACOL, V157, P281, DOI 10.1111/j.1476-5381.2009.00137.x; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Regueiro M, 2009, GASTROENTEROLOGY, V136, pe1; Regueiro M, 2009, GASTROENTEROLOGY, V136, P441, DOI 10.1053/j.gastro.2008.10.051; Rousseau MC, 2008, PEDIAT ALLERG IMM-UK, V19, P438, DOI 10.1111/j.1399-3038.2007.00669.x; Salzman NH, 2010, NAT IMMUNOL, V11, P76, DOI 10.1038/ni.1825; Sandborn WJ, 2008, GASTROENTEROLOGY, V135, P1130, DOI 10.1053/j.gastro.2008.07.014; Seksik P, 2009, INFLAMM BOWEL DIS, V15, P734, DOI 10.1002/ibd.20828; Selby W, 2007, GASTROENTEROLOGY, V132, P2313, DOI 10.1053/j.gastro.2007.03.031; Silverberg MS, 2005, CAN J GASTROENTEROL, V19, p5A, DOI 10.1155/2005/269076; Soderholm JD, 2002, GUT, V50, P307, DOI 10.1136/gut.50.3.307; Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105; Soler D, 2009, J PHARMACOL EXP THER, V330, P864, DOI 10.1124/jpet.109.153973; Spehlmann ME, 2008, INFLAMM BOWEL DIS, V14, P968, DOI 10.1002/ibd.20380; Stefanich EG, 2011, BRIT J PHARMACOL, V162, P1855, DOI 10.1111/j.1476-5381.2011.01205.x; Stein J, 2010, NAT REV GASTRO HEPAT, V7, P599, DOI 10.1038/nrgastro.2010.151; Takazoe M, 2009, GASTROENTEROLOGY, V136, pA181; Talley NJ, 2011, AM J GASTROENTEROL, V106, pS2, DOI 10.1038/ajg.2011.58; Tan CS, 2010, LANCET NEUROL, V9, P425, DOI 10.1016/S1474-4422(10)70040-5; Thia KT, 2010, GASTROENTEROLOGY, V139, P1147, DOI 10.1053/j.gastro.2010.06.070; Toruner M, 2008, GASTROENTEROLOGY, V134, P929, DOI 10.1053/j.gastro.2008.01.012; Travassos LH, 2010, NAT IMMUNOL, V11, P55, DOI 10.1038/ni.1823; Turnbaugh PJ, 2010, P NATL ACAD SCI USA, V107, P7503, DOI 10.1073/pnas.1002355107; Tuvlin JA, 2007, INFLAMM BOWEL DIS, V13, P573, DOI 10.1002/ibd.20043; Van Assche G, 2008, GASTROENTEROLOGY, V134, P1861, DOI 10.1053/j.gastro.2008.03.004; Van Assche G, 2010, J CROHNS COLITIS, V4, P63, DOI 10.1016/j.crohns.2009.09.009; van der Woude CJ, 2010, J CROHNS COLITIS, V4, P493, DOI 10.1016/j.crohns.2010.07.004; van Heel DA, 2005, LANCET, V365, P1794, DOI 10.1016/S0140-6736(05)66582-8; Vavricka SR, 2011, AM J GASTROENTEROL, V106, P110, DOI 10.1038/ajg.2010.343; Vijay-Kumar M, 2007, J CLIN INVEST, V117, P3909, DOI 10.1172/JCI33084; Walters MJ, 2010, J PHARMACOL EXP THER, V335, P61, DOI 10.1124/jpet.110.169714; Weaver CT, 2009, NAT REV IMMUNOL, V9, P883, DOI 10.1038/nri2660; Weber CR, 2010, J BIOL CHEM, V285, P12037, DOI 10.1074/jbc.M109.064808; Willing BP, 2010, GASTROENTEROLOGY, V139, P1844, DOI 10.1053/j.gastro.2010.08.049; Zeissig S, 2007, GUT, V56, P61, DOI 10.1136/gut.2006.094375; Zhang FR, 2009, NEW ENGL J MED, V361, P2609, DOI 10.1056/NEJMoa0903753; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878	140	1286	1353	12	309	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 3	2012	380	9853					1590	1605		10.1016/S0140-6736(12)60026-9	http://dx.doi.org/10.1016/S0140-6736(12)60026-9			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	030VR	22914295				2022-12-28	WOS:000310598700035
J	Steinbrook, R				Steinbrook, Robert			Controlling Health Care Costs in Massachusetts With a Global Spending Target	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06520 USA	Yale University	Steinbrook, R (corresponding author), Yale Univ, Sch Med, Dept Internal Med, 333 Cedar St,I-456 SHM,POB 208008, New Haven, CT 06520 USA.	rsteinbrook@attglobal.net						[Anonymous], 2011, EX HLTH CAR COST TRE; [Anonymous], 2010, EX HLTH CAR COST TRE; Baicker K, 2012, NEW ENGL J MED, V366, P2433, DOI 10.1056/NEJMp1204891; Centers for Medicare and Medicaid Services, TOT ALL PRAY STAT ES; Cuckler Gigi, 2011, Medicare Medicaid Res Rev, V1, DOI 10.5600/mmrr.001.04.a03; Long SK, 2012, HEALTH AFFAIR, V31, P444, DOI 10.1377/hlthaff.2011.0653; Steinbrook R, 2006, NEW ENGL J MED, V354, P2095, DOI 10.1056/NEJMp068097	7	9	10	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 26	2012	308	12					1215	1216		10.1001/2012.jama.11322	http://dx.doi.org/10.1001/2012.jama.11322			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	010OK	22918407	Bronze			2022-12-28	WOS:000309103600022
J	Ringe, D; Petsko, GA				Ringe, Dagmar; Petsko, Gregory A.			Behind the Movement	CELL			English	Editorial Material							SQUID GIANT-AXON; MOTOR DOMAIN; CRYSTAL-STRUCTURE; MYOSIN; FILAMENTS; ACTIN; MICROTUBULES; ORGANELLES; MECHANISM; AXOPLASM		[Ringe, Dagmar; Petsko, Gregory A.] Brandeis Univ, Dept Biochem, Waltham, MA 02454 USA; [Ringe, Dagmar; Petsko, Gregory A.] Brandeis Univ, Dept Chem, Waltham, MA 02454 USA; [Ringe, Dagmar; Petsko, Gregory A.] Brandeis Univ, Rosenstiel Basic Med Sci Res Ctr, Waltham, MA 02454 USA; [Petsko, Gregory A.] Weill Cornell Med Coll, Dept Neurol & Neurosci, New York, NY 10065 USA	Brandeis University; Brandeis University; Brandeis University; Cornell University	Ringe, D (corresponding author), Brandeis Univ, Dept Biochem, Waltham, MA 02454 USA.	ringe@brandeis.edu; petsko@brandeis.edu						Bryant Z, 2007, P NATL ACAD SCI USA, V104, P772, DOI 10.1073/pnas.0610144104; Carter AP, 2011, SCIENCE, V331, P1159, DOI 10.1126/science.1202393; Cho C, 2012, BBA-MOL CELL RES, V1823, P182, DOI 10.1016/j.bbamcr.2011.10.009; Huxley HE, 2004, PHILOS T ROY SOC B, V359, P1879, DOI 10.1098/rstb.2004.1556; Kull FJ, 1996, NATURE, V380, P550, DOI 10.1038/380550a0; Robinson DN, 2004, CURR OPIN CELL BIOL, V16, P182, DOI 10.1016/j.ceb.2004.02.002; SCHNAPP BJ, 1985, CELL, V40, P455, DOI 10.1016/0092-8674(85)90160-6; SHEETZ MP, 1983, NATURE, V303, P31, DOI 10.1038/303031a0; SPUDICH JA, 1985, NATURE, V315, P584, DOI 10.1038/315584a0; Sweeney HL, 2010, ANNU REV BIOPHYS, V39, P539, DOI 10.1146/annurev.biophys.050708.133751; Vale RD, 2000, SCIENCE, V288, P88, DOI 10.1126/science.288.5463.88; VALE RD, 1985, CELL, V42, P39, DOI 10.1016/S0092-8674(85)80099-4; VALE RD, 1985, CELL, V43, P623, DOI 10.1016/0092-8674(85)90234-X; VALE RD, 1985, CELL, V40, P559, DOI 10.1016/0092-8674(85)90204-1; VALE RD, 1985, CELL, V40, P449, DOI 10.1016/0092-8674(85)90159-X; VALE RD, 1984, P NATL ACAD SCI-BIOL, V81, P6775, DOI 10.1073/pnas.81.21.6775	16	1	1	0	17	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 14	2012	150	6					1093	1095		10.1016/j.cell.2012.08.031	http://dx.doi.org/10.1016/j.cell.2012.08.031			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	007ZY	22980970	Bronze			2022-12-28	WOS:000308928100001
J	Wachter, RM; Verghese, A				Wachter, Robert M.; Verghese, Abraham			The Attending Physician on the Wards Finding a New Homeostasis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Wachter, Robert M.] Univ Calif San Francisco, Dept Med, Div Hosp Med, San Francisco, CA USA; [Verghese, Abraham] Stanford Univ, Dept Med, Stanford, CA 94305 USA	University of California System; University of California San Francisco; Stanford University	Wachter, RM (corresponding author), Room M994,505 Parnassus Ave, San Francisco, CA 94143 USA.	bobw@medicine.ucsf.edu						Kugler J, 2010, J GEN INTERN MED, V25, P756, DOI 10.1007/s11606-010-1400-3; Natarajan P, 2009, J HOSP MED, V4, P490, DOI 10.1002/jhm.537; Orr D. W., 2002, NATURE DESIGN ECOLOG; Sehgal NL, 2011, J HOSP MED, V6, P161, DOI 10.1002/jhm.845; Verghese A, 2008, NEW ENGL J MED, V359, P2748, DOI 10.1056/NEJMp0807461; Wachter RM, 1999, AM J MED, V106, P127	6	14	14	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 12	2012	308	10					977	978		10.1001/2012.jama.10476	http://dx.doi.org/10.1001/2012.jama.10476			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	003AA	22968883				2022-12-28	WOS:000308579300017
J	Lagomarsino, G; Garabrant, A; Adyas, A; Muga, R; Otoo, N				Lagomarsino, Gina; Garabrant, Alice; Adyas, Atikah; Muga, Richard; Otoo, Nathaniel			Moving towards universal health coverage: health insurance reforms in nine developing countries in Africa and Asia	LANCET			English	Article							SOUTH-AFRICA; GHANA; TANZANIA; LESSONS; SYSTEMS; EQUITY; CARE	We analyse nine low-income and lower-middle-income countries in Africa and Asia that have implemented national health insurance reforms designed to move towards universal health coverage. Using the functions-of-health-systems framework, we describe these countries' approaches to raising prepaid revenues, pooling risk, and purchasing services. Then, using the coverage-box framework, we assess their progress across three dimensions of coverage: who, what services, and what proportion of health costs are covered. We identify some patterns in the structure of these countries' reforms, such as use of tax revenues to subsidise target populations, steps towards broader risk pools, and emphasis on purchasing services through demand-side financing mechanisms. However, none of the reforms purely conform to common health-system archetypes, nor are they identical to each other. We report some trends in these countries' progress towards universal coverage, such as increasing enrolment in government health insurance, a movement towards expanded benefits packages, and decreasing out-of-pocket spending accompanied by increasing government share of spending on health. Common, comparable indicators of progress towards universal coverage are needed to enable countries undergoing reforms to assess outcomes and make midcourse corrections in policy and implementation.	[Lagomarsino, Gina; Garabrant, Alice] Results Dev Inst, Washington, DC 20005 USA; [Adyas, Atikah] Minist Hlth, Natl Inst Human Resource Dev, Jakarta, Indonesia; [Muga, Richard] Great Lakes Univ Kisumu, Kisumu, Kenya; [Otoo, Nathaniel] Natl Hlth Insurance Author, Accra, Ghana	Ministry of Health - Indonesia	Lagomarsino, G (corresponding author), Results Dev Inst, 1100 15th St NW,Suite 400, Washington, DC 20005 USA.	glagomarsino@resultsfordevelopment.org			Rockefeller Foundation	Rockefeller Foundation	We thank Cheryl Cashin, David de Ferranti, Charlie Griffin, Dave Gwatkin, Amanda Folsom, Nishant Jain, Allison Kelley, Jack Langenbrunner, Robert Marten, Rodrigo Moreno-Serra, Waziri Dogo-Muhammad, Bill Savedoff, Julian Schweitzer, Peter Smith, and six anonymous reviewers for their comments. This report is part of a Series on universal health coverage funded by the Rockefeller Foundation. We thank the foundation for convening various author meetings and workshops.	[Anonymous], PRINC MAH AW C 2012; [Anonymous], 2009, SEM ORG UN TECHN MUT; [Anonymous], 2011, DAILY GRAPHIC A 1116; [Anonymous], 2012, RSBY CONN; Apoya P, 2011, ACHIEVING SHARED GOA; Aryeetey GC, 2012, TROP MED INT HEALTH, V17, P43, DOI 10.1111/j.1365-3156.2011.02886.x; Balarajan Y, 2011, LANCET, V377, P505, DOI 10.1016/S0140-6736(10)61894-6; Bang A, 2011, HIGH LEVEL EXPERT GR; Barnighausen T, 2002, SOC SCI MED, V54, P1559, DOI 10.1016/S0277-9536(01)00137-X; Basu S, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001244; Berendes S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000433; Berman P, 2012, PRINC MAH AW C BANGK; Chan M., 2012, 65 WORLD HLTH ASS GE; Chankova S, 2010, IMPACT OF HEALTH INSURANCE IN LOW- AND MIDDLE-INCOME COUNTRIES, P58; Das J, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000432; Deloitte, 2011, NHIF STRAT REV MARK; Fuenzalida-Puelma HL., 2010, IMPLEMENTING HLTH FI, V21, P155; Garshong B, 2011, SESS EXP CHALL LESS; GTZ, 2007, KAL SIG AB KAYA SA P; Gwatkin D. R, 2000, CURRENT STATE KNOWLE; Gwatkin DR, 2004, LANCET, V364, P1273, DOI 10.1016/S0140-6736(04)17145-6; Immergut E., 1992, HLTH POLITICS INTERE; International Finance Corporation, 2011, BUS HLTH AFR PARTN P; International Labour Organization, 2009, INT I LAB STUD INF D; International Labour Organization (ILO), 2013, STAT UPD EMPL INF EC; Joint Learning Network, MOB PHON COMM RES MO; Joint Learning Network, VOL CONTR SYST SOFTW; Joint Learning Network Quality track (Institute for Healthcare Improvement and NICE International), 2012, FRAM PAYERS DR UNPUB; Jowett M, 2007, WBI DEV STUD, P81; Krishnaswamy K, 2011, RASHTRIYA SWASTHYA B; Kumar AKS, 2011, LANCET, V377, P668, DOI 10.1016/S0140-6736(10)61884-3; Kutzin J, 2009, B WORLD HEALTH ORGAN, V87, P549, DOI 10.2471/BLT.07.049544; Lu CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039282; Makinen M., 2011, PRIVATE HLTH SECTOR; McIntyre D, 2003, HEALTH POLICY PLANN, V18, P47, DOI 10.1093/heapol/18.1.47; McIntyre D, 2008, B WORLD HEALTH ORGAN, V86, P871, DOI 10.2471/BLT.08.053413; Meessen B, 2011, HEALTH POLICY PLANN, V26, pII1, DOI 10.1093/heapol/czr071; Mensah SA, 2012, NATL HLTH INSURANCE; Mills A, 2012, LANCET, V380, P126, DOI 10.1016/S0140-6736(12)60357-2; Ministere du Developpement Social de la Solidarite et des Personnes Agees, 2011, STRAT NAT EXT COUV M; Ministry of Health, 2010, ANN REP JUL 2009 JUN; Ministry of Health, 2006, REV TRENDS 2 NAT HLT; Ministry of Health and Family Welfare, 2010, ANN REP PEOPL HLTH; Ministry of Health of Rwanda, 2010, RWAND COMM BAS HLTH; Montagu D, 2011, IHEA S ROL PRIV SECT; Mukti AG, 2012, POLICY PAPER BPJS UH; Murray CJL, 2000, B WORLD HEALTH ORGAN, V78, P717; Musgrove P, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P271; Mwangi J, 2011, GHAN ANN HLTH SUMM A; National Health Insurance Authority, 2011, NAT HLTH INS SCHEM 2; Ogundipe S, 2011, VANGUARD LAGOS  1213; Philippine Health Insurance Corporation, 2011, ANN REP 2010; Rathi Prateek, 2012, EVALUATION RASHTRIYA; Reddy KS, 2011, LANCET, V377, P760, DOI 10.1016/S0140-6736(10)61960-5; Rosario GAA, 2009, ANAL REPORT KA UNPUB; Savedoff WD, 2012, LANCET, V380, P924, DOI 10.1016/S0140-6736(12)61083-6; Seddoh A, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-S1-S10; Sheiman I, 2010, IMPLEMENTING HLTH FI, P87; Spaan E, B WHO IN PRESS; The Research Institute Rajagiri College of Social Sciences, 2009, RSBY CHIS EV SURV FA; Tien TV, 2011, HLTH FINANCING REV V; Wagstaff A, UNIVERSAL COVERAGE 3; Wagstaff A, 2010, HEALTH ECON, V19, P503, DOI 10.1002/hec.1492; WHO, 2010, WORLD MALARIA REPORT 2010, P1; Witter S, 2009, BMC INT HEALTH HUM R, V9, DOI 10.1186/1472-698X-9-20; Yates R, 2009, LANCET, V373, P2078, DOI 10.1016/S0140-6736(09)60258-0	66	318	323	4	107	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 8	2012	380	9845					933	943		10.1016/S0140-6736(12)61147-7	http://dx.doi.org/10.1016/S0140-6736(12)61147-7			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	002QL	22959390				2022-12-28	WOS:000308547300037
J	Savedoff, WD; de Ferranti, D; Smith, AL; Fan, V				Savedoff, William D.; de Ferranti, David; Smith, Amy L.; Fan, Victoria			Political and economic aspects of the transition to universal health coverage	LANCET			English	Article							CARE EXPENDITURE; UNITED-STATES; SYSTEM REFORM; INSURANCE; GROWTH; POPULATION; EXPERIENCE; PAYMENTS; LESSONS; TRENDS	Countries have reached universal health coverage by different paths and with varying health systems. Nonetheless, the trajectory toward universal health coverage regularly has three common features. The first is a political process driven by a variety of social forces to create public programmes or regulations that expand access to care, improve equity, and pool financial risks. The second is a growth in incomes and a concomitant rise in health spending, which buys more health services for more people. The third is an increase in the share of health spending that is pooled rather than paid out-of-pocket by households. This pooled share is sometimes mobilised as taxes and channelled through governments that provide or subsidise care-in other cases it is mobilised in the form of contributions to mandatory insurance schemes. The predominance of pooled spending is a necessary condition (but not sufficient) for achieving universal health coverage. This paper describes common patterns in countries that have successfully provided universal access to health care and considers how economic growth, demographics, technology, politics, and health spending have intersected to bring about this major development in public health.	[Savedoff, William D.; Fan, Victoria] Ctr Global Dev, Washington, DC 20036 USA; [de Ferranti, David] Results Dev Inst, Washington, DC USA; [Smith, Amy L.] Social Insight, Bath, ME USA		Savedoff, WD (corresponding author), Ctr Global Dev, 1800 Massachusetts Ave NW, Washington, DC 20036 USA.	wsavedoff@cgdev.org	Fan, Victoria/AGG-4359-2022	Fan, Victoria/0000-0001-7755-9425	Rockefeller Foundation	Rockefeller Foundation	We gratefully acknowledge comments from Alice Garabrant, Gina Lagomarsino, Robert Marten, Rodrigo Moreno-Serra, Peter Smith, and six anonymous reviewers. The paper also benefited from discussions with and papers by researchers who participated in the Transitions in Health Financing project, including Ricardo Bitran, Priyanka Saksena, and Ke Xu. This paper is part of a series funded by the Rockefeller Foundation. We thank them for convening various author meetings and workshops.	ANDERSON GF, 1989, HEALTH AFFAIR, V8, P24, DOI 10.1377/hlthaff.8.2.24; Balabanova D, 2011, GOOD HLTH LOW COST 2; Baltagi BH, 2010, ECON MODEL, V27, P804, DOI 10.1016/j.econmod.2009.12.001; Bump JB, 2010, LONG ROAD UNIVERSAL; Campbell J, 1998, ART BALANCE HLTH POL; Carrin G, 2004, REACHING UNIVERSAL C; Centers for Medicare Medicaid Services, NAT HLTH EXP DAT; Chee Heng Leng, 2007, HLTH CARE MALAYSIA D; Chernew ME, 2012, HLTH CARE SPENDING G; Cutler D, 2000, HDB HLTH EC, P461; CUTLER DM, 2001, HEALTH AFFAIR, V20, P11; Das J, 2008, J ECON PERSPECT, V22, P93, DOI 10.1257/jep.22.2.93; Davis K, 2007, MIRROR MIRROR WALL I; de Ferranti D, 2007, HLTH LEAD C MADR APR; DELAJARA JJ, 1995, HEALTH POLICY, V32, P155, DOI 10.1016/0168-8510(95)00733-9; Digby A., 1998, RADICALISM REALITY N; Docteur E, 2003, HLTH CARE SYSTEMS LE; DONABEDIAN A, 1973, ASPECTS MED CARE ADM; Dormont B, 2006, HEALTH ECON, V15, P947, DOI 10.1002/hec.1165; Escobar ML, 2010, IMPACT OF HEALTH INSURANCE IN LOW- AND MIDDLE-INCOME COUNTRIES, P1; Fan V, 2012, HLTH FINANCING TRANS; Feachem RGA, 2002, BMJ-BRIT MED J, V324, P135, DOI 10.1136/bmj.324.7330.135; Fogel RW, 2004, POPUL DEV REV, V30, P19; Freedman VA, 2002, JAMA-J AM MED ASSOC, V288, P3137, DOI 10.1001/jama.288.24.3137; Frenk J, 2006, LANCET, V368, P1524, DOI 10.1016/S0140-6736(06)69564-0; Gerdtham U-G, 2000, INT COMPARISONS HLTH; GETZEN TE, 1992, J GERONTOL, V47, pS98, DOI 10.1093/geronj/47.3.S98; Gottret P, 2008, GOOD PRACTICES HLTH; GRILICHES Z, 1994, AM ECON REV, V84, P1213; Hsiao WC, 2003, HEALTH AFFAIR, V22, P377; Hu SL, 2008, LANCET, V372, P1846, DOI 10.1016/S0140-6736(08)61368-9; Hughes D, 2007, HEALTH AFFAIR, V26, P999, DOI 10.1377/hlthaff.26.4.999; ILO, 2008, SOC HLTH PROT ILO ST; Immergut E., 1992, HLTH POLITICS INTERE; Inter-American Development Bank, 1996, EC SOC PROGR LAT AM; Kamat V. R., 1997, PRIVATE HLTH PROVIDE, P124; Kutzin J, 2007, EXTENDING SOCIAL PRO; Kutzin J, 2002, FUNDING HLTH CARE OP; Latko B, 2011, LANCET, V377, P2161, DOI 10.1016/S0140-6736(10)62006-5; LUBITZ JD, 1993, NEW ENGL J MED, V328, P1092, DOI 10.1056/NEJM199304153281506; Moreno-Serra R, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001087; Musgrove P, 2000, B WORLD HEALTH ORGAN, V78, P845; Nunn AS, 2007, PLOS MED, V4, P1804, DOI 10.1371/journal.pmed.0040305; OECD, OECD HLTH DAT 2012 F; Ogawa S, 2003, HEALTH POLICY PLANN, V18, P270, DOI 10.1093/heapol/czg033; Reddy KS, 2011, LANCET, V377, P760, DOI 10.1016/S0140-6736(10)61960-5; Rivett G., 1997, CRADLE GRAVE 50 YEAR; ROTHSCHILD M, 1976, Q J ECON, V90, P629, DOI 10.2307/1885326; Savedoff WD, 2011, ACHIEVING UNIVERSAL; Schoen C, 2007, HEALTH AFFAIR, V26, pW717, DOI 10.1377/hlthaff.26.6.w717; Sekhri N, 2005, B WORLD HEALTH ORGAN, V83, P127; Shengelia B, 2003, ACCESS UTILIZATION D; Somkotra T, 2008, SOC SCI MED, V67, P2027, DOI 10.1016/j.socscimed.2008.09.047; TANAHASHI T, 1978, B WORLD HEALTH ORGAN, V56, P295; Van de Ven WPMM, 2000, HDB HLTH EC; Van Doorslaer E., 2004, INCOME RELATED INEQU; van Ours, 2010, AGEING HLTH PRODUCTI, P16; Victora CG, 2011, LANCET, V377, P2042, DOI 10.1016/S0140-6736(11)60055-X; White C, 2007, HEALTH AFFAIR, V26, P154, DOI 10.1377/hlthaff.26.1.154; WHO, 2010, WORLD MALARIA REPORT 2010, P1; WHO, GLOB HLTH EXP DAT; World Health Organization, 2005, SUST HLTH FIN UN COV; Xu K, 2011, INCOME OTHER DETERMI; Yamin AE, 2009, PLOS MED, V6, P147, DOI 10.1371/journal.pmed.1000032; Zweifel P, 1999, HEALTH ECON, V8, P485, DOI 10.1002/(SICI)1099-1050(199909)8:6<485::AID-HEC461>3.0.CO;2-4	65	127	133	0	41	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 8	2012	380	9845					924	932		10.1016/S0140-6736(12)61083-6	http://dx.doi.org/10.1016/S0140-6736(12)61083-6			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	002QL	22959389				2022-12-28	WOS:000308547300036
J	Byrne, TN; Isakoff, SJ; Rincon, SP; Gudewicz, TM				Byrne, Thomas N.; Isakoff, Steven Jay; Rincon, Sandra P.; Gudewicz, Thomas M.			Case 27-2012: A 60-Year-Old Woman with Painful Muscle Spasms and Hyperreflexia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							STIFF-PERSON SYNDROME; PRIMARY BREAST-CANCER; CARCINOMA; ANTIBODIES		[Byrne, Thomas N.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Isakoff, Steven Jay] Massachusetts Gen Hosp, Dept Hematol Oncol, Boston, MA 02114 USA; [Rincon, Sandra P.] Massachusetts Gen Hosp, Dept Neuroradiol, Boston, MA 02114 USA; [Gudewicz, Thomas M.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Byrne, Thomas N.] Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; [Isakoff, Steven Jay] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Rincon, Sandra P.] Harvard Univ, Sch Med, Dept Neuroradiol, Boston, MA 02115 USA; [Gudewicz, Thomas M.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Byrne, TN (corresponding author), Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA.		Isakoff, Steven/ABE-3566-2020					Alexopoulos H, 2010, EUR J CLIN INVEST, V40, P1018, DOI 10.1111/j.1365-2362.2010.02340.x; [Anonymous], 2008, NEW ENGL J MED, V359, P842; Buchanan CL, 2005, ANN SURG ONCOL, V12, P1045, DOI 10.1245/ASO.2005.03.520; Citron ML, 2003, J CLIN ONCOL, V21, P1431, DOI 10.1200/JCO.2003.09.081; Dalakas MC, 2009, CURR TREAT OPTION NE, V11, P102, DOI 10.1007/s11940-009-0013-9; Darnell RB, 2003, NEW ENGL J MED, V349, P1543, DOI 10.1056/NEJMra023009; Donofrio PD, 2009, MUSCLE NERVE, V40, P890, DOI 10.1002/mus.21433; Foroudi F, 2000, INT J RADIAT ONCOL, V47, P143, DOI 10.1016/S0360-3016(99)00542-8; Graus F, 2004, J NEUROL NEUROSUR PS, V75, P1135, DOI 10.1136/jnnp.2003.034447; Greenlee JE, 2010, CURR TREAT OPTION NE, V12, P212, DOI 10.1007/s11940-010-0066-9; Halsted WS, 1907, ANN SURG, V46, P1, DOI 10.1097/00000658-190707000-00001; Masinghe SP, 2011, CLIN ONCOL-UK, V23, P95, DOI 10.1016/j.clon.2010.10.001; Murinson BB, 2008, NEUROLOGY, V71, P1955, DOI 10.1212/01.wnl.0000327342.58936.e0; Pittock SJ, 2005, ANN NEUROL, V58, P96, DOI 10.1002/ana.20529; Psimaras D, 2010, J NEUROL NEUROSUR PS, V81, P42, DOI 10.1136/jnnp.2008.159483; Roberts WK, 2004, CURR OPIN IMMUNOL, V16, P616, DOI 10.1016/j.coi.2004.07.009; ROSEN PP, 1990, HUM PATHOL, V21, P518, DOI 10.1016/0046-8177(90)90008-S; SOLIMENA M, 1990, NEW ENGL J MED, V322, P1555, DOI 10.1056/NEJM199005313222202; Sommer C, 2005, LANCET, V365, P1406, DOI 10.1016/S0140-6736(05)66376-3; Walker GV, 2010, CANCER-AM CANCER SOC, V116, P4000, DOI 10.1002/cncr.25197	20	5	6	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 30	2012	367	9					851	861		10.1056/NEJMcpc1114036	http://dx.doi.org/10.1056/NEJMcpc1114036			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	996EN	22931320				2022-12-28	WOS:000308067400009
J	Bakker, K				Bakker, Karen			Water Security: Research Challenges and Opportunities	SCIENCE			English	Editorial Material							RESOURCES MANAGEMENT		[Bakker, Karen] Univ British Columbia, Dept Geog, Program Water Governance, Vancouver, BC V6T 1Z2, Canada; [Bakker, Karen] Univ British Columbia, Inst Resources Environm & Sustainabil, Vancouver, BC V6T 1Z2, Canada	University of British Columbia; University of British Columbia	Bakker, K (corresponding author), Univ British Columbia, Dept Geog, Program Water Governance, Vancouver, BC V6T 1Z2, Canada.	karen.bakker@ubc.ca	Quinn, Patrick/B-5489-2010					Alcamo Joseph M., 2008, Environmental Research Letters, V3, P010202, DOI 10.1088/1748-9326/3/1/010202; Allan JA, 2003, WATER INT, V28, P106, DOI 10.1080/02508060.2003.9724812; Bogardi JJ, 2012, CURR OPIN ENV SUST, V4, P35, DOI 10.1016/j.cosust.2011.12.002; Braden JB, 2009, WATER RESOUR RES, V45, DOI 10.1029/2009WR008216; Briscoe J., 2009, Innovations: Technology / Governance / Globalisation, V4, P3, DOI 10.1162/itgg.2009.4.3.3; Cook C, 2012, GLOBAL ENVIRON CHANG, V22, P94, DOI 10.1016/j.gloenvcha.2011.10.011; Dominic W, 2011, CHOICE REV ONLINE; Falkenmark M., 2004, EARTHSCAN; Gleick PH, 2000, WATER INT, V25, P127, DOI 10.1080/02508060008686804; Grey D, 2007, WATER POLICY, V9, P545, DOI 10.2166/wp.2007.021; GWP, 2000, GLOBAL WATER PARTNER; Hering JG, 2012, SCIENCE, V336, P1234, DOI 10.1126/science.1218230; Hope R., 2012, SYNTHESIS REPORT SUB; Mehta L., 2012, Water Alternatives, V5, P193; Milly PCD, 2008, SCIENCE, V319, P573, DOI 10.1126/science.1151915; Nuzzo JB, 2006, BIOSECUR BIOTERROR, V4, P147, DOI 10.1089/bsp.2006.4.147; Office of the Director of National Intelligence, 2012, GLOB WAT SEC; Pahl-Wostl C, 2008, ECOL SOC, V13; Palmer MA, 2010, NATURE, V467, P534, DOI 10.1038/467534a; Priscoli J.D., 2009, MANAGING TRANSFORMIN; Rockstrom J, 2009, WATER RESOUR RES, V45, DOI 10.1029/2007WR006767; Rockstrom J, 2009, NATURE, V461, P472, DOI 10.1038/461472a; Sivapalan M, 2012, HYDROL PROCESS, V26, P1270, DOI 10.1002/hyp.8426; Sophocleous M, 2002, HYDROGEOL J, V10, P52, DOI 10.1007/s10040-001-0170-8; Swyngedouw E, 2009, J CONTEMP WAT RES ED, V142, P56, DOI 10.1111/j.1936-704X.2009.00054.x; United Nations Environment Program, 2009, WAT SEC EC SERV CRIT; Vorosmarty CJ, 2010, NATURE, V467, P555, DOI 10.1038/nature09440; Vorosmarty C., 2004, EOS, V85, P509, DOI DOI 10.1029/2004EO480001; Warner J, 2008, WATER POLICY, V10, P121, DOI 10.2166/wp.2008.210; WHO, 2005, EC HUM WELL BEING HL; WWAP U. N, 2003, WAT PEOPL WAT LIF UN; Zeitoun M, 2011, GLOB POLICY, V2, P286, DOI 10.1111/j.1758-5899.2011.00097.x; [No title captured]; [No title captured]; [No title captured]	35	301	313	26	304	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 24	2012	337	6097					914	915		10.1126/science.1226337	http://dx.doi.org/10.1126/science.1226337			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	992VI	22923564				2022-12-28	WOS:000307807600027
J	Frost, PJ; Wise, MP				Frost, Paul J.; Wise, Matt P.			Early management of acutely ill ward patients	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							EARLY WARNING SCORE; CARE		[Frost, Paul J.] Cardiff Univ, Inst Med Educ, Sch Med, Cardiff CF14 4XN, S Glam, Wales; [Frost, Paul J.; Wise, Matt P.] Univ Wales Hosp, Crit Care Directorate, Cardiff CF14 4XW, S Glam, Wales	Cardiff University; Cardiff University	Frost, PJ (corresponding author), Cardiff Univ, Inst Med Educ, Sch Med, Cardiff CF14 4XN, S Glam, Wales.	frostp2@cf.ac.uk		Wise, Matt/0000-0002-2763-4316				Cecconi M, 2011, CURR OPIN CRIT CARE, V17, P290, DOI 10.1097/MCC.0b013e32834699cd; Gordon CF, 2011, SCOT MED J, V56, P15, DOI 10.1258/smj.2010.010009; Kause J, 2004, RESUSCITATION, V62, P275, DOI 10.1016/j.resuscitation.2004.05.016; *NAT CONF ENQ PAT, 2005, AC PROBL; National Institute for Health and Clinical Excellence, 2007, AC ILL PAT HOSP; NHS Institute for Innovation and Improvement, SBAR SIT BACKGR ASS; O'Driscoll BR, 2008, THORAX, V63, DOI 10.1136/thx.2008.102947; Royal College of Physicians, NAT EARL WARN SCOR N; Royal College of Physicians, 2011, AC CAR TOOLK 2 HIGH; Smith CM, 2007, INTENS CARE MED, V33, P901, DOI 10.1007/s00134-007-0564-8; Smith T, 2012, BRIT J SURG, V99, P192, DOI 10.1002/bjs.7777; STACPOOLE PW, 1994, AM J MED, V97, P47, DOI 10.1016/0002-9343(94)90047-7; Subbe CP, 2001, QJM-MON J ASSOC PHYS, V94, P521, DOI 10.1093/qjmed/94.10.521; The General Medical Council, 2010, TREATM CAR END LIF; Turkington PM, 2002, STROKE, V33, P2037, DOI 10.1161/01.STR.0000023576.94311.27	15	11	11	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 24	2012	345								e5677	10.1136/bmj.e5677	http://dx.doi.org/10.1136/bmj.e5677			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	996HC	22923534				2022-12-28	WOS:000308074500005
J	Mattaini, KR; Vander Heiden, MG				Mattaini, Katherine R.; Vander Heiden, Matthew G.			Glycosylation to Adapt to Stress	SCIENCE			English	Editorial Material							RABBIT MUSCLE PHOSPHOFRUCTOKINASE; CANCER-CELLS; METABOLISM; PHOSPHORYLATION; REGULATOR		[Mattaini, Katherine R.; Vander Heiden, Matthew G.] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Mattaini, Katherine R.; Vander Heiden, Matthew G.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Vander Heiden, Matthew G.] Dana Farber Canc Inst, Boston, MA 02115 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Dana-Farber Cancer Institute	Mattaini, KR (corresponding author), MIT, Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	mvh@mit.edu						Bensaad K, 2006, CELL, V126, P107, DOI 10.1016/j.cell.2006.05.036; Brunelle JK, 2005, CELL METAB, V1, P409, DOI 10.1016/j.cmet.2005.05.002; Cai GZ, 1997, BIOPHYS CHEM, V64, P199, DOI 10.1016/S0301-4622(96)02232-6; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Chang SH, 2002, BIOCHEM BIOPH RES CO, V290, P670, DOI 10.1006/bbrc.2001.6262; Love, 2005, SCI STKE, V2005, DOI DOI 10.1126/STKE.3122005RE13; Lynch TP, 2012, J BIOL CHEM, V287, P11070, DOI 10.1074/jbc.M111.302547; Mor I, 2011, COLD SH Q B, V76, P211, DOI 10.1101/sqb.2011.76.010868; Ros S, 2012, CANCER DISCOV, V2, P328, DOI 10.1158/2159-8290.CD-11-0234; Taylor RP, 2008, J BIOL CHEM, V283, P6050, DOI 10.1074/jbc.M707328200; Tong XM, 2009, CURR OPIN GENET DEV, V19, P32, DOI 10.1016/j.gde.2009.01.002; WEBER G, 1977, NEW ENGL J MED, V296, P541, DOI 10.1056/NEJM197703102961005; Yalcin A, 2009, EXP MOL PATHOL, V86, P174, DOI 10.1016/j.yexmp.2009.01.003; Yi W, 2012, SCIENCE, V337, P975, DOI 10.1126/science.1222278	14	8	11	0	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 24	2012	337	6097					925	926		10.1126/science.1227513	http://dx.doi.org/10.1126/science.1227513			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992VI	22923571				2022-12-28	WOS:000307807600034
J	Esfandbod, M; Kabootari, M				Esfandbod, Mohsen; Kabootari, Maryam			Chronic Granulomatous Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Esfandbod, Mohsen; Kabootari, Maryam] Univ Tehran Med Sci, Tehran, Iran	Tehran University of Medical Sciences	Esfandbod, M (corresponding author), Univ Tehran Med Sci, Tehran, Iran.	sfandbod@sina.tums.ac.ir	Kabootari, Maryam/I-2077-2018; Reyes-Mugica, Miguel/C-2483-2008; Goldblatt, David/C-5972-2008	Kabootari, Maryam/0000-0001-7460-9669; Reyes-Mugica, Miguel/0000-0001-5698-3702; Goldblatt, David/0000-0002-0769-5242; Esfandbod, Mohsen/0000-0002-6497-2306					0	4	4	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 23	2012	367	8					753	753		10.1056/NEJMicm1106350	http://dx.doi.org/10.1056/NEJMicm1106350			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	992CX	22913685				2022-12-28	WOS:000307754200010
J	Morthorst, B; Krogh, J; Erlangsen, A; Alberdi, F; Nordentoft, M				Morthorst, Britt; Krogh, Jesper; Erlangsen, Annette; Alberdi, Francisco; Nordentoft, Merete			Effect of assertive outreach after suicide attempt in the AID (assertive intervention for deliberate self harm) trial: randomised controlled trial	BRITISH MEDICAL JOURNAL			English	Article							ADOLESCENT SUICIDE; RISK-FACTORS; PREVENTING REPETITION; HELP-SEEKING; YOUNG-PEOPLE; ADHERENCE; HEALTH; PARASUICIDE; EUROPE; CARE	Objective To assess whether an assertive outreach intervention after suicide attempt could reduce the frequency of subsequent suicidal acts, compared with standard treatment. Design Randomised, parallel group, superiority trial with blinded outcome assessment. Setting Outpatient intervention at one location at Copenhagen University Hospital, Denmark. Participants Patients older than 12 years admitted to regional hospitals in Copenhagen with a suicide attempt within the past 14 days. We excluded patients diagnosed with schizophrenia spectrum disorders and patients living in institutions. Intervention Case management through assertive outreach that provided crisis intervention and flexible problem solving. This approach incorporated motivational support and actively assisted patients to scheduled appointments to improve adherence with after-treatment as an add on to standard treatment. Main outcome Repeated suicide attempt and death by suicide, recorded in medical records and death register at 1-year follow-up. Results 243 patients were included. During 12 months of follow-up, 20/123 (16%) patients in the intervention group had been registered in hospital records with subsequent suicide attempt, compared with 13/120 (11%) in the control group (odds ratio 1.60, 95% confidence interval 0.76 to 3.38; P = 0.22). By contrast, self reported data on new events showed 11/95 (12%) in the intervention group versus 13/74 (18%) in the control group (0.61, 0.26 to 1.46; P = 0.27). By imputing missing data on the selfreported outcomes, we estimated 15/123 (12%) events in the intervention group and 23/120 (19%) in the control group (0.69, 0.34 to 1.43; P = 0.32). Conclusion Assertive outreach showed no significant effect on subsequent suicide attempt. The difference in rates of events between register data and self reported data could indicate detection bias.	[Morthorst, Britt; Krogh, Jesper; Erlangsen, Annette; Alberdi, Francisco; Nordentoft, Merete] Univ Copenhagen, Res Unit, Mental Hlth Ctr Copenhagen, Fac Hlth Sci, DK-2400 Copenhagen, Denmark; [Erlangsen, Annette] Johns Hopkins Sch Publ Hlth, Dept Mental Hlth, Baltimore, MD USA	University of Copenhagen; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Morthorst, B (corresponding author), Univ Copenhagen, Res Unit, Mental Hlth Ctr Copenhagen, Fac Hlth Sci, Bispebjerg Bakke 23, DK-2400 Copenhagen, Denmark.	britt.morthorst@regionh.dk	Erlangsen, Annette/ABE-1547-2021; Erlangsen, Annette/A-7153-2017; Nordentoft, Merete/AAH-3253-2019; Krogh, Jesper/C-6876-2013	Erlangsen, Annette/0000-0003-3475-0558; Erlangsen, Annette/0000-0003-3475-0558; Nordentoft, Merete/0000-0003-4895-7023; Krogh, Jesper/0000-0003-4834-6724	Ministry of Health and Internal Affairs, Denmark; National Board of Social Services, an independent subdivision of The Ministry of Social Affairs and Integration, TrygFonden; Aase og Ejnar Danielsens Foundation	Ministry of Health and Internal Affairs, Denmark; National Board of Social Services, an independent subdivision of The Ministry of Social Affairs and Integration, TrygFonden; Aase og Ejnar Danielsens Foundation	The study received funding from the Ministry of Health and Internal Affairs, Denmark, the National Board of Social Services, an independent subdivision of The Ministry of Social Affairs and Integration, TrygFonden, and Aase og Ejnar Danielsens Foundation.	Bergen H, 2010, BRIT J PSYCHIAT, V197, P493, DOI 10.1192/bjp.bp.110.077651; Bertolote J.M., 2009, OXFORD TXB SUICIDOLO, P91; Bertolote JM, 2005, AM J MED GENET C, V133C, P8, DOI 10.1002/ajmg.c.30041; Borges G, 2010, J CLIN PSYCHIAT, V71, P1617, DOI 10.4088/JCP.08m04967blu; Brent DA, 2009, J AM ACAD CHILD PSY, V48, P987, DOI 10.1097/CHI.0b013e3181b5dbe4; Bridge JA, 2006, J CHILD PSYCHOL PSYC, V47, P372, DOI 10.1111/j.1469-7610.2006.01615.x; Bruffaerts R, 2011, BRIT J PSYCHIAT, V199, P64, DOI 10.1192/bjp.bp.110.084129; Cedereke M, 2005, EUR PSYCHIAT, V20, P101, DOI 10.1016/j.eurpsy.2004.09.008; Crawford MJ, 2007, BRIT J PSYCHIAT, V190, P11, DOI 10.1192/bjp.bp.106.025437; Daniel SS, 2009, SUICIDE LIFE-THREAT, V39, P252, DOI 10.1521/suli.2009.39.3.252; DUPONT WD, 1990, CONTROL CLIN TRIALS, V11, P116, DOI 10.1016/0197-2456(90)90005-M; Ellis TE, 2009, B MENNINGER CLIN, V73, P339, DOI 10.1521/bumc.2009.73.4.339; Gluud LL, 2006, AM J EPIDEMIOL, V163, P493, DOI 10.1093/aje/kwj069; Gulliver A, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-113; Hawton K, 1998, J EPIDEMIOL COMMUN H, V52, P191, DOI 10.1136/jech.52.3.191; Hawton K, 1998, BRIT MED J, V317, P441; Hawton K, 2000, COCHRANE DB SYST REV, V2; Hawton K, 2009, LANCET, V373, P1372, DOI 10.1016/S0140-6736(09)60372-X; Hvid M, 2011, NORD J PSYCHIAT, V65, P292, DOI 10.3109/08039488.2010.544404; Hvid M, 2009, NORD J PSYCHIAT, V63, P148, DOI 10.1080/08039480802423022; Jobes DA, 2005, SUICIDE LIFE-THREAT, V35, P483, DOI 10.1521/suli.2005.35.5.483; Johannessen HA, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-81; Krug EG, 2002, LANCET, V360, P1083, DOI 10.1016/S0140-6736(02)11133-0; Lizardi D, 2010, PSYCHIAT SERV, V61, P1183, DOI 10.1176/ps.2010.61.12.1183; Mann JJ, 2005, JAMA-J AM MED ASSOC, V294, P2064, DOI 10.1001/jama.294.16.2064; Mortensen PB, 2000, LANCET, V355, P9, DOI 10.1016/S0140-6736(99)06376-X; National Institute for Clinical Excellence (NICE), 2004, SELF HARM SHORT TERM; Nordentoft M, 2005, NORD J PSYCHIAT, V59, P213, DOI 10.1080/08039480510027706; Nordentoft M., 2007, PREVENTION SUICIDE A; Owens D, 2002, BRIT J PSYCHIAT, V181, P193, DOI 10.1192/bjp.181.3.193; Pagura J, 2009, PSYCHIAT SERV, V60, P943, DOI 10.1176/appi.ps.60.7.943; Pelkonen Mirjami, 2003, Paediatr Drugs, V5, P243, DOI 10.2165/00148581-200305040-00004; PLATT S, 1992, ACTA PSYCHIAT SCAND, V85, P97, DOI 10.1111/j.1600-0447.1992.tb01451.x; Qin P, 2009, PSYCHOL MED, V39, P1867, DOI 10.1017/S0033291709005741; Qin P, 2000, BRIT J PSYCHIAT, V177, P546, DOI 10.1192/bjp.177.6.546; RotheramBorus MJ, 1996, J AM ACAD CHILD PSY, V35, P654, DOI 10.1097/00004583-199605000-00021; Schmidtke A, 1996, ACTA PSYCHIAT SCAND, V93, P327, DOI 10.1111/j.1600-0447.1996.tb10656.x; Spirito A, 2002, J AM ACAD CHILD PSY, V41, P435, DOI 10.1097/00004583-200204000-00016; Tim K, 2011, BMJ, P343; World Health Organization, 2009, SUIC RAT PER 100 000	40	50	50	0	22	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	AUG 22	2012	345								e4972	10.1136/bmj.e4972	http://dx.doi.org/10.1136/bmj.e4972			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	996GV	22915730	Green Published, hybrid			2022-12-28	WOS:000308073800001
J	Halim, SA; Newby, LK				Halim, Sharif A.; Newby, L. Kristin			Review: Omega-3 fatty acid supplements provide no protective benefit in cardiovascular disease	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Halim, Sharif A.; Newby, L. Kristin] Duke Univ, Med Ctr, Durham, NC 27706 USA	Duke University	Halim, SA (corresponding author), Duke Univ, Med Ctr, Durham, NC 27706 USA.							Boden WE, 2011, NEW ENGL J MED, V365, P2255, DOI 10.1056/NEJMoa1107579; Cannon CP, 2008, AM HEART J, V156, P826, DOI 10.1016/j.ahj.2008.07.023	2	3	4	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 21	2012	157	4							JC4-3	10.7326/0003-4819-157-4-201208210-02003	http://dx.doi.org/10.7326/0003-4819-157-4-201208210-02003			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	992XG	22910957				2022-12-28	WOS:000307813200002
J	Krupic, J; Burgess, N; O'Keefe, J				Krupic, Julija; Burgess, Neil; O'Keefe, John			Neural Representations of Location Composed of Spatially Periodic Bands	SCIENCE			English	Article							MEDIAL ENTORHINAL CORTEX; GRID CELLS; OSCILLATORY INTERFERENCE; PATH-INTEGRATION; PLACE CELLS; THETA; RAT; PHASE; MODEL; PARASUBICULUM	The mammalian hippocampal formation provides neuronal representations of environmental location, but the underlying mechanisms are poorly understood. Here, we report a class of cells whose spatially periodic firing patterns are composed of plane waves (or bands) drawn from a discrete set of orientations and wavelengths. The majority of cells recorded in parasubicular and medial entorhinal cortices of freely moving rats belonged to this class and included grid cells, an important subset that corresponds to three bands at 60 orientations and has the most stable firing pattern. Occasional changes between hexagonal and nonhexagonal patterns imply a common underlying mechanism. Our results indicate a Fourier-like spatial analysis underlying neuronal representations of location, and suggest that path integration is performed by integrating displacement along a restricted set of directions.	[Krupic, Julija; O'Keefe, John] UCL, Dept Cell & Dev Biol, London WC1E 6BT, England; [Burgess, Neil] UCL, Inst Cognit Neurosci, London WC1N 3AR, England; [Burgess, Neil] UCL, Inst Neurol, London WC1N 3BG, England; [O'Keefe, John] UCL, Sainsbury Wellcome Ctr Neural Circuits & Behav, London WC1E 6BT, England	University of London; University College London; University of London; University College London; University of London; University College London; University of London; University College London	O'Keefe, J (corresponding author), UCL, Dept Cell & Dev Biol, London WC1E 6BT, England.	j.okeefe@ucl.ac.uk	Burgess, Neil/B-2420-2009	Burgess, Neil/0000-0003-0646-6584; Krupic, Julija/0000-0001-6299-1629; O'Keefe, John/0000-0001-5697-4881	European Union; UK Medical Research Council; Gatsby Charitable Foundation; Wellcome Trust; CoMPLEX studentship; Medical Research Council [G1000854] Funding Source: researchfish; MRC [G1000854] Funding Source: UKRI	European Union(European Commission); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Gatsby Charitable Foundation; Wellcome Trust(Wellcome TrustEuropean Commission); CoMPLEX studentship; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the European Union Framework 7 (SPACEBRAIN) grant, the UK Medical Research Council, the Gatsby Charitable Foundation, and the Wellcome Trust. J.K. received support from a CoMPLEX studentship. We thank M. Bauza, T. Wills, C. Barry, F. Cacucci, and M. Witter for useful discussions and S. Burton for help with histology. This work was conducted in accordance with the UK Animals (Scientific Procedures) Act (1986).	Barry C., 2009, SOC NEUR ANN M CHIC; Barry C, 2007, NAT NEUROSCI, V10, P682, DOI 10.1038/nn1905; Blair HT, 2007, J NEUROSCI, V27, P3211, DOI 10.1523/JNEUROSCI.4724-06.2007; Blair HT, 2008, HIPPOCAMPUS, V18, P1239, DOI 10.1002/hipo.20509; Boccara CN, 2010, NAT NEUROSCI, V13, P987, DOI 10.1038/nn.2602; Borckmans P, 2002, INT J BIFURCAT CHAOS, V12, P2307, DOI 10.1142/S0218127402005881; Burgalossi A, 2011, NEURON, V70, P773, DOI 10.1016/j.neuron.2011.04.003; Burgess N, 2007, HIPPOCAMPUS, V17, P801, DOI 10.1002/hipo.20327; Burgess N, 2008, HIPPOCAMPUS, V18, P1157, DOI 10.1002/hipo.20518; Doeller CF, 2010, NATURE, V463, P657, DOI 10.1038/nature08704; Fiete IR, 2008, J NEUROSCI, V28, P6858, DOI 10.1523/JNEUROSCI.5684-07.2008; Fuhs MC, 2006, J NEUROSCI, V26, P4266, DOI 10.1523/JNEUROSCI.4353-05.2006; Fyhn M, 2007, NATURE, V446, P190, DOI 10.1038/nature05601; Geisler C, 2007, P NATL ACAD SCI USA, V104, P8149, DOI 10.1073/pnas.0610121104; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Hasselmo ME, 2008, HIPPOCAMPUS, V18, P1213, DOI 10.1002/hipo.20512; KOHLER C, 1985, J COMP NEUROL, V236, P504, DOI 10.1002/cne.902360407; Maurer AP, 2005, HIPPOCAMPUS, V15, P841, DOI 10.1002/hipo.20114; McNaughton BL, 2006, NAT REV NEUROSCI, V7, P663, DOI 10.1038/nrn1932; Mhatre H, 2012, HIPPOCAMPUS, V22, P320, DOI 10.1002/hipo.20901; O'Keefe J, 2005, HIPPOCAMPUS, V15, P853, DOI 10.1002/hipo.20115; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; Sreenivasan S, 2011, NAT NEUROSCI, V14, P1330, DOI 10.1038/nn.2901; VANGROEN T, 1990, BRAIN RES, V518, P227, DOI 10.1016/0006-8993(90)90976-I; Welday AC, 2011, J NEUROSCI, V31, P16157, DOI 10.1523/JNEUROSCI.0712-11.2011	26	103	107	2	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 17	2012	337	6096					853	857		10.1126/science.1222403	http://dx.doi.org/10.1126/science.1222403			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	989BQ	22904012	Green Submitted, Green Accepted			2022-12-28	WOS:000307535600046
J	Sabate, M; Cequier, A; Iniguez, A; Serra, A; Hernandez-Antolin, R; Mainar, V; Valgimigli, M; Tespili, M; den Heijer, P; Bethencourt, A; Vazquez, N; Gomez-Hospital, JA; Baz, JA; Martin-Yuste, V; van Geuns, RJ; Alfonso, F; Bordes, P; Tebaldi, M; Masotti, M; Silvestro, A; Backx, B; Brugaletta, S; van Es, GA; Serruys, PW				Sabate, Manel; Cequier, Angel; Iniguez, Andres; Serra, Antonio; Hernandez-Antolin, Rosana; Mainar, Vicente; Valgimigli, Marco; Tespili, Maurizio; den Heijer, Pieter; Bethencourt, Armando; Vazquez, Nicolas; Antoni Gomez-Hospital, Joan; Antonio Baz, Jose; Martin-Yuste, Victoria; van Geuns, Robert-Jan; Alfonso, Fernando; Bordes, Pascual; Tebaldi, Matteo; Masotti, Monica; Silvestro, Antonio; Backx, Bianca; Brugaletta, Salvatore; van Es, Gerrit Anne; Serruys, Patrick W.			Everolimus-eluting stent versus bare-metal stent in ST-segment elevation myocardial infarction (EXAMINATION): 1 year results of a randomised controlled trial	LANCET			English	Article							GLYCOPROTEIN IIB/IIIA INHIBITOR; CORONARY STENT; FOLLOW-UP; UNCOATED STENTS; CLINICAL-PRACTICE; THROMBOSIS; IMPLANTATION; MULTICENTER; DESIGN; REVASCULARIZATION	Background Everolimus-eluting stent (EES) reduces the risk of restenosis in elective percutaneous coronary intervention. However, the use of drug-eluting stent in patients with ST-segment elevation myocardial infarction (STEMI) is still controversial. Data regarding the performance of second-generation EES in this setting are scarce. We report the 1-year result of the EXAMINATION (clinical Evaluation of the Xience-V stent in Acute Myocardial INfArcTION) trial, comparing EES with bare-metal stents (BMS) in patients with STEMI. Methods This multicentre, prospective, randomised, all-comer controlled trial was done in 12 medical centres in three countries. Between Dec 31, 2008, and May 15, 2010, we recruited patients with STEMI up to 48 h after the onset of symptoms requiring emergent percutaneous coronary intervention. Patients were randomly assigned (ratio 1:1) to receive EES or BMS. Randomisation was in blocks of four or six patients, stratified by centre and centralised by telephone. Patients were masked to treatment. The primary endpoint was the patient-oriented combined endpoint of all-cause death, any recurrent myocardial infarction, and any revascularisation at 1 year and was analysed by intention to treat. The secondary endpoints of the study included the device-oriented combined endpoint of cardiac death, target vessel myocardial infarction or target lesion revascularisation, and rates of all cause or cardiac death, recurrent myocardial infarction, target lesion or target vessel revascularisation, stent thrombosis, device and procedure success, and major and minor bleeding. This trial is registered with ClinicalTrials.gov, number NCT00828087. Findings Of the 1504 patients randomised, 1498 patients were randomly assigned to receive EES (n=751) or BMS (n=747). The primary endpoint was similar in both groups (89 [11.9%] of 751 patients in the EES group vs 106 [14.2%] of 747 patients in the BMS group; difference -2.34 [95% CI-5.75 to 1.07]; p=0.19). Device-oriented endpoint (44 [5.9%] in the EES group vs 63 [8.4%] in the BMS group; difference -2.57 [95% CI-5.18 to 0.03]; p=0.05) did not differ between groups, although rates of target lesion and vessel revascularisation were significantly lower in the EES group (16 [2.1%] vs 37 [5.0%], p=0.003, and 28 [3.7%] vs 51 [6.8%], p=0.0077, respectively). Rates of all cause (26 [3.5%] for EES vs 26 [3.5%] for BMS, p=1.00) or cardiac death (24 [3.2%] for EES vs 21 [2.8%] for BMS, p=0.76) or myocardial infarction (10 [1.3%] vs 15 [2.0%], p=0.32) did not differ between groups. Stent thrombosis rates were significantly lower in the EES group (4 [0.5%] patients with definite stent thrombosis in the EES group vs 14 [1.9%] in the BMS group and seven [0.9%] patients with definite or probable stent thrombosis in the EES group vs 19 [2.5%] in the BMS group, both p=0.019). Although device success rate was similar between groups, procedure success rate was significantly higher in the EES group (731 [97.5%] vs 705 [94.6%]; p=0.0050). Finally, Bleeding rates at 1 year were comparable between groups (29 [3.9%] patients in the EES group vs 39 [5.2%] in the BMS group; p=0.19). Interpretation The use of EES compared with BMS in the setting of STEMI did not lower the patient-oriented endpoint. However, at the stent level both rates of target lesion revascularisation and stent thrombosis were reduced in recipients of EES.	[Sabate, Manel; Masotti, Monica] Inst Invest Biomed August Pi & Sunyer IDIBAPS, Univ Hosp Clin, Barcelona, Spain; [Cequier, Angel; Antoni Gomez-Hospital, Joan] Univ Hosp Bellvitge, Barcelona, Spain; [Iniguez, Andres; Antonio Baz, Jose] Hosp Meixoeiro, Vigo, Spain; [Serra, Antonio; Martin-Yuste, Victoria] Univ Hosp St Pau, Barcelona, Spain; [Hernandez-Antolin, Rosana; Alfonso, Fernando] Univ Hosp San Carlos, Madrid, Spain; [Mainar, Vicente; Bordes, Pascual] Hosp Gen Alicante, Alicante, Spain; [Valgimigli, Marco; Tebaldi, Matteo] Univ Hosp Ferrara, Ferrara, Italy; [Tespili, Maurizio; Silvestro, Antonio] Univ Hosp Bolognini Seriate, Bergamo, Italy; [den Heijer, Pieter] Amphia Ziekenhuis, Breda, Netherlands; [Bethencourt, Armando] Hosp Son Dureta, Palma de Mallorca, Spain; [Vazquez, Nicolas] Hosp Juan Canalejo, La Coruna, Spain; [van Geuns, Robert-Jan; Serruys, Patrick W.] Erasmus MC, Rotterdam, Netherlands; [Backx, Bianca; Brugaletta, Salvatore; van Es, Gerrit Anne] Cardialysis, Rotterdam, Netherlands	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; Complexo Hospitalario Universitario de Vigo; Hospital Clinico San Carlos; General University Hospital of Alicante; University of Ferrara; Arcispedale Sant'Anna; Amphia Hospital; Hospital Universitari Son Espases; Hospital Universitari Son Dureta; Complejo Hospitalario Universitario A Coruna; Erasmus University Rotterdam; Erasmus MC; Cardialysis	Sabate, M (corresponding author), Univ Barcelona, IDIBAPS, Thorax Inst, Cardiol Dept,Hosp Clin, C Villarroel 170, E-08036 Barcelona, Spain.	masabate@clinic.ub.es	Brugaletta, Salvatore/AAJ-2090-2020; van Geuns, Robert-Jan M/N-7976-2017; van Geuns, Robert/AAR-6386-2021; Valgimigli, Marco/AAE-9103-2019; Sabate, Manel/AAX-7245-2021; Tebaldi, Matteo/Y-3157-2018	van Geuns, Robert-Jan M/0000-0003-2943-5932; Valgimigli, Marco/0000-0002-4353-7110; Tebaldi, Matteo/0000-0002-2805-8090; Sabate Tenas, Manel/0000-0002-2316-3705; Cequier, Angel/0000-0002-3230-0011	Abbott Vascular; Medtronic; Cordis JJ; St Jude Medical; Spanish Heart Foundation	Abbott Vascular(Abbott Laboratories); Medtronic(Medtronic); Cordis JJ; St Jude Medical(St. Jude Medical); Spanish Heart Foundation	MS has received consultant and speaker fees from Abbott Vascular, Medtronic, and Cordis J&J. MV received an honorarium as a public speaker Terumo, The Medicines Company, Medtronic, Iroko, Merck, Abbott, Ely Lilly, AstraZeneca, Cordis, CID, and Bayer. BB and G-AvE are employees of Cardialysis. SB has received speaker fees from Abbott Vascular and St Jude Medical. All other authors declare that they have no conflicts of interest.; Spanish Heart Foundation.	Bangalore S, 2012, CIRCULATION, V125, P2873, DOI 10.1161/CIRCULATIONAHA.112.097014; Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313; Daemen J, 2007, AM J CARDIOL, V99, P1027, DOI 10.1016/j.amjcard.2006.11.070; Daemen J, 2007, LANCET, V369, P667, DOI 10.1016/S0140-6736(07)60314-6; de Boer SPM, 2011, EUR HEART J, V32, P2161, DOI 10.1093/eurheartj/ehr126; Hernandez JMDT, 2010, JACC-CARDIOVASC INTE, V3, P911, DOI 10.1016/j.jcin.2010.06.010; Dirksen Maurits T, 2008, EuroIntervention, V4, P64, DOI 10.4244/EIJV4I1A12; Guagliumi G, 2011, CIRCULATION, V123, P274, DOI 10.1161/CIRCULATIONAHA.110.963181; Iakovou I, 2005, JAMA-J AM MED ASSOC, V293, P2126, DOI 10.1001/jama.293.17.2126; Kaltoft A, 2010, J AM COLL CARDIOL, V56, P641, DOI 10.1016/j.jacc.2010.05.009; Kastrati A, 2001, CIRCULATION, V103, P2816; Kastrati A, 2007, EUR HEART J, V28, P2706, DOI 10.1093/eurheartj/ehm402; Kedhi E, 2010, LANCET, V375, P201, DOI 10.1016/S0140-6736(09)62127-9; Kolandaivelu K, 2011, CIRCULATION, V123, P1400, DOI 10.1161/CIRCULATIONAHA.110.003210; Kukreja N, 2009, JACC-CARDIOVASC INTE, V2, P534, DOI 10.1016/j.jcin.2009.04.003; Laarman GJ, 2006, NEW ENGL J MED, V355, P1105, DOI 10.1056/NEJMoa062598; Libby P, 2009, J AM COLL CARDIOL, V54, P2129, DOI 10.1016/j.jacc.2009.09.009; Palmerini T, 2012, LANCET, V379, P1393, DOI 10.1016/S0140-6736(12)60324-9; Piscione F, 2010, EUROINTERVENTION, V5, P853, DOI 10.4244/EIJV5I7A143; Planer D, 2011, JACC-CARDIOVASC INTE, V4, P1104, DOI 10.1016/j.jcin.2011.06.018; Raber L, 2012, CIRCULATION, V125, P1110, DOI 10.1161/CIRCULATIONAHA.111.058560; Ruygrok PN, 1999, J AM COLL CARDIOL, V34, P1507, DOI 10.1016/S0735-1097(99)00380-0; Sabate M, 2011, EUROINTERVENTION, V7, P977, DOI 10.4244/EIJV7I8A154; Serruys Patrick W, 2006, EuroIntervention, V2, P286; Serruys PW, 2010, NEW ENGL J MED, V363, P136, DOI 10.1056/NEJMoa1004130; Sheiban I, 2008, VASC HEALTH RISK MAN, V4, P31, DOI 10.2147/vhrm.2008.04.01.31; Spaulding C, 2011, JACC-CARDIOVASC INTE, V4, P14, DOI 10.1016/j.jcin.2010.10.007; Spaulding C, 2006, NEW ENGL J MED, V355, P1093, DOI 10.1056/NEJMoa062006; Steg PG, 2009, EUR HEART J, V30, P321, DOI 10.1093/eurheartj/ehn604; Stone GW, 2011, LANCET, V377, P2193, DOI 10.1016/S0140-6736(11)60764-2; Tanimoto Shuzou, 2006, EuroIntervention, V2, P23; Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS), 2010, Eur Heart J, V31, P2501, DOI 10.1093/eurheartj/ehq277; Urban P, 2006, CIRCULATION, V113, P1434, DOI 10.1161/CIRCULATIONAHA.104.532242; Urban P, 2011, J AM COLL CARDIOL, V57, P1445, DOI 10.1016/j.jacc.2010.11.028; Valgimigli M, 2008, JAMA-J AM MED ASSOC, V299, P1788, DOI 10.1001/jama.299.15.joc80026; Valgimigli M, 2007, J AM COLL CARDIOL, V50, P138, DOI 10.1016/j.jacc.2007.04.029; Violini R, 2010, J AM COLL CARDIOL, V55, P810, DOI 10.1016/j.jacc.2009.09.046; Vranckx P, 2010, EUROINTERVENTION, V5, P871, DOI 10.4244/EIJV5I7A146	38	323	333	0	25	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 27	2012	380	9852					1482	1490		10.1016/S0140-6736(12)61223-9	http://dx.doi.org/10.1016/S0140-6736(12)61223-9			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	026JJ	22951305				2022-12-28	WOS:000310272000028
J	Chen, W; Jongkamonwiwat, N; Abbas, L; Eshtan, SJ; Johnson, SL; Kuhn, S; Milo, M; Thurlow, JK; Andrews, PW; Marcotti, W; Moore, HD; Rivolta, MN				Chen, Wei; Jongkamonwiwat, Nopporn; Abbas, Leila; Eshtan, Sarah Jacob; Johnson, Stuart L.; Kuhn, Stephanie; Milo, Marta; Thurlow, Johanna K.; Andrews, Peter W.; Marcotti, Walter; Moore, Harry D.; Rivolta, Marcelo N.			Restoration of auditory evoked responses by human ES-cell-derived otic progenitors	NATURE			English	Article							EMBRYONIC STEM-CELLS; INNER-EAR; SPIRAL GANGLION; IN-VITRO; PLACODE INDUCTION; HAIR-CELLS; DIFFERENTIATION; NEURONS; NERVE; TRANSPLANTATION	Deafness is a condition with a high prevalence worldwide, produced primarily by the loss of the sensory hair cells and their associated spiral ganglion neurons (SGNs). Of all the forms of deafness, auditory neuropathy is of particular concern. This condition, defined primarily by damage to the SGNs with relative preservation of the hair cells(1), is responsible for a substantial proportion of patients with hearing impairment(2). Although the loss of hair cells can be circumvented partially by a cochlear implant, no routine treatment is available for sensory neuron loss, as poor innervation limits the prospective performance of an implant(3). Using stem cells to recover the damaged sensory circuitry is a potential therapeutic strategy. Here we present a protocol to induce differentiation from human embryonic stem cells (hESCs) using signals involved in the initial specification of the otic placode. We obtained two types of otic progenitors able to differentiate in vitro into hair-cell-like cells and auditory neurons that display expected electrophysiological properties. Moreover, when transplanted into an auditory neuropathy model, otic neuroprogenitors engraft, differentiate and significantly improve auditory-evoked response thresholds. These results should stimulate further research into the development of a cell-based therapy for deafness.	[Chen, Wei; Jongkamonwiwat, Nopporn; Abbas, Leila; Eshtan, Sarah Jacob; Thurlow, Johanna K.; Andrews, Peter W.; Moore, Harry D.; Rivolta, Marcelo N.] Univ Sheffield, Ctr Stem Cell Biol, Sheffield S10 2TN, S Yorkshire, England; [Chen, Wei; Jongkamonwiwat, Nopporn; Abbas, Leila; Eshtan, Sarah Jacob; Johnson, Stuart L.; Kuhn, Stephanie; Milo, Marta; Thurlow, Johanna K.; Andrews, Peter W.; Marcotti, Walter; Moore, Harry D.; Rivolta, Marcelo N.] Univ Sheffield, Dept Biomed Sci, Sheffield S10 2TN, S Yorkshire, England; [Jongkamonwiwat, Nopporn] Srinakharinwirot Univ, Fac Hlth Sci, Ongkharak 26120, Nakhonnayok, Thailand	University of Sheffield; University of Sheffield; Srinakharinwirot University	Rivolta, MN (corresponding author), Univ Sheffield, Ctr Stem Cell Biol, Sheffield S10 2TN, S Yorkshire, England.	m.n.rivolta@sheffield.ac.uk		, Stephanie/0000-0001-6633-9478; Andrews, Peter/0000-0001-7215-4410; Jongkamonwiwat, Nopporn/0000-0002-3592-8787	Action on Hearing Loss (RNID); Deafness Research UK; Wellcome Trust [088719]; Medical Research Council; ESTOOLS; Wellcome Trust VIP award; RNID; MRC [G0801059, G0700785, G0900919] Funding Source: UKRI; Medical Research Council [G0801059, G0900919, G0700785] Funding Source: researchfish; RNID [515:SHE:MR, G44] Funding Source: researchfish	Action on Hearing Loss (RNID); Deafness Research UK; Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); ESTOOLS(European Commission); Wellcome Trust VIP award(Wellcome Trust); RNID; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); RNID	This work was supported primarily by grants from Action on Hearing Loss (RNID) to M.N.R. Other support included Deafness Research UK (M.N.R and W. M.), the Wellcome Trust (088719, W. M.), Medical Research Council (P. W. A, H. D. M. and M.N.R) and ESTOOLS (P. W. A). S.L.J. was supported by a Wellcome Trust VIP award and the RNID. W. M. and S.L.J. are Royal Society university research fellows. Confocal images were taken at the Light Microscopy Facility of the Department of Biomedical Sciences, University of Sheffield. We are grateful for the advice of M. Mulheran and I. Russell on the tests of auditory function, provided at the earlier stages of this project, and to the assistance of P. Gokhale on the use of the InCell Analyzer. M.N.R. acknowledges the support and encouragement of his late parents, Noemi Lujan-Ceballos and Juan Carlos Rivolta.	Alvarez Y, 2003, DEVELOPMENT, V130, P6329, DOI 10.1242/dev.00881; BOETTCHER FA, 1993, HEARING RES, V71, P137, DOI 10.1016/0378-5955(93)90029-Z; Bradley Jane, 2008, Cochlear Implants Int, V9, P34, DOI 10.1179/cim.2008.9.1.34; BURKARD R, 1993, J ACOUST SOC AM, V94, P2441, DOI 10.1121/1.407465; Chen W, 2009, STEM CELLS, V27, P1196, DOI 10.1002/stem.62; Coleman B, 2007, EXP CELL RES, V313, P232, DOI 10.1016/j.yexcr.2006.10.010; Corrales CE, 2006, J NEUROBIOL, V66, P1489, DOI 10.1002/neu.20310; Freter S, 2008, DEVELOPMENT, V135, P3415, DOI 10.1242/dev.026674; Hildebrand MS, 2005, JARO-J ASSOC RES OTO, V6, P341, DOI 10.1007/s10162-005-0012-9; Hu ZQ, 2004, BRAIN RES, V1026, P68, DOI 10.1016/j.brainres.2004.08.013; Jeon SJ, 2007, MOL CELL NEUROSCI, V34, P59, DOI 10.1016/j.mcn.2006.10.003; Kondo T, 2005, P NATL ACAD SCI USA, V102, P4789, DOI 10.1073/pnas.0408239102; Lang H, 2005, JARO-J ASSOC RES OTO, V6, P63, DOI 10.1007/s10162-004-5021-6; Lang HN, 2008, JARO-J ASSOC RES OTO, V9, P225, DOI 10.1007/s10162-008-0119-x; Lee G, 2007, NAT BIOTECHNOL, V25, P1468, DOI 10.1038/nbt1365; Li HW, 2003, P NATL ACAD SCI USA, V100, P13495, DOI 10.1073/pnas.2334503100; Li HW, 2003, NAT MED, V9, P1293, DOI 10.1038/nm925; Martin K, 2006, DEVELOPMENT, V133, P877, DOI 10.1242/dev.02267; McLean WJ, 2009, JARO-J ASSOC RES OTO, V10, P37, DOI 10.1007/s10162-008-0152-9; Oshima K, 2010, CELL, V141, P704, DOI 10.1016/j.cell.2010.03.035; Rask-Andersen H, 2005, HEARING RES, V203, P180, DOI 10.1016/j.heares.2004.12.005; Reyes JH, 2008, J NEUROSCI, V28, P12622, DOI 10.1523/JNEUROSCI.0563-08.2008; Schmiedt RA, 2002, JARO, V3, P223, DOI 10.1007/s1016200220017; Sekiya T, 2007, EUR J NEUROSCI, V25, P2307, DOI 10.1111/j.1460-9568.2007.05478.x; Shi FX, 2007, EUR J NEUROSCI, V26, P3016, DOI 10.1111/j.1460-9568.2007.05909.x; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Uus K, 2006, PEDIATRICS, V117, pE887, DOI 10.1542/peds.2005-1064; Vlastarakos PV, 2008, INT J PEDIATR OTORHI, V72, P1135, DOI 10.1016/j.ijporl.2008.04.004; Wright TJ, 2003, DEVELOPMENT, V130, P3379, DOI 10.1242/dev.00555	29	240	255	3	74	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 11	2012	490	7419					278	+		10.1038/nature11415	http://dx.doi.org/10.1038/nature11415			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019IY	22972191	Green Accepted			2022-12-28	WOS:000309733300053
J	Orosz, JA; Welsh, WF; Carter, JA; Fabrycky, DC; Cochran, WD; Endl, M; Ford, EB; Haghighipour, N; MacQueen, PJ; Mazeh, T; Sanchis-Ojeda, R; Short, DR; Torres, G; Agol, E; Buchhave, LA; Doyle, LR; Isaacson, H; Lissauer, JJ; Marcy, GW; Shporer, A; Windmiller, G; Barclay, T; Boss, AP; Clarke, BD; Fortney, J; Geary, JC; Holman, MJ; Huber, D; Jenkins, JM; Kinemuchi, K; Kruse, E; Ragozzine, D; Sasselov, D; Still, M; Tenenbaum, P; Uddin, K; Winn, JN; Koch, DG; Borucki, WJ				Orosz, Jerome A.; Welsh, William F.; Carter, Joshua A.; Fabrycky, Daniel C.; Cochran, William D.; Endl, Michael; Ford, Eric B.; Haghighipour, Nader; MacQueen, Phillip J.; Mazeh, Tsevi; Sanchis-Ojeda, Roberto; Short, Donald R.; Torres, Guillermo; Agol, Eric; Buchhave, Lars A.; Doyle, Laurance R.; Isaacson, Howard; Lissauer, Jack J.; Marcy, Geoffrey W.; Shporer, Avi; Windmiller, Gur; Barclay, Thomas; Boss, Alan P.; Clarke, Bruce D.; Fortney, Jonathan; Geary, John C.; Holman, Matthew J.; Huber, Daniel; Jenkins, Jon M.; Kinemuchi, Karen; Kruse, Ethan; Ragozzine, Darin; Sasselov, Dimitar; Still, Martin; Tenenbaum, Peter; Uddin, Kamal; Winn, Joshua N.; Koch, David G.; Borucki, William J.			Kepler-47: A Transiting Circumbinary Multiplanet System	SCIENCE			English	Article							SPIN-ORBIT ALIGNMENT; HIERARCHICAL TRIPLE; PLANETS; STARSPOTS	We report the detection of Kepler-47, a system consisting of two planets orbiting around an eclipsing pair of stars. The inner and outer planets have radii 3.0 and 4.6 times that of Earth, respectively. The binary star consists of a Sun-like star and a companion roughly one-third its size, orbiting each other every 7.45 days. With an orbital period of 49.5 days, 18 transits of the inner planet have been observed, allowing a detailed characterization of its orbit and those of the stars. The outer planet's orbital period is 303.2 days, and although the planet is not Earth-like, it resides within the classical "habitable zone," where liquid water could exist on an Earth-like planet. With its two known planets, Kepler-47 establishes that close binary stars can host complete planetary systems.	[Orosz, Jerome A.; Welsh, William F.; Short, Donald R.; Windmiller, Gur] San Diego State Univ, Dept Astron, San Diego, CA 92182 USA; [Carter, Joshua A.; Torres, Guillermo; Geary, John C.; Holman, Matthew J.; Kruse, Ethan; Ragozzine, Darin; Sasselov, Dimitar] Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; [Fabrycky, Daniel C.; Fortney, Jonathan] Univ Calif Santa Cruz, Dept Astron & Astrophys, Santa Cruz, CA 95064 USA; [Cochran, William D.; Endl, Michael; MacQueen, Phillip J.] Univ Texas Austin, McDonald Observ, Austin, TX 78712 USA; [Ford, Eric B.] Univ Florida, Dept Astron, Bryant Space Sci Ctr 211, Gainesville, FL 32611 USA; [Haghighipour, Nader] Univ Hawaii Manoa, Inst Astron, Honolulu, HI 96822 USA; [Mazeh, Tsevi] Tel Aviv Univ, Sch Phys & Astron, IL-69978 Tel Aviv, Israel; [Sanchis-Ojeda, Roberto; Winn, Joshua N.] MIT, Dept Phys, Cambridge, MA 02139 USA; [Agol, Eric] Univ Washington, Dept Astron, Seattle, WA 98195 USA; [Buchhave, Lars A.] Univ Copenhagen, Niels Bohr Inst, DK-2100 Copenhagen, Denmark; [Buchhave, Lars A.] Univ Copenhagen, Ctr Star & Planet Format, Nat Hist Museum Denmark, DK-1350 Copenhagen, Denmark; [Doyle, Laurance R.; Clarke, Bruce D.; Jenkins, Jon M.; Tenenbaum, Peter] SETI Inst, Mountain View, CA 94043 USA; [Isaacson, Howard; Marcy, Geoffrey W.] Univ Calif Berkeley, Dept Astron, Berkeley, CA 94720 USA; [Lissauer, Jack J.; Barclay, Thomas; Clarke, Bruce D.; Huber, Daniel; Jenkins, Jon M.; Kinemuchi, Karen; Still, Martin; Tenenbaum, Peter; Uddin, Kamal; Koch, David G.; Borucki, William J.] NASA, Ames Res Ctr, Moffett Field, CA 94035 USA; [Shporer, Avi] Las Cumbres Observ, Global Telescope Network, Goleta, CA 93117 USA; [Sanchis-Ojeda, Roberto; Winn, Joshua N.] MIT, Kavli Inst Astrophys & Space Res, Cambridge, MA 02139 USA; [Shporer, Avi] Univ Calif Santa Barbara, Dept Phys, Santa Barbara, CA 93106 USA; [Shporer, Avi] CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA; [Barclay, Thomas; Kinemuchi, Karen] Bay Area Environm Res Inst Inc, Sonoma, CA 95476 USA; [Boss, Alan P.] Carnegie Inst Sci, Dept Terr Magnetism, Washington, DC 20015 USA; [Uddin, Kamal] Orbital Sci Corp, Dulles, VA 20166 USA; [Haghighipour, Nader] Univ Hawaii Manoa, NASA Astrobiol Inst, Honolulu, HI 96822 USA	California State University System; San Diego State University; Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; University of California System; University of California Santa Cruz; University of Texas System; University of Texas Austin; State University System of Florida; University of Florida; University of Hawaii System; University of Hawaii Manoa; Tel Aviv University; Massachusetts Institute of Technology (MIT); University of Washington; University of Washington Seattle; University of Copenhagen; Niels Bohr Institute; University of Copenhagen; University of California System; University of California Berkeley; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; Massachusetts Institute of Technology (MIT); University of California System; University of California Santa Barbara; California Institute of Technology; Carnegie Institution for Science; National Aeronautics & Space Administration (NASA); University of Hawaii System; University of Hawaii Manoa	Orosz, JA (corresponding author), San Diego State Univ, Dept Astron, 5500 Campanile Dr, San Diego, CA 92182 USA.	orosz@sciences.sdsu.edu	Carter, Joshua A/A-8280-2013; Agol, Eric/B-8775-2013; Marcy, Geoff/AAC-6050-2019; Cochran, William D/M-4421-2014; Huber, Daniel/AAE-9440-2019; Ford, Eric B./AAB-5479-2019; Welsh, William/AAS-3445-2021; Shporer, Avi/Y-2777-2019; Buchhave, Lars A./ABF-2000-2020; Ragozzine, Darin/C-4926-2013; Sanchis-Ojeda, Roberto/B-6574-2013; Fortney, Jonathan/F-8813-2014	Agol, Eric/0000-0002-0802-9145; Cochran, William D/0000-0001-9662-3496; Huber, Daniel/0000-0001-8832-4488; Ford, Eric B./0000-0001-6545-639X; Shporer, Avi/0000-0002-1836-3120; Buchhave, Lars A./0000-0003-1605-5666; Sanchis-Ojeda, Roberto/0000-0002-6193-972X; Fabrycky, Daniel/0000-0003-3750-0183; Barclay, Thomas/0000-0001-7139-2724; Kruse, Ethan/0000-0002-0493-1342; Fortney, Jonathan/0000-0002-9843-4354	NASA, Science Mission Directorate; NASA [NAS5-26555, NNX12AD23G, HF-51267.01-A, HF-51272.01-A]; NASA Office of Space Science [NXX09AF08G]; NSF [AST-1109928, AST-1007992]; STScI; Division Of Astronomical Sciences [1109928] Funding Source: National Science Foundation	NASA, Science Mission Directorate(National Aeronautics & Space Administration (NASA)); NASA(National Aeronautics & Space Administration (NASA)); NASA Office of Space Science(National Aeronautics & Space Administration (NASA)); NSF(National Science Foundation (NSF)); STScI(Space Telescope Science Institute); Division Of Astronomical Sciences(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	Kepler was selected as the 10th mission of the Discovery Program. Funding for this mission is provided by NASA, Science Mission Directorate. The Kepler data presented in this paper were obtained from the Mikulski Archive for Space Telescopes (MAST). The Space Telescope Science Institute (STScI) is operated by the Association of Universities for Research in Astronomy, Inc., under NASA contract NAS5-26555. Support for MAST for non-HTS data is provided by the NASA Office of Space Science via grant NXX09AF08G and by other grants and contracts. This work is based in part on observations obtained with the Hobby-Eberly Telescope, which is a joint project of the University of Texas at Austin, the Pennsylvania State University, Stanford University, Ludwig-Maximilians-Universitat Munchen, and Georg-August-Universitat Gottingen. J.A.O. and W.F.W. acknowledge support from the Kepler Participating Scientist Program via NASA grant NNX12AD23G; J.A.O., W.F.W., and G.W. also gratefully acknowledge support from the NSF via grant AST-1109928. G.T. acknowledges partial support for this work from NSF grant AST-1007992. J.A.C. and D.C.F. acknowledge NASA support through Hubble Fellowship grants HF-51267.01-A and HF-51272.01-A, respectively, awarded by STScI. Our dear friend and colleague David G. Koch passed away after this work was completed. He was a critical part of Kepler's success, and he will be missed.	Borkovits T, 2003, ASTRON ASTROPHYS, V398, P1091, DOI 10.1051/0004-6361:20021688; Borucki WJ, 2010, SCIENCE, V327, P977, DOI 10.1126/science.1185402; Carter JA, 2011, SCIENCE, V331, P562, DOI 10.1126/science.1201274; Desert JM, 2011, ASTROPHYS J SUPPL S, V197, DOI 10.1088/0067-0049/197/1/14; Holman MJ, 1999, ASTRON J, V117, P621, DOI 10.1086/300695; Kane SR, 2012, PUBL ASTRON SOC PAC, V124, P323, DOI 10.1086/665271; Koch DG, 2010, ASTROPHYS J LETT, V713, pL79, DOI 10.1088/2041-8205/713/2/L79; Lissauer JJ, 2011, ASTROPHYS J SUPPL S, V197, DOI 10.1088/0067-0049/197/1/8; Meschiari S, 2012, ASTROPHYS J, V752, DOI 10.1088/0004-637X/752/1/71; Nutzman PA, 2011, ASTROPHYS J LETT, V740, DOI 10.1088/2041-8205/740/1/L10; Paardekooper SJ, 2012, ASTROPHYS J LETT, V754, DOI 10.1088/2041-8205/754/1/L16; Prsa A, 2011, ASTRON J, V141, DOI 10.1088/0004-6256/141/3/83; Sanchis-Ojeda R, 2012, NATURE, V487, P449, DOI 10.1038/nature11301; Sanchis-Ojeda R, 2011, ASTROPHYS J, V733, DOI 10.1088/0004-637X/733/2/127; Slawson RW, 2011, ASTRON J, V142, DOI 10.1088/0004-6256/142/5/160; Underwood DR, 2003, INT J ASTROBIOL, V2, P289, DOI [10.1017/S1473550404001715, DOI 10.1017/S1473550404001715]; Welsh WF, 2012, NATURE, V481, P475, DOI 10.1038/nature10768; Youdin AN, 2012, ASTROPHYS J, V755, DOI 10.1088/0004-637X/755/1/17	21	246	249	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 21	2012	337	6101					1511	1514		10.1126/science.1228380	http://dx.doi.org/10.1126/science.1228380			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007UC	22933522	Green Submitted			2022-12-28	WOS:000308912900044
J	Savovic, J; Jones, HE; Altman, DG; Harris, RJ; Juni, P; Pildal, J; Als-Nielsen, B; Balk, EM; Gluud, C; Gluud, LL; Ioannidis, JPA; Schulz, KF; Beynon, R; Welton, NJ; Wood, L; Moher, D; Deeks, JJ; Sterne, JAC				Savovic, Jelena; Jones, Hayley E.; Altman, Douglas G.; Harris, Ross J.; Jueni, Peter; Pildal, Julie; Als-Nielsen, Bodil; Balk, Ethan M.; Gluud, Christian; Gluud, Lise Lotte; Ioannidis, John P. A.; Schulz, Kenneth F.; Beynon, Rebecca; Welton, Nicky J.; Wood, Lesley; Moher, David; Deeks, Jonathan J.; Sterne, Jonathan A. C.			Influence of Reported Study Design Characteristics on Intervention Effect Estimates From Randomized, Controlled Trials	ANNALS OF INTERNAL MEDICINE			English	Article							ALLOCATION CONCEALMENT; EMPIRICAL-EVIDENCE; METHODOLOGICAL QUALITY; PRIOR DISTRIBUTIONS; BIAS; IMPACT; METAANALYSES; PROTOCOLS; PLACEBO	Published evidence suggests that aspects of trial design lead to biased intervention effect estimates, but findings from different studies are inconsistent. This study combined data from 7 meta-epidemiologic studies and removed overlaps to derive a final data set of 234 unique meta-analyses containing 1973 trials. Outcome measures were classified as "mortality," "other objective," "or subjective," and Bayesian hierarchical models were used to estimate associations of trial characteristics with average bias and between-trial heterogeneity. Intervention effect estimates seemed to be exaggerated in trials with inadequate or unclear (vs. adequate) random-sequence generation (ratio of odds ratios, 0.89 [95% credible interval {CrI}, 0.82 to 0.96]) and with inadequate or unclear (vs. adequate) allocation concealment (ratio of odds ratios, 0.93 [CrI, 0.87 to 0.99]). Lack of or unclear double-blinding (vs. double-blinding) was associated with an average of 13% exaggeration of intervention effects (ratio of odds ratios, 0.87 [CrI, 0.79 to 0.96]), and between-trial heterogeneity was increased for such studies (SD increase in heterogeneity, 0.14 [CrI, 0.02 to 0.30]). For each characteristic, average bias and increases in between-trial heterogeneity were driven primarily by trials with subjective outcomes, with little evidence of bias in trials with objective and mortality outcomes. This study is limited by incomplete trial reporting, and findings may be confounded by other study design characteristics. Bias associated with study design characteristics may lead to exaggeration of intervention effect estimates and increases in between-trial heterogeneity in trials reporting subjectively assessed outcomes.	[Sterne, Jonathan A. C.] Univ Bristol, Sch Social & Community Med, Bristol BS8 2PS, Avon, England; Univ Oxford, Ctr Stat Med, Oxford, England; Hlth Protect Agcy, London, England; Univ Bern, Inst Social & Prevent Med, CH-3012 Bern, Switzerland; Univ Copenhagen Hosp, Ctr Clin Intervent Res, Nordic Cochrane Ctr, DK-2100 Copenhagen, Denmark; Univ Copenhagen Hosp, Ctr Clin Intervent Res, Copenhagen Trial Unit, DK-2100 Copenhagen, Denmark; Hilleroed Hosp, Hillerod, Denmark; Tufts Med Ctr, Tufts Clin & Translat Sci Inst, Boston, MA USA; Copenhagen Univ Hosp Gentofte, Hellerup, Denmark; Stanford Univ, Med Ctr, Sch Med, Stanford Prevent Res Ctr, Stanford, CA 94305 USA; Stanford Univ, Sch Humanities & Sci, Stanford, CA 94305 USA; FHI 360, Durham, NC USA; Ottawa Hosp, Ottawa Methods Ctr, Res Inst, Ottawa, ON, Canada; Childrens Food Trust, Sheffield, S Yorkshire, England; Univ Birmingham, Coll Med & Dent Sci, Sch Hlth & Populat Sci, Birmingham, W Midlands, England	University of Bristol; University of Oxford; Health Protection Agency; University of Bern; University of Copenhagen; University of Copenhagen; University of Copenhagen; Tufts Medical Center; University of Copenhagen; Herlev & Gentofte Hospital; Stanford University; Stanford University; FHI 360; University of Ottawa; Ottawa Hospital Research Institute; University of Birmingham	Sterne, JAC (corresponding author), Univ Bristol, Sch Social & Community Med, Canynge Hall,39 Whatley Rd, Bristol BS8 2PS, Avon, England.		Gluud, Christian/HGB-3191-2022; Ioannidis, John P. A./G-9836-2011; Savovic, Jelena/H-8869-2012; Gluud, Christian/AAY-1027-2021; Balk, Ethan/AAJ-2547-2020; Savović, Jelena/O-4107-2019; Gluud, Lise L/AAY-2120-2020; Moher, David/I-3408-2019; Deeks, Jon/AAV-5745-2020; Sterne, Jonathan/Z-3106-2019; Juni, Peter/Q-8700-2016	Gluud, Christian/0000-0002-8861-0799; Savović, Jelena/0000-0002-2861-0578; Gluud, Lise L/0000-0002-9462-4468; Moher, David/0000-0003-2434-4206; Deeks, Jon/0000-0002-8850-1971; Sterne, Jonathan/0000-0001-8496-6053; Juni, Peter/0000-0002-5985-0670; Jones, Hayley/0000-0002-4265-2854; Welton, Nicky/0000-0003-2198-3205	National Institute for Health Research Health Technology Assessment programme in the United Kingdom [06/91/10]; Medical Research Council UK [G0701659/1]; Danish Centre for Evaluation and Health Technology Assessment; MRC [G0800800, G0802413, G0701659] Funding Source: UKRI; Medical Research Council [G0802413, G0800800, G0701659] Funding Source: researchfish; National Institute for Health Research [NF-SI-0611-10168] Funding Source: researchfish	National Institute for Health Research Health Technology Assessment programme in the United Kingdom; Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Danish Centre for Evaluation and Health Technology Assessment; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This project was funded by the National Institute for Health Research Health Technology Assessment programme in the United Kingdom (project 06/91/10) and will be published in full (13). See the Health Technology Assessment programme Web site for further project information (www.hta.ac.uk). Dr. Savovic was partially funded by the Medical Research Council UK (grant G0701659/1). Data contributed by Dr. Als-Nielsen and colleagues were from a study that was partially funded by the Danish Centre for Evaluation and Health Technology Assessment.	Als-Nielsen B, 2004, 12 COCHR C BRIDG GAP; Balk EM, 2002, JAMA-J AM MED ASSOC, V287, P2973, DOI 10.1001/jama.287.22.2973; Contopoulos-Ioannidis DG, 2005, AM J PSYCHIAT, V162, P578, DOI 10.1176/appi.ajp.162.3.578; Dechartres A, 2011, ANN INTERN MED, V155, P39, DOI 10.7326/0003-4819-155-1-201107050-00006; Devereaux PJ, 2001, JAMA-J AM MED ASSOC, V285, P2000, DOI 10.1001/jama.285.15.2000; Dwan K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003081; Egger M, 2003, Health Technol Assess, V7, P1; Forder PM, 2005, MED J AUSTRALIA, V182, P87, DOI 10.5694/j.1326-5377.2005.tb06584.x; Gelman A, 2006, BAYESIAN ANAL, V1, P515, DOI 10.1214/06-BA117A; Gluud LL, 2006, AM J EPIDEMIOL, V163, P493, DOI 10.1093/aje/kwj069; Goodman S, 2011, ANN INTERN MED, V155, P61, DOI 10.7326/0003-4819-155-1-201107050-00010; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Hill CL, 2002, J CLIN EPIDEMIOL, V55, P783, DOI 10.1016/S0895-4356(02)00440-7; Hopewell Sally, 2010, BMJ, V340, pc723, DOI 10.1136/bmj.c723; Hrobjartsson A, 2001, NEW ENGL J MED, V344, P1594, DOI 10.1056/NEJM200105243442106; Hrobjartsson A, 2009, J CLIN EPIDEMIOL, V62, P967, DOI 10.1016/j.jclinepi.2009.04.003; Huwiler-Muntener K, 2002, JAMA-J AM MED ASSOC, V287, P2801, DOI 10.1001/jama.287.21.2801; Kirkham JJ, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c365; Kjaergard LL, 2001, ANN INTERN MED, V135, P982, DOI 10.7326/0003-4819-135-11-200112040-00010; Krogsboll LT, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-1; Lambert PC, 2005, STAT MED, V24, P2401, DOI 10.1002/sim.2112; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Moher D, 1998, LANCET, V352, P609, DOI 10.1016/S0140-6736(98)01085-X; Moher David, 2010, BMJ, V340, pc869, DOI [10.1016/j.jclinepi.2010.03.004, 10.1136/bmj.c869]; Moja LP, 2005, BMJ-BRIT MED J, V330, P1053, DOI 10.1136/bmj.38414.515938.8F; Montori VM, 2002, J CLIN EPIDEMIOL, V55, P787, DOI 10.1016/S0895-4356(02)00446-8; Nuesch E, 2009, ARTHRIT RHEUM-ARTHR, V61, P1633, DOI 10.1002/art.24894; Nuesch E, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3244; Pildal J, 2007, INT J EPIDEMIOL, V36, P847, DOI 10.1093/ije/dym087; Pildal J, 2005, BMJ-BRIT MED J, V330, P1049, DOI 10.1136/bmj.38414.422650.8F; Savovic J, 2012, HLTH TECHNO IN PRESS; Savovic J, 2010, RES SYNTH METHODS, V1, P212, DOI 10.1002/jrsm.18; Schulz KF, 2010, BMC MED, V8, DOI [10.1186/1741-7015-8-18, 10.1136/bmj.c332]; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; Siersma V, 2007, STAT MED, V26, P2745, DOI 10.1002/SIM.2752; Siontis GCM, 2011, ARCH INTERN MED, V171, P1721, DOI 10.1001/archinternmed.2011.334; Soares HP, 2004, BRIT MED J, V328, P22, DOI 10.1136/bmj.328.7430.22; Vestbo J, 2011, CLIN RESPIR J, V5, P44, DOI 10.1111/j.1752-699X.2010.00198.x; Welton NJ, 2009, J R STAT SOC A STAT, V172, P119, DOI 10.1111/j.1467-985X.2008.00548.x; Wood L, 2008, BMJ-BRIT MED J, V336, P601, DOI 10.1136/bmj.39465.451748.AD; World Health Organization, 2019, INT STAT CLASS DIS R, V11th Edn	42	621	624	4	41	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 18	2012	157	6					429	U97		10.7326/0003-4819-157-6-201209180-00537	http://dx.doi.org/10.7326/0003-4819-157-6-201209180-00537			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	007UB	22945832				2022-12-28	WOS:000308912800017
J	Jesus, JE; Landry, A				Jesus, John Edwin; Landry, Alden			Chvostek's and Trousseau's Signs	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Jesus, John Edwin] Christiana Care Hlth Syst, Newark, DE USA; [Landry, Alden] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA	Christiana Care Health System; Harvard University; Beth Israel Deaconess Medical Center	Jesus, JE (corresponding author), Christiana Care Hlth Syst, Newark, DE USA.			Jesus, John/0000-0003-2484-5035					0	16	17	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 13	2012	367	11					E15	E15		10.1056/NEJMicm1110569	http://dx.doi.org/10.1056/NEJMicm1110569			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	003ZE	22970971				2022-12-28	WOS:000308649100012
J	Romey, WL				Romey, W. L.			Real Fish Attack Simulated Plankton	SCIENCE			English	Editorial Material									SUNY Coll Potsdam, Dept Biol, Potsdam, NY 13676 USA	State University of New York (SUNY) System	Romey, WL (corresponding author), SUNY Coll Potsdam, Dept Biol, Potsdam, NY 13676 USA.	romeywl@potsdam.edu						CLARK DL, 1990, ANIM BEHAV, V40, P884, DOI 10.1016/S0003-3472(05)80990-X; HUTH A, 1992, J THEOR BIOL, V156, P365, DOI 10.1016/S0022-5193(05)80681-2; Ioannou CC, 2008, ANIM BEHAV, V75, P1383, DOI 10.1016/j.anbehav.2007.09.012; Ioannou CC, 2012, SCIENCE, V337, P1212, DOI 10.1126/science.1218919; Krause J, 2011, TRENDS ECOL EVOL, V26, P369, DOI 10.1016/j.tree.2011.03.015; Parrish JK, 1999, SCIENCE, V284, P99, DOI 10.1126/science.284.5411.99; Patricelli GL, 2010, BEHAV ECOL, V21, P97, DOI 10.1093/beheco/arp155; Romey WL, 2008, BEHAV ECOL, V19, P74, DOI 10.1093/beheco/arm105; Swain DT, 2012, P IEEE, V100, P150, DOI 10.1109/JPROC.2011.2165449; Tinbergen N., 1953, HERRING GULLS WORLD	10	1	1	2	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 7	2012	337	6099					1181	1182		10.1126/science.1228217	http://dx.doi.org/10.1126/science.1228217			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	000UJ	22955823				2022-12-28	WOS:000308414000023
J	Barnes, KA; Kroening-Roche, JC; Comfort, BW				Barnes, Kathleen A.; Kroening-Roche, Jason C.; Comfort, Branden W.			The Developing Vision of Primary Care	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							HEALTH		[Barnes, Kathleen A.; Kroening-Roche, Jason C.; Comfort, Branden W.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Barnes, Kathleen A.] Harvard Univ, Sch Publ Hlth, Harvard Med Sch, Boston, MA 02115 USA; [Kroening-Roche, Jason C.] Oregon Hlth & Sci Univ Family Med Residency, Portland, OR USA; [Comfort, Branden W.] Univ Kansas, Sch Med, Wichita, KS 67214 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Harvard T.H. Chan School of Public Health; Oregon Health & Science University; University of Kansas; University of Kansas Medical Center	Barnes, KA (corresponding author), Harvard Univ, Sch Publ Hlth, 665 Huntington Ave, Boston, MA 02115 USA.							Berenson RA, 2008, HEALTH AFFAIR, V27, P1219, DOI 10.1377/hlthaff.27.5.1219; McGinnis JM, 2002, HEALTH AFFAIR, V21, P78, DOI 10.1377/hlthaff.21.2.78; Rittenhouse DR, 2009, NEW ENGL J MED, V361, P2301, DOI 10.1056/NEJMp0909327; Schroeder SA, 2007, NEW ENGL J MED, V357, P1221, DOI 10.1056/NEJMsa073350; Willard R., 2012, BUILDING BLOCKS HIGH	5	14	14	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 6	2012	367	10					891	893		10.1056/NEJMp1204487	http://dx.doi.org/10.1056/NEJMp1204487			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	999VO	22931258				2022-12-28	WOS:000308343300005
J	Smith-Spangler, C; Brandeau, ML; Hunter, GE; Bavinger, C; Pearson, M; Eschbach, PJ; Sundaram, V; Liu, H; Schirmer, P; Stave, C; Olkin, I; Bravata, DM				Smith-Spangler, Crystal; Brandeau, Margaret L.; Hunter, Grace E.; Bavinger, Clay; Pearson, Maren; Eschbach, Paul J.; Sundaram, Vandana; Liu, Hau; Schirmer, Patricia; Stave, Christopher; Olkin, Ingram; Bravata, Dena M.			Are Organic Foods Safer or Healthier Than Conventional Alternatives?	ANNALS OF INTERNAL MEDICINE			English	Review							FATTY-ACID-COMPOSITION; ORGANOPHOSPHORUS PESTICIDE EXPOSURE; INTEGRATED PEST-MANAGEMENT; ANTIMICROBIAL SUSCEPTIBILITY PATTERNS; NITROGEN-FERTILIZATION TRIALS; WHEAT TRITICUM-AESTIVUM; MALUS-DOMESTICA BORK.; PRUNUS-PERSICA L.; OCHRATOXIN-A; NUTRITIONAL QUALITY	Background: The health benefits of organic foods are unclear. Purpose: To review evidence comparing the health effects of organic and conventional foods. Data Sources: MEDLINE (January 1966 to May 2011), EMBASE, CAB Direct, Agricola, TOXNET, Cochrane Library (January 1966 to May 2009), and bibliographies of retrieved articles. Study Selection: English-language reports of comparisons of organically and conventionally grown food or of populations consuming these foods. Data Extraction: 2 independent investigators extracted data on methods, health outcomes, and nutrient and contaminant levels. Data Synthesis: 17 studies in humans and 223 studies of nutrient and contaminant levels in foods met inclusion criteria. Only 3 of the human studies examined clinical outcomes, finding no significant differences between populations by food type for allergic outcomes (eczema, wheeze, atopic sensitization) or symptomatic Campylobacter infection. Two studies reported significantly lower urinary pesticide levels among children consuming organic versus conventional diets, but studies of biomarker and nutrient levels in serum, urine, breast milk, and semen in adults did not identify clinically meaningful differences. All estimates of differences in nutrient and contaminant levels in foods were highly heterogeneous except for the estimate for phosphorus; phosphorus levels were significantly higher than in conventional produce, although this difference is not clinically significant. The risk for contamination with detectable pesticide residues was lower among organic than conventional produce (risk difference, 30% [CI, -37% to -23%]), but differences in risk for exceeding maximum allowed limits were small. Escherichia coli contamination risk did not differ between organic and conventional produce. Bacterial contamination of retail chicken and pork was common but unrelated to farming method. However, the risk for isolating bacteria resistant to 3 or more antibiotics was higher in conventional than in organic chicken and pork (risk difference, 33% [CI, 21% to 45%]). Limitation: Studies were heterogeneous and limited in number, and publication bias may be present. Conclusion: The published literature lacks strong evidence that organic foods are significantly more nutritious than conventional foods. Consumption of organic foods may reduce exposure to pesticide residues and antibiotic-resistant bacteria. Primary Funding Source: None.	Stanford Univ, Ctr Hlth Policy, Ctr Primary Care Outcomes Res, Dept Management Sci & Engn, Stanford, CA 94305 USA; Stanford Univ, Dept Stat, Stanford, CA 94305 USA; Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA 94304 USA; Stanford Sch Med, Div Gen Med Disciplines, Stanford, CA USA; Stanford Sch Med, Lane Med Lib, Stanford, CA USA	Stanford University; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University; Stanford University	Smith-Spangler, C (corresponding author), Stanford Univ, Stanford Ctr Hlth Policy, 117 Encina Commons, Stanford, CA 94305 USA.	csmithsp@stanford.edu	Stave, Christopher/P-1919-2018	Stave, Christopher/0000-0001-8232-3994	Stanford Under-graduate Research Grant	Stanford Under-graduate Research Grant	Ms. Pearson was supported by a Stanford Under-graduate Research Grant.	Aldrich HT, 2010, J SCI FOOD AGR, V90, P2548, DOI 10.1002/jsfa.4116; Amodio ML, 2007, J SCI FOOD AGR, V87, P1228, DOI 10.1002/jsfa.2820; Amvrazi EG, 2009, FOOD CHEM, V113, P253, DOI 10.1016/j.foodchem.2008.06.073; Andersen JH, 2001, FOOD ADDIT CONTAM, V18, P906, DOI 10.1080/02652030110054759; Angood KM, 2008, MEAT SCI, V78, P176, DOI 10.1016/j.meatsci.2007.06.002; Anttonen MJ, 2006, J AGR FOOD CHEM, V54, P7530, DOI 10.1021/jf0615350; Asami DK, 2003, J AGR FOOD CHEM, V51, P1237, DOI 10.1021/jf020635c; Bacchi MA, 2004, J RADIOANAL NUCL CH, V259, P421, DOI 10.1023/B:JRNC.0000020911.19342.1c; Bahadur A, 2006, INDIAN J AGR SCI, V76, P596; Baker BP, 2002, FOOD ADDIT CONTAM, V19, P427, DOI 10.1080/02652030110113799; Barrett DM, 2007, J FOOD SCI, V72, pC441, DOI 10.1111/j.1750-3841.2007.00500.x; Bavec M, 2010, J AGR FOOD CHEM, V58, P11825, DOI 10.1021/jf103085p; Beltran-Gonzalez F, 2008, J SCI FOOD AGR, V88, P1731, DOI 10.1002/jsfa.3272; Benbrook C., 2008, NEW EVIDENCE CONFIRM; Bennedsgaard TW, 2006, ACTA VET SCAND, V48, DOI 10.1186/1751-0147-48-24; Beretta B, 2002, FOOD ADDIT CONTAM A, V19, P70, DOI 10.1080/02652030110070021; Bergamo P, 2003, FOOD CHEM, V82, P625, DOI 10.1016/S0308-8146(03)00036-0; Bernhoft A, 2010, FOOD ADDIT CONTAM A, V27, P842, DOI 10.1080/19440041003645761; Bicanova E, 2006, ZEMDIRBYSTE, V93, P297; Biffi R, 2004, FOOD ADDIT CONTAM A, V21, P586, DOI 10.1080/02652030410001687708; Blanco-Penedo I, 2010, FOOD ADDIT CONTAM A, V27, P36, DOI 10.1080/02652030903161598; BOKANYI RP, 1990, POULTRY SCI, V69, P592, DOI 10.3382/ps.0690592; Bombyk RAM, 2008, J APPL MICROBIOL, V104, P1726, DOI 10.1111/j.1365-2672.2007.03681.x; Boraychuk VM, 2009, J FOOD PROTECT, V72, P415, DOI 10.4315/0362-028X-72.2.415; Bourn D, 2002, CRIT REV FOOD SCI, V42, P1, DOI 10.1080/10408690290825439; Brandt K, 2011, CRIT REV PLANT SCI, V30, P177, DOI 10.1080/07352689.2011.554417; Briviba K, 2007, J AGR FOOD CHEM, V55, P7716, DOI 10.1021/jf0710534; Butler G, 2011, J DAIRY SCI, V94, P24, DOI 10.3168/jds.2010-3331; Butler G, 2009, J SCI FOOD AGR, V89, P697, DOI 10.1002/jsfa.3504; Butler G, 2008, J SCI FOOD AGR, V88, P1431, DOI 10.1002/jsfa.3235; Carbonaro M, 2002, J AGR FOOD CHEM, V50, P5458, DOI 10.1021/jf0202584; Carbonaro M, 2001, FOOD CHEM, V72, P419, DOI 10.1016/S0308-8146(00)00248-X; Carcea M, 2006, INT J FOOD SCI TECH, V41, P102, DOI 10.1111/j.1365-2621.2006.01422.x; Caris-Veyrat C, 2004, J AGR FOOD CHEM, V52, P6503, DOI 10.1021/jf0346861; Castellini C, 2002, MEAT SCI, V60, P219, DOI 10.1016/S0309-1740(01)00124-3; Cayuela JA, 1997, J AGR FOOD CHEM, V45, P1736, DOI 10.1021/jf960745h; Centers for Disease Control and Prevention, 2011, FOODNET GOODB DIS AC; Champagne ET, 2007, CEREAL CHEM, V84, P320, DOI 10.1094/CCHEM-84-4-0320; Champeil A, 2004, CROP PROT, V23, P531, DOI 10.1016/j.cropro.2003.10.011; Chang P.-T., 1978, Journal of Food Quality, V1, P373, DOI 10.1111/j.1745-4557.1977.tb01072.x; Charlett A, 2003, EPIDEMIOL INFECT, V130, P367; Chassy AW, 2006, J AGR FOOD CHEM, V54, P8244, DOI 10.1021/jf060950p; Cirillo T, 2003, J AGR FOOD CHEM, V51, P8128, DOI [10.1021/jf030203h, 10.1021/jf034523c]; Citak S, 2009, J AGR FOOD CHEM, V57, P7892, DOI 10.1021/jf900660k; CLARKE RP, 1979, ECOL FOOD NUTR, V8, P37, DOI 10.1080/03670244.1979.9990543; Colla G, 2002, J SUSTAIN AGR, V20, P53, DOI 10.1300/J064v20n02_07; COLLINS M, 1993, FOOD AUST, V45, P429; Collomb M, 2008, INT DAIRY J, V18, P976, DOI 10.1016/j.idairyj.2008.05.010; Coorevits A, 2008, SYST APPL MICROBIOL, V31, P126, DOI 10.1016/j.syapm.2008.03.002; Corrales M, 2010, FOOD CHEM TOXICOL, V48, P3471, DOI 10.1016/j.fct.2010.09.025; Cubon J., 2008, Acta Universitatis Agriculturae et Silviculturae Mendelianae Brunensis, V56, P25; Cui SH, 2005, APPL ENVIRON MICROB, V71, P4108, DOI 10.1128/AEM.71.7.4108-4111.2005; Curl CL, 2003, ENVIRON HEALTH PERSP, V111, P377, DOI 10.1289/ehp.5754; Czerwiecki L, 2002, FOOD ADDIT CONTAM, V19, P1051, DOI 10.1080/02652030210156313; D'Amico DJ, 2010, J DAIRY SCI, V93, P134, DOI 10.3168/jds.2009-2426; D'Evoli L, 2010, J FOOD SCI, V75, pC94, DOI 10.1111/j.1750-3841.2009.01435.x; Dahl L, 2003, BRIT J NUTR, V90, P679, DOI 10.1079/BJN2003921; Dangour AD, 2009, AM J CLIN NUTR, V90, P680, DOI 10.3945/ajcn.2009.28041; Dani C, 2007, FOOD CHEM TOXICOL, V45, P2574, DOI 10.1016/j.fct.2007.06.022; Dani C, 2010, TOXICOL IN VITRO, V24, P148, DOI 10.1016/j.tiv.2009.08.006; Danilchenko H., 2002, Folia Horticulturae, V14, P103; Daood H. G., 2006, Acta Agronomica Hungarica, V54, P133, DOI 10.1556/AAgr.54.2006.2.2; De Lorenzo A, 2010, CURR PHARM DESIGN, V16, P814, DOI 10.2174/138161210790883561; De Pascale S, 2006, ACTA HORTIC, P107, DOI 10.17660/ActaHortic.2006.700.14; DEELL JR, 1993, CAN J PLANT SCI, V73, P223, DOI 10.4141/cjps93-036; del Amor FM, 2007, RENEW AGR FOOD SYST, V22, P233, DOI 10.1017/S1742170507001792; Dimitri C, 2009, USDA EC INFORM B; Doll S, 2000, Mycotoxin Res, V16 Suppl 1, P38, DOI 10.1007/BF02942977; Edwards SG, 2009, FOOD ADDIT CONTAM A, V26, P496, DOI 10.1080/02652030802530679; Ellis K, 2006, ORGANIC STUDIES CTR; Ellis KA, 2006, J DAIRY SCI, V89, P1938, DOI 10.3168/jds.S0022-0302(06)72261-5; Ellis KA, 2007, J DAIRY RES, V74, P484, DOI 10.1017/S0022029907002816; Eurola M, 2003, J AGR FOOD CHEM, V51, P2608, DOI 10.1021/jf020893+; European Food Safety Authority (EFSA), 2011, ANT RES EFSAS ROL; Fernandes André Luís Teixeira, 2003, Sci. agric. (Piracicaba, Braz.), V60, P149, DOI 10.1590/S0103-90162003000100022; Fjelkner-Modig Stina, 2000, Acta Agriculturae Scandinavica Section B Soil and Plant Science, V50, P102, DOI 10.1080/090647100750374250; Floistrup H, 2006, J ALLERGY CLIN IMMUN, V117, P59, DOI 10.1016/j.jaci.2005.09.039; Food and Drug Administration, 2008, PEST MON PROGR FY 20; [Food and Nutrition Board Institute of Medicine Standing Committee on the Scientific Evaluation of Dietary Reference Intakes], 1997, DIET REF INT CALC PH, DOI 10.17226/5776; Forster MP, 2002, J AGR FOOD CHEM, V50, P7586, DOI 10.1021/jf0257796; Forster MP, 2002, J AGR FOOD CHEM, V50, P6130, DOI 10.1021/jf0255578; Gabryszuk M, 2008, ANIM SCI PAP REP, V26, P199; Garmo RT, 2010, ACTA VET SCAND, V52, DOI 10.1186/1751-0147-52-11; Ghidini S, 2005, FOOD ADDIT CONTAM, V22, P9, DOI 10.1080/02652030400027995; Giannenas I, 2009, FOOD CHEM, V114, P706, DOI 10.1016/j.foodchem.2008.09.079; Gonzalez L, 2006, INT J FOOD MICROBIOL, V107, P223, DOI 10.1016/j.ijfoodmicro.2005.10.001; Gonzalez M, 2005, FOOD CHEM TOXICOL, V43, P261, DOI 10.1016/j.fct.2004.10.002; Griesshaber Dorrit, 2004, Mitteilungen aus Lebensmitteluntersuchung und Hygiene, V95, P251; Grinder-Pedersen L, 2003, J AGR FOOD CHEM, V51, P5671, DOI 10.1021/jf030217n; Gundersen V, 2000, J AGR FOOD CHEM, V48, P6094, DOI 10.1021/jf0009652; Gutierrez F, 1999, J AM OIL CHEM SOC, V76, P617, DOI 10.1007/s11746-999-0012-8; Hajslova J, 2005, FOOD ADDIT CONTAM A, V22, P514, DOI 10.1080/02652030500137827; Hakala M, 2003, J FOOD COMPOS ANAL, V16, P67, DOI 10.1016/S0889-1575(02)00165-5; Hakkinen SH, 2000, FOOD RES INT, V33, P517, DOI 10.1016/S0963-9969(00)00086-7; Halbert LW, 2006, JAVMA-J AM VET MED A, V228, P1074, DOI 10.2460/javma.228.7.1074; Halbert LW, 2006, J FOOD PROTECT, V69, P482, DOI 10.4315/0362-028X-69.3.482; Hallmann E., 2007, Improving sustainability in organic and low input food production systems. Proceedings of the 3rd International Congress of the European Integrated Project Quality Low Input Food (QLIF), University of Hohenheim, Germany, 20-23 March, 2007, P131; Hamouz K, 2005, PLANT SOIL ENVIRON, V51, P397, DOI 10.17221/3603-PSE; Hamouz K, 1999, ROST VYROBA, V45, P293; Han FF, 2009, FOODBORNE PATHOG DIS, V6, P163, DOI 10.1089/fpd.2008.0171; Hanell U, 2004, ACTA AGR SCAND B-S P, V54, P254, DOI 10.1080/09064710410030302; Hansen H., 1981, PLANT FOOD HUM NUTR, V30, P203, DOI [10.1007/BF01094025, DOI 10.1007/BF01094025]; Hansen LL, 2006, MEAT SCI, V74, P605, DOI 10.1016/j.meatsci.2006.02.014; Harcz P, 2007, FOOD ADDIT CONTAM A, V24, P713, DOI 10.1080/02652030601185071; Harker FR, 2004, FOOD QUAL PREFER, V15, P91, DOI 10.1016/S0950-3293(03)00035-1; Heaton S., 2001, ORGANIC FARMING FOOD; Heimler D, 2009, FOOD CHEM, V114, P765, DOI 10.1016/j.foodchem.2008.10.010; Hellstrom S, 2010, J FOOD PROTECT, V73, P641, DOI 10.4315/0362-028X-73.4.641; Hermansen JE, 2005, J DAIRY RES, V72, P362, DOI 10.1017/S0022029905000968; Hietaniemi V, 2004, AGR FOOD SCI, V13, P54, DOI 10.2137/1239099041837996; Hildermann I, 2010, J SCI FOOD AGR, V90, P2027, DOI 10.1002/jsfa.4048; Hogberg A, 2003, FOOD CHEM, V80, P177, DOI 10.1016/S0308-8146(02)00252-2; Hogstad S, 1997, ACTA AGR SCAND B-S P, V47, P253, DOI 10.1080/09064719709362469; Hoikkala A, 2007, MOL NUTR FOOD RES, V51, P782, DOI 10.1002/mnfr.200600222; Hoogenboom LAP, 2008, FOOD ADDIT CONTAM A, V25, P1195, DOI 10.1080/02652030802014930; Huber M, 2011, NJAS-WAGEN J LIFE SC, V58, P103, DOI 10.1016/j.njas.2011.01.004; Husak RL, 2008, POULTRY SCI, V87, P2367, DOI 10.3382/ps.2007-00294; IFOAM, 2006, IFOAM NORMS ORG PROD; IFOAM International Federation of Organic Agriculture Movements, 2009, PRINC ORG AGR; IZAT AL, 1991, POULTRY SCI, V70, P1438, DOI 10.3382/ps.0701438; Jahan K, 2004, INT J FOOD SCI TECH, V39, P443, DOI 10.1111/j.1365-2621.2004.00799.x; Jahan K, 2007, INT J FOOD SCI TECH, V42, P251, DOI 10.1111/j.1365-2621.2006.01013.x; JOLLY DA, 1989, FOOD TECHNOL-CHICAGO, V43, P60; Jorgensen K, 2002, FOOD ADDIT CONTAM, V19, P1184, DOI 10.1080/0265203021000012376; Jorhem L, 2000, J SCI FOOD AGR, V80, P43, DOI [10.1002/(SICI)1097-0010(20000101)80:1<43::AID-JSFA482>3.0.CO;2-Y, 10.1002/(SICI)1097-0010(20000101)80:1&lt;43::AID-JSFA482&gt;3.0.CO;2-Y]; Juan C, 2008, FOOD CHEM, V107, P525, DOI 10.1016/j.foodchem.2007.08.019; Juhler RK, 1999, ARCH ENVIRON CON TOX, V37, P415, DOI 10.1007/s002449900533; Juroszek P, 2009, J AGR FOOD CHEM, V57, P1188, DOI 10.1021/jf801992s; Kahu K, 2009, ACTA AGR SCAND B-S P, V59, P63, DOI 10.1080/09064710701865139; Kannan P., 2006, Crop Research (Hisar), V32, P196; Karavoltsos S, 2002, FOOD ADDIT CONTAM, V19, P954, DOI 10.1080/02652030210136973; Knoblauch WA, 1990, ORGANIC FIELD CROP P; Krejcirova L., 2006, Zemdirbyste, Mokslo Darbai, V93, P285; Krejcirova L, 2007, PLANT SOIL ENVIRON, V53, P499, DOI 10.17221/2304-PSE; Kristensen M, 2008, J SCI FOOD AGR, V88, P2161, DOI 10.1002/jsfa.3328; Kummeling I, 2008, BRIT J NUTR, V99, P598, DOI 10.1017/S0007114507815844; L-Baeckstrom G, 2004, J SUSTAIN AGR, V24, P53, DOI 10.1300/J064v24n01_06; La Torre A., 2005, Communications in Agricultural and Applied Biological Sciences, V70, P351; LAIRON D, 1984, QUAL PLANT, V34, P97, DOI 10.1007/BF01094837; LAIRON D, 2010, AGRON SUSTAIN DEV, V30, P33, DOI DOI 10.1051/AGRO/2009019; Lamperi L, 2008, J AGR FOOD CHEM, V56, P6536, DOI 10.1021/jf801378m; Langenkamper G, 2006, J APPL BOT FOOD QUAL, V80, P150; Larsen MK, 2010, J DAIRY SCI, V93, P2863, DOI 10.3168/jds.2009-2953; Laukkanen R, 2008, APPL ENVIRON MICROB, V74, P5444, DOI 10.1128/AEM.02664-07; Lazcano C, 2011, J SCI FOOD AGR, V91, P1244, DOI 10.1002/jsfa.4306; LECLERC J, 1991, BIOL AGRIC HORTIC, V7, P339, DOI 10.1080/01448765.1991.9754564; Lehesranta SJ, 2007, PROTEOMICS, V7, P597, DOI 10.1002/pmic.200600889; Lestari SI, 2009, J FOOD PROTECT, V72, P1165, DOI 10.4315/0362-028X-72.6.1165; Lester GE, 2007, J AGR FOOD CHEM, V55, P4474, DOI 10.1021/jf070901s; Lesueur C., 2007, Ernahrung, V31, P247; Linden A, 2001, ARCH ENVIRON CON TOX, V40, P425, DOI 10.1007/s002440010193; Lombardi-Boccia G, 2004, J AGR FOOD CHEM, V52, P90, DOI 10.1021/jf0344690; Lu C, 2005, J TOXICOL ENV HEAL A, V68, P209, DOI 10.1080/15287390590890554; Lu CS, 2008, ENVIRON HEALTH PERSP, V116, P537, DOI 10.1289/ehp.10912; Lu CS, 2009, J EXPO SCI ENV EPID, V19, P69, DOI 10.1038/jes.2008.49; Lu CS, 2006, ENVIRON HEALTH PERSP, V114, P260, DOI 10.1289/ehp.8418; M'ikanatha NM, 2010, FOODBORNE PATHOG DIS, V7, P929, DOI 10.1089/fpd.2009.0499; Mader P., 1993, Acta Horticulturae, P11; Mader P, 2007, J SCI FOOD AGR, V87, P1826, DOI 10.1002/jsfa.2866; Magkos F, 2003, INT J FOOD SCI NUTR, V54, P357, DOI [10.1080/09637480120092071, 10.1080/096374803767755814]; Malmauret L, 2002, FOOD ADDIT CONTAM, V19, P524, DOI 10.1080/02652030210123878; Mansour SA, 2009, CHEMOSPHERE, V75, P601, DOI 10.1016/j.chemosphere.2009.01.058; Mansour SA, 2009, FOOD CHEM TOXICOL, V47, P615, DOI 10.1016/j.fct.2008.12.019; Martin A, 2008, NY TIMES        1121; Martino G., 2008, World Poultry, V24, P33; Masamba KG, 2008, AFR J BIOTECHNOL, V7, P2915; Mason H, 2007, RENEW AGR FOOD SYST, V22, P157, DOI 10.1017/S1742170507001688; Mathews KH, 2001, AGR INFORM B USDA; Mazzoncini M, 2007, 3 INT C EUR INT PROJ; MEIERPLOEGER A, 1989, AGR ECOSYST ENVIRON, V27, P483, DOI 10.1016/0167-8809(89)90109-6; MERCADANTE AZ, 1991, J AGR FOOD CHEM, V39, P1094, DOI 10.1021/jf00006a018; Messens W, 2007, J FOOD PROTECT, V70, P623, DOI 10.4315/0362-028X-70.3.623; Mikkonen TP, 2001, J AGR FOOD CHEM, V49, P3274, DOI 10.1021/jf0010228; Millet S, 2004, LIVEST PROD SCI, V87, P109, DOI 10.1016/j.livprodsci.2003.10.001; Miranda JM, 2008, EUR FOOD RES TECHNOL, V226, P371, DOI 10.1007/s00217-006-0547-y; Miranda JM, 2008, FOOD CONTROL, V19, P412, DOI 10.1016/j.foodcont.2007.05.002; Miranda JM, 2007, J FOOD PROTECT, V70, P1021, DOI 10.4315/0362-028X-70.4.1021; Miranda JN, 2008, J FOOD PROTECT, V71, P2537, DOI 10.4315/0362-028X-71.12.2537; Mitchell AE, 2007, J AGR FOOD CHEM, V55, P6154, DOI 10.1021/jf070344+; Mladenova R, 2009, FOOD ADDIT CONTAM A, V26, P854, DOI 10.1080/02652030902726060; Molkentin J, 2007, ANAL BIOANAL CHEM, V388, P297, DOI 10.1007/s00216-007-1222-2; Moreira MD, 2003, LEBENSM-WISS TECHNOL, V36, P135, DOI 10.1016/S0023-6438(02)00207-4; Mueller A, 2010, LIPIDS, V45, P245, DOI 10.1007/s11745-010-3390-7; Mukhejee A, 2007, INT J FOOD MICROBIOL, V120, P296, DOI 10.1016/j.ijfoodmicro.2007.09.007; Mukherjee A, 2004, J FOOD PROTECT, V67, P894, DOI 10.4315/0362-028X-67.5.894; Mukherjee A, 2006, J FOOD PROTECT, V69, P1928, DOI 10.4315/0362-028X-69.8.1928; Nakamura YN, 2007, J FAC AGR KYUSHU U, V52, P1; Nelson JM, 2007, CLIN INFECT DIS, V44, P977, DOI 10.1086/512369; NILSSON T, 1979, Acta Horticulturae (Wageningen), P209; Ninfali P, 2008, J AM OIL CHEM SOC, V85, P151, DOI 10.1007/s11746-007-1171-0; Nitika, 2008, INT J FOOD SCI NUTR, V59, P224, DOI 10.1080/09637480701523249; Nowak B, 2006, VET MICROBIOL, V117, P219, DOI 10.1016/j.vetmic.2006.06.002; Nyanjage MO, 2001, BIOL AGRIC HORTIC, V18, P221, DOI 10.1080/01448765.2001.9754885; O'Donnell AM, 2010, J DAIRY SCI, V93, P1918, DOI 10.3168/jds.2009-2799; Ogbadu G. H., 1989, Tropical Science, V29, P237; Oliveira M, 2010, FOOD MICROBIOL, V27, P679, DOI 10.1016/j.fm.2010.03.008; Olivo C. J., 2005, LIVESTOCK RES, V17, P1; Olsson IM, 2001, J ENVIRON MONITOR, V3, P531, DOI 10.1039/b104506g; Olsson ME, 2006, J AGR FOOD CHEM, V54, P1248, DOI 10.1021/jf0524776; Olsson V, 2003, MEAT SCI, V64, P287, DOI 10.1016/S0309-1740(02)00200-0; Organic Trade Association, US ORG IND VAL NEARL; Ottesen AR, 2009, J FOOD PROTECT, V72, P2321, DOI 10.4315/0362-028X-72.11.2321; Palupi E, 2012, J SCI FOOD AGR, V92, P2774, DOI 10.1002/jsfa.5639; Peck GM, 2004, ORCHARD PRODUCTIVITY; Perez-Lopez AJ, 2007, EUR FOOD RES TECHNOL, V225, P255, DOI 10.1007/s00217-006-0412-z; Perez-Lopez AJ, 2007, J AGR FOOD CHEM, V55, P8158, DOI 10.1021/jf071534n; Perez-Lopez AJ, 2007, J SCI FOOD AGR, V87, P2075, DOI 10.1002/jsfa.2966; Perkowski J, 2007, FOOD ADDIT CONTAM A, V24, P1292, DOI 10.1080/02652030701416566; Petr J., 2006, Scientia Agriculturae Bohemica, V37, P95; Petr J, 2000, MONATSSCHR BRAUWISS, V53, P90; Pettersson BD, 1988, ORG BIOD CONV CROPP; Phillips CA, 2005, J FOOD PROTECT, V68, P1143, DOI 10.4315/0362-028X-68.6.1143; Pieper JR, 2009, J SCI FOOD AGR, V89, P177, DOI 10.1002/jsfa.3437; PIMPINI F, 1992, J AGR SCI, V118, P215, DOI 10.1017/S0021859600068817; Pla A, 2008, LIVEST SCI, V115, P1, DOI 10.1016/j.livsci.2007.06.001; Pla M, 2007, FOOD CHEM, V100, P165, DOI 10.1016/j.foodchem.2005.09.029; Polat E, 2008, AFR J BIOTECHNOL, V7, P1235; Porretta S, 1994, ACTA HORTIC, V376, P259; Poulsen ME, 2003, FOOD ADDIT CONTAM A, V20, P742, DOI 10.1080/0265203031000152433; Pozzo L, 2010, J SCI FOOD AGR, V90, P1467, DOI 10.1002/jsfa.3965; Prandini A, 2009, J DAIRY RES, V76, P278, DOI 10.1017/S0022029909004099; Procida G., 1998, Rivista di Scienza dell'Alimentazione, V27, P181; Pussemier L, 2006, FOOD ADDIT CONTAM A, V23, P1208, DOI 10.1080/02652030600699312; Raigon MD, 2010, J AGR FOOD CHEM, V58, P6833, DOI 10.1021/jf904438n; Raigon MD, 2003, NCEA ANN REP, V46, P109; Reganold JP, 2001, NATURE, V410, P926, DOI 10.1038/35073574; Rembialkowska E, 1998, Rocz Panstw Zakl Hig, V49, P159; Rist L, 2007, BRIT J NUTR, V97, P735, DOI 10.1017/S0007114507433074; Rodriguez J., 2006, International Journal of Agricultural Research, V1, P452; Roesch M, 2006, SCHWEIZ ARCH TIERH, V148, P387, DOI 10.1024/0036-7281.148.8.387; Roesch M, 2006, J DAIRY SCI, V89, P989, DOI 10.3168/jds.S0022-0302(06)72164-6; Rossi F, 2006, ITAL J FOOD SCI, V18, P355; Rossi F, 2008, EUR J NUTR, V47, P266, DOI 10.1007/s00394-008-0721-z; Ruimy R, 2010, ENVIRON MICROBIOL, V12, P608, DOI 10.1111/j.1462-2920.2009.02100.x; Ryan MH, 2004, J SCI FOOD AGR, V84, P207, DOI 10.1002/jsfa.1634; Sablani SS, 2010, J SCI FOOD AGR, V90, P769, DOI 10.1002/jsfa.3882; Saleha Abu, 1992, Journal of Maharashtra Agricultural Universities, V17, P133; Sato K, 2004, J FOOD PROTECT, V67, P1104, DOI 10.4315/0362-028X-67.6.1104; Schollenberger M, 2002, INT J FOOD MICROBIOL, V72, P85, DOI 10.1016/S0168-1605(01)00627-4; Schwaiger K, 2008, ZOONOSES PUBLIC HLTH, V55, P331, DOI 10.1111/j.1863-2378.2008.01151.x; Schwaiger K, 2010, ZOONOSES PUBLIC HLTH, V57, P171, DOI 10.1111/j.1863-2378.2008.01229.x; SHIER NW, 1984, NUTR REP INT, V30, P71; Singh S. R., 2004, Haryana Journal of Horticultural Sciences, V33, P265; Skaug MA, 1999, FOOD ADDIT CONTAM A, V16, P75, DOI 10.1080/026520399284235; Slots T, 2009, J DAIRY SCI, V92, P2057, DOI 10.3168/jds.2008-1392; Slots T, 2008, MILCHWISSENSCHAFT, V63, P352; Soltoft M, 2011, J SCI FOOD AGR, V91, P767, DOI 10.1002/jsfa.4248; Soonthornchaikul N, 2006, INT J ANTIMICROB AG, V27, P125, DOI 10.1016/j.ijantimicag.2005.09.020; Sousa C, 2005, J AGR FOOD CHEM, V53, P9128, DOI 10.1021/jf051445f; Sousa C, 2008, J AGR FOOD CHEM, V56, P2231, DOI 10.1021/jf073041o; SRIKUMAR TS, 1991, FOOD CHEM, V42, P225, DOI 10.1016/0308-8146(91)90036-N; SRIKUMAR TS, 1990, FOOD CHEM, V37, P47, DOI 10.1016/0308-8146(90)90044-5; Stalenga J, 2007, J PLANT NUTR, V30, P351, DOI 10.1080/01904160601171207; Stracke BA, 2010, EUR J NUTR, V49, P301, DOI 10.1007/s00394-009-0088-9; Stracke BA, 2009, J AGR FOOD CHEM, V57, P10116, DOI 10.1021/jf901267z; Stracke BA, 2009, BRIT J NUTR, V101, P1664, DOI 10.1017/S0007114508116269; Stracke BA, 2009, J AGR FOOD CHEM, V57, P4598, DOI 10.1021/jf803961f; Sutton AJ, 2000, BMJ-BRIT MED J, V320, P1574, DOI 10.1136/bmj.320.7249.1574; do Amarante CVT, 2008, PESQUI AGROPECU BRAS, V43, P333, DOI 10.1590/S0100-204X2008000300007; Tarozzi A, 2006, EUR J NUTR, V45, P152, DOI 10.1007/s00394-005-0575-6; Tarozzi A, 2004, J NUTR, V134, P1105, DOI 10.1093/jn/134.5.1105; Tasiopoulou S, 2007, J ENVIRON SCI HEAL B, V42, P835, DOI 10.1080/03601230701555054; TERMINE E, 1987, PLANT FOOD HUM NUTR, V37, P321, DOI 10.1007/BF01092208; Tikofsky LL, 2003, MICROB DRUG RESIST, V9, pS39; Toledo P, 2002, INT DAIRY J, V12, P75, DOI 10.1016/S0958-6946(01)00148-0; Tran thi Ngoc Son, 2001, Omonrice, P55; Tsatsakis AM, 2003, FOOD ADDIT CONTAM, V20, P553, DOI 10.1080/02652030010025383; Tsiplakou E, 2010, J DAIRY RES, V77, P343, DOI 10.1017/S0022029910000270; Tulika Acharya, 2007, Indian Journal of Nutrition and Dietetics, V44, P403; Turgut C, 2011, ENVIRON MONIT ASSESS, V173, P315, DOI 10.1007/s10661-010-1389-4; U.S. Department of Agriculture Economic Research Service, 2009, DAT PROD ORG PRIC; Vanova M, 2008, PLANT SOIL ENVIRON, V54, P395, DOI 10.17221/411-PSE; Vicini J, 2008, J AM DIET ASSOC, V108, P1198, DOI 10.1016/j.jada.2008.04.021; Vogtmann H., 1993, Compost Science and Utilization, V1, P82; Walshe BE, 2006, MEAT SCI, V73, P319, DOI 10.1016/j.meatsci.2005.12.008; Wang SY, 2008, J AGR FOOD CHEM, V56, P5788, DOI 10.1021/jf703775r; Warman P. R., 1996, Journal of Vegetable Crop Production, V2, P13; Warman PR, 1997, AGR ECOSYST ENVIRON, V61, P155, DOI 10.1016/S0167-8809(96)01110-3; Warman PR, 1998, AGR ECOSYST ENVIRON, V68, P207, DOI 10.1016/S0167-8809(97)00102-3; Williams PRD, 2000, RISK ANAL, V20, P735, DOI 10.1111/0272-4332.205066; Williams PRD, 2001, RISK ANAL, V21, P319, DOI 10.1111/0272-4332.212114; Winter CK, 2006, J FOOD SCI, V71, pR117, DOI 10.1111/j.1750-3841.2006.00196.x; Woese K, 1997, J SCI FOOD AGR, V74, P281, DOI [10.1002/(SICI)1097-0010(199707)74:3&lt;281::AID-JSFA794&gt;3.0.CO;2-Z, 10.1002/(SICI)1097-0010(199707)74:3<281::AID-JSFA794>3.3.CO;2-Q]; Worthington V, 2001, J ALTERN COMPLEM MED, V7, P161, DOI 10.1089/107555301750164244; Wszelaki AL, 2005, J SCI FOOD AGR, V85, P720, DOI 10.1002/jsfa.2051; Wunderlich SM, 2008, INT J FOOD SCI NUTR, V59, P34, DOI 10.1080/09637480701453637; Young I, 2009, EPIDEMIOL INFECT, V137, P1217, DOI 10.1017/S0950268809002635; Young JE, 2005, MOL NUTR FOOD RES, V49, P1136, DOI 10.1002/mnfr.200500080; Zahradnik A, 2007, HORTIC SCI, V34, P65, DOI 10.17221/1850-HORTSCI; Zhao CW, 2001, APPL ENVIRON MICROB, V67, P5431, DOI 10.1128/AEM.67.12.5431-5436.2001; Zhao X, 2007, HORTSCIENCE, V42, P71, DOI 10.21273/HORTSCI.42.1.71; Zhao X, 2009, J SCI FOOD AGR, V89, P940, DOI 10.1002/jsfa.3534; Zheng DM, 2007, LIVEST SCI, V106, P189, DOI 10.1016/j.livsci.2006.08.003; Zorb C, 2009, J AGR FOOD CHEM, V57, P9555, DOI 10.1021/jf9019739; Zorb C, 2009, J AGR FOOD CHEM, V57, P2932, DOI 10.1021/jf802923r; Zuchowski J, 2011, J SCI FOOD AGR, V91, P1089, DOI 10.1002/jsfa.4288	296	320	329	13	576	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 4	2012	157	5					348	U112		10.7326/0003-4819-157-5-201209040-00007	http://dx.doi.org/10.7326/0003-4819-157-5-201209040-00007			22	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	000BM	22944875				2022-12-28	WOS:000308361500005
J	Smith, SM; Soubhi, H; Fortin, M; Hudon, C; O'Dowd, T				Smith, Susan M.; Soubhi, Hassan; Fortin, Martin; Hudon, Catherine; O'Dowd, Tom			Managing patients with multimorbidity: systematic review of interventions in primary care and community settings	BMJ-BRITISH MEDICAL JOURNAL			English	Article							MULTIPLE CHRONIC CONDITIONS; RANDOMIZED-CONTROLLED-TRIAL; FUNCTIONAL DIFFICULTIES; HOME INTERVENTION; OLDER-ADULTS; PREVALENCE; HEALTH; CHALLENGES; DEPRESSION; MANAGEMENT	Objective To determine the effectiveness of interventions designed to improve outcomes in patients with multimorbidity in primary care and community settings. Design Systematic review. Data sources Medline, Embase, CINAHL, CAB Health, Cochrane central register of controlled trials, the database of abstracts of reviews of effectiveness, and the Cochrane EPOC (effective practice and organisation of care) register (searches updated in April 2011). Eligibility criteria Randomised controlled trials, controlled clinical trials, controlled before and after studies, and interrupted time series analyses reporting on interventions to improve outcomes for people with multimorbidity in primary care and community settings. Multimorbidity was defined as two or more chronic conditions in the same individual. Outcomes included any validated measure of physical or mental health and psychosocial status, including quality of life outcomes, wellbeing, and measures of disability or functional status. Also included were measures of patient and provider behaviour, including drug adherence, utilisation of health services, acceptability of services, and costs. Data selection Two reviewers independently assessed studies for eligibility, extracted data, and assessed study quality. As meta-analysis of results was not possible owing to heterogeneity in participants and interventions, a narrative synthesis of the results from the included studies was carried out. Results 10 studies examining a range of complex interventions totalling 3407 patients with multimorbidity were identified. All were randomised controlled trials with a low risk of bias. Two studies described interventions for patients with specific comorbidities. The remaining eight studies focused on multimorbidity, generally in older patients. Consideration of the impact of socioeconomic deprivation was minimal. All studies involved complex interventions with multiple components. In six of the 10 studies the predominant component was a change to the organisation of care delivery, usually through case management or enhanced multidisciplinary team work. In the remaining four studies, intervention components were predominantly patient oriented. Overall the results were mixed, with a trend towards improved prescribing and drug adherence. The results indicated that it is difficult to improve outcomes in this population but that interventions focusing on particular risk factors in comorbid conditions or functional difficulties in multimorbidity may be more effective. No economic analyses were included, although the improvements in prescribing and risk factor management in some studies could provide potentially important cost savings. Conclusions Evidence on the care of patients with multimorbidity is limited, despite the prevalence of multimorbidity and its impact on patients and healthcare systems. Interventions to date have had mixed effects, although are likely to be more effective if targeted at risk factors or specific functional difficulties. A need exists to clearly identify patients with multimorbidity and to develop cost effective and specifically targeted interventions that can improve health outcomes.	[Smith, Susan M.] Royal Coll Surgeons Ireland, Dept Gen Practice, Dublin 2, Ireland; [Soubhi, Hassan; Fortin, Martin; Hudon, Catherine] Univ Sherbrooke, Dept Family Med, Chicoutimi, PQ, Canada; [O'Dowd, Tom] Trinity Coll Dublin, Ctr Hlth Sci, Dept Publ Hlth & Primary Care, Dublin 24, Ireland	Royal College of Surgeons - Ireland; University of Sherbrooke; Trinity College Dublin	Smith, SM (corresponding author), Royal Coll Surgeons Ireland, Dept Gen Practice, Dublin 2, Ireland.	susansmith@rcsi.ie	Smith, Susan/D-1872-2012	Smith, Susan/0000-0001-6027-2727	Health Research Board of Ireland	Health Research Board of Ireland	This review was not directly funded by any external organisation. SMS and TO'D are affliliated to the HRB Centre for Primary Care Research, which is funded by the Health Research Board of Ireland (http://www.hrbcentreprimarycare.ie/).	Barnett K, 2012, J GERONTOL B; Bayliss EA, 2012, ANN FAM MED, V10, P3, DOI 10.1370/afm.1352; Bogner HR, 2008, ANN FAM MED, V6, P295, DOI 10.1370/afm.843; Boult C, 2011, ARCH INTERN MED, V171, P460, DOI 10.1001/archinternmed.2010.540; Eakin EG, 2007, HEALTH PSYCHOL, V26, P392, DOI 10.1037/0278-6133.26.4.392; Fortin M, 2006, ANN FAM MED, V4, P104, DOI 10.1370/afm.516; Fortin M, 2005, ANN FAM MED, V3, P223, DOI 10.1370/afm.272; Fortin M, 2007, BMJ-BRIT MED J, V334, P1016, DOI 10.1136/bmj.39201.463819.2C; Fortin Martin, 2004, Health Qual Life Outcomes, V2, P51, DOI 10.1186/1477-7525-2-51; Fortin M, 2012, ANN FAM MED, V10, P142, DOI 10.1370/afm.1337; Foster G, 2007, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858.CD005108.PUB2; France EF, 2012, BRIT J GEN PRACT, V62, DOI 10.3399/bjgp12X636146; Gitlin LN, 2006, J AM GERIATR SOC, V54, P809, DOI 10.1111/j.1532-5415.2006.00703.x; Gitlin LN, 2009, J AM GERIATR SOC, V57, P476, DOI 10.1111/j.1532-5415.2008.02147.x; Hochhalter AK, 2010, PATIENT EDUC COUNS, V81, P207, DOI 10.1016/j.pec.2010.01.018; Hogg W, 2008, CAN FAM PHYSICIAN, V54, P712; Kamerow D, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e1487; Katon WJ, 2010, NEW ENGL J MED, V363, P2611, DOI 10.1056/NEJMoa1003955; Krska J, 2001, AGE AGEING, V30, P205, DOI 10.1093/ageing/30.3.205; Lorig KR, 1999, MED CARE, V37, P5, DOI 10.1097/00005650-199901000-00003; Marengoni A, 2011, AGEING RES REV, V10, P430, DOI 10.1016/j.arr.2011.03.003; Menotti A, 2001, J CLIN EPIDEMIOL, V54, P680, DOI 10.1016/S0895-4356(00)00368-1; Smith SM, 2007, BRIT J GEN PRACT, V57, P268; Smith SM, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006560.pub2; Smith SM, 2010, BRIT J GEN PRACT, V60, DOI 10.3399/bjgp10X514756; Sommers LS, 2000, ARCH INTERN MED, V160, P1825, DOI 10.1001/archinte.160.12.1825; Stange KC, 2012, ANN FAM MED, V10, P2, DOI 10.1370/afm.1354; Starfield B, 2001, BRIT J GEN PRACT, V51, P303; Taylor AW, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-718; Townsend A, 2003, BRIT MED J, V327, P837, DOI 10.1136/bmj.327.7419.837; Turner BJ, 2011, ANN INTERN MED, V155, P851, DOI 10.7326/0003-4819-155-12-201112200-00009; van den Akker M, 1998, J CLIN EPIDEMIOL, V51, P367, DOI 10.1016/S0895-4356(97)00306-5; VANSELOW NA, 1995, JAMA-J AM MED ASSOC, V273, P192, DOI 10.1001/jama.273.3.192; Vogeli C, 2007, J GEN INTERN MED, V22, P391, DOI 10.1007/s11606-007-0322-1; WHO, 2002, INNOVATIVE CARE CHRO; Zwarenstein M, 2000, COCHRANE DB SYST REV, V4	36	370	380	3	83	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 3	2012	345								e5205	10.1136/bmj.e5205	http://dx.doi.org/10.1136/bmj.e5205			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	003TH	22945950	Green Accepted, hybrid, Green Submitted, Green Published			2022-12-28	WOS:000308633700013
J	Haskel-Ittah, M; Ben-Zvi, D; Branski-Arieli, M; Schejter, ED; Shilo, BZ; Barkai, N				Haskel-Ittah, Michal; Ben-Zvi, Danny; Branski-Arieli, Merav; Schejter, Eyal D.; Shilo, Ben-Zion; Barkai, Naama			Self-Organized Shuttling: Generating Sharp Dorsoventral Polarity in the Early Drosophila Embryo	CELL			English	Article							DORSAL-VENTRAL POLARITY; MORPHOGEN GRADIENT; SPATZLE PROTEIN; POSITIONAL INFORMATION; BLASTODERM EMBRYO; NUCLEAR GRADIENT; GENE-EXPRESSION; NERVOUS-SYSTEM; AXIS FORMATION; TRANSPORT	Morphogen gradients pattern tissues and organs during development. When morphogen production is spatially restricted, diffusion and degradation are sufficient to generate sharp concentration gradients. It is less clear how sharp gradients can arise within the source of a broadly expressed morphogen. A recent solution relies on localized production of an inhibitor outside the domain of morphogen production, which effectively redistributes (shuttles) and concentrates the morphogen within its expression domain. Here, we study how a sharp gradient is established without a localized inhibitor, focusing on early dorsoventral patterning of the Drosophila embryo, where an active ligand and its inhibitor are concomitantly generated in a broad ventral domain. Using theory and experiments, we show that a sharp Toll activation gradient is produced through "self-organized shuttling," which dynamically relocalizes inhibitor production to lateral regions, followed by inhibitor-dependent ventral shuttling of the activating ligand Spatzle. Shuttling may represent a general paradigm for patterning early embryos.	[Haskel-Ittah, Michal; Ben-Zvi, Danny; Branski-Arieli, Merav; Schejter, Eyal D.; Shilo, Ben-Zion; Barkai, Naama] Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Shilo, BZ (corresponding author), Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel.	benny.shilo@weizmann.ac.il; naama.barkai@weizmann.ac.il		Haskel-Ittah, Michal/0000-0003-2626-5835; Ben-Zvi, Danny/0000-0002-8697-9744	Adams Fellowship Program of the Israeli Academy of Sciences and Humanities; European Research Council; Israel Science Foundation; Minerva; Helen and Martin Kimmel Award for Innovative Investigations; Minerva Foundation	Adams Fellowship Program of the Israeli Academy of Sciences and Humanities; European Research Council(European Research Council (ERC)European Commission); Israel Science Foundation(Israel Science Foundation); Minerva; Helen and Martin Kimmel Award for Innovative Investigations; Minerva Foundation	We thank R. DeLotto, T. Ip, Z. Paroush, and D. Stein for reagents; Y. Gilad, A. Rubinstein, and I. Koren for technical help; T. Volk for insightful suggestions; and Orit Bechar, Tali Wiesel, and Itzchak Reuven for their dedicated graphic design and animation work. We thank members of our groups for fruitful discussions. D.B.-Z. is supported by the Adams Fellowship Program of the Israeli Academy of Sciences and Humanities. This work was supported by the European Research Council, Israel Science Foundation, Minerva, and the Helen and Martin Kimmel Award for Innovative Investigations to N.B., who is the incumbent of the Lorna Greenberg Scherzer Professorial Chair, and the Minerva Foundation to B.-Z.S., who is an incumbent of the Hilda and Cecil Lewis Professorial Chair in Molecular Genetics.	Anderson KV, 1998, CELL, V95, P439, DOI 10.1016/S0092-8674(00)81610-4; Ben-Yaacov S, 2001, J CELL BIOL, V152, P1, DOI 10.1083/jcb.152.1.1; Ben-Zvi D, 2008, NATURE, V453, P1205, DOI 10.1038/nature07059; BIER E, 1990, GENE DEV, V4, P190, DOI 10.1101/gad.4.2.190; Bollenbach T, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.018103; Cadigan KM, 2002, SEMIN CELL DEV BIOL, V13, P83, DOI 10.1016/S1084-9521(02)00014-9; Cho YS, 2012, CURR BIOL, V22, P1013, DOI 10.1016/j.cub.2012.03.065; Cho YS, 2010, CURR BIOL, V20, P1133, DOI 10.1016/j.cub.2010.04.056; Chu H, 1998, GENE DEV, V12, P3613, DOI 10.1101/gad.12.22.3613; DeLotto R, 2007, DEVELOPMENT, V134, P4233, DOI 10.1242/dev.010934; DeLotto Y, 2001, MOL GEN GENET, V264, P643, DOI 10.1007/s004380000350; DeLotto Y, 1998, MECH DEVELOP, V72, P141, DOI 10.1016/S0925-4773(98)00024-0; DRIEVER W, 1988, CELL, V54, P83, DOI 10.1016/0092-8674(88)90182-1; Eldar A, 2003, DEV CELL, V5, P635, DOI 10.1016/S1534-5807(03)00292-2; Eldar A, 2002, NATURE, V419, P304, DOI 10.1038/nature01061; Ephrussi A, 2004, CELL, V116, P143, DOI 10.1016/S0092-8674(04)00037-6; Ge GX, 2005, MOL CELL BIOL, V25, P5846, DOI 10.1128/MCB.25.14.5846-5858.2005; Huang AM, 1997, GENE DEV, V11, P1963, DOI 10.1101/gad.11.15.1963; James KE, 2002, DEVELOPMENT, V129, P2209; Kanodia JS, 2009, P NATL ACAD SCI USA, V106, P21707, DOI 10.1073/pnas.0912395106; Lecuit T, 1996, NATURE, V381, P387, DOI 10.1038/381387a0; LeMosy EK, 1999, TRENDS CELL BIOL, V9, P102, DOI 10.1016/S0962-8924(98)01494-9; Liberman LM, 2009, P NATL ACAD SCI USA, V106, P22317, DOI 10.1073/pnas.0906227106; Matsuda S, 2012, DEV BIOL, V366, P153, DOI 10.1016/j.ydbio.2012.04.009; Meinhardt H, 2002, NATURE, V419, P261, DOI 10.1038/419261a; Melen GJ, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100036; Mizutani CM, 2005, DEV CELL, V8, P915, DOI 10.1016/j.devcel.2005.04.009; Morisato D, 1995, ANNU REV GENET, V29, P371, DOI 10.1146/annurev.genet.29.1.371; MORISATO D, 1994, CELL, V76, P677, DOI 10.1016/0092-8674(94)90507-X; Morisato D, 2001, DEVELOPMENT, V128, P2309; Moussian B, 2005, CURR BIOL, V15, pR887, DOI 10.1016/j.cub.2005.10.026; Nellen D, 1996, CELL, V85, P357, DOI 10.1016/S0092-8674(00)81114-9; Paulsen M, 2011, P NATL ACAD SCI USA, V108, P10202, DOI 10.1073/pnas.1100179108; Peri F, 2002, DEVELOPMENT, V129, P2965; Plouhinec JL, 2011, CURR OPIN GENET DEV, V21, P696, DOI 10.1016/j.gde.2011.09.001; Reeves GT, 2012, DEV CELL, V22, P544, DOI 10.1016/j.devcel.2011.12.007; ROTH S, 1994, DEVELOPMENT, V120, P2245; ROTH S, 1989, CELL, V59, P1189, DOI 10.1016/0092-8674(89)90774-5; Rusch J, 1996, CURR OPIN GENET DEV, V6, P416, DOI 10.1016/S0959-437X(96)80062-1; RUSHLOW CA, 1989, CELL, V59, P1165, DOI 10.1016/0092-8674(89)90772-1; Schier AF, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003459; Schlesinger A, 2004, DEV CELL, V7, P535, DOI 10.1016/j.devcel.2004.09.001; SCHNEIDER DS, 1994, DEVELOPMENT, V120, P1243; Sen J, 1998, CELL, V95, P471, DOI 10.1016/S0092-8674(00)81615-3; Shimmi O, 2005, CELL, V120, P873, DOI 10.1016/j.cell.2005.02.009; Stathopoulos A, 2002, DEVELOPMENT, V129, P3411; Stein D, 1995, CURR BIOL, V5, P1360, DOI 10.1016/S0960-9822(95)00270-3; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; van der Zee M, 2006, P NATL ACAD SCI USA, V103, P16307, DOI 10.1073/pnas.0605154103; Wang YC, 2005, NATURE, V434, P229, DOI 10.1038/nature03318; Weber ANR, 2007, J BIOL CHEM, V282, P13522, DOI 10.1074/jbc.M700068200; Wolfman NM, 2003, P NATL ACAD SCI USA, V100, P15842, DOI 10.1073/pnas.2534946100; WOLPERT L, 1989, DEVELOPMENT, V107, P3; Zhang ZY, 2009, CURR BIOL, V19, P1200, DOI 10.1016/j.cub.2009.05.050; Zhao GY, 2007, INT J DEV BIOL, V51, P107, DOI 10.1387/ijdb.062188gz; Zhu XJ, 2007, DEVELOPMENT, V134, P1465, DOI 10.1242/dev.003426	56	35	35	0	21	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 31	2012	150	5					1016	1028		10.1016/j.cell.2012.06.044	http://dx.doi.org/10.1016/j.cell.2012.06.044			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	001ZU	22939625	Bronze			2022-12-28	WOS:000308500200015
J	Glover, TE; Fritz, DM; Cammarata, M; Allison, TK; Coh, S; Feldkamp, JM; Lemke, H; Zhu, D; Feng, Y; Coffee, RN; Fuchs, M; Ghimire, S; Chen, J; Shwartz, S; Reis, DA; Harris, SE; Hastings, JB				Glover, T. E.; Fritz, D. M.; Cammarata, M.; Allison, T. K.; Coh, Sinisa; Feldkamp, J. M.; Lemke, H.; Zhu, D.; Feng, Y.; Coffee, R. N.; Fuchs, M.; Ghimire, S.; Chen, J.; Shwartz, S.; Reis, D. A.; Harris, S. E.; Hastings, J. B.			X-ray and optical wave mixing	NATURE			English	Article							SCATTERING; DIFFRACTION; CONVERSION; DIAMOND; FIELD; BOND	Light-matter interactions are ubiquitous, and underpin a wide range of basic research fields and applied technologies. Although optical interactions have been intensively studied, their microscopic details are often poorly understood and have so far not been directly measurable. X-ray and optical wave mixing was proposed nearly half a century ago as an atomic-scale probe of optical interactions but has not yet been observed owing to a lack of sufficiently intense X-ray sources. Here we use an X-ray laser to demonstrate X-ray and optical sum-frequency generation. The underlying nonlinearity is a reciprocal-space probe of the optically induced charges and associated microscopic fields that arise in an illuminated material. To within the experimental errors, the measured efficiency is consistent with first-principles calculations of microscopic optical polarization in diamond. The ability to probe optical interactions on the atomic scale offers new opportunities in both basic and applied areas of science.	[Glover, T. E.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Adv Light Source Div, Berkeley, CA 94720 USA; [Fritz, D. M.; Feldkamp, J. M.; Lemke, H.; Zhu, D.; Feng, Y.; Coffee, R. N.; Hastings, J. B.] SLAC Natl Accelerator Lab, Linac Coherent Light Source, Menlo Pk, CA 94025 USA; [Cammarata, M.] Univ Rennes 1, Inst Phys Rennes, CNRS UR1, UMR 6251, F-35042 Rennes, France; [Allison, T. K.] NIST, JILA, Boulder, CO 80309 USA; [Allison, T. K.] Univ Colorado, Boulder, CO 80309 USA; [Coh, Sinisa] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; [Coh, Sinisa] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Mat Sci, Berkeley, CA 94720 USA; [Fuchs, M.; Ghimire, S.; Chen, J.; Reis, D. A.] SLAC Natl Accelerator Lab, PULSE Inst, Menlo Pk, CA 94025 USA; [Chen, J.; Shwartz, S.; Reis, D. A.; Harris, S. E.] Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA; [Reis, D. A.] Stanford Univ, Dept Photon Sci, Stanford, CA 94305 USA; [Harris, S. E.] Stanford Univ, Dept Elect Engn, Stanford, CA 94305 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Universite de Rennes; National Institute of Standards & Technology (NIST) - USA; University of Colorado System; University of Colorado Boulder; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Stanford University; Stanford University; Stanford University	Glover, TE (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Adv Light Source Div, Berkeley, CA 94720 USA.	teglover@lbl.gov	Zhu, Diling/D-1302-2013; Fuchs, Matthias/K-8476-2013; Cammarata, Marco/C-2322-2008; Lemke, Henrik Till T/N-7419-2016	Fuchs, Matthias/0000-0003-1878-8986; Cammarata, Marco/0000-0003-3013-1186; Lemke, Henrik Till T/0000-0003-1577-8643; Allison, Thomas/0000-0003-0289-8830; Coh, Sinisa/0000-0002-2331-4008	Office of Science, Office of Basic Energy Sciences, of the US Department of Energy [DE-AC02-05CH11231]; US Air Force Office of Scientific Research; US Army Research Office; AMOS programme within the Chemical Sciences, Geosciences, and Biosciences Division, Office of Basic Energy Sciences, US Department of Energy	Office of Science, Office of Basic Energy Sciences, of the US Department of Energy(United States Department of Energy (DOE)); US Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); US Army Research Office; AMOS programme within the Chemical Sciences, Geosciences, and Biosciences Division, Office of Basic Energy Sciences, US Department of Energy	We thank J. D. Jackson, D. Vanderbilt, and J. C. H. Spence for commenting on various aspects of this work. T. E. G. was supported by the Office of Science, Office of Basic Energy Sciences, of the US Department of Energy under contract no. DE-AC02-05CH11231. The work of S. E. H. and S. S. was supported by the US Air Force Office of Scientific Research and the US Army Research Office. D. A. R. and S. G. were supported as part of the AMOS programme within the Chemical Sciences, Geosciences, and Biosciences Division, Office of Basic Energy Sciences, US Department of Energy. Portions of this research were carried out at the LCLS at SLAC National Accelerator Laboratory. LCLS is an Office of Science User Facility operated for the US Department of Energy Office of Science by Stanford University. Preliminary experiments were performed at the Advanced Light Source at Lawrence Berkeley National Laboratory.	Adams B, 2000, J SYNCHROTRON RADIAT, V7, P81, DOI 10.1107/S0909049599015113; Arya K., 1974, Pramana, V2, P116, DOI 10.1007/BF02847322; ARYA K, 1974, PHYS REV B, V10, P4485, DOI 10.1103/PhysRevB.10.4485; Cavalleri A, 2006, NATURE, V442, P664, DOI 10.1038/nature05041; Coppens P., 1997, XRAY CHARGE DENSITIE; DANINO H, 1981, PHYS REV LETT, V46, P1127, DOI 10.1103/PhysRevLett.46.1127; EISENBERGER P, 1971, PHYS REV LETT, V26, P684, DOI 10.1103/PhysRevLett.26.684; EISENBERGER PM, 1971, PHYS REV A-GEN PHYS, V3, P1145, DOI 10.1103/PhysRevA.3.1145; Emma P, 2010, NAT PHOTONICS, V4, P641, DOI [10.1038/NPHOTON.2010.176, 10.1038/nphoton.2010.176]; FREUND I, 1969, PHYS REV LETT, V23, P854, DOI 10.1103/PhysRevLett.23.854; FREUND I, 1970, PHYS REV LETT, V25, P1241, DOI 10.1103/PhysRevLett.25.1241; FREUND I, 1973, PHYS REV B, V8, P3059, DOI 10.1103/PhysRevB.8.3059; FREUND I, 1972, CHEM PHYS LETT, V12, P583, DOI 10.1016/0009-2614(72)80013-7; Fritz DM, 2007, SCIENCE, V315, P633, DOI 10.1126/science.1135009; Giannozzi P, 2009, J PHYS-CONDENS MAT, V21, DOI 10.1088/0953-8984/21/39/395502; HUDIS E, 1994, APPL PHYS LETT, V64, P818, DOI 10.1063/1.111024; Ihee H, 2005, SCIENCE, V309, P1223, DOI [10.1126/science.1114782, 10.1126/scheme.1114782]; Jackson J., 1975, CLASSICAL ELECTRODYN; JOHNSON DL, 1974, PHYS REV B, V9, P4475, DOI 10.1103/PhysRevB.9.4475; Kotani A, 2001, REV MOD PHYS, V73, P203, DOI 10.1103/RevModPhys.73.203; LEVINE BF, 1969, PHYS REV LETT, V22, P787, DOI 10.1103/PhysRevLett.22.787; Lindenberg AM, 2000, PHYS REV LETT, V84, P111, DOI 10.1103/PhysRevLett.84.111; Mohr-Vorobeva E, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.036403; Nazarkin A, 2003, PHYS REV A, V67, DOI 10.1103/PhysRevA.67.041804; Palikin E. D., 1998, HDB OPTICAL CONSTANT, P313; PHILLIPS JC, 1968, PHYS REV, V166, P832, DOI 10.1103/PhysRev.166.832; PINE AS, 1965, PHYS REV, V139, pA901, DOI 10.1103/PhysRev.139.A901; Platzman PM, 1998, PHYS REV B, V57, P11107, DOI 10.1103/PhysRevB.57.11107; Schweigert IV, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.163001; Shen Y. R., 1984, PRINCIPLES NONLINEAR, P5; Souza I, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.117602; SPACKMAN MA, 1991, ACTA CRYSTALLOGR A, V47, P420, DOI 10.1107/S0108767391001447; Tamasaku K, 2011, NAT PHYS, V7, P705, DOI [10.1038/NPHYS2044, 10.1038/nphys2044]; Tanaka S, 2003, PHYS REV A, V67, DOI 10.1103/PhysRevA.67.033818; Tanaka S, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.043001; VANVECHTEN JA, 1972, PHYS REV LETT, V28, P446, DOI 10.1103/PhysRevLett.28.446; WOO JWF, 1972, PHYS REV B, V6, P4081, DOI 10.1103/PhysRevB.6.4081; Wu JS, 2004, ACTA CRYSTALLOGR A, V60, P326, DOI 10.1107/S0108767304012231; Yoda Y, 1998, J SYNCHROTRON RADIAT, V5, P980, DOI 10.1107/S0909049597020232	40	156	157	0	79	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 30	2012	488	7413					603	+		10.1038/nature11340	http://dx.doi.org/10.1038/nature11340			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996NC	22932384	Green Published			2022-12-28	WOS:000308095100046
J	Venstrom, JM; Pittari, G; Gooley, TA; Chewning, JH; Spellman, S; Haagenson, M; Gallagher, MM; Malkki, M; Petersdorf, E; Dupont, B; Hsu, KC				Venstrom, Jeffrey M.; Pittari, Gianfranco; Gooley, Ted A.; Chewning, Joseph H.; Spellman, Stephen; Haagenson, Michael; Gallagher, Meighan M.; Malkki, Mari; Petersdorf, Effie; Dupont, Bo; Hsu, Katharine C.			HLA-C-Dependent Prevention of Leukemia Relapse by Donor Activating KIR2DS1	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							STEM-CELL TRANSPLANTATION; KIR-LIGAND INCOMPATIBILITY; IMMUNOGLOBULIN-LIKE RECEPTORS; ACUTE MYELOGENOUS LEUKEMIA; NK CELLS; MYELOID-LEUKEMIA; SURVIVAL; ALLOREACTIVITY; RECOGNITION; HAPLOTYPES	BACKGROUND Of the cancers treated with allogeneic hematopoietic stem-cell transplantation (HSCT), acute myeloid leukemia (AML) is most sensitive to natural killer (NK)-cell reactivity. The activating killer-cell immunoglobulin-like receptor (KIR) 2DS1 has ligand specificity for HLA-C2 antigens and activates NK cells in an HLA-dependent manner. Donor-derived NK reactivity controlled by KIR2DS1 and HLA could have beneficial effects in patients with AML who undergo allogeneic HSCT. METHODS We assessed clinical data, HLA genotyping results, and donor cell lines or genomic DNA for 1277 patients with AML who had received hematopoietic stem-cell transplants from unrelated donors matched for HLA-A, B, C, DR, and DQ or with a single mismatch. We performed donor KIR genotyping and evaluated the clinical effect of donor KIR genotype and donor and recipient HLA genotypes. RESULTS Patients with AML who received allografts from donors who were positive for KIR2DS1 had a lower rate of relapse than those with allografts from donors who were negative for KIR2DS1 (26.5% vs. 32.5%; hazard ratio, 0.76; 95% confidence interval [CI], 0.61 to 0.96; P = 0.02). Of allografts from donors with KIR2DS1, those from donors who were homozygous or heterozygous for HLA-C1 antigens could mediate this antileukemic effect, whereas those from donors who were homozygous for HLA-C2 did not provide any advantage (24.9% with homozygosity or heterozygosity for HLA-C1 vs. 37.3% with homozygosity for HLA-C2; hazard ratio, 0.46; 95% CI, 0.28 to 0.75; P = 0.002). Recipients of KIR2DS1-positive allografts mismatched for a single HLA-C locus had a lower relapse rate than recipients of KIR2DS1-negative allografts with a mismatch at the same locus (17.1% vs. 35.6%; hazard ratio, 0.40; 95% CI, 0.20 to 0.78; P = 0.007). KIR3DS1, in positive genetic linkage disequilibrium with KIR2DS1, had no effect on leukemia relapse but was associated with decreased mortality (60.1%, vs. 66.9% without KIR3DS1; hazard ratio, 0.83; 95% CI, 0.71 to 0.96; P = 0.01). CONCLUSIONS Activating KIR genes from donors were associated with distinct outcomes of allogeneic HSCT for AML. Donor KIR2DS1 appeared to provide protection against relapse in an HLA-C-dependent manner, and donor KIR3DS1 was associated with reduced mortality. (Funded by the National Institutes of Health and others.)	[Venstrom, Jeffrey M.; Hsu, Katharine C.] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA; [Pittari, Gianfranco; Chewning, Joseph H.; Gallagher, Meighan M.; Dupont, Bo] Mem Sloan Kettering Canc Ctr, Program Immunol, New York, NY 10021 USA; [Hsu, Katharine C.] Weill Cornell Med Coll, New York, NY USA; [Gooley, Ted A.; Malkki, Mari; Petersdorf, Effie] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; [Spellman, Stephen; Malkki, Mari] Ctr Int Blood & Marrow Transplant Res, Minneapolis, MN USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University; Fred Hutchinson Cancer Center; Center for International Blood & Marrow Transplant Research	Hsu, KC (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA.	dupontb@mskcc.org; hsuk@mskcc.org		Dupont, Bo/0000-0001-9069-105X	National Institutes of Health [U01 AI69197, KL2 RR024997, R01 HL088134, P01 CA23766]; Public Health Service grant/cooperative agreement from the National Cancer Institute (NCI); National Heart, Lung, and Blood Institute (NHLBI); National Institute of Allergy and Infectious Diseases [U24-CA76518]; NHLBI; NCI [5U01HL069294]; Health Resources and Services Administration [HHSH234200637015C]; Office of Naval Research [N00014-10-1-0204, N00014-1-1-0339]; Allos Therapeutics; Amgen; Angioblast Systems; Ariad; Be the Match Foundation; Blue Cross and Blue Shield Association; Buchanan Family Foundation; CaridianBCT; Celgene; CellGenix; Children's Leukemia Research Association; Fresenius Biotech North America; Gamida Cell-Teva Joint Venture; Genentech; Genzyme; GlaxoSmithKline; Kiadis Pharma; Leukemia and Lymphoma Society; Medical College of Wisconsin; Millennium Pharmaceuticals; Milliman USA; Miltenyi Biotec; National Marrow Donor Program; OptumHealth Care Solutions; Otsuka America Pharmaceutical; Seattle Genetics; Sigma-Tau Pharmaceuticals; Soligenix; Swedish Orphan Biovitrum; Therakos; WellPoint; NATIONAL CANCER INSTITUTE [P01CA023766, U24CA076518, P30CA008748] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024997] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL069294, R01HL088134] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI069197] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Public Health Service grant/cooperative agreement from the National Cancer Institute (NCI); National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Health Resources and Services Administration(United States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA)); Office of Naval Research(Office of Naval Research); Allos Therapeutics; Amgen(Amgen); Angioblast Systems; Ariad; Be the Match Foundation; Blue Cross and Blue Shield Association; Buchanan Family Foundation; CaridianBCT; Celgene(Bristol-Myers SquibbCelgene Corporation); CellGenix; Children's Leukemia Research Association; Fresenius Biotech North America; Gamida Cell-Teva Joint Venture(Teva Pharmaceutical Industries); Genentech(Roche HoldingGenentech); Genzyme(Sanofi-AventisGenzyme Corporation); GlaxoSmithKline(GlaxoSmithKline); Kiadis Pharma(Dexcel Pharma); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Medical College of Wisconsin(General Electric); Millennium Pharmaceuticals(Takeda Pharmaceutical Company Ltd); Milliman USA; Miltenyi Biotec; National Marrow Donor Program; OptumHealth Care Solutions; Otsuka America Pharmaceutical(Otsuka Pharmaceutical); Seattle Genetics; Sigma-Tau Pharmaceuticals; Soligenix; Swedish Orphan Biovitrum; Therakos; WellPoint; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funded by the National Institutes of Health and others.; Supported in part by grants from the National Institutes of Health (U01 AI69197, KL2 RR024997, R01 HL088134, and P01 CA23766). The CIBMTR is supported by a Public Health Service grant/cooperative agreement from the National Cancer Institute (NCI), the National Heart, Lung, and Blood Institute (NHLBI), and the National Institute of Allergy and Infectious Diseases (U24-CA76518); a grant/cooperative agreement from the NHLBI and NCI (5U01HL069294); a contract with the Health Resources and Services Administration (HHSH234200637015C); grants from the Office of Naval Research (N00014-10-1-0204 and N00014-1-1-0339); and funding from Allos Therapeutics, Amgen, Angioblast Systems, Ariad, Be the Match Foundation, Blue Cross and Blue Shield Association, Buchanan Family Foundation, CaridianBCT, Celgene, CellGenix, Children's Leukemia Research Association, Fresenius Biotech North America, Gamida Cell-Teva Joint Venture, Genentech, Genzyme, GlaxoSmithKline, Kiadis Pharma, the Leukemia and Lymphoma Society, the Medical College of Wisconsin, Millennium Pharmaceuticals, Milliman USA, Miltenyi Biotec, National Marrow Donor Program, OptumHealth Care Solutions, Otsuka America Pharmaceutical, Seattle Genetics, Sigma-Tau Pharmaceuticals, Soligenix, Swedish Orphan Biovitrum, Therakos, WellPoint, and an anonymous donation to the Medical College of Wisconsin.	Biassoni R, 2001, IMMUNOL REV, V181, P203, DOI 10.1034/j.1600-065X.2001.1810117.x; Biassoni R, 1997, EUR J IMMUNOL, V27, P3095, DOI 10.1002/eji.1830271203; Chewning JH, 2007, J IMMUNOL, V179, P854, DOI 10.4049/jimmunol.179.2.854; Cook MA, 2004, BLOOD, V103, P1521, DOI 10.1182/blood-2003-02-0438; Cooley S, 2010, BLOOD, V116, P2411, DOI 10.1182/blood-2010-05-283051; Cooley S, 2009, BLOOD, V113, P726, DOI 10.1182/blood-2008-07-171926; Farag SS, 2006, BIOL BLOOD MARROW TR, V12, P876, DOI 10.1016/j.bbmt.2006.05.007; Fauriat C, 2010, BLOOD, V115, P1166, DOI 10.1182/blood-2009-09-245746; Gagne K, 2009, BIOL BLOOD MARROW TR, V15, P1366, DOI 10.1016/j.bbmt.2009.06.015; Giebel S, 2005, BRIT J HAEMATOL, V131, P483, DOI 10.1111/j.1365-2141.2005.05797.x; Giebel S, 2003, BLOOD, V102, P814, DOI 10.1182/blood-2003-01-0091; Hsu KC, 2006, BIOL BLOOD MARROW TR, V12, P828, DOI 10.1016/j.bbmt.2006.04.008; Hsu KC, 2002, J IMMUNOL, V169, P5118, DOI 10.4049/jimmunol.169.9.5118; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Lee SJ, 2007, BLOOD, V110, P4576, DOI 10.1182/blood-2007-06-097386; Ogasawara K, 2005, NAT IMMUNOL, V6, P938, DOI 10.1038/ni1236; Pende D, 2009, BLOOD, V113, P3119, DOI 10.1182/blood-2008-06-164103; Petersdorf EW, 2004, BLOOD, V104, P2976, DOI 10.1182/blood-2004-04-1674; Ruggeri L, 2002, SCIENCE, V295, P2097, DOI 10.1126/science.1068440; Ruggeri L, 1999, BLOOD, V94, P333, DOI 10.1182/blood.V94.1.333.413a31_333_339; Ruggeri L, 2007, BLOOD, V110, P433, DOI 10.1182/blood-2006-07-038687; Single RM, 2007, NAT GENET, V39, P1114, DOI 10.1038/ng2077; Sivori S, 2011, BLOOD, V117, P4284, DOI 10.1182/blood-2010-10-316125; Stewart CA, 2005, P NATL ACAD SCI USA, V102, P13224, DOI 10.1073/pnas.0503594102; Sun JC, 2008, J EXP MED, V205, P1819, DOI 10.1084/jem.20072448; Tripathy SK, 2008, J EXP MED, V205, P1829, DOI 10.1084/jem.20072446; Venstrom JM, 2010, BLOOD, V115, P3162, DOI 10.1182/blood-2009-08-236943; Willemze R, 2009, LEUKEMIA, V23, P492, DOI 10.1038/leu.2008.365; Willemze R, 2009, LEUKEMIA, V23, P630, DOI 10.1038/leu.2009.11; Woolfrey A, 2011, BIOL BLOOD MARROW TR, V17, P885, DOI 10.1016/j.bbmt.2010.09.012	30	301	305	1	27	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 30	2012	367	9					805	816		10.1056/NEJMoa1200503	http://dx.doi.org/10.1056/NEJMoa1200503			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	996EN	22931314	Green Accepted			2022-12-28	WOS:000308067400002
J	Carlsson, LMS; Peltonen, M; Ahlin, S; Anveden, A; Bouchard, C; Carlsson, B; Jacobson, P; Lonroth, H; Maglio, C; Naslund, I; Pirazzi, C; Romeo, S; Sjoholm, K; Sjostrom, E; Wedel, H; Svensson, PA; Sjostrom, L				Carlsson, Lena M. S.; Peltonen, Markku; Ahlin, Sofie; Anveden, Asa; Bouchard, Claude; Carlsson, Bjorn; Jacobson, Peter; Lonroth, Hans; Maglio, Cristina; Naslund, Ingmar; Pirazzi, Carlo; Romeo, Stefano; Sjoholm, Kajsa; Sjostrom, Elisabeth; Wedel, Hans; Svensson, Per-Arne; Sjostrom, Lars			Bariatric Surgery and Prevention of Type 2 Diabetes in Swedish Obese Subjects	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LIFE-STYLE INTERVENTION; RISK-FACTOR; FOLLOW-UP; WEIGHT; REDUCTION; MORTALITY; MELLITUS; OUTCOMES; WOMEN	BACKGROUND Weight loss protects against type 2 diabetes but is hard to maintain with behavioral modification alone. In an analysis of data from a nonrandomized, prospective, controlled study, we examined the effects of bariatric surgery on the prevention of type 2 diabetes. METHODS In this analysis, we included 1658 patients who underwent bariatric surgery and 1771 obese matched controls (with matching performed on a group, rather than individual, level). None of the participants had diabetes at baseline. Patients in the bariatric-surgery cohort underwent banding (19%), vertical banded gastroplasty (69%), or gastric bypass (12%); nonrandomized, matched, prospective controls received usual care. Participants were 37 to 60 years of age, and the body-mass index (BMI; the weight in kilograms divided by the square of the height in meters) was 34 or more in men and 38 or more in women. This analysis focused on the rate of incident type 2 diabetes, which was a prespecified secondary end point in the main study. At the time of this analysis (January 1, 2012), participants had been followed for up to 15 years. Despite matching, some baseline characteristics differed significantly between the groups; the baseline body weight was higher and risk factors were more pronounced in the bariatric-surgery group than in the control group. At 15 years, 36.2% of the original participants had dropped out of the study, and 30.9% had not yet reached the time for their 15-year follow-up examination. RESULTS During the follow-up period, type 2 diabetes developed in 392 participants in the control group and in 110 in the bariatric-surgery group, corresponding to incidence rates of 28.4 cases per 1000 person-years and 6.8 cases per 1000 person-years, respectively (adjusted hazard ratio with bariatric surgery, 0.17; 95% confidence interval, 0.13 to 0.21; P< 0.001). The effect of bariatric surgery was influenced by the presence or absence of impaired fasting glucose (P = 0.002 for the interaction) but not by BMI (P = 0.54). Sensitivity analyses, including end-point imputations, did not change the overall conclusions. The postoperative mortality was 0.2%, and 2.8% of patients who underwent bariatric surgery required reoperation within 90 days owing to complications. CONCLUSIONS Bariatric surgery appears to be markedly more efficient than usual care in the prevention of type 2 diabetes in obese persons. (Funded by the Swedish Research Council and others; ClinicalTrials.gov number, NCT01479452.)	[Carlsson, Lena M. S.; Peltonen, Markku; Ahlin, Sofie; Anveden, Asa; Carlsson, Bjorn; Jacobson, Peter; Maglio, Cristina; Pirazzi, Carlo; Romeo, Stefano; Sjoholm, Kajsa; Sjostrom, Elisabeth; Svensson, Per-Arne; Sjostrom, Lars] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Gothenburg, Sweden; [Lonroth, Hans] Univ Gothenburg, Sahlgrenska Acad, Inst Surg, Gothenburg, Sweden; [Wedel, Hans] Nord Sch Publ Hlth, Gothenburg, Sweden; [Naslund, Ingmar] Univ Hosp, Dept Surg, Orebro, Sweden; [Peltonen, Markku] Natl Inst Hlth & Welf, Dept Chron Dis Prevent, Helsinki, Finland; [Bouchard, Claude] Louisiana State Univ Syst, Pennington Biomed Res Ctr, Baton Rouge, LA USA	University of Gothenburg; University of Gothenburg; Orebro University; Finland National Institute for Health & Welfare; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center	Sjostrom, L (corresponding author), Sahlgrens Univ Hosp, SOS Secretariat, Vita Straket 15, S-41345 Gothenburg, Sweden.	lars.v.sjostrom@medfak.gu.se	Carlsson, Lena/F-7570-2018; Bouchard, Claude/AAE-2035-2019; Maglio, Cristina/AAN-6004-2021; Romeo, Stefano/L-6861-2015; Svensson, Per-Arne/R-4626-2019; Bouchard, Claude/A-7637-2009; Peltonen, Markku/F-3037-2015	Carlsson, Lena/0000-0003-4145-6242; Romeo, Stefano/0000-0001-9168-4898; Bouchard, Claude/0000-0002-0048-491X; Peltonen, Markku/0000-0002-3767-4223; Svensson, Per-Arne/0000-0002-6731-806X; Maglio, Cristina/0000-0002-3786-5767; Sjoholm, Kajsa/0000-0003-0146-8193; Ahlin, Sofie/0000-0003-0619-2683; Jacobson, Peter/0000-0002-1769-1827	AstraZeneca; New York Obesity Nutrition Research Center; Pathway Genomics; Weight Watchers; Nike; Human Kinetics and Informa Healthcare; Pfizer; Roche; Novartis; Johnson Johnson; Swedish Research Council [K2012-55X-22082-01-3, K2010-55X-11285-13, K2008-65x-20753-01-4]; Swedish Foundation for Strategic Research; Swedish federal government under the LUA/ALF; VINNOVA-VINNMER program; Wenner-Gren Foundations; Hoffmann-La Roche; Cederroth; Sanofi-Aventis	AstraZeneca(AstraZeneca); New York Obesity Nutrition Research Center; Pathway Genomics; Weight Watchers; Nike; Human Kinetics and Informa Healthcare; Pfizer(Pfizer); Roche(Roche Holding); Novartis(Novartis); Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Swedish federal government under the LUA/ALF; VINNOVA-VINNMER program(Vinnova); Wenner-Gren Foundations; Hoffmann-La Roche(Hoffmann-La Roche); Cederroth; Sanofi-Aventis(Sanofi-Aventis)	Dr. Lena Carlsson reports receiving consulting fees from AstraZeneca and owning stock in Sahltech; Dr. Bouchard, receiving consulting fees from New York Obesity Nutrition Research Center, Pathway Genomics, Weight Watchers, and Nike, payment for manuscript preparation from Elsevier and Wiley-Blackwell, royalties from Human Kinetics and Informa Healthcare, honoraria from NaturALPHA, and reimbursement for travel expenses from European College of Sports Sciences, Nordic Physiotherapy, Wingate Congress, and Euro Sci Open Forum; Dr. Bjorn Carlsson, being employed by and owning stock in AstraZeneca; Dr. Sjoholm, owning stock in Pfizer; Dr. Wedel, receiving consulting fees from AstraZeneca, Pfizer, Roche, and Novartis; and Dr. Lars Sjostrom, serving as a member of the board of Lenimen, receiving lecture fees from AstraZeneca and Johnson & Johnson, and providing an expert statement on drug effects and weight-loss effects on obesity for AstraZeneca. No other potential conflict of interest relevant to this article was reported.; Supported by grants from the Swedish Research Council (K2012-55X-22082-01-3, K2010-55X-11285-13, K2008-65x-20753-01-4), the Swedish Foundation for Strategic Research to Sahlgrenska Center for Cardiovascular and Metabolic Research, the Swedish federal government under the LUA/ALF agreement concerning research and education of doctors, the VINNOVA-VINNMER program, and the Wenner-Gren Foundations. The SOS study has previously been supported by grants to one of the authors from Hoffmann-La Roche, AstraZeneca, Cederroth, Sanofi-Aventis, and Johnson & Johnson.	American Diabetes Association, 2011, Diabetes Care, V34 Suppl 1, pS4, DOI 10.2337/dc11-S004; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bray GA, 2009, LANCET, V374, P1677, DOI 10.1016/S0140-6736(09)61457-4; Buchwald H, 2009, AM J MED, V122, P248, DOI 10.1016/j.amjmed.2008.09.041; Burke JP, 2003, DIABETES CARE, V26, P1999, DOI 10.2337/diacare.26.7.1999; COLDITZ GA, 1995, ANN INTERN MED, V122, P481, DOI 10.7326/0003-4819-122-7-199504010-00001; COLDITZ GA, 1990, AM J EPIDEMIOL, V132, P501, DOI 10.1093/oxfordjournals.aje.a115686; de Lauzon-Guillain B, 2010, DIABETES CARE, V33, P298, DOI 10.2337/dc09-1304; Dixon JB, 2011, DIABETIC MED, V28, P628, DOI 10.1111/j.1464-5491.2011.03306.x; Edelstein SL, 1997, DIABETES, V46, P701, DOI 10.2337/diabetes.46.4.701; Ford ES, 1997, AM J EPIDEMIOL, V146, P214, DOI 10.1093/oxfordjournals.aje.a009256; Gregg EW, 2007, PREV MED, V45, P348, DOI 10.1016/j.ypmed.2007.07.020; Hall TC, 2010, OBES SURG, V20, P1245, DOI 10.1007/s11695-010-0198-8; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Larsson I., 2004, Scandinavian Journal of Nutrition, V48, P165, DOI 10.1080/11026480410003785; Leibson CL, 2001, DIABETES CARE, V24, P1584, DOI 10.2337/diacare.24.9.1584; Li GW, 2008, LANCET, V371, P1783, DOI 10.1016/S0140-6736(08)60766-7; LINDROOS AK, 1993, EUR J CLIN NUTR, V47, P461; Lindstrom J, 2006, LANCET, V368, P1673, DOI 10.1016/S0140-6736(06)69701-8; Marchetti P, 2008, REGUL PEPTIDES, V146, P4, DOI 10.1016/j.regpep.2007.08.017; McTigue K, 2006, JAMA-J AM MED ASSOC, V296, P79, DOI 10.1001/jama.296.1.79; Naser KA, 2006, INT J CLIN PRACT, V60, P1093, DOI 10.1111/j.1742-1241.2006.01003.x; Orozco LJ, 2008, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD003054.PUB3; Rubino F, 2010, ANN SURG, V251, P399, DOI 10.1097/SLA.0b013e3181be34e7; Rubino F, 2010, ANNU REV MED, V61, P393, DOI 10.1146/annurev.med.051308.105148; Runkel N, 2011, INT J COLORECTAL DIS, V26, P397, DOI 10.1007/s00384-011-1136-5; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; Singer J.D., 2003, APPL LONGITUDINAL DA; Sjostrom L, 2004, NEW ENGL J MED, V351, P2683, DOI 10.1056/NEJMoa035622; Sjostrom L, 2007, NEW ENGL J MED, V357, P741, DOI 10.1056/NEJMoa066254; Sjostrom L, 2012, JAMA-J AM MED ASSOC, V307, P56, DOI 10.1001/jama.2011.1914; Sjostrom L, 2009, LANCET ONCOL, V10, P653, DOI 10.1016/S1470-2045(09)70159-7; Thune I, 1998, ARCH INTERN MED, V158, P1633, DOI 10.1001/archinte.158.15.1633; Torgerson JS, 2004, DIABETES CARE, V27, P155, DOI 10.2337/diacare.27.1.155; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; WESTLUND K, 1972, SCAND J CLIN LAB INV, V30, P1; Wilhelmsen L, 1976, Adv Cardiol, V18, P217; World Health Organization, 1999, DEF DIAGN CLASS DI 1; Yamaoka K, 2005, DIABETES CARE, V28, P2780, DOI 10.2337/diacare.28.11.2780	39	504	528	2	56	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 23	2012	367	8					695	704		10.1056/NEJMoa1112082	http://dx.doi.org/10.1056/NEJMoa1112082			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	992CX	22913680				2022-12-28	WOS:000307754200004
J	French, WJ; Reddy, VS; Barron, HV				French, William J.; Reddy, Vanessa S.; Barron, Hal V.			Transforming Quality of Care and Improving Outcomes After Acute MI Lessons From the National Registry of Myocardial Infarction	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							REPERFUSION; TRENDS		[French, William J.] Univ Calif Los Angeles, Dept Med, David Geffen Sch Med, Harbor UCLA Med Ctr, Torrance, CA 90509 USA; [Reddy, Vanessa S.; Barron, Hal V.] Genentech Inc, San Francisco, CA 94080 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Roche Holding; Genentech	French, WJ (corresponding author), Univ Calif Los Angeles, Dept Med, David Geffen Sch Med, Harbor UCLA Med Ctr, Torrance, CA 90509 USA.	wjfrench@labiomed.org						Antman Elliott M, 2004, J Am Coll Cardiol, V44, P671, DOI 10.1016/j.jacc.2004.07.002; Canto JG, 1999, AM J CARDIOL, V84, P923; French WJ, 2000, AM J CARDIOL, V85, p5B; Gibson CM, 2008, AM HEART J, V156, P1035, DOI 10.1016/j.ahj.2008.07.029; McNamara RL, 2006, J AM COLL CARDIOL, V47, P45, DOI 10.1016/j.jacc.2005.04.071; Peterson ED, 2008, AM HEART J, V156, P1045, DOI 10.1016/j.ahj.2008.07.028	6	8	9	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 22	2012	308	8					771	772		10.1001/jama.2012.9500	http://dx.doi.org/10.1001/jama.2012.9500			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	991ML	22910752				2022-12-28	WOS:000307705300018
J	Raji, OY; Duffy, SW; Agbaje, OF; Baker, SG; Christiani, DC; Cassidy, A; Field, JK				Raji, Olaide Y.; Duffy, Stephen W.; Agbaje, Olorunshola F.; Baker, Stuart G.; Christiani, David C.; Cassidy, Adrian; Field, John K.			Predictive Accuracy of the Liverpool Lung Project Risk Model for Stratifying Patients for Computed Tomography Screening for Lung Cancer A Case-Control and Cohort Validation Study	ANNALS OF INTERNAL MEDICINE			English	Article							DECISION CURVE ANALYSIS; PROGNOSTIC MODELS; IMPACT; MULTICENTER; PREVENTION; WORKSHOP; DISEASE; SCORE	Background: External validation of existing lung cancer risk prediction models is limited. Using such models in clinical practice to guide the referral of patients for computed tomography (CT) screening for lung cancer depends on external validation and evidence of predicted clinical benefit. Objective: To evaluate the discrimination of the Liverpool Lung Project (LLP) risk model and demonstrate its predicted benefit for stratifying patients for CT screening by using data from 3 independent studies from Europe and North America. Design: Case-control and prospective cohort study. Setting: Europe and North America. Patients: Participants in the European Early Lung Cancer (EUELC) and Harvard case-control studies and the LLP population-based prospective cohort (LLPC) study. Measurements: 5-year absolute risks for lung cancer predicted by the LLP model. Results: The LLP risk model had good discrimination in both the Harvard (area under the receiver-operating characteristic curve [AUC], 0.76 [95% CI, 0.75 to 0.78]) and the LLPC (AUC, 0.82 [CI, 0.80 to 0.85]) studies and modest discrimination in the EUELC (AUC, 0.67 [CI, 0.64 to 0.69]) study. The decision utility analysis, which incorporates the harms and benefit of using a risk model to make clinical decisions, indicates that the LLP risk model performed better than smoking duration or family history alone in stratifying high-risk patients for lung cancer CT screening. Limitations: The model cannot assess whether including other risk factors, such as lung function or genetic markers, would improve accuracy. Lack of information on asbestos exposure in the LLPC limited the ability to validate the complete LLP risk model. Conclusion: Validation of the LLP risk model in 3 independent external data sets demonstrated good discrimination and evidence of predicted benefits for stratifying patients for lung cancer CT screening. Further studies are needed to prospectively evaluate model performance and evaluate the optimal population risk thresholds for initiating lung cancer screening.	[Field, John K.] Univ Liverpool, Inst Translat Med, Roy Castle Lung Canc Res Programme, Canc Res Ctr, Liverpool L3 9TA, Merseyside, England; Queen Mary Univ London, Wolfson Inst Prevent Med, Barts & London Sch Med & Dent, Kings Coll London, London, England; Guys Hosp, London SE1 9RT, England; NCI, Bethesda, MD 20892 USA; Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	University of Liverpool; University of London; King's College London; Queen Mary University London; Guy's & St Thomas' NHS Foundation Trust; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Harvard University; Harvard T.H. Chan School of Public Health	Field, JK (corresponding author), Univ Liverpool, Inst Translat Med, Roy Castle Lung Canc Res Programme, Canc Res Ctr, Liverpool L3 9TA, Merseyside, England.	J.K.Field@liv.ac.uk	Field, John K./AAD-5674-2020	Field, John K./0000-0003-3951-6365	Roy Castle Lung Cancer Foundation; National Institute for Health; American Cancer Society; National Cancer Institute, National Institutes of Health [CA74386, CA092824, CA090578]; NATIONAL CANCER INSTITUTE [R01CA074386, R01CA092824, P50CA090578, P20CA090578] Funding Source: NIH RePORTER	Roy Castle Lung Cancer Foundation; National Institute for Health; American Cancer Society(American Cancer Society); National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	By the Roy Castle Lung Cancer Foundation, the National Institute for Health Research Health Technology Assessment program, and the American Cancer Society, as well as grants CA74386, CA092824, and CA090578 from the National Cancer Institute, National Institutes of Health (Dr. Christiani).	Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Altman DG, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b605; Apicella C, 2007, CLIN GENET, V72, P87, DOI 10.1111/j.1399-0004.2007.00841.x; Bach PB, 2003, JNCI-J NATL CANCER I, V95, P470, DOI 10.1093/jnci/95.6.470; Baker SG, 2012, INT J BIOSTAT, V8, DOI 10.1515/1557-4679.1395; Baker SG, 2009, JNCI-J NATL CANCER I, V101, P1538, DOI 10.1093/jnci/djp353; Baldwin DR, 2011, THORAX, V66, P308, DOI 10.1136/thx.2010.152066; Barlow WE, 2006, JNCI-J NATL CANCER I, V98, P1204, DOI 10.1093/jnci/djj331; Brindle P, 2006, HEART, V92, P1752, DOI 10.1136/hrt.2006.087932; Brindle PM, 2005, BRIT J GEN PRACT, V55, P838; Carel R, 2007, OCCUP ENVIRON MED, V64, P502, DOI 10.1136/oem.2006.027748; Cassidy A, 2008, BRIT J CANCER, V98, P270, DOI 10.1038/sj.bjc.6604158; Cassidy A, 2007, INT J CANCER, V120, P1, DOI 10.1002/ijc.22331; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; EFRON B, 1986, J AM STAT ASSOC, V81, P461, DOI 10.2307/2289236; Field JK, 2008, BRIT J CANCER, V99, P557, DOI 10.1038/sj.bjc.6604509; Field JK, 2009, EUR RESPIR J, V34, P1477, DOI 10.1183/09031936.00077809; Field JK, 2005, INT J ONCOL, V27, P1633; Field JK, 2012, J THORAC ONCOL, V7, P10, DOI 10.1097/JTO.0b013e31823c58ab; Freedman AN, 2005, JNCI-J NATL CANCER I, V97, P715, DOI 10.1093/jnci/dji128; Gail MH, 2005, BIOSTATISTICS, V6, P227, DOI 10.1093/biostatistics/kxi005; Gail MH, 2008, J NATL CANCER I, V100, P1037, DOI 10.1093/jnci/djn180; GarciaClosas M, 1997, CANCER CAUSE CONTROL, V8, P544, DOI 10.1023/A:1018481910663; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Hung RJ, 2008, NATURE, V452, P633, DOI 10.1038/nature06885; Kerlikowske K, 2009, ANN INTERN MED, V151, P750, DOI 10.7326/0003-4819-151-10-200911170-00012; Moons KGM, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b606; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Pegna AL, 2009, CURR OPIN PULM MED, V15, P327, DOI 10.1097/MCP.0b013e32832b98be; Pepe MS, 2008, JNCI-J NATL CANCER I, V100, P978, DOI 10.1093/jnci/djn215; Reilly BM, 2006, ANN INTERN MED, V144, P201, DOI 10.7326/0003-4819-144-3-200602070-00009; Rockhill B, 2001, J NATL CANCER I, V93, P358, DOI 10.1093/jnci/93.5.358; Schiller JH, 2002, NEW ENGL J MED, V346, P92, DOI 10.1056/NEJMoa011954; Simmons RK, 2008, ARCH INTERN MED, V168, P1209, DOI 10.1001/archinte.168.11.1209; Spitz MR, 2007, JNCI-J NATL CANCER I, V99, P715, DOI 10.1093/jnci/djk153; Steyerberg EW, 2009, CLIN PREDICTION MODE, DOI 10.1007/978-0-387-77244-8; Tammemagi CM, 2011, JNCI-J NATL CANCER I, V103, P1058, DOI 10.1093/jnci/djr173; Truong T, 2010, JNCI-J NATL CANCER I, V102, P959, DOI 10.1093/jnci/djq178; van Klaveren RJ, 2002, LUNG CANCER, V38, P243, DOI 10.1016/S0169-5002(02)00222-2; van Klaveren RJ, 2001, EUR RESPIR J, V18, P857, DOI 10.1183/09031936.01.00076701; Vergouwe Y, 2010, AM J EPIDEMIOL, V172, P971, DOI 10.1093/aje/kwq223; Vickers AJ, 2006, MED DECIS MAKING, V26, P565, DOI 10.1177/0272989X06295361; Vickers AJ, 2008, BMC MED INFORM DECIS, V8, DOI 10.1186/1472-6947-8-53	43	135	138	1	18	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 21	2012	157	4					242	+		10.7326/0003-4819-157-4-201208210-00004	http://dx.doi.org/10.7326/0003-4819-157-4-201208210-00004			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	992XG	22910935	Green Accepted			2022-12-28	WOS:000307813200015
J	Iyer, G; Hanrahan, AJ; Milowsky, MI; Al-Ahmadie, H; Scott, SN; Janakiraman, M; Pirun, M; Sander, C; Socci, ND; Ostrovnaya, I; Viale, A; Heguy, A; Peng, LK; Chan, TA; Bochner, B; Bajorin, DF; Berger, MF; Taylor, BS; Solit, DB				Iyer, Gopa; Hanrahan, Aphrothiti J.; Milowsky, Matthew I.; Al-Ahmadie, Hikmat; Scott, Sasinya N.; Janakiraman, Manickam; Pirun, Mono; Sander, Chris; Socci, Nicholas D.; Ostrovnaya, Irina; Viale, Agnes; Heguy, Adriana; Peng, Luke; Chan, Timothy A.; Bochner, Bernard; Bajorin, Dean F.; Berger, Michael F.; Taylor, Barry S.; Solit, David B.			Genome Sequencing Identifies a Basis for Everolimus Sensitivity	SCIENCE			English	Article									[Iyer, Gopa; Hanrahan, Aphrothiti J.; Scott, Sasinya N.; Janakiraman, Manickam; Heguy, Adriana; Peng, Luke; Chan, Timothy A.; Solit, David B.] Human Oncol & Pathogenesis Program, Mem Sloan Kettering Canc Ctr, New York, NY 10065 USA; [Iyer, Gopa; Milowsky, Matthew I.; Solit, David B.] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USA; [Iyer, Gopa; Milowsky, Matthew I.; Solit, David B.] Weill Med Coll Cornell Univ, Dept Med, New York, NY 10065 USA; [Al-Ahmadie, Hikmat; Berger, Michael F.] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10065 USA; [Pirun, Mono; Sander, Chris; Taylor, Barry S.] Mem Sloan Kettering Canc Ctr, Computat Biol, New York, NY 10065 USA; [Socci, Nicholas D.] Mem Sloan Kettering Canc Ctr, Bioinformat Core Lab, New York, NY 10065 USA; [Ostrovnaya, Irina] Mem Sloan Kettering Canc Ctr, Dept Biostat, New York, NY 10065 USA; [Viale, Agnes] Mem Sloan Kettering Canc Ctr, Genom Core Lab, New York, NY 10065 USA; [Bochner, Bernard] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Taylor, BS (corresponding author), Univ Calif San Francisco, Dept Epidemiol & Biostatist, Dept Med, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94158 USA.	barry.taylor@ucsf.edu; solitd@mskcc.org	Solit, David B./AAC-5309-2019; Chan, Timothy A/ABD-5850-2021; Heguy, Adriana/GPP-3907-2022	Janakiraman, Manickam/0000-0003-4423-6237	NATIONAL CANCER INSTITUTE [T32CA009207] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA008748, R25 CA020449, T32 CA009207] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Krueger DA, 2010, NEW ENGL J MED, V363, P1801, DOI 10.1056/NEJMoa1001671; Lopez-Lago MA, 2009, MOL CELL BIOL, V29, P4235, DOI 10.1128/MCB.01578-08; Platt FM, 2009, CLIN CANCER RES, V15, P6008, DOI 10.1158/1078-0432.CCR-09-0898	3	532	541	1	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 12	2012	338	6104					221	221		10.1126/science.1226344	http://dx.doi.org/10.1126/science.1226344			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019BQ	22923433	Green Accepted			2022-12-28	WOS:000309712300036
J	Vilchez, D; Morantte, I; Liu, Z; Douglas, PM; Merkwirth, C; Rodrigues, APC; Manning, G; Dillin, A				Vilchez, David; Morantte, Ianessa; Liu, Zheng; Douglas, Peter M.; Merkwirth, Carsten; Rodrigues, Ana P. C.; Manning, Gerard; Dillin, Andrew			RPN-6 determines C. elegans longevity under proteotoxic stress conditions	NATURE			English	Article							UBIQUITIN-PROTEASOME SYSTEM; HEAT-SHOCK FACTOR; CAENORHABDITIS-ELEGANS; LIFE-SPAN; STEM-CELLS; DAF-16; RESTRICTION; METABOLISM; AUTOPHAGY; GENE	Organisms that protect their germ-cell lineages from damage often do so at considerable cost: limited metabolic resources become partitioned away from maintenance of the soma, leaving the ageing somatic tissues to navigate survival amid an environment containing damaged and poorly functioning proteins. Historically, experimental paradigms that limit reproductive investment result in lifespan extension. We proposed that germline-deficient animals might exhibit heightened protection from proteotoxic stressors in somatic tissues. We find that the forced re-investment of resources from the germ line to the soma in Caenorhabditis elegans results in elevated somatic proteasome activity, clearance of damaged proteins and increased longevity. This activity is associated with increased expression of rpn-6, a subunit of the 19S proteasome, by the FOXO transcription factor DAF-16. Ectopic expression of rpn-6 is sufficient to confer proteotoxic stress resistance and extend lifespan, indicating that rpn-6 is a candidate to correct deficiencies in age-related protein homeostasis disorders.	[Vilchez, David; Morantte, Ianessa; Liu, Zheng; Douglas, Peter M.; Merkwirth, Carsten; Dillin, Andrew] Salk Inst Biol Studies, Howard Hughes Med Inst, Glenn Ctr Aging Res, Mol & Cell Biol Lab, La Jolla, CA 92037 USA; [Rodrigues, Ana P. C.; Manning, Gerard] Salk Inst Biol Studies, Razavi Newman Ctr Bioinformat, La Jolla, CA 92037 USA	Howard Hughes Medical Institute; Salk Institute; Salk Institute	Dillin, A (corresponding author), Salk Inst Biol Studies, Howard Hughes Med Inst, Glenn Ctr Aging Res, Mol & Cell Biol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	dillin@salk.edu	Merkwirth, Carsten/H-5992-2012; Vilchez, David/A-8446-2008; Manning, Gerard/C-8308-2009; Liu, Zheng/E-6302-2012	Merkwirth, Carsten/0000-0001-8895-3495; Vilchez, David/0000-0002-0801-0743; Douglas, Peter/0000-0002-0734-1049; Manning, Gerard/0000-0002-5087-9151; Liu, Zheng/0000-0002-7968-3849; Grant, Ana/0000-0002-5439-9331	HHMI; NIA; F.M. Kirby, Inc. Foundation Postdoctoral Scholar Award; Beatriu de Pinos (AGAUR) fellowship; NATIONAL INSTITUTE ON AGING [R01AG042679] Funding Source: NIH RePORTER	HHMI(Howard Hughes Medical Institute); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); F.M. Kirby, Inc. Foundation Postdoctoral Scholar Award; Beatriu de Pinos (AGAUR) fellowship; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank S. Panowski for help with the generation of transgenic strains. We thank D. Joyce for proteasome activity assays and S. Wolff for comments on the manuscript. This work was supported by HHMI and the NIA. D. V. was a recipient of the F.M. Kirby, Inc. Foundation Postdoctoral Scholar Award and Beatriu de Pinos (AGAUR) fellowship.	Alam J, 1999, J BIOL CHEM, V274, P26071, DOI 10.1074/jbc.274.37.26071; An JH, 2003, GENE DEV, V17, P1882, DOI 10.1101/gad.1107803; Arantes-Oliveira N, 2002, SCIENCE, V295, P502, DOI 10.1126/science.1065768; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Bennett EJ, 2005, MOL CELL, V17, P351, DOI 10.1016/j.molcel.2004.12.021; Berman JR, 2006, CELL, V124, P1055, DOI 10.1016/j.cell.2006.01.039; BRENNER S, 1974, GENETICS, V77, P71; Brignull HR, 2006, J NEUROSCI, V26, P7597, DOI 10.1523/JNEUROSCI.0990-06.2006; Celniker SE, 2009, NATURE, V459, P927, DOI 10.1038/459927a; Chai YH, 2002, P NATL ACAD SCI USA, V99, P9310, DOI 10.1073/pnas.152101299; Cohen E, 2006, SCIENCE, V313, P1604, DOI 10.1126/science.1124646; Dillin A, 2002, SCIENCE, V298, P2398, DOI 10.1126/science.1077780; Dillin A, 2002, SCIENCE, V298, P830, DOI 10.1126/science.1074240; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Furuyama T, 2000, BIOCHEM J, V349, P629, DOI 10.1042/0264-6021:3490629; Gerisch B, 2001, DEV CELL, V1, P841, DOI 10.1016/S1534-5807(01)00085-5; Ghazi A, 2007, P NATL ACAD SCI USA, V104, P5947, DOI 10.1073/pnas.0700638104; Goudeau J, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000599; Hamer G, 2010, NAT METHODS, V7, P473, DOI [10.1038/nmeth.1460, 10.1038/NMETH.1460]; Hansen M, 2005, PLOS GENET, V1, P119, DOI 10.1371/journal.pgen.0010017; Hansen M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040024; Hoogewijs D, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-9; Hsin H, 1999, NATURE, V399, P362, DOI 10.1038/20694; Hsu AL, 2003, SCIENCE, V300, P1142, DOI 10.1126/science.1083701; Kenyon C, 2010, ANN NY ACAD SCI, V1204, P156, DOI 10.1111/j.1749-6632.2010.05640.x; KIRKWOOD TBL, 1977, NATURE, V270, P301, DOI 10.1038/270301a0; Kisselev AF, 2005, METHOD ENZYMOL, V398, P364, DOI 10.1016/S0076-6879(05)98030-0; Kohler A, 2001, MOL CELL, V7, P1143, DOI 10.1016/S1097-2765(01)00274-X; Lakowski B, 1998, P NATL ACAD SCI USA, V95, P13091, DOI 10.1073/pnas.95.22.13091; Lapierre LR, 2012, AUTOPHAGY, V8, P144, DOI 10.4161/auto.8.1.18722; Li XJ, 2011, NEUROBIOL DIS, V43, P4, DOI 10.1016/j.nbd.2010.11.018; Lin K, 2001, NAT GENET, V28, P139, DOI 10.1038/88850; Melendez A, 2003, SCIENCE, V301, P1387, DOI 10.1126/science.1087782; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; MITCHELL DH, 1979, J GERONTOL, V34, P28, DOI 10.1093/geronj/34.1.28; Morley JF, 2004, MOL BIOL CELL, V15, P657, DOI 10.1091/mbc.E03-07-0532; Partridge L, 2005, CELL, V120, P461, DOI 10.1016/j.cell.2005.01.026; Pathare GR, 2012, P NATL ACAD SCI USA, V109, P149, DOI 10.1073/pnas.1117648108; Powers ET, 2009, ANNU REV BIOCHEM, V78, P959, DOI 10.1146/annurev.biochem.052308.114844; PRIESS JR, 1987, CELL, V51, P601, DOI 10.1016/0092-8674(87)90129-2; Santamaria PG, 2003, J BIOL CHEM, V278, P6687, DOI 10.1074/jbc.M209420200; Shanley DP, 2000, EVOLUTION, V54, P740, DOI 10.1111/j.0014-3820.2000.tb00076.x; Vazquez-Manrique RP, 2005, FASEB J, V19, P172, DOI 10.1096/fj.05-4212fje; Wang MC, 2008, SCIENCE, V322, P957, DOI 10.1126/science.1162011; Wolff S, 2006, CELL, V124, P1039, DOI 10.1016/j.cell.2005.12.042; Zabel C, 2010, J PROTEOMICS, V73, P2230, DOI 10.1016/j.jprot.2010.08.008	47	286	294	0	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 13	2012	489	7415					263	+		10.1038/nature11315	http://dx.doi.org/10.1038/nature11315			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003UC	22922647				2022-12-28	WOS:000308635900035
J	Lesser, LI; Cohen, DA; Brook, RH				Lesser, Lenard I.; Cohen, Deborah A.; Brook, Robert H.			Changing Eating Habits for the Medical Profession	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PHYSICIANS		[Lesser, Lenard I.] Palo Alto Med Fdn Res Inst, Palo Alto, CA 94306 USA; [Cohen, Deborah A.; Brook, Robert H.] RAND Corp, Santa Monica, CA USA; [Brook, Robert H.] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA	Palo Alto Medical Foundation Research Institute; RAND Corporation; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Lesser, LI (corresponding author), Palo Alto Med Fdn Res Inst, 795 El Camion Real Ames Bldg, Palo Alto, CA 94306 USA.	LesserL@pamfri.org		Lesser, Lenard/0000-0002-0713-6707				Ajani UA, 2004, ANN EPIDEMIOL, V14, P731, DOI 10.1016/j.annepidem.2003.10.008; [Anonymous], 2011, ACCME ANN REP DAT 20; Arora R, 2004, MIL MED, V169, P522, DOI 10.7205/MILMED.169.7.522; Institute of Medicine, 2012, ACC PROGR OB PREV, P478; La Puma John, 2003, Dis Manag, V6, P191; Lesser LI, 2012, ACAD PEDIATR, V12, P62, DOI 10.1016/j.acap.2011.09.004; WELLS KB, 1984, JAMA-J AM MED ASSOC, V252, P2846, DOI 10.1001/jama.252.20.2846	7	16	16	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 12	2012	308	10					983	984		10.1001/2012.jama.10427	http://dx.doi.org/10.1001/2012.jama.10427			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	003AA	22968886				2022-12-28	WOS:000308579300020
J	Jones, R				Jones, Richard			Government advisers' suggestions for NHS savings don't add up	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Leeds, Yorkshire Ctr Hlth Informat, Leeds LS2 9JT, W Yorkshire, England	University of Leeds	Jones, R (corresponding author), Univ Leeds, Yorkshire Ctr Hlth Informat, Leeds LS2 9JT, W Yorkshire, England.	r.g.jones@leeds.ac.uk						Craig D., 2006, PLUNDERING PUBLIC SE; Department of Health, 2012, POW INF IMP ASS SPRE; Department of Health, 2012, POW INF PUTT ALL US; Glasziou PP, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5047; Heritage S, 2012, GUARDIAN        0913; The NHS Information Centre for Health and Social Care, 2009, TRENDS CONS RAT GEN; Transform Innovation Ltd, 2012, DIG DEF DEL CHOIC EN; Yorkshire Centre for Health Informatics, 2012, PMIP UN MEAS AUD	8	0	0	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	SEP 11	2012	345								e6024	10.1136/bmj.e6024	http://dx.doi.org/10.1136/bmj.e6024			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	007BG	22968723				2022-12-28	WOS:000308863200007
J	Feldman, BE; Krauss, B; Smet, JH; Yacoby, A				Feldman, Benjamin E.; Krauss, Benjamin; Smet, Jurgen H.; Yacoby, Amir			Unconventional Sequence of Fractional Quantum Hall States in Suspended Graphene	SCIENCE			English	Article							ELECTRON	Graphene provides a rich platform to study many-body effects, owing to its massless chiral charge carriers and the fourfold degeneracy arising from their spin and valley degrees of freedom. We use a scanning single-electron transistor to measure the local electronic compressibility of suspended graphene, and we observed an unusual pattern of incompressible fractional quantum Hall states that follows the standard composite fermion sequence between filling factors nu = 0 and 1 but involves only even-numerator fractions between nu = 1 and 2. We further investigated this surprising hierarchy by extracting the corresponding energy gaps as a function of the magnetic field. The sequence and relative strengths of the fractional quantum Hall states provide insight into the interplay between electronic correlations and the inherent symmetries of graphene.	[Feldman, Benjamin E.; Yacoby, Amir] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Krauss, Benjamin; Smet, Jurgen H.] Max Planck Inst Festkorperforsch, D-70569 Stuttgart, Germany	Harvard University; Max Planck Society	Yacoby, A (corresponding author), Harvard Univ, Dept Phys, Cambridge, MA 02138 USA.	yacoby@physics.harvard.edu		Feldman, Benjamin/0000-0002-4962-0548	U.S. Department of Energy, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering [DE-SC0001819]; Deutsche Forschungsgemeinschaft; Bayer Science and Education Foundation; NSF [ECS-0335765]	U.S. Department of Energy, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering(United States Department of Energy (DOE)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bayer Science and Education Foundation; NSF(National Science Foundation (NSF))	We thank M. T. Allen for useful discussions and for helping to current anneal the device and B. I. Halperin, D. Abanin, J. K. Jain, S. das Sarma, J. Martin, V. Venkatachalam, S. Hart, and G. Ben-Shach for helpful discussions. This work is supported by the U.S. Department of Energy, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering, under award no. DE-SC0001819. J. H. S. and B. K. acknowledge financial support from the Deutsche Forschungsgemeinschaft graphene priority program, and B. K. acknowledges financial support from the Bayer Science and Education Foundation. This work was performed in part at the Center for Nanoscale Systems (of Harvard Univ.), a member of the National Nanotechnology Infrastructure Network, which is supported by the NSF under award no. ECS-0335765.	Apalkov VM, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.126801; Bishop NC, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.266404; Bolotin KI, 2009, NATURE, V462, P196, DOI 10.1038/nature08582; Du X, 2009, NATURE, V462, P192, DOI 10.1038/nature08522; Ghahari F, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.046801; Goerbig MO, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.241405; Goerbig MO, 2012, PHYS SCRIPTA, VT146, DOI 10.1088/0031-8949/2012/T146/014017; HALPERIN BI, 1983, HELV PHYS ACTA, V56, P75; JAIN JK, 1989, PHYS REV LETT, V63, P199, DOI 10.1103/PhysRevLett.63.199; Jiang Z, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.106802; Khrapai VS, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.196805; Khveshchenko DV, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.153405; Lai K, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.156805; Lee DS, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.056602; Martin J, 2009, NAT PHYS, V5, P669, DOI 10.1038/NPHYS1344; Modak S, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.165118; Novoselov KS, 2005, NATURE, V438, P197, DOI 10.1038/nature04233; Padmanabhan M, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.113301; Padmanabhan M, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.016805; Padmanabhan M, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.035423; Papic Z, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.241306; Papic Z, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.176802; Papic Z, 2009, SOLID STATE COMMUN, V149, P1056, DOI 10.1016/j.ssc.2009.02.050; Shibata N, 2009, J PHYS SOC JPN, V78, DOI 10.1143/JPSJ.78.104708; Shibata N, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.235426; Toke C, 2012, J PHYS-CONDENS MAT, V24, DOI 10.1088/0953-8984/24/23/235601; Toke C, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.245440; Toke C, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.235417; Yacoby A, 1999, SOLID STATE COMMUN, V111, P1, DOI 10.1016/S0038-1098(99)00139-8; Yang K, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.075423; Yoo MJ, 1997, SCIENCE, V276, P579, DOI 10.1126/science.276.5312.579; Zhang Y, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.136806; Zhang YB, 2005, NATURE, V438, P201, DOI 10.1038/nature04235	38	135	135	3	164	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 7	2012	337	6099					1196	1199		10.1126/science.1224784	http://dx.doi.org/10.1126/science.1224784			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	000UJ	22955829	Green Submitted			2022-12-28	WOS:000308414000029
J	Mello, MM; Goodman, SN; Faden, RR				Mello, Michelle M.; Goodman, Steven N.; Faden, Ruth R.			Ethical Considerations in Studying Drug Safety - The Institute of Medicine Report	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CARDIOVASCULAR EVENTS; MYOCARDIAL-INFARCTION; RISK; ROSIGLITAZONE; DEATH; PIOGLITAZONE; NESIRITIDE		[Mello, Michelle M.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; [Goodman, Steven N.] Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA; [Goodman, Steven N.] Stanford Univ, Sch Med, Dept Hlth Res & Policy, Stanford, CA 94305 USA; [Faden, Ruth R.] Johns Hopkins Univ, Berman Inst Bioeth, Baltimore, MD USA	Harvard University; Harvard T.H. Chan School of Public Health; Stanford University; Stanford University; Johns Hopkins University	Mello, MM (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, 665 Huntington Ave, Boston, MA 02115 USA.			Goodman, Steven/0000-0002-3872-5723; Mello, Michelle/0000-0003-2877-4270				Baucus M, 2010, PREFECT POLICE F PEC; Chen JY, 2010, AM J BIOETHICS, V10, P35, DOI 10.1080/15265161.2010.494220; Committee on Ethical and Scientific Issues in Studying the Safety of Approved Drugs Institute of Medicine, 2010, ETH ISS STUD SAF APP; Committee on Ethical and Scientific Issues in Studying the Safety of Approved Drugs Institute of Medicine, 2012, ETH SCI ISS STUD SAF; Committee on the Assessment of the U.S. Drug Safety System Institute of Medicine, 2007, FUT DRUG SAF PROM PR; Curfman GD, 2005, NEW ENGL J MED, V353, P2813, DOI 10.1056/NEJMe058314; Dormandy JA, 2005, LANCET, V366, P1279, DOI 10.1016/S0140-6736(05)67528-9; Doshi P, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001201; Food and Drug Administration Center for Drug Evaluation and Research, 2010, JOINT M END MET DRUG; Graham D, 2008, PREFECT POLICE F PEC; Hamburg M, 2010, PREFECT POLICE F PEC; Kesselheim AS, 2007, HEALTH AFFAIR, V26, P483, DOI 10.1377/hlthaff.26.2.483; Krumholz H., FORBES          0516; Levine C, 1988, Law Med Health Care, V16, P167, DOI 10.1111/j.1748-720X.1988.tb01942.x; Lincoff AM, 2007, JAMA-J AM MED ASSOC, V298, P1180, DOI 10.1001/jama.298.10.1180; London AJ, 2012, SCIENCE, V336, P544, DOI 10.1126/science.1216086; Mahoney K, 2010, ADV COMM CLIN BRIEF; Misbin RI, 2007, DIABETES CARE, V30, P3141, DOI 10.2337/dc07-1908; Nissen SE, 2005, JAMA-J AM MED ASSOC, V294, P2581, DOI 10.1001/JAMA.294.20.JOC50147; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; Nissen SE, 2010, ARCH INTERN MED, V170, P1191, DOI 10.1001/archinternmed.2010.207; Nissen SE, 2010, EUR HEART J, V31, P773, DOI 10.1093/eurheartj/ehq016; Punthakee Z, 2012, DIABETOLOGIA, V55, P36, DOI 10.1007/s00125-011-2357-4; Rising K, 2009, PLOS MED, V6, P117, DOI 10.1371/journal.pmed.1000017; Rising K, 2008, PLOS MED, V5, P1561, DOI 10.1371/journal.pmed.0050217; Sackner-Bernstein, 2005, CIRCULATION, V111, P2274; Sackner-Bernstein JD, 2005, JAMA-J AM MED ASSOC, V293, P1900, DOI 10.1001/jama.293.15.1900; Sackner-Bernstein JD, 2005, CIRCULATION, V111, P1487, DOI 10.1161/01.CIR.0000159340.93220.E4; Solomon DH, 2005, ARTHRITIS RHEUM, V52, P1968, DOI 10.1002/art.21132; Woodcock J, 2010, NEW ENGL J MED, V363, P1489, DOI 10.1056/NEJMp1010788	30	15	15	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 6	2012	367	10					959	964		10.1056/NEJMhle1207160	http://dx.doi.org/10.1056/NEJMhle1207160			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	999VO	22913661				2022-12-28	WOS:000308343300017
J	Vonk, JE; Sanchez-Garcia, L; van Dongen, BE; Alling, V; Kosmach, D; Charkin, A; Semiletov, IP; Dudarev, OV; Shakhova, N; Roos, P; Eglinton, TI; Andersson, A; Gustafsson, O				Vonk, J. E.; Sanchez-Garcia, L.; van Dongen, B. E.; Alling, V.; Kosmach, D.; Charkin, A.; Semiletov, I. P.; Dudarev, O. V.; Shakhova, N.; Roos, P.; Eglinton, T. I.; Andersson, A.; Gustafsson, O.			Activation of old carbon by erosion of coastal and subsea permafrost in Arctic Siberia	NATURE			English	Article							OFFSHORE PERMAFROST; SHELF; DEGRADATION; RELEASE; MATTER; LAPTEV; CYCLE	The future trajectory of greenhouse gas concentrations depends on interactions between climate and the biogeosphere(1,2). Thawing of Arctic permafrost could release significant amounts of carbon into the atmosphere in this century(3). Ancient Ice Complex deposits outcropping along the similar to 7,000-kilometre-long coastline of the East Siberian Arctic Shelf (ESAS)(4,5), and associated shallow subsea permafrost(6,7), are two large pools of permafrost carbon(8), yet their vulnerabilities towards thawing and decomposition are largely unknown(9-11). Recent Arctic warming is stronger than has been predicted by several degrees, and is particularly pronounced over the coastal ESAS region(12,13). There is thus a pressing need to improve our understanding of the links between permafrost carbon and climate in this relatively inaccessible region. Here we show that extensive release of carbon from these Ice Complex deposits dominates (57 +/- 2 per cent) the sedimentary carbon budget of the ESAS, the world's largest continental shelf, overwhelming the marine and topsoil terrestrial components. Inverse modelling of the dual-carbon isotope composition of organic carbon accumulating in ESAS surface sediments, using Monte Carlo simulations to account for uncertainties, suggests that 44 +/- 10 teragrams of old carbon is activated annually from Ice Complex permafrost, an order of magnitude more than has been suggested by previous studies(14). We estimate that about two-thirds (66 +/- 16 per cent) of this old carbon escapes to the atmosphere as carbon dioxide, with the remainder being re-buried in shelf sediments. Thermal collapse and erosion of these carbon-rich Pleistocene coastline and seafloor deposits may accelerate with Arctic amplification of climate warming(2,13).	[Vonk, J. E.; Sanchez-Garcia, L.; van Dongen, B. E.; Alling, V.; Andersson, A.; Gustafsson, O.] Stockholm Univ, Dept Appl Environm Sci ITM, SE-11418 Stockholm, Sweden; [Vonk, J. E.; Sanchez-Garcia, L.; van Dongen, B. E.; Alling, V.; Andersson, A.; Gustafsson, O.] Stockholm Univ, Bert Bolin Ctr Climate Res, SE-11418 Stockholm, Sweden; [Kosmach, D.; Charkin, A.; Semiletov, I. P.; Dudarev, O. V.; Shakhova, N.] Russian Acad Sci, Pacific Oceanol Inst, Vladivostok 690041, Russia; [Semiletov, I. P.; Shakhova, N.] Univ Alaska, Int Arctic Res Ctr, Fairbanks, AK 99775 USA; [Roos, P.] Riso Natl Lab Sustainable Energy, DK-4000 Roskilde, Denmark; [Eglinton, T. I.] Swiss Fed Inst Technol, Inst Geol, CH-8092 Zurich, Switzerland	Stockholm University; Stockholm University; Ilichev Pacific Oceanological Institute; Russian Academy of Sciences; University of Alaska System; University of Alaska Fairbanks; Technical University of Denmark; Swiss Federal Institutes of Technology Domain; ETH Zurich	Gustafsson, O (corresponding author), Stockholm Univ, Dept Appl Environm Sci ITM, Svante Arrhenius Vag 8, SE-11418 Stockholm, Sweden.	orjan.gustafsson@itm.su.se	Oleg, Dudarev Victorovich/A-8269-2019; Kosmach, Denis Alekseevich/AAT-5710-2020; Vonk, Jorien E/H-5422-2011; Shakhova, Natalia Evgenievna/H-6691-2016; Semiletov, Igor/CAJ-4412-2022; Sanchez-Garcia, Laura/N-1172-2013; Charkin, Alexander/G-8883-2019; Semiletov, Igor P/B-3616-2013	Kosmach, Denis Alekseevich/0000-0002-2276-324X; Vonk, Jorien E/0000-0002-1206-5878; Sanchez-Garcia, Laura/0000-0002-7444-1242; van Dongen, Bart/0000-0003-1189-142X; Charkin, Alexander/0000-0001-9273-9950; Eglinton, Timothy/0000-0001-5060-2155	Knut and Alice Wallenberg Foundation; Far Eastern Branch of the Russian Academy of Sciences; Swedish Research Council; US National Oceanic and Atmospheric Administration; Russian Foundation of Basic Research; Swedish Polar Research Secretariat; Nordic Council of Ministers; Swedish Royal Academy of Sciences; EU Marie Curie grant; US National Science Foundation; NOAA OAR Climate Program Office; Natural Environment Research Council [NE/I024798/1] Funding Source: researchfish; NERC [NE/I024798/1] Funding Source: UKRI	Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Far Eastern Branch of the Russian Academy of Sciences(Russian Academy of Sciences); Swedish Research Council(Swedish Research CouncilEuropean Commission); US National Oceanic and Atmospheric Administration(National Oceanic Atmospheric Admin (NOAA) - USA); Russian Foundation of Basic Research(Russian Foundation for Basic Research (RFBR)); Swedish Polar Research Secretariat; Nordic Council of Ministers; Swedish Royal Academy of Sciences; EU Marie Curie grant; US National Science Foundation(National Science Foundation (NSF)); NOAA OAR Climate Program Office; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank all ISSS-08 colleagues and crew, in particular M. Krusa, P. Andersson and V. Mordukhovich, who helped with sampling. The ISSS program is supported by the Knut and Alice Wallenberg Foundation, the Far Eastern Branch of the Russian Academy of Sciences, the Swedish Research Council, the US National Oceanic and Atmospheric Administration, the Russian Foundation of Basic Research, the Swedish Polar Research Secretariat and the Nordic Council of Ministers (Arctic Co-Op and TRI-DEFROST programs). O.G. and L.S.-G. acknowledge an Academy Research Fellow grant from the Swedish Royal Academy of Sciences and an EU Marie Curie grant, respectively. N.S. and I. P. S. acknowledge grants from the US National Science Foundation and the NOAA OAR Climate Program Office.	Dmitrenko IA, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2011JC007218; Dudarev OV, 2006, DOKL EARTH SCI, V409, P1000, DOI 10.1134/S1028334X06060389; Dutta K, 2006, GLOBAL CHANGE BIOL, V12, P2336, DOI 10.1111/j.1365-2486.2006.01259.x; Friedlingstein P, 2006, J CLIMATE, V19, P3337, DOI 10.1175/JCLI3800.1; Grigoriev M. N, 2008, THESIS YAKUTSK MELNI; Gruber N, 2004, SCOPE SER, V62, P45; Keil RG, 2004, MAR CHEM, V92, P157, DOI 10.1016/j.marchem.2004.06.024; Lantuit H, 2009, MAR GEOL, V257, P1, DOI 10.1016/j.margeo.2008.10.004; Mastepanov M, 2008, NATURE, V456, P628, DOI 10.1038/nature07464; Nicolsky D, 2010, ENVIRON RES LETT, V5, DOI 10.1088/1748-9326/5/1/015006; Overduin PP, 2007, GEOL SOC AM SPEC PAP, V426, P97, DOI 10.1130/2007.2426(07); Rachold V, 2000, INT J EARTH SCI, V89, P450, DOI 10.1007/s005310000113; Razumov S.O., 2000, GEOMORPHOLOGY, V3, P88; Richter-Menge J., 2010, ARCTIC REPORT CARD 2; Rivkina E, 1998, GEOMICROBIOL J, V15, P187, DOI 10.1080/01490459809378075; Romanovskii N. N., 1993, FUNDAMENTALS CRYOGEN; Romanovskii NN, 2005, GEO-MAR LETT, V25, P167, DOI 10.1007/s00367-004-0198-6; Sanchez-Garcia L, 2011, GLOBAL BIOGEOCHEM CY, V25, DOI 10.1029/2010GB003862; Schirrmeister L, 2011, QUATERN INT, V241, P3, DOI 10.1016/j.quaint.2010.04.004; Schuur EAG, 2009, NATURE, V459, P556, DOI 10.1038/nature08031; Semiletov I. P, 1999, DOKL EARTH SCI, V369, P1140; Shakhova N, 2010, SCIENCE, V327, P1246, DOI 10.1126/science.1182221; Solomon S., 2007, PHYS SCI BASIS WORKI; Soloviev V.A., 1987, CRYOTHERMIA GAS HYDR; Stein R., 2004, ORGANIC CARBON CYCLE; Tarnocai C, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003327; Vonk JE, 2010, BIOGEOSCIENCES, V7, P3153, DOI 10.5194/bg-7-3153-2010; Vonk JE, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL042909; Wegner C, 2003, ESTUAR COAST SHELF S, V57, P55, DOI 10.1016/S0272-7714(02)00328-1; Zimov SA, 2006, SCIENCE, V312, P1612, DOI 10.1126/science.1128908	30	229	248	6	297	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 6	2012	489	7414					137	140		10.1038/nature11392	http://dx.doi.org/10.1038/nature11392			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999WW	22932271				2022-12-28	WOS:000308347000050
J	Formenti, SC; DeWyngaert, JK; Jozsef, G; Goldberg, JD				Formenti, Silvia C.; DeWyngaert, J. Keith; Jozsef, Gabor; Goldberg, Judith D.			Prone vs Supine Positioning for Breast Cancer Radiotherapy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Formenti, Silvia C.; DeWyngaert, J. Keith; Jozsef, Gabor] NYU, Sch Med, Dept Radiat Oncol, New York, NY 10003 USA; [Goldberg, Judith D.] NYU, Sch Med, Dept Environm Med, New York, NY USA	New York University; New York University	Formenti, SC (corresponding author), NYU, Sch Med, Dept Radiat Oncol, New York, NY 10003 USA.	silvia.formenti@nyumc.org		Goldberg, Judith D./0000-0003-3758-6976				DARBY S, 2011, LANCET, V12, P1707, DOI DOI 10.1016/S0140-6736(11)61629-2; Darby SC, 2005, LANCET ONCOL, V6, P557, DOI 10.1016/S1470-2045(05)70251-5; Formenti SC, 2007, J CLIN ONCOL, V25, P2236, DOI 10.1200/JCO.2006.09.1041; Lymberis SC, 2012, INT J RADIAT ONCOL, V84, P902, DOI 10.1016/j.ijrobp.2012.01.040; Stegman LD, 2007, INT J RADIAT ONCOL, V68, P73, DOI 10.1016/j.ijrobp.2006.11.054	5	114	121	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 5	2012	308	9					861	863		10.1001/2012.jama.10759	http://dx.doi.org/10.1001/2012.jama.10759			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	999ET	22948692	Bronze			2022-12-28	WOS:000308292900010
J	Sokol, DK				Sokol, Daniel K.			Is bioethics a bully?	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ London Imperial Coll Sci Technol & Med, London SW7 2AZ, England	Imperial College London	Sokol, DK (corresponding author), Univ London Imperial Coll Sci Technol & Med, London SW7 2AZ, England.	daniel.sokol@talk21.com						Gillon R, 2003, J MED ETHICS, V29, P307, DOI 10.1136/jme.29.5.307	1	5	5	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	SEP 3	2012	345								e5802	10.1136/bmj.e5802	http://dx.doi.org/10.1136/bmj.e5802			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	003TH	22945953				2022-12-28	WOS:000308633700004
J	Shetty, P				Shetty, Priya			Profile Herawati Sudoyo: champion of basic science in Indonesia	LANCET			English	Biographical-Item																			0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 1	2012	380	9844					797	797		10.1016/S0140-6736(12)61437-8	http://dx.doi.org/10.1016/S0140-6736(12)61437-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	000OP	22939673				2022-12-28	WOS:000308396300011
J	Metcalf, WW; Griffin, BM; Cicchillo, RM; Gao, JT; Janga, SC; Cooke, HA; Circello, BT; Evans, BS; Martens-Habbena, W; Stahl, DA; van der Donk, WA				Metcalf, William W.; Griffin, Benjamin M.; Cicchillo, Robert M.; Gao, Jiangtao; Janga, Sarath Chandra; Cooke, Heather A.; Circello, Benjamin T.; Evans, Bradley S.; Martens-Habbena, Willm; Stahl, David A.; van der Donk, Wilfred A.			Synthesis of Methylphosphonic Acid by Marine Microbes: A Source for Methane in the Aerobic Ocean	SCIENCE			English	Article							HETEROLOGOUS EXPRESSION; MOLECULAR-CLONING; BIOSYNTHESIS; PHOSPHORUS	Relative to the atmosphere, much of the aerobic ocean is supersaturated with methane; however, the source of this important greenhouse gas remains enigmatic. Catabolism of methylphosphonic acid by phosphorus-starved marine microbes, with concomitant release of methane, has been suggested to explain this phenomenon, yet methylphosphonate is not a known natural product, nor has it been detected in natural systems. Further, its synthesis from known natural products would require unknown biochemistry. Here we show that the marine archaeon Nitrosopumilus maritimus encodes a pathway for methylphosphonate biosynthesis and that it produces cell-associated methylphosphonate esters. The abundance of a key gene in this pathway in metagenomic data sets suggests that methylphosphonate biosynthesis is relatively common in marine microbes, providing a plausible explanation for the methane paradox.	[Metcalf, William W.; Griffin, Benjamin M.; Cicchillo, Robert M.; Gao, Jiangtao; Janga, Sarath Chandra; Cooke, Heather A.; Circello, Benjamin T.; Evans, Bradley S.; van der Donk, Wilfred A.] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA; [Cicchillo, Robert M.; Gao, Jiangtao; Cooke, Heather A.; van der Donk, Wilfred A.] Univ Illinois, Dept Chem, Urbana, IL 61801 USA; [Cicchillo, Robert M.; Gao, Jiangtao; Cooke, Heather A.; van der Donk, Wilfred A.] Univ Illinois, Howard Hughes Med Inst, Urbana, IL 61801 USA; [Metcalf, William W.; Circello, Benjamin T.] Univ Illinois, Dept Microbiol, Urbana, IL 61801 USA; [Martens-Habbena, Willm; Stahl, David A.] Univ Washington, Dept Civil & Environm Engn, Seattle, WA 98195 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Howard Hughes Medical Institute; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Washington; University of Washington Seattle	Metcalf, WW (corresponding author), Univ Illinois, Inst Genom Biol, 1206 West Gregory, Urbana, IL 61801 USA.	metcalf@uiuc.edu; vddonk@illinois.edu	Evans, Bradley S/M-2842-2013; Martens-Habbena, Willm/AAK-1372-2021; Martens-Habbena, Willm/I-7656-2013; van der Donk, Wilfred/K-2961-2015	Evans, Bradley S/0000-0002-1207-9006; Martens-Habbena, Willm/0000-0002-8495-9125; Martens-Habbena, Willm/0000-0002-8495-9125; van der Donk, Wilfred/0000-0002-5467-7071; Gao, Jiangtao/0000-0002-9669-4718; Cooke, Heather/0000-0001-9742-5993; Janga, Sarath Chandra/0000-0001-7351-6268	NIH [GM PO1 GM077596, F32 GM095024]; Howard Hughes Medical Institute (HHMI); NSF [MCB-0604448, OCE-1046017, MCB-0920741]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR028833] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM077596, F32GM095024] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute (HHMI)(Howard Hughes Medical Institute); NSF(National Science Foundation (NSF)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the NIH (grants GM PO1 GM077596 and F32 GM095024), the Howard Hughes Medical Institute (HHMI), and NSF (grants MCB-0604448, OCE-1046017, and MCB-0920741). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the National Institute of General Medical Sciences, NIH, NSF, or HHMI. The authors thank L. Zhu (University of Illinois at Urbana-Champaign) for valuable help with NMR experiments.	Blodgett JAV, 2005, ANTIMICROB AGENTS CH, V49, P230, DOI 10.1128/AAC.49.1.230-240.2005; Borisova SA, 2010, CHEM BIOL, V17, P28, DOI 10.1016/j.chembiol.2009.11.017; Circello BT, 2010, CHEM BIOL, V17, P402, DOI 10.1016/j.chembiol.2010.03.007; Clark LL, 1998, NATURE, V393, P426, DOI 10.1038/30881; Clark LL, 1999, AM J SCI, V299, P724, DOI 10.2475/ajs.299.7-9.724; DAUGHTON CG, 1979, FEMS MICROBIOL LETT, V5, P91, DOI 10.1016/0378-1097(79)90191-5; Eliot AC, 2008, CHEM BIOL, V15, P765, DOI 10.1016/j.chembiol.2008.07.010; Hilderbrand R. L., 1983, ROLE PHOSPHONATES LI; Howard EC, 2008, ENVIRON MICROBIOL, V10, P2397, DOI 10.1111/j.1462-2920.2008.01665.x; Ilikchyan IN, 2009, ENVIRON MICROBIOL, V11, P1314, DOI 10.1111/j.1462-2920.2009.01869.x; Karl DM, 2008, NAT GEOSCI, V1, P473, DOI 10.1038/ngeo234; Karner MB, 2001, NATURE, V409, P507, DOI 10.1038/35054051; Konneke M, 2005, NATURE, V437, P543, DOI 10.1038/nature03911; Martinez A, 2010, ENVIRON MICROBIOL, V12, P222, DOI 10.1111/j.1462-2920.2009.02062.x; Metcalf WW, 2009, ANNU REV BIOCHEM, V78, P65, DOI 10.1146/annurev.biochem.78.091707.100215; Morris RM, 2002, NATURE, V420, P806, DOI 10.1038/nature01240; Reeburgh WS, 2007, CHEM REV, V107, P486, DOI 10.1021/cr050362v; Rogers J.E., 1991, MICROBIAL PRODUCTION; SEIDEL HM, 1988, NATURE, V335, P457, DOI 10.1038/335457a0; Shao ZY, 2008, J BIOL CHEM, V283, P23161, DOI 10.1074/jbc.M801788200; Tebby J. C., 1991, CRC HDB PHOSPHORUS 3; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578; Yooseph S, 2007, PLOS BIOL, V5, P432, DOI 10.1371/journal.pbio.0050016	23	181	193	7	189	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 31	2012	337	6098					1104	1107		10.1126/science.1219875	http://dx.doi.org/10.1126/science.1219875			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996WP	22936780	Green Accepted, Green Submitted			2022-12-28	WOS:000308125800050
J	Sun, GH; Steinberg, JD; Jagsi, R				Sun, Gordon H.; Steinberg, Jeffrey D.; Jagsi, Reshma			The Calculus of National Medical Research Policy - The United States versus Asia	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Sun, Gordon H.; Jagsi, Reshma] Univ Michigan, Robert Wood Johnson Fdn Clin Scholars Program, Ann Arbor, MI 48109 USA; [Sun, Gordon H.] Univ Michigan, Dept Otolaryngol, Ann Arbor, MI 48109 USA; [Jagsi, Reshma] Univ Michigan, Dept Radiat Oncol, Ann Arbor, MI 48109 USA; [Sun, Gordon H.] VA Ann Arbor Healthcare Syst, Hlth Serv Res & Dev Serv, Ann Arbor, MI USA; [Steinberg, Jeffrey D.] Agcy Sci Technol & Res, Singapore Bioimaging Consortium, Singapore, Singapore	Robert Wood Johnson Foundation (RWJF); University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Bioengineering & Bioimaging (IBB); A*STAR - Singapore Bioimaging Consortium (SBIC)	Sun, GH (corresponding author), Univ Michigan, Robert Wood Johnson Fdn Clin Scholars Program, Ann Arbor, MI 48109 USA.		Steinberg, Jeffrey D/H-3540-2013	Steinberg, Jeffrey D/0000-0003-4110-3586; Jagsi, Reshma/0000-0001-6562-1228				COLLINS F S, 2011, FISCAL YEAR 2012 BUD; Ding YM, 2001, SCIENCE, V291, P1477; Ehrlich E., 2012, ENGINE STALLED SEQUE; Murphy KM, 1998, EC VALUE MED RES; Thiers FA, 2008, NAT REV DRUG DISCOV, V7, P13, DOI 10.1038/nrd2441	5	14	14	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 23	2012	367	8					687	690		10.1056/NEJMp1206643	http://dx.doi.org/10.1056/NEJMp1206643			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	992CX	22913678				2022-12-28	WOS:000307754200002
J	Brott, BC; Hillegass, WB				Brott, Brigitta C.; Hillegass, William B.			24- and 6-month dual antiplatelet therapy after coronary stenting did not differ for clinical outcomes	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							DRUG-ELUTING STENTS; IMPLANTATION		[Brott, Brigitta C.] Univ Alabama Birmingham, Birmingham, AL USA; [Hillegass, William B.] HeartSouth Cardiovasc Grp, Alabaster, AL USA	University of Alabama System; University of Alabama Birmingham	Brott, BC (corresponding author), Univ Alabama Birmingham, Birmingham, AL USA.			Brott, Brigitta/0000-0002-9707-7500				Gwon HC, 2012, CIRCULATION, V125, P505, DOI 10.1161/CIRCULATIONAHA.111.059022; Levine GN, 2011, CIRCULATION, V124, P2574, DOI 10.1161/CIR.0b013e31823a5596; Park SJ, 2010, NEW ENGL J MED, V362, P1374, DOI 10.1056/NEJMoa1001266	3	1	1	1	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 21	2012	157	4							JC2-9	10.7326/0003-4819-157-4-201208210-02009	http://dx.doi.org/10.7326/0003-4819-157-4-201208210-02009			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	992XG	22910963				2022-12-28	WOS:000307813200008
J	Chung, KF				Chung, Kian Fan			Gabapentin: a suppressant for refractory chronic cough	LANCET			English	Editorial Material							THERAPY		Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London SW3 6LY, England	Imperial College London	Chung, KF (corresponding author), Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London SW3 6LY, England.	f.chung@imperial.ac.uk	Chung, Kian Fan/I-8456-2019; Chung, Kian Fan/B-1872-2012	Chung, Kian Fan/0000-0001-7101-1426; Chung, Kian Fan/0000-0001-7101-1426	Medical Research Council [G0801056B] Funding Source: researchfish; National Institute for Health Research [NF-SI-0509-10080] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))		Chen C. -Y., 2009, V187, P187, DOI 10.1007/978-3-540-79842-2_9; Chung KF, 2011, PULM PHARMACOL THER, V24, P267, DOI 10.1016/j.pupt.2011.01.012; Chung KF, 2008, LANCET, V371, P1364, DOI 10.1016/S0140-6736(08)60595-4; Hendrich J, 2008, P NATL ACAD SCI USA, V105, P3628, DOI 10.1073/pnas.0708930105; Lee JK, 2006, ANN OTO RHINOL LARYN, V115, P871, DOI 10.1177/000348940611501113; Mintz S, 2006, AM J MED, V119, DOI 10.1016/j.amjmed.2005.10.046; Morice AH, 2007, AM J RESP CRIT CARE, V175, P312, DOI 10.1164/rccm.200607-892OC; Morice AH, 2012, LUNG, V190, P3, DOI 10.1007/s00408-011-9351-y; Pavord ID, 2008, LANCET, V371, P1375, DOI 10.1016/S0140-6736(08)60596-6; Raj AA, 2007, PULM PHARMACOL THER, V20, P334, DOI 10.1016/j.pupt.2006.10.002; Ryan NM, 2012, LANCET; Undem BJ, 2010, CHEST, V137, P177, DOI 10.1378/chest.09-1960; Widdicombe J, 2011, PULM PHARMACOL THER, V24, P344, DOI 10.1016/j.pupt.2010.12.010; Woodcock A, 2010, LUNG, V188, pS47, DOI 10.1007/s00408-009-9197-8	14	6	6	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 3	2012	380	9853					1540	1541		10.1016/S0140-6736(12)61070-8	http://dx.doi.org/10.1016/S0140-6736(12)61070-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	030VR	22951081				2022-12-28	WOS:000310598700010
J	Koike, N; Yoo, SH; Huang, HC; Kumar, V; Lee, C; Kim, TK; Takahashi, JS				Koike, Nobuya; Yoo, Seung-Hee; Huang, Hung-Chung; Kumar, Vivek; Lee, Choogon; Kim, Tae-Kyung; Takahashi, Joseph S.			Transcriptional Architecture and Chromatin Landscape of the Core Circadian Clock in Mammals	SCIENCE			English	Article							RNA-POLYMERASE-II; REV-ERB-ALPHA; GENE-EXPRESSION; HUMAN GENOME; PROTEIN DBP; METABOLISM; PROMOTERS; DEGRADATION; MECHANISMS; REPRESSION	The mammalian circadian clock involves a transcriptional feedback loop in which CLOCK and BMAL1 activate the Period and Cryptochrome genes, which then feed back and repress their own transcription. We have interrogated the transcriptional architecture of the circadian transcriptional regulatory loop on a genome scale in mouse liver and find a stereotyped, time-dependent pattern of transcription factor binding, RNA polymerase II (RNAPII) recruitment, RNA expression, and chromatin states. We find that the circadian transcriptional cycle of the clock consists of three distinct phases: a poised state, a coordinated de novo transcriptional activation state, and a repressed state. Only 22% of messenger RNA (mRNA) cycling genes are driven by de novo transcription, suggesting that both transcriptional and posttranscriptional mechanisms underlie the mammalian circadian clock. We also find that circadian modulation of RNAPII recruitment and chromatin remodeling occurs on a genome-wide scale far greater than that seen previously by gene expression profiling.	[Koike, Nobuya; Yoo, Seung-Hee; Huang, Hung-Chung; Kumar, Vivek; Kim, Tae-Kyung; Takahashi, Joseph S.] Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA; [Lee, Choogon] Florida State Univ, Coll Med, Dept Biomed Sci, Tallahassee, FL 32306 USA; [Takahashi, Joseph S.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; State University System of Florida; Florida State University; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Takahashi, JS (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA.	joseph.takahashi@utsouthwestern.edu	Koike, Nobuya/G-1116-2016; Takahashi, Joseph S/E-8482-2012; Takahashi, Joseph S./Y-2781-2019; Kim, Tae-Kyung/AAX-4230-2020; Kumar, Vivek/P-8749-2014	Takahashi, Joseph S/0000-0003-0384-8878; Takahashi, Joseph S./0000-0003-0384-8878; Kim, Tae-Kyung/0000-0001-5161-9864; Kumar, Vivek/0000-0001-6643-7465	Howard Hughes Medical Institute; Whitehall Foundation grant; NIH [R01 NS053616, F32 DA024556]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS053616] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [F32DA024556] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Whitehall Foundation grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the Howard Hughes Medical Institute (J.S.T.), Whitehall Foundation grant (T.-K.K.), and NIH grants R01 NS053616 (C. L.) and F32 DA024556 (V. K.). We thank H. Hobbs and D. Mangelsdorf for helpful discussions and support; B. Crider, V. Schmid, A. Guillory, S. Hildebrand, J. Knepper, J. Denton, S. Niu, and the McDermott Next Generation Sequencing Facility for outstanding technical and computational support; and S. L. McKnight for NPAS2 antibody. J. S. T. is an Investigator and S.-H.Y. and V. K. were Associates in the Howard Hughes Medical Institute. J. S. T. is a cofounder of, a Scientific Advisory Board member of, and a paid consultant for Reset Therapeutics, Incorporated, a biotechnology company aimed at discovering small-molecule therapies that modulate circadian activity for a variety of disease indications. ChIP-seq and RNA-seq data sets have been deposited in National Center for Biotechnology Information's Gene Expression Omnibus and are accessible through GEO Series accession number GSE39860 (www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE39860).	Ameur A, 2011, NAT STRUCT MOL BIOL, V18, P1435, DOI 10.1038/nsmb.2143; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bass J, 2010, SCIENCE, V330, P1349, DOI 10.1126/science.1195027; Bugge A, 2012, GENE DEV, V26, P657, DOI 10.1101/gad.186858.112; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Busino L, 2007, SCIENCE, V316, P900, DOI 10.1126/science.1141194; Chapman RD, 2007, SCIENCE, V318, P1780, DOI 10.1126/science.1145977; Cho H, 2012, NATURE, V485, P123, DOI 10.1038/nature11048; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Doi M, 2006, CELL, V125, P497, DOI 10.1016/j.cell.2006.03.033; Duong HA, 2011, SCIENCE, V332, P1436, DOI 10.1126/science.1196766; Etchegaray JP, 2003, NATURE, V421, P177, DOI 10.1038/nature01314; Feng D, 2012, MOL CELL, V47, P158, DOI 10.1016/j.molcel.2012.06.026; Feng D, 2011, SCIENCE, V331, P1315, DOI 10.1126/science.1198125; Fuda NJ, 2009, NATURE, V461, P186, DOI 10.1038/nature08449; Gachon F, 2006, CELL METAB, V4, P25, DOI 10.1016/j.cmet.2006.04.015; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Griffin EA, 1999, SCIENCE, V286, P768, DOI 10.1126/science.286.5440.768; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Hatanaka F, 2010, MOL CELL BIOL, V30, P5636, DOI 10.1128/MCB.00781-10; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Hogenesch JB, 2011, NAT REV GENET, V12, P407, DOI 10.1038/nrg2972; Hosoda H, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-34; Hughes ME, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000442; Jones JC, 2004, J BIOL CHEM, V279, P24957, DOI 10.1074/jbc.M402218200; Katada S, 2010, NAT STRUCT MOL BIOL, V17, P1414, DOI 10.1038/nsmb.1961; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; King DP, 1997, CELL, V89, P641, DOI 10.1016/S0092-8674(00)80245-7; Kojima S, 2011, J CELL SCI, V124, P311, DOI 10.1242/jcs.065771; Kramer C, 2003, NATURE, V421, P948, DOI 10.1038/nature01427; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Lamia KA, 2011, NATURE, V480, P552, DOI 10.1038/nature10700; Lee C, 2001, CELL, V107, P855, DOI 10.1016/S0092-8674(01)00610-9; Lee Y, 2010, J CELL SCI, V123, P3547, DOI 10.1242/jcs.070300; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Lowrey PL, 2011, ADV GENET, V74, P175, DOI 10.1016/B978-0-12-387690-4.00006-4; Masri S, 2010, NAT NEUROSCI, V13, P1324, DOI 10.1038/nn.2668; Menet JS, 2010, GENE DEV, V24, P358, DOI 10.1101/gad.1883910; Ong CT, 2011, NAT REV GENET, V12, P283, DOI 10.1038/nrg2957; Padmanabhan K, 2012, SCIENCE, V337, P599, DOI 10.1126/science.1221592; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Perissi V, 2010, NAT REV GENET, V11, P109, DOI 10.1038/nrg2736; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Reischl S, 2007, J BIOL RHYTHM, V22, P375, DOI 10.1177/0748730407303926; Rey G, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000595; Ripperger JRA, 2006, NAT GENET, V38, P369, DOI 10.1038/ng1738; Salmon-Divon M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-415; Schmutz I, 2010, GENE DEV, V24, P345, DOI 10.1101/gad.564110; Shirogane T, 2005, J BIOL CHEM, V280, P26863, DOI 10.1074/jbc.M502862200; Siepka S. M., 2007, CELL, V129, P1011; Sim RJ, 2004, GENE DEV, V18, P2437, DOI 10.1101/gad.1235904; Staiger D, 2011, CELL MOL LIFE SCI, V68, P71, DOI 10.1007/s00018-010-0513-5; Storch KF, 2002, NATURE, V417, P78, DOI 10.1038/nature744; Stratmann M, 2010, GENE DEV, V24, P1317, DOI 10.1101/gad.578810; Ueda HR, 2002, NATURE, V418, P534, DOI 10.1038/nature00906; WUARIN J, 1992, J CELL SCI, P123; Ye R, 2011, J BIOL CHEM, V286, P25891, DOI 10.1074/jbc.M111.254680; Zhang EE, 2009, CELL, V139, P199, DOI 10.1016/j.cell.2009.08.031; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	62	884	910	5	154	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 19	2012	338	6105					349	354		10.1126/science.1226339	http://dx.doi.org/10.1126/science.1226339			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022JS	22936566	Green Accepted			2022-12-28	WOS:000309955800033
J	Scirica, BM; Bonaca, MP; Braunwald, E; De Ferrari, GM; Isaza, D; Lewis, BS; Mehrhof, F; Merlini, PA; Murphy, SA; Sabatine, MS; Tendera, M; Van de Werf, F; Wilcox, R; Morrow, DA				Scirica, Benjamin M.; Bonaca, Marc P.; Braunwald, Eugene; De Ferrari, Gaetano M.; Isaza, Daniel; Lewis, Basil S.; Mehrhof, Felix; Merlini, Piera A.; Murphy, Sabina A.; Sabatine, Marc S.; Tendera, Michal; Van de Werf, Frans; Wilcox, Robert; Morrow, David A.		Tra 2 P-Timi 50 Steering Comm Inve	Vorapaxar for secondary prevention of thrombotic events for patients with previous myocardial infarction: a prespecified subgroup analysis of the TRA 2 degrees P-TIMI 50 trial	LANCET			English	Article							ACUTE CORONARY SYNDROMES; ANTIPLATELET THERAPY; RECEPTOR ANTAGONIST; DOUBLE-BLIND; TASK-FORCE; CLOPIDOGREL; ASPIRIN; PRASUGREL; INTERVENTION; GUIDELINES	Background Vorapaxar inhibits platelet activation by antagonising thrombin-mediated activation of the protease-activated receptor 1 on human platelets. The effect of adding other antiplatelet drugs to aspirin for long-term secondary prevention of thrombotic events in stable patients with previous myocardial infarction is uncertain. We tested this effect in a subgroup of patients from the Thrombin Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events (TRA 2 degrees P)-TIMI 50 trial. Methods In TRA 2 degrees P-TIMI 50-a randomised, placebo-controlled, parallel trial-we randomly assigned patients with a history of atherothrombosis to receive vorapaxar (2.5 mg daily) or matching placebo in a 1:1 ratio. Patients, and those giving treatment, assessing outcomes, and analysing results were masked to treatment allocation. Patients with a qualifying myocardial infarction within the previous 2 weeks to 12 months were analysed as a pre-defined subgroup. The primary efficacy endpoint was cardiovascular death, myocardial infarction, or stroke, analysed by intention to treat. We analysed events by Kaplan-Meier analysis and compared groups with a Cox proportional hazard model. TRA 2 degrees P-TIMI 50 is registered at ClinicalTrials.gov (NCT00526474). Findings 17 779 of 26 449 patients had a qualifying myocardial infarction and were assigned treatment (8898 to vorapaxar and 8881 to placebo). Median follow-up was 2.5 years (IQR 2.0-2.9). Cardiovascular death, myocardial infarction, or stroke occurred in 610 of 8898 patients in the vorapaxar group and 750 of 8881 in the placebo group (3-year Kaplan-Meier estimates 8.1% vs 9.7%, HR 0.80, 95% CI 0.72-0.89; p<0.0001). Moderate or severe bleeding was more common in the vorapaxar group versus the placebo group (241/8880 [3.4%, 3-year Kaplan-Meier estimate] vs 151/8849 [2.1%, 3-year Kaplan-Meier estimate], HR 1.61, 95% CI 1.31-1.97; p<0.0001). Intracranial haemorrhage occurred in 43 of 8880 patients (0.6%, 3-year Kaplan-Meier estimate) with vorapaxar versus 28 of 8849 (0.4%, 3-year Kaplan-Meier estimate) with placebo (p=0.076). Other serious adverse events were equally distributed between groups. Interpretation For patients with a history of myocardial infarction, inhibition of protease-activated receptor 1 with vorapaxar reduces the risk of cardiovascular death or ischaemic events when added to standard antiplatelet treatment, including aspirin, and increases the risk of moderate or severe bleeding.	[Scirica, Benjamin M.; Bonaca, Marc P.; Braunwald, Eugene; Murphy, Sabina A.; Sabatine, Marc S.; Morrow, David A.] Harvard Univ, Brigham & Womens Hosp, TIMI Study Grp, Cardiovasc Div,Dept Med,Med Sch, Boston, MA 02115 USA; [De Ferrari, Gaetano M.] Fdn IRCCS Policlin San Matteo, Dept Cardiol, Pavia, Italy; [Isaza, Daniel] Fdn CardioInfantil, Bogota, Colombia; [Lewis, Basil S.] Technion Israel Inst Technol, Lady Davis Carmel Med Ctr, Haifa, Israel; [Lewis, Basil S.] Technion Israel Inst Technol, Ruth & Bruce Rappaport Sch Med, Haifa, Israel; [Mehrhof, Felix] Charite, Dept Cardiol, D-13353 Berlin, Germany; [Merlini, Piera A.] Azienda Osped Niguarda Ca Granda, Div 4, Milan, Italy; [Tendera, Michal] Med Univ Silesia, Katowice, Poland; [Van de Werf, Frans] Katholieke Univ Leuven Hosp, Dept Cardiovasc Med, Louvain, Belgium; [Wilcox, Robert] Univ Nottingham Hosp, Queens Med Ctr, Nottingham NG7 2UH, England	Harvard University; Brigham & Women's Hospital; Harvard Medical School; IRCCS Fondazione San Matteo; Fundacion Cardioinfantil - Instituto de Cardiologia; Clalit Health Services; Carmel Medical Center; Technion Israel Institute of Technology; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; IRCCS Ca Granda Ospedale Maggiore Policlinico; Ospedale Niguarda Ca' Granda; Medical University Silesia; Flanders Institute for Biotechnology (VIB); KU Leuven; University Hospital Leuven; University of Nottingham	Scirica, BM (corresponding author), Harvard Univ, Brigham & Womens Hosp, TIMI Study Grp, Cardiovasc Div,Dept Med,Med Sch, Boston, MA 02115 USA.	bscirica@partners.org	De Ferrari, Gaetano M/K-5188-2016; Tendera, Michal/AAA-1875-2022; Bonaca, Marc/AAJ-2397-2021; Mehrhof, Felix/AAS-2663-2020; Sabatine, Marc/AAJ-6751-2020; Macleod, Malcolm Robert/B-2052-2010; Domitrz, Izabela/M-8960-2018	De Ferrari, Gaetano M/0000-0003-4940-0876; Bonaca, Marc/0000-0002-9860-3584; Sabatine, Marc/0000-0002-0691-3359; Macleod, Malcolm Robert/0000-0001-9187-9839; Domitrz, Izabela/0000-0003-3130-1036; Tendera, Michal/0000-0002-0812-6113; Mehrhof, Felix/0000-0003-0553-4290; Van de Werf, Frans/0000-0001-9479-7767	Merck; Abbott; AstraZeneca; Amgen; Bayer Healthcare; Bristol-Myers Squibb; Daichii Sankyo; Eli Lilly; Gilead; GlaxoSmithKline; Merck (SPRI); Novartis; Pfizer; Roche Diagnostics; Sanofi-Aventis; Johnson Johnson; Brigham and Women's Hospital from BRAHMS; Critical Diagnostics; Genzyme; Nanosphere; Takeda; Merck Sharp Dohme; Boehringer Ingelheim; Daiichi Sankyo	Merck(Merck & Company); Abbott(Abbott Laboratories); AstraZeneca(AstraZeneca); Amgen(Amgen); Bayer Healthcare(Bayer AGBayer Healthcare Pharmaceuticals); Bristol-Myers Squibb(Bristol-Myers Squibb); Daichii Sankyo(Daiichi Sankyo Company Limited); Eli Lilly(Eli Lilly); Gilead(Gilead Sciences); GlaxoSmithKline(GlaxoSmithKline); Merck (SPRI); Novartis(Novartis); Pfizer(Pfizer); Roche Diagnostics; Sanofi-Aventis(Sanofi-Aventis); Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); Brigham and Women's Hospital from BRAHMS; Critical Diagnostics; Genzyme(Sanofi-AventisGenzyme Corporation); Nanosphere; Takeda(Takeda Pharmaceutical Company Ltd); Merck Sharp Dohme(Merck & Company); Boehringer Ingelheim(Boehringer Ingelheim); Daiichi Sankyo(Daiichi Sankyo Company Limited)	Merck.; The TIMI Study Group has received research grants from Abbott, AstraZeneca, Amgen, Bayer Healthcare, Bristol-Myers Squibb, Daichii Sankyo, Eli Lilly, Gilead, GlaxoSmithKline, Merck (SPRI), Novartis, Pfizer, Roche Diagnostics, Sanofi-Aventis, and Johnson & Johnson and grant support through Brigham and Women's Hospital from BRAHMS, Critical Diagnostics, Genzyme, Nanosphere, Takeda. BMS has served as a consultant for Lexicon, Arena, Gilead, and Eisai. EB has served as a consultant for Merck (no compensation), Amorcyte, Daiichi Sankyo, Medicines Co, Ikaria, CardioRentis, Sanofi-Aventis, and CVRx (no compensation). GMDF has received honoraria from Merck for presentations and participation on advisory boards. BSL has received research support and served on advisory boards for Merck Sharp & Dohme, Bristol-Myers Squibb, AstraZeneca, Sanofi-Aventis, and Bayer Healthcare. FM has served on a national advisory board for vorapaxar for Merck Sharp & Dohme and has received honoraria from Essex Pharma for oral presentations. SAM has served as a consultant for Eli Lilly and Amarin Pharmaceuticals. MSS has served as a consultant for Amgen, AstraZeneca, Bristol-Myers Squibb, Sanofi-Aventis, Daiichi-Sankyo, Eli Lilly, Diasorin, GlaxoSmithKline, Merck, Pfizer, and Sanofi-Aventis and given accredited Continuing Medical Education talks supported by medical education companies that received unrestricted educational grants from AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Sanofi-Aventis, Daiichi Sankyo, Eli Lilly. FVdW has received honoraria from Merck for presentations and participation on advisory boards. DAM has served as consultant for Merck (SPRI), Boeringher Ingelheim, CV Therapeutics (now Gilead Sciences), Genentech, Ikaria, Johnson & Johnson, Menarini, Novartis, Servier, and Roche Diagnostics.	Anderson JL, 2011, J AM COLL CARDIOL, V57, pE215, DOI 10.1016/j.jacc.2011.02.011; Antman EM, 2008, J AM COLL CARDIOL, V51, P2028, DOI [10.1016/j.jacc.2008.04.002, 10.1016/j.jacc.2007.10.001]; Bhatt DL, 2007, J AM COLL CARDIOL, V49, P1982, DOI 10.1016/j.jacc.2007.03.025; Bhatt DL, 2006, NEW ENGL J MED, V354, P1706, DOI 10.1056/NEJMoa060989; Cannon CP, 2001, J AM COLL CARDIOL, V38, P2114, DOI 10.1016/S0735-1097(01)01702-8; Diener HC, 2004, LANCET, V364, P331, DOI 10.1016/S0140-6736(04)16721-4; Eikelboom JW, 2012, CHEST, V141, pE89S, DOI 10.1378/chest.11-2293; Fowkes FGR, 2010, JAMA-J AM MED ASSOC, V303, P841, DOI 10.1001/jama.2010.221; Hamm CW, 2011, EUR HEART J, V32, P2999, DOI 10.1093/eurheartj/ehr236; Levine GN, 2011, J AM COLL CARDIOL, V58, pE44, DOI 10.1016/j.jacc.2011.08.007; Mauri L, 2010, AM HEART J, V160, P1035, DOI 10.1016/j.ahj.2010.07.038; Morrow DA, 2012, NEW ENGL J MED, V366, P1404, DOI 10.1056/NEJMoa1200933; Morrow DA, 2009, AM HEART J, V158, P335, DOI 10.1016/j.ahj.2009.06.027; Sacco RL, 2008, NEW ENGL J MED, V359, P1238, DOI 10.1056/NEJMoa0805002; Steg PG, 2007, JAMA-J AM MED ASSOC, V297, P1197, DOI 10.1001/jama.297.11.1197; Thygesen K, 2007, EUR HEART J, V28, P2525; Tricoci P, 2012, NEW ENGL J MED, V366, P20, DOI 10.1056/NEJMoa1109719; Wallentin L, 2009, NEW ENGL J MED, V361, P1045, DOI 10.1056/NEJMoa0904327; Wiviott SD, 2007, NEW ENGL J MED, V357, P2001, DOI 10.1056/NEJMoa0706482; Wiviott SD, 2011, AM J CARDIOL, V108, P905, DOI 10.1016/j.amjcard.2011.05.020; Yusuf S, 2001, NEW ENGL J MED, V345, P494	21	172	178	0	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 13	2012	380	9850					1317	1324		10.1016/S0140-6736(12)61269-0	http://dx.doi.org/10.1016/S0140-6736(12)61269-0			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	022BZ	22932716				2022-12-28	WOS:000309931400030
J	Marmot, M; Allen, J; Bell, R; Bloomer, E; Goldblatt, P				Marmot, Michael; Allen, Jessica; Bell, Ruth; Bloomer, Ellen; Goldblatt, Peter		Consortium European Review Social	WHO European review of social determinants of health and the health divide	LANCET			English	Review								The European region has seen remarkable heath gains in those populations that have experienced progressive improvements in the conditions in which people are born, grow, live, and work. However, inequities, both between and within countries, persist. The review reported here, of inequities in health between and within countries across the 53 Member States of the WHO European region, was commissioned to support the development of the new health policy framework for Europe: Health 2020. Much more is understood now about the extent, and social causes, of these inequities, particularly since the publication in 2008 of the report of the Commission on Social Determinants of Health. The European review builds on the global evidence and recommends policies to ensure that progress can be made in reducing health inequities and the health divide across all countries, including those with low incomes. Action is needed-on the social determinants of health, across the life course, and in wider social and economic spheres-to achieve greater health equity and protect future generations.	[Marmot, Michael; Allen, Jessica; Bell, Ruth; Bloomer, Ellen; Goldblatt, Peter] UCL, UCL Inst Hlth Equ, UCL Dept Epidemiol & Publ Hlth, London WC1E 7HB, England	University of London; University College London	Marmot, M (corresponding author), UCL, UCL Inst Hlth Equ, UCL Dept Epidemiol & Publ Hlth, London WC1E 7HB, England.	m.marmot@ucl.ac.uk	Marmot, M G/Y-3920-2019	Marmot, M G/0000-0002-2431-6419; Suhrcke, Marc/0000-0001-7263-8626; Grundy, Emily/0000-0002-9633-1116	WHO Regional Office for Europe; WHO European Regional Office; Matilda Allen; MRC [G0902037] Funding Source: UKRI; British Heart Foundation [RG/07/008/23674] Funding Source: researchfish; Medical Research Council [G0100222, G0902037, G19/35, G8802774] Funding Source: researchfish	WHO Regional Office for Europe; WHO European Regional Office; Matilda Allen; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The European Review of Social Determinants and the Health Divide was commissioned by the WHO Regional Office for Europe to inform the new European policy framework for health and well-being-Health 2020. The focus of the review was to identify key policy areas in the European region likely to be most effective in addressing social determinants of health and in reducing health inequities, building on the work of the Commission on Social Determinants of Health. The aim was to make recommendations that can be actioned in all countries in the European region, taking account of their very different social and economic situations. The review was carried out by a consortium chaired by Michael Marmot of the Institute of Health Equity, University College London (London, UK) and supported by a joint secretariat from the Institute and the WHO European Regional Office. The review was informed and shaped by the work of 13 task groups and guided by a senior advisory board whose members are: Guillem Lopez Casanovas, Zsuzsa Ferge, Ilona Kickbusch, Johan Mackenbach, Tilek Meimanaliev, Amartya Sen, Vladimir Starodubov, Tomris Turmen, Denny Vagero, Margaret Whitehead, and ex-officio representatives of WHO, Agis Tsouros, and the European Commission, Michael Huebel. The task groups were based around the major social determinants of health. The available evidence was collated and interpreted by task groups, each comprising experts in the particular social determinant and related areas. The task groups and their chairs were early years, education and family (Alan Dyson and Naomi Eisenstadt), employment and working conditions (Johannes Siegrist), social exclusion, disadvantage, and vulnerability (Jennie Popay), GDP, taxation, income, and welfare (Olle Lundeberg), sustainability and community (Anna Coote), gender issues (Maria Kopp), older people (Emily Grundy), ill health prevention and treatment (Gauden Galea and Witold Zatonski), economics (Marc Suhrcke and Richard Cookson), governance and delivery mechanisms (Harry Burns and Erio Ziglio), global influences (Ronald Labonte), equity, equality, and human rights (Karien Stronks), and measurements and targets (Martin Bobak and Claudia Stein). The authors of the paper formed the UCL Secretariat, supported by Matilda Allen. The WHO Secretariat was led by Agis Tsouros, with Johanna Hanefeld, Piroska Ostlin, Asa Nihlen, Chris Brown, Isabel Yordi, Sarah Simpson, and Richard Alderslade.	Annandale E, 1998, SOCIOLOGICAL PERSPEC; [Anonymous], 2010, HLTH ENV EUR PROGR A; [Anonymous], 1999, DEV FREEDOM; [Anonymous], EUR HLTH ALL DAT; [Anonymous], 2011, HLTH JUSTICE; Bradshaw J., 2010, MINIMUM SOCIAL PROTE; Castro JE, 2006, ST ANTONYS SER, P1, DOI 10.1057/9780230508811; CEU Center for Environmental Policy and Law (CEPL) The Health and Environment Alliance (HEAL) The Coalition for Environmental Justice, 2007, MAK CAS ENV JUST CEN; European Public Health Alliance, 2010, 2010 EPHA BRIEF HLTH; Eurostat, 2009, AD HOC MOD; Eurostat, 2012, SUPPL IND UN ANN AV; Eurostat, UN RAT SEX AG GROUPS; Eurostat, 2012, HLTH LIF YEARS LIF E; Eurostat, 2012, EUR DAT; FAO, LIV LONG SHAD ENV IS; Garnett T., 2008, COOKING STORM FOOD G; Kentikelenis A, 2011, LANCET, V378, P1457, DOI 10.1016/S0140-6736(11)61556-0; Marmot Review Team, FAIR SOC HLTH LIV ST; MICS UNICEF Devinfo, EM CHALL CHILDR E EU; Olshanskaya M., OVERHEATED 2 DECADES; Putnam R, 1993, MAK DEM WORK CIV TRA; Roskam AJR, 2010, INT J EPIDEMIOL, V39, P392, DOI 10.1093/ije/dyp329; Sen G, UNEQUAL UNFAIR INEFF; Social Protection Floor Work Group, 2010, SOC PROT FLOOR IN; STATE OF CAL. COMM'N ON JUDICIAL PERFORMANCE, 2011, 2 STAT CAL COMM JUD; Stuckler D, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c3311; The SHARE projec, SURV HLTH AG RET EUR; The World Bank, WORLDW GOV IND; UNICEF, 2007, STAT WORLDS CHILDR 2; UNICEF Innocenti Research Centre, 2009, INN SOC MON 2009 CHI; UNICEF (United Nations Children's Fund), 2011, TRANSMONEE DAT; Wahrendorf M, 2013, EUR SOCIOL REV, V29, P792, DOI 10.1093/esr/jcs058; WHO Regional Office for Europe, 2011, GOV HLTH 21 CENT; WHO Regional Office for Europe, 2010, ENV HLTH RISKS REV I; World Health Organization, DIET NUTR PREV CHRON; World Health Organization Regional Office for Europe, 2010, SOC GEND IN ENV HLTH; World Health Organization Regional Office for Europe, 2009, ACC IMPR SAN WAST TR; World Health Organization (WHO) Regional Office for Europe, 2011, ENV BURD DIS ASS IN	38	775	792	8	209	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 15	2012	380	9846					1011	1029		10.1016/S0140-6736(12)61228-8	http://dx.doi.org/10.1016/S0140-6736(12)61228-8			19	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	005JF	22964159				2022-12-28	WOS:000308746000031
J	McKnight, SL				McKnight, Steven L.			Pure Genes, Pure Genius	CELL			English	Editorial Material							RIBOSOMAL RNA; 5S RNA; DNA; TRANSCRIPTION; OOCYTES		Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	McKnight, SL (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA.	steven.mcknight@utsouthwestern.edu						BIRKENMEIER EH, 1978, CELL, V15, P1077, DOI 10.1016/0092-8674(78)90291-X; Birnstiel M L, 1971, Prog Nucleic Acid Res Mol Biol, V11, P351, DOI 10.1016/S0079-6603(08)60332-3; BOGENHAGEN DF, 1980, CELL, V19, P27, DOI 10.1016/0092-8674(80)90385-2; BROWN DD, 1968, SCIENCE, V160, P272, DOI 10.1126/science.160.3825.272; BROWN DD, 1968, J MOL BIOL, V34, P681, DOI 10.1016/0022-2836(68)90189-7; EFSTRATIADIS A, 1977, CELL, V10, P571, DOI 10.1016/0092-8674(77)90090-3; EFSTRATIADIS A, 1976, CELL, V7, P279, DOI 10.1016/0092-8674(76)90027-1; FRITSCH EF, 1980, CELL, V19, P959, DOI 10.1016/0092-8674(80)90087-2; GALL JG, 1968, P NATL ACAD SCI USA, V60, P553, DOI 10.1073/pnas.60.2.553; KLUG A, 1987, COLD SPRING HARB SYM, V52, P473, DOI 10.1101/SQB.1987.052.01.054; MANIATIS T, 1978, CELL, V15, P687, DOI 10.1016/0092-8674(78)90036-3; Maniatis T., 1982, MOL CLONING LAB MANU; MCKNIGHT SL, 1982, SCIENCE, V217, P316, DOI 10.1126/science.6283634; MILLER OL, 1969, SCIENCE, V164, P955, DOI 10.1126/science.164.3882.955; PELHAM HRB, 1980, P NATL ACAD SCI-BIOL, V77, P4170, DOI 10.1073/pnas.77.7.4170; WIGLER M, 1979, CELL, V16, P777, DOI 10.1016/0092-8674(79)90093-X	16	0	0	0	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 14	2012	150	6					1100	1102		10.1016/j.cell.2012.08.022	http://dx.doi.org/10.1016/j.cell.2012.08.022			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	007ZY	22980972	Bronze			2022-12-28	WOS:000308928100003
J	Pal, A; Barber, TM; Van de Bunt, M; Rudge, SA; Zhang, QF; Lachlan, KL; Cooper, NS; Linden, H; Levy, JC; Wakelam, MJO; Walker, L; Karpe, F; Gloyn, AL				Pal, Aparna; Barber, Thomas M.; Van de Bunt, Martijn; Rudge, Simon A.; Zhang, Qifeng; Lachlan, Katherine L.; Cooper, Nicola S.; Linden, Helen; Levy, Jonathan C.; Wakelam, Michael J. O.; Walker, Lisa; Karpe, Fredrik; Gloyn, Anna L.			PTEN Mutations as a Cause of Constitutive Insulin Sensitivity and Obesity	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ORAL GLUCOSE-TOLERANCE; PROSTATE-CANCER RISK; PLASMA ADIPONECTIN; TUMOR-SUPPRESSOR; RESISTANCE; HOMEOSTASIS; DELETION; PTEN/MMAC1; PROTECTS; MODEL	Background Epidemiologic and genetic evidence links type 2 diabetes, obesity, and cancer. The tumor-suppressor phosphatase and tensin homologue (PTEN) has roles in both cellular growth and metabolic signaling. Germline PTEN mutations cause a cancer-predisposition syndrome, providing an opportunity to study the effect of PTEN haploinsufficiency in humans. Methods We measured insulin sensitivity and beta-cell function in 15 PTEN mutation carriers and 15 matched controls. Insulin signaling was measured in muscle and adipose-tissue biopsy specimens from 5 mutation carriers and 5 well-matched controls. We also assessed the effect of PTEN haploinsufficiency on obesity by comparing anthropometric indexes between the 15 patients and 2097 controls from a population-based study of healthy adults. Body composition was evaluated by means of dual-emission x-ray absorptiometry and skinfold thickness. Results Measures of insulin resistance were lower in the patients with a PTEN mutation than in controls (e.g., mean fasting plasma insulin level, 29 pmol per liter [range, 9 to 99] vs. 74 pmol per liter [range, 22 to 185]; P = 0.001). This finding was confirmed with the use of hyperinsulinemic euglycemic clamping, showing a glucose infusion rate among carriers 2 times that among controls (P = 0.009). The patients' insulin sensitivity could be explained by the presence of enhanced insulin signaling through the PI3K-AKT pathway, as evidenced by increased AKT phosphorylation. The PTEN mutation carriers were obese as compared with population-based controls (mean body-mass index [the weight in kilograms divided by the square of the height in meters], 32 [range, 23 to 42] vs. 26 [range, 15 to 48]; P<0.001). This increased body mass in the patients was due to augmented adiposity without corresponding changes in fat distribution. Conclusions PTEN haploinsufficiency is a monogenic cause of profound constitutive insulin sensitization that is apparently obesogenic. We demonstrate an apparently divergent effect of PTEN mutations: increased risks of obesity and cancer but a decreased risk of type 2 diabetes owing to enhanced insulin sensitivity. (Funded by the Wellcome Trust and others.)	[Pal, Aparna; Barber, Thomas M.; Van de Bunt, Martijn; Levy, Jonathan C.; Karpe, Fredrik; Gloyn, Anna L.] Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, Oxford OX3 7LE, England; [Pal, Aparna; Levy, Jonathan C.; Karpe, Fredrik; Gloyn, Anna L.] Churchill Hosp, Oxford Natl Inst Hlth Res, Biomed Res Ctr, Oxford OX3 7LJ, England; [Linden, Helen; Walker, Lisa] Churchill Hosp, Oxford Reg Genet Ctr, Oxford OX3 7LJ, England; [Rudge, Simon A.; Zhang, Qifeng; Wakelam, Michael J. O.] Inositide Lab, Cambridge, England; [Rudge, Simon A.; Zhang, Qifeng; Wakelam, Michael J. O.] Babraham Inst, Cambridge, England; [Lachlan, Katherine L.] Southampton Univ Hosp, Wessex Clin Genet Serv, Southampton, Hants, England; [Lachlan, Katherine L.] Univ Southampton, Fac Med, Dept Human Genet & Genom Med, Southampton SO9 5NH, Hants, England; [Cooper, Nicola S.] Birmingham Womens Hosp, W Midlands Reg Clin Genet Serv, Birmingham, W Midlands, England	University of Oxford; University of Oxford; University of Oxford; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; University of Southampton; University of Southampton; Birmingham Women's Hospital	Gloyn, AL (corresponding author), Univ Oxford, Churchill Hosp, Oxford Ctr Diabet Endocrinol & Metab, Oxford OX3 7LE, England.	anna.gloyn@drl.ox.ac.uk	LACHLAN, KATHERINE/ABH-6991-2020	LACHLAN, KATHERINE/0000-0002-3816-7346; Wakelam, Michael/0000-0003-4059-9276; Levy, Jonathan/0000-0002-9486-1885; Gloyn, Anna/0000-0003-1205-1844; van de Bunt, Martijn/0000-0002-6744-6125; Karpe, Fredrik/0000-0002-2751-1770	Wellcome Trust [095101/Z/10Z]; Medical Research Council [G0700222, G0800467]; National Institute for Health Research Oxford Biomedical Research Centre; Biotechnology and Biological Sciences Research Council; European Union Seventh Framework Program LipodomicNet [202272]; Biotechnology and Biological Sciences Research Council [BBS/E/B/000C0415, BBS/E/B/0000C227, BBS/E/B/000C0413] Funding Source: researchfish; BBSRC [BBS/E/B/000C0413, BBS/E/B/000C0415, BBS/E/B/0000C227] Funding Source: UKRI; MRC [G0800467, G0700222] Funding Source: UKRI	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research Oxford Biomedical Research Centre(National Institute for Health Research (NIHR)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Union Seventh Framework Program LipodomicNet; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Funded by the Wellcome Trust and others.; Supported by grants from the Wellcome Trust (095101/Z/10Z, to Dr. Gloyn), the Medical Research Council (G0700222, to Dr. Gloyn; and G0800467, to Drs. Pal and Gloyn), the National Institute for Health Research Oxford Biomedical Research Centre (to Drs. Pal, Karpe, and Gloyn), the Biotechnology and Biological Sciences Research Council (to Drs. Rudge, Zhang, and Wakelam), and the European Union Seventh Framework Program LipodomicNet (202272, for adipocyte signaling work, to Drs. Wakelam and Karpe).	Agalliu I, 2008, PROSTATE, V68, P740, DOI 10.1002/pros.20732; Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; Barb D, 2006, EXPERT OPIN INV DRUG, V15, P917, DOI 10.1517/13543784.15.8.917; Berger AH, 2011, NATURE, V476, P163, DOI 10.1038/nature10275; Blumenthal GM, 2008, EUR J HUM GENET, V16, P1289, DOI 10.1038/ejhg.2008.162; Cohen P, 2006, NAT REV MOL CELL BIO, V7, P867, DOI 10.1038/nrm2043; COLE TRP, 1991, AM J MED GENET, V41, P115, DOI 10.1002/ajmg.1320410128; DEFRONZO RA, 1979, AM J PHYSIOL, V237, pE214; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Garcia-Cao I, 2012, CELL, V149, P49, DOI 10.1016/j.cell.2012.02.030; Goberdhan DCI, 2003, HUM MOL GENET, V12, pR239, DOI 10.1093/hmg/ddg288; Gudmundsson J, 2007, NAT GENET, V39, P977, DOI 10.1038/ng2062; Holly JMP, 2008, BEST PRACT RES CL EN, V22, P539, DOI 10.1016/j.beem.2008.07.007; Iida S, 2000, ANTICANCER RES, V20, P1901; Karpe F, 2005, BIOCHEM SOC T, V33, P1045, DOI 10.1042/BST0331045; Kloting N, 2010, AM J PHYSIOL-ENDOC M, V299, pE506, DOI 10.1152/ajpendo.00586.2009; Kurlawalla-Martinez C, 2005, MOL CELL BIOL, V25, P2498, DOI 10.1128/MCB.25.6.2498-2510.2005; Levy JC, 1998, DIABETES CARE, V21, P2191, DOI 10.2337/diacare.21.12.2191; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; Nguyen KTT, 2006, MOL CELL BIOL, V26, P4511, DOI 10.1128/MCB.00238-06; PHILLIPS DIW, 1994, DIABETIC MED, V11, P286, DOI 10.1111/j.1464-5491.1994.tb00273.x; Semple RK, 2006, J CLIN ENDOCR METAB, V91, P3219, DOI 10.1210/jc.2006-0166; Smith U, 2010, DIABETOLOGIA, V53, P1541, DOI 10.1007/s00125-010-1815-8; Stiles B, 2004, P NATL ACAD SCI USA, V101, P5180, DOI 10.1073/pnas.0401220101; Stiles B, 2004, P NATL ACAD SCI USA, V101, P2082, DOI 10.1073/pnas.0308617100; Stiles BL, 2006, MOL CELL BIOL, V26, P2772, DOI 10.1128/MCB.26.7.2772-2781.2006; Stumvoll M, 2000, DIABETES CARE, V23, P295, DOI 10.2337/diacare.23.3.295; Thomas G, 2008, NAT GENET, V40, P310, DOI 10.1038/ng.91; Wei EK, 2005, JNCI-J NATL CANCER I, V97, P1688, DOI 10.1093/jnci/dji376; Wijesekara N, 2005, MOL CELL BIOL, V25, P1135, DOI 10.1128/MCB.25.3.1135-1145.2005; Wong JT, 2007, DIABETOLOGIA, V50, P395, DOI 10.1007/s00125-006-0531-x	32	164	168	0	16	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 13	2012	367	11					1002	1011		10.1056/NEJMoa1113966	http://dx.doi.org/10.1056/NEJMoa1113966			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	003ZE	22970944	Green Accepted			2022-12-28	WOS:000308649100006
J	Conway, PH; Cassel, CK				Conway, Patrick H.; Cassel, Christine K.			Engaging Physicians and Leveraging Professionalism A Key to Success for Quality Measurement and Improvement	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Conway, Patrick H.] Ctr Medicare Serv, Baltimore, MD 21224 USA; [Conway, Patrick H.] Ctr Medicaid Serv, Baltimore, MD 21224 USA; [Conway, Patrick H.] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH USA; [Cassel, Christine K.] Amer Board Internal Med, Philadelphia, PA USA	Centers for Medicare & Medicaid Services; Centers for Medicare & Medicaid Services; Cincinnati Children's Hospital Medical Center; American Board of Internal Medicine	Conway, PH (corresponding author), Ctr Medicare Serv, 7500 Secur Blvd, Baltimore, MD 21224 USA.	patrick.conway@cms.hhs.gov						American Board of Medical Specialties, MAINT CERT; [Anonymous], 2007, PLAN IMPL MED HOSP V; CMS Physician Quality Reporting System, CMS PHYS QUAL REP SY; Department of Health & Human Services, NAT STRAT QUAL IMPR; Dougherty D, 2008, JAMA-J AM MED ASSOC, V299, P2319, DOI 10.1001/jama.299.19.2319	5	12	12	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 12	2012	308	10					979	980		10.1001/jama.2012.9844	http://dx.doi.org/10.1001/jama.2012.9844			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	003AA	22968884				2022-12-28	WOS:000308579300018
J	Rees, J				Rees, Jonathan			PERSONAL VIEW The UK needs office dermatologists	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Edinburgh, Edinburgh EH3 9HA, Midlothian, Scotland	University of Edinburgh	Rees, J (corresponding author), Univ Edinburgh, Edinburgh EH3 9HA, Midlothian, Scotland.	reestheskin@me.com						Burge S, 2002, BRIT J DERMATOL, V146, P295, DOI 10.1046/j.1365-2133.2002.04522.x; Levell NJ, 2011, CONSULTANT PHYS WORK, P73; Norman G, 2007, MED EDUC, V41, P1140, DOI 10.1111/j.1365-2923.2007.02914.x; NORMAN GR, 1992, ACAD MED, V67, pS78, DOI 10.1097/00001888-199210000-00045; Schofield JK, 2011, BRIT J DERMATOL, V165, P1044, DOI 10.1111/j.1365-2133.2011.10464.x	5	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	SEP 10	2012	345								e6006	10.1136/bmj.e6006	http://dx.doi.org/10.1136/bmj.e6006			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	007BC	22966175				2022-12-28	WOS:000308862800010
J	Evans, DB; Marten, R; Etienne, C				Evans, David B.; Marten, Robert; Etienne, Carissa			Universal health coverage is a development issue	LANCET			English	Editorial Material									[Evans, David B.; Etienne, Carissa] WHO, Hlth Syst & Serv, CH-1211 Geneva 27, Switzerland; [Marten, Robert] Rockefeller Fdn, New York, NY USA	World Health Organization	Evans, DB (corresponding author), WHO, Hlth Syst & Serv, CH-1211 Geneva 27, Switzerland.	evansd@who.int						Bloom DE, 2004, WORLD DEV, V32, P1, DOI 10.1016/j.worlddev.2003.07.002; Bundy D, 2011, RETHINKING SCH HLTH; Shahrawat R, 2012, HEALTH POLICY PLANN, V27, P213, DOI 10.1093/heapol/czr029; Tangcharoensathien V, 2011, LANCET, V377, P863, DOI 10.1016/S0140-6736(10)61890-9; undp, HUM DEV IND; United Nations, FUT WE WANT; WHO, 2010, WOR HEALT REP, P1; WHO, 2001, INV HLTH SUMM FIND C; Xu K, 2007, HEALTH AFFAIR, V26, P972, DOI 10.1377/hlthaff.26.4.972	9	39	43	0	10	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 8	2012	380	9845					864	865		10.1016/S0140-6736(12)61483-4	http://dx.doi.org/10.1016/S0140-6736(12)61483-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	002QL	22959373				2022-12-28	WOS:000308547300006
J	Davidson, BL; Monteys, AM				Davidson, Beverly L.; Monteys, Alex Mas			Singles Engage the RNA Interference Pathway	CELL			English	Editorial Material							HUNTINGTONS-DISEASE; TARGETS	Single-stranded RNAs interact with components of the RNA interference pathway to reduce the expression of target mRNAs. Now, Lima et al. and Yu et al. show that, with extensive chemical modifications, small single-stranded RNAs can robustly induce gene silencing with efficacy similar to their double-stranded counterparts.	[Davidson, Beverly L.; Monteys, Alex Mas] Univ Iowa, Dept Internal Med, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Davidson, Beverly L.; Monteys, Alex Mas] Univ Iowa, Dept Neurol, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Davidson, Beverly L.; Monteys, Alex Mas] Univ Iowa, Dept Mol Physiol & Biophys, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; University of Iowa	Davidson, BL (corresponding author), Univ Iowa, Dept Internal Med, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA.	beverly-davidson@uiowa.edu		Davidson, Beverly/0000-0002-3715-6290	NINDS NIH HHS [RC1 NS068280, P01NS050210] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS050210, RC1NS068280] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bennett CF, 2010, ANNU REV PHARMACOL, V50, P259, DOI 10.1146/annurev.pharmtox.010909.105654; Birmingham A, 2006, NAT METHODS, V3, P199, DOI 10.1038/NMETH854; Boudreau RL, 2009, MOL THER, V17, P1053, DOI 10.1038/mt.2009.17; Davidson BL, 2011, NAT REV GENET, V12, P329, DOI 10.1038/nrg2968; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Kordasiewicz HB, 2012, NEURON, V74, P1031, DOI 10.1016/j.neuron.2012.05.009; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lima WF, 2012, CELL, V150, P883, DOI 10.1016/j.cell.2012.08.014; Obad S, 2011, NAT GENET, V43, P371, DOI 10.1038/ng.786; Schwarz DS, 2002, MOL CELL, V10, P537, DOI 10.1016/S1097-2765(02)00651-2; Yu DB, 2012, CELL, V150, P895, DOI 10.1016/j.cell.2012.08.002	11	12	20	0	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 31	2012	150	5					873	875		10.1016/j.cell.2012.08.008	http://dx.doi.org/10.1016/j.cell.2012.08.008			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	001ZU	22939614	Bronze			2022-12-28	WOS:000308500200001
J	Litchinitser, NM				Litchinitser, Natalia M.			Structured Light Meets Structured Matter	SCIENCE			English	Editorial Material							ORBITAL ANGULAR-MOMENTUM		SUNY Buffalo, Dept Elect Engn, Buffalo, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Litchinitser, NM (corresponding author), SUNY Buffalo, Dept Elect Engn, Buffalo, NY 14260 USA.	natashal@buffalo.edu						BERRY MV, 1984, PROC R SOC LON SER-A, V392, P45, DOI 10.1098/rspa.1984.0023; Dholakia K, 1996, PHYS REV A, V54, pR3742, DOI 10.1103/PhysRevA.54.R3742; Gorodetski Y, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.043903; Mair A, 2001, NATURE, V412, P313, DOI 10.1038/35085529; Molina-Terriza G, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.013601; Ni XJ, 2012, SCIENCE, V335, P427, DOI 10.1126/science.1214686; Tamburini F, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/3/033001; Toyoda K, 2012, NANO LETT, V12, P3645, DOI 10.1021/nl301347j; Vincotte A, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.193901; Wang J, 2012, NAT PHOTONICS, V6, P488, DOI [10.1038/nphoton.2012.138, 10.1038/NPHOTON.2012.138]; Yannopapas V, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.113101; Yu NF, 2011, SCIENCE, V334, P333, DOI 10.1126/science.1210713	12	143	144	3	118	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 31	2012	337	6098					1054	1055		10.1126/science.1226204	http://dx.doi.org/10.1126/science.1226204			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996WP	22936768				2022-12-28	WOS:000308125800035
J	Pohlker, C; Wiedemann, KT; Sinha, B; Shiraiwa, M; Gunthe, SS; Smith, M; Su, H; Artaxo, P; Chen, Q; Cheng, YF; Elbert, W; Gilles, MK; Kilcoyne, ALD; Moffet, RC; Weigand, M; Martin, ST; Poeschl, U; Andreae, MO				Poehlker, Christopher; Wiedemann, Kenia T.; Sinha, Baerbel; Shiraiwa, Manabu; Gunthe, Sachin S.; Smith, Mackenzie; Su, Hang; Artaxo, Paulo; Chen, Qi; Cheng, Yafang; Elbert, Wolfgang; Gilles, Mary K.; Kilcoyne, Arthur L. D.; Moffet, Ryan C.; Weigand, Markus; Martin, Scot T.; Poeschl, Ulrich; Andreae, Meinrat O.			Biogenic Potassium Salt Particles as Seeds for Secondary Organic Aerosol in the Amazon	SCIENCE			English	Article							LIQUID PHASE-SEPARATION; ATMOSPHERE; FOREST; BASIN; RELEASE; NUCLEI; SULFUR; CLOUDS; CARBON; WET	The fine particles serving as cloud condensation nuclei in pristine Amazonian rainforest air consist mostly of secondary organic aerosol. Their origin is enigmatic, however, because new particle formation in the atmosphere is not observed. Here, we show that the growth of organic aerosol particles can be initiated by potassium-salt-rich particles emitted by biota in the rainforest. These particles act as seeds for the condensation of low- or semi-volatile organic compounds from the atmospheric gas phase or multiphase oxidation of isoprene and terpenes. Our findings suggest that the primary emission of biogenic salt particles directly influences the number concentration of cloud condensation nuclei and affects the microphysics of cloud formation and precipitation over the rainforest.	[Poehlker, Christopher; Shiraiwa, Manabu; Gunthe, Sachin S.; Su, Hang; Cheng, Yafang; Elbert, Wolfgang; Poeschl, Ulrich; Andreae, Meinrat O.] Max Planck Inst Chem, Biogeochem Dept, D-55020 Mainz, Germany; [Wiedemann, Kenia T.; Artaxo, Paulo] Univ Sao Paulo, Inst Phys, BR-05508900 Sao Paulo, Brazil; [Wiedemann, Kenia T.; Smith, Mackenzie; Chen, Qi; Martin, Scot T.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Wiedemann, Kenia T.] Univ Arizona, Ecol & Evolutionary Biol Dept, Tucson, AZ 85721 USA; [Sinha, Baerbel] Max Planck Inst Chem, Particle Chem Dept, D-55020 Mainz, Germany; [Sinha, Baerbel] Indian Inst Sci Educ & Res Mohali, Dept Earth & Environm Sci, Sas Nagar, Manauli PO, India; [Shiraiwa, Manabu] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA; [Gunthe, Sachin S.; Moffet, Ryan C.] Indian Inst Technol, Environm & Water Resources Engn Div, Dept Civil Engn, Madras 600036, Tamil Nadu, India; [Gilles, Mary K.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Chem Sci, Berkeley, CA 94720 USA; [Kilcoyne, Arthur L. D.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Adv Light Source, Berkeley, CA 94720 USA; [Moffet, Ryan C.] Univ Pacific, Dept Chem, Stockton, CA 95211 USA; [Weigand, Markus] Max Planck Inst Intelligent Syst, D-70569 Stuttgart, Germany	Max Planck Society; Universidade de Sao Paulo; Harvard University; University of Arizona; Max Planck Society; Indian Institute of Science Education & Research (IISER) - Mohali; California Institute of Technology; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Madras; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of the Pacific; Max Planck Society	Pohlker, C (corresponding author), Max Planck Inst Chem, Biogeochem Dept, D-55020 Mainz, Germany.	c.pohlker@mpic.de; u.poschl@mpic.de; u.poschl@mpic.de	Artaxo, Paulo/E-8874-2010; Martin, Scot/G-1094-2015; Gunthe, Sachin/E-4934-2016; Shiraiwa, Manabu/A-6246-2010; Andreae, Meinrat O./B-1068-2008; Sinha, Baerbel/H-1250-2012; Pöhlker, Christopher/S-5207-2016; Gunthe, Sachin/A-1970-2010; Pöschl, Ulrich/A-6263-2010; Su, Hang/A-6226-2010; Cheng, Yafang/F-9362-2010; Kilcoyne, Arthur A L/I-1465-2013	Artaxo, Paulo/0000-0001-7754-3036; Martin, Scot/0000-0002-8996-7554; Gunthe, Sachin/0000-0002-7903-7783; Shiraiwa, Manabu/0000-0003-2532-5373; Andreae, Meinrat O./0000-0003-1968-7925; Sinha, Baerbel/0000-0001-8614-7473; Pöhlker, Christopher/0000-0001-6958-425X; Pöschl, Ulrich/0000-0003-1412-3557; Su, Hang/0000-0003-4889-1669; Cheng, Yafang/0000-0003-4912-9879; Kilcoyne, Arthur A L/0000-0002-8805-8690; Moffet, Ryan/0000-0002-2352-5454	Max Planck Society; Max Planck Graduate Center; Geocycles Cluster Mainz (Landesexzellenzcluster Rheinland-Pfalz); European Community (PEGASOS) [FP7-265148]; Office of Science, Office of Basic Energy Sciences (BES), U.S. Department of Energy (DOE) [DE-FG02-08ER6452]; U.S. NSF [0925467]; Office of Science, BES, of the U.S. DOE [DE-AC02-05CH11231]	Max Planck Society(Max Planck Society); Max Planck Graduate Center(Max Planck Society); Geocycles Cluster Mainz (Landesexzellenzcluster Rheinland-Pfalz); European Community (PEGASOS); Office of Science, Office of Basic Energy Sciences (BES), U.S. Department of Energy (DOE); U.S. NSF(National Science Foundation (NSF)); Office of Science, BES, of the U.S. DOE(United States Department of Energy (DOE))	This work has been supported by the Max Planck Society, the Max Planck Graduate Center, the Geocycles Cluster Mainz (Landesexzellenzcluster Rheinland-Pfalz), and the European Community (PEGASOS, FP7-265148). The Harvard Environmental Chamber was supported by the Office of Science, Office of Basic Energy Sciences (BES), U.S. Department of Energy (DOE), grant no. DE-FG02-08ER6452, and the U.S. NSF under grant no. 0925467. The Advanced Light Source is supported by the Director, Office of Science, BES, of the U.S. DOE under contract no. DE-AC02-05CH11231. We thank the Helmholtz-Zentrum Berlin for the allocation of synchrotron radiation beamtime at BESSY II. We thank the Instituto Nacional de Pesquisas da Amazonia (INPA), Manaus, and the ATTO team under the Brazilian coordinator, A. O. Manzi, for their collaboration and field support. We also thank G. R. Carmichael and the Center for Global and Regional Environmental Research at the University of Iowa for support in the Weather Research and Forecasting (WRF) model simulations. We gratefully acknowledge R. Ditz, I. Trebs, X. Chi, J. A. Huffman, J. Kesselmeier, J. Schongart, M. Kuwata, T. Tyliszczak, J. Huth, G. Schutz, E. Goering, M. Bechtel, J.-D. Forster, and T. Behrendt for support and helpful discussions.	Andreae MO, 2007, SCIENCE, V315, P50, DOI 10.1126/science.1136529; Andreae MO, 1997, SCIENCE, V276, P1052, DOI 10.1126/science.276.5315.1052; ANDREAE MO, 1983, SCIENCE, V220, P1148, DOI 10.1126/science.220.4602.1148; ARTAXO P, 1990, J GEOPHYS RES-ATMOS, V95, P16971, DOI 10.1029/JD095iD10p16971; ARTAXO P, 1995, ATMOS ENVIRON, V29, P393, DOI 10.1016/1352-2310(94)00178-N; BEAUFORD W, 1975, NATURE, V256, P35, DOI 10.1038/256035a0; BEAUFORD W, 1977, SCIENCE, V195, P571, DOI 10.1126/science.195.4278.571; Bertram AK, 2011, ATMOS CHEM PHYS, V11, P10995, DOI 10.5194/acp-11-10995-2011; Chen Q, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL039880; Claeys M, 2004, SCIENCE, V303, P1173, DOI 10.1126/science.1092805; CROZAT G, 1979, TELLUS, V31, P52, DOI 10.1111/j.2153-3490.1979.tb00881.x; Ekman AML, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034970; Elbert W, 2007, ATMOS CHEM PHYS, V7, P4569, DOI 10.5194/acp-7-4569-2007; GOATLEY JL, 1966, PLANT PHYSIOL, V41, P373, DOI 10.1104/pp.41.3.373; Gunthe SS, 2009, ATMOS CHEM PHYS, V9, P7551, DOI 10.5194/acp-9-7551-2009; Hallquist M, 2009, ATMOS CHEM PHYS, V9, P5155, DOI 10.5194/acp-9-5155-2009; Jimenez JL, 2009, SCIENCE, V326, P1525, DOI 10.1126/science.1180353; LAWSON DR, 1978, GEOPHYS RES LETT, V5, P195, DOI 10.1029/GL005i003p00195; LAWSON DR, 1979, J GEOPHYS RES-OC ATM, V84, P3723, DOI 10.1029/JC084iC07p03723; Li J, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002310; Maria SF, 2004, SCIENCE, V306, P1921, DOI 10.1126/science.1103491; Martin ST, 2010, REV GEOPHYS, V48, DOI 10.1029/2008RG000280; NEMERYUK G E, 1970, Soviet Plant Physiology, V17, P560; Poschl U, 2010, SCIENCE, V329, P1513, DOI 10.1126/science.1191056; Solomon S., 2007, 4 IPCC; Song M, 2012, ATMOS CHEM PHYS, V12, P2691, DOI 10.5194/acp-12-2691-2012; Spracklen DV, 2006, ATMOS CHEM PHYS, V6, P5631, DOI 10.5194/acp-6-5631-2006; Tivanski AV, 2007, J PHYS CHEM A, V111, P5448, DOI 10.1021/jp070155u; Weigel R, 2011, ATMOS CHEM PHYS, V11, P9983, DOI 10.5194/acp-11-9983-2011; Worobiec A, 2007, ATMOS ENVIRON, V41, P9217, DOI 10.1016/j.atmosenv.2007.07.056; Zuend A, 2012, ATMOS CHEM PHYS, V12, P3857, DOI 10.5194/acp-12-3857-2012	31	134	136	11	255	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 31	2012	337	6098					1075	1078		10.1126/science.1223264	http://dx.doi.org/10.1126/science.1223264			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996WP	22936773				2022-12-28	WOS:000308125800041
J	Gehrels, N; Meszaros, P				Gehrels, Neil; Meszaros, Peter			Gamma-Ray Bursts	SCIENCE			English	Review							SHORT GRB 090510; STAR-FORMATION HISTORY; HIGH-ENERGY EMISSION; 28 FEBRUARY 1997; FERMI OBSERVATIONS; TELESCOPE OBSERVATIONS; SPECTRAL COMPONENT; GALAXY EVOLUTION; HOST GALAXY; SWIFT ERA	Gamma-ray bursts (GRBs) are bright flashes of gamma rays coming from the cosmos. They occur roughly once per day, typically last for tens of seconds, and are the most luminous events in the universe. More than three decades after their discovery, and after pioneering advances from space and ground experiments, they still remain mysterious. The launch of the Swift and Fermi satellites in 2004 and 2008 brought in a trove of qualitatively new data. In this Review, we survey the interplay between these recent observations and the theoretical models of the prompt GRB emission and the subsequent afterglow.	[Gehrels, Neil] NASA, Astrophys Sci Div, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Meszaros, Peter] Penn State Univ, Dept Astron & Astrophys, University Pk, PA 16802 USA	National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Gehrels, N (corresponding author), NASA, Astrophys Sci Div, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA.	neil.gehrels@nasa.gov		Meszaros, Peter/0000-0002-4132-1746				Abdo AA, 2010, ASTROPHYS J, V712, P558, DOI 10.1088/0004-637X/712/1/558; Abdo AA, 2009, NATURE, V462, P331, DOI 10.1038/nature08574; Abdo AA, 2009, ASTROPHYS J LETT, V706, pL138, DOI 10.1088/0004-637X/706/1/L138; Ackermann M, 2011, ASTROPHYS J, V729, DOI 10.1088/0004-637X/729/2/114; Ackermann M, 2010, ASTROPHYS J, V716, P1178, DOI 10.1088/0004-637X/716/2/1178; Asano K, 2009, ASTROPHYS J LETT, V705, pL191, DOI 10.1088/0004-637X/705/2/L191; Atwood WB, 2009, ASTROPHYS J, V697, P1071, DOI 10.1088/0004-637X/697/2/1071; Barthelmy SD, 2005, SPACE SCI REV, V120, P143, DOI 10.1007/s11214-005-5096-3; Barthelmy SD, 2005, NATURE, V438, P994, DOI 10.1038/nature04392; Berger E, 2005, NATURE, V438, P988, DOI 10.1038/nature04238; Bloom JS, 2006, ASTROPHYS J, V638, P354, DOI 10.1086/498107; Bouwens RJ, 2008, ASTROPHYS J, V686, P230, DOI 10.1086/590103; Burrows DN, 2006, ASTROPHYS J, V653, P468, DOI 10.1086/508740; Burrows DN, 2005, SPACE SCI REV, V120, P165, DOI 10.1007/s11214-005-5097-2; Corsi A, 2010, ASTROPHYS J, V720, P1008, DOI 10.1088/0004-637X/720/2/1008; Costa E, 1997, NATURE, V387, P783, DOI 10.1038/42885; De Pasquale M, 2010, ASTROPHYS J LETT, V709, pL146, DOI 10.1088/2041-8205/709/2/L146; EICHLER D, 1989, NATURE, V340, P126, DOI 10.1038/340126a0; Finn LS, 1999, PHYS REV D, V60, DOI 10.1103/PhysRevD.60.121101; Fong W, 2010, ASTROPHYS J, V708, P9, DOI 10.1088/0004-637X/708/1/9; Fong W., 2012, MINIMIZATION RECEIVE; Fox DB, 2005, NATURE, V437, P845, DOI 10.1038/nature04189; Fruchter AS, 2006, NATURE, V441, P463, DOI 10.1038/nature04787; Gehrels N, 2005, NATURE, V437, P851, DOI 10.1038/nature04142; Gehrels N, 2006, NATURE, V444, P1044, DOI 10.1038/nature05376; Gehrels N, 2009, ANNU REV ASTRON ASTR, V47, P567, DOI 10.1146/annurev.astro.46.060407.145147; Ghisellini G, 2010, MON NOT R ASTRON SOC, V403, P926, DOI 10.1111/j.1365-2966.2009.16171.x; Harrison FA, 1999, ASTROPHYS J, V523, pL121, DOI 10.1086/312282; He HN, 2011, ASTROPHYS J, V733, DOI 10.1088/0004-637X/733/1/22; Hjorth J, 2005, NATURE, V437, P859, DOI 10.1038/nature04174; Hopkins AM, 2006, ASTROPHYS J, V651, P142, DOI 10.1086/506610; Kistler MD, 2009, ASTROPHYS J LETT, V705, pL104, DOI 10.1088/0004-637X/705/2/L104; KLEBESADEL RW, 1973, ASTROPHYS J, V182, pL85, DOI 10.1086/181225; Kocevski D, 2008, ASTROPHYS J, V680, P531, DOI 10.1086/586693; KOUVELIOTOU C, 1993, ASTROPHYS J, V413, pL101, DOI 10.1086/186969; Kumar P, 2009, MON NOT R ASTRON SOC, V400, pL75, DOI 10.1111/j.1745-3933.2009.00766.x; Levesque E. M., 2010, MINIMIZATION RECEIVE; MacFadyen AI, 1999, ASTROPHYS J, V524, P262, DOI 10.1086/307790; Madau P, 1999, ASTROPHYS J, V514, P648, DOI 10.1086/306975; MEEGAN CA, 1992, NATURE, V355, P143, DOI 10.1038/355143a0; Meegan C, 2009, ASTROPHYS J, V702, P791, DOI 10.1088/0004-637X/702/1/791; MESZAROS P, 1993, ASTROPHYS J, V418, pL59, DOI 10.1086/187116; Meszaros P, 1997, ASTROPHYS J, V476, P232, DOI 10.1086/303625; Murase K, 2012, ASTROPHYS J, V746, DOI 10.1088/0004-637X/746/2/164; Nakar E, 2007, PHYS REP, V442, P166, DOI 10.1016/j.physrep.2007.02.005; Norris JP, 2006, ASTROPHYS J, V643, P266, DOI 10.1086/502796; Nousek JA, 2006, ASTROPHYS J, V642, P389, DOI 10.1086/500724; Ota K, 2008, ASTROPHYS J, V677, P12, DOI 10.1086/529006; Paczynski B., 1991, Acta Astronomica, V41, P257; Razzaque S, 2010, ASTROPHYS J LETT, V724, pL109, DOI 10.1088/2041-8205/724/1/L109; REES MJ, 1994, ASTROPHYS J, V430, pL93, DOI 10.1086/187446; REES MJ, 1992, MON NOT R ASTRON SOC, V258, pP41, DOI 10.1093/mnras/258.1.41P; Robertson BE, 2012, ASTROPHYS J, V744, DOI 10.1088/0004-637X/744/2/95; Roming PWA, 2005, SPACE SCI REV, V120, P95, DOI 10.1007/s11214-005-5095-4; Salvaterra R, 2009, NATURE, V461, P1258, DOI 10.1038/nature08445; Savaglio S, 2006, NEW J PHYS, V8, DOI 10.1088/1367-2630/8/9/195; Soderberg AM, 2006, NATURE, V442, P1014, DOI 10.1038/nature05087; Tanvir NR, 2009, NATURE, V461, P1254, DOI 10.1038/nature08459; Toma K, 2011, MON NOT R ASTRON SOC, V415, P1663, DOI 10.1111/j.1365-2966.2011.18807.x; Uso V., 1992, NATUR, V357, P472; vanParadijs J, 1997, NATURE, V386, P686, DOI 10.1038/386686a0; Veres P., 2012, MINIMIZATION RECEIVE; Villasenor JS, 2005, NATURE, V437, P855, DOI 10.1038/nature04213; Willingale R, 2007, ASTROPHYS J, V662, P1093, DOI 10.1086/517989; Zhang B, 2006, ASTROPHYS J, V642, P354, DOI 10.1086/500723	68	68	68	3	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 24	2012	337	6097					932	936		10.1126/science.1216793	http://dx.doi.org/10.1126/science.1216793			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992VI	22923573	Green Submitted			2022-12-28	WOS:000307807600036
J	Mckee, M				McKee, Maggie			Sally Ride (1951-2012) Obituary	NATURE			English	Biographical-Item												maggieqmckee@gmail.com						RIDE S, PUBLICATIN LIST	1	0	0	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 23	2012	488	7412					460	460		10.1038/488460a	http://dx.doi.org/10.1038/488460a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992FS	22914157	Bronze			2022-12-28	WOS:000307761600020
J	Norman, G; Monteiro, S; Salama, S				Norman, Geoffrey; Monteiro, Sandra; Salama, Suzette			Sample size calculations: should the emperor's clothes be off the peg or made to measure?	BMJ-BRITISH MEDICAL JOURNAL			English	Article							NEED		[Norman, Geoffrey; Monteiro, Sandra] McMaster Univ, Dept Psychol, Hamilton, ON L8S 2T1, Canada; [Salama, Suzette] Hamilton Hlth Sci, Med, Hamilton, ON, Canada	McMaster University; McMaster University	Norman, G (corresponding author), McMaster Univ, Dept Psychol, MDCL 3519,1280 Main St W, Hamilton, ON L8S 2T1, Canada.	norman@mcmaster.ca	Monteiro, S/AAN-6291-2020	Monteiro, S/0000-0001-8723-5942	Canada research chair	Canada research chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs)	All authors have completed the ICMJE unified disclosure form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare GN is funded by a Canada research chair; they have no financial relationships with any organisations that might have an interest in the submitted work in the previous three years and no other relationships or activities that could appear to have influenced the submitted work.	Altman DG, 2005, WORLD J SURG, V29, P554, DOI 10.1007/s00268-005-7911-0; Bacchetti P, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-17; Cohen JJ, 2002, JAMA-J AM MED ASSOC, V288, P358; Glynn LG, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005182.pub4; LEHR R, 1992, STAT MED, V11, P1099, DOI 10.1002/sim.4780110811; LIPSEY MW, 1993, AM PSYCHOL, V48, P1181, DOI 10.1037/0003-066X.48.12.1181; Norman GR, 2003, MED CARE, V41, P582, DOI 10.1097/00005650-200305000-00004; YUSUF S, 1984, STAT MED, V3, P409, DOI 10.1002/sim.4780030421	8	71	71	1	15	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 23	2012	345								e5278	10.1136/bmj.e5278	http://dx.doi.org/10.1136/bmj.e5278			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	996GY	22918496	Green Published, Bronze			2022-12-28	WOS:000308074100006
J	Bona, R				Bona, Robert			Review: Factor Xa inhibitors reduce DVT more than LMWH in total knee or hip replacement	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							SURGERY		Quinnipiac Univ, Frank H Netter Sch Med, Hamden, CT USA	Quinnipiac University	Bona, R (corresponding author), Quinnipiac Univ, Frank H Netter Sch Med, Hamden, CT USA.							COLLINS R, 1988, NEW ENGL J MED, V318, P1162, DOI 10.1056/NEJM198805053181805; Kakkar AK, 2008, LANCET, V372, P31, DOI 10.1016/S0140-6736(08)60880-6; Sobieraj DM, 2012, ANN INTERN MED, V156, P720, DOI 10.7326/0003-4819-156-10-201205150-00423	3	1	2	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 21	2012	157	4							JC4-5	10.7326/0003-4819-157-4-201208210-02005	http://dx.doi.org/10.7326/0003-4819-157-4-201208210-02005			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	992XG	22910959				2022-12-28	WOS:000307813200004
J	Sutcliffe, AG; Barnes, J; Belsky, J; Gardiner, J; Melhuish, E				Sutcliffe, Alastair G.; Barnes, Jacqueline; Belsky, Jay; Gardiner, Julian; Melhuish, Edward			The health and development of children born to older mothers in the United Kingdom: observational study using longitudinal cohort data	BRITISH MEDICAL JOURNAL			English	Article							YOUNG MATERNAL AGE; PATERNAL AGE; RISK; SCHIZOPHRENIA; OUTCOMES; AUTISM	Objective To assess relations between children's health and development and maternal age. Design Observational study of longitudinal cohorts. Setting Millennium Cohort Study (a random sample of UK children) and the National Evaluation of Sure Start study (a random sample of children in deprived areas in England), 2001 to 2007. Participants 31 257 children at age 9 months, 24 781 children at age 3 years, and 22 504 at age 5 years. Main outcome measures Childhood unintentional injuries and hospital admissions (aged 9 months, 3 years, and 5 years), immunisations (aged 9 months and 3 years), body mass index, language development, and difficulties with social development (aged 3 and 5 years). Results Associations were independent of personal and family characteristics and parity. The risk of children having unintentional injuries requiring medical attention or being admitted to hospital both declined with increasing maternal age. For example, at three years the risk of unintentional injuries declined from 36.6% for mothers aged 20 to 28.6% for mothers aged 40 and hospital admissions declined, respectively, from 27.1% to 21.6%. Immunisation rates at nine months increased with maternal age from 94.6% for mothers aged 20 to 98.1% for mothers aged 40. At three years, immunisation rates reached a maximum, at 81.3% for mothers aged 27, being lower for younger and older mothers. This was linked to rates for the combined measles, mumps, and rubella immunisation because excluding these resulted in no significant relation with maternal age. An increase in overweight children at ages 3 and 5 years associated with increasing maternal age was eliminated once maternal body mass index was included as a covariate. Language development was associated with improvements with increasing maternal age, with scores for children of mothers aged 20 being lower than those of children of mothers aged 40 by 0.21 to 0.22 standard deviations at ages 3 and 4 years. There were fewer social and emotional difficulties associated with increasing maternal age. Children of teenage mothers had more difficulties than children of mothers aged 40 (difference 0.28 SD at age 3 and 0.16 SD at age 5). Conclusion Increasing maternal age was associated with improved health and development for children up to 5 years of age.	[Barnes, Jacqueline; Belsky, Jay; Gardiner, Julian; Melhuish, Edward] Univ London, Inst Study Children Families & Social Issues, London WC1E 7HX, England; [Sutcliffe, Alastair G.] UCL, Inst Child Hlth, London WC1E 6BT, England; [Belsky, Jay] Univ Calif Davis, Davis, CA 95616 USA	University of London; Birkbeck University London; University of London; University College London; University of California System; University of California Davis	Melhuish, E (corresponding author), Univ London, Inst Study Children Families & Social Issues, London WC1E 7HX, England.	e.melhuish@bbk.ac.uk	Gardiner, Julian/AAO-2583-2020	Belsky, Jay/0000-0003-2191-2503; Sutcliffe, Alastair/0000-0001-8542-6155; Gardiner, Julian/0000-0001-8988-3812	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	This research was funded by the Wellcome Trust through a grant entitled "Health of children born to older mothers"; the funding body had no involvement in the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript. All authors are independent of the funding agency.	Berryman J., 1995, OLDER MOTHERS CONCEP; Botting B, 1998, Popul Trends, P19; Centers for Disease Control and Prevention, 2010, PERC DAT FIL LMS VAL; Centers for Disease Control and Prevention, 2007, MEASL MUMPS RUB MMR; Croen LA, 2007, ARCH PEDIAT ADOL MED, V161, P334, DOI 10.1001/archpedi.161.4.334; Dex S, 2004, MILLENNIUM COHORT ST; Eisenberg DTA, 2012, P NATL ACAD SCI US; Elliott C., 1996, ADM SCORING MANUAL; Fergusson DM, 1999, J CHILD PSYCHOL PSYC, V40, P479, DOI 10.1111/1469-7610.00464; FRASER AM, 1995, NEW ENGL J MED, V332, P1113, DOI 10.1056/NEJM199504273321701; Gilbert William, 2004, J Matern Fetal Neonatal Med, V16, P265, DOI 10.1080/14767050400018064; Goodman R, 1997, J CHILD PSYCHOL PSYC, V38, P581, DOI 10.1111/j.1469-7610.1997.tb01545.x; Hesterberg T, 1998, 75 MATHSOFT; Honaker J, 2010, AMELIA 2 R PACKAGE; Irwin LG, 2007, EARLY CHILD DEV POWE; Kiernan KE, 2009, MATERNAL INDICATORS; Martin JA, 2004, NATL VITAL STAT REPO, V55; Melhuish E, 2008, LANCET, V372, P1641, DOI 10.1016/S0140-6736(08)61687-6; Moffitt TE, 2002, J CHILD PSYCHOL PSYC, V43, P727, DOI 10.1111/1469-7610.00082; Noble M, 2000, MEASURING MULTIPLE D; Office for National Statistics, 2007, SER FM1, V35; Phipps MG, 2002, OBSTET GYNECOL, V100, P481, DOI 10.1016/S0029-7844(02)02172-5; Plewis I., 2007, MILLENNIUM COHORT ST; Rubin D.B., 1987, MULTIPLE IMPUTATION, DOI DOI 10.1002/9780470316696.FMATTER; Statistics New Zealand, 2012, BIRTHS DEATHS YEAR E; Sutcliffe A, 2009, REPROD AGEING, P173; Venables WN, MASS R PACKAGE; Vohr BR, 2009, J PEDIATR-US, V154, P498, DOI 10.1016/j.jpeds.2008.10.044; Weiser M, 2008, SCHIZOPHRENIA BULL, V34, P1042, DOI 10.1093/schbul/sbn109; Zammit S, 2003, BRIT J PSYCHIAT, V183, P405, DOI 10.1192/bjp.183.5.405	31	77	78	0	24	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	AUG 21	2012	345								e5116	10.1136/bmj.e5116	http://dx.doi.org/10.1136/bmj.e5116			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	996GP	22915663	hybrid, Green Submitted, Green Published, Green Accepted			2022-12-28	WOS:000308073200001
J	Wallace, EA; Schumann, JH; Weinberger, SE				Wallace, Erik A.; Schumann, John H.; Weinberger, Steven E.			Ethics of Commercial Screening Tests	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							CARE; PHYSICIANS		[Wallace, Erik A.] Univ Oklahoma, Sch Community Med, Dept Internal Med, Tulsa, OK 74135 USA; Amer Coll Physicians, Philadelphia, PA 19106 USA	University of Oklahoma System; University of Oklahoma - Tulsa; American College of Physicians	Wallace, EA (corresponding author), Univ Oklahoma, Sch Community Med, Dept Internal Med, 4502 E 41st St, Tulsa, OK 74135 USA.	erik-wallace@ouhsc.edu						Berwick DM, 2012, JAMA-J AM MED ASSOC, V307, P1513, DOI 10.1001/jama.2012.362; Blumenthal D, 2001, NEW ENGL J MED, V344, P766, DOI 10.1056/NEJM200103083441012; Brawley OW, 2011, WE DO HARM DOCTOR BR; Brett AS, 2012, JAMA-J AM MED ASSOC, V307, P149, DOI 10.1001/jama.2011.1999; Calonge N, 2005, ANN INTERN MED, V142, P198, DOI 10.7326/0003-4819-142-3-200502010-00011; Cassel CK, 2012, JAMA-J AM MED ASSOC, V307, P1801, DOI 10.1001/jama.2012.476; Cooke M, 2010, NEW ENGL J MED, V362, P1253, DOI 10.1056/NEJMp0911502; Frieden TR, 2011, NEW ENGL J MED, V365, DOI [10.1056/NEJMp1110421, 10.1056/NEJMP1110421]; Qaseem A, 2012, ANN INTERN MED, V156, P147, DOI 10.7326/0003-4819-156-2-201201170-00011; Rodondi N, 2012, ARCH INTERN MED, V172, P344, DOI 10.1001/archinternmed.2011.1326; Snyder L, 2012, ANN INTERN MED, V156, DOI 10.7326/0003-4819-156-1-201201031-00001; USPSTF, 2007, ANN INTERN MED, V147, P854, DOI 10.7326/0003-4819-147-12-200712180-00005; Woolf SH, 2012, JAMA-J AM MED ASSOC, V307, P565, DOI 10.1001/jama.2012.100; Yarnall KSH, 2003, AM J PUBLIC HEALTH, V93, P635, DOI 10.2105/AJPH.93.4.635	14	6	6	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 20	2012	157	10					747	U141		10.7326/0003-4819-157-10-201211200-00536	http://dx.doi.org/10.7326/0003-4819-157-10-201211200-00536			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	043VZ	22928174				2022-12-28	WOS:000311580000021
J	Gring, M; Kuhnert, M; Langen, T; Kitagawa, T; Rauer, B; Schreitl, M; Mazets, I; Smith, DA; Demler, E; Schmiedmayer, J				Gring, M.; Kuhnert, M.; Langen, T.; Kitagawa, T.; Rauer, B.; Schreitl, M.; Mazets, I.; Smith, D. Adu; Demler, E.; Schmiedmayer, J.			Relaxation and Prethermalization in an Isolated Quantum System	SCIENCE			English	Article							BOSE-GAS; INTERFERENCE; DYNAMICS; STATE	Understanding relaxation processes is an important unsolved problem in many areas of physics. A key challenge is the scarcity of experimental tools for the characterization of complex transient states. We used measurements of full quantum mechanical probability distributions of matter-wave interference to study the relaxation dynamics of a coherently split one-dimensional Bose gas and obtained comprehensive information about the dynamical states of the system. After an initial rapid evolution, the full distributions reveal the approach toward a thermal-like steady state characterized by an effective temperature that is independent from the initial equilibrium temperature of the system before the splitting process. We conjecture that this state can be described through a generalized Gibbs ensemble and associate it with prethermalization.	[Gring, M.; Kuhnert, M.; Langen, T.; Rauer, B.; Schreitl, M.; Mazets, I.; Smith, D. Adu; Schmiedmayer, J.] Vienna Univ Technol, Vienna Ctr forQuantum Sci & Technol, Atominst, A-1020 Vienna, Austria; [Kitagawa, T.; Demler, E.] Harvard Univ, Harvard Massachussets Inst Technol, Ctr Ultracold Atoms, Dept Phys, Cambridge, MA 02138 USA; [Mazets, I.] Russian Acad Sci, AF Ioffe Physicotech Inst, St Petersburg 194021, Russia; [Schmiedmayer, J.] TU Wien, Zentrum Mikro & Nanostrukturen ZMNS, A-1040 Vienna, Austria	Technische Universitat Wien; Harvard University; Russian Academy of Sciences; St. Petersburg Scientific Centre of the Russian Academy of Sciences; Ioffe Physical Technical Institute; Technische Universitat Wien	Schmiedmayer, J (corresponding author), Vienna Univ Technol, Vienna Ctr forQuantum Sci & Technol, Atominst, Stad Allee 2, A-1020 Vienna, Austria.	schmiedmayer@atomchip.org	Demler, Eugene/ABG-1933-2021; Schmiedmayer, Jörg/M-9669-2019; Mazets, Igor/T-6610-2019; Adu Smith, David/C-2046-2008; Langen, Tim/I-6357-2012; Schmiedmayer, Jörg/B-4717-2008; Rauer, Bernhard/U-8788-2019; Mazets, Igor E./D-4862-2011	Demler, Eugene/0000-0002-2499-632X; Schmiedmayer, Jörg/0000-0001-7799-5614; Mazets, Igor/0000-0002-3769-8313; Adu Smith, David/0000-0001-6531-7680; Langen, Tim/0000-0003-2561-0326; Schmiedmayer, Jörg/0000-0001-7799-5614; Rauer, Bernhard/0000-0001-5180-3100; Mazets, Igor E./0000-0002-3769-8313; LANGEN, TIM/0000-0002-2012-2895	Austrian Science Fund (FWF) [P22590-N16, M1040-N16]; Doctoral Programme CoQuS [W1210]; European Union through the integrating project AQUTE; Siemens Austria; City of Vienna; Defense Advanced Research Projects Agency Optical Lattice Emulator program; Harvard-MIT CUA; NSF [DMR-07-05472]; Air Force Office of Scientific Research Quantum Simulation Multidisciplinary University Research Initiative (MURI); Army Research Office-MURI on Atomtronics; Austrian Science Fund (FWF) [P 22590, I 145, Z 118] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Doctoral Programme CoQuS; European Union through the integrating project AQUTE; Siemens Austria(Siemens AG); City of Vienna; Defense Advanced Research Projects Agency Optical Lattice Emulator program(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Harvard-MIT CUA; NSF(National Science Foundation (NSF)); Air Force Office of Scientific Research Quantum Simulation Multidisciplinary University Research Initiative (MURI); Army Research Office-MURI on Atomtronics; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	We thank Ch. v. Hagen and M. Gobel for early work on the experimental apparatus and the Vienna group for invaluable discussions and assistance. The atom chip was fabricated at ZMNS, TU Wien by W. Schrenk and M. Trinker. The experiments were supported by the Austrian Science Fund (FWF) through grants P22590-N16 and M1040-N16, the Doctoral Programme CoQuS (W1210), grant P22590-N16 and the Wittgenstein Prize, and the European Union through the integrating project AQUTE, Siemens Austria, and the City of Vienna. T. K. and E. D. thank the Army Research Office for funding from the Defense Advanced Research Projects Agency Optical Lattice Emulator program, Harvard-MIT CUA, NSF grant DMR-07-05472, Air Force Office of Scientific Research Quantum Simulation Multidisciplinary University Research Initiative (MURI), and the Army Research Office-MURI on Atomtronics.	Barnett R, 2011, PHYS REV A, V84, DOI 10.1103/PhysRevA.84.023606; Berges J, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.142002; Eckstein M, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.056403; Goldstein S, 2010, EUR PHYS J H, V35, P173, DOI 10.1140/epjh/e2010-00007-7; Gritsev V, 2006, NAT PHYS, V2, P705, DOI 10.1038/nphys410; Hofferberth S, 2008, NAT PHYS, V4, P489, DOI 10.1038/nphys941; Hofferberth S, 2006, NAT PHYS, V2, P710, DOI 10.1038/nphys420; Kheruntsyan KV, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.040403; Kinoshita T, 2006, NATURE, V440, P900, DOI 10.1038/nature04693; Kitagawa T, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/7/073018; Kitagawa T, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.255302; Kollar M, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.054304; LIEB EH, 1963, PHYS REV, V130, P1605, DOI 10.1103/PhysRev.130.1605; Mazets IE, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/5/055023; Mazets IE, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.210403; Moeckel M, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/5/055016; Olshanii M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1653; Polkovnikov A, 2006, P NATL ACAD SCI USA, V103, P6125, DOI 10.1073/pnas.0510276103; Polkovnikov A, 2011, REV MOD PHYS, V83, P863, DOI 10.1103/RevModPhys.83.863; Reichel J., 2011, ATOM CHIPS; Rigol M, 2008, NATURE, V452, P854, DOI 10.1038/nature06838; Ritter S, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.090402; Sadler LE, 2006, NATURE, V443, P312, DOI 10.1038/nature05094; Stimming HP, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.015301; Tan S, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.090404; Trotzky S, 2012, NAT PHYS, V8, P325, DOI [10.1038/nphys2232, 10.1038/NPHYS2232]; Widera A, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.140401	32	683	684	3	75	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 14	2012	337	6100					1318	1322		10.1126/science.1224953	http://dx.doi.org/10.1126/science.1224953			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	004TW	22956685	Green Submitted			2022-12-28	WOS:000308705000036
J	Harris, LH				Harris, Lisa H.			Recognizing Conscience in Abortion Provision	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Harris, Lisa H.] Univ Michigan, Dept Obstet & Gynecol, Ann Arbor, MI 48109 USA; [Harris, Lisa H.] Univ Michigan, Dept Womens Studies, Ann Arbor, MI 48109 USA; [Harris, Lisa H.] Univ Michigan, Ctr Bioeth & Social Sci Med, Ann Arbor, MI 48109 USA; [Harris, Lisa H.] Univ Michigan, Program Sexual Rights & Reprod Justice, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Harris, LH (corresponding author), Univ Michigan, Dept Obstet & Gynecol, Ann Arbor, MI 48109 USA.							Joffe C. E, 1995, DOCTORS CONSCIENCE S; Parker W. A, 2012, CONSCIENCE, V33, P17; Poppema Suzanne T., 1996, WHY I AM ABORTION DO; Wicclair M.R., 2011, CONSCIENTIOUS OBJECT	4	52	52	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 13	2012	367	11					981	983		10.1056/NEJMp1206253	http://dx.doi.org/10.1056/NEJMp1206253			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	003ZE	22970942				2022-12-28	WOS:000308649100001
J	Maynard, CL; Elson, CO; Hatton, RD; Weaver, CT				Maynard, Craig L.; Elson, Charles O.; Hatton, Robin D.; Weaver, Casey T.			Reciprocal interactions of the intestinal microbiota and immune system	NATURE			English	Review							REGULATORY T-CELLS; INNATE LYMPHOID-CELLS; SEGMENTED FILAMENTOUS BACTERIA; INFLAMMATORY-BOWEL-DISEASE; TOLL-LIKE RECEPTORS; INDUCER-LIKE CELLS; CROHNS-DISEASE; RETINOIC-ACID; DENDRITIC CELLS; GUT MICROBIOTA	The emergence of the adaptive immune system in vertebrates set the stage for evolution of an advanced symbiotic relationship with the intestinal microbiota. The defining features of specificity and memory that characterize adaptive immunity have afforded vertebrates the mechanisms for efficiently tailoring immune responses to diverse types of microbes, whether to promote mutualism or host defence. These same attributes can put the host at risk of immune-mediated diseases that are increasingly linked to the intestinal microbiota. Understanding how the adaptive immune system copes with the remarkable number and diversity of microbes that colonize the digestive tract, and how the system integrates with more primitive innate immune mechanisms to maintain immune homeostasis, holds considerable promise for new approaches to modulate immune networks to treat and prevent disease.	[Maynard, Craig L.; Hatton, Robin D.; Weaver, Casey T.] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Elson, Charles O.] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Weaver, CT (corresponding author), Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA.	cweaver@uab.edu		Weaver, Casey/0000-0002-2180-1793; Hatton, Robin/0000-0002-4797-9899	National Institutes of Health; Crohn's and Colitis Foundation of America; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI057956, T32AI007051] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R24DK064400, R01DK093015, P01DK071176] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's and Colitis Foundation of America; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank D. Randolph and C. Morrow for discussions and critical review of this manuscript. C. T. W., C.O.E. and R. D. H. are supported by grants from the National Institutes of Health, and C. T. W. and C. L. M. are supported by grants from the Crohn's and Colitis Foundation of America. The authors extend their apologies to colleagues whose work could not be adequately acknowledged owing to space limitations.	Annunziato F, 2007, J EXP MED, V204, P1849, DOI 10.1084/jem.20070663; Atarashi K, 2008, NATURE, V455, P808, DOI 10.1038/nature07240; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Bager P, 2008, CLIN EXP ALLERGY, V38, P634, DOI 10.1111/j.1365-2222.2008.02939.x; Bergstrom KSB, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000902; Bouskra D, 2008, NATURE, V456, P507, DOI 10.1038/nature07450; Buonocore S, 2010, NATURE, V464, P1371, DOI 10.1038/nature08949; Cash HL, 2006, SCIENCE, V313, P1126, DOI 10.1126/science.1127119; Cella M, 2009, NATURE, V457, P722, DOI 10.1038/nature07537; Chaudhry A, 2011, IMMUNITY, V34, P566, DOI 10.1016/j.immuni.2011.03.018; Cherrier M, 2012, CURR OPIN IMMUNOL, V24, P178, DOI 10.1016/j.coi.2012.02.003; Colonna M, 2009, IMMUNITY, V31, P15, DOI 10.1016/j.immuni.2009.06.008; Cong YZ, 2009, P NATL ACAD SCI USA, V106, P19256, DOI 10.1073/pnas.0812681106; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; DePaolo RW, 2011, NATURE, V471, P220, DOI 10.1038/nature09849; Dominguez-Bello MG, 2010, P NATL ACAD SCI USA, V107, P11971, DOI 10.1073/pnas.1002601107; Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022; Franchi L, 2012, NAT IMMUNOL, V13, P449, DOI 10.1038/ni.2263; Franke A, 2008, NAT GENET, V40, P1319, DOI 10.1038/ng.221; Fukuda S, 2011, NATURE, V469, P543, DOI 10.1038/nature09646; Gaboriau-Routhiau V, 2009, IMMUNITY, V31, P677, DOI 10.1016/j.immuni.2009.08.020; Garrett WS, 2010, CELL HOST MICROBE, V8, P292, DOI 10.1016/j.chom.2010.08.004; Geuking MB, 2011, IMMUNITY, V34, P794, DOI 10.1016/j.immuni.2011.03.021; Glocker EO, 2009, NEW ENGL J MED, V361, P2033, DOI 10.1056/NEJMoa0907206; Hall JA, 2008, IMMUNITY, V29, P637, DOI 10.1016/j.immuni.2008.08.009; Hansen CHF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034043; He B, 2007, IMMUNITY, V26, P812, DOI 10.1016/j.immuni.2007.04.014; Hill DA, 2010, ANNU REV IMMUNOL, V28, P623, DOI 10.1146/annurev-immunol-030409-101330; Huber S, 2011, IMMUNITY, V34, P554, DOI 10.1016/j.immuni.2011.01.020; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Ismail AS, 2011, P NATL ACAD SCI USA, V108, P8743, DOI 10.1073/pnas.1019574108; Ivanov II, 2008, CELL HOST MICROBE, V4, P337, DOI 10.1016/j.chom.2008.09.009; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Izcue A, 2009, ANNU REV IMMUNOL, V27, P313, DOI 10.1146/annurev.immunol.021908.132657; Johansson MEV, 2011, P NATL ACAD SCI USA, V108, P4659, DOI 10.1073/pnas.1006451107; Josefowicz SZ, 2012, NATURE, V482, P395, DOI 10.1038/nature10772; Kanamori Y, 1996, J EXP MED, V184, P1449, DOI 10.1084/jem.184.4.1449; Kastelein RA, 2007, ANNU REV IMMUNOL, V25, P221, DOI 10.1146/annurev.immunol.22.012703.104758; Kelly D, 2004, NAT IMMUNOL, V5, P104, DOI 10.1038/ni1018; Khor B, 2011, NATURE, V474, P307, DOI 10.1038/nature10209; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Lane PJL, 2009, MUCOSAL IMMUNOL, V2, P472, DOI 10.1038/mi.2009.111; Lathrop SK, 2011, NATURE, V478, P250, DOI 10.1038/nature10434; Lee YK, 2011, P NATL ACAD SCI USA, V108, P4615, DOI 10.1073/pnas.1000082107; Lee YK, 2009, CURR OPIN IMMUNOL, V21, P274, DOI 10.1016/j.coi.2009.05.021; Lee YK, 2009, IMMUNITY, V30, P92, DOI 10.1016/j.immuni.2008.11.005; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Lodes MJ, 2004, J CLIN INVEST, V113, P1296, DOI 10.1172/JCI200420295; Lotz M, 2006, J EXP MED, V203, P973, DOI 10.1084/jem.20050625; Lupp C, 2007, CELL HOST MICROBE, V2, P119, DOI 10.1016/j.chom.2007.06.010; Macpherson AJ, 2004, SCIENCE, V303, P1662, DOI 10.1126/science.1091334; Maslowski KM, 2009, NATURE, V461, P1282, DOI 10.1038/nature08530; Maynard CL, 2007, NAT IMMUNOL, V8, P931, DOI 10.1038/ni1504; Maynard CL, 2009, J EXP MED, V206, P343, DOI 10.1084/jem.20080950; McFall-Ngai M, 2007, NATURE, V445, P153, DOI 10.1038/445153a; McGovern DPB, 2010, HUM MOL GENET, V19, P3468, DOI 10.1093/hmg/ddq248; Morrow AL, 2011, J PEDIATR-US, V158, P745, DOI 10.1016/j.jpeds.2010.10.043; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Neish AS, 2000, SCIENCE, V289, P1560, DOI 10.1126/science.289.5484.1560; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Olszak T, 2012, SCIENCE, V336, P489, DOI 10.1126/science.1219328; Ota N, 2011, NAT IMMUNOL, V12, P941, DOI 10.1038/ni.2089; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; Petersson J, 2011, AM J PHYSIOL-GASTR L, V300, pG327, DOI 10.1152/ajpgi.00422.2010; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Qiu J, 2012, IMMUNITY, V36, P92, DOI 10.1016/j.immuni.2011.11.011; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Rakoff-Nahoum S, 2006, IMMUNITY, V25, P319, DOI 10.1016/j.immuni.2006.06.010; Rescigno M, 2009, J CLIN INVEST, V119, P2441, DOI 10.1172/JCI39134; Roers A, 2004, J EXP MED, V200, P1289, DOI 10.1084/jem.20041789; Round JL, 2011, SCIENCE, V332, P974, DOI 10.1126/science.1206095; Rydell GE, 2011, REV MED VIROL, V21, P370, DOI 10.1002/rmv.704; Salzman NH, 2010, NAT IMMUNOL, V11, P76, DOI 10.1038/ni.1825; Sawa S, 2011, NAT IMMUNOL, V12, P320, DOI 10.1038/ni.2002; Sellon RK, 1998, INFECT IMMUN, V66, P5224, DOI 10.1128/IAI.66.11.5224-5231.1998; Shaw MH, 2012, J EXP MED, V209, P251, DOI 10.1084/jem.20111703; Smythies LE, 2005, J CLIN INVEST, V115, P66, DOI 10.1172/JCI200519229; Sonnenberg GF, 2011, NAT IMMUNOL, V12, P383, DOI 10.1038/ni.2025; Sonnenberg GF, 2011, IMMUNITY, V34, P122, DOI 10.1016/j.immuni.2010.12.009; Spits H, 2011, NAT IMMUNOL, V12, P21, DOI 10.1038/ni.1962; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Takatori H, 2009, J EXP MED, V206, P35, DOI 10.1084/jem.20072713; Takeda K, 1999, IMMUNITY, V10, P39, DOI 10.1016/S1074-7613(00)80005-9; Talham GL, 1999, INFECT IMMUN, V67, P1992; Targan SR, 2005, GASTROENTEROLOGY, V128, P2020, DOI 10.1053/j.gastro.2005.03.046; Tsuji M, 2008, IMMUNITY, V29, P261, DOI 10.1016/j.immuni.2008.05.014; Tsuji M, 2009, SCIENCE, V323, P1488, DOI 10.1126/science.1169152; Tumanov AV, 2011, CELL HOST MICROBE, V10, P44, DOI 10.1016/j.chom.2011.06.002; Vaishnava S, 2011, SCIENCE, V334, P255, DOI 10.1126/science.1209791; van de Pavert SA, 2010, NAT REV IMMUNOL, V10, P664, DOI 10.1038/nri2832; Van der Sluis M, 2006, GASTROENTEROLOGY, V131, P117, DOI 10.1053/j.gastro.2006.04.020; Vijay-Kumar M, 2008, SEMIN IMMUNOPATHOL, V30, P11, DOI 10.1007/s00281-007-0100-5; Wacklin P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020113; Wang Q, 2006, J EXP MED, V203, P2853, DOI 10.1084/jem.20062008; Weaver CT, 2009, NAT REV IMMUNOL, V9, P883, DOI 10.1038/nri2660; Wohlfert E, 2010, MUCOSAL IMMUNOL, V3, P213, DOI 10.1038/mi.2010.11; Wu HJ, 2010, IMMUNITY, V32, P815, DOI 10.1016/j.immuni.2010.06.001; Yen D, 2006, J CLIN INVEST, V116, P1310, DOI 10.1172/JCI21404; Zaph C, 2008, J EXP MED, V205, P2191, DOI 10.1084/jem.20080720; Zhang YA, 2010, NAT IMMUNOL, V11, P827, DOI 10.1038/ni.1913	100	925	992	21	376	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 13	2012	489	7415					231	241		10.1038/nature11551	http://dx.doi.org/10.1038/nature11551			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003UC	22972296	Green Accepted			2022-12-28	WOS:000308635900031
J	McCartney, M				McCartney, Margaret			Statins for all?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				Cohen JD, 2012, J CLIN LIPIDOL, V6, P208, DOI 10.1016/j.jacl.2012.03.003; Collins N, DAILY TELEGRAPH; Collins R, TOP NEWS        0829; European Society of Cardiology, CAS STAT WID POP; Gaskell S, WALES ONLINE    0830; Hippisley-Cox J, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2197; Hope J, ADELAIDE NOW    0829; Hope J, DAILY MAIL; Lefever R, DAILY MAIL; MRC/BHF Heart Protection Study Collaborative Group, 2009, BMC Clin Pharmacol, V9, P6, DOI 10.1186/1472-6904-9-6; Rosenbaum D, 2013, NUTR METAB CARDIOVAS, V23, P871, DOI 10.1016/j.numecd.2012.04.012; Sattar N, 2010, LANCET, V375, P735, DOI 10.1016/S0140-6736(09)61965-6; Taylor F, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004816.pub4	13	7	7	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 12	2012	345								e6044	10.1136/bmj.e6044	http://dx.doi.org/10.1136/bmj.e6044			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	007BP	22977108				2022-12-28	WOS:000308864100010
J	Gale, EAM				Gale, Edwin A. M.			Newer insulins in type 2 diabetes	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							MELLITUS; EFFICACY; REGIMENS; ANALOGS		[Gale, Edwin A. M.] Univ Bristol, Bristol, Avon, England	University of Bristol	Gale, EAM (corresponding author), Southmead Hosp, Bristol BS10 5NB, Avon, England.	Edwin.Gale@bristol.ac.uk						Cameron CG, 2009, CAN MED ASSOC J, V180, P400, DOI 10.1503/cmaj.081180; Donnelly LA, 2007, QJM-INT J MED, V100, P345, DOI 10.1093/qjmed/hcm031; Gerstein HC, 2012, NEW ENGL J MED, V367, P319, DOI 10.1056/NEJMoa1203858; Heller SR, 2007, DIABETOLOGIA, V50, P1140, DOI 10.1007/s00125-007-0599-y; Hemmingsen B, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008143.pub2; Holden SE, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000258; Holleman F, 2007, DIABETOLOGIA, V50, P1783, DOI 10.1007/s00125-007-0763-4; Holman RR, 2009, NEW ENGL J MED, V361, P1736, DOI 10.1056/NEJMoa0905479; Horvath K, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005613.pub3; Lasserson DS, 2009, DIABETOLOGIA, V52, P1990, DOI 10.1007/s00125-009-1468-7; *NAT COLL CTR CHRO, 2008, TYP 2 DIAB NAT CLIN; NHS Information Centre for Health and Social Care, 2011, PRESCR DIAB ENGL 200; Sciacca L, 2010, DIABETOLOGIA, V53, P1743, DOI 10.1007/s00125-010-1760-6; Siebenhofer A, 2006, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/1465158.CD003287.PUB4; Singh SR, 2009, CAN MED ASSOC J, V180, P385, DOI 10.1503/cmaj.081041; Sommerfeld MR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009540; Swinnen SG, 2011, COCHRANE DB SYST REV, V7; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; WAUGH N, 2010, HEALTH TECHNOL ASSES, V14, P1; Yudkin JS, 2010, DIABETOLOGIA, V53, P2079, DOI 10.1007/s00125-010-1864-z	20	3	3	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 11	2012	345								e4611	10.1136/bmj.e4611	http://dx.doi.org/10.1136/bmj.e4611			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	007BG	22968720				2022-12-28	WOS:000308863200001
J	Roberts, I; Perel, P; Prieto-Merino, D; Shakur, H; Coats, T; Hunt, BJ; Lecky, F; Brohi, K; Willett, K				Roberts, Ian; Perel, Pablo; Prieto-Merino, David; Shakur, Haleema; Coats, Tim; Hunt, Beverley J.; Lecky, Fiona; Brohi, Karim; Willett, Keith		Crash-2 Collaborators	Effect of tranexamic acid on mortality in patients with traumatic bleeding: prespecified analysis of data from randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article								Objectives To examine whether the effect of tranexamic acid on the risk of death and thrombotic events in patients with traumatic bleeding varies according to baseline risk of death. To assess the extent to which current protocols for treatment with tranexamic acid maximise benefits to patients. Design Prespecified stratified analysis of data from an international multicentre randomised controlled trial (the CRASH-2 trial) with an estimation of the proportion of premature deaths that could potentially be averted through the administration of tranexamic acid. Participants 13 273 trauma patients in the CRASH-2 trial who were treated with tranexamic acid or placebo within three hours of injury and trauma patients enrolled in UK Trauma and Audit Research Network, stratified by risk of death at baseline (<6%, 6-20%, 21-50%, >50%). Intervention Tranexamic acid (1 g over 10 minutes followed by 1 g over eight hours) or matching placebo. Main outcome measure Odds ratios and 95% confidence intervals for death in hospital within four weeks of injury, deaths from bleeding, and fatal and non-fatal thrombotic events associated with the use of tranexamic acid according to baseline risk of death. Unless there was strong evidence against the null hypothesis of homogeneity of effects (P<0.001), the overall odds ratio was used as the most reliable guide to the odds ratios in all strata. Results Tranexamic acid was associated with a significant reduction in all cause mortality and deaths from bleeding. In each stratum of baseline risk, there were fewer deaths among patients treated with tranexamic acid. There was no evidence of heterogeneity in the effect of tranexamic acid on all cause mortality (P=0.96 for interaction) or deaths from bleeding (P=0.98) by baseline risk of death. In those treated with tranexamic acid there was a significant reduction in the odds of fatal and non-fatal thrombotic events (odds ratio 0.69, 95% confidence interval 0.53 to 0.89; P=0.005) and a significant reduction in arterial thrombotic events (0.58, 0.40 to 0.83; P=0.003) but no significant reduction in venous thrombotic events (0.83, 0.59 to 1.17; P=0.295). There was no evidence of heterogeneity in the effect of tranexamic acid on the risk of thrombotic events (P=0.74). If the effect of tranexamic acid is assumed to be the same in all risk strata (<6%, 6-20%, 21-50%, >50% risk of death at baseline), the percentage of deaths that could be averted by administration of tranexamic acid within three hours of injury in each group is 17%, 36%, 30%, and 17%, respectively. Conclusions Tranexamic acid can be administered safely to a wide spectrum of patients with traumatic bleeding and should not be restricted to the most severely injured.	[Roberts, Ian; Perel, Pablo; Prieto-Merino, David; Shakur, Haleema] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; [Coats, Tim] Univ Leicester, Dept Cardiovasc Sci, Leicester LE1 5WW, Leics, England; [Hunt, Beverley J.] Guys & St Thomas NHS Fdn Trust, London SE1 7EH, England; [Lecky, Fiona] Univ Sheffield, Sch Hlth & Related Res, Sheffield S1 4DA, S Yorkshire, England; [Brohi, Karim] Queen Mary Univ London, Ctr Trauma Sci, Barts & London Sch Med & Dent, London, England; [Willett, Keith] Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Nuffield Orthopaed Ctr, Oxford OX3 7HE, England	University of London; London School of Hygiene & Tropical Medicine; University of Leicester; Guy's & St Thomas' NHS Foundation Trust; University of Sheffield; University of London; Queen Mary University London; Nuffield Orthopaedic Centre; University of Oxford	Roberts, I (corresponding author), Univ London London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England.	ian.roberts@lshtm.ac.uk	Coats, Timothy/AAW-1254-2021	Coats, Timothy/0000-0003-2736-2784; Shakur-Still, Haleema/0000-0002-6511-109X; /0000-0002-2342-301X; Prieto-Merino, David/0000-0001-5001-0061	UK Health Technology Assessment programme [09/22/165]; Pfizer; Medical Research Council [G0902393] Funding Source: researchfish; National Institute for Health Research [06/303/20, 09/22/165] Funding Source: researchfish; MRC [G0902393] Funding Source: UKRI	UK Health Technology Assessment programme(National Institute for Health Research (NIHR)); Pfizer(Pfizer); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was funded by the UK Health Technology Assessment programme (09/22/165) and will be published in full in the Health Technology Assessment journal series. The views and opinions expressed therein are those of the authors and do not necessarily reflect those of the Department of Health.; All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare that the London School of Hygiene and Tropical Medicine has received funding from Pfizer, who manufacture tranexamic acid.	Committee on Tactical Combat Casualty Care, 2011, TRAN AC TXA TACT COM; GEERTS WH, 1994, NEW ENGL J MED, V331, P1601, DOI 10.1056/NEJM199412153312401; Godier A, 2012, CRIT CARE, V16, DOI 10.1186/cc11374; Guly HR, 2011, RESUSCITATION, V82, P556, DOI 10.1016/j.resuscitation.2011.01.013; Jimenez JJ, 2007, CRIT CARE, V11, DOI 10.1186/cc6173; Ker K, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3054; Luz Luis da, 2012, Rev Col Bras Cir, V39, P77; Perel P, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5166; Roberts I, 2011, LANCET, V377, P1096, DOI 10.1016/S0140-6736(11)60278-X; Shakur H, 2010, LANCET, V376, P23, DOI 10.1016/S0140-6736(10)60835-5; Sun X, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c117	11	82	85	2	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 11	2012	345								e5839	10.1136/bmj.e5839	http://dx.doi.org/10.1136/bmj.e5839			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	007BG	22968527	Green Accepted, Green Submitted, hybrid, Green Published			2022-12-28	WOS:000308863200004
J	Andrews, DU; Heazlewood, BR; Maccarone, AT; Conroy, T; Payne, RJ; Jordan, MJT; Kable, SH				Andrews, Duncan U.; Heazlewood, Brianna R.; Maccarone, Alan T.; Conroy, Trent; Payne, Richard J.; Jordan, Meredith J. T.; Kable, Scott H.			Photo-Tautomerization of Acetaldehyde to Vinyl Alcohol: A Potential Route to Tropospheric Acids	SCIENCE			English	Article							GAS-PHASE; DEPENDENCE; ALDEHYDES; ENERGY; AIR	Current atmospheric models underestimate the production of organic acids in the troposphere. We report a detailed kinetic model of the photochemistry of acetaldehyde (ethanal) under tropospheric conditions. The rate constants are benchmarked to collision-free experiments, where extensive photo-isomerization is observed upon irradiation with actinic ultraviolet radiation (310 to 330 nanometers). The model quantitatively reproduces the experiments and shows unequivocally that keto-enol photo-tautomerization, forming vinyl alcohol (ethenol), is the crucial first step. When collisions at atmospheric pressure are included, the model quantitatively reproduces previously reported quantum yields for photodissociation at all pressures and wavelengths. The model also predicts that 21 +/- 4% of the initially excited acetaldehyde forms stable vinyl alcohol, a known precursor to organic acid formation, which may help to account for the production of organic acids in the troposphere.	[Andrews, Duncan U.; Heazlewood, Brianna R.; Maccarone, Alan T.; Conroy, Trent; Payne, Richard J.; Jordan, Meredith J. T.; Kable, Scott H.] Univ Sydney, Sch Chem, Sydney, NSW 2006, Australia	University of Sydney	Jordan, MJT (corresponding author), Univ Sydney, Sch Chem, Sydney, NSW 2006, Australia.	m.jordan@chem.usyd.edu.au; scott.kable@sydney.edu.au	Jordan, Meredith/M-3901-2013; Payne, Richard/AAH-3666-2021	Payne, Richard/0000-0002-3618-9226; Jordan, Meredith/0000-0002-9871-8605; Kable, Scott/0000-0002-0331-6137; Heazlewood, Brianna/0000-0003-2073-4004	Australian Research Council [DP1094559]; National Computational Infrastructure Facility	Australian Research Council(Australian Research Council); National Computational Infrastructure Facility	This work was funded by the Australian Research Council (DP1094559) and National Computational Infrastructure Facility. We thank G. Da Silva (University of Melbourne) for discussions about acids in the atmosphere.	Archibald AT, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL031032; Atkinson R, 2006, ATMOS CHEM PHYS, V6, P3625, DOI 10.5194/acp-6-3625-2006; Barker JR, 2009, INT J CHEM KINET, V41, P748, DOI 10.1002/kin.20447; Barker John R, 2012, MULTIWELL 2012 1 SOF; Barker JR, 2001, INT J CHEM KINET, V33, P232, DOI 10.1002/kin.1017; da Silva G, 2010, ANGEW CHEM INT EDIT, V49, P7523, DOI 10.1002/anie.201003530; Goldstein AH, 2007, ENVIRON SCI TECHNOL, V41, P1514, DOI 10.1021/es072476p; HANSEN DA, 1975, J CHEM PHYS, V63, P3272, DOI 10.1063/1.431802; Harding LB, 2010, J PHYS CHEM A, V114, P765, DOI 10.1021/jp906919w; Heazlewood BR, 2011, NAT CHEM, V3, P443, DOI [10.1038/NCHEM.1052, 10.1038/nchem.1052]; Heazlewood BR, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3070517; HOROWITZ A, 1982, J PHYS CHEM-US, V86, P3105, DOI 10.1021/j100213a011; Ito A, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2005JD006556; Lee A, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2006JD007050; MARTINEZ RD, 1992, ATMOS ENVIRON A-GEN, V26, P785, DOI 10.1016/0960-1686(92)90238-G; Moortgat GK, 2010, CHEMPHYSCHEM, V11, P3896, DOI 10.1002/cphc.201000757; Paulot F, 2011, ATMOS CHEM PHYS, V11, P1989, DOI 10.5194/acp-11-1989-2011; Perez P, 2000, J PHYS CHEM A, V104, P1557, DOI 10.1021/jp9930797; Pitts Jr J. N., 2000, CHEM UPPER LOWER ATM; Tadic J, 2001, J PHOTOCH PHOTOBIO A, V143, P169, DOI 10.1016/S1010-6030(01)00524-X; West AC, 2009, J PHYS CHEM A, V113, P12663, DOI 10.1021/jp905070z	21	78	78	5	119	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 7	2012	337	6099					1203	1206		10.1126/science.1220712	http://dx.doi.org/10.1126/science.1220712			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	000UJ	22903524				2022-12-28	WOS:000308414000031
J	Petruk, S; Sedkov, Y; Johnston, DM; Hodgson, JW; Black, KL; Kovermann, SK; Beck, S; Canaani, E; Brock, HW; Mazo, A				Petruk, Svetlana; Sedkov, Yurii; Johnston, Danika M.; Hodgson, Jacob W.; Black, Kathryn L.; Kovermann, Sina K.; Beck, Samantha; Canaani, Eli; Brock, Hugh W.; Mazo, Alexander			TrxG and PcG Proteins but Not Methylated Histones Remain Associated with DNA through Replication	CELL			English	Article							POLYCOMB RESPONSE ELEMENT; EPIGENETIC INHERITANCE; METHYLTRANSFERASE ACTIVITY; CHROMATIN; DROSOPHILA; TRITHORAX; COMPLEX; BINDING; GENES; SITES	Propagation of gene-expression patterns through the cell cycle requires the existence of an epigenetic mark that re-establishes the chromatin architecture of the parental cell in the daughter cells. We devised assays to determine which potential epigenetic marks associate with epigenetic maintenance elements during DNA replication in Drosophila embryos. Histone H3 trimethylated at lysines 4 or 27 is present during transcription but, surprisingly, is replaced by nonmethylated H3 following DNA replication. Methylated H3 is detected on DNA only in nuclei not in S phase. In contrast, the TrxG and PcG proteins Trithorax and Enhancer-of-Zeste, which are H3K4 and H3K27 methylases, and Polycomb continuously associate with their response elements on the newly replicated DNA. We suggest that histone modification enzymes may re-establish the histone code on newly assembled unmethylated histones and thus may act as epigenetic marks.	[Petruk, Svetlana; Sedkov, Yurii; Johnston, Danika M.; Black, Kathryn L.; Mazo, Alexander] Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA; [Petruk, Svetlana; Sedkov, Yurii; Johnston, Danika M.; Black, Kathryn L.; Mazo, Alexander] Thomas Jefferson Univ, Kimmel Canc Ctr, Philadelphia, PA 19107 USA; [Hodgson, Jacob W.; Kovermann, Sina K.; Beck, Samantha; Brock, Hugh W.] Univ British Columbia, Dept Zool, Vancouver, BC V6T 1Z4, Canada; [Canaani, Eli] Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel	Jefferson University; Jefferson University; University of British Columbia; Weizmann Institute of Science	Mazo, A (corresponding author), Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA.	mazo@mail.jci.tju.edu			Canadian Institutes of Health Research;  [NIH R01GM075141];  [NIH P01CA129242]; NATIONAL CANCER INSTITUTE [P01CA129242, P01CA050507] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075141] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Valerio Orlando, Nicole Francis, Richard Jones, and Yi Zhang for antibodies. This work was supported by the following grants: NIH R01GM075141, NIH P01CA129242 to A.M., and a grant from the Canadian Institutes of Health Research to H.W.B.	Beisel C, 2007, P NATL ACAD SCI USA, V104, P16615, DOI 10.1073/pnas.0701538104; BROWN DD, 1984, PHILOS T ROY SOC B, V307, P297, DOI 10.1098/rstb.1984.0130; Buchenau P, 1998, J CELL BIOL, V141, P469, DOI 10.1083/jcb.141.2.469; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Cavalli G, 1998, CELL, V93, P505, DOI 10.1016/S0092-8674(00)81181-2; Corpet A, 2009, TRENDS CELL BIOL, V19, P29, DOI 10.1016/j.tcb.2008.10.002; Czermin B, 2002, CELL, V111, P185, DOI 10.1016/S0092-8674(02)00975-3; Deal RB, 2010, SCIENCE, V328, P1161, DOI 10.1126/science.1186777; Dellino GI, 2002, INT J DEV BIOL, V46, P133; Dietzel S, 1999, CHROMOSOMA, V108, P83, DOI 10.1007/s004120050355; Fanti L, 2008, CHROMOSOMA, V117, P25, DOI 10.1007/s00412-007-0123-7; Floer M, 2010, CELL, V141, P407, DOI 10.1016/j.cell.2010.03.048; Fonseca JP, 2012, GENE DEV, V26, P857, DOI 10.1101/gad.184648.111; Francis NJ, 2009, CELL, V137, P110, DOI 10.1016/j.cell.2009.02.017; Gullerova M, 2008, CELL, V132, P983, DOI 10.1016/j.cell.2008.02.040; Hansen KH, 2008, NAT CELL BIOL, V10, P1291, DOI 10.1038/ncb1787; Henikoff S, 2011, TRENDS GENET, V27, P389, DOI 10.1016/j.tig.2011.06.006; Hernandez-Munoz I, 2005, MOL CELL BIOL, V25, P11047, DOI 10.1128/MCB.25.24.11047-11058.2005; Hervouet E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011333; Huen MSY, 2008, J BIOL CHEM, V283, P11073, DOI 10.1074/jbc.C700242200; JACKSON V, 1976, J MOL BIOL, V104, P471, DOI 10.1016/0022-2836(76)90282-5; JACKSON V, 1985, BIOCHEMISTRY-US, V24, P6930, DOI 10.1021/bi00345a027; Kaneko S, 2010, GENE DEV, V24, P2615, DOI 10.1101/gad.1983810; KASSIS JA, 1994, GENETICS, V136, P1025; Krajewski WA, 2005, MOL CELL BIOL, V25, P1891, DOI 10.1128/MCB.25.5.1891-1899.2005; KRIEGSTEIN HJ, 1974, P NATL ACAD SCI USA, V71, P135, DOI 10.1073/pnas.71.1.135; Lanzuolo C, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002370; Loyola A, 2006, MOL CELL, V24, P309, DOI 10.1016/j.molcel.2006.08.019; Mishra RK, 2001, MOL CELL BIOL, V21, P1311, DOI 10.1128/MCB.21.4.1311-1318.2001; Muller J, 2006, CURR OPIN GENET DEV, V16, P476, DOI 10.1016/j.gde.2006.08.005; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; Ng RK, 2008, CELL CYCLE, V7, P1173, DOI 10.4161/cc.7.9.5791; Petruk S, 2006, CELL, V127, P1209, DOI 10.1016/j.cell.2006.10.039; Puschendorf M, 2008, NAT GENET, V40, P411, DOI 10.1038/ng.99; Radman-Livaja M, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001075; Ringrose L, 2007, DEVELOPMENT, V134, P223, DOI 10.1242/dev.02723; Rozovskaia T, 2000, ONCOGENE, V19, P351, DOI 10.1038/sj.onc.1203307; Sarraf SA, 2004, MOL CELL, V15, P595, DOI 10.1016/j.molcel.2004.06.043; Scharf AND, 2009, NUCLEIC ACIDS RES, V37, P5032, DOI 10.1093/nar/gkp518; Sharif J, 2007, NATURE, V450, P908, DOI 10.1038/nature06397; Shermoen AW, 2010, CURR BIOL, V20, P2067, DOI 10.1016/j.cub.2010.10.021; Smith ST, 2004, NAT CELL BIOL, V6, P162, DOI 10.1038/ncb1088; Tavares L, 2012, CELL, V148, P664, DOI 10.1016/j.cell.2011.12.029; Tillib S, 1999, MOL CELL BIOL, V19, P5189	44	179	186	0	30	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 31	2012	150	5					922	933		10.1016/j.cell.2012.06.046	http://dx.doi.org/10.1016/j.cell.2012.06.046			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	001ZU	22921915	Bronze, Green Accepted			2022-12-28	WOS:000308500200008
J	Prasad, KVSK; Song, BH; Olson-Manning, C; Anderson, JT; Lee, CR; Schranz, ME; Windsor, AJ; Clauss, MJ; Manzaneda, AJ; Naqvi, I; Reichelt, M; Gershenzon, J; Rupasinghe, SG; Schuler, MA; Mitchell-Olds, T				Prasad, Kasavajhala V. S. K.; Song, Bao-Hua; Olson-Manning, Carrie; Anderson, Jill T.; Lee, Cheng-Ruei; Schranz, M. Eric; Windsor, Aaron J.; Clauss, Maria J.; Manzaneda, Antonio J.; Naqvi, Ibtehaj; Reichelt, Michael; Gershenzon, Jonathan; Rupasinghe, Sanjeewa G.; Schuler, Mary A.; Mitchell-Olds, Thomas			A Gain-of-Function Polymorphism Controlling Complex Traits and Fitness in Nature	SCIENCE			English	Article							BOECHERA-STRICTA; BIOSYNTHESIS; CYTOCHROME-P450; CYP79F1; CYP83B1	Identification of the causal genes that control complex trait variation remains challenging, limiting our appreciation of the evolutionary processes that influence polymorphisms in nature. We cloned a quantitative trait locus that controls plant defensive chemistry, damage by insect herbivores, survival, and reproduction in the natural environments where this polymorphism evolved. These ecological effects are driven by duplications in the BCMA (branched-chain methionine allocation) loci controlling this variation and by two selectively favored amino acid changes in the glucosinolate-biosynthetic cytochrome P450 proteins that they encode. These changes cause a gain of novel enzyme function, modulated by allelic differences in catalytic rate and gene copy number. Ecological interactions in diverse environments likely contribute to the widespread polymorphism of this biochemical function.	[Prasad, Kasavajhala V. S. K.; Song, Bao-Hua; Olson-Manning, Carrie; Anderson, Jill T.; Lee, Cheng-Ruei; Schranz, M. Eric; Windsor, Aaron J.; Manzaneda, Antonio J.; Naqvi, Ibtehaj; Mitchell-Olds, Thomas] Duke Univ, Dept Biol, Inst Genome Sci & Policy, Durham, NC 27708 USA; [Clauss, Maria J.; Reichelt, Michael; Gershenzon, Jonathan] Max Planck Inst Chem Ecol, D-07745 Jena, Germany; [Rupasinghe, Sanjeewa G.; Schuler, Mary A.] Univ Illinois, Dept Cell & Dev Biol, Urbana, IL 61801 USA	Duke University; Max Planck Society; University of Illinois System; University of Illinois Urbana-Champaign	Mitchell-Olds, T (corresponding author), Duke Univ, Dept Biol, Inst Genome Sci & Policy, Durham, NC 27708 USA.	tmo1@duke.edu	Manzaneda, Antonio/AAG-1776-2019; Mitchell-Olds, Thomas/K-8121-2012; Gershenzon, Jonathan/K-1331-2013; Schranz, M. Eric/AAB-7601-2022; Schranz, Michael/D-7155-2017; Olson-Manning, Carrie/K-2724-2012; Song, Bao-Hua/B-4867-2017	Mitchell-Olds, Thomas/0000-0003-3439-9921; Gershenzon, Jonathan/0000-0002-1812-1551; Schranz, M. Eric/0000-0001-6777-6565; Schranz, Michael/0000-0001-6777-6565; Anderson, Jill/0000-0002-3253-8142; Lee, Cheng-Ruei/0000-0002-1913-9964; Manzaneda Avila, Antonio Jose/0000-0001-9384-7910; Olson-Manning, Carrie/0000-0001-8054-3889; Song, Bao-Hua/0000-0003-3537-7783	Heald family; NIH [R01-GM086496, R01-GM079530]; NSF [EF-0723447, 1011167, 1110445]; Netherlands Organization for Scientific Research (NWO); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086496, R01GM079530] Funding Source: NIH RePORTER; Division Of Environmental Biology [1011167] Funding Source: National Science Foundation	Heald family; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank R. Colautti, K. Donohue, M. Feder, T. Pendergast, M. Rausher, C. Rushworth, A. Shumate, M. Wagner, J. Willis, and two anonymous reviewers for helpful comments. K. Springer, E. Ballweg, M. Cameron, K. Chu, S. Hurst, V. Cousins, K. Dales, R. Doll, J. Lutkenhaus, M. Mitchell-Olds, S. Mitchell-Olds, E. Raskin, J. Rivera, L. Saucier, M. Wagner, and T. Weiss-Lehman helped in lab and field. N. Wicks and Bitterroot National Forest allowed us to work on their property. We thank the Heald family for support and hospitality. Supported by NIH grants R01-GM086496 (T.M.-O.) and R01-GM079530 (M. A. S.), NSF grant EF-0723447 (T.M.-O.); NSF dissertation grants 1011167 (C.O.-M.) and 1110445 (C.-R.L.); and a Netherlands Organization for Scientific Research (NWO) Ecogenomics grant (M. E. S.). Data in the supplementary materials are also available as GenBank accession nos. JX185680, JX185681, and BCMA JQ337904 to BCMA JQ337909. Data are deposited in the Dryad Repository: http://dx.doi.org/10.5061/dryad.kc6m8.	Bak S, 2001, PLANT CELL, V13, P101, DOI 10.1105/tpc.13.1.101; Barrett RDH, 2011, NAT REV GENET, V12, P767, DOI 10.1038/nrg3015; Brader G, 2006, PLANT J, V46, P758, DOI 10.1111/j.1365-313X.2006.02743.x; Bressan M, 2009, ISME J, V3, P1243, DOI 10.1038/ismej.2009.68; Brunelle A, 2005, QUATERNARY SCI REV, V24, P2281, DOI 10.1016/j.quascirev.2004.11.010; Chen SX, 2003, PLANT J, V33, P923, DOI 10.1046/j.1365-313X.2003.01679.x; Futuyma DJ, 2009, P NATL ACAD SCI USA, V106, P18054, DOI 10.1073/pnas.0904106106; Halkier BA, 2006, ANNU REV PLANT BIOL, V57, P303, DOI 10.1146/annurev.arplant.57.032905.105228; Hopkins RJ, 2009, ANNU REV ENTOMOL, V54, P57, DOI 10.1146/annurev.ento.54.110807.090623; Naur P, 2003, PLANT PHYSIOL, V133, P63, DOI 10.1104/pp.102.019240; Poulos T. L., 2005, CYTOCHROME P450 STRU, P217; Poulos T. L., 2007, UBIQUITOUS ROLES CYT, P57; Reintanz B, 2001, PLANT CELL, V13, P351, DOI 10.1105/tpc.13.2.351; Rogers RL, 2012, MOL BIOL EVOL, V29, P517, DOI 10.1093/molbev/msr184; Rushworth CA, 2011, MOL ECOL, V20, P4843, DOI 10.1111/j.1365-294X.2011.05340.x; Schranz ME, 2009, HEREDITY, V102, P465, DOI 10.1038/hdy.2009.12; Schranz ME, 2007, PLANT PHYSIOL, V144, P286, DOI 10.1104/pp.107.096685; Windsor AJ, 2005, PHYTOCHEMISTRY, V66, P1321, DOI 10.1016/j.phytochem.2005.04.016; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	19	123	123	2	155	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 31	2012	337	6098					1081	1084		10.1126/science.1221636	http://dx.doi.org/10.1126/science.1221636			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996WP	22936775	Green Accepted			2022-12-28	WOS:000308125800043
J	Trokter, M; Surrey, T				Trokter, Martina; Surrey, Thomas			LIS1 Clamps Dynein to the Microtubule	CELL			English	Editorial Material							CYTOPLASMIC DYNEIN; MECHANISMS; NDEL1; MOTOR	Cytoplasmic dynein is a motor essential for numerous mechanical processes in eukaryotic cells. How its activity is regulated is largely unknown. By using a combination of approaches including single-molecule biophysics and electron microscopy, Huang et al. in this issue uncover the regulatory mechanism by which LIS1 controls the activity of cytoplasmic dynein.	[Trokter, Martina; Surrey, Thomas] Canc Res UK, London Res Inst, London WC2A 3LY, England	Cancer Research UK	Surrey, T (corresponding author), Canc Res UK, London Res Inst, 44 Lincolns Inn Fields, London WC2A 3LY, England.	thomas.surrey@cancer.org.uk	Surrey, Thomas/AAC-4608-2021	Surrey, Thomas/0000-0001-9082-1870	Cancer Research UK [14256] Funding Source: researchfish	Cancer Research UK(Cancer Research UK)		Allan VJ, 2011, BIOCHEM SOC T, V39, P1169, DOI 10.1042/BST0391169; Cho C, 2012, BBA-MOL CELL RES, V1823, P182, DOI 10.1016/j.bbamcr.2011.10.009; Erzberger JP, 2006, ANNU REV BIOPH BIOM, V35, P93, DOI 10.1146/annurev.biophys.35.040405.101933; Huang J, 2012, CELL, V150, P975, DOI 10.1016/j.cell.2012.07.022; Kardon JR, 2009, NAT REV MOL CELL BIO, V10, P854, DOI 10.1038/nrm2804; Li J, 2005, NAT CELL BIOL, V7, P686, DOI 10.1038/ncb1273; Markus SM, 2009, CURR BIOL, V19, P196, DOI 10.1016/j.cub.2008.12.047; McKenney RJ, 2010, CELL, V141, P304, DOI 10.1016/j.cell.2010.02.035; REINER O, 1993, NATURE, V364, P717, DOI 10.1038/364717a0; Torisawa T, 2011, J BIOL CHEM, V286, P1959, DOI 10.1074/jbc.M110.169847; Yamada M, 2008, EMBO J, V27, P2471, DOI 10.1038/emboj.2008.182	11	4	4	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 31	2012	150	5					877	879		10.1016/j.cell.2012.08.010	http://dx.doi.org/10.1016/j.cell.2012.08.010			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	001ZU	22939616	Bronze			2022-12-28	WOS:000308500200003
J	Bouckaert, R; Lemey, P; Dunn, M; Greenhill, SJ; Alekseyenko, AV; Drummond, AJ; Gray, RD; Suchard, MA; Atkinson, QD				Bouckaert, Remco; Lemey, Philippe; Dunn, Michael; Greenhill, Simon J.; Alekseyenko, Alexander V.; Drummond, Alexei J.; Gray, Russell D.; Suchard, Marc A.; Atkinson, Quentin D.			Mapping the Origins and Expansion of the Indo-European Language Family	SCIENCE			English	Article							DIFFUSION; PACIFIC; TIME; EAST; DNA	There are two competing hypotheses for the origin of the Indo-European language family. The conventional view places the homeland in the Pontic steppes about 6000 years ago. An alternative hypothesis claims that the languages spread from Anatolia with the expansion of farming 8000 to 9500 years ago. We used Bayesian phylogeographic approaches, together with basic vocabulary data from 103 ancient and contemporary Indo-European languages, to explicitly model the expansion of the family and test these hypotheses. We found decisive support for an Anatolian origin over a steppe origin. Both the inferred timing and root location of the Indo-European language trees fit with an agricultural expansion from Anatolia beginning 8000 to 9500 years ago. These results highlight the critical role that phylogeographic inference can play in resolving debates about human prehistory.	[Greenhill, Simon J.; Gray, Russell D.; Atkinson, Quentin D.] Univ Auckland, Dept Psychol, Auckland 1142, New Zealand; [Bouckaert, Remco; Drummond, Alexei J.] Univ Auckland, Dept Comp Sci, Auckland 1142, New Zealand; [Lemey, Philippe] Katholieke Univ Leuven, Rega Inst, Dept Microbiol & Immunol, B-3000 Louvain, Belgium; [Dunn, Michael] Max Planck Inst Psycholinguist, NL-6500 AH Nijmegen, Netherlands; [Dunn, Michael] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 EN Nijmegen, Netherlands; [Greenhill, Simon J.] Australian Natl Univ, Sch Culture Hist & Language, Canberra, ACT 0200, Australia; [Greenhill, Simon J.] Australian Natl Univ, Coll Asia & Pacific, Canberra, ACT 0200, Australia; [Alekseyenko, Alexander V.] NYU, Sch Med, Ctr Hlth Informat & Bioinformat, New York, NY 10016 USA; [Drummond, Alexei J.] Univ Auckland, Allan Wilson Ctr Mol Ecol & Evolut, Auckland 1142, New Zealand; [Gray, Russell D.] Australian Natl Univ, Res Sch Social Sci, Dept Philosophy, Canberra, ACT 0200, Australia; [Suchard, Marc A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biomath, Los Angeles, CA 90095 USA; [Suchard, Marc A.] Univ Calif Los Angeles, Sch Publ Hlth, Dept Biostat, Los Angeles, CA 90095 USA; [Suchard, Marc A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; [Atkinson, Quentin D.] Univ Oxford, Inst Cognit & Evolutionary Anthropol, Oxford OX2 6PN, England	University of Auckland; University of Auckland; KU Leuven; Max Planck Society; Radboud University Nijmegen; Australian National University; Australian National University; New York University; Massey University; University of Auckland; Australian National University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Oxford	Atkinson, QD (corresponding author), Univ Auckland, Dept Psychol, Auckland 1142, New Zealand.	q.atkinson@auckland.ac.nz	Lemey, Philippe/C-3755-2018; Greenhill, Simon J/B-3114-2011; Dunn, Michael/F-1077-2012; Gray, Russell/H-2078-2015; Drummond, Alexei J/A-3209-2010; Greenhill, Simon/I-3554-2019	Lemey, Philippe/0000-0003-2826-5353; Greenhill, Simon J/0000-0001-7832-6156; Dunn, Michael/0000-0001-5349-5252; Gray, Russell/0000-0002-9858-0191; Drummond, Alexei J/0000-0003-4454-2576; Greenhill, Simon/0000-0001-7832-6156; Alekseyenko, Alexander/0000-0002-5748-2085; Atkinson, Quentin/0000-0002-8499-7535	National Evolutionary Synthesis Center (NESCent) NSF [EF-0423641]; Marsden Fund; Rutherford Discovery Fellowships; NIH [R01 GM086887, R01 HG006139]; European Union [278433-PREDEMICS]; European Research Council (ERC) [260864]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006139] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086887] Funding Source: NIH RePORTER	National Evolutionary Synthesis Center (NESCent) NSF(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ)); Rutherford Discovery Fellowships; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Union(European Commission); European Research Council (ERC)(European Research Council (ERC)European Commission); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the New Zealand Phylogenetics Meeting and the National Evolutionary Synthesis Center (NESCent) NSF grant EF-0423641, for fostering collaboration on this project. Supported by the Marsden Fund (R. B., R. D. G., S.J.G., and A.J.D.), Rutherford Discovery Fellowships (Q. D. A., A.J.D.), administered by the Royal Society of New Zealand, and by NIH grants R01 GM086887 and R01 HG006139 (M. A. S.). The research leading to these results has received funding from the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement 278433-PREDEMICS and European Research Council (ERC) grant agreement 260864.	Alekseyenko AV, 2008, SYST BIOL, V57, P772, DOI 10.1080/10635150802434394; Anthony DW, 2007, HORSE, THE WHEEL, AND LANGUAGE: HOW BRONZE-AGE RIDERS FROM THE EURASIAN STEPPES SHAPED THE MODERN WORLD, P1; Balter M, 2003, SCIENCE, V302, P1490; Chikhi L, 2009, HUM BIOL, V81, P639, DOI 10.3378/027.081.0612; Currie TE, 2010, NATURE, V467, P801, DOI 10.1038/nature09461; Diamond J, 2003, SCIENCE, V300, P597, DOI 10.1126/science.1078208; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; DYEN I, 1992, T AM PHILOS SOC, V82, P1; GIMBUTAS M, 1977, J INDO-EUR STUD, V5, P277; Gimbutas M., 1970, INDOEUROPEAN INDOEUR, P155; Gkiasta M, 2003, ANTIQUITY, V77, P45, DOI 10.1017/S0003598X00061330; GLOVER IC, 1996, ORIGINS SPREAD AGR P, P413; Gray RD, 2009, SCIENCE, V323, P479, DOI 10.1126/science.1166858; Haak W, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000536; Heggarty P., 2006, PHYLOGENETIC METHODS, P183; Holden CJ, 2002, P ROY SOC B-BIOL SCI, V269, P793, DOI 10.1098/rspb.2002.1955; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kitchen A, 2009, P ROY SOC B-BIOL SCI, V276, P2703, DOI 10.1098/rspb.2009.0408; Koivulehto Jorma., 2001, EARLY CONTACTS URALI, P235; Lacan M, 2011, P NATL ACAD SCI USA, V108, P9788, DOI 10.1073/pnas.1100723108; Lemey P, 2010, MOL BIOL EVOL, V27, P1877, DOI 10.1093/molbev/msq067; Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520; MALLORY J.P., 2006, OXFORD INTRO PROTO I; Nicholls GeoffK., 2006, PHYLOGENETIC METHODS, P161; RENFREW C, 1987, ARCHAEOLOGY LANGUAGE; Ringe D, 2002, T PHILOL SOC, V100, P59, DOI 10.1111/1467-968X.00091; Suchard MA, 2001, MOL BIOL EVOL, V18, P1001, DOI 10.1093/oxfordjournals.molbev.a003872; von Cramon-Taubadel N, 2011, P ROY SOC B-BIOL SCI, V278, P2874, DOI 10.1098/rspb.2010.2678	28	311	314	5	168	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 24	2012	337	6097					957	960		10.1126/science.1219669	http://dx.doi.org/10.1126/science.1219669			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	992VI	22923579	Green Accepted, Green Published			2022-12-28	WOS:000307807600043
J	Lum, L; Clevers, H				Lum, Lawrence; Clevers, Hans			The Unusual Case of Porcupine	SCIENCE			English	Editorial Material							INTESTINAL STEM-CELLS; LUNG ADENOCARCINOMA; WNT; MUTATIONS; METASTASIS; PATHWAYS; DISEASE; CANCER; GENES		[Lum, Lawrence] Univ Texas SW Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA; [Clevers, Hans] Hubrecht Inst, NL-3584 CT Utrecht, Netherlands; [Clevers, Hans] Univ Med Ctr Utrecht, Utrecht, Netherlands	University of Texas System; University of Texas Southwestern Medical Center Dallas; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center	Lum, L (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Cell Biol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	lawrence.lum@utsouthwestern.edu; h.clevers@hubrecht.eu			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD061303] Funding Source: NIH RePORTER; NICHD NIH HHS [R21 HD061303] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		[Anonymous], 2012, EMBO C 30 YEARS WNT; Chen BZ, 2009, NAT CHEM BIOL, V5, P100, DOI 10.1038/nchembio.137; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Durand A, 2012, P NATL ACAD SCI USA, V109, P8965, DOI 10.1073/pnas.1201652109; Hao HX, 2012, NATURE, V485, P195, DOI 10.1038/nature11019; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Jacob LS, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001225; Janda CY, 2012, SCIENCE, V337, P59, DOI 10.1126/science.1222879; Kim TH, 2012, P NATL ACAD SCI USA, V109, P3932, DOI 10.1073/pnas.1113890109; Koo BK, 2012, NATURE, V488, P665, DOI 10.1038/nature11308; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nguyen DX, 2009, CELL, V138, P51, DOI 10.1016/j.cell.2009.04.030; Pinto D, 2003, GENE DEV, V17, P1709, DOI 10.1101/gad.267103; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; VANDENHEUVEL M, 1993, EMBO J, V12, P5293, DOI 10.1002/j.1460-2075.1993.tb06225.x; Wu J, 2011, P NATL ACAD SCI USA, V108, P21188, DOI 10.1073/pnas.1118046108; Yu M, 2012, NATURE, V487, P510, DOI 10.1038/nature11217	18	53	53	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 24	2012	337	6097					922	923		10.1126/science.1228179	http://dx.doi.org/10.1126/science.1228179			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992VI	22923569	Green Accepted			2022-12-28	WOS:000307807600032
J	Nachbur, U; Vince, JE; O'Reilly, LA; Strasser, A; Silke, J				Nachbur, Ueli; Vince, James E.; O'Reilly, Lorraine A.; Strasser, Andreas; Silke, John			Is BID required for NOD signalling?	NATURE			English	Letter							INDUCED APOPTOSIS; INNATE		[Nachbur, Ueli; Vince, James E.; O'Reilly, Lorraine A.; Strasser, Andreas; Silke, John] Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3052, Australia; [Nachbur, Ueli; Vince, James E.; O'Reilly, Lorraine A.; Strasser, Andreas; Silke, John] Univ Melbourne, Dept Med Biol, Melbourne, Vic 3010, Australia	Walter & Eliza Hall Institute; University of Melbourne	Nachbur, U (corresponding author), Walter & Eliza Hall Inst Med Res, 1G Royal Parade, Melbourne, Vic 3052, Australia.	j.silke@latrobe.edu.au	Strasser, Andreas/C-7581-2013; Silke, John/B-7622-2008	Strasser, Andreas/0000-0002-5020-4891; Silke, John/0000-0002-7611-5774; Nachbur, Ueli/0000-0001-5968-2235				Jost PJ, 2009, NATURE, V460, P1035, DOI 10.1038/nature08229; Kaufmann T, 2007, CELL DEATH DIFFER, V14, P637, DOI 10.1038/sj.cdd.4402061; Kaufmann T, 2007, CELL, V129, P423, DOI 10.1016/j.cell.2007.03.017; Kobayashi K, 2002, NATURE, V416, P194, DOI 10.1038/416194a; SAIKI I, 1985, J IMMUNOL, V135, P684; Yeretssian G, 2011, NATURE, V474, P96, DOI 10.1038/nature09982; Yin XM, 1999, NATURE, V400, P886, DOI 10.1038/23730	7	16	17	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 23	2012	488	7412					E4	E6		10.1038/nature11366	http://dx.doi.org/10.1038/nature11366			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992FS	22914170				2022-12-28	WOS:000307761600001
J	Nandi, D; Finck, ADK; Eisenstein, JP; Pfeiffer, LN; West, KW				Nandi, D.; Finck, A. D. K.; Eisenstein, J. P.; Pfeiffer, L. N.; West, K. W.			Exciton condensation and perfect Coulomb drag	NATURE			English	Article							BOSE-EINSTEIN CONDENSATION; COUPLED QUANTUM-WELLS; ELECTRON-SYSTEMS; COHERENCE; POLARITONS	Coulomb drag is a process whereby the repulsive interactions between electrons in spatially separated conductors enable a current flowing in one of the conductors to induce a voltage drop in the other(1-3). If the second conductor is part of a closed circuit, a net current will flow in that circuit. The drag current is typically much smaller than the drive current owing to the heavy screening of the Coulomb interaction. There are, however, rare situations in which strong electronic correlations exist between the two conductors. For example, double quantum well systems can support exciton condensates, which consist of electrons in one well tightly bound to holes in the other(4-6). 'Perfect' drag is therefore expected; a steady transport current of electrons driven through one quantum well should be accompanied by an equal current of holes in the other(7). Here we demonstrate this effect, taking care to ensure that the electron-hole pairs dominate the transport and that tunnelling of charge between the quantum wells, which can readily compromise drag measurements, is negligible. We note that, from an electrical engineering perspective, perfect Coulomb drag is analogous to an electrical transformer that functions at zero frequency.	[Nandi, D.; Finck, A. D. K.; Eisenstein, J. P.] CALTECH, Pasadena, CA 91125 USA; [Pfeiffer, L. N.; West, K. W.] Princeton Univ, Dept Elect Engn, Princeton, NJ 08544 USA	California Institute of Technology; Princeton University	Eisenstein, JP (corresponding author), CALTECH, Pasadena, CA 91125 USA.	jpe@caltech.edu			NSF [DMR-1003080]	NSF(National Science Foundation (NSF))	We thank A.H. MacDonald and D. Pesin for discussions. This work was supported by NSF grant DMR-1003080.	Butov LV, 2003, SOLID STATE COMMUN, V127, P89, DOI 10.1016/S0038-1098(03)00312-0; Eisenstein JP, 2004, NATURE, V432, P691, DOI 10.1038/nature03081; EISENSTEIN JP, 1990, APPL PHYS LETT, V57, P2324, DOI 10.1063/1.103882; Fertig HA, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.156802; FERTIG HA, 1989, PHYS REV B, V40, P1087, DOI 10.1103/PhysRevB.40.1087; Fil DV, 2007, LOW TEMP PHYS+, V33, P780, DOI 10.1063/1.2781504; Finck ADK, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.236807; High AA, 2012, NATURE, V483, P584, DOI 10.1038/nature10903; Huse DA, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.064514; Kasprzak J, 2006, NATURE, V443, P409, DOI 10.1038/nature05131; Kellogg M, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.036801; Lee DKK, 2011, ADV COND MATTER PHYS, V2011, DOI 10.1155/2011/792125; MacDonald A H, 1997, PERSPECTIVES QUANTUM, P161; Pesin DA, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.075308; POGREBINSKII MB, 1977, SOV PHYS SEMICOND+, V11, P372; PRICE PJ, 1983, PHYSICA B & C, V117, P750, DOI 10.1016/0378-4363(83)90642-3; Rojo AG, 1999, J PHYS-CONDENS MAT, V11, pR31, DOI 10.1088/0953-8984/11/5/004; Snoke D, 2002, SCIENCE, V298, P1368, DOI 10.1126/science.1078082; Spielman IB, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.036803; Spielman IB, 2000, PHYS REV LETT, V84, P5808, DOI 10.1103/PhysRevLett.84.5808; Su JJ, 2008, NAT PHYS, V4, P799, DOI 10.1038/nphys1055; Tiemann L, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/4/045018; Tiemann L, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.033306; Tiemann L, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.165120; Tutuc E, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.036802; Wiersma RD, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.266805; Yang S, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.187402	27	139	140	1	69	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 23	2012	488	7412					481	484		10.1038/nature11302	http://dx.doi.org/10.1038/nature11302			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992FS	22914164	Green Accepted, Green Submitted			2022-12-28	WOS:000307761600030
J	Heath, I				Heath, Iona			Every day in every way we are getting better and better: the optimism of health policy	BRITISH MEDICAL JOURNAL			English	Editorial Material									Royal Coll Gen Practitioners, London, England		Heath, I (corresponding author), Royal Coll Gen Practitioners, London, England.	iona.heath22@yahoo.co.uk						Coue Emile, 1922, SELF MASTERY CONSCIO; Mayor S, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e5322; Perigo G, 2011, COMMISSIONING OUTCOM; Woloshin S, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5132	4	0	0	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	AUG 22	2012	345								e5608	10.1136/bmj.e5608	http://dx.doi.org/10.1136/bmj.e5608			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	996GV	22915731				2022-12-28	WOS:000308073800003
J	Halstead, SB				Halstead, Scott B.			Dengue vaccine development: a 75% solution?	LANCET			English	Editorial Material							VIRUS; EFFICACY; CHILDREN				Halstead, SB (corresponding author), 5824 Edson Lane, Bethesda, MD 20852 USA.	halsteads@erols.com						Alonso PL, 2004, LANCET, V364, P1411, DOI 10.1016/S0140-6736(04)17223-1; Brady OJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001760; Capeding RZ, 2011, VACCINE, V29, P3863, DOI 10.1016/j.vaccine.2011.03.057; Cummings DAT, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000139; de Alwis R, 2012, P NATL ACAD SCI USA, V109, P7439, DOI 10.1073/pnas.1200566109; Francis DP, 2003, AIDS, V17, P147, DOI 10.1097/00002030-200301240-00003; Gibbons RV, 2007, AM J TROP MED HYG, V77, P910, DOI 10.4269/ajtmh.2007.77.910; Guy B, 2009, AM J TROP MED HYG, V80, P302, DOI 10.4269/ajtmh.2009.80.302; Halloran ME, 2010, STAT BIOL HEALTH, P131, DOI 10.1007/978-0-387-68636-3_7; Halstead SB, 2010, CLIN INFECT DIS, V50, P1155, DOI 10.1086/651271; Monath T. P., 2008, VACCINES, P959; Murphy BR, 2011, ANNU REV IMMUNOL, V29, P587, DOI 10.1146/annurev-immunol-031210-101315; Sabchareon A, 2012, LANCET; Wahala WMPB, 2011, VIRUSES-BASEL, V3, P2374, DOI 10.3390/v3122374	14	91	94	0	15	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 3	2012	380	9853					1535	1536		10.1016/S0140-6736(12)61510-4	http://dx.doi.org/10.1016/S0140-6736(12)61510-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	030VR	22975339				2022-12-28	WOS:000310598700007
J	Ryan, NM; Birring, SS; Gibson, PG				Ryan, Nicole M.; Birring, Surinder S.; Gibson, Peter G.			Gabapentin for refractory chronic cough: a randomised, double-blind, placebo-controlled trial	LANCET			English	Article							CLINICAL-PRACTICE GUIDELINES; CHRONIC IDIOPATHIC COUGH; SENSORY NEUROPATHY; MANAGEMENT; SYMPTOMS; QUESTIONNAIRE; FREQUENCY; DIAGNOSIS; MONITOR; AIRWAY	Background Refractory chronic cough causes substantial symptoms and quality-of-life impairment. Similarities between central reflex sensitisation in refractory chronic cough and neuropathic pain suggest that neuromodulators such as gabapentin might be effective for refractory chronic cough. We established the efficacy of gabapentin in patients with refractory chronic cough. Methods This randomised, double-blind, placebo-controlled trial was undertaken at an outpatient clinic in Australia. Adults with refractory chronic cough (>8 weeks' duration) without active respiratory disease or infection were randomly assigned to receive gabapentin (maximum tolerable daily dose of 1800 mg) or matching placebo for 10 weeks. Block randomisation was done with randomisation generator software, stratified by sex. Patients and investigators were masked to assigned treatment. The primary endpoint was change in cough-specific quality of life (Leicester cough questionnaire [LCQ] score) from baseline to 8 weeks of treatment, analysed by intention to treat. This study is registered with the Australian New Zealand Clinical Trials Registry, number ACTRN12608000248369. Findings 62 patients were randomly assigned to gabepentin (n=32) or placebo (n=30) and ten patients withdrew before the study end. Gabapentin significantly improved cough-specific quality of life compared with placebo (between-group difference in LCQ score during treatment period 1.80, 95% CI 0.56-3.04; p=0.004; number needed to treat of 3.58). Side-effects occurred in ten patients (31%) given gabapentin (the most common being nausea and fatigue) and three (10%) given placebo. Interpretation The treatment of refractory chronic cough with gabapentin is both effective and well tolerated. These positive effects suggest that central reflex sensitisation is a relevant mechanism in refractory chronic cough.	[Ryan, Nicole M.; Gibson, Peter G.] Univ Newcastle, Sch Med & Publ Hlth, Prior Ctr Asthma & Resp Dis, Newcastle, NSW 2308, Australia; [Ryan, Nicole M.; Gibson, Peter G.] John Hunter Hosp, Hunter Med Res Inst, Dept Resp & Sleep Med, Newcastle, NSW, Australia; [Gibson, Peter G.] Woolcock Inst Med Res, Sydney, NSW, Australia; [Birring, Surinder S.] Kings Coll London, Div Asthma Allergy & Lung Biol, London WC2R 2LS, England	University of Newcastle; Hunter Medical Research Institute; John Hunter Hospital; University of Newcastle; University of Sydney; Woolcock Institute of Medical Research; University of London; King's College London	Ryan, NM (corresponding author), Univ Newcastle, Sch Med & Publ Hlth, Prior Ctr Asthma & Resp Dis, Newcastle, NSW 2308, Australia.	nicole.ryan@newcastle.edu.au	Ryan, Nicole M/G-7736-2013; Birring, Surinder/GWU-6967-2022; gibson, peter/G-6194-2014	Ryan, Nicole M/0000-0003-0334-1938; gibson, peter/0000-0001-5865-489X	National Health and Medical Research Council of Australia; Hunter Medical Research Institute, Newcastle, Australia; National Health and Medical Research Council of Australia (NHMRC); NHMRC Centre for Clinical Excellence in Respiratory and Sleep Medicine; Greaves family	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Hunter Medical Research Institute, Newcastle, Australia; National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Centre for Clinical Excellence in Respiratory and Sleep Medicine(National Health and Medical Research Council (NHMRC) of Australia); Greaves family	National Health and Medical Research Council of Australia and Hunter Medical Research Institute, Newcastle, Australia.; This study was funded by the National Health and Medical Research Council of Australia (NHMRC). NMR held a PhD scholarship funded by the NHMRC Centre for Clinical Excellence in Respiratory and Sleep Medicine and was the recipient of a Hunter Medical Research Institute, Research Higher Degree support scholarship donated by the Greaves family. PGG is an NHMRC Practitioner Fellow. We were not paid to write this article by a pharmaceutical company or other agency. We thank Rebecca Oldham, Heather Powell, and Patrick McElduff for assistance, and the men and women who participated in the study.	American Thoracic Society, 2005, AM J RESP CRIT CARE, V171, P912, DOI 10.1164/rccm.200406-710ST; Bastian RW, 2006, OTOLARYNG HEAD NECK, V135, P17, DOI 10.1016/j.otohns.2006.02.003; Birring SS, 2008, EUR RESPIR J, V31, P1013, DOI 10.1183/09031936.00057407; Birring SS, 2003, THORAX, V58, P339, DOI 10.1136/thorax.58.4.339; Birring SS, 2003, THORAX, V58, P1066, DOI 10.1136/thorax.58.12.1066; BUCCA C, 1991, ALLERGY, V46, P147, DOI 10.1111/j.1398-9995.1991.tb00559.x; Chung KF, 2011, PULM PHARMACOL THER, V24, P267, DOI 10.1016/j.pupt.2011.01.012; DAVIS JN, 1974, ARCH NEUROL-CHICAGO, V30, P480, DOI 10.1001/archneur.1974.00490360056011; Dicpinigaitis PV, 2003, PULM PHARMACOL THER, V16, P61, DOI 10.1016/S1094-5539(02)00149-9; Ford AC, 2006, THORAX, V61, P975, DOI 10.1136/thx.2006.060087; Greene SM, 2010, OTOLARYNG CLIN N AM, V43, P67, DOI 10.1016/j.otc.2009.11.003; Haque RA, 2005, CHEST, V127, P1710, DOI 10.1378/chest.127.5.1710; HSU JY, 1994, EUR RESPIR J, V7, P1246, DOI 10.1183/09031936.94.07071246; Irwin RS, 2006, CHEST, V129, p24S, DOI 10.1378/chest.129.1_suppl.24S; Kimos P, 2007, PAIN, V127, P151, DOI 10.1016/j.pain.2006.08.028; Latremoliere A, 2009, J PAIN, V10, P895, DOI 10.1016/j.jpain.2009.06.012; Lee B, 2005, ANN OTO RHINOL LARYN, V114, P253, DOI 10.1177/000348940511400401; Lee KK, 2010, THORAX, V65, pA54, DOI 10.1136/thx.2010.150946.18; Mintz S, 2006, AM J MED, V119, DOI 10.1016/j.amjmed.2005.10.046; Morice AH, 2007, AM J RESP CRIT CARE, V175, P312, DOI 10.1164/rccm.200607-892OC; Nieto CML, 2001, ARCH BRONCONEUMOL, V37, P292; Patterson N, 2009, J CLIN GASTROENTEROL, V43, P414, DOI 10.1097/MCG.0b013e31818859a3; Pavord ID, 2008, LANCET, V371, P1375, DOI 10.1016/S0140-6736(08)60596-6; Pratter MR, 2006, CHEST, V129, p220S, DOI 10.1378/chest.129.1_suppl.220S; Raj A. A., 2009, V187, P311, DOI 10.1007/978-3-540-79842-2_16; Reich JM, 2007, CHEST, V131, P636, DOI 10.1378/chest.06-2136; Ryan Nicole M, 2009, Cough, V5, P4, DOI 10.1186/1745-9974-5-4; Ryan Nicole M, 2008, Cough, V4, P7, DOI 10.1186/1745-9974-4-7; Vertigan AE, 2007, J VOICE, V21, P361, DOI 10.1016/j.jvoice.2005.12.008; Vertigan AE, 2011, J VOICE, V25, P596, DOI 10.1016/j.jvoice.2010.07.009	30	261	280	5	22	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 3	2012	380	9853					1583	1589		10.1016/S0140-6736(12)60776-4	http://dx.doi.org/10.1016/S0140-6736(12)60776-4			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	030VR	22951084				2022-12-28	WOS:000310598700034
J	Nogueira, RG; Lutsep, HL; Gupta, R; Jovin, TG; Albers, GW; Walker, GA; Liebeskind, DS; Smith, WS				Nogueira, Raul G.; Lutsep, Helmi L.; Gupta, Rishi; Jovin, Tudor G.; Albers, Gregory W.; Walker, Gary A.; Liebeskind, David S.; Smith, Wade S.		TREVO 2 Trialists	Trevo versus Merci retrievers for thrombectomy revascularisation of large vessel occlusions in acute ischaemic stroke (TREVO 2): a randomised trial	LANCET			English	Article							TISSUE-PLASMINOGEN ACTIVATOR; RT-PA STROKE; RECANALIZATION; THROMBOLYSIS; EFFICACY; DISEASE; DEVICES; SAFETY	Background Present mechanical devices are unable to achieve recanalisation in up to 20-40% of large vessel occlusion strokes. We compared efficacy and safety of the Trevo Retriever, a new stent-like device, with its US Food and Drug Administration-cleared predecessor, the Merci Retriever. Methods In this open-label randomised controlled trial, we recruited patients at 26 sites in the USA and one in Spain. We included adults aged 18-85 years with angiographically confirmed large vessel occlusion strokes and US National Institutes of Health Stroke Scale (NIHSS) scores of 8-29 within 8 h of symptom onset. We randomly assigned patients (1:1) with sequentially numbered sealed envelopes to thrombectomy with Trevo or Merci devices. Randomisation was stratified by age (<= 68 years vs 69-85 years) and NIHSS scores (<= 18 vs 19-29) with alternating blocks of various sizes. The primary efficacy endpoint, assessed by an unmasked core laboratory, was thrombolysis in cerebral infarction (TICI) scores of 2 or greater reperfusion with the assigned device alone. The primary safety endpoint was a composite of procedure-related adverse events. Analyses were done by intention to treat. This study is registered with ClinicalTrials.gov, number NCT01270867. Findings Between Feb 3, 2011, and Dec 1, 2011, we randomly assigned 88 patients to the Trevo Retriever group and 90 patients to Merci Retriever group. 76 (86%) patients in the Trevo group and 54 (60%) in the Merci group met the primary endpoint after the assigned device was used (odds ratio 4.22, 95% CI 1.92-9.69; p(superiority) < 0.0001). Incidence of the primary safety endpoint did not differ between groups (13 [15%] patients in the Trevo group vs 21 [23%] in the Merci group; p=0.1826). Interpretation Patients who have had large vessel occlusion strokes but are ineligible for (or refractory to) intravenous tissue plasminogen activator should be treated with the Trevo Retriever in preference to the Merci Retriever.	[Nogueira, Raul G.; Gupta, Rishi] Emory Univ, Sch Med, Marcus Stroke & Neurosci Ctr, Dept Neurol,Grady Mem Hosp, Atlanta, GA 30303 USA; [Nogueira, Raul G.; Gupta, Rishi] Emory Univ, Sch Med, Marcus Stroke & Neurosci Ctr, Dept Neurosurg,Grady Mem Hosp, Atlanta, GA 30303 USA; [Nogueira, Raul G.; Gupta, Rishi] Emory Univ, Sch Med, Marcus Stroke & Neurosci Ctr, Dept Radiol,Grady Mem Hosp, Atlanta, GA 30303 USA; [Lutsep, Helmi L.] Oregon Hlth & Sci Univ, Dept Neurol, Portland, OR 97201 USA; [Jovin, Tudor G.] Univ Pittsburgh, Dept Neurol, Med Ctr, UPMC Stroke Ctr, Pittsburgh, PA 15260 USA; [Albers, Gregory W.] Stanford Univ, Med Ctr, Dept Neurol, Stanford Stroke Ctr, Palo Alto, CA 94304 USA; [Walker, Gary A.] Stryker Neurovasc, Dept Clin Res, Mountain View, CA USA; [Liebeskind, David S.] Univ Calif Los Angeles, Dept Neurol, UCLA Stroke Ctr, Los Angeles, CA 90024 USA; [Smith, Wade S.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA	Emory University; Emory University; Emory University; Oregon Health & Science University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Stanford University; University of California System; University of California Los Angeles; University of California System; University of California San Francisco	Nogueira, RG (corresponding author), Emory Univ, Sch Med, Marcus Stroke & Neurosci Ctr, Dept Neurol, Atlanta, GA 30303 USA.	raul.g.nogueira@emory.edu	Demchuk, Andrew M/E-1103-2012	Demchuk, Andrew M/0000-0002-4930-7789; Albers, Gregory/0000-0003-0263-4632; Macho Fernandez, Juan Miguel/0000-0002-8417-7094	Stryker Neurovascular; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K24NS072272] Funding Source: NIH RePORTER	Stryker Neurovascular; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Stryker Neurovascular	Baker WL, 2011, ANN INTERN MED, V154, P243, DOI 10.7326/0003-4819-154-4-201102150-00306; Berger C, 2001, STROKE, V32, P1330, DOI 10.1161/01.STR.32.6.1330; Bhatia R, 2010, STROKE, V41, P2254, DOI 10.1161/STROKEAHA.110.592535; BLACKWELDER WC, 1982, CONTROL CLIN TRIALS, V3, P345, DOI 10.1016/0197-2456(82)90024-1; Furlan A, 1999, JAMA-J AM MED ASSOC, V282, P2003, DOI 10.1001/jama.282.21.2003; Hacke W, 2004, LANCET, V363, P768; Hacke W, 2008, NEW ENGL J MED, V359, P1317, DOI 10.1056/NEJMoa0804656; Higashida RT, 2003, STROKE, V34, pE109, DOI 10.1161/01.STR.0000082721.62796.09; Hussain MS, 2010, J NEUROINTERV SURG, V2, P71, DOI 10.1136/jnis.2009.001081; Katzan IL, 2004, ARCH NEUROL-CHICAGO, V61, P346, DOI 10.1001/archneur.61.3.346; Langer D, 2009, STROKE, V40, P2761, DOI 10.1161/STROKEAHA.108.544957; Lee M, 2010, STROKE, V41, P932, DOI 10.1161/STROKEAHA.109.574335; Loh Y, 2010, AM J NEURORADIOL, V31, P935, DOI 10.3174/ajnr.A1958; Marler JR, 2000, NEUROLOGY, V55, P1649, DOI 10.1212/WNL.55.11.1649; Mendonca N, 2013, J NEUROIMAGING, V23, P7, DOI 10.1111/j.1552-6569.2011.00666.x; Nogueira RG, 2009, AM J NEURORADIOL, V30, P859, DOI 10.3174/ajnr.A1604; Nogueira RG, 2012, J NEUROINTERV SURG, V4, P295, DOI 10.1136/neurintsurg-2011-010053; Nogueira RG, 2009, STROKE, V40, P3777, DOI 10.1161/STROKEAHA.109.561431; Riedel CH, 2011, STROKE, V42, P1775, DOI 10.1161/STROKEAHA.110.609693; Roman LS, 2012, STROKE, V43, P1657, DOI 10.1161/STROKEAHA.111.640011; Smith WS, 2008, STROKE, V39, P1205, DOI 10.1161/STROKEAHA.107.497115; Smith WS, 2005, STROKE, V36, P1432, DOI 10.1161/01.STR.0000171066.25248.1d; Wahlgren N., 2012, INT STROK C NEW ORL	23	793	843	3	63	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 6	2012	380	9849					1231	1240		10.1016/S0140-6736(12)61299-9	http://dx.doi.org/10.1016/S0140-6736(12)61299-9			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	020NG	22932714	Green Accepted			2022-12-28	WOS:000309817500030
J	Min, JK; Leipsic, J; Pencina, MJ; Berman, DS; Koo, BK; van Mieghem, C; Erglis, A; Lin, FY; Dunning, AM; Apruzzese, P; Budoff, MJ; Cole, JH; Jaffer, FA; Leon, MB; Malpeso, J; Mancini, GBJ; Park, SJ; Schwartz, RS; Shaw, LJ; Mauri, L				Min, James K.; Leipsic, Jonathon; Pencina, Michael J.; Berman, Daniel S.; Koo, Bon-Kwon; van Mieghem, Carlos; Erglis, Andrejs; Lin, Fay Y.; Dunning, Allison M.; Apruzzese, Patricia; Budoff, Matthew J.; Cole, Jason H.; Jaffer, Farouc A.; Leon, Martin B.; Malpeso, Jennifer; Mancini, G. B. John; Park, Seung-Jung; Schwartz, Robert S.; Shaw, Leslee J.; Mauri, Laura			Diagnostic Accuracy of Fractional Flow Reserve From Anatomic CT Angiography	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PERCUTANEOUS CORONARY INTERVENTION; CARDIOVASCULAR-COMPUTED-TOMOGRAPHY; OPTIMAL MEDICAL THERAPY; AMERICAN-COLLEGE; ARTERY-DISEASE; ECONOMIC-EVALUATION; MAGNETIC-RESONANCE; NUCLEAR-CARDIOLOGY; HEART-ASSOCIATION; DISCOVER-FLOW	Context Coronary computed tomographic (CT) angiography is a noninvasive anatomic test for diagnosis of coronary stenosis that does not determine whether a stenosis causes ischemia. In contrast, fractional flow reserve (FFR) is a physiologic measure of coronary stenosis expressing the amount of coronary flow still attainable despite the presence of a stenosis, but it requires an invasive procedure. Noninvasive FFR computed from CT (FFRCT) is a novel method for determining the physiologic significance of coronary artery disease (CAD), but its ability to identify ischemia has not been adequately examined to date. Objective To assess the diagnostic performance of FFRCT plus CT for diagnosis of hemodynamically significant coronary stenosis. Design, Setting, and Patients Multicenter diagnostic performance study involving 252 stable patients with suspected or known CAD from 17 centers in 5 countries who underwent CT, invasive coronary angiography (ICA), FFR, and FFRCT between October 2010 and October 2011. Computed tomography, ICA, FFR, and FFRCT were interpreted in blinded fashion by independent core laboratories. Accuracy of FFRCT plus CT for diagnosis of ischemia was compared with an invasive FFR reference standard. Ischemia was defined by an FFR or FFRCT of 0.80 or less, while anatomically obstructive CAD was defined by a stenosis of 50% or larger on CT and ICA. Main Outcome Measures The primary study outcome assessed whether FFRCT plus CT could improve the per-patient diagnostic accuracy such that the lower boundary of the 1-sided 95% confidence interval of this estimate exceeded 70%. Results Among study participants, 137 (54.4%) had an abnormal FFR determined by ICA. On a per-patient basis, diagnostic accuracy, sensitivity, specificity, positive predictive value, and negative predictive value of FFRCT plus CT were 73% (95% CI, 67%78%), 90% (95% CI, 84%-95%), 54% (95% CI, 46%-83%), 67% (95% CI, 60%74%), and 84% (95% CI, 74%-90%), respectively. Compared with obstructive CAD diagnosed by CT alone (area under the receiver operating characteristic curve [AUC], 0.68; 95% CI, 0.62-0.74), FFRCT was associated with improved discrimination (AUC, 0.81; 95% CI, 0.75-0.86; P<.001). Conclusion Although the study did not achieve its prespecified primary outcome goal for the level of per-patient diagnostic accuracy, use of noninvasive FFRCT plus CT among stable patients with suspected or known CAD was associated with improved diagnostic accuracy and discrimination vs CT alone for the diagnosis of hemodynamically significant CAD when FFR determined at the time of ICA was the reference standard. JAMA. 2012;308(12):1237-1245 Published online August 26, 2012. doi: 10.1001/2012.jama.11274 www.jama.com	[Min, James K.] Cedars Sinai Heart Inst, Dept Med, Div Cardiol, Los Angeles, CA 90048 USA; [Min, James K.; Berman, Daniel S.] David Geffen Univ Calif, Sch Med, Los Angeles, CA USA; [Budoff, Matthew J.; Malpeso, Jennifer] Harbor UCLA Med Ctr, Los Angeles, CA USA; [Leipsic, Jonathon] St Pauls Hosp, Dept Radiol, Vancouver, BC V6Z 1Y6, Canada; [Mancini, G. B. John] Vancouver Gen Hosp, Dept Med, Div Cardiol, Vancouver, BC, Canada; [Mancini, G. B. John] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; [Pencina, Michael J.; Apruzzese, Patricia] Harvard Clin Res Inst, Boston, MA USA; [Jaffer, Farouc A.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Med,Div Cardiol, Boston, MA USA; [Mauri, Laura] Brigham & Womens Hosp, Div Cardiovasc Med, Boston, MA 02115 USA; [Koo, Bon-Kwon] Seoul Natl Univ Hosp, Seoul 110744, South Korea; [Park, Seung-Jung] Univ Ulsan, Coll Med, Asan Med Ctr, Div Cardiol, Seoul, South Korea; [van Mieghem, Carlos] Erasmus MC, Rotterdam, Netherlands; [Erglis, Andrejs] Pauls Stradins Clin Univ Hosp, Dept Med, Riga, Latvia; [Lin, Fay Y.; Dunning, Allison M.] Weill Cornell Med Coll, New York, NY USA; [Leon, Martin B.] Columbia Univ, Med Ctr, Ctr Intervent Vasc Therapy, New York, NY USA; [Leon, Martin B.] New York Presbyterian Hosp, New York, NY USA; [Cole, Jason H.] Cardiol Associates, Mobile, AL USA; [Schwartz, Robert S.] Minneapolis Heart Inst & Fdn, Minneapolis, MN USA; [Shaw, Leslee J.] Emory Univ, Sch Med, Dept Med, Div Cardiol, Atlanta, GA USA	Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; St. Paul's Hospital; University of Saskatchewan; University of British Columbia; University of British Columbia; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Seoul National University (SNU); Seoul National University Hospital; University of Ulsan; Asan Medical Center; Erasmus University Rotterdam; Erasmus MC; Pauls Stradins Clinical University Hospital; Cornell University; Columbia University; NewYork-Presbyterian Hospital; Minneapolis Heart Institute Foundation; Emory University	Min, JK (corresponding author), Cedars Sinai Heart Inst, Dept Med, Div Cardiol, 8700 Beverly Blvd,S Taper Bldg 1258, Los Angeles, CA 90048 USA.	James.Min@cshs.org	Lin, Fay/AAJ-9453-2021; mauri, laura/GPS-4868-2022; Budoff, Matthew/ABD-5175-2021; Koo, Bon-Kwon/J-5374-2012; Leipsic, Jonathon/ABE-6194-2020; Jaffer, Farouc/AAK-8803-2020	Budoff, Matthew/0000-0002-9616-1946; Jaffer, Farouc/0000-0001-7980-384X; Erglis, Andrejs/0000-0002-3999-0182; Pencina, Michael/0000-0001-5798-8855	GE Healthcare; Philips Medical; Heart-Flow; Siemens Medical Systems; Lantheus Medical Imaging and stock options in Spectrum Dynamics; Roche; Pfizer; Abbott Vascular; Medtronic; Cordis; Abbott; Boston Scientific; Eli Lilly; Daiichi Sankyo; Bristol-Myers Squibb; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER	GE Healthcare(General ElectricGE Healthcare); Philips Medical; Heart-Flow; Siemens Medical Systems(Siemens AG); Lantheus Medical Imaging and stock options in Spectrum Dynamics; Roche(Roche Holding); Pfizer(Pfizer); Abbott Vascular(Abbott Laboratories); Medtronic(Medtronic); Cordis; Abbott(Abbott Laboratories); Boston Scientific(Boston Scientific); Eli Lilly(Eli Lilly); Daiichi Sankyo(Daiichi Sankyo Company Limited); Bristol-Myers Squibb(Bristol-Myers Squibb); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Min reports research support from GE Healthcare and Philips Medical. Dr Leipsic reports research support from GE Healthcare and serving as a consultant to Edwards Lifesciences. Dr Pencina reports consulting fees from Heart-Flow to his institution. Dr Berman reports research support from Siemens Medical Systems and Lantheus Medical Imaging and stock options in Spectrum Dynamics. Dr Budoff reports research support from GE Healthcare and grants to his institution from Roche and Pfizer. Dr Cole reports grant for research support from HeartFlow. Dr Jaffer reports serving as consultant to Boston Scientific, Siemens, and Merck and receiving nonfinancial research support from Abbott Vascular. Dr Mancini reports a grant to his institution from HeartFlow. Dr Mauri reports serving as a consultant to Medtronic and Cordis and receiving research support from Medtronic, Cordis, Abbott, Boston Scientific, Eli Lilly, Daiichi Sankyo, Bristol-Myers Squibb, and sanofi-aventis; she also reports grants and consulting fees paid to her institution from HeartFlow. No other disclosures were reported.	Abbara Suhny, 2009, J Cardiovasc Comput Tomogr, V3, P190, DOI 10.1016/j.jcct.2009.03.004; Berman DS, 2007, J NUCL CARDIOL, V14, P521, DOI 10.1016/j.nuclcard.2007.05.008; Boden WE, 2007, NEW ENGL J MED, V356, P1503, DOI 10.1056/NEJMoa070829; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Fearon WF, 2000, AM J CARDIOL, V86, P1013, DOI 10.1016/S0002-9149(00)01139-5; Fearon WF, 2010, CIRCULATION, V122, P2545, DOI 10.1161/CIRCULATIONAHA.109.925396; Frye RL, 2009, NEW ENGL J MED, V360, P2503, DOI [DOI 10.1056/NEJMOA0805796, 10.1056/NEJMoa0805796]; Gaemperli O, 2011, EUR HEART J, V32, P2100, DOI 10.1093/eurheartj/ehr057; Hachamovitch R, 2003, CIRCULATION, V107, P2900, DOI 10.1161/01.CIR.0000072790.23090.41; Hachamovitch R, 2008, CIRCULATION, V117, P2684, DOI 10.1161/CIRCULATIONAHA.107.708586; Halliburton SS, 2011, J CARDIOVASC COMPUT, V5, P198, DOI 10.1016/j.jcct.2011.06.001; Hendel RC, 2006, J AM COLL CARDIOL, V48, P1475, DOI 10.1016/j.jacc.2006.07.003; Hendel RC, 2009, J AM COLL CARDIOL, V53, P2201, DOI 10.1016/j.jacc.2009.02.013; Kim HJ, 2010, ANN BIOMED ENG, V38, P3195, DOI 10.1007/s10439-010-0083-6; Klocke FJ, 2003, CIRCULATION, V108, P1404, DOI 10.1161/01.CIR.0000080946.42225.4D; Koo BK, 2011, J AM COLL CARDIOL, V58, P1989, DOI 10.1016/j.jacc.2011.06.066; Lauer MS, 2009, CIRC-CARDIOVASC IMAG, V2, P1, DOI 10.1161/CIRCIMAGING.108.841429; Meijboom WB, 2008, J AM COLL CARDIOL, V52, P636, DOI 10.1016/j.jacc.2008.05.024; Min JK, 2012, J CARDIOVASC COMPUT, V6, P191, DOI 10.1016/j.jcct.2012.04.010; Min JK, 2011, J CARDIOVASC COMPUT, V5, P301, DOI 10.1016/j.jcct.2011.08.003; Min JK, 2010, J AM COLL CARDIOL, V55, P957, DOI 10.1016/j.jacc.2009.08.087; Mowatt G, 2004, HEALTH TECHNOL ASSES, V8, P1; Naidu SS, 2012, CATHETER CARDIO INTE, V80, P456, DOI 10.1002/ccd.24311; Pijls NHJ, 1998, HEART, V80, P539, DOI 10.1136/hrt.80.6.539; Pijls NHJ, 2010, J AM COLL CARDIOL, V56, P177, DOI 10.1016/j.jacc.2010.04.012; Schuijf JD, 2008, HEART, V94, P255, DOI 10.1136/hrt.2006.105833; Shaw LJ, 2008, CIRCULATION, V117, P1283, DOI 10.1161/CIRCULATIONAHA.107.743963; Tonino PAL, 2009, NEW ENGL J MED, V360, P213, DOI 10.1056/NEJMoa0807611	28	743	815	3	72	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 26	2012	308	12					1237	1245		10.1001/2012.jama.11274	http://dx.doi.org/10.1001/2012.jama.11274			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	010OK	22922562	Bronze, Green Accepted			2022-12-28	WOS:000309103600027
J	Beall, J				Beall, Jeffrey			Predatory publishers are corrupting open access	NATURE			English	Editorial Material									Univ Colorado Denver, Aurora, CO 80045 USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Beall, J (corresponding author), Univ Colorado Denver, Aurora, CO 80045 USA.	jeffrey.beall@ucdenver.edu	Beall, Jeffrey/C-3093-2008	Beall, Jeffrey/0000-0001-9012-5330					0	425	447	38	148	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 13	2012	489	7415					179	179		10.1038/489179a	http://dx.doi.org/10.1038/489179a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	003UC	22972258	Bronze			2022-12-28	WOS:000308635900004
J	Goenka, N; Ropper, AH				Goenka, Naila; Ropper, Allan H.			Cerebral Fat Embolism	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Goenka, Naila; Ropper, Allan H.] Brigham & Womens Hosp, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital	Goenka, N (corresponding author), Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.								0	7	7	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 13	2012	367	11					1045	1045		10.1056/NEJMicm1100944	http://dx.doi.org/10.1056/NEJMicm1100944			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	003ZE	22970947				2022-12-28	WOS:000308649100011
J	Spracklen, DV; Arnold, SR; Taylor, CM				Spracklen, D. V.; Arnold, S. R.; Taylor, C. M.			Observations of increased tropical rainfall preceded by air passage over forests	NATURE			English	Article							AMAZON DEFORESTATION; CLIMATE-CHANGE; LEAF-AREA; IMPACT; CLOUDS; BASIN	Vegetation affects precipitation patterns by mediating moisture, energy and trace-gas fluxes between the surface and atmosphere(1). When forests are replaced by pasture or crops, evapotranspiration of moisture from soil and vegetation is often diminished, leading to reduced atmospheric humidity and potentially suppressing precipitation(2,3). Climate models predict that large-scale tropical deforestation causes reduced regional precipitation(4-10), although the magnitude of the effect is model(9,11) and resolution(8) dependent. In contrast, observational studies have linked deforestation to increased precipitation locally(12-14) but have been unable to explore the impact of large-scale deforestation. Here we use satellite remote-sensing data of tropical precipitation and vegetation, combined with simulated atmospheric transport patterns, to assess the pan-tropical effect of forests on tropical rainfall. We find that for more than 60 per cent of the tropical land surface (latitudes 30 degrees south to 30 degrees north), air that has passed over extensive vegetation in the preceding few days produces at least twice as much rain as air that has passed over little vegetation. We demonstrate that this empirical correlation is consistent with evapotranspiration maintaining atmospheric moisture in air that passes over extensive vegetation. We combine these empirical relationships with current trends of Amazonian deforestation to estimate reductions of 12 and 21 per cent in wet-season and dry-season precipitation respectively across the Amazon basin by 2050, due to less-efficient moisture recycling. Our observation-based results complement similar estimates from climate models(4-10), in which the physical mechanisms and feedbacks at work could be explored in more detail.	[Spracklen, D. V.; Arnold, S. R.] Univ Leeds, Sch Earth & Environm, Leeds LS2 9JT, W Yorkshire, England; [Taylor, C. M.] Ctr Ecol & Hydrol, Oxford OX10 8BB, England	University of Leeds; UK Centre for Ecology & Hydrology (UKCEH)	Spracklen, DV (corresponding author), Univ Leeds, Sch Earth & Environm, Leeds LS2 9JT, W Yorkshire, England.	d.v.spracklen@leeds.ac.uk	Arnold, Steve/B-8856-2014; Taylor, Chris/K-2319-2012; Taylor, Christopher/Y-7529-2019; Spracklen, Dominick/AAA-6257-2019; Spracklen, Dominick V/B-4890-2014	Taylor, Chris/0000-0002-0120-3198; Arnold, Steve/0000-0002-4881-5685	Natural Environment Research Council [NE/G015015/1]; NERC [NE/G018499/1, NE/F00060X/1, earth010002] Funding Source: UKRI; Natural Environment Research Council [NE/G018499/1, NE/F00060X/1, ceh010023, NE/B505538/1, earth010002] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	D.V.S. acknowledges a Natural Environment Research Council grant (NE/G015015/1). The GLDAS data used in this study were acquired as part of the mission of NASA's Earth Science Division and were archived and distributed by the Goddard Earth Sciences Data and Information Services Center.	Andreae MO, 2004, SCIENCE, V303, P1337, DOI 10.1126/science.1092779; [Anonymous], TECH REP; Aragao LEOC, 2005, IEEE T GEOSCI REMOTE, V43, P2526, DOI 10.1109/TGRS.2005.856632; Aragao LEOC, 2005, FOREST ECOL MANAG, V211, P240, DOI 10.1016/j.foreco.2005.02.062; Aragao LEOC, 2007, GEOPHYS RES LETT, V34, DOI [10.1029/2006GL028946., 10.1029/2006GL028946]; Bonan GB, 2008, SCIENCE, V320, P1444, DOI 10.1126/science.1155121; Butt N, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2010JD015174; Chagnon FJF, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022722; Da Silva RR, 2008, J CLIMATE, V21, P1153, DOI 10.1175/2007JCLI1304.1; Davidson EA, 2012, NATURE, V481, P321, DOI 10.1038/nature10717; ELTAHIR EAB, 1994, Q J ROY METEOR SOC, V120, P861, DOI 10.1002/qj.49712051806; Garcia-Carreras L, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL049099; Gimeno L, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL043712; Hasler N, 2009, J CLIMATE, V22, P1124, DOI 10.1175/2008JCLI2157.1; HENDERSON-SELLERS A, 1984, CLIMATIC CHANGE, V6, P231, DOI 10.1007/BF00142475; Huffman GJ, 2007, J HYDROMETEOROL, V8, P38, DOI 10.1175/JHM560.1; Huffman GJ, 1997, J APPL METEOROL, V36, P1191, DOI 10.1175/1520-0450(1997)036<1191:EORMSR>2.0.CO;2; Koren I, 2012, NAT GEOSCI, V5, P118, DOI [10.1038/ngeo1364, 10.1038/NGEO1364]; LEAN J, 1989, NATURE, V342, P411, DOI 10.1038/342411a0; Myneni RB, 2002, REMOTE SENS ENVIRON, V83, P214, DOI 10.1016/S0034-4257(02)00074-3; Negri AJ, 2004, J CLIMATE, V17, P1306, DOI 10.1175/1520-0442(2004)017&lt;1306:TIOADO&gt;2.0.CO;2; Nobre P, 2009, J CLIMATE, V22, P5686, DOI 10.1175/2009JCLI2757.1; Phillips OL, 2009, SCIENCE, V323, P1344, DOI 10.1126/science.1164033; Pitman AJ, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL039076; Rodell M, 2004, B AM METEOROL SOC, V85, P381, DOI 10.1175/BAMS-85-3-381; SHUKLA J, 1990, SCIENCE, V247, P1322, DOI 10.1126/science.247.4948.1322; SHUKLA J, 1982, SCIENCE, V215, P1498, DOI 10.1126/science.215.4539.1498; Smith TM, 2006, J HYDROMETEOROL, V7, P841, DOI 10.1175/JHM524.1; Soares BS, 2006, NATURE, V440, P520, DOI 10.1038/nature04389; van der Ent RJ, 2010, WATER RESOUR RES, V46, DOI 10.1029/2010WR009127; Wang JF, 2000, J HYDROMETEOROL, V1, P267, DOI 10.1175/1525-7541(2000)001<0267:TIOODO>2.0.CO;2; Werth D, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD000717	32	363	369	12	258	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 13	2012	489	7415					282	U127		10.1038/nature11390	http://dx.doi.org/10.1038/nature11390			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003UC	22951966				2022-12-28	WOS:000308635900039
J	Vilchez, D; Boyer, L; Morantte, I; Lutz, M; Merkwirth, C; Joyce, D; Spencer, B; Page, L; Masliah, E; Berggren, WT; Gage, FH; Dillin, A				Vilchez, David; Boyer, Leah; Morantte, Ianessa; Lutz, Margaret; Merkwirth, Carsten; Joyce, Derek; Spencer, Brian; Page, Lesley; Masliah, Eliezer; Berggren, W. Travis; Gage, Fred H.; Dillin, Andrew			Increased proteasome activity in human embryonic stem cells is regulated by PSMD11	NATURE			English	Article							DIFFERENTIATION; PROTEOSTASIS; SUBUNIT; MUTANT; RPN6P; CORE	Embryonic stem cells can replicate continuously in the absence of senescence and, therefore, are immortal in culture(1,2). Although genome stability is essential for the survival of stem cells, proteome stability may have an equally important role in stem-cell identity and function. Furthermore, with the asymmetric divisions invoked by stem cells, the passage of damaged proteins to daughter cells could potentially destroy the resulting lineage of cells. Therefore, a firm understanding of how stem cells maintain their proteome is of central importance. Here we show that human embryonic stem cells (hESCs) exhibit high proteasome activity that is correlated with increased levels of the 19S proteasome subunit PSMD11 (known as RPN-6 in Caenorhabditis elegans)(3-5) and a corresponding increased assembly of the 26S/30S proteasome. Ectopic expression of PSMD11 is sufficient to increase proteasome assembly and activity. FOXO4, an insulin/insulin-like growth factor-I (IGF-I) responsive transcription factor associated with long lifespan in invertebrates(6,7), regulates proteasome activity by modulating the expression of PSMD11 in hESCs. Proteasome inhibition in hESCs affects the expression of pluripotency markers and the levels of specific markers of the distinct germ layers. Our results suggest a new regulation of proteostasis in hESCs that links longevity and stress resistance in invertebrates to hESC function and identity.	[Vilchez, David; Morantte, Ianessa; Merkwirth, Carsten; Joyce, Derek; Dillin, Andrew] Salk Inst Biol Studies, Howard Hughes Med Inst, Glenn Ctr Aging Res, Mol & Cell Biol Lab, La Jolla, CA 92037 USA; [Boyer, Leah; Gage, Fred H.] Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92037 USA; [Lutz, Margaret; Berggren, W. Travis] Salk Inst Biol Studies, Stem Cell Core, La Jolla, CA 92037 USA; [Spencer, Brian; Masliah, Eliezer] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Page, Lesley] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA	Howard Hughes Medical Institute; Salk Institute; Salk Institute; Salk Institute; University of California System; University of California San Diego; Scripps Research Institute	Dillin, A (corresponding author), Salk Inst Biol Studies, Howard Hughes Med Inst, Glenn Ctr Aging Res, Mol & Cell Biol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	dillin@salk.edu	Merkwirth, Carsten/H-5992-2012; Vilchez, David/A-8446-2008	Merkwirth, Carsten/0000-0001-8895-3495; Vilchez, David/0000-0002-0801-0743; Boyer, Leah/0000-0002-0546-4344	Howard Hughes Medical Institute; F.M. Kirby, Inc. Foundation Postdoctoral Scholar Award; Beatriu de Pinos (AGAUR) fellowship; NATIONAL INSTITUTE ON AGING [R37AG018440, P01AG031097] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); F.M. Kirby, Inc. Foundation Postdoctoral Scholar Award; Beatriu de Pinos (AGAUR) fellowship; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank W. E. Balch for critical comments on this work. We thank A. Stauffer and V. Modesto for their help with BrdU assays and cell culture, respectively. We thank S. Ruiz for advice on hESC culture and lentiviral infection. This work was supported by the Howard Hughes Medical Institute. D. V. was a recipient of the F.M. Kirby, Inc. Foundation Postdoctoral Scholar Award and Beatriu de Pinos (AGAUR) fellowship. F. H. G. acknowledges the Helmsley Foundation, JPB Foundation, Mathers Foundation, Lookout Fund and California Institute for Regenerative Medicine.	Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Brennand KJ, 2011, NATURE, V473, P221, DOI 10.1038/nature09915; Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Hanna JH, 2010, CELL, V143, P508, DOI 10.1016/j.cell.2010.10.008; Isono E, 2005, J BIOL CHEM, V280, P6537, DOI 10.1074/jbc.M409364200; Itoh M, 2011, P NATL ACAD SCI USA, V108, P8797, DOI 10.1073/pnas.1100332108; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kisselev AF, 2005, METHOD ENZYMOL, V398, P364, DOI 10.1016/S0076-6879(05)98030-0; Kohler A, 2001, MOL CELL, V7, P1143, DOI 10.1016/S1097-2765(01)00274-X; Kops GJPL, 1999, NATURE, V398, P630, DOI 10.1038/19328; Matsuzaki H, 2005, J BIOCHEM, V138, P485, DOI 10.1093/jb/mvi146; Osafune K, 2008, NAT BIOTECHNOL, V26, P313, DOI 10.1038/nbt1383; Panopoulos AD, 2011, CELL STEM CELL, V8, P347, DOI 10.1016/j.stem.2011.03.003; Pathare GR, 2012, P NATL ACAD SCI USA, V109, P149, DOI 10.1073/pnas.1117648108; Powers ET, 2009, ANNU REV BIOCHEM, V78, P959, DOI 10.1146/annurev.biochem.052308.114844; Santamaria PG, 2003, J BIOL CHEM, V278, P6687, DOI 10.1074/jbc.M209420200; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tatar M, 2001, SCIENCE, V292, P107, DOI 10.1126/science.1057987; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tiscornia G, 2006, NAT PROTOC, V1, P234, DOI 10.1038/nprot.2006.36; Xu RH, 2002, NAT BIOTECHNOL, V20, P1261, DOI 10.1038/nbt761; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	26	270	277	1	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 13	2012	489	7415					304	+		10.1038/nature11468	http://dx.doi.org/10.1038/nature11468			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003UC	22972301	Green Accepted			2022-12-28	WOS:000308635900044
J	Desai, N; Kalra, A				Desai, Nayan; Kalra, Ankur			Short Fourth and Fifth Metacarpals	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Desai, Nayan; Kalra, Ankur] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Cooper Univ Hosp, Div Internal Med,Dept Med, Camden, NJ 08103 USA	Cooper University Hospital; Rutgers State University New Brunswick; Rutgers State University Medical Center	Desai, N (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Cooper Univ Hosp, Div Internal Med,Dept Med, Educ & Res Bldg,3rd Floor, Camden, NJ 08103 USA.	nayandesai_16@yahoo.co.in		Kalra, MD, FACP, FACC, FSCAI, Ankur/0000-0003-0080-1660				Kelsey G, 2010, AM J MED GENET C, V154C, P377, DOI 10.1002/ajmg.c.30271; Koo B B, 1995, Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi, V36, P3; Lalande M, 2001, J CLIN INVEST, V107, P793, DOI 10.1172/JCI12645; Levine MA, 1999, J BONE MINER RES, V14, P1255, DOI 10.1359/jbmr.1999.14.8.1255; Wemeau JL, 2006, J PEDIATR ENDOCR MET, V19, P653	5	0	0	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 12	2012	308	10					1034	1035		10.1001/2012.jama.11065	http://dx.doi.org/10.1001/2012.jama.11065			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	003AA	22968892				2022-12-28	WOS:000308579300027
J	Burghardt, TP; Ajtai, K				Burghardt, Thomas P.; Ajtai, Katalin			Heart Brakes	SCIENCE			English	Editorial Material							BINDING PROTEIN-C; MYOSIN; PHOSPHORYLATION; CARDIOMYOPATHY; VISUALIZATION; DISEASE; MUSCLE; CHAIN; MOTOR		[Burghardt, Thomas P.; Ajtai, Katalin] Mayo Clin Rochester, Rochester, MN 55905 USA	Mayo Clinic	Burghardt, TP (corresponding author), Mayo Clin Rochester, Rochester, MN 55905 USA.	burghardt@mayo.edu			NHLBI NIH HHS [R01 HL095572] Funding Source: Medline; NIAMS NIH HHS [R01 AR049277] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049277] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Ajtai K, 2009, BIOCHEMISTRY-US, V48, P5263, DOI 10.1021/bi900584q; Barefield D, 2010, J MOL CELL CARDIOL, V48, P866, DOI 10.1016/j.yjmcc.2009.11.014; Burghardt Thomas P, 2010, Biophys Rev, V2, P159, DOI 10.1007/s12551-010-0038-z; Dominguez R, 1998, CELL, V94, P559, DOI 10.1016/S0092-8674(00)81598-6; HUXLEY HE, 1969, SCIENCE, V164, P1356, DOI 10.1126/science.164.3886.1356; Luther PK, 2011, P NATL ACAD SCI USA, V108, P11423, DOI 10.1073/pnas.1103216108; McConnell BK, 1999, J CLIN INVEST, V104, P1235, DOI 10.1172/JCI7377; Olivotto I, 2008, MAYO CLIN PROC, V83, P630, DOI 10.4065/83.6.630; Previs MJ, 2012, SCIENCE, V337, P1215, DOI 10.1126/science.1223602; RAYMENT I, 1993, SCIENCE, V261, P50, DOI 10.1126/science.8316857; Sadayappan S, 2009, CIRCULATION, V119, P1253, DOI 10.1161/CIRCULATIONAHA.108.798983; Sheikh F, 2012, J CLIN INVEST, V122, P1209, DOI 10.1172/JCI61134; STOUT AL, 1989, APPL OPTICS, V28, P5237, DOI 10.1364/AO.28.005237	13	3	3	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 7	2012	337	6099					1182	1183		10.1126/science.1227943	http://dx.doi.org/10.1126/science.1227943			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	000UJ	22955824				2022-12-28	WOS:000308414000024
J	Hawkes, N				Hawkes, Nigel			Andrew Lansley: unlucky or incompetent?	BRITISH MEDICAL JOURNAL			English	Editorial Material												nigel.hawkes1@btinternet.com						Corrigan P, 2012, A LANSLEY EPITAPH HL; Timmins N, 2012, NEVER AGAIN STORY HL; Wright O., 2012, INDEPENDENT	3	0	0	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	SEP 7	2012	345								e6067	10.1136/bmj.e6067	http://dx.doi.org/10.1136/bmj.e6067			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	003TM	22960464				2022-12-28	WOS:000308634200009
J	Morlon, H				Morlon, Helene			Microbial Cooperative Warfare	SCIENCE			English	Editorial Material							SOCIAL-BEHAVIOR; EVOLUTION; BACTERIAL		Ecole Polytech, CNRS, UMR 7641, Ctr Appl Math, F-91128 Palaiseau, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Mathematical Sciences (INSMI); Institut Polytechnique de Paris	Morlon, H (corresponding author), Ecole Polytech, CNRS, UMR 7641, Ctr Appl Math, Route Saclay Palaiseau, F-91128 Palaiseau, France.	helene.morlon@cmap.polytechnique.fr	Hélène, MORLON/AAM-4912-2020	Hélène, MORLON/0000-0002-3195-7521				Cordero OX, 2012, SCIENCE, V337, P1228, DOI 10.1126/science.1219385; Crespi BJ, 2001, TRENDS ECOL EVOL, V16, P178, DOI 10.1016/S0169-5347(01)02115-2; Czaran TL, 2002, P NATL ACAD SCI USA, V99, P786, DOI 10.1073/pnas.012399899; Freilich S, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1597; Gomez JM, 2010, NATURE, V465, P918, DOI 10.1038/nature09113; Griffin AS, 2004, NATURE, V430, P1024, DOI 10.1038/nature02744; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI [10.1016/0022-5193(64)90038-4, 10.1016/0022-5193(64)90039-6]; Hunt DE, 2008, SCIENCE, V320, P1081, DOI 10.1126/science.1157890; Kerr B, 2002, NATURE, V418, P171, DOI 10.1038/nature00823; Lee HH, 2010, NATURE, V467, P82, DOI 10.1038/nature09354; Riley MA, 2002, ANNU REV MICROBIOL, V56, P117, DOI 10.1146/annurev.micro.56.012302.161024; Steele JA, 2011, ISME J, V5, P1414, DOI 10.1038/ismej.2011.24; Vetsigian K, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001184; West SA, 2006, NAT REV MICROBIOL, V4, P597, DOI 10.1038/nrmicro1461	14	9	10	0	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 7	2012	337	6099					1184	1185		10.1126/science.1227512	http://dx.doi.org/10.1126/science.1227512			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	000UJ	22955826				2022-12-28	WOS:000308414000026
J	Previs, MJ; Previs, SB; Gulick, J; Robbins, J; Warshaw, DM				Previs, M. J.; Previs, S. Beck; Gulick, J.; Robbins, J.; Warshaw, D. M.			Molecular Mechanics of Cardiac Myosin-Binding Protein C in Native Thick Filaments	SCIENCE			English	Article							KINASE-A PHOSPHORYLATION; CMYBP-C; MUSCLE; ACTIN; ACCELERATION; ACTIVATION; MICROSCOPY; KNOCKOUT; DOMAIN	The heart's pumping capacity results from highly regulated interactions of actomyosin molecular motors. Mutations in the gene for a potential regulator of these motors, cardiac myosin-binding protein C (cMyBP-C), cause hypertrophic cardiomyopathy. However, cMyBP-C's ability to modulate cardiac contractility is not well understood. Using single-particle fluorescence imaging techniques, transgenic protein expression, proteomics, and modeling, we found that cMyBP-C slowed actomyosin motion generation in native cardiac thick filaments. This mechanical effect was localized to where cMyBP-C resides within the thick filament (i.e., the C-zones) and was modulated by phosphorylation and site-specific proteolytic degradation. These results provide molecular insight into why cMyBP-C should be considered a member of a tripartite complex with actin and myosin that allows fine tuning of cardiac muscle contraction.	[Previs, M. J.; Previs, S. Beck; Warshaw, D. M.] Univ Vermont, Dept Mol Physiol & Biophys, Burlington, VT 05405 USA; [Gulick, J.; Robbins, J.] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Cincinnati, OH 45229 USA; [Gulick, J.; Robbins, J.] Cincinnati Childrens Hosp Med Ctr, Inst Heart, Cincinnati, OH 45229 USA	University of Vermont; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center	Warshaw, DM (corresponding author), Univ Vermont, Dept Mol Physiol & Biophys, Burlington, VT 05405 USA.	david.warshaw@uvm.edu			NIH [HL007647, HL059408]; Vermont Genetics Network [8P20GM103449]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL059408, R01HL086728] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103449] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vermont Genetics Network; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	NIH funds supported M. P. (HL007647); J.G., J.R., and D. W. (HL059408); and the Vermont Genetics Network for the LC-MS instrumentation (8P20GM103449). We thank B. Palmer and Y. Wang for mouse colony management; S. Tremble for technical assistance; M. Jennings for LC-MS expertise; M. Von Turkovich and the University of Vermont Microscopy Imaging Center for electron microscopy assistance; and G. Kennedy, from the Instrumentation and Modeling Facility, for imaging expertise. Data described in the paper are presented in the supplementary materials.	Decker RS, 2005, CIRCULATION, V111, P906, DOI 10.1161/01.CIR.0000155609.95618.75; GAUTEL M, 1995, EMBO J, V14, P1952, DOI 10.1002/j.1460-2075.1995.tb07187.x; Govindan S, 2012, J MOL CELL CARDIOL, V52, P154, DOI 10.1016/j.yjmcc.2011.09.011; Harris SP, 2011, CIRC RES, V108, P751, DOI 10.1161/CIRCRESAHA.110.231670; HOFMANN PA, 1991, J PHYSIOL-LONDON, V439, P701, DOI 10.1113/jphysiol.1991.sp018689; Jacques AM, 2008, J MOL CELL CARDIOL, V45, P209, DOI 10.1016/j.yjmcc.2008.05.020; Jia WT, 2010, J PROTEOME RES, V9, P1843, DOI 10.1021/pr901006h; Karsai A, 2011, BIOPHYS J, V101, P1968, DOI 10.1016/j.bpj.2011.08.030; Korte FS, 2003, CIRC RES, V93, P752, DOI 10.1161/01.RES.0000096363.85588.9A; Luther PK, 2008, J MOL BIOL, V384, P60, DOI 10.1016/j.jmb.2008.09.013; Luther PK, 2011, P NATL ACAD SCI USA, V108, P11423, DOI 10.1073/pnas.1103216108; Mun JY, 2011, J MOL BIOL, V410, P214, DOI 10.1016/j.jmb.2011.05.010; Ratti J, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.156646; Razumova MV, 2006, J BIOL CHEM, V281, P35846, DOI 10.1074/jbc.M606949200; Sadayappan S, 2005, CIRC RES, V97, P1156, DOI 10.1161/01.RES.0000190605.79013.4d; Sadayappan S, 2006, P NATL ACAD SCI USA, V103, P16918, DOI 10.1073/pnas.0607069103; Sadayappan S, 2009, CIRCULATION, V119, P1253, DOI 10.1161/CIRCULATIONAHA.108.798983; Stelzer JE, 2006, CIRC RES, V99, P884, DOI 10.1161/01.RES.0000245191.34690.66; Tong CW, 2008, CIRC RES, V103, P974, DOI 10.1161/CIRCRESAHA.108.177683; Weith A, 2012, J MOL CELL CARDIOL, V52, P219, DOI 10.1016/j.yjmcc.2011.09.019; Winegrad S, 1999, CIRC RES, V84, P1117, DOI 10.1161/01.RES.84.10.1117; Zoghbi ME, 2008, P NATL ACAD SCI USA, V105, P2386, DOI 10.1073/pnas.0708912105	22	119	121	0	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 7	2012	337	6099					1215	1218		10.1126/science.1223602	http://dx.doi.org/10.1126/science.1223602			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	000UJ	22923435	Green Accepted			2022-12-28	WOS:000308414000035
J	Rodwin, MA; Abramson, JD				Rodwin, Marc A.; Abramson, John D.			Clinical Trial Data as a Public Good	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Rodwin, Marc A.] Harvard Univ, Edmond J Safra Ctr Eth, Cambridge, MA 02138 USA; [Rodwin, Marc A.] Suffolk Univ, Sch Law, Boston, MA 02114 USA; [Abramson, John D.] Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA	Harvard University; Suffolk University; Harvard University; Harvard Medical School	Rodwin, MA (corresponding author), Harvard Univ, Edmond J Safra Ctr Eth, 124 Mt Auburn St,Ste 520N, Cambridge, MA 02138 USA.	mrodwin@ethics.harvard.edu						Department of Health and Human Services, 1996, FED REGISTER, V61, P37320; Doshi P, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001201; Dwan K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003081; Graham DY, 2011, AM J MED SCI, V342, P356, DOI 10.1097/MAJ.0b013e3182113658; Kesselheim AS, 2007, HEALTH AFFAIR, V26, P483, DOI 10.1377/hlthaff.26.2.483; Krumholz HM, 2011, JAMA-J AM MED ASSOC, V306, P1593, DOI 10.1001/jama.2011.1459; Mathieu S, 2009, JAMA-J AM MED ASSOC, V302, P977, DOI 10.1001/jama.2009.1242; Turner EH, 2004, PLOS MED, V1, P180, DOI 10.1371/journal.pmed.0010060; Vedula SS, 2009, NEW ENGL J MED, V361, P1963, DOI 10.1056/NEJMsa0906126	9	37	37	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 5	2012	308	9					871	872		10.1001/jama.2012.9661	http://dx.doi.org/10.1001/jama.2012.9661			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	999ET	22948695				2022-12-28	WOS:000308292900015
J	Emanuel, M; Rawlins, M; Duff, G; Breckenridge, A				Emanuel, Michael; Rawlins, Michael; Duff, Gordon; Breckenridge, Alasdair			Thalidomide and its sequelae	LANCET			English	Editorial Material									[Breckenridge, Alasdair] Med & Healthcare Prod Regulatory Agcy, London SW1W 9SZ, England; [Emanuel, Michael] Oxford Brookes Univ, Ctr Hlth Med & Soc, Oxford OX3 0BP, England; [Rawlins, Michael] Natl Inst Hlth & Clin Excellence, Oxford, England; [Duff, Gordon] Univ Sheffield, Dept Med, Sheffield, S Yorkshire, England	The Medicines & Healthcare Products Regulatory Agency; Oxford Brookes University; National Institute for Health & Care Excellence; University of Sheffield	Breckenridge, A (corresponding author), Med & Healthcare Prod Regulatory Agcy, London SW1W 9SZ, England.	alasdair.breckenridge@mhra.gsi.gov.uk						[Anonymous], 2012, LANCET, V379, P2402; BARTRIP P, 1992, MED HIST, V36, P53, DOI 10.1017/S0025727300054624; Bombardier C, 2000, NEW ENGL J MED, V343, P1520, DOI 10.1056/NEJM200011233432103; Dunn JH, 1938, FEDERAL FOOD DRUG CO; KRANTZ JC, 1966, J NEW DRUGS, V6, P77; Mann RD, 1984, MODERN DRUG USE ENQU, P606; Mann RD, 1984, MODERN DRUG USE ENQU, P598; MCBRIDE WG, 1961, LANCET, V2, P1358; Quirke V, 2009, PREPRINT, V363, P125; Suntharalingam G, 2006, NEW ENGL J MED, V355, P1018, DOI 10.1056/NEJMoa063842; Tansey EM, 1997, WELLCOME WITNESSES 2, V1, P103	11	18	18	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 1	2012	380	9844					781	783		10.1016/S0140-6736(12)60468-1	http://dx.doi.org/10.1016/S0140-6736(12)60468-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	000OP	22939670				2022-12-28	WOS:000308396300004
J	Andersson, LS; Larhammar, M; Memic, F; Wootz, H; Schwochow, D; Rubin, CJ; Patra, K; Arnason, T; Wellbring, L; Hjalm, G; Imsland, F; Petersen, JL; McCue, ME; Mickelson, JR; Cothran, G; Ahituv, N; Roepstorff, L; Mikko, S; Vallstedt, A; Lindgren, G; Andersson, L; Kullander, K				Andersson, Lisa S.; Larhammar, Martin; Memic, Fatima; Wootz, Hanna; Schwochow, Doreen; Rubin, Carl-Johan; Patra, Kalicharan; Arnason, Thorvaldur; Wellbring, Lisbeth; Hjalm, Goran; Imsland, Freyja; Petersen, Jessica L.; McCue, Molly E.; Mickelson, James R.; Cothran, Gus; Ahituv, Nadav; Roepstorff, Lars; Mikko, Sofia; Vallstedt, Anna; Lindgren, Gabriella; Andersson, Leif; Kullander, Klas			Mutations in DMRT3 affect locomotion in horses and spinal circuit function in mice	NATURE			English	Article							LAMINA-VIII INTERNEURONS; PATTERN GENERATION; CORD; NETWORKS; DIFFERENTIATION; PATHWAYS; WALKING; GENES; CAT	Locomotion in mammals relies on a central pattern-generating circuitry of spinal interneurons established during development that coordinates limb movement(1). These networks produce left-right alternation of limbs as well as coordinated activation of flexor and extensor muscles(2). Here we show that a premature stop codon in the DMRT3 gene has a major effect on the pattern of locomotion in horses. The mutation is permissive for the ability to perform alternate gaits and has a favourable effect on harness racing performance. Examination of wild-type and Dmrt3-null mice demonstrates that Dmrt3 is expressed in the dI6 subdivision of spinal cord neurons, takes part in neuronal specification within this subdivision, and is critical for the normal development of a coordinated locomotor network controlling limb movements. Our discovery positions Dmrt3 in a pivotal role for configuring the spinal circuits controlling stride in vertebrates. The DMRT3 mutation has had a major effect on the diversification of the domestic horse, as the altered gait characteristics of a number of breeds apparently require this mutation.	[Andersson, Lisa S.; Schwochow, Doreen; Wellbring, Lisbeth; Mikko, Sofia; Lindgren, Gabriella; Andersson, Leif] Swedish Univ Agr Sci, Dept Anim Breeding & Genet, SE-75124 Uppsala, Sweden; [Larhammar, Martin; Memic, Fatima; Wootz, Hanna; Patra, Kalicharan; Vallstedt, Anna; Kullander, Klas] Uppsala Univ, Dept Neurosci, SE-75124 Uppsala, Sweden; [Rubin, Carl-Johan; Hjalm, Goran; Imsland, Freyja; Andersson, Leif] Uppsala Univ, Dept Med Biochem & Microbiol, SE-75123 Uppsala, Sweden; [Arnason, Thorvaldur] Agr Univ Iceland, Fac Land & Anim Resources, IS-311 Borgarnes, Iceland; [Petersen, Jessica L.; McCue, Molly E.; Mickelson, James R.] Univ Minnesota, Coll Vet Med, St Paul, MN 55108 USA; [Cothran, Gus] Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Vet Integrat Biosci, College Stn, TX 77483 USA; [Ahituv, Nadav] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA; [Ahituv, Nadav] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA; [Roepstorff, Lars] Swedish Univ Agr Sci, Unit Equine Studies, SE-75007 Uppsala, Sweden	Swedish University of Agricultural Sciences; Uppsala University; Uppsala University; University of Minnesota System; University of Minnesota Twin Cities; Texas A&M University System; Texas A&M University College Station; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Swedish University of Agricultural Sciences	Andersson, LS (corresponding author), Swedish Univ Agr Sci, Dept Anim Breeding & Genet, SE-75124 Uppsala, Sweden.	leif.andersson@imbim.uu.se	Petersen, Jessica/ABF-2462-2020; Mikko, Sofia/F-1347-2017	Petersen, Jessica/0000-0001-5438-8555; Mikko, Sofia/0000-0002-6375-1376; Roepstorff, Lars/0000-0002-4109-9284; Lindgren, Gabriella/0000-0001-6046-9669; Imsland, Freyja/0000-0002-9452-5566; Kullander, Klas/0000-0001-6418-5460; Ahituv, Nadav/0000-0002-7434-8144; Mickelson, James/0000-0001-6951-0234; McCue, Molly/0000-0002-6807-0318; Rubin, Carl-Johan/0000-0001-8238-5052	Swedish Foundation for Strategic Research; Swedish Research Council Formas [221-2009-1631]; Swedish Research Council Medicine and Health [2007-3630/4479, 2010-4394]; Swedish Society for Medical Research; National Institute of Child Health & Human Development [R01HD059862]; Swedish Brain Foundation; Uppsala University and Hospital, SciLife Lab - Uppsala and the Swedish Research Council [80576801, 70374401]; Knut and Alice Wallenberg Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD059862] Funding Source: NIH RePORTER	Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Swedish Research Council Formas(Swedish Research CouncilSwedish Research Council Formas); Swedish Research Council Medicine and Health; Swedish Society for Medical Research; National Institute of Child Health & Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Swedish Brain Foundation; Uppsala University and Hospital, SciLife Lab - Uppsala and the Swedish Research Council; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Thanks to S. Mikulovic and E. Restrepo for valuable input, C. Birchmeier for Lbx1 antibody, L. Enquist and J. Martin for PRV152, S. Ewart for horse samples, and B. Agerup for access to race horses. The work was supported by grants from the Swedish Foundation for Strategic Research, the Swedish Research Council Formas (221-2009-1631), Swedish Research Council Medicine and Health (2007-3630/4479, 2010-4394), Swedish Society for Medical Research (H. W.), National Institute of Child Health & Human Development R01HD059862 (N.A.), and the Swedish Brain Foundation. Sequencing was performed by the SNP&SEQ Technology Platform, supported by Uppsala University and Hospital, SciLife Lab - Uppsala and the Swedish Research Council (80576801 and 70374401). Computer resources were supplied by UPPMAX. K. K. is a Royal Swedish Academy of Sciences Research Fellow supported by a grant from the Knut and Alice Wallenberg Foundation.	Ahituv N, 2007, PLOS BIOL, V5, P1906, DOI 10.1371/journal.pbio.0050234; Alaynick WA, 2011, CELL, V146, P178, DOI 10.1016/j.cell.2011.06.038; Albertsdottir E, 2011, J ANIM BREED GENET, V128, P124, DOI 10.1111/j.1439-0388.2010.00902.x; Burrill JD, 1997, DEVELOPMENT, V124, P4493; COWLEY KC, 1995, J NEUROPHYSIOL, V74, P1109, DOI 10.1152/jn.1995.74.3.1109; Culbertson MR, 2003, CURR OPIN GENET DEV, V13, P207, DOI 10.1016/S0959-437X(03)00014-5; Gallarda BW, 2010, ANN NY ACAD SCI, V1198, P133, DOI 10.1111/j.1749-6632.2010.05437.x; Gezelius H, 2006, J PHYSIOL-PARIS, V100, P297, DOI 10.1016/j.jphysparis.2007.05.001; Goulding M, 2009, NAT REV NEUROSCI, V10, P507, DOI 10.1038/nrn2608; GRILLNER S, 1980, ACTA PHYSIOL SCAND, V110, P103, DOI 10.1111/j.1748-1716.1980.tb06637.x; Grillner S, 2006, NEURON, V52, P751, DOI 10.1016/j.neuron.2006.11.008; Gross MK, 2002, NEURON, V34, P535, DOI 10.1016/S0896-6273(02)00690-6; HARRISON PJ, 1986, J PHYSIOL-LONDON, V371, P147, DOI 10.1113/jphysiol.1986.sp015965; Hong CS, 2007, DEV BIOL, V310, P1, DOI 10.1016/j.ydbio.2007.07.035; JANKOWSKA E, 1990, BRAIN RES, V535, P327, DOI 10.1016/0006-8993(90)91618-Q; Jankowska E, 2005, J PHYSIOL-LONDON, V565, P645, DOI 10.1113/jphysiol.2005.083014; JOSTES B, 1990, MECH DEVELOP, V33, P27, DOI 10.1016/0925-4773(90)90132-6; Jovanovic K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011743; Kullander K, 2005, TRENDS NEUROSCI, V28, P239, DOI 10.1016/j.tins.2005.03.001; Kullander K, 2003, SCIENCE, V299, P1889, DOI 10.1126/science.1079641; Lanuza GM, 2004, NEURON, V42, P375, DOI 10.1016/S0896-6273(04)00249-1; Mor Y, 2007, J NEUROPHYSIOL, V98, P2807, DOI 10.1152/jn.00740.2007; Moran-Rivard L, 2001, NEURON, V29, P385, DOI 10.1016/S0896-6273(01)00213-6; Muller T, 2002, NEURON, V34, P551, DOI 10.1016/S0896-6273(02)00689-X; Pierani A, 2001, NEURON, V29, P367, DOI 10.1016/S0896-6273(01)00212-4; Rabe N, 2009, J NEUROSCI, V29, P15642, DOI 10.1523/JNEUROSCI.5096-09.2009; Vallstedt A, 2001, NEURON, V31, P743, DOI 10.1016/S0896-6273(01)00412-3	27	255	269	1	100	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 30	2012	488	7413					642	646		10.1038/nature11399	http://dx.doi.org/10.1038/nature11399			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996NC	22932389	Green Accepted, hybrid, Green Published			2022-12-28	WOS:000308095100053
J	Levendorf, MP; Kim, CJ; Brown, L; Huang, PY; Havener, RW; Muller, DA; Park, J				Levendorf, Mark P.; Kim, Cheol-Joo; Brown, Lola; Huang, Pinshane Y.; Havener, Robin W.; Muller, David A.; Park, Jiwoong			Graphene and boron nitride lateral heterostructures for atomically thin circuitry	NATURE			English	Article							CHEMICAL-VAPOR-DEPOSITION; MONOLAYER GRAPHENE; GRAIN-BOUNDARIES; HIGH-QUALITY; TRANSISTORS; GROWTH; FILMS	Precise spatial control over the electrical properties of thin films is the key capability enabling the production of modern integrated circuitry. Although recent advances in chemical vapour deposition methods have enabled the large-scale production of both intrinsic and doped graphene(1-6), as well as hexagonal boron nitride (h-BN)(7-10), controlled fabrication of lateral heterostructures in these truly atomically thin systems has not been achieved. Graphene/h-BN interfaces are of particular interest, because it is known that areas of different atomic compositions may coexist within continuous atomically thin films(5,10) and that, with proper control, the bandgap and magnetic properties can be precisely engineered(11-13). However, previously reported approaches for controlling these interfaces have fundamental limitations and cannot be easily integrated with conventional lithography(14-16). Here we report a versatile and scalable process, which we call 'patterned regrowth', that allows for the spatially controlled synthesis of lateral junctions between electrically conductive graphene and insulating h-BN, as well as between intrinsic and substitutionally doped graphene. We demonstrate that the resulting films form mechanically continuous sheets across these heterojunctions. Conductance measurements confirm laterally insulating behaviour for h-BN regions, while the electrical behaviour of both doped and undoped graphene sheets maintain excellent properties, with low sheet resistances and high carrier mobilities. Our results represent an important step towards developing atomically thin integrated circuitry and enable the fabrication of electrically isolated active and passive elements embedded in continuous, one-atom-thick sheets, which could be manipulated and stacked to form complex devices at the ultimate thickness limit.	[Levendorf, Mark P.; Kim, Cheol-Joo; Brown, Lola; Park, Jiwoong] Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14853 USA; [Huang, Pinshane Y.; Havener, Robin W.; Muller, David A.] Cornell Univ, Sch Appl & Engn Phys, Ithaca, NY 14853 USA; [Muller, David A.; Park, Jiwoong] Cornell Nanoscale Sci, Kavli Inst, Ithaca, NY 14853 USA	Cornell University; Cornell University	Park, J (corresponding author), Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14853 USA.	jpark@cornell.edu	Park, Jiwoong/C-2327-2013; Muller, David/A-7745-2010; Kim, Cheol-Joo/A-2217-2010	Muller, David/0000-0003-4129-0473; Huang, Pinshane/0000-0002-1095-1833; Kim, Cheol-Joo/0000-0002-4312-3866	AFOSR [FA9550-09-1-0691, FA9550-10-1-0410]; NSF through the Cornell Centers for Materials Research [NSF DMR-1120296]; Alfred P. Sloan Foundation; Fullbright scholarship; NSF Graduate Research Fellowship; National Science Foundation [ECS-0335765]	AFOSR(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); NSF through the Cornell Centers for Materials Research; Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); Fullbright scholarship; NSF Graduate Research Fellowship(National Science Foundation (NSF)); National Science Foundation(National Science Foundation (NSF))	We thank P. McEuen and M. Spencer for discussions. This work was mainly supported by AFOSR grants (FA9550-09-1-0691 and FA9550-10-1-0410) and the NSF through the Cornell Centers for Materials Research (NSF DMR-1120296), which also provided the electron microscopy facilities. Additional funding was provided by the Alfred P. Sloan Foundation. L. B. was partially supported by a Fullbright scholarship; R. W. H. and P.Y.H. were supported by an NSF Graduate Research Fellowship. Device fabrication was performed at the Cornell NanoScale Facility, a member of the National Nanotechnology Infrastructure Network, which is supported by the National Science Foundation (grant ECS-0335765).	Britnell L, 2012, NANO LETT, V12, P1707, DOI 10.1021/nl3002205; Chen SS, 2011, ACS NANO, V5, P1321, DOI 10.1021/nn103028d; Ci L, 2010, NAT MATER, V9, P430, DOI [10.1038/nmat2711, 10.1038/NMAT2711]; Dean CR, 2010, NAT NANOTECHNOL, V5, P722, DOI 10.1038/nnano.2010.172; Dresselhaus MS, 2010, NANO LETT, V10, P751, DOI 10.1021/nl904286r; Huang PY, 2011, NATURE, V469, P389, DOI 10.1038/nature09718; Jin Z, 2011, ACS NANO, V5, P4112, DOI 10.1021/nn200766e; Kim KK, 2012, NANO LETT, V12, P161, DOI 10.1021/nl203249a; Kim K, 2011, ACS NANO, V5, P2142, DOI 10.1021/nn1033423; Kim YJ, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3266836; Kubota Y, 2007, SCIENCE, V317, P932, DOI 10.1126/science.1144216; Lee GH, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3662043; Li XS, 2009, SCIENCE, V324, P1312, DOI 10.1126/science.1171245; Liang XL, 2011, ACS NANO, V5, P9144, DOI 10.1021/nn203377t; Liu YY, 2011, NANO LETT, V11, P3113, DOI 10.1021/nl2011142; Meric I, 2008, NAT NANOTECHNOL, V3, P654, DOI 10.1038/nnano.2008.268; MIYAMOTO Y, 1994, PHYS REV B, V50, P4976, DOI 10.1103/PhysRevB.50.4976; Moser J, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2789673; Novoselov KS, 2005, NATURE, V438, P197, DOI 10.1038/nature04233; Novoselov KS, 2004, SCIENCE, V306, P666, DOI 10.1126/science.1102896; Pruneda JM, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.161409; Radisavljevic B, 2011, NAT NANOTECHNOL, V6, P147, DOI [10.1038/nnano.2010.279, 10.1038/NNANO.2010.279]; Sanchez-Yamagishi JD, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.076601; Song L, 2010, NANO LETT, V10, P3209, DOI 10.1021/nl1022139; Sun ZZ, 2010, NATURE, V468, P549, DOI 10.1038/nature09579; Tsen AW, 2012, SCIENCE, V336, P1143, DOI 10.1126/science.1218948; Wehling TO, 2008, NANO LETT, V8, P173, DOI [10.1021/nl072364w, 10.1021/nL072364w]; Williams JR, 2007, SCIENCE, V317, P638, DOI 10.1126/science.1144657; Yu QK, 2011, NAT MATER, V10, P443, DOI [10.1038/NMAT3010, 10.1038/nmat3010]; Zhang YB, 2005, NATURE, V438, P201, DOI 10.1038/nature04235; Zhao LY, 2011, SCIENCE, V333, P999, DOI 10.1126/science.1208759	31	667	683	18	880	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 30	2012	488	7413					627	632		10.1038/nature11408	http://dx.doi.org/10.1038/nature11408			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996NC	22932386				2022-12-28	WOS:000308095100050
J	Nisselle, P				Nisselle, Paul			Rising litigation does not mean falling standards	BRITISH MEDICAL JOURNAL			English	Editorial Material									Med Protect Soc Ltd, Educ Serv, London W1G 0PS, England		Nisselle, P (corresponding author), Med Protect Soc Ltd, Educ Serv, 33 Cavendish Sq, London W1G 0PS, England.	paul.nisselle@mps.org.uk						Ford ES, 2007, NEW ENGL J MED, V356, P2388, DOI 10.1056/NEJMsa053935; Fuchs VR, 2012, NEW ENGL J MED, V366, P973, DOI 10.1056/NEJMp1200478; Leonhardt D, 2009, NY TIMES; Nader R., 1965, UNSAFE ANY SPEED DES; The National Health Service Litigation Authority, 2011, REP ACC 2010 2011	5	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	AUG 28	2012	345								e5760	10.1136/bmj.e5760	http://dx.doi.org/10.1136/bmj.e5760			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	036SJ	22930704				2022-12-28	WOS:000311050500007
J	Hastings, G				Hastings, Gerard			Why corporate power is a public health priority	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Hastings, Gerard] Univ Stirling, Inst Social Mkt, Stirling FK9 4LA, Scotland; [Hastings, Gerard] Open Univ, Stirling FK9 4LA, Scotland	University of Stirling; Open University - UK	Hastings, G (corresponding author), Univ Stirling, Inst Social Mkt, Stirling FK9 4LA, Scotland.	gerard.hastings@stir.ac.uk			Medical Research Council [G0501282, MR/J000523/1] Funding Source: Medline; MRC [G0501282, MR/J000523/1] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Anderson P, 2009, ALCOHOL ALCOHOLISM, V44, P229, DOI 10.1093/alcalc/agn115; Bakan Joel, 2004, CORPORATION PATHOLOG; Bradshaw T., 2011, FINANCIAL TIMES; CAIRNS G, 2009, EXTENT NATURE EFFECT; Collingwood Learning, CAS STUD SMASH RESP; Foxall G., 1994, CONSUMER PSYCHOL MAR; Framework Convention on Tobacco Control, TREAT; Grant IC, 2008, INT J NONPROFIT VOLU, V13, P275, DOI 10.1002/nvsm.329; Hastings G, 2010, BRIT MED J, V340, DOI 10.1136/bmj.b5650; Hill L, 2005, GAPA SHORE M AS PAC; Jahiel RI, 2007, ADDICTION, V102, P1335, DOI 10.1111/j.1360-0443.2007.01900.x; Lovato Chris, 2011, Cochrane Database Syst Rev, pCD003439, DOI 10.1002/14651858.CD003439.pub2; Marmot M, 2005, LANCET, V365, P1099, DOI 10.1016/S0140-6736(05)74234-3; Porter M., 2011, HARVARD BUSINESS REV; Rayner G, 2012, ECOLOGICAL PUBLIC HEALTH: RESHAPING THE CONDITIONS FOR GOOD HEALTH, P1; Richter Judith, 2012, SOCIAL MED, V6, P141; Robinson TN, 2007, ARCH PEDIAT ADOL MED, V161, P792, DOI 10.1001/archpedi.161.8.792; University of Stirling, DEAL DRUGS AN PHARM; Walker G, 2012, CONVENIENCE STO 0608, P53; Wensley R, 2003, MARKETING BOOK, P53; Wilkinson R., 2010, SPIRIT LEVEL WHY EQU	21	83	83	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 21	2012	345								e5124	10.1136/bmj.e5124	http://dx.doi.org/10.1136/bmj.e5124			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	996GP	22915664	Green Submitted			2022-12-28	WOS:000308073200010
J	Rao, VM; Levin, DC				Rao, Vijay M.; Levin, David C.			The Overuse of Diagnostic Imaging and the Choosing Wisely Initiative	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							MANAGEMENT; PHYSICIANS; POLICY; CARE		[Rao, Vijay M.] Thomas Jefferson Univ Hosp, Dept Radiol, Philadelphia, PA 19107 USA	Jefferson University	Rao, VM (corresponding author), Thomas Jefferson Univ Hosp, Dept Radiol, 132 S 10th St,Suite 1087 Main, Philadelphia, PA 19107 USA.	vijay.rao@jefferson.edu						[Anonymous], 2012, NY TIMES; Bautista AB, 2009, AM J ROENTGENOL, V192, P1581, DOI 10.2214/AJR.08.1622; Cassel CK, 2012, JAMA-J AM MED ASSOC, V307, P1801, DOI 10.1001/jama.2012.476; Childs A W, 1972, Med Care, V10, P323, DOI 10.1097/00005650-197207000-00005; HILLMAN BJ, 1992, JAMA-J AM MED ASSOC, V268, P2050, DOI 10.1001/jama.268.15.2050; Hughes DR, 2010, HEALTH AFFAIR, V29, P2244, DOI 10.1377/hlthaff.2010.0413; Iglehart JK, 2009, NEW ENGL J MED, V360, P1030, DOI 10.1056/NEJMhpr0808703; Jaslow R, 2012, CBS NEWS        0404; Laine C, 2012, ANN INTERN MED, V156, P162, DOI 10.7326/0003-4819-156-2-201201170-00016; Levin DC, 2012, J AM COLL RADIOL, V9, P643, DOI 10.1016/j.jacr.2012.05.004; Levin DC, 2011, AM J ROENTGENOL, V196, P848, DOI 10.2214/AJR.10.5823; Levin DC, 2011, AM J ROENTGENOL, V196, pW25, DOI 10.2214/AJR.10.4835; Levin DC, 2010, J AM COLL RADIOL, V7, P33, DOI 10.1016/j.jacr.2009.09.012; Levin DC, 2010, HEALTH AFFAIR, V29, P189, DOI 10.1377/hlthaff.2009.0528; Levin DC, 2012, J AM COLL R IN PRESS; Mitchell JM, 2009, MED CARE RES REV, V66, P339, DOI 10.1177/1077558709332055; Plans AsHI,, 2008, ENS QUAL APPR US DIA; Qaseem A, 2012, ANN INTERN MED, V156, P147, DOI 10.7326/0003-4819-156-2-201201170-00011; Rabin Roni Caryn, 2012, NY TIMES; Sistrom CL, 2009, RADIOLOGY, V251, P147, DOI 10.1148/radiol.2511081174	20	124	127	0	10	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 16	2012	157	8					574	+		10.7326/0003-4819-157-8-201210160-00535	http://dx.doi.org/10.7326/0003-4819-157-8-201210160-00535			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	021SP	22928172				2022-12-28	WOS:000309906000019
J	de Vanssay, A; Bouge, AL; Boivin, A; Hermant, C; Teysset, L; Delmarre, V; Antoniewski, C; Ronsseray, S				de Vanssay, Augustin; Bouge, Anne-Laure; Boivin, Antoine; Hermant, Catherine; Teysset, Laure; Delmarre, Valerie; Antoniewski, Christophe; Ronsseray, Stephane			Paramutation in Drosophila linked to emergence of a piRNA-producing locus	NATURE			English	Article							P-ELEMENT REPRESSION; HETEROCHROMATIN FORMATION; B1 LOCUS; MAIZE; MELANOGASTER; TRANS; GENE; ESTABLISHMENT; SEQUENCES; CYTOTYPE	A paramutation is an epigenetic interaction between two alleles of a locus, through which one allele induces a heritable modification in the other allele without modifying the DNA sequence(1,2). The paramutated allele itself becomes paramutagenic, that is, capable of epigenetically converting a new paramutable allele. Here we describe a case of paramutation in animals showing long-term transmission over generations. We previously characterized a homology-dependent silencing mechanism referred to as the trans-silencing effect (TSE), involved in P-transposable-element repression in the germ line(3-5). We now show that clusters of P-element-derived transgenes that induce strong TSE6,7 can convert other homologous transgene clusters incapable of TSE into strong silencers, which transmit the acquired silencing capacity through 50 generations. The paramutation occurs without any need for chromosome pairing between the paramutagenic and the paramutated loci, and is mediated by maternal inheritance of cytoplasm carrying Piwi-interacting RNAs (piRNAs) homologous to the transgenes. The repression capacity of the paramutated locus is abolished by a loss-of-function mutation of the aubergine gene involved in piRNA biogenesis, but not by a loss-of-function mutation of the Dicer-2 gene involved in siRNA production. The paramutated cluster, previously producing barely detectable levels of piRNAs, is converted into a stable, strong piRNA-producing locus by the paramutation and becomes fully paramutagenic itself. Our work provides a genetic model for the emergence of piRNA loci, as well as for RNA-mediated trans-generational repression of transposable elements.	[de Vanssay, Augustin; Boivin, Antoine; Hermant, Catherine; Teysset, Laure; Delmarre, Valerie; Ronsseray, Stephane] Univ Paris 06, CNRS, UMR7622, Dev Biol Lab, F-75005 Paris, France; [Bouge, Anne-Laure; Antoniewski, Christophe] Inst Pasteur, CNRS, URA2578, F-75015 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Ronsseray, S (corresponding author), Univ Paris 06, CNRS, UMR7622, Dev Biol Lab, 9 Quai St Bernard, F-75005 Paris, France.	christophe.antoniewski@upmc.fr; stephane.ronsseray@upmc.fr	Antoniewski, Christophe/G-4519-2011; Ronsseray, Stephane/AAD-6378-2021	Antoniewski, Christophe/0000-0001-7709-2116; Hermant, catherine/0000-0002-3906-2546; Teysset, Laure/0000-0002-7413-1850; Boivin, Antoine/0000-0001-8671-1599	Ministere de l'Enseignement Superieur et de la Recherche; Fondation pour la Recherche Medicale; Association Nationale de la Recherche (ANR); Association pour la Recherche contre le Cancer; ANR (project "Nuclear endosiRNAs")	Ministere de l'Enseignement Superieur et de la Recherche; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Association Nationale de la Recherche (ANR)(French National Research Agency (ANR)); Association pour la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); ANR (project "Nuclear endosiRNAs")(French National Research Agency (ANR))	We thank O. Sismeiro, J.-Y. Copee, E. Mouchel-Vielh, V. Ribeiro, C. Pappatico and P. Graca for technical assistance, D. Dorer, S. Henikoff and the Bloomington Stock Center for providing stocks, and flybase.org for providing databases. We thank T. Josse for preliminary experiments. We thank J.-R. Huynh, V. Colot, N. Randsholt, A.-M. Pret, C. Carre and F. Peronnet for critical reading of the manuscript. S.R. thanks D. Anxolabehere and M. Lehmann for previous help. This work was supported by fellowships from the Ministere de l'Enseignement Superieur et de la Recherche to A.d.V. and C.H., from the Fondation pour la Recherche Medicale to A.d.V., from the Association Nationale de la Recherche (ANR) to A.-L.B., and by grants from the Association pour la Recherche contre le Cancer to S.R. and from the ANR (project "Nuclear endosiRNAs") to C.A.	Alleman M, 2006, NATURE, V442, P295, DOI 10.1038/nature04884; Arteaga-Vazquez M, 2010, P NATL ACAD SCI USA, V107, P12986, DOI 10.1073/pnas.1007972107; BIER E, 1989, GENE DEV, V3, P1273, DOI 10.1101/gad.3.9.1273; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; BRINK RA, 1956, GENETICS, V41, P872; Chandler VL, 2007, CELL, V128, P641, DOI 10.1016/j.cell.2007.02.007; COE EH, 1959, P NATL ACAD SCI USA, V45, P828, DOI 10.1073/pnas.45.6.828; Czech B, 2008, NATURE, V453, P798, DOI 10.1038/nature07007; DORER DR, 1994, CELL, V77, P993, DOI 10.1016/0092-8674(94)90439-1; Dorer DR, 1997, GENETICS, V147, P1181; Dorweiler JE, 2000, PLANT CELL, V12, P2101, DOI 10.1105/tpc.12.11.2101; Engels W. R., 1989, P ELEMENTS DROSOPHIL; Grandjean V, 2009, DEVELOPMENT, V136, P3647, DOI 10.1242/dev.041061; Harris AN, 2001, DEVELOPMENT, V128, P2823; HOLLICK JB, 1995, GENETICS, V141, P709; Josse T, 2007, PLOS GENET, V3, P1633, DOI 10.1371/journal.pgen.0030158; Josse T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003249; KIDWELL MG, 1977, GENETICS, V86, P813; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2; LEMAITRE B, 1993, GENETICS, V135, P149; Marin L, 2000, GENETICS, V155, P1841; Muerdter F, 2012, RNA, V18, P42, DOI 10.1261/rna.029769.111; OKANE CJ, 1987, P NATL ACAD SCI USA, V84, P9123, DOI 10.1073/pnas.84.24.9123; Pilu R, 2009, HEREDITY, V102, P236, DOI 10.1038/hdy.2008.96; Poyhonen M, 2012, G3-GENES GENOM GENET, V2, P331, DOI 10.1534/g3.111.001925; Rassoulzadegan M, 2006, NATURE, V441, P469, DOI 10.1038/nature04674; Roche SE, 1998, GENETICS, V149, P1839; Ronsseray S, 1996, GENETICS, V143, P1663; Ronsseray S, 2001, GENETICS, V159, P1631; SCHUPBACH T, 1991, GENETICS, V129, P1119; Sidorenko LV, 2001, PLANT CELL, V13, P319, DOI 10.1105/tpc.13.2.319; Stam M, 2002, GENE DEV, V16, P1906, DOI 10.1101/gad.1006702; Stam M, 2009, MOL PLANT, V2, P578, DOI 10.1093/mp/ssp020; Stuart JR, 2002, GENETICS, V162, P1641; Todeschini AL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011032; Wilson JE, 1996, DEV GENET, V19, P199, DOI 10.1002/(SICI)1520-6408(1996)19:3<199::AID-DVG3>3.0.CO;2-4	37	149	154	0	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 4	2012	490	7418					112	U132		10.1038/nature11416	http://dx.doi.org/10.1038/nature11416			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015LG	22922650	Green Published			2022-12-28	WOS:000309446800043
J	Perez, C; Koshy, C; Yildiz, O; Ziegler, C				Perez, Camilo; Koshy, Caroline; Yildiz, Oezkan; Ziegler, Christine			Alternating-access mechanism in conformationally asymmetric trimers of the betaine transporter BetP	NATURE			English	Article							NA+/BETAINE SYMPORTER BETP; CORYNEBACTERIUM-GLUTAMICUM; CRYSTAL-STRUCTURE; MOLECULAR-BASIS; CARRIER BETP; OPEN STATES; K+; HOMOLOG; BINDING; SODIUM	Betaine and Na+ symport has been extensively studied in the osmotically regulated transporter BetP from Corynebacterium glutamicum, a member of the betaine/choline/carnitine transporter family, which shares the conserved LeuT-like fold of two inverted structural repeats(1). BetP adjusts its transport activity by sensing the cytoplasmic K+ concentration as a measure for hyperosmotic stress via the osmosensing carboxy-terminal domain(2,3). BetP needs to be in a trimeric state for communication between individual protomers through several intratrimeric interaction sites(4). Recently, crystal structures of inward-facing BetP trimers have contributed to our understanding of activity regulation on a molecular level(5,6). Here we report new crystal structures, which reveal two conformationally asymmetric BetP trimers(7), capturing among them three distinct transport states. We observe a total of four new conformations at once: an outward-open apo and an outward-occluded apo state, and two closed transition states-one in complex with betaine and one substrate-free. On the basis of these new structures, we identified local and global conformational changes in BetP that underlie the molecular transport mechanism, which partially resemble structural changes observed in other sodium-coupled LeuT-like fold transporters, but show differences we attribute to the osmolytic nature of betaine, the exclusive substrate specificity and the regulatory properties of BetP.	[Perez, Camilo; Koshy, Caroline; Yildiz, Oezkan; Ziegler, Christine] Max Planck Inst Biophys, Dept Biol Struct, D-60438 Frankfurt, Germany; [Ziegler, Christine] Univ Regensburg, Inst Biophys & Biophys Chem, D-93053 Regensburg, Germany	Max Planck Society; University of Regensburg	Ziegler, C (corresponding author), Max Planck Inst Biophys, Dept Biol Struct, D-60438 Frankfurt, Germany.	christine.ziegler@biophys.mpg.de	Perez, Camilo/AAA-8733-2021; Yildiz, Ozkan/P-9207-2016	Perez, Camilo/0000-0002-5800-0084; Yildiz, Ozkan/0000-0003-3659-2805; Ziegler, Christine Maria/0000-0003-3439-7213	International Max-Planck Research School; DFG (German Research Foundation), Collaborative Research Center 807 "Transport and Communication across Biological Membranes"	International Max-Planck Research School; DFG (German Research Foundation), Collaborative Research Center 807 "Transport and Communication across Biological Membranes"	We thank L. Forrest and R. Kramer for careful reading of the manuscript and suggestions and discussions. This work was supported by the International Max-Planck Research School (C.K. and C.P.), and by the DFG (German Research Foundation), Collaborative Research Center 807 "Transport and Communication across Biological Membranes" (C.Z.).	Bourot S, 2000, J BIOL CHEM, V275, P1050, DOI 10.1074/jbc.275.2.1050; Fang YL, 2009, NATURE, V460, P1040, DOI 10.1038/nature08201; Gartner RM, 2011, J MOL BIOL, V414, P327, DOI 10.1016/j.jmb.2011.10.013; Ge L, 2011, P NATL ACAD SCI USA, V108, pE890, DOI 10.1073/pnas.1109597108; Hunte C, 2005, NATURE, V435, P1197, DOI 10.1038/nature03692; Krishnamurthy H, 2012, NATURE, V481, P469, DOI 10.1038/nature10737; Ott V, 2008, BIOCHEMISTRY-US, V47, P12208, DOI 10.1021/bi801325r; Perez C, 2011, EMBO REP, V12, P804, DOI 10.1038/embor.2011.102; Perez C, 2011, EMBO J, V30, P1221, DOI 10.1038/emboj.2011.46; Ressl S, 2009, NATURE, V458, P47, DOI 10.1038/nature07819; Rubenhagen R, 2001, EMBO J, V20, P5412, DOI 10.1093/emboj/20.19.5412; Schiller D, 2004, BIOCHEMISTRY-US, V43, P5583, DOI 10.1021/bi0359628; Shi L, 2010, BIOPHYS J, V99, pL103, DOI 10.1016/j.bpj.2010.10.003; Shimamura T, 2010, SCIENCE, V328, P470, DOI 10.1126/science.1186303; Tsai CJ, 2011, J MOL BIOL, V407, P368, DOI 10.1016/j.jmb.2011.01.028; Watanabe A, 2010, NATURE, V468, P988, DOI 10.1038/nature09580; Wetzel KJ, 2011, FEMS IMMUNOL MED MIC, V61, P346, DOI 10.1111/j.1574-695X.2011.00781.x; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Zhao YF, 2010, NATURE, V465, P188, DOI 10.1038/nature09057; Ziegler C, 2004, J MOL BIOL, V337, P1137, DOI 10.1016/j.jmb.2004.02.026; Ziegler C, 2010, MOL MICROBIOL, V78, P13, DOI 10.1111/j.1365-2958.2010.07332.x	21	106	107	0	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 4	2012	490	7418					126	130		10.1038/nature11403	http://dx.doi.org/10.1038/nature11403			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015LG	22940865				2022-12-28	WOS:000309446800046
J	Jakab, Z				Jakab, Zsuzsanna			Promoting health and reducing health inequities in Europe	LANCET			English	Editorial Material									WHO, Reg Off Europe, DK-2100 Copenhagen, Denmark	World Health Organization	Jakab, Z (corresponding author), WHO, Reg Off Europe, DK-2100 Copenhagen, Denmark.	zja@euro.who.int						Kickbusch I., 2012, GOVERNANCE HLTH 21 C; Marmot M, 2012, J GERONTOL B; WHO, 2012, EV BAS HLTH 2020; WHO, 2008, PHARMAFORUM 0121; WHO, 2012, HLTH 2020 EUR POL FR; WHO Commission on Social Determinants of Health World Health Organization, 2008, CLOS GAP GEN HLTH EQ; World Health Organisation, 2012, EUR ACT PLAN STRENGT; World Health Organization, EUR HLTH ALL DAT; World Health Organization, 2012, EX SUMM EUR HLTH REP	9	7	7	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 15	2012	380	9846					951	953		10.1016/S0140-6736(12)61481-0	http://dx.doi.org/10.1016/S0140-6736(12)61481-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	005JF	22964158				2022-12-28	WOS:000308746000007
J	Berg, JM				Berg, Jeremy M.			Well-funded investigators should receive extra scrutiny	NATURE			English	Editorial Material									Univ Pittsburgh, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Berg, JM (corresponding author), Univ Pittsburgh, Pittsburgh, PA 15260 USA.	jberg@pitt.edu	Berg, Jeremy/GRY-6706-2022	Berg, Jeremy/0000-0002-2444-8139; Berg, Jeremy/0000-0003-3022-0963					0	16	16	1	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 13	2012	489	7415					203	203		10.1038/489203a	http://dx.doi.org/10.1038/489203a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	003UC	22972279				2022-12-28	WOS:000308635900014
J	Chawla, MPS; Sundriyal, D				Chawla, M. P. S.; Sundriyal, Deepak			Burton's Line	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Chawla, M. P. S.] Dr Ram Manohar Lohia Hosp, Postgrad Inst Med Educ & Res, New Delhi, India; [Sundriyal, Deepak] Himalayan Inst Med Sci, Uttarakhand, India	PGIMER Chandigarh	Chawla, MPS (corresponding author), Dr Ram Manohar Lohia Hosp, Postgrad Inst Med Educ & Res, New Delhi, India.	drmpschawla@gmail.com	CHAWLA, MPS/ABD-7961-2021	sundriyal, deepak/0000-0002-6378-7694					0	1	1	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 6	2012	367	10					937	937		10.1056/NEJMicm1108354	http://dx.doi.org/10.1056/NEJMicm1108354			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	999VO	22931262				2022-12-28	WOS:000308343300011
J	Pijpe, A; Andrieu, N; Easton, DF; Kesminiene, A; Cardis, E; Nogues, C; Gauthier-Villars, M; Lasset, C; Fricker, JP; Peock, S; Frost, D; Evans, DG; Eeles, RA; Paterson, J; Manders, P; van Asperen, CJ; Ausems, MGEM; Meijers-Heijboer, H; Thierry-Chef, I; Hauptmann, M; Goldgar, D; Rookus, MA; van Leeuwen, FE				Pijpe, Anouk; Andrieu, Nadine; Easton, Douglas F.; Kesminiene, Ausrele; Cardis, Elisabeth; Nogues, Catherine; Gauthier-Villars, Marion; Lasset, Christine; Fricker, Jean-Pierre; Peock, Susan; Frost, Debra; Evans, D. Gareth; Eeles, Rosalind A.; Paterson, Joan; Manders, Peggy; van Asperen, Christi J.; Ausems, Margreet G. E. M.; Meijers-Heijboer, Hanne; Thierry-Chef, Isabelle; Hauptmann, Michael; Goldgar, David; Rookus, Matti A.; van Leeuwen, Flora E.		GENEPSO; EMBRACE; HEBON	Exposure to diagnostic radiation and risk of breast cancer among carriers of BRCA1/2 mutations: retrospective cohort study (GENE-RAD-RISK)	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ATOMIC-BOMB SURVIVORS; SCREENING MAMMOGRAPHY; IONIZING-RADIATION; VALIDATION; WOMEN; SUSCEPTIBILITY; PROGRAM; HISTORY; REPAIR	Objective To estimate the risk of breast cancer associated with diagnostic radiation in carriers of BRCA1/2 mutations. Design Retrospective cohort study (GENE-RAD-RISK). Setting Three nationwide studies (GENEPSO, EMBRACE, HEBON) in France, United Kingdom, and the Netherlands, Participants 1993 female carriers of BRCA1/2 mutations recruited in 2006-09. Main outcome measure Risk of breast cancer estimated with a weighted Cox proportional hazards model with a time dependent individually estimated cumulative breast dose, based on nominal estimates of organ dose and frequency of self reported diagnostic procedures. To correct for potential survival bias, the analysis excluded carriers who were diagnosed more than five years before completion of the study questionnaire. Results In carriers of BRCA1/2 mutations any exposure to diagnostic radiation before the age of 30 was associated with an increased risk of breast cancer (hazard ratio 1.90, 95% confidence interval 1.20 to 3.00), with a dose-response pattern. The risks by quarter of estimated cumulative dose <0.0020 Gy, >= 0.0020-0.0065 Gy, >= 0.0066-0.0173 Gy, and >= 0.0174 Gy were 1.63 (0.96 to 2.77), 1.78 (0.88 to 3.58), 1.75 (0.72 to 4.25), and 3.84 (1.67 to 8.79), respectively. Analyses on the different types of diagnostic procedures showed a pattern of increasing risk with increasing number of radiographs before age 20 and before age 30 compared with no exposure. A history of mammography before age 30 was also associated with an increased risk of breast cancer (hazard ratio 1.43, 0.85 to 2.40). Sensitivity analysis showed that this finding was not caused by confounding by indication of family history. Conclusion In this large European study among carriers of BRCA1/2 mutations, exposure to diagnostic radiation before age 30 was associated with an increased risk of breast cancer at dose levels considerably lower than those at which increases have been found in other cohorts exposed to radiation. The results of this study support the use of non-ionising radiation imaging techniques (such as magnetic resonance imaging) as the main tool for surveillance in young women with BRCA1/2 mutations.	[Pijpe, Anouk; Rookus, Matti A.; van Leeuwen, Flora E.] Netherlands Canc Inst, Dept Epidemiol & Biostat, NL-1066 CX Amsterdam, Netherlands; [Andrieu, Nadine] Inst Natl Sante & Rech Med, Unite U900, F-75248 Paris, France; [Andrieu, Nadine] Res Ctr & Serv Biostat, Inst Curie, F-75248 Paris, France; [Andrieu, Nadine] Paris Tech, Ecole Mines Paris, F-77300 Fontainebleau, France; [Easton, Douglas F.] Univ Cambridge, Ctr Canc Genet Epidemiol, Dept Publ Hlth & Primary Care, Strangeways Res Lab, Cambridge CB1 8RN, England; [Kesminiene, Ausrele] Int Agcy Res Canc, Sect Environm & Radiat, F-69372 Lyon 08, France; [Nogues, Catherine] Hop Rene Huguenin, Inst Curie, F-92210 Paris, France; [Gauthier-Villars, Marion] Inst Curie, Serv Oncogenet, F-75005 Paris, France; [Fricker, Jean-Pierre] Ctr Paul Strauss, F-67065 Strasbourg, France; [Lasset, Christine] Ctr Leon Berard, F-69008 Lyon, France; [Evans, D. Gareth] St Marys Hosp, Dept Genet Med, Manchester M13 9WL, Lancs, England; [Eeles, Rosalind A.] Inst Canc Res, Oncogenet Team, Surrey SM2 5PT, England; [Paterson, Joan] Addenbrookes Hosp, Dept Clin Genet, E Anglian Reg Genet Serv, Cambridge CB2 0QQ, England; [Manders, Peggy] Radboud Univ Nijmegen, Dept Human Genet, Med Ctr, NL-6525 GA Nijmegen, Netherlands; [van Asperen, Christi J.] Leiden Univ, Dept Clin Genet, Med Ctr, NL-2333 ZA Leiden, Netherlands; [Ausems, Margreet G. E. M.] Univ Med Ctr Utrecht, Dept Med Genet, NL-3584 CX Utrecht, Netherlands; [Meijers-Heijboer, Hanne] Vrije Univ Amsterdam, Dept Clin Genet & Human Genet, Med Ctr, Amsterdam, Netherlands; [Goldgar, David] Univ Utah, Dept Dermatol, Sch Med, Salt Lake City, UT 84132 USA	Netherlands Cancer Institute; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; MINES ParisTech; University of Cambridge; World Health Organization; International Agency for Research on Cancer (IARC); Rene Huguenin Hospital; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UNICANCER; Centre Paul Strauss; UNICANCER; Centre Leon Berard; University of Manchester; University of London; Institute of Cancer Research - UK; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Radboud University Nijmegen; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Utrecht University; Utrecht University Medical Center; Vrije Universiteit Amsterdam; Utah System of Higher Education; University of Utah	van Leeuwen, FE (corresponding author), Netherlands Canc Inst, Dept Epidemiol & Biostat, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	f.v.leeuwen@nki.nl	van Asperen, Christi J/D-3970-2012; Oosterwijk, Jan C./G-5770-2011; ANDRIEU, Nadine/H-4255-2014; Ligtenberg, Marjolijn/N-9666-2013; Evans, D Gareth/AAB-4308-2022; GLADIEFF, Laurence/O-5129-2014; THIERRY-CHEF, Isabelle/P-8324-2018; Hauptmann, Michael/AAQ-8420-2021; Cardis, Elisabeth/C-3904-2017	van Asperen, Christi J/0000-0002-1436-7650; Ligtenberg, Marjolijn/0000-0003-1290-1474; Evans, D Gareth/0000-0002-8482-5784; GLADIEFF, Laurence/0000-0002-6980-9719; THIERRY-CHEF, Isabelle/0000-0001-6304-2783; Hauptmann, Michael/0000-0001-8539-0148; Cardis, Elisabeth/0000-0003-0999-6839; Bancroft, Elizabeth/0000-0002-5482-5660; Vasen, Hans/0000-0003-2682-2603; Pijpe, Anouk/0000-0002-3594-4621; van der Luijt, Rob/0000-0002-0018-1089; Gomez-Garcia, Encarna/0000-0003-4999-8847; Eeles, Rosalind/0000-0002-3698-6241; Devilee, Peter/0000-0002-8023-2009	NIHR; Cancer Research UK [C5047/A8385]; Euratom Programme [012926 (FI6R)]; GENEPSO: Fondation de France; GENEPSO: Ligue National Contre le Cancer; EMBRACE: Cancer Research UK [C1287/A10118, C1287/A8874]; HEBON: Dutch Cancer Society [NKI1998-1854, NKI2004-3088, NKI 2007-3756]; Tepnel; Illumina; Vista Diagnostics; NATIONAL CANCER INSTITUTE [R01CA142657] Funding Source: NIH RePORTER; Cancer Research UK [10118, 11022, 15007] Funding Source: researchfish; National Institute for Health Research [NF-SI-0510-10096] Funding Source: researchfish	NIHR(National Institute for Health Research (NIHR)); Cancer Research UK(Cancer Research UK); Euratom Programme; GENEPSO: Fondation de France; GENEPSO: Ligue National Contre le Cancer; EMBRACE: Cancer Research UK; HEBON: Dutch Cancer Society; Tepnel; Illumina; Vista Diagnostics; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Research UK(Cancer Research UK); National Institute for Health Research(National Institute for Health Research (NIHR))	Coordinating Centre, Cambridge: Susan Peock, Margaret Cook, Debra Frost, Clare Oliver; North of Scotland Regional Genetics Service, Aberdeen: Helen Gregory; West Midlands Regional Clinical Genetics Service, Birmingham: Trevor Cole, Lucy Burgess; East Anglian Regional Genetics Service, Cambridge: Joan Paterson; Medical Genetics Services for Wales, Cardiff: Mark Rogers, Lisa Hughes; Peninsula Clinical Genetics Service, Exeter: Carole Brewer; West of Scotland Regional Genetics Service, Glasgow: Rosemarie Davidson, Nicola Bradshaw; South East Thames Regional Genetics Service, London: Louise Izatt, Gabriella Pichert, Caroline Langman; Yorkshire Regional Genetics Service, Leeds: Carol Chu, Julie Miller; Manchester Regional Genetics Service, Manchester: Gareth Evans, Fiona Lalloo, Andrew Shenton; Oxford Regional Genetics Service, Oxford: Lucy Side; Department of Cancer Genetics, Royal Marsden NHS Foundation Trust: Ros Eeles, Elizabeth Bancroft, Elizabeth Page, Elena Castro, Audray Ardern-Jones, Richard Houlston, Nazneen Rahman, Susan Shanley; North Trent Clinical Genetics Service, Sheffield: Jackie Cook, Lauren Baxter; South West Thames Regional Genetics Service, London: Shirley Hodgson, Sheila Goff; and Wessex Clinical Genetics Service, Southampton: Diana Eccles. Gareth Evans and Fiona Lalloo are supported by an NIHR grant to the Biomedical Research Centre, Manchester. The investigators at The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust are supported by an NIHR grant to the Biomedical Research Centre at The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust. Ros Eeles and Elizabeth Bancroft are also supported by Cancer Research UK Grant C5047/A8385.; The GENE-RAD-RISK study was supported by grant No 012926 (FI6R) under Euratom Programme; GENEPSO: Fondation de France and Ligue National Contre le Cancer; EMBRACE: Cancer Research UK (grant C1287/A10118 and C1287/A8874); HEBON: Dutch Cancer Society (grants NKI1998-1854, NKI2004-3088, NKI 2007-3756). DFE is a principal research fellow of Cancer Research UK. The sponsors had no role in the design of the study; in the collection, analysis, and interpretation of the data; in the writing of the report; and in the decision to submit the paper for publication.; All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: DFE is board member of Genome Canada. RAE receives royalties for the book Genetic Predisposition to Cancer, has received educational grants from Tepnel, Illumina, and Vista Diagnostics and has received honoraria for BRCA-related lectures from MD Anderson and University of Southampton. DG receives royalties from BRCA1 testing.	Andrieu N, 2006, J CLIN ONCOL, V24, P3361, DOI 10.1200/JCO.2005.03.3126; Antoniou A, 2003, AM J HUM GENET, V72, P1117, DOI 10.1086/375033; Antoniou AC, 2005, GENET EPIDEMIOL, V29, P1, DOI 10.1002/gepi.20074; Berrington de Gonzalez A, 2003, AM J EPIDEMIOL, V157, P652, DOI 10.1093/aje/kwg026; Boulton SJ, 2006, BIOCHEM SOC T, V34, P633, DOI 10.1042/BST0340633; Broeks A, 2010, INT J RADIAT ONCOL, V76, P540, DOI 10.1016/j.ijrobp.2009.09.004; Chen SN, 2007, J CLIN ONCOL, V25, P1329, DOI 10.1200/JCO.2006.09.1066; DRION R, 1961, Ned Tijdschr Geneeskd, V105, P1920; Eleveld H, 2003, 861020002 RIVM; Goldfrank D, 2006, CANCER EPIDEM BIOMAR, V15, P2311, DOI 10.1158/1055-9965.EPI-06-0176; Gronwald J, 2008, BREAST CANCER RES TR, V112, P581, DOI 10.1007/s10549-008-9892-9; Howe GR, 1996, RADIAT RES, V145, P694, DOI 10.2307/3579360; ICRP, 2007, ICRP PUBL, V103, DOI 10.1016/j.icrp.2007.10.003; Land CE, 2003, RADIAT RES, V160, P707, DOI 10.1667/RR3082; LAND CE, 1995, JAMA-J AM MED ASSOC, V274, P402, DOI 10.1001/jama.274.5.402; LAND CE, 1980, CANCER, V46, P868, DOI 10.1002/1097-0142(19800815)46:4+<868::AID-CNCR2820461304>3.0.CO;2-S; Langholz B, 2010, AM J EPIDEMIOL, V171, P377, DOI 10.1093/aje/kwp403; Meeuwsen EJ, 2007, 300081001 RIVM; Mullenders L, 2009, NAT REV CANCER, V9, P596, DOI 10.1038/nrc2677; Narod SA, 2006, LANCET ONCOL, V7, P402, DOI 10.1016/S1470-2045(06)70624-6; National Research Council, 1999, HLTH RISKS EXP LOW L; Nieuwenhuis B, 2002, INT J RADIAT BIOL, V78, P285, DOI 10.1080/09553000110097974; Norman SA, 2003, AM J EPIDEMIOL, V158, P264, DOI 10.1093/aje/kwg136; Pijpe A, 2011, J CLIN EPIDEMIOL, V64, P1434, DOI 10.1016/j.jclinepi.2011.04.005; Pijpe A, 2010, EUR J EPIDEMIOL, V25, P103, DOI 10.1007/s10654-009-9416-x; Pijpe A, 2010, BREAST CANCER RES TR, V120, P235, DOI 10.1007/s10549-009-0476-0; Pogoda JM, 2002, HEALTH PHYS, V83, P907, DOI 10.1097/00004032-200212000-00019; Powell SN, 2003, ONCOGENE, V22, P5784, DOI 10.1038/sj.onc.1206678; Preston DL, 2002, RADIAT RES, V158, P220, DOI 10.1667/0033-7587(2002)158[0220:REOBCR]2.0.CO;2; PRESTONMARTIN S, 1985, AM J EPIDEMIOL, V121, P430, DOI 10.1093/oxfordjournals.aje.a114015; Ronckers CM, 2005, BREAST CANCER RES, V7, P21, DOI 10.1186/bcr970; SICKENGA F N, 1959, Ned Tijdschr Geneeskd, V103, P1998; Sickenga FN, 1961, NED TIJDSCHR GENEES, V105, P2417; SICKENGA FN, 1980, SHORT HIST TUBERCULO; Sigurdson AJ, 2007, CANCER EPIDEM BIOMAR, V16, P2000, DOI 10.1158/1055-9965.EPI-07-0282; Venkitaraman AR, 2002, CELL, V108, P171, DOI 10.1016/S0092-8674(02)00615-3; Yoshida K, 2004, CANCER SCI, V95, P866, DOI 10.1111/j.1349-7006.2004.tb02195.x; Young KC, 2005, BRIT J RADIOL, V78, P207, DOI 10.1259/bjr/41095952; Young KC, 2000, BRIT J RADIOL, V73, P278, DOI 10.1259/bjr.73.867.10817044	39	143	147	0	24	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 6	2012	345								e5660	10.1136/bmj.e5660	http://dx.doi.org/10.1136/bmj.e5660			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	003TL	22956590	Green Published, hybrid			2022-12-28	WOS:000308634100002
J	Spence, D				Spence, Des			Why do we overtreat hypertension?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk						Diao D, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006742.pub2; National Institute for Health and Clinical Excellence, 2011, HYPERT CLIN MAN PRI; Willis EA, 2012, RE NHS HLTH CHECKS Q	3	0	0	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 4	2012	345								e5923	10.1136/bmj.e5923	http://dx.doi.org/10.1136/bmj.e5923			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	003TI	22951565				2022-12-28	WOS:000308633800020
J	Forsberg, KJ; Reyes, A; Bin, W; Selleck, EM; Sommer, MOA; Dantas, G				Forsberg, Kevin J.; Reyes, Alejandro; Wang, Bin; Selleck, Elizabeth M.; Sommer, Morten O. A.; Dantas, Gautam			The Shared Antibiotic Resistome of Soil Bacteria and Human Pathogens	SCIENCE			English	Article							RESISTANCE GENES; KLUYVERA; ECOLOGY; SPREAD; BUGS	Soil microbiota represent one of the ancient evolutionary origins of antibiotic resistance and have been proposed as a reservoir of resistance genes available for exchange with clinical pathogens. Using a high-throughput functional metagenomic approach in conjunction with a pipeline for the de novo assembly of short-read sequence data from functional selections (termed PARFuMS), we provide evidence for recent exchange of antibiotic resistance genes between environmental bacteria and clinical pathogens. We describe multidrug-resistant soil bacteria containing resistance cassettes against five classes of antibiotics (beta-lactams, aminoglycosides, amphenicols, sulfonamides, and tetracyclines) that have perfect nucleotide identity to genes from diverse human pathogens. This identity encompasses noncoding regions as well as multiple mobilization sequences, offering not only evidence of lateral exchange but also a mechanism by which antibiotic resistance disseminates.	[Sommer, Morten O. A.] Tech Univ Denmark, Dept Syst Biol, DK-2800 Lyngby, Denmark; [Forsberg, Kevin J.; Reyes, Alejandro; Wang, Bin; Dantas, Gautam] Washington Univ, Sch Med, Ctr Genome Sci & Syst Biol, St Louis, MO 63108 USA; [Wang, Bin; Dantas, Gautam] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63108 USA; [Selleck, Elizabeth M.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; [Sommer, Morten O. A.] Novo Nordisk Fdn Ctr Biosustainabil, DK-2900 Horsholm, Denmark	Technical University of Denmark; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Technical University of Denmark	Sommer, MOA (corresponding author), Tech Univ Denmark, Dept Syst Biol, DK-2800 Lyngby, Denmark.	msom@bio.dtu.dk; dantas@wustl.edu	Reyes, Alejandro/AAD-8445-2022	Reyes, Alejandro/0000-0003-2907-3265; Dantas, Gautam/0000-0003-0455-8370; Sommer, Morten Otto Alexander/0000-0003-4005-5674; Selleck Fiore, Elizabeth/0000-0003-0213-1250; Forsberg, Kevin/0000-0002-1545-8925	Children's Discovery Institute [MD-II-2011-117]; International Center for Advanced Renewable Energy and Sustainability at Washington University; National Academies Keck Futures Initiatives, Synthetic Biology-SB2; Lundbeck foundation; European Union [282004]; NSF [DGE-1143954]; International Fulbright Science and Technology Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007067] Funding Source: NIH RePORTER; Novo Nordisk Fonden [NNF10CC1016517] Funding Source: researchfish	Children's Discovery Institute; International Center for Advanced Renewable Energy and Sustainability at Washington University; National Academies Keck Futures Initiatives, Synthetic Biology-SB2; Lundbeck foundation(Lundbeckfonden); European Union(European Commission); NSF(National Science Foundation (NSF)); International Fulbright Science and Technology Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Novo Nordisk Fonden(Novo Nordisk Foundation)	We thank R. Mitra for initial discussions regarding simulations of metagenomic assembly; T. Druley for discussions surrounding the use of the six beta-lactamase control fragments; J. Fay for discussions on dating horizontal gene transfer; J. Gordon for support, thoughtful discussion, and as the advisor to A. R.; A. Moore for naming PARFuMS; and the Genome Technology Access Center at Washington University in St. Louis for generating Illumina sequence data. This work was supported by awards to G. D. through the Children's Discovery Institute (award MD-II-2011-117), the International Center for Advanced Renewable Energy and Sustainability at Washington University, and the National Academies Keck Futures Initiatives, Synthetic Biology-SB2. M.O.A.S. received funding from the Lundbeck foundation and the European Union FP7-HEALTH-2011-single-stage grant agreement 282004, EvoTAR. K. J. F. is a NSF graduate research fellow (award DGE-1143954). A. R. is the recipient of an International Fulbright Science and Technology Award. The data reported in this paper are described in the supplementary materials. Raw sequencing reads have been deposited to MG-RAST with accession nos. 4489630-39, 4489641-43, 4489645-46, 4489648-49, 4489650-51, 4489653-57, 4489659, 4489661-63, 4489665, and 4489667-68. Assembled sequences have been deposited to GenBank with accession nos. JX009202 to JX009380. The authors declare no competing financial interests.	Allen HK, 2010, NAT REV MICROBIOL, V8, P251, DOI 10.1038/nrmicro2312; Allen HK, 2009, ISME J, V3, P243, DOI 10.1038/ismej.2008.86; Aminov RI, 2007, FEMS MICROBIOL LETT, V271, P147, DOI 10.1111/j.1574-6968.2007.00757.x; Arias CA, 2009, NEW ENGL J MED, V360, P439, DOI 10.1056/NEJMp0804651; BENVENISTE R, 1973, P NATL ACAD SCI USA, V70, P2276, DOI 10.1073/pnas.70.8.2276; Boucher HW, 2009, CLIN INFECT DIS, V48, P1, DOI 10.1086/595011; Chain PSG, 2011, J BACTERIOL, V193, P4274, DOI 10.1128/JB.05335-11; CLARK VL, 1977, ANTIMICROB AGENTS CH, V11, P871, DOI 10.1128/AAC.11.5.871; D'Costa VM, 2011, NATURE, V477, P457, DOI 10.1038/nature10388; D'Costa VM, 2006, SCIENCE, V311, P374, DOI 10.1126/science.1120800; Dantas G, 2008, SCIENCE, V320, P100, DOI 10.1126/science.1155157; Davies J, 2010, MICROBIOL MOL BIOL R, V74, P417, DOI 10.1128/MMBR.00016-10; Donato JJ, 2010, APPL ENVIRON MICROB, V76, P4396, DOI 10.1128/AEM.01763-09; FARMER JJ, 1981, J CLIN MICROBIOL, V13, P919, DOI 10.1128/JCM.13.5.919-933.1981; Heuer H, 2011, CURR OPIN MICROBIOL, V14, P236, DOI 10.1016/j.mib.2011.04.009; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; Marshall BM, 2011, CLIN MICROBIOL REV, V24, P718, DOI 10.1128/CMR.00002-11; Martinez JL, 2008, SCIENCE, V321, P365, DOI 10.1126/science.1159483; McManus PS, 2002, ANNU REV PHYTOPATHOL, V40, P443, DOI 10.1146/annurev.phyto.40.120301.093927; Poirel L, 2005, ANTIMICROB AGENTS CH, V49, P3593, DOI 10.1128/AAC.49.8.3593-3597.2005; Poirel L, 2002, ANTIMICROB AGENTS CH, V46, P4038, DOI 10.1128/AAC.46.12.4038-4040.2002; Rezzonico F, 2004, APPL ENVIRON MICROB, V70, P5119, DOI 10.1128/AEM.70.9.5119-5131.2004; Romano S, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-267; Silby MW, 2011, FEMS MICROBIOL REV, V35, P652, DOI 10.1111/j.1574-6976.2011.00269.x; Smillie CS, 2011, NATURE, V480, P241, DOI 10.1038/nature10571; Sommer MOA, 2009, SCIENCE, V325, P1128, DOI 10.1126/science.1176950; Stalder T, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00119; Walsh C, 2000, NATURE, V406, P775, DOI 10.1038/35021219	28	930	988	41	860	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 31	2012	337	6098					1107	1111		10.1126/science.1220761	http://dx.doi.org/10.1126/science.1220761			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996WP	22936781	Green Accepted			2022-12-28	WOS:000308125800051
J	Glowacki, DR; Lockhart, J; Blitz, MA; Klippenstein, SJ; Pilling, MJ; Robertson, SH; Seakins, PW				Glowacki, David R.; Lockhart, James; Blitz, Mark A.; Klippenstein, Stephen J.; Pilling, Michael J.; Robertson, Struan H.; Seakins, Paul W.			Interception of Excited Vibrational Quantum States by O-2 in Atmospheric Association Reactions	SCIENCE			English	Article							PHASE BIMOLECULAR REACTIONS; REACTION DYNAMICS; MASTER EQUATION; CHEMICAL-DYNAMICS; CHLORINE ATOM; KINETICS; RADICALS; GASES; OH; CHEMISTRY	Bimolecular reactions in Earth's atmosphere are generally assumed to proceed between reactants whose internal quantum states are fully thermally relaxed. Here, we highlight a dramatic role for vibrationally excited bimolecular reactants in the oxidation of acetylene. The reaction proceeds by preliminary adduct formation between the alkyne and OH radical, with subsequent O-2 addition. Using a detailed theoretical model, we show that the product-branching ratio is determined by the excited vibrational quantum-state distribution of the adduct at the moment it reacts with O-2. Experimentally, we found that under the simulated atmospheric conditions O-2 intercepts similar to 25% of the excited adducts before their vibrational quantum states have fully relaxed. Analogous interception of excited-state radicals by O-2 is likely common to a range of atmospheric reactions that proceed through peroxy complexes.	[Glowacki, David R.] Univ Bristol, Sch Chem, Bristol BS8 1TS, Avon, England; [Lockhart, James; Blitz, Mark A.; Pilling, Michael J.; Seakins, Paul W.] Univ Leeds, Sch Chem, Leeds LS2 9JT, W Yorkshire, England; [Klippenstein, Stephen J.] Argonne Natl Lab, Chem Sci & Engn Div, Argonne, IL 60439 USA; [Robertson, Struan H.] Accelrys, Cambridge CB4 0WN, England	University of Bristol; University of Leeds; United States Department of Energy (DOE); Argonne National Laboratory; BIOVIA	Glowacki, DR (corresponding author), Univ Bristol, Sch Chem, Cantocks Close, Bristol BS8 1TS, Avon, England.	drglowacki@gmail.com; p.w.seakins@leeds.ac.uk	Klippenstein, Stephen/AAF-1741-2021; blitz, mark/A-1195-2009	blitz, mark/0000-0001-6710-4021; Klippenstein, Stephen/0000-0001-6297-9187	Engineering and Physical Sciences Research Council [EP/G00224X]; Natural Environment Research Council via the National Centre for Atmospheric Science; U.S. Department of Energy, Office of Basic Energy Sciences, Division of Chemical Sciences, Geosciences, and Biosciences [DE-AC02-06CH11357];  [NE/F018754/1]; EPSRC [EP/J010871/1] Funding Source: UKRI; NERC [ncas10006, NE/F018754/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/J010871/1] Funding Source: researchfish; Natural Environment Research Council [ncas10006, NE/F018754/1] Funding Source: researchfish	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Natural Environment Research Council via the National Centre for Atmospheric Science; U.S. Department of Energy, Office of Basic Energy Sciences, Division of Chemical Sciences, Geosciences, and Biosciences(United States Department of Energy (DOE)); ; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	D.R.G. is supported by Engineering and Physical Sciences Research Council Programme Grant EP/G00224X. M. A. B., P. W. S., and J.L. received support from the Natural Environment Research Council via the National Centre for Atmospheric Science and grant NE/F018754/1. S.J.K. was supported by the U.S. Department of Energy, Office of Basic Energy Sciences, Division of Chemical Sciences, Geosciences, and Biosciences, under contract DE-AC02-06CH11357.	Blake NJ, 1996, J GEOPHYS RES-ATMOS, V101, P24151, DOI 10.1029/96JD00561; Bohn B, 1998, J CHEM SOC FARADAY T, V94, P1203, DOI 10.1039/a708536b; Bohn B, 1996, J CHEM SOC FARADAY T, V92, P1459, DOI 10.1039/ft9969201459; Carr SA, 2011, J PHYS CHEM A, V115, P1069, DOI 10.1021/jp1099199; Clary DC, 2008, P NATL ACAD SCI USA, V105, P12649, DOI 10.1073/pnas.0800088105; Crim FF, 2008, P NATL ACAD SCI USA, V105, P12654, DOI 10.1073/pnas.0803010105; Czako G, 2011, SCIENCE, V334, P343, DOI 10.1126/science.1208514; Dibble TS, 2002, J PHYS CHEM A, V106, P6643, DOI 10.1021/jp025682m; Elles CG, 2006, ANNU REV PHYS CHEM, V57, P273, DOI 10.1146/annurev.physchem.57.032905.104538; Fernandez-Ramos A, 2006, CHEM REV, V106, P4518, DOI 10.1021/cr050205w; Fleming DG, 2011, SCIENCE, V331, P448, DOI 10.1126/science.1199421; Frankcombe TJ, 2003, J THEOR COMPUT CHEM, V2, P179, DOI 10.1142/S0219633603000483; Georgievskii Y, 2003, J CHEM PHYS, V118, P5442, DOI 10.1063/1.1539035; Glowacki DR, 2011, NAT CHEM, V3, P850, DOI [10.1038/NCHEM.1154, 10.1038/nchem.1154]; Glowacki DR, 2010, CHEMPHYSCHEM, V11, P3836, DOI 10.1002/cphc.201000469; Glowacki DR, 2010, J AM CHEM SOC, V132, P13621, DOI 10.1021/ja105100f; Goldman LM, 2011, J AM CHEM SOC, V133, P5312, DOI 10.1021/ja1095717; Greaves SJ, 2011, SCIENCE, V331, P1423, DOI 10.1126/science.1197796; Grubb MP, 2012, SCIENCE, V335, P1075, DOI 10.1126/science.1216911; Maranzana A, 2008, J PHYS CHEM A, V112, P3666, DOI 10.1021/jp077180k; Maranzana A, 2008, J PHYS CHEM A, V112, P3656, DOI 10.1021/jp077174o; Mckee KW, 2007, J PHYS CHEM A, V111, P4043, DOI 10.1021/jp067594y; Miller JA, 2006, J PHYS CHEM A, V110, P10528, DOI 10.1021/jp062693x; Mollner AK, 2010, SCIENCE, V330, P646, DOI 10.1126/science.1193030; Olzmann M, 2002, PHYS CHEM CHEM PHYS, V4, P3614, DOI 10.1039/b203244a; POLANYI JC, 1987, SCIENCE, V236, P680, DOI 10.1126/science.236.4802.680; RAFTERY D, 1994, J CHEM PHYS, V101, P8572, DOI 10.1063/1.468052; SCHMIDT V, 1985, BER BUNSEN PHYS CHEM, V89, P321, DOI 10.1002/bbpc.19850890337; Senosiain JP, 2005, J PHYS CHEM A, V109, P6045, DOI 10.1021/jp050737g; SINHA A, 1990, J CHEM PHYS, V92, P6333, DOI 10.1063/1.458312; Skouteris D, 1999, SCIENCE, V286, P1713, DOI 10.1126/science.286.5445.1713; Truhlar DG, 1996, J PHYS CHEM-US, V100, P12771, DOI 10.1021/jp953748q; Wu T, 2004, SCIENCE, V306, P2227, DOI 10.1126/science.1104085; Yan S, 2007, SCIENCE, V316, P1723, DOI 10.1126/science.1142313; Zare RN, 1998, SCIENCE, V279, P1875, DOI 10.1126/science.279.5358.1875	35	77	77	3	113	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 31	2012	337	6098					1066	1069		10.1126/science.1224106	http://dx.doi.org/10.1126/science.1224106			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996WP	22936771				2022-12-28	WOS:000308125800038
J	Vonend, O; Antoch, G; Rump, LC; Blondin, D				Vonend, Oliver; Antoch, Gerald; Rump, Lars Christian; Blondin, Dirk			Secondary rise in blood pressure after renal denervation	LANCET			English	Editorial Material							SYMPATHETIC DENERVATION; RESISTANT HYPERTENSION		[Vonend, Oliver; Rump, Lars Christian] Univ Dusseldorf, Dept Nephrol, Fac Med, Dusseldorf, Germany; [Antoch, Gerald; Blondin, Dirk] Univ Dusseldorf, Dept Diagnost & Intervent Radiol, Fac Med, D-40225 Dusseldorf, Germany	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf	Rump, LC (corresponding author), Moorenstr 5, D-40225 Dusseldorf, Germany.	christian.rump@med.uni-duesseldorf.de						Esler MD, 2010, LANCET, V376, P1903, DOI 10.1016/S0140-6736(10)62039-9; Krum H, 2009, LANCET, V373, P1275, DOI 10.1016/S0140-6736(09)60566-3; Rippy MK, 2011, CLIN RES CARDIOL, V100, P1095, DOI 10.1007/s00392-011-0346-8; Sadowski J, 2011, HYPERTENSION, V57, P911, DOI 10.1161/HYPERTENSIONAHA.110.163014	4	100	133	0	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG 25	2012	380	9843					778	778		10.1016/S0140-6736(12)61145-3	http://dx.doi.org/10.1016/S0140-6736(12)61145-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	995IK	22920752				2022-12-28	WOS:000308001300035
J	Kmietowicz, Z				Kmietowicz, Zosia			How do we evaluate the impact of the health reforms on the NHS?	BRITISH MEDICAL JOURNAL			English	Editorial Material																		Black N, 2012, LANCET, V379, P1167, DOI 10.1016/S0140-6736(11)61782-0; Kmietowicz Z, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e2243	2	2	2	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	AUG 21	2012	345								e5539	10.1136/bmj.e5539	http://dx.doi.org/10.1136/bmj.e5539			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	996GP	22915689	Green Submitted			2022-12-28	WOS:000308073200029
J	Adam, SS; McDuffie, JR; Ortel, TL; Williams, JW				Adam, Soheir S.; McDuffie, Jennifer R.; Ortel, Thomas L.; Williams, John W., Jr.			Comparative Effectiveness of Warfarin and New Oral Anticoagulants for the Management of Atrial Fibrillation and Venous Thromboembolism A Systematic Review	ANNALS OF INTERNAL MEDICINE			English	Review							TISSUE-PLASMINOGEN ACTIVATOR; VITAMIN-K; DABIGATRAN ETEXILATE; STROKE PREVENTION; BLEEDING COMPLICATIONS; ANTITHROMBOTIC THERAPY; RANDOMIZED EVALUATION; COST-EFFECTIVENESS; SUBGROUP ANALYSIS; DOUBLE-BLIND	Background: New oral anticoagulants (NOACs), including direct thrombin inhibitors (DTIs) and factor Xa (FXa) inhibitors, are emerging alternatives for prophylaxis and treatment of atrial fibrillation (AF) and venous thromboembolism (VTE). Purpose: To compare the benefits and harms of NOACs versus warfarin for AF and VTE. Data Sources: MEDLINE, EMBASE, and the Cochrane Database of Systematic Reviews from January 2001 through July 2012; U.S. Food and Drug Administration (FDA) database for adverse event reports. Study Selection: English-language, randomized, controlled trials (RCTs) comparing NOACs with warfarin for management of AF or VTE and observational studies and FDA reports on adverse effects. Data Extraction: Two independent reviewers abstracted data and rated study quality and strength of evidence. Data Synthesis: Six good-quality RCTs compared NOACs (2 DTI studies, 4 FXa inhibitor studies) with warfarin. In AF, NOACs decreased all-cause mortality (risk ratio [RR], 0.88 [95% CI, 0.82 to 0.96]); in VTE, NOACs did not differ for mortality or VTE out-comes. Across indications, adverse effects of NOACs compared with warfarin were fatal bleeding (RR, 0.60 [CI, 0.46 to 0.77]), major bleeding (RR, 0.80 [CI, 0.63 to 1.01]), gastrointestinal bleeding (RR, 1.30 [CI, 0.97 to 1.73]), and discontinuation due to adverse events (RR, 1.23 [CI, 1.05 to 1.44]). Subgroup analyses suggest a higher risk for myocardial infarction with DTIs than with FXa inhibitors. Bleeding risk for NOACs may be increased in persons older than 75 years or those receiving warfarin who have good control. Limitation: There were no head-to-head comparisons of NOACs and limited data on harms. Conclusion: New oral anticoagulants are a viable option for patients receiving long-term anticoagulation. Treatment benefits compared with warfarin are small and vary depending on the control achieved by warfarin treatment.	[Adam, Soheir S.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; Durham Vet Affairs Med Ctr, Durham, NC 27701 USA; King Abdulaziz Univ, Jeddah 21413, Saudi Arabia	Duke University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center; King Abdulaziz University	Adam, SS (corresponding author), Duke Univ, Med Ctr, Dept Med, Box 3939, Durham, NC 27710 USA.		Williams, John/AAM-4572-2020	Williams, John/0000-0002-5267-5558	Veterans Affairs Office of Research and Development, Quality Enhancement Research Initiative (VA-ESP) [09-010]; Department of Veterans Affairs	Veterans Affairs Office of Research and Development, Quality Enhancement Research Initiative (VA-ESP); Department of Veterans Affairs(US Department of Veterans Affairs)	By the Veterans Affairs Office of Research and Development, Quality Enhancement Research Initiative (VA-ESP Project 09-010; 2012).; Department of Veterans Affairs.	Agency for Healthcare Research and Quality, 2012, METH GUID EFF COMP E; Akl EA, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006650.pub2; Ansell J, 2008, CHEST, V133, p160S, DOI 10.1378/chest.08-0670; Avorn J, 2011, CIRCULATION, V123, P2519, DOI 10.1161/CIRCULATIONAHA.111.030148; Baker RI, 2004, MED J AUSTRALIA, V181, P492, DOI 10.5694/j.1326-5377.2004.tb06407.x; Barton CA, 2012, PHARMACOTHERAPY, V32, pE103, DOI 10.1002/j.1875-9114.2012.01036.x; Bauersachs R, 2010, NEW ENGL J MED, V363, P2499, DOI 10.1056/NEJMoa1007903; Betriu A, 2008, EUR HEART J SUPPL, V10, P30, DOI 10.1093/eurheartj/sun040; Bovio JA, 2011, ANN PHARMACOTHER, V45, P603, DOI 10.1345/aph.1P644; Buller HR, 2012, NEW ENGL J MED, V366, P1287, DOI 10.1056/NEJMoa1113572; CANNEGIETER SC, 1994, CIRCULATION, V89, P635, DOI 10.1161/01.CIR.89.2.635; Carrier M, 2010, ANN INTERN MED, V152, P578, DOI 10.7326/0003-4819-152-9-201005040-00008; Naranjo IC, 2011, CEREBROVASC DIS, V32, P614, DOI 10.1159/000334578; Center for Drug Evaluation and Research, 2011, SUMM REV APPL 022406; Connolly SJ, 2010, NEW ENGL J MED, V363, P1875, DOI 10.1056/NEJMc1007378; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Matute MC, 2011, THROMB HAEMOSTASIS, V106, P178, DOI 10.1160/TH11-01-0042; Cooper NJ, 2006, ARCH INTERN MED, V166, P1269, DOI 10.1001/archinte.166.12.1269; De Smedt A, 2010, CEREBROVASC DIS, V30, P533, DOI 10.1159/000319886; Denas G, 2009, J THROMB THROMBOLYS, V27, P340, DOI 10.1007/s11239-008-0211-4; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Diener HC, 2010, LANCET NEUROL, V9, P1157, DOI 10.1016/S1474-4422(10)70274-X; Eikelboom JW, 2011, CIRCULATION, V123, P2363, DOI 10.1161/CIRCULATIONAHA.110.004747; Eikelboom JW, 2010, CIRCULATION, V121, P1523, DOI 10.1161/CIRCULATIONAHA.109.853119; Eriksson BI, 2007, J THROMB HAEMOST, V5, P2178, DOI 10.1111/j.1538-7836.2007.02748.x; Eriksson BI, 2007, LANCET, V370, P949, DOI 10.1016/S0140-6736(07)61445-7; Eriksson BI, 2011, THROMB HAEMOSTASIS, V105, P721, DOI 10.1160/TH10-10-0679; Ezekowitz MD, 2007, AM J CARDIOL, V100, P1419, DOI 10.1016/j.amjcard.2007.06.034; Fareed J, 2012, ANNU REV PHARMACOL, V52, P79, DOI 10.1146/annurev-pharmtox-010611-134633; Fellows SE, 2012, J EMERG MED; GOHLKEBARWOLF C, 1995, EUR HEART J, V16, P1320; Granger CB, 2011, NEW ENGL J MED, V365, P981, DOI 10.1056/NEJMoa1107039; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1283, DOI 10.1016/j.jclinepi.2011.01.012; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hohnloser SH, 2012, CIRCULATION, V125, P669, DOI 10.1161/CIRCULATIONAHA.111.055970; Jones M, 2005, HEART, V91, P472, DOI 10.1136/hrt.2004.042465; Kearon C, 2012, CHEST, V141, pE419S, DOI 10.1378/chest.11-2301; Kernan L, 2012, CLIN TOXICOL PHILA; Lane DA, 2010, LANCET NEUROL, V9, P1140, DOI 10.1016/S1474-4422(10)70275-1; LAUPACIS A, 1994, ARCH INTERN MED, V154, P1449; Legrand M, 2011, ARCH INTERN MED, V171, P1285, DOI 10.1001/archinternmed.2011.314; Lip GYH, 2010, AM J MED, V123, P785, DOI 10.1016/j.amjmed.2010.01.031; Lloyd NS, 2008, J THROMB HAEMOST, V6, P405, DOI 10.1111/j.1538-7836.2007.02847.x; MacLean S, 2012, CHEST, V141, pE1S, DOI 10.1378/chest.11-2290; Meade TW, 1998, LANCET, V351, P233; Miller CS, 2012, AM J CARDIOL, V110, P453, DOI 10.1016/j.amjcard.2012.03.049; Moore CH, 2011, AM J EMERG MED; Moore TJ, 2012, SIGNALS DABIGATRAN M; Moore TJ, 2011, SIGNALS 2 NEWLY APPR; Moore TJ, 2012, ANTICOAGULANTS LEADI; Oldgren J, 2011, EUR HEART J, V32, P2781, DOI 10.1093/eurheartj/ehr113; Oldgren J, 2011, ANN INTERN MED, V155, P660, DOI 10.7326/0003-4819-155-10-201111150-00004; Patel MR, 2011, NEW ENGL J MED, V365, P883, DOI 10.1056/NEJMoa1009638; Pautas E, 2011, AM J MED, V124, P527, DOI 10.1016/j.amjmed.2011.01.016; Rose AJ, 2011, CIRC-CARDIOVASC QUAL, V4, P416, DOI 10.1161/CIRCOUTCOMES.111.960591; Rubboli A, 2011, WORLD J CARDIOL, V3, P351, DOI 10.4330/wjc.v3.i11.351; Schulman S, 2009, NEW ENGL J MED, V361, P2342, DOI 10.1056/NEJMoa0906598; Shah SV, 2011, CIRCULATION, V123, P2562, DOI 10.1161/CIRCULATIONAHA.110.985655; Song FJ, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1147; Stein PD, 2001, CHEST, V119, p220S, DOI 10.1378/chest.119.1_suppl.220S; Tzeis S, 2012, ANGIOLOGY, V63, P164, DOI 10.1177/0003319711422808; Uchino K, 2012, ARCH INTERN MED, V172, P397, DOI 10.1001/archinternmed.2011.1666; Wallentin L, 2010, CIRCULATION, V120, P2158; Wallentin L, 2010, LANCET, V376, P975, DOI 10.1016/S0140-6736(10)61194-4; Wann LS, 2011, CIRCULATION, V123, P1144, DOI 10.1161/CIR.0b013e31820f14c0; Wilczynski NL, 2007, J MED LIBR ASSOC, V95, P117, DOI 10.3163/1536-5050.95.2.117; Wrigley BJ, 2010, INT J CLIN PRACT, V64, P835, DOI 10.1111/j.1742-1241.2010.02351.x; Wysowski DK, 2007, ARCH INTERN MED, V167, P1414, DOI 10.1001/archinte.167.13.1414	68	138	142	1	17	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 4	2012	157	11					796	+		10.7326/0003-4819-157-10-201211200-00532	http://dx.doi.org/10.7326/0003-4819-157-10-201211200-00532			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	049RC	22928173				2022-12-28	WOS:000312000100005
J	Viswanathan, M; Golin, CE; Jones, CD; Ashok, M; Blalock, SJ; Wines, RCM; Coker-Schwimmer, EJL; Rosen, DL; Sista, P; Lohr, KN				Viswanathan, Meera; Golin, Carol E.; Jones, Christine D.; Ashok, Mahima; Blalock, Susan J.; Wines, Roberta C. M.; Coker-Schwimmer, Emmanuel J. L.; Rosen, David L.; Sista, Priyanka; Lohr, Kathleen N.			Interventions to Improve Adherence to Self-administered Medications for Chronic Diseases in the United States A Systematic Review	ANNALS OF INTERNAL MEDICINE			English	Review							RANDOMIZED CONTROLLED-TRIAL; BLOOD-PRESSURE CONTROL; ACTIVE ANTIRETROVIRAL THERAPY; PHARMACEUTICAL CARE PROGRAM; CONGESTIVE-HEART-FAILURE; TYPE-2 DIABETES-MELLITUS; HEALTH-CARE; COLLABORATIVE CARE; MANAGEMENT PROGRAM; PATIENT COMPLIANCE	Background: Suboptimum medication adherence is common in the United States and leads to serious negative health consequences but may respond to intervention. Purpose: To assess the comparative effectiveness of patient, provider, systems, and policy interventions that aim to improve medication adherence for chronic health conditions in the United States. Data Sources: Eligible peer-reviewed publications from MEDLINE and the Cochrane Library indexed through 4 June 2012 and additional studies from reference lists and technical experts. Study Selection: Randomized, controlled trials of patient, provider, or systems interventions to improve adherence to long-term medications and nonrandomized studies of policy interventions to improve medication adherence. Data Extraction: Two investigators independently selected, extracted data from, and rated the risk of bias of relevant studies. Data Synthesis: The evidence was synthesized separately for each clinical condition; within each condition, the type of intervention was synthesized. Two reviewers graded the strength of evidence by using established criteria. From 4124 eligible abstracts, 62 trials of patient-, provider-, or systems-level interventions evaluated 18 types of interventions; another 4 observational studies and 1 trial of policy interventions evaluated the effect of reduced medication copayments or improved prescription drug coverage. Clinical conditions amenable to multiple approaches to improving adherence include hypertension, heart failure, depression, and asthma. Interventions that improve adherence across multiple clinical conditions include policy interventions to reduce copayments or improve prescription drug coverage, systems interventions to offer case management, and patient-level educational interventions with behavioral support. Limitations: Studies were limited to adults with chronic conditions (excluding HIV, AIDS, severe mental illness, and substance abuse) in the United States. Clinical and methodological heterogeneity hindered quantitative data pooling. Conclusion: Reduced out-of-pocket expenses, case management, and patient education with behavioral support all improved medication adherence for more than 1 condition. Evidence is limited on whether these approaches are broadly applicable or affect long-term medication adherence and health outcomes.	[Viswanathan, Meera] RTI Int, Durham, NC 27709 USA; Univ N Carolina, Chapel Hill, NC 27599 USA	Research Triangle Institute; University of North Carolina; University of North Carolina Chapel Hill	Viswanathan, M (corresponding author), RTI Int, 3040 Cornwallis Rd, Durham, NC 27709 USA.	viswanathan@rti.org		Lohr, Kathleen/0000-0002-3825-0713	AHRQ [290200710056I]; NIH/HRSA [T32HP14001-25]; Agency for Healthcare Research and Quality; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI050410] Funding Source: NIH RePORTER	AHRQ(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NIH/HRSA; Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	By AHRQ (contract 290200710056I). Dr. Jones is supported by an NIH/HRSA training grant (T32HP14001-25).; Agency for Healthcare Research and Quality.	Agency for Healthcare Research and Quality, 2003, PRIOR AR NAT ACT TRA; Agency for Healthcare Research and Quality, 2011, METH GUID EFF COMP E; Akerblad AC, 2003, INT CLIN PSYCHOPHARM, V18, P347, DOI 10.1097/01.yic.0000091305.72168.6e; Guirado EA, 2011, GAC SANIT, V25, P62, DOI 10.1016/j.gaceta.2010.09.015; Andrejak M, 2000, AM J HYPERTENS, V13, P184, DOI 10.1016/S0895-7061(99)00175-2; [Anonymous], 2003, ADHERENCE LONG TERM; Atherton-Naji A, 2001, PRIMARY CARE PSYCHIA, V7, P61, DOI 10.1185/135525701750384473; Beckles GLA, 1998, DIABETES CARE, V21, P1432, DOI 10.2337/diacare.21.9.1432; Begley S., 1997, INT J PHARM PRACT, V5, P111, DOI [10.1111/j.2042-7174.1997.tb00895.x, DOI 10.1111/J.2042-7174.1997.TB00895.X, DOI 10.1111/j.2042-7174.1997.tb00895.x]; Bender BG, 2010, J AM BOARD FAM MED, V23, P159, DOI 10.3122/jabfm.2010.02.090112; Berg J, 1997, Clin Nurs Res, V6, P225, DOI 10.1177/105477389700600304; Berger BA, 2005, J AM PHARM ASSOC, V45, P466, DOI 10.1331/1544345054475469; BILLAULT B, 1995, M D COMPUT, V12, P31; Bocchi EA, 2008, CIRC-HEART FAIL, V1, P115, DOI 10.1161/CIRCHEARTFAILURE.107.744870; Bogner HR, 2008, ANN FAM MED, V6, P295, DOI 10.1370/afm.843; Bogner HR, 2012, ANN FAM MED, V10, P15, DOI 10.1370/afm.1344; Bogner HR, 2010, DIABETES EDUCATOR, V36, P284, DOI 10.1177/0145721709356115; Boissel JP, 1996, EUR J CLIN PHARMACOL, V50, P63, DOI 10.1007/s002280050070; Bosworth HB, 2008, PATIENT EDUC COUNS, V70, P338, DOI 10.1016/j.pec.2007.11.014; Bosworth HB, 2007, CONTEMP CLIN TRIALS, V28, P33, DOI 10.1016/j.cct.2006.08.006; Bosworth HB, 2005, PATIENT EDUC COUNS, V57, P5, DOI 10.1016/j.pec.2004.03.011; Briesacher BA, 2007, J GEN INTERN MED, V22, P864, DOI 10.1007/s11606-007-0180-x; Brown I, 2009, EPILEPSY BEHAV, V16, P634, DOI 10.1016/j.yebeh.2009.09.014; Brus HLM, 1998, ANN RHEUM DIS, V57, P146, DOI 10.1136/ard.57.3.146; Capoccia KL, 2004, AM J HEALTH-SYST PH, V61, P364, DOI 10.1093/ajhp/61.4.364; Carter BL, 2009, ARCH INTERN MED, V169, P1996, DOI 10.1001/archinternmed.2009.358; Charles T, 2007, J ALLERGY CLIN IMMUN, V119, P811, DOI 10.1016/j.jaci.2006.11.700; Chen SY, 2010, J NURS RES, V18, P266, DOI 10.1097/NRJ.0b013e3181fbe33f; Chernew ME, 2008, HEALTH AFFAIR, V27, P103, DOI 10.1377/hlthaff.27.1.103; Choudhry NK, 2011, NEW ENGL J MED, V365, P2088, DOI 10.1056/NEJMsa1107913; Choudhry NK, 2010, HEALTH AFFAIR, V29, P1995, DOI 10.1377/hlthaff.2010.0336; Christensen A, 2010, J HYPERTENS, V28, P194, DOI 10.1097/HJH.0b013e328331b718; Claxton A, 2000, J CLIN PSYCHIAT, V61, P928, DOI 10.4088/JCP.v61n1207; Clowes JA, 2004, J CLIN ENDOCR METAB, V89, P1117, DOI 10.1210/jc.2003-030501; Cooper A, 2006, INT J CLIN PRACT, V60, P896, DOI 10.1111/j.1742-1241.2006.01059.x; Cote J, 1997, AM J RESP CRIT CARE, V155, P1509, DOI 10.1164/ajrccm.155.5.9154850; Cote J, 2001, AM J RESP CRIT CARE, V163, P1415, DOI 10.1164/ajrccm.163.6.2006069; Davidoff F, 2008, QUAL SAF HEALTH CARE, V17, P3, DOI 10.1136/qshc.2008.029066; de Castro MS, 2006, AM J HYPERTENS, V19, P528, DOI 10.1016/j.amjhyper.2005.11.009; Delmas PD, 2007, J CLIN ENDOCR METAB, V92, P1296, DOI 10.1210/jc.2006-1526; DiMatteo MR, 2002, MED CARE, V40, P794, DOI 10.1097/01.MLR.0000024612.61915.2D; Dunbar-Jacob J, 2000, Annu Rev Nurs Res, V18, P48; Edworthy SM, 2007, CAN J CARDIOL, V23, P1066, DOI 10.1016/S0828-282X(07)70875-9; Elkjaer M, 2010, GUT, V59, P1652, DOI 10.1136/gut.2010.220160; Eussen SRBM, 2010, ANN PHARMACOTHER, V44, P1905, DOI 10.1345/aph.1P281; Friedman RH, 1996, AM J HYPERTENS, V9, P285, DOI 10.1016/0895-7061(95)00353-3; Fulmer T T, 1999, J Gerontol Nurs, V25, P6; Gallefoss F, 1999, AM J RESP CRIT CARE, V160, P2000, DOI 10.1164/ajrccm.160.6.9901028; Gellad WF, 2011, AM J GERIATR PHARMAC, V9, P11, DOI 10.1016/j.amjopharm.2011.02.004; Gensichen J, 2009, ANN INTERN MED, V151, P369, DOI 10.7326/0003-4819-151-6-200909150-00001; GOODYER LI, 1995, BRIT J CLIN PRACT, V49, P173; Gourley G A, 1998, J Am Pharm Assoc (Wash), V38, P586; Grant RW, 2003, ANN PHARMACOTHER, V37, P962, DOI 10.1345/aph.1C452; Grenard JL, 2011, J GEN INTERN MED, V26, P1175, DOI 10.1007/s11606-011-1704-y; Grosset KA, 2007, BMC NEUROL, V7, DOI 10.1186/1471-2377-7-20; Guthrie RM, 2001, CLIN THER, V23, P970, DOI 10.1016/S0149-2918(01)80084-9; Gwadry-Sridhar FH, 2005, AM HEART J, V150, DOI 10.1016/j.ahj.2005.08.016; Hardstaff R, 2003, TRANSPLANT P, V35, P796, DOI 10.1016/S0041-1345(03)00074-5; Haynes RB, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000011.pub3; Hill J, 2001, ANN RHEUM DIS, V60, P869; Hoffman L, 2003, AM J MANAG CARE, V9, P70; Homer D, 2009, MUSCULOSKELET CARE, V7, P78, DOI 10.1002/msc.141; Hornnes N, 2011, J STROKE CEREBROVASC, V20, P16, DOI 10.1016/j.jstrokecerebrovasdis.2009.10.002; Hunt JS, 2008, J GEN INTERN MED, V23, P1966, DOI 10.1007/s11606-008-0791-x; Janson SL, 2003, AM J MED, V115, P620, DOI 10.1016/j.amjmed.2003.07.008; Janson SL, 2009, J ALLERGY CLIN IMMUN, V123, P840, DOI 10.1016/j.jaci.2009.01.053; Johnson S.S., 2006, DIS MANAG, V9, P102, DOI DOI 10.1089/DIS.2006.9.102; Johnson Sara S, 2006, Dis Manag, V9, P291, DOI 10.1089/dis.2006.9.291; Jones LA, 2009, MED DECIS MAKING, V29, P468, DOI 10.1177/0272989X09333120; Katon W, 2002, J GEN INTERN MED, V17, P741, DOI 10.1046/j.1525-1497.2002.11051.x; Katon W, 2001, ARCH GEN PSYCHIAT, V58, P241, DOI 10.1001/archpsyc.58.3.241; Katon W, 1999, ARCH GEN PSYCHIAT, V56, P1109, DOI 10.1001/archpsyc.56.12.1109; Katon W, 1996, ARCH GEN PSYCHIAT, V53, P924; KATON W, 1995, JAMA-J AM MED ASSOC, V273, P1026, DOI 10.1001/jama.273.13.1026; Kennedy J, 2006, CLIN THER, V28, P1217, DOI 10.1016/j.clinthera.2006.07.009; Kennedy J, 2009, CLIN THER, V31, P213, DOI 10.1016/j.clinthera.2009.01.006; Klein A, 2009, TRANSPLANTATION, V87, P839, DOI 10.1097/TP.0b013e318199d122; Lee JK, 2006, JAMA-J AM MED ASSOC, V296, P2563, DOI 10.1001/jama.296.21.joc60162; Leenen FHH, 1997, CAN J CARDIOL, V13, P914; Lin EHB, 2006, ANN FAM MED, V4, P46, DOI 10.1370/afm.423; Lopez Cabezas C, 2006, Farm Hosp, V30, P328; Lopez-Vina A, 2000, RESP MED, V94, P760, DOI 10.1053/rmed.2000.0815; Ludman E, 2003, PSYCHOL MED, V33, P1061, DOI 10.1017/S003329170300816X; Maciejewski ML, 2010, HEALTH AFFAIR, V29, P2002, DOI 10.1377/hlthaff.2010.0571; Mahoney JJ, 2008, J MANAGE CARE PHARM, V14, pS3, DOI 10.18553/jmcp.2008.14.S6-B.3; Mann DM, 2010, PATIENT EDUC COUNS, V80, P138, DOI 10.1016/j.pec.2009.10.008; Mengden Thomas, 2006, BMC Cardiovasc Disord, V6, P36, DOI 10.1186/1471-2261-6-36; Montori VM, 2011, AM J MED, V124, P549, DOI 10.1016/j.amjmed.2011.01.013; Murray MD, 2007, ANN INTERN MED, V146, P714, DOI 10.7326/0003-4819-146-10-200705150-00005; Nazareth I, 2001, AGE AGEING, V30, P33, DOI 10.1093/ageing/30.1.33; New England Healthcare Institute, 2009, THINK OUTS PILLB SYS; Nielsen D, 2010, PATIENT EDUC COUNS, V81, P155, DOI 10.1016/j.pec.2010.03.010; Nietert PJ, 2009, MED CARE, V47, P32, DOI 10.1097/MLR.0b013e3181808c17; Norris SL, 2011, J CLIN EPIDEMIOL, V64, P1178, DOI 10.1016/j.jclinepi.2010.04.027; Ogedegbe GO, 2012, ARCH INTERN MED, V172, P322, DOI 10.1001/archinternmed.2011.1307; Okeke CO, 2009, OPHTHALMOLOGY, V116, P2286, DOI 10.1016/j.ophtha.2009.05.026; Osterberg L, 2005, NEW ENGL J MED, V353, P487, DOI 10.1056/NEJMra050100; Owens DK, 2010, J CLIN EPIDEMIOL, V63, P513, DOI 10.1016/j.jclinepi.2009.03.009; Pathman DE, 1996, MED CARE, V34, P873, DOI 10.1097/00005650-199609000-00002; Pearce KA, 2008, J AM BOARD FAM MED, V21, P269, DOI 10.3122/jabfm.2008.04.080007; Perahia DGS, 2008, J AFFECT DISORDERS, V108, P33, DOI 10.1016/j.jad.2007.08.023; Peterson AM, 2003, AM J HEALTH-SYST PH, V60, P657, DOI 10.1093/ajhp/60.7.657; Peterson GM, 2004, J CLIN PHARM THER, V29, P23, DOI 10.1046/j.1365-2710.2003.00532.x; Peveler R, 1999, BRIT MED J, V319, P612, DOI 10.1136/bmj.319.7210.612; Phumipamorn S, 2008, PRIM CARE DIABETES, V2, P31, DOI 10.1016/j.pcd.2007.12.001; Pladevall M, 2010, CIRCULATION, V122, P1183, DOI 10.1161/CIRCULATIONAHA.109.892778; Ponnusankar S, 2004, PATIENT EDUC COUNS, V54, P55, DOI 10.1016/s0738-3991(03)00193-9; POWELL KM, 1995, AM J HEALTH-SYST PH, V52, P2196, DOI 10.1093/ajhp/52.20.2196; Powers BJ, 2011, AM HEART J, V161, P673, DOI 10.1016/j.ahj.2010.12.021; PSATY BM, 1990, JAMA-J AM MED ASSOC, V263, P1653, DOI 10.1001/jama.263.12.1653; Pyne JM, 2011, ARCH INTERN MED, V171, P23, DOI 10.1001/archinternmed.2010.395; Rich MW, 1996, AM J MED, V101, P270, DOI 10.1016/S0002-9343(96)00172-6; Rickles NM, 2005, J AM PHARM ASSOC, V45, P344, DOI 10.1331/1544345054003732; Rinfret S, 2009, CIRC-CARDIOVASC QUAL, V2, P170, DOI 10.1161/CIRCOUTCOMES.108.823765; Rogers PG, 1995, J PHARMACOEPIDEMIOL, V3, P3; Ross SE, 2004, J MED INTERNET RES, V6, DOI 10.2196/jmir.6.2.e12; Roter DL, 1998, MED CARE, V36, P1138, DOI 10.1097/00005650-199808000-00004; Rubak S, 2011, SCAND J PRIM HEALTH, V29, P92, DOI 10.3109/02813432.2011.554271; Rudd P, 2004, AM J HYPERTENS, V17, P921, DOI 10.1016/j.amjhyper.2004.06.006; Rudd RE, 2009, PATIENT EDUC COUNS, V75, P334, DOI 10.1016/j.pec.2009.03.001; Rueda S, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001442.pub2; Sarquis L M, 1998, Rev Esc Enferm USP, V32, P335; Schaffer Susan D, 2004, Clin Nurs Res, V13, P69, DOI 10.1177/1054773803259300; SCHECTMAN G, 1994, ANN PHARMACOTHER, V28, P29, DOI 10.1177/106002809402800104; Schiff GD, 2003, AM J MED, V114, P625, DOI 10.1016/S0002-9343(03)00132-3; Schneider PJ, 2008, J AM PHARM ASSOC, V48, P58, DOI 10.1331/JAPhA.2008.07040; Schnipper JL, 2006, ARCH INTERN MED, V166, P565, DOI 10.1001/archinte.166.5.565; Seck BC, 2008, PUBLIC HEALTH NUTR, V11, P596, DOI 10.1017/S1368980007000924; Sherrard Heather, 2009, Can J Cardiovasc Nurs, V19, P9; Shojania KG, 2004, AHRQ PUBLICATION, V04-0051-2; Showalter A., 2006, COSTS PATIENT NONCOM, V2006, P1; Simon GE, 2004, JAMA-J AM MED ASSOC, V292, P935, DOI 10.1001/jama.292.8.935; Simon GE, 2006, PSYCHIAT SERV, V57, P1441, DOI 10.1176/appi.ps.57.10.1441; Simoni JM, 2006, JAIDS-J ACQ IMM DEF, V43, pS23, DOI 10.1097/01.qai.0000248342.05438.52; Sledge William H, 2006, Dis Manag, V9, P328, DOI 10.1089/dis.2006.9.328; Smith DH, 2008, ARCH INTERN MED, V168, P477, DOI 10.1001/archinternmed.2007.132; Solomon D K, 1998, J Am Pharm Assoc (Wash), V38, P574; Solomon DH, 2012, ARCH INTERN MED, V172, P477, DOI 10.1001/archinternmed.2011.1977; Sookaneknun P, 2004, ANN PHARMACOTHER, V38, P2023, DOI 10.1345/aph.1D605; Sovani MP, 2008, BRIT J GEN PRACT, V58, P37, DOI 10.3399/bjgp08X263802; Stacy JN, 2009, POPUL HEALTH MANAG, V12, P241, DOI 10.1089/pop.2008.0046; Stewart A, 2005, Cardiovasc J S Afr, V16, P102; Sturgess IK, 2003, PHARM WORLD SCI, V25, P218, DOI 10.1023/A:1025860402256; Tamblyn R, 2010, MED DECIS MAKING, V30, P176, DOI 10.1177/0272989X09342752; Task Force for Compliance, 1994, NONC MED EC TRAG IMP; Taylor CT, 2003, AM J HEALTH-SYST PH, V60, P1123, DOI 10.1093/ajhp/60.11.1123; Tsuyuki RT, 2004, J CARD FAIL, V10, P473, DOI 10.1016/j.cardfail.2004.02.005; Varma S, 1999, PHARMACOTHERAPY, V19, P860, DOI 10.1592/phco.19.10.860.31565; Vergouwen AC, 2005, PSYCHOL MED, V35, P25, DOI 10.1017/S003329170400296X; Viswanathan M, 2012, J CLIN EPIDEMIOL, V65, P163, DOI 10.1016/j.jclinepi.2011.05.008; Vivian EM, 2002, PHARMACOTHERAPY, V22, P1533, DOI 10.1592/phco.22.17.1533.34127; Von Korff M, 2003, PSYCHOSOM MED, V65, P938, DOI 10.1097/01.PSY.0000097336.95046.0C; Vrijens B, 1997, CONTROL CLIN TRIALS, V18, P187, DOI 10.1016/S0197-2456(96)00235-8; Waalen J, 2009, AM J MANAG CARE, V15, pE60; Waeber B, 2000, J CARDIOVASC PHARM, V35, pS23, DOI 10.1097/00005344-200035063-00006; Wakefield BJ, 2011, TELEMED E-HEALTH, V17, P254, DOI 10.1089/tmj.2010.0176; Waters BM, 2005, CAN J GASTROENTEROL, V19, P235, DOI 10.1155/2005/250504; Weinberger M, 2002, JAMA-J AM MED ASSOC, V288, P1594, DOI 10.1001/jama.288.13.1594; Weymiller AJ, 2007, ARCH INTERN MED, V167, P1076, DOI 10.1001/archinte.167.10.1076; Williams LK, 2010, J ALLERGY CLIN IMMUN, V126, P225, DOI 10.1016/j.jaci.2010.03.034; Wilson SR, 2010, AM J RESP CRIT CARE, V181, P566, DOI 10.1164/rccm.200906-0907OC; Wolever RQ, 2010, DIABETES EDUCATOR, V36, P629, DOI 10.1177/0145721710371523; Wong FKY, 2010, INT J NURS STUD, V47, P268, DOI 10.1016/j.ijnurstu.2009.07.001; World Health Organization, 2003, NONC DIS MENT HLTH P; World Health Organization (WHO), 2013, WORLD HLTH REPORT 20; Wu JYF, 2006, BMJ-BRIT MED J, V333, P522, DOI 10.1136/bmj.38905.447118.2F; Wu JR, 2012, J CARD FAIL, V18, P1, DOI 10.1016/j.cardfail.2011.09.006; Zhang YT, 2010, MED CARE, V48, P409, DOI 10.1097/MLR.0b013e3181d68978	168	474	480	10	148	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 4	2012	157	11					785	+		10.7326/0003-4819-157-11-201212040-00538	http://dx.doi.org/10.7326/0003-4819-157-11-201212040-00538			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	049RC	22964778				2022-12-28	WOS:000312000100004
J	Cleland, JGF; Clark, AL				Cleland, John G. F.; Clark, Andrew L.			Heart failure-does it matter whether LVEF is reduced?	LANCET			English	Editorial Material							RANDOMIZED-TRIAL; EVENTS		[Cleland, John G. F.; Clark, Andrew L.] Univ Hull, Dept Cardiol, Castle Hill Hosp, Hull York Med Sch, Kingston Upon Hull HU6 5JQ, Yorks, England	University of Hull; University of York - UK	Cleland, JGF (corresponding author), Univ Hull, Dept Cardiol, Castle Hill Hosp, Hull York Med Sch, Kingston Upon Hull HU6 5JQ, Yorks, England.	j.g.cleland@hull.ac.uk	Cleland, John G./AAZ-4185-2020	Cleland, John G./0000-0002-1471-7016	National Institute for Health Research [NF-SI-0611-10227] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))		Banerjee P, 2004, EUR J HEART FAIL, V6, P427, DOI 10.1016/j.ejheart.2004.02.006; Beckett N, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d7541; Caruana L, 2000, BRIT MED J, V321, P215, DOI 10.1136/bmj.321.7255.215; Cleland JGF, 2006, EUR HEART J, V27, P2338, DOI 10.1093/eurheartj/ehl250; Cleland JGF, 2009, J AM COLL CARDIOL, V54, P1850, DOI 10.1016/j.jacc.2009.06.041; ClinicalTrials. gov, THIS STUD WILL EV EF; Dagenais GR, 2006, LANCET, V368, P581, DOI 10.1016/S0140-6736(06)69201-5; GOOD JM, 1995, J AM COLL CARDIOL, V25, P1273, DOI 10.1016/0735-1097(94)00561-4; Konstam MA, 2009, LANCET, V374, P1840, DOI 10.1016/S0140-6736(09)61913-9; MARANTZ PR, 1988, ANN INTERN MED, V109, P55, DOI 10.7326/0003-4819-109-1-55; Massie BM, 2008, NEW ENGL J MED, V359, P2456, DOI 10.1056/NEJMoa0805450; Packer M, 2002, CIRCULATION, V106, P920, DOI 10.1161/01.CIR.0000029801.86489.50; Pitt B, 2000, LANCET, V355, P1582, DOI 10.1016/S0140-6736(00)02213-3; SOLOMON SD, 2012, LANCET; YUSUF S, 2003, LANCET, V362, P771	15	12	14	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 20	2012	380	9851					1363	1365		10.1016/S0140-6736(12)61349-X	http://dx.doi.org/10.1016/S0140-6736(12)61349-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	025NM	22932711				2022-12-28	WOS:000310196500006
J	Novarino, G; El-Fishawy, P; Kayserili, H; Meguid, NA; Scott, EM; Schroth, J; Silhavy, JL; Kara, M; Khalil, RO; Ben-Omran, T; Ercan-Sencicek, AG; Hashish, AF; Sanders, SJ; Gupta, AR; Hashem, HS; Matern, D; Gabriel, S; Sweetman, L; Rahimi, Y; Harris, RA; State, MW; Gleeson, JG				Novarino, Gaia; El-Fishawy, Paul; Kayserili, Hulya; Meguid, Nagwa A.; Scott, Eric M.; Schroth, Jana; Silhavy, Jennifer L.; Kara, Majdi; Khalil, Rehab O.; Ben-Omran, Tawfeg; Ercan-Sencicek, A. Gulhan; Hashish, Adel F.; Sanders, Stephan J.; Gupta, Abha R.; Hashem, Hebatalla S.; Matern, Dietrich; Gabriel, Stacey; Sweetman, Larry; Rahimi, Yasmeen; Harris, Robert A.; State, Matthew W.; Gleeson, Joseph G.			Mutations in BCKD-kinase Lead to a Potentially Treatable Form of Autism with Epilepsy	SCIENCE			English	Article							SYRUP-URINE-DISEASE; DEHYDROGENASE KINASE; AMINO-ACIDS; METABOLISM; EXPRESSION; TRANSPORT; MICE	Autism spectrum disorders are a genetically heterogeneous constellation of syndromes characterized by impairments in reciprocal social interaction. Available somatic treatments have limited efficacy. We have identified inactivating mutations in the gene BCKDK (Branched Chain Ketoacid Dehydrogenase Kinase) in consanguineous families with autism, epilepsy, and intellectual disability. The encoded protein is responsible for phosphorylation-mediated inactivation of the E1 alpha subunit of branched-chain ketoacid dehydrogenase (BCKDH). Patients with homozygous BCKDK mutations display reductions in BCKDK messenger RNA and protein, E1 alpha phosphorylation, and plasma branched-chain amino acids. Bckdk knockout mice show abnormal brain amino acid profiles and neurobehavioral deficits that respond to dietary supplementation. Thus, autism presenting with intellectual disability and epilepsy caused by BCKDK mutations represents a potentially treatable syndrome.	[Novarino, Gaia; Scott, Eric M.; Schroth, Jana; Silhavy, Jennifer L.; Gleeson, Joseph G.] Univ Calif San Diego, Howard Hughes Med Inst, Neurogenet Lab, Dept Neurosci, La Jolla, CA 92093 USA; [Ercan-Sencicek, A. Gulhan; Sanders, Stephan J.; State, Matthew W.] Yale Univ, Ctr Child Study, Sch Med, Program Neurogenet,Dept Psychiat, New Haven, CT 06520 USA; [Kayserili, Hulya] Istanbul Univ, Istanbul Fac Med, Dept Med Genet, TR-34093 Faith Istanbul, Turkey; [Meguid, Nagwa A.; Khalil, Rehab O.; Hashish, Adel F.; Hashem, Hebatalla S.] Natl Res Ctr, Dept Res Children Special Needs, Cairo, Egypt; [Kara, Majdi] Tripoli Childrens Hosp, Dept Pediat, Tripoli, Libya; [Ben-Omran, Tawfeg] Hamad Med Corp, Dept Pediat, Clin & Metab Genet Div, Doha, Qatar; [Ercan-Sencicek, A. Gulhan; Sanders, Stephan J.; State, Matthew W.] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06520 USA; [Gupta, Abha R.] Yale Univ, Sch Med, Dept Pediat, Ctr Child Study, New Haven, CT 06520 USA; [Matern, Dietrich] Mayo Clin, Dept Lab Med & Pathol, Biochem Genet Lab, Rochester, MN 55905 USA; [Gabriel, Stacey] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA; [Sweetman, Larry] Baylor Res Inst, Inst Metab Dis, Dallas, TX 75226 USA; [Rahimi, Yasmeen; Harris, Robert A.] Indiana Univ Sch Med, Roudebush VA Med Ctr, Indianapolis, IN 46202 USA; [Rahimi, Yasmeen; Harris, Robert A.] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA	Howard Hughes Medical Institute; University of California System; University of California San Diego; Yale University; Istanbul University; Egyptian Knowledge Bank (EKB); National Research Centre (NRC); Hamad Medical Corporation; Yale University; Yale University; Mayo Clinic; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Baylor Scott & White Health; Baylor University Medical Center; Indiana University System; Indiana University Bloomington; US Department of Veterans Affairs; Veterans Health Administration (VHA); Richard L. Roudebush VA Medical Center; Indiana University System; Indiana University Bloomington	Novarino, G (corresponding author), Univ Calif San Diego, Howard Hughes Med Inst, Neurogenet Lab, Dept Neurosci, La Jolla, CA 92093 USA.	gnovarino@ucsd.edu; jogleeson@ucsd.edu	meguid, nagwa/S-7099-2016; Sanders, Stephan/S-8645-2019; Kayserili, Hülya/AAA-5593-2021; State, Matthew/W-2256-2019	Kayserili, Hülya/0000-0003-0376-499X; State, Matthew/0000-0003-1624-8302; Sanders, Stephan/0000-0001-9112-5148; Meguid, Nagwa/0000-0002-7962-2501; HASHISH, ADEL/0000-0001-9549-2973	NIH [P01HD070494, R01NS048453, P30NS047101, RC2MH089956, K08MH087639, T32MH018268]; Broad Institute [U54HG003067]; Center for Inherited Disease Research for genotyping; Simons Foundation Autism Research Initiative; Veterans Administration Merit Award; German Research Foundation; American Academy of Child and Adolescent Psychiatry Pilot Research Award/Elaine Schlosser Lewis Fund; American Psychiatric Association/Lilly Research Fellowship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD070494] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R25MH077823, RC2MH089956, T32MH018268, K08MH087639] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048453, R01NS041537, P30NS047101] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Broad Institute; Center for Inherited Disease Research for genotyping; Simons Foundation Autism Research Initiative; Veterans Administration Merit Award; German Research Foundation(German Research Foundation (DFG)); American Academy of Child and Adolescent Psychiatry Pilot Research Award/Elaine Schlosser Lewis Fund; American Psychiatric Association/Lilly Research Fellowship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the families for their participation; R. Weavers and E. Morava (Nijmegen Medical Center, Netherlands) and B. Barshop for providing patients; M. Kara's colleague for arranging shipment during the Libyan revolution; C. Lynch for the pSer293 antibody; the S. Taylor lab (UCSD) for help in protein modeling; M. Seashore, W. MacLean Jr., T. Cowan, and A. El-Gharabawy for suggestions; N. Wright-Davis, M. Murtha, M. Raubeson, N. DiLullo, M. Walker, Y. Song, N. Lifton, K. Bilguvar, A. Caglayan, Z. Omay, M. Choi, N. Carriero, R. D. Bjornson, P. Ventola, K. Koenig, and A. Bozik for technical assistance; the Yale Center for Genome Analysis (S. Mane); and the Sanford Burnham Institute. Supported by NIH grants P01HD070494, R01NS048453, and P30NS047101 (J.G.G.), RC2MH089956 (M. W. S.), K08MH087639 (A. R. G.), T32MH018268 and (P.E.-F.); Broad Institute grant U54HG003067 (E. L.); the Center for Inherited Disease Research for genotyping; the Simons Foundation Autism Research Initiative (J.G.G. and M. W. S.); a Veterans Administration Merit Award (R. A. H.); the German Research Foundation (G. N.); the American Academy of Child and Adolescent Psychiatry Pilot Research Award/Elaine Schlosser Lewis Fund (P.E.-F.); and the American Psychiatric Association/Lilly Research Fellowship (P.E.-F.). J.G.G. is an investigator of the Howard Hughes Medical Institute. Data have been deposited into dbGap (phs000288) and the NCBI Sequence Read Archive (SRS351252) (whole exome sequencing) and into GEO (GSE39447) (microarrays). J.G.G. is a consultant for Halozyme Therapeutics, a biopharmaceutical company that develops products targeting the extracellular matrix. M. W. S. is a consultant to Synapdx, that is developing diagnostic tests for autism, and to Pfizer Pharmaceuticals that is working to develop autism therapeutics. Bckdk gene trap mice are available for noncommercial research from R. A. H. under MTA agreement with Lexicon. J.G.G. and M. W. S. are inventors on a patent application filed 17 July 2012 by UCSD covering diagnostic and therapeutic strategies for patients with autism and epilepsy.	BAILEY A, 1995, PSYCHOL MED, V25, P63, DOI 10.1017/S0033291700028099; Chao HT, 2010, NATURE, V468, P263, DOI 10.1038/nature09582; Doering CB, 1998, GENE, V212, P213, DOI 10.1016/S0378-1119(98)00182-6; Duelli R, 2000, J CEREBR BLOOD F MET, V20, P1557, DOI 10.1097/00004647-200011000-00005; Harris RA, 2005, J NUTR, V135, p1527S, DOI 10.1093/jn/135.6.1527S; Hawkins RA, 2006, J NUTR, V136, p218S, DOI 10.1093/jn/136.1.218S; Joshi MA, 2006, BIOCHEM J, V400, P153, DOI 10.1042/BJ20060869; Lepage N, 1997, CLIN CHEM, V43, P2397; Lynch CJ, 2003, AM J PHYSIOL-ENDOC M, V285, pE854, DOI 10.1152/ajpendo.00153.2003; Machius M, 2001, P NATL ACAD SCI USA, V98, P11218, DOI 10.1073/pnas.201220098; MENKES JH, 1954, PEDIATRICS, V14, P462; Okita K, 2011, NAT METHODS, V8, P409, DOI [10.1038/NMETH.1591, 10.1038/nmeth.1591]; Schmeisser MJ, 2012, NATURE, V486, P256, DOI 10.1038/nature11015; Seelow D, 2009, NUCLEIC ACIDS RES, V37, pW593, DOI 10.1093/nar/gkp369; SNYDERMAN SE, 1964, PEDIATRICS, V34, P454; Suryawan A, 1998, AM J CLIN NUTR, V68, P72, DOI 10.1093/ajcn/68.1.72; Tuchman R, 2002, LANCET NEUROL, V1, P352, DOI 10.1016/S1474-4422(02)00160-6; Verrey F, 2003, PFLUG ARCH EUR J PHY, V445, P529, DOI 10.1007/S00424-002-0973-Z; Wagner CA, 2001, AM J PHYSIOL-CELL PH, V281, pC1077, DOI 10.1152/ajpcell.2001.281.4.C1077; Yuan SH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017540; Zinnanti WJ, 2009, BRAIN, V132, P903, DOI 10.1093/brain/awp024	21	201	210	1	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 19	2012	338	6105					394	397		10.1126/science.1224631	http://dx.doi.org/10.1126/science.1224631			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022JS	22956686	Green Accepted			2022-12-28	WOS:000309955800044
J	Qiao, H; Shen, ZX; Huang, SSC; Schmitz, RJ; Urich, MA; Briggs, SP; Ecker, JR				Qiao, Hong; Shen, Zhouxin; Huang, Shao-shan Carol; Schmitz, Robert J.; Urich, Mark A.; Briggs, Steven P.; Ecker, Joseph R.			Processing and Subcellular Trafficking of ER-Tethered EIN2 Control Response to Ethylene Gas	SCIENCE			English	Article							ARABIDOPSIS-THALIANA; SEEDLINGS; PATHWAY; ACTIVATION; PROTEOMICS; REGULATOR; PROTEINS; RECEPTOR; FAMILY; CTR1	Ethylene gas is essential for many developmental processes and stress responses in plants. ETHYLENE INSENSITIVE2 (EIN2), an NRAMP-like integral membrane protein, plays an essential role in ethylene signaling, but its function remains enigmatic. Here we report that phosphorylation-regulated proteolytic processing of EIN2 triggers its endoplasmic reticulum (ER)-to-nucleus translocation. ER-tethered EIN2 shows CONSTITUTIVE TRIPLE RESPONSE1 (CTR1) kinase-dependent phosphorylation. Ethylene triggers dephosphorylation at several sites and proteolytic cleavage at one of these sites, resulting in nuclear translocation of a carboxyl-terminal EIN2 fragment (EIN2-C'). Mutations that mimic EIN2 dephosphorylation, or inactivate CTR1, show constitutive cleavage and nuclear localization of EIN2-C' and EIN3 and EIN3-LIKE1-dependent activation of ethylene responses. These findings uncover a mechanism of subcellular communication whereby ethylene stimulates phosphorylation-dependent cleavage and nuclear movement of the EIN2-C' peptide, linking hormone perception and signaling components in the ER with nuclear-localized transcriptional regulators.	[Qiao, Hong; Huang, Shao-shan Carol; Schmitz, Robert J.; Urich, Mark A.; Ecker, Joseph R.] Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA; [Shen, Zhouxin; Briggs, Steven P.] Univ Calif San Diego, Sect Cell & Dev Biol, La Jolla, CA 92093 USA; [Huang, Shao-shan Carol; Schmitz, Robert J.; Urich, Mark A.; Ecker, Joseph R.] Salk Inst Biol Studies, Genom Anal Lab, La Jolla, CA 92037 USA; [Huang, Shao-shan Carol; Ecker, Joseph R.] Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA	Salk Institute; University of California System; University of California San Diego; Salk Institute; Howard Hughes Medical Institute; Salk Institute	Ecker, JR (corresponding author), Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA.	ecker@salk.edu	qiao, hong/J-7796-2012; Schmitz, Robert/AAY-7659-2020; Ecker, Joseph R/B-9144-2008	Schmitz, Robert/0000-0001-7538-6663; Ecker, Joseph R/0000-0001-5799-5895	NIH National Research Service Award postdoctoral fellowship [F32-HG004830]; NSF [MCB-0924871, MCB-1024999, DBI-0924023]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [F32HG004830] Funding Source: NIH RePORTER; Direct For Biological Sciences [1024999] Funding Source: National Science Foundation	NIH National Research Service Award postdoctoral fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank L. Song, N. Benson, and R. O'Malley for comments; J. Lin for plant maintenance; J. Chory for access to, and N. Geldner for assistance with, confocal microscopy; and J. Harper for the antibody to ACA2. We thank J. Nery for assistance with next-generation sequencing. R. J. S. was supported by an NIH National Research Service Award postdoctoral fellowship (F32-HG004830). This work was supported by grants from NSF (MCB-0924871 and MCB-1024999 to J. R. E. and DBI-0924023 to S. P. B.). J. R. E is an Investigator of the Howard Hughes Medical Institute and the Gordon and Betty Moore Foundation. Sequence data can be downloaded from the National Center for Biotechnology Information's Sequence Read Archive (accession no. SRA052247).	Alonso JM, 1999, SCIENCE, V284, P2148, DOI 10.1126/science.284.5423.2148; Binder BM, 2004, PLANT PHYSIOL, V136, P2921, DOI 10.1104/pp.104.050393; Bisson MMA, 2011, PLANT SIGNAL BEHAV, V6, P164, DOI [10.4161/psb.6.1.14034, 10.4161/psb.5.12.14034]; Bisson MMA, 2009, BIOCHEM J, V424, P1, DOI 10.1042/BJ20091102; CHANG C, 1993, SCIENCE, V262, P539, DOI 10.1126/science.8211181; Chao QM, 1997, CELL, V89, P1133, DOI 10.1016/S0092-8674(00)80300-1; Chen RQ, 2011, MOL BIOSYST, V7, P2637, DOI 10.1039/c1mb05159h; Chen YF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008640; Cravatt BF, 2007, NATURE, V450, P991, DOI 10.1038/nature06525; Dong CH, 2010, J BIOL CHEM, V285, P40706, DOI 10.1074/jbc.M110.146605; Hirayama T, 1999, CELL, V97, P383, DOI 10.1016/S0092-8674(00)80747-3; Hua J, 1998, CELL, V94, P261, DOI 10.1016/S0092-8674(00)81425-7; Huang YF, 2003, PLANT J, V33, P221, DOI 10.1046/j.1365-313X.2003.01620.x; Kendrick MD, 2008, CURR OPIN PLANT BIOL, V11, P479, DOI 10.1016/j.pbi.2008.06.011; KIEBER JJ, 1993, CELL, V72, P427, DOI 10.1016/0092-8674(93)90119-B; Lange V, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.61; Li H, 2009, PROTEOMICS, V9, P1646, DOI 10.1002/pmic.200800420; Nargund AM, 2012, SCIENCE, V337, P587, DOI 10.1126/science.1223560; Qiao H, 2009, GENE DEV, V23, P512, DOI 10.1101/gad.1765709; Roczniak-Ferguson A, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002790; ROMAN G, 1995, GENETICS, V139, P1393; Sakai H, 1998, P NATL ACAD SCI USA, V95, P5812, DOI 10.1073/pnas.95.10.5812	22	316	342	10	186	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 19	2012	338	6105					390	393		10.1126/science.1225974	http://dx.doi.org/10.1126/science.1225974			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022JS	22936567	Green Accepted			2022-12-28	WOS:000309955800043
J	Moyer, VA				Moyer, Virginia A.		US Preventive Serv Task Force	Screening for Chronic Kidney Disease: US Preventive Services Task Force Recommendation Statement	ANNALS OF INTERNAL MEDICINE			English	Article							STAGE RENAL-DISEASE	Description: New U.S. Preventive Services Task Force (USPSTF) recommendation statement on screening for chronic kidney disease (CKD). Methods: The USPSTF reviewed evidence on screening for CKD, including evidence on screening, accuracy of screening, early treatment, and harms of screening and early treatment. Population: This recommendation applies to asymptomatic adults without diagnosed CKD. Testing for and monitoring CKD for the purpose of chronic disease management (including testing and monitoring patients with diabetes or hypertension) are not covered by this recommendation. Recommendation: The USPSTF concludes that the evidence is insufficient to assess the balance of benefits and harms of routine screening for CKD in asymptomatic adults (I statement).	[Moyer, Virginia A.; US Preventive Serv Task Force] US Prevent Serv Task Force, Rockville, MD USA		Moyer, VA (corresponding author), US Prevent Serv Task Force, Rockville, MD USA.							[Anonymous], 2012, DIABETES CARE, V35, pS11, DOI [10.2337/dc12-s011, 10.2337/dc35-S011, 10.2337/dc12-s004]; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Coresh J, 2003, AM J KIDNEY DIS, V41, P1, DOI 10.1053/ajkd.2003.50007; Fink HA, 2012, COMP EFFECTIVENESS R, V37; Fink HA, 2012, AHRQ PUBLICATION, V11; Fink HA, 2012, ANN INTERN MED, V156, P570, DOI [10.7326/0003-4819-156-8-201204170-00008, 10.7326/0003-4819-156-8-201204170-00004]; Hsu CY, 2003, J AM SOC NEPHROL, V14, P2902, DOI 10.1097/01.ASN.0000091586.46532.B4; Miller WG, 2009, CLIN CHEM, V55, P24, DOI 10.1373/clinchem.2008.106567; National Kidney Foundation, 2002, KDOQI CLIN PRACT GUI; Perkins BA, 2003, NEW ENGL J MED, V348, P2285, DOI 10.1056/NEJMoa021835; Xue JL, 2007, J AM SOC NEPHROL, V18, P1299, DOI 10.1681/ASN.2006050524	11	96	99	0	9	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 16	2012	157	8					567	+		10.7326/0003-4819-157-8-201210160-00533	http://dx.doi.org/10.7326/0003-4819-157-8-201210160-00533			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	021SP	22928170				2022-12-28	WOS:000309906000017
J	Church, GM; Gao, Y; Kosuri, S				Church, George M.; Gao, Yuan; Kosuri, Sriram			Next-Generation Digital Information Storage in DNA	SCIENCE			English	Article							GENOME		[Church, George M.; Kosuri, Sriram] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Church, George M.; Kosuri, Sriram] Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA; [Gao, Yuan] Johns Hopkins Univ, Dept Biomed Engn, Neuroregenerat & Stem Cell Biol Program, Inst Cell Engn,Lieber Inst Brain Dev, Baltimore, MD 21205 USA	Harvard University; Harvard Medical School; Johns Hopkins University	Kosuri, S (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.	sri.kosuri@wyss.harvard.edu		Kosuri, Sriram/0000-0002-4661-0600; church, george/0000-0001-6232-9969	U.S. Office of Naval Research [N000141010144]; Agilent Technologies; Wyss Institute	U.S. Office of Naval Research(Office of Naval Research); Agilent Technologies; Wyss Institute	This work was supported by U.S. Office of Naval Research (N000141010144), Agilent Technologies, and the Wyss Institute. Agilent Technologies is a commercial provider for DNA microchips. G. M. C. and S. K. designed and performed all experiments and analyses and wrote the manuscript; Y.G. performed the sequencing. We thank J. Aach, C. Fracchia, S. Raman, H. H. Wang, A. W. Briggs, J. Lee, T. Wu, and D. B. Goodman for helpful suggestions on the manuscript.	ADLEMAN LM, 1994, SCIENCE, V266, P1021, DOI 10.1126/science.7973651; Bancroft C, 2001, SCIENCE, V293, P1763; Benner SA, 2011, CR CHIM, V14, P372, DOI 10.1016/j.crci.2010.06.013; Bonnet J, 2010, NUCLEIC ACIDS RES, V38, P1531, DOI 10.1093/nar/gkp1060; Carr PA, 2009, NAT BIOTECHNOL, V27, P1151, DOI 10.1038/nbt.1590; Davis J, 1996, ART J, V55, P70, DOI 10.2307/777811; Gantz J., 2011, IDC IVIEW; Gibson DG, 2010, SCIENCE, V329, P52, DOI 10.1126/science.1190719; Kosuri S, 2012, ACS SYNTH BIOL, V1, P109, DOI 10.1021/sb300015f; LeProust EM, 2010, NUCLEIC ACIDS RES, V38, P2522, DOI 10.1093/nar/gkq163; Paabo S, 2004, ANNU REV GENET, V38, P645, DOI 10.1146/annurev.genet.37.110801.143214; Pennisi E, 2012, SCIENCE, V336, P534, DOI 10.1126/science.336.6081.534; StJohn J., 2011, SEQPREP	13	577	657	53	521	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 28	2012	337	6102					1628	1628		10.1126/science.1226355	http://dx.doi.org/10.1126/science.1226355			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012DJ	22903519	Bronze			2022-12-28	WOS:000309215400037
J	Kuhn, JR; Bush, R; Emilio, M; Scholl, IF				Kuhn, J. R.; Bush, R.; Emilio, M.; Scholl, I. F.			The Precise Solar Shape and Its Variability	SCIENCE			English	Article							SURFACE MAGNETISM; LARGE EXCESS; OBLATENESS; ROTATION	The precise shape of the Sun has not been convincingly determined, despite half a century of modern photoelectric observations. The expected deviation of the solar-limb shape from a perfect circle is very small, but such asphericity is sensitive to the Sun's otherwise invisible interior conditions, as well as the solar atmosphere. We use evidence from a long-running experiment based in space to show that, when analyzed with sufficiently high spatial resolution, the Sun's oblate shape is distinctly constant and almost completely unaffected by the solar-cycle variability seen on its surface. The solar oblateness is significantly lower than theoretical expectations by an amount that could be explained by a slower differential rotation in the outer few percent of the Sun.	[Kuhn, J. R.; Scholl, I. F.] Univ Hawaii, Inst Astron, Maui, HI 96790 USA; [Emilio, M.] Univ Estadual Ponta Grossa, Observ Astron, Dept Geociencias, Parana, Brazil; [Bush, R.] Stanford Univ, Stanford, CA 94305 USA	University of Hawaii System; Universidade Estadual de Ponta Grossa; Stanford University	Kuhn, JR (corresponding author), Univ Hawaii, Inst Astron, 34 Ohia Ku St, Maui, HI 96790 USA.	kuhn@ifa.hawaii.edu	Emilio, Marcelo/C-4118-2011	Emilio, Marcelo/0000-0001-5589-9015; Kuhn, Jeff/0000-0003-1361-9104	NASA [NAS5-02139]; Univ. of Hawaii [NNX09AI90G]; Instituto Nacional de Estudos do Espaco (CNPq); CNPq [303873/2010-8]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior [0873/11-0]	NASA(National Aeronautics & Space Administration (NASA)); Univ. of Hawaii; Instituto Nacional de Estudos do Espaco (CNPq); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The raw and astrometric data used for this analysis are available via the HMI public archives (http://jsoc.stanford.edu). The development of the HMI astrometry pipeline was supported by NASA and a grant to Stanford Univ. and the Univ. of Hawaii (NNX09AI90G). The HMI experiment aboard the SDO satellite was funded, in part, by a NASA contract to Stanford (NAS5-02139). J.R.K. was supported by a senior Humboldt prize while some of this work was done at the Kiepenheuer Institut fur Sonnenphysik. M. E. was partially supported by Instituto Nacional de Estudos do Espaco (CNPq), CNPq grant 303873/2010-8, and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior grant 0873/11-0. We thank H. Hudson for comments on this manuscript.	Armstrong J, 1999, ASTROPHYS J, V525, P533, DOI 10.1086/307879; Bray R.J., 1965, SUNSPOTS; Bush RI, 2010, ASTROPHYS J, V716, P1381, DOI 10.1088/0004-637X/716/2/1381; Damiani C, 2011, J ATMOS SOL-TERR PHY, V73, P241, DOI 10.1016/j.jastp.2010.02.021; DICKE RH, 1987, ASTROPHYS J, V318, P451, DOI 10.1086/165382; DICKE RH, 1964, NATURE, V202, P432, DOI 10.1038/202432a0; Egidi A, 2006, SOL PHYS, V235, P407, DOI 10.1007/s11207-006-0073-x; Emilio M, 2007, ASTROPHYS J, V660, pL161, DOI 10.1086/518212; Fivian MD, 2008, SCIENCE, V322, P560, DOI 10.1126/science.1160863; Hill H. A., 1975, ASTROPHYS J, V200, P477; Howe R, 2009, LIVING REV SOL PHYS, V6, DOI 10.12942/lrsp-2009-1; Kuhn JR, 2009, SCIENCE, V324, DOI 10.1126/science.1170358; Kuhn JR, 1998, NATURE, V392, P155, DOI 10.1038/32361; Rosch J, 1996, SOL PHYS, V165, P1, DOI 10.1007/BF00149086; Rozelot JP, 2011, EUR PHYS J H, V36, P407, DOI 10.1140/epjh/e2011-20017-4; Schou J, 2012, SOL PHYS, V275, P229, DOI 10.1007/s11207-011-9842-2	16	37	38	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 28	2012	337	6102					1638	1640		10.1126/science.1223231	http://dx.doi.org/10.1126/science.1223231			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012DJ	22903522				2022-12-28	WOS:000309215400040
J	Agus, MSD; Steil, GM; Wypij, D; Costello, JM; Laussen, PC; Langer, M; Alexander, JL; Scoppettuolo, LA; Pigula, FA; Charpie, JR; Ohye, RG; Gaies, MG				Agus, Michael S. D.; Steil, Garry M.; Wypij, David; Costello, John M.; Laussen, Peter C.; Langer, Monica; Alexander, Jamin L.; Scoppettuolo, Lisa A.; Pigula, Frank A.; Charpie, John R.; Ohye, Richard G.; Gaies, Michael G.		SPECS Study Investigators	Tight Glycemic Control versus Standard Care after Pediatric Cardiac Surgery	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ARTERIAL SWITCH OPERATION; INTENSIVE INSULIN THERAPY; GLUCOSE CONTROL; DIABETIC-PATIENTS; WOUND-INFECTION; HYPERGLYCEMIA; MORTALITY; UNIT; INFANTS; PROFILE	BACKGROUND In some studies, tight glycemic control with insulin improved outcomes in adults undergoing cardiac surgery, but these benefits are unproven in critically ill children at risk for hyperinsulinemic hypoglycemia. We tested the hypothesis that tight glycemic control reduces morbidity after pediatric cardiac surgery. METHODS In this two-center, prospective, randomized trial, we enrolled 980 children, 0 to 36 months of age, undergoing surgery with cardiopulmonary bypass. Patients were randomly assigned to either tight glycemic control (with the use of an insulin-dosing algorithm targeting a blood glucose level of 80 to 110 mg per deciliter [4.4 to 6.1 mmol per liter]) or standard care in the cardiac intensive care unit (ICU). Continuous glucose monitoring was used to guide the frequency of blood glucose measurement and to detect impending hypoglycemia. The primary outcome was the rate of health care-associated infections in the cardiac ICU. Secondary outcomes included mortality, length of stay, organ failure, and hypoglycemia. RESULTS A total of 444 of the 490 children assigned to tight glycemic control (91%) received insulin versus 9 of 490 children assigned to standard care (2%). Although normoglycemia was achieved earlier with tight glycemic control than with standard care (6 hours vs. 16 hours, P<0.001) and was maintained for a greater proportion of the critical illness period (50% vs. 33%, P<0.001), tight glycemic control was not associated with a significantly decreased rate of health care-associated infections (8.6 vs. 9.9 per 1000 patient-days, P=0.67). Secondary outcomes did not differ significantly between groups, and tight glycemic control did not benefit high-risk subgroups. Only 3% of the patients assigned to tight glycemic control had severe hypoglycemia (blood glucose <40 mg per deciliter [2.2 mmol per liter]). CONCLUSIONS Tight glycemic control can be achieved with a low hypoglycemia rate after cardiac surgery in children, but it does not significantly change the infection rate, mortality, length of stay, or measures of organ failure, as compared with standard care. (Funded by the National Heart, Lung, and Blood Institute and others; SPECS ClinicalTrials.gov number, NCT00443599.)	[Agus, Michael S. D.; Steil, Garry M.; Wypij, David; Costello, John M.; Laussen, Peter C.; Alexander, Jamin L.; Scoppettuolo, Lisa A.; Pigula, Frank A.] Childrens Hosp, Boston, MA 02115 USA; [Agus, Michael S. D.; Steil, Garry M.; Wypij, David; Costello, John M.; Laussen, Peter C.; Alexander, Jamin L.; Scoppettuolo, Lisa A.; Pigula, Frank A.] Harvard Univ, Sch Med, Boston, MA USA; [Langer, Monica] Tufts Univ, Sch Med, Boston, MA 02111 USA; [Langer, Monica] Maine Med Ctr, Portland, Dorset, England; [Charpie, John R.; Ohye, Richard G.; Gaies, Michael G.] Univ Michigan, CS Mott Childrens Hosp, Ann Arbor, MI 48109 USA; [Charpie, John R.; Ohye, Richard G.; Gaies, Michael G.] Univ Michigan, Sch Med, Ann Arbor, MI USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Tufts University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Agus, MSD (corresponding author), Childrens Hosp, 300 Longwood Ave, Boston, MA 02115 USA.	michael.agus@childrens.harvard.edu	Curley, Martha A/F-3579-2016; Steil, Garry/R-7673-2019	Curley, Martha A/0000-0001-5228-6694; Wypij, David/0000-0001-8367-8711; Asaro, Lisa/0000-0001-5736-0304	National Heart, Lung, and Blood Institute, National Institutes of Health [R01HL088448]; American Recovery and Reinvestment Act Supplement [R01HL088448-02S1]; Harvard Catalyst Clinical and Translational Research Center (National Center for Advancing Translational Sciences) [UL1 RR 05758]; National Heart, Lung, and Blood Institute [NCT00443599]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088448] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Recovery and Reinvestment Act Supplement; Harvard Catalyst Clinical and Translational Research Center (National Center for Advancing Translational Sciences); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funded by the National Heart, Lung, and Blood Institute and others; SPECS ClinicalTrials.gov number, NCT00443599.; Supported by grants from the National Heart, Lung, and Blood Institute, National Institutes of Health (R01HL088448, to Dr. Agus), the American Recovery and Reinvestment Act Supplement (R01HL088448-02S1, to Dr. Agus), and the Harvard Catalyst Clinical and Translational Research Center (National Center for Advancing Translational Sciences grant UL1 RR 05758).	Arabi YM, 2008, CRIT CARE MED, V36, P3190, DOI 10.1097/CCM.0b013e31818f21aa; Ballweg JA, 2007, ANN THORAC SURG, V84, P2052, DOI 10.1016/j.athoracsur.2007.06.099; Dandona P, 2009, J AM COLL CARDIOL, V53, pS14, DOI 10.1016/j.jacc.2008.10.038; DeCampli WM, 2010, ANN THORAC SURG, V89, P181, DOI 10.1016/j.athoracsur.2009.08.062; De la Rosa GD, 2008, CRIT CARE, V12, DOI 10.1186/cc7017; Edwards JR, 2009, AM J INFECT CONTROL, V37, P783, DOI 10.1016/j.ajic.2009.10.001; Faustino E Vincent S, 2012, J Diabetes Sci Technol, V6, P48; Finfer S, 2009, NEW ENGL J MED, V360, P1283, DOI 10.1056/NEJMoa0810625; Furnary AP, 1999, ANN THORAC SURG, V67, P352, DOI 10.1016/S0003-4975(99)00014-4; Furnary AP, 2003, J THORAC CARDIOV SUR, V125, P1007, DOI 10.1067/mtc.2003.181; Gaies MG, 2012, PEDIAT CRIT CARE MED; Gauglitz GG, 2010, CRIT CARE MED, V38, P202, DOI 10.1097/CCM.0b013e3181b43236; Hirshberg E, 2008, PEDIATR CRIT CARE ME, V9, P361, DOI 10.1097/PCC.0b013e318172d401; Hirshberg E, 2008, CHEST, V133, P1328, DOI 10.1378/chest.07-2702; Hoffman JIE, 2002, J AM COLL CARDIOL, V39, P1890, DOI 10.1016/S0735-1097(02)01886-7; Horan TC., 2004, HOSP EPIDEMIOL INFEC, P1659; Jenkins KJ, 2002, J THORAC CARDIOV SUR, V124, P97, DOI 10.1067/mtc.2002.122311; MALMBERG K, 1995, J AM COLL CARDIOL, V26, P57, DOI 10.1016/0735-1097(95)00126-K; Marik PE, 2010, CHEST, V137, P544, DOI 10.1378/chest.09-1737; Moga MA, 2011, CRIT CARE MED, V39, P266, DOI 10.1097/CCM.0b013e3181fee88e; O'Brien SM, 2009, J THORAC CARDIOV SUR, V138, P1139, DOI 10.1016/j.jtcvs.2009.03.071; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; Polito A, 2008, CIRCULATION, V118, P2235, DOI 10.1161/CIRCULATIONAHA.108.804286; Preiser JC, 2009, INTENS CARE MED, V35, P1738, DOI 10.1007/s00134-009-1585-2; Reller MD, 2008, J PEDIATR-US, V153, P807, DOI 10.1016/j.jpeds.2008.05.059; Rossano JW, 2008, J THORAC CARDIOV SUR, V135, P739, DOI 10.1016/j.jtcvs.2007.11.030; Sarvikivi E, 2008, AM J INFECT CONTROL, V36, P564, DOI 10.1016/j.ajic.2007.11.006; Scott MG, 2009, CLIN CHEM, V55, P18, DOI 10.1373/clinchem.2008.117291; Shuhaiber J, 2012, J THORAC CARDIOVASC; Srinivasan V, 2006, PEDIATR CRIT CARE ME, V7, P516; Srinivasan Vijay, 2004, Pediatr Crit Care Med, V5, P329, DOI 10.1097/01.PCC.0000128607.68261.7C; Steil GM, 2011, PEDIATR CRIT CARE ME, V12, P643, DOI 10.1097/PCC.0b013e31821926a5; Steil Garry M, 2009, J Diabetes Sci Technol, V3, P125; Ulate KP, 2008, PEDIATRICS, V122, pE898, DOI 10.1542/peds.2008-0871; Van den Berghe G, 2006, NEW ENGL J MED, V354, P449, DOI 10.1056/NEJMoa052521; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; Vlasselaers D, 2009, LANCET, V373, P547, DOI 10.1016/S0140-6736(09)60044-1; WERNOVSKY G, 1995, CIRCULATION, V92, P2226, DOI 10.1161/01.CIR.92.8.2226; Wintergerst KA, 2007, DIABETES TECHNOL THE, V9, P211, DOI 10.1089/dia.2006.0031; Yates AR, 2006, PEDIATR CRIT CARE ME, V7, P351, DOI 10.1097/01.PCC.0000227755.96700.98	40	177	186	0	27	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 27	2012	367	13					1208	1219		10.1056/NEJMoa1206044	http://dx.doi.org/10.1056/NEJMoa1206044			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	011JO	22957521	Green Published, Green Accepted			2022-12-28	WOS:000309161100007
J	Andersen, CBF; Torvund-Jensen, M; Nielsen, MJ; de Oliveira, CLP; Hersleth, HP; Andersen, NH; Pedersen, JS; Andersen, GR; Moestrup, SK				Andersen, Christian Brix Folsted; Torvund-Jensen, Morten; Nielsen, Marianne Jensby; Pinto de Oliveira, Cristiano Luis; Hersleth, Hans-Petter; Andersen, Niels Hojmark; Pedersen, Jan Skov; Andersen, Gregers Rom; Moestrup, Soren Kragh			Structure of the haptoglobin-haemoglobin complex	NATURE			English	Article							SERINE-PROTEASE; BIOLOGICAL MACROMOLECULES; SUBUNIT DISSOCIATION; SOLUTION SCATTERING; CRYSTAL-STRUCTURE; CATALYTIC DOMAIN; BINDING; RESOLUTION; CD163; EQUILIBRIUM	Red cell haemoglobin is the fundamental oxygen-transporting molecule in blood, but also a potentially tissue-damaging compound owing to its highly reactive haem groups. During intravascular haemolysis, such as in malaria and haemoglobinopathies(1), haemoglobin is released into the plasma, where it is captured by the protective acute-phase protein haptoglobin. This leads to formation of the haptoglobin-haemoglobin complex, which represents a virtually irreversible non-covalent protein-protein interaction(2). Here we present the crystal structure of the dimeric porcine haptoglobin-haemoglobin complex determined at 2.9 angstrom resolution. This structure reveals that haptoglobin molecules dimerize through an unexpected beta-strand swap between two complement control protein (CCP) domains, defining a new fusion CCP domain structure. The haptoglobin serine protease domain forms extensive interactions with both the alpha- and beta-subunits of haemoglobin, explaining the tight binding between haptoglobin and haemoglobin. The haemoglobin-interacting region in the alpha beta dimer is highly overlapping with the interface between the two alpha beta dimers that constitute the native haemoglobin tetramer. Several haemoglobin residues prone to oxidative modification after exposure to haem-induced reactive oxygen species are buried in the haptoglobin-haemoglobin interface, thus showing a direct protective role of haptoglobin. The haptoglobin loop previously shown to be essential for binding of haptoglobin-haemoglobin to the macrophage scavenger receptor CD163 (ref. 3) protrudes from the surface of the distal end of the complex, adjacent to the associated haemoglobin alpha-subunit. Small-angle X-ray scattering measurements of human haptoglobin-haemoglobin bound to the ligand-binding fragment of CD163 confirm receptor binding in this area, and show that the rigid dimeric complex can bind two receptors. Such receptor cross-linkage may facilitate scavenging and explain the increased functional affinity of multimeric haptoglobin-haemoglobin for CD163 (ref. 4).	[Andersen, Christian Brix Folsted; Torvund-Jensen, Morten; Nielsen, Marianne Jensby; Moestrup, Soren Kragh] Aarhus Univ, Dept Biomed, DK-8000 Aarhus C, Denmark; [Pinto de Oliveira, Cristiano Luis] Univ Sao Paulo, Inst Phys, BR-0531497 Sao Paulo, Brazil; [Pinto de Oliveira, Cristiano Luis; Pedersen, Jan Skov] Aarhus Univ, Dept Chem, DK-8000 Aarhus C, Denmark; [Pinto de Oliveira, Cristiano Luis; Pedersen, Jan Skov] Aarhus Univ, INANO Interdisciplinary Nanosci Ctr, DK-8000 Aarhus C, Denmark; [Hersleth, Hans-Petter] Univ Oslo, Dept Mol Biosci, NO-0316 Oslo, Norway; [Andersen, Niels Hojmark] Univ Oslo, Dept Chem, NO-0315 Oslo, Norway; [Andersen, Gregers Rom] Aarhus Univ, Dept Mol Biol & Genet, DK-8000 Aarhus C, Denmark	Aarhus University; Universidade de Sao Paulo; Aarhus University; Aarhus University; University of Oslo; University of Oslo; Aarhus University	Andersen, CBF (corresponding author), Aarhus Univ, Dept Biomed, DK-8000 Aarhus C, Denmark.	cbfa@biokemi.au.dk; skm@biokemi.au.dk	Oliveira, Cristiano L P/B-4403-2008; Moestrup, Søren Kragh/AAD-1735-2019; Moestrup, Søren Kragh/A-1403-2014; Nielsen, Marina/F-5625-2012; Complexos, INCT Fluidos/H-9172-2013; Pedersen, Jan Skov/A-8346-2008	Oliveira, Cristiano L P/0000-0002-3426-6507; Moestrup, Søren Kragh/0000-0003-3862-2107; Pedersen, Jan Skov/0000-0002-7768-0206; Andersen, Gregers Rom/0000-0001-6292-3319; Hersleth, Hans-Petter/0000-0002-1142-9983; Andersen, Niels Hojmark/0000-0003-3668-2800	Lundbeck Foundation; Novo Nordisk Foundation; Research Council of Norway; European Research Council; Danish Council for Independent Research; Lundbeck Foundation [R54-2010-5637] Funding Source: researchfish	Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Research Council of Norway(Research Council of Norway); European Research Council(European Research Council (ERC)European Commission); Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); Lundbeck Foundation(Lundbeckfonden)	We are grateful to G. Ratz for technical assistance, R. Kidmose, N. S. Laursen and the staff at the Swiss Light Source beamlines for help with data collection. We thank G. V. Jensen for performing SAXS measurements and R. E. Weber for scientific discussion. The research was supported by The Lundbeck Foundation, The Novo Nordisk Foundation, The Research Council of Norway, The European Research Council and The Danish Council for Independent Research.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Azarov I, 2008, NITRIC OXIDE-BIOL CH, V18, P296, DOI 10.1016/j.niox.2008.02.006; Bond CS, 2009, ACTA CRYSTALLOGR D, V65, P510, DOI 10.1107/S0907444909007835; Budayova-Spano M, 2002, EMBO J, V21, P231, DOI 10.1093/emboj/21.3.231; Buehler PW, 2009, BLOOD, V113, P2578, DOI 10.1182/blood-2008-08-174466; Bunn H. F., 1977, HEMOGLOBINOPATHIES, V308; Dickerson R.E., 1983, HEMOGLOBIN STRUCTURE; Fagoonee S, 2005, AM J PATHOL, V166, P973, DOI 10.1016/S0002-9440(10)62319-X; Gaboriaud C, 2000, EMBO J, V19, P1755, DOI 10.1093/emboj/19.8.1755; GLATTER O, 1977, J APPL CRYSTALLOGR, V10, P415, DOI 10.1107/S0021889877013879; IP SHC, 1976, BIOCHEMISTRY-US, V15, P654, DOI 10.1021/bi00648a032; Jia YP, 2007, J BIOL CHEM, V282, P4894, DOI 10.1074/jbc.M609955200; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kardos J, 2008, MOL IMMUNOL, V45, P1752, DOI 10.1016/j.molimm.2007.09.031; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kristiansen M, 2001, NATURE, V409, P198, DOI 10.1038/35051594; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lim SK, 1998, BLOOD, V92, P1870, DOI 10.1182/blood.V92.6.1870.418k38_1870_1877; Madsen M, 2004, J BIOL CHEM, V279, P51561, DOI 10.1074/jbc.M409629200; MAEDA N, 1984, NATURE, V309, P131, DOI 10.1038/309131a0; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miller YI, 1997, BIOCHEMISTRY-US, V36, P12189, DOI 10.1021/bi970258a; NAGEL RL, 1971, J BIOL CHEM, V246, P69; NAGEL RL, 1965, BIOCHIM BIOPHYS ACTA, V100, P286, DOI 10.1016/0304-4165(65)90454-X; Nielsen MJ, 2007, J BIOL CHEM, V282, P1072, DOI 10.1074/jbc.M605684200; Nielsen MJ, 2006, BLOOD, V108, P2846, DOI 10.1182/blood-2006-05-022327; Oliveira CLP, 2009, J MOL BIOL, V387, P147, DOI 10.1016/j.jmb.2009.01.020; Park SY, 2006, J MOL BIOL, V360, P690, DOI 10.1016/j.jmb.2006.05.036; Pedersen JS, 2004, J APPL CRYSTALLOGR, V37, P369, DOI 10.1107/S0021889804004170; PEDERSEN JS, 1994, EUR BIOPHYS J BIOPHY, V22, P379, DOI 10.1007/BF00180159; Perona JJ, 1997, J BIOL CHEM, V272, P29987, DOI 10.1074/jbc.272.48.29987; PERUTZ MF, 1960, NATURE, V185, P416, DOI 10.1038/185416a0; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; Pimenova T, 2010, J PROTEOME RES, V9, P4061, DOI 10.1021/pr100252e; SADRZADEH SMH, 1984, J BIOL CHEM, V259, P4354; Schrodinger LLC, 2010, PYMOL MOL GRAPH SYST; SHIM BS, 1965, NATURE, V207, P1264, DOI 10.1038/2071264a0; SMITHIES O, 1956, NATURE, V178, P694, DOI 10.1038/178694a0; Smulevich G, 1998, J RAMAN SPECTROSC, V29, P57, DOI 10.1002/(SICI)1097-4555(199801)29:1<57::AID-JRS209>3.0.CO;2-P; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Vanhollebeke B, 2008, SCIENCE, V320, P677, DOI 10.1126/science.1156296; Venkatesh B, 2004, J BIOCHEM, V136, P595, DOI 10.1093/jb/mvh166; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; WEJMAN JC, 1984, J MOL BIOL, V174, P319, DOI 10.1016/0022-2836(84)90341-3	47	171	179	1	95	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 20	2012	489	7416					456	U150		10.1038/nature11369	http://dx.doi.org/10.1038/nature11369			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AK	22922649				2022-12-28	WOS:000308860900051
J	Weinstock, GM				Weinstock, George M.			Genomic approaches to studying the human microbiota	NATURE			English	Review							CLOSTRIDIUM-DIFFICILE INFECTION; HUMAN GUT VIROME; COMMENSAL MICROBIOTA; FECAL MICROBIOTA; DIVERSITY; DISEASE; COMMUNITIES; BACTERIA; TRANSPLANTATION; SUSCEPTIBILITY	The human body is colonized by a vast array of microbes, which form communities of bacteria, viruses and microbial eukaryotes that are specific to each anatomical environment. Every community must be studied as a whole because many organisms have never been cultured independently, and this poses formidable challenges. The advent of next-generation DNA sequencing has allowed more sophisticated analysis and sampling of these complex systems by culture-independent methods. These methods are revealing differences in community structure between anatomical sites, between individuals, and between healthy and diseased states, and are transforming our view of human biology.	Washington Univ, Genome Inst, St Louis, MO 63108 USA	Washington University (WUSTL)	Weinstock, GM (corresponding author), Washington Univ, Genome Inst, 4444 Forest Pk Ave,Campus Box 8501, St Louis, MO 63108 USA.	gweinsto@genome.wustl.edu	Weinstock, George M/C-6314-2013	Weinstock, George M/0000-0002-2997-4592	NHGRI NIH HHS [U54 HG004968] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG004968] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Abubucker S, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002358; Allander T, 2005, P NATL ACAD SCI USA, V102, P12891, DOI 10.1073/pnas.0504666102; Angiuoli SV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026624; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Benson AK, 2010, P NATL ACAD SCI USA, V107, P18933, DOI 10.1073/pnas.1007028107; Bent SJ, 2007, APPL ENVIRON MICROB, V73, P2399, DOI 10.1128/AEM.02383-06; Brandt LJ, 2011, J CLIN GASTROENTEROL, V45, pS159, DOI 10.1097/MCG.0b013e318222e603; Breitbart M, 2005, BIOTECHNIQUES, V39, P729, DOI 10.2144/000112019; Breitbart M, 2003, J BACTERIOL, V185, P6220, DOI 10.1128/JB.185.20.6220-6223.2003; Breitbart M, 2008, RES MICROBIOL, V159, P367, DOI 10.1016/j.resmic.2008.04.006; Bruls T, 2011, HUM MOL GENET, V20, pR142, DOI 10.1093/hmg/ddr353; Cantarel BL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028742; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Caporaso JG, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-r50; Casas V, 2007, METHOD ENZYMOL, V421, P259, DOI 10.1016/S0076-6879(06)21020-6; Chitsaz H, 2011, NAT BIOTECHNOL, V29, P915, DOI 10.1038/nbt.1966; Claesson MJ, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq873; Croswell A, 2009, INFECT IMMUN, V77, P2741, DOI 10.1128/IAI.00006-09; D'Onofrio A, 2010, CHEM BIOL, V17, P254, DOI 10.1016/j.chembiol.2010.02.010; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; Dichosa AEK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037387; DOE Joint Genome Institute, 2012, GEN ENC BACT ARCH; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022; Finkbeiner SR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000011; Flint HJ, 2008, NAT REV MICROBIOL, V6, P121, DOI 10.1038/nrmicro1817; Foxman B, 2008, INTERDISCIP PERSPECT; Fredricks DN, 2005, NEW ENGL J MED, V353, P1899, DOI 10.1056/NEJMoa043802; Gans J, 2005, SCIENCE, V309, P1387, DOI 10.1126/science.1112665; Gloor GB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015406; Gough E, 2011, CLIN INFECT DIS, V53, P994, DOI 10.1093/cid/cir632; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Handelsman J, 1998, CHEM BIOL, V5, pR245, DOI 10.1016/S1074-5521(98)90108-9; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Hooper LV, 2001, SCIENCE, V292, P1115, DOI 10.1126/science.1058709; Hummelen R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012078; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Jakobsson HE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009836; Jarchum I, 2011, CURR OPIN IMMUNOL, V23, P353, DOI 10.1016/j.coi.2011.03.001; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Lazarevic V, 2009, J MICROBIOL METH, V79, P266, DOI 10.1016/j.mimet.2009.09.012; Lepage P, 2008, GUT, V57, DOI 10.1136/gut.2007.134668; Lozupone C, 2011, ISME J, V5, P169, DOI 10.1038/ismej.2010.133; LUCKEY TD, 1972, AM J CLIN NUTR, V25, P1292; Manichanh C, 2006, GUT, V55, P205, DOI 10.1136/gut.2005.073817; Marsland BJ, 2012, THORAX, V67, P93, DOI 10.1136/thoraxjnl-2011-200750; Martin J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036427; Methe BA, 2012, NATURE, V486, P215, DOI 10.1038/nature11209; MILLER C P, 1956, Trans Am Clin Climatol Assoc, V68, P51; Minot S, 2012, P NATL ACAD SCI USA, V109, P3962, DOI 10.1073/pnas.1119061109; Minot S, 2011, GENOME RES, V21, P1616, DOI 10.1101/gr.122705.111; MULLIGAN ME, 1984, REV INFECT DIS, V6, pS222; Nelson KE, 2010, SCIENCE, V328, P994, DOI 10.1126/science.1183605; Nelson TA, 2011, NEUROGASTROENT MOTIL, V23, DOI 10.1111/j.1365-2982.2010.01637.x; OLSEN GJ, 1986, ANNU REV MICROBIOL, V40, P337, DOI 10.1146/annurev.mi.40.100186.002005; Palacios G, 2007, EMERG INFECT DIS, V13, P73, DOI 10.3201/eid1301.060837; Parfrey LW, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00153; Peterson J, 2009, GENOME RES, V19, P2317, DOI 10.1101/gr.096651.109; Possemiers S, 2011, FITOTERAPIA, V82, P53, DOI 10.1016/j.fitote.2010.07.012; Pride DT, 2012, ISME J, V6, P915, DOI 10.1038/ismej.2011.169; Proctor LM, 2011, CELL HOST MICROBE, V10, P287, DOI 10.1016/j.chom.2011.10.001; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Raes J, 2007, CURR OPIN MICROBIOL, V10, P490, DOI 10.1016/j.mib.2007.09.001; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; Riesenfeld CS, 2004, ANNU REV GENET, V38, P525, DOI 10.1146/annurev.genet.38.072902.091216; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sekirov I, 2008, INFECT IMMUN, V76, P4726, DOI 10.1128/IAI.00319-08; Shanahan F, 2002, BEST PRACT RES CL GA, V16, P915, DOI 10.1053/bega.2002.0342; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; SRIKANTH CV, 2008, INTERDISCIP PERSPECT; Stein JL, 1996, J BACTERIOL, V178, P591, DOI 10.1128/jb.178.3.591-599.1996; Turnbaugh PJ, 2009, J PHYSIOL-LONDON, V587, P4153, DOI 10.1113/jphysiol.2009.174136; Vergin KL, 1998, APPL ENVIRON MICROB, V64, P3075; Wang D, 2003, PLOS BIOL, V1, P257, DOI 10.1371/journal.pbio.0000002; Wang ZN, 2011, NATURE, V472, P57, DOI 10.1038/nature09922; Ward DV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039315; Willner D, 2010, VIRULENCE, V1, P309, DOI 10.4161/viru.1.4.12071; Wooley JC, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000667; Wright ES, 2012, APPL ENVIRON MICROB, V78, P717, DOI 10.1128/AEM.06516-11; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Wylie K. M., 2012, TRANSL RES; Wylie KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0027735; ZUBRZYCKI L, 1962, J BACTERIOL, V83, P968, DOI 10.1128/JB.83.5.968-974.1962	85	314	337	5	149	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 13	2012	489	7415					250	256		10.1038/nature11553	http://dx.doi.org/10.1038/nature11553			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003UC	22972298	Green Accepted			2022-12-28	WOS:000308635900033
J	Calhoun, WJ; Ameredes, BT; King, TS; Icitovic, N; Bleecker, ER; Castro, M; Cherniack, RM; Chinchilli, VM; Craig, T; Denlinger, L; DiMango, EA; Engle, LL; Fahy, JV; Grant, JA; Israel, E; Jarjour, N; Kazani, SD; Kraft, M; Kunselman, SJ; Lazarus, SC; Lemanske, RF; Lugogo, N; Martin, RJ; Meyers, DA; Moore, WC; Pascual, R; Peters, SP; Ramsdell, J; Sorkness, CA; Sutherland, ER; Szefler, SJ; Wasserman, SI; Walter, MJ; Wechsler, ME; Boushey, HA				Calhoun, William J.; Ameredes, Bill T.; King, Tonya S.; Icitovic, Nikolina; Bleecker, Eugene R.; Castro, Mario; Cherniack, Reuben M.; Chinchilli, Vernon M.; Craig, Timothy; Denlinger, Loren; DiMango, Emily A.; Engle, Linda L.; Fahy, John V.; Grant, J. Andrew; Israel, Elliot; Jarjour, Nizar; Kazani, Shamsah D.; Kraft, Monica; Kunselman, Susan J.; Lazarus, Stephen C.; Lemanske, Robert F., Jr.; Lugogo, Njira; Martin, Richard J.; Meyers, Deborah A.; Moore, Wendy C.; Pascual, Rodolfo; Peters, Stephen P.; Ramsdell, Joe; Sorkness, Christine A.; Sutherland, E. Rand; Szefler, Stanley J.; Wasserman, Stephen I.; Walter, Michael J.; Wechsler, Michael E.; Boushey, Homer A.		Natl Heart Lung Blood Inst	Comparison of Physician-, Biomarker-, and Symptom-Based Strategies for Adjustment of Inhaled Corticosteroid Therapy in Adults With Asthma The BASALT Randomized Controlled Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							EXHALED NITRIC-OXIDE; SPUTUM EOSINOPHIL COUNTS; ETHNIC-DIFFERENCES; HYPERRESPONSIVENESS; ADOLESCENTS; ALBUTEROL; GUIDE	Context No consensus exists for adjusting inhaled corticosteroid therapy in patients with asthma. Approaches include adjustment at outpatient visits guided by physician assessment of asthma control (symptoms, rescue therapy, pulmonary function), based on exhaled nitric oxide, or on a day-to-day basis guided by symptoms. Objective To determine if adjustment of inhaled corticosteroid therapy based on exhaled nitric oxide or day-to-day symptoms is superior to guideline-informed, physician assessment-based adjustment in preventing treatment failure in adults with mild to moderate asthma. Design, Setting, and Participants A randomized, parallel, 3-group, placebo-controlled, multiply-blinded trial of 342 adults with mild to moderate asthma controlled by low-dose inhaled corticosteroid therapy (n = 114 assigned to physician assessment-based adjustment [101 completed], n = 115 to biomarker-based [exhaled nitric oxide] adjustment [92 completed], and n = 113 to symptom-based adjustment [97 completed]), the Best Adjustment Strategy for Asthma in the Long Term (BASALT) trial was conducted by the Asthma Clinical Research Network at 10 academic medical centers in the United States for 9 months between June 2007 and July 2010. Interventions For physician assessment-based adjustment and biomarker-based (exhaled nitric oxide) adjustment, the dose of inhaled corticosteroids was adjusted every 6 weeks; for symptom-based adjustment, inhaled corticosteroids were taken with each albuterol rescue use. Main Outcome Measure The primary outcome was time to treatment failure. Results There were no significant differences in time to treatment failure. The 9-month Kaplan-Meier failure rates were 22% (97.5% CI, 14%-33%; 24 events) for physician assessment-based adjustment, 20% (97.5% CI, 13%-30%; 21 events) for biomarker-based adjustment, and 15% (97.5% CI, 9%-25%; 16 events) for symptom-based adjustment. The hazard ratio for physician assessment-based adjustment vs biomarker-based adjustment was 1.2 (97.5% CI, 0.6-2.3). The hazard ratio for physician assessment-based adjustment vs symptom-based adjustment was 1.6 (97.5% CI, 0.8-3.3). Conclusion Among adults with mild to moderate persistent asthma controlled with low-dose inhaled corticosteroid therapy, the use of either biomarker-based or symptom-based adjustment of inhaled corticosteroids was not superior to physician assessment-based adjustment of inhaled corticosteroids in time to treatment failure.	[Calhoun, William J.; Ameredes, Bill T.; Grant, J. Andrew] Univ Texas Med Branch, Dept Internal Med, Galveston, TX 77555 USA; [King, Tonya S.; Icitovic, Nikolina; Chinchilli, Vernon M.; Craig, Timothy; Engle, Linda L.; Kunselman, Susan J.] Penn State Univ, Dept Publ Hlth Sci, State Coll, PA USA; [Bleecker, Eugene R.; Meyers, Deborah A.; Moore, Wendy C.; Pascual, Rodolfo; Peters, Stephen P.] Wake Forest Univ, Bowman Gray Sch Med, Winston Salem, NC USA; [Castro, Mario; Walter, Michael J.] Washington Univ, Dept Med, St Louis, MO USA; [Cherniack, Reuben M.; Martin, Richard J.; Sutherland, E. Rand; Szefler, Stanley J.] Natl Jewish Hlth, Denver, CO USA; [Denlinger, Loren; Jarjour, Nizar; Lemanske, Robert F., Jr.; Sorkness, Christine A.] Univ Wisconsin Hosp & Clin, Severe Asthma Res Program, Madison, WI 53792 USA; [DiMango, Emily A.] Columbia Univ, Dept Med, New York, NY USA; [Fahy, John V.; Lazarus, Stephen C.; Boushey, Homer A.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Israel, Elliot; Kazani, Shamsah D.; Wechsler, Michael E.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Kraft, Monica; Lugogo, Njira] Duke Univ, Dept Med, Durham, NC USA; [Ramsdell, Joe; Wasserman, Stephen I.] Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA; [Szefler, Stanley J.] Univ Colorado, Sch Med, Denver, CO USA	University of Texas System; University of Texas Medical Branch Galveston; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Wake Forest University; Wake Forest Baptist Medical Center; Washington University (WUSTL); National Jewish Health; University of Wisconsin System; University of Wisconsin Madison; Columbia University; University of California System; University of California San Francisco; Harvard University; Brigham & Women's Hospital; Duke University; University of California System; University of California San Diego; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Calhoun, WJ (corresponding author), Univ Texas Med Branch, Dept Internal Med, JSA 4-118,301 Univ Blvd, Galveston, TX 77555 USA.	william.calhoun@utmb.edu	Wechsler, Michael/AAC-5506-2019	Szefler, Stanley/0000-0002-6911-3199; Calhoun, William/0000-0001-7075-712X	National Heart, Lung, and Blood Institute (NHLBI); Merck; American Lung Association; AsthmaTx; Amgen; Ception; enentech; MedImmune; Novartis; GlaxoSmithKline; sanofi-aventis; Boehringer; Pfizer; Genentech; Viropharma; CSL Behring; Shire; Dyax; Pharming; Forest; Biota; Grifols; Teva Pharmaceuticals; Vietnam Education Foundation; American Thoracic Society; National Institutes of Health (NIH); Aerovance; Icagen; Johnson Johnson; GE Healthcare; N30; Michigan Public Health Institute; Allegheny General Hospital; American Academy of Pediatrics (AAP); West Allegheny Health System; AAP California chapter; Colorado Allergy Society; Pennsylvania Allergy and Asthma Society; Harvard Pilgrim Health; California Society of Allergy; New York City Allergy Society; World Allergy Organization; American College of Chest Physicians; Genentech/Novartis; Centacor; United Therapeutics and Actelion; Integrity; Ross; Abbott; NKT; MapPharma; Allergy, Asthma, and Immunology Foundation of Northern California; Breath California; Institute for Translational Sciences at the University of Texas Medical Branch; National Center for Advancing Translational Sciences, National Institutes of Health [UL1TR000071]; National Institutes of Health [U10 HL074225, U10 HL074227, U10 HL074231, U10 HL074204, U10 HL074212, U10 HL074073, U10 HL074206, U10 HL074208, U10 HL074218]; National Heart, Lung, and Blood Institute; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000071] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000073] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U10HL074227, U10HL074212, U10HL074218, U10HL074073, U10HL074206, U10HL074231, U10HL074225, U10HL074208, U10HL074204] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Merck(Merck & Company); American Lung Association; AsthmaTx; Amgen(Amgen); Ception; enentech; MedImmune(AstraZenecaMedimmune); Novartis(Novartis); GlaxoSmithKline(GlaxoSmithKline); sanofi-aventis(Sanofi-Aventis); Boehringer(Boehringer Ingelheim); Pfizer(Pfizer); Genentech(Roche HoldingGenentech); Viropharma; CSL Behring; Shire; Dyax; Pharming; Forest; Biota; Grifols; Teva Pharmaceuticals(Teva Pharmaceutical Industries); Vietnam Education Foundation; American Thoracic Society; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Aerovance; Icagen; Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); GE Healthcare(General ElectricGE Healthcare); N30; Michigan Public Health Institute; Allegheny General Hospital(General Electric); American Academy of Pediatrics (AAP); West Allegheny Health System; AAP California chapter; Colorado Allergy Society; Pennsylvania Allergy and Asthma Society; Harvard Pilgrim Health; California Society of Allergy; New York City Allergy Society; World Allergy Organization; American College of Chest Physicians(General Electric); Genentech/Novartis(Roche HoldingGenentech); Centacor; United Therapeutics and Actelion; Integrity; Ross; Abbott(Abbott Laboratories); NKT; MapPharma; Allergy, Asthma, and Immunology Foundation of Northern California; Breath California; Institute for Translational Sciences at the University of Texas Medical Branch; National Center for Advancing Translational Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Drs Calhoun, Ameredes, and Kazani reported receiving funding from the National Heart, Lung, and Blood Institute (NHLBI) for this study and reimbursement for study travel. Dr King reported receiving funding from the NHLBI for this study and having an NHLBI grant pending. Ms Icitovic and Drs Lazarus and Walter reported receiving funding from the NHLBI for this study. Dr Bleecker reported receiving funding from the NHLBI for this study, study-related travel, review activities, and writing or reviewing this manuscript; consultancies with Aerovance, AstraZeneca, Boehringer, Centocor, GlaxoSmithKline, Genentech, Merck, Novartis, Pfizer, and Roche; lecture fees from Merck; and performing clinical trials at Wake Forest University supported by Boehringer, Centocor, GlaxoSmithKline, MedImmune, Genetech, Aerovance, Ception, AstraZeneca, Novartis, Amgen, Pfizer, Forest, and sanofi-aventis. Dr Castro reported receiving funding from the NHLBI for this study and study-related travel; consultancies with Schering, AsthmaTx, Genentech, IPS, Pulmogen, and sanofi-aventis; grants pending from American Lung Association, AsthmaTx, Amgen, Ception, enentech, MedImmune, Merck, Novartis, GlaxoSmithKline, and sanofi-aventis; lecture fees from Boehringer, Pfizer, Merck, GlaxoSmithKline, Genentech, AsthmaTx; and royalties from Elsevier. Dr Chinchilli reported receiving funding from the NHLBI for this study; and consultancies with GlaxoSmithKline, Merck, AstraZeneca, and Novartis. Dr Craig reported consultancies with CSL Behring, Dyax, Viropharma, and Shire; providing expert testimony in a legal case; grants pending from Viropharma, CSL Behring, Shire, Dyax, Pharming, Forest, Genentech, Biota, GlaxoSmithKline, and Grifols; lecture fees from Viropharma, CSL Behring, Dyax, Merck, Novartis, Genentech, and Teva Pharmaceuticals; and educational development funding from Vietnam Education Foundation. Dr Denlinger reported receiving funding from the NHLBI for this study; funding from the American Thoracic Society; consultancy for Merck; having a grant pending with the National Institutes of Health (NIH); and holding a patent through the Wisconsin Alumni Research Foundation. Ms Engle reported receiving funding from NHLBI for this study; and having a grant pending from the NIH. Dr Fahy reported receiving funding from the NHLBI for this study and study travel; board membership for Cytokinetics; consultancies with Amira, Oxagen, Gilead, GlaxoSmithKline, Amgen, Portola, Five Prime Therapeutics, and Merck; having grants pending with Genentech, Boehringer, Aerovance; and receiving travel support from GlaxoSmithKline, Merck, Amira, and Amgen. Dr Grant reported receiving funding from the NHLBI for this study; serving on the US Food and Drug Administration's (FDA's) Allergenic Extracts Advisory Committee; having grants pending with Baxter, Dyax, and Pharming; lecture fees from Shire; payment for manuscript preparation from Lev Pharma; and travel expenses from American Academy of Allergy, Asthma and Immunology (AAAAI), Shire, and the FDA's Allergenic Extracts Advisory Committee.; Dr Israel reported consultancies with Abbott, Amgen, Astellas, Cowen, GlaxoSmithKline, Icagen, Infinity, AstraZeneca, Merck, newMentor, NKT, Novartis, Ono, PDL, Pumatrix, Regeneron, Schering, Sepracor, Teva Pharmaceuticals, and Agenzia; expert testimony for 6 law firms; having grants pending with Aerovance, Amgen, Biota, Genetech, Icagen, Johnson & Johnson, MedImmune, Novartis; speaking fees from Merck and Genentech; and royalties from UpToDate. Dr Jarjour reported receiving funding from the NHLBI for this study; consultancies with AsthmaTx and Genentech; and having grants pending with Merck, GlaxoSmithKline, and Genentech. Dr Kraft reported receiving funding from the NHLBI for this study; grant support from Merck, GE Healthcare, AsthmaTx, Novartis, N30, Genentech, and GlaxoSmithKline; board membership for the American Thoracic Society; royalties from Elsevier; and payment for continuing medical education activities. Ms Kunselman reported receiving funding from NHLBI for this study; having a pending NIH grant; and stock in Merck. Dr Lemanske reported receiving funding from the NHLBI for this study, study travel, data review, manuscript review, and writing assistance; consultancies with Merck, Sepracor, SA Boney, GlaxoSmithKline, AIR, Genentech, Double Helix; having grants pending from the NHLBI and Pharmaxis; speaking fees from the Michigan Public Health Institute, Allegheny General Hospital, American Academy of Pediatrics (AAP), West Allegheny Health System, AAP California chapter, Colorado Allergy Society, Pennsylvania Allergy and Asthma Society, Harvard Pilgrim Health, California Society of Allergy, New York City Allergy Society, World Allergy Organization, and American College of Chest Physicians; a pending patent; and royalties from Elsevier and UpToDate. Dr Lugogo reported receiving funding from the NHLBI for this study and reimbursement for study travel; and having a pending grant from the NIH. Dr Martin reported consultancies with Teva Pharmaceuticals, Merck, AstraZeneca, and Genentech/Novartis; having grants pending with AsthmaNet, Genentech, and MedImmune; lecture fees from Teva Pharmaceuticals, Merck, and Genentech/Novartis; royalties from UpToDate; and payment for educational presentations from Teva Pharmaceuticals and Genentech. Dr Moore reported receiving funding from the NHLBI for this study and study travel; and grants from Aerovance, Amgen, AstraZeneca, Boehringer, Centacor, Ception, Forest, Genentech, GlaxoSmithKline, MedImmune, Novartis, Pfizer, and sanofi-aventis. Dr Pascual reported receiving funding from the NHLBI for this study; consultancies with United Therapeutics and Gilead; and having grants pending from United Therapeutics and Actelion. Dr Peters reported receiving funding from the NHLBI for this study, study travel, data review, manuscript review; consultancies with Aerocrine, AstraZeneca, Airsonnet, Delmedica, GlaxoSmithKline, Merck, and Teva Pharmaceuticals; and lecture fees from Integrity and Merck. Dr Ramsdell reported receiving funding from NHLBI for this study; and receiving a grant from Boehringer. Dr Sutherland reported receiving funding from the NHLBI for this study and study travel; consultancies with Forest, GlaxoSmithKline, Merck, Novartis, Day, and Genentech; having grants pending from Boehringer, Novartis, and the NIH; and fees for educational presentations from Genentech.; Dr Szefler reported receiving funding from the NHLBI for this study, study travel, review, and writing; consultancies with Merck, Genentech, Schering, Boehringer, Novartis, and GlaxoSmithKline; having grants pending from GlaxoSmithKline, Ross, and Abbott; lecture fees from Merck; and fees for manuscript preparation from Genentech. Dr Wasserman reported receiving funding from the NHLBI for this study and study travel; employment by the AAAAI; and expert testimony for various law firms. Dr Wechsler reported consultancies with and lecture fees from GlaxoSmithKline, Novartis, Cephalon, Sepracor, Schering, NKT, AsthmaTx, Genzyme, MapPharma, Merck, Genentech, and Boehringer. Dr Boushey reported receiving funding from the NHLBI for this study; consultancies with Merck, GlaxoSmithKline, Genentech, Kalblos, Pharmaxis, Johnson & Johnson; having pending grants from GlaxoSmithKline, Genentech, and the Allergy, Asthma, and Immunology Foundation of Northern California; lecture fees from Breath California; and royalties from McGraw-Hill. Drs Cherniack, DiMango, Meyers, and Sorkness reported no conflicts.; This study was conducted with the support of the Institute for Translational Sciences at the University of Texas Medical Branch, supported in part by a Clinical and Translational Science Award UL1TR000071 from the National Center for Advancing Translational Sciences, National Institutes of Health. The study was also supported by the following National Institutes of Health grants U10 HL074225, U10 HL074227, U10 HL074231, U10 HL074204, U10 HL074212, U10 HL074073, U10 HL074206, U10 HL074208, and U10 HL074218 that were awarded by the National Heart, Lung, and Blood Institute. Teva Pharmaceuticals provided the study drug and matching placebo.	Boushey HA, 2005, NEW ENGL J MED, V352, P1519, DOI 10.1056/NEJMoa042552; Brightling Christopher E, 2005, Treat Respir Med, V4, P309, DOI 10.2165/00151829-200504050-00002; Burchard EG, 2004, AM J RESP CRIT CARE, V169, P386, DOI 10.1164/rccm.200309-1293OC; Childhood Asthma Management Program Research Group, 2000, FACTS RES GERONTOL, V343, P1054; Choudhry S, 2005, AM J RESP CRIT CARE, V171, P563, DOI 10.1164/rccm.200409-1286OC; Deykin A, 2005, J ALLERGY CLIN IMMUN, V115, P720, DOI 10.1016/j.jaci.2004.12.1129; Fritz GK, 2010, AM J RESP CRIT CARE, V182, P12, DOI 10.1164/rccm.200906-0836OC; Global Initiative for Asthma, GLOB STRAT ASTHM MAN; Green RH, 2002, LANCET, V360, P1715, DOI 10.1016/S0140-6736(02)11679-5; Hardie GE, 2000, CHEST, V117, P935, DOI 10.1378/chest.117.4.935; Juniper EF, 2005, RESP MED, V99, P553, DOI 10.1016/j.rmed.2004.10.008; JUNIPER EF, 1993, AM REV RESPIR DIS, V147, P832, DOI 10.1164/ajrccm/147.4.832; Leuppi JD, 2005, PULM PHARMACOL THER, V18, P83, DOI 10.1016/j.pupt.2004.10.005; National Asthma Education and Prevention Program National Heart Lung and Blood Institute, 2007, NIH PUBL; O'Byrne PM, 2005, AM J RESP CRIT CARE, V171, P129, DOI 10.1164/rccm.200407-884OC; Oborne J, 2009, AM J RESP CRIT CARE, V180, P598, DOI 10.1164/rccm.200904-0616OC; Papi A, 2007, NEW ENGL J MED, V356, P2040, DOI 10.1056/NEJMoa063861; Peters SP, 2010, NEW ENGL J MED, V363, P1715, DOI 10.1056/NEJMoa1008770; Smith AD, 2005, NEW ENGL J MED, V352, P2163, DOI 10.1056/NEJMoa043596; Sont JK, 1999, AM J RESP CRIT CARE, V159, P1043, DOI 10.1164/ajrccm.159.4.9806052; Sutherland ER, 2005, J ALLERGY CLIN IMMUN, V116, P1179, DOI 10.1016/j.jaci.2005.09.028; Szefler S, 2008, LANCET, V372, P1065, DOI 10.1016/S0140-6736(08)61448-8; van den Toorn LM, 2000, AM J RESP CRIT CARE, V162, P953, DOI 10.1164/ajrccm.162.3.9909033	23	144	148	0	15	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 12	2012	308	10					987	997		10.1001/2012.jama.10893	http://dx.doi.org/10.1001/2012.jama.10893			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	003AA	22968888	Green Accepted, Bronze			2022-12-28	WOS:000308579300022
J	Vize, R				Vize, Richard			Friend or foe: can doctors trust Jeremy Hunt with the NHS?	BRITISH MEDICAL JOURNAL			English	Editorial Material												richard.vize@gmail.com							0	0	0	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	SEP 7	2012	345								e6071	10.1136/bmj.e6071	http://dx.doi.org/10.1136/bmj.e6071			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	003TM	22960465				2022-12-28	WOS:000308634200010
J	Taipale, M; Krykbaeva, I; Koeva, M; Kayatekin, C; Westover, KD; Karras, GI; Lindquist, S				Taipale, Mikko; Krykbaeva, Irina; Koeva, Martina; Kayatekin, Can; Westover, Kenneth D.; Karras, Georgios I.; Lindquist, Susan			Quantitative Analysis of Hsp90-Client Interactions Reveals Principles of Substrate Recognition	CELL			English	Article							HSP90; KINASE; PROTEIN; BINDING; INHIBITORS; CAPACITOR; RECEPTOR; SURFACE; KINOME; SRC	HSP90 is a molecular chaperone that associates with numerous substrate proteins called clients. It plays many important roles in human biology and medicine, but determinants of client recognition by HSP90 have remained frustratingly elusive. We systematically and quantitatively surveyed most human kinases, transcription factors, and E3 ligases for interaction with HSP90 and its cochaperone CDC37. Unexpectedly, many more kinases than transcription factors bound HSP90. CDC37 interacted with kinases, but not with transcription factors or E3 ligases. HSP90::kinase interactions varied continuously over a 100-fold range and provided a platform to study client protein recognition. In wild-type clients, HSP90 did not bind particular sequence motifs, but rather associated with intrinsically unstable kinases. Stabilization of the kinase in either its active or inactive conformation with diverse small molecules decreased HSP90 association. Our results establish HSP90 client recognition as a combinatorial process: CDC37 provides recognition of the kinase family, whereas thermodynamic parameters determine client binding within the family.	[Taipale, Mikko; Krykbaeva, Irina; Koeva, Martina; Kayatekin, Can; Karras, Georgios I.; Lindquist, Susan] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Westover, Kenneth D.] UT SW, Dept Biochem, Dallas, TX 75390 USA; [Lindquist, Susan] MIT, Dept Biol, Cambridge, MA 02142 USA; [Lindquist, Susan] MIT, Howard Hughes Med Inst, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Lindquist, S (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	lindquist_admin@wi.mit.edu	Westover, Ken/AAZ-1795-2020; Kayatekin, Can/B-6618-2009	Westover, Ken/0000-0003-3653-5923; Taipale, Mikko/0000-0003-3811-1761; Krykbaeva, Irina/0000-0003-1380-7607; Karras, Georgios/0000-0002-6169-5569; Kayatekin, Can/0000-0002-4367-9645; Karras, Georgios/0000-0003-2933-1535	Academy of Finland; Sigrid Juselius Foundation; Human Frontier Science Program; EMBO; NIH Genomics Based Drug Discovery-Driving Medical Projects [UL1-DE019585]; NIH [RL1-GM084437, RL1-CA133834, RL1-HG004671]; NATIONAL CANCER INSTITUTE [RL1CA133834] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [RL1HG004671] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [UL1DE019585] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [RL1GM084437] Funding Source: NIH RePORTER	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Human Frontier Science Program(Human Frontier Science Program); EMBO(European Molecular Biology Organization (EMBO)); NIH Genomics Based Drug Discovery-Driving Medical Projects(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank D. F. Jarosz, L. Whitesell, and M. Mendillo for valuable comments, K. Salehi-Ashtiani and M. Vidal (Dana-Farber Cancer Institute) for the human ORFeome collection, D. Proia (Synta Pharmaceuticals) for ganetespib, and N.S. Gray (Dana-Farber Cancer Institute) for DPH. M.T. was supported by the Academy of Finland, Sigrid Juselius Foundation and the Human Frontier Science Program. G. I. K. was supported by an EMBO Long-Term Fellowship and the Human Frontier Science Program. S. L. is an investigator of the Howard Hughes Medical Institute. Support for this study was also provided by the NIH Genomics Based Drug Discovery-Driving Medical Projects grant UL1-DE019585, administratively linked to NIH grants RL1-GM084437, RL1-CA133834, and RL1-HG004671. M.T. and S.L. planned the project and designed the experiments. M. T. developed and validated LUMIER with BACON assay and performed all the experiments with the help of I. K. G. I. K. assayed HSP90 interactions against E3 ligases. K. D. W. and M. T. expressed and purified recombinant ABL, and C. K. and M. T. analyzed ABL with circular dichroism. M. T. and M. K. performed computational analyses of HSP90 interactions. M. T. and S. L. wrote the paper, with comments from all the coauthors.	Adrian FJ, 2006, NAT CHEM BIOL, V2, P95, DOI 10.1038/nchembio760; Barrios-Rodiles M, 2005, SCIENCE, V307, P1621, DOI 10.1126/science.1105776; Boulon S, 2010, MOL CELL, V39, P912, DOI 10.1016/j.molcel.2010.08.023; Buchner J, 2010, MOL MICROBIOL, V76, P540, DOI 10.1111/j.1365-2958.2010.07140.x; Caplan AJ, 2007, TRENDS CELL BIOL, V17, P87, DOI 10.1016/j.tcb.2006.12.002; Chen HB, 2007, MOL CELL, V27, P717, DOI 10.1016/j.molcel.2007.06.028; Citri A, 2006, J BIOL CHEM, V281, P14361, DOI 10.1074/jbc.M512613200; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Dias SD, 2005, CANCER RES, V65, P10686, DOI 10.1158/0008-5472.CAN-05-2632; Ehrlich ES, 2009, P NATL ACAD SCI USA, V106, P20330, DOI 10.1073/pnas.0810571106; Falsone SF, 2007, PROTEOMICS, V7, P2375, DOI 10.1002/pmic.200600996; Falsone SF, 2005, FEBS LETT, V579, P6350, DOI 10.1016/j.febslet.2005.10.020; Falsone SF, 2004, J MOL BIOL, V344, P281, DOI 10.1016/j.jmb.2004.08.091; Fan YX, 2008, J BIOL CHEM, V283, P1588, DOI 10.1074/jbc.M708116200; Fedorov O, 2007, P NATL ACAD SCI USA, V104, P20523, DOI 10.1073/pnas.0708800104; Fodor AA, 2004, PROTEINS, V56, P211, DOI 10.1002/prot.20098; Ghosh A, 2011, FASEB J, V25, P2049, DOI 10.1096/fj.10-180554; Grammatikakis N, 1999, MOL CELL BIOL, V19, P1661; Gray PJ, 2008, NAT REV CANCER, V8, P491, DOI 10.1038/nrc2420; Iacob RE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015929; Iwasaki S, 2010, MOL CELL, V39, P292, DOI 10.1016/j.molcel.2010.05.015; Krukenberg KA, 2011, Q REV BIOPHYS, V44, P229, DOI 10.1017/S0033583510000314; Mandal AK, 2007, J CELL BIOL, V176, P319, DOI 10.1083/jcb.200604106; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Manning G, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-7-r66; Pace CN, 1998, BIOPHYS J, V75, P422, DOI 10.1016/S0006-3495(98)77529-0; Picard D, 2006, TRENDS ENDOCRIN MET, V17, P229, DOI 10.1016/j.tem.2006.06.003; Pratt WB, 2008, J BIOL CHEM, V283, P22885, DOI 10.1074/jbc.R800023200; Queitsch C, 2002, NATURE, V417, P618, DOI 10.1038/nature749; Richter K, 2008, J BIOL CHEM, V283, P17757, DOI 10.1074/jbc.M800540200; Ricketson D, 2007, J MOL BIOL, V368, P729, DOI 10.1016/j.jmb.2007.02.057; Rutherford SL, 1998, NATURE, V396, P336, DOI 10.1038/24550; Specchia V, 2010, NATURE, V463, P662, DOI 10.1038/nature08739; Taylor SS, 2011, TRENDS BIOCHEM SCI, V36, P65, DOI 10.1016/j.tibs.2010.09.006; Vaughan CK, 2006, MOL CELL, V23, P697, DOI 10.1016/j.molcel.2006.07.016; Xu WP, 2005, NAT STRUCT MOL BIOL, V12, P120, DOI 10.1038/nsmb885; Xu Y, 1999, P NATL ACAD SCI USA, V96, P109, DOI 10.1073/pnas.96.1.109; Yang JS, 2011, CHEM BIOL, V18, P177, DOI 10.1016/j.chembiol.2010.12.013; Ying WW, 2012, MOL CANCER THER, V11, P475, DOI 10.1158/1535-7163.MCT-11-0755	39	573	585	10	111	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 31	2012	150	5					987	1001		10.1016/j.cell.2012.06.047	http://dx.doi.org/10.1016/j.cell.2012.06.047			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	001ZU	22939624	Green Accepted, Bronze, Green Published			2022-12-28	WOS:000308500200013
J	Den Ruijter, HM; Peters, SAE; Anderson, TJ; Britton, AR; Dekker, JM; Eijkemans, MJ; Engstrom, G; Evans, GW; de Graaf, J; Grobbee, DE; Hedblad, B; Hofman, A; Holewijn, S; Ikeda, A; Kavousi, M; Kitagawa, K; Kitamura, A; Koffijberg, H; Lonn, EM; Lorenz, MW; Mathiesen, EB; Nijpels, G; Okazaki, S; O'Leary, DH; Polak, JF; Price, JF; Robertson, C; Rembold, CM; Rosvall, M; Rundek, T; Salonen, JT; Sitzer, M; Stehouwer, CDA; Witteman, JC; Moons, KG; Bots, ML				Den Ruijter, Hester M.; Peters, Sanne A. E.; Anderson, Todd J.; Britton, Annie R.; Dekker, Jacqueline M.; Eijkemans, Marinus J.; Engstrom, Gunnar; Evans, Gregory W.; de Graaf, Jacqueline; Grobbee, Diederick E.; Hedblad, Bo; Hofman, Albert; Holewijn, Suzanne; Ikeda, Ai; Kavousi, Maryam; Kitagawa, Kazuo; Kitamura, Akihiko; Koffijberg, Hendrik; Lonn, Eva M.; Lorenz, Matthias W.; Mathiesen, Ellisiv B.; Nijpels, Giel; Okazaki, Shuhei; O'Leary, Daniel H.; Polak, Joseph F.; Price, Jackie F.; Robertson, Christine; Rembold, Christopher M.; Rosvall, Maria; Rundek, Tatjana; Salonen, Jukka T.; Sitzer, Matthias; Stehouwer, Coen D. A.; Witteman, Jacqueline C.; Moons, Karel G.; Bots, Michiel L.			Common Carotid Intima-Media Thickness Measurements in Cardiovascular Risk Prediction A Meta-analysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORONARY-HEART-DISEASE; TASK-FORCE; ATHEROSCLEROSIS PROGRESSION; GENERAL-POPULATION; ARTERY-DISEASE; PLAQUE; EVENTS; ASSOCIATION; MEN; GUIDELINES	Context The evidence that measurement of the common carotid intima-media thickness (CIMT) improves the risk scores in prediction of the absolute risk of cardiovascular events is inconsistent. Objective To determine whether common CIMT has added value in 10-year risk prediction of first-time myocardial infarctions or strokes, above that of the Framingham Risk Score. Data Sources Relevant studies were identified through literature searches of databases (PubMed from 1950 to June 2012 and EMBASE from 1980 to June 2012) and expert opinion. Study Selection Studies were included if participants were drawn from the general population, common CIMT was measured at baseline, and individuals were followed up for first-time myocardial infarction or stroke. Data Extraction Individual data were combined into 1 data set and an individual participant data meta-analysis was performed on individuals without existing cardiovascular disease. Results We included 14 population-based cohorts contributing data for 45 828 individuals. During a median follow-up of 11 years, 4007 first-time myocardial infarctions or strokes occurred. We first refitted the risk factors of the Framingham Risk Score and then extended the model with common CIMT measurements to estimate the absolute 10-year risks to develop a first-time myocardial infarction or stroke in both models. The C statistic of both models was similar (0.757; 95% CI, 0.749-0.764; and 0.759; 95% CI, 0.752-0.766). The net reclassification improvement with the addition of common CIMT was small (0.8%; 95% CI, 0.1%-1.6%). In those at intermediate risk, the net reclassification improvement was 3.6% in all individuals (95% CI, 2.7%-4.6%) and no differences between men and women. Conclusion The addition of common CIMT measurements to the Framingham Risk Score was associated with small improvement in 10-year risk prediction of first-time myocardial infarction or stroke, but this improvement is unlikely to be of clinical importance. JAMA. 2012;308(8):796-803 www.jama.com	[Den Ruijter, Hester M.; Peters, Sanne A. E.; Eijkemans, Marinus J.; Grobbee, Diederick E.; Koffijberg, Hendrik; Moons, Karel G.; Bots, Michiel L.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, NL-3584 CX Utrecht, Netherlands; [Den Ruijter, Hester M.] Univ Med Ctr Utrecht, Dept Expt Cardiol, NL-3584 CX Utrecht, Netherlands; [Anderson, Todd J.] Univ Calgary, Dept Cardiac Sci, Calgary, AB, Canada; [Anderson, Todd J.] Univ Calgary, Libin Cardiovasc Inst Alberta, Calgary, AB, Canada; [Britton, Annie R.] UCL, Dept Epidemiol & Publ Hlth, London, England; [Dekker, Jacqueline M.; Nijpels, Giel] Vrije Univ Amsterdam Med Ctr, Inst Hlth & Care Res, Amsterdam, Netherlands; [Engstrom, Gunnar; Hedblad, Bo; Rosvall, Maria] Lund Univ, Dept Clin Sci Malmo, Skane Univ Hosp, Malmo, Sweden; [Evans, Gregory W.] Wake Forest Sch Med, Dept Biostat Sci & Neurol, Winston Salem, NC USA; [de Graaf, Jacqueline; Holewijn, Suzanne] Univ Nijmegen, Med Ctr, Dept Gen Internal Med, Div Vasc Med, Nijmegen, Netherlands; [Grobbee, Diederick E.] Univ Malaya, Med Ctr, Kuala Lumpur, Malaysia; [Hofman, Albert; Kavousi, Maryam; Witteman, Jacqueline C.] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Ikeda, Ai; Kitamura, Akihiko] Osaka Med Ctr Hlth Sci & Promot, Osaka, Japan; [Kitagawa, Kazuo; Okazaki, Shuhei] Osaka Univ, Stroke Ctr, Dept Neurol, Grad Sch Med, Osaka, Japan; [Lonn, Eva M.] McMaster Univ, Dept Med, Div Cardiol, Hamilton, ON, Canada; [Lonn, Eva M.] McMaster Univ, Populat Hlth Res Inst, Hamilton, ON, Canada; [Lorenz, Matthias W.; Sitzer, Matthias] Goethe Univ Frankfurt, Dept Neurol, Univ Hosp, Frankfurt, Germany; [Mathiesen, Ellisiv B.] Univ Tromso, Inst Clin Med, Brain & Circulat Res Grp, Tromso, Norway; [O'Leary, Daniel H.; Polak, Joseph F.] Tufts Med Ctr, Dept Radiol, Boston, MA USA; [Price, Jackie F.; Robertson, Christine] Univ Edinburgh, Ctr Populat Hlth Sci, Edinburgh, Midlothian, Scotland; [Rembold, Christopher M.] Univ Virginia, Dept Internal Med, Div Cardiol, Charlottesville, VA USA; [Rundek, Tatjana] Univ Miami, Miller Sch Med, Dept Neurol, Miami, FL 33136 USA; [Salonen, Jukka T.] MAS Metab Analyt Serv Oy, Helsinki, Finland; [Sitzer, Matthias] Klinikum Herford, Dept Neurol, Herford, Germany; [Stehouwer, Coen D. A.] Maastricht Univ, Med Ctr, Dept Internal Med, Maastricht, Netherlands; [Stehouwer, Coen D. A.] Maastricht Univ, Med Ctr, Cardiovasc Res Inst Maastricht, Maastricht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of Calgary; Libin Cardiovascular Institute Of Alberta; University of Calgary; University of London; University College London; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Lund University; Skane University Hospital; Wake Forest University; Radboud University Nijmegen; Universiti Malaya; Erasmus University Rotterdam; Erasmus MC; Osaka University; McMaster University; McMaster University; Population Health Research Institute; Goethe University Frankfurt; Goethe University Frankfurt Hospital; UiT The Arctic University of Tromso; Tufts Medical Center; University of Edinburgh; University of Virginia; University of Miami; Ruhr University Bochum; Maastricht University; Maastricht University	Den Ruijter, HM (corresponding author), Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Heidelberglaan 100, NL-3584 CX Utrecht, Netherlands.	hruijte2@umcutrecht.nl	Peters, Sanne A.E./H-3028-2012; de Graaf, J./H-8038-2014; Rembold, Christopher/K-8359-2013; Stehouwer, Coen/AAB-3435-2021; Kavousi, Maryam/F-1174-2018; Grobbee, Diederick/C-7651-2014	Kavousi, Maryam/0000-0001-5976-6519; Grobbee, Diederick/0000-0003-4472-4468; Rembold, Christopher/0000-0003-0819-7488; Peters, Sanne/0000-0003-0346-5412; den Ruijter, Hester/0000-0001-9762-014X; Engstrom, Gunnar/0000-0002-8618-9152; Koffijberg, Hendrik/0000-0002-1753-0652; Price, Jackie/0000-0003-3251-3970; Stehouwer, Coen/0000-0001-8752-3223	Ministry of Education, Culture, Sports, and Technology of Japan; Dutch Heart Foundation; sanofi-aventis; AstraZeneca; Novartis; GlaxoSmithKline; National Heart, Lung, and Blood Institute; British Heart Foundation; National Institutes of Health; Netherlands Organisation for Health Research and Development [ZonMw 200320003]	Ministry of Education, Culture, Sports, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Dutch Heart Foundation(Netherlands Heart Foundation); sanofi-aventis(Sanofi-Aventis); AstraZeneca(AstraZeneca); Novartis(Novartis); GlaxoSmithKline(GlaxoSmithKline); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); British Heart Foundation(British Heart Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Netherlands Organisation for Health Research and Development(Netherlands Organization for Health Research and Development)	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr de Graaf reported having received a Dutch Heart Foundation grant to perform the NBS2 study (Nijmegen Biomedical Study). Dr Engstrom reported being employed as a senior epidemiologist by AstraZeneca R&D. Dr Kitagawa reported being employed by Osaka University Hospital; having received a grant from the Ministry of Education, Culture, Sports, and Technology of Japan; and having received lecture fees from sanofi-aventis. Dr Lonn reported having been a consultant for Merck and Hoffman Laroche; having provided expert testimony for Merck; having received grants from AstraZeneca, sanofi-aventis, Novartis, and GlaxoSmithKline; and having received lecture fees from Merck and Novartis. Dr Mathiesen reported having received a grant from the North Norwegian Health Authorities. Dr O'Leary reported owning stock in Medpace. Dr Polak reported having received a grant from the National Heart, Lung, and Blood Institute. Dr Price reported having received a grant from the British Heart Foundation. Dr Rundek reported having received grants from the National Institutes of Health. Dr Salonen reported having received a grant from the University of Eastern Finland for the funding of the Kuopio Ischaemic Heart Disease Risk Factor study. Dr Grobbee and Dr Bots reported having been a consultant for and having received grants and lecture fees from AstraZeneca. No other disclosures were reported.; This project is supported by a grant from the Netherlands Organisation for Health Research and Development (ZonMw 200320003).	Akosah KO, 2003, J AM COLL CARDIOL, V41, P1475, DOI 10.1016/S0735-1097(03)00187-6; Ali YS, 2006, ATHEROSCLEROSIS, V187, P186, DOI 10.1016/j.atherosclerosis.2005.09.003; Allan PL, 1997, STROKE, V28, P348, DOI 10.1161/01.STR.28.2.348; Anderson TJ, 2011, CIRCULATION, V123, P163, DOI 10.1161/CIRCULATIONAHA.110.953653; [Anonymous], 2011, ATHEROSCLEROSIS, V214, P43, DOI 10.1016/j.atherosclerosis.2010.10.045; Berger JS, 2010, J AM COLL CARDIOL, V55, P1169, DOI 10.1016/j.jacc.2009.09.066; Bots ML, 1997, J CLIN EPIDEMIOL, V50, P801, DOI 10.1016/S0895-4356(97)00059-0; Bots ML, 1996, ANN EPIDEMIOL, V6, P147, DOI 10.1016/1047-2797(96)00001-4; Cao JJ, 2007, CIRCULATION, V116, P32, DOI 10.1161/CIRCULATIONAHA.106.645606; Cook NR, 2011, BIOMETRICAL J, V53, P237, DOI 10.1002/bimj.201000078; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; D'Agostino RB, 2001, JAMA-J AM MED ASSOC, V286, P180, DOI 10.1001/jama.286.2.180; Elias-Smale SE, 2012, EUR J PREV CARDIOL, V19, P698, DOI 10.1177/1741826711414623; Greenland P, 2010, CIRCULATION, V122, P2748, DOI 10.1161/CIR.0b013e3182051bab; HARRELL FE, 1984, STAT MED, V3, P143, DOI 10.1002/sim.4780030207; Henry RMA, 2003, CIRCULATION, V107, P2089, DOI 10.1161/01.CIR.0000065222.34933.FC; Hofman A, 2011, EUR J EPIDEMIOL, V26, P657, DOI 10.1007/s10654-011-9610-5; Holewijn S, 2009, J CLIN ENDOCR METAB, V94, P2893, DOI 10.1210/jc.2009-0084; Hollander M, 2003, STROKE, V34, P2367, DOI 10.1161/01.STR.0000091393.32060.0E; Inaba Y, 2012, ATHEROSCLEROSIS, V220, P128, DOI 10.1016/j.atherosclerosis.2011.06.044; Kitagawa K, 2007, CEREBROVASC DIS, V24, P35, DOI 10.1159/000103114; Kitamura A, 2004, STROKE, V35, P2788, DOI 10.1161/01.STR.0000147723.52033.9e; LI RL, 1994, STROKE, V25, P2377, DOI 10.1161/01.STR.25.12.2377; Libby P, 2005, CIRCULATION, V111, P3481, DOI 10.1161/CIRCULATIONAHA.105.537878; Lorenz MW, 2007, CIRCULATION, V115, P459, DOI 10.1161/CIRCULATIONAHA.106.628875; Lorenz MW, 2010, EUR HEART J, V31, P2041, DOI 10.1093/eurheartj/ehq189; Lorenz MW, 2006, STROKE, V37, P87, DOI 10.1161/01.STR.0000196964.24024.ea; Moons KGM, 2006, J CLIN EPIDEMIOL, V59, P1092, DOI 10.1016/j.jclinepi.2006.01.009; Mora S, 2007, ATHEROSCLEROSIS, V192, P211, DOI 10.1016/j.atherosclerosis.2006.05.007; Naghavi M, 2006, AM J CARDIOL, V98, p2H, DOI 10.1016/j.amjcard.2006.03.002; Nambi V, 2010, J AM COLL CARDIOL, V55, P1600, DOI 10.1016/j.jacc.2009.11.075; Pencina MJ, 2010, CLIN CHEM LAB MED, V48, P1703, DOI 10.1515/CCLM.2010.340; Pencina MJ, 2011, STAT MED, V30, P11, DOI 10.1002/sim.4085; Peters SAE, 2011, J ATHEROSCLER THROMB, V18, P784, DOI 10.5551/jat.8169; Plantinga Y, 2009, EUR J CARDIOV PREV R, V16, P639, DOI 10.1097/HJR.0b013e3283312ece; Polak JF, 2011, NEW ENGL J MED, V365, P213, DOI 10.1056/NEJMoa1012592; Prabhakaran Shyam, 2007, Atherosclerosis, V195, pe197, DOI 10.1016/j.atherosclerosis.2007.03.044; Rosvall M, 2000, AM J EPIDEMIOL, V152, P334, DOI 10.1093/aje/152.4.334; SALONEN JT, 1991, ARTERIOSCLER THROMB, V11, P1245, DOI 10.1161/01.ATV.11.5.1245; SALONEN R, 1991, J INTERN MED, V229, P225, DOI 10.1111/j.1365-2796.1991.tb00336.x; Singh-Manoux A, 2008, ATHEROSCLEROSIS, V197, P541, DOI 10.1016/j.atherosclerosis.2007.08.010; Stein JH, 2008, J AM SOC ECHOCARDIOG, V21, P93, DOI 10.1016/j.echo.2007.11.011; Stensland-Bugge E, 2000, STROKE, V31, P574, DOI 10.1161/01.STR.31.3.574; Whincup PH, 2012, STROKE, V43, P1747, DOI 10.1161/STROKEAHA.111.644955; Xie WX, 2011, J AM SOC ECHOCARDIOG, V24, P729, DOI 10.1016/j.echo.2011.02.011	45	507	520	0	42	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 22	2012	308	8					796	803		10.1001/jama.2012.9630	http://dx.doi.org/10.1001/jama.2012.9630			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	991ML	22910757	Bronze, Green Published			2022-12-28	WOS:000307705300023
J	Raber, L; Kelbaek, H; Ostoijc, M; Baumbach, A; Heg, D; Tuller, D; von Birgelen, C; Roffi, M; Moschovitis, A; Khattab, AA; Wenaweser, P; Bonvini, R; Pedrazzini, G; Kornowski, R; Weber, K; Trelle, S; Luscher, TF; Taniwaki, M; Matter, CM; Meier, B; Juni, P; Windecker, S				Raeber, Lorenz; Kelbaek, Henning; Ostoijc, Miodrag; Baumbach, Andreas; Heg, Dik; Tueller, David; von Birgelen, Clemens; Roffi, Marco; Moschovitis, Aris; Khattab, Ahmed A.; Wenaweser, Peter; Bonvini, Robert; Pedrazzini, Giovanni; Kornowski, Ran; Weber, Klaus; Trelle, Sven; Luescher, Thomas F.; Taniwaki, Masanori; Matter, Christian M.; Meier, Bernhard; Jueni, Peter; Windecker, Stephan		COMFORTABLE AMI Trial Investigator	Effect of Biolimus-Eluting Stents With Biodegradable Polymer vs Bare-Metal Stents on Cardiovascular Events Among Patients With Acute Myocardial Infarction The COMFORTABLE AMI Randomized Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PERCUTANEOUS CORONARY INTERVENTION; UNCOATED STENTS; DURABLE POLYMER; SYNTAX SCORE; FOLLOW-UP; ANGIOPLASTY; PACLITAXEL; THROMBOSIS; ABCIXIMAB; REVASCULARIZATION	Context The efficacy and safety of drug-eluting stents compared with bare-metal stents remains controversial in patients with ST-segment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PCI). Objective To compare stents eluting biolimus from a biodegradable polymer with bare-metal stents in primary PCI. Design, Setting, and Patients A prospective, randomized, single-blinded, controlled trial of 1161 patients presenting with STEMI at 11 sites in Europe and Israel between September 19, 2009, and January 25, 2011. Clinical follow-up was performed at 1 and 12 months. Intervention Patients were randomized 1: 1 to receive the biolimus-eluting stent (n=575) or the bare-metal stent (n=582). Main Outcome Measures Primary end point was the rate of major adverse cardiac events, a composite of cardiac death, target vessel-related reinfarction, and ischemia-driven target-lesion revascularization at 1 year. Results Major adverse cardiac events at 1 year occurred in 24 patients (4.3%) receiving biolimus-eluting stents with biodegradable polymer and 49 patients (8.7%) receiving bare-metal stents (hazard ratio [HR], 0.49; 95% CI, 0.30-0.80; P=.004). The difference was driven by a lower risk of target vessel-related reinfarction (3 [0.5%] vs 15 [2.7%]; HR, 0.20; 95% CI, 0.06-0.69; P=.01) and ischemia-driven target-lesion revascularization (9 [1.6%] vs 32 [5.7%]; HR, 0.28; 95% CI, 0.13-0.59; P < .001) in patients receiving biolimus-eluting stents compared with those receiving bare-metal stents. Rates of cardiac death were not significantly different (16 [2.9%] vs 20 [3.5%], P=.53). Definite stent thrombosis occurred in 5 patients (0.9%) treated with biolimus-eluting stents and 12 patients (2.1%; HR, 0.42; 95% CI, 0.15-1.19; P=.10) treated with bare-metal stents. Conclusion Compared with a bare-metal stent, the use of biolimus-eluting stents with a biodegradable polymer resulted in a lower rate of the composite of major adverse cardiac events at 1 year among patients with STEMI undergoing primary PCI.	[Raeber, Lorenz; Moschovitis, Aris; Khattab, Ahmed A.; Wenaweser, Peter; Taniwaki, Masanori; Meier, Bernhard; Windecker, Stephan] Univ Hosp Bern, Dept Cardiol, CH-3010 Bern, Switzerland; [Kelbaek, Henning] Rigshosp, Cardiac Catheterizat Lab, DK-2100 Copenhagen, Denmark; [Ostoijc, Miodrag] Clin Ctr Serbia, Dept Cardiol, Belgrade, Serbia; [Baumbach, Andreas] Bristol Heart Inst, Bristol, Avon, England; [Heg, Dik; Jueni, Peter] Univ Bern, Inst Social & Prevent Med, Bern, Switzerland; [Trelle, Sven; Jueni, Peter; Windecker, Stephan] Univ Bern, Dept Clin Res, Clin Trials Unit, Bern, Switzerland; [Tueller, David] Triemli Municipal Hosp, Dept Cardiol, Zurich, Switzerland; [von Birgelen, Clemens] Univ Twente, Thoraxctr Twente, NL-7500 AE Enschede, Netherlands; [Roffi, Marco; Bonvini, Robert] Univ Hosp, Div Cardiol, Geneva, Switzerland; [Pedrazzini, Giovanni] Cardioctr, Lugano, Switzerland; [Kornowski, Ran] Rabin Med Ctr, Petah Tiqwa, Israel; [Kornowski, Ran] Tel Aviv Univ, IL-69978 Tel Aviv, Israel; [Weber, Klaus] Herzzentrum Bodensee, Kreuzlingen, Switzerland; [Luescher, Thomas F.; Matter, Christian M.] Univ Zurich Hosp, Dept Cardiol, CH-8091 Zurich, Switzerland	University of Bern; University Hospital of Bern; Rigshospitalet; University of Copenhagen; Clinical Centre of Serbia; University of Bristol; University of Bern; University of Bern; Triemli Hospital; University of Twente; University of Geneva; Rabin Medical Center; Tel Aviv University; University of Zurich; University Zurich Hospital	Windecker, S (corresponding author), Univ Hosp Bern, Dept Cardiol, CH-3010 Bern, Switzerland.	stephan.windecker@insel.ch	Trelle, Sven/D-3760-2009; Wenaweser, Peter/AAN-7009-2021; Juni, Peter/Q-8700-2016	Trelle, Sven/0000-0002-8162-8910; Juni, Peter/0000-0002-5985-0670; Baumbach, Andreas/0000-0001-7707-2254; Heg, Dik/0000-0002-8766-7945; Engstrom, Thomas/0000-0001-5436-9194; Saunamaki, Kari/0000-0001-5953-5243; Kurz, David/0000-0002-3921-6939; Jelena, Kostic Rakocevic/0000-0001-8365-4840	Abbott Vascular; Ablynx; Amgen; AstraZeneca; Biosensors; Biotronic; Boehringer Ingelheim; Eisai; Ei Lilly; Exelixis; Geron; Gilead Sciences; Nestle; Novo nordisc; Padma; Roche; Schering-Plough; St. Jude Medical; Swiss Cardio Technologies; Boston Scientific; Medicines Company; Biotronik; Terumo; Medtronic; Cordis; Swiss National Science Foundation [33CM30-124112]; Biosensors Europe SA, Morges, Switzerland; SPUM; Swiss National Science Foundation	Abbott Vascular(Abbott Laboratories); Ablynx(Ablynx); Amgen(Amgen); AstraZeneca(AstraZeneca); Biosensors; Biotronic; Boehringer Ingelheim(Boehringer Ingelheim); Eisai(Eisai Co Ltd); Ei Lilly; Exelixis; Geron; Gilead Sciences(Gilead Sciences); Nestle(Nestle SA); Novo nordisc(Novo Nordisk); Padma; Roche(Roche Holding); Schering-Plough(Merck & CompanySchering Plough Corporation); St. Jude Medical(St. Jude Medical); Swiss Cardio Technologies; Boston Scientific(Boston Scientific); Medicines Company; Biotronik; Terumo; Medtronic(Medtronic); Cordis; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Biosensors Europe SA, Morges, Switzerland; SPUM; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Clinical Trials Unit (CTU Bern), which is part of the University of Bern, Bern, Switzerland, has a staff policy of not accepting honoraria or consultancy fees. However, CTU Bern is involved in design, conduct, or analysis of clinical studies funded by Abbott Vascular, Ablynx, Amgen, AstraZeneca, Biosensors, Biotronic, Boehringer Ingelheim, Eisai, Ei Lilly, Exelixis, Geron, Gilead Sciences, Nestle, Novo nordisc, Padma, Roche, Schering-Plough, St. Jude Medical, and Swiss Cardio Technologies. Dr Baumbach reported being on advisory boards and receiving consultancy fees from Boston Scientific, Medicines Company, and Abbott Vascular; and receiving payment for lectures from Medicines Company and Japan Stent Inc. Dr Tuller reported receiving travel expenses from Biotronik, Biosensors, Terumo, and Medtronic. Dr von Birgelen reported board memberships and receiving lecture fees from Abbott Vascular, Medtronic, and Boston Scientific; receiving consultancy fees from Medtronic; unpaid consultancies from Abbott Vascular, Boston Scientific, Biosensors, Biotronik, and Cordis; receiving grants from Abbott Vascular, Boston Scientific, Biosensors, Biotronik, Cordis, Medtronic, and St Jude Medical; payment for lectures from Abbott Vascular, Boston Scientific, Medtronic, and MSD; and receiving payment for development of educational presentations from Cordis. Dr Roffi reported receiving grants from Boston Scientific, Abbott Vascular, Medtronic, and Biopsensor; and payment for lectures from Lilly-Daiichy Sankyo. Dr Khattab reported receiving payment for lectures from Biosensors. Dr Wenaweser reported receiving consultancy fees from NVT, grants from Medtronic, and payment for lectures from Medtronic, Edwards Lifesciences, and Cordis, and payment for development of educational presentations from Medtronic. Dr Luscher reported receiving research grants to the institution from Abbott, Biosensors, Biotronik, Boston Scientific, and Medtronic, and consultant payments from AstraZeneca, Boehringer Ingelheim, Bayer, Merck, and Pfizer. Dr Matter reported receiving grants from MSD, Eli Lilly, AstraZeneca, and Bayer; expert testimony from MSD; payment for lectures from MSD, AstraZeneca, and Roche; and having patents from Mabimmune, CH. Dr Meier reported receiving research contracts to the institution from Abbott, Boston Scientific, Biosensors, and Cordis. Dr Juni is an unpaid steering committee or statistical executive committee member of trials funded by Abbott Vascular, Biosensors, Medtronic, and St. Jude Medical. Dr Windecker reported receiving research contracts to the institution from Abbott, Boston Scientific, Biosensors, Biotronik, Cordis, Medtronic, and St. Jude Medical. All other authors reported no conflicts of interest.; The COMFORTABLE AMI trial was investigator-initiated, managed by the Clinical Trials Unit, University of Bern, Bern, Switzerland, and supported by the Swiss National Science Foundation (grant 33CM30-124112), and an unrestricted research grant from Biosensors Europe SA, Morges, Switzerland (Drs Juni and Windecker). Dr Raber is the recipient of a research fellowship (SPUM) funded by the Swiss National Science Foundation.	Brar SS, 2009, J AM COLL CARDIOL, V53, P1677, DOI 10.1016/j.jacc.2009.03.013; Daemen J, 2007, LANCET, V369, P667, DOI 10.1016/S0140-6736(07)60314-6; Davi G, 2007, NEW ENGL J MED, V357, P2482, DOI 10.1056/NEJMra071014; de la Ilera LSD, 2007, AM HEART J, V154, DOI 10.1016/j.ahj.2007.04.007; De Luca G, 2012, ARCH INTERN MED, V172, P611, DOI 10.1001/archinternmed.2012.758; Di Lorenzo E, 2009, AM HEART J, V158, DOI 10.1016/j.ahj.2009.03.016; Diaz de la Llera LS, 2007, AM HEART J, V154, pe1; Grines CL, 1999, NEW ENGL J MED, V341, P1949, DOI 10.1056/NEJM199912233412601; GRINES CL, 1993, NEW ENGL J MED, V328, P673, DOI 10.1056/NEJM199303113281001; Kalesan B, 2012, EUR HEART J, V33, P977, DOI 10.1093/eurheartj/ehs036; Kolandaivelu K, 2011, CIRCULATION, V123, P1400, DOI 10.1161/CIRCULATIONAHA.110.003210; Laarman GJ, 2006, NEW ENGL J MED, V355, P1105, DOI 10.1056/NEJMoa062598; Magro M, 2011, AM HEART J, V161, P771, DOI 10.1016/j.ahj.2011.01.004; Montalescot G, 2009, LANCET, V373, P723, DOI 10.1016/S0140-6736(09)60441-4; Nakazawa G, 2008, CIRCULATION, V118, P1138, DOI 10.1161/CIRCULATIONAHA.107.762047; Raber L, 2012, EUROINTERVENTION, V7, P1435, DOI 10.4244/EIJV7I12A224; Raber L, 2011, CARDIOVASC THER, V29, P176, DOI 10.1111/j.1755-5922.2010.00144.x; Sabate M, 2011, EUR SOC CARD C AUG 3; Serruys PW, 2009, EUROINTERVENTION, V5, P50, DOI 10.4244/EIJV5I1A9; Sianos G, 2007, J AM COLL CARDIOL, V50, P573, DOI 10.1016/j.jacc.2007.04.059; Spaulding C, 2006, NEW ENGL J MED, V355, P1093, DOI 10.1056/NEJMoa062006; Stefanini GG, 2011, LANCET, V378, P1940, DOI 10.1016/S0140-6736(11)61672-3; Stone GW, 2009, NEW ENGL J MED, V360, P1946, DOI 10.1056/NEJMoa0810116; Stone GW, 2002, NEW ENGL J MED, V346, P957, DOI 10.1056/NEJMoa013404; Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS), 2010, Eur Heart J, V31, P2501, DOI 10.1093/eurheartj/ehq277; Valgimigli M, 2005, JAMA-J AM MED ASSOC, V293, P2109, DOI 10.1001/jama.293.17.2109; Valgimigli M, 2008, JAMA-J AM MED ASSOC, V299, P1788, DOI 10.1001/jama.299.15.joc80026; van der Hoeven BL, 2008, J AM COLL CARDIOL, V51, P618, DOI 10.1016/j.jacc.2007.09.056; Virmani R, 2006, J AM COLL CARDIOL, V47, pC13, DOI 10.1016/j.jacc.2005.10.065; Vlaar PJ, 2008, LANCET, V371, P1915, DOI 10.1016/S0140-6736(08)60833-8; Windecker S, 2008, LANCET, V372, P1163, DOI 10.1016/S0140-6736(08)61244-1; ZIJLSTRA F, 1993, NEW ENGL J MED, V328, P680, DOI 10.1056/NEJM199303113281002	32	228	235	0	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 22	2012	308	8					777	787		10.1001/jama.2012.10065	http://dx.doi.org/10.1001/jama.2012.10065			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	991ML	22910755	Bronze			2022-12-28	WOS:000307705300021
J	Chu, JW; Chen, VHT; Bunton, R				Chu, John W.; Chen, Victor H. T.; Bunton, Richard			Thrombosis of a Mechanical Heart Valve Despite Dabigatran	ANNALS OF INTERNAL MEDICINE			English	Letter									[Chu, John W.; Chen, Victor H. T.; Bunton, Richard] Dunedin Publ Hosp, Dunedin 9016, New Zealand	Dunedin Public Hospital	Chu, JW (corresponding author), Dunedin Publ Hosp, Dunedin 9016, New Zealand.							[Anonymous], 2012, DAB IS THER BLEED PR; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Eriksson BI, 2007, J THROMB HAEMOST, V5, P2178, DOI 10.1111/j.1538-7836.2007.02748.x; Maegdefessel L, 2010, THROMB RES, V126, pE196, DOI 10.1016/j.thromres.2010.06.011	4	10	10	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 21	2012	157	4					304	304		10.7326/0003-4819-157-4-201208210-00026	http://dx.doi.org/10.7326/0003-4819-157-4-201208210-00026			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	992XG	22910954				2022-12-28	WOS:000307813200031
J	Brouns, SJJ				Brouns, Stan J. J.			A Swiss Army Knife of Immunity	SCIENCE			English	Editorial Material							SMALL RNAS; BACTERIA; DNA; RESISTANCE; SYSTEMS		Wageningen Univ, Microbiol Lab, NL-6703 HB Wageningen, Netherlands	Wageningen University & Research	Brouns, SJJ (corresponding author), Wageningen Univ, Microbiol Lab, NL-6703 HB Wageningen, Netherlands.	stan.brouns@wur.nl		Brouns, Stan/0000-0002-9573-1724				Baker M, 2012, NAT METHODS, V9, P23, DOI 10.1038/nmeth.1807; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bhaya D, 2011, ANNU REV GENET, V45, P273, DOI 10.1146/annurev-genet-110410-132430; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Deveau H, 2008, J BACTERIOL, V190, P1390, DOI 10.1128/JB.01412-07; Friedberg EC, 2003, NATURE, V421, P436, DOI 10.1038/nature01408; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Sapranauskas R, 2011, NUCLEIC ACIDS RES, V39, P9275, DOI 10.1093/nar/gkr606; Storz G, 2011, MOL CELL, V43, P880, DOI 10.1016/j.molcel.2011.08.022; Westra ER, 2012, MOL CELL, V46, P595, DOI 10.1016/j.molcel.2012.03.018; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886	12	8	46	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 17	2012	337	6096					808	809		10.1126/science.1227253	http://dx.doi.org/10.1126/science.1227253			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	989BQ	22904002				2022-12-28	WOS:000307535600030
J	Morin, SA; Shepherd, RF; Kwok, SW; Stokes, AA; Nemiroski, A; Whitesides, GM				Morin, Stephen A.; Shepherd, Robert F.; Kwok, Sen Wai; Stokes, Adam A.; Nemiroski, Alex; Whitesides, George M.			Camouflage and Display for Soft Machines	SCIENCE			English	Article							CEPHALOPOD DYNAMIC CAMOUFLAGE; DISRUPTIVE COLORATION; EVOLUTION; VISION; CHROMATOPHORES; IRIDOPHORES; ORIGINS; LIGHT	Synthetic systems cannot easily mimic the color-changing abilities of animals such as cephalopods. Soft machines-machines fabricated from soft polymers and flexible reinforcing sheets-are rapidly increasing in functionality. This manuscript describes simple microfluidic networks that can change the color, contrast, pattern, apparent shape, luminescence, and surface temperature of soft machines for camouflage and display. The color of these microfluidic networks can be changed simultaneously in the visible and infrared-a capability that organisms do not have. These strategies begin to imitate the functions, although not the anatomies, of color-changing animals.	[Morin, Stephen A.; Shepherd, Robert F.; Kwok, Sen Wai; Stokes, Adam A.; Nemiroski, Alex; Whitesides, George M.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Whitesides, George M.] Harvard Univ, Wyss Inst Biologically Inspired Engn, Cambridge, MA 02138 USA	Harvard University; Harvard University	Whitesides, GM (corresponding author), Harvard Univ, Dept Chem & Chem Biol, 12 Oxford St, Cambridge, MA 02138 USA.	gwhitesides@gmwgroup.harvard.edu	Shepherd, Robert/A-7081-2018	Shepherd, Robert/0000-0002-0631-9587; Stokes, Adam/0000-0002-6140-619X	U.S. Department of Energy [DE-FG02-00ER45852]; Defense Advanced Research Projects Agency [W911NF-11-1-0094]	U.S. Department of Energy(United States Department of Energy (DOE)); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA))	The development of biomimetic camouflage strategies was supported by the U.S. Department of Energy under award DE-FG02-00ER45852. Soft machine development was supported by the Defense Advanced Research Projects Agency under award W911NF-11-1-0094. Patent applications "Flexible Robotic Actuators" and "Soft Robotic Actuators" have been filed but not yet published.	Cott H. B, 1957, ADAPTIVE COLORATION; Cuthill IC, 2005, NATURE, V434, P72, DOI 10.1038/nature03312; ENDLER JA, 1990, BIOL J LINN SOC, V41, P315, DOI 10.1111/j.1095-8312.1990.tb00839.x; GOLDSMITH TH, 1990, Q REV BIOL, V65, P281, DOI 10.1086/416840; Goris RC, 2011, J HERPETOL, V45, P2, DOI 10.1670/10-238.1; Hanlon RT, 2009, PHILOS T R SOC B, V364, P429, DOI 10.1098/rstb.2008.0270; Hanlon R, 2007, CURR BIOL, V17, pR400, DOI 10.1016/j.cub.2007.03.034; HASTINGS JW, 1983, J MOL EVOL, V19, P309, DOI 10.1007/BF02101634; Hayes RA, 2003, NATURE, V425, P383, DOI 10.1038/nature01988; Heikenfeld J, 2009, NAT PHOTONICS, V3, P292, DOI 10.1038/NPHOTON.2009.68; Hunt DM, 2001, CELL MOL LIFE SCI, V58, P1583, DOI 10.1007/PL00000798; Ilievski F, 2011, ANGEW CHEM INT EDIT, V50, P1890, DOI 10.1002/anie.201006464; JACOBS GH, 1993, BIOL REV, V68, P413, DOI 10.1111/j.1469-185X.1993.tb00738.x; Langridge KV, 2009, ANIM BEHAV, V77, P847, DOI 10.1016/j.anbehav.2008.11.023; Luo DG, 2011, SCIENCE, V332, P1307, DOI 10.1126/science.1200172; Martinez RV, 2012, ADV FUNCT MATER, V22, P1376, DOI 10.1002/adfm.201102978; Mathger LM, 2007, CELL TISSUE RES, V329, P179, DOI 10.1007/s00441-007-0384-8; Merilaita S, 2005, P ROY SOC B-BIOL SCI, V272, P665, DOI 10.1098/rspb.2004.3000; Norman MD, 1999, P ROY SOC B-BIOL SCI, V266, P1347, DOI 10.1098/rspb.1999.0786; PETRIE M, 1991, ANIM BEHAV, V41, P323, DOI 10.1016/S0003-3472(05)80484-1; Rogalski A, 2003, PROG QUANT ELECTRON, V27, P59, DOI 10.1016/S0079-6727(02)00024-1; Scholes E, 2008, BIOL J LINN SOC, V94, P491, DOI 10.1111/j.1095-8312.2008.01012.x; Stevens M, 2009, PHILOS T R SOC B, V364, P423, DOI 10.1098/rstb.2008.0217; Stuart-Fox D, 2009, PHILOS T R SOC B, V364, P463, DOI 10.1098/rstb.2008.0254; Sutherland RL, 2008, J OPT SOC AM A, V25, P588, DOI 10.1364/JOSAA.25.000588; Thayer GH, 1909, CONCEALING COLORATIO; Whitesides GM, 2006, NATURE, V442, P368, DOI 10.1038/nature05058; Wilson T, 1998, ANNU REV CELL DEV BI, V14, P197, DOI 10.1146/annurev.cellbio.14.1.197	28	526	552	44	669	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 17	2012	337	6096					828	832		10.1126/science.1222149	http://dx.doi.org/10.1126/science.1222149			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	989BQ	22904008	Green Submitted			2022-12-28	WOS:000307535600039
J	Ravishankara, AR				Ravishankara, A. R.			Water Vapor in the Lower Stratosphere	SCIENCE			English	Editorial Material							TROPOSPHERE		Natl Ocean & Atmospher Adm, Div Chem Sci, Earth Syst Res Lab, Boulder, CO 80305 USA	National Oceanic Atmospheric Admin (NOAA) - USA	Ravishankara, AR (corresponding author), Natl Ocean & Atmospher Adm, Div Chem Sci, Earth Syst Res Lab, Boulder, CO 80305 USA.	a.r.ravishankara@noaa.gov	Dailey-Fisher, Debra/I-6725-2013; Ravishankara, Akkihebbal R/A-2914-2011					Anderson JG, 2012, SCIENCE, V337, P835, DOI 10.1126/science.1222978; BREWER AW, 1949, Q J ROY METEOR SOC, V75, P351, DOI 10.1002/qj.49707532603; Dessler AE, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2009JD012075; Grobecker A. J., 1974, DOTTST7550 CLIM IMP; Hampson J., 1964, 1627 CAN ARM RES DEV, P280; Hanisco TF, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL027899; HOLTON JR, 1995, REV GEOPHYS, V33, P403, DOI 10.1029/95RG02097; JONES RL, 1986, Q J ROY METEOR SOC, V112, P1127, DOI 10.1002/qj.49711247412; Pan LL, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2010JD015462; Ravishankara AR, 1997, SCIENCE, V276, P1058, DOI 10.1126/science.276.5315.1058; Solomon S, 2010, SCIENCE, V327, P1219, DOI 10.1126/science.1182488; Wang PK, 2011, TERR ATMOS OCEAN SCI, V22, P447, DOI 10.3319/TAO.2011.06.13.01(A)	12	25	29	0	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 17	2012	337	6096					809	810		10.1126/science.1227004	http://dx.doi.org/10.1126/science.1227004			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	989BQ	22904003				2022-12-28	WOS:000307535600031
J	Smith, BD; Morgan, RL; Beckett, GA; Falck-Ytter, Y; Holtzman, D; Ward, JW				Smith, Bryce D.; Morgan, Rebecca L.; Beckett, Geoff A.; Falck-Ytter, Yngve; Holtzman, Deborah; Ward, John W.			Hepatitis C Virus Testing of Persons Born During 1945-1965: Recommendations From the Centers for Disease Control and Prevention	ANNALS OF INTERNAL MEDICINE			English	Article							UNITED-STATES; HEPATOCELLULAR-CARCINOMA; VIRAL-HEPATITIS; PREVALENCE; TELAPREVIR; INFECTION; MORTALITY; LIVER; RISK; PEGINTERFERON	Description: The Centers for Disease Control and Prevention (CDC) and a group of governmental and private sector partners developed these evidence-based recommendations to increase the proportion of hepatitis C virus (HCV)-infected persons who know their status and are linked to appropriate care and treatment. The recommendations also address brief alcohol screening, as alcohol accelerates progression of liver disease among HCV-infected individuals. These recommendations augment CDC's 1998 and 1999 recommendations based on risk and medical indications and are not meant to replace those recommendations. Methods: These recommendations are based on systematic reviews of evidence published from 1995 through February 2012 in MEDLINE, EMBASE, CINAHL, the Cochrane Central Register of Controlled Trials, Sociological Abstracts, and Database of Abstracts of Reviews of Effects. Selected studies included cross-sectional and cohort studies that addressed either prevalence of hepatitis C in the United States or clinical outcomes (for example, hepatocellular carcinoma and serious adverse events) among treated patients and systematic reviews of trials that assessed effectiveness of brief screening interventions for alcohol consumption. The Grading of Recommendations Assessment, Development, and Evaluation framework was used to assess quality of the evidence. Recommendation 1: Adults born during 1945-1965 should receive 1-time testing for HCV without prior ascertainment of HCV risk. (Grade: strong recommendation; moderate-quality evidence). Recommendation 2: All persons with identified HCV infection should receive a brief alcohol screening and intervention as clinically indicated, followed by referral to appropriate care and treatment services for HCV infection and related conditions (Grade: strong recommendation; moderate-quality evidence). Ann Intern Med. 2012; 157: 817-822. www.annals.org For author affiliations, see end of text. This article was published at www.annals.org on 16 August 2012.	Ctr Dis Control & Prevent, Div Viral Hepatitis, Atlanta, GA USA; Case Western Reserve Univ, Louis Stokes Vet Affairs Med Ctr, Cleveland, OH USA; Univ Hosp Case Med Ctr, Cleveland, OH USA	Centers for Disease Control & Prevention - USA; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; Case Western Reserve University; Case Western Reserve University Hospital	Smith, BD (corresponding author), 1600 Clifton Rd,MS G-37, Atlanta, GA 30333 USA.	BSmith6@cdc.gov	Yngve Falck-Ytter, AGAF/AAC-5362-2019; Falck-Ytter, Yngve/GZH-0993-2022	Yngve Falck-Ytter, AGAF/0000-0002-4688-3211; Morgan, Rebecca/0000-0002-1012-4897	Division of Viral Hepatitis at the CDC	Division of Viral Hepatitis at the CDC	Division of Viral Hepatitis at the CDC.	Alter MJ, 1999, NEW ENGL J MED, V341, P556, DOI 10.1056/NEJM199908193410802; [Anonymous], 1999, MMWR Recomm Rep, V48, P1; [Anonymous], LIV M SAN FRANC CAL; Armstrong GL, 2006, ANN INTERN MED, V144, P705, DOI 10.7326/0003-4819-144-10-200605160-00004; Backus LI, 2011, CLIN GASTROENTEROL H, V9, P509, DOI 10.1016/j.cgh.2011.03.004; Berg AO, 2004, ANN INTERN MED, V140, P462, DOI 10.7326/0003-4819-140-6-200403160-00013; Davis GL, 2010, GASTROENTEROLOGY, V138, P513, DOI 10.1053/j.gastro.2009.09.067; Eheman C, 2012, CANCER-AM CANCER SOC, V118, P2338, DOI 10.1002/cncr.27514; El-Serag HB, 2007, HEPATOL RES, V37, pS88, DOI 10.1111/j.1872-034X.2007.00168.x; Ferrante JM, 2008, FAM MED, V40, P345; Freeman RB, 2008, AM J TRANSPLANT, V8, P958, DOI 10.1111/j.1600-6143.2008.02174.x; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Hagan H, 2006, PUBLIC HEALTH REP, V121, P710, DOI 10.1177/003335490612100611; Hezode C, 2009, NEW ENGL J MED, V360, P1839, DOI 10.1056/NEJMoa0807650; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Kaner EFS, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004148.pub4; Kwo PY, 2010, LANCET, V376, P705, DOI 10.1016/S0140-6736(10)60934-8; Ly KN, 2012, ANN INTERN MED, V156, P271, DOI 10.7326/0003-4819-156-4-201202210-00004; Mazurek Gerald H., 2010, Morbidity and Mortality Weekly Report, V59, P1; McHutchison JG, 2009, NEW ENGL J MED, V360, P1827, DOI 10.1056/NEJMoa0806104; McQuillian Geraldine M, 2010, NCHS Data Brief, P1; Napper LE, 2010, AIDS BEHAV, V14, P152, DOI 10.1007/s10461-009-9575-5; Poordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494; Rein DB, 2012, ANN INTERN MED, V156, P263, DOI 10.7326/0003-4819-156-4-201202210-00378; Rein DB, 2011, DIGEST LIVER DIS, V43, P66, DOI 10.1016/j.dld.2010.05.006; Roblin DW, 2011, AM J MANAG CARE, V17, P548; Sanyal AJ, 2010, HEPATOLOGY, V51, P727, DOI 10.1002/hep.23583; Shehab TM, 1999, HEPATOLOGY, V30, P794, DOI 10.1002/hep.510300328; Shehab TM, 2002, AM J GASTROENTEROL, V97, P1216; Smith Bryce D., 2012, Morbidity and Mortality Weekly Report, V61, P1; Southern WN, 2011, J VIRAL HEPATITIS, V18, P474, DOI 10.1111/j.1365-2893.2010.01327.x; Spiegel BMR, 2005, HEPATOLOGY, V41, P790, DOI 10.1002/hep.20659; Spradling PR, 2012, CLIN INFECT DIS, V55, P1047, DOI 10.1093/cid/cis616; USPHS/IDSA Prevention of Opportunistic Infections Working Group, 1999, MMWR RECOMM REP, V48, P61; Velazquez RF, 2003, HEPATOLOGY, V37, P520, DOI 10.1053/jhep.2003.50093; Volk ML, 2009, HEPATOLOGY, V50, P1750, DOI 10.1002/hep.23220; WASSERTHEIL S, 1970, BIOMETRICS, V26, P588, DOI 10.2307/2529115; Watson J C, 1998, MMWR Recomm Rep, V47, P1; Westin J, 2002, J VIRAL HEPATITIS, V9, P235, DOI 10.1046/j.1365-2893.2002.00356.x; Yang JD, 2011, CLIN GASTROENTEROL H, V9, P64, DOI 10.1016/j.cgh.2010.08.019; Zapata R, 2010, ANN HEPATOL, V9, pS72, DOI 10.1016/S1665-2681(19)31728-4	41	214	217	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 4	2012	157	11					817	+		10.7326/0003-4819-157-9-201211060-00529	http://dx.doi.org/10.7326/0003-4819-157-9-201211060-00529			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	049RC	22910836	Green Accepted			2022-12-28	WOS:000312000100007
J	Lavzin, M; Rapoport, S; Polsky, A; Garion, L; Schiller, J				Lavzin, Maria; Rapoport, Sophia; Polsky, Alon; Garion, Liora; Schiller, Jackie			Nonlinear dendritic processing determines angular tuning of barrel cortex neurons in vivo	NATURE			English	Article							PRIMARY VISUAL-CORTEX; 5 PYRAMIDAL NEURONS; BASAL DENDRITES; THALAMOCORTICAL SYNAPSES; DIRECTION SELECTIVITY; SOMATOSENSORY CORTEX; NMDA SPIKES; LAYER-IV; CELLS; ORGANIZATION	Layer 4 neurons in primary sensory cortices receive direct sensory information from the external world(1,2). A general feature of these neurons is their selectivity to specific features of the sensory stimulation(3-5). Various theories try to explain the manner in which these neurons are driven by their incoming sensory information(6-11). In all of these theories neurons are regarded as simple elements summing small biased inputs to create tuned output through the axosomatic amplification mechanism(12). However, the possible role of active dendritic integration(13-15) in further amplifying the sensory responses and sharpening the tuning curves of neurons(16-19) is disregarded. Our findings show that dendrites of layer 4 spiny stellate neurons in the barrel cortex can generate local and global multi-branch N-methyl-D-aspartate (NMDA) spikes, which are the main regenerative events in these dendrites. In turn, these NMDA receptor (NMDAR) regenerative mechanisms can sum supralinearly the coactivated thalamocortical and corticocortical inputs. Using in vivo whole-cell recordings combined with an intracellular NMDAR blocker and membrane hyperpolarization, we show that dendritic NMDAR-dependent regenerative responses contribute substantially to the angular tuning of layer 4 neurons by preferentially amplifying the preferred angular directions over non-preferred angles. Taken together, these findings indicate that dendritic NMDAR regenerative amplification mechanisms contribute markedly to sensory responses and critically determine the tuning of cortical neurons.	[Lavzin, Maria; Rapoport, Sophia; Garion, Liora; Schiller, Jackie] Technion Israel Inst Technol, Rappaport Fac Med, Dept Physiol, IL-31096 Haifa, Israel; [Lavzin, Maria; Rapoport, Sophia; Garion, Liora; Schiller, Jackie] Technion Israel Inst Technol, Res Inst, IL-31096 Haifa, Israel; [Polsky, Alon] NINDS, Synapt Physiol Sect, NIH, Bethesda, MD 20892 USA	Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Technion Israel Institute of Technology; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Schiller, J (corresponding author), Technion Israel Inst Technol, Rappaport Fac Med, Dept Physiol, IL-31096 Haifa, Israel.	Jackie@tx.technion.ac.il		Poleg-Polsky, Alon/0000-0003-1327-5129	Israel Science Foundation (ISF); Rappaport Foundation	Israel Science Foundation (ISF)(Israel Science Foundation); Rappaport Foundation	We thank Y. Schiller and G. Major for their helpful comments and discussions on the manuscript. We thank A. Korngreen and C. de Kock for help with Neurolucida reconstructions, U. Dubin for help in programming the stimulus and analysis programs, O. Schiff for help with Igor software and R. Azouz for help with the passive stimulus. We thank I. Reiter for her technical help, particularly with histology. We also thank R. Bruno for sharing his knowledge of in vivo patch clamp recordings. This study was supported by the Israel Science Foundation (ISF) and the Rappaport Foundation (J.S.).	Alonso JM, 1996, NATURE, V383, P815, DOI 10.1038/383815a0; Archie KA, 2000, NAT NEUROSCI, V3, P54, DOI 10.1038/71125; BENSHALOM G, 1986, J COMP NEUROL, V253, P303, DOI 10.1002/cne.902530303; Binzegger T, 2004, J NEUROSCI, V24, P8441, DOI 10.1523/JNEUROSCI.1400-04.2004; Branco T, 2010, CURR OPIN NEUROBIOL, V20, P494, DOI 10.1016/j.conb.2010.07.009; Bruno RM, 2006, SCIENCE, V312, P1622, DOI 10.1126/science.1124593; Bruno RM, 2003, J NEUROSCI, V23, P9565; Fleidervish IA, 1998, NEURON, V21, P1055, DOI 10.1016/S0896-6273(00)80623-6; Gil Z, 1999, NEURON, V23, P385, DOI 10.1016/S0896-6273(00)80788-6; Hausser M, 2000, SCIENCE, V290, P739, DOI 10.1126/science.290.5492.739; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Jia HB, 2010, NATURE, V464, P1307, DOI 10.1038/nature08947; Johnston D, 1996, ANNU REV NEUROSCI, V19, P165, DOI 10.1146/annurev.ne.19.030196.001121; Kremer Y, 2011, J NEUROSCI, V31, P10689, DOI 10.1523/JNEUROSCI.6541-10.2011; Larkum ME, 2009, SCIENCE, V325, P756, DOI 10.1126/science.1171958; Magee J, 1998, ANNU REV PHYSIOL, V60, P327, DOI 10.1146/annurev.physiol.60.1.327; Major G, 2008, J NEUROPHYSIOL, V99, P2584, DOI 10.1152/jn.00011.2008; Poirazi P, 2001, NEURON, V29, P779, DOI 10.1016/S0896-6273(01)00252-5; Polsky A, 2004, NAT NEUROSCI, V7, P621, DOI 10.1038/nn1253; Polsky A, 2009, J NEUROSCI, V29, P11891, DOI 10.1523/JNEUROSCI.5250-08.2009; Priebe NJ, 2008, NEURON, V57, P482, DOI 10.1016/j.neuron.2008.02.005; Priebe NJ, 2005, NEURON, V45, P133, DOI 10.1016/j.neuron.2004.12.024; Sarid L, 2007, P NATL ACAD SCI USA, V104, P16353, DOI 10.1073/pnas.0707853104; Schiller J, 2000, NATURE, V404, P285, DOI 10.1038/35005094; Schiller J, 2001, CURR OPIN NEUROBIOL, V11, P343, DOI 10.1016/S0959-4388(00)00217-8; Stratford KJ, 1996, NATURE, V382, P258, DOI 10.1038/382258a0; Wang HP, 2010, SCIENCE, V328, P106, DOI 10.1126/science.1183108; WHITE EL, 1980, J NEUROCYTOL, V9, P615, DOI 10.1007/BF01205029; WOOLSEY TA, 1970, BRAIN RES, V17, P205, DOI 10.1016/0006-8993(70)90079-X	29	165	170	1	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 18	2012	490	7420					397	401		10.1038/nature11451	http://dx.doi.org/10.1038/nature11451			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	021XI	22940864				2022-12-28	WOS:000309918500045
J	Rolland, M; Edlefsen, PT; Larsen, BB; Tovanabutra, S; Sanders-Buell, E; Hertz, T; deCamp, AC; Carrico, C; Menis, S; Magaret, CA; Ahmed, H; Juraska, M; Chen, L; Konopa, P; Nariya, S; Stoddard, JN; Wong, K; Zhao, H; Deng, WJ; Maust, BS; Bose, M; Howell, S; Bates, A; Lazzaro, M; O'Sullivan, A; Lei, E; Bradfield, A; Ibitamuno, G; Assawadarachai, V; O'Connell, RJ; deSouza, MS; Nitayaphan, S; Rerks-Ngarm, S; Robb, ML; McLellan, JS; Georgiev, I; Kwong, PD; Carlson, JM; Michael, NL; Schief, WR; Gilbert, PB; Mullins, JI; Kim, JH				Rolland, Morgane; Edlefsen, Paul T.; Larsen, Brendan B.; Tovanabutra, Sodsai; Sanders-Buell, Eric; Hertz, Tomer; deCamp, Allan C.; Carrico, Chris; Menis, Sergey; Magaret, Craig A.; Ahmed, Hasan; Juraska, Michal; Chen, Lennie; Konopa, Philip; Nariya, Snehal; Stoddard, Julia N.; Wong, Kim; Zhao, Hong; Deng, Wenjie; Maust, Brandon S.; Bose, Meera; Howell, Shana; Bates, Adam; Lazzaro, Michelle; O'Sullivan, Annemarie; Lei, Esther; Bradfield, Andrea; Ibitamuno, Grace; Assawadarachai, Vatcharain; O'Connell, Robert J.; deSouza, Mark S.; Nitayaphan, Sorachai; Rerks-Ngarm, Supachai; Robb, Merlin L.; McLellan, Jason S.; Georgiev, Ivelin; Kwong, Peter D.; Carlson, Jonathan M.; Michael, Nelson L.; Schief, William R.; Gilbert, Peter B.; Mullins, James I.; Kim, Jerome H.			Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2	NATURE			English	Article							COMPETING RISKS; SUBTYPE-C; TRIAL; NEUTRALIZATION; PROTECTION; INFECTION; SEQUENCES; EPITOPES; THAILAND; AIDSVAX	The RV144 trial demonstrated 31% vaccine efficacy at preventing human immunodeficiency virus (HIV)-1 infection(1). Antibodies against the HIV-1 envelope variable loops 1 and 2 (Env V1 and V2) correlated inversely with infection risk(2). We proposed that vaccine-induced immune responses against V1/V2 would have a selective effect against, or sieve, HIV-1 breakthrough viruses. A total of 936 HIV-1 genome sequences from 44 vaccine and 66 placebo recipients were examined. We show that vaccine-induced immune responses were associated with two signatures in V2 at amino acid positions 169 and 181. Vaccine efficacy against viruses matching the vaccine at position 169 was 48% (confidence interval 18% to 66%; P = 0.0036), whereas vaccine efficacy against viruses mismatching the vaccine at position 181 was 78% (confidence interval 35% to 93%; P = 0.0028). Residue 169 is in a cationic glycosylated region recognized by broadly neutralizing and RV144-derived antibodies. The predicted distance between the two signature sites (21 +/- 7 angstrom) and their match/mismatch dichotomy indicate that multiple factors may be involved in the protection observed in RV144. Genetic signatures of RV144 vaccination in V2 complement the finding of an association between high V1/V2-binding antibodies and reduced risk of HIV-1 acquisition, and provide evidence that vaccine-induced V2 responses plausibly had a role in the partial protection conferred by the RV144 regimen.	[Rolland, Morgane; Tovanabutra, Sodsai; Sanders-Buell, Eric; Bose, Meera; Howell, Shana; Bates, Adam; Lazzaro, Michelle; O'Sullivan, Annemarie; Lei, Esther; Bradfield, Andrea; Ibitamuno, Grace; O'Connell, Robert J.; Robb, Merlin L.; Michael, Nelson L.; Kim, Jerome H.] US Mil HIV Res Program, Silver Spring, MD 20910 USA; [Edlefsen, Paul T.; Hertz, Tomer; deCamp, Allan C.; Magaret, Craig A.; Ahmed, Hasan; Juraska, Michal; Gilbert, Peter B.] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Stat Ctr HIV AIDS Res & Prevent, Seattle, WA 98109 USA; [Larsen, Brendan B.; Chen, Lennie; Konopa, Philip; Nariya, Snehal; Stoddard, Julia N.; Wong, Kim; Zhao, Hong; Deng, Wenjie; Maust, Brandon S.; Mullins, James I.] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [Carrico, Chris; Menis, Sergey; Schief, William R.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Carrico, Chris; Menis, Sergey; Schief, William R.] Scripps Res Inst, IAVI Neutralizing Antibody Ctr, La Jolla, CA 92037 USA; [Carrico, Chris; Menis, Sergey; Schief, William R.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Assawadarachai, Vatcharain; deSouza, Mark S.; Nitayaphan, Sorachai] Royal Thai Army Component, AFRIMS, Bangkok 10400, Thailand; [Rerks-Ngarm, Supachai] Thai Minist Publ Hlth, Nonthaburi 11000, Thailand; [McLellan, Jason S.; Georgiev, Ivelin; Kwong, Peter D.] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; [Carlson, Jonathan M.] Microsoft Res, Redmond, WA 98052 USA	Walter Reed Army Institute of Research (WRAIR); Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; International AIDS Vaccine Initiative; Scripps Research Institute; Scripps Research Institute; Walter Reed Army Institute of Research (WRAIR); Armed Forces Research Institute of Medical Science (AFRIMS); Ministry of Public Health - Thailand; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Microsoft	Rolland, M (corresponding author), US Mil HIV Res Program, Silver Spring, MD 20910 USA.	mrolland@hivresearch.org	Hertz, Tomer/S-5744-2016; Schief, William/ABF-3645-2020	Hertz, Tomer/0000-0002-0561-1578; Schief, William/0000-0002-1120-0150; McLellan, Jason/0000-0003-3991-542X; Carrico, Chris/0000-0003-0939-9006	US Army Medical Research and Material Command (USAMRMC) [Y1-AI-2642-12]; National Institutes of Allergy and Infectious Diseases [Y1-AI-2642-12]; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. [W81XWH-07-2-0067]; US Department of Defense (DOD) [W81XWH-07-2-0067]; NIH [2R37AI05465-10]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI054165, UM1AI068635, ZIAAI005023, R01AI054165, N01AI002642, U01AI068635, K25AI087397] Funding Source: NIH RePORTER	US Army Medical Research and Material Command (USAMRMC)(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); National Institutes of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.; US Department of Defense (DOD)(United States Department of Defense); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank B. F. Haynes and F. A. Matsen for advice and comments, and I. A. Wilson and R. L. Stanfield for assistance. This study was supported in part by an Interagency Agreement Y1-AI-2642-12 between US Army Medical Research and Material Command (USAMRMC) and the National Institutes of Allergy and Infectious Diseases. This work was also supported by a cooperative agreement (W81XWH-07-2-0067) between the Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., and the US Department of Defense (DOD). Additional support was provided to P.B.G. through the NIH grant 2R37AI05465-10. The opinions herein are those of the authors and should not be construed as official or representing the views of the US Department of Defense or the Department of the Army.	Carlson JM, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000225; Derdeyn CA, 2004, SCIENCE, V303, P2019, DOI 10.1126/science.1093137; Doria-Rose NA, 2012, J VIROL, V86, P8319, DOI 10.1128/JVI.00696-12; Edlefsen P. T., 2012, MODEL BASED SIEVE AN; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Gilbert P, 2001, J CLIN EPIDEMIOL, V54, P68, DOI 10.1016/S0895-4356(00)00258-4; Gilbert PB, 2000, STAT MED, V19, P3065; Gilbert PB, 1998, BIOMETRICS, V54, P799, DOI 10.2307/2533835; Gilbert PB, 2005, AIDS RES HUM RETROV, V21, P1016, DOI 10.1089/aid.2005.21.1016; Gilbert PB, 2008, BIOMETRICS, V64, P198, DOI 10.1111/j.1541-0420.2007.00845.x; Gilbert PB, 2011, J INFECT DIS, V203, P969, DOI 10.1093/infdis/jiq152; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; LUNN M, 1995, BIOMETRICS, V51, P524, DOI 10.2307/2532940; Lynch RM, 2011, J VIROL, V85, P905, DOI 10.1128/JVI.02006-10; McLellan JS, 2011, NATURE, V480, P336, DOI 10.1038/nature10696; Moore PL, 2011, J VIROL, V85, P3128, DOI 10.1128/JVI.02658-10; Moore PL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000598; Plotkin SA, 2012, CLIN INFECT DIS, V54, P1615, DOI 10.1093/cid/cis238; Pond SLK, 2005, BIOINFORMATICS, V21, P2531, DOI 10.1093/bioinformatics/bti320; Poon AFY, 2007, PLOS COMPUT BIOL, V3, P2279, DOI 10.1371/journal.pcbi.0030231; PRENTICE RL, 1978, BIOMETRICS, V34, P541, DOI 10.2307/2530374; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Robb ML, 2012, LANCET INFECT DIS, V12, P531, DOI 10.1016/S1473-3099(12)70088-9; Rolland M, 2012, AIDS RES HUM RETROV, V28, P400, DOI [10.1089/aid.2011.0240, 10.1089/AID.2011.0240]; Rolland M, 2011, NAT MED, V17, P366, DOI 10.1038/nm.2316; Rubinstein ND, 2008, MOL IMMUNOL, V45, P3477, DOI 10.1016/j.molimm.2007.10.016; Storey JD, 2003, ANN STAT, V31, P2013, DOI 10.1214/aos/1074290335; Tomaras GD, 2011, J VIROL, V85, P11502, DOI 10.1128/JVI.05363-11; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470	30	323	331	1	80	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 18	2012	490	7420					417	+		10.1038/nature11519	http://dx.doi.org/10.1038/nature11519			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	021XI	22960785	Green Accepted			2022-12-28	WOS:000309918500049
J	Puymirat, E; Simon, T; Steg, PG; Schiele, F; Gueret, P; Blanchard, D; Khalife, K; Goldstein, P; Cattan, S; Vaur, L; Cambou, JP; Ferrieres, J; Danchin, N				Puymirat, Etienne; Simon, Tabassome; Steg, Philippe Gabriel; Schiele, Francois; Gueret, Pascal; Blanchard, Didier; Khalife, Khalife; Goldstein, Patrick; Cattan, Simon; Vaur, Laurent; Cambou, Jean-Pierre; Ferrieres, Jean; Danchin, Nicolas		USIK USIC 2000 Investigator; FAST MI Investigator	Association of Changes in Clinical Characteristics and Management With Improvement in Survival Among Patients With ST-Elevation Myocardial Infarction	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACUTE CORONARY SYNDROMES; INTENSIVE-CARE UNITS; HOSPITAL MORTALITY; FAST-MI; TRENDS; REGISTRY; DECREASE; DECLINE; DISEASE	Context The contemporary decline in mortality reported in patients with ST-segment elevation myocardial infarction (STEMI) has been attributed mainly to improved use of reperfusion therapy. Objective To determine potential factors-beyond reperfusion therapy-associated with improved survival in patients with STEMI over a 15-year period. Design, Setting, and Patients Four 1-month French nationwide registries, conducted 5 years apart (between 1995, 2000, 2005, 2010), including a total of 6707 STEMI patients admitted to intensive care or coronary care units. Main Outcome Measures Changes over time in crude 30-day mortality, and mortality standardized to the 2010 population characteristics. Results Mean(SD) age decreased from 66.2 (14.0) to 63.3 (14.5) years, with a concomitant decline in history of cardiovascular events and comorbidities. The proportion of younger patients increased, particularly in women younger than 60 years (from 11.8% to 25.5%), in whom prevalence of current smoking (37.3% to 73.1%) and obesity (17.6% to 27.1%) increased. Time from symptom onset to hospital admission decreased, with a shorter time from onset to first call, and broader use of mobile intensive care units. Reperfusion therapy increased from 49.4% to 74.7%, driven by primary percutaneous coronary intervention (11.9% to 60.8%). Early use of recommended medications increased, particularly low-molecular-weight heparins and statins. Crude 30-day mortality decreased from 13.7% (95% CI, 12.0-15.4) to 4.4% (95% CI, 3.5-5.4), whereas standardized mortality decreased from 11.3% (95% CI, 9.5-13.2) to 4.4% (95% CI, 3.5-5.4). Multivariable analysis showed a consistent reduction in mortality from 1995 to 2010 after controlling for clinical characteristics in addition to the initial population risk score and use of reperfusion therapy, with odds mortality ratios of 0.39 (95%, 0.29-0.53, P < .001) in 2010 compared with 1995. Conclusion In France, the overall rate of cardiovascular mortality among patients with STEMI decreased from 1995 to 2010, accompanied by an increase in the proportion of women younger than 60 years with STEMI, changes in other population characteristics, and greater use of reperfusion therapy and recommended medications. JAMA. 2012;308(10):998-1006 Published online August 27, 2012. doi:10.1001/jama.2012.11348 www.jama.com	[Puymirat, Etienne; Danchin, Nicolas] Univ Paris 05, Hop Europeen Georges Pompidou, AP HP, Dept Cardiol, F-75015 Paris, France; [Puymirat, Etienne] INSERM, U970, Paris, France; [Simon, Tabassome] Hop St Antoine, AP HP, Dept Clin Pharmacol, F-75571 Paris, France; [Simon, Tabassome] Unite Rech Clin URCEST, Paris, France; [Simon, Tabassome] Univ Paris 06, Paris, France; [Steg, Philippe Gabriel] Hop Bichat Claude Bernard, AP HP, F-75877 Paris, France; [Steg, Philippe Gabriel] Univ Paris Diderot, Paris, France; [Steg, Philippe Gabriel] INSERM, U698, Paris, France; [Schiele, Francois] Univ Hosp Jean Minjoz, Dept Cardiol, Besancon, France; [Gueret, Pascal] Univ Hosp Henri Mondor, Dept Cardiol, Creteil, France; [Blanchard, Didier] Clin St Gatien, Tours, France; [Khalife, Khalife] Metz Reg Hosp, Dept Cardiol, Metz, France; [Goldstein, Patrick] Lille Reg Univ Hosp, Emergency Dept, Lille, France; [Vaur, Laurent] Novo Nordisk, Paris, France; [Cambou, Jean-Pierre; Ferrieres, Jean] Toulouse Rangueil Univ Hosp, Dept Cardiol, Toulouse, France; [Cambou, Jean-Pierre; Ferrieres, Jean] Fac Med Toulouse, INSERM, UMR1027, F-31073 Toulouse, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Franche-Comte; CHU Besancon; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; CHR Metz-Thionville; Universite de Lille - ISITE; CHU Lille; Novo Nordisk; CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm)	Danchin, N (corresponding author), Univ Paris 05, Hop Europeen Georges Pompidou, AP HP, Dept Cardiol, 20 Rue Leblanc, F-75015 Paris, France.	nicolas.danchin@egp.aphp.fr	Danchin, Nicolas/AAN-8291-2020; Puymirat, Etienne/AAP-8895-2021; STEG, Philippe Gabriel/Z-1567-2019; Ferrieres, Jean/S-7993-2016	Puymirat, Etienne/0000-0002-0533-9682; Ferrieres, Jean/0000-0001-6144-1297; SIMON, Tabassome/0000-0002-4550-0450; STEG, Philippe Gabriel/0000-0001-6896-2941	Astra-Zeneca; Daiichi-Sankyo; Eli-Lilly; Glaxo-Smith-Kline; MSD; Novartis; Pfizer; sanofi-aventis; Servier; AstraZeneca; Bayer-Schering; NYU School of Medicine; Ablynx; Amarin; Astellas; Bayer; Boehringer-Ingelheim; BMS; Daiichi-Sankyo-Lilly; GSK; Medtronic; Otsuka; Roche; Medicines Company; Lilly; Takeda; Toshiba; General Electric Systems; Ipsen; Lilly Daiichi Sankyo; Boehringer Ingelheim; Boston Scientific; Genzyme; Merck; Bristol-Myers Squibb; Menarini; Merck-Serono; Novo-Nordisk; Laboratoire Roussel; Aventis-France; Caisse Nationale d'Assurance Maladie-Travailleurs Salaries; Daiichi-Sankyo-Eli-Lilly alliance; GlaxoSmithKline; French Society of Cardiology	Astra-Zeneca(AstraZeneca); Daiichi-Sankyo(Daiichi Sankyo Company Limited); Eli-Lilly(Eli Lilly); Glaxo-Smith-Kline(GlaxoSmithKline); MSD; Novartis(Novartis); Pfizer(Pfizer); sanofi-aventis(Sanofi-Aventis); Servier(Servier); AstraZeneca(AstraZeneca); Bayer-Schering(Bayer AG); NYU School of Medicine; Ablynx(Ablynx); Amarin; Astellas(Astellas Pharmaceuticals); Bayer(Bayer AG); Boehringer-Ingelheim(Boehringer Ingelheim); BMS(Bristol-Myers Squibb); Daiichi-Sankyo-Lilly(Daiichi Sankyo Company LimitedEli Lilly); GSK(GlaxoSmithKline); Medtronic(Medtronic); Otsuka(Otsuka Pharmaceutical); Roche(Roche Holding); Medicines Company; Lilly(Eli Lilly); Takeda(Takeda Pharmaceutical Company Ltd); Toshiba; General Electric Systems(General Electric); Ipsen(Ipsen); Lilly Daiichi Sankyo(Daiichi Sankyo Company LimitedEli Lilly); Boehringer Ingelheim(Boehringer Ingelheim); Boston Scientific(Boston Scientific); Genzyme(Sanofi-AventisGenzyme Corporation); Merck(Merck & Company); Bristol-Myers Squibb(Bristol-Myers Squibb); Menarini(Menarini Group); Merck-Serono(Merck & Company); Novo-Nordisk(Novo Nordisk); Laboratoire Roussel; Aventis-France(Sanofi-Aventis); Caisse Nationale d'Assurance Maladie-Travailleurs Salaries; Daiichi-Sankyo-Eli-Lilly alliance(Daiichi Sankyo Company Limited); GlaxoSmithKline(GlaxoSmithKline); French Society of Cardiology	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Simon reported receiving research grants: Astra-Zeneca, Daiichi-Sankyo, Eli-Lilly, Glaxo-Smith-Kline, MSD, Novartis, Pfizer, sanofi-aventis, and Servier and speaker and consulting fees: AstraZeneca, Bayer-Schering, Eli-Lilly, and sanofi-aventis. Dr Steg reported receiving institutional research grant support: NYU School of Medicine, sanofi-aventis, and Servier; Consulting/advisory board fees: Ablynx, Amarin, Astellas, AstraZeneca, Bayer, Boehringer-Ingelheim, BMS, Daiichi-Sankyo-Lilly, GSK, Medtronic, MSD, Novartis, Otsuka, Pfizer, Roche, sanofi-aventis, Servier, and The Medicines Company; and being a stockholder and co-founder: Aterovax. Dr Schiele reported receiving grant support to his institution and travel support for scientific meetings: AstraZeneca, Boehringer-Ingelheim, Daiichi-Sankyo, Lilly, Medtronic, Pfizer; sanofi-aventis, Servier, and Takeda. Dr Gueret reported receiving research grants: Toshiba and General Electric Systems and consulting and speaker's fees: Boehringer-Ingelheim, Daiichi-Sankyo, Eli-Lilly, General Electric Systems, Ipsen, Pfizer, sanofi-aventis, and Servier. Dr Goldstein reported speaker, board membership, and consulting fees: Boeringer-Ingelheim, The Medicines Company, sanofi-aventis, BMS, AstraZeneca, Bayer, and Lilly Daiichi Sankyo. Dr Cattan reported receiving grants: AstraZeneca, Boehringer Ingelheim, Boston Scientific, Medtronic, and Servier. Dr Vaur reported being a former full-time employee of Roussel and Aventis-France and being currently employed at Novo-Nordisk. Dr Ferrieres reported receiving grants and speaker fees: AstraZeneca, Genzyme, Merck, Novartis, and Servier. Dr Danchin reported receiving research grants: AstraZeneca, Daiichi-Sankyo, Eli-Lilly, Glaxo-Smith-Kline, MSD, Novartis, Pfizer, sanofi-aventis, Servier, and The Medicines Company and advisory panels or lecture fees: AstraZeneca, Boehringer-Ingelheim, Bristol-Myers Squibb, Eli-Lilly, Menarini, Merck-Serono, Novo-Nordisk, Servier, and sanofi-aventis. Drs Puymirat, Blanchard, Khalife, and Cambou reported no conflicts of interest.; USIK 1995 was funded by Laboratoire Roussel, which was involved in the design and conduct of the study, as well as data collection and management. USIC 2000 was funded by Aventis-France, which was involved in the design and conduct of the study, as well as data collection and management. FAST-MI 2005 and FAST-MI 2010 are registries of the French Society of Cardiology. FAST-MI 2005 was supported by unrestricted grants from Pfizer and Servier, and an additional grant from the Caisse Nationale d'Assurance Maladie-Travailleurs Salaries. FAST-MI 2010 was supported by unrestricted grants from AstraZeneca, the Daiichi-Sankyo-Eli-Lilly alliance, GlaxoSmithKline, Merck, Novartis, and sanofi-aventis. Sophie Rushton-Smith provided editorial assistance on the first submitted version of the manuscript and was funded by the French Society of Cardiology.	Beck F., 2011, Bulletin Epidemiologique Hebdomadaire, P230; Berry JD, 2012, NEW ENGL J MED, V366, P321, DOI 10.1056/NEJMoa1012848; Cambou JP, 2007, ARCH MAL COEUR VAISS, V100, P524; Danchin N, 1997, J AM COLL CARDIOL, V30, P1598, DOI 10.1016/S0735-1097(97)00371-9; Danchin N, 1999, CIRCULATION, V99, P2639, DOI 10.1161/01.CIR.99.20.2639; Ford ES, 2007, NEW ENGL J MED, V356, P2388, DOI 10.1056/NEJMsa053935; Ford ES, 2012, CIRCULATION, V125, P987, DOI 10.1161/CIRCULATIONAHA.111.049122; Fox KAA, 2007, JAMA-J AM MED ASSOC, V297, P1892, DOI 10.1001/jama.297.17.1892; Gale CP, 2009, HEART, V95, P221, DOI 10.1136/hrt.2008.144022; Hanania G, 2004, HEART, V90, P1404, DOI 10.1136/hrt.2003.025460; Hanssen M, 2012, HEART, V98, P699, DOI 10.1136/heartjnl-2012-301700; Hardoon SL, 2008, CIRCULATION, V117, P598, DOI 10.1161/CIRCULATIONAHA.107.705947; Jernberg T, 2011, JAMA-J AM MED ASSOC, V305, P1677, DOI 10.1001/jama.2011.522; Kostis WJ, 2010, CIRC-CARDIOVASC QUAL, V3, P581, DOI 10.1161/CIRCOUTCOMES.110.957803; Movahed MR, 2009, AM J CARDIOL, V104, P1030, DOI 10.1016/j.amjcard.2009.05.051; Rogers WJ, 2008, AM HEART J, V156, P1026, DOI 10.1016/j.ahj.2008.07.030; Rosamond WD, 2012, CIRCULATION, V125, P1848, DOI 10.1161/CIRCULATIONAHA.111.047480; Schiele F, 2010, EUR HEART J, V31, P2614, DOI 10.1093/eurheartj/ehq305; Steiger VS, 2009, SWISS MED WKLY, V139, P453, DOI smw-12607; Wagner A., 2011, BEH, V40-41, P414; Yeh RW, 2010, NEW ENGL J MED, V362, P2155, DOI 10.1056/NEJMoa0908610	21	319	334	0	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 12	2012	308	10					998	1006		10.1001/2012.jama.11348	http://dx.doi.org/10.1001/2012.jama.11348			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	003AA	22928184	Bronze			2022-12-28	WOS:000308579300023
J	Frayling, TM				Frayling, Timothy M.			Are the causes of obesity primarily environmental? No	BRITISH MEDICAL JOURNAL			English	Editorial Material							BODY-MASS INDEX; CHILDREN; ADIPOSITY; TWIN		Univ Exeter, Peninsula Coll Med & Dent, Exeter EX1 2LU, Devon, England	University of Exeter; University of Plymouth	Frayling, TM (corresponding author), Univ Exeter, Peninsula Coll Med & Dent, Exeter EX1 2LU, Devon, England.	tim.frayling@pms.ac.uk		Frayling, Timothy/0000-0001-8362-2603				Church C, 2010, NAT GENET, V42, P1086, DOI 10.1038/ng.713; Economist, 2012, ECONOMIST        062; Harris KC, 2009, CAN MED ASSOC J, V180, P719, DOI 10.1503/cmaj.080966; Kilpelainen TO, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001116; Llewellyn CH, 2012, AM J CLIN NUTR, V95, P633, DOI 10.3945/ajcn.111.023671; Metcalf BS, 2011, ARCH DIS CHILD, V96, P942, DOI 10.1136/adc.2009.175927; Schousboe K, 2003, TWIN RES, V6, P409, DOI 10.1375/twin.6.5.409; Silventoinen K, 2010, INT J OBESITY, V34, P29, DOI 10.1038/ijo.2009.177; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Timpson NJ, 2008, AM J CLIN NUTR, V88, P971, DOI 10.1093/ajcn/88.4.971; Voss LD, 2008, CHILD CARE HLTH DEV, V34, P470, DOI 10.1111/j.1365-2214.2008.00827.x; Wardle J, 2008, AM J CLIN NUTR, V87, P398, DOI 10.1093/ajcn/87.2.398	12	11	11	0	11	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	SEP 11	2012	345								e5844	10.1136/bmj.e5844	http://dx.doi.org/10.1136/bmj.e5844			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	007BG	22968529				2022-12-28	WOS:000308863200006
J	Hutton, B; Joseph, L; Fergusson, D; Mazer, CD; Shapiro, S; Tinmouth, A				Hutton, Brian; Joseph, Lawrence; Fergusson, Dean; Mazer, C. David; Shapiro, Stan; Tinmouth, Alan			Risks of harms using antifibrinolytics in cardiac surgery: systematic review and network meta-analysis of randomised and observational studies	BMJ-BRITISH MEDICAL JOURNAL			English	Article							TRANEXAMIC ACID; BLOOD-LOSS; APROTININ; TRANSFUSION; OUTCOMES; MORTALITY; AGENTS	Objective To estimate the relative risks of death, myocardial infarction, stroke, and renal failure or dysfunction between antifibrinolytics and no treatment following the suspension of aprotinin from the market in 2008 for safety reasons and its recent reintroduction in Europe and Canada. Design Systematic review and network meta-analysis. Data sources A Cochrane review of antifibrinolytic treatments was chosen as the starting point for this systematic review. Medline, Embase, and the Cochrane register of trials were searched with no date restrictions for observational evidence. Study selection Propensity matched or adjusted observational studies with two or more of the interventions of interest (aprotinin, tranexamic acid, epsilon-aminocaproic acid, and no treatment) that were carried out in patients undergoing cardiac surgery. Data analysis Network meta-analysis was used to compare treatments, and odds ratios with 95% credible intervals were estimated. Meta-analyses were carried out for randomised controlled trials alone and for randomised controlled trials with observational studies. Results 106 randomised controlled trials and 11 observational studies (43 270 patients) were included. Based on the results from analysis of randomised controlled trials, tranexamic acid was associated on average with a reduced risk of death compared with aprotinin (odds ratio 0.64, 95% credible interval 0.41 to 0.99). When observational data were incorporated, comparisons showed an increased risk of mortality with aprotinin on average relative to tranexamic acid (odds ratio 0.71, 95% credible interval 0.50 to 0.98) and epsilon-aminocaproic acid (0.60, 0.43 to 0.87), and an increased risk of renal failure or dysfunction on average relative to all comparators: odds ratio 0.66 (95% credible interval 0.45 to 0.88) compared with no treatment, 0.66 (0.48 to 0.91) versus tranexamic acid, and 0.65 (0.45 to 0.88) versus epsilon-aminocaproic acid. Conclusion Although meta-analyses of randomised controlled trials were largely inconclusive, inclusion of observational data suggest concerns remain about the safety of aprotinin. Tranexamic and epsilon-aminocaproic acid are effective alternatives that may be safer for patients.	[Hutton, Brian] Ottawa Hosp, Res Inst, Clin Epidemiol Program, Ctr Practice Changing Res Bldg, Ottawa, ON K1H 8L6, Canada; [Joseph, Lawrence; Shapiro, Stan] McGill Univ, Dept Epidemiol & Biostat, Montreal, PQ, Canada; [Mazer, C. David] Univ Toronto, Dept Anesthesia, Toronto, ON, Canada; [Mazer, C. David] St Michaels Hosp, Keenan Res Ctr, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada	University of Ottawa; Ottawa Hospital Research Institute; McGill University; University of Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto	Hutton, B (corresponding author), Ottawa Hosp, Res Inst, Clin Epidemiol Program, Ctr Practice Changing Res Bldg, Gen Campus,POB 201, Ottawa, ON K1H 8L6, Canada.	bhutton@ohri.ca		Fergusson, Dean/0000-0002-3389-2485; Hutton, Brian/0000-0001-5662-8647; Mazer, Cyril David/0000-0003-2566-4308	Astra Zeneca; Oxygen Biotherapeutics; Cubist; Medicines Company; Quark; NovoNordisk; Hospira; Boeringer-Ingelheim; Canadian Blood Services	Astra Zeneca(AstraZeneca); Oxygen Biotherapeutics; Cubist; Medicines Company; Quark; NovoNordisk(Novo Nordisk); Hospira; Boeringer-Ingelheim; Canadian Blood Services	All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: no support from any organisation for the submitted work; CDM has received consultancy fees from Astra Zeneca, Oxygen Biotherapeutics, Cubist, Medicines Company, and Quark, and has received grant funding from NovoNordisk, Cubist, Hospira, and Boeringer-Ingelheim; AT has received consultancy fees from Canadian Blood Services; and no other relationships or activities that could appear to have influenced the submitted work.	Bennett-Guerrero E, 2010, J CARDIOTHOR VASC AN, V24, P814, DOI 10.1053/j.jvca.2010.06.003; Bradburn MJ, 2007, STAT MED, V26, P53, DOI 10.1002/sim.2528; Brown JR, 2007, CIRCULATION, V115, P2801, DOI 10.1161/CIRCULATIONAHA.106.671222; Carless Paul A, 2005, BMC Cardiovasc Disord, V5, P19, DOI 10.1186/1471-2261-5-19; Dias S, 2010, STAT MED, V29, P932, DOI 10.1002/sim.3767; Dias S, 2011, 2 NICE DSU; Dias S, 2011, 3 NICE DSU; European Medicines Agency, 2012, EUR MED AG REC LIFT; Fergusson DA, 2008, NEW ENGL J MED, V358, P2319, DOI 10.1056/NEJMoa0802395; Gelman A., 2003, BAYESIAN DATA ANAL; Gillespie EL, 2005, AM J HEALTH-SYST PH, V62, P1370, DOI 10.2146/ajhp040495; Henry DA, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001886.pub4; Jakobsen CJ, 2009, EUR J CARDIO-THORAC, V36, P863, DOI 10.1016/j.ejcts.2009.05.040; Karkouti K, 2006, TRANSFUSION, V46, P327, DOI 10.1111/j.1537-2995.2006.00724.x; Karkouti K, 2010, ANESTH ANALG, V110, P21, DOI 10.1213/ANE.0b013e3181c0ea6d; Laupacis A, 1997, ANESTH ANALG, V85, P1258, DOI 10.1097/00000539-199712000-00014; Levi M, 1999, LANCET, V354, P1940, DOI 10.1016/S0140-6736(99)01264-7; Lu G, 2004, STAT MED, V23, P3105, DOI 10.1002/sim.1875; Mangano DT, 2006, NEW ENGL J MED, V354, P353, DOI 10.1056/NEJMoa051379; McMullan V, 2010, J CARDIOTHOR VASC AN, V24, P418, DOI 10.1053/j.jvca.2009.10.028; Muedra V, 2011, REV ESP ANEST REANIM, V58, P140, DOI 10.1016/S0034-9356(11)70020-2; Ngaage DL, 2008, ANN THORAC SURG, V86, P1195, DOI 10.1016/j.athoracsur.2008.06.048; Olenchock SA, 2008, ANN THORAC SURG, V86, P560, DOI 10.1016/j.athoracsur.2008.04.048; Rahman Z, 2011, Mymensingh Med J, V20, P45; Riley RD, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d549; Salanti G, 2011, J CLIN EPIDEMIOL, V64, P163, DOI 10.1016/j.jclinepi.2010.03.016; Schneeweiss S, 2008, NEW ENGL J MED, V358, P771, DOI 10.1056/NEJMoa0707571; Shaw AD, 2008, NEW ENGL J MED, V358, P784, DOI 10.1056/NEJMoa0707768; Sniecinski RM, 2010, J CARDIOTHOR VASC AN, V24, P959, DOI 10.1053/j.jvca.2010.02.018; Spiess Bruce D, 2004, Semin Cardiothorac Vasc Anesth, V8, P267, DOI 10.1177/108925320400800402; Stamou SC, 2009, EUR J CARDIO-THORAC, V36, P869, DOI 10.1016/j.ejcts.2009.04.053; Strouch ZY, 2009, J CLIN ANESTH, V21, P502, DOI 10.1016/j.jclinane.2008.12.021; Sutton Alexander J, 2002, Expert Rev Pharmacoecon Outcomes Res, V2, P367, DOI 10.1586/14737167.2.4.367; Sweeting MJ, 2004, STAT MED, V23, P1351, DOI 10.1002/sim.1761; Wang XQ, 2010, ANN THORAC SURG, V89, P1489, DOI 10.1016/j.athoracsur.2010.02.006; Wells GA, 2014, NEWCASTLE OTTAWA SCA, DOI DOI 10.2307/632432	36	39	40	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 11	2012	345								e5798	10.1136/bmj.e5798	http://dx.doi.org/10.1136/bmj.e5798			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	007BG	22968722	Green Published, hybrid			2022-12-28	WOS:000308863200003
J	Wu, DW				Wu, Dawei			The shock of the new-cigarette pack warnings	LANCET			English	Editorial Material									The Lancet, London NW1 7BY, England		Wu, DW (corresponding author), The Lancet, London NW1 7BY, England.	wu.dawei@me.com						Borland R, 2009, ADDICTION, V104, P669, DOI 10.1111/j.1360-0443.2009.02508.x; Fong GT, 2006, TOB CONTROL, V15, P3, DOI 10.1136/tc.2005.015438; Fong GT, 2010, TOB CONTROL, V19, DOI 10.1136/tc.2010.036483; Fong GT, 2009, B WORLD HEALTH ORGAN, V87, P640, DOI 10.2471/BLT.09.069575; Hammond D, 2012, CANCER CAUSE CONTROL, V23, P57, DOI 10.1007/s10552-012-9902-4; Hammond D, 2011, TOB CONTROL, V20, P327, DOI 10.1136/tc.2010.037630; Ingram D, 2012, REUTERS         0624; Kirby T, 2012, LANCET ONCOL; Miller CL, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-238	9	3	3	0	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 8	2012	380	9845					871	871		10.1016/S0140-6736(12)61482-2	http://dx.doi.org/10.1016/S0140-6736(12)61482-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	002QL	22959374				2022-12-28	WOS:000308547300010
J	Lerner, BH				Lerner, Barron H.			The art of medicine Days of the giants: remembering Robert F Loeb	LANCET			English	Editorial Material									NYU, Sch Med, Div Gen Internal Med, New York, NY 10016 USA	New York University	Lerner, BH (corresponding author), NYU, Sch Med, Div Gen Internal Med, New York, NY 10016 USA.	Barron.Lerner@nyumc.org						Cushing H, 1925, LIFE TIMES W OSLER; Fee Elizabeth, 1997, MAKING MED HIST LIFE; Linker Beth, 2007, HIST POETICS SCI BIO, P221; Meador C, 2007, 20 CENTURY MEN MED P; Rosner David, 2004, LOCATING MED HIST ST	5	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 1	2012	380	9844					798	799		10.1016/S0140-6736(12)61438-X	http://dx.doi.org/10.1016/S0140-6736(12)61438-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	000OP	22950118				2022-12-28	WOS:000308396300012
J	Milligan, E; Winch, S; Adams, R				Milligan, Eleanor; Winch, Sarah; Adams, Rebekah			Marketing to register organ donors may circumvent principles of informed consent	BRITISH MEDICAL JOURNAL			English	Editorial Material							TRANSPLANT RECIPIENTS; DONATION		[Milligan, Eleanor] Griffith Univ, Sch Med, Gold Coast, Qld 4215, Australia; [Winch, Sarah; Adams, Rebekah] Univ Queensland, Sch Med, Brisbane, Qld, Australia	Griffith University; University of Queensland	Milligan, E (corresponding author), Griffith Univ, Sch Med, Gold Coast, Qld 4215, Australia.	e.milligan@griffith.edu.au	Winch, Sarah/C-9019-2009	Winch, Sarah/0000-0003-4946-7624				Beauchamp T L, 2012, PRINCIPLES BIOMEDICA; Cleiren MPHD, 2002, DEATH STUD, V26, P837, DOI 10.1080/07481180290106607; Kizilisik A Tarik, 2003, Prog Transplant, V13, P278; Le Mire L, 2006, BRIT J DERMATOL, V154, P472, DOI 10.1111/j.1365-2133.2005.07094.x; Machnicki G, 2006, TRANSPLANT REV-ORLAN, V20, P61, DOI DOI 10.1016/J.TRRE.2006.05.001; Pearson A, 1998, 2 U AD DEP CLIN NURS; Taghavi R, 2001, TRANSPLANT P, V33, P2636, DOI 10.1016/S0041-1345(01)02123-6; Tong A, 2009, J PEDIATR-US, V155, P542, DOI 10.1016/j.jpeds.2009.04.009; Wight C, 1997, BRIT MED BULL, V53, P817; Williams Anne M, 2009, Nephrol Nurs J, V36, P423; Winter S, 2010, J APPL PHILOS, V27, P186, DOI 10.1111/j.1468-5930.2009.00477.x; Young GS, 2003, PEDIATRICS, V111, pE725, DOI 10.1542/peds.111.6.e725	12	5	5	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	AUG 31	2012	345								e5850	10.1136/bmj.e5850	http://dx.doi.org/10.1136/bmj.e5850			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	036SN	22942190	Green Published			2022-12-28	WOS:000311050900005
J	Macilwain, C				Macilwain, Colin			What matters for science is who runs the country	NATURE			English	Editorial Material												cfmworldview@gmail.com							0	0	0	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 30	2012	488	7413					559	559		10.1038/488559a	http://dx.doi.org/10.1038/488559a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	996NC	22932342	Bronze			2022-12-28	WOS:000308095100014
J	Wadham, JL; Arndt, S; Tulaczyk, S; Stibal, M; Tranter, M; Telling, J; Lis, GP; Lawson, E; Ridgwell, A; Dubnick, A; Sharp, MJ; Anesio, AM; Butler, CEH				Wadham, J. L.; Arndt, S.; Tulaczyk, S.; Stibal, M.; Tranter, M.; Telling, J.; Lis, G. P.; Lawson, E.; Ridgwell, A.; Dubnick, A.; Sharp, M. J.; Anesio, A. M.; Butler, C. E. H.			Potential methane reservoirs beneath Antarctica	NATURE			English	Article							GAS-HYDRATE; PRODUCTION-RATES; CASCADIA MARGIN; ICE-SHEET; SEDIMENTS; DEEP; LAKE; GEOCHEMISTRY; POPULATIONS; DIAGENESIS	Once thought to be devoid of life, the ice-covered parts of Antarctica are now known to be a reservoir of metabolically active microbial cells and organic carbon(1). The potential for methanogenic archaea to support the degradation of organic carbon to methane beneath the ice, however, has not yet been evaluated. Large sedimentary basins containing marine sequences up to 14 kilometres thick(2) and an estimated 21,000 petagrams (1 Pg equals 10(15) g) of organic carbon are buried beneath the Antarctic Ice Sheet. No data exist for rates of methanogenesis in sub-Antarctic marine sediments. Here we present experimental data from other subglacial environments that demonstrate the potential for overridden organic matter beneath glacial systems to produce methane. We also numerically simulate the accumulation of methane in Antarctic sedimentary basins using an established one-dimensional hydrate model(3) and show that pressure/temperature conditions favour methane hydrate formation down to sediment depths of about 300 metres in West Antarctica and 700 metres in East Antarctica. Our results demonstrate the potential for methane hydrate accumulation in Antarctic sedimentary basins, where the total inventory depends on rates of organic carbon degradation and conditions at the ice-sheet bed. We calculate that the sub-Antarctic hydrate inventory could be of the same order of magnitude as that of recent estimates made for Arctic permafrost. Our findings suggest that the Antarctic Ice Sheet may be a neglected but important component of the global methane budget, with the potential to act as a positive feedback on climate warming during ice-sheet wastage.	[Wadham, J. L.; Arndt, S.; Stibal, M.; Tranter, M.; Telling, J.; Lis, G. P.; Lawson, E.; Ridgwell, A.; Anesio, A. M.; Butler, C. E. H.] Univ Bristol, Sch Geog Sci, Bristol BS8 1SS, Avon, England; [Arndt, S.] Univ Utrecht, Dept Earth Sci Geochem, NL-3508 Utrecht, Netherlands; [Tulaczyk, S.; Sharp, M. J.] Univ Calif Santa Cruz, Dept Earth & Planetary Sci, Santa Cruz, CA 95064 USA; [Dubnick, A.] Univ Alberta, Dept Earth & Atmospher Sci, Edmonton, AB T6G 2E3, Canada	University of Bristol; Utrecht University; University of California System; University of California Santa Cruz; University of Alberta	Wadham, JL (corresponding author), Univ Bristol, Sch Geog Sci, Bristol BS8 1SS, Avon, England.	j.l.wadham@bris.ac.uk	Stibal, Marek/I-3852-2016; Wadham, Jemma L/G-3138-2014; Wadham, Jemma L/A-8352-2012; Telling, Jon/M-7643-2013; Tranter, Martyn/E-3722-2010; Arndt, Sandra/E-7639-2017; Ridgwell, Andy/AAD-9487-2021; Tulaczyk, Slawek/O-7375-2018; Anesio, Alexandre/A-7597-2008	Stibal, Marek/0000-0002-9998-5086; Tranter, Martyn/0000-0003-2071-3094; Arndt, Sandra/0000-0002-0235-8124; Ridgwell, Andy/0000-0003-2333-0128; Tulaczyk, Slawek/0000-0002-9711-4332; Anesio, Alexandre/0000-0003-2990-4014; O'Donnell, Emily/0000-0003-4303-4705; Telling, Jon/0000-0002-8180-0979; Lis, Grzegorz/0000-0001-5796-7798	Natural Environment Research Council (UK-NERC) [NE/E004016/1]; National Science Foundation WISSARD project [NSF-AISS 0839142]; Leverhulme Trust via a Phillip Leverhulme award; Netherlands Organisation for Scientific Research (NWO); NSERC; Antarctica New Zealand; Polar Continental Shelf Project; NSERC Undergraduate Student Research Award; US National Science Foundation; Natural Environment Research Council [NE/I021322/1, NE/E004016/1] Funding Source: researchfish; NERC [NE/E004016/1, NE/I021322/1] Funding Source: UKRI; Directorate For Geosciences [0838947, 0839142] Funding Source: National Science Foundation	Natural Environment Research Council (UK-NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); National Science Foundation WISSARD project; Leverhulme Trust via a Phillip Leverhulme award; Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Antarctica New Zealand; Polar Continental Shelf Project(Natural Resources Canada); NSERC Undergraduate Student Research Award(Natural Sciences and Engineering Research Council of Canada (NSERC)); US National Science Foundation(National Science Foundation (NSF)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This research was funded by the Natural Environment Research Council (UK-NERC grant NE/E004016/1) and the National Science Foundation WISSARD project (NSF-AISS 0839142). Support to J.L.W. was also provided by the Leverhulme Trust via a Phillip Leverhulme award and to S. A. by the Netherlands Organisation for Scientific Research (NWO). We acknowledge NSERC and Antarctica New Zealand for financial and logistic support for sampling in Antarctica and the Polar Continental Shelf Project for financial and logistic support for sampling in Arctic Canada. We thank S. Fitzsimons for assistance with sampling in Antarctica. A. D. was funded by an NSERC Undergraduate Student Research Award. This research used data provided by the Ocean Drilling Program. The Ocean Drilling Program is sponsored by the US National Science Foundation and participating countries under the management of the Joint Oceanographic Institutions, Inc. We thank C. Ruppel for comments on this manuscript.	Archer D, 2007, BIOGEOSCIENCES, V4, P521, DOI 10.5194/bg-4-521-2007; Barker P. F., 1999, P ODP INIT REP, V178, P60; Boswell R, 2011, ENERG ENVIRON SCI, V4, P1206, DOI 10.1039/c0ee00203h; BOUDREAU BP, 1991, AM J SCI, V291, P507, DOI 10.2475/ajs.291.5.507; Boyd ES, 2010, ENV MICROBIOL REP, V2, P685, DOI 10.1111/j.1758-2229.2010.00162.x; Claypool G., 2004, PROC OCEAN DRILL SCI, V188, P1, DOI DOI 10.2973/0DP.PR0C.SR.188.004.2003; Colwell FS, 2008, APPL ENVIRON MICROB, V74, P3444, DOI 10.1128/AEM.02114-07; Cragg BA, 1996, EARTH PLANET SC LETT, V139, P497, DOI 10.1016/0012-821X(95)00246-9; Davie MK, 2001, J GEOPHYS RES-SOL EA, V106, P497, DOI 10.1029/2000JB900363; Dickens GR, 1997, NATURE, V385, P426, DOI 10.1038/385426a0; Dyke A. S., 1987, MAP GEOLOGICAL SURVE; ELLISEVANS JC, 1984, POLAR BIOL, V3, P63, DOI 10.1007/BF00258149; Etiope G, 2002, CHEMOSPHERE, V49, P777, DOI 10.1016/S0045-6535(02)00380-6; Ferraccioli F, 2009, TECTONOPHYSICS, V478, P62, DOI 10.1016/j.tecto.2009.03.013; FRANZMANN PD, 1991, HYDROBIOLOGIA, V210, P191, DOI 10.1007/BF00034677; Houghton RA, 2007, ANNU REV EARTH PL SC, V35, P313, DOI 10.1146/annurev.earth.35.031306.140057; Kotsyurbenko OR, 2004, ENVIRON MICROBIOL, V6, P1159, DOI 10.1111/j.1462-2920.2004.00634.x; Lanoil B, 2009, ENVIRON MICROBIOL, V11, P609, DOI 10.1111/j.1462-2920.2008.01831.x; Maule CF, 2005, SCIENCE, V309, P464, DOI 10.1126/science.1106888; MEYERS PA, 1993, ORG GEOCHEM, V20, P867, DOI 10.1016/0146-6380(93)90100-P; PARKES RJ, 1990, PHILOS T R SOC A, V331, P139, DOI 10.1098/rsta.1990.0061; Pattyn F, 2010, EARTH PLANET SC LETT, V295, P451, DOI 10.1016/j.epsl.2010.04.025; Pollard D, 2009, NATURE, V458, P329, DOI 10.1038/nature07809; Priscu J, 2009, POLAR LAKES RIVERS, P320; Reeburgh W. S., 1993, P1; SMITH RL, 1993, BIOGEOCHEMISTRY, V21, P95, DOI 10.1007/BF00000873; Tarnocai C, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003327; Torres ME, 2002, EARTH PLANET SC LETT, V201, P525, DOI 10.1016/S0012-821X(02)00733-1; Wadham JL, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB002951; Wallmann K, 2006, EARTH PLANET SC LETT, V248, P545, DOI 10.1016/j.epsl.2006.06.026; Wellsbury P, 2002, FEMS MICROBIOL ECOL, V42, P59, DOI 10.1111/j.1574-6941.2002.tb00995.x; Yoshioka H, 2009, GEOCHEM J, V43, P315, DOI 10.2343/geochemj.1.0028	32	113	121	8	227	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 30	2012	488	7413					633	637		10.1038/nature11374	http://dx.doi.org/10.1038/nature11374			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996NC	22932387				2022-12-28	WOS:000308095100051
J	Weertman, JR				Weertman, Julia R.			Retaining the Nano in Nanocrystalline Alloys	SCIENCE			English	Editorial Material							ROOM-TEMPERATURE; GRAIN-GROWTH; SEGREGATION		Northwestern Univ, Dept Mat Sci & Engn, Evanston, IL 60208 USA	Northwestern University	Weertman, JR (corresponding author), Northwestern Univ, Dept Mat Sci & Engn, Evanston, IL 60208 USA.	jrweertman@northwestern.edu	Weertman, Julia R/B-7540-2009					Chookajorn T, 2012, SCIENCE, V337, P951, DOI 10.1126/science.1224737; Detor AJ, 2007, J MATER RES, V22, P3233, DOI 10.1557/JMR.2007.0403; Detor AJ, 2007, ACTA MATER, V55, P4221, DOI 10.1016/j.actamat.2007.03.024; Erb U., 2007, NANOSTRUCT MATER, P235, DOI DOI 10.1016/13978-081551534-0.50008-7; GERTSMAN VY, 1994, SCRIPTA METALL MATER, V30, P577, DOI 10.1016/0956-716X(94)90432-4; GLEITER H, 1981, DEFORMATION POLYCRYS, P15; HALL EO, 1951, P ROY SOC LOND B BIO, V64, P474; Jin M, 2004, ACTA MATER, V52, P5381, DOI 10.1016/j.actamat.2004.07.044; Jones A. R., 2010, FINISHING, V97, P52; Kirchheim R, 2002, ACTA MATER, V50, P413, DOI 10.1016/S1359-6454(01)00338-X; Krill CE, 2005, Z METALLKD, V96, P1134, DOI 10.3139/146.101152; PETCH NJ, 1953, J IRON STEEL I, V174, P25; Trelewicz JR, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.094112; WEISSMULLER J, 1993, NANOSTRUCT MATER, V3, P261, DOI 10.1016/0965-9773(93)90088-S; Zhang K, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2008377	15	43	44	0	127	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 24	2012	337	6097					921	922		10.1126/science.1226724	http://dx.doi.org/10.1126/science.1226724			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992VI	22923568				2022-12-28	WOS:000307807600031
J	Tayi, AS; Shveyd, AK; Sue, ACH; Szarko, JM; Rolczynski, BS; Cao, D; Kennedy, TJ; Sarjeant, AA; Stern, CL; Paxton, WF; Wu, W; Dey, SK; Fahrenbach, AC; Guest, JR; Mohseni, H; Chen, LX; Wang, KL; Stoddart, JF; Stupp, SI				Tayi, Alok S.; Shveyd, Alexander K.; Sue, Andrew C-H; Szarko, Jodi M.; Rolczynski, Brian S.; Cao, Dennis; Kennedy, T. Jackson; Sarjeant, Amy A.; Stern, Charlotte L.; Paxton, Walter F.; Wu, Wei; Dey, Sanjeev K.; Fahrenbach, Albert C.; Guest, Jeffrey R.; Mohseni, Hooman; Chen, Lin X.; Wang, Kang L.; Stoddart, J. Fraser; Stupp, Samuel I.			Room-temperature ferroelectricity in supramolecular networks of charge-transfer complexes	NATURE			English	Article							IONIC PHASE-TRANSITION; TETRATHIAFULVALENE-CHLORANIL; MOLECULAR-CRYSTAL; STACK	Materials exhibiting a spontaneous electrical polarization(1,2) that can be switched easily between antiparallel orientations are of potential value for sensors, photonics and energy-efficient memories. In this context, organic ferroelectrics(3,4) are of particular interest because they promise to be lightweight, inexpensive and easily processed into devices. A recently identified family of organic ferroelectric structures is based on intermolecular charge transfer, where donor and acceptor molecules co-crystallize in an alternating fashion known as a mixed stack(5-8): in the crystalline lattice, a collective transfer of electrons from donor to acceptor molecules results in the formation of dipoles that can be realigned by an external field as molecules switch partners in the mixed stack. Although mixed stacks have been investigated extensively, only three systems are known(9,10) to show ferroelectric switching, all below 71 kelvin. Here we describe supramolecular charge-transfer networks that undergo ferroelectric polarization switching with a ferroelectric Curie temperature above room temperature. These polar and switchable systems utilize a structural synergy between a hydrogen-bonded network and charge-transfer complexation of donor and acceptor molecules in a mixed stack. This supramolecular motif could help guide the development of other functional organic systems that can switch polarization under the influence of electric fields at ambient temperatures.	[Shveyd, Alexander K.; Sue, Andrew C-H; Szarko, Jodi M.; Rolczynski, Brian S.; Cao, Dennis; Sarjeant, Amy A.; Stern, Charlotte L.; Paxton, Walter F.; Dey, Sanjeev K.; Fahrenbach, Albert C.; Chen, Lin X.; Stoddart, J. Fraser; Stupp, Samuel I.] Northwestern Univ, Dept Chem, Evanston, IL 60208 USA; [Tayi, Alok S.; Stupp, Samuel I.] Northwestern Univ, Dept Mat Sci & Engn, Evanston, IL 60208 USA; [Sue, Andrew C-H; Wang, Kang L.] Univ Calif Los Angeles, Dept Elect Engn, Los Angeles, CA 90095 USA; [Szarko, Jodi M.; Rolczynski, Brian S.; Chen, Lin X.] Northwestern Univ, ANSER Ctr, Evanston, IL 60208 USA; [Szarko, Jodi M.; Rolczynski, Brian S.; Chen, Lin X.] Argonne Natl Lab, Chem Sci & Engn Div, Argonne, IL 60439 USA; [Cao, Dennis; Fahrenbach, Albert C.; Stoddart, J. Fraser] Korea Adv Inst Sci & Technol, Grad Sch EEWS, Taejon 305701, South Korea; [Kennedy, T. Jackson] Northwestern Univ, Dept Phys, Evanston, IL 60208 USA; [Wu, Wei; Mohseni, Hooman] Northwestern Univ, Dept Elect Engn, Evanston, IL 60208 USA; [Guest, Jeffrey R.] Argonne Natl Lab, Ctr Nanoscale Mat, Argonne, IL 60439 USA; [Stupp, Samuel I.] Northwestern Univ, Dept Med, Chicago, IL 60611 USA; [Stupp, Samuel I.] Northwestern Univ, Inst BioNanotechnol Med, Chicago, IL 60611 USA	Northwestern University; Northwestern University; University of California System; University of California Los Angeles; Northwestern University; United States Department of Energy (DOE); Argonne National Laboratory; Korea Advanced Institute of Science & Technology (KAIST); Northwestern University; Northwestern University; United States Department of Energy (DOE); Argonne National Laboratory; Northwestern University; Northwestern University	Stoddart, JF (corresponding author), Northwestern Univ, Dept Chem, 2145 Sheridan Rd, Evanston, IL 60208 USA.	stoddart@northwestern.edu; s-stupp@northwestern.edu	Cao, Dennis/C-2240-2013; Stupp, Samuel/B-6737-2009; Paxton, Walter/AAP-8682-2021; Masino, Matteo/O-5429-2015; Mohseni, Hooman/AAX-7824-2021; Stoddart, James Fraser/H-1518-2011; Mohseni, Hooman/B-7253-2009; Mohseni, Hooman/AAZ-5878-2020; Stupp, Samuel/AGV-1942-2022; Fahrenbach, Albert/B-3042-2014; Guest, Jeffrey R/B-2715-2009; Sue, Andrew C.-H./K-1641-2015; Szarko, Jodi/L-1497-2015	Cao, Dennis/0000-0002-0315-1619; Paxton, Walter/0000-0002-2438-4542; Masino, Matteo/0000-0002-5869-6800; Stoddart, James Fraser/0000-0003-3161-3697; Mohseni, Hooman/0000-0002-0183-4213; Guest, Jeffrey R/0000-0002-9756-8801; Sue, Andrew C.-H./0000-0001-9557-2658; Szarko, Jodi/0000-0002-2181-9408	Non-equilibrium Energy Research Center (NERC) at Northwestern University; US Department of Energy (DOE), Office of Basic Energy Sciences [DE-SC0000989]; Materials Research Science and Engineering Centre (MRSEC) at Northwestern University; National Science Foundation (NSF); WCU program at KAIST in Korea [R-31-2008-000-10055-0]; US Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]; NERC; Initiative for Sustainability and Energy at Northwestern (ISEN)	Non-equilibrium Energy Research Center (NERC) at Northwestern University(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); US Department of Energy (DOE), Office of Basic Energy Sciences(United States Department of Energy (DOE)); Materials Research Science and Engineering Centre (MRSEC) at Northwestern University(National Science Foundation (NSF)); National Science Foundation (NSF)(National Science Foundation (NSF)); WCU program at KAIST in Korea; US Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Initiative for Sustainability and Energy at Northwestern (ISEN)	This work was supported by the Non-equilibrium Energy Research Center (NERC) at Northwestern University, funded by the US Department of Energy (DOE), Office of Basic Energy Sciences under award number DE-SC0000989. A.K.S. received support from the Materials Research Science and Engineering Centre (MRSEC) at Northwestern University, funded by the National Science Foundation (NSF). D.C., A.C.F. and J.F.S. were supported by the WCU program (R-31-2008-000-10055-0) at KAIST in Korea. Use of the Center for Nanoscale Materials was supported by the US Department of Energy, Office of Science, Office of Basic Energy Sciences, under contract no. DE-AC02-06CH11357. D.C. and A.C.F. were supported by NSF Graduate Research Fellowships. A.K.S. and A.C.-H.S. were supported by a fellowship from the NERC. A.S.T. was supported by a fellowship from the Initiative for Sustainability and Energy at Northwestern (ISEN) and NERC. We thank J.B. Ketterson and O. Chernyashevskyy (Northwestern University) for discussions and advice, Y.D. Shah (Northwestern University) for assistance with ferroelectricity measurements, A.M.Z. Slawin (University of St Andrews) for initial help with crystallographic data collection and refinement, M. Mara (Northwestern University) for assistance with spectroscopy, Y. Liu (The Molecular Foundry, Lawrence Berkeley National Laboratory) for discussions, and the Integrated Molecular Structure Education and Research Centre (IMSERC) and the Magnet and Low Temperature Facility at Northwestern University for providing access to equipment for the relevant experiments. Molecular crystal images were produced using the UCSF Chimera package from the Resource for Biocomputing, Visualisation and Informatics at the University of California, San Francisco.	[Anonymous], 2007, CRYST EXPL V 2 1; Collet E, 2003, SCIENCE, V300, P612, DOI 10.1126/science.1082001; GIRLANDO A, 1985, SOLID STATE COMMUN, V54, P753, DOI 10.1016/0038-1098(85)90279-0; GIRLANDO A, 1983, J CHEM PHYS, V79, P1075, DOI 10.1063/1.445833; Hamilton DG, 1997, AUST J CHEM, V50, P439, DOI 10.1071/C97033; Horiuchi S, 2003, SCIENCE, V299, P229, DOI 10.1126/science.1076129; Horiuchi S, 2008, NAT MATER, V7, P357, DOI 10.1038/nmat2137; Horiuchi S, 2010, NATURE, V463, P789, DOI 10.1038/nature08731; Kagawa F, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.227602; Kobayashi K, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.237601; KUWATA-GONOKAMI M, 1994, NATURE, V367, P47, DOI 10.1038/367047a0; McKinnon JJ, 2004, ACTA CRYSTALLOGR B, V60, P627, DOI 10.1107/S0108768104020300; Meneghetti M, 1996, J CHEM PHYS, V105, P397, DOI 10.1063/1.471916; Miyajima D, 2012, SCIENCE, V336, P209, DOI 10.1126/science.1217954; Nielsen MB, 1999, EUR J ORG CHEM, V1999, P2807; OKAMOTO H, 1991, PHYS REV B, V43, P8224, DOI 10.1103/PhysRevB.43.8224; Saha S, 2005, CHEM-EUR J, V11, P6846, DOI 10.1002/chem.200500371; Soos ZG, 2007, CHEM PHYS LETT, V440, P87, DOI 10.1016/j.cplett.2007.04.024; Stupp SI, 1997, SCIENCE, V276, P384, DOI 10.1126/science.276.5311.384; TOKURA Y, 1989, PHYS REV LETT, V63, P2405, DOI 10.1103/PhysRevLett.63.2405; TORRANCE JB, 1979, ACCOUNTS CHEM RES, V12, P79, DOI 10.1021/ar50135a001; TORRANCE JB, 1981, PHYS REV LETT, V46, P253, DOI 10.1103/PhysRevLett.46.253; TORRANCE JB, 1981, PHYS REV LETT, V47, P1747, DOI 10.1103/PhysRevLett.47.1747; Zhang QM, 1998, SCIENCE, V280, P2101, DOI 10.1126/science.280.5372.2101	24	368	376	12	570	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 23	2012	488	7412					485	489		10.1038/nature11395	http://dx.doi.org/10.1038/nature11395			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992FS	22914165				2022-12-28	WOS:000307761600031
J	Lang, T; Rayner, G				Lang, Tim; Rayner, Geof			Ecological public health: the 21st century's big idea? An essay by Tim Lang and Geof Rayner	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Lang, Tim; Rayner, Geof] City Univ London, Ctr Food Policy, London EC1V 0HB, England	City University London	Lang, T (corresponding author), City Univ London, Ctr Food Policy, Northampton Sq, London EC1V 0HB, England.	t.lang@city.ac.uk						Commission on Macroeconomics and Health, 2002, MACR HLTH INV HLTH E; Fogel R., 2004, ESCAPE HUNGER PREMAT, DOI [10.1017/CBO9780511817649, DOI 10.1017/CBO9780511817649]; Fogel R. W., 2008, 14361 NBER; Foresight, 2012, FOR PROGR CHIEF SCI; Institute of Medicine of the National Academies, 2002, FUT PUBL HLTH 21 CEN; International Research Institutes (IRIS), 2004, HLTH PERC GLOB 23 CO; Jackson T., 2009, PROSPERITY GROWTH EC, DOI 10.4324/9781315677453; Lang T, 2006, FOOD IND DIET PHYS A; Rayner G, 2012, ECOLOGICAL PUBLIC HEALTH: RESHAPING THE CONDITIONS FOR GOOD HEALTH, P1; Shattuck Lemuel, 1850, REPORT GEN PLAN PROM; Thorpe K. E., 2009, FUTURE COSTS OBESITY; Wang YF, 2008, OBESITY, V16, P2323, DOI 10.1038/oby.2008.351; WHO Commission on Social Determinants of Health World Health Organization, 2008, CLOS GAP GEN HLTH EQ; WHO Commission on the Social Determinants of Health, 2007, ACH HLTH EQ ROOT CAU; Winslow CEA, 1920, SCIENCE, V51, P23, DOI 10.1126/science.51.1306.23	15	118	119	1	28	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 21	2012	345								e5466	10.1136/bmj.e5466	http://dx.doi.org/10.1136/bmj.e5466			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	996GP	22915666	Green Accepted			2022-12-28	WOS:000308073200011
J	Pike, SD; Thompson, AL; Algarra, AG; Apperley, DC; Macgregor, SA; Weller, AS				Pike, Sebastian D.; Thompson, Amber L.; Algarra, Andres G.; Apperley, David C.; Macgregor, Stuart A.; Weller, Andrew S.			Synthesis and Characterization of a Rhodium(I) sigma-Alkane Complex in the Solid State	SCIENCE			English	Article							C-H BOND; ALKYL DEHYDROGENATION; CRYSTAL-STRUCTURES; METAL-COMPLEXES; COORDINATION; ACTIVATION; HYDROGENATION; REACTIVITY; CHEMISTRY; LIGAND	Transition metal-alkane complexes-termed sigma-complexes because the alkane donates electron density to the metal from a sigma-symmetry carbon-hydrogen (C-H) orbital-are key intermediates in catalytic C-H activation processes, yet these complexes remain tantalizingly elusive to characterization in the solid state by single-crystal x-ray diffraction techniques. Here, we report an approach to the synthesis and characterization of transition metal-alkane complexes in the solid state by a simple gas-solid reaction to produce an alkane sigma-complex directly. This strategy enables the structural determination, by x-ray diffraction, of an alkane (norbornane) sigma-bound to a d(8)-rhodium(I) metal center, in which the chelating alkane ligand is coordinated to the pseudosquare planar metal center through two sigma-C-H bonds.	[Algarra, Andres G.; Macgregor, Stuart A.] Heriot Watt Univ, Inst Chem Sci, Edinburgh EH14 4S, Midlothian, Scotland; [Pike, Sebastian D.; Thompson, Amber L.; Weller, Andrew S.] Univ Oxford, Dept Chem, Chem Res Labs, Oxford OX1 3TA, England; [Apperley, David C.] Univ Durham, Engn & Phys Sci Res Council, Solid State Nucl Magnet Resonance Serv, Dept Chem, Durham DH1 3LE, England	Heriot Watt University; University of Oxford; Durham University; UK Research & Innovation (UKRI); Engineering & Physical Sciences Research Council (EPSRC)	Macgregor, SA (corresponding author), Heriot Watt Univ, Inst Chem Sci, Edinburgh EH14 4S, Midlothian, Scotland.	s.a.macgregor@hw.ac.uk; andrew.weller@chem.ox.ac.uk	Apperley, David C/H-6118-2012; Algarra, Andrés G./C-1280-2011; Macgregor, Stuart/U-5822-2019; Pike, Sebastian/R-6287-2016; Weller, Andrew/C-3004-2009; Pike, Sebastian D./AAG-7483-2021; Algarra, Andrés/A-9111-2013	Apperley, David C/0000-0001-7102-0314; Algarra, Andrés G./0000-0002-5062-2858; Macgregor, Stuart/0000-0003-3454-6776; Pike, Sebastian/0000-0002-9791-5244; Weller, Andrew/0000-0003-1646-8081; 	EPSRC; Spanish Government; Diamond Light Source [MT1858]	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Spanish Government(Spanish GovernmentEuropean Commission); Diamond Light Source	We thank P. Low, P. Schauer, and R. Jacobs for experimental assistance; the EPSRC (S. D. P.) and the Spanish Government (A. G. A.) for funding; Johnson Matthey for the loan of Rh salts; and Diamond Light Source for an award of beamtime (MT1858). The crystallographic data for 1, 2, 3, and 4 have been deposited with the Cambridge Crystallographic Data Centre as entries 892326 to 892329, respectively.	Albright T. A., 1985, ORBITAL INTERACTIONS; ARNDTSEN BA, 1995, ACCOUNTS CHEM RES, V28, P154, DOI 10.1021/ar00051a009; Bernskoetter WH, 2009, SCIENCE, V326, P553, DOI 10.1126/science.1177485; Betteridge PW, 2003, J APPL CRYSTALLOGR, V36, P1487, DOI 10.1107/S0021889803021800; Bloch ED, 2012, SCIENCE, V335, P1606, DOI 10.1126/science.1217544; Brayshaw SK, 2007, P NATL ACAD SCI USA, V104, P6921, DOI 10.1073/pnas.0609824104; Brookhart M, 2007, P NATL ACAD SCI USA, V104, P6908, DOI 10.1073/pnas.0610747104; Budzelaar PHM, 2000, EUR J INORG CHEM, P753; Calladine JA, 2011, J AM CHEM SOC, V133, P2303, DOI 10.1021/ja110451k; Castro-Rodriguez I, 2003, J AM CHEM SOC, V125, P15734, DOI 10.1021/ja0379316; Chaplin AB, 2009, CHEM COMMUN, P244, DOI 10.1039/b816739g; Cooper RI, 2010, J APPL CRYSTALLOGR, V43, P1100, DOI 10.1107/S0021889810025598; Cowan AJ, 2008, COORDIN CHEM REV, V252, P2504, DOI 10.1016/j.ccr.2008.05.008; CRABTREE RH, 1985, CHEM REV, V85, P245, DOI 10.1021/cr00068a002; Delpech F, 1999, J AM CHEM SOC, V121, P6668, DOI 10.1021/ja990199j; Douglas TM, 2008, NEW J CHEM, V32, P966, DOI 10.1039/b718615k; Douglas TM, 2007, ORGANOMETALLICS, V26, P463, DOI 10.1021/om060975d; Evans DR, 1997, J AM CHEM SOC, V119, P3633, DOI 10.1021/ja970008h; Geftakis S, 1998, J AM CHEM SOC, V120, P9953, DOI 10.1021/ja981702f; Hall C, 1996, CHEM REV, V96, P3125, DOI 10.1021/cr9502615; HALPERN J, 1977, J AM CHEM SOC, V99, P8055, DOI 10.1021/ja00466a051; Huang Z, 2010, NATURE, V465, P598, DOI 10.1038/nature09085; Jones WD, 2005, INORG CHEM, V44, P4475, DOI 10.1021/ic050007n; Jones WD, 2003, ACCOUNTS CHEM RES, V36, P140, DOI 10.1021/ar020148i; Kubas G, 2001, MODERN INORGANIC CHE; Labinger JA, 2002, NATURE, V417, P507, DOI 10.1038/417507a; Luo XL, 1995, INORG CHEM, V34, P6538, DOI 10.1021/ic00130a022; Matthes J, 2004, J AM CHEM SOC, V126, P8366, DOI 10.1021/ja0475961; McNamara BK, 1999, J AM CHEM SOC, V121, P6437, DOI 10.1021/ja9904282; Nguyen B, 2009, ADV SYNTH CATAL, V351, P1333, DOI 10.1002/adsc.200900013; Palatinus L, 2007, J APPL CRYSTALLOGR, V40, P786, DOI 10.1107/S0021889807029238; PASQUALI M, 1978, J AM CHEM SOC, V100, P4918, DOI 10.1021/ja00483a061; PERUTZ RN, 1975, J AM CHEM SOC, V97, P4791, DOI 10.1021/ja00850a001; Popelier PLA, 1998, J ORGANOMET CHEM, V555, P101, DOI 10.1016/S0022-328X(97)00710-9; van der Boom ME, 2011, ANGEW CHEM INT EDIT, V50, P11846, DOI 10.1002/anie.201105940; Young RD, 2011, J AM CHEM SOC, V133, P13806, DOI 10.1021/ja203470y	36	108	108	2	217	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 28	2012	337	6102					1648	1651		10.1126/science.1225028	http://dx.doi.org/10.1126/science.1225028			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012DJ	22923436				2022-12-28	WOS:000309215400043
J	Han, S; Tai, C; Westenbroek, RE; Yu, FH; Cheah, CS; Potter, GB; Rubenstein, JL; Scheuer, T; de la Iglesia, HO; Catterall, WA				Han, Sung; Tai, Chao; Westenbroek, Ruth E.; Yu, Frank H.; Cheah, Christine S.; Potter, Gregory B.; Rubenstein, John L.; Scheuer, Todd; de la Iglesia, Horacio O.; Catterall, William A.			Autistic-like behaviour in Scn1a(+/-) mice and rescue by enhanced GABA-mediated neurotransmission	NATURE			English	Article							SEVERE MYOCLONIC EPILEPSY; DE-NOVO MUTATIONS; REDUCED SODIUM CURRENT; FRAGILE-X-SYNDROME; DRAVET-SYNDROME; MOUSE MODEL; SPECTRUM DISORDERS; NA(V)1.1 CHANNELS; RETT-SYNDROME; INFANCY	Haploinsufficiency of the SCN1A gene encoding voltage-gated sodium channel Na(V)1.1 causes Dravet's syndrome, a childhood neuropsychiatric disorder including recurrent intractable seizures, cognitive deficit and autism-spectrum behaviours. The neural mechanisms responsible for cognitive deficit and autism-spectrum behaviours in Dravet's syndrome are poorly understood. Here we report that mice with Scn1a haploinsufficiency exhibit hyperactivity, stereotyped behaviours, social interaction deficits and impaired context-dependent spatial memory. Olfactory sensitivity is retained, but novel food odours and social odours are aversive to Scn1a(+/-) mice. GABAergic neurotransmission is specifically impaired by this mutation, and selective deletion of Na(V)1.1 channels in forebrain interneurons is sufficient to cause these behavioural and cognitive impairments. Remarkably, treatment with low-dose clonazepam, a positive allosteric modulator of GABA(A) receptors, completely rescued the abnormal social behaviours and deficits in fear memory in the mouse model of Dravet's syndrome, demonstrating that they are caused by impaired GABAergic neurotransmission and not by neuronal damage from recurrent seizures. These results demonstrate a critical role for Na(V)1.1 channels in neuropsychiatric functions and provide a potential therapeutic strategy for cognitive deficit and autism-spectrum behaviours in Dravet's syndrome.	[Han, Sung; de la Iglesia, Horacio O.; Catterall, William A.] Univ Washington, Graduate Program Neurobiol & Behav, Seattle, WA 98195 USA; [Han, Sung; Tai, Chao; Westenbroek, Ruth E.; Yu, Frank H.; Cheah, Christine S.; Scheuer, Todd; Catterall, William A.] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; [Han, Sung; de la Iglesia, Horacio O.] Univ Washington, Dept Biol, Seattle, WA 98195 USA; [Potter, Gregory B.; Rubenstein, John L.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94158 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of California System; University of California San Francisco	Catterall, WA (corresponding author), Univ Washington, Graduate Program Neurobiol & Behav, Seattle, WA 98195 USA.	horaciod@uw.edu; wcatt@uw.edu		Yu, Frank/0000-0001-9306-1731; Potter, Gregory/0000-0002-0585-6575	National Institutes of Health [R01 NS25704, R01 MH075016, R37 MH049428]; McKnight Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH049428, R01MH075016] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS025704] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); McKnight Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by Research Grants R01 NS25704 (W. A. C.), R01 MH075016 (H.O.d.) and R37 MH049428 (J.L.R.) from the National Institutes of Health and by a grant from the McKnight Foundation (W. A. C.). The authors thank E. Strakbein in the Machine Division at the University of Washington for making all the mazes for the behavioural experiments in this study.	Abrahams BS, 2008, NAT REV GENET, V9, P341, DOI 10.1038/nrg2346; BESAG FMC, 2004, EPILEPSY BEHAV, V5, P3; Brunklaus A, 2011, EPILEPSIA, V52, P1476, DOI 10.1111/j.1528-1167.2011.03129.x; Catterall WA, 2000, NEURON, V26, P13, DOI 10.1016/S0896-6273(00)81133-2; Catterall WA, 2010, J PHYSIOL-LONDON, V588, P1849, DOI 10.1113/jphysiol.2010.187484; Chao HT, 2010, NATURE, V468, P263, DOI 10.1038/nature09582; Cheah C. S., P NATL ACAD IN PRESS; Claes L, 2001, AM J HUM GENET, V68, P1327, DOI 10.1086/320609; Genton P, 2011, EPILEPSIA, V52, P44, DOI 10.1111/j.1528-1167.2011.03001.x; Geschwind DH, 2011, TRENDS COGN SCI, V15, P409, DOI 10.1016/j.tics.2011.07.003; Gomot M, 2006, NEUROIMAGE, V29, P475, DOI 10.1016/j.neuroimage.2005.07.027; Han S, 2012, P NATL ACAD SCI USA, V109, pE368, DOI 10.1073/pnas.1115729109; Hussman JP, 2001, J AUTISM DEV DISORD, V31, P247, DOI 10.1023/A:1010715619091; Kalume F, 2007, J NEUROSCI, V27, P11065, DOI 10.1523/JNEUROSCI.2162-07.2007; Li BM, 2011, EPILEPSY BEHAV, V21, P291, DOI 10.1016/j.yebeh.2011.04.060; Long J.E., 2009, CEREB CORTEX, V19, pi96, DOI [10.1093/cercor/bhp045, DOI 10.1093/CERCOR/BHP045]; Low K, 2000, SCIENCE, V290, P131, DOI 10.1126/science.290.5489.131; Mahoney K, 2009, SEIZURE-EUR J EPILEP, V18, P492, DOI 10.1016/j.seizure.2009.04.009; Markram K, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00224; Moretti P, 2005, HUM MOL GENET, V14, P205, DOI 10.1093/hmg/ddi016; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; O'Roak BJ, 2011, NAT GENET, V43, P585, DOI 10.1038/ng.835; Oakley JC, 2009, P NATL ACAD SCI USA, V106, P3994, DOI 10.1073/pnas.0813330106; Ogiwara I, 2007, J NEUROSCI, V27, P5903, DOI 10.1523/JNEUROSCI.5270-06.2007; Paluszkiewicz SM, 2011, DEV NEUROSCI-BASEL, V33, P349, DOI 10.1159/000329420; Paluszkiewicz SM, 2011, J NEUROPHYSIOL, V106, P2264, DOI 10.1152/jn.00421.2011; Penagarikano O, 2011, CELL, V147, P235, DOI 10.1016/j.cell.2011.08.040; Pescucci C, 2007, EUR J MED GENET, V50, P21, DOI 10.1016/j.ejmg.2006.09.001; Potter GB, 2009, MOL CELL NEUROSCI, V40, P167, DOI 10.1016/j.mcn.2008.10.003; Ramoz N, 2008, AM J MED GENET B, V147B, P1152, DOI 10.1002/ajmg.b.30739; Rossignol E, 2011, NEURAL PLAST, V2011, DOI 10.1155/2011/649325; Rubenstein JLR, 2003, GENES BRAIN BEHAV, V2, P255, DOI 10.1034/j.1601-183X.2003.00037.x; Rudolph U, 2011, NAT REV DRUG DISCOV, V10, P685, DOI 10.1038/nrd3502; Silverman JL, 2010, NAT REV NEUROSCI, V11, P490, DOI 10.1038/nrn2851; Stockhorst U, 2004, PHYSIOL BEHAV, V83, P3, DOI 10.1016/j.physbeh.2004.07.018; Van Wart A, 2007, J COMP NEUROL, V500, P339, DOI 10.1002/cne.21173; Wang ZS, 2006, J NEUROSCI, V26, P7375, DOI 10.1523/JNEUROSCI.1967-06.2006; Weiss LA, 2003, MOL PSYCHIATR, V8, P186, DOI 10.1038/sj.mp.4001241; WESTENBROEK RE, 1989, NEURON, V3, P695, DOI 10.1016/0896-6273(89)90238-9; Wolff M, 2006, EPILEPSIA, V47, P45, DOI 10.1111/j.1528-1167.2006.00688.x; YAKOUB M, 1992, BRAIN DEV-JPN, V14, P299, DOI 10.1016/S0387-7604(12)80147-1; Yang M, 2012, PHYSL BEHAV; Yizhar O, 2011, NATURE, V477, P171, DOI 10.1038/nature10360; Yu FH, 2006, NAT NEUROSCI, V9, P1142, DOI 10.1038/nn1754	44	408	427	4	101	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 20	2012	489	7416					385	390		10.1038/nature11356	http://dx.doi.org/10.1038/nature11356			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AK	22914087	Green Accepted, Green Submitted			2022-12-28	WOS:000308860900036
J	Kennedy, J; Blodgett, E				Kennedy, Jae; Blodgett, Elizabeth			Health Insurance-Motivated Disability Enrollment and the ACA	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Kennedy, Jae] Washington State Univ, Dept Hlth Policy & Adm, Spokane, WA 99202 USA; [Blodgett, Elizabeth] Univ N Carolina, Dept Hlth Policy & Management, Chapel Hill, NC USA	Washington State University; University of North Carolina; University of North Carolina Chapel Hill	Kennedy, J (corresponding author), Washington State Univ, Dept Hlth Policy & Adm, Spokane, WA 99202 USA.		Wood, Elizabeth/T-3561-2019; Kennedy, James/A-5868-2008	Kennedy, James/0000-0002-4521-3590				McDonough JE, 2012, NEW ENGL J MED, V367, P199, DOI 10.1056/NEJMp1206845; Social Security Administration, 2011, ANN STAT S SOC SEC B; State Health Access Data Assistance Center, 2011, STAT LEV TRENDS EMPL; The Board of Trustees for the Old Age and Survivors Insurance and Federal Disability Insurance Trust Funds, 2012, 2012 ANN REP TRUST U	4	18	18	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 20	2012	367	12								10.1056/NEJMp1208212	http://dx.doi.org/10.1056/NEJMp1208212			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	007AS	22950841				2022-12-28	WOS:000308861800003
J	Gozem, S; Schapiro, I; Ferre, N; Olivucci, M				Gozem, Samer; Schapiro, Igor; Ferre, Nicolas; Olivucci, Massimo			The Molecular Mechanism of Thermal Noise in Rod Photoreceptors	SCIENCE			English	Article							POTENTIAL-ENERGY SURFACES; VISUAL PIGMENTS; CONICAL INTERSECTION; RHODOPSIN; ISOMERIZATION; VISION; ACTIVATION; DARK; PHOTOISOMERIZATION; PHOTOACTIVATION	Spontaneous electrical signals in the retina's photoreceptors impose a limit on visual sensitivity. Their origin is attributed to a thermal, rather than photochemical, activation of the transduction cascade. Although the mechanism of such a process is under debate, the observation of a relationship between the maximum absorption wavelength (lambda(max)) and the thermal activation kinetic constant (k) of different visual pigments (the Barlow correlation) indicates that the thermal and photochemical activations are related. Here we show that a quantum chemical model of the bovine rod pigment provides a molecular-level understanding of the Barlow correlation. The transition state mediating thermal activation has the same electronic structure as the photoreceptor excited state, thus creating a direct link between lambda(max) and k. Such a link appears to be the manifestation of intrinsic chromophore features associated with the existence of a conical intersection between its ground and excited states.	[Gozem, Samer; Schapiro, Igor; Olivucci, Massimo] Bowling Green State Univ, Dept Chem, Bowling Green, OH 43403 USA; [Ferre, Nicolas] Univ Aix Marseille, Inst Chim Radicalaire, UMR 7273, F-13397 Marseille 20, France; [Olivucci, Massimo] Univ Siena, Dipartimento Chim, I-53100 Siena, Italy	University System of Ohio; Bowling Green State University; UDICE-French Research Universities; Aix-Marseille Universite; University of Siena	Olivucci, M (corresponding author), Bowling Green State Univ, Dept Chem, Bowling Green, OH 43403 USA.	molivuc@bgsu.edu	OLIVUCCI, MASSIMO/O-2588-2019; Ferré, Nicolas/K-8228-2012; Schapiro, Igor/C-7335-2014	OLIVUCCI, MASSIMO/0000-0002-8247-209X; Ferré, Nicolas/0000-0002-5583-8834; Gozem, Samer/0000-0002-6429-2853; Schapiro, Igor/0000-0001-8536-6869	Bowling Green State University; Center for Photochemical Sciences of Bowling Green State University; School of Arts and Sciences of Bowling Green State University	Bowling Green State University; Center for Photochemical Sciences of Bowling Green State University; School of Arts and Sciences of Bowling Green State University	We are grateful to M. A. Robb for a critical reading of the manuscript. This work was supported by the Bowling Green State University. M.O. is grateful to the Center for Photochemical Sciences and the School of Arts and Sciences of Bowling Green State University for startup funds. We are grateful to the Ohio Supercomputer Center for granted computer time.	Ala-Laurila P, 2004, VISION RES, V44, P2153, DOI 10.1016/j.visres.2004.03.031; Ala-Laurila P, 2004, BIOPHYS J, V86, P3653, DOI 10.1529/biophysj.103.035626; Andruniow T, 2004, P NATL ACAD SCI USA, V101, P17908, DOI 10.1073/pnas.0407997101; ATCHITY GJ, 1991, J CHEM PHYS, V95, P1862, DOI 10.1063/1.461036; BARLOW HB, 1957, NATURE, V179, P255, DOI 10.1038/179255b0; BARLOW RB, 1993, NATURE, V366, P64, DOI 10.1038/366064a0; BAYLOR DA, 1980, J PHYSIOL-LONDON, V309, P591, DOI 10.1113/jphysiol.1980.sp013529; Bokkon I, 2009, J PHOTOCH PHOTOBIO B, V96, P255, DOI 10.1016/j.jphotobiol.2009.07.002; Coto PB, 2006, MOL PHYS, V104, P983, DOI 10.1080/00268970500415865; De Vico L, 2005, J CHEM THEORY COMPUT, V1, P1029, DOI 10.1021/ct0500949; Frutos LM, 2007, P NATL ACAD SCI USA, V104, P7764, DOI 10.1073/pnas.0701732104; HERZBERG G, 1963, DISCUSS FARADAY SOC, P77, DOI 10.1039/df9633500077; Kaila VRI, 2012, J PHYS CHEM B, V116, P2249, DOI 10.1021/jp205918m; Kandori H, 2001, BIOCHEMISTRY-MOSCOW+, V66, P1197, DOI 10.1023/A:1013123016803; Khrenova MG, 2010, PROTEINS, V78, P614, DOI 10.1002/prot.22590; Kukura P, 2005, SCIENCE, V310, P1006, DOI 10.1126/science.1118379; Liu J, 2011, J BIOL CHEM, V286, P27622, DOI 10.1074/jbc.M111.233312; Liu J, 2009, J AM CHEM SOC, V131, P8750, DOI 10.1021/ja903154u; Lorenz-Fonfria VA, 2010, J AM CHEM SOC, V132, P5693, DOI 10.1021/ja907756e; Luo DG, 2011, SCIENCE, V332, P1307, DOI 10.1126/science.1200172; MILDER SJ, 1991, BIOPHYS J, V60, P440, DOI 10.1016/S0006-3495(91)82070-7; Polli D, 2010, NATURE, V467, P440, DOI 10.1038/nature09346; Sampath AP, 2002, BIOPHYS J, V83, P184, DOI 10.1016/S0006-3495(02)75160-6; SCHICK GA, 1987, BIOCHEMISTRY-US, V26, P2556, DOI 10.1021/bi00383a022; SCHOENLEIN RW, 1991, SCIENCE, V254, P412, DOI 10.1126/science.1925597; Terakita A, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-213; WALD G, 1968, NATURE, V219, P800, DOI 10.1038/219800a0; WANG Q, 1994, SCIENCE, V266, P422, DOI 10.1126/science.7939680; WARSHEL A, 1978, P NATL ACAD SCI USA, V75, P2558, DOI 10.1073/pnas.75.6.2558; Zilberg S, 2003, PHOTOCH PHOTOBIO SCI, V2, P1256, DOI 10.1039/b306137j	30	84	85	1	77	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 7	2012	337	6099					1225	1228		10.1126/science.1220461	http://dx.doi.org/10.1126/science.1220461			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	000UJ	22955833				2022-12-28	WOS:000308414000038
J	Gerstein, MB; Kundaje, A; Hariharan, M; Landt, SG; Yan, KK; Cheng, C; Mu, XJ; Khurana, E; Rozowsky, J; Alexander, R; Min, RQ; Alves, P; Abyzov, A; Addleman, N; Bhardwaj, N; Boyle, AP; Cayting, P; Charos, A; Chen, DZ; Cheng, Y; Clarke, D; Eastman, C; Euskirchen, G; Frietze, S; Fu, Y; Gertz, J; Grubert, F; Harmanci, A; Jain, P; Kasowski, M; Lacroute, P; Leng, J; Lian, J; Monahan, H; O'Geen, H; Ouyang, ZQ; Partridge, EC; Patacsil, D; Pauli, F; Raha, D; Ramirez, L; Reddy, TE; Reed, B; Shi, MY; Slifer, T; Wang, J; Wu, LF; Yang, XQ; Yip, KY; Zilberman-Schapira, G; Batzoglou, S; Sidow, A; Farnham, PJ; Myers, RM; Weissman, SM; Snyder, M				Gerstein, Mark B.; Kundaje, Anshul; Hariharan, Manoj; Landt, Stephen G.; Yan, Koon-Kiu; Cheng, Chao; Mu, Xinmeng Jasmine; Khurana, Ekta; Rozowsky, Joel; Alexander, Roger; Min, Renqiang; Alves, Pedro; Abyzov, Alexej; Addleman, Nick; Bhardwaj, Nitin; Boyle, Alan P.; Cayting, Philip; Charos, Alexandra; Chen, David Z.; Cheng, Yong; Clarke, Declan; Eastman, Catharine; Euskirchen, Ghia; Frietze, Seth; Fu, Yao; Gertz, Jason; Grubert, Fabian; Harmanci, Arif; Jain, Preti; Kasowski, Maya; Lacroute, Phil; Leng, Jing; Lian, Jin; Monahan, Hannah; O'Geen, Henriette; Ouyang, Zhengqing; Partridge, E. Christopher; Patacsil, Dorrelyn; Pauli, Florencia; Raha, Debasish; Ramirez, Lucia; Reddy, Timothy E.; Reed, Brian; Shi, Minyi; Slifer, Teri; Wang, Jing; Wu, Linfeng; Yang, Xinqiong; Yip, Kevin Y.; Zilberman-Schapira, Gili; Batzoglou, Serafim; Sidow, Arend; Farnham, Peggy J.; Myers, Richard M.; Weissman, Sherman M.; Snyder, Michael			Architecture of the human regulatory network derived from ENCODE data	NATURE			English	Article							EMBRYONIC STEM-CELLS; HIERARCHICAL STRUCTURE; TRANSCRIPTION FACTORS; ESCHERICHIA-COLI; GENOMIC ANALYSIS; MOTIFS; CHROMATIN; BINDING; SPECIFICITY; EXPRESSION	Transcription factors bind in a combinatorial fashion to specify the on-and-off states of genes; the ensemble of these binding events forms a regulatory network, constituting the wiring diagram for a cell. To examine the principles of the human transcriptional regulatory network, we determined the genomic binding information of 119 transcription-related factors in over 450 distinct experiments. We found the combinatorial, co-association of transcription factors to be highly context specific: distinct combinations of factors bind at specific genomic locations. In particular, there are significant differences in the binding proximal and distal to genes. We organized all the transcription factor binding into a hierarchy and integrated it with other genomic information (for example, microRNA regulation), forming a dense meta-network. Factors at different levels have different properties; for instance, top-level transcription factors more strongly influence expression and middle-level ones co-regulate targets to mitigate information-flow bottlenecks. Moreover, these co-regulations give rise to many enriched network motifs (for example, noise-buffering feed-forward loops). Finally, more connected network components are under stronger selection and exhibit a greater degree of allele-specific activity (that is, differential binding to the two parental alleles). The regulatory information obtained in this study will be crucial for interpreting personal genome sequences and understanding basic principles of human biology and disease.	[Gerstein, Mark B.; Yan, Koon-Kiu; Cheng, Chao; Mu, Xinmeng Jasmine; Khurana, Ekta; Alexander, Roger; Min, Renqiang; Alves, Pedro; Abyzov, Alexej; Bhardwaj, Nitin; Fu, Yao; Harmanci, Arif; Leng, Jing; Wang, Jing; Yip, Kevin Y.; Zilberman-Schapira, Gili] Yale Univ, Program Computat Biol & Bioinformat, New Haven, CT 06520 USA; [Gerstein, Mark B.; Yan, Koon-Kiu; Cheng, Chao; Khurana, Ekta; Rozowsky, Joel; Alexander, Roger; Min, Renqiang; Abyzov, Alexej; Bhardwaj, Nitin; Harmanci, Arif; Yip, Kevin Y.] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Gerstein, Mark B.; Chen, David Z.] Yale Univ, Dept Commun Sci, New Haven, CT 06511 USA; [Kundaje, Anshul; Batzoglou, Serafim] Stanford Univ, Dept Comp Sci, Stanford, CA 94305 USA; [Hariharan, Manoj; Landt, Stephen G.; Addleman, Nick; Boyle, Alan P.; Cayting, Philip; Cheng, Yong; Eastman, Catharine; Euskirchen, Ghia; Grubert, Fabian; Kasowski, Maya; Lacroute, Phil; Ouyang, Zhengqing; Patacsil, Dorrelyn; Ramirez, Lucia; Shi, Minyi; Slifer, Teri; Wu, Linfeng; Yang, Xinqiong; Snyder, Michael] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Min, Renqiang] NEC Labs Amer, Dept Machine Learning, Princeton, NJ 08540 USA; [Charos, Alexandra; Monahan, Hannah; Raha, Debasish; Reed, Brian] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; [Clarke, Declan] Yale Univ, Dept Chem, New Haven, CT 06520 USA; [Frietze, Seth; Farnham, Peggy J.] Univ So Calif, Dept Biochem & Mol Biol, Norris Comprehens Canc Ctr, Los Angeles, CA 90089 USA; [Gertz, Jason; Jain, Preti; Partridge, E. Christopher; Pauli, Florencia; Reddy, Timothy E.; Myers, Richard M.] HudsonAlpha Inst Biotechnol, Huntsville, AL 35806 USA; [Lian, Jin; Weissman, Sherman M.] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; [O'Geen, Henriette] Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA; [Yip, Kevin Y.] Chinese Univ Hong Kong, Dept Comp Sci & Engn, Hong Kong, Hong Kong, Peoples R China; [Sidow, Arend] Stanford Univ, Dept Pathol, Stanford, CA 94305 USA	Yale University; Yale University; Yale University; Stanford University; Stanford University; NEC Corporation; Yale University; Yale University; University of Southern California; HudsonAlpha Institute for Biotechnology; Yale University; University of California System; University of California Davis; Chinese University of Hong Kong; Stanford University	Gerstein, MB (corresponding author), Yale Univ, Program Computat Biol & Bioinformat, Bass 432,266 Whitney Ave, New Haven, CT 06520 USA.	Mark.gerstein@yale.edu; mpsnyder@stanford.edu	Abyzov, Alexej/M-4284-2013; cheng, yong/I-4270-2012; Kundaje, Anshul/Y-2739-2019; Yan, Koon-Kiu/A-5940-2009; Mu, Xinmeng/P-2562-2016; Abyzov, Alexej/AAT-4615-2020; Khurana, Ekta/C-4933-2013; Yip, Kevin/AAT-4771-2020; Kundaje, Anshul/Y-2598-2019; Boyle, Alan/I-1848-2014; Hariharan, Manoj/N-2855-2015	Kundaje, Anshul/0000-0003-3084-2287; Mu, Xinmeng/0000-0002-8079-0828; Yip, Kevin/0000-0001-5516-9944; Kundaje, Anshul/0000-0003-3084-2287; Boyle, Alan/0000-0002-2081-1105; Hariharan, Manoj/0000-0002-1006-5372; Rozowsky, Joel/0000-0002-3565-0762; Alexander, Roger/0000-0002-2967-7395; Pauli Behn, Florencia/0000-0002-8984-4044; Reddy, Timothy/0000-0002-7629-061X; Farnham, Peggy/0000-0003-4469-7914; Snyder, Michael/0000-0003-0784-7987; Gertz, Jason/0000-0001-7568-6789; Abyzov, Alexej/0000-0001-5405-6729	ENCODE Project (National Institutes of Health/National Human Genome Research Institute (NIH/NHGRI)); NIH Predoctoral Training Program in Biophysics [T32 GM008283-24]; Sackler institute; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004695, U54HG004558] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007205, T32GM008283] Funding Source: NIH RePORTER	ENCODE Project (National Institutes of Health/National Human Genome Research Institute (NIH/NHGRI)); NIH Predoctoral Training Program in Biophysics; Sackler institute; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the ENCODE Project (National Institutes of Health/National Human Genome Research Institute (NIH/NHGRI)) for funding. We thank P. Bickel and B. Brown for conversations. Funding has also been provided by the NIH Predoctoral Training Program in Biophysics (D. C.; T32 GM008283-24) and the Sackler institute (G.Z.-S.). M. H. thanks G. Nair for designing database operations.	Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Balaji S, 2007, J MOL BIOL, V372, P1108, DOI 10.1016/j.jmb.2007.06.084; Balaji S, 2006, J MOL BIOL, V360, P204, DOI 10.1016/j.jmb.2006.04.026; Balazsi G, 2005, P NATL ACAD SCI USA, V102, P7841, DOI 10.1073/pnas.0500365102; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; BARON MH, 1994, MOL CELL BIOL, V14, P3108, DOI 10.1128/MCB.14.5.3108; Barski A, 2009, GENOME RES, V19, P1742, DOI 10.1101/gr.090951.109; Beyer A, 2007, NAT REV GENET, V8, P699, DOI 10.1038/nrg2144; Bhardwaj N, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001014; Bhardwaj N, 2010, P NATL ACAD SCI USA, V107, P6841, DOI 10.1073/pnas.0910867107; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Burda Z, 2011, P NATL ACAD SCI USA, V108, P17263, DOI 10.1073/pnas.1109435108; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Cheng C., 2012, GENOME RES; Cheng C, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002190; Cheng C, 2011, BIOINFORMATICS, V27, P3221, DOI 10.1093/bioinformatics/btr552; Chinenov Y, 2001, ONCOGENE, V20, P2438, DOI 10.1038/sj.onc.1204385; Cosentino Lagomarsino M, 2007, P NATL ACAD SCI USA, V104, P5516, DOI 10.1073/pnas.0609023104; CURRAN T, 1988, CELL, V55, P395, DOI 10.1016/0092-8674(88)90024-4; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Hu ZZ, 2007, NAT GENET, V39, P683, DOI 10.1038/ng2012; Jothi R, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.52; Kerenyi MA, 2010, J EXP MED, V207, P2537, DOI 10.1084/jem.20102260; Kim HD, 2009, SCIENCE, V325, P429, DOI 10.1126/science.1171347; Kim PM, 2007, P NATL ACAD SCI USA, V104, P20274, DOI 10.1073/pnas.0710183104; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Lindblad-Toh K, 2011, NATURE, V478, P476, DOI 10.1038/nature10530; Ma HW, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-199; MacArthur DG, 2012, SCIENCE, V335, P823, DOI 10.1126/science.1215040; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; McDaniell R, 2010, SCIENCE, V328, P235, DOI 10.1126/science.1184655; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Novershtern N, 2011, CELL, V144, P296, DOI 10.1016/j.cell.2011.01.004; Ozsolak F, 2008, GENE DEV, V22, P3172, DOI 10.1101/gad.1706508; Parelho V, 2008, CELL, V132, P422, DOI 10.1016/j.cell.2008.01.011; Ptacek J, 2005, NATURE, V438, P679, DOI 10.1038/nature04187; Ravasi T, 2010, CELL, V140, P744, DOI 10.1016/j.cell.2010.01.044; Reed BD, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000133; Rozowsky J, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.54; Rubio ED, 2008, P NATL ACAD SCI USA, V105, P8309, DOI 10.1073/pnas.0801273105; Stark C, 2011, NUCLEIC ACIDS RES, V39, pD698, DOI 10.1093/nar/gkq1116; Vaquerizas JM, 2009, NAT REV GENET, V10, P252, DOI 10.1038/nrg2538; Yip KY, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r48; Yu HY, 2006, P NATL ACAD SCI USA, V103, P14724, DOI 10.1073/pnas.0508637103; Yu HY, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r55; Zhou JX, 2011, TRENDS GENET, V27, P55, DOI 10.1016/j.tig.2010.11.002	47	1016	1038	4	168	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 6	2012	489	7414					91	100		10.1038/nature11245	http://dx.doi.org/10.1038/nature11245			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999WW	22955619	Green Accepted, hybrid			2022-12-28	WOS:000308347000042
J	Unutzer, J; Park, MJ				Unuetzer, Juergen; Park, Mijung			Older Adults With Severe, Treatment-Resistant Depression	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LATE-LIFE DEPRESSION; BEHAVIORAL ACTIVATION TREATMENTS; PRIMARY-CARE PATIENTS; ELECTROCONVULSIVE-THERAPY; MAJOR DEPRESSION; COLLABORATIVE CARE; 2ND-GENERATION ANTIDEPRESSANTS; INTERPERSONAL PSYCHOTHERAPY; SOMATIC SYMPTOMS; ELDERLY-PATIENTS	Depression is a common, disabling, and costly condition encountered in older patients. Effective strategies for detection and treatment of late-life depression are summarized based on a case of a 69-year-old woman who struggled with prolonged depression. Clinicians should screen older patients for depression using a standard rating scale, initiate treatment such as antidepressant medications or evidence-based psychotherapy, and monitor depression symptoms. Patients who are not improving should be considered for psychiatric consultation and treatment changes including electroconvulsive therapy. Several changes in treatment approaches are usually needed before patients achieve complete remission. Maintenance treatment and relapse-prevention planning (summarization of early warning signs for depression, maintenance treatments such as medications, and other strategies to reduce the risk of relapse [eg, regular physical activity or pleasant activities]) can reduce the risk of relapse. Collaborative programs, in which primary care clinicians work closely with mental health specialists following a measurement-based treatment-to-target approach, are significantly more effective than typical primary care treatment. JAMA. 2012;308(9):909-918	[Unuetzer, Juergen] Univ Washington, Ctr Med, UW AIMS Ctr, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Unuetzer, Juergen] Univ Washington, Ctr Med, IMPACT Implementat Program, Seattle, WA 98195 USA; [Park, Mijung] Univ Pittsburgh, Dept Hlth & Community Syst, Pittsburgh, PA USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Unutzer, J (corresponding author), Univ Washington, Ctr Med, UW AIMS Ctr, Dept Psychiat & Behav Sci, 1959 NE Pacific St,Box 356560, Seattle, WA 98195 USA.	unutzer@u.washington.edu	Unutzer, Jurgen/N-4048-2018	Park, Mijung/0000-0003-0528-2142	National Institute of Mental Health (NIMH); John A. Hartford Foundation; Alaska Mental Health Trust Authority; George Foundation; Hogg Foundation for Mental Health; Henry M. Jackson Foundation; NIMH [NIMH 2 T32 MH 73553-6]; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH073553] Funding Source: NIH RePORTER	National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); John A. Hartford Foundation; Alaska Mental Health Trust Authority; George Foundation; Hogg Foundation for Mental Health; Henry M. Jackson Foundation; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Both authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Unutzer reports having received grant and contract funding from the National Institute of Mental Health (NIMH), the John A. Hartford Foundation, the Alaska Mental Health Trust Authority, the George Foundation, the Hogg Foundation for Mental Health, and the Henry M. Jackson Foundation; reports provision of technical assistance, consultation, or both to the Community Health Plan of Washington, Public Health of Seattle & King County, AARP (American Association of Retired Persons) Services Inc, the National Council of Community Behavioral Health Care; and serving as an advisor to the Carter Center Mental Health Program, the Institute for Clinical Systems Improvement, and the World Health Organization. Dr Park reports receipt of funding from Geriatric Mental Health Services Research Fellowship by NIMH (NIMH 2 T32 MH 73553-6).	Akincigil A, 2012, AM J PUBLIC HEALTH, V102, P319, DOI 10.2105/AJPH.2011.300349; Akincigil A, 2011, J AM GERIATR SOC, V59, P1042, DOI 10.1111/j.1532-5415.2011.03447.x; Alegria M, 2008, PSYCHIAT SERV, V59, P1264, DOI 10.1176/appi.ps.59.11.1264; Alexopoulos G S, 1992, Clin Geriatr Med, V8, P363; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Arean P, 2008, GERONTOLOGIST, V48, P311, DOI 10.1093/geront/48.3.311; Beekman ATF, 2000, AM J PSYCHIAT, V157, P89, DOI 10.1176/ajp.157.1.89; Bell AC, 2009, CLIN PSYCHOL REV, V29, P348, DOI 10.1016/j.cpr.2009.02.003; Blake H, 2009, CLIN REHABIL, V23, P873, DOI 10.1177/0269215509337449; Bruce ML, 2004, JAMA-J AM MED ASSOC, V291, P1081, DOI 10.1001/jama.291.9.1081; Byers AL, 2010, ARCH GEN PSYCHIAT, V67, P489, DOI 10.1001/archgenpsychiatry.2010.35; Case BG, 2012, J AFFECT DISORDERS, V136, P359, DOI 10.1016/j.jad.2011.11.026; Chesla CA, 2010, J FAM NURS, V16, P355, DOI 10.1177/1074840710383145; Cole MG, 2003, AM J PSYCHIAT, V160, P1147, DOI 10.1176/appi.ajp.160.6.1147; Crystal S, 2003, J AM GERIATR SOC, V51, P1718, DOI 10.1046/j.1532-5415.2003.51555.x; Cuijpers P, 2007, CLIN PSYCHOL REV, V27, P318, DOI 10.1016/j.cpr.2006.11.001; Cuijpers P, 2006, INT J GERIATR PSYCH, V21, P1139, DOI 10.1002/gps.1620; Damm J, 2010, J ECT, V26, P282, DOI 10.1097/YCT.0b013e3181cadbf5; de Mello MF, 2005, EUR ARCH PSY CLIN N, V255, P75, DOI 10.1007/s00406-004-0542-x; Dombrovski Alexandre Y, 2007, Int Psychogeriatr, V19, P10, DOI 10.1017/S1041610206224384; Drayer RA, 2005, INT J GERIATR PSYCH, V20, P973, DOI 10.1002/gps.1389; Ekers D, 2008, PSYCHOL MED, V38, P611, DOI 10.1017/S0033291707001614; Evans DL, 2005, BIOL PSYCHIAT, V58, P175, DOI 10.1016/j.biopsych.2005.05.001; Fawzi W, 2012, INT PSYCHOGERIATR, V24, P159, DOI 10.1017/S1041610211001049; Gagne GG, 2000, AM J PSYCHIAT, V157, P1960, DOI 10.1176/appi.ajp.157.12.1960; Gallo JJ, 1997, J AM GERIATR SOC, V45, P570, DOI 10.1111/j.1532-5415.1997.tb03089.x; Gardner BK, 2008, J ECT, V24, P68, DOI 10.1097/YCT.0b013e318165c7b0; Gartlehner G, 2008, ANN INTERN MED, V149, P734, DOI 10.7326/0003-4819-149-10-200811180-00008; Gilbody S, 2006, ARCH INTERN MED, V166, P2314, DOI 10.1001/archinte.166.21.2314; Gilbody S, 2006, BRIT J PSYCHIAT, V189, P297, DOI 10.1192/bjp.bp.105.016006; Greenberger H, 2003, CAN J AGING, V22, P395, DOI 10.1017/S0714980800004256; Gum AM, 2006, GERONTOLOGIST, V46, P14, DOI 10.1093/geront/46.1.14; Henke RM, 2009, MED CARE, V47, P959, DOI 10.1097/MLR.0b013e31819a5da0; Hinton L, 2006, AM J GERIAT PSYCHIAT, V14, P884, DOI 10.1097/01.JGP.0000219282.32915.a4; Hoover DR, 2010, INT PSYCHOGERIATR, V22, P1161, DOI 10.1017/S1041610210000578; Iosifescu DV, 2004, PSYCHOSOMATICS, V45, P419, DOI 10.1176/appi.psy.45.5.419; Kellner CH, 2006, ARCH GEN PSYCHIAT, V63, P1337, DOI 10.1001/archpsyc.63.12.1337; Kok RM, 2011, AM J GERIAT PSYCHIAT, V19, P249, DOI 10.1097/JGP.0b013e3181ec8085; Kroenke K, 2003, MED CARE, V41, P1284, DOI 10.1097/01.MLR.0000093487.78664.3C; Kroenke K, 2010, GEN HOSP PSYCHIAT, V32, P345, DOI 10.1016/j.genhosppsych.2010.03.006; Licht-Strunk E, 2007, FAM PRACT, V24, P168, DOI 10.1093/fampra/cml071; Lyness JM, 1999, J GEN INTERN MED, V14, P249, DOI 10.1046/j.1525-1497.1999.00326.x; Martire LM, 2004, HEALTH PSYCHOL, V23, P599, DOI 10.1037/0278-6133.23.6.599; Mazzucchelli T, 2009, CLIN PSYCHOL-SCI PR, V16, P383, DOI 10.1111/j.1468-2850.2009.01178.x; McCall Louise, 2002, Aust Fam Physician, V31, P299; Mitchell AJ, 2010, PSYCHOTHER PSYCHOSOM, V79, P285, DOI 10.1159/000318295; Mojtabai R, 2004, PSYCHOL MED, V34, P623, DOI 10.1017/S0033291703001764; Nelson JC, 2008, AM J GERIAT PSYCHIAT, V16, P558, DOI 10.1097/JGP.0b013e3181693288; Olfson M, 1998, AM J PSYCHIAT, V155, P22, DOI 10.1176/ajp.155.1.22; Pinquart M, 2007, AGING MENT HEALTH, V11, P645, DOI 10.1080/13607860701529635; Pinquart M, 2006, AM J PSYCHIAT, V163, P1493, DOI 10.1176/appi.ajp.163.9.1493; Rayner L, 2010, COCHRANE DB SYST REV, V17; Reynolds CF, 2006, NEW ENGL J MED, V354, P1130, DOI 10.1056/NEJMoa052619; Reynolds CF, 1999, JAMA-J AM MED ASSOC, V281, P39, DOI 10.1001/jama.281.1.39; Rush AJ, 2006, AM J PSYCHIAT, V163, P1905, DOI 10.1176/appi.ajp.163.11.1905; Sackeim HA, 2001, JAMA-J AM MED ASSOC, V285, P1299, DOI 10.1001/jama.285.10.1299; Sarkisian CA, 2003, J GEN INTERN MED, V18, P1001, DOI 10.1111/j.1525-1497.2003.30215.x; Schulberg HC, 2007, INT J GERIATR PSYCH, V22, P106, DOI 10.1002/gps.1700; Sheehan B, 1999, INT J GERIATR PSYCH, V14, P1044, DOI 10.1002/(SICI)1099-1166(199912)14:12<1044::AID-GPS55>3.0.CO;2-0; Simon GE, 2010, AM J PSYCHIAT, V167, P1445, DOI 10.1176/appi.ajp.2010.09111680; Sjosten N, 2006, INT J GERIATR PSYCH, V21, P410, DOI 10.1002/gps.1494; Snowden Mark, 2008, Prev Chronic Dis, V5, pA26; Sorensen S, 2002, GERONTOLOGIST, V42, P356, DOI 10.1093/geront/42.3.356; Strothers HS, 2005, J AM GERIATR SOC, V53, P456, DOI 10.1111/j.1532-5415.2005.53164.x; Teresi J, 2001, SOC PSYCH PSYCH EPID, V36, P613, DOI 10.1007/s127-001-8202-7; Tess AV, 2009, NEW ENGL J MED, V360, P1437, DOI 10.1056/NEJMra0707755; U.S. Preventive Services Task Force, SCREEN DEPR AD; Unutzer J, 2007, NEW ENGL J MED, V357, P2269, DOI 10.1056/NEJMcp073754; Unutzer J, 2002, JAMA-J AM MED ASSOC, V288, P2836, DOI 10.1001/jama.288.22.2836; Unutzer J, 2008, AM J MANAG CARE, V14, P95; van der Wurff FB, 2003, INT J GERIATR PSYCH, V18, P894, DOI 10.1002/gps.944; Van der Wurff FB, 2003, COCHRANE DB SYST REV, V2; van Schaik AM, 2012, AM J GERIAT PSYCHIAT, V20, P5, DOI 10.1097/JGP.0b013e31820dcbf9; Vink D, 2008, J AFFECT DISORDERS, V106, P29, DOI 10.1016/j.jad.2007.06.005; Voils CI, 2005, AM J GERIAT PSYCHIAT, V13, P157, DOI 10.1176/appi.ajgp.13.2.157; Wilson KCM, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004853.pub2; Yu DSF, 2012, INT J GERIATR PSYCH, V27, P119, DOI 10.1002/gps.2692	77	32	34	1	16	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 5	2012	308	9					909	918		10.1001/2012.jama.10690	http://dx.doi.org/10.1001/2012.jama.10690			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	999ET	22948701	Green Accepted			2022-12-28	WOS:000308292900021
J	Havugimana, PC; Hart, GT; Nepusz, T; Yang, HX; Turinsky, AL; Li, ZH; Wang, PI; Boutz, DR; Fong, V; Phanse, S; Babu, M; Craig, SA; Hu, PZ; Wan, CH; Vlasblom, J; Dar, VUN; Bezginov, A; Clark, GW; Wu, GC; Wodak, SJ; Tillier, ERM; Paccanaro, A; Marcotte, EM; Emili, A				Havugimana, Pierre C.; Hart, G. Traver; Nepusz, Tamas; Yang, Haixuan; Turinsky, Andrei L.; Li, Zhihua; Wang, Peggy I.; Boutz, Daniel R.; Fong, Vincent; Phanse, Sadhna; Babu, Mohan; Craig, Stephanie A.; Hu, Pingzhao; Wan, Cuihong; Vlasblom, James; Dar, Vaqaar-un-Nisa; Bezginov, Alexandr; Clark, Gregory W.; Wu, Gabriel C.; Wodak, Shoshana J.; Tillier, Elisabeth R. M.; Paccanaro, Alberto; Marcotte, Edward M.; Emili, Andrew			A Census of Human Soluble Protein Complexes	CELL			English	Article							SYSTEMATIC ANALYSIS; INTERACTION NETWORK; CELL; ORGANIZATION; GENES; SCALE; MUTATIONS; DISCOVERY; 8Q24; MAP	Cellular processes often depend on stable physical associations between proteins. Despite recent progress, knowledge of the composition of human protein complexes remains limited. To close this gap, we applied an integrative global proteomic profiling approach, based on chromatographic separation of cultured human cell extracts into more than one thousand biochemical fractions that were subsequently analyzed by quantitative tandem mass spectrometry, to systematically identify a network of 13,993 high-confidence physical interactions among 3,006 stably associated soluble human proteins. Most of the 622 putative protein complexes we report are linked to core biological processes and encompass both candidate disease genes and unannotated proteins to inform on mechanism. Strikingly, whereas larger multiprotein assemblies tend to be more extensively annotated and evolutionarily conserved, human protein complexes with five or fewer subunits are far more likely to be functionally unannotated or restricted to vertebrates, suggesting more recent functional innovations.	[Nepusz, Tamas; Yang, Haixuan; Paccanaro, Alberto] Univ London, Dept Comp Sci, Egham TW20 0EX, Surrey, England; [Havugimana, Pierre C.; Hart, G. Traver; Fong, Vincent; Phanse, Sadhna; Babu, Mohan; Hu, Pingzhao; Wan, Cuihong; Emili, Andrew] Univ Toronto, Banting & Best Dept Med Res, Donnelly Ctr Cellular & Biomol Res, Toronto, ON M5S 3E1, Canada; [Havugimana, Pierre C.; Hart, G. Traver; Vlasblom, James; Wodak, Shoshana J.; Emili, Andrew] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 3E1, Canada; [Wodak, Shoshana J.] Univ Toronto, Dept Biochem, Toronto, ON M5S 3E1, Canada; [Turinsky, Andrei L.; Vlasblom, James; Wodak, Shoshana J.] Hosp Sick Children, Toronto, ON M5G 1X8, Canada; [Li, Zhihua; Wang, Peggy I.; Boutz, Daniel R.; Craig, Stephanie A.; Wu, Gabriel C.; Marcotte, Edward M.] Univ Texas Austin, Dept Chem & Biochem, Ctr Syst & Synthet Biol, Inst Cellular & Mol Biol, Austin, TX 78712 USA; [Dar, Vaqaar-un-Nisa; Bezginov, Alexandr; Clark, Gregory W.; Tillier, Elisabeth R. M.] Univ Toronto, Campbell Family Inst Canc Res, Ontario Canc Inst, Univ Hlth Network, Toronto, ON M5G 1L7, Canada	University of London; Royal Holloway University London; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Texas System; University of Texas Austin; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Paccanaro, A (corresponding author), Univ London, Dept Comp Sci, Egham TW20 0EX, Surrey, England.	alberto.paccanaro@cs.rhul.ac.uk; marcotte@icmb.utexas.edu; andrew.emili@utoronto.ca	Mohan, Babu P./I-7362-2019; Nepusz, Tamás/E-2832-2016; Paccanaro, Alberto/AAW-5625-2020; Boutz, Daniel/M-4872-2013	Nepusz, Tamás/0000-0002-1451-338X; Boutz, Daniel/0000-0001-7462-4105; Clark, Greg/0000-0002-9805-4300; Hu, Pingzhao/0000-0002-9546-2245; wodak, shoshana/0000-0002-0701-6545; Hart, Traver/0000-0002-1880-3341; Marcotte, Edward/0000-0001-8808-180X; Tillier, Elisabeth/0000-0003-2194-9058; Phanse, Sadhna/0000-0001-6306-0551	University of Toronto; Royal Society [NF080750]; Biotechnology and Biological Sciences Research Council [BB/F00964X/1, BB/K004131/1]; Canada Institutes of Health Research [MOP 82940]; SickKids Foundation; National Institutes of Health; National Science Foundation; Cancer Prevention Research Institute of Texas; Welch Foundation [F1515]; Packard Foundation; Ontario Ministry of Research and Innovation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [DP1GM106408, R01GM076536, R01GM067779, R01GM088624] Funding Source: NIH RePORTER; BBSRC [BB/K004131/1, BB/F00964X/1] Funding Source: UKRI	University of Toronto(University of Toronto); Royal Society(Royal Society of London); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Canada Institutes of Health Research; SickKids Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Cancer Prevention Research Institute of Texas; Welch Foundation(The Welch Foundation); Packard Foundation(The David & Lucile Packard Foundation); Ontario Ministry of Research and Innovation(Ministry of Research and Innovation, Ontario); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank R. Isserlin, Z. Ni, H. Guo, D. Merico and A. Alpert for technical assistance and J. Parkinson, G. Bader, A. Wilde, and J. Greenblatt for critical suggestions. P.C.H. was a recipient of a University of Toronto Open Fellowship, T.N. was supported by the Newton International Fellowship Scheme of the Royal Society, A.E. is an Ontario Research Chair, and S.J.W. is a Canada Research Chair Tier 1. This work was supported by grants from the Biotechnology and Biological Sciences Research Council (BB/F00964X/1 and BB/K004131/1) and the Royal Society (NF080750) to A.P., the Canada Institutes of Health Research (MOP 82940) and the SickKids Foundation to S.J.W., the National Institutes of Health, National Science Foundation, Cancer Prevention Research Institute of Texas, and Welch (F1515) and Packard Foundations to E.M.M., and the Ontario Ministry of Research and Innovation to A.E.	Alberts B, 1998, CELL, V92, P291, DOI 10.1016/S0092-8674(00)80922-8; Apweiler R, 2011, NUCLEIC ACIDS RES, V39, pD214, DOI 10.1093/nar/gkq1020; Babu M., 2012, NATURE; Becker KG, 2004, NAT GENET, V36, P431, DOI 10.1038/ng0504-431; Behrends C, 2010, NATURE, V466, P68, DOI 10.1038/nature09204; Bouwmeester T, 2004, NAT CELL BIOL, V6, P97, DOI 10.1038/ncb1086; Butland G, 2005, NATURE, V433, P531, DOI 10.1038/nature03239; Deardorff MA, 2012, AM J HUM GENET, V90, P1014, DOI 10.1016/j.ajhg.2012.04.019; DeScipio C, 2005, AM J MED GENET A, V137A, P276, DOI 10.1002/ajmg.a.30857; Eng JK, 2008, J PROTEOME RES, V7, P4598, DOI 10.1021/pr800420s; Ewing RM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100134; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Geiger T, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.014050; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Guruharsha KG, 2011, CELL, V147, P690, DOI 10.1016/j.cell.2011.08.047; Hamosh A, 2005, NUCLEIC ACIDS RES, V33, pD514; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Havugimana PC, 2007, J CHROMATOGR B, V847, P54, DOI 10.1016/j.jchromb.2006.10.075; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Hu PZ, 2009, PLOS BIOL, V7, P929, DOI 10.1371/journal.pbio.1000096; Hutchins JRA, 2010, SCIENCE, V328, P593, DOI 10.1126/science.1181348; Jansen R, 2004, CURR OPIN MICROBIOL, V7, P535, DOI 10.1016/j.mib.2004.08.012; Jeronimo C, 2007, MOL CELL, V27, P262, DOI 10.1016/j.molcel.2007.06.027; Kislinger T, 2003, MOL CELL PROTEOMICS, V2, P96, DOI 10.1074/mcp.M200074-MCP200; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Kuhner S, 2009, SCIENCE, V326, P1235, DOI 10.1126/science.1176343; Lage K, 2007, NAT BIOTECHNOL, V25, P309, DOI 10.1038/nbt1295; Lee I, 2011, GENOME RES, V21, P1109, DOI 10.1101/gr.118992.110; Mak AB, 2010, MOL CELL PROTEOMICS, V9, P811, DOI 10.1074/mcp.M000002-MCP201; Malovannaya A, 2011, CELL, V145, P787, DOI 10.1016/j.cell.2011.05.006; Masters JR, 2002, NAT REV CANCER, V2, P315, DOI 10.1038/nrc775; McBrien J, 2008, AM J MED GENET A, V146A, P1587, DOI 10.1002/ajmg.a.32347; Nagaraj N, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.81; Nepusz T, 2012, NAT METHODS, V9, P471, DOI [10.1038/nmeth.1938, 10.1038/NMETH.1938]; Oliver S, 2000, NATURE, V403, P601, DOI 10.1038/35001165; Pesquita C, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000443; Pie J, 2010, AM J MED GENET A, V152A, P924, DOI 10.1002/ajmg.a.33348; Popow J, 2011, SCIENCE, V331, P760, DOI 10.1126/science.1197847; Ramani AK, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.19; Rhodes DR, 2005, NAT BIOTECHNOL, V23, P951, DOI 10.1038/nbt1103; Ruepp A, 2010, NUCLEIC ACIDS RES, V38, pD497, DOI 10.1093/nar/gkp914; Sardiu ME, 2008, P NATL ACAD SCI USA, V105, P1454, DOI 10.1073/pnas.0706983105; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Tillier ERM, 2009, GENOME RES, V19, P1861, DOI 10.1101/gr.092452.109; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; Vidal M, 2011, CELL, V144, P986, DOI 10.1016/j.cell.2011.02.016; Wessels HJCT, 2009, PROTEOMICS, V9, P4221, DOI 10.1002/pmic.200900157; Wuyts W, 2002, AM J MED GENET, V113, P326, DOI 10.1002/ajmg.10845; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Yang HX, 2012, BIOINFORMATICS, V28, P1383, DOI 10.1093/bioinformatics/bts129	51	561	571	3	93	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 31	2012	150	5					1068	1081		10.1016/j.cell.2012.08.011	http://dx.doi.org/10.1016/j.cell.2012.08.011			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	001ZU	22939629	Bronze, Green Accepted			2022-12-28	WOS:000308500200019
J	Kowalchuk, GA				Kowalchuk, George A.			Bad News for Soil Carbon Sequestration?	SCIENCE			English	Editorial Material							TERRESTRIAL ECOSYSTEMS; MYCORRHIZAL FUNGI; ORGANIC MATERIAL; CLIMATE-CHANGE; DECOMPOSITION		[Kowalchuk, George A.] Netherlands Inst Ecol NIOO KNAW, Dept Microbial Ecol, Wageningen, Netherlands; [Kowalchuk, George A.] Vrije Univ Amsterdam, Dept Ecol Sci, Amsterdam, Netherlands	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); Vrije Universiteit Amsterdam	Kowalchuk, GA (corresponding author), Netherlands Inst Ecol NIOO KNAW, Dept Microbial Ecol, Wageningen, Netherlands.	g.kowalchuk@nioo.knaw.nl	Kowalchuk, George A/C-4298-2011; KNAW, NIOO-KNAW/A-4320-2012	KNAW, NIOO-KNAW/0000-0002-3835-159X; Kowalchuk, George/0000-0003-3866-0832				Ayres E, 2009, SOIL BIOL BIOCHEM, V41, P606, DOI 10.1016/j.soilbio.2008.12.022; BINGEMAN C. W., 1953, Proceedings. Soil Science Society of America, V17, P34; Cheng L, 2012, SCIENCE, V337, P1084, DOI 10.1126/science.1224304; Drigo B, 2010, P NATL ACAD SCI USA, V107, P10938, DOI 10.1073/pnas.0912421107; Drigo B, 2009, ISME J, V3, P1204, DOI 10.1038/ismej.2009.65; Finzi AC, 2011, FRONT ECOL ENVIRON, V9, P61, DOI 10.1890/100001; Hodge A, 2001, NATURE, V413, P297, DOI 10.1038/35095041; Hodge A, 2010, P NATL ACAD SCI USA, V107, P13754, DOI 10.1073/pnas.1005874107; Kiers ET, 2011, SCIENCE, V333, P880, DOI 10.1126/science.1208473; King GM, 2011, TRENDS MICROBIOL, V19, P75, DOI 10.1016/j.tim.2010.11.006; Lal R, 2004, SCIENCE, V304, P1623, DOI 10.1126/science.1097396; LeBauer DS, 2008, ECOLOGY, V89, P371, DOI 10.1890/06-2057.1; Marschner P, 2003, PLANT SOIL, V251, P279, DOI 10.1023/A:1023034825871; Megharaj M, 2011, ENVIRON INT, V37, P1362, DOI 10.1016/j.envint.2011.06.003; Staddon PL, 2005, NEW PHYTOL, V167, P635, DOI 10.1111/j.1469-8137.2005.01521.x	15	10	13	4	232	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 31	2012	337	6098					1049	1050		10.1126/science.1227303	http://dx.doi.org/10.1126/science.1227303			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996WP	22936765				2022-12-28	WOS:000308125800032
J	Kushner, JA				Kushner, Jake A.			Esophageal Stem Cells, Where Art Thou?	SCIENCE			English	Editorial Material									[Kushner, Jake A.] Baylor Coll Med, McNair Med Inst, Houston, TX 77030 USA; [Kushner, Jake A.] Texas Childrens Hosp, Texas Childrens Diabet & Endocrinol Ctr, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine	Kushner, JA (corresponding author), Baylor Coll Med, McNair Med Inst, Houston, TX 77030 USA.	kushner@bcm.edu	Kushner, Jake A/AFJ-8198-2022; Kushner, Jake A/AAF-5049-2022	Kushner, Jake A/0000-0002-3646-1744; Kushner, Jake A/0000-0002-3646-1744	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081469, K08DK064101, P30DK079638] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG040110] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Clayton E, 2007, NATURE, V446, P185, DOI 10.1038/nature05574; Croagh D, 2008, STEM CELL REV, V4, P261, DOI 10.1007/s12015-008-9031-3; Doupe DP, 2012, SCIENCE, V337, P1091, DOI 10.1126/science.1218835; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kalabis J, 2008, J CLIN INVEST, V118, P3860, DOI 10.1172/JCI35012; Okumura T, 2003, ONCOGENE, V22, P4017, DOI 10.1038/sj.onc.1206525; Quante M, 2009, NAT REV GASTRO HEPAT, V6, P724, DOI 10.1038/nrgastro.2009.195; Seery JP, 2000, CURR BIOL, V10, P1447, DOI 10.1016/S0960-9822(00)00803-4	8	6	6	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 31	2012	337	6098					1051	1052		10.1126/science.1227506	http://dx.doi.org/10.1126/science.1227506			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996WP	22936766	Green Accepted			2022-12-28	WOS:000308125800033
J	Bassani, R				Bassani, Roberto			Voluntary Nystagmus	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Osped G Salvini, Milan, Italy		Bassani, R (corresponding author), Osped G Salvini, Milan, Italy.	rdbass@libero.it	Bassani, Roberto/HHC-9585-2022						0	5	5	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 30	2012	367	9					E13	E13		10.1056/NEJMicm1104924	http://dx.doi.org/10.1056/NEJMicm1104924			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	996EN	22931345				2022-12-28	WOS:000308067400008
J	Cho, I; Yamanishi, S; Cox, L; Methe, BA; Zavadil, J; Li, K; Gao, Z; Mahana, D; Raju, K; Teitler, I; Li, HL; Alekseyenko, AV; Blaser, MJ				Cho, Ilseung; Yamanishi, Shingo; Cox, Laura; Methe, Barbara A.; Zavadil, Jiri; Li, Kelvin; Gao, Zhan; Mahana, Douglas; Raju, Kartik; Teitler, Isabel; Li, Huilin; Alekseyenko, Alexander V.; Blaser, Martin J.			Antibiotics in early life alter the murine colonic microbiome and adiposity	NATURE			English	Article							GASTRIC-INHIBITORY POLYPEPTIDE; CHAIN FATTY-ACIDS; RECEPTOR KNOCKOUT MICE; DIET-INDUCED OBESITY; GUT MICROBIOME; INTESTINAL MICROBIOTA; COMMUNITIES; DIVERSITY; SEQUENCES; DISEASE	Antibiotics administered in low doses have been widely used as growth promoters in the agricultural industry since the 1950s, yet the mechanisms for this effect are unclear. Because antimicrobial agents of different classes and varying activity are effective across several vertebrate species, we proposed that such subtherapeutic administration alters the population structure of the gut microbiome as well as its metabolic capabilities. We generated a model of adiposity by giving subtherapeutic antibiotic therapy to young mice and evaluated changes in the composition and capabilities of the gut microbiome. Administration of subtherapeutic antibiotic therapy increased adiposity in young mice and increased hormone levels related to metabolism. We observed substantial taxonomic changes in the microbiome, changes in copies of key genes involved in the metabolism of carbohydrates to short-chain fatty acids, increases in colonic short-chain fatty acid levels, and alterations in the regulation of hepatic metabolism of lipids and cholesterol. In this model, we demonstrate the alteration of early-life murine metabolic homeostasis through antibiotic manipulation.	[Cho, Ilseung; Yamanishi, Shingo; Alekseyenko, Alexander V.; Blaser, Martin J.] NYU, Sch Med, Dept Med, New York, NY 10016 USA; [Cho, Ilseung; Blaser, Martin J.] VA New York Harbor Healthcare Syst, Med Serv, New York, NY 10010 USA; [Cox, Laura; Gao, Zhan; Mahana, Douglas; Raju, Kartik; Teitler, Isabel; Blaser, Martin J.] NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA; [Methe, Barbara A.; Li, Kelvin] J Craig Venter Inst, Rockville, MD 20850 USA; [Zavadil, Jiri] NYU, Sch Med, Dept Pathol, New York, NY 10016 USA; [Zavadil, Jiri; Alekseyenko, Alexander V.] NYU, Sch Med, Ctr Hlth Informat & Bioinformat, New York, NY 10016 USA; [Li, Huilin] NYU, Sch Med, Dept Populat Hlth, New York, NY 10016 USA	New York University; New York University; J. Craig Venter Institute; New York University; New York University; New York University	Blaser, MJ (corresponding author), NYU, Sch Med, Dept Med, New York, NY 10016 USA.	martin.blaser@med.nyu.edu	Cox, Laura/ABG-5883-2020; Zavadil, Jiri/ABG-1780-2020; Blaser, Martin/ABF-6878-2021	Cox, Laura/0000-0002-9564-9894; Zavadil, Jiri/0000-0003-0640-5562; Li, Huilin/0000-0002-8288-7068; Alekseyenko, Alexander/0000-0002-5748-2085; Cho, Ilseung/0000-0002-7308-8707	NIH [T-RO1-DK090989, 1UL1-RR029893, UL1-TR000038]; Diane Belfer Program in Human Microbial Ecology; Philip and Janice Levin Foundation; Michael Saperstein Fellowship; J. Craig Venter Institute; NYU Genome Technology Center; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000038] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029893] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK090989] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Diane Belfer Program in Human Microbial Ecology; Philip and Janice Levin Foundation; Michael Saperstein Fellowship; J. Craig Venter Institute; NYU Genome Technology Center; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part with grants from the NIH (T-RO1-DK090989, 1UL1-RR029893, UL1-TR000038), the Diane Belfer Program in Human Microbial Ecology, the Philip and Janice Levin Foundation, the Michael Saperstein Fellowship, and institutional funds provided by the J. Craig Venter Institute, and the NYU Genome Technology Center. We thank N. Javitt for advice and J. Chung for technical assistance.	Abreu MT, 2005, J IMMUNOL, V174, P4453, DOI 10.4049/jimmunol.174.8.4453; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Andrikopoulos S, 2008, AM J PHYSIOL-ENDOC M, V295, pE1323, DOI 10.1152/ajpendo.90617.2008; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; BERGMAN EN, 1990, PHYSIOL REV, V70, P567, DOI 10.1152/physrev.1990.70.2.567; Blaser MJ, 2007, NATURE, V449, P843, DOI 10.1038/nature06198; Blaser MJ, 2009, NAT REV MICROBIOL, V7, P887, DOI 10.1038/nrmicro2245; BUFFA R, 1975, HISTOCHEMISTRY, V43, P249, DOI 10.1007/BF00499706; Butaye P, 2003, CLIN MICROBIOL REV, V16, P175, DOI 10.1128/CMR.16.2.175-188.2003; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Cho I, 2012, NAT REV GENET, V13, P260, DOI 10.1038/nrg3182; Dethlefsen L, 2011, P NATL ACAD SCI USA, V108, P4554, DOI 10.1073/pnas.1000087107; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Favier CF, 2002, APPL ENVIRON MICROB, V68, P219, DOI 10.1128/AEM.68.1.219-226.2002; Fleissner CK, 2010, BRIT J NUTR, V104, P919, DOI 10.1017/S0007114510001303; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gesta S, 2007, CELL, V131, P242, DOI 10.1016/j.cell.2007.10.004; Hansotia T, 2005, REGUL PEPTIDES, V128, P125, DOI 10.1016/j.regpep.2004.07.019; Harkness J.E., 1989, BIOL MED RABBITS ROD, V3rd ed.; Henderson G, 2010, APPL ENVIRON MICROB, V76, P2058, DOI 10.1128/AEM.02580-09; Hong F, 2004, HEPATOLOGY, V40, P933, DOI 10.1002/hep.20400; Hong YH, 2005, ENDOCRINOLOGY, V146, P5092, DOI 10.1210/en.2005-0545; Ihaka R., 1996, J COMPUTATIONAL GRAP, V5, P299, DOI [10.2307/1390807, DOI 10.1080/10618600.1996.10474713]; JUKES TH, 1970, NEW ENGL J MED, V282, P49; Kozyrskyj AL, 2007, CHEST, V131, P1753, DOI 10.1378/chest.06-3008; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Li Kelvin, 2010, BMC Res Notes, V3, P199, DOI 10.1186/1756-0500-3-199; Lovell CR, 2005, METHOD ENZYMOL, V397, P454, DOI 10.1016/S0076-6879(05)97028-6; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lozupone C, 2011, ISME J, V5, P169, DOI 10.1038/ismej.2010.133; Manichanh C, 2010, GENOME RES, V20, P1411, DOI 10.1101/gr.107987.110; MARTINEZMURCIA AJ, 1995, FEMS MICROBIOL ECOL, V17, P247, DOI 10.1111/j.1574-6941.1995.tb00149.x; MCCAIG LF, 1995, JAMA-J AM MED ASSOC, V273, P214, DOI 10.1001/jama.273.3.214; McCracken VJ, 2001, J NUTR, V131, P1862, DOI 10.1093/jn/131.6.1862; Miyawaki K, 2002, NAT MED, V8, P738, DOI 10.1038/nm727; Murphy EF, 2010, GUT, V59, P1635, DOI 10.1136/gut.2010.215665; OZAWA E, 1955, J ANTIBIOT, V8, P205; Pace NR, 1997, SCIENCE, V276, P734, DOI 10.1126/science.276.5313.734; Paine RT, 1998, ECOSYSTEMS, V1, P535, DOI 10.1007/s100219900049; Pavoine S, 2004, J THEOR BIOL, V228, P523, DOI 10.1016/j.jtbi.2004.02.014; Pavoine S, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-156; Pickett S. T. A., 1985, ECOLOGY NATURAL DIST; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Reeder SB, 2005, MAGNET RESON MED, V54, P636, DOI 10.1002/mrm.20624; Reikvam DH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017996; Robinson CJ, 2010, GUT MICROBES, V1, P279, DOI 10.4161/gmic.1.4.12614; Sole RV, 2001, P ROY SOC B-BIOL SCI, V268, P2039, DOI 10.1098/rspb.2001.1767; Spor A, 2011, NAT REV MICROBIOL, V9, P279, DOI 10.1038/nrmicro2540; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tsukiyama K, 2004, EUR J ENDOCRINOL, V151, P407, DOI 10.1530/eje.0.1510407; Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wlodarska M, 2011, INFECT IMMUN, V79, P1536, DOI 10.1128/IAI.01104-10; Wong JMW, 2006, J CLIN GASTROENTEROL, V40, P235, DOI 10.1097/00004836-200603000-00015; Yamada Y, 2004, HORM METAB RES, V36, P771, DOI 10.1055/s-2004-826162; Yip RGC, 1998, ENDOCRINOLOGY, V139, P4004, DOI 10.1210/en.139.9.4004; Zhao GH, 2006, BIOMED CHROMATOGR, V20, P674, DOI 10.1002/bmc.580; Zhou HY, 2005, BIOCHEM BIOPH RES CO, V335, P937, DOI 10.1016/j.bbrc.2005.07.164	62	1045	1109	16	427	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 30	2012	488	7413					621	+		10.1038/nature11400	http://dx.doi.org/10.1038/nature11400			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996NC	22914093	Green Accepted			2022-12-28	WOS:000308095100049
J	Dutra, M; Massumoto, C				Dutra, Mariana; Massumoto, Celso			Cerebral Air Embolism	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Dutra, Mariana; Massumoto, Celso] Hosp Sirio Libanes, Sao Paulo, Brazil	Hospital Sirio Libanes	Dutra, M (corresponding author), Hosp Sirio Libanes, Sao Paulo, Brazil.	uti@hsl.org.br							0	3	3	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 30	2012	367	9					850	850		10.1056/NEJMicm1108591	http://dx.doi.org/10.1056/NEJMicm1108591			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	996EN	22931319				2022-12-28	WOS:000308067400007
J	McMullan, LK; Folk, SM; Kelly, AJ; MacNeil, A; Goldsmith, CS; Metcalfe, MG; Batten, BC; Albarino, CG; Zaki, SR; Rollin, PE; Nicholson, WL; Nichol, ST				McMullan, Laura K.; Folk, Scott M.; Kelly, Aubree J.; MacNeil, Adam; Goldsmith, Cynthia S.; Metcalfe, Maureen G.; Batten, Brigid C.; Albarino, Cesar G.; Zaki, Sherif R.; Rollin, Pierre E.; Nicholson, William L.; Nichol, Stuart T.			A New Phlebovirus Associated with Severe Febrile Illness in Missouri	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TO-PERSON TRANSMISSION; AMBLYOMMA-AMERICANUM; FEVER VIRUS; BUNYAVIRUS; CHINA	Two men from northwestern Missouri independently presented to a medical facility with fever, fatigue, diarrhea, thrombocytopenia, and leukopenia, and both had been bitten by ticks 5 to 7 days before the onset of illness. Ehrlichia chaffeensis was suspected as the causal agent but was not found on serologic analysis, polymerase-chain-reaction (PCR) assay, or cell culture. Electron microscopy revealed viruses consistent with members of the Bunyaviridae family. Next-generation sequencing and phylogenetic analysis identified the viruses as novel members of the phlebovirus genus. Although Koch's postulates have not been completely fulfilled, we believe that this phlebovirus, which is novel in the Americas, is the cause of this clinical syndrome.	[McMullan, Laura K.; MacNeil, Adam; Albarino, Cesar G.; Rollin, Pierre E.; Nichol, Stuart T.] Ctr Dis Control & Prevent, Viral Special Pathogens Branch, Div High Consequence Pathogens & Pathol, Atlanta, GA USA; [Goldsmith, Cynthia S.; Metcalfe, Maureen G.; Batten, Brigid C.; Zaki, Sherif R.] Ctr Dis Control & Prevent, Infect Dis Pathol Branch, Div High Consequence Pathogens & Pathol, Atlanta, GA USA; [Kelly, Aubree J.; Nicholson, William L.] Ctr Dis Control & Prevent, Rickettsial Zoonoses Branch, Div Vector Borne Dis, Atlanta, GA USA; [Folk, Scott M.] Heartland Reg Med Ctr, St Joseph, MO USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Nichol, ST (corresponding author), Ctr Dis Control & Prevent, Viral Special Pathogens Branch MS G14, 1600 Clifton Rd NE,MS G-14, Atlanta, GA 30333 USA.	wnicholson@cdc.gov; snichol@cdc.gov	McMullan, Laura/AAI-1404-2021	McMullan, Laura/0000-0003-2748-5151; Rollin, Pierre/0000-0002-4608-2641				Bao CJ, 2011, CLIN INFECT DIS, V53, P1208, DOI 10.1093/cid/cir732; Bird BH, 2009, JAVMA-J AM VET MED A, V234, P883, DOI 10.2460/javma.234.7.883; Bouloy M, 2011, BUNYAVIRIDAE: MOLECULAR AND CELLULAR BIOLOGY, P95; Brown HE, 2011, AM J TROP MED HYG, V84, P411, DOI 10.4269/ajtmh.2011.10-0593; Childs JE, 2003, ANNU REV ENTOMOL, V48, P307, DOI 10.1146/annurev.ento.48.091801.112728; Childs JE, 1999, J CLIN MICROBIOL, V37, P2997, DOI 10.1128/JCM.37.9.2997-3000.1999; Depaquit J, 2010, EUROSURVEILLANCE, V15, P40; Gai ZT, 2012, CLIN INFECT DIS, V54, P249, DOI 10.1093/cid/cir776; KOKERNOT RH, 1969, AM J TROP MED HYG, V18, P789, DOI 10.4269/ajtmh.1969.18.789; Liu Y, 2012, VECTOR-BORNE ZOONOT, V12, P156, DOI 10.1089/vbz.2011.0758; McMullan LK, 2012, VIROLOGY, V422, P1, DOI 10.1016/j.virol.2011.08.024; Nichol S. T., 2005, VIRUS TAXONOMY, P695; Xu BL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002369; Yu XJ, 2011, NEW ENGL J MED, V364, P1523, DOI 10.1056/NEJMoa1010095; Zhang YZ, 2012, CLIN INFECT DIS, V54, P527, DOI 10.1093/cid/cir804	15	417	457	3	49	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 30	2012	367	9					834	841		10.1056/NEJMoa1203378	http://dx.doi.org/10.1056/NEJMoa1203378			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	996EN	22931317	Bronze			2022-12-28	WOS:000308067400005
J	Odoardi, F; Sie, C; Streyl, K; Ulaganathan, VK; Schlager, C; Lodygin, D; Heckelsmiller, K; Nietfeld, W; Ellwart, J; Klinkert, WEF; Lottaz, C; Nosov, M; Brinkmann, V; Spang, R; Lehrach, H; Vingron, M; Wekerle, H; Flugel-Koch, C; Flugel, A				Odoardi, Francesca; Sie, Christopher; Streyl, Kristina; Ulaganathan, Vijay K.; Schlaeger, Christian; Lodygin, Dmitri; Heckelsmiller, Klaus; Nietfeld, Wilfried; Ellwart, Joachim; Klinkert, Wolfgang E. F.; Lottaz, Claudio; Nosov, Mikhail; Brinkmann, Volker; Spang, Rainer; Lehrach, Hans; Vingron, Martin; Wekerle, Hartmut; Fluegel-Koch, Cassandra; Fluegel, Alexander			T cells become licensed in the lung to enter the central nervous system	NATURE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; MULTIPLE-SCLEROSIS; ADHESION MOLECULE; MICROARRAY DATA; MYELOID CELLS; LYMPHOCYTES; MIGRATION; ANTIGEN; CNS; INFECTIONS	The blood-brain barrier (BBB) and the environment of the central nervous system (CNS) guard the nervous tissue from peripheral immune cells. In the autoimmune disease multiple sclerosis, myelin-reactive T-cell blasts are thought to transgress the BBB1,2 and create a pro-inflammatory environment in the CNS, thereby making possible a second autoimmune attack that starts from the leptomeningeal vessels and progresses into the parenchyma(3-6). Using a Lewis rat model of experimental autoimmune encephalomyelitis, we show here that contrary to the expectations of this concept, T-cell blasts do not efficiently enter the CNS and are not required to prepare the BBB for immune-cell recruitment. Instead, intravenously transferred T-cell blasts gain the capacity to enter the CNS after residing transiently within the lung tissues. Inside the lung tissues, they move along and within the airways to bronchus-associated lymphoid tissues and lung-draining mediastinal lymph nodes before they enter the blood circulation from where they reach the CNS. Effector T cells transferred directly into the airways showed a similar migratory pattern and retained their full pathogenicity. On their way the T cells fundamentally reprogrammed their gene-expression profile, characterized by downregulation of their activation program and upregulation of cellular locomotion molecules together with chemokine and adhesion receptors. The adhesion receptors include ninjurin 1, which participates in T-cell intravascular crawling on cerebral blood vessels. We detected that the lung constitutes a niche not only for activated T cells but also for resting myelin-reactive memory T cells. After local stimulation in the lung, these cells strongly proliferate and, after assuming migratory properties, enter the CNS and induce paralytic disease. The lung could therefore contribute to the activation of potentially autoaggressive T cells and their transition to a migratory mode as a prerequisite to entering their target tissues and inducing autoimmune disease.	[Odoardi, Francesca; Sie, Christopher; Schlaeger, Christian; Lodygin, Dmitri; Fluegel, Alexander] Gemeinnutzige Hertie Stiftung, Inst Multiple Sclerosis Res, Dept Neuroimmunol, D-37073 Gottingen, Germany; [Odoardi, Francesca; Sie, Christopher; Schlaeger, Christian; Lodygin, Dmitri; Fluegel, Alexander] Univ Med Ctr Gottingen, D-37073 Gottingen, Germany; [Streyl, Kristina; Ulaganathan, Vijay K.; Heckelsmiller, Klaus; Klinkert, Wolfgang E. F.; Wekerle, Hartmut] Max Planck Inst Neurobiol, D-82152 Martinsried, Germany; [Nietfeld, Wilfried; Lehrach, Hans; Vingron, Martin] Max Planck Inst Mol Genet, D-14195 Berlin, Germany; [Ellwart, Joachim] Helmholtz Zentrum Munchen, Inst Mol Immunol, D-81377 Munich, Germany; [Lottaz, Claudio; Spang, Rainer] Univ Regensburg, Inst Funct Genom, D-93053 Regensburg, Germany; [Nosov, Mikhail] Natl Univ Ireland, Natl Ctr Biomed Engn Sci, Regenerat Med Inst, Coll Med Nursing & Hlth Sci, Galway, Ireland; [Brinkmann, Volker] Autoimmun Novartis Inst BioMed Res, CH-4056 Basel, Switzerland; [Brinkmann, Volker] Transplantat Novartis Inst BioMed Res, CH-4056 Basel, Switzerland; [Brinkmann, Volker] Inflammat Novartis Inst BioMed Res, CH-4056 Basel, Switzerland; [Fluegel-Koch, Cassandra] Univ Erlangen Nurnberg, Inst Anat 2, D-91054 Erlangen, Germany	University of Gottingen; Max Planck Society; Max Planck Society; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Regensburg; Ollscoil na Gaillimhe-University of Galway; Novartis; Novartis; Novartis; University of Erlangen Nuremberg	Flugel, A (corresponding author), Gemeinnutzige Hertie Stiftung, Inst Multiple Sclerosis Res, Dept Neuroimmunol, D-37073 Gottingen, Germany.	fluegel@med.uni-goettingen.de	Ulaganathan, Vijay Kumar/AAO-6077-2020	Ulaganathan, Vijay Kumar/0000-0002-4717-6228; Lottaz, Claudio/0000-0003-0781-4827; Spang, Rainer/0000-0002-1326-4297	Deutsche Forschungsgemeinschaft [TRR-SFB43, FORR 1336]; Bundesministerium fur Bildung und Forschung ('UNDERSTAND MS'); Hertie Foundation [1.01.1/11/004]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung ('UNDERSTAND MS')(Federal Ministry of Education & Research (BMBF)); Hertie Foundation	The authors thank A. Stas, S. Hamann, N. Meyer and I. Haarmann for technical assistance. N. Plesnila supported this work with advice in surgical preparations; T. Issekutz provided anti-CXCR3 and anti-VLA4 monoclonal antibodies. We are grateful to D. Johnson and F. Luhder for critical reading of the manuscript. We thank W. Leibold for critical discussions. We thank C. Ludwig for text editing. Hartmut Wekerle is Senior Research Professor of the Hertie Foundation. This work was supported by the Deutsche Forschungsgemeinschaft (TRR-SFB43, FORR 1336), the Bundesministerium fur Bildung und Forschung ('UNDERSTAND MS') and the Hertie Foundation (grant 1.01.1/11/004).	Ahn BJ, 2009, BIOCHEM BIOPH RES CO, V387, P321, DOI 10.1016/j.bbrc.2009.07.019; Araki T, 1997, J BIOL CHEM, V272, P21373, DOI 10.1074/jbc.272.34.21373; Araki T, 1996, NEURON, V17, P353, DOI 10.1016/S0896-6273(00)80166-X; Asperti-Boursin F, 2007, J EXP MED, V204, P1167, DOI 10.1084/jem.20062079; Bartholomaus I, 2009, NATURE, V462, P94, DOI 10.1038/nature08478; BENNUN A, 1981, EUR J IMMUNOL, V11, P195, DOI 10.1002/eji.1830110307; Berer K, 2011, NATURE, V479, P538, DOI 10.1038/nature10554; Brinkmann V, 2002, J BIOL CHEM, V277, P21453, DOI 10.1074/jbc.C200176200; Brinkmann V, 2010, NAT REV DRUG DISCOV, V9, P883, DOI 10.1038/nrd3248; Brown DA, 2007, J COMP NEUROL, V502, P236, DOI 10.1002/cne.21307; Carlson CM, 2006, NATURE, V442, P299, DOI 10.1038/nature04882; Cordiglieri C, 2010, BRAIN, V133, P1930, DOI 10.1093/brain/awq135; Dahlquist KD, 2002, NAT GENET, V31, P19, DOI 10.1038/ng0502-19; Eylar E H, 1974, Methods Enzymol, V32, P323; Flugel A, 1999, NAT MED, V5, P843, DOI 10.1038/10567; Flugel A, 2001, IMMUNITY, V14, P547, DOI 10.1016/s1074-7613(01)00143-1; Glabinski AR, 1995, BRAIN BEHAV IMMUN, V9, P315, DOI 10.1006/brbi.1995.1030; HICKEY WF, 1991, J NEUROSCI RES, V28, P254, DOI 10.1002/jnr.490280213; Hogan RJ, 2001, J EXP MED, V193, P981, DOI 10.1084/jem.193.8.981; Huber W., 2003, STAT APPL GENET MOL, V2, pARTICL, DOI [10.2202/1544-6115.1008, DOI 10.2202/1544-6115.1008]; Ichinohe T, 2011, P NATL ACAD SCI USA, V108, P5354, DOI 10.1073/pnas.1019378108; Ifergan I, 2011, ANN NEUROL, V70, P751, DOI 10.1002/ana.22519; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; KARIN N, 1993, J IMMUNOL, V150, P4116; Kataoka H, 2005, CELL MOL IMMUNOL, V2, P439; Kawakami N, 2005, J IMMUNOL, V175, P69, DOI 10.4049/jimmunol.175.1.69; Kawakami N, 2005, J EXP MED, V201, P1805, DOI 10.1084/jem.20050011; Kawakami N, 2004, J EXP MED, V199, P185, DOI 10.1084/jem.20031064; Kivisakk P, 2009, ANN NEUROL, V65, P457, DOI 10.1002/ana.21379; LENARDO MJ, 1991, NATURE, V353, P858, DOI 10.1038/353858a0; Lo JC, 2003, J CLIN INVEST, V112, P1495, DOI 10.1172/JCI200319188; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Odoardi F, 2007, P NATL ACAD SCI USA, V104, P920, DOI 10.1073/pnas.0608383104; Pham THM, 2008, IMMUNITY, V28, P122, DOI 10.1016/j.immuni.2007.11.017; Pintelon I, 2005, CELL TISSUE RES, V321, P21, DOI 10.1007/s00441-005-1111-y; Reinhardt RL, 2001, NATURE, V410, P101, DOI 10.1038/35065111; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; SIBLEY WA, 1985, LANCET, V1, P1313; Sporici R, 2010, EUR J IMMUNOL, V40, P2751, DOI 10.1002/eji.200939975; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Tham EL, 2002, J IMMUNOL, V168, P1190, DOI 10.4049/jimmunol.168.3.1190; WEKERLE H, 1986, TRENDS NEUROSCI, V9, P271, DOI 10.1016/0166-2236(86)90077-9; YEDNOCK TA, 1992, NATURE, V356, P63, DOI 10.1038/356063a0; Zheng HM, 2011, INFLAMM RES, V60, P759, DOI 10.1007/s00011-011-0331-8	44	280	287	2	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 30	2012	488	7413					675	+		10.1038/nature11337	http://dx.doi.org/10.1038/nature11337			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996NC	22914092	Green Published			2022-12-28	WOS:000308095100060
J	Sanderson, K				Sanderson, Katharine			VACCINATION A durable design	NATURE			English	Editorial Material																		Wick DA, 2011, VACCINE, V29, P7857, DOI 10.1016/j.vaccine.2011.07.090	1	2	2	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 30	2012	488	7413					S7	S7		10.1038/488S7a	http://dx.doi.org/10.1038/488S7a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	996NC	22932439	Bronze			2022-12-28	WOS:000308095100006
J	Kolb, S; Weindling, P; Roelcke, V; Seithe, H				Kolb, Stephan; Weindling, Paul; Roelcke, Volker; Seithe, Horst			The art of medicine Apologising for Nazi medicine: a constructive starting point	LANCET			English	Editorial Material									[Weindling, Paul] Oxford Brookes Univ, Dept Hist Philosophy & Relig, Ctr Hlth Med & Soc, Oxford OX3 0BP, England; [Kolb, Stephan; Seithe, Horst] Klinikum Nurnberg, Nurnberg, Germany; [Roelcke, Volker] Univ Giessen, Inst Hist Med, Giessen, Germany; [Kolb, Stephan; Seithe, Horst] IPPNW Nurnberg Furth Erlangen, Nurnberg, Germany	Oxford Brookes University; Klinikum Nurnberg Nord; Justus Liebig University Giessen	Weindling, P (corresponding author), Oxford Brookes Univ, Dept Hist Philosophy & Relig, Ctr Hlth Med & Soc, Oxford OX3 0BP, England.	pjweindling@brookes.ac.uk			AHRC [AH/E509398/1] Funding Source: UKRI; Wellcome Trust [096580/Z/11/A, 096580] Funding Source: Medline; Arts and Humanities Research Council [AH/E509398/1] Funding Source: researchfish	AHRC(UK Research & Innovation (UKRI)Arts & Humanities Research Council (AHRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Arts and Humanities Research Council(UK Research & Innovation (UKRI)Arts & Humanities Research Council (AHRC))			0	11	11	0	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG 25	2012	380	9843					722	723		10.1016/S0140-6736(12)61396-8	http://dx.doi.org/10.1016/S0140-6736(12)61396-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	995IK	22928190	Green Accepted, Bronze			2022-12-28	WOS:000308001300014
J	Afdhal, NH; Giannini, EG; Tayyab, G; Mohsin, A; Lee, JW; Andriulli, A; Jeffers, L; McHutchison, J; Chen, PJ; Han, KH; Campbell, F; Hyde, D; Brainsky, A; Theodore, D				Afdhal, Nezam H.; Giannini, Edoardo G.; Tayyab, Ghias; Mohsin, Aftab; Lee, Jin-Woo; Andriulli, Angelo; Jeffers, Lennox; McHutchison, John; Chen, Pei-Jer; Han, Kwang-Hyub; Campbell, Fiona; Hyde, Denise; Brainsky, Andres; Theodore, Dickens		ELEVATE Study Grp	Eltrombopag before Procedures in Patients with Cirrhosis and Thrombocytopenia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CHRONIC LIVER-DISEASE; PORTAL-VEIN THROMBOSIS; COAGULATION; ARTICLE	BACKGROUND Eltrombopag is an oral thrombopoietin-receptor agonist. This study evaluated the efficacy of eltrombopag for increasing platelet counts and reducing the need for platelet transfusions in patients with thrombocytopenia and chronic liver disease who are undergoing an elective invasive procedure. METHODS We randomly assigned 292 patients with chronic liver disease of diverse causes and platelet counts of less than 50,000 per cubic millimeter to receive eltrombopag, at a dose of 75 mg daily, or placebo for 14 days before a planned elective invasive procedure that was performed within 5 days after the last dose. The primary end point was the avoidance of a platelet transfusion before, during, and up to 7 days after the procedure. A key secondary end point was the occurrence of bleeding (World Health Organization [ WHO] grade 2 or higher) during this period. RESULTS A platelet transfusion was avoided in 104 of 145 patients who received eltrombopag (72%) and in 28 of 147 who received placebo (19%) (P<0.001). No significant difference between the eltrombopag and placebo groups was observed in bleeding episodes of WHO grade 2 or higher, which were reported in 17% and 23% of patients, respectively. Thrombotic events of the portal venous system were observed in 6 patients who received eltrombopag, as compared with 1 who received placebo, resulting in the early termination of the study. The incidence and severity of other adverse events were similar in the eltrombopag and placebo groups. CONCLUSIONS Eltrombopag reduced the need for platelet transfusions in patients with chronic liver disease who were undergoing elective invasive procedures, but it was associated with an increased incidence of portal-vein thrombosis, as compared with placebo. (Funded by GlaxoSmithKline; ELEVATE ClinicalTrials.gov number, NCT00678587.)	[Afdhal, Nezam H.] Beth Israel Deaconess Med Ctr, Div Gastroenterol, Ctr Liver, Boston, MA 02215 USA; [Giannini, Edoardo G.] Univ Genoa, Dept Internal Med, Gastroenterol Unit, I-16126 Genoa, Italy; [Andriulli, Angelo] Casa Sollievo Sofferenza Hosp, Div Gastroenterol, Dept Internal Med, San Giovanni Rotondo, Italy; [Tayyab, Ghias] Postgrad Med Inst, Dept Med Gastroenterol & Hepatol, Lahore, Pakistan; [Tayyab, Ghias] Lahore Gen Hosp, Lahore, Pakistan; [Mohsin, Aftab] Serv Inst Med Sci, Serv Hosp Lahore, Dept Gastroenterol, Lahore, Pakistan; [Lee, Jin-Woo] Inha Univ, Sch Med, Dept Internal Med, Div Hepatol, Inchon, South Korea; [Han, Kwang-Hyub] Yonsei Univ, Coll Med, Yonsei Inst Gastroenterol, Yonsei Liver Canc Special Clin,Dept Internal Med, Seoul, South Korea; [Jeffers, Lennox] Univ Miami, Miller Sch Med, Ctr Liver Dis, Miami, FL 33136 USA; [McHutchison, John] Duke Univ, Med Ctr, Duke Clin Res Inst, Durham, NC USA; [McHutchison, John] Duke Univ, Med Ctr, Div Gastroenterol, Durham, NC USA; [Chen, Pei-Jer] Natl Taiwan Univ, Coll Med, Hepatitis Res Ctr, Dept Internal Med,Grad Inst Clin Med, Taipei 10764, Taiwan; [Chen, Pei-Jer] Natl Taiwan Univ Hosp, Taipei, Taiwan; [Campbell, Fiona; Hyde, Denise] GlaxoSmithKline Stockley Pk, Oncol Clin Dev, Uxbridge, Middx, England; [Brainsky, Andres] GlaxoSmithKline Stockley Pk, Oncol Clin Dev, Collegeville, PA USA; [Theodore, Dickens] GlaxoSmithKline Stockley Pk, Oncol Clin Dev, Res Triangle Pk, NC USA	Harvard University; Beth Israel Deaconess Medical Center; University of Genoa; IRCCS Casa Sollievo Della Sofferenza; Inha University; Yonsei University; Yonsei University Health System; University of Miami; Duke University; Duke University; National Taiwan University; National Taiwan University; National Taiwan University Hospital; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline	Afdhal, NH (corresponding author), Beth Israel Deaconess Med Ctr, Div Gastroenterol, Ctr Liver, 110 Francis St,Suite 8E, Boston, MA 02215 USA.	nafdhal@bidmc.harvard.edu	Rafalskiy, Vladimir V/G-3172-2013; Andreone, Pietro/K-8050-2016; Andriulli, Angelo/B-5027-2017; Vargas, Hugo E./K-1562-2019; Giannini, Edoardo Giovanni/E-1120-2012	Rafalskiy, Vladimir V/0000-0002-2503-9580; Andreone, Pietro/0000-0002-4794-9809; Andriulli, Angelo/0000-0001-8862-7083; Vargas, Hugo E./0000-0002-7802-688X; Giannini, Edoardo Giovanni/0000-0001-8526-837X; cardenas, andres/0000-0002-0764-7873; Chen, Pei-Jer/0000-0001-8316-3785; Afdhal, Nezam/0000-0002-7342-6593; Kuliczkowski, Kazimierz/0000-0001-6812-1421; Finazzi, Renato Alberto/0000-0001-5494-1154; Xiol, Xavier/0000-0002-4461-4704	Vertex Pharmaceuticals; Merck; Pharmasset; Boehringer Ingelheim; Idera Pharmaceuticals; GlaxoSmithKline; Biolex Therapeutics; FibroGen; Human Genome Sciences; Quest Diagnostics; Novartis; Gilead Sciences; Abbott Laboratories; Bristol-Myers Squibb	Vertex Pharmaceuticals(Vertex Pharmaceuticals); Merck(Merck & Company); Pharmasset; Boehringer Ingelheim(Boehringer Ingelheim); Idera Pharmaceuticals; GlaxoSmithKline(GlaxoSmithKline); Biolex Therapeutics; FibroGen; Human Genome Sciences(GlaxoSmithKline); Quest Diagnostics; Novartis(Novartis); Gilead Sciences(Gilead Sciences); Abbott Laboratories(Abbott Laboratories); Bristol-Myers Squibb(Bristol-Myers Squibb)	Dr. Afdhal reports receiving consulting fees from Vertex Pharmaceuticals, Merck, Pharmasset, Boehringer Ingelheim, Idera Pharmaceuticals, GlaxoSmithKline, Biolex Therapeutics, FibroGen, Human Genome Sciences, Quest Diagnostics, and Novartis; receiving grant support from Vertex Pharmaceuticals, GlaxoSmithKline, Merck, Gilead Sciences, Pharmasset, and Abbott Laboratories; receiving stock options from Medgenics and Spring Bank Pharmaceuticals; receiving travel reimbursement from GlaxoSmithKline and Merck; and being a member of the board for Idenix Pharmaceuticals, Gilead Sciences, Merck, Medgenics, Spring Bank Pharmaceuticals, and Ligand; Dr. Giannini, being a member of the board and receiving grant support, consulting fees, lecture fees, and travel reimbursement from GlaxoSmithKline and participating as an expert witness at a Strategic Advisory Group meeting at the European Medicines Agency concerning eltrombopag for GlaxoSmithKline; Dr. McHutchison, being an employee of and owning stock in Gilead Sciences; Dr. Chen, receiving grant support and lecture fees from Bristol-Myers Squibb; receiving travel reimbursement from Bristol-Myers Squibb and Bayer; and being a member of the board for Bristol-Myers Squibb, Bayer, GlaxoSmithKline, and Roche; Dr. Han, receiving grant support from GlaxoSmithKline; Dr. Hyde, receiving travel reimbursement from GlaxoSmithKline and being an employee of and owning stock in GlaxoSmithKline; Ms. Campbell, being an employee of and owning stock in GlaxoSmithKline and receiving travel reimbursement from GlaxoSmithKline; Dr. Brainsky, being an employee of and owning stock in GlaxoSmithKline and holding two pending patents that relate to eltrombopag; and Dr. Theodore, being an employee of and owning stock in GlaxoSmithKline, and being the co-inventor on two eltrombopag patents held by GlaxoSmithKline. No other conflicts relevant to this article were reported.	Afdhal N, 2008, J HEPATOL, V48, P1000, DOI 10.1016/j.jhep.2008.03.009; Amitrano L, 2007, CLIN LAB, V53, P583; Bashour FN, 2000, AM J GASTROENTEROL, V95, P2936, DOI 10.1016/S0002-9270(00)01117-5; De Stefano V, 2010, INTERN EMERG MED, V5, P487, DOI 10.1007/s11739-010-0413-6; Giannini EG, 2010, CLIN GASTROENTEROL H, V8, P899, DOI 10.1016/j.cgh.2010.06.018; Giannini EG, 2006, ALIMENT PHARM THER, V23, P1055, DOI 10.1111/j.1365-2036.2006.02889.x; Heddle NM, 2003, TRANSFUSION, V43, P742, DOI 10.1046/j.1537-2995.2003.00418.x; Kamath PS, 2001, HEPATOLOGY, V33, P464, DOI 10.1053/jhep.2001.22172; Kulik LM, 2008, HEPATOLOGY, V47, P71, DOI 10.1002/hep.21980; Lisman T, 2010, J HEPATOL, V53, P362, DOI 10.1016/j.jhep.2010.01.042; McHutchison JG, 2007, NEW ENGL J MED, V357, P2227, DOI 10.1056/NEJMoa073255; Peck-Radosavljevic M, 2000, Can J Gastroenterol, V14 Suppl D, p60D; Poordad F, 2007, ALIMENT PHARM THER, V26, P5, DOI 10.1111/j.1365-2036.2007.03510.x; PUGH RNH, 1973, BRIT J SURG, V60, P646, DOI 10.1002/bjs.1800600817; Qamar AA, 2009, CLIN GASTROENTEROL H, V7, P689, DOI 10.1016/j.cgh.2009.02.021; Sallah S, 1999, POSTGRAD MED, V106, P187, DOI 10.3810/pgm.1999.10.1.720; Slichter Sherrill J, 2007, Hematology Am Soc Hematol Educ Program, P172, DOI 10.1182/asheducation-2007.1.172; Tripodi A, 2010, INTERN EMERG MED, V5, P7, DOI 10.1007/s11739-009-0302-z; Trotter James F, 2006, Clin Liver Dis, V10, P665, DOI 10.1016/j.cld.2006.08.006	19	208	216	0	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 23	2012	367	8					716	724		10.1056/NEJMoa1110709	http://dx.doi.org/10.1056/NEJMoa1110709			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	992CX	22913681	Bronze, Green Submitted			2022-12-28	WOS:000307754200006
J	Al-Ubaydli, M				Al-Ubaydli, Mohammad			Patients must have control of their medical records	BRITISH MEDICAL JOURNAL			English	Editorial Material									Patients Know Best, Cambridge CB1 8NR, England		Al-Ubaydli, M (corresponding author), Patients Know Best, Cambridge CB1 8NR, England.	mohammad@patientsknowbest.com							0	8	8	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	AUG 21	2012	345								e5575	10.1136/bmj.e5575	http://dx.doi.org/10.1136/bmj.e5575			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	996GP	22915690				2022-12-28	WOS:000308073200013
J	Ursano, RJ; Benedek, DM; Engel, CC				Ursano, Robert J.; Benedek, David M.; Engel, Charles C.			Trauma-Informed Care for Primary Care: The Lessons of War	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Ursano, Robert J.] Uniformed Serv Univ Hlth Sci, Sch Med, Dept Psychiat, Bethesda, MD 20814 USA	Uniformed Services University of the Health Sciences - USA	Ursano, RJ (corresponding author), Uniformed Serv Univ Hlth Sci, Sch Med, Dept Psychiat, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.	Robert.Ursano@usuhs.edu	Ursano, Robert J/ABE-6533-2020	Ursano, Robert/0000-0002-1861-9173; Engel, Charles/0000-0002-9232-3389				American College of Physicians, ACP DEPR CAR GUID; Benedek D. M., 2009, GUIDELINE WATCH MARC; Department of Defense Task Force on the Prevention of Suicide by Members of the Armed Forces, 2010, CHALL PROM STRENGH F; Kroenke K, 2010, GEN HOSP PSYCHIAT, V32, P345, DOI 10.1016/j.genhosppsych.2010.03.006; Kuehn BM, 2009, JAMA-J AM MED ASSOC, V301, P1111, DOI 10.1001/jama.2009.342; Ursano RJ, 2007, TEXTBOOK OF DISASTER PSYCHIATRY, P1, DOI 10.1017/CBO9780511544415; Ursano RJ, 2011, PREV CHRONIC DIS, V8	7	9	9	0	10	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 18	2012	157	12					905	U121		10.7326/0003-4819-157-11-201212040-00542	http://dx.doi.org/10.7326/0003-4819-157-11-201212040-00542			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	057SB	22964876				2022-12-28	WOS:000312583200020
J	Girirajan, S; Rosenfeld, JA; Coe, BP; Parikh, S; Friedman, N; Goldstein, A; Filipink, RA; McConnell, JS; Angle, B; Meschino, WS; Nezarati, MM; Asamoah, A; Jackson, KE; Gowans, GC; Martin, JA; Carmany, EP; Stockton, DW; Schnur, RE; Penney, LS; Martin, DM; Raskin, S; Leppig, K; Thiese, H; Smith, R; Aberg, E; Niyazov, DM; Escobar, LF; El-Khechen, D; Johnson, KD; Lebel, RR; Siefkas, K; Ball, S; Shur, N; McGuire, M; Brasington, CK; Spence, JE; Martin, LS; Clericuzio, C; Ballif, BC; Shaffer, LG; Eichler, EE				Girirajan, Santhosh; Rosenfeld, Jill A.; Coe, Bradley P.; Parikh, Sumit; Friedman, Neil; Goldstein, Amy; Filipink, Robyn A.; McConnell, Juliann S.; Angle, Brad; Meschino, Wendy S.; Nezarati, Marjan M.; Asamoah, Alexander; Jackson, Kelly E.; Gowans, Gordon C.; Martin, Judith A.; Carmany, Erin P.; Stockton, David W.; Schnur, Rhonda E.; Penney, Lynette S.; Martin, Donna M.; Raskin, Salmo; Leppig, Kathleen; Thiese, Heidi; Smith, Rosemarie; Aberg, Erika; Niyazov, Dmitriy M.; Escobar, Luis F.; El-Khechen, Dima; Johnson, Kisha D.; Lebel, Robert R.; Siefkas, Kiana; Ball, Susie; Shur, Natasha; McGuire, Marianne; Brasington, Campbell K.; Spence, J. Edward; Martin, Laura S.; Clericuzio, Carol; Ballif, Blake C.; Shaffer, Lisa G.; Eichler, Evan E.			Phenotypic Heterogeneity of Genomic Disorders and Rare Copy-Number Variants	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SMITH-MAGENIS-SYNDROME; MICRODELETION SYNDROME; DEVELOPMENTAL DELAY; MENTAL-RETARDATION; MULTIPLE GENES; AUTISM; SCHIZOPHRENIA; 16P11.2; MICRODUPLICATIONS; REARRANGEMENTS	Background Some copy-number variants are associated with genomic disorders with extreme phenotypic heterogeneity. The cause of this variation is unknown, which presents challenges in genetic diagnosis, counseling, and management. Methods We analyzed the genomes of 2312 children known to carry a copy- number variant associated with intellectual disability and congenital abnormalities, using array comparative genomic hybridization. Results Among the affected children, 10.1% carried a second large copy-number variant in addition to the primary genetic lesion. We identified seven genomic disorders, each defined by a specific copy-number variant, in which the affected children were more likely to carry multiple copy-number variants than were controls. We found that syndromic disorders could be distinguished from those with extreme phenotypic heterogeneity on the basis of the total number of copy-number variants and whether the variants are inherited or de novo. Children who carried two large copy-number variants of unknown clinical significance were eight times as likely to have developmental delay as were controls (odds ratio, 8.16; 95% confidence interval, 5.33 to 13.07; P = 2.11x10(-38)). Among affected children, inherited copy-number variants tended to co-occur with a second-site large copy-number variant (Spearman correlation coefficient, 0.66; P < 0.001). Boys were more likely than girls to have disorders of phenotypic heterogeneity (P < 0.001), and mothers were more likely than fathers to transmit second-site copy-number variants to their offspring (P = 0.02). Conclusions Multiple, large copy-number variants, including those of unknown pathogenic significance, compound to result in a severe clinical presentation, and secondary copy-number variants are preferentially transmitted from maternal carriers. (Funded by the Simons Foundation Autism Research Initiative and the National Institutes of Health.)	[Eichler, Evan E.] Univ Washington, Sch Med, Howard Hughes Med Inst, Dept Genome Sci, Seattle, WA 98195 USA; [Rosenfeld, Jill A.; Ballif, Blake C.; Shaffer, Lisa G.] PerkinElmer, Signature Genom Labs, Spokane, WA USA; [Martin, Judith A.] Providence Sacred Heart Hosp, Spokane, WA USA; [Leppig, Kathleen; Thiese, Heidi] Grp Hlth Cooperat Puget Sound, Seattle, WA USA; [Siefkas, Kiana; Ball, Susie] Yakima Valley Mem Hosp, Yakima, WA USA; [Parikh, Sumit; Friedman, Neil] Cleveland Clin, Cleveland, OH USA; [Goldstein, Amy; Filipink, Robyn A.] Univ Pittsburgh, Childrens Hosp Pittsburgh, Div Child Neurol, Med Ctr, Pittsburgh, PA 15213 USA; [McConnell, Juliann S.; McGuire, Marianne] Univ Pittsburgh, Childrens Hosp Pittsburgh, Dept Pediat, Med Ctr, Pittsburgh, PA 15213 USA; [McGuire, Marianne] Univ Pittsburgh, Sch Med, Dept Pediat, Pittsburgh, PA 15261 USA; [Angle, Brad] Rush Univ, Med Ctr, Ann & Robert H Lurie Childrens Hosp, Chicago, IL 60612 USA; [Johnson, Kisha D.] Rush Univ, Med Ctr, Dept Pediat, Chicago, IL 60612 USA; [Meschino, Wendy S.; Nezarati, Marjan M.] N York Gen Hosp, Toronto, ON, Canada; [Penney, Lynette S.] Dalhousie Univ, Dept Pediat, Halifax, NS, Canada; [Aberg, Erika] Izaak Walton Killam Hlth Ctr, Halifax, NS, Canada; [Asamoah, Alexander; Jackson, Kelly E.; Gowans, Gordon C.] Univ Louisville, Dept Pediat, Weisskopf Child Evaluat Ctr, Louisville, KY 40292 USA; [Carmany, Erin P.; Stockton, David W.] Childrens Hosp Michigan, Detroit, MI 48201 USA; [Martin, Donna M.] Univ Michigan, Med Ctr, Dept Pediat, Ann Arbor, MI 48109 USA; [Martin, Donna M.] Univ Michigan, Med Ctr, Dept Human Genet, Ann Arbor, MI 48109 USA; [Schnur, Rhonda E.] Rowan Univ, Cooper Med Sch, Dept Pediat, Div Genet, Camden, NJ USA; [Raskin, Salmo] Pontificia Univ Catolica Parana, Ctr Biol & Hlth Sci, Grad Program Hlth Sci, Grp Adv Mol Invest, Curitiba, Parana, Brazil; [Raskin, Salmo] Ctr Aconselhamento & Lab Genet, Curitiba, Parana, Brazil; [Niyazov, Dmitriy M.] Ochsner Clin Fdn, Dept Pediat, New Orleans, LA USA; [Escobar, Luis F.; El-Khechen, Dima] Peyton Manning Childrens Hosp St Vincent, Indianapolis, IN USA; [Lebel, Robert R.] SUNY Upstate Med Univ, Syracuse, NY USA; [Shur, Natasha] Rhode Isl Hosp, Hasbro Childrens Hosp, Providence, RI USA; [Brasington, Campbell K.; Spence, J. Edward] Carolinas Med Ctr, Levine Childrens Hosp, Dept Pediat, Charlotte, NC 28203 USA; [Martin, Laura S.] Nemours Childrens Clin, Jacksonville, FL USA; [Clericuzio, Carol] Univ New Mexico, Div Pediat Genet, Hlth Sci Ctr, Div Clin Genet Dysmorphol, Albuquerque, NM 87131 USA	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; Group Health Cooperative; Cleveland Clinic Foundation; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Ann & Robert H. Lurie Children's Hospital of Chicago; Rush University; Rush University; University of Toronto; University Toronto Affiliates; North York General Hospital; Dalhousie University; Dalhousie University; University of Louisville; Children's Hospital of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Rowan University; Cooper Medical School of Rowan University; Pontificia Universidade Catolica do Parana; Ochsner Health System; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; Hasbro Children's Hospital; Lifespan Health Rhode Island; Rhode Island Hospital; Carolinas Medical Center; University of New Mexico; University of New Mexico's Health Sciences Center	Eichler, EE (corresponding author), Univ Washington, Sch Med, Howard Hughes Med Inst, Dept Genome Sci, Foege S-413A,Box 355065,3720 15th Ave NE, Seattle, WA 98195 USA.	eee@gs.washington.edu	Coe, Bradley/A-2878-2009; Raskin, Salmo/C-4155-2013; Girirajan, Santhosh/AAR-3659-2020	Coe, Bradley/0000-0001-8471-4016; Martin, Donna/0000-0002-8070-2007; Friedman, Neil/0000-0002-7349-7981	Simons Foundation Autism Research Initiative; National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD065285] Funding Source: NIH RePORTER	Simons Foundation Autism Research Initiative; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Funded by the Simons Foundation Autism Research Initiative and the National Institutes of Health.	Andrieux J, 2009, AM J MED GENET A, V149A, P2813, DOI 10.1002/ajmg.a.33097; Antonell A, 2010, J MED GENET, V47, P312, DOI 10.1136/jmg.2009.071712; Ballif BC, 2008, CLIN GENET, V74, P469, DOI 10.1111/j.1399-0004.2008.01094.x; Ballif BC, 2008, MOL CYTOGENET, V1, DOI 10.1186/1755-8166-1-8; Bruno DL, 2010, J MED GENET, V47, P299, DOI 10.1136/jmg.2009.069906; Cooper GM, 2011, NAT GENET, V43, P838, DOI 10.1038/ng.909; de Vries BBA, 2001, J MED GENET, V38, P145, DOI 10.1136/jmg.38.3.145; Dipple KM, 2000, AM J HUM GENET, V66, P1729, DOI 10.1086/302938; Duker AL, 2010, EUR J HUM GENET, V18, P1196, DOI 10.1038/ejhg.2010.102; Feenstra I, 2011, EUR J HUM GENET, V19, P1152, DOI 10.1038/ejhg.2011.120; Girirajan S, 2006, GENET MED, V8, P417, DOI 10.1097/01.gim.0000228215.32110.89; Girirajan S, 2010, HUM MOL GENET, V19, pR176, DOI 10.1093/hmg/ddq366; Girirajan S, 2010, NAT GENET, V42, P203, DOI 10.1038/ng.534; Greenway SC, 2009, NAT GENET, V41, P931, DOI 10.1038/ng.415; Helbig I, 2009, NAT GENET, V41, P160, DOI 10.1038/ng.292; Itsara A, 2009, AM J HUM GENET, V84, P148, DOI 10.1016/j.ajhg.2008.12.014; Kaminsky EB, 2011, GENET MED, V13, P777, DOI 10.1097/GIM.0b013e31822c79f9; Leonard H, 2002, MENT RETARD DEV D R, V8, P117, DOI 10.1002/mrdd.10031; Liburd N, 2001, HUM GENET, V109, P535, DOI 10.1007/s004390100604; McCarthy SE, 2009, NAT GENET, V41, P1223, DOI 10.1038/ng.474; Mefford HC, 2008, NEW ENGL J MED, V359, P1685, DOI 10.1056/NEJMoa0805384; Mefford HC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000962; Mefford HC, 2009, GENOME RES, V19, P1579, DOI 10.1101/gr.094987.109; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; Pagnamenta AT, 2009, EUR J HUM GENET, V17, P687, DOI 10.1038/ejhg.2008.228; Raj A, 2010, NATURE, V463, P913, DOI 10.1038/nature08781; Ropers HH, 2010, ANNU REV GENOM HUM G, V11, P161, DOI 10.1146/annurev-genom-082509-141640; Rosenfeld JA, 2011, EUR J HUM GENET, V19, P547, DOI 10.1038/ejhg.2010.237; Rosenfeld JA, 2010, J NEURODEV DISORD, V2, P26, DOI 10.1007/s11689-009-9037-4; Sanders SJ, 2011, NEURON, V70, P863, DOI 10.1016/j.neuron.2011.05.002; Sarasua SM, 2011, J MED GENET, V48, P761, DOI 10.1136/jmedgenet-2011-100225; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Sharp AJ, 2008, NAT GENET, V40, P322, DOI 10.1038/ng.93; Stankiewicz P, 2010, ANNU REV MED, V61, P437, DOI 10.1146/annurev-med-100708-204735; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Walters RG, 2010, NATURE, V463, P671, DOI 10.1038/nature08727; Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974	38	392	403	0	44	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 4	2012	367	14					1321	1331		10.1056/NEJMoa1200395	http://dx.doi.org/10.1056/NEJMoa1200395			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	014WJ	22970919	Green Accepted			2022-12-28	WOS:000309406100008
J	Kerstjens, HAM; Engel, M; Dahl, R; Paggiaro, P; Beck, E; Vandewalker, M; Sigmund, R; Seibold, W; Moroni-Zentgraf, P; Bateman, ED				Kerstjens, Huib A. M.; Engel, Michael; Dahl, Ronald; Paggiaro, Pierluigi; Beck, Ekkehard; Vandewalker, Mark; Sigmund, Ralf; Seibold, Wolfgang; Moroni-Zentgraf, Petra; Bateman, Eric D.			Tiotropium in Asthma Poorly Controlled with Standard Combination Therapy	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LUNG-FUNCTION; QUESTIONNAIRE	BACKGROUND Some patients with asthma have frequent exacerbations and persistent airflow obstruction despite treatment with inhaled glucocorticoids and long-acting beta-agonists (LABAs). METHODS In two replicate, randomized, controlled trials involving 912 patients with asthma who were receiving inhaled glucocorticoids and LABAs, we compared the effect on lung function and exacerbations of adding tiotropium (a total dose of 5 mu g) or placebo, both delivered by a soft-mist inhaler once daily for 48 weeks. All the patients were symptomatic, had a post-bronchodilator forced expiratory volume in 1 second (FEV1) of 80% or less of the predicted value, and had a history of at least one severe exacerbation in the previous year. RESULTS The patients had a mean baseline FEV1 of 62% of the predicted value; the mean age was 53 years. At 24 weeks, the mean (+/- SE) change in the peak FEV1 from baseline was greater with tiotropium than with placebo in the two trials: a difference of 86 +/- 34 ml in trial 1 (P=0.01) and 154 +/- 32 ml in trial 2 (P<0.001). The predose (trough) FEV1 also improved in trials 1 and 2 with tiotropium, as compared with placebo: a difference of 88 +/- 31 ml (P=0.01) and 111 +/- 30 ml (P<0.001), respectively. The addition of tiotropium increased the time to the first severe exacerbation (282 days vs. 226 days), with an overall reduction of 21% in the risk of a severe exacerbation (hazard ratio, 0.79; P=0.03). No deaths occurred; adverse events were similar in the two groups. CONCLUSIONS In patients with poorly controlled asthma despite the use of inhaled glucocorticoids and LABAs, the addition of tiotropium significantly increased the time to the first severe exacerbation and provided modest sustained bronchodilation. (Funded by Boehringer Ingelheim and Pfizer; ClinicalTrials.gov numbers, NCT00772538 and NCT00776984.)	[Kerstjens, Huib A. M.] Univ Groningen, Dept Pulmonol, Univ Med Ctr Groningen, NL-9700 RB Groningen, Netherlands; [Kerstjens, Huib A. M.] Univ Med Ctr Groningen, Dept Pulm Med & TB, NL-9713 AV Groningen, Netherlands; [Kerstjens, Huib A. M.] Groningen Res Inst Asthma & COPD, Groningen, Netherlands; [Engel, Michael; Moroni-Zentgraf, Petra] Boehringer Ingelheim Pharma GmbH & Co KG, Therapeut Area Resp Dis, Ingelheim, Germany; [Beck, Ekkehard] Inst Gesundheitsforderung, Dept Med, Rudersdorf Brandenburg, Germany; [Sigmund, Ralf] Boehringer Ingelheim Pharma GmbH & Co KG, Biostat, Biberach, Germany; [Seibold, Wolfgang] Boehringer Ingelheim Pharma GmbH & Co KG, Clin Res, Biberach, Germany; [Dahl, Ronald] Aarhus Univ Hosp, Dept Resp Dis, DK-8000 Aarhus, Denmark; [Paggiaro, Pierluigi] Univ Hosp Pisa, CardioThorac Dept, Pulm Unit, Pisa, Italy; [Vandewalker, Mark] Clin Res Ozarks, Clin Trials, Columbia, MO USA; [Bateman, Eric D.] Univ Cape Town, Dept Med, ZA-7925 Cape Town, South Africa	University of Groningen; University of Groningen; Boehringer Ingelheim; Boehringer Ingelheim; Boehringer Ingelheim; Aarhus University; University of Pisa; Azienda Ospedaliero Universitaria Pisana; University of Cape Town	Kerstjens, HAM (corresponding author), Univ Groningen, Dept Pulmonol, Univ Med Ctr Groningen, POB 30-001, NL-9700 RB Groningen, Netherlands.	h.a.m.kerstjens@umcg.nl	Dahl, Ronahl/F-8170-2013; Kerstjens, Huib/N-4754-2017	Kerstjens, Huib/0000-0001-7705-7927	Boehringer Ingelheim; Pfizer; Nycomed; Novartis; Almirall; Chiesi; GlaxoSmithKline; Merck; Takeda/Nycomed; AstraZeneca; Menarini; ALK-Abello; Navigant Consulting; IMS Consulting Group; Hoffmann-La Roche	Boehringer Ingelheim(Boehringer Ingelheim); Pfizer(Pfizer); Nycomed; Novartis(Novartis); Almirall(Almirall); Chiesi(Chiesi Pharmaceuticals Inc); GlaxoSmithKline(GlaxoSmithKline); Merck(Merck & Company); Takeda/Nycomed; AstraZeneca(AstraZeneca); Menarini(Menarini Group); ALK-Abello; Navigant Consulting; IMS Consulting Group; Hoffmann-La Roche(Hoffmann-La Roche)	Supported by Boehringer Ingelheim and Pfizer.; Dr. Kerstjens reports receiving on behalf of his institution consulting fees or honoraria and support from Boehringer Ingelheim for his travel to meetings or for other purposes connected with this clinical study and support from Boehringer Ingelheim, Pfizer, Nycomed, Novartis, Almirall, and Chiesi for his service on advisory boards and from Boehringer Ingelheim, Pfizer, and Nycomed for consulting work; Dr. Engel, being an employee of Boehringer Ingelheim; Dr. Dahl, receiving consulting fees and travel support from Boehringer Ingelheim connected with this clinical study and receiving on behalf of his institution a grant from Boehringer Ingelheim connected with this clinical study; Dr. Paggiaro, receiving consulting fees from Boehringer Ingelheim in connection with this study, support for service on advisory boards from GlaxoSmithKline, Merck, Novartis, and Takeda/Nycomed, and lecture fees from AstraZeneca, Chiesi, GlaxoSmithKline, Menarini, Novartis, and Takeda/Nycomed and serving on the board of directors for the Global Initiative for Asthma and receiving on behalf of his institution grant support from Boehringer Ingelheim in connection with this clinical study; Dr. Beck, receiving support for participation in review activities and for travel from Boehringer Ingelheim in connection with this study, support from Almirall and Mundipharma for service on advisory boards, and lecture fees from AstraZeneca, Bayer, Novartis, and Takeda/Nycomed and receiving on behalf of his institution grant support related to this clinical study from Boehringer Ingelheim; Dr. Vandewalker, receiving consulting fees, support to participate in review activities, and travel support and receiving on behalf of his institution a grant from Boehringer Ingelheim connected with this clinical study, receiving grant support from Boehringer Ingelheim, and receiving lecture fees from GlaxoSmithKline, AstraZeneca, and Merck; Drs. Sigmund, Seibold, and Moroni-Zentgraf, being employees of Boehringer Ingelheim; Dr. Bateman, receiving consulting fees and support to review results and receiving on behalf of his institution a grant and travel support from Boehringer Ingelheim related to this clinical study, receiving lecture fees from Boehringer Ingelheim, GlaxoSmithKline, AstraZeneca, ALK-Abello, Chiesi, Novartis, Pfizer, and Takeda/Nycomed, receiving support for service on advisory boards for Almirall, AstraZeneca, Boehringer Ingelheim, Elevation Pharma, GlaxoSmithKline, Napp Pharma, Novartis, Forest, and Merck, receiving consulting fees from Navigant Consulting, IMS Consulting Group, ALK-Abello, Almirall, and Hoffmann-La Roche, receiving support for his participation in educational presentations for Indegene Life-systems, and being a member of the Task Force on Severe Asthma of the American Thoracic Society and the European Respiratory Society and an advisory board member for the Global Initiative for Asthma. No other potential conflict of interest relevant to this article was reported.	Bateman ED, 2004, AM J RESP CRIT CARE, V170, P836, DOI 10.1164/rccm.200401-033OC; Bateman ED, 2011, J ALLERGY CLIN IMMUN, V128, P315, DOI 10.1016/j.jaci.2011.06.004; Cui L, 1999, BIOMETRICS, V55, P853, DOI 10.1111/j.0006-341X.1999.00853.x; Global Initiative for Asthma, 2011, GLOB STRAT ASTHM MAN; Juniper EF, 1999, EUR RESPIR J, V14, P902, DOI 10.1034/j.1399-3003.1999.14d29.x; JUNIPER EF, 1992, THORAX, V47, P76, DOI 10.1136/thx.47.2.76; Kerstjens HAM, 2011, J ALLERGY CLIN IMMUN, V128, P308, DOI 10.1016/j.jaci.2011.04.039; Matera MG, 2007, DRUGS, V67, P503, DOI 10.2165/00003495-200767040-00002; Peters SP, 2010, NEW ENGL J MED, V363, P1715, DOI 10.1056/NEJMoa1008770; QUANJER PH, 1993, EUR RESPIR J, V6, P5, DOI 10.1183/09041950.005s1693; Reddel HK, 2009, AM J RESP CRIT CARE, V180, P59, DOI 10.1164/rccm.200801-060ST; Tashkin DP, 2008, NEW ENGL J MED, V359, P1543, DOI 10.1056/NEJMoa0805800; van Noord JA, 2005, EUR RESPIR J, V26, P214, DOI 10.1183/09031936.05.00140404	13	462	480	1	24	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 27	2012	367	13					1198	1207		10.1056/NEJMoa1208606	http://dx.doi.org/10.1056/NEJMoa1208606			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	011JO	22938706				2022-12-28	WOS:000309161100006
J	Puri, S; Hebrok, M				Puri, Sapna; Hebrok, Matthias			Diabetic beta Cells: To Be or Not To Be?	CELL			English	Editorial Material									[Puri, Sapna; Hebrok, Matthias] Univ Calif San Francisco, Dept Med, Ctr Diabet, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Hebrok, M (corresponding author), Univ Calif San Francisco, Dept Med, Ctr Diabet, San Francisco, CA 94143 USA.	mhebrok@diabetes.ucsf.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK060533] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK60533, R01 DK060533] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Buteau J, 2007, DIABETES OBES METAB, V9, P140, DOI 10.1111/j.1463-1326.2007.00782.x; Chang-Chen KJ, 2008, REV ENDOCR METAB DIS, V9, P329, DOI 10.1007/s11154-008-9101-5; Collombat P, 2007, J CLIN INVEST, V117, P961, DOI 10.1172/JCI29115; Landsman L, 2011, P NATL ACAD SCI USA, V108, P17010, DOI 10.1073/pnas.1105404108; Oslowski CM, 2011, CURR OPIN CELL BIOL, V23, P207, DOI 10.1016/j.ceb.2010.11.005; Talchai C, 2012, CELL, V150, P1223, DOI 10.1016/j.cell.2012.07.029; Thorel F, 2010, NATURE, V464, P1149, DOI 10.1038/nature08894	7	21	21	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 14	2012	150	6					1103	1104		10.1016/j.cell.2012.08.021	http://dx.doi.org/10.1016/j.cell.2012.08.021			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	007ZY	22980973	Bronze, Green Accepted			2022-12-28	WOS:000308928100004
J	Andersson, C; Lyngbaek, S; Nguyen, CD; Nielsen, M; Gislason, GH; Kober, L; Torp-Pedersen, C				Andersson, Charlotte; Lyngbaek, Stig; Cu Dinh Nguyen; Nielsen, Mia; Gislason, Gunnar H.; Kober, Lars; Torp-Pedersen, Christian			Association of Clopidogrel Treatment With Risk of Mortality and Cardiovascular Events Following Myocardial Infarction in Patients With and Without Diabetes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PERCUTANEOUS CORONARY INTERVENTION; ORAL ANTIPLATELET THERAPY; ARTERY-DISEASE; PRACTICE GUIDELINES; FOCUSED UPDATE; HEART-FAILURE; TASK-FORCE; ASPIRIN; PRASUGREL; INHIBITION	Context Pharmacodynamic studies have shown that persistently high platelet reactivity is common in patients with diabetes in spite of clopidogrel treatment. Clinical trials have not convincingly demonstrated that clopidogrel benefits patients with diabetes as much patients without diabetes. Objectives To estimate the clinical effectiveness associated with clopidogrel treatment after myocardial infarction (MI) in patients with diabetes. Design, Setting, and Patients By individual-level linkage of the Danish nationwide administrative registries between 2002-2009, patients who were hospitalized with incident MI and who had survived and not undergone coronary artery bypass surgery 30 days after discharge were followed up for as long as 1 year (maximally until December 31, 2009). Adjusted for age, sex, comorbidity, calendar year, concomitant pharmacotherapy, and invasive interventions, hazard ratios that were associated with clopidogrel in patients with and without diabetes were analyzed by Cox proportional-hazard models and propensity score-matched models. Main Outcome Measures All-cause mortality, cardiovascular mortality, and a composite end point of recurrent MI and all-cause mortality. Results Of the 58 851 patients included in the study, 7247 (12%) had diabetes and 35 380 (60%) received clopidogrel. In total, 1790 patients (25%) with diabetes and 7931 patients (15%) without diabetes met the composite end point. Of these, 1225 (17%) with and 5377 (10%) without diabetes died. In total, 978 patients (80%) with and 4100 patients (76%) without diabetes died of events of cardiovascular origin. For patients with diabetes who were treated with clopidogrel, the unadjusted mortality rates (events/100 person-years) were 13.4 (95% CI, 12.8-14.0) vs 29.3 (95% CI, 28.3-30.4) for those not treated. For patients without diabetes who were treated with clopidogrel, the unadjusted mortality rates were 6.4 (95% CI, 6.3-6.6) vs 21.3 (95% CI, 21.0-21.7) for those not treated. However, among patients with diabetes vs those without diabetes, clopidogrel was associated with less effectiveness for all-cause mortality (HR, 0.89 [95% CI, 0.79-1.00] vs 0.75 [95% CI, 0.70-0.80]; P for interaction, .001) and for cardiovascular mortality (HR, 0.93 [95% CI, 0.81-1.06] vs 0.77 [95% CI, 0.72-0.83]; P for interaction, .01) but not for the composite end point (HR, 1.00 [95% CI, 0.91-1.10] vs 0.91 [95% CI, 0.87-0.96]; P for interaction, .08). Propensity score-matched models gave similar results. Conclusion Among patients with diabetes compared with patients without diabetes, the use of conventional clopidogrel treatment after MI was associated with lower reduction in the risk of all-cause death and cardiovascular death. JAMA. 2012;308(9):882-889	[Andersson, Charlotte; Lyngbaek, Stig; Cu Dinh Nguyen; Nielsen, Mia; Gislason, Gunnar H.; Torp-Pedersen, Christian] Gentofte Univ Hosp, Dept Cardiol, DK-2900 Hellerup, Denmark; [Kober, Lars] Univ Copenhagen, Rigshosp, Dept Cardiol, Ctr Heart, DK-1168 Copenhagen, Denmark	University of Copenhagen; Herlev & Gentofte Hospital; Rigshospitalet; University of Copenhagen	Andersson, C (corresponding author), Gentofte Univ Hosp, Dept Cardiol, Niels Andersens Vej 65, DK-2900 Hellerup, Denmark.	ca@heart.dk	Andersson, Charlotte/P-4849-2014; Gislason, Gunnar/B-7561-2009; Torp-Pedersen, Christian/E-5931-2013	Gislason, Gunnar/0000-0002-0548-402X; Kober, Lars/0000-0002-6635-1466	Bristol-Myers Squibb; Sanofi; internal research foundation at Department of Cardiology, Gentofte Hospital	Bristol-Myers Squibb(Bristol-Myers Squibb); Sanofi(Sanofi-Aventis); internal research foundation at Department of Cardiology, Gentofte Hospital	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Kober reported that he has received honorarium as speaker for Servier. Dr Torp-Pedersen reported that he has served on advisory boards and served on study steering committees for Cardiome, Sanofi, and Merck; and has obtained research grants from Bristol-Myers Squibb, and Sanofi. Dr Andersson reported receiving a month's salary for work on the study.; The study was founded by an internal research foundation at Department of Cardiology, Gentofte Hospital.	Andersson C, 2011, DIABETES CARE, V34, P1788, DOI 10.2337/dc11-0154; Andersson C, 2010, ESSENTIAL DURER, P12; Angiolillo DJ, 2005, DIABETES, V54, P2430, DOI 10.2337/diabetes.54.8.2430; Angiolillo DJ, 2007, J AM COLL CARDIOL, V50, P1541, DOI 10.1016/j.jacc.2007.05.049; Angiolillo DJ, 2007, CIRCULATION, V115, P708, DOI 10.1161/CIRCULATIONAHA.106.667741; Bhatt DL, 2006, NEW ENGL J MED, V354, P1706, DOI 10.1056/NEJMoa060989; Eshaghian S, 2006, AM J CARDIOL, V97, P1759, DOI 10.1016/j.amjcard.2005.12.072; Gaist D, 1997, DAN MED BULL, V44, P445; Gurbel PA, 2012, JAMA-J AM MED ASSOC, V307, P2495, DOI 10.1001/jama.2012.5930; Haffner SM, 1998, NEW ENGL J MED, V339, P229, DOI 10.1056/NEJM199807233390404; Hamm CW, 2011, EUR HEART J, V32, P2999, DOI 10.1093/eurheartj/ehr236; Jernberg T, 2006, EUR HEART J, V27, P1166, DOI 10.1093/eurheartj/ehi877; Kumler T, 2008, EUR J HEART FAIL, V10, P658, DOI 10.1016/j.ejheart.2008.05.006; Kushner FG, 2009, J AM COLL CARDIOL, V54, P2205, DOI [10.1016/j.jacc.2009.10.015, 10.1002/ccd.22351]; Ferreiro JL, 2011, CIRCULATION, V123, P798, DOI 10.1161/CIRCULATIONAHA.109.913376; Madsen M, 2003, J CLIN EPIDEMIOL, V56, P124, DOI 10.1016/S0895-4356(02)00591-7; Norgaard ML, 2010, DIABETOLOGIA, V53, P1612, DOI 10.1007/s00125-010-1783-z; Schramm TK, 2008, CIRCULATION, V117, P1945, DOI 10.1161/CIRCULATIONAHA.107.720847; Sorensen R, 2011, J AM COLL CARDIOL, V57, P1202, DOI 10.1016/j.jacc.2010.09.069; Sorensen R, 2010, BMC CARDIOVASC DISOR, V10, DOI 10.1186/1471-2261-10-6; Sorensen R, 2009, LANCET, V374, P1967, DOI 10.1016/S0140-6736(09)61751-7; Steinhubl SR, 2002, JAMA-J AM MED ASSOC, V288, P2411, DOI 10.1001/jama.288.19.2411; Tu JV, 2001, J AM COLL CARDIOL, V37, P992, DOI 10.1016/S0735-1097(01)01109-3; Wallentin L, 2009, NEW ENGL J MED, V361, P1045, DOI 10.1056/NEJMoa0904327; Wiviott SD, 2008, CIRCULATION, V118, P1626, DOI 10.1161/CIRCULATIONAHA.108.791061; Wiviott SD, 2007, CIRCULATION, V116, P2923, DOI 10.1161/CIRCULATIONAHA.107.740324; Wiviott SD, 2007, NEW ENGL J MED, V357, P2001, DOI 10.1056/NEJMoa0706482; Wright RS, 2011, J AM COLL CARDIOL, V57, P1920, DOI 10.1016/j.jacc.2011.02.009; Yusuf S, 2001, NEW ENGL J MED, V345, P494	29	41	42	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 5	2012	308	9					882	889		10.1001/2012.jama.10779	http://dx.doi.org/10.1001/2012.jama.10779			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	999ET	22948698	Bronze			2022-12-28	WOS:000308292900018
J	Kaess, BM; Rong, J; Larson, MG; Hamburg, NM; Vita, JA; Levy, D; Benjamin, EJ; Vasan, RS; Mitchell, GF				Kaess, Bernhard M.; Rong, Jian; Larson, Martin G.; Hamburg, Naomi M.; Vita, Joseph A.; Levy, Daniel; Benjamin, Emelia J.; Vasan, Ramachandran S.; Mitchell, Gary F.			Aortic Stiffness, Blood Pressure Progression, and Incident Hypertension	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PULSE-WAVE VELOCITY; FLOW-MEDIATED DILATION; CORONARY-HEART-DISEASE; ARTERIAL STIFFNESS; CARDIOVASCULAR EVENTS; RISK-FACTORS; INDEPENDENT PREDICTOR; COMMUNITY; INCREASE; ADULTS	Context Vascular stiffness increases with advancing age and is a major risk factor for age-related morbidity and mortality. Vascular stiffness and blood pressure pulsatility are related; however, temporal relationships between vascular stiffening and blood pressure elevation have not been fully delineated. Objective To examine temporal relationships among vascular stiffness, central hemodynamics, microvascular function, and blood pressure progression. Design, Setting, and Participants Longitudinal community-based cohort study conducted in Framingham, Massachusetts. The present investigation is based on the 2 latest examination cycles (cycle 7: 1998-2001; cycle 8: 2005-2008 [last visit: January 25, 2008]) of the Framingham Offspring study (recruited: 1971-1975). Temporal relationships among blood pressure and 3 measures of vascular stiffness and pressure pulsatility derived from arterial tonometry (carotid-femoral pulse wave velocity [CFPWV], forward wave amplitude [FWA], and augmentation index) were examined over a 7-year period in 1759 participants (mean [SD] age: 60 [9] years; 974 women). Main Outcome Measures The primary outcomes were blood pressure and incident hypertension during examination cycle 8. The secondary outcomes were CFPWV, FWA, and augmentation index during examination cycle 8. Results In a multivariable-adjusted regression model, higher FWA (beta, 1.3 [95% CI, 0.5-2.1] mm Hg per 1 SD; P = .002) and higher CFPWV (beta, 1.5 [95% CI, 0.5-2.6] mm Hg per 1 SD; P = .006) during examination cycle 7 were jointly associated with systolic blood pressure during examination cycle 8. Similarly, in a model that included systolic and diastolic blood pressure and additional risk factors during examination cycle 7, higher FWA (odds ratio [OR], 1.6 [95% CI, 1.3-2.0] per 1 SD; P < .001), augmentation index (OR, 1.7 [95% CI, 1.4-2.0] per 1 SD; P < .001), and CFPWV (OR, 1.3 [95% CI, 1.0-1.6] per 1 SD; P = .04) were associated with incident hypertension during examination cycle 8 (338 cases [32%] in 1048 participants without hypertension during examination cycle 7). Conversely, blood pressure during examination cycle 7 was not associated with CFPWV during examination cycle 8. Higher resting brachial artery flow (OR, 1.23 [95% CI, 1.04-1.46]) and lower flow-mediated dilation (OR, 0.80 [95% CI, 0.67-0.96]) during examination cycle 7 were associated with incident hypertension (in models that included blood pressure and tonometry measures collected during examination cycle 7). Conclusion In this cohort, higher aortic stiffness, FWA, and augmentation index were associated with higher risk of incident hypertension; however, initial blood pressure was not independently associated with risk of progressive aortic stiffening. JAMA. 2012;308(9):875-881	[Mitchell, Gary F.] Cardiovasc Engn Inc, Norwood, MA 02062 USA; [Kaess, Bernhard M.; Rong, Jian; Levy, Daniel; Benjamin, Emelia J.; Vasan, Ramachandran S.] NHLBI, Framingham Heart Study, Framingham, MA USA; [Kaess, Bernhard M.] Univ Hosp Regensburg, Klin & Poliklin Innere Med 2, Regensburg, Germany; [Larson, Martin G.] Boston Univ, Dept Math & Stat, Boston, MA 02215 USA; [Larson, Martin G.] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Benjamin, Emelia J.; Vasan, Ramachandran S.] Boston Univ, Prevent Med & Epidemiol Sect, Boston, MA 02215 USA; [Benjamin, Emelia J.; Vasan, Ramachandran S.] Boston Univ, Cardiol Sect, Boston, MA 02215 USA; [Hamburg, Naomi M.; Vita, Joseph A.; Benjamin, Emelia J.; Vasan, Ramachandran S.] Boston Univ, Sch Med, Evans Dept Med, Boston, MA 02118 USA; [Hamburg, Naomi M.; Vita, Joseph A.; Benjamin, Emelia J.; Vasan, Ramachandran S.] Boston Univ, Sch Med, Whitaker Cardiovasc Inst, Boston, MA 02118 USA; [Levy, Daniel] NHLBI, Bethesda, MD 20892 USA	Cardiovascular Engineering; Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Regensburg; Boston University; Boston University; Boston University; Boston University; Boston University; Boston University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Mitchell, GF (corresponding author), Cardiovasc Engn Inc, 1 Edgewater Dr,Ste 201A, Norwood, MA 02062 USA.	garyfmitchell@mindspring.com	Hamburg, Naomi/AAY-6685-2020; Levy, Daniel/ABF-6873-2021; Levy, Daniel/ABB-2752-2021; Ramachandran, Vasan/Y-2527-2019; Stefanadis, Christodoulos/ABH-2232-2020; Benjamin, Emelia/E-7103-2011	Levy, Daniel/0000-0003-1843-8724; Ramachandran, Vasan/0000-0001-7357-5970; Stefanadis, Christodoulos/0000-0001-5974-6454; Benjamin, Emelia/0000-0003-4076-2336; Hamburg, Naomi/0000-0001-5504-5589; Vita, Joseph/0000-0001-5607-1797; Larson, Martin/0000-0002-9631-1254	National Institutes of Health, National Heart, Lung, and Blood Institute [NO1-HC25195, HL076784, AG028321, HL070100, HL060040, HL080124, HL071039, HL077447, HL107385]; Donald W. Reynolds Foundation; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC025195] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076784, R01HL107385, R01HL080124, R01HL071039, R01HL070100, R01HL077447, ZIAHL006001, R01HL060040] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG028321] Funding Source: NIH RePORTER	National Institutes of Health, National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Donald W. Reynolds Foundation; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported through contracts NO1-HC25195, HL076784, AG028321, HL070100, HL060040, HL080124, HL071039, HL077447, and HL107385 with the National Institutes of Health, National Heart, Lung, and Blood Institute, and a grant from the Donald W. Reynolds Foundation.	Aatola H, 2010, HYPERTENSION, V55, P806, DOI 10.1161/HYPERTENSIONAHA.109.145102; Benetos A, 2002, CIRCULATION, V105, P1202, DOI 10.1161/hc1002.105135; Benjamin EJ, 2004, CIRCULATION, V109, P613, DOI 10.1161/01.CIR.0000112565.60887.1E; Cavalcante JL, 2011, J AM COLL CARDIOL, V57, P1511, DOI 10.1016/j.jacc.2010.12.017; Dernellis J, 2005, HYPERTENSION, V45, P426, DOI 10.1161/01.HYP.0000157818.58878.93; Hansen TW, 2006, CIRCULATION, V113, P664, DOI 10.1161/CIRCULATIONAHA.105.579342; KANNEL WB, 1979, AM J EPIDEMIOL, V110, P281, DOI 10.1093/oxfordjournals.aje.a112813; Laurent S, 2006, EUR HEART J, V27, P2588, DOI 10.1093/eurheartj/ehl254; Li SX, 2004, HYPERTENSION, V43, P541, DOI 10.1161/01.HYP.0000115922.98155.23; Liao DP, 1999, HYPERTENSION, V34, P201, DOI 10.1161/01.HYP.34.2.201; Mancia G, 2007, EUR HEART J, V28, P1462, DOI [10.1093/eurheartj/ehm236, 10.1093/eurheartj/eht151]; Mattace-Raso FUS, 2006, CIRCULATION, V113, P657, DOI 10.1161/CIRCULATIONAHA.105.555235; McEniery CM, 2010, HYPERTENSION, V56, P36, DOI 10.1161/HYPERTENSIONAHA.110.150896; Mitchell GF, 2007, CIRCULATION, V115, P2628, DOI 10.1161/CIRCULATIONAHA.106.667733; Mitchell GF, 2010, CIRCULATION, V122, P1379, DOI 10.1161/CIRCULATIONAHA.109.914507; Mitchell GF, 2009, ARTERY RES, V3, P56, DOI 10.1016/j.artres.2009.02.002; Mitchell GF, 2010, CIRCULATION, V121, P505, DOI 10.1161/CIRCULATIONAHA.109.886655; Mitchell GF, 2005, CIRCULATION, V112, P3722, DOI 10.1161/CIRCULATIONAHA.105.551168; Mitchell GF, 2004, HYPERTENSION, V44, P134, DOI 10.1161/01.HYP.0000137305.77635.68; Mitchell GF, 2004, HYPERTENSION, V43, P1239, DOI 10.1161/01.HYP.0000128420.01881.aa; Najjar SS, 2008, J AM COLL CARDIOL, V51, P1377, DOI 10.1016/j.jacc.2007.10.065; Sutton-Tyrrell K, 2005, CIRCULATION, V111, P3384, DOI 10.1161/CIRCULATIONAHA.104.483628; Sutton-Tyrrell K, 2001, HYPERTENSION, V38, P429, DOI 10.1161/01.HYP.38.3.429; Takase H, 2011, AM J HYPERTENS, V24, P667, DOI 10.1038/ajh.2011.19; Vasan RS, 2001, NEW ENGL J MED, V345, P1291, DOI 10.1056/NEJMoa003417; Vlachopoulos C, 2010, J AM COLL CARDIOL, V55, P1318, DOI 10.1016/j.jacc.2009.10.061	26	675	695	0	57	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 5	2012	308	9					875	881		10.1001/2012.jama.10503	http://dx.doi.org/10.1001/2012.jama.10503			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	999ET	22948697	Green Accepted, Bronze			2022-12-28	WOS:000308292900017
J	King, NB; Harper, S; Young, ME				King, Nicholas B.; Harper, Sam; Young, Meredith E.			Use of relative and absolute effect measures in reporting health inequalities: structured review	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; EVIDENCE-BASED MEDICINE; SOCIOECONOMIC INEQUALITIES; RISK REDUCTION; AIDS MORTALITY; UNITED-STATES; LUNG-CANCER; ETHICS; DISPARITIES; MORBIDITY		[King, Nicholas B.] McGill Univ, Fac Med, Biomed Eth Unit, Montreal, PQ H3A 1X1, Canada; [Harper, Sam] McGill Univ, Fac Med, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ H3A 1A2, Canada; [Young, Meredith E.] McGill Univ, Fac Med, Dept Med, Montreal, PQ H3A 1A1, Canada	McGill University; McGill University; McGill University	King, NB (corresponding author), McGill Univ, Fac Med, Biomed Eth Unit, 3647 Peel St, Montreal, PQ H3A 1X1, Canada.	nicholas.king@mcgill.ca	Harper, Sam/A-3406-2008	Harper, Sam/0000-0002-2767-1053; King, Nicholas/0000-0002-2093-3380				Barratt A, 2004, CAN MED ASSOC J, V171, P353, DOI 10.1503/cmaj.1021197; Borrell C, 2006, EUR J PUBLIC HEALTH, V16, P601, DOI 10.1093/eurpub/ckl062; Braveman P, 2011, ANNU REV PUBL HEALTH, V32, P381, DOI 10.1146/annurev-publhealth-031210-101218; CORNFIELD J, 1959, J NATL CANCER I, V22, P173; Culpepper L, 1999, LANCET, V353, P829, DOI 10.1016/S0140-6736(98)09101-6; Deaton A, 2002, HEALTH AFFAIR, V21, P13, DOI 10.1377/hlthaff.21.2.13; FORROW L, 1992, AM J MED, V92, P121, DOI 10.1016/0002-9343(92)90100-P; FREEDMAN B, 1994, J STAT PLAN INFER, V42, P223, DOI 10.1016/0378-3758(94)90198-8; Fries JF, 2004, ARTHRITIS RES THER, V6, pR250, DOI 10.1186/ar1170; Harper S, 2005, METHODS MEASURING CA; Harper S, 2008, AM J EPIDEMIOL, V167, P889, DOI 10.1093/aje/kwn016; Harper S, 2007, EUR J PUBLIC HEALTH, V17, P231, DOI 10.1093/eurpub/ckl278; Harper S, 2010, MILBANK Q, V88, P4, DOI 10.1111/j.1468-0009.2010.00587.x; Houweling Tanja Aj, 2007, Int J Equity Health, V6, P15, DOI 10.1186/1475-9276-6-15; Kelly MP, 2007, FINAL REPORT COMMISS; Keppel KG, 2007, AM J EPIDEMIOL, V166, P97, DOI 10.1093/aje/kwm044; King NB, 2010, MILBANK Q, V88, P623, DOI 10.1111/j.1468-0009.2010.00617.x; King NB, 2010, AM J PUBLIC HEALTH, V100, P2014, DOI 10.2105/AJPH.2010.203232; Levine RS, 2007, AM J PUBLIC HEALTH, V97, P1884, DOI 10.2105/AJPH.2005.081489; Low A, 2006, BRIT MED J, V332, P967, DOI 10.1136/bmj.332.7547.967; Low A, 2004, J PUBLIC HEALTH-UK, V26, P388, DOI 10.1093/pubmed/fdh175; Mackenbach JP, 1997, LANCET, V349, P1655, DOI 10.1016/S0140-6736(96)07226-1; Mackenbach JP, 1997, SOC SCI MED, V44, P757, DOI 10.1016/S0277-9536(96)00073-1; MALENKA DJ, 1993, J GEN INTERN MED, V8, P543, DOI 10.1007/BF02599636; Mechanic D, 2002, HEALTH AFFAIR, V21, P48, DOI 10.1377/hlthaff.21.2.48; Mechanic D, 2007, MILBANK Q, V85, P533, DOI 10.1111/j.1468-0009.2007.00498.x; Moser K, 2007, INT J EPIDEMIOL, V36, P1285, DOI 10.1093/ije/dym176; NAYLOR CD, 1992, ANN INTERN MED, V117, P916, DOI 10.7326/0003-4819-117-11-916; Oliver A, 2002, LANCET, V360, P565, DOI 10.1016/S0140-6736(02)09713-1; Poole C, 2010, EPIDEMIOLOGY, V21, P3, DOI 10.1097/EDE.0b013e3181c30eba; Regidor E, 2009, SOC SCI MED, V68, P419, DOI 10.1016/j.socscimed.2008.10.039; Schechtman E, 2002, VALUE HEALTH, V5, P431; Schulz KF, 2010, ANN INTERN MED, V152, P726, DOI 10.7326/0003-4819-152-11-201006010-00232; Schwartz LM, 2006, BMJ-BRIT MED J, V333, P1248, DOI 10.1136/bmj.38985.564317.7C; Schwartz PH, 2008, J GEN INTERN MED, V23, P867, DOI 10.1007/s11606-008-0616-y; Slowther A, 2004, J MED ETHICS, V30, P151, DOI 10.1136/jme.2003.003434; Vagero D, 1997, LANCET, V350, P516, DOI 10.1016/S0140-6736(97)26033-2; Vandenbroucke JP, 2007, EPIDEMIOLOGY, V18, P805, DOI 10.1097/EDE.0b013e3181577511; Vineis P, 2004, J MED ETHICS, V30, P126, DOI 10.1136/jme.2003.007211	39	152	152	2	39	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 3	2012	345								e5774	10.1136/bmj.e5774	http://dx.doi.org/10.1136/bmj.e5774			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	003TH	22945952	hybrid, Green Published			2022-12-28	WOS:000308633700003
J	Huang, J; Roberts, AJ; Leschziner, AE; Reck-Peterson, SL				Huang, Julie; Roberts, Anthony J.; Leschziner, Andres E.; Reck-Peterson, Samara L.			Lis1 Acts as a "Clutch" between the ATPase and Microtubule-Binding Domains of the Dynein Motor	CELL			English	Article							CYTOPLASMIC DYNEIN; HEAVY-CHAIN; ASPERGILLUS-NIDULANS; INTRACELLULAR-TRANSPORT; ORGANELLE TRANSPORT; NEURONAL MIGRATION; LISSENCEPHALY GENE; CRYSTAL-STRUCTURE; PLUS-ENDS; NDEL1	The lissencephaly protein Lis1 has been reported to regulate the mechanical behavior of cytoplasmic dynein, the primary minus-end-directed microtubule motor. However, the regulatory mechanism remains poorly understood. Here, we address this issue using purified proteins from Saccharomyces cerevisiae and a combination of techniques, including single-molecule imaging and single-particle electron microscopy. We show that rather than binding to the main ATPase site within dynein's AAA+ ring or its microtubule-binding stalk directly, Lis1 engages the interface between these elements. Lis1 causes individual dynein motors to remain attached to microtubules for extended periods, even during cycles of ATP hydrolysis that would canonically induce detachment. Thus, Lis1 operates like a "clutch" that prevents dynein's ATPase domain from transmitting a detachment signal to its track-binding domain. We discuss how these findings provide a conserved mechanism for dynein functions in living cells that require prolonged microtubule attachments.	[Huang, Julie; Roberts, Anthony J.; Reck-Peterson, Samara L.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Roberts, Anthony J.] Univ Leeds, Astbury Ctr Struct Mol Biol, Sch Mol & Cellular Biol, Fac Biol Sci, Leeds LS2 9JT, W Yorkshire, England; [Huang, Julie; Roberts, Anthony J.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; University of Leeds; Harvard University	Reck-Peterson, SL (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.	reck-peterson@hms.harvard.edu		Reck-Peterson, Samara/0000-0002-1553-465X; Leschziner, Andres/0000-0002-7732-7023	Reck-Peterson lab; University of Leeds [092436/Z/10/Z]; Alfred P. Sloan Foundation; Rita Allen Foundation; Giovanni Armenise-Harvard Foundation; National Institutes of Health [1 DP2 OD004268-01]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD004268] Funding Source: NIH RePORTER	Reck-Peterson lab; University of Leeds; Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); Rita Allen Foundation; Giovanni Armenise-Harvard Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Andrew P. Carter, Peter J. Knight, Tom A. Rapoport, James R. Sellers, Katerina Toropova, and Xin Xiang for critical comments on the manuscript; the Nikon Imaging Center at Harvard Medical School for technical assistance; Priscilla Yang's lab for sharing equipment; Stephen Hinshaw for initial experiments and suggesting the clutch analogy; Weihong Qiu for initial experiments; Brian Goodman for kinesin; and the Reck-Peterson lab for support. A. J. R. is funded by a Sir Henry Wellcome Postdoctoral Fellowship (092436/Z/10/Z) sponsored by Peter J. Knight and Stan A. Burgess (University of Leeds). A.E.L. is funded in part by a research fellowship from the Alfred P. Sloan Foundation. S.R.-P. is funded by the Rita Allen Foundation, the Giovanni Armenise-Harvard Foundation, and a National Institutes of Health New Innovator award (1 DP2 OD004268-01).	Allan VJ, 2011, BIOCHEM SOC T, V39, P1169, DOI 10.1042/BST0391169; Burgess SA, 2003, NATURE, V421, P715, DOI 10.1038/nature01377; Cho C, 2008, J BIOL CHEM, V283, P25839, DOI 10.1074/jbc.M802951200; Cho C, 2012, BBA-MOL CELL RES, V1823, P182, DOI 10.1016/j.bbamcr.2011.10.009; Delanoue R, 2005, CELL, V122, P97, DOI 10.1016/j.cell.2005.04.033; Ding C, 2009, J CELL SCI, V122, P2820, DOI 10.1242/jcs.048777; Efimov VP, 2003, MOL BIOL CELL, V14, P871, DOI 10.1091/mbc.E02-06-0359; Egan MJ, 2012, J CELL BIOL, V197, P971, DOI 10.1083/jcb.201112101; Erzberger JP, 2006, ANNU REV BIOPH BIOM, V35, P93, DOI 10.1146/annurev.biophys.35.040405.101933; Faulkner NE, 2000, NAT CELL BIOL, V2, P784, DOI 10.1038/35041020; Feng YY, 2000, NEURON, V28, P665, DOI 10.1016/S0896-6273(00)00145-8; Gerdes JM, 2005, CELL MOL LIFE SCI, V62, P1556, DOI 10.1007/s00018-005-5007-5; GIBBONS IR, 1991, NATURE, V352, P640, DOI 10.1038/352640a0; Imamula K, 2007, P NATL ACAD SCI USA, V104, P16134, DOI 10.1073/pnas.0702370104; Kardon JR, 2009, NAT REV MOL CELL BIO, V10, P854, DOI 10.1038/nrm2804; Karki S, 1999, CURR OPIN CELL BIOL, V11, P45, DOI 10.1016/S0955-0674(99)80006-4; Kon T, 2005, NAT STRUCT MOL BIOL, V12, P513, DOI 10.1038/nsmb930; Kon T, 2004, BIOCHEMISTRY-US, V43, P11266, DOI 10.1021/bi048985a; Kon T, 2012, NATURE, V484, P345, DOI 10.1038/nature10955; Kon T, 2009, NAT STRUCT MOL BIOL, V16, P325, DOI 10.1038/nsmb.1555; Lam C, 2010, J CELL SCI, V123, P202, DOI 10.1242/jcs.059337; Lee WL, 2003, J CELL BIOL, V160, P355, DOI 10.1083/jcb.200209022; Lenz JH, 2006, EMBO J, V25, P2275, DOI 10.1038/sj.emboj.7601119; Li J, 2005, NAT CELL BIOL, V7, P686, DOI 10.1038/ncb1273; Markus SM, 2011, DEV CELL, V20, P639, DOI 10.1016/j.devcel.2011.04.011; Markus SM, 2009, CURR BIOL, V19, P196, DOI 10.1016/j.cub.2008.12.047; McKenney RJ, 2011, J BIOL CHEM, V286, P39615, DOI 10.1074/jbc.M111.289017; McKenney RJ, 2010, CELL, V141, P304, DOI 10.1016/j.cell.2010.02.035; Mesngon MT, 2006, J NEUROSCI, V26, P2132, DOI 10.1523/JNEUROSCI.5095-05.2006; Neuwald AF, 1999, GENOME RES, V9, P27; Niethammer M, 2000, NEURON, V28, P697, DOI 10.1016/S0896-6273(00)00147-1; Pandey JP, 2011, J NEUROSCI, V31, P17207, DOI 10.1523/JNEUROSCI.4108-11.2011; Qiu WH, 2012, NAT STRUCT MOL BIOL, V19, P193, DOI 10.1038/nsmb.2205; Reck-Peterson SL, 2006, CELL, V126, P335, DOI 10.1016/j.cell.2006.05.046; REINER O, 1993, NATURE, V364, P717, DOI 10.1038/364717a0; Roberts A.J., 2012, STRUCTURE IN PRESS; Roberts AJ, 2009, CELL, V136, P485, DOI 10.1016/j.cell.2008.11.049; Sasaki S, 2000, NEURON, V28, P681, DOI 10.1016/S0896-6273(00)00146-X; Schmidt H, 2012, NAT STRUCT MOL BIOL, V19, P492, DOI 10.1038/nsmb.2272; Sheeman B, 2003, CURR BIOL, V13, P364, DOI 10.1016/S0960-9822(03)00013-7; Smith DS, 2000, NAT CELL BIOL, V2, P767, DOI 10.1038/35041000; Tanaka T, 2004, J CELL BIOL, V165, P709, DOI 10.1083/jcb.200309025; Tarricone C, 2004, NEURON, V44, P809, DOI 10.1016/S0896-6273(04)00751-2; Torisawa T, 2011, J BIOL CHEM, V286, P1959, DOI 10.1074/jbc.M110.169847; Tsai JW, 2007, NAT NEUROSCI, V10, P970, DOI 10.1038/nn1934; Vale RD, 2003, CELL, V112, P467, DOI 10.1016/S0092-8674(03)00111-9; Vallee RB, 2012, NAT CELL BIOL, V14, P224, DOI 10.1038/ncb2420; Wang SS, 2011, J BIOL CHEM, V286, P587, DOI 10.1074/jbc.M110.181578; Woodruff JB, 2009, MOL BIOL CELL, V20, P3003, DOI 10.1091/mbc.E09-03-0186; Yamada M, 2008, EMBO J, V27, P2471, DOI 10.1038/emboj.2008.182; Yi JY, 2011, J CELL BIOL, V195, P193, DOI 10.1083/jcb.201104076; Zhang J, 2002, MOL MICROBIOL, V44, P381, DOI 10.1046/j.1365-2958.2002.02900.x; Zhuang L, 2007, GENETICS, V175, P1185, DOI 10.1534/genetics.106.069013; Zylkiewicz E, 2011, J CELL BIOL, V192, P433, DOI 10.1083/jcb.201011142	54	147	148	0	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 31	2012	150	5					975	986		10.1016/j.cell.2012.07.022	http://dx.doi.org/10.1016/j.cell.2012.07.022			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	001ZU	22939623	hybrid, Green Published			2022-12-28	WOS:000308500200012
J	Nam, H; Lewis, NE; Lerman, JA; Lee, DH; Chang, RL; Kim, D; Palsson, BO				Nam, Hojung; Lewis, Nathan E.; Lerman, Joshua A.; Lee, Dae-Hee; Chang, Roger L.; Kim, Donghyuk; Palsson, Bernhard O.			Network Context and Selection in the Evolution to Enzyme Specificity	SCIENCE			English	Article							ESCHERICHIA-COLI; METABOLIC NETWORK; GENE-EXPRESSION; FLUXES; YEAST; RECONSTRUCTION; PROMISCUITY; PERSPECTIVE; MODELS	Enzymes are thought to have evolved highly specific catalytic activities from promiscuous ancestral proteins. By analyzing a genome-scale model of Escherichia coli metabolism, we found that 37% of its enzymes act on a variety of substrates and catalyze 65% of the known metabolic reactions. However, it is not apparent why these generalist enzymes remain. Here, we show that there are marked differences between generalist enzymes and specialist enzymes, known to catalyze a single chemical reaction on one particular substrate in vivo. Specialist enzymes (i) are frequently essential, (ii) maintain higher metabolic flux, and (iii) require more regulation of enzyme activity to control metabolic flux in dynamic environments than do generalist enzymes. Furthermore, these properties are conserved in Archaea and Eukarya. Thus, the metabolic network context and environmental conditions influence enzyme evolution toward high specificity.	[Nam, Hojung; Lewis, Nathan E.; Lee, Dae-Hee; Kim, Donghyuk; Palsson, Bernhard O.] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Lerman, Joshua A.; Chang, Roger L.] Univ Calif San Diego, Bioinformat & Syst Biol Grad Program, La Jolla, CA 92093 USA; [Lewis, Nathan E.] Harvard Univ, Wyss Inst Biol Inspired Engn, Sch Med, Boston, MA 02115 USA; [Lewis, Nathan E.] Harvard Univ, Dept Genet, Sch Med, Boston, MA 02115 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Lewis, NE (corresponding author), Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA.	nlewis@genetics.med.harvard.edu; palsson@ucsd.edu	Kim, Donghyuk/AAS-9141-2020; LEE, DAE-HEE/O-5243-2018; Nam, Hojung/AAR-4065-2020; Lewis, Nathan/ABE-7290-2020	LEE, DAE-HEE/0000-0002-0423-9057; Nam, Hojung/0000-0002-5109-9114; Lewis, Nathan/0000-0001-7700-3654; Palsson, Bernhard/0000-0003-2357-6785; Lerman, Joshua/0000-0003-0377-2674; Chang, Roger/0000-0003-1630-6584	NIH; NSF; U.S. Department of Energy [2R01GM057089-13, NSF GK-12 742551, DE-SC0004917, DE-FG02-09ER25917]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057089] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); U.S. Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. Zielinski for insightful discussion on this work. This work was supported by NIH, NSF, and U.S. Department of Energy grants 2R01GM057089-13, NSF GK-12 742551, DE-SC0004917, and DE-FG02-09ER25917. Data are available at the NCBI Gene Expression Omnibus (GEO) database (GSE34631).	Aharoni A, 2005, NAT GENET, V37, P73, DOI 10.1038/ng1482; Almaas E, 2005, PLOS COMPUT BIOL, V1, P557, DOI 10.1371/journal.pcbi.0010068; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bar-Even A, 2011, BIOCHEMISTRY-US, V50, P4402, DOI 10.1021/bi2002289; Bordel S, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000859; Carbonell P, 2011, J BIOL CHEM, V286, P43994, DOI 10.1074/jbc.M111.274050; Chang RL, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.52; Copley SD, 2012, J BIOL CHEM, V287, P3, DOI 10.1074/jbc.R111.254714; Deutscher D, 2006, NAT GENET, V38, P993, DOI 10.1038/ng1856; Feist AM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100155; Feist AM, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100046; Gerosa L, 2011, CURR OPIN BIOTECH, V22, P566, DOI 10.1016/j.copbio.2011.04.016; Gur E, 2011, NAT REV MICROBIOL, V9, P839, DOI 10.1038/nrmicro2669; Innan H, 2010, NAT REV GENET, V11, P97, DOI 10.1038/nrg2689; JENSEN RA, 1976, ANNU REV MICROBIOL, V30, P409, DOI 10.1146/annurev.mi.30.100176.002205; Khersonsky O, 2011, BIOCHEMISTRY-US, V50, P2683, DOI 10.1021/bi101763c; Khersonsky O, 2010, ANNU REV BIOCHEM, V79, P471, DOI 10.1146/annurev-biochem-030409-143718; Lewis NE, 2012, NAT REV MICROBIOL, V10, P291, DOI 10.1038/nrmicro2737; Lewis NE, 2009, J BACTERIOL, V191, P3437, DOI 10.1128/JB.00034-09; Mo ML, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-37; Morar M, 2010, ANNU REV GENET, V44, P25, DOI 10.1146/annurev-genet-102209-163517; Nam H, 2011, CURR OPIN BIOTECH, V22, P595, DOI 10.1016/j.copbio.2011.03.006; Papp B, 2004, NATURE, V429, P661, DOI 10.1038/nature02636; Papp B, 2011, NAT REV GENET, V12, P591, DOI 10.1038/nrg3033; Schuetz R, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100162; Wagner A, 2007, J EXP ZOOL PART B, V308B, P322, DOI 10.1002/jez.b.21152; Zhang ZH, 2011, NAT CHEM BIOL, V7, P58, DOI 10.1038/NCHEMBIO.495	28	199	202	1	70	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 31	2012	337	6098					1101	1104		10.1126/science.1216861	http://dx.doi.org/10.1126/science.1216861			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996WP	22936779	Green Accepted			2022-12-28	WOS:000308125800049
J	Mir, N; Satish, H				Mir, Nisar; Satish, Hulikere			Skin rash in a preterm infant	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SIMPLEX; INFECTIONS		[Mir, Nisar; Satish, Hulikere] Warrington & Halton Hosp NHS Fdn Trust, Neonatal Intens Care Unit, Warrington WA5 1QG, Cheshire, England		Mir, N (corresponding author), Warrington & Halton Hosp NHS Fdn Trust, Neonatal Intens Care Unit, Warrington WA5 1QG, Cheshire, England.	nisar.mir@whh.nhs.uk						[Anonymous], COCHRANE DATABASE SY; Brown ZA, 2003, JAMA-J AM MED ASSOC, V289, P203, DOI 10.1001/jama.289.2.203; Corey L, 2009, NEW ENGL J MED, V361, P1376, DOI 10.1056/NEJMra0807633; Kimberlin DW, 2007, SEMIN PERINATOL, V31, P19, DOI 10.1053/j.semperi.2007.01.003; MacMahon E, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e1790; O'Riordan DP, 2006, PEDIATRICS, V118, pE1612, DOI 10.1542/peds.2005-1228; Rudnick CM, 2002, AM FAM PHYSICIAN, V65, P1138; Sladden MJ, 2005, BMJ-BRIT MED J, V330, P1194, DOI 10.1136/bmj.330.7501.1194	8	1	1	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 30	2012	345								e5390	10.1136/bmj.e5390	http://dx.doi.org/10.1136/bmj.e5390			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	036SM	22936793				2022-12-28	WOS:000311050800010
J	Spence, D				Spence, Des			Believe in better	BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk							0	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	AUG 30	2012	345								e5826	10.1136/bmj.e5826	http://dx.doi.org/10.1136/bmj.e5826			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	036SM	22936796				2022-12-28	WOS:000311050800009
J	Vamos, EP; Harris, M; Millett, C; Pape, UJ; Khunti, K; Curcin, V; Molokhia, M; Majeed, A				Vamos, Eszter Panna; Harris, Matthew; Millett, Christopher; Pape, Utz J.; Khunti, Kamlesh; Curcin, Vasa; Molokhia, Mariam; Majeed, Azeem			Association of systolic and diastolic blood pressure and all cause mortality in people with newly diagnosed type 2 diabetes: retrospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							HYPERTENSIVE PATIENTS; CARDIOVASCULAR OUTCOMES; DISEASE; METAANALYSIS; MANAGEMENT; HOT	Objective To examine the effect of systolic and diastolic blood pressure achieved in the first year of treatment on all cause mortality in patients newly diagnosed with type 2 diabetes, with and without established cardiovascular disease. Design Retrospective cohort study. Setting United Kingdom General Practice Research Database, between 1990 and 2005. Participants 126 092 adult patients (age >= 18 years) with a new diagnosis of type 2 diabetes who had been registered with participating practices for at least 12 months. Main outcome measure All cause mortality. Results Before diagnosis, 12 379 (9.8%) patients had established cardiovascular disease (myocardial infarction or stroke). During a median follow-up of 3.5 years, we recorded 25 495 (20.2%) deaths. In people with cardiovascular disease, tight control of systolic (<130 mm Hg) and diastolic (<80 mm Hg) blood pressure was not associated with improved survival, after adjustment for baseline characteristics (age at diagnosis, sex, practice level clustering, deprivation score, body mass index, smoking, HbA(1c) and cholesterol levels, and blood pressure). Low blood pressure was also associated with an increased risk of all cause mortality. Compared with patients who received usual control of systolic blood pressure (130-139 mm Hg), the hazard ratio of all cause mortality was 2.79 (95% confidence interval 1.74 to 4.48, P<0.001) for systolic blood pressure at 110 mm Hg. Compared with patients who received usual control of diastolic blood pressure (80-84 mm Hg), the hazard ratios were 1.32 (1.02 to 1.78, P=0.04) and 1.89 (1.40 to 2.56, P<0.001) for diastolic blood pressures at 70-74 mm Hg and lower than 70 mm Hg, respectively. Similar associations were found in people without cardiovascular disease. Subgroup analyses of people diagnosed with hypertension and who received treatment for hypertension confirmed initial findings. Conclusion Blood pressure below 130/80 mm Hg was not associated with reduced risk of all cause mortality in patients with newly diagnosed diabetes, with or without known cardiovascular disease. Low blood pressure, particularly below 110/75 mm Hg, was associated with an increased risk for poor outcomes.	[Vamos, Eszter Panna; Harris, Matthew; Millett, Christopher; Pape, Utz J.; Majeed, Azeem] Univ London Imperial Coll Sci Technol & Med, Dept Primary Care & Publ Hlth, London W6 8RP, England; [Khunti, Kamlesh] Univ Leicester, Dept Hlth Sci, Leicester, Leics, England; [Curcin, Vasa] Univ London Imperial Coll Sci Technol & Med, Dept Comp, London W6 8RP, England; [Molokhia, Mariam] Kings Coll London, Dept Primary Care & Publ Hlth Sci, London WC2R 2LS, England	Imperial College London; University of Leicester; Imperial College London; University of London; King's College London	Harris, M (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Primary Care & Publ Hlth, London W6 8RP, England.	m.harris@imperial.ac.uk	/ABC-9527-2021	Curcin, Vasa/0000-0002-8308-2886; Millett, Christopher/0000-0002-0793-9884; Majeed, Azeem/0000-0002-2357-9858; Harris, Matthew/0000-0002-0005-9710; Khunti, Kamlesh/0000-0003-2343-7099	National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care (CLAHRC) scheme; NIHR Biomedical Research Centre scheme; Imperial Centre for Patient Safety and Service Quality; European Community Seventh Framework Programme [277047]; Higher Education Funding Council for England; NIHR; National Institute for Health Research [CL-2010-21-014] Funding Source: researchfish	National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care (CLAHRC) scheme(National Institute for Health Research (NIHR)); NIHR Biomedical Research Centre scheme(National Institute for Health Research (NIHR)); Imperial Centre for Patient Safety and Service Quality; European Community Seventh Framework Programme(European Commission); Higher Education Funding Council for England(UK Research & Innovation (UKRI)Higher Education Funding Council for England (HEFCE)); NIHR(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	The Department of Primary Care and Public Health at Imperial College thank the National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care (CLAHRC) scheme, NIHR Biomedical Research Centre scheme, and Imperial Centre for Patient Safety and Service Quality for their support. The Department of Health Sciences at Leicester University thank the NIHR CLAHRC scheme for their support. This study uses data from the Full Feature General Practice Research Database, obtained under license from the UK Medicines and Healthcare Products Regulatory Agency (MHRA). The interpretation and conclusions contained in this study are those of the authors alone. Access to the General Practice Research Database was funded through the Medical Research Council's licence agreement with the MHRA.; This study received funding from the European Community Seventh Framework Programme under grant agreement 277047. Competing interests: All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: support from the European Community Seventh Framework Programme for the submitted work; CM is funded by the Higher Education Funding Council for England and the NIHR; EV and MH are partly funded by the NIHR; no other relationships or activities that could appear to have influenced the submitted work.	American Diabetes Association, 2010, DIABETES CARE S1, V33, P692, DOI [10.2337/dc10-S011, DOI 10.2337/DC10-S011]; [Anonymous], 2007, INDEX MULTIPLE DEPRI; Bakris GL, 2004, HYPERTENSION, V44, P637, DOI 10.1161/01.HYP.0000143851.23721.26; Bangalore S, 2010, EUR HEART J, V31, P2897, DOI 10.1093/eurheartj/ehq328; Berl T, 2005, J AM SOC NEPHROL, V16, P2170, DOI 10.1681/ASN.2004090763; Chen YC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021404; Cooper-DeHoff RM, 2010, JAMA-J AM MED ASSOC, V304, P61, DOI 10.1001/jama.2010.884; Cushman WC, 2010, NEW ENGL J MED, V362, P1575, DOI 10.1056/NEJMoa1001286; Estacio RO, 2000, DIABETES CARE, V23, pB54; Gray J, 2003, BRIT MED J, V326, P1130, DOI 10.1136/bmj.326.7399.1130; Hansson L, 1998, LANCET, V351, P1755, DOI 10.1016/S0140-6736(98)04311-6; Hollowell J, 1997, Popul Trends, P36; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Mancia G, 2007, J HYPERTENS, V25, P1751, DOI 10.1097/HJH.0b013e3282f0580f; Mancia G, 2009, J HYPERTENS, V27, P2121, DOI 10.1097/HJH.0b013e328333146d; Messerli FH, 2006, ANN INTERN MED, V144, P884, DOI 10.7326/0003-4819-144-12-200606200-00005; Reboldi G, 2011, J HYPERTENS, V29, P1253, DOI 10.1097/HJH.0b013e3283469976; Rutter MK, 2011, EUR HEART J, V32, P2247, DOI 10.1093/eurheartj/ehr154; STAESSEN J, 1989, BMJ-BRIT MED J, V298, P1552, DOI 10.1136/bmj.298.6687.1552; Stearne MR, 1998, BRIT MED J, V317, P713; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; TURNER RC, 1993, J HYPERTENS, V11, P319; Turner RC, 1998, BMJ-BRIT MED J, V316, P823, DOI 10.1136/bmj.316.7134.823; Zanchetti A, 2003, J HYPERTENS, V21, P797, DOI 10.1097/00004872-200304000-00024; Zanchetti A, 2009, J HYPERTENS, V27, P923, DOI 10.1097/HJH.0b013e32832aa6b5	25	70	72	0	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 30	2012	345								e5567	10.1136/bmj.e5567	http://dx.doi.org/10.1136/bmj.e5567			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	036SM	22936794	Green Published, hybrid			2022-12-28	WOS:000311050800004
J	McKinney, JC				McKinney, Jonathan C.			Probing Black Hole Gravity	SCIENCE			English	Editorial Material							QUASI-PERIODIC OSCILLATIONS; SAGITTARIUS A-ASTERISK; X-RAY BINARIES; SIMULATIONS; EMISSION; DISKS; SPIN		Stanford Univ, Kavli Inst Particle Astrophys & Cosmol, Stanford, CA 94309 USA	Stanford University	McKinney, JC (corresponding author), Stanford Univ, Kavli Inst Particle Astrophys & Cosmol, POB 20450,MS 29, Stanford, CA 94309 USA.	jmckinne@stanford.edu						BLANDFORD RD, 1977, MON NOT R ASTRON SOC, V179, P433, DOI 10.1093/mnras/179.3.433; Broderick AE, 2011, ASTROPHYS J, V735, DOI 10.1088/0004-637X/735/2/110; Davis SW, 2010, ASTROPHYS J, V713, P52, DOI 10.1088/0004-637X/713/1/52; Dexter J, 2012, MON NOT R ASTRON SOC, V421, P1517, DOI 10.1111/j.1365-2966.2012.20409.x; Dolence JC, 2012, ASTROPHYS J LETT, V746, DOI 10.1088/2041-8205/746/1/L10; McClintock JE, 2006, ASTROPHYS J, V652, P518, DOI 10.1086/508457; McKinney JC, 2012, MON NOT R ASTRON SOC, V423, P3083, DOI 10.1111/j.1365-2966.2012.21074.x; Meyer L, 2008, ASTROPHYS J LETT, V688, pL17, DOI 10.1086/593147; Reis RC, 2012, SCIENCE, V337, P949, DOI 10.1126/science.1223940; Stella L, 1999, PHYS REV LETT, V82, P17, DOI 10.1103/PhysRevLett.82.17; TANAKA Y, 1995, NATURE, V375, P659, DOI 10.1038/375659a0; van der Klis M, 1998, ADV SPACE RES, V22, P925, DOI 10.1016/S0273-1177(98)00125-2	15	0	0	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 24	2012	337	6097					916	917		10.1126/science.1227083	http://dx.doi.org/10.1126/science.1227083			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992VI	22923565				2022-12-28	WOS:000307807600028
J	Jaar, BG				Jaar, Bernard G.			Review: Antiplatelet therapy does not reduce mortality in chronic kidney disease	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Johns Hopkins Med Inst, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Medicine	Jaar, BG (corresponding author), Johns Hopkins Med Inst, Baltimore, MD 21205 USA.							Burden R, 2005, CLIN MED, V5, P635, DOI 10.7861/clinmedicine.5-6-635; Levey AS, 2007, KIDNEY INT, V72, P247, DOI 10.1038/sj.ki.5002343	2	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 21	2012	157	4							JC4-8	10.7326/0003-4819-157-4-201208210-02008	http://dx.doi.org/10.7326/0003-4819-157-4-201208210-02008			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	992XG	22910962				2022-12-28	WOS:000307813200007
J	Krishnan, E; Lingala, B; Bhalla, V				Krishnan, Eswar; Lingala, Bharathi; Bhalla, Vivek			Low-Level Lead Exposure and the Prevalence of Gout An Observational Study	ANNALS OF INTERNAL MEDICINE			English	Article							BLOOD LEAD; SERUM CREATININE; NATIONAL-HEALTH; KIDNEY-FUNCTION; SATURNINE GOUT; BONE LEAD; RISK; MEN; NEPHROPATHY; MORTALITY	Background: Blood lead levels (BLLs) less than 1.21 mu mol/L (<25 mu g/dL) among adults are considered acceptable by current national standards. Lead toxicity can lead to gouty arthritis (gout), but whether the low lead exposure in the contemporary general population confers risk for gout is not known. Objective: To determine whether BLLs within the range currently considered acceptable are associated with gout. Design: Population-based cross-sectional study. Setting: The National Health and Nutrition Examination Survey for 2005 through 2008. Patients: 6153 civilians aged 40 years or older with an estimated glomerular filtration rate greater than 10 mL/min per 1.73 m(2). Measurements: Outcome variables were self-reported physician diagnosis of gout and serum urate level. Blood lead level was the principal exposure variable. Additional data collected were anthropometric measures, blood pressure, dietary purine intake, medication use, medical history, and serum creatinine concentration. Results: The prevalence of gout was 6.05% (95% CI, 4.49% to 7.62%) among patients in the highest BLL quartile (mean, 0.19 mu mol/L [3.95 mu g/dL]) compared with 1.76% (CI, 1.10% to 2.42%) among those in the lowest quartile (mean, 0.04 mu mol/L [0.89 mu g/dL]). Each doubling of BLL was associated with an unadjusted odds ratio of 1.74 (CI, 1.47 to 2.05) for gout and 1.25 (CI, 1.12 to 1.40) for hyperuricemia. After adjustment for renal function, diabetes, diuretic use, hypertension, race, body mass index, income, and education level, the highest BLL quartile was associated with a 3.6-fold higher risk for gout and a 1.9-fold higher risk for hyperuricemia compared with the lowest quartile. Limitation: Blood lead level does not necessarily reflect the total body lead burden. Conclusion: Blood lead levels in the range currently considered acceptable are associated with increased prevalence of gout and hyperuricemia.	[Krishnan, Eswar; Lingala, Bharathi; Bhalla, Vivek] Stanford Univ, Sch Med, Palo Alto, CA 94304 USA	Stanford University	Krishnan, E (corresponding author), Stanford Univ, Sch Med, 1000 Welch Rd,Suite 203, Palo Alto, CA 94304 USA.		krishnan, Eswar/AAY-1269-2020	Bhalla, Vivek/0000-0002-5420-9657				Alarcon W. A., 2009, Morbidity and Mortality Weekly Report, V58, P365; Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc12-S064, 10.2337/dc09-S062, 10.2337/dc11-S011]; BAKER MD, 1981, RHEUMATOL REHABIL, V20, P208, DOI 10.1093/rheumatology/20.4.208; Barbosa F, 2005, ENVIRON HEALTH PERSP, V113, P1669, DOI 10.1289/ehp.7917; BARRY PSI, 1970, BRIT J IND MED, V27, P339; BATUMAN V, 1981, NEW ENGL J MED, V304, P520, DOI 10.1056/NEJM198102263040905; BATUMAN V, 1993, AM J MED SCI, V305, P241, DOI 10.1097/00000441-199304000-00008; CAMPBELL BC, 1978, BRIT MED J, V2, P1403, DOI 10.1136/bmj.2.6149.1403; Centers for Disease Control and Prevention, 2012, LAB PROC MAN LEAD CA; Centers for Disease Control and Prevention, LAB PROC MAN UR AC; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Choi HK, 2008, RHEUMATOLOGY, V47, P1567, DOI 10.1093/rheumatology/ken305; Choi HK, 2004, LANCET, V363, P1277, DOI 10.1016/S0140-6736(04)16000-5; Choi HK, 2004, NEW ENGL J MED, V350, P1093, DOI 10.1056/NEJMoa035700; Choi HK, 2007, CIRCULATION, V116, P894, DOI 10.1161/CIRCULATIONAHA.107.703389; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Coresh J, 2006, CURR OPIN NEPHROL HY, V15, P276, DOI 10.1097/01.mnh.0000222695.84464.61; DEKLERK NH, 1989, INT J EPIDEMIOL, V18, P705, DOI 10.1093/ije/18.3.705; EMMERSON BT, 1963, AUSTRALAS ANN MED, V12, P310, DOI 10.1111/imj.1963.12.4.310; EMMERSON BT, 1968, ARTHRITIS RHEUM-US, V11, P623, DOI 10.1002/art.1780110504; Gelber AC, 1997, ARCH INTERN MED, V157, P1436, DOI 10.1001/archinte.157.13.1436; Gulson BL, 1996, B ENVIRON CONTAM TOX, V56, P543; GULSON BL, 1995, J LAB CLIN MED, V125, P703; Hernberg S, 2000, AM J IND MED, V38, P244, DOI 10.1002/1097-0274(200009)38:3<244::AID-AJIM3>3.3.CO;2-6; Hu H, 1998, ENVIRON HEALTH PERSP, V106, P1, DOI 10.2307/3433626; Kim R, 1996, JAMA-J AM MED ASSOC, V275, P1177, DOI 10.1001/jama.275.15.1177; KLINENBERG JR, 1969, NEW ENGL J MED, V280, P1238, DOI 10.1056/NEJM196905292802213; Kosnett MJ, 2010, CLIN PHARMACOL THER, V88, P412, DOI 10.1038/clpt.2010.132; KOSTER J, 1989, EUR J CLIN INVEST, V19, P228, DOI 10.1111/j.1365-2362.1989.tb00222.x; Krishnan E, 2006, ARTHRITIS RHEUM-US, V54, P2688, DOI 10.1002/art.22014; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Lin JL, 2002, AM J MED, V113, P563, DOI 10.1016/S0002-9343(02)01296-2; LoghmanAdham M, 1997, ENVIRON HEALTH PERSP, V105, P928, DOI 10.4103/0019-5278.44689; LUDWIG GD, 1957, ARCH INTERN MED, V100, P802, DOI 10.1001/archinte.1957.00260110118017; Madero M, 2006, CURR OPIN NEPHROL HY, V15, P610, DOI 10.1097/01.mnh.0000247505.71915.05; McAdams MA, 2011, J RHEUMATOL, V38, P135, DOI 10.3899/jrheum.100418; Menke A, 2006, CIRCULATION, V114, P1388, DOI 10.1161/CIRCULATIONAHA.106.628321; MIRANDA ME, 1991, ADV EXP MED BIOL, V309, P209; Morgan BW, 2001, ANN EMERG MED, V37, P51, DOI 10.1067/mem.2001.111708; MORGAN JM, 1972, ARCH INTERN MED, V130, P335, DOI 10.1001/archinte.130.3.335; Muntner P, 2005, ARCH INTERN MED, V165, P2155, DOI 10.1001/archinte.165.18.2155; Perazella M A, 1996, Conn Med, V60, P521; POOR G, 1989, BAILLIERE CLIN RHEUM, V3, P51, DOI 10.1016/S0950-3579(89)80035-4; Roberts JR, 2001, J TOXICOL-CLIN TOXIC, V39, P153, DOI 10.1081/CLT-100103831; Rothman KJ, 1998, MODERN EPIDEMIOLOGY, V4; Schock MR, 2008, ENVIRON SCI TECHNOL, V42, P4285, DOI 10.1021/es702488v; Selvin E, 2007, AM J KIDNEY DIS, V50, P918, DOI 10.1053/j.ajkd.2007.08.020; Shadick NA, 2000, J RHEUMATOL, V27, P1708; Smith DR, 1996, ENVIRON HEALTH PERSP, V104, P60, DOI 10.2307/3432761; Souci SW., 2000, FOOD COMPOSITION NUT; Stevens LA, 2006, NEW ENGL J MED, V354, P2473, DOI 10.1056/NEJMra054415; Thottam Jyoti, 2007, Time, V170, P50; U.S. Environmental Protection Agency, 1995, REV STUD ADDR LEAD A; WALLACE SL, 1977, ARTHRITIS RHEUM, V20, P895, DOI 10.1002/art.1780200320; WEDEEN RP, 1988, ENVIRON HEALTH PERSP, V78, P57, DOI 10.2307/3430500; Wengrovitz Anne M., 2009, Morbidity and Mortality Weekly Report, V58, P1; Wigle DT, 2005, PLOS MED, V2, P1232, DOI 10.1371/journal.pmed.0020350	57	39	39	0	12	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 21	2012	157	4					233	+		10.7326/0003-4819-157-4-201208210-00003	http://dx.doi.org/10.7326/0003-4819-157-4-201208210-00003			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	992XG	22910934				2022-12-28	WOS:000307813200014
J	Ordas, I; Eckmann, L; Talamini, M; Baumgart, DC; Sandborn, WJ				Ordas, Ingrid; Eckmann, Lars; Talamini, Mark; Baumgart, Daniel C.; Sandborn, William J.			Ulcerative colitis	LANCET			English	Article							INFLAMMATORY-BOWEL-DISEASE; POUCH-ANAL ANASTOMOSIS; FACTOR-KAPPA-B; RANDOMIZED CONTROLLED-TRIAL; EVIDENCE-BASED CONSENSUS; NECROSIS-FACTOR-ALPHA; COLORECTAL-CANCER; CROHNS-DISEASE; RISK-FACTORS; DOUBLE-BLIND	Ulcerative colitis is an idiopathic, chronic inflammatory disorder of the colonic mucosa, which starts in the rectum and generally extends proximally in a continuous manner through part of, or the entire, colon; however, some patients with proctitis or left-sided colitis might have a caecal patch of inflammation. Bloody diarrhoea is the characteristic symptom of the disease. The clinical course is unpredictable, marked by alternating periods of exacerbation and remission. In this Seminar we discuss the epidemiology, pathophysiology, diagnostic approach, natural history, medical and surgical management, and main disease-related complications of ulcerative colitis, and briefly outline novel treatment options. Enhanced understanding of how the interaction between environmental factors, genetics, and the immune system results in mucosal inflammation has increased knowledge of disease pathophysiology. We provide practical therapeutic algorithms that are easily applicable in daily clinical practice, emphasising present controversies in treatment management and novel therapies.	[Ordas, Ingrid; Eckmann, Lars; Sandborn, William J.] Univ Calif San Diego, Div Gastroenterol, San Diego, CA 92103 USA; [Talamini, Mark] Univ Calif San Diego, Dept Surg, San Diego, CA 92103 USA; [Ordas, Ingrid] Univ Barcelona, Div Gastroenterol,Hosp Clin, Inst Invest Biomed August Pi i Sunyer IDIBAPS, Ctr Invest Biomed Red Areatemat Enfermedades Hepa, Barcelona, Spain; [Baumgart, Daniel C.] Humboldt Univ, Dept Med, Div Gastroenterol & Hepatol, Charite Med Ctr,Virchow Hosp,Sch Med, D-10099 Berlin, Germany	University of California System; University of California San Diego; University of California System; University of California San Diego; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Sandborn, WJ (corresponding author), Univ Calif San Diego, Div Gastroenterol, La Jolla, CA 92093 USA.	wsandborn@ucsd.edu	Baumgart, Daniel C./AAU-2930-2021; Sandborn, William/ABE-8342-2020	Baumgart, Daniel C./0000-0003-2146-507X; Ordas, Ingrid/0000-0001-7632-0340	Abbott; Astellas; Biocodex; Facet Biotech; Shire; AstraZeneca; Bayer Schering Pharma; Cellerix; TiGenix; Genentech; medac autoimmun; MSD; Otsuka; Abbott Laboratories; Bristol Meyers Squibb; Glaxo Smith Kline; Janssen; Takeda; Novartis; Pfizer; Procter; Gamble Pharmaceuticals; Shire Pharmaceuticals; UCB Pharma; ActoGeniX NV; AGI Therapeutics; Alba Therapeutics Corporation; Albireo; Alfa Wasserman; Amgen; AM-Pharma BV; Anaphore; Astellas Pharma; Athersys; Atlantic Healthcare Limited; Aptalis; BioBalance Corporation; Boehringer-Ingelheim Inc; Celegene; Celek Pharmaceuticals; Cellerix SL; Cerimon Pharmaceuticals; ChemoCentryx; CoMentis; Cosmo Technologies; Coronado Biosciences; Cytokine Pharmasciences; Eagle Pharmaceuticals; Eisai Medical Research; Elan Pharmaceuticals; EnGene; Eli Lilly Enteromedics; Exagen Diagnostics; Ferring Pharmaceuticals; Flexion Therapeutics; Funxional Therapeutics Limited; Genzyme Corporation; Roche; Gilead Sciences; Given Imaging; Human Genome Sciences; Ironwood Pharmaceuticals; KaloBios Pharmaceuticals; Lexicon Pharmaceuticals; Lycera Corporation; Meda Pharmaceuticals; Merck Research Laboratories; MerckSerono; Millennium Pharmaceuticals; Nisshin Kyorin Pharmaceuticals; Novo Nordisk; NPS Pharmaceuticals; Optimer Pharmaceuticals; Orexigen Therapeutics; PDL Biopharma; Procter and Gamble; Prometheus Laboratories; ProtAb Limited; Purgenesis Technologies; Relypsa; Salient Pharmaceuticals; Salix Pharmaceuticals; Santarus; Schering Plough Corporation; Sigmoid Pharma Limited; Sirtris Pharmaceuticals; SLA Pharma (UK) Limited; Targacept; Teva Pharmaceuticals; Therakos; Tillotts Pharma AG; TxCell SA; Viamet Pharmaceuticals; Vascular Biogenics Limited; Warner Chilcott UK Limited	Abbott(Abbott Laboratories); Astellas(Astellas Pharmaceuticals); Biocodex; Facet Biotech; Shire; AstraZeneca(AstraZeneca); Bayer Schering Pharma(Bayer AG); Cellerix; TiGenix; Genentech(Roche HoldingGenentech); medac autoimmun; MSD; Otsuka(Otsuka Pharmaceutical); Abbott Laboratories(Abbott Laboratories); Bristol Meyers Squibb(Bristol-Myers Squibb); Glaxo Smith Kline(GlaxoSmithKline); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Takeda(Takeda Pharmaceutical Company Ltd); Novartis(Novartis); Pfizer(Pfizer); Procter(Procter & Gamble); Gamble Pharmaceuticals(Procter & Gamble); Shire Pharmaceuticals; UCB Pharma(UCB Pharma SA); ActoGeniX NV; AGI Therapeutics; Alba Therapeutics Corporation; Albireo; Alfa Wasserman; Amgen(Amgen); AM-Pharma BV; Anaphore; Astellas Pharma(Astellas Pharmaceuticals); Athersys; Atlantic Healthcare Limited; Aptalis; BioBalance Corporation; Boehringer-Ingelheim Inc(Boehringer Ingelheim); Celegene; Celek Pharmaceuticals; Cellerix SL; Cerimon Pharmaceuticals; ChemoCentryx; CoMentis; Cosmo Technologies; Coronado Biosciences; Cytokine Pharmasciences; Eagle Pharmaceuticals; Eisai Medical Research(Eisai Co Ltd); Elan Pharmaceuticals; EnGene; Eli Lilly Enteromedics(Eli Lilly); Exagen Diagnostics; Ferring Pharmaceuticals(Ferring Pharmaceuticals); Flexion Therapeutics; Funxional Therapeutics Limited; Genzyme Corporation(Sanofi-AventisGenzyme Corporation); Roche(Roche Holding); Gilead Sciences(Gilead Sciences); Given Imaging; Human Genome Sciences(GlaxoSmithKline); Ironwood Pharmaceuticals; KaloBios Pharmaceuticals; Lexicon Pharmaceuticals; Lycera Corporation; Meda Pharmaceuticals; Merck Research Laboratories(Merck & Company); MerckSerono(Merck & Company); Millennium Pharmaceuticals(Takeda Pharmaceutical Company Ltd); Nisshin Kyorin Pharmaceuticals; Novo Nordisk(Novo Nordisk); NPS Pharmaceuticals; Optimer Pharmaceuticals; Orexigen Therapeutics; PDL Biopharma; Procter and Gamble(Procter & Gamble); Prometheus Laboratories; ProtAb Limited; Purgenesis Technologies; Relypsa; Salient Pharmaceuticals; Salix Pharmaceuticals; Santarus; Schering Plough Corporation(Merck & CompanySchering Plough Corporation); Sigmoid Pharma Limited; Sirtris Pharmaceuticals; SLA Pharma (UK) Limited; Targacept; Teva Pharmaceuticals(Teva Pharmaceutical Industries); Therakos; Tillotts Pharma AG; TxCell SA; Viamet Pharmaceuticals; Vascular Biogenics Limited; Warner Chilcott UK Limited	DCB has received research support from Abbott, Astellas, Biocodex, Facet Biotech, and Shire; fees for consultancy from Abbott, AstraZeneca, Bayer Schering Pharma, Cellerix, TiGenix, Genentech, medac autoimmun, MSD, Otsuka, Facet Biotech, UCB; and lecture fees from Abbott, AstraZeneca, Dr Falk Pharma, Ferring, MSD, Otsuka, Shire, and UCB. All DCB's activities and contracts are in conformity with the FSA-Kodex Fachkreise (voluntary self-monitoring code for expert consultants to the pharmaceutical industry), have been checked by the legal Department of Charite Universitatsmedizin Berlin, and have been approved by the directorate of the Faculty of Medicine of Charite Universitatsmedizin Berlin. WJS has received research support from Abbott Laboratories, Bristol Meyers Squibb, Genentech, Glaxo Smith Kline, Janssen, Takeda, Novartis, Pfizer, Procter and Gamble Pharmaceuticals, Shire Pharmaceuticals, and UCB Pharma; fees for consultancy from Abbott Laboratories, ActoGeniX NV, AGI Therapeutics, Alba Therapeutics Corporation, Albireo, Alfa Wasserman, Amgen, AM-Pharma BV, Anaphore, Astellas Pharma, Athersys, Atlantic Healthcare Limited, Aptalis, BioBalance Corporation, Boehringer-Ingelheim Inc, Bristol Meyers Squibb, Celegene, Celek Pharmaceuticals, Cellerix SL, Cerimon Pharmaceuticals, ChemoCentryx, CoMentis, Cosmo Technologies, Coronado Biosciences, Cytokine Pharmasciences, Eagle Pharmaceuticals, Eisai Medical Research, Elan Pharmaceuticals, EnGene, Eli Lilly Enteromedics, Exagen Diagnostics, Ferring Pharmaceuticals, Flexion Therapeutics, Funxional Therapeutics Limited, Genzyme Corporation, Roche, Gilead Sciences, Given Imaging, Glaxo Smith Kline, Human Genome Sciences, Ironwood Pharmaceuticals, Janssen, KaloBios Pharmaceuticals, Lexicon Pharmaceuticals, Lycera Corporation, Meda Pharmaceuticals, Merck Research Laboratories, MerckSerono, Millennium Pharmaceuticals, Nisshin Kyorin Pharmaceuticals, Novo Nordisk, NPS Pharmaceuticals, Optimer Pharmaceuticals, Orexigen Therapeutics, PDL Biopharma, Pfizer, Procter and Gamble, Prometheus Laboratories, ProtAb Limited, Purgenesis Technologies, Relypsa, Salient Pharmaceuticals, Salix Pharmaceuticals, Santarus, Schering Plough Corporation, Shire Pharmaceuticals, Sigmoid Pharma Limited, Sirtris Pharmaceuticals,, SLA Pharma (UK) Limited, Targacept, Teva Pharmaceuticals, Therakos, Tillotts Pharma AG, TxCell SA, UCB Pharma, Viamet Pharmaceuticals, Vascular Biogenics Limited, Warner Chilcott UK Limited, and Pfizer; and lecture fees from Abbott Laboratories, Bristol Meyers Squibb, Janssen. All other authors declare that they have no conflicts of interest.	Aberra FN, 2003, GASTROENTEROLOGY, V125, P320, DOI 10.1016/S0016-5085(03)00883-7; Abraham C, 2009, NEW ENGL J MED, V361, P2066, DOI 10.1056/NEJMra0804647; Alberto L, 2006, GASTROENTEROLOGY, V130, P1588, DOI 10.1053/j.gastro.2006.02.004; Ananthakrishnan AN, 2011, INFLAMM BOWEL DIS, V17, P976, DOI 10.1002/ibd.21457; Ananthakrishnan AN, 2009, INFLAMM BOWEL DIS, V15, P176, DOI 10.1002/ibd.20639; Anderson CA, 2011, NAT GENET, V43, P246, DOI 10.1038/ng.764; Andersson RE, 2001, NEW ENGL J MED, V344, P808, DOI 10.1056/NEJM200103153441104; Ardizzone S, 2006, GUT, V55, P47, DOI 10.1136/gut.2005.068809; Arts J, 2004, INFLAMM BOWEL DIS, V10, P73, DOI 10.1097/00054725-200403000-00002; BARON J H, 1962, Br Med J, V2, P441; Barrett JC, 2009, NAT GENET, V41, P1330, DOI 10.1038/ng.483; Baumgart DC, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007216; Beaugerie L, 2001, AM J GASTROENTEROL, V96, P2113, DOI 10.1016/S0002-9270(01)02507-2; Beaugerie L, 2009, GASTROENTEROLOGY, V136, pA54; Bernstein CN, 2006, AM J GASTROENTEROL, V101, P1559, DOI 10.1111/j.1572-0241.2006.00603.x; Bernstein CN, 2006, AM J GASTROENTEROL, V101, P993, DOI 10.1111/j.1572-0241.2006.00381.x; Biancone L, 2008, J CROHNS COLITIS, V2, P63, DOI 10.1016/j.crohns.2007.12.001; Birkenfeld S, 2009, J CLIN GASTROENTEROL, V43, P743, DOI 10.1097/MCG.0b013e31818b3a02; Bjornsson S, 2000, EUR J GASTROEN HEPAT, V12, P31, DOI 10.1097/00042737-200012010-00007; Bolin TD, 2009, AM J GASTROENTEROL, V104, P2476, DOI 10.1038/ajg.2009.388; Bouma G, 1999, CLIN EXP IMMUNOL, V115, P294, DOI 10.1046/j.1365-2249.1999.00797.x; BRAEGGER CP, 1992, LANCET, V339, P89, DOI 10.1016/0140-6736(92)90999-J; Briskin M, 1997, AM J PATHOL, V151, P97; Cairns SR, 2010, GUT, V59, P666, DOI 10.1136/gut.2009.179804; CARBONNEL F, 1994, DIGEST DIS SCI, V39, P1550, DOI 10.1007/BF02088063; Cario E, 2000, INFECT IMMUN, V68, P7010, DOI 10.1128/IAI.68.12.7010-7017.2000; Cohen JL, 2005, DIS COLON RECTUM, V48, P1997, DOI 10.1007/s10350-005-0180-z; Colombel JF, 2011, GASTROENTEROLOGY, V141, P1194, DOI 10.1053/j.gastro.2011.06.054; Cornish JA, 2008, AM J GASTROENTEROL, V103, P2394, DOI 10.1111/j.1572-0241.2008.02064.x; D'Haens GR, 2011, AM J GASTROENTEROL, V106, P199, DOI 10.1038/ajg.2010.392; DHaens G, 1997, AM J GASTROENTEROL, V92, P1275; Dinesen LC, 2010, J CROHNS COLITIS, V4, P431, DOI 10.1016/j.crohns.2010.02.001; Eaden JA, 2001, GUT, V48, P526, DOI 10.1136/gut.48.4.526; Eckmann L, 2008, P NATL ACAD SCI USA, V105, P15058, DOI 10.1073/pnas.0808216105; EKBOM A, 1990, NEW ENGL J MED, V323, P1228, DOI 10.1056/NEJM199011013231802; Fajardo AD, 2010, J AM COLL SURGEONS, V211, P377, DOI 10.1016/j.jamcollsurg.2010.05.018; FARMER RG, 1980, CLIN GASTROENTEROL, V9, P271; Farraye FA, 2010, GASTROENTEROLOGY, V138, P746, DOI [10.1053/j.gastro.2009.12.037, 10.1053/j.gastro.2009.12.035]; Faubion WA, 2001, GASTROENTEROLOGY, V121, P255, DOI 10.1053/gast.2001.26279; Frank DN, 2011, INFLAMM BOWEL DIS, V17, P179, DOI 10.1002/ibd.21339; Fuss IJ, 2004, J CLIN INVEST, V113, P1490, DOI 10.1172/JCI200419836; GALANDIUK S, 1990, ANN SURG, V212, P446, DOI 10.1097/00000658-199010000-00007; Gisbert JP, 2007, ALIMENT PHARM THER, V25, P19, DOI 10.1111/j.1365-2036.2006.03131.x; Gisbert JP, 2009, ALIMENT PHARM THER, V30, P126, DOI 10.1111/j.1365-2036.2009.04023.x; Glocker EO, 2009, NEW ENGL J MED, V361, P2033, DOI 10.1056/NEJMoa0907206; Hanauer SB, 2007, CAN J GASTROENTEROL, V21, P827, DOI 10.1155/2007/862917; Hart AL, 2005, GASTROENTEROLOGY, V129, P50, DOI 10.1053/j.gastro.2005.05.013; HAWTHORNE AB, 1992, BRIT MED J, V305, P20, DOI 10.1136/bmj.305.6844.20; Heller F, 2008, MUCOSAL IMMUNOL, V1, pS58, DOI 10.1038/mi.2008.46; Heller F, 2005, GASTROENTEROLOGY, V129, P550, DOI 10.1053/j.gastro.2005.05.002; Heller F, 2002, IMMUNITY, V17, P629, DOI 10.1016/S1074-7613(02)00453-3; Herrinton LJ, 2008, AM J GASTROENTEROL, V103, P1998, DOI 10.1111/j.1572-0241.2008.01960.x; Heuschen UA, 2002, ANN SURG, V235, P207, DOI 10.1097/00000658-200202000-00008; Hoie O, 2007, GASTROENTEROLOGY, V132, P507, DOI 10.1053/j.gastro.2006.11.015; Indar AA, 2009, SURG ENDOSC, V23, P174, DOI 10.1007/s00464-008-0139-y; Jess T, 2006, GASTROENTEROLOGY, V130, P1039, DOI 10.1053/j.gastro.2005.12.037; Jess T, 2007, AM J GASTROENTEROL, V102, P609, DOI 10.1111/j.1572-0241.2006.01000.x; Etchevers MJ, 2009, INFLAMM BOWEL DIS, V15, P1320, DOI 10.1002/ibd.20897; Kamm MA, 2008, GUT, V57, P893, DOI 10.1136/gut.2007.138248; Kandiel A, 2006, AM J GASTROENTEROL, V101, P2857, DOI 10.1111/j.1572-0241.2006.00869.x; Kane SV, 2006, ALIMENT PHARM THER, V23, P577, DOI 10.1111/j.1365-2036.2006.02809.x; Kappelman MD, 2007, CLIN GASTROENTEROL H, V5, P1424, DOI 10.1016/j.cgh.2007.07.012; Klement E, 2004, AM J CLIN NUTR, V80, P1342, DOI 10.1093/ajcn/80.5.1342; Kornbluth A, 2010, AM J GASTROENTEROL, V105, P501, DOI 10.1038/ajg.2009.727; Kornfeld K, 1997, GUT, V41, P522, DOI 10.1136/gut.41.4.522; Koutroubakis IE, 2000, AM J GASTROENTEROL, V95, P171; Kruis W, 2011, ALIMENT PHARM THER, V33, P313, DOI 10.1111/j.1365-2036.2010.04537.x; Laharie D, 2011, J CROHNS COLITIS, V5, pS3; LANGHOLZ E, 1992, GASTROENTEROLOGY, V103, P1444, DOI 10.1016/0016-5085(92)91163-X; LANGHOLZ E, 1994, GASTROENTEROLOGY, V107, P3, DOI 10.1016/0016-5085(94)90054-X; Langholz E, 1996, SCAND J GASTROENTERO, V31, P260, DOI 10.3109/00365529609004876; LANGHOLZ E, 1991, SCAND J GASTROENTERO, V26, P1247, DOI 10.3109/00365529108998621; Leblanc S, 2011, AM J GASTROENTEROL, V106, P771, DOI 10.1038/ajg.2011.62; LEIJONMARCK CE, 1990, GUT, V31, P329, DOI 10.1136/gut.31.3.329; Leung Y, 2008, DIGEST DIS SCI, V53, P1455, DOI 10.1007/s10620-007-0036-6; LEVINE DS, 1991, GASTROENTEROLOGY, V101, P1198, DOI 10.1016/0016-5085(91)90068-V; Lewis JD, 2004, GASTROENTEROLOGY, V126, P665, DOI 10.1053/j.gastro.2003.12.003; LICHTIGER S, 1994, NEW ENGL J MED, V330, P1841, DOI 10.1056/NEJM199406303302601; Loftus CG, 2007, INFLAMM BOWEL DIS, V13, P254, DOI 10.1002/ibd.20029; Loftus EV, 2002, GASTROENTEROL CLIN N, V31, P1, DOI 10.1016/S0889-8553(01)00002-4; Loftus EV, 2005, GUT, V54, P91, DOI 10.1136/gut.2004.046615; Lopez-Serrano P, 2010, SCAND J GASTROENTERO, V45, P1464, DOI 10.3109/00365521.2010.510575; MacLean AR, 2002, ANN SURG, V235, P200, DOI 10.1097/00000658-200202000-00007; Magro F, 2012, INFLAMM BOWEL DIS, V18, P573, DOI 10.1002/ibd.21815; Mahadevan U, 2002, INFLAMM BOWEL DIS, V8, P311, DOI 10.1097/00054725-200209000-00001; Mahid SS, 2006, MAYO CLIN PROC, V81, P1462, DOI 10.4065/81.11.1462; Manninen P, 2010, SCAND J GASTROENTERO, V45, P1063, DOI 10.3109/00365521.2010.485323; Marshall JK, 1997, GUT, V40, P775, DOI 10.1136/gut.40.6.775; Marshall JK, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004115.pub2; Marteau P, 2005, GUT, V54, P960, DOI 10.1136/gut.2004.060103; Maser EA, 2008, CLIN GASTROENTEROL H, V6, P1112, DOI 10.1016/j.cgh.2008.04.035; Masuda H, 1995, J Clin Lab Immunol, V46, P111; Mathy C, 2003, INFLAMM BOWEL DIS, V9, P351, DOI 10.1097/00054725-200311000-00002; Matsuda R, 2009, INFLAMM BOWEL DIS, V15, P328, DOI 10.1002/ibd.20759; MONSEN U, 1987, SCAND J GASTROENTERO, V22, P214, DOI 10.3109/00365528708991882; Moskovitz DN, 2006, CLIN GASTROENTEROL H, V4, P760, DOI 10.1016/j.cgh.2006.04.001; Mowat C, 2011, GUT, V60, P571, DOI 10.1136/gut.2010.224154; MURCH SH, 1991, GUT, V32, P913, DOI 10.1136/gut.32.8.913; Niess JH, 2005, SCIENCE, V307, P254, DOI 10.1126/science.1102901; Orholm M, 2000, SCAND J GASTROENTERO, V35, P1075; ORHOLM M, 1991, NEW ENGL J MED, V324, P84, DOI 10.1056/NEJM199101103240203; Panaccione R, 2011, J CROHNS COLITIS, V5, pS3; Panes J, 1998, GASTROENTEROLOGY, V114, P1066, DOI 10.1016/S0016-5085(98)70328-2; Penna C, 1996, GUT, V38, P234, DOI 10.1136/gut.38.2.234; Peyrin-Biroulet L, 2012, GUT, V61, P241, DOI 10.1136/gutjnl-2011-300049; Porter CK, 2008, GASTROENTEROLOGY, V135, P781, DOI 10.1053/j.gastro.2008.05.081; Rahier JF, 2009, J CROHNS COLITIS, V3, P47, DOI 10.1016/j.crohns.2009.02.010; Rahman A, 2011, CLIN EXP IMMUNOL, V163, P123, DOI 10.1111/j.1365-2249.2010.04282.x; Rahman A, 2007, INFLAMM BOWEL DIS, V13, P847, DOI 10.1002/ibd.20141; Randall J, 2010, BRIT J SURG, V97, P404, DOI 10.1002/bjs.6874; Reinisch W, 2011, GUT, V60, P780, DOI 10.1136/gut.2010.221127; Rogler G, 1998, GASTROENTEROLOGY, V115, P357, DOI 10.1016/S0016-5085(98)70202-1; Rubin GP, 2000, ALIMENT PHARM THER, V14, P1553, DOI 10.1046/j.1365-2036.2000.00886.x; Rutgeerts P, 2005, NEW ENGL J MED, V353, P2462, DOI 10.1056/NEJMoa050516; Rutter M, 2004, GASTROENTEROLOGY, V126, P451, DOI 10.1053/j.gastro.2003.11.010; Safdi M, 1997, AM J GASTROENTEROL, V92, P1867; Sandborn WJ, 2009, GASTROENTEROLOGY, V137, P1250, DOI 10.1053/j.gastro.2009.06.061; Sandborn WJ, 2012, GASTROENTEROLOGY, V142, P257, DOI 10.1053/j.gastro.2011.10.032; Sandborn WJ, 2009, GASTROENTEROLOGY, V137, p[1934, e1]; Sang LX, 2010, WORLD J GASTROENTERO, V16, P1908, DOI 10.3748/wjg.v16.i15.1908; Sartor RB, 2003, KIRSNERS INFLAMMATOR; SCHROEDER KW, 1987, NEW ENGL J MED, V317, P1625, DOI 10.1056/NEJM198712243172603; Selvasekar CR, 2007, J AM COLL SURGEONS, V204, P956, DOI 10.1016/j.jamcollsurg.2006.12.044; Shen XY, 2010, DIGESTION, V81, P69, DOI 10.1159/000260417; Silverberg MS, 2005, CAN J GASTROENTEROL, V19, p5A, DOI 10.1155/2005/269076; Silverberg MS, 2009, NAT GENET, V41, P216, DOI 10.1038/ng.275; Solberg IC, 2009, SCAND J GASTROENTERO, V44, P431, DOI 10.1080/00365520802600961; Spehlmann ME, 2009, CURR OPIN GASTROEN, V25, P92, DOI 10.1097/MOG.0b013e328324f857; Steel AW, 2011, ALIMENT PHARM THER, V33, P115, DOI 10.1111/j.1365-2036.2010.04499.x; STEWENIUS J, 1995, SCAND J GASTROENTERO, V30, P38, DOI 10.3109/00365529509093233; Subramanian V, 2011, ALIMENT PHARM THER, V33, P304, DOI 10.1111/j.1365-2036.2010.04525.x; Sutherland L, 2006, COCHRANE DB SYST REV, V2; Sutherland L, 2006, COCHRANE DB SYST REV, V2; Swidsinski A, 2002, GASTROENTEROLOGY, V122, P44, DOI 10.1053/gast.2002.30294; Takeuchi K, 2006, CLIN GASTROENTEROL H, V4, P196, DOI 10.1016/S1542-3565(05)00980-8; TAUROG JD, 1994, J EXP MED, V180, P2359, DOI 10.1084/jem.180.6.2359; Timmer A, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000478.pub2; Travis SPL, 2008, J CROHNS COLITIS, V2, P24, DOI 10.1016/j.crohns.2007.11.002; Travis SPL, 1996, GUT, V38, P905, DOI 10.1136/gut.38.6.905; Turner D, 2007, CLIN GASTROENTEROL H, V5, P103, DOI 10.1016/j.cgh.2006.09.033; TYSK C, 1993, SCAND J GASTROENTERO, V28, P95, DOI 10.3109/00365529309096052; TYSK C, 1988, GUT, V29, P990, DOI 10.1136/gut.29.7.990; Vamadevan AS, 2010, INNATE IMMUN-LONDON, V16, P93, DOI 10.1177/1753425909339231; Van Assche G, 2003, GASTROENTEROLOGY, V125, P1025, DOI 10.1016/S0016-5085(03)01214-9; Van Klinken BJW, 1999, GUT, V44, P387, DOI 10.1136/gut.44.3.387; Velayos FS, 2005, AM J GASTROENTEROL, V100, P1345, DOI 10.1111/j.1572-0241.2005.41442.x; Vidal A, 2006, AM J GASTROENTEROL, V101, P775, DOI 10.1111/j.1572-0241.2006.00476.x; Vind I, 2006, AM J GASTROENTEROL, V101, P1274, DOI 10.1111/j.1572-0241.2006.00552.x; Waljee A, 2006, GUT, V55, P1575, DOI 10.1136/gut.2005.090316; Wheeler JMD, 2001, GUT, V48, P367, DOI 10.1136/gut.48.3.367; Williamson MER, 1997, DIS COLON RECTUM, V40, P1019, DOI 10.1007/BF02050922; Zhang FX, 1999, J BIOL CHEM, V274, P7611, DOI 10.1074/jbc.274.12.7611	152	908	943	20	214	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 3	2012	380	9853					1606	1619		10.1016/S0140-6736(12)60150-0	http://dx.doi.org/10.1016/S0140-6736(12)60150-0			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	030VR	22914296				2022-12-28	WOS:000310598700036
J	Mallam, AL; Del Campo, M; Gilman, B; Sidote, DJ; Lambowitz, AM				Mallam, Anna L.; Del Campo, Mark; Gilman, Benjamin; Sidote, David J.; Lambowitz, Alan M.			Structural basis for RNA-duplex recognition and unwinding by the DEAD-box helicase Mss116p	NATURE			English	Article							CRYSTAL-STRUCTURE; PROTEIN MSS116P; ATP HYDROLYSIS; GROUP-I; ACTIVATION; MECHANISM; RIBOSE; ROLES	DEAD-box proteins are the largest family of nucleic acid helicases, and are crucial to RNA metabolism throughout all domains of life(1,2). They contain a conserved 'helicase core' of two RecA-like domains (domains (D)1 and D2), which uses ATP to catalyse the unwinding of short RNA duplexes by non-processive, local strand separation(3). This mode of action differs from that of translocating helicases and allows DEAD-box proteins to remodel large RNAs and RNA-protein complexes without globally disrupting RNA structure(4). However, the structural basis for this distinctive mode of RNA unwinding remains unclear. Here, structural, biochemical and genetic analyses of the yeast DEAD-box protein Mss116p indicate that the helicase core domains have modular functions that enable a novel mechanism for RNA-duplex recognition and unwinding. By investigating D1 and D2 individually and together, we find that D1 acts as an ATP-binding domain and D2 functions as an RNA-duplex recognition domain. D2 contains a nucleic-acid-binding pocket that is formed by conserved DEAD-box protein sequence motifs and accommodates A-form but not B-form duplexes, providing a basis for RNA substrate specificity. Upon a conformational change in which the two core domains join to form a 'closed state' with an ATPase active site, conserved motifs in D1 promote the unwinding of duplex substrates bound to D2 by excluding one RNA strand and bending the other. Our results provide a comprehensive structural model for how DEAD-box proteins recognize and unwind RNA duplexes. This model explains key features of DEAD-box protein function and affords a new perspective on how the evolutionarily related cores of other RNA and DNA helicases diverged to use different mechanisms.	[Mallam, Anna L.; Del Campo, Mark; Gilman, Benjamin; Sidote, David J.; Lambowitz, Alan M.] Univ Texas Austin, Dept Chem & Biochem, Inst Cellular & Mol Biol, Austin, TX 78712 USA; [Mallam, Anna L.; Del Campo, Mark; Gilman, Benjamin; Sidote, David J.; Lambowitz, Alan M.] Univ Texas Austin, Sch Biol Sci, Sect Mol Genet & Microbiol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Lambowitz, AM (corresponding author), Univ Texas Austin, Dept Chem & Biochem, Inst Cellular & Mol Biol, Austin, TX 78712 USA.	lambowitz@austin.utexas.edu			National Institutes of Health (NIH), National Institute of General Medical Sciences; Howard Hughes Medical Institute; Office of Science, Office of Basic Energy Sciences, of the US Department of Energy [DE-AC02-05CH11231]; EMBO [ALTF 389-2010]; NIH [GM037951]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM037951, R01GM037951] Funding Source: NIH RePORTER	National Institutes of Health (NIH), National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Office of Science, Office of Basic Energy Sciences, of the US Department of Energy(United States Department of Energy (DOE)); EMBO(European Molecular Biology Organization (EMBO)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Monzingo (University of Texas at Austin Macromolecular Crystallography Facility) for help with X-ray diffraction data collection, and R. Russell (University of Texas at Austin) and E. Jankowsky (Case Western Reserve University) for comments on the manuscript. X-ray diffraction data were collected at the Berkeley Center for Structural Biology, which is supported in part by the National Institutes of Health (NIH), National Institute of General Medical Sciences and the Howard Hughes Medical Institute. The Advanced Light Source is supported by the Director, Office of Science, Office of Basic Energy Sciences, of the US Department of Energy under contract no. DE-AC02-05CH11231. A.L.M. is the recipient of an EMBO long-term fellowship (ALTF 389-2010). This work was supported by NIH grant GM037951.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Andersen CBF, 2006, SCIENCE, V313, P1968, DOI 10.1126/science.1131981; Cao WX, 2011, J MOL BIOL, V409, P399, DOI 10.1016/j.jmb.2011.04.004; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chen YF, 2008, P NATL ACAD SCI USA, V105, P20203, DOI 10.1073/pnas.0811075106; Del Campo M, 2009, MOL CELL, V35, P598, DOI 10.1016/j.molcel.2009.07.032; Del Campo M, 2009, J MOL BIOL, V389, P674, DOI 10.1016/j.jmb.2009.04.043; EGLI M, 1993, BIOCHEMISTRY-US, V32, P3221, DOI 10.1021/bi00064a004; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fairman-Williams ME, 2010, CURR OPIN STRUC BIOL, V20, P313, DOI 10.1016/j.sbi.2010.03.011; GORBALENYA AE, 1989, NUCLEIC ACIDS RES, V17, P4713, DOI 10.1093/nar/17.12.4713; Halls C, 2007, J MOL BIOL, V365, P835, DOI 10.1016/j.jmb.2006.09.083; Henn A, 2010, P NATL ACAD SCI USA, V107, P4046, DOI 10.1073/pnas.0913081107; Huang HR, 2005, P NATL ACAD SCI USA, V102, P163, DOI 10.1073/pnas.0407896101; Jarmoskaite I, 2011, WIRES RNA, V2, P135, DOI 10.1002/wrna.50; Jiang FG, 2011, NATURE, V479, P423, DOI 10.1038/nature10537; Kowalinski E, 2011, CELL, V147, P423, DOI 10.1016/j.cell.2011.09.039; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Linder P, 2011, NAT REV MOL CELL BIO, V12, P505, DOI 10.1038/nrm3154; Liu F, 2008, P NATL ACAD SCI USA, V105, P20209, DOI 10.1073/pnas.0811115106; Luo DH, 2011, CELL, V147, P409, DOI 10.1016/j.cell.2011.09.023; Mallam AL, 2011, P NATL ACAD SCI USA, V108, P12254, DOI 10.1073/pnas.1109566108; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mohr G, 2011, J MOL BIOL, V413, P952, DOI 10.1016/j.jmb.2011.09.015; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ozalp VC, 2010, J BIOL CHEM, V285, P37579, DOI 10.1074/jbc.M110.155119; Pan C, 2010, RNA BIOL, V7, P667, DOI 10.4161/rna.7.6.13571; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; Potratz JP, 2011, J MOL BIOL, V411, P661, DOI 10.1016/j.jmb.2011.05.047; Rocak S, 2004, NAT REV MOL CELL BIO, V5, P232, DOI 10.1038/nrm1335; Rudolph MG, 2006, J MOL BIOL, V361, P731, DOI 10.1016/j.jmb.2006.06.065; Schutz P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012791; Sengoku T, 2006, CELL, V125, P287, DOI 10.1016/j.cell.2006.01.054; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; Tang GQ, 2005, J BIOL CHEM, V280, P40707, DOI 10.1074/jbc.M508013200; Vonrhein C, 2011, ACTA CRYSTALLOGR D, V67, P293, DOI 10.1107/S0907444911007773; Wahl MC, 2000, NUCLEIC ACIDS RES, V28, P4356, DOI 10.1093/nar/28.21.4356; Wang S, 2008, BIOPHYS J, V94, pL1, DOI 10.1529/biophysj.107.120709; Wilkins MR, 1999, METH MOL B, V112, P531; Yang Q, 2007, MOL CELL, V28, P253, DOI 10.1016/j.molcel.2007.08.016	41	81	87	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 4	2012	490	7418					121	+		10.1038/nature11402	http://dx.doi.org/10.1038/nature11402			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015LG	22940866	Green Accepted			2022-12-28	WOS:000309446800045
J	Chng, SS; Xue, MY; Garner, RA; Kadokura, H; Boyd, D; Beckwith, J; Kahne, D				Chng, Shu-Sin; Xue, Mingyu; Garner, Ronald A.; Kadokura, Hiroshi; Boyd, Dana; Beckwith, Jonathan; Kahne, Daniel			Disulfide Rearrangement Triggered by Translocon Assembly Controls Lipopolysaccharide Export	SCIENCE			English	Article							OUTER-MEMBRANE; PROTEIN COMPLEX; IDENTIFICATION; BIOGENESIS	The presence of lipopolysaccharide (LPS) on the cell surface of Gram-negative bacteria is critical for viability. A conserved beta-barrel membrane protein LptD (lipopolysaccharide transport protein D) translocates LPS from the periplasm across the outer membrane (OM). In Escherichia coli, this protein contains two disulfide bonds and forms the OM LPS translocon with the lipoprotein LptE. Here, we identified seven in vivo states on the oxidative-folding pathway of LptD. Proper assembly involved a nonfunctional intermediate containing non-native disulfides. Intermediate formation required the oxidase DsbA, and subsequent maturation to the active form with native disulfides was triggered by LptE. Thus, disulfide bond-dependent protein folding of LptD requires the proper assembly of a two-protein complex to promote disulfide bond rearrangement.	[Chng, Shu-Sin; Xue, Mingyu; Garner, Ronald A.; Kahne, Daniel] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Chng, Shu-Sin; Kadokura, Hiroshi; Boyd, Dana; Beckwith, Jonathan] Harvard Univ, Dept Microbiol & Immunobiol, Sch Med, Boston, MA 02115 USA; [Kadokura, Hiroshi] Nara Inst Sci & Technol, Grad Sch Biol Sci, Nara 6300192, Japan; [Kahne, Daniel] Harvard Univ, Dept Biol Chem & Mol Pharmacol, Sch Med, Boston, MA 02115 USA	Harvard University; Harvard University; Harvard Medical School; Nara Institute of Science & Technology; Harvard University; Harvard Medical School	Kahne, D (corresponding author), Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA.	kahne@chemistry.harvard.edu	Kadokura, Hiroshi/AAE-1645-2019; Chng, Shu Sin/B-1759-2018	Chng, Shu Sin/0000-0001-5466-7183; Kadokura, Hiroshi/0000-0001-7308-7141	NIH [AI081059]; NIGMS [41883]; Japan Society for the Promotion of Science [21580092]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI081059] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041883] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank E. Freinkman for pET23/42lptD-FLAG<INF>3</INF>. J.B. is an American Cancer Society Professor. This work is supported by NIH grants AI081059 (to D. K.) and NIGMS 41883 (to J.B.) and in part by Japan Society for the Promotion of Science Grant-in-Aid for Scientific Research (C) 21580092 (to H.K.).	Braun M, 2002, MOL MICROBIOL, V45, P1289, DOI 10.1046/j.1365-2958.2002.03091.x; Chimalakonda G, 2011, P NATL ACAD SCI USA, V108, P2492, DOI 10.1073/pnas.1019089108; Chng SS, 2010, BIOCHEMISTRY-US, V49, P4565, DOI 10.1021/bi100493e; Chng SS, 2010, P NATL ACAD SCI USA, V107, P5363, DOI 10.1073/pnas.0912872107; Eggert US, 2001, SCIENCE, V294, P361, DOI 10.1126/science.1063611; Freinkman E, 2012, BIOCHEMISTRY-US, V51, P4800, DOI 10.1021/bi300592c; Freinkman E, 2011, P NATL ACAD SCI USA, V108, P2486, DOI 10.1073/pnas.1015617108; Jansens A, 2002, SCIENCE, V298, P2401, DOI 10.1126/science.1078376; Kadokura H, 2004, SCIENCE, V303, P534, DOI 10.1126/science.1091724; Kadokura H, 2009, CELL, V138, P1164, DOI 10.1016/j.cell.2009.07.030; MUHLRADT PF, 1975, EUR J BIOCHEM, V51, P343, DOI 10.1111/j.1432-1033.1975.tb03934.x; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Ruiz N, 2010, P NATL ACAD SCI USA, V107, P12245, DOI 10.1073/pnas.1007319107; SAMPSON BA, 1989, GENETICS, V122, P491; Sklar JG, 2007, P NATL ACAD SCI USA, V104, P6400, DOI 10.1073/pnas.0701579104; Ureta AR, 2007, J BACTERIOL, V189, P446, DOI 10.1128/JB.01103-06; Wu T, 2005, CELL, V121, P235, DOI 10.1016/j.cell.2005.02.015; Wu T, 2006, P NATL ACAD SCI USA, V103, P11754, DOI 10.1073/pnas.0604744103	19	76	79	1	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 28	2012	337	6102					1665	1668		10.1126/science.1227215	http://dx.doi.org/10.1126/science.1227215			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012DJ	22936569	Green Accepted			2022-12-28	WOS:000309215400048
J	Acuna, DE; Allesina, S; Kording, KP				Acuna, Daniel E.; Allesina, Stefano; Kording, Konrad P.			Predicting scientific success	NATURE			English	Editorial Material							INDEX		[Acuna, Daniel E.; Kording, Konrad P.] Rehabil Inst Chicago, Chicago, IL 60611 USA; [Acuna, Daniel E.; Kording, Konrad P.] Northwestern Univ, Evanston, IL 60208 USA; [Allesina, Stefano] Univ Chicago, Computat Inst, Chicago, IL 60637 USA	Shirley Ryan AbilityLab; Northwestern University; University of Chicago	Acuna, DE (corresponding author), Rehabil Inst Chicago, Chicago, IL 60611 USA.	daniel.acuna@northwestern.edu	Allesina, Stefano/A-2255-2009; Kording, Konrad P/A-1233-2007; Acuna, Daniel/O-8006-2016	Kording, Konrad P/0000-0001-8408-4499; Acuna, Daniel/0000-0002-7765-1595; Allesina, Stefano/0000-0003-0313-8374	NCATS NIH HHS [UL1 TR000150] Funding Source: Medline; NINDS NIH HHS [R01 NS063399] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS063399] Funding Source: NIH RePORTER	NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Allesina S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021160; Alonso S, 2009, J INFORMETR, V3, P273, DOI 10.1016/j.joi.2009.04.001; Dwan K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003081; Ginther DK, 2011, SCIENCE, V333, P1015, DOI 10.1126/science.1196783; Hirsch JE, 2007, P NATL ACAD SCI USA, V104, P19193, DOI 10.1073/pnas.0707962104; Hirsch JE, 2005, P NATL ACAD SCI USA, V102, P16569, DOI 10.1073/pnas.0507655102; Peterson I., 2005, SCIENCENEWS     1202; Redner S., 2010, J STAT MECH-THEORY E, V3; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	9	170	175	6	152	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 13	2012	489	7415					201	202		10.1038/489201a	http://dx.doi.org/10.1038/489201a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	003UC	22972278	Bronze, Green Accepted			2022-12-28	WOS:000308635900013
J	Milstein, JM; Kovar, LB; Kovar, LJ; Paterniti, DA				Milstein, Jay M.; Kovar, Lorraine B.; Kovar, Leonard J.; Paterniti, Debora A.			A Path to Wholeness	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Milstein, Jay M.] Univ Calif Davis, Dept Pediat, Div Neonatol, Davis, CA 95616 USA; [Paterniti, Debora A.] Univ Calif Davis, Dept Internal Med, Davis, CA 95616 USA; [Paterniti, Debora A.] Univ Calif Davis, Dept Sociol, Davis, CA 95616 USA; [Paterniti, Debora A.] Univ Calif Davis, Ctr Healthcare Policy & Res, Davis, CA 95616 USA; [Kovar, Lorraine B.; Kovar, Leonard J.] Renaissance Soc, Sacramento, CA USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Milstein, JM (corresponding author), Univ Calif Davis, Dept Pediat, Div Neonatol, Davis, CA 95616 USA.	jmmilstein@ucdavis.edu						Adzick NS, 2011, NEW ENGL J MED, V364, P993, DOI 10.1056/NEJMoa1014379; ANNAS GJ, 1984, AM J PUBLIC HEALTH, V74, P618, DOI 10.2105/AJPH.74.6.618; Cadge W, 2008, SOUTH MED J, V101, P626, DOI 10.1097/SMJ.0b013e3181706856; Milstein Jay, 2005, J Perinatol, V25, P563, DOI 10.1038/sj.jp.7211358; Milstein JM, 2008, JAMA-J AM MED ASSOC, V299, P2440, DOI 10.1001/jama.299.20.2440; Ozek M, 2008, SPINA BIFIDA MANAGEM, P3; Worden A., 2009, WORDEN LAB, V14	7	1	1	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 12	2012	308	10					985	986		10.1001/2012.jama.10425	http://dx.doi.org/10.1001/2012.jama.10425			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	003AA	22968887				2022-12-28	WOS:000308579300021
J	Katz, JE; Zhang, XY; Attenkofer, K; Chapman, KW; Frandsen, C; Zarzycki, P; Rosso, KM; Falcone, RW; Waychunas, GA; Gilbert, B				Katz, Jordan E.; Zhang, Xiaoyi; Attenkofer, Klaus; Chapman, Karena W.; Frandsen, Cathrine; Zarzycki, Piotr; Rosso, Kevin M.; Falcone, Roger W.; Waychunas, Glenn A.; Gilbert, Benjamin			Electron Small Polarons and Their Mobility in Iron (Oxyhydr)oxide Nanoparticles	SCIENCE			English	Article							RAY-ABSORPTION SPECTROSCOPY; NEAR-EDGE STRUCTURE; NANOCRYSTALLINE MATERIAL; FERRIHYDRITE; TRANSFORMATION; OXIDATION; DYNAMICS; KINETICS; OXIDES; RECOMBINATION	Electron mobility within iron (oxyhydr)oxides enables charge transfer between widely separated surface sites. There is increasing evidence that this internal conduction influences the rates of interfacial reactions and the outcomes of redox-driven phase transformations of environmental interest. To determine the links between crystal structure and charge-transport efficiency, we used pump-probe spectroscopy to study the dynamics of electrons introduced into iron(III) (oxyhydr) oxide nanoparticles via ultrafast interfacial electron transfer. Using time-resolved x-ray spectroscopy and ab initio calculations, we observed the formation of reduced and structurally distorted metal sites consistent with small polarons. Comparisons between different phases (hematite, maghemite, and ferrihydrite) revealed that short-range structural topology, not long-range order, dominates the electron-hopping rate.	[Zarzycki, Piotr; Rosso, Kevin M.] Pacific NW Natl Lab, Div Chem & Mat Sci, Richland, WA 99354 USA; [Katz, Jordan E.; Waychunas, Glenn A.; Gilbert, Benjamin] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Earth Sci, Berkeley, CA 94720 USA; [Katz, Jordan E.; Falcone, Roger W.] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; [Zhang, Xiaoyi; Attenkofer, Klaus; Chapman, Karena W.] Argonne Natl Lab, Xray Sci Div, Argonne, IL 60439 USA; [Frandsen, Cathrine] Tech Univ Denmark, Dept Phys, DK-2800 Lyngby, Denmark; [Zarzycki, Piotr] Polish Acad Sci, Inst Phys Chem, PL-01224 Warsaw, Poland	United States Department of Energy (DOE); Pacific Northwest National Laboratory; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Argonne National Laboratory; Technical University of Denmark; Polish Academy of Sciences; Institute of Physical Chemistry of the Polish Academy of Sciences	Rosso, KM (corresponding author), Pacific NW Natl Lab, Div Chem & Mat Sci, Richland, WA 99354 USA.	kevin.rosso@pnnl.gov; bgilbert@lbl.gov	Rosso, Kevin/AAQ-1561-2021; Gilbert, Benjamin/E-3182-2010; Zarzycki, Piotr Pawel/L-3802-2017; Katz, Jordan E/J-5599-2016; Attenkofer, Klaus/AAR-8772-2021; Frandsen, Cathrine/A-5729-2011; Frandsen, Cathrine/O-5656-2019	Zarzycki, Piotr Pawel/0000-0003-3891-7159; Katz, Jordan E/0000-0002-6242-2124; Frandsen, Cathrine/0000-0001-5006-924X; Gilbert, Benjamin/0000-0003-0853-0826; Attenkofer, Klaus/0000-0003-1588-3611	New Facility and Mid-scale Instrumentation grants; U.S. Department of Energy, Office of Science, and Office of Basic Energy Sciences (DOE-BES) [DE-AC02-05CH11231]; DOE-BES Geosciences program; Danish Council for Independent Research; DOE-BES [DE-AC02-06CH11357]	New Facility and Mid-scale Instrumentation grants; U.S. Department of Energy, Office of Science, and Office of Basic Energy Sciences (DOE-BES)(United States Department of Energy (DOE)); DOE-BES Geosciences program(United States Department of Energy (DOE)); Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); DOE-BES(United States Department of Energy (DOE))	Time-resolved x-ray transient spectroscopy was performed at beamline 11-ID-D at the Advanced Photon Source (APS). Laser facilities at 11-ID-D were provided by the Solar Energy Conversion group of Chemical Sciences and Engineering Division of Argonne National Laboratory, which is funded through New Facility and Mid-scale Instrumentation grants to L. X. Chen et al. We thank L. X. Chen, G. Jennings, and C. Kurtz. PDF analysis was performed at beamline 11-ID-B at the APS. Transient absorption spectroscopy was performed at the Argonne Center for Nanoscale Materials (CNM), and we thank G. Wiederrecht and D. Gosztola. This work was supported by the Chemical Imaging program of the U.S. Department of Energy, Office of Science, and Office of Basic Energy Sciences (DOE-BES), under contract DE-AC02-05CH11231. K. M. R. and P.Z. gratefully acknowledge support from DOE-BES Geosciences program to PNNL. C. F. acknowledges support from the Danish Council for Independent Research. Use of the APS and the CNM is supported by DOE-BES under contract DE-AC02-06CH11357.	Alexandrov A.S., 1996, POLARONS BIPOLARONS; Ankudinov AL, 1998, PHYS REV B, V58, P7565, DOI 10.1103/PhysRevB.58.7565; Benko G, 2001, J PHYS CHEM B, V105, P967, DOI 10.1021/jp002010s; Bressler C, 2004, CHEM REV, V104, P1781, DOI 10.1021/cr0206667; Bressler C, 2009, SCIENCE, V323, P489, DOI 10.1126/science.1165733; Cannizzo A, 2010, COORDIN CHEM REV, V254, P2677, DOI 10.1016/j.ccr.2009.12.007; Chen J, 2007, J PHYS CHEM A, V111, P9326, DOI 10.1021/jp0733466; Chen LX, 2005, ANNU REV PHYS CHEM, V56, P221, DOI 10.1146/annurev.physchem.56.092503.141310; Cherepy NJ, 1998, J PHYS CHEM B, V102, P770, DOI 10.1021/jp973149e; COLOMBO U, 1968, NATURE, V219, P1036, DOI 10.1038/2191036a0; Cowley JM, 2000, J STRUCT BIOL, V131, P210, DOI 10.1006/jsbi.2000.4292; Cox P.A., 2010, TRANSITION METAL OXI; Djerdj I, 2008, J AM CHEM SOC, V130, P11364, DOI 10.1021/ja801813a; Ederth J, 2004, J APPL PHYS, V96, P5722, DOI 10.1063/1.1804617; Gilbert B, 2003, J PHYS CHEM A, V107, P2839, DOI 10.1021/jp021493s; Gratzel M, 2001, NATURE, V414, P338, DOI 10.1038/35104607; Hansel CM, 2005, ENVIRON SCI TECHNOL, V39, P7147, DOI 10.1021/es050666z; Hilgendorff M, 1998, J PHYS CHEM B, V102, P10505, DOI 10.1021/jp982210s; HOLSTEIN T, 1959, ANN PHYS-NEW YORK, V8, P343, DOI 10.1016/0003-4916(59)90003-X; Iordanova N, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1869492; Katz JE, 2010, J PHYS CHEM LETT, V1, P1372, DOI 10.1021/jz100296r; Larsen O, 2001, GEOCHIM COSMOCHIM AC, V65, P1367, DOI 10.1016/S0016-7037(00)00623-2; Manceau A, 2009, CLAY MINER, V44, P19, DOI 10.1180/claymin.2009.044.1.19; Mannella N, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.166401; Michel FM, 2007, SCIENCE, V316, P1726, DOI 10.1126/science.1142525; Pedersen HD, 2006, GEOCHIM COSMOCHIM AC, V70, P4116, DOI 10.1016/j.gca.2006.06.1370; Pedersen HD, 2005, GEOCHIM COSMOCHIM AC, V69, P3967, DOI 10.1016/j.gca.2005.03.016; Rancourt DG, 2008, AM MINERAL, V93, P1412, DOI 10.2138/am.2008.2782; Rosso KM, 2004, J CHEM PHYS, V120, P7050, DOI 10.1063/1.1676117; STUMM W, 1992, GEOCHIM COSMOCHIM AC, V56, P3233, DOI 10.1016/0016-7037(92)90301-X; Tang J, 2003, J PHYS CHEM B, V107, P7501, DOI 10.1021/jp027048e; TRONC E, 1992, LANGMUIR, V8, P313, DOI 10.1021/la00037a057; WAYCHUNAS GA, 1983, PHYS CHEM MINER, V10, P1, DOI 10.1007/BF01204319; Wilke M, 2001, AM MINERAL, V86, P714; Xu WQ, 2011, AM MINERAL, V96, P513, DOI 10.2138/am.2011.3460; Yanina SV, 2008, SCIENCE, V320, P218, DOI 10.1126/science.1154833	36	137	140	6	271	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 7	2012	337	6099					1200	1203		10.1126/science.1223598	http://dx.doi.org/10.1126/science.1223598			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	000UJ	22955830	Green Submitted			2022-12-28	WOS:000308414000030
J	Sun, JY; Zhao, XH; Illeperuma, WRK; Chaudhuri, O; Oh, KH; Mooney, DJ; Vlassak, JJ; Suo, ZG				Sun, Jeong-Yun; Zhao, Xuanhe; Illeperuma, Widusha R. K.; Chaudhuri, Ovijit; Oh, Kyu Hwan; Mooney, David J.; Vlassak, Joost J.; Suo, Zhigang			Highly stretchable and tough hydrogels	NATURE			English	Article							DOUBLE-NETWORK GELS; HIGH MECHANICAL STRENGTH; LARGE-STRAIN; FRACTURE; HYSTERESIS; FATIGUE; MODEL	Hydrogels are used as scaffolds for tissue engineering(1), vehicles for drug delivery(2), actuators for optics and fluidics(3), and model extracellular matrices for biological studies(4). The scope of hydrogel applications, however, is often severely limited by their mechanical behaviour(5). Most hydrogels do not exhibit high stretchability; for example, an alginate hydrogel ruptures when stretched to about 1.2 times its original length. Some synthetic elastic hydrogels(6,7) have achieved stretches in the range 10-20, but these values are markedly reduced in samples containing notches. Most hydrogels are brittle, with fracture energies of about 10 J m(-2) (ref. 8), as compared with similar to 1,000 J m(-2) for cartilage(9) and similar to 10,000 J m(-2) for natural rubbers(10). Intense efforts are devoted to synthesizing hydrogels with improved mechanical properties(11-18); certain synthetic gels have reached fracture energies of 100-1,000 J m(-2) (refs 11, 14, 17). Here we report the synthesis of hydrogels from polymers forming ionically and covalently crosslinked networks. Although such gels contain similar to 90% water, they can be stretched beyond 20 times their initial length, and have fracture energies of similar to 9,000 J m(-2). Even for samples containing notches, a stretch of 17 is demonstrated. We attribute the gels' toughness to the synergy of two mechanisms: crack bridging by the network of covalent crosslinks, and hysteresis by unzipping the network of ionic crosslinks. Furthermore, the network of covalent crosslinks preserves the memory of the initial state, so that much of the large deformation is removed on unloading. The unzipped ionic crosslinks cause internal damage, which heals by re-zipping. These gels may serve as model systems to explore mechanisms of deformation and energy dissipation, and expand the scope of hydrogel applications.	[Sun, Jeong-Yun; Illeperuma, Widusha R. K.; Chaudhuri, Ovijit; Mooney, David J.; Vlassak, Joost J.; Suo, Zhigang] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Sun, Jeong-Yun; Oh, Kyu Hwan] Seoul Natl Univ, Dept Mat Sci & Engn, Seoul 151742, South Korea; [Zhao, Xuanhe] Duke Univ, Dept Mech Engn & Mat Sci, Durham, NC 27708 USA; [Mooney, David J.] Harvard Univ, Wyss Inst Biologically Inspired Engn, Cambridge, MA 02138 USA; [Suo, Zhigang] Harvard Univ, Kavli Inst Bionano Sci & Technol, Cambridge, MA 02138 USA	Harvard University; Seoul National University (SNU); Duke University; Harvard University; Harvard University	Suo, ZG (corresponding author), Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA.	suo@seas.harvard.edu	Sun, Jeong-Yun/AAR-4630-2020; Zhao, Xuanhe/B-1532-2008; Suo, Zhigang/B-1067-2008; Sun, Jeong-Yun/F-5662-2012; oh, kyuhwan/H-5265-2018	Zhao, Xuanhe/0000-0001-5387-6186; Suo, Zhigang/0000-0002-4068-4844; Mooney, David/0000-0001-6299-1194; Chaudhuri, Ovijit/0000-0002-9287-3401	ARO [W911NF-09-1-0476]; NSF [CMMI-0800161]; DARPA [W911NF-10-1-0113]; NIH [R37 DE013033]; MRSEC [DMR-0820484]; NSF Research Triangle MRSEC [DMR-1121107]; Haythornthwaite Research Initiation grants; National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [R11-2005-065]; Alexander von Humboldt Award; Harvard University; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R37DE013033, R01DE013033] Funding Source: NIH RePORTER	ARO; NSF(National Science Foundation (NSF)); DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRSEC(National Science Foundation (NSF)); NSF Research Triangle MRSEC; Haythornthwaite Research Initiation grants; National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Alexander von Humboldt Award(Alexander von Humboldt Foundation); Harvard University; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	The work at Harvard was supported by ARO (W911NF-09-1-0476), NSF (CMMI-0800161), DARPA (W911NF-10-1-0113), NIH (R37 DE013033) and MRSEC (DMR-0820484). X.Z. acknowledges the support of the NSF Research Triangle MRSEC (DMR-1121107) and Haythornthwaite Research Initiation grants. K.H.O. is supported by the National Research Foundation of Korea (NRF), funded by the Ministry of Education, Science and Technology (R11-2005-065). Z.S. acknowledges a sabbatical leave at the Karlsruhe Institute of Technology funded by the Alexander von Humboldt Award and by Harvard University.	Baumberger T, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3078267; Brown HR, 2007, MACROMOLECULES, V40, P3815, DOI 10.1021/ma062642y; Calvert P, 2009, ADV MATER, V21, P743, DOI 10.1002/adma.200800534; Discher DE, 2009, SCIENCE, V324, P1673, DOI 10.1126/science.1171643; Dong L, 2006, NATURE, V442, P551, DOI 10.1038/nature05024; EVANS AG, 1990, J AM CERAM SOC, V73, P187, DOI 10.1111/j.1151-2916.1990.tb06493.x; Gong JP, 2003, ADV MATER, V15, P1155, DOI 10.1002/adma.200304907; Haque MA, 2011, MACROMOLECULES, V44, P8916, DOI 10.1021/ma201653t; Haraguchi K, 2002, ADV MATER, V14, P1120, DOI 10.1002/1521-4095(20020816)14:16<1120::AID-ADMA1120>3.0.CO;2-9; Henderson KJ, 2010, MACROMOLECULES, V43, P6193, DOI 10.1021/ma100963m; Hernandez RM, 2010, ADV DRUG DELIVER REV, V62, P711, DOI 10.1016/j.addr.2010.02.004; Huang T, 2007, ADV MATER, V19, P1622, DOI 10.1002/adma.200602533; Hui CY, 2003, P ROY SOC A-MATH PHY, V459, P1489, DOI 10.1098/rspa.2002.1057; JACKSON AP, 1990, BIOMATERIALS, V11, P403, DOI 10.1016/0142-9612(90)90095-8; Kong HJ, 2003, MACROMOLECULES, V36, P4582, DOI 10.1021/ma034137w; LAKE GJ, 1967, PROC R SOC LON SER-A, V300, P108, DOI 10.1098/rspa.1967.0160; LAKE GJ, 1995, RUBBER CHEM TECHNOL, V68, P435, DOI 10.5254/1.3538750; Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x; Lin WC, 2010, MACROMOLECULES, V43, P2554, DOI 10.1021/ma901937r; Maldonado-Codina C, 2004, OPHTHAL PHYSL OPT, V24, P551, DOI 10.1111/j.1475-1313.2004.00236.x; Okumura Y, 2001, ADV MATER, V13, P485, DOI 10.1002/1521-4095(200104)13:7<485::AID-ADMA485>3.0.CO;2-T; Qiu Y, 2001, ADV DRUG DELIVER REV, V53, P321, DOI 10.1016/S0169-409X(01)00203-4; Sakai T, 2008, MACROMOLECULES, V41, P5379, DOI 10.1021/ma800476x; Seitz ME, 2009, SOFT MATTER, V5, P447, DOI 10.1039/b810041a; Simha N. K., 2003, J MATER SCI-MATER M, V14, P631; Tanaka Y, 2007, EPL-EUROPHYS LETT, V78, DOI 10.1209/0295-5075/78/56005; Tuncaboylu DC, 2011, MACROMOLECULES, V44, P4997, DOI 10.1021/ma200579v; Wang Q, 2010, NATURE, V463, P339, DOI 10.1038/nature08693; Webber RE, 2007, MACROMOLECULES, V40, P2919, DOI 10.1021/ma062924y; Yu QM, 2009, MACROMOLECULES, V42, P3852, DOI 10.1021/ma900622s	30	3258	3374	416	6338	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 6	2012	489	7414					133	136		10.1038/nature11409	http://dx.doi.org/10.1038/nature11409			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999WW	22955625	Green Accepted			2022-12-28	WOS:000308347000049
J	Thurman, RE; Rynes, E; Humbert, R; Vierstra, J; Maurano, MT; Haugen, E; Sheffield, NC; Stergachis, AB; Wang, H; Vernot, B; Garg, K; John, S; Sandstrom, R; Bates, D; Boatman, L; Canfield, TK; Diegel, M; Dunn, D; Ebersol, AK; Frum, T; Giste, E; Johnson, AK; Johnson, EM; Kutyavin, T; Lajoie, B; Lee, BK; Lee, K; London, D; Lotakis, D; Neph, S; Neri, F; Nguyen, ED; Qu, HZ; Reynolds, AP; Roach, V; Safi, A; Sanchez, ME; Sanyal, A; Shafer, A; Simon, JM; Song, LY; Vong, S; Weaver, M; Yan, YQ; Zhang, ZC; Zhang, ZZ; Lenhard, B; Tewari, M; Dorschner, MO; Hansen, RS; Navas, PA; Stamatoyannopoulos, G; Iyer, VR; Lieb, JD; Sunyaev, SR; Akey, JM; Sabo, PJ; Kaul, R; Furey, TS; Dekker, J; Crawford, GE; Stamatoyannopoulos, JA				Thurman, Robert E.; Rynes, Eric; Humbert, Richard; Vierstra, Jeff; Maurano, Matthew T.; Haugen, Eric; Sheffield, Nathan C.; Stergachis, Andrew B.; Wang, Hao; Vernot, Benjamin; Garg, Kavita; John, Sam; Sandstrom, Richard; Bates, Daniel; Boatman, Lisa; Canfield, Theresa K.; Diegel, Morgan; Dunn, Douglas; Ebersol, Abigail K.; Frum, Tristan; Giste, Erika; Johnson, Audra K.; Johnson, Ericka M.; Kutyavin, Tanya; Lajoie, Bryan; Lee, Bum-Kyu; Lee, Kristen; London, Darin; Lotakis, Dimitra; Neph, Shane; Neri, Fidencio; Nguyen, Eric D.; Qu, Hongzhu; Reynolds, Alex P.; Roach, Vaughn; Safi, Alexias; Sanchez, Minerva E.; Sanyal, Amartya; Shafer, Anthony; Simon, Jeremy M.; Song, Lingyun; Vong, Shinny; Weaver, Molly; Yan, Yongqi; Zhang, Zhancheng; Zhang, Zhuzhu; Lenhard, Boris; Tewari, Muneesh; Dorschner, Michael O.; Hansen, R. Scott; Navas, Patrick A.; Stamatoyannopoulos, George; Iyer, Vishwanath R.; Lieb, Jason D.; Sunyaev, Shamil R.; Akey, Joshua M.; Sabo, Peter J.; Kaul, Rajinder; Furey, Terrence S.; Dekker, Job; Crawford, Gregory E.; Stamatoyannopoulos, John A.			The accessible chromatin landscape of the human genome	NATURE			English	Article							LOCUS-CONTROL REGION; BETA-GLOBIN LOCUS; TRANSCRIPTION; BINDING; DISTINCT; PROTEIN; NF-E2	DNase I hypersensitive sites (DHSs) are markers of regulatory DNA and have underpinned the discovery of all classes of cis-regulatory elements including enhancers, promoters, insulators, silencers and locus control regions. Here we present the first extensive map of human DHSs identified through genome-wide profiling in 125 diverse cell and tissue types. We identify similar to 2.9 million DHSs that encompass virtually all known experimentally validated cis-regulatory sequences and expose a vast trove of novel elements, most with highly cell-selective regulation. Annotating these elements using ENCODE data reveals novel relationships between chromatin accessibility, transcription, DNA methylation and regulatory factor occupancy patterns. We connect similar to 580,000 distal DHSs with their target promoters, revealing systematic pairing of different classes of distal DHSs and specific promoter types. Patterning of chromatin accessibility at many regulatory regions is organized with dozens to hundreds of co-activated elements, and the transcellular DNase I sensitivity pattern at a given region can predict cell-type-specific functional behaviours. The DHS landscape shows signatures of recent functional evolutionary constraint. However, the DHS compartment in pluripotent and immortalized cells exhibits higher mutation rates than that in highly differentiated cells, exposing an unexpected link between chromatin accessibility, proliferative potential and patterns of human variation.	[Thurman, Robert E.; Rynes, Eric; Humbert, Richard; Vierstra, Jeff; Maurano, Matthew T.; Haugen, Eric; Stergachis, Andrew B.; Wang, Hao; Vernot, Benjamin; John, Sam; Sandstrom, Richard; Bates, Daniel; Canfield, Theresa K.; Diegel, Morgan; Dunn, Douglas; Giste, Erika; Johnson, Audra K.; Kutyavin, Tanya; Lee, Kristen; Neph, Shane; Neri, Fidencio; Qu, Hongzhu; Reynolds, Alex P.; Roach, Vaughn; Shafer, Anthony; Vong, Shinny; Weaver, Molly; Akey, Joshua M.; Sabo, Peter J.; Stamatoyannopoulos, John A.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Sheffield, Nathan C.; London, Darin; Safi, Alexias; Song, Lingyun; Crawford, Gregory E.] Duke Univ, Inst Genome Sci & Policy, Durham, NC 27708 USA; [Garg, Kavita; Tewari, Muneesh] Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98109 USA; [Boatman, Lisa; Ebersol, Abigail K.; Frum, Tristan; Johnson, Ericka M.; Lotakis, Dimitra; Nguyen, Eric D.; Sanchez, Minerva E.; Yan, Yongqi; Hansen, R. Scott; Navas, Patrick A.; Stamatoyannopoulos, George; Kaul, Rajinder] Univ Washington, Dept Med, Div Med Genet, Seattle, WA 98195 USA; [Lajoie, Bryan; Sanyal, Amartya; Dekker, Job] Univ Massachusetts, Program Syst Biol, Sch Med, Worcester, MA 01605 USA; [Lee, Bum-Kyu; Iyer, Vishwanath R.] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA; [Qu, Hongzhu] Chinese Acad Sci, Lab Dis Genom & Individualized Med, Beijing Inst Genom, Beijing 100029, Peoples R China; [Simon, Jeremy M.; Zhang, Zhancheng; Zhang, Zhuzhu; Lieb, Jason D.; Furey, Terrence S.] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; [Lenhard, Boris] Univ Bergen, Dept Biol, N-5008 Bergen, Norway; [Lenhard, Boris] Univ Bergen, Bergen Ctr Computat Sci, N-5008 Bergen, Norway; [Dorschner, Michael O.] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Sunyaev, Shamil R.] Brigham & Womens Hosp, Dept Med, Div Genet, Boston, MA 02115 USA; [Sunyaev, Shamil R.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Stamatoyannopoulos, John A.] Univ Washington, Dept Med, Div Oncol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Duke University; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Massachusetts System; University of Massachusetts Worcester; University of Texas System; University of Texas Austin; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; University of North Carolina; University of North Carolina Chapel Hill; University of Bergen; University of Bergen; University of Washington; University of Washington Seattle; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Washington; University of Washington Seattle	Stamatoyannopoulos, JA (corresponding author), Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.	jstam@uw.edu	SANYAL, AMARTYA/D-7240-2015; Vernot, Benjamin/ABH-1495-2021; Sheffield, Nathan/ABG-8124-2020	SANYAL, AMARTYA/0000-0002-2109-4478; Vernot, Benjamin/0000-0002-6820-2181; Sheffield, Nathan/0000-0001-5643-4068; Furey, Terry/0000-0001-5546-9672; FRUM, Tristan/0000-0003-3452-8762; Lenhard, Boris/0000-0002-1114-1509; Vierstra, Jeff/0000-0001-6406-8563; Akey, Joshua/0000-0002-4411-1330; Haugen, Eric/0000-0001-7444-8981; Lee, Bum Kyu/0000-0001-7835-419X; Kaul, Rajinder/0000-0002-7895-9284; Lieb, Jason/0000-0001-7601-8061; Nguyen, Eric/0000-0002-0516-2434; Sandstrom, Richard/0000-0002-3356-1547	National Institutes of Health [HG004592, HG004563, GM076036, R01MH084676]; National Science Foundation Graduate Research Fellowship [DGE-0718124]; National Science Foundation; Research Council of Norway; caBIG In Silico Center of Excellence, NCI/NIH [HHSN261200800001E]; NATIONAL CANCER INSTITUTE [P30CA016086] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG004592, U54HG004563, R01HG003143] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F30DK095678] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076036] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH084676] Funding Source: NIH RePORTER; Medical Research Council [MC_UP_1102/1] Funding Source: researchfish; MRC [MC_UP_1102/1] Funding Source: UKRI	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); National Science Foundation(National Science Foundation (NSF)); Research Council of Norway(Research Council of Norway); caBIG In Silico Center of Excellence, NCI/NIH; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank our ENCODE colleagues for many insights into the data types generated by different centres and for help with coordinated analyses. We thank I. Stanaway for assistance with the variation analysis, and many colleagues, particularly F. Urnov, for helpful critiques of the manuscript and figures. This work was funded by National Institutes of Health grants HG004592 (J.A.S.), HG004563 (G. E. C.), GM076036 (J.M.A.) and R01MH084676 (S. R. S), and J.V. is supported by the National Science Foundation Graduate Research Fellowship under grant no. DGE-0718124. N.C.S. is supported by a National Science Foundation Graduate Research Fellowship and the Research Council of Norway. M. T. and K. G. acknowledge funding support from the caBIG In Silico Center of Excellence, NCI/NIH contract no. HHSN261200800001E.	Biggin MD, 2011, DEV CELL, V21, P611, DOI 10.1016/j.devcel.2011.09.008; Boyle AP, 2008, CELL, V132, P311, DOI 10.1016/j.cell.2007.12.014; Dahle O, 2004, EXP CELL RES, V297, P118, DOI 10.1016/j.yexcr.2004.03.014; Dostie J, 2006, GENOME RES, V16, P1299, DOI 10.1101/gr.5571506; Farazi TA, 2011, J PATHOL, V223, P102, DOI 10.1002/path.2806; Felsenfeld G, 1996, P NATL ACAD SCI USA, V93, P9384, DOI 10.1073/pnas.93.18.9384; Forsberg EC, 2000, BLOOD, V96, P334, DOI 10.1182/blood.V96.1.334.013k17_334_339; Frietze S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015082; Gaszner M, 2006, NAT REV GENET, V7, P703, DOI 10.1038/nrg1925; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; GROSS DS, 1988, ANNU REV BIOCHEM, V57, P159, DOI 10.1146/annurev.bi.57.070188.001111; Harrow J., GENOME RES IN PRESS; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Henikoff S, 2009, GENOME RES, V19, P460, DOI 10.1101/gr.087619.108; Hesselberth JR, 2009, NAT METHODS, V6, P283, DOI [10.1038/NMETH.1313, 10.1038/nmeth.1313]; John S, 2011, NAT GENET, V43, P264, DOI 10.1038/ng.759; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Li GL, 2012, CELL, V148, P84, DOI 10.1016/j.cell.2011.12.014; Li QL, 1999, TRENDS GENET, V15, P403, DOI 10.1016/S0168-9525(99)01780-1; O'Geen H, 2007, PLOS GENET, V3, P916, DOI 10.1371/journal.pgen.0030089; Rasheed ZA, 2002, EXP CELL RES, V277, P152, DOI 10.1006/excr.2002.5550; REDDY PMS, 1994, J BIOL CHEM, V269, P8287; Schultz DC, 2002, GENE DEV, V16, P919, DOI 10.1101/gad.973302; Siegfried Z, 1999, NAT GENET, V22, P203, DOI 10.1038/9727; Song LY, 2011, GENOME RES, V21, P1757, DOI 10.1101/gr.121541.111; Stadler MB, 2011, NATURE, V480, P490, DOI 10.1038/nature10716; Stergachis AB, 2011, NAT METHODS, V8, P1041, DOI [10.1038/NMETH.1770, 10.1038/nmeth.1770]; TALBOT D, 1991, EMBO J, V10, P1391, DOI 10.1002/j.1460-2075.1991.tb07659.x; TUAN D, 1992, P NATL ACAD SCI USA, V89, P11219, DOI 10.1073/pnas.89.23.11219; Vernot B., GENOME RES IN PRESS; WEISBROD S, 1979, P NATL ACAD SCI USA, V76, P630, DOI 10.1073/pnas.76.2.630	32	1719	1773	7	210	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 6	2012	489	7414					75	82		10.1038/nature11232	http://dx.doi.org/10.1038/nature11232			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999WW	22955617	Green Accepted, Green Submitted, hybrid			2022-12-28	WOS:000308347000040
J	Moore, TJ; Furberg, CD				Moore, Thomas J.; Furberg, Curt D.			The Safety Risks of Innovation The FDA's Expedited Drug Development Pathway	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							DABIGATRAN		[Moore, Thomas J.] Inst Safe Medicat Practices, Alexandria, VA 22314 USA; [Furberg, Curt D.] Wake Forest Sch Med, Div Publ Hlth Sci, Winston Salem, NC USA	Wake Forest University	Moore, TJ (corresponding author), Inst Safe Medicat Practices, 101 N Columbus St, Alexandria, VA 22314 USA.	tmoore@ismp.org						[Anonymous], DRIV BIOM INN IN IMP; [Anonymous], FY2011 INN DRUG APPR; Cohen JA, 2010, NEW ENGL J MED, V362, P402, DOI 10.1056/NEJMoa0907839; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Cotton BA, 2011, NEW ENGL J MED, V365, P2039, DOI 10.1056/NEJMc1111095; Justice RL, 2011, SUMMARY REV REGULATO; Lourdes V, 2010, CLIN REV SAFETY NDA; Moore TJ, QUARTERWATCH MONITOR; Schiff GD, 2011, ARCH INTERN MED, V171, P1433, DOI 10.1001/archinternmed.2011.256; Unger EF, 2010, DEP OFF DIR DEC MEM	10	19	19	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 5	2012	308	9					869	870		10.1001/jama.2012.9658	http://dx.doi.org/10.1001/jama.2012.9658			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	999ET	22948694				2022-12-28	WOS:000308292900014
J	Hoppins, S; Nunnari, J				Hoppins, Suzanne; Nunnari, Jodi			Mitochondrial Dynamics and Apoptosis-the ER Connection	SCIENCE			English	Editorial Material							BAX; FUSION; MEMBRANE; SITES; MFN2; DRP1		[Hoppins, Suzanne; Nunnari, Jodi] Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA	University of California System; University of California Davis	Hoppins, S (corresponding author), Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA.	jmnunnari@ucdavis.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K99HL103722] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062942, R01GM097432] Funding Source: NIH RePORTER; NHLBI NIH HHS [K99HL103722] Funding Source: Medline; NIGMS NIH HHS [R01GM062942, R01GM097432] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Chipuk JE, 2012, CELL, V148, P988, DOI 10.1016/j.cell.2012.01.038; Cipolat S, 2006, CELL, V126, P163, DOI 10.1016/j.cell.2006.06.021; Cleland MM, 2011, CELL DEATH DIFFER, V18, P235, DOI 10.1038/cdd.2010.89; de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534; DeVay RM, 2009, J CELL BIOL, V186, P793, DOI 10.1083/jcb.200906098; Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025; Friedman JR, 2011, SCIENCE, V334, P358, DOI 10.1126/science.1207385; Griffin EE, 2006, J BIOL CHEM, V281, P16599, DOI 10.1074/jbc.M601847200; Hoppins S, 2007, ANNU REV BIOCHEM, V76, P751, DOI 10.1146/annurev.biochem.76.071905.090048; Hoppins S, 2011, MOL CELL, V41, P150, DOI 10.1016/j.molcel.2010.11.030; Ingerman E, 2005, J CELL BIOL, V170, P1021, DOI 10.1083/jcb.200506078; Karbowski M, 2002, J CELL BIOL, V159, P931, DOI 10.1083/jcb.200209124; Labrousse AM, 1999, MOL CELL, V4, P815, DOI 10.1016/S1097-2765(00)80391-3; Lane N, 2010, NATURE, V467, P929, DOI 10.1038/nature09486; Montessuit S, 2010, CELL, V142, P889, DOI 10.1016/j.cell.2010.08.017; Schon EA, 2011, NEURON, V70, P1033, DOI 10.1016/j.neuron.2011.06.003; Yoon Y, 2001, MOL BIOL CELL, V12, P2894, DOI 10.1091/mbc.12.9.2894; Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855	18	106	110	1	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 31	2012	337	6098					1052	1054		10.1126/science.1224709	http://dx.doi.org/10.1126/science.1224709			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996WP	22936767				2022-12-28	WOS:000308125800034
J	Guermazi, A; Niu, JB; Hayashi, D; Roemer, FW; Englund, M; Neogi, T; Aliabadi, P; McLennan, CE; Felson, DT				Guermazi, Ali; Niu, Jingbo; Hayashi, Daichi; Roemer, Frank W.; Englund, Martin; Neogi, Tuhina; Aliabadi, Piran; McLennan, Christine E.; Felson, David T.			Prevalence of abnormalities in knees detected by MRI in adults without knee osteoarthritis: population based observational study (Framingham Osteoarthritis Study)	BRITISH MEDICAL JOURNAL			English	Article							BONE-MARROW LESIONS; JOINT SPACE WIDTH; BODY-MASS INDEX; CARTILAGE LOSS; RADIOGRAPHIC FEATURES; RHEUMATIC CONDITIONS; UNITED-STATES; RISK-FACTORS; PAIN; ASSOCIATION	Objective To examine use of magnetic resonance imaging (MRI) of knees with no radiographic evidence of osteoarthritis to determine the prevalence of structural lesions associated with osteoarthritis and their relation to age, sex, and obesity. Design Population based observational study. Setting Community cohort in Framingham, MA, United States (Framingham osteoarthritis study). Participants 710 people aged >50 who had no radiographic evidence of knee osteoarthritis (Kellgren-Lawrence grade 0) and who underwent MRI of the knee. Main outcome measures Prevalence of MRI findings that are suggestive of knee osteoarthritis (osteophytes, cartilage damage, bone marrow lesions, subchondral cysts, meniscal lesions, synovitis, attrition, and ligamentous lesions) in all participants and after stratification by age, sex, body mass index (BMI), and the presence or absence of knee pain. Pain was assessed by three different questions and also by WOMAC questionnaire. Results Of the 710 participants, 393 (55%) were women, 660 (93%) were white, and 206 (29%) had knee pain in the past month. The mean age was 62.3 years and mean BMI was 27.9. Prevalence of "any abnormality" was 89% (631/710) overall. Osteophytes were the most common abnormality among all participants (74%, 524/710), followed by cartilage damage (69%, 492/710) and bone marrow lesions (52%, 371/710). The higher the age, the higher the prevalence of all types of abnormalities detectable by MRI. There were no significant differences in the prevalence of any of the features between BMI groups. The prevalence of at least one type of pathology ("any abnormality") was high in both painful (90-97%, depending on pain definition) and painless (86-88%) knees. Conclusions MRI shows lesions in the tibiofemoral joint in most middle aged and elderly people in whom knee radiographs do not show any features of osteoarthritis, regardless of pain.	[Guermazi, Ali; Hayashi, Daichi; Roemer, Frank W.] Boston Univ, Sch Med, Dept Radiol, Boston, MA 02118 USA; [Niu, Jingbo; Englund, Martin; Neogi, Tuhina; Felson, David T.] Boston Univ, Sch Med, Clin Epidemiol Res & Training Unit, Boston, MA 02118 USA; [Roemer, Frank W.] Klinikum Augsburg, Dept Radiol, Augsburg, Germany; [Englund, Martin] Lund Univ, Dept Orthopaed, Lund, Sweden; [Aliabadi, Piran] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Radiol, Boston, MA 02115 USA; [McLennan, Christine E.] OptumInsight Life Sci, Waltham, MA 02451 USA	Boston University; Boston University; Klinikum Augsburg; Lund University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Optum	Guermazi, A (corresponding author), Boston Univ, Sch Med, Dept Radiol, FGH Bldg,820 Harrison Ave, Boston, MA 02118 USA.	guermazi@bu.edu	Hayashi, Daichi/J-9875-2012; Englund, Martin/J-7245-2012; Neogi, Tuhina/AAM-1110-2020; Roemer, Frank/AAS-6317-2020	Englund, Martin/0000-0003-3320-2437; Felson, David/0000-0002-2668-2447; Niu, Jingbo/0000-0002-6170-1965; Neogi, Tuhina/0000-0002-9515-1711	National Institutes of Health [AG18393, AR47785]; Arthritis Foundation; Swedish Research Council; Greta and Johan Kock Foundation; King Gustaf V 80-year Birthday Foundation; Faculty of Medicine, Lund University, Sweden; NIAMS [AR055127]; Arthritis Foundation Arthritis Investigator Award; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K23AR055127, P60AR047785] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG018393] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Arthritis Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Greta and Johan Kock Foundation; King Gustaf V 80-year Birthday Foundation; Faculty of Medicine, Lund University, Sweden; NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Arthritis Foundation Arthritis Investigator Award; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was funded by the National Institutes of Health (AG18393 and AR47785) and the Arthritis Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The researchers work independently of their funders.; All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: AG is the president of Boston Imaging Core Lab (BICL), LLC, and a consultant to Merck Serono, Stryker, Genzyme, AstraZeneca, and Novartis; FWR a vice president and shareholder of BICL and is a consultant to Merck Serono and National Institute of Health; ME is funded by the Swedish Research Council, the Greta and Johan Kock Foundation, King Gustaf V 80-year Birthday Foundation, and the Faculty of Medicine, Lund University, Sweden; TN is supported by NIAMS AR055127 and the Arthritis Foundation Arthritis Investigator Award.	Amin S, 2005, ARTHRITIS RHEUM, V52, P3152, DOI 10.1002/art.21296; Avasthi S, 2009, INT J ORTHOPED SURG, V13, P1; Bedson J, 2005, FAM PRACT, V22, P103, DOI 10.1093/fampra/cmh700; Chou R, 2009, LANCET, V373, P463, DOI 10.1016/S0140-6736(09)60172-0; Conaghan PG, 2006, OSTEOARTHR CARTILAGE, V14, pA87, DOI 10.1016/j.joca.2006.02.028; Englund M, 2008, NEW ENGL J MED, V359, P1108, DOI 10.1056/NEJMoa0800777; Felson DT, 2001, ANN INTERN MED, V134, P541, DOI 10.7326/0003-4819-134-7-200104030-00007; Felson DT, 1998, ARTHRITIS RHEUM, V41, P1343, DOI 10.1002/1529-0131(199808)41:8<1343::AID-ART3>3.0.CO;2-9; Felson DT, 2005, RHEUMATOLOGY, V44, P100, DOI 10.1093/rheumatology/keh411; FELSON DT, 1987, ARTHRITIS RHEUM, V30, P914, DOI 10.1002/art.1780300811; Guermazi A, 2012, SKELETAL RADIOL, V41, P179, DOI 10.1007/s00256-011-1142-2; Guermazi A, 2011, CURR OPIN RHEUMATOL, V23, P484, DOI 10.1097/BOR.0b013e328349c2d2; Hill CL, 2001, J RHEUMATOL, V28, P1330; Hunter DJ, 2006, ARTHRITIS RHEUM-US, V54, P2488, DOI 10.1002/art.22016; Javaid MK, 2010, OSTEOARTHR CARTILAGE, V18, P323, DOI 10.1016/j.joca.2009.11.002; KELLGREN JH, 1957, ANN RHEUM DIS, V16, P494, DOI 10.1136/ard.16.4.494; Kothari M, 2004, EUR RADIOL, V14, P1568, DOI 10.1007/s00330-004-2312-6; Lawrence RC, 2008, ARTHRITIS RHEUM, V58, P26, DOI 10.1002/art.23176; Murphy L, 2008, ARTHRIT RHEUM-ARTHR, V59, P1207, DOI 10.1002/art.24021; Neogi T, 2011, CURR OPIN RHEUMATOL, V23, P185, DOI 10.1097/BOR.0b013e32834307eb; Neogi T, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2844; Peterfy CG, 2006, OSTEOARTHR CARTILAGE, V14, pA95, DOI 10.1016/j.joca.2006.02.029; Peterfy CG, 2004, OSTEOARTHR CARTILAGE, V12, P177, DOI 10.1016/j.joca.2003.11.003; Roemer FW, 2009, OSTEOARTHR CARTILAGE, V17, P1115, DOI 10.1016/j.joca.2009.03.012; Roemer FW, 2009, ANN RHEUM DIS, V68, P1461, DOI 10.1136/ard.2008.096834; Roemer FW, 2009, RADIOLOGY, V252, P772, DOI 10.1148/radiol.2523082197; Sacks JJ, 2010, ARTHRIT CARE RES, V62, P460, DOI 10.1002/acr.20041; Sanghi D, 2011, J ORTHOP SCI, V16, P719, DOI 10.1007/s00776-011-0147-y; Szebenyi B, 2006, ARTHRITIS RHEUM-US, V54, P230, DOI 10.1002/art.21534; Theiler R, 1999, OSTEOARTHR CARTILAGE, V7, P515, DOI 10.1053/joca.1999.0262; Vernooij MW, 2007, NEW ENGL J MED, V357, P1821, DOI 10.1056/NEJMoa070972; Wills AK, 2012, ANN RHEUM DIS, V71, P655, DOI 10.1136/ard.2011.154021; Yusuf E, 2011, OSTEOARTHR CARTILAGE, V19, P1117, DOI 10.1016/j.joca.2011.06.001; Yusuf E, 2011, ANN RHEUM DIS, V70, P60, DOI 10.1136/ard.2010.131904; Zhang YQ, 2011, ARTHRITIS RHEUM-US, V63, P691, DOI 10.1002/art.30148	35	274	279	7	36	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	AUG 29	2012	345								e5339	10.1136/bmj.e5339	http://dx.doi.org/10.1136/bmj.e5339			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	036SK	22932918	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000311050600002
J	Sarewitz, D				Sarewitz, Daniel			Sometimes science must give way to religion	NATURE			English	Editorial Material									Arizona State Univ, Consortium Sci Policy & Outcomes, Tempe, AZ 85287 USA	Arizona State University; Arizona State University-Tempe	Sarewitz, D (corresponding author), Arizona State Univ, Consortium Sci Policy & Outcomes, Tempe, AZ 85287 USA.	daniel.sarewitz@asu.edu							0	3	3	1	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 23	2012	488	7412					431	431		10.1038/488431a	http://dx.doi.org/10.1038/488431a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	992FS	22914130	Bronze			2022-12-28	WOS:000307761600005
J	Turnhout, E; Bloomfield, B; Hulme, M; Vogel, J; Wynne, B				Turnhout, Esther; Bloomfield, Bob; Hulme, Mike; Vogel, Johannes; Wynne, Brian			Listen to the voices of experience	NATURE			English	Editorial Material									[Turnhout, Esther] Wageningen Univ, Forest & Nat Conservat Policy Grp, Wageningen, Netherlands; [Bloomfield, Bob] Nat Hist Museum, Sci Soc, London SW7 5BD, England; [Hulme, Mike] Univ E Anglia, Sch Environm Sci, Sci Soc & Sustainabil Grp, Norwich NR4 7TJ, Norfolk, England; [Vogel, Johannes] Museum Nat Kunde, Berlin, Germany; [Wynne, Brian] Univ Lancaster, UK ESRC Ctr Econ & Social Aspects Genom, Lancaster LA1 4YW, England	Wageningen University & Research; Natural History Museum London; University of East Anglia; Leibniz Institut fur Evolutions und Biodiversitatsforschung; Lancaster University; UK Research & Innovation (UKRI); Economic & Social Research Council (ESRC)	Turnhout, E (corresponding author), Wageningen Univ, Forest & Nat Conservat Policy Grp, Wageningen, Netherlands.	esther.turnhout@wur.nl	Hulme, Mike/F-9012-2010; Turnhout, Esther/K-9338-2017	Hulme, Mike/0000-0002-1273-7662; Turnhout, Esther/0000-0002-2190-2076				AGRAWAL A, 1995, DEV CHANGE, V26, P413, DOI 10.1111/j.1467-7660.1995.tb00560.x; Hayden Cori., 2003, NATURE GOES PUBLIC M; Karanth KU, 2003, ANIM CONSERV, V6, P141, DOI 10.1017/S1367943003003184; Pinheiro S., 2009, EARTHSCAN READER SUS, P352; *ROYAL SOC, 2003, MEAS BIOD CONS; Van der Pleog J., 1993, ANTHR CRITIQUE DEV G, P209, DOI DOI 10.1525/AE.1995.22.3.02A00190; Walker S, 2009, CONSERV LETT, V2, P149, DOI 10.1111/j.1755-263X.2009.00061.x; Waterton C., 2003, SALMO TRUTTA, V6, P56; William W. B., 2003, IOWA LAW REV, V89, P3; Wynne B., 1989, ENV THREATS PERCEPTI, P233	10	153	160	0	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 23	2012	488	7412					454	455		10.1038/488454a	http://dx.doi.org/10.1038/488454a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	992FS	22914151	Bronze			2022-12-28	WOS:000307761600016
J	Koh, HK; Sebelius, KG				Koh, Howard K.; Sebelius, Kathleen G.			Ending the Tobacco Epidemic	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material											Koh, HK (corresponding author), 200 Independence Ave,Suite 716-G, Washington, DC 20201 USA.	howard.koh@hhs.gov						Centers for Disease Control and Prevention National Center for Chronic Disease Prevention and Health Promotion Office on Smoking and Health, 2010, TOB SMOK CAUS DIS BI; Centers for Disease Control and Prevention Office on Smoking and Health, 2012, PREV TOB US YOUTH YO; Fiore MC, 2008, TREATING TOBACCO USE; King Brian, 2011, Morbidity and Mortality Weekly Report, V60, P1207; U.S. Department of Health and Human Services, 2010, END TOB EP TOB CONTR	5	29	29	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 22	2012	308	8					767	768		10.1001/jama.2012.9741	http://dx.doi.org/10.1001/jama.2012.9741			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	991ML	22910750				2022-12-28	WOS:000307705300016
J	Meyer, M; Kircher, M; Gansauge, MT; Li, H; Racimo, F; Mallick, S; Schraiber, JG; Jay, F; Prufer, K; de Filippo, C; Sudmant, PH; Alkan, C; Fu, QM; Do, R; Rohland, N; Tandon, A; Siebauer, M; Green, RE; Bryc, K; Briggs, AW; Stenzel, U; Dabney, J; Shendure, J; Kitzman, J; Hammer, MF; Shunkov, MV; Derevianko, AP; Patterson, N; Andres, AM; Eichler, EE; Slatkin, M; Reich, D; Kelso, J; Paabo, S				Meyer, Matthias; Kircher, Martin; Gansauge, Marie-Theres; Li, Heng; Racimo, Fernando; Mallick, Swapan; Schraiber, Joshua G.; Jay, Flora; Pruefer, Kay; de Filippo, Cesare; Sudmant, Peter H.; Alkan, Can; Fu, Qiaomei; Do, Ron; Rohland, Nadin; Tandon, Arti; Siebauer, Michael; Green, Richard E.; Bryc, Katarzyna; Briggs, Adrian W.; Stenzel, Udo; Dabney, Jesse; Shendure, Jay; Kitzman, Jacob; Hammer, Michael F.; Shunkov, Michael V.; Derevianko, Anatoli P.; Patterson, Nick; Andres, Aida M.; Eichler, Evan E.; Slatkin, Montgomery; Reich, David; Kelso, Janet; Paeaebo, Svante			A High-Coverage Genome Sequence from an Archaic Denisovan Individual	SCIENCE			English	Article							NEANDERTHAL GENOME; PATTERNS; HISTORY; HOMININ; SIBERIA; ORIGIN; ASIA	We present a DNA library preparation method that has allowed us to reconstruct a high-coverage (30x) genome sequence of a Denisovan, an extinct relative of Neandertals. The quality of this genome allows a direct estimation of Denisovan heterozygosity indicating that genetic diversity in these archaic hominins was extremely low. It also allows tentative dating of the specimen on the basis of "missing evolution" in its genome, detailed measurements of Denisovan and Neandertal admixture into present-day human populations, and the generation of a near-complete catalog of genetic changes that swept to high frequency in modern humans since their divergence from Denisovans.	[Meyer, Matthias; Kircher, Martin; Gansauge, Marie-Theres; Racimo, Fernando; Pruefer, Kay; de Filippo, Cesare; Fu, Qiaomei; Siebauer, Michael; Stenzel, Udo; Dabney, Jesse; Andres, Aida M.; Kelso, Janet; Paeaebo, Svante] Max Planck Inst Evolutionary Anthropol, Dept Evolutionary Genet, D-04103 Leipzig, Germany; [Li, Heng; Mallick, Swapan; Do, Ron; Rohland, Nadin; Tandon, Arti; Patterson, Nick; Reich, David] Broad Inst Massachusetts Inst Technol & Harvard, Cambridge, MA 02142 USA; [Mallick, Swapan; Rohland, Nadin; Tandon, Arti; Bryc, Katarzyna; Briggs, Adrian W.; Reich, David] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Schraiber, Joshua G.; Jay, Flora; Slatkin, Montgomery] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Alkan, Can] Bilkent Univ, Dept Comp Engn, TR-06800 Ankara, Turkey; [Sudmant, Peter H.; Alkan, Can; Shendure, Jay; Kitzman, Jacob; Eichler, Evan E.] Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98195 USA; [Fu, Qiaomei] Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, CAS MPS Joint Lab Human Evolut, Beijing 100044, Peoples R China; [Green, Richard E.] Univ Calif Santa Cruz, Jack Baskin Sch Engn, Santa Cruz, CA 95064 USA; [Hammer, Michael F.] Univ Arizona, Arizona Res Labs, Div Biotechnol, Tucson, AZ 85721 USA; [Shunkov, Michael V.; Derevianko, Anatoli P.] Russian Acad Sci, Siberian Branch, Inst Archaeol & Ethnog, Palaeolith Dept, Novosibirsk 630090, Russia; [Eichler, Evan E.] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA	Max Planck Society; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; University of California System; University of California Berkeley; Ihsan Dogramaci Bilkent University; University of Washington; University of Washington Seattle; Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS; University of California System; University of California Santa Cruz; University of Arizona; Russian Academy of Sciences; Institute of Archaeology & Ethnography, Siberian Branch of Russian Academy of Sciences; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Meyer, M (corresponding author), Max Planck Inst Evolutionary Anthropol, Dept Evolutionary Genet, D-04103 Leipzig, Germany.	mmeyer@eva.mpg.de; reich@genetics.med.harvard.edu; paabo@eva.mpg.de	Shunkov, Mikhail V./Q-6576-2016; Alkan, Can/D-2982-2009; Kircher, Martin/H-6909-2019; Shendure, Jay/AAU-3684-2021; Dabney, Jesse/Y-8889-2019; Kircher, Martin/HDL-9392-2022; Andres, Aida/B-4088-2014; Li, Heng/D-9344-2011; Kelso, Janet/N-1812-2019; Derevianko, Anatoly P./Q-5975-2016	Shunkov, Mikhail V./0000-0003-1388-2308; Alkan, Can/0000-0002-5443-0706; Kircher, Martin/0000-0001-9278-5471; Dabney, Jesse/0000-0001-8893-1245; Andres, Aida/0000-0002-8590-9672; Li, Heng/0000-0003-4874-2874; Kelso, Janet/0000-0002-3618-322X; Derevianko, Anatoly P./0000-0003-1156-8331; Kitzman, Jacob/0000-0002-6145-882X; Sudmant, Peter/0000-0002-9573-8248; jay, flora/0000-0001-5884-4730; Racimo, Fernando/0000-0002-5025-2607; Green, Richard/0000-0003-0516-5827; Shendure, Jay/0000-0002-1516-1865	Max Planck Society; NSF HOMINID [1032255]; NIH [GM100233, R01-GM40282]; HHMI International Student Fellowship; German Academic Exchange Service (DAAD); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040282, R01GM100233] Funding Source: NIH RePORTER	Max Planck Society(Max Planck Society); NSF HOMINID; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHMI International Student Fellowship; German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The Denisovan sequence reads are available from the European Nucleotide Archive (ENA) under study accession ERP001519. The present-day human sequence reads are available from the Short Read Archive (SRA) under accession SRA047577. Alignments and genotype calls for each of the sequenced individuals are available at www.eva.mpg.de/denisova/. In addition, the Denisovan sequence reads and alignments are available as a public data set via Amazon Web Services (AWS) at http://aws.amazon.com/datasets/2357/ and as a track in the University of California, Santa Cruz genome browser. We thank D. Falush, P. Johnson, J. Krause, M. Lachmann, S. Sawyer, L. Vigilant and B. Viola for comments, help, and suggestions; A. Aximu, B. Hober, B. Hoffner, A. Weihmann, T. Kratzer, and R. Roesch for expert technical assistance; R. Schultz for help with data management; and M. Schreiber for improvement of graphics. The Presidential Innovation Fund of the Max Planck Society made this project possible. D. R. and N.P. are grateful for support from NSF HOMINID grant no. 1032255 and NIH grant GM100233. J. G. S., F. J., and M. S. were supported by NIH grant R01-GM40282 to M. S. P. H. S. is supported by an HHMI International Student Fellowship. F. R. is supported by a German Academic Exchange Service (DAAD) study scholarship. E. E. E. is on the scientific advisory boards for Pacific Biosciences, Inc., SynapDx Corp, and DNAnexus, Inc.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Briggs AW, 2007, P NATL ACAD SCI USA, V104, P14616, DOI 10.1073/pnas.0704665104; Burbano HA, 2010, SCIENCE, V328, P723, DOI 10.1126/science.1188046; Cerqueira CCS, 2012, AM J HUM BIOL, V24, P705, DOI 10.1002/ajhb.22263; Conrad DF, 2011, NAT GENET, V43, P712, DOI 10.1038/ng.862; Coyne J.A., 1989, P180; Currat M, 2011, P NATL ACAD SCI USA, V108, P15129, DOI 10.1073/pnas.1107450108; Enard W, 2009, CELL, V137, P961, DOI 10.1016/j.cell.2009.03.041; Gibbons A, 2011, SCIENCE, V333, P1084, DOI 10.1126/science.333.6046.1084; Goodman M, 1999, AM J HUM GENET, V64, P31, DOI 10.1086/302218; Green RE, 2008, CELL, V134, P416, DOI 10.1016/j.cell.2008.06.021; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Hublin JJ, 2009, P NATL ACAD SCI USA, V106, P16022, DOI 10.1073/pnas.0904119106; IJDO JW, 1991, P NATL ACAD SCI USA, V88, P9051, DOI 10.1073/pnas.88.20.9051; KIDD JR, 1991, HUM BIOL, V63, P775; Kircher M, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr771; Krause J, 2010, NATURE, V464, P894, DOI 10.1038/nature08976; Li H, 2011, NATURE, V475, P493, DOI 10.1038/nature10231; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Orlando L, 2011, GENOME RES, V21, P1705, DOI 10.1101/gr.122747.111; Petit RJ, 2009, TRENDS ECOL EVOL, V24, P386, DOI 10.1016/j.tree.2009.02.011; Pickrell J., 2012, NATURE PRECEDINGS; Reich D, 2011, AM J HUM GENET, V89, P516, DOI 10.1016/j.ajhg.2011.09.005; Reich D, 2010, NATURE, V468, P1053, DOI 10.1038/nature09710; Skoglund P, 2011, P NATL ACAD SCI USA, V108, P18301, DOI 10.1073/pnas.1108181108; Vernes SC, 2008, NEW ENGL J MED, V359, P2337, DOI 10.1056/NEJMoa0802828	27	1072	1102	32	544	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 12	2012	338	6104					222	226		10.1126/science.1224344	http://dx.doi.org/10.1126/science.1224344			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019BQ	22936568	Green Accepted, Green Submitted			2022-12-28	WOS:000309712300037
J	Neph, S; Stergachis, AB; Reynolds, A; Sandstrom, R; Borenstein, E; Stamatoyannopoulos, JA				Neph, Shane; Stergachis, Andrew B.; Reynolds, Alex; Sandstrom, Richard; Borenstein, Elhanan; Stamatoyannopoulos, John A.			Circuitry and Dynamics of Human Transcription Factor Regulatory Networks	CELL			English	Article							PROTEIN-DNA; IN-VIVO; GLUCOCORTICOID-RECEPTOR; ERYTHROID LINEAGE; STEM-CELLS; CHROMATIN; GENE; DATABASE; EXPRESSION; DIFFERENTIATION	The combinatorial cross-regulation of hundreds of sequence-specific transcription factors (TFs) defines a regulatory network that underlies cellular identity and function. Here we use genome-wide maps of in vivo DNaseI footprints to assemble an extensive core human regulatory network comprising connections among 475 sequence-specific TFs and to analyze the dynamics of these connections across 41 diverse cell and tissue types. We find that human TF networks are highly cell selective and are driven by cohorts of factors that include regulators with previously unrecognized roles in control of cellular identity. Moreover, we identify many widely expressed factors that impact transcriptional regulatory networks in a cell-selective manner. Strikingly, in spite of their inherent diversity, all cell-type regulatory networks independently converge on a common architecture that closely resembles the topology of living neuronal networks. Together, our results provide an extensive description of the circuitry, dynamics, and organizing principles of the human TF regulatory network.	[Neph, Shane; Stergachis, Andrew B.; Reynolds, Alex; Sandstrom, Richard; Borenstein, Elhanan; Stamatoyannopoulos, John A.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Borenstein, Elhanan] Univ Washington, Dept Comp Sci & Engn, Seattle, WA 98195 USA; [Stamatoyannopoulos, John A.] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Borenstein, Elhanan] Santa Fe Inst, Santa Fe, NM 87501 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; The Santa Fe Institute	Borenstein, E (corresponding author), Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.	elbo@uw.edu; jstam@uw.edu		Sandstrom, Richard/0000-0002-3356-1547	NIH [HG004592]; NIDDK F30 fellowship [FDK095678A]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG004592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F30DK095678] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDDK F30 fellowship; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Dr. Sam John for critical reading of the manuscript and our colleagues for many helpful and insightful observations and discussions. This work was supported by NIH grant HG004592 to J.A.S. All data are available through the ENCODE data repository at the UCSC genome browser (http://genome.ucsc.edu). E.B. is an Alfred P. Sloan Research Fellow. A.B.S. was supported by an NIDDK F30 fellowship (FDK095678A).	Alon U., 2006, INTRO SYSTEMS BIOL D; Badis G, 2009, SCIENCE, V324, P1720, DOI 10.1126/science.1162327; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Basso K, 2005, NAT GENET, V37, P382, DOI 10.1038/ng1532; Berger MF, 2008, CELL, V133, P1266, DOI 10.1016/j.cell.2008.05.024; Bernstein BE, 2010, NAT BIOTECHNOL, V28, P1045, DOI 10.1038/nbt1010-1045; Biddie SC, 2011, MOL CELL, V43, P145, DOI 10.1016/j.molcel.2011.06.016; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Bryne JC, 2008, NUCLEIC ACIDS RES, V36, pD102, DOI 10.1093/nar/gkm955; Carro MS, 2010, NATURE, V463, P318, DOI 10.1038/nature08712; Davidson EH, 2002, DEV BIOL, V246, P162, DOI 10.1006/dbio.2002.0635; Davidson EH, 2002, SCIENCE, V295, P1669, DOI 10.1126/science.1069883; DYNAN WS, 1983, CELL, V35, P79, DOI 10.1016/0092-8674(83)90210-6; Gerstein MB, 2010, SCIENCE, V330, P1775, DOI 10.1126/science.1196914; Graf T, 2009, NATURE, V462, P587, DOI 10.1038/nature08533; GRIGNANI F, 1993, CELL, V74, P423, DOI 10.1016/0092-8674(93)80044-F; GROUDINE M, 1982, CELL, V30, P131, DOI 10.1016/0092-8674(82)90019-8; Hesselberth JR, 2009, NAT METHODS, V6, P283, DOI [10.1038/NMETH.1313, 10.1038/nmeth.1313]; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Jolma A, 2010, GENOME RES, V20, P861, DOI 10.1101/gr.100552.109; KADONAGA JT, 1987, CELL, V51, P1079, DOI 10.1016/0092-8674(87)90594-0; KARIN M, 1984, NATURE, V308, P513, DOI 10.1038/308513a0; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; KUO MT, 1979, NUCLEIC ACIDS RES, V7, P2105, DOI 10.1093/nar/7.8.2105; MacNeill C, 2000, DEV BIOL, V217, P62, DOI 10.1006/dbio.1999.9539; Magrane M, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar009; Milo R, 2004, SCIENCE, V303, P1538, DOI 10.1126/science.1089167; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Molkentin JD, 1997, GENE DEV, V11, P1061, DOI 10.1101/gad.11.8.1061; NAIDU PS, 1995, MOL CELL BIOL, V15, P2707; Neph S.J., 2012, NATURE; Newburger DE, 2009, NUCLEIC ACIDS RES, V37, pD77, DOI 10.1093/nar/gkn660; Nutt SL, 1999, NATURE, V401, P556, DOI 10.1038/44076; ORKIN SH, 1995, J BIOL CHEM, V270, P4955, DOI 10.1074/jbc.270.10.4955; PFEIFER GP, 1991, GENE DEV, V5, P1102, DOI 10.1101/gad.5.6.1102; Ramachandran B, 2008, J BIOL CHEM, V283, P10318, DOI 10.1074/jbc.M707623200; Reece-Hoyes JS, 2011, NAT METHODS, V8, P1059, DOI [10.1038/NMETH.1748, 10.1038/nmeth.1748]; RIGAUD G, 1991, CELL, V67, P977, DOI 10.1016/0092-8674(91)90370-E; Roy S, 2010, SCIENCE, V330, P1787, DOI 10.1126/science.1198374; Serov VN, 1998, BIOINFORMATICS, V14, P546, DOI 10.1093/bioinformatics/14.6.546; Shimazaki T, 1999, EMBO J, V18, P444, DOI 10.1093/emboj/18.2.444; Slattery M, 2011, CELL, V147, P1270, DOI 10.1016/j.cell.2011.10.053; Spemann H, 1918, ARCH ENTWICKLUNG ORG, V43, P448, DOI 10.1007/BF02267308; STALDER J, 1980, CELL, V20, P451, DOI 10.1016/0092-8674(80)90631-5; Sucov HM, 1996, BIOCHEM SOC SYMP, P143; Swiers G, 2006, DEV BIOL, V294, P525, DOI 10.1016/j.ydbio.2006.02.051; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; The ENCODE Project Consortium, 2012, NATURE; TSAI SF, 1989, NATURE, V339, P446, DOI 10.1038/339446a0; Vaquerizas JM, 2009, NAT REV GENET, V10, P252, DOI 10.1038/nrg2538; Waddington C.H., 1940, ORG GENES; Waddington C H, 1957, STRATEGY GENES DISCU; Waddington C. H., 1939, INTRO MODERN GENETIC; Walhout AJM, 2006, GENOME RES, V16, P1445, DOI 10.1101/gr.5321506; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Wingender E, 1996, NUCLEIC ACIDS RES, V24, P238, DOI 10.1093/nar/24.1.238; WU C, 1980, NATURE, V286, P854, DOI 10.1038/286854a0; WU C, 1979, CELL, V16, P797, DOI 10.1016/0092-8674(79)90095-3; Xing YM, 2010, DEVELOPMENT, V137, P825, DOI 10.1242/dev.040535; YUH CH, 1994, MECH DEVELOP, V47, P165, DOI 10.1016/0925-4773(94)90088-4; Yun KS, 1996, CURR OPIN CELL BIOL, V8, P877, DOI 10.1016/S0955-0674(96)80091-3	62	295	304	1	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 14	2012	150	6					1274	1286		10.1016/j.cell.2012.04.040	http://dx.doi.org/10.1016/j.cell.2012.04.040			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	007ZY	22959076	Green Accepted, Bronze			2022-12-28	WOS:000308928100019
J	Mattison, JA; Roth, GS; Beasley, TM; Tilmont, EM; Handy, AM; Herbert, RL; Longo, DL; Allison, DB; Young, JE; Bryant, M; Barnard, D; Ward, WF; Qi, WB; Ingram, DK; de Cabo, R				Mattison, Julie A.; Roth, George S.; Beasley, T. Mark; Tilmont, Edward M.; Handy, April M.; Herbert, Richard L.; Longo, Dan L.; Allison, David B.; Young, Jennifer E.; Bryant, Mark; Barnard, Dennis; Ward, Walter F.; Qi, Wenbo; Ingram, Donald K.; de Cabo, Rafael			Impact of caloric restriction on health and survival in rhesus monkeys from the NIA study	NATURE			English	Article							T-CELL SENESCENCE; DIETARY RESTRICTION; LIFE-SPAN; AGE; MORTALITY; DISEASE; MODEL; RATS; MICE; INFLAMMATION	Calorie restriction (CR), a reduction of 10-40% in intake of a nutritious diet, is often reported as the most robust non-genetic mechanism to extend lifespan and healthspan. CR is frequently used as a tool to understand mechanisms behind ageing and age-associated diseases. In addition to and independently of increasing lifespan, CR has been reported to delay or prevent the occurrence of many chronic diseases in a variety of animals. Beneficial effects of CR on outcomes such as immune function(1,2), motor coordination(3) and resistance to sarcopenia(4) in rhesus monkeys have recently been reported. We report here that a CR regimen implemented in young and older age rhesus monkeys at the National Institute on Aging (NIA) has not improved survival outcomes. Our findings contrast with an ongoing study at the Wisconsin National Primate Research Center (WNPRC), which reported improved survival associated with 30% CR initiated in adult rhesus monkeys (7-14 years)(5) and a preliminary report with a small number of CR monkeys(6). Over the years, both NIA and WNPRC have extensively documented beneficial health effects of CR in these two apparently parallel studies. The implications of the WNPRC findings were important as they extended CR findings beyond the laboratory rodent and to a long-lived primate. Our study suggests a separation between health effects, morbidity andmortality, and similar to what has been shown in rodents(7-9), study design, husbandry and diet composition may strongly affect the life-prolonging effect of CR in a long-lived nonhuman primate.	[Mattison, Julie A.; Tilmont, Edward M.; Handy, April M.; Young, Jennifer E.] NIA, Lab Expt Gerontol, NIH, Anim Ctr, Dickerson, MD 20842 USA; [Roth, George S.] GeroScience, Pylesville, MD 21132 USA; [Beasley, T. Mark] Univ Alabama Birmingham, Dept Biostat, Birmingham, AL 35294 USA; [Handy, April M.] SoBran Inc, Burtonsville, MD 20866 USA; [Herbert, Richard L.] NIAID, NIH, Anim Ctr, Dickerson, MD 20842 USA; [Longo, Dan L.] NIA, Lab Mol Biol & Immunol, NIH, Baltimore, MD 21224 USA; [Allison, David B.] Univ Alabama Birmingham, Off Energet, Birmingham, AL 35294 USA; [Bryant, Mark; Barnard, Dennis] NIH, Off Director, Diagnost & Res Serv Branch, Bethesda, MD 20814 USA; [Ward, Walter F.] Univ Texas Hlth Sci Ctr San Antonio, Dept Physiol, Barshop Inst Longev & Aging Studies, San Antonio, TX 78229 USA; [Qi, Wenbo] Univ Texas Hlth Sci Ctr San Antonio, Barshop Inst Longev & Aging Studies, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA; [Ingram, Donald K.] Louisiana State Univ, Pennington Biomed Res Ctr, Nutr Neurosci & Aging Lab, Baton Rouge, LA 70808 USA; [de Cabo, Rafael] NIA, Lab Expt Gerontol, NIH, Baltimore, MD 21224 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Alabama System; University of Alabama Birmingham; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Alabama System; University of Alabama Birmingham; National Institutes of Health (NIH) - USA; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Mattison, JA (corresponding author), NIA, Lab Expt Gerontol, NIH, Anim Ctr, 16701 Elmer Sch Rd,Bldg 103, Dickerson, MD 20842 USA.	mattisonj@mail.nih.gov; Donald.Ingram@pbrc.edu; deCaboRa@grc.nia.nih.gov	de Cabo, Rafael Carlos/J-5230-2016; Longo, Dan L./F-6022-2011; de Cabo, Rafael/E-7996-2010; de Cabo, Rafael/J-5230-2016	de Cabo, Rafael Carlos/0000-0003-2830-5693; de Cabo, Rafael/0000-0003-2830-5693; Allison, David/0000-0003-3566-9399; de Cabo, Rafael/0000-0002-3354-2442	NIH, National Institute on Aging; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIGAI001047] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056336] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000368, ZIAAG000371] Funding Source: NIH RePORTER	NIH, National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank the animal care staff and technicians, both past and present, especially J. Travis and M. Szarowicz; K. Vaughan for her editorial help; and the many collaborators that have contributed to this project. This research was supported by the Intramural Research Program of the NIH, National Institute on Aging.	Allison P. D., 1995, SURVIVAL ANAL USING; [Anonymous], 2006, SAS MIXED MODELS; Bodkin NL, 2003, J GERONTOL A-BIOL, V58, P212; Branch-Mays GL, 2008, J PERIODONTOL, V79, P1184, DOI 10.1902/jop.2008.070629 ; Colman R. J., 1998, METHODS AGING RES, P249; Colman RJ, 2008, J GERONTOL A-BIOL, V63, P556, DOI 10.1093/gerona/63.6.556; Colman RJ, 2009, SCIENCE, V325, P201, DOI 10.1126/science.1173635; Duffy PH, 2001, AGING-CLIN EXP RES, V13, P263; Forster MJ, 2003, FASEB J, V17, P690, DOI 10.1096/fj.02-0533fje; Harper JM, 2006, AGING CELL, V5, P441, DOI 10.1111/j.1474-9726.2006.00236.x; INGRAM DK, 1990, J GERONTOL, V45, pB148, DOI 10.1093/geronj/45.5.B148; Kastman EK, 2010, J NEUROSCI, V30, P7940, DOI 10.1523/JNEUROSCI.0835-10.2010; LANE MA, 1995, J NUTR, V125, P1600; Liao CY, 2010, AGING CELL, V9, P92, DOI 10.1111/j.1474-9726.2009.00533.x; Lomba A, 2009, J NUTRIGENET NUTRIGE, V2, P267, DOI 10.1159/000308465; Mattison JA, 2005, NEUROBIOL AGING, V26, P1117, DOI 10.1016/j.neurobiolaging.2004.09.013; Messaoudi I, 2006, P NATL ACAD SCI USA, V103, P19448, DOI 10.1073/pnas.0606661103; Messaoudi I, 2010, CALORIE RESTRICTION, AGING AND LONGEVITY, P55, DOI 10.1007/978-90-481-8556-6_4; Messaoudi I, 2008, AGING CELL, V7, P908, DOI 10.1111/j.1474-9726.2008.00440.x; MURTAGHMARK CM, 1995, J GERONTOL A-BIOL, V50, pB148, DOI 10.1093/gerona/50A.3.B148; Nadon NL, 2006, AGING CELL, V5, P9, DOI 10.1111/j.1474-9726.2006.00185.x; Omodei D, 2011, FEBS LETT, V585, P1537, DOI 10.1016/j.febslet.2011.03.015; Raman A, 2007, AM J PHYSIOL-ENDOC M, V292, pE101, DOI 10.1152/ajpendo.00127.2006; Redman LM, 2011, ANTIOXID REDOX SIGN, V14, P275, DOI 10.1089/ars.2010.3253; Roncal-Jimenez CA, 2011, METABOLISM, V60, P1259, DOI 10.1016/j.metabol.2011.01.008; Roth GS, 2004, SCIENCE, V305, P1423, DOI 10.1126/science.1102541; Speakman JR, 2007, J NUTR, V137, P1078, DOI 10.1093/jn/137.4.1078; Swindell WR, 2012, AGEING RES REV, V11, P254, DOI 10.1016/j.arr.2011.12.006; Ward WF, 2005, J GERONTOL A-BIOL, V60, P847, DOI 10.1093/gerona/60.7.847; [No title captured]	30	726	745	10	235	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 13	2012	489	7415					318	+		10.1038/nature11432	http://dx.doi.org/10.1038/nature11432			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003UC	22932268	Green Accepted			2022-12-28	WOS:000308635900047
J	Harris, T; Rhys, GO; Brohi, K				Harris, Tim; Rhys, G. O.; Brohi, Karim			Early fluid resuscitation in severe trauma	BMJ-BRITISH MEDICAL JOURNAL			English	Review							MASSIVE TRANSFUSION; BRAIN-INJURY; HEMORRHAGE; MORTALITY; COAGULOPATHY; IMPACT; SHOCK		[Harris, Tim; Brohi, Karim] Queen Mary Univ London, Barts & London Sch Med & Dent, London, England; [Harris, Tim; Rhys, G. O.; Brohi, Karim] Barts Hlth NHS Trust, London, England	University of London; Queen Mary University London; Barts Health NHS Trust	Harris, T (corresponding author), Royal London Hosp, Dept Emergency Med, London E1 1BB, England.	tim.harris@bartshealth.nhs.uk			Octapharma; Thromboelastometry; National Institute for Health Research [RP-PG-0407-10036] Funding Source: researchfish	Octapharma; Thromboelastometry; National Institute for Health Research(National Institute for Health Research (NIHR))	All authors have completed the Unified Competing Interest form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: no support from any organisation for the submitted work; KB has received unrestricted research funding from Octapharma and Thromboelastometry and has consulted for Haemonetics and Sangart; no other relationships or activities that could appear to have influenced the submitted work.	American College of Surgeons Committee on Trauma, 1997, ADV TRAUM LIF SUPP D; BICKELL WH, 1994, NEW ENGL J MED, V331, P1105, DOI 10.1056/NEJM199410273311701; Borgman MA, 2007, J TRAUMA, V63, P805, DOI 10.1097/TA.0b013e3181271ba3; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS7; Bulger EM, 2010, JAMA-J AM MED ASSOC, V304, P1455, DOI 10.1001/jama.2010.1405; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Chytra I, 2007, CRIT CARE, V11, DOI 10.1186/cc5703; Claridge JA, 2000, J TRAUMA, V48, P8, DOI 10.1097/00005373-200001000-00003; Cooper DJ, 2004, JAMA-J AM MED ASSOC, V291, P1350, DOI 10.1001/jama.291.11.1350; Cotton BA, 2006, SHOCK, V26, P115, DOI 10.1097/01.shk.0000209564.84822.f2; Davenport R, 2011, CRIT CARE MED, V39, P2652, DOI 10.1097/CCM.0b013e3182281af5; Davenport R, 2011, J TRAUMA, V70, P90, DOI 10.1097/TA.0b013e318202e486; Dutton RP, 2002, J TRAUMA, V52, P1141, DOI 10.1097/00005373-200206000-00020; Eastridge BJ, 2007, J TRAUMA, V63, P291, DOI 10.1097/TA.0b013e31809ed924; Floccard B, 2012, INJURY, V43, P26, DOI 10.1016/j.injury.2010.11.003; Guly HR, 2011, RESUSCITATION, V82, P556, DOI 10.1016/j.resuscitation.2011.01.013; Hess JR, 2008, J TRAUMA, V65, P748, DOI 10.1097/TA.0b013e3181877a9c; Kauvar DS, 2006, J TRAUMA, V60, pS3, DOI 10.1097/01.ta.0000199961.02677.19; Larson CR, 2010, J TRAUMA, V69, pS26, DOI 10.1097/TA.0b013e3181e423f4; Ley EJ, 2011, J TRAUMA, V70, P398, DOI 10.1097/TA.0b013e318208f99b; Mapstone J, 2003, J TRAUMA, V55, P571, DOI 10.1097/01.TA.0000062968.69867.6F; McKinley Bruce A, 2003, Curr Opin Crit Care, V9, P292, DOI 10.1097/00075198-200308000-00007; Myburgh J, 2007, NEW ENGL J MED, V357, P874; National Institute for Health and Clinical Excellence, 2004, PREH IN FLUID REPL T, V74; Perel P, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000567.pub4; Rajasekhar A, 2011, CRIT CARE MED, V39, P1507, DOI 10.1097/CCM.0b013e31820eb517; Roberts I, 2005, BRIT MED J, V331, P1094, DOI 10.1136/bmj.331.7525.1094; Santry HP, 2010, SHOCK, V33, P229, DOI 10.1097/SHK.0b013e3181c30f0c; Shakur H, 2010, LANCET, V376, P23, DOI 10.1016/S0140-6736(10)60835-5; SHIRES GT, 1973, SURG CLIN N AM, V53, P1341; Stanworth SJ, 2010, CRIT CARE, V14, DOI 10.1186/cc9394; Strehlow MC, 2010, EMERG MED CLIN N AM, V28, P57, DOI 10.1016/j.emc.2009.09.006; WO CCJ, 1993, CRIT CARE MED, V21, P218, DOI 10.1097/00003246-199302000-00012	33	51	52	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 11	2012	345								e5752	10.1136/bmj.e5752	http://dx.doi.org/10.1136/bmj.e5752			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	007BG	22968721				2022-12-28	WOS:000308863200002
J	Keshavjee, S; Farmer, PE				Keshavjee, Salmaan; Farmer, Paul E.			Tuberculosis, Drug Resistance, and the History of Modern Medicine	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PRIMARY HEALTH-CARE; NEW-YORK-CITY; MYCOBACTERIUM-TUBERCULOSIS; TREATMENT FAILURE; PUBLIC-HEALTH; UNITED-STATES; RETREATMENT; RIFAMPIN; DISEASE; RISE		[Keshavjee, Salmaan] Harvard Univ, Sch Med, Dept Global Hlth & Social Med, Program Infect Dis & Social Change, Boston, MA 02215 USA; Brigham & Womens Hosp, Div Global Hlth Equ, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Keshavjee, S (corresponding author), Harvard Univ, Sch Med, Dept Global Hlth & Social Med, Program Infect Dis & Social Change, 641 Huntington Ave, Boston, MA 02215 USA.	salmaan_keshavjee@hms.harvard.edu		Keshavjee, Salmaan/0000-0002-6967-3305	Eli Lilly	Eli Lilly(Eli Lilly)	Dr. Keshavjee reports receiving grant support from Eli Lilly. No other potential conflict of interest relevant to this article was reported.	[Anonymous], 1992, MMWR Recomm Rep, V41, P5; [Anonymous], 1950, Br Med J, V2, P1073; [Anonymous], 1948, Br Med J, V2, P769; Becerra MC, 2000, INT J TUBERC LUNG D, V4, P108; BERMAN PA, 1982, SOC SCI MED, V16, P1054, DOI 10.1016/0277-9536(82)90178-2; Bifani PJ, 1996, JAMA-J AM MED ASSOC, V275, P452, DOI 10.1001/jama.275.6.452; Castro KG, 2011, EMERG INFECT DIS, V17, P337, DOI 10.3201/eid1703.110031; Cegielski JP, 2010, CLIN INFECT DIS, V50, pS195, DOI 10.1086/651491; CROFTON J, 1948, BMJ-BRIT MED J, V2, P1009, DOI 10.1136/bmj.2.4588.1009; DANIEL TM, 1969, NEW ENGL J MED, V280, P615, DOI 10.1056/NEJM196903132801112; Daniel TM, 1997, CAPTAIN DEATH STORY, P80; Dheda K, 2008, NEW ENGL J MED, V359, P2390, DOI 10.1056/NEJMc081884; Farmer P, 1997, SOC SCI MED, V44, P347, DOI 10.1016/S0277-9536(96)00143-8; Farmer P., 1999, INFECT INEQUALITIES; Fauci AS, 2008, RES PATH TUBERCULOSI; Fox W, 1999, INT J TUBERC LUNG D, V3, pS231; FOX W., 1957, TUBERCLE, V38, P71, DOI 10.1016/S0041-3879(57)80001-4; FRIEDEN TR, 1995, NEW ENGL J MED, V333, P229, DOI 10.1056/NEJM199507273330406; GISH O, 1982, SOC SCI MED, V16, P1049, DOI 10.1016/0277-9536(82)90177-0; Gupta R, 2001, SCIENCE, V293, P1049, DOI 10.1126/science.1061861; Han LL, 2005, INT J TUBERC LUNG D, V9, P818; HINSHAW HC, 1946, JAMA-J AM MED ASSOC, V132, P778; HOLMBERG SD, 1990, AM REV RESPIR DIS, V142, P1228, DOI 10.1164/ajrccm/142.5.1228; JELLINEK K, 1949, NEW ENGL J MED, V240, P680, DOI 10.1056/NEJM194904282401703; Keshavjee S, 2010, INT J TUBERC LUNG D, V14, P1222; Keshavjee S, 2010, NEW ENGL J MED, V363, P1781, DOI 10.1056/NEJMp1010023; Kim JY, 2003, TUBERCULOSIS, V83, P59, DOI 10.1016/S1472-9792(02)00078-1; Kimerling ME, 1999, INT J TUBERC LUNG D, V3, P451; Koch R, 1932, AETIOLOGY TUBERCULOS, P47; Kochi A, 1997, WORLD HEALTH FORUM, V18, P225; Leimane V, 2005, LANCET, V365, P318, DOI 10.1016/S0140-6736(05)17786-1; MANTEN A, 1969, CHEMOTHERAPY, V14, P93, DOI 10.1159/000220615; McKenna MT, 1998, AM J PUBLIC HEALTH, V88, P1059, DOI 10.2105/AJPH.88.7.1059; Migliori GB, 2002, INT J TUBERC LUNG D, V6, P858; Mitnick C, 2003, NEW ENGL J MED, V348, P119, DOI 10.1056/NEJMoa022928; MURRAY CJL, 1994, B WORLD HEALTH ORGAN, V72, P429; NARDELL E, 1986, NEW ENGL J MED, V315, P1570, DOI 10.1056/NEJM198612183152502; SELIKOFF IJ, 1952, JAMA-J AM MED ASSOC, V150, P973, DOI 10.1001/jama.1952.03680100015006; Stein Howard, 2008, WORLD BANK AGENDA I; STEINER M, 1970, NEW ENGL J MED, V283, P1353, DOI 10.1056/NEJM197012172832501; Suarez PG, 2002, LANCET, V359, P1980, DOI 10.1016/S0140-6736(02)08830-X; Tahaoglu K, 2001, NEW ENGL J MED, V345, P170, DOI 10.1056/NEJM200107193450303; Udwadia ZF, 2012, CLIN INFECT DIS, V54, P579, DOI 10.1093/cid/cir889; UNGER JP, 1986, SOC SCI MED, V22, P1001, DOI 10.1016/0277-9536(86)90200-5; VALLSPINOSA A, 1970, NEW ENGL J MED, V283, P616, DOI 10.1056/NEJM197009172831202; Vasquez-Campos L, 2004, INT J TUBERC LUNG D, V8, P465; VILLARINO ME, 1992, PUBLIC HEALTH REP, V107, P616; WALSH JA, 1979, NEW ENGL J MED, V301, P967, DOI 10.1056/NEJM197911013011804; *WHO, 1997, WHO REP TUB EP; *WORLD BANK, 1993, WORLD DEV REP 1993 I	50	171	178	0	43	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 6	2012	367	10					931	936		10.1056/NEJMra1205429	http://dx.doi.org/10.1056/NEJMra1205429			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	999VO	22931261				2022-12-28	WOS:000308343300010
J	Mulvaney, R; Abram, NJ; Hindmarsh, RCA; Arrowsmith, C; Fleet, L; Triest, J; Sime, LC; Alemany, O; Foord, S				Mulvaney, Robert; Abram, Nerilie J.; Hindmarsh, Richard C. A.; Arrowsmith, Carol; Fleet, Louise; Triest, Jack; Sime, Louise C.; Alemany, Olivier; Foord, Susan			Recent Antarctic Peninsula warming relative to Holocene climate and ice-shelf history	NATURE			English	Article							SEA-ICE; SURFACE; CORES	Rapid warming over the past 50 years on the Antarctic Peninsula is associated with the collapse of a number of ice shelves and accelerating glacier mass loss(1-7). In contrast, warming has been comparatively modest over West Antarctica and significant changes have not been observed over most of East Antarctica(8,9), suggesting that the ice-core palaeoclimate records available from these areas may not be representative of the climate history of the Antarctic Peninsula. Here we show that the Antarctic Peninsula experienced an early-Holocene warm period followed by stable temperatures, from about 9,200 to 2,500 years ago, that were similar to modern-day levels. Our temperature estimates are based on an ice-core record of deuterium variations from James Ross Island, off the northeastern tip of the Antarctic Peninsula. We find that the late-Holocene development of ice shelves near James Ross Island was coincident with pronounced cooling from 2,500 to 600 years ago. This cooling was part of a millennial-scale climate excursion with opposing anomalies on the eastern and western sides of the Antarctic Peninsula. Although warming of the northeastern Antarctic Peninsula began around 600 years ago, the high rate of warming over the past century is unusual (but not unprecedented) in the context of natural climate variability over the past two millennia. The connection shown here between past temperature and ice-shelf stability suggests that warming for several centuries rendered ice shelves on the northeastern Antarctic Peninsula vulnerable to collapse. Continued warming to temperatures that now exceed the stable conditions of most of the Holocene epoch is likely to cause ice-shelf instability to encroach farther southward along the Antarctic Peninsula.	[Mulvaney, Robert; Abram, Nerilie J.; Hindmarsh, Richard C. A.; Fleet, Louise; Triest, Jack; Sime, Louise C.; Foord, Susan] British Antarctic Survey, NERC, Cambridge CB3 0ET, England; [Abram, Nerilie J.] Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT 0200, Australia; [Arrowsmith, Carol] NERC, Isotope Geosci Lab, Keyworth NG12 5GG, Notts, England; [Alemany, Olivier] UJF Grenoble 1, CNRS, LGGE, UMR 5183, F-38041 Grenoble, France	UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey; Australian National University; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Geological Survey; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Mulvaney, R (corresponding author), British Antarctic Survey, NERC, Cambridge CB3 0ET, England.	rmu@bas.ac.uk	Mulvaney, Robert/K-3929-2012; Sime, Louise/AAX-7730-2021; Abram, Nerilie/AAT-5171-2021; Sime, Louise/F-8058-2012; Hindmarsh, Richard/N-1195-2019; Hindmarsh, Richard C A/C-1405-2012	Mulvaney, Robert/0000-0002-5372-8148; Sime, Louise/0000-0002-9093-7926; Sime, Louise/0000-0002-9093-7926; Hindmarsh, Richard/0000-0003-1633-2416; Hindmarsh, Richard C A/0000-0003-1633-2416; Arrowsmith, Carol/0000-0003-3849-5179; Abram, Nerilie/0000-0003-1246-2344	Natural Environment Research Council; Institut Polaire Francais - Paul Emile Victor (IPEV); Institut National des Sciences de l'Univers in France (INSU/PNEDC "AMANCAY" project); NERC [bas0100024, NE/F015526/1] Funding Source: UKRI; Natural Environment Research Council [bas0100024, NE/F015526/1] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Institut Polaire Francais - Paul Emile Victor (IPEV); Institut National des Sciences de l'Univers in France (INSU/PNEDC "AMANCAY" project); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank our colleague in the field, S. Shelley, who took part in the ice-core drilling project; the captain and crew of HMS Endurance, who provided logistical support for the drilling field season; S. Kipfstuhl and the Alfred Wegner Institute at Bremerhaven for assistance in the processing of the ice core; J. Smellie and S. Roberts for discussions on Antarctic Peninsula tephras; D. Hodgson and E. Wolff for comments during preparation of the manuscript; and E. Capron, N. Lang, J. Levine and E. Ludlow for laboratory assistance. This study is part of the British Antarctic Survey Polar Science for Planet Earth Programme and was funded by the Natural Environment Research Council. Support from the Institut Polaire Francais - Paul Emile Victor (IPEV), and from the Institut National des Sciences de l'Univers in France (INSU/PNEDC "AMANCAY" project), facilitated by J. Chappellaz and F. Vimeux, enabled the technical contribution of the French National Center for Drilling and Coring (INSU/C2FN).	Abram NJ, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2011JD016147; Aristarain AJ, 2004, CLIMATIC CHANGE, V67, P63, DOI 10.1007/s10584-004-0708-6; Augustin L, 2004, NATURE, V429, P623, DOI 10.1038/nature02599; Barbante C, 2006, NATURE, V444, P195, DOI 10.1038/nature05301; Bentley MJ, 2009, HOLOCENE, V19, P51, DOI 10.1177/0959683608096603; Bintanja R, 2005, NATURE, V437, P125, DOI 10.1038/nature03975; Bracegirdle TJ, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD008933; Brachfeld S, 2003, GEOLOGY, V31, P749, DOI 10.1130/G19643.1; Cook AJ, 2005, SCIENCE, V308, P541, DOI 10.1126/science.1104235; Domack E, 2005, NATURE, V436, P681, DOI 10.1038/nature03908; Hall BL, 2010, GEOLOGY, V38, P635, DOI 10.1130/G30932.1; Hansen J, 2010, REV GEOPHYS, V48, DOI 10.1029/2010RG000345; Hodgson DA, 2011, P NATL ACAD SCI USA, V108, P18859, DOI 10.1073/pnas.1116515108; Johnson JH, 2011, VENICE INCOGNITO: MASKS IN THE SERENE REPUBLIC, P30; Jouzel J, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002677; Mann ME, 2008, P NATL ACAD SCI USA, V105, P13252, DOI 10.1073/pnas.0805721105; Masson-Delmotte V, 2008, J CLIMATE, V21, P3359, DOI 10.1175/2007JCLI2139.1; Masson-Delmotte V, 2011, CLIM PAST, V7, P397, DOI 10.5194/cp-7-397-2011; Pudsey CJ, 2006, QUATERNARY SCI REV, V25, P2357, DOI 10.1016/j.quascirev.2006.01.029; Pudsey CJ, 2001, GEOLOGY, V29, P787, DOI 10.1130/0091-7613(2001)029<0787:FSOASI>2.0.CO;2; Shevenell AE, 2011, NATURE, V470, P250, DOI 10.1038/nature09751; Sime LC, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2008JD010395; Smith TM, 2008, J CLIMATE, V21, P2283, DOI 10.1175/2007JCLI2100.1; Steig EJ, 2009, NATURE, V457, P459, DOI 10.1038/nature07669; Stenni B, 2010, QUATERNARY SCI REV, V29, P146, DOI 10.1016/j.quascirev.2009.10.009; Sterken M, 2012, QUATERNARY SCI REV, V31, P93, DOI 10.1016/j.quascirev.2011.10.017; THOMPSON LG, 1994, ANN GLACIOL, V20, P420, DOI 10.3189/172756494794587438; Turner J, 2005, INT J CLIMATOL, V25, P279, DOI 10.1002/joc.1130; Vaughan DG, 2003, CLIMATIC CHANGE, V60, P243, DOI 10.1023/A:1026021217991; Yuan XJ, 2004, ANTARCT SCI, V16, P415, DOI 10.1017/S0954102004002238	30	207	218	1	159	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 6	2012	489	7414					141	U204		10.1038/nature11391	http://dx.doi.org/10.1038/nature11391			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999WW	22914090	Green Accepted			2022-12-28	WOS:000308347000051
J	Feld, ED				Feld, Ellen D.			Worries	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Drexel Univ, Coll Nursing & Hlth Profess, Phys Assistant Dept, Philadelphia, PA 19104 USA	Drexel University	Feld, ED (corresponding author), Drexel Univ, Coll Nursing & Hlth Profess, Phys Assistant Dept, Philadelphia, PA 19104 USA.	edf26@drexel.edu							0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 5	2012	308	9					873	874		10.1001/2012.jama.10452	http://dx.doi.org/10.1001/2012.jama.10452			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	999ET	22948696				2022-12-28	WOS:000308292900016
J	Pinheiro, I; Margueron, R; Shukeir, N; Eisold, M; Fritzsch, C; Richter, FM; Mittler, G; Genoud, C; Goyama, S; Kurokawa, M; Son, J; Reinberg, D; Lachner, M; Jenuwein, T				Pinheiro, Ines; Margueron, Raphael; Shukeir, Nicholas; Eisold, Michael; Fritzsch, Christoph; Richter, Florian M.; Mittler, Gerhard; Genoud, Christel; Goyama, Susumu; Kurokawa, Mineo; Son, Jinsook; Reinberg, Danny; Lachner, Monika; Jenuwein, Thomas			Prdm3 and Prdm16 are H3K9me1 Methyltransferases Required for Mammalian Heterochromatin Integrity	CELL			English	Article							GERM-CELL LINEAGE; HISTONE H3; LYSINE 9; PERICENTRIC HETEROCHROMATIN; NONHISTONE PROTEINS; CHROMATIN-STRUCTURE; METHYLATION STATES; GENES; MOUSE; MONOMETHYLATION	Heterochromatin serves important functions, protecting genome integrity and stabilizing gene expression programs. Although the Suv39h methyltransferases (KMTs) are known to ensure pericentric H3K9me3 methylation, the mechanisms that initiate and maintain mammalian heterochromatin organization remain elusive. We developed a biochemical assay and used in vivo analyses in mouse embryonic fibroblasts to identify Prdm3 and Prdm16 as redundant H3K9me1-specific KMTs that direct cytoplasmic H3K9me1 methylation. The H3K9me1 is converted in the nucleus to H3K9me3 by the Suv39h enzymes to reinforce heterochromatin. Simultaneous depletion of Prdm3 and Prdm16 abrogates H3K9me1 methylation, prevents Suv39h-dependent H3K9me3 trimethylation, and derepresses major satellite transcription. Most strikingly, DNA-FISH and electron microscopy reveal that combined impairment of Prdm3 and Prdm16 results in disintegration of heterochromatic foci and disruption of the nuclear lamina. Our data identify Prdm3 and Prdm16 as H3K9me1 methyltransferases and expose a functional framework in which anchoring to the nuclear periphery helps maintain the integrity of mammalian heterochromatin.	[Pinheiro, Ines; Shukeir, Nicholas; Eisold, Michael; Fritzsch, Christoph; Richter, Florian M.; Mittler, Gerhard; Lachner, Monika; Jenuwein, Thomas] Max Planck Inst Immunobiol & Epigenet, Dept Epigenet, D-79108 Freiburg, Germany; [Pinheiro, Ines; Jenuwein, Thomas] Res Inst Mol Pathol, A-1030 Vienna, Austria; [Margueron, Raphael; Son, Jinsook; Reinberg, Danny] NYU, Sch Med, Dept Biochem, Smilow Res Ctr, New York, NY 10016 USA; [Genoud, Christel] Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland; [Goyama, Susumu; Kurokawa, Mineo] Tokyo Univ Hosp, Dept Hematol & Oncol, Bunkyo Ku, Tokyo 1138655, Japan	Max Planck Society; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); New York University; Friedrich Miescher Institute for Biomedical Research; University of Tokyo	Jenuwein, T (corresponding author), Max Planck Inst Immunobiol & Epigenet, Dept Epigenet, Stubeweg 51, D-79108 Freiburg, Germany.	jenuwein@ie-freiburg.mpg.de	Margueron, Raphael F/B-9996-2015	Margueron, Raphael F/0000-0002-9093-7977; genoud, christel/0000-0002-0933-9911; Reinberg, Danny/0000-0003-4288-2016	IMP through Boehringer Ingelheim; European Union NoE network "The Epigenome" [LSHG-CT-2004-503433]; Austrian GEN-AU initiative; Max-Planck Society; Boehringer Ingelheim	IMP through Boehringer Ingelheim(Boehringer Ingelheim); European Union NoE network "The Epigenome"; Austrian GEN-AU initiative; Max-Planck Society(Max Planck Society); Boehringer Ingelheim(Boehringer Ingelheim)	We thank the MS facility at Rutgers University, New Jersey, USA, for analyzing fractions enriched for H3K9me1 activity. We are also grateful to Masato Yonezawa (University of Tokyo) for providing the Eset Baculovirus expression construct, to Gunter Reuter (Martin Luther University Halle-Wittenberg) for sharing information on Prdm orthologues in Drosophila and to Antoine Peters (FMI Basel) for insightful discussions and help with IF analysis. We further acknowledge interactions and discussions with Susan Gasser (FMI Basel) on the general relevance of H3K9 methylation for anchoring heterochromatin to the nuclear lamina in C. elegans. We would also like to thank Rudi Grosschedl (MPI of Immunobiology and Epigenetics) for insightful comments. Research in the laboratory of T.J. was sponsored by the IMP through Boehringer Ingelheim, the European Union NoE network "The Epigenome" (LSHG-CT-2004-503433), the Austrian GEN-AU initiative, and is now provided by the Max-Planck Society. During part of this work, I.P. was supported by a Boehringer Ingelheim doctoral Fellowship (2007-2009).	Aguilo F, 2011, BLOOD, V117, P5057, DOI 10.1182/blood-2010-08-300145; An S, 2011, J BIOL CHEM, V286, P8369, DOI 10.1074/jbc.M110.203380; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Chuikov S, 2010, NAT CELL BIOL, V12, P999, DOI 10.1038/ncb2101; Denk W, 2004, PLOS BIOL, V2, P1900, DOI 10.1371/journal.pbio.0020329; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Dodge JE, 2004, MOL CELL BIOL, V24, P2478, DOI 10.1128/MCB.24.6.2478-2486.2004; Fischle W, 2003, GENE DEV, V17, P1870, DOI 10.1101/gad.1110503; Fodor BD, 2010, ANNU REV CELL DEV BI, V26, P471, DOI 10.1146/annurev.cellbio.042308.113225; Fritsch L, 2010, MOL CELL, V37, P46, DOI 10.1016/j.molcel.2009.12.017; Fumasoni I, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-187; Goyama S, 2008, CELL STEM CELL, V3, P207, DOI 10.1016/j.stem.2008.06.002; Gregory GD, 2007, MOL CELL BIOL, V27, P8466, DOI 10.1128/MCB.00993-07; Hayashi K, 2005, NATURE, V438, P374, DOI 10.1038/nature04112; Huang J, 2008, CURR OPIN GENET DEV, V18, P152, DOI 10.1016/j.gde.2008.01.012; Huang S, 2002, NAT REV CANCER, V2, P469, DOI 10.1038/nrc819; Jacob Y, 2009, NAT STRUCT MOL BIOL, V16, P763, DOI 10.1038/nsmb.1611; Karslioglu A.B., 2012, NAT STRUCT IN PRESS; Kim KC, 2003, CANCER RES, V63, P7619; Kind J, 2010, CURR OPIN CELL BIOL, V22, P320, DOI 10.1016/j.ceb.2010.04.002; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Lan F, 2009, SCI CHINA SER C, V52, P311, DOI 10.1007/s11427-009-0054-z; Lehnertz B, 2003, CURR BIOL, V13, P1192, DOI 10.1016/S0960-9822(03)00432-9; LeRoy G, 1998, SCIENCE, V282, P1900, DOI 10.1126/science.282.5395.1900; Loyola A, 2006, MOL CELL, V24, P309, DOI 10.1016/j.molcel.2006.08.019; Loyola A, 2009, EMBO REP, V10, P769, DOI 10.1038/embor.2009.90; Ma ZY, 2011, NAT STRUCT MOL BIOL, V18, P120, DOI 10.1038/nsmb.2000; Martens JHA, 2005, EMBO J, V24, P800, DOI 10.1038/sj.emboj.7600545; McStay B, 2008, ANNU REV CELL DEV BI, V24, P131, DOI 10.1146/annurev.cellbio.24.110707.175259; Mochizuki N, 2000, BLOOD, V96, P3209, DOI 10.1182/blood.V96.9.3209.h8003209_3209_3214; Morishita K, 2007, INT J HEMATOL, V85, P279, DOI 10.1532/IJH97.06174; Nemeth A, 2011, TRENDS GENET, V27, P149, DOI 10.1016/j.tig.2011.01.002; Nishioka K, 2002, MOL CELL, V9, P1201, DOI 10.1016/S1097-2765(02)00548-8; Oda H, 2009, MOL CELL BIOL, V29, P2278, DOI 10.1128/MCB.01768-08; Ohinata Y, 2005, NATURE, V436, P207, DOI 10.1038/nature03813; Pal S, 2004, MOL CELL BIOL, V24, P9630, DOI 10.1128/MCB.24.21.9630-9645.2004; Peng JC, 2007, NAT CELL BIOL, V9, P25, DOI 10.1038/ncb1514; PERKINS AS, 1991, MOL CELL BIOL, V11, P2665, DOI 10.1128/MCB.11.5.2665; Peters AHFM, 2003, MOL CELL, V12, P1577, DOI 10.1016/S1097-2765(03)00477-5; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Reimann M, 2010, CANCER CELL, V17, P262, DOI 10.1016/j.ccr.2009.12.043; Rouquette J, 2009, CHROMOSOME RES, V17, P801, DOI 10.1007/s10577-009-9070-x; Schotta G, 2004, GENE DEV, V18, P1251, DOI 10.1101/gad.300704; Schotta G, 2008, GENE DEV, V22, P2048, DOI 10.1101/gad.476008; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Towbin BD, 2012, CELL, V150, P934, DOI 10.1016/j.cell.2012.06.051; Towbin BD, 2009, CURR OPIN GENET DEV, V19, P180, DOI 10.1016/j.gde.2009.01.006; Wang HB, 2003, MOL CELL, V12, P475, DOI 10.1016/j.molcel.2003.08.007; Wu H, 2011, CELL RES, V21, P365, DOI 10.1038/cr.2010.157; Yamaji M, 2008, NAT GENET, V40, P1016, DOI 10.1038/ng.186; Yatsula B, 2005, J BIOL CHEM, V280, P30712, DOI 10.1074/jbc.M504293200; Ye QA, 1997, J BIOL CHEM, V272, P14983, DOI 10.1074/jbc.272.23.14983	53	206	213	2	27	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 31	2012	150	5					948	960		10.1016/j.cell.2012.06.048	http://dx.doi.org/10.1016/j.cell.2012.06.048			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	001ZU	22939622	Bronze			2022-12-28	WOS:000308500200010
J	Youle, RJ; van der Bliek, AM				Youle, Richard J.; van der Bliek, Alexander M.			Mitochondrial Fission, Fusion, and Stress	SCIENCE			English	Review							PARKIN; DEGRADATION; AUTOPHAGY; SEGREGATION; DROSOPHILA-PINK1; COMPLEMENTATION; PHOSPHORYLATION; DYSFUNCTION; MUTATIONS; SELECTION	Mitochondrial fission and fusion play critical roles in maintaining functional mitochondria when cells experience metabolic or environmental stresses. Fusion helps mitigate stress by mixing the contents of partially damaged mitochondria as a form of complementation. Fission is needed to create new mitochondria, but it also contributes to quality control by enabling the removal of damaged mitochondria and can facilitate apoptosis during high levels of cellular stress. Disruptions in these processes affect normal development, and they have been implicated in neurodegenerative diseases, such as Parkinson's.	[Youle, Richard J.] NINDS, Biochem Sect, Surg Neurol Branch, NIH, Bethesda, MD 20892 USA; [van der Bliek, Alexander M.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Youle, RJ (corresponding author), NINDS, Biochem Sect, Surg Neurol Branch, NIH, Bethesda, MD 20892 USA.	youler@ninds.nih.gov; avan@mednet.ucla.edu			Intramural Program of the National Institute of Neurological Disorders and Stroke; NIH [GM051866]; NSF [0552271]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051866] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003123, ZIANS003127] Funding Source: NIH RePORTER	Intramural Program of the National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank members of the Youle lab for thoughtful comments. This work was supported by Intramural Program of the National Institute of Neurological Disorders and Stroke and grants from the NIH (GM051866) and the NSF (0552271) to A.M.v.d.B.	Autret A, 2009, MOL CELL, V36, P355, DOI 10.1016/j.molcel.2009.10.011; Baker MJ, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a007559; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Buchet K, 1998, J BIOL CHEM, V273, P22983, DOI 10.1074/jbc.273.36.22983; Burman JL, 2012, P NATL ACAD SCI USA, V109, P10438, DOI 10.1073/pnas.1120688109; Chen HC, 2005, J BIOL CHEM, V280, P26185, DOI 10.1074/jbc.M503062200; Chen H, 2010, ANN NY ACAD SCI, V1201, P21, DOI 10.1111/j.1749-6632.2010.05615.x; Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779; de Castro P, 2012, CELL DEATH DIFFER, V19, P1308, DOI 10.1038/cdd.2012.5; Egan DF, 2011, SCIENCE, V331, P456, DOI 10.1126/science.1196371; Ehses S, 2009, J CELL BIOL, V187, P1023, DOI 10.1083/jcb.200906084; Elgass K., BIOCH BIOPHYS ACTA; Fan WW, 2008, SCIENCE, V319, P958, DOI 10.1126/science.1147786; Friedman JR, 2011, SCIENCE, V334, P358, DOI 10.1126/science.1207385; Fuentealba LC, 2008, P NATL ACAD SCI USA, V105, P7732, DOI 10.1073/pnas.0803027105; Gomes LC, 2011, NAT CELL BIOL, V13, P589, DOI 10.1038/ncb2220; Greene JC, 2003, P NATL ACAD SCI USA, V100, P4078, DOI 10.1073/pnas.0737556100; Grumati P, 2010, NAT MED, V16, P1313, DOI 10.1038/nm.2247; He J, 2012, NUCLEIC ACIDS RES, V40, P6109, DOI 10.1093/nar/gks266; Head B, 2009, J CELL BIOL, V187, P959, DOI 10.1083/jcb.200906083; Hoppins S, 2007, ANNU REV BIOCHEM, V76, P751, DOI 10.1146/annurev.biochem.76.071905.090048; Johansen T, 2011, AUTOPHAGY, V7, P279, DOI 10.4161/auto.7.3.14487; Kim I, 2011, ANTIOXID REDOX SIGN, V14, P1919, DOI 10.1089/ars.2010.3768; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Kowald Axel, 2011, Commun Integr Biol, V4, P627, DOI 10.4161/cib.4.5.17110; Lindner AB, 2008, P NATL ACAD SCI USA, V105, P3076, DOI 10.1073/pnas.0708931105; Meeusen S, 2006, CELL, V127, P383, DOI 10.1016/j.cell.2006.09.021; Montessuit S, 2010, CELL, V142, P889, DOI 10.1016/j.cell.2010.08.017; Nakada K, 2001, NAT MED, V7, P934, DOI 10.1038/90976; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Nargund AM, 2012, SCIENCE, V337, P587, DOI 10.1126/science.1223560; Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788; Rambold AS, 2011, P NATL ACAD SCI USA, V108, P10190, DOI 10.1073/pnas.1107402108; Rossignol R, 2004, CANCER RES, V64, P985, DOI 10.1158/0008-5472.CAN-03-1101; Schon EA, 2010, BBA-GEN SUBJECTS, V1800, P245, DOI 10.1016/j.bbagen.2009.07.007; Soubannier V, 2012, CURR BIOL, V22, P135, DOI 10.1016/j.cub.2011.11.057; Stewart JB, 2008, PLOS BIOL, V6, P63, DOI 10.1371/journal.pbio.0060010; Suen DF, 2008, GENE DEV, V22, P1577, DOI 10.1101/gad.1658508; Tanaka A, 2010, J CELL BIOL, V191, P1367, DOI 10.1083/jcb.201007013; Tondera D, 2009, EMBO J, V28, P1589, DOI 10.1038/emboj.2009.89; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Wang XN, 2011, CELL, V147, P893, DOI 10.1016/j.cell.2011.10.018; YONEDA M, 1994, MOL CELL BIOL, V14, P2699, DOI 10.1128/MCB.14.4.2699	45	1960	2026	21	554	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 31	2012	337	6098					1062	1065		10.1126/science.1219855	http://dx.doi.org/10.1126/science.1219855			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996WP	22936770	Green Accepted			2022-12-28	WOS:000308125800037
J	Kargaltsev, O; Durant, M; Misanovic, Z; Pavlov, GG				Kargaltsev, Oleg; Durant, Martin; Misanovic, Zdenka; Pavlov, George G.			Absorption Features in the X-ray Spectrum of an Ordinary Radio Pulsar	SCIENCE			English	Article							MAGNETIZED NEUTRON-STARS; RADIATION; DISCOVERY; SURFACE; NEARBY	The vast majority of known nonaccreting neutron stars (NSs) are rotation-powered radio and/or gamma-ray pulsars. So far, their multiwavelength spectra have all been described satisfactorily by thermal and nonthermal continuum models, with no spectral lines. Spectral features have, however, been found in a handful of exotic NSs and were thought to be a manifestation of their unique traits. Here, we report the detection of absorption features in the x-ray spectrum of an ordinary rotation-powered radio pulsar, J1740+1000. Our findings bridge the gap between the spectra of pulsars and other, more exotic, NSs, suggesting that the features are more common in the NS spectra than they have been thought so far.	[Kargaltsev, Oleg; Durant, Martin] Univ Florida, Dept Astron, Bryant Space Sci Ctr 222, Gainesville, FL 32611 USA; [Misanovic, Zdenka] Monash Univ, Sch Phys, Melbourne, Vic 3800, Australia; [Pavlov, George G.] Penn State Univ, Dept Astron & Astrophys, Davey Lab 525, University Pk, PA 16802 USA; [Pavlov, George G.] St Petersburg State Polytech Univ, St Petersburg 195251, Russia	State University System of Florida; University of Florida; Monash University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Peter the Great St. Petersburg Polytechnic University	Kargaltsev, O (corresponding author), George Washington Univ, Dept Phys, Corcoran 105,725 21st St, Washington, DC 20052 USA.	kargaltsev@astro.ufl.edu			National Aeronautics and Space Administration [NNX06AH67G, NNX09AC84G]; Chandra X-ray Observatory Center [G0-11096A]; NASA [NAS8-03060]; Ministry of Education and Science of the Russian Federation [11.G34.310001]	National Aeronautics and Space Administration(National Aeronautics & Space Administration (NASA)); Chandra X-ray Observatory Center; NASA(National Aeronautics & Space Administration (NASA)); Ministry of Education and Science of the Russian Federation(Ministry of Education and Science, Russian Federation)	We thank I. Volkov for useful discussions and advice and Z. Arzoumanian for his help in preparing the observing proposal. This work was supported by National Aeronautics and Space Administration grants NNX06AH67G and NNX09AC84G and through Chandra Award G0-11096A issued by the Chandra X-ray Observatory Center, which is operated by the Smithsonian Astrophysical Observatory for and on behalf of NASA under contract NAS8-03060. The work was also partly supported by the Ministry of Education and Science of the Russian Federation (contract 11.G34.310001). The data used in this publication are freely available from the Chandra Data Archive (http://cxc.harvard.edu/cda) and the XMM-Newton Science Archive (http://xmm.esac.esa.int/xsa).	Bucciantini N, 2011, MON NOT R ASTRON SOC, V410, P381, DOI 10.1111/j.1365-2966.2010.17449.x; Cordes J. M., 2002, 0207156 ARXIV; De Luca A, 2005, ASTROPHYS J, V623, P1051, DOI 10.1086/428567; Gotthelf EV, 2009, ASTROPHYS J LETT, V695, pL35, DOI 10.1088/0004-637X/695/1/L35; Haberl F, 2004, ASTRON ASTROPHYS, V419, P1077, DOI 10.1051/0004-6361:20034129; Hambaryan V, 2011, ASTRON ASTROPHYS, V534, DOI 10.1051/0004-6361/201117548; Harding AK, 2006, REP PROG PHYS, V69, P2631, DOI 10.1088/0034-4885/69/9/R03; Jackson MS, 2005, ASTROPHYS J, V633, P1114, DOI 10.1086/491615; Kalberla PMW, 2005, ASTRON ASTROPHYS, V440, P775, DOI 10.1051/0004-6361:20041864; Kaplan DL, 2011, ASTROPHYS J, V736, DOI 10.1088/0004-637X/736/2/117; Kargaltsev O, 2008, ASTROPHYS J, V684, P542, DOI 10.1086/589145; Kaspi VM, 2010, P NATL ACAD SCI USA, V107, P7147, DOI 10.1073/pnas.1000812107; Luo QH, 2007, MON NOT R ASTRON SOC, V378, P1481, DOI 10.1111/j.1365-2966.2007.11889.x; Manchester RN, 2005, ASTRON J, V129, P1993, DOI 10.1086/428488; McLaughlin MA, 2002, ASTROPHYS J, V564, P333, DOI 10.1086/324151; Mori K, 2007, MON NOT R ASTRON SOC, V377, P905, DOI 10.1111/j.1365-2966.2007.11663.x; Pavlov G. G., 2002, PROC 270 HERAEUS SEM, V278, P273; Rajagopal M, 1997, ASTROPHYS J, V491, P296, DOI 10.1086/304952; Ruder H., 1994, ATOMS STRONG MAGNETI; Sanwal D, 2002, ASTROPHYS J, V574, pL61, DOI 10.1086/342368; Suleimanov VF, 2012, ASTROPHYS J, V751, DOI 10.1088/0004-637X/751/1/15; TAYLOR JH, 1993, ASTROPHYS J, V411, P674, DOI 10.1086/172870; van Adelsberg M, 2005, ASTROPHYS J, V628, P902, DOI 10.1086/430871; van Kerkwijk MH, 2004, ASTROPHYS J, V608, P432, DOI 10.1086/386299	25	31	31	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 24	2012	337	6097					946	949		10.1126/science.1221378	http://dx.doi.org/10.1126/science.1221378			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992VI	22923576	Green Submitted			2022-12-28	WOS:000307807600039
J	Drapkin, MS; Kamath, RS; Kim, JY				Drapkin, Mark S.; Kamath, Ravi S.; Kim, Ji Yeon			Case 26-2012: A 70-Year-Old Woman with Fever and Back Pain	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LUMBAR SPINE MIMICKING; EPIDURAL ABSCESS; CAMEL BRUCELLOSIS; TOPHACEOUS GOUT; OSTEOMYELITIS; SPONDYLODISCITIS; SPONDYLITIS; INFECTION; REGIMENS		[Drapkin, Mark S.] Newton Wellesley Hosp, Infect Dis Serv, Newton, MA USA; [Kamath, Ravi S.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Kim, Ji Yeon] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Drapkin, Mark S.] Tufts Univ, Sch Med, Dept Med, Boston, MA 02111 USA; [Kamath, Ravi S.] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Kim, Ji Yeon] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Newton Wellesley Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Tufts University; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Drapkin, MS (corresponding author), Newton Wellesley Hosp, Infect Dis Serv, Newton, MA USA.							Abbas B, 2002, PREV VET MED, V55, P47, DOI 10.1016/S0167-5877(02)00055-7; [Anonymous], 2000, MMWR Recomm Rep, V49, P1; Ahmed MO, 2010, EUROSURVEILLANCE, V15, P19; [Anonymous], 2008, N ENGL J MED, V359, P1942; [Anonymous], 2010, MMWR RECOMM REP, V59, P1; Bayindir Y, 2003, J CHEMOTHERAPY, V15, P466, DOI 10.1179/joc.2003.15.5.466; Beier CP, 2005, J NEUROSURG-SPINE, V3, P485, DOI 10.3171/spi.2005.3.6.0485; Bonaldi VM, 1996, AM J NEURORADIOL, V17, P1949; Bouaziz MC, 2008, SKELETAL RADIOL, V37, P785, DOI 10.1007/s00256-007-0371-x; BRACIKOWSKI JP, 1984, SOUTHERN MED J, V77, P1611, DOI 10.1097/00007611-198412000-00044; Colmenero JD, 1997, ANN RHEUM DIS, V56, P709, DOI 10.1136/ard.56.12.709; Corbel M.J., 2006, BRUCELLOSIS HUMANS A; Gines R, 1998, AM J EMERG MED, V16, P216, DOI 10.1016/S0735-6757(98)90052-3; Jung NY, 2004, AM J ROENTGENOL, V182, P1405, DOI 10.2214/ajr.182.6.1821405; Kalimuddin S, 2010, SCAND J INFECT DIS, V42, P228, DOI 10.3109/00365540903402971; Mylonakis E, 2001, NEW ENGL J MED, V345, P1318, DOI 10.1056/NEJMra010082; Park SY, 2009, SCAND J INFECT DIS, V41, P818, DOI 10.3109/00365540903214298; PETERSON MC, 1993, CLIN INFECT DIS, V16, P439, DOI 10.1093/clind/16.3.439; Rafieipour A, 2007, VET ON LINE INT J VE; Ranjbar M, 2007, INT J INFECT DIS, V11, P152, DOI 10.1016/j.ijid.2005.11.007; Refai M, 2002, VET MICROBIOL, V90, P81, DOI 10.1016/S0378-1135(02)00248-1; Rutherford M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012020; Teshome H, 2003, TROP ANIM HEALTH PRO, V35, P381, DOI 10.1023/A:1025874310261; Turunc T, 2007, J INFECTION, V55, P158, DOI 10.1016/j.jinf.2007.04.002; Vandenberg Olivier, 2003, International Journal of Infectious Diseases, V7, P164, DOI 10.1016/S1201-9712(03)90016-6; Yen PS, 2005, J CLIN NEUROSCI, V12, P44, DOI 10.1016/j.jocn.2004.03.020; zur Wiesch JS, 2010, ZOONOSES PUBLIC HLTH, V57, P315, DOI 10.1111/j.1863-2378.2009.01258.x	27	6	7	0	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 23	2012	367	8					754	762		10.1056/NEJMcpc1200087	http://dx.doi.org/10.1056/NEJMcpc1200087			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	992CX	22913686				2022-12-28	WOS:000307754200012
J	Gamuyao, R; Chin, JH; Pariasca-Tanaka, J; Pesaresi, P; Catausan, S; Dalid, C; Slamet-Loedin, I; Tecson-Mendoza, EM; Wissuwa, M; Heuer, S				Gamuyao, Rico; Chin, Joong Hyoun; Pariasca-Tanaka, Juan; Pesaresi, Paolo; Catausan, Sheryl; Dalid, Cheryl; Slamet-Loedin, Inez; Tecson-Mendoza, Evelyn Mae; Wissuwa, Matthias; Heuer, Sigrid			The protein kinase Pstol1 from traditional rice confers tolerance of phosphorus deficiency	NATURE			English	Article							REPRODUCTIVE-STAGE; RESPONSE-FACTOR; DROUGHT STRESS; GENE; PUP1; EXPRESSION; INFERENCE; SEQUENCE; FAMILY; YIELD	As an essential macroelement for all living cells, phosphorus is indispensable in agricultural production systems. Natural phosphorus reserves are limited(1), and it is therefore important to develop phosphorus-efficient crops. A major quantitative trait locus for phosphorus-deficiency tolerance, Pup1, was identified in the traditional aus-type rice variety Kasalath about a decade ago(2,3). However, its functional mechanism remained elusive(4,5) until the locus was sequenced, showing the presence of a Pup1-specific protein kinase gene(6), which we have named phosphorus-starvation tolerance 1 (PSTOL1). This gene is absent from the rice reference genome and other phosphorus-starvation-intolerant modern varieties(7,8). Here we show that overexpression of PSTOL1 in such varieties significantly enhances grain yield in phosphorus-deficient soil. Further analyses show that PSTOL1 acts as an enhancer of early root growth, thereby enabling plants to acquire more phosphorus and other nutrients. The absence of PSTOL1 and other genes-for example, the submergence-tolerance gene SUB1A-from modern rice varieties underlines the importance of conserving and exploring traditional germplasm. Introgression of this quantitative trait locus into locally adapted rice varieties in Asia and Africa is expected to considerably enhance productivity under low phosphorus conditions.	[Gamuyao, Rico; Chin, Joong Hyoun; Catausan, Sheryl; Dalid, Cheryl; Slamet-Loedin, Inez; Heuer, Sigrid] Int Rice Res Inst, Manila 1301, Philippines; [Pariasca-Tanaka, Juan; Wissuwa, Matthias] JIRCAS, Tsukuba, Ibaraki 3058686, Japan; [Pesaresi, Paolo] Univ Milan, Dipartimento Biosci, I-20133 Milan, Italy; [Tecson-Mendoza, Evelyn Mae] Univ Philippines, Los Banos 4031, Laguna, Philippines	CGIAR; International Rice Research Institute (IRRI); Japan International Research Center for Agricultural Sciences; University of Milan; University of the Philippines System; University of the Philippines Los Banos; University of the Philippines Open University	Heuer, S (corresponding author), Int Rice Res Inst, DAPO Box 7777, Manila 1301, Philippines.	s.heuer@cgiar.org	Chin, Joong Hyoun/L-1307-2015; Dalid, Cheryl/AAI-8043-2021; Pesaresi, Paolo/F-9476-2014	Chin, Joong Hyoun/0000-0003-3932-8639; Dalid, Cheryl/0000-0001-6327-404X; Pesaresi, Paolo/0000-0002-3236-7005; Gamuyao, Rico/0000-0002-0112-6428; Wissuwa, Matthias/0000-0003-3505-9398; Slamet-Loedin, Inez/0000-0001-9145-3571	Generation Challenge Program (GCP)	Generation Challenge Program (GCP)	We would like to thank A. Cruz, E. Ramos and L. Olivo for technical and secretarial support, the staff at the transformation laboratory, F. Rossi for help with the Pstol1 kinase assay, M. Akutsu for help with the analysis of transgenic plants, and S. Haefele and his team for their support. We thank J. Prasetiyono, M. Bustamam and S. Moeljopawiro for their long-term collaboration. This project has been primarily funded by the Generation Challenge Program (GCP) since 2005.	[Anonymous], 2010, WORLD PHOSPHATE ROCK; Bernier J, 2007, CROP SCI, V47, P507, DOI 10.2135/cropsci2006.07.0495; Bi DL, 2010, PLANT PHYSIOL, V153, P1771, DOI 10.1104/pp.110.158501; Bimpong I.K., 2011, J PLANT BREED CROP S, V3, P60; Bonardi V, 2005, NATURE, V437, P1179, DOI 10.1038/nature04016; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Chin JH, 2011, PLANT PHYSIOL, V156, P1202, DOI 10.1104/pp.111.175471; Chin JH, 2010, THEOR APPL GENET, V120, P1073, DOI 10.1007/s00122-009-1235-7; Cordell D, 2009, GLOBAL ENVIRON CHANG, V19, P292, DOI 10.1016/j.gloenvcha.2008.10.009; Courtois B, 2009, RICE, V2, P115, DOI 10.1007/s12284-009-9028-9; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; Dardick C, 2007, PLANT PHYSIOL, V143, P579, DOI 10.1104/pp.106.087270; Dawe D., 2010, RICE GLOBAL EC STRAT, P5; Falush D, 2003, GENETICS, V164, P1567; Gomez MS., 2006, AM, V2, P161, DOI [10.3844/ajbbsp.2006.161.169, DOI 10.3844/AJBBSP.2006.161.169]; Gowda VRP, 2012, FUNCT PLANT BIOL, V39, P402, DOI 10.1071/FP12015; Gregory PD, 2000, FOOD TECHNOL BIOTECH, V38, P295; Haefele S. M., 2009, RICE TODAY, V8, P30; HAEFELE SM, 2007, SCI TECHNOLOGY TRADE, P297; Haldrup A, 1999, PLANT J, V17, P689, DOI 10.1046/j.1365-313X.1999.00419.x; Heuer S, 2009, PLANT BIOTECHNOL J, V7, P456, DOI 10.1111/j.1467-7652.2009.00415.x; Hiei Y, 2006, PLANT CELL TISS ORG, V87, P233, DOI 10.1007/s11240-006-9157-4; Inukai Y, 2005, PLANT CELL, V17, P1387, DOI 10.1105/tpc.105.030981; JEFFERSON RA, 1987, EMBO J, V6, P3901; Kong ZS, 2006, PLANT PHYSIOL, V141, P1376, DOI 10.1104/pp.106.082941; Lanceras JC, 2004, PLANT PHYSIOL, V135, P384, DOI 10.1104/pp.103.035527; Lohrmann J, 2002, PLANT PHYSIOL, V128, P363, DOI 10.1104/pp.010907; Londo JP, 2006, P NATL ACAD SCI USA, V103, P9578, DOI 10.1073/pnas.0603152103; Manzanilla DO, 2011, AGR SYST, V104, P335, DOI 10.1016/j.agsy.2010.12.005; Miki D, 2004, PLANT CELL PHYSIOL, V45, P490, DOI 10.1093/pcp/pch048; Ni JJ, 1998, THEOR APPL GENET, V97, P1361, DOI 10.1007/s001220051030; Ouyang J, 2010, PLANT SCI, V179, P374, DOI 10.1016/j.plantsci.2010.06.013; Pariasca-Tanaka J, 2009, RICE, V2, P167, DOI 10.1007/s12284-009-9032-0; Pribil M, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000288; Pritchard JK, 2000, GENETICS, V155, P945; Scarpella E, 2005, PLANT CELL PHYSIOL, V46, P1400, DOI 10.1093/pcp/pci153; Thomson MJ, 2012, MOL BREEDING, V29, P875, DOI 10.1007/s11032-011-9663-x; Vij S, 2008, MOL PLANT, V1, P732, DOI 10.1093/mp/ssn047; Wang XQ, 1996, P NATL ACAD SCI USA, V93, P2598, DOI 10.1073/pnas.93.6.2598; Wissuwa M, 2005, PLANT SOIL, V269, P57, DOI 10.1007/s11104-004-2026-1; Wissuwa M, 1998, THEOR APPL GENET, V97, P777, DOI 10.1007/s001220050955; Wissuwa M, 2002, THEOR APPL GENET, V105, P890, DOI 10.1007/s00122-002-1051-9; Wissuwa M, 2001, PLANT BREEDING, V120, P43, DOI 10.1046/j.1439-0523.2001.00561.x; Xu K, 2006, NATURE, V442, P705, DOI 10.1038/nature04920; Yang XJ, 2010, ANN BOT-LONDON, V105, P513, DOI 10.1093/aob/mcq015; Yoshida S., 1972, LAB MANUAL PHYSL STU, V2nd edn, P1; Zhao Y, 2009, PLANT CELL, V21, P736, DOI 10.1105/tpc.108.061655	47	464	494	26	353	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 23	2012	488	7412					535	+		10.1038/nature11346	http://dx.doi.org/10.1038/nature11346			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992FS	22914168				2022-12-28	WOS:000307761600042
J	Rosenbaum, JT				Rosenbaum, James T.			Eyeing Macular Degeneration - A Few Inflammatory Remarks	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Rosenbaum, James T.] Oregon Hlth & Sci Univ, Dept Ophthalmol, Portland, OR 97201 USA; [Rosenbaum, James T.] Oregon Hlth & Sci Univ, Dept Med, Portland, OR 97201 USA; [Rosenbaum, James T.] Oregon Hlth & Sci Univ, Dept Cell Biol, Portland, OR 97201 USA	Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University	Rosenbaum, JT (corresponding author), Oregon Hlth & Sci Univ, Dept Ophthalmol, Portland, OR 97201 USA.							Doyle SL, 2012, NAT MED, V18, P791, DOI 10.1038/nm.2717; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Hoffman HM, 2001, NAT GENET, V29, P301, DOI 10.1038/ng756; Mullins RF, 2000, FASEB J, V14, P835, DOI 10.1096/fasebj.14.7.835; Tarallo V, 2012, CELL, V149, P847, DOI 10.1016/j.cell.2012.03.036	5	10	13	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 23	2012	367	8					768	770		10.1056/NEJMcibr1204973	http://dx.doi.org/10.1056/NEJMcibr1204973			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	992CX	22913688				2022-12-28	WOS:000307754200015
J	Belle, MDC; Piggins, HD				Belle, Mino D. C.; Piggins, Hugh D.			Circadian Time Redoxed	SCIENCE			English	Editorial Material							CLOCK; RHYTHMS; NEURONS; PERIOD		[Belle, Mino D. C.; Piggins, Hugh D.] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England	University of Manchester	Belle, MDC (corresponding author), Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England.	hugh.d.piggins@manchester.ac.uk	Belle, Mino/AAV-6093-2020	Belle, Mino/0000-0002-4917-957X; Piggins, Hugh/0000-0003-2555-9858				Albus H, 2002, CURR BIOL, V12, P1130, DOI 10.1016/S0960-9822(02)00923-5; Belle MDC, 2009, SCIENCE, V326, P281, DOI 10.1126/science.1169657; Brown TM, 2007, PROG NEUROBIOL, V82, P229, DOI 10.1016/j.pneurobio.2007.05.002; Colwell CS, 2011, NAT REV NEUROSCI, V12, P553, DOI 10.1038/nrn3086; Dodd AN, 2007, SCIENCE, V318, P1789, DOI 10.1126/science.1146757; Edgar RS, 2012, NATURE, V485, P459, DOI 10.1038/nature11088; Guilding C, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-28; Herzog ED, 1998, NAT NEUROSCI, V1, P708, DOI 10.1038/3708; Meng QJ, 2008, NEURON, V58, P78, DOI 10.1016/j.neuron.2008.01.019; Nakajima M, 2005, SCIENCE, V308, P414, DOI 10.1126/science.1108451; Nitabach MN, 2002, CELL, V109, P485, DOI 10.1016/S0092-8674(02)00737-7; O'Neill JS, 2011, NATURE, V469, P498, DOI 10.1038/nature09702; O'Neill JS, 2011, NATURE, V469, P554, DOI 10.1038/nature09654; Ramsey KM, 2009, SCIENCE, V324, P651, DOI 10.1126/science.1171641; Schwartz WJ, 1991, SUPRACHIASMATIC NUCL, P144; Wang TA, 2012, SCIENCE, V337, P839, DOI 10.1126/science.1222826	16	3	3	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 17	2012	337	6096					805	806		10.1126/science.1227203	http://dx.doi.org/10.1126/science.1227203			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	989BQ	22904000				2022-12-28	WOS:000307535600028
J	Brosi, BJ; Biber, EGN				Brosi, Berry J.; Biber, Eric G. N.			Citizen Involvement in the US Endangered Species Act	SCIENCE			English	Editorial Material							EXTINCTION		[Brosi, Berry J.] Emory Univ, Dept Environm Studies, Atlanta, GA 30322 USA; [Biber, Eric G. N.] Univ Calif Berkeley, Sch Law, Berkeley, CA 94720 USA	Emory University; University of California System; University of California Berkeley	Brosi, BJ (corresponding author), Emory Univ, Dept Environm Studies, Atlanta, GA 30322 USA.	bbrosi@emory.edu		Brosi, Berry/0000-0002-9233-1151				Biber E, 2010, UCLA LAW REV, V58, P321; Ceballos G, 2002, SCIENCE, V296, P904, DOI 10.1126/science.1069349; Cronin M. A., 2006, RANGE MAGAZINE, V2006, P14; Holthouse David, 2005, DENVER WESTWORD 0120; Patlis JM., 2003, TULANE ENV LAW J, V16, P257; Restani M, 2002, BIOSCIENCE, V52, P169, DOI 10.1641/0006-3568(2002)052[0169:FEBNAP]2.0.CO;2; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Sugg IC, 1993, CUMB L REV, V24, P1; 1983, FED REG, V48, P43098	9	18	19	0	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 17	2012	337	6096					802	803		10.1126/science.1220660	http://dx.doi.org/10.1126/science.1220660			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	989BQ	22903999				2022-12-28	WOS:000307535600027
J	Ward, LD; Kellis, M				Ward, Lucas D.; Kellis, Manolis			Evidence of Abundant Purifying Selection in Humans for Recently Acquired Regulatory Functions	SCIENCE			English	Article							HUMAN GENOME; NONCODING SEQUENCES; ELEMENTS; EVOLUTION; INNOVATION; DYNAMICS; REVEALS; PROJECT; GENES; MAP	Although only 5% of the human genome is conserved across mammals, a substantially larger portion is biochemically active, raising the question of whether the additional elements evolve neutrally or confer a lineage-specific fitness advantage. To address this question, we integrate human variation information from the 1000 Genomes Project and activity data from the ENCODE Project. A broad range of transcribed and regulatory nonconserved elements show decreased human diversity, suggesting lineage-specific purifying selection. Conversely, conserved elements lacking activity show increased human diversity, suggesting that some recently became nonfunctional. Regulatory elements under human constraint in nonconserved regions were found near color vision and nerve-growth genes, consistent with purifying selection for recently evolved functions. Our results suggest continued turnover in regulatory regions, with at least an additional 4% of the human genome subject to lineage-specific constraint.	[Ward, Lucas D.; Kellis, Manolis] MIT, Comp Sci & Artificial Intelligence Lab, Cambridge, MA 02139 USA; [Ward, Lucas D.; Kellis, Manolis] Broad Inst MIT & Harvard, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Kellis, M (corresponding author), MIT, Comp Sci & Artificial Intelligence Lab, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	manoli@mit.edu	Kellis, Manolis/ABE-7385-2020	Kellis, Manolis/0000-0001-7113-9630; Ward, Lucas/0000-0002-8017-809X	NIH [R01HG004037, RC1HG005334]; NSF CAREER [0644282]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [RC1HG005334, R01HG004037] Funding Source: NIH RePORTER; Div Of Biological Infrastructure [0644282] Funding Source: National Science Foundation	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF CAREER(National Science Foundation (NSF)NSF - Office of the Director (OD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank the ENCODE Project Consortium data producers and the ENCODE Data Analysis Center for coordinating access and performing quality control and peak-calling analysis; the Analysis Working Group of the ENCODE Project Consortium for feedback throughout this project, especially E. Birney, I. Dunham, M. Gerstein, R. Hardison, J. Stamatoyannopoulos, J. Herrero, S. Parker, P. Sabeti, S. Sunyaev, R. Altshuler, P. Kheradpour, and J. Ernst; and other members of the Kellis laboratory for discussions. L. D. W. and M. K. were funded by NIH grants R01HG004037 and RC1HG005334 and NSF CAREER grant 0644282. Data from the ENCODE consortium are available from the UCSC Genome Browser at http://genome.ucsc.edu/ENCODE, and data from the 1000 Genomes Project is available at www.1000genomes.org/data. ENCODE annotations, mammalian constraint, human diversity, background selection, and filtering information for every SNP and every human nucleotide are available at http://compbio.mit.edu/human-constraint. L. D. W. and M. K. designed the study, analyzed data, and wrote the paper.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Asthana S, 2007, P NATL ACAD SCI USA, V104, P12410, DOI 10.1073/pnas.0705140104; Bejerano G, 2006, NATURE, V441, P87, DOI 10.1038/nature04696; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Brawand D, 2011, NATURE, V478, P343, DOI 10.1038/nature10532; Dorus S, 2004, CELL, V119, P1027, DOI 10.1016/j.cell.2004.11.040; Drake JA, 2006, NAT GENET, V38, P223, DOI 10.1038/ng1710; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Eddy SR, 2005, PLOS BIOL, V3, P95, DOI 10.1371/journal.pbio.0030010; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Ernst J, 2010, NAT BIOTECHNOL, V28, P817, DOI 10.1038/nbt.1662; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Jacobs GH, 2012, ADV EXP MED BIOL, V739, P156, DOI 10.1007/978-1-4614-1704-0_10; Katzman S, 2007, SCIENCE, V317, P915, DOI 10.1126/science.1142430; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Li XY, 2008, PLOS BIOL, V6, P365, DOI 10.1371/journal.pbio.0060027; Lindblad-Toh K, 2011, NATURE, V478, P476, DOI 10.1038/nature10530; Lomelin D, 2010, GENOME RES, V20, P311, DOI 10.1101/gr.094151.109; Lowe CB, 2011, SCIENCE, V333, P1019, DOI 10.1126/science.1202702; McVicker G, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000471; Meader S, 2010, GENOME RES, V20, P1335, DOI 10.1101/gr.108795.110; Mikkelsen TS, 2007, NATURE, V447, P167, DOI 10.1038/nature05805; Mu XJ, 2011, NUCLEIC ACIDS RES, V39, P7058, DOI 10.1093/nar/gkr342; Nelson MR, 2012, SCIENCE, V337, P100, DOI 10.1126/science.1217876; Pollard KS, 2006, NATURE, V443, P167, DOI 10.1038/nature05113; Ponting CP, 2011, GENOME RES, V21, P1769, DOI 10.1101/gr.116814.110; Sabeti PC, 2006, SCIENCE, V312, P1614, DOI 10.1126/science.1124309; Schmidt D, 2010, SCIENCE, V328, P1036, DOI 10.1126/science.1186176; Torgerson DG, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000592	29	136	140	0	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 28	2012	337	6102					1675	1678		10.1126/science.1225057	http://dx.doi.org/10.1126/science.1225057			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012DJ	22956687	Green Submitted, Green Accepted			2022-12-28	WOS:000309215400051
J	Vilarinho, S; Lifton, RP				Vilarinho, Silvia; Lifton, Richard P.			Liver Transplantation: From Inception to Clinical Practice	CELL			English	Editorial Material							CYCLOSPORIN-A; HOMOTRANSPLANTATION; INFECTION		[Lifton, Richard P.] Yale Univ, Sch Med, Howard Hughes Med Inst, Dept Genet, New Haven, CT 06510 USA; Yale Univ, Sch Med, Howard Hughes Med Inst, Dept Internal Med, New Haven, CT 06510 USA	Howard Hughes Medical Institute; Yale University; Howard Hughes Medical Institute; Yale University	Lifton, RP (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, Dept Genet, New Haven, CT 06510 USA.	richard.lifton@yale.edu						CALNE RY, 1968, BMJ-BRIT MED J, V4, P535, DOI 10.1136/bmj.4.5630.535; CALNE RY, 1978, LANCET, V2, P1323; CALNE RY, 1979, LANCET, V2, P1033; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; MOORE FD, 1960, ANN SURG, V152, P374, DOI 10.1097/00000658-196015230-00003; Poordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494; ROLLES K, 1984, HEPATOLOGY, V4, pS50, DOI 10.1002/hep.1840040715; STARZL TE, 1968, ANN SURG, V168, P392, DOI 10.1097/00000658-196809000-00009; STARZL TE, 1981, NEW ENGL J MED, V305, P266, DOI 10.1056/NEJM198107303050507; STARZL TE, 1963, SURG GYNECOL OBSTET, V117, P659; STARZL TE, 1982, HEPATOLOGY, V2, P614; STARZL TE, 1960, SURG GYNECOL OBSTET, V111, P733	12	17	17	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 14	2012	150	6					1096	1099		10.1016/j.cell.2012.08.030	http://dx.doi.org/10.1016/j.cell.2012.08.030			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	007ZY	22980971	Bronze			2022-12-28	WOS:000308928100002
J	De Bruyne, B; Pijls, NHJ; Kalesan, B; Barbato, E; Tonino, PAL; Piroth, Z; Jagic, N; Mobius-Winckler, S; Rioufol, G; Witt, N; Kala, P; MacCarthy, P; Engstrom, T; Oldroyd, KG; Mavromatis, K; Manoharan, G; Verlee, P; Frobert, O; Curzen, N; Johnson, JB; Juni, P; Fearon, WF				De Bruyne, Bernard; Pijls, Nico H. J.; Kalesan, Bindu; Barbato, Emanuele; Tonino, Pim A. L.; Piroth, Zsolt; Jagic, Nikola; Mobius-Winckler, Sven; Rioufol, Gilles; Witt, Nils; Kala, Petr; MacCarthy, Philip; Engstrom, Thomas; Oldroyd, Keith G.; Mavromatis, Kreton; Manoharan, Ganesh; Verlee, Peter; Frobert, Ole; Curzen, Nick; Johnson, Jane B.; Jueni, Peter; Fearon, William F.		FAME 2 Trial Investigators	Fractional Flow Reserve-Guided PCI versus Medical Therapy in Stable Coronary Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							OUTCOMES UTILIZING REVASCULARIZATION; ARTERY-DISEASE; CLINICAL-OUTCOMES; CONSERVATIVE TREATMENT; PRESSURE MEASUREMENTS; FOLLOW-UP; INTERVENTION; STENOSIS; ANGIOPLASTY; SEVERITY	BACKGROUND The preferred initial treatment for patients with stable coronary artery disease is the best available medical therapy. We hypothesized that in patients with functionally significant stenoses, as determined by measurement of fractional flow reserve (FFR), percutaneous coronary intervention (PCI) plus the best available medical therapy would be superior to the best available medical therapy alone. METHODS In patients with stable coronary artery disease for whom PCI was being considered, we assessed all stenoses by measuring FFR. Patients in whom at least one stenosis was functionally significant (FFR, <= 0.80) were randomly assigned to FFR-guided PCI plus the best available medical therapy (PCI group) or the best available medical therapy alone (medical-therapy group). Patients in whom all stenoses had an FFR of more than 0.80 were entered into a registry and received the best available medical therapy. The primary end point was a composite of death, myocardial infarction, or urgent revascularization. RESULTS Recruitment was halted prematurely after enrollment of 1220 patients (888 who underwent randomization and 332 enrolled in the registry) because of a significant between-group difference in the percentage of patients who had a primary end-point event: 4.3% in the PCI group and 12.7% in the medical-therapy group (hazard ratio with PCI, 0.32; 95% confidence interval [CI], 0.19 to 0.53; P<0.001). The difference was driven by a lower rate of urgent revascularization in the PCI group than in the medical-therapy group (1.6% vs. 11.1%; hazard ratio, 0.13; 95% CI, 0.06 to 0.30; P<0.001); in particular, in the PCI group, fewer urgent revascularizations were triggered by a myocardial infarction or evidence of ischemia on electrocardiography (hazard ratio, 0.13; 95% CI, 0.04 to 0.43; P<0.001). Among patients in the registry, 3.0% had a primary end-point event. CONCLUSIONS In patients with stable coronary artery disease and functionally significant stenoses, FFR-guided PCI plus the best available medical therapy, as compared with the best available medical therapy alone, decreased the need for urgent revascularization. In patients without ischemia, the outcome appeared to be favorable with the best available medical therapy alone. (Funded by St. Jude Medical; ClinicalTrials.gov number, NCT01132495.)	[De Bruyne, Bernard; Barbato, Emanuele] OLV Clin, Cardiovasc Ctr Aalst, B-9300 Aalst, Belgium; [Pijls, Nico H. J.; Tonino, Pim A. L.] Eindhoven Univ Technol, Dept Cardiol, Catharina Hosp, NL-5600 MB Eindhoven, Netherlands; [Pijls, Nico H. J.; Tonino, Pim A. L.] Eindhoven Univ Technol, Dept Biomed Engn, NL-5600 MB Eindhoven, Netherlands; [Kalesan, Bindu; Jueni, Peter] Univ Bern, Inst Social & Prevent Med, Div Clin Epidemiol & Biostat, Bern, Switzerland; [Kalesan, Bindu; Jueni, Peter] Univ Bern, Clin Trials Unit Bern, Bern, Switzerland; [Piroth, Zsolt] Hungarian Inst Cardiol, Budapest, Hungary; [Jagic, Nikola] Clin Ctr Kragujevac, Kragujevac, Serbia; [Mobius-Winckler, Sven] Heart Ctr Leipzig, Leipzig, Germany; [Rioufol, Gilles] Cardiovasc Hosp, Lyon, France; [Witt, Nils] Soder Sjukhuset, Stockholm, Sweden; [Frobert, Ole] Orebro Univ Hosp, Orebro, Sweden; [Kala, Petr] Univ Hosp Brno, Dept Internal Med & Cardiol, Brno, Czech Republic; [MacCarthy, Philip] Kings Coll Hosp London, London, England; [Oldroyd, Keith G.] Golden Jubilee Natl Hosp, Glasgow, Lanark, Scotland; [Manoharan, Ganesh] Royal Victoria Hosp, Belfast BT12 6BA, Antrim, North Ireland; [Curzen, Nick] Southampton Univ Hosp Trust, Dept Cardiol, Southampton, Hants, England; [Engstrom, Thomas] Rigshosp, Univ Hosp, Dept Cardiol, DK-2100 Copenhagen, Denmark; [Mavromatis, Kreton] Atlanta Vet Affairs Med Ctr, Atlanta, GA USA; [Verlee, Peter] NE Cardiol Associates, Bangor, ME USA; [Fearon, William F.] Stanford Univ, Med Ctr, Stanford, CA 94305 USA; [Johnson, Jane B.] St Jude Med, Plymouth, MN USA	Cardiovascular Center Aalst; Catharina Hospital; Eindhoven University of Technology; Eindhoven University of Technology; University of Bern; University of Bern; Heart Center Leipzig GMBH; CHU Lyon; Sodersjukhuset Hospital; Orebro University; University Hospital Brno; King's College Hospital NHS Foundation Trust; King's College Hospital; Golden Jubilee Hospital; University of Southampton; University Hospital Southampton NHS Foundation Trust; Rigshospitalet; University of Copenhagen; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System; Stanford University; St. Jude Medical	De Bruyne, B (corresponding author), OLV Clin, Cardiovasc Ctr Aalst, Moorselbaan 164, B-9300 Aalst, Belgium.	bernard.de.bruyne@olvz-aalst.be	Oldroyd, Keith G/C-2281-2014; curzen, nick/AAD-8161-2020; Barbato, Emanuele/I-5826-2012; Juni, Peter/Q-8700-2016	Oldroyd, Keith G/0000-0002-7842-3463; Juni, Peter/0000-0002-5985-0670; Curzen, Nick/0000-0001-9651-7829; Barbato, Emanuele/0000-0002-0050-5178; Wijns, William/0000-0002-7267-4376; Frobert, Ole/0000-0002-5846-345X	St. Jude Medical	St. Jude Medical(St. Jude Medical)	Funded by St. Jude Medical; ClinicalTrials.gov number, NCT01132495.; Supported by St. Jude Medical.	Agency for Healthcare Research and Quality (US), 2005, CALC US POP BAS EQ 5; Bari D Study Grp, 2009, NEW ENGL J MED, V360, P2503, DOI 10.1056/NEJMoa0805796; Bech GJW, 2001, CIRCULATION, V103, P2928, DOI 10.1161/01.CIR.103.24.2928; Boden WE, 2007, NEW ENGL J MED, V356, P1503, DOI 10.1056/NEJMoa070829; Damman P, 2010, J AM COLL CARDIOL, V55, P858, DOI 10.1016/j.jacc.2009.11.026; DEBRUYNE B, 1993, J AM COLL CARDIOL, V22, P119, DOI 10.1016/0735-1097(93)90825-L; DEBRUYNE B, 1994, CIRCULATION, V89, P1013, DOI 10.1161/01.CIR.89.3.1013; Fox KAA, 2002, LANCET, V360, P743, DOI 10.1016/S0140-6736(02)09894-X; Hachamovitch R, 2003, CIRCULATION, V107, P2900, DOI 10.1161/01.CIR.0000072790.23090.41; Hamilos M, 2009, CIRCULATION, V120, P1505, DOI 10.1161/CIRCULATIONAHA.109.850073; Hannan EL, 2012, CIRCULATION, V125, P1870, DOI 10.1161/CIRCULATIONAHA.111.071811; Juni P, 2001, BMJ-BRIT MED J, V323, P42, DOI 10.1136/bmj.323.7303.42; Katritsis DG, 2005, CIRCULATION, V111, P2906, DOI 10.1161/CIRCULATIONAHA.104.521864; Lin GA, 2008, JAMA-J AM MED ASSOC, V300, P1765, DOI 10.1001/jama.300.15.1765; Maron DJ, 2010, J AM COLL CARDIOL, V55, P1348, DOI 10.1016/j.jacc.2009.10.062; Mehta SR, 2005, JAMA-J AM MED ASSOC, V293, P2908, DOI 10.1001/jama.293.23.2908; Mukherjee D, 2009, LANCET, V373, P870, DOI 10.1016/S0140-6736(09)60522-5; Muller O, 2011, JACC-CARDIOVASC INTE, V4, P1175, DOI 10.1016/j.jcin.2011.09.007; Naderi SH, 2012, AM J MED; PIJLS NHJ, 1993, CIRCULATION, V87, P1354, DOI 10.1161/01.CIR.87.4.1354; Pijls NHJ, 1996, NEW ENGL J MED, V334, P1703, DOI 10.1056/NEJM199606273342604; Pijls NHJ, 2007, J AM COLL CARDIOL, V49, P2105, DOI 10.1016/j.jacc.2007.01.087; Puymirat E, 2012, CIRC-CARDIOVASC INTE, V5, P62, DOI 10.1161/CIRCINTERVENTIONS.111.966937; Serruys PW, 2010, NEW ENGL J MED, V363, P136, DOI 10.1056/NEJMoa1004130; Shaw LJ, 2008, CIRCULATION, V117, P1283, DOI 10.1161/CIRCULATIONAHA.107.743963; Simoons ML, 2010, EUR HEART J, V31, P530, DOI 10.1093/eurheartj/ehp605; Stone GW, 2010, NEW ENGL J MED, V362, P1663, DOI 10.1056/NEJMoa0910496; Tonino PAL, 2009, NEW ENGL J MED, V360, P213, DOI 10.1056/NEJMoa0807611; Wallentin L, 2000, LANCET, V356, P9, DOI 10.1016/S0140-6736(00)02427-2; Windecker S, 2008, LANCET, V372, P1163, DOI 10.1016/S0140-6736(08)61244-1	30	1711	1753	3	108	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 13	2012	367	11					991	1001		10.1056/NEJMoa1205361	http://dx.doi.org/10.1056/NEJMoa1205361			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	003ZE	22924638	Green Published			2022-12-28	WOS:000308649100005
J	Frenk, J; de Ferranti, D				Frenk, Julio; de Ferranti, David			Universal health coverage: good health, good economics	LANCET			English	Editorial Material									[de Ferranti, David] Results Dev Inst, Washington, DC 20005 USA; [Frenk, Julio] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	de Ferranti, D (corresponding author), Results Dev Inst, Washington, DC 20005 USA.	ddeferranti@resultsfordevelopment.org						ANAND S, 2012, COST INACTION CASE S; [Anonymous], 2001, MACR HLTH INV HLTH E; Frenk J, 2006, LANCET, V368, P1524, DOI 10.1016/S0140-6736(06)69564-0; Gonzalez-Pier E, 2006, LANCET, V368, P1608, DOI 10.1016/S0140-6736(06)69567-6; Knaul FM, 2006, LANCET, V368, P1828, DOI 10.1016/S0140-6736(06)69565-2; Knaul FM, 2012, LANCET; Lagomarsino G, 2009, LANCET, V374, P1577, DOI 10.1016/S0140-6736(09)61241-1; Murray CJL, 2011, LANCET, V378, P8, DOI 10.1016/S0140-6736(10)62356-2; Patcharanarumol W, 2011, GOOD HLTH LOW COST 2, P193; The Lancet, 2012, LANCET, V380, P622; *WORLD BANK, 1993, WORLD DEV REP 1993 I	11	38	42	0	13	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 8	2012	380	9845					862	864		10.1016/S0140-6736(12)61341-5	http://dx.doi.org/10.1016/S0140-6736(12)61341-5			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	002QL	22959372				2022-12-28	WOS:000308547300005
J	Cordero, OX; Wildschutte, H; Kirkup, B; Proehl, S; Ngo, L; Hussain, F; Le Roux, F; Mincer, T; Polz, MF				Cordero, Otto X.; Wildschutte, Hans; Kirkup, Benjamin; Proehl, Sarah; Ngo, Lynn; Hussain, Fatima; Le Roux, Frederique; Mincer, Tracy; Polz, Martin F.			Ecological Populations of Bacteria Act as Socially Cohesive Units of Antibiotic Production and Resistance	SCIENCE			English	Article							ANTAGONISTIC INTERACTIONS; MARINE; DIFFERENTIATION; DIVERSITY	In animals and plants, social structure can reduce conflict within populations and bias aggression toward competing populations; however, for bacteria in the wild it remains unknown whether such population-level organization exists. Here, we show that environmental bacteria are organized into socially cohesive units in which antagonism occurs between rather than within ecologically defined populations. By screening approximately 35,000 possible mutual interactions among Vibrionaceae isolates from the ocean, we show that genotypic clusters known to have cohesive habitat association also act as units in terms of antibiotic production and resistance. Genetic analyses show that within populations, broad-range antibiotics are produced by few genotypes, whereas all others are resistant, suggesting cooperation between conspecifics. Natural antibiotics may thus mediate competition between populations rather than solely increase the success of individuals.	[Cordero, Otto X.; Wildschutte, Hans; Kirkup, Benjamin; Proehl, Sarah; Ngo, Lynn; Hussain, Fatima; Polz, Martin F.] MIT, Dept Civil & Environm Engn, Cambridge, MA 02139 USA; [Le Roux, Frederique] IFREMER, Lab Genet & Pathol BP 133, F-17390 La Tremblade, France; [Mincer, Tracy] Woods Hole Oceanog Inst, Dept Marine Chem & Geochem, Woods Hole, MA 02543 USA	Massachusetts Institute of Technology (MIT); Ifremer; Woods Hole Oceanographic Institution	Polz, MF (corresponding author), MIT, Dept Civil & Environm Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	mpolz@mit.edu	Kirkup, Benjamin/C-3610-2009; Polz, Martin/ABE-7199-2020	Kirkup, Benjamin/0000-0002-8722-6218; Le Roux, Frederique/0000-0002-9112-6199; Mincer, Tracy/0000-0002-4644-5609; /0000-0001-9296-3733; Polz, Martin/0000-0002-4975-2946	Gordon and Betty Moore Foundation; Broad Institute's Scientific Planning and Allocation of Resources Committee (SPARC); NSF [DEB 0821391]; Netherlands Organisation for Scientific Research; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES002109] Funding Source: NIH RePORTER	Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Broad Institute's Scientific Planning and Allocation of Resources Committee (SPARC); NSF(National Science Foundation (NSF)); Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank W. Hanage and E. Alm for valuable suggestions. Funding was provided by the Gordon and Betty Moore Foundation, the Broad Institute's Scientific Planning and Allocation of Resources Committee (SPARC) program, NSF grant DEB 0821391, and the NSF-sponsored Woods Hole Center for Oceans and Human Health. Support for O.X.C. was provided by the Netherlands Organisation for Scientific Research. Whole Genome Shotgun projects have been deposited at DDBJ/EMBL/GenBank under the accessions AJWN00000000, AJYD00000000 to AJYZ00000000, and AJZA00000000 to AJZQ00000000 (table S4).	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; BURKHOLDER PR, 1966, APPL MICROBIOL, V14, P649, DOI 10.1128/AEM.14.4.649-653.1966; Cascales E, 2007, MICROBIOL MOL BIOL R, V71, P158, DOI 10.1128/MMBR.00036-06; Doolittle WF, 2009, COLD SH Q B, V74, P197, DOI 10.1101/sqb.2009.74.002; Doolittle WF, 2010, BIOSCIENCE, V60, P102, DOI 10.1525/bio.2010.60.2.5; Hunt DE, 2008, SCIENCE, V320, P1081, DOI 10.1126/science.1157890; Kerr B, 2002, NATURE, V418, P171, DOI 10.1038/nature00823; Koeppel A, 2008, P NATL ACAD SCI USA, V105, P2504, DOI 10.1073/pnas.0712205105; Long RA, 2005, APPL ENVIRON MICROB, V71, P8531, DOI 10.1128/AEM.71.12.8531-8536.2005; Long RA, 2001, APPL ENVIRON MICROB, V67, P4975, DOI 10.1128/AEM.67.11.4975-4983.2001; Preheim SP, 2011, APPL ENVIRON MICROB, V77, P7195, DOI 10.1128/AEM.00665-11; Preheim SP, 2011, ENVIRON MICROBIOL, V13, P265, DOI 10.1111/j.1462-2920.2010.02328.x; Raaijmakers JM, 2010, FEMS MICROBIOL REV, V34, P1037, DOI 10.1111/j.1574-6976.2010.00221.x; Shapiro BJ, 2012, SCIENCE, V336, P48, DOI 10.1126/science.1218198; Tarnita CE, 2009, P NATL ACAD SCI USA, V106, P8601, DOI 10.1073/pnas.0903019106; Thompson JR, 2005, SCIENCE, V307, P1311, DOI 10.1126/science.1106028; Vetsigian K, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001184	17	199	203	5	169	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 7	2012	337	6099					1228	1231		10.1126/science.1219385	http://dx.doi.org/10.1126/science.1219385			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	000UJ	22955834	Green Submitted			2022-12-28	WOS:000308414000039
J	Crook, JM; O'Callaghan, CJ; Duncan, G; Dearnaley, DP; Higano, CS; Horwitz, EM; Frymire, E; Malone, S; Chin, J; Nabid, A; Warde, P; Corbett, T; Angyalfi, S; Goldenberg, SL; Gospodarowicz, MK; Saad, F; Logue, JP; Hall, E; Schellhammer, PF; Ding, KY; Klotz, L				Crook, Juanita M.; O'Callaghan, Christopher J.; Duncan, Graeme; Dearnaley, David P.; Higano, Celestia S.; Horwitz, Eric M.; Frymire, Eliot; Malone, Shawn; Chin, Joseph; Nabid, Abdenour; Warde, Padraig; Corbett, Thomas; Angyalfi, Steve; Goldenberg, S. Larry; Gospodarowicz, Mary K.; Saad, Fred; Logue, John P.; Hall, Emma; Schellhammer, Paul F.; Ding, Keyue; Klotz, Laurence			Intermittent Androgen Suppression for Rising PSA Level after Radiotherapy	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ADVANCED PROSTATE-CANCER; BONE-MINERAL DENSITY; DEPRIVATION THERAPY; COGNITIVE FUNCTION; ENDOCRINE THERAPY; CLINICAL-TRIALS; FOLLOW-UP; ANTIGEN; CARCINOMA	BACKGROUND Intermittent androgen deprivation for prostate-specific antigen (PSA) elevation after radiotherapy may improve quality of life and delay hormone resistance. We assessed overall survival with intermittent versus continuous androgen deprivation in a noninferiority randomized trial. METHODS We enrolled patients with a PSA level greater than 3 ng per milliliter more than 1 year after primary or salvage radiotherapy for localized prostate cancer. Intermittent treatment was provided in 8-month cycles, with nontreatment periods determined according to the PSA level. The primary end point was overall survival. Secondary end points included quality of life, time to castration-resistant disease, and duration of nontreatment intervals. RESULTS Of 1386 enrolled patients, 690 were randomly assigned to intermittent therapy and 696 to continuous therapy. Median follow-up was 6.9 years. There were no significant between-group differences in adverse events. In the intermittent-therapy group, full testosterone recovery occurred in 35% of patients, and testosterone recovery to the trial-entry threshold occurred in 79%. Intermittent therapy provided potential benefits with respect to physical function, fatigue, urinary problems, hot flashes, libido, and erectile function. There were 268 deaths in the intermittent-therapy group and 256 in the continuous-therapy group. Median overall survival was 8.8 years in the intermittent-therapy group versus 9.1 years in the continuous-therapy group (hazard ratio for death, 1.02; 95% confidence interval, 0.86 to 1.21). The estimated 7-year cumulative rates of disease-related death were 18% and 15% in the two groups, respectively (P = 0.24). CONCLUSIONS Intermittent androgen deprivation was noninferior to continuous therapy with respect to overall survival. Some quality-of-life factors improved with intermittent therapy. (Funded by the Canadian Cancer Society Research Institute and others; ClinicalTrials. gov number, NCT00003653.)	[Crook, Juanita M.] British Columbia Canc Agcy, Canc Ctr So Interior, Kelowna, BC V1Y 5L3, Canada; [O'Callaghan, Christopher J.; Frymire, Eliot; Ding, Keyue] Queens Univ, NCIC Clin Trials Grp, Kingston, ON, Canada; [Malone, Shawn] Ottawa Canc Ctr, Ottawa, ON, Canada; [Chin, Joseph] London Hlth Sci Ctr, London, ON, Canada; [Nabid, Abdenour] Univ Sherbrooke, Sherbrooke, PQ J1K 2R1, Canada; [Warde, Padraig; Gospodarowicz, Mary K.] Univ Toronto, Princess Margaret Hosp, Toronto, ON, Canada; [Klotz, Laurence] Univ Toronto, Sunnybrook Hlth Sci Ctr, Toronto, ON, Canada; [Corbett, Thomas] Juravinski Canc Ctr, Hamilton, ON, Canada; [Angyalfi, Steve] Tom Baker Canc Clin, Calgary, AB, Canada; [Goldenberg, S. Larry] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; [Saad, Fred] Univ Montreal, Univ Montreal Hosp, Montreal, PQ, Canada; [Saad, Fred] Univ Montreal, Res Ctr, Montreal, PQ, Canada; [Dearnaley, David P.; Hall, Emma] Inst Canc Res, London SW3 6JB, England; [Logue, John P.] Christie Hosp, Manchester, Lancs, England; [Higano, Celestia S.] Seattle Canc Care Alliance, Seattle, WA USA; [Horwitz, Eric M.] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA; [Schellhammer, Paul F.] Eastern Virginia Med Sch, Dept Urol, Norfolk, VA 23501 USA	British Columbia Cancer Agency; Queens University - Canada; Canadian Cancer Trials Group; London Health Sciences Centre; University of Sherbrooke; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; McMaster University; Tom Baker Cancer Clinic; University of Calgary; University of British Columbia; Universite de Montreal; Universite de Montreal; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Christie NHS Foundation Trust; Christie Hospital; Seattle Cancer Care Alliance; Fox Chase Cancer Center; Eastern Virginia Medical School	Crook, JM (corresponding author), British Columbia Canc Agcy, Canc Ctr So Interior, 399 Royal Ave, Kelowna, BC V1Y 5L3, Canada.	jcrook@bccancer.bc.ca	Dearnaley, David P/J-2318-2014; Crook, Juanita/AAL-1874-2021	Dearnaley, David P/0000-0002-3954-2806; Warde, Padraig/0000-0002-4236-0026; Hall, Emma/0000-0001-5999-5020	Canadian Cancer Society Research Institute [015469, 021039]; U.S. National Cancer Institute [CA077202]; Hoechst Marion Roussel Canada Research; NATIONAL CANCER INSTITUTE [U10CA077202] Funding Source: NIH RePORTER; Cancer Research UK [10588] Funding Source: researchfish	Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS)); U.S. National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Hoechst Marion Roussel Canada Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Research UK(Cancer Research UK)	Supported by grants from the Canadian Cancer Society Research Institute (021039 and 015469), the U.S. National Cancer Institute (CA077202), and Hoechst Marion Roussel Canada Research.	AKAKURA K, 1993, CANCER, V71, P2782, DOI 10.1002/1097-0142(19930501)71:9<2782::AID-CNCR2820710916>3.0.CO;2-Z; Bolla M, 2010, LANCET ONCOL, V11, P1066, DOI 10.1016/S1470-2045(10)70223-0; BRUCHOVSKY N, 1990, CANCER RES, V50, P2275; Bruchovsky N, 2000, MOL UROL, V4, P191; Cherrier MM, 2003, J UROLOGY, V170, P1808, DOI 10.1097/01.ju.0000091640.59812.83; Crook JM, 1999, UROLOGY, V53, P530, DOI 10.1016/S0090-4295(98)00547-0; D'Amico AV, 2007, J CLIN ONCOL, V25, P2420, DOI 10.1200/JCO.2006.09.3369; FREEDMAN LS, 1984, BIOMETRICS, V40, P575, DOI 10.2307/2530902; Goldenberg SL, 1999, MOL UROL, V3, P287; Green HJ, 2002, BJU INT, V90, P427, DOI 10.1046/j.1464-410X.2002.02917.x; Harle Lindsey K, 2006, Clin Adv Hematol Oncol, V4, P687; Higano C, 2004, UROLOGY, V64, P1182, DOI 10.1016/j.urology.2004.07.019; Higano CS, 1996, UROLOGY, V48, P800, DOI 10.1016/S0090-4295(96)00381-0; Horwich A, 1998, BRIT J UROL, V81, P96; Horwitz EM, 2008, J CLIN ONCOL, V26, P2497, DOI 10.1200/JCO.2007.14.9021; Huggins C, 2002, J UROLOGY, V168, P9, DOI 10.1016/S0022-5347(05)64820-3; Keating NL, 2006, J CLIN ONCOL, V24, P4448, DOI 10.1200/JCO.2006.06.2497; KLOTZ LH, 1986, CANCER, V58, P2546, DOI 10.1002/1097-0142(19861201)58:11<2546::AID-CNCR2820581131>3.0.CO;2-N; Klotz LH, 1986, CANCER, V58, P2546; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; Oliver RTD, 1997, UROLOGY, V49, P79, DOI 10.1016/S0090-4295(96)00373-1; Osoba D, 1998, J CLIN ONCOL, V16, P139, DOI 10.1200/JCO.1998.16.1.139; Roach M, 2008, J CLIN ONCOL, V26, P585, DOI 10.1200/JCO.2007.13.9881; Sato N, 1996, J STEROID BIOCHEM, V58, P139, DOI 10.1016/0960-0760(96)00018-0; Spry NA, 2009, BJU INT, V104, P806, DOI 10.1111/j.1464-410X.2009.08458.x; Theyer G, 1997, BRIT J CANCER, V75, P1515, DOI 10.1038/bjc.1997.259; Tunn UW, 1996, EUR UROL, V30, P22; Willian Andrew R., 1994, Controlled Clinical Trials, V15, P211, DOI 10.1016/0197-2456(94)90058-2	28	332	339	2	34	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 6	2012	367	10					895	903		10.1056/NEJMoa1201546	http://dx.doi.org/10.1056/NEJMoa1201546			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	999VO	22931259	Green Accepted			2022-12-28	WOS:000308343300006
J	Oliver, I; Treasure, T				Oliver, Ian; Treasure, Tom			Constrictive pericarditis	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Treasure, Tom] UCL, Dept Math, Clin Operat Res Unit, London WC1H 0BT, England	University of London; University College London		snowbird@ifb.co.uk							0	1	1	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	SEP 3	2012	345								e3995	10.1136/bmj.e3995	http://dx.doi.org/10.1136/bmj.e3995			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	003TH	22945949				2022-12-28	WOS:000308633700001
J	Garrett, L				Garrett, Laurie			Class, health, and the American elections	LANCET			English	News Item																			0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 1	2012	380	9844					791	794		10.1016/S0140-6736(12)61434-2	http://dx.doi.org/10.1016/S0140-6736(12)61434-2			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	000OP	22950117				2022-12-28	WOS:000308396300010
J	Abmayr, SM; Workman, JL				Abmayr, Susan M.; Workman, Jerry L.			Holding on through DNA Replication: Histone Modification or Modifier?	CELL			English	Editorial Material							CHROMATIN	Histone methylation is widely believed to contribute to epigenetic inheritance by persevering through DNA replication and subsequently templating methylation of daughter chromosome regions. However, a report in this issue (Petruk et al.) suggests that chromatin association of the methytransferase complexes themselves persists through replication and re-establishes histone methylation.	[Abmayr, Susan M.; Workman, Jerry L.] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Abmayr, Susan M.] Univ Kansas, Med Ctr, Dept Anat & Cell Biol, Kansas City, KS 66160 USA	Stowers Institute for Medical Research; University of Kansas; University of Kansas Medical Center	Workman, JL (corresponding author), Stowers Inst Med Res, Kansas City, MO 64110 USA.	jlw@stowers.org			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM099945] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM099945] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Corpet A, 2009, TRENDS CELL BIOL, V19, P29, DOI 10.1016/j.tcb.2008.10.002; Francis NJ, 2009, CELL, V137, P110, DOI 10.1016/j.cell.2009.02.017; Krajewski WA, 2005, MOL CELL BIOL, V25, P1891, DOI 10.1128/MCB.25.5.1891-1899.2005; Mohan M, 2011, MOL CELL BIOL, V31, P4310, DOI 10.1128/MCB.06092-11; Petruk S, 2012, CELL, V150, P922, DOI 10.1016/j.cell.2012.06.046; Simon JA, 2009, NAT REV MOL CELL BIO, V10, P697, DOI 10.1038/nrm2763; Suganuma T, 2011, ANNU REV BIOCHEM, V80, P473, DOI 10.1146/annurev-biochem-061809-175347; Zhu B, 2011, CELL RES, V21, P435, DOI 10.1038/cr.2011.26	8	11	13	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 31	2012	150	5					875	877		10.1016/j.cell.2012.08.006	http://dx.doi.org/10.1016/j.cell.2012.08.006			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	001ZU	22939615	Bronze			2022-12-28	WOS:000308500200002
J	Hyman, AA; Simons, K				Hyman, Anthony A.; Simons, Kai			Beyond Oil and Water-Phase Transitions in Cells	SCIENCE			English	Editorial Material							PROTEINS; GRANULES; RNA; ASSEMBLIES		[Hyman, Anthony A.; Simons, Kai] Max Planck Inst Mol Cell Biol & Genet, D-01309 Dresden, Germany	Max Planck Society	Hyman, AA (corresponding author), Max Planck Inst Mol Cell Biol & Genet, D-01309 Dresden, Germany.	hyman@mpi-cbg.de; simons@mpi-cbg.de	Hyman, Anthony A/B-3917-2017; Hyman, Tony/F-1923-2011	Hyman, Anthony A/0000-0003-3664-154X; Simons, Kai/0000-0002-9231-9996				Ball P., 2004, CRITICAL MASS ONE TH; Brangwynne CP, 2011, P NATL ACAD SCI USA, V108, P4334, DOI 10.1073/pnas.1017150108; Brangwynne CP, 2009, SCIENCE, V324, P1729, DOI 10.1126/science.1172046; Choi YH, 2011, PLANT PHYSIOL, V156, P1701, DOI 10.1104/pp.111.178426; Coskun U, 2011, STRUCTURE, V19, P1543, DOI 10.1016/j.str.2011.10.010; Han TNW, 2012, CELL, V149, P768, DOI 10.1016/j.cell.2012.04.016; Hanazawa M, 2011, J CELL BIOL, V192, P929, DOI 10.1083/jcb.201010106; Hyman AA, 2011, DEV CELL, V21, P14, DOI 10.1016/j.devcel.2011.06.013; Kato M, 2012, CELL, V149, P753, DOI 10.1016/j.cell.2012.04.017; Li PL, 2012, NATURE, V483, P336, DOI 10.1038/nature10879; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Narayanaswamy R, 2009, P NATL ACAD SCI USA, V106, P10147, DOI 10.1073/pnas.0812771106; Oparin, 1936, ORIGINS LIFE EVOL B; Sear RP, 2008, FARADAY DISCUSS, V139, P21, DOI 10.1039/b713076g; Weber SC, 2012, CELL, V149, P1188, DOI 10.1016/j.cell.2012.05.022; Wilson E. B., 1899, Science, Vx, P33	16	177	178	3	95	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 31	2012	337	6098					1047	1049		10.1126/science.1223728	http://dx.doi.org/10.1126/science.1223728			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996WP	22936764				2022-12-28	WOS:000308125800031
J	Yuan, W; Wu, T; Fu, H; Dai, C; Wu, H; Liu, N; Li, X; Xu, M; Zhang, ZQ; Niu, TH; Han, ZF; Chai, JJ; Zhou, XJ; Gao, SR; Zhu, B				Yuan, Wen; Wu, Tong; Fu, Hang; Dai, Chao; Wu, Hui; Liu, Nan; Li, Xiang; Xu, Mo; Zhang, Zhuqiang; Niu, Tianhui; Han, Zhifu; Chai, Jijie; Zhou, Xianghong Jasmine; Gao, Shaorong; Zhu, Bing			Dense Chromatin Activates Polycomb Repressive Complex 2 to Regulate H3 Lysine 27 Methylation	SCIENCE			English	Article							HISTONE METHYLTRANSFERASE ACTIVITY; GROUP PROTEIN SUZ12; HUMAN GENOME; MARKS; GENE; ENHANCER; CELLS	Polycomb repressive complex 2 (PRC2)-mediated histone H3 lysine 27 (H3K27) methylation is vital for Polycomb gene silencing, a classic epigenetic phenomenon that maintains transcriptional silencing throughout cell divisions. We report that PRC2 activity is regulated by the density of its substrate nucleosome arrays. Neighboring nucleosomes activate the PRC2 complex with a fragment of their H3 histones (Ala(31) to Arg(42)). We also identified mutations on PRC2 subunit Su(z)12, which impair its binding and response to the activating peptide and its ability in establishing H3K27 trimethylation levels in vivo. In mouse embryonic stem cells, local chromatin compaction occurs before the formation of trimethylated H3K27 upon transcription cessation of the retinoic acid-regulated gene CYP26a1. We propose that PRC2 can sense the chromatin environment to exert its role in the maintenance of transcriptional states.	[Yuan, Wen; Wu, Tong; Fu, Hang; Niu, Tianhui] China Agr Univ, Coll Biol Sci, Beijing 100094, Peoples R China; [Yuan, Wen; Wu, Tong; Fu, Hang; Wu, Hui; Liu, Nan; Li, Xiang; Xu, Mo; Zhang, Zhuqiang; Niu, Tianhui; Han, Zhifu; Chai, Jijie; Gao, Shaorong; Zhu, Bing] Natl Inst Biol Sci, Beijing 102206, Peoples R China; [Dai, Chao; Zhou, Xianghong Jasmine] Univ So Calif, Program Mol & Computat Biol, Los Angeles, CA 90089 USA; [Wu, Hui; Li, Xiang; Xu, Mo] Chinese Acad Med Sci, Beijing 100730, Peoples R China; [Wu, Hui; Li, Xiang; Xu, Mo] Peking Union Med Coll, Beijing 100730, Peoples R China; [Liu, Nan] Beijing Normal Univ, Beijing 100875, Peoples R China; [Chai, Jijie] Tsinghua Univ, Beijing 10084, Peoples R China	China Agricultural University; National Institute of Biological Sciences, Beijing; University of Southern California; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Beijing Normal University; Tsinghua University	Gao, SR (corresponding author), Natl Inst Biol Sci, Beijing 102206, Peoples R China.	gaoshaorong@nibs.ac.cn; zhubing@nibs.ac.cn	Zhang, Zhuqiang/P-7329-2019; li, ran/K-1896-2012	Zhang, Zhuqiang/0000-0001-6513-2854; Chai, Jijie/0000-0001-7591-3873; yuan, wen/0000-0003-0029-2544	Chinese Ministry of Science and Technology [2011CB812700, 2011CB965300, 2010CB944900, 2011CB964800, 2010CB835300]; Howard Hughes Medical Institute International Early Career Scientist Program; NSF [0747475]	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); Howard Hughes Medical Institute International Early Career Scientist Program; NSF(National Science Foundation (NSF))	We appreciate K. Helin and Y. Shinkai for providing the Su(z)12 null and TT2 ES cells. This work was supported by the Chinese Ministry of Science and Technology (grants 2011CB812700 and 2011CB965300 to B.Z.; 2010CB944900 and 2011CB964800 to S. G.; and 2010CB835300 to J.C.), the Howard Hughes Medical Institute International Early Career Scientist Program (to B.Z.), and NSF Career award 0747475 (to X.J.Z.).	Allis C. D., 2006, EPIGENETICS; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Birve A, 2001, DEVELOPMENT, V128, P3371; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Burdine L, 2004, J AM CHEM SOC, V126, P11442, DOI 10.1021/ja045982c; Cao R, 2004, CURR OPIN GENET DEV, V14, P155, DOI 10.1016/j.gde.2004.02.001; Cao R, 2004, MOL CELL, V15, P57, DOI 10.1016/j.molcel.2004.06.020; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Czermin B, 2002, CELL, V111, P185, DOI 10.1016/S0092-8674(02)00975-3; Gillespie RF, 2007, J MOL BIOL, V372, P298, DOI 10.1016/j.jmb.2007.06.079; Hansen KH, 2008, NAT CELL BIOL, V10, P1291, DOI 10.1038/ncb1787; Ketel CS, 2005, MOL CELL BIOL, V25, P6857, DOI 10.1128/MCB.25.16.6857-6868.2005; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Margueron R, 2009, NATURE, V461, P762, DOI 10.1038/nature08398; Martin C, 2006, J BIOL CHEM, V281, P8365, DOI 10.1074/jbc.M513425200; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; Pasini D, 2007, MOL CELL BIOL, V27, P3769, DOI 10.1128/MCB.01432-06; Plath K, 2003, SCIENCE, V300, P131, DOI 10.1126/science.1084274; Rao SH, 2001, J IMMUNOL, V167, P4494, DOI 10.4049/jimmunol.167.8.4494; Schmitges FW, 2011, MOL CELL, V42, P330, DOI 10.1016/j.molcel.2011.03.025; Schones DE, 2008, CELL, V132, P887, DOI 10.1016/j.cell.2008.02.022; Schwartz YB, 2008, CURR OPIN CELL BIOL, V20, P266, DOI 10.1016/j.ceb.2008.03.002; Simon JA, 2009, NAT REV MOL CELL BIO, V10, P697, DOI 10.1038/nrm2763; Wu H, 2010, SCIENCE, V329, P444, DOI 10.1126/science.1190485; Yuan W, 2011, J BIOL CHEM, V286, P7983, DOI 10.1074/jbc.M110.194027	26	193	198	5	104	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 24	2012	337	6097					971	975		10.1126/science.1225237	http://dx.doi.org/10.1126/science.1225237			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992VI	22923582				2022-12-28	WOS:000307807600047
J	Kourtis, N; Nikoletopoulou, V; Tavernarakis, N				Kourtis, Nikos; Nikoletopoulou, Vassiliki; Tavernarakis, Nektarios			Small heat-shock proteins protect from heat-stroke-associated neurodegeneration	NATURE			English	Article							NECROTIC CELL-DEATH; CAENORHABDITIS-ELEGANS; C-ELEGANS; ENDOPLASMIC-RETICULUM; GOLGI-APPARATUS; LIFE-SPAN; MOLECULAR CHAPERONES; STRESS-RESPONSE; NEURONS; GENE	Heat stroke is a life-threatening condition, characterized by catastrophic collapse of thermoregulation and extreme hyperthermia. In recent years, intensification of heat waves has caused a surge of heat-stroke fatalities. The mechanisms underlying heat-related pathology are poorly understood. Here we show that heat stroke triggers pervasive necrotic cell death and neurodegeneration in Caenorhabditis elegans. Preconditioning of animals at a mildly elevated temperature strongly protects from heat-induced necrosis. The heat-shock transcription factor HSF-1 and the small heat-shock protein HSP-16.1 mediate cytoprotection by preconditioning. HSP-16.1 localizes to the Golgi, where it functions with the Ca2+- and Mn2+-transporting ATPase PMR-1 to maintain Ca2+ homeostasis under heat stroke. Preconditioning also suppresses cell death inflicted by diverse insults, and protects mammalian neurons from heat cytotoxicity. These findings reveal an evolutionarily conserved mechanism that defends against diverse necrotic stimuli, and may be relevant to heat stroke and other pathological conditions involving necrosis in humans.	[Kourtis, Nikos; Nikoletopoulou, Vassiliki; Tavernarakis, Nektarios] Fdn Res & Technol, Inst Mol Biol & Biotechnol, Iraklion 71110, Crete, Greece		Tavernarakis, N (corresponding author), Fdn Res & Technol, Inst Mol Biol & Biotechnol, Iraklion 71110, Crete, Greece.	tavernarakis@imbb.forth.gr	Tavernarakis, Nektarios/B-9684-2013	Tavernarakis, Nektarios/0000-0002-5253-1466; Nikoletopoulou, Vassiliki/0000-0003-3646-992X	National Center for Research Resources (NCRR) of the National Institutes of Health (NIH); National Bioresource Project in Japan; European Molecular Biology Organization (EMBO) Long Term Fellowship; European Research Council (ERC); European Commission 7th Framework Programme	National Center for Research Resources (NCRR) of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Bioresource Project in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); European Molecular Biology Organization (EMBO) Long Term Fellowship; European Research Council (ERC)(European Research Council (ERC)European Commission); European Commission 7th Framework Programme(European Commission)	We thank K. Georgila, K. Palikaras and E. Bessa for help with cell-death assays, A. Pasparaki for technical support with experiments and C. Olendrowitz for help with electron microscopy. We thank S. Eimer for providing the Golgi and endosomal reporter constructs and for support with the electron microscopy, N. Chronis for providing the pN1-GCaMP2.0 plasmid, G. Caldwell for the alpha-synuclein-expressing C. elegans strain and K. Palikaras for the skn-1 RNAi plasmid. We thank J. Vanoevelen and F. Wuytack for the antibody against PMR-1, S. Mitrovic for the antibody against mannosidase II, G. Sourvinos for lentiviral plasmids, and S. Gascon for the pLV plasmid. Some nematode strains used in this work were provided by the Caenorhabditis Genetics Center, which is funded by the National Center for Research Resources (NCRR) of the National Institutes of Health (NIH), and S. Mitani (National Bioresource Project) in Japan. We thank A. Fire for plasmid vectors. V. N. is supported by an European Molecular Biology Organization (EMBO) Long Term Fellowship. This work was funded by grants from the European Research Council (ERC) and the European Commission 7th Framework Programme.	Akerfelt M, 2010, NAT REV MOL CELL BIO, V11, P545, DOI 10.1038/nrm2938; An JH, 2003, GENE DEV, V17, P1882, DOI 10.1101/gad.1107803; Artal-Sanz M, 2006, J CELL BIOL, V173, P231, DOI 10.1083/jcb.200511103; Bibel M, 2007, NAT PROTOC, V2, P1034, DOI 10.1038/nprot.2007.147; Bouchama A, 2002, NEW ENGL J MED, V346, P1978, DOI 10.1056/NEJMra011089; Brady JP, 1997, P NATL ACAD SCI USA, V94, P884, DOI 10.1073/pnas.94.3.884; BRENNER S, 1974, GENETICS, V77, P71; Calabrese EJ, 2004, EMBO REP, V5, pS37, DOI 10.1038/sj.embor.7400222; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Cao SS, 2005, J NEUROSCI, V25, P3801, DOI 10.1523/JNEUROSCI.5157-04.2005; Chiang WC, 2012, CELL, V148, P322, DOI 10.1016/j.cell.2011.12.019; DHOPESH VP, 1976, NEW ENGL J MED, V294, P557; Ferri KF, 2001, NAT CELL BIOL, V3, pE255, DOI 10.1038/ncb1101-e255; Gascon S, 2008, J NEUROSCI METH, V168, P104, DOI 10.1016/j.jneumeth.2007.09.023; Gidday JM, 2006, NAT REV NEUROSCI, V7, P437, DOI 10.1038/nrn1927; Gitler AD, 2008, P NATL ACAD SCI USA, V105, P145, DOI 10.1073/pnas.0710685105; Greffrath W, 2001, NEUROSCIENCE, V104, P539, DOI 10.1016/S0306-4522(01)00088-4; Hall DM, 2001, AM J PHYSIOL-HEART C, V280, pH509, DOI 10.1152/ajpheart.2001.280.2.H509; Haslbeck M, 2005, NAT STRUCT MOL BIOL, V12, P842, DOI 10.1038/nsmb993; Hsu AL, 2003, SCIENCE, V300, P1142, DOI 10.1126/science.1083701; Kourtis N, 2011, EMBO J, V30, P2520, DOI 10.1038/emboj.2011.162; Lanner JT, 2012, NAT MED, V18, P244, DOI 10.1038/nm.2598; Lehotsky J, 2002, GEN PHYSIOL BIOPHYS, V21, P31; Lin K, 2001, NAT GENET, V28, P139, DOI 10.1038/88850; Lin P, 1999, J CELL BIOL, V145, P279, DOI 10.1083/jcb.145.2.279; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; LITHGOW GJ, 1995, P NATL ACAD SCI USA, V92, P7540, DOI 10.1073/pnas.92.16.7540; Lowe M, 2011, CURR OPIN CELL BIOL, V23, P85, DOI 10.1016/j.ceb.2010.10.004; McCall K, 2010, CURR OPIN CELL BIOL, V22, P882, DOI 10.1016/j.ceb.2010.09.002; McColl G, 2010, CELL METAB, V12, P260, DOI 10.1016/j.cmet.2010.08.004; Michelangeli F, 2005, CURR OPIN CELL BIOL, V17, P135, DOI 10.1016/j.ceb.2005.01.005; Missiaen L, 2007, CELL CALCIUM, V41, P405, DOI 10.1016/j.ceca.2006.11.001; Morimoto RI, 1998, GENE DEV, V12, P3788, DOI 10.1101/gad.12.24.3788; Morimoto RI, 2008, GENE DEV, V22, P1427, DOI 10.1101/gad.1657108; Morley JF, 2004, MOL BIOL CELL, V15, P657, DOI 10.1091/mbc.E03-07-0532; Patz JA, 2005, NATURE, V438, P310, DOI 10.1038/nature04188; Pavlikova M, 2009, CELL MOL NEUROBIOL, V29, P909, DOI 10.1007/s10571-009-9374-6; Pinton P, 1998, EMBO J, V17, P5298, DOI 10.1093/emboj/17.18.5298; Protasi F, 2009, J PHYSIOL-LONDON, V587, P3095, DOI 10.1113/jphysiol.2009.171967; Richardson CE, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002391; Rostaing P, 2004, J HISTOCHEM CYTOCHEM, V52, P1, DOI 10.1177/002215540405200101; Rowlands DJ, 2012, NAT GEOSCI, V5, P256, DOI [10.1038/NGEO1430, 10.1038/ngeo1430]; Rutkowski DT, 2006, PLOS BIOL, V4, P2024, DOI 10.1371/journal.pbio.0040374; Scott BA, 2002, SCIENCE, V296, P2388, DOI 10.1126/science.1072302; Shull GE, 2003, ANN NY ACAD SCI, V986, P453, DOI 10.1111/j.1749-6632.2003.tb07229.x; Syntichaki P, 2003, NAT REV NEUROSCI, V4, P672, DOI 10.1038/nrn1174; Syntichaki P, 2002, NATURE, V419, P939, DOI 10.1038/nature01108; Van Baelen K, 2004, BBA-MOL CELL RES, V1742, P103, DOI 10.1016/j.bbamcr.2004.08.018; Van Baelen K, 2001, J BIOL CHEM, V276, P10683, DOI 10.1074/jbc.M010553200; van Montfort RLM, 2001, NAT STRUCT BIOL, V8, P1025, DOI 10.1038/nsb722; von Blume J, 2011, DEV CELL, V20, P652, DOI 10.1016/j.devcel.2011.03.014; Walker GA, 2003, AGING CELL, V2, P131, DOI 10.1046/j.1474-9728.2003.00045.x; Xu KL, 2001, NEURON, V31, P957, DOI 10.1016/S0896-6273(01)00432-9; Yamashima T, 2003, HIPPOCAMPUS, V13, P791, DOI 10.1002/hipo.10127; Yamashima T, 2000, PROG NEUROBIOL, V62, P273, DOI 10.1016/S0301-0082(00)00006-X; Yoneda T, 2004, J CELL SCI, V117, P4055, DOI 10.1242/jcs.01275	56	108	127	0	69	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 11	2012	490	7419					213	+		10.1038/nature11417	http://dx.doi.org/10.1038/nature11417			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019IY	22972192				2022-12-28	WOS:000309733300040
J	Quint, M; Drost, HG; Gabel, A; Ullrich, KK; Bonn, M; Grosse, I				Quint, Marcel; Drost, Hajk-Georg; Gabel, Alexander; Ullrich, Kristian Karsten; Boenn, Markus; Grosse, Ivo			A transcriptomic hourglass in plant embryogenesis	NATURE			English	Article							GENE-EXPRESSION; ARABIDOPSIS; BEGINNINGS; EVOLUTION	Animal and plant development starts with a constituting phase called embryogenesis, which evolved independently in both lineages(1). Comparative anatomy of vertebrate development-based on the Meckel-Serres law(2) and von Baer's laws of embryology(3) from the early nineteenth century-shows that embryos from various taxa appear different in early stages, converge to a similar form during mid-embryogenesis, and again diverge in later stages. This morphogenetic series is known as the embryonic 'hourglass'(4,5), and its bottleneck of high conservation in mid-embryogenesis is referred to as the phylotypic stage(6). Recent analyses in zebrafish and Drosophila embryos provided convincing molecular support for the hourglass model, because during the phylotypic stage the transcriptome was dominated by ancient genes(7) and global gene expression profiles were reported to be most conserved(8). Although extensively explored in animals, an embryonic hourglass has not been reported in plants, which represent the second major kingdom in the tree of life that evolved embryogenesis. Here we provide phylotranscriptomic evidence for a molecular embryonic hourglass in Arabidopsis thaliana, using two complementary approaches. This is particularly significant because the possible absence of an hourglass based on morphological features in plants suggests that morphological and molecular patterns might be uncoupled. Together with the reported developmental hourglass patterns in animals, these findings indicate convergent evolution of the molecular hourglass and a conserved logic of embryogenesis across kingdoms.	[Quint, Marcel; Ullrich, Kristian Karsten] Leibniz Inst Plant Biochem, Independent Jr Res Grp, Dept Mol Signal Proc, D-06120 Halle, Saale, Germany; [Drost, Hajk-Georg; Gabel, Alexander; Boenn, Markus; Grosse, Ivo] Univ Halle Wittenberg, Inst Comp Sci, D-06120 Halle, Saale, Germany; [Boenn, Markus] UFZ Helmholtz Ctr Environm Res, Dept Soil Ecol, D-06120 Halle, Saale, Germany	Leibniz Institut fur Pflanzenbiochemie; Martin Luther University Halle Wittenberg; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ)	Quint, M (corresponding author), Leibniz Inst Plant Biochem, Independent Jr Res Grp, Dept Mol Signal Proc, Weinberg 3, D-06120 Halle, Saale, Germany.	mquint@ipb-halle.de	Ullrich, Kristian/AAP-6724-2021; Drost, Hajk-Georg/G-2632-2015; quint, marcel/J-8483-2012	Ullrich, Kristian/0000-0003-4308-9626; Drost, Hajk-Georg/0000-0002-1567-306X; Quint, Marcel/0000-0003-2935-4083	'Exzellenznetzwerk fur Biowissenschaften' of the Federal State of Sachsen-Anhalt, Germany	'Exzellenznetzwerk fur Biowissenschaften' of the Federal State of Sachsen-Anhalt, Germany	We are grateful to S. Abel, L. I. A. Calderon Villalobos, C. Delker, T. Greb, D. Grubb, J. J. Harada, D. Jackson, R. Paxton, A. Soro and C. Wasternack for discussions, to S. Neumann for support with the IPB-cluster, and the 'Exzellenznetzwerk fur Biowissenschaften' of the Federal State of Sachsen-Anhalt, Germany, for financial support of M.Q.	Arakaki M, 2011, P NATL ACAD SCI USA, V108, P8379, DOI 10.1073/pnas.1100628108; Baer v., 1828, ENTWICKLUNGSGESCHICH; Carbon S, 2009, BIOINFORMATICS, V25, P288, DOI 10.1093/bioinformatics/btn615; De Smet I, 2010, PLANT J, V61, P959, DOI 10.1111/j.1365-313X.2010.04143.x; Domazet-Loso T, 2007, TRENDS GENET, V23, P533, DOI 10.1016/j.tig.2007.08.014; Domazet-Loso T, 2010, NATURE, V468, P815, DOI 10.1038/nature09632; DUBOULE D, 1994, DEVELOPMENT, P135; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; Irie N, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1248; Irie N, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-1; Kalinka AT, 2010, NATURE, V468, P811, DOI 10.1038/nature09634; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Koch MA, 2005, AM J BOT, V92, P761, DOI 10.3732/ajb.92.4.761; Koch MA, 2000, MOL BIOL EVOL, V17, P1483, DOI 10.1093/oxfordjournals.molbev.a026248; Lau S, 2012, ANNU REV PLANT BIOL, V63, P483, DOI 10.1146/annurev-arplant-042811-105507; Le BH, 2010, P NATL ACAD SCI USA, V107, P8063, DOI 10.1073/pnas.1003530107; Levin M, 2012, DEV CELL, V22, P1101, DOI 10.1016/j.devcel.2012.04.004; Meckel JF, 1811, BEYTRAGE VERGLEICHEN; Meyerowitz EM, 2002, SCIENCE, V295, P1482, DOI 10.1126/science.1066609; Nodine MD, 2012, NATURE, V482, P94, DOI 10.1038/nature10756; Oh DH, 2010, PLANT PHYSIOL, V154, P1040, DOI 10.1104/pp.110.163923; Park Soornin, 2008, V427, P3, DOI 10.1007/978-1-59745-273-1_1; Peris CIL, 2010, CURR TOP DEV BIOL, V91, P1, DOI 10.1016/S0070-2153(10)91001-6; Raff R. A., 1996, SHAPE LIFE GENES DEV; Sander K., 1983, DEV EVOLUTION, P137; SLACK JMW, 1993, NATURE, V361, P490, DOI 10.1038/361490a0; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; Thornton K, 2003, BIOINFORMATICS, V19, P2325, DOI 10.1093/bioinformatics/btg316; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Xiang DQ, 2011, PLANT PHYSIOL, V156, P346, DOI 10.1104/pp.110.171702; Zuber H, 2010, PLANT PHYSIOL, V154, P913, DOI 10.1104/pp.110.162123	31	123	126	1	79	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 4	2012	490	7418					98	+		10.1038/nature11394	http://dx.doi.org/10.1038/nature11394			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015LG	22951968				2022-12-28	WOS:000309446800040
J	Kim, T; Sandra, ZYX; Clauder-Munster, S; Steinmetz, LM; Buratowski, S				Kim, TaeSoo; Sandra, Zhenyu Xu; Clauder-Muenster, Sandra; Steinmetz, Lars M.; Buratowski, Stephen			Set3 HDAC Mediates Effects of Overlapping Noncoding Transcription on Gene Induction Kinetics	CELL			English	Article							HISTONE H3; SACCHAROMYCES-CEREVISIAE; METHYLATION; RNA; PHD; ACETYLATION; DEACETYLASE; EXPRESSION; CHROMATIN; LYSINE-4	The Set3 histone deacetylase complex (Set3C) binds histone H3 dimethylated at lysine 4 (H3K4me2) to mediate deacetylation of histones in 50-transcribed regions. To discern how Set3C affects gene expression, genome-wide transcription was analyzed in yeast undergoing a series of carbon source shifts. Deleting SET3 primarily caused changes during transition periods, as genes were induced or repressed. Surprisingly, a majority of Set3-affected genes are overlapped by noncoding RNA (ncRNA) transcription. Many Set3-repressed genes have H3K4me2 instead of me3 over promoter regions, due to either reduced H3K4me3 or ncRNA transcription from distal or antisense promoters. Set3C also represses internal cryptic promoters, but in different regions of genes than the Set2/Rpd3S pathway. Finally, Set3C stimulates some genes by repressing an overlapping antagonistic antisense transcript. These results show that overlapping noncoding transcription can fine-tune gene expression, not via the ncRNA but by depositing H3K4me2 to recruit the Set3C deacetylase.	[Kim, TaeSoo; Buratowski, Stephen] Harvard Univ, Dept Biol Chem & Mol Pharmacol, Sch Med, Boston, MA 02115 USA; [Sandra, Zhenyu Xu; Clauder-Muenster, Sandra; Steinmetz, Lars M.] European Mol Biol Lab, Genome Biol Unit, D-69117 Heidelberg, Germany	Harvard University; Harvard Medical School; European Molecular Biology Laboratory (EMBL)	Buratowski, S (corresponding author), Harvard Univ, Dept Biol Chem & Mol Pharmacol, Sch Med, 240 Longwood Ave, Boston, MA 02115 USA.	steveb@hms.harvard.edu		Clauder-Muenster, Sandra/0000-0002-9530-2938; Steinmetz, Lars/0000-0002-3962-2865; Kim, TaeSoo/0000-0002-3902-1058	US National Institutes of Health [GM068717, GM46498, GM56663]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM046498, R01GM046498, R01GM056663, R01GM068717] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to Angelika Amon (MIT) for sharing unpublished work, Sebastian Marquardt for the northern blot analysis protocol, and Ollie Rando (University of Massachusetts, Worcester) and all members of the Buratowski lab for helpful advice and discussions. T.K. is a Special Fellow of the Leukemia and Lymphoma Society. This research was supported by grants GM068717 to L.M.S. and GM46498 and GM56663 to S.B. from the US National Institutes of Health.	Alejandro-Osorio AL, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-r57; Bumgarner SL, 2012, MOL CELL, V45, P470, DOI 10.1016/j.molcel.2011.11.029; Bumgarner SL, 2009, P NATL ACAD SCI USA, V106, P18321, DOI 10.1073/pnas.0909641106; Buratowski S., 2011, COLD SPRING HARB SYM, V75, P95; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Cheung V, 2008, PLOS BIOL, V6, P2550, DOI 10.1371/journal.pbio.0060277; Collins SR, 2007, NATURE, V446, P806, DOI 10.1038/nature05649; David L, 2006, P NATL ACAD SCI USA, V103, P5320, DOI 10.1073/pnas.0601091103; Gomez-del Arco P, 2010, IMMUNITY, V33, P685, DOI 10.1016/j.immuni.2010.11.008; Govind CK, 2010, MOL CELL, V39, P234, DOI 10.1016/j.molcel.2010.07.003; Hang MD, 2011, GENETICS, V187, P1053, DOI 10.1534/genetics.110.125419; Hongay CF, 2006, CELL, V127, P735, DOI 10.1016/j.cell.2006.09.038; Hung T, 2009, MOL CELL, V33, P248, DOI 10.1016/j.molcel.2008.12.016; Kaplan CD, 2003, SCIENCE, V301, P1096, DOI 10.1126/science.1087374; Keogh MC, 2005, CELL, V123, P593, DOI 10.1016/j.cell.2005.10.025; Kim T, 2009, CELL, V137, P259, DOI 10.1016/j.cell.2009.02.045; Kirmizis A, 2007, NATURE, V449, P928, DOI 10.1038/nature06160; Kizer KO, 2005, MOL CELL BIOL, V25, P3305, DOI 10.1128/MCB.25.8.3305-3316.2005; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kowalczyk MS, 2012, MOL CELL, V45, P447, DOI 10.1016/j.molcel.2011.12.021; Krogan NJ, 2003, MOL CELL BIOL, V23, P4207, DOI 10.1128/MCB.23.12.4207-4218.2003; Lenstra TL, 2011, MOL CELL, V42, P536, DOI 10.1016/j.molcel.2011.03.026; Leung AKL, 2010, MOL CELL, V40, P205, DOI 10.1016/j.molcel.2010.09.027; Li B, 2007, GENE DEV, V21, P1422, DOI 10.1101/gad.1539307; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li B, 2007, SCIENCE, V316, P1050, DOI 10.1126/science.1139004; Li JX, 2002, J BIOL CHEM, V277, P49383, DOI 10.1074/jbc.M209294200; Liang G, 2007, NAT STRUCT MOL BIOL, V14, P243, DOI 10.1038/nsmb1204; Marquardt S, 2011, TRANSCR-AUSTIN, V2, P145, DOI 10.4161/trns.2.3.16298; Martens JA, 2004, NATURE, V429, P571, DOI 10.1038/nature02538; Ng HH, 2003, MOL CELL, V11, P709, DOI 10.1016/S1097-2765(03)00092-3; Nishizawa M, 2008, PLOS BIOL, V6, P2817, DOI 10.1371/journal.pbio.0060326; Pijnappel WWMP, 2001, GENE DEV, V15, P2991, DOI 10.1101/gad.207401; Pinskaya M, 2009, EMBO J, V28, P1697, DOI 10.1038/emboj.2009.108; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Ruiz-Roig C, 2010, MOL MICROBIOL, V76, P1049, DOI 10.1111/j.1365-2958.2010.07167.x; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; Shi XB, 2007, J BIOL CHEM, V282, P2450, DOI 10.1074/jbc.C600286200; Sims RJ, 2005, J BIOL CHEM, V280, P41789, DOI 10.1074/jbc.C500395200; Storici F, 2001, NAT BIOTECHNOL, V19, P773, DOI 10.1038/90837; Strahl BD, 2002, MOL CELL BIOL, V22, P1298, DOI 10.1128/MCB.22.5.1298-1306.2002; Taverna SD, 2006, MOL CELL, V24, P785, DOI 10.1016/j.molcel.2006.10.026; van Dijk EL, 2011, NATURE, V475, P114, DOI 10.1038/nature10118; van Werven FJ, 2012, CELL, V150, P1170, DOI 10.1016/j.cell.2012.06.049; Vermeulen M, 2007, CELL, V131, P58, DOI 10.1016/j.cell.2007.08.016; Villa-Garcia MJ, 2011, MOL GENET GENOMICS, V285, P125, DOI 10.1007/s00438-010-0592-x; Wang A, 2002, SCIENCE, V298, P1412, DOI 10.1126/science.1077790; Wang KC, 2011, MOL CELL, V43, P904, DOI 10.1016/j.molcel.2011.08.018; Weinberger L, 2012, MOL CELL, V47, P193, DOI 10.1016/j.molcel.2012.05.008; Xu ZY, 2009, NATURE, V457, P1033, DOI 10.1038/nature07728	50	138	140	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 14	2012	150	6					1158	1169		10.1016/j.cell.2012.08.016	http://dx.doi.org/10.1016/j.cell.2012.08.016			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	007ZY	22959268	Green Accepted, Bronze			2022-12-28	WOS:000308928100010
J	Ludwig, DS; Ebbeling, CB; Livingston, EH				Ludwig, David S.; Ebbeling, Cara B.; Livingston, Edward H.			Surgical vs Lifestyle Treatment for Type 2 Diabetes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							BARIATRIC SURGERY; RISK-FACTORS; WEIGHT		[Ludwig, David S.; Ebbeling, Cara B.] Boston Childrens Hosp, New Balance Fdn Obes Prevent Ctr, Boston, MA 02115 USA; [Livingston, Edward H.] Univ Texas SW Med Ctr Dallas, Div Gastrointestinal & Endocrine Surg, Dallas, TX 75390 USA	Harvard University; Boston Children's Hospital; University of Texas System; University of Texas Southwestern Medical Center Dallas	Ludwig, DS (corresponding author), Boston Childrens Hosp, New Balance Fdn Obes Prevent Ctr, 300 Longwood Ave, Boston, MA 02115 USA.	david.ludwig@childrens.harvard.edu		Ludwig, David/0000-0003-3307-8544	NIDDK NIH HHS [K24DK082730] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK082730] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		[Anonymous], 1990, METABOLISM, V39, P905, DOI 10.1016/0026-0495(90)90299-R; Gardner CD, 2007, JAMA-J AM MED ASSOC, V297, P969, DOI 10.1001/jama.297.9.969; HENRY RR, 1985, J CLIN ENDOCR METAB, V61, P917, DOI 10.1210/jcem-61-5-917; Lim EL, 2011, DIABETOLOGIA, V54, P2506, DOI 10.1007/s00125-011-2204-7; Ludwig DS, 2011, JAMA-J AM MED ASSOC, V305, P1352, DOI 10.1001/jama.2011.380; May AL, 2012, PEDIATRICS, V129, P1035, DOI 10.1542/peds.2011-1082; Mingrone G, 2012, NEW ENGL J MED, V366, P1577, DOI 10.1056/NEJMoa1200111; Shah M, 2006, J CLIN ENDOCR METAB, V91, P4223, DOI 10.1210/jc.2006-0557; Zeitler P, 2012, NEW ENGL J MED, V366, P2247, DOI 10.1056/NEJMoa1109333	9	9	10	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 12	2012	308	10					981	982		10.1001/2012.jama.10156	http://dx.doi.org/10.1001/2012.jama.10156			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	003AA	22968885				2022-12-28	WOS:000308579300019
J	Stoffels, I; Boy, C; Poppel, T; Kuhn, J; Klotgen, K; Dissemond, J; Schadendorf, D; Klode, J				Stoffels, Ingo; Boy, Christian; Poeppel, Thorsten; Kuhn, Jasna; Kloetgen, Kerstin; Dissemond, Joachim; Schadendorf, Dirk; Klode, Joachim			Association Between Sentinel Lymph Node Excision With or Without Preoperative SPECT/CT and Metastatic Node Detection and Disease-Free Survival in Melanoma	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							COST-EFFECTIVENESS; GERMAN GUIDELINES; TUMOR LOAD; BIOPSY; HEAD; INVOLVEMENT; EXPERIENCE; DIAGNOSIS	Context Malignant melanoma has become an increasing interdisciplinary public health challenge worldwide. Sentinel lymph node excision (SLNE) is considered the most sensitive and specific staging test for the detection of micrometastatic melanoma in regional lymph nodes. Objective To compare metastatic node detection and disease-free survival using single-photon emission computed tomography/computed tomography (SPECT/CT)-aided SLNE vs standard SLNE in patients with melanoma. Design, Setting, and Patients A prospective, computerized melanoma patient database at the University Hospital Essen, Skin Cancer Center, Essen, Germany, was used to identify a cohort of 464 patients eligible for SLNE between March 2003 and April 2011. A total of 403 patients with clinically negative lymph nodes, who underwent SLNE with or without preoperative SPECT/CT, qualified for subsequent analysis. Main Outcome Measures Metastatic node detection and disease-free survival. Results Between March 2003 and October 2008, 254 patients underwent the standard SLNE technique. After November 2008, 149 patients underwent the SPECT/CT technique. Patients who did not receive SNLE in both intervals (46/300 [15.34%] for standard cohort vs 15/164 [9.15%] for SPECT/CT cohort; P = .06) did not differ in either age (difference, 69.20 years; 95% CI, 62.84-72.07 years; P = .38), tumor depth (difference, 2.90 mm; 95% CI, 2.87-4.54 mm; P = .54), or ulceration of the primary tumor (difference, -8.00%; 95% CI, -35.74% to 19.81%; P = .59). However, using SPECT/CT allowed SLNE in the head and neck area more frequently (2.0% for standard vs 23.5% for SPECT/CT; difference, 21.1%; 95% CI, 14.1%-28.2%; P < .001). In the SPECT/CT cohort, more sentinel lymph nodes per patient were detected than in the standard cohort (2.40 vs 1.87; 95% CI, 1.93-2.18; P < .001). The number of positive sentinel lymph nodes per patient was significantly higher in the SPECT/CT cohort than in the standard cohort (0.34 vs 0.21; 95% CI, 0.21-0.31; P = .04). The local relapse rate in the SPECT/CT cohort was lower than in the standard cohort (6.8% vs 23.8%, P = .03), which prolonged 4-year disease-free survival (93.9% vs 79.2%; P = .02). Conclusion Among patients with clinically lymph node-negative melanoma, the use of SPECT/CT-aided SLNE compared with SLNE alone was associated with a higher frequency of metastatic involvement and a higher rate of disease-free survival. JAMA. 2012;308(10):1007-1014 www.jama.com	[Stoffels, Ingo; Kuhn, Jasna; Kloetgen, Kerstin; Dissemond, Joachim; Schadendorf, Dirk; Klode, Joachim] Univ Essen Duisburg, Dept Dermatol Venerol & Allergol, Essen, Germany; [Boy, Christian; Poeppel, Thorsten] Univ Essen Duisburg, Dept Nucl Med, Essen, Germany	University of Duisburg Essen; University of Duisburg Essen	Klode, J (corresponding author), Univ Sch Med Essen Duisburg, Dept Dermatol, Hufelandstr 55, D-45122 Essen, Germany.	joachim.klode@uk-essen.de	Schadendorf, Dirk/AAE-8206-2019; Boy, Christian/ACK-7633-2022; Boy, Christian/AAE-9193-2020; Dissemond, Joachim/AFG-0691-2022	Boy, Christian/0000-0002-8924-4997; Stoffels, Ingo/0000-0003-0111-1303	GlaxoSmithKline; Novartis; Amgen; Bristol-Myers Squibb; Roche; Genentech; MSD	GlaxoSmithKline(GlaxoSmithKline); Novartis(Novartis); Amgen(Amgen); Bristol-Myers Squibb(Bristol-Myers Squibb); Roche(Roche Holding); Genentech(Roche HoldingGenentech); MSD	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Schadendorf reported receiving consultancy fees, having board membership, and receiving lecture fees from GlaxoSmithKline, Novartis, Amgen, Bristol-Myers Squibb, Roche, Genentech, and MSD. No other authors reported any disclosures.	American Cancer Society, 2015, MEL SKIN CANC OV; American Cancer Society, 2011, CANC FACTS FIG 2011; Balch CM, 2009, J CLIN ONCOL, V27, P6199, DOI 10.1200/JCO.2009.23.4799; BALCH CM, 1980, J AM ACAD DERMATOL, V3, P511, DOI 10.1016/S0190-9622(80)80118-6; Balch CM, 2001, J CLIN ONCOL, V19, P3622, DOI 10.1200/JCO.2001.19.16.3622; Barthelmes L, 2010, EJSO-EUR J SURG ONC, V36, P399, DOI 10.1016/j.ejso.2009.10.007; Chakera AH, 2009, EUR J NUCL MED MOL I, V36, P1713, DOI 10.1007/s00259-009-1228-4; Covarelli P, 2007, MELANOMA RES, V17, P323, DOI 10.1097/CMR.0b013e3282ef415b; Garbe C, 2008, MELANOMA RES, V18, P152, DOI 10.1097/CMR.0b013e3282f702bf; Garbe C, 2007, MELANOMA RES, V17, P393, DOI 10.1097/CMR.0b013e3282f05039; Gershenwald JE, 1999, J CLIN ONCOL, V17, P976, DOI 10.1200/JCO.1999.17.3.976; Gershenwald JE, 2008, J CLIN ONCOL, V26, P4296, DOI 10.1200/JCO.2007.15.4179; Gershenwald JE, 2011, NEW ENGL J MED, V364, P1738, DOI 10.1056/NEJMct1002967; Klode J, 2011, J EUR ACAD DERMATOL, V25, P1213, DOI 10.1111/j.1468-3083.2010.03954.x; Leiter U, 2010, ANN SURG ONCOL, V17, P129, DOI 10.1245/s10434-009-0780-2; Lerman H, 2007, J NUCL MED, V48, P201; Livingstone E, 2011, EUR J CANCER, V47, P1977, DOI 10.1016/j.ejca.2011.04.029; Mar MV, 2007, J NUCL MED TECHNOL, V35, P10; Morton DL, 2006, NEW ENGL J MED, V355, P1307, DOI 10.1056/NEJMoa060992; Morton RL, 2009, ANN SURG ONCOL, V16, P929, DOI 10.1245/s10434-008-0164-z; Nieweg OE, 2009, ANN SURG ONCOL, V16, P2089, DOI 10.1245/s10434-009-0540-3; Prieto Victor G, 2002, Ann Diagn Pathol, V6, P257, DOI 10.1053/adpa.2002.35400; Ross MI, 2010, SEMIN CUTAN MED SURG, V29, P238, DOI 10.1016/j.sder.2010.11.002; Satzger I, 2008, ANN SURG ONCOL, V15, P1723, DOI 10.1245/s10434-008-9888-z; Sondak VK, 2010, ANN SURG ONCOL, V17, P670, DOI 10.1245/s10434-009-0857-y; Stephan K Haerle, 2011, Int J Mol Imaging, V2011, P106068, DOI 10.1155/2011/106068; Stoffels I, 2011, J EUR ACAD DERMATOL, V25, P306, DOI 10.1111/j.1468-3083.2010.03786.x; van Akkooi ACJ, 2010, NAT REV CLIN ONCOL, V7, P446, DOI 10.1038/nrclinonc.2010.100; van der Ploeg APT, 2011, J CLIN ONCOL, V29, P2206, DOI 10.1200/JCO.2010.31.6760; Ploeg IMCD, 2008, WORLD J SURG, V32, P1930, DOI 10.1007/s00268-008-9618-5; van der Ploeg IMC, 2009, ANN SURG ONCOL, V16, P1537, DOI 10.1245/s10434-009-0339-2; Veenstra HJ, 2011, J SURG ONCOL, V104, P454, DOI 10.1002/jso.21967; Vermeeren L, 2011, HEAD NECK-J SCI SPEC, V33, P1, DOI 10.1002/hed.21392; Vlymen JV, 2000, ANESTHESIA, P2213	34	85	87	0	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 12	2012	308	10					1007	1014		10.1001/2012.jama.11030	http://dx.doi.org/10.1001/2012.jama.11030			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	003AA	22968889				2022-12-28	WOS:000308579300024
J	Holmes, D				Holmes, David			Margaret Chan: committed to universal health coverage	LANCET			English	Biographical-Item																		CHAN MG, PUBLICATION LIST	1	13	14	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 8	2012	380	9845					879	879		10.1016/S0140-6736(12)61493-7	http://dx.doi.org/10.1016/S0140-6736(12)61493-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	002QL	22959376	Green Published, Bronze			2022-12-28	WOS:000308547300015
J	Ball, P				Ball, Philip			Martin Fleischmann (1927-2012) OBITUARY	NATURE			English	Biographical-Item												p.ball@btinternet.com						FLEISCHMANN M, PUBLICATION LIST	1	3	3	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 6	2012	489	7414					34	34		10.1038/489034a	http://dx.doi.org/10.1038/489034a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999WW	22955604	Bronze			2022-12-28	WOS:000308347000024
J	Brenner, H; Chang-Claude, J; Jansen, L; Seiler, CM; Hoffmeister, M				Brenner, Hermann; Chang-Claude, Jenny; Jansen, Lina; Seiler, Christoph M.; Hoffmeister, Michael			Role of Colonoscopy and Polyp Characteristics in Colorectal Cancer After Colonoscopic Polyp Detection A Population-Based Case-Control Study	ANNALS OF INTERNAL MEDICINE			English	Article							SURVEILLANCE COLONOSCOPY; ADENOMA CHARACTERISTICS; SCREENING COLONOSCOPY; RISK-FACTORS; FOLLOW-UP; RECURRENCE; PREDICTORS; PROTECTION; NEOPLASMS; HISTORY	Background: Studies have identified characteristics of adenomas detected on colonoscopy to be predictive of adenoma recurrence. Objective: To assess the role of both colonoscopy-related factors and polyp characteristics on the risk for colorectal cancer after colonoscopic polyp detection. Design: Population-based case-control study (3148 case participants and 3274 control participants). Setting: Rhine-Neckar region of Germany. Patients: Case and control participants with physician-validated detection of polyps (other than hyperplastic polyps) at a previous colonoscopy in the past 10 years. Measurements: Detailed history and results of previous colonoscopies were obtained through interviews and medical records. Case and control participants were compared according to colonoscopy-related factors (incompleteness, poor bowel preparation, incomplete removal of all polyps, and no surveillance colonoscopy within 5 years) and polyp characteristics (>= 1 cm, villous components or high-grade dysplasia, >= 3 polyps, and >= 1 proximal polyp). Odds ratios (ORs) and attributable fractions were derived by using multiple logistic regression and the Levin formula. Results: 155 case participants and 260 control participants with physician-validated polyp detection in the past 10 years were identified. The following characteristics were significantly more common among case participants than among control participants: not all polyps completely removed (29.0% vs. 9.6%; OR, 3.73 [95% CI, 2.11 to 6.60]), no surveillance colonoscopy within 5 years (26.5% vs. 11.5%; OR, 2.96 [CI, 1.70 to 5.16]), and detection of 3 or more polyps (14.2% vs. 7.3%; OR, 2.21 [CI, 1.07 to 4.54]). Odds ratios ranged from 1.12 to 1.42 and CIs included 1.00 for all other variables. Overall, 41.1% and 21.7% of cancer cases were statistically attributable to colonoscopy-related factors and polyp characteristics, respectively. Limitation: This was an observational study with potential for residual confounding and selection bias. Conclusion: Colonoscopy-related factors are more important than polyp characteristics for stratification of colorectal cancer risk after colonoscopic polyp detection in the community setting.	[Brenner, Hermann] German Canc Res Ctr, Div Clin Epidemiol & Aging Res, D-69120 Heidelberg, Germany; Heidelberg Univ, Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Brenner, H (corresponding author), German Canc Res Ctr, Div Clin Epidemiol & Aging Res, Neuenheimer Feld 280, D-69120 Heidelberg, Germany.	h.brenner@dkfz.de	Hoffmeister, Michael/T-7187-2019; Jansen, Lina/D-7255-2016; Hoffmeister, Michael/AAB-2321-2022; Brenner, Hermann/ABE-6383-2020; Seiler, Christoph/AAG-7056-2021; Brenner, Hermann/B-4627-2017	Hoffmeister, Michael/0000-0002-8307-3197; Jansen, Lina/0000-0001-8004-4940; Hoffmeister, Michael/0000-0002-8307-3197; Brenner, Hermann/0000-0002-6129-1572; Brenner, Hermann/0000-0002-6129-1572	German Research Council (Deutsche Forschungsgemeinschaft) [BR 1704/6-1, BR 1704/6-3, BR 1704/6-4, CH 117/1-1]; German Federal Ministry of Education and Research [01KH0404, 01ER0814]; German Research Council	German Research Council (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); German Research Council(German Research Foundation (DFG))	By grants BR 1704/6-1, BR 1704/6-3, BR 1704/6-4, and CH 117/1-1 from the German Research Council (Deutsche Forschungsgemeinschaft) and grants 01KH0404 and 01ER0814 from the German Federal Ministry of Education and Research.; Primary Funding Source: German Research Council and German Federal Ministry of Education and Research.	Avidan B, 2002, AM J GASTROENTEROL, V97, P1524, DOI 10.1016/S0002-9270(02)04157-6; Bertario L, 2003, INT J CANCER, V105, P82, DOI 10.1002/ijc.11036; Bonithon-Kopp C, 2004, DIS COLON RECTUM, V47, P323, DOI 10.1007/s10350-003-0054-1; Brenner H, 2011, J CLIN ONCOL, V29, P3761, DOI 10.1200/JCO.2011.35.9307; Brenner H, 2011, ANN INTERN MED, V154, P22, DOI 10.7326/0003-4819-154-1-201101040-00004; Cafferty FH, 2007, CANCER J, V13, P263, DOI 10.1097/PPO.0b013e318046ebf1; Calonge N, 2008, ANN INTERN MED, V149, P627, DOI 10.7326/0003-4819-149-9-200811040-00243; Imperiale TF, 2008, NEW ENGL J MED, V359, P1218, DOI 10.1056/NEJMoa0803597; Kaminski MF, 2010, NEW ENGL J MED, V362, P1795, DOI 10.1056/NEJMoa0907667; Laiyemo AO, 2008, ANN INTERN MED, V148, P419, DOI 10.7326/0003-4819-148-6-200803180-00004; Levin B, 2008, GASTROENTEROLOGY, V134, P1570, DOI 10.1053/j.gastro.2008.02.002; Lieberman DA, 2007, GASTROENTEROLOGY, V133, P1077, DOI 10.1053/j.gastro.2007.07.006; Mannath J, 2011, DIGEST DIS SCI, V56, P2389, DOI 10.1007/s10620-011-1609-y; Martinez ME, 2009, GASTROENTEROLOGY, V136, P832, DOI 10.1053/j.gastro.2008.12.007; Martinez ME, 2001, GASTROENTEROLOGY, V120, P1077, DOI 10.1053/gast.2001.23247; MULLER AD, 1995, ARCH INTERN MED, V155, P1741, DOI 10.1001/archinte.155.16.1741; Noshirwani KC, 2000, GASTROINTEST ENDOSC, V51, P433, DOI 10.1016/S0016-5107(00)70444-5; Pinsky PF, 2009, CLIN GASTROENTEROL H, V7, P86, DOI 10.1016/j.cgh.2008.07.014; Ruckinger S, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-7; Saini SD, 2006, GASTROINTEST ENDOSC, V64, P614, DOI 10.1016/j.gie.2006.06.057; Schmiegel W, 2008, Z GASTROENTEROL, V46, P799, DOI 10.1055/s-2008-1027726; van Stolk RU, 1998, GASTROENTEROLOGY, V115, P13, DOI 10.1016/S0016-5085(98)70359-2; WINAWER SJ, 1993, NEW ENGL J MED, V329, P1977, DOI 10.1056/NEJM199312303292701	23	56	59	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 21	2012	157	4					225	233		10.7326/0003-4819-157-4-201208210-00002	http://dx.doi.org/10.7326/0003-4819-157-4-201208210-00002			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	992XG	22910933				2022-12-28	WOS:000307813200013
J	Roseman, M; Turner, EH; Lexchin, J; Coyne, JC; Bero, LA; Thombs, BD				Roseman, Michelle; Turner, Erick H.; Lexchin, Joel; Coyne, James C.; Bero, Lisa A.; Thombs, Brett D.			Reporting of conflicts of interest from drug trials in Cochrane reviews: cross sectional study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PHARMACEUTICAL-INDUSTRY; FINANCIAL TIES; METAANALYSES; QUALITY; IMPACT; CONCLUSIONS; PUBLICATION; ASSOCIATION; CONSORT; BIAS	Objectives To investigate the degree to which Cochrane reviews of drug interventions published in 2010 reported conflicts of interest from included trials and, among reviews that reported this information, where it was located in the review documents. Design Cross sectional study. Data sources Cochrane Database of Systematic Reviews. Selection criteria Systematic reviews of drug interventions published in 2010 in the Cochrane Database of Systematic Reviews, with review content classified as up to date in 2008 or later and with results from one or more randomised controlled trials. Results Of 151 included Cochrane reviews, 46 (30%, 95% confidence interval 24% to 38%) reported information on the funding sources of included trials, including 30 (20%, 14% to 27%) that reported information on trial funding for all included trials and 16 (11%, 7% to 17%) that reported for some, but not all, trials. Only 16 of the 151 Cochrane reviews (11%, 7% to 17%) provided any information on trial author-industry financial ties or trial author-industry employment. Information on trial funding and trial author-industry ties was reported in one to seven locations within each review, with no consistent reporting location observed. Conclusions Most Cochrane reviews of drug trials published in 2010 did not provide information on trial funding sources or trial author-industry financial ties or employment. When this information was reported, location of reporting was inconsistent across reviews.	[Roseman, Michelle; Thombs, Brett D.] Jewish Gen Hosp, Lady Davis Inst Med Res, Montreal, PQ H3T 1E4, Canada; [Roseman, Michelle; Thombs, Brett D.] McGill Univ, Montreal, PQ H3T 1E4, Canada; [Turner, Erick H.] Oregon Hlth & Sci Univ, Dept Psychiat, Portland, OR 97201 USA; [Turner, Erick H.] Portland VA Med Ctr, Portland, OR USA; [Lexchin, Joel] York Univ, Sch Hlth Policy & Management, Toronto, ON M3J 2R7, Canada; [Coyne, James C.] Univ Groningen, Univ Med Ctr Groningen, Dept Hlth Sci, Hlth Psychol Sect, NL-9700 AB Groningen, Netherlands; [Bero, Lisa A.] Univ Calif San Francisco, Sch Pharm, Dept Clin Pharm, San Francisco, CA 94143 USA; [Bero, Lisa A.] Univ Calif San Francisco, Sch Med, Inst Hlth Policy Studies, San Francisco, CA 94143 USA	Lady Davis Institute; McGill University; McGill University; Oregon Health & Science University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Portland VA Medical Center; York University - Canada; University of Groningen; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Thombs, BD (corresponding author), Jewish Gen Hosp, Lady Davis Inst Med Res, Montreal, PQ H3T 1E4, Canada.	brett.thombs@mcgill.ca	Turner, Erick/A-4848-2008	Turner, Erick/0000-0002-3522-3357; Thombs, Brett D./0000-0002-5644-8432; Bero, Lisa/0000-0003-1893-6651	Canadian Institutes of Health Research; Fonds de la Recherche en Sante Quebec; McGill University provost's graduate fellowship; McGill University principal's graduate fellowship; Etablissement de Jeunes Chercheurs award from the Fonds de la Recherche en Sante Quebec; Cochrane Collaboration Methodological Fund	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Fonds de la Recherche en Sante Quebec(Fonds de la Recherche en Sante du Quebec); McGill University provost's graduate fellowship; McGill University principal's graduate fellowship; Etablissement de Jeunes Chercheurs award from the Fonds de la Recherche en Sante Quebec; Cochrane Collaboration Methodological Fund	MR was supported by a Frederick Banting and Charles Best Canadian graduate scholarship-master's award from the Canadian Institutes of Health Research, a master's training award from the Fonds de la Recherche en Sante Quebec, a McGill University provost's graduate fellowship, and a McGill University principal's graduate fellowship. BDT was supported by a new investigator award from the Canadian Institutes of Health Research and an Etablissement de Jeunes Chercheurs award from the Fonds de la Recherche en Sante Quebec. This study received no funding, and no funding body had any input into any aspect of the study.; All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare that: no authors had any financial support for the submitted work; JL was a consultant to a law firm representing Apotex in 2007, a consultant to the Canadian federal government in a lawsuit challenging the Canadian ban on direct to consumer advertising of prescription drugs in 2007-08, and a consultant to a law firm representing a plaintiff in a case against Allergan in 2010; LAB has received a grant from the Cochrane Collaboration Methodological Fund to examine how systematic reviewers identify unpublished drug trial data, and is an active member of the Cochrane Collaboration.	Bekelman JE, 2003, JAMA-J AM MED ASSOC, V289, P454, DOI 10.1001/jama.289.4.454; Bero L, 2007, PLOS MED, V4, P1001, DOI 10.1371/journal.pmed.0040184; Canadian Cochrane Centre, 2012, PARTN; Canadian Institutes of Health Research, 2010, COCHR CAN REC 9 6 MI; Chaudhry S, 2002, BRIT MED J, V325, P1391, DOI 10.1136/bmj.325.7377.1391; Cho MK, 1996, ANN INTERN MED, V124, P485, DOI 10.7326/0003-4819-124-5-199603010-00004; Cochrane Collaboration, 2012, COLL FUNDR; Cochrane Collaboration, 2012, REL WHO; Drazen JM, 2010, JAMA-J AM MED ASSOC, V304, P212, DOI 10.1001/jama.2010.918; Harbour R, 2001, BRIT MED J, V323, P334, DOI 10.1136/bmj.323.7308.334; Higgins J., 2022, COCHRANE HDB SYSTEMA, DOI DOI 10.1002/9781119536604; Higgins J.P., 2011, COCHRANE HDB SYSTEMA, V4, DOI [10.1002/9780470712184, DOI 10.1002/9780470712184]; Higgins JPT, 2012, COCHRANE HDB SYSTEMA; Hopewell S, 2008, LANCET, V371, P281, DOI 10.1016/S0140-6736(07)61835-2; Jorgensen AW, 2006, BMJ-BRIT MED J, V333, P782, DOI 10.1136/bmj.38973.444699.0B; Kirkham JJ, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c365; Kjaergard LL, 2002, BMJ-BRIT MED J, V325, P249, DOI 10.1136/bmj.325.7358.249; Lexchin J, 2003, BMJ-BRIT MED J, V326, P1167, DOI 10.1136/bmj.326.7400.1167; Lexchin J., 2011, SCI ENG ETHICS  0215; Liberati A, 2009, BMJ-BRIT MED J, V339, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Licurse A, 2010, ARCH INTERN MED, V170, P675, DOI 10.1001/archinternmed.2010.39; Lo B, 2009, CONFLICT INTEREST ME; Melander H, 2003, BMJ-BRIT MED J, V326, P1171, DOI 10.1136/bmj.326.7400.1171; Moher David, 2012, Int J Surg, V10, P28, DOI 10.1016/j.ijsu.2011.10.001; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1016/j.ijsu.2010.02.007, 10.1136/bmj.b2535]; Moher D, 2007, PLOS MED, V4, P447, DOI 10.1371/journal.pmed.0040078; Moja LP, 2005, BMJ-BRIT MED J, V330, P1053, DOI 10.1136/bmj.38414.515938.8F; Moynihan R, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d3004; National Institute for Health Research, 2010, EMB HLTH RES NIH RES; Patsopoulos NA, 2005, JAMA-J AM MED ASSOC, V293, P2362, DOI 10.1001/jama.293.19.2362; Rattinger G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005826; Rising K, 2008, PLOS MED, V5, P1561, DOI 10.1371/journal.pmed.0050217; Roseman M, 2011, JAMA-J AM MED ASSOC, V305, P1008, DOI 10.1001/jama.2011.257; Schroter S, 2004, BRIT MED J, V328, P742, DOI 10.1136/bmj.38035.705185.F6; Schunemann H, 2008, COCHRANE HDB SYSTEMA, DOI [10.1002/9780470712184.ch11, DOI 10.1002/9780470712184.CH11]; Schunemann HJ, 2012, COCHRANE HDB SYSTEMA; Sismondo S, 2008, SOC SCI MED, V66, P1909, DOI 10.1016/j.socscimed.2008.01.010; Sismondo S, 2008, CONTEMP CLIN TRIALS, V29, P109, DOI 10.1016/j.cct.2007.08.001; Tatsioni A, 2010, J GEN INTERN MED, V25, P914, DOI 10.1007/s11606-010-1360-7; Turner Erick H, 2008, N Engl J Med, V358, P252, DOI 10.1056/NEJMsa065779; Wang AT, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1344; Wen J, 2008, J CLIN EPIDEMIOL, V61, P770, DOI 10.1016/j.jclinepi.2007.10.008; West S, 2002, Evid Rep Technol Assess (Summ), P1; Yank V, 2007, BMJ-BRIT MED J, V335, P1202, DOI 10.1136/bmj.39376.447211.BE	44	38	38	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 21	2012	345								e5155	10.1136/bmj.e5155	http://dx.doi.org/10.1136/bmj.e5155			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	996GP	22906823	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000308073200004
J	Wieers, G; Lhommel, R; Lecouvet, F; Van den Bergh, P; Lambert, M				Wieers, Gregoire; Lhommel, Renaud; Lecouvet, Frederic; Van den Bergh, Peter; Lambert, Michel			A tiger man	LANCET			English	Editorial Material									[Wieers, Gregoire; Lambert, Michel] St Luc Univ Hosp, Dept Gen Internal Med, B-1200 Brussels, Belgium; [Lhommel, Renaud] St Luc Univ Hosp, Dept Nucl Med, B-1200 Brussels, Belgium; [Lecouvet, Frederic] St Luc Univ Hosp, Dept Radiol, B-1200 Brussels, Belgium; [Van den Bergh, Peter] St Luc Univ Hosp, Dept Neuropathol, B-1200 Brussels, Belgium	Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Universite Libre de Bruxelles; Vrije Universiteit Brussel; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Universite Libre de Bruxelles; Vrije Universiteit Brussel; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc	Lambert, M (corresponding author), St Luc Univ Hosp, Dept Gen Internal Med, B-1200 Brussels, Belgium.	michel.lambert@uclouvain.be	Wieërs, Grégoire/AAK-9798-2020; Wieërs, Grégoire/ABC-4187-2021	Wieërs, Grégoire/0000-0001-7540-8068; Lhommel, Renaud/0000-0003-0668-6122					0	19	20	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	NOV 24	2012	380	9856					1859	1859		10.1016/S0140-6736(12)60683-7	http://dx.doi.org/10.1016/S0140-6736(12)60683-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	041XK	22922001				2022-12-28	WOS:000311435000031
J	Solomon, SD; Zile, M; Pieske, B; Voors, AA; Shah, A; Kraigher-Krainer, E; Shi, V; Bransford, T; Takeuchi, M; Gong, JJ; Lefkowitz, M; Packer, M; McMurray, JJV				Solomon, Scott D.; Zile, Michael; Pieske, Burkert; Voors, Adriaan A.; Shah, Amil; Kraigher-Krainer, Elisabeth; Shi, Victor; Bransford, Toni; Takeuchi, Madoka; Gong, Jianjian; Lefkowitz, Martin; Packer, Milton; McMurray, John J. V.		Prospective Comparison ARNI ARB Ma	The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trial	LANCET			English	Article							NATRIURETIC-PEPTIDE; EUROPEAN-SOCIETY; ECHOCARDIOGRAPHY; PATHOPHYSIOLOGY; CARDIOMYOPATHY; ABNORMALITIES; HYPERTENSION; PREVALENCE; GUIDELINES; DIAGNOSIS	Background Heart failure with preserved ejection fraction is associated with substantial morbidity and mortality, but effective treatments are lacking. We assessed the efficacy and safety of LCZ696, a first-in-class angiotensin receptor neprilysin inhibitor (ARNI), in patients with this disorder. Methods PARAMOUNT was a phase 2, randomised, parallel-group, double-blind multicentre trial in patients with New York Heart Association (NYHA) class II-III heart failure, left ventricular ejection fraction 45% or higher, and NT-proBNP greater than 400 pg/mL. Participants were randomly assigned (1: 1) by central interactive voice response system to LCZ696 titrated to 200 mg twice daily or valsartan titrated to 160 mg twice daily, and treated for 36 weeks. Investigators and participants were masked to treatment assignment. The primary endpoint was change in NT-proBNP, a marker of left ventricular wall stress, from baseline to 12 weeks; analysis included all patients randomly assigned to treatment groups who had a baseline and at least one postbaseline assessment. This trial is registered at Clinicaltrials.gov, number NCT00887588. Findings 149 patients were randomly assigned to LCZ696 and 152 to valsartan; 134 in the LCZ696 group and 132 in the valsartan group were included in analysis of the primary endpoint. NT-proBNP was significantly reduced at 12 weeks in the LCZ696 group compared with the valsartan group (LCZ696: baseline, 783 pg/mL [95% CI 670-914], 12 weeks, 605 pg/mL [512-714]; valsartan: baseline, 862 pg/mL [733-1012], 12 weeks, 835 [710-981]; ratio LCZ696/valsartan, 0.77, 95% CI 0.64-0.92, p=0.005). LCZ696 was well tolerated with adverse effects similar to those of valsartan; 22 patients (15%) on LCZ696 and 30 (20%) on valsartan had one or more serious adverse event. Interpretation In patients with heart failure with preserved ejection fraction, LCZ696 reduced NT-proBNP to a greater extent than did valsartan at 12 weeks and was well tolerated. Whether these effects would translate into improved outcomes needs to be tested prospectively.	[Solomon, Scott D.; Shah, Amil; Kraigher-Krainer, Elisabeth; Takeuchi, Madoka] Brigham & Womens Hosp, Div Cardiovasc, Boston, MA 02115 USA; [Zile, Michael] Med Univ S Carolina, Charleston, SC 29425 USA; [Pieske, Burkert] Graz Univ, Graz, Austria; [Voors, Adriaan A.] Univ Groningen, Univ Med Ctr Groningen, Groningen, Netherlands; [Shi, Victor; Bransford, Toni; Gong, Jianjian; Lefkowitz, Martin] Novartis Pharmaceut, E Hanover, NJ USA; [Packer, Milton] Univ Texas SW, Dallas, TX USA; [McMurray, John J. V.] Univ Glasgow, Glasgow, Lanark, Scotland	Harvard University; Brigham & Women's Hospital; Medical University of South Carolina; University of Graz; University of Groningen; Novartis; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Glasgow	Solomon, SD (corresponding author), Brigham & Womens Hosp, Div Cardiovasc, 75 Francis St, Boston, MA 02115 USA.	ssolomon@rics.bwh.harvard.edu	Solomon, Scott/I-5789-2013; Ponikowski, Piotr/O-6454-2015; mcmurray, John/B-2467-2013; Voors, Adriaan/ABE-6784-2020; Senni, Michele/J-9380-2018; Pieske, Burkert/M-8089-2016	Ponikowski, Piotr/0000-0002-3391-7064; mcmurray, John/0000-0002-6317-3975; Senni, Michele/0000-0001-5502-7882; Zile, Michael/0000-0001-7076-221X; Gupta, Milan/0000-0002-7385-9006; Pieske, Burkert/0000-0002-6466-5306; Edelmann, Frank/0000-0003-4401-5936	Novartis	Novartis(Novartis)	Novartis.	Aronow WS, 1997, AM J CARDIOL, V80, P207, DOI 10.1016/S0002-9149(97)00320-2; Aurigemma GP, 2004, NEW ENGL J MED, V351, P1097, DOI 10.1056/NEJMcp022709; Bhatia RS, 2006, NEW ENGL J MED, V355, P260, DOI 10.1056/NEJMoa051530; Borlaug BA, 2011, EUR HEART J, V32, P670, DOI 10.1093/eurheartj/ehq426; Brenyo A, 2011, J AM COLL CARDIOL, V58, P1682, DOI 10.1016/j.jacc.2011.07.020; Chow SL, 2011, J CARD FAIL, V17, P181, DOI 10.1016/j.cardfail.2010.10.005; Cleland JGF, 2007, NEW ENGL J MED, V357, P829, DOI 10.1056/NEJMc076179; Cleland JGF, 2006, EUR HEART J, V27, P2338, DOI 10.1093/eurheartj/ehl250; Daniels LB, 2007, J AM COLL CARDIOL, V50, P2357, DOI 10.1016/j.jacc.2007.09.021; Fonarow GC, 2007, J AM COLL CARDIOL, V50, P768, DOI 10.1016/j.jacc.2007.04.064; Fryer RM, 2008, BRIT J PHARMACOL, V153, P947, DOI 10.1038/sj.bjp.0707641; Gardner DG, 2007, HYPERTENSION, V49, P419, DOI 10.1161/01.HYP.0000258532.07418.fa; Giannetta E, 2012, CIRCULATION, V125, P2323, DOI 10.1161/CIRCULATIONAHA.111.063412; Green CP, 2000, J AM COLL CARDIOL, V35, P1245, DOI 10.1016/S0735-1097(00)00531-3; Gu J, 2010, J CLIN PHARMACOL, V50, P401, DOI 10.1177/0091270009343932; Komajda M, 2011, CIRC-HEART FAIL, V4, P27, DOI 10.1161/CIRCHEARTFAILURE.109.932996; Kostis OB, 2004, AM J HYPERTENS, V17, P103, DOI 10.1016/j.amjhyper.2003.09.014; Lam CSP, 2011, EUR J HEART FAIL, V13, P18, DOI 10.1093/eurjhf/hfq121; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Martinez-Rumayor A, 2008, AM J CARDIOL, V101, p3A, DOI 10.1016/j.amjcard.2007.11.012; Massie BM, 2008, NEW ENGL J MED, V359, P2456, DOI 10.1056/NEJMoa0805450; Masson S, 2008, J AM COLL CARDIOL, V52, P997, DOI 10.1016/j.jacc.2008.04.069; McKie PM, 2011, J AM COLL CARDIOL, V58, P2095, DOI 10.1016/j.jacc.2011.07.042; McMurray JJV, 2012, EUR HEART J, V33, P1787, DOI 10.1093/eurheartj/ehs104; Ruilope LM, 2010, LANCET, V375, P1255, DOI 10.1016/S0140-6736(09)61966-8; Owan TE, 2006, NEW ENGL J MED, V355, P251, DOI 10.1056/NEJMoa052256; Packer M, 2001, J CARD FAIL, V7, P176, DOI 10.1054/jcaf.2001.25652; Potter LR, 2006, ENDOCR REV, V27, P47, DOI 10.1210/er.2005-0014; RICHARDS AM, 1993, J HYPERTENS, V11, P407, DOI 10.1097/00004872-199304000-00011; SETARO JF, 1990, AM J CARDIOL, V66, P981, DOI 10.1016/0002-9149(90)90937-V; Shah RV, 2010, J CARD FAIL, V16, P260, DOI 10.1016/j.cardfail.2009.11.007; Solomon SD, 2007, LANCET, V369, P2079, DOI 10.1016/S0140-6736(07)60980-5; Solomon SD, 2005, CIRCULATION, V112, P3738, DOI 10.1161/CIRCULATIONAHA.105.561423; Tan YT, 2009, J AM COLL CARDIOL, V54, P36, DOI 10.1016/j.jacc.2009.03.037; Tartiere-Kesri L, 2012, J AM COLL CARDIOL, V59, P455, DOI 10.1016/j.jacc.2011.10.873; VESELY DL, 1994, J CLIN ENDOCR METAB, V78, P1128, DOI 10.1210/jc.78.5.1128; Yip G, 2002, HEART, V87, P121, DOI 10.1136/heart.87.2.121; Yu CM, 2002, CIRCULATION, V105, P1195, DOI 10.1161/hc1002.105185; Yusuf S, 2003, LANCET, V362, P777, DOI 10.1016/S0140-6736(03)14285-7; Zile MR, 2011, CIRCULATION, V124, P2491, DOI 10.1161/CIRCULATIONAHA.110.011031; Zile MR, 2004, NEW ENGL J MED, V350, P1953, DOI 10.1056/NEJMoa032566	41	763	806	5	107	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 20	2012	380	9851					1387	1395		10.1016/S0140-6736(12)61227-6	http://dx.doi.org/10.1016/S0140-6736(12)61227-6			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	025NM	22932717				2022-12-28	WOS:000310196500028
J	Maitre, JL; Berthoumieux, H; Krens, SFG; Salbreux, G; Julicher, F; Paluch, E; Heisenberg, CP				Maitre, Jean-Leon; Berthoumieux, Helene; Krens, Simon Frederik Gabriel; Salbreux, Guillaume; Juelicher, Frank; Paluch, Ewa; Heisenberg, Carl-Philipp			Adhesion Functions in Cell Sorting by Mechanically Coupling the Cortices of Adhering Cells	SCIENCE			English	Article							E-CADHERIN; TENSION; HYPOTHESIS; CONTACTS; CATENIN; FORCES; RETINA	Differential cell adhesion and cortex tension are thought to drive cell sorting by controlling cell-cell contact formation. Here, we show that cell adhesion and cortex tension have different mechanical functions in controlling progenitor cell-cell contact formation and sorting during zebrafish gastrulation. Cortex tension controls cell-cell contact expansion by modulating interfacial tension at the contact. By contrast, adhesion has little direct function in contact expansion, but instead is needed to mechanically couple the cortices of adhering cells at their contacts, allowing cortex tension to control contact expansion. The coupling function of adhesion is mediated by E-cadherin and limited by the mechanical anchoring of E-cadherin to the cortex. Thus, cell adhesion provides the mechanical scaffold for cell cortex tension to drive cell sorting during gastrulation.	[Paluch, Ewa] Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany; [Paluch, Ewa] Int Inst Mol & Cell Biol, Warsaw, Poland; [Maitre, Jean-Leon; Krens, Simon Frederik Gabriel; Heisenberg, Carl-Philipp] IST Austria, Klosterneuburg, Austria; [Berthoumieux, Helene; Salbreux, Guillaume; Juelicher, Frank] Max Planck Inst Phys Komplexer Syst, Dresden, Germany; [Berthoumieux, Helene] Univ Paris 06, CNRS, Lab Phys Theor Mat Condensee, UMR 7600, Paris, France	Max Planck Society; Miedzynarodowy Instytut Biologii Molekularnej i Komorkowej; Institute of Science & Technology - Austria; Max Planck Society; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Sorbonne Universite	Paluch, E (corresponding author), Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany.	paluch@mpi-cbg.de; heisenberg@ist.ac.at	Maître, Jean-Léon/C-4372-2017; Krens, Gabriel/U-6760-2017; Julicher, Frank/B-1828-2009	Maître, Jean-Léon/0000-0002-3688-1474; Krens, Gabriel/0000-0003-4761-5996; Julicher, Frank/0000-0003-4731-9185; Salbreux, Guillaume/0000-0001-7041-1292; Heisenberg, Carl-Philipp/0000-0002-0912-4566; Paluch, Ewa/0000-0003-4691-2323	Max-Planck-Society; Polish Ministry of Science and Higher Education [454/N-MPG/2009/0]; Human Frontier Science Program [RGY0067/2008]; Fonds zur Forderung der wissenschaftlichen Forschung (FWF) [HE3231/6, I812-B12]; Austrian Science Fund (FWF) [I 812] Funding Source: researchfish	Max-Planck-Society(Max Planck Society); Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); Human Frontier Science Program(Human Frontier Science Program); Fonds zur Forderung der wissenschaftlichen Forschung (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	We thank M. Biro, J.-Y. Tinevez, and J. Ronsch for technical assistance, V. Barone for critical reading of earlier versions of this manuscript, and the facilities of the MPI-CBG and IST Austria for their continuous support. This work was supported by the Max-Planck-Society and grants from the Polish Ministry of Science and Higher Education to E. P. (454/N-MPG/2009/0), the Human Frontier Science Program to E. P. (RGY0067/2008), and the Fonds zur Forderung der wissenschaftlichen Forschung (FWF) to C.-P. H. (HE3231/6; I812-B12).	Bertet C, 2004, NATURE, V429, P667, DOI 10.1038/nature02590; Borghi N, 2012, P NATL ACAD SCI USA, V109, P12568, DOI 10.1073/pnas.1204390109; Brodland GW, 2002, J BIOMECH ENG-T ASME, V124, P188, DOI 10.1115/1.1449491; Chu YS, 2004, J CELL BIOL, V167, P1183, DOI 10.1083/jcb.200403043; Foty RA, 2005, DEV BIOL, V278, P255, DOI 10.1016/j.ydbio.2004.11.012; Hayashi T, 2004, NATURE, V431, P647, DOI 10.1038/nature02952; Kafer J, 2007, P NATL ACAD SCI USA, V104, P18549, DOI 10.1073/pnas.0704235104; Krieg M, 2008, NAT CELL BIOL, V10, P429, DOI 10.1038/ncb1705; le Duc Q, 2010, J CELL BIOL, V189, P1107, DOI 10.1083/jcb.201001149; Maitre JL, 2011, CURR OPIN CELL BIOL, V23, P508, DOI 10.1016/j.ceb.2011.07.004; Manning ML, 2010, P NATL ACAD SCI USA, V107, P12517, DOI 10.1073/pnas.1003743107; Martin AC, 2010, J CELL BIOL, V188, P735, DOI 10.1083/jcb.200910099; Seifert U, 2000, PHYS REV LETT, V84, P2750, DOI 10.1103/PhysRevLett.84.2750; Yamada S, 2005, CELL, V123, P889, DOI 10.1016/j.cell.2005.09.020; Yonemura S, 2010, NAT CELL BIOL, V12, P533, DOI 10.1038/ncb2055	15	352	354	2	104	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 12	2012	338	6104					253	256		10.1126/science.1225399	http://dx.doi.org/10.1126/science.1225399			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019BQ	22923438				2022-12-28	WOS:000309712300045
J	Mueller, ND; Gerber, JS; Johnston, M; Ray, DK; Ramankutty, N; Foley, JA				Mueller, Nathaniel D.; Gerber, James S.; Johnston, Matt; Ray, Deepak K.; Ramankutty, Navin; Foley, Jonathan A.			Closing yield gaps through nutrient and water management	NATURE			English	Article							INTENSIFICATION; CLIMATE; IMBALANCES; CHALLENGE; DEMAND	In the coming decades, a crucial challenge for humanity will be meeting future food demands without undermining further the integrity of the Earth's environmental systems(1-6). Agricultural systems are already major forces of global environmental degradation(4,7), but population growth and increasing consumption of calorie- and meat-intensive diets are expected to roughly double human food demand by 2050 (ref. 3). Responding to these pressures, there is increasing focus on 'sustainable intensification' as a means to increase yields on underperforming landscapes while simultaneously decreasing the environmental impacts of agricultural systems(2-4,8-11). However, it is unclear what such efforts might entail for the future of global agricultural landscapes. Here we present a global-scale assessment of intensification prospects from closing 'yield gaps' (differences between observed yields and those attainable in a given region), the spatial patterns of agricultural management practices and yield limitation, and the management changes that may be necessary to achieve increased yields. We find that global yield variability is heavily controlled by fertilizer use, irrigation and climate. Large production increases (45% to 70% for most crops) are possible from closing yield gaps to 100% of attainable yields, and the changes to management practices that are needed to close yield gaps vary considerably by region and current intensity. Furthermore, we find that there are large opportunities to reduce the environmental impact of agriculture by eliminating nutrient overuse, while still allowing an approximately 30% increase in production of major cereals (maize, wheat and rice). Meeting the food security and sustainability challenges of the coming decades is possible, but will require considerable changes in nutrient and water management.	[Mueller, Nathaniel D.; Gerber, James S.; Johnston, Matt; Ray, Deepak K.; Foley, Jonathan A.] Univ Minnesota, Inst Environm IonE, St Paul, MN 55108 USA; [Ramankutty, Navin] McGill Univ, Dept Geog, Montreal, PQ H3A 2K6, Canada; [Ramankutty, Navin] McGill Univ, Global Environm & Climate Change Ctr, Montreal, PQ H3A 2K6, Canada	University of Minnesota System; University of Minnesota Twin Cities; McGill University; McGill University	Mueller, ND (corresponding author), Univ Minnesota, Inst Environm IonE, St Paul, MN 55108 USA.	muell512@umn.edu	Ramankutty, Navin/AAM-6074-2020; Ray, Deepak K/F-7720-2012; Foley, Jonathan A/GRS-5522-2022; Mueller, Nathan D/E-5864-2010	Ramankutty, Navin/0000-0002-3737-5717; Mueller, Nathan D/0000-0003-1857-5104; Gerber, James/0000-0002-6890-0481; Ray, Deepak/0000-0002-2856-9608	National Science Foundation Graduate Research Fellowship; University of Minnesota College of Food, Agricultural and Natural Resource Sciences Fellowship; Natural Sciences and Engineering Research Council (NSERC) of Canada Discovery Grant; Gordon and Betty Moore Foundation; University of Minnesota Institute on the Environment	National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); University of Minnesota College of Food, Agricultural and Natural Resource Sciences Fellowship; Natural Sciences and Engineering Research Council (NSERC) of Canada Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); University of Minnesota Institute on the Environment	We thank G. Allez and K. Milligan for assistance with data collection. We are grateful to R. Licker, G. MacDonald, M. Mueller, S. Polasky, P. Potter, P. Reich, L. Schulte-Moore, D. Tilman, J. Van Wart and the Foley Laboratory for helpful conversations. We thank P. Robertson and P. Smith for helpful comments on the manuscript. Funding was provided by a National Science Foundation Graduate Research Fellowship and a University of Minnesota College of Food, Agricultural and Natural Resource Sciences Fellowship to N.D.M., a Natural Sciences and Engineering Research Council (NSERC) of Canada Discovery Grant to N.R., Gordon and Betty Moore Foundation funding to J. A. F., and support from the University of Minnesota Institute on the Environment.	[Anonymous], 2009, REAP BEN SCI SUST IN, p[1, 47]; Burney JA, 2010, P NATL ACAD SCI USA, V107, P12052, DOI 10.1073/pnas.0914216107; Cassman KG, 2002, AMBIO, V31, P132, DOI 10.1639/0044-7447(2002)031[0132:ANUEAN]2.0.CO;2; Cassman KG, 1999, P NATL ACAD SCI USA, V96, P5952, DOI 10.1073/pnas.96.11.5952; Cassman KG, 2003, ANNU REV ENV RESOUR, V28, P315, DOI 10.1146/annurev.energy.28.040202.122858; Clough Y, 2011, P NATL ACAD SCI USA, V108, P8311, DOI 10.1073/pnas.1016799108; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Foley JA, 2011, NATURE, V478, P337, DOI 10.1038/nature10452; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; Howden SM, 2007, P NATL ACAD SCI USA, V104, P19691, DOI 10.1073/pnas.0701890104; Johnston M, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/3/034028; Jordan N, 2007, SCIENCE, V316, P1570, DOI 10.1126/science.1141700; Ju XT, 2009, P NATL ACAD SCI USA, V106, P3041, DOI 10.1073/pnas.0813417106; Lambin EF, 2001, GLOBAL ENVIRON CHANG, V11, P261, DOI 10.1016/S0959-3780(01)00007-3; Licker R, 2010, GLOBAL ECOL BIOGEOGR, V19, P769, DOI 10.1111/j.1466-8238.2010.00563.x; Liu JG, 2010, P NATL ACAD SCI USA, V107, P8035, DOI 10.1073/pnas.0913658107; Lobell DB, 2009, ANNU REV ENV RESOUR, V34, P179, DOI 10.1146/annurev.environ.041008.093740; Lobell DB, 2011, SCIENCE, V333, P616, DOI [10.1126/science.1204531, 10.1126/science.1206376]; MacDonald GK, 2011, P NATL ACAD SCI USA, V108, P3086, DOI 10.1073/pnas.1010808108; Matson PA, 2006, CONSERV BIOL, V20, P709, DOI 10.1111/j.1523-1739.2006.00442.x; Monfreda C, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB002947; Oenema O, 2002, AMBIO, V31, P159, DOI 10.1639/0044-7447(2002)031[0159:NMIFPA]2.0.CO;2; Parry M. L., 2007, CLIMATE CHANGE 2007, P23; Portmann FT, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2008GB003435; Ramankutty N, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB002952; Robertson GP, 2005, FRONT ECOL ENVIRON, V3, P38, DOI 10.1890/1540-9295(2005)003[0038:RAPAEI]2.0.CO;2; Sanchez PA, 2010, NAT GEOSCI, V3, P299, DOI 10.1038/ngeo853; Tilman D, 2011, P NATL ACAD SCI USA, V108, P20260, DOI 10.1073/pnas.1116437108; Vitousek PM, 2009, SCIENCE, V324, P1519, DOI 10.1126/science.1170261	29	1525	1602	105	2042	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 11	2012	490	7419					254	257		10.1038/nature11420	http://dx.doi.org/10.1038/nature11420			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019IY	22932270				2022-12-28	WOS:000309733300048
J	de Moya, MA; Wong, JT; Kroshinsky, D; Robbins, GK; Shenoy-Bhangle, AS; Gimbel, DC				de Moya, Marc A.; Wong, Johnson T.; Kroshinsky, Daniela; Robbins, Gregory K.; Shenoy-Bhangle, Anuradha S.; Gimbel, Devon C.			Case 28-2012: A 30-Year-Old Woman with Shock and Abdominal-Wall Necrosis after Cesarean Section	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							FEBRILE NEUTROPHILIC DERMATOSIS; SOFT-TISSUE INFECTIONS; SWEETS-SYNDROME; NECROTIZING FASCIITIS; IMMUNODEFICIENCY; DETERMINANTS; DIAGNOSIS; MORTALITY		[de Moya, Marc A.] Massachusetts Gen Hosp, Dept Surg, Div Trauma Emergency Surg & Surg Crit Care, Boston, MA 02114 USA; [Wong, Johnson T.; Robbins, Gregory K.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Kroshinsky, Daniela] Massachusetts Gen Hosp, Dept Dermatol, Boston, MA 02114 USA; [Shenoy-Bhangle, Anuradha S.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Gimbel, Devon C.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [de Moya, Marc A.] Harvard Univ, Sch Med, Dept Surg, Boston, MA 02115 USA; [Wong, Johnson T.; Robbins, Gregory K.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Kroshinsky, Daniela] Harvard Univ, Sch Med, Dept Dermatol, Boston, MA 02115 USA; [Shenoy-Bhangle, Anuradha S.] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Gimbel, Devon C.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	de Moya, MA (corresponding author), Massachusetts Gen Hosp, Dept Surg, Div Trauma Emergency Surg & Surg Crit Care, Boston, MA 02114 USA.		Kroshinsky, Daniela/AAM-4608-2020	Kroshinsky, Daniela/0000-0002-4781-9676; Robbins, Gregory/0000-0001-7545-5817				Anaya DA, 2007, CLIN INFECT DIS, V44, P705, DOI 10.1086/511638; Anteby E Y, 1999, Infect Dis Obstet Gynecol, V7, P276, DOI 10.1155/S1064744999000514; Castro AG, 2008, ARCH GYNECOL OBSTET, V277, P579, DOI 10.1007/s00404-007-0509-z; Cohen P R, 1993, Obstet Gynecol Surv, V48, P584, DOI 10.1097/00006254-199308000-00027; Cohen PR, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-34; de Moya MA, 2009, NEW ENGL J MED, V361, P1689, DOI 10.1056/NEJMcpc0900646; Haliasos E, 2005, PEDIATR DERMATOL, V22, P530, DOI 10.1111/j.1525-1470.2005.00133.x; Kroshinsky D, 2012, J AM ACAD DERMATOL; Lear JT, 1997, POSTGRAD MED J, V73, P65, DOI 10.1136/pgmj.73.856.65; Lipp KE, 1999, J AM ACAD DERMATOL, V40, P838, DOI 10.1053/jd.1999.v40.a95650; Lopez-Sanchez M, 2008, EUR J OBSTET GYN R B, V140, P283, DOI 10.1016/j.ejogrb.2008.01.009; Marie I, 2001, J AM ACAD DERMATOL, V44, P137, DOI 10.1067/mjd.2001.110903; MCHENRY CR, 1995, ANN SURG, V221, P558, DOI 10.1097/00000658-199505000-00013; Menias CO, 2007, EMERG RADIOL, V13, P299, DOI 10.1007/s10140-006-0570-0; NEMLANDER A, 1983, TRANSPLANTATION, V36, P1, DOI 10.1097/00007890-198307000-00001; O'Regan GM, 2009, CLIN EXP DERMATOL, V34, P192, DOI 10.1111/j.1365-2230.2008.02814.x; SWEET RD, 1964, BRIT J DERMATOL, V76, P349, DOI 10.1111/j.1365-2133.1964.tb14541.x; Vignon-Pennamen MD, 2000, CLIN DERMATOL, V18, P339, DOI 10.1016/S0738-081X(99)00125-X; Wallach D, 2006, J AM ACAD DERMATOL, V55, P1066, DOI 10.1016/j.jaad.2006.07.016; Wong CH, 2004, CRIT CARE MED, V32, P1535, DOI 10.1097/01.CCM.0000129486.35458.7D; Wong CH, 2003, J BONE JOINT SURG AM, V85A, P1454, DOI 10.2106/00004623-200308000-00005; Zacharias N, 2010, ARCH SURG-CHICAGO, V145, P452, DOI 10.1001/archsurg.2010.50	22	3	3	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 13	2012	367	11					1046	1057		10.1056/NEJMcpc1208146	http://dx.doi.org/10.1056/NEJMcpc1208146			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	003ZE	22970948				2022-12-28	WOS:000308649100013
J	Prasad, M; Chow, G				Prasad, Manish; Chow, Gabriel			Neonatal seizure: what is the cause?	BRITISH MEDICAL JOURNAL			English	Editorial Material							CEREBRAL SINOVENOUS THROMBOSIS; SINUS THROMBOSIS; VENOUS THROMBOSIS; CHILDREN; DIAGNOSIS		[Prasad, Manish; Chow, Gabriel] Univ Nottingham, Queens Med Ctr, Childrens Hosp, Nottingham NG7 2UH, England	University of Nottingham	Prasad, M (corresponding author), Univ Nottingham, Queens Med Ctr, Childrens Hosp, Nottingham NG7 2UH, England.	m.prasad@nhs.net						BRAY PF, 1977, JAMA-J AM MED ASSOC, V237, P1342, DOI 10.1001/jama.237.13.1342; Carvalho KS, 2001, J CHILD NEUROL, V16, P574, DOI 10.1177/088307380101600807; DAOUSTROY J, 1992, AM J DIS CHILD, V146, P1236, DOI 10.1001/archpedi.1992.02160220122037; deVeber G, 2001, NEW ENGL J MED, V345, P417, DOI 10.1056/NEJM200108093450604; Einhaupl K, 2010, EUR J NEUROL, V17, P1229, DOI 10.1111/j.1468-1331.2010.03011.x; Ferro JM, 2004, STROKE, V35, P664, DOI 10.1161/01.STR.0000117571.76197.26; FERRO JM, 2007, CEREBROVASC DIS, V23, P48; Fitzgerald KC, 2006, ARCH NEUROL-CHICAGO, V63, P405, DOI 10.1001/archneur.63.3.405; Heller C, 2003, CIRCULATION, V108, P1362, DOI 10.1161/01.CIR.0000087598.05977.45; LEVENE MI, 1986, ARCH DIS CHILD, V61, P78, DOI 10.1136/adc.61.1.78; Masuhr F, 2006, EUR J NEUROL, V13, P852, DOI 10.1111/j.1468-1331.2006.01371.x; Mizrahi EM., 1998, DIAGNOSIS MANAGEMENT; Monagle P, 2008, CHEST, V133, p887S, DOI 10.1378/chest.08-0762; Saposnik G, 2011, STROKE, V42, P1158, DOI 10.1161/STR.0b013e31820a8364; Tsai FY, 2008, ACTA NEUROCHIR SUPPL, V101, P83; Volpe JJ, 2008, NEUROLOGY NEWBORN, P203; Volpe JJ, 2000, NEUROLOGY NEWBORN, P217; Yang JYK, 2010, PEDIATRICS, V126, pE693, DOI 10.1542/peds.2010-1035	18	2	2	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	SEP 12	2012	345								e6003	10.1136/bmj.e6003	http://dx.doi.org/10.1136/bmj.e6003			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	007BP	22977127				2022-12-28	WOS:000308864100008
J	Srivastava, R				Srivastava, Ranjana			Art of medicine It's about time	LANCET			English	Editorial Material									Dandenong Hosp, Dept Med Oncol, Dandenong, Vic 3175, Australia		Srivastava, R (corresponding author), Dandenong Hosp, Dept Med Oncol, Dandenong, Vic 3175, Australia.	ranjana.srivastava@southernhealth.org.au							0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 8	2012	380	9845					880	881		10.1016/S0140-6736(12)61494-9	http://dx.doi.org/10.1016/S0140-6736(12)61494-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	002QL	22966494				2022-12-28	WOS:000308547300016
J	Wang, C; Cai, WP; Tucker, JD; Li, LH; Hu, FY				Wang, Charles; Cai, Wei-Ping; Tucker, Joseph D.; Li, Ling-Hua; Hu, Feng-Yu			Falling down and following up	LANCET			English	Editorial Material									[Cai, Wei-Ping; Li, Ling-Hua; Hu, Feng-Yu] Guangxi Univ Tradit Chinese Med, Peoples Hosp Guangzhou 8, Guangzhou 510060, Guangdong, Peoples R China; [Wang, Charles; Tucker, Joseph D.] Univ N Carolina, Project China, Guangzhou, Guangdong, Peoples R China	Guangxi University of Chinese Medicine	Cai, WP (corresponding author), Guangxi Univ Tradit Chinese Med, Peoples Hosp Guangzhou 8, 627 Dongfeng Rd E, Guangzhou 510060, Guangdong, Peoples R China.	caiwp@163.net		Tucker, Joseph/0000-0003-2804-1181	FOGARTY INTERNATIONAL CENTER [K01TW008200] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R13AI102515] Funding Source: NIH RePORTER; FIC NIH HHS [K01 TW008200] Funding Source: Medline; NIAID NIH HHS [R13 AI102515] Funding Source: Medline	FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Kaplan Jonathan E., 2009, Morbidity and Mortality Weekly Report, V58, P1; Rosen S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001056; SUPPARATPINYO K, 1994, LANCET, V344, P110, DOI 10.1016/S0140-6736(94)91287-4; Wong K H, 1995, Zhonghua Yi Xue Za Zhi (Taipei), V55, P127; Zhang FJ, 2009, ANN INTERN MED, V151, P241, DOI 10.7326/0003-4819-151-4-200908180-00006	5	0	0	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 8	2012	380	9845					948	948		10.1016/S0140-6736(12)60645-X	http://dx.doi.org/10.1016/S0140-6736(12)60645-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	002QL	22959392	Green Accepted			2022-12-28	WOS:000308547300039
J	Rollins, AW; Browne, EC; Min, KE; Pusede, SE; Wooldridge, PJ; Gentner, DR; Goldstein, AH; Liu, S; Day, DA; Russell, LM; Cohen, RC				Rollins, A. W.; Browne, E. C.; Min, K-E; Pusede, S. E.; Wooldridge, P. J.; Gentner, D. R.; Goldstein, A. H.; Liu, S.; Day, D. A.; Russell, L. M.; Cohen, R. C.			Evidence for NOx Control over Nighttime SOA Formation	SCIENCE			English	Article							SECONDARY ORGANIC AEROSOL; ISOPRENE OXIDATION; NITRATE; EVOLUTION; IMPACT	Laboratory studies have established a number of chemical pathways by which nitrogen oxides (NOx) affect atmospheric organic aerosol (OA) production. However, these effects have not been directly observed in ambient OA. We report measurements of particulate organic nitrates in Bakersfield, California, the nighttime formation of which increases with NOx and is suppressed by high concentrations of organic molecules that rapidly react with nitrate radical (NO3)-evidence that multigenerational chemistry is responsible for organic nitrate aerosol production. This class of molecules represents about a third of the nighttime increase in OA, suggesting that most nighttime secondary OA is due to the NO3 product of anthropogenic NOx emissions. Consequently, reductions in NOx emissions should reduce the concentration of organic aerosol in Bakersfield and the surrounding region.	[Rollins, A. W.; Browne, E. C.; Pusede, S. E.; Wooldridge, P. J.; Cohen, R. C.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Min, K-E; Cohen, R. C.] Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA; [Gentner, D. R.; Goldstein, A. H.] Univ Calif Berkeley, Dept Civil & Environm Engn, Berkeley, CA 94720 USA; [Goldstein, A. H.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [Liu, S.; Day, D. A.; Russell, L. M.] Univ Calif San Diego, Scripps Inst Oceanog, San Diego, CA 92093 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California San Diego; Scripps Institution of Oceanography	Cohen, RC (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.	rccohen@berkeley.edu	Day, Douglas/ABE-6285-2020; Wooldridge, Paul/AFP-4233-2022; Goldstein, Allen H/A-6857-2011; Rollins, Andrew/G-7214-2012; Liu, Shang/F-9085-2011; Browne, Eleanor C/J-4517-2015; Cohen, Ronald C/A-8842-2011; Min, Kyung-Eun/I-2839-2013; Browne, Eleanor/K-4047-2019	Day, Douglas/0000-0003-3213-4233; Goldstein, Allen H/0000-0003-4014-4896; Liu, Shang/0000-0002-3403-8651; Browne, Eleanor C/0000-0002-8076-9455; Cohen, Ronald C/0000-0001-6617-7691; Browne, Eleanor/0000-0002-8076-9455; Russell, Lynn/0000-0002-6108-2375; Pusede, Sally/0000-0002-3041-0209	California Air Resources Board [CARB 08-316, 09-328]; NASA ESSF fellowship	California Air Resources Board; NASA ESSF fellowship	This work is supported by the California Air Resources Board under grants CARB 08-316 and 09-328. E. C. B. was supported by NASA ESSF fellowship.	Aiken AC, 2009, ATMOS CHEM PHYS, V9, P6633, DOI 10.5194/acp-9-6633-2009; Bianco L, 2011, BOUND-LAY METEOROL, V140, P361, DOI 10.1007/s10546-011-9617-1; Brown SS, 2009, ATMOS CHEM PHYS, V9, P3027, DOI 10.5194/acp-9-3027-2009; Carslaw David, 2011, TRENDS NOX NO2 EMISS; De Gouw J, 2009, ENVIRON SCI TECHNOL, V43, P7614, DOI 10.1021/es9006004; Fry JL, 2011, ATMOS CHEM PHYS, V11, P3879, DOI 10.5194/acp-11-3879-2011; Hallquist M, 1999, ENVIRON SCI TECHNOL, V33, P553, DOI 10.1021/es980292s; Hallquist M, 2009, ATMOS CHEM PHYS, V9, P5155, DOI 10.5194/acp-9-5155-2009; Heald CL, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL045095; Hennigan CJ, 2009, ATMOS CHEM PHYS, V9, P3613, DOI 10.5194/acp-9-3613-2009; Hildebrandt L, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL045193; Hoyle CR, 2011, ATMOS CHEM PHYS, V11, P321, DOI 10.5194/acp-11-321-2011; Jimenez JL, 2009, SCIENCE, V326, P1525, DOI 10.1126/science.1180353; Kroll JH, 2008, ATMOS ENVIRON, V42, P3593, DOI 10.1016/j.atmosenv.2008.01.003; LaFranchi BW, 2011, ATMOS CHEM PHYS, V11, P6945, DOI 10.5194/acp-11-6945-2011; Ng NL, 2008, ATMOS CHEM PHYS, V8, P4117, DOI 10.5194/acp-8-4117-2008; Rollins AW, 2009, ATMOS CHEM PHYS, V9, P6685, DOI 10.5194/acp-9-6685-2009; Rollins AW, 2010, ENVIRON SCI TECHNOL, V44, P5540, DOI 10.1021/es100926x; Surratt JD, 2008, J PHYS CHEM A, V112, P8345, DOI 10.1021/jp802310p; US EPA, 2010, OUR NAT AIR STAT TRE; Williams BJ, 2010, ATMOS CHEM PHYS, V10, P11577, DOI 10.5194/acp-10-11577-2010; WINER AM, 1984, SCIENCE, V224, P156, DOI 10.1126/science.224.4645.156; Zhang Q, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL029979; Zhang Q, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2007JD008684	24	188	198	17	394	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 7	2012	337	6099					1210	1212		10.1126/science.1221520	http://dx.doi.org/10.1126/science.1221520			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	000UJ	22955831				2022-12-28	WOS:000308414000033
J	Djebali, S; Davis, CA; Merkel, A; Dobin, A; Lassmann, T; Mortazavi, A; Tanzer, A; Lagarde, J; Lin, W; Schlesinger, F; Xue, CH; Marinov, GK; Khatun, J; Williams, BA; Zaleski, C; Rozowsky, J; Roder, M; Kokocinski, F; Abdelhamid, RF; Alioto, T; Antoshechkin, I; Baer, MT; Bar, NS; Batut, P; Bell, K; Bell, I; Chakrabortty, S; Chen, X; Chrast, J; Curado, J; Derrien, T; Drenkow, J; Dumais, E; Dumais, J; Duttagupta, R; Falconnet, E; Fastuca, M; Fejes-Toth, K; Ferreira, P; Foissac, S; Fullwood, MJ; Gao, H; Gonzalez, D; Gordon, A; Gunawardena, H; Howald, C; Jha, S; Johnson, R; Kapranov, P; King, B; Kingswood, C; Luo, OJ; Park, E; Persaud, K; Preall, JB; Ribeca, P; Risk, B; Robyr, D; Sammeth, M; Schaffer, L; See, LH; Shahab, A; Skancke, J; Suzuki, AM; Takahashi, H; Tilgner, H; Trout, D; Walters, N; Wang, H; Wrobel, J; Yu, YB; Ruan, XA; Hayashizaki, Y; Harrow, J; Gerstein, M; Hubbard, T; Reymond, A; Antonarakis, SE; Hannon, G; Giddings, MC; Ruan, YJ; Wold, B; Carninci, P; Guigo, R; Gingeras, TR				Djebali, Sarah; Davis, Carrie A.; Merkel, Angelika; Dobin, Alex; Lassmann, Timo; Mortazavi, Ali; Tanzer, Andrea; Lagarde, Julien; Lin, Wei; Schlesinger, Felix; Xue, Chenghai; Marinov, Georgi K.; Khatun, Jainab; Williams, Brian A.; Zaleski, Chris; Rozowsky, Joel; Roeder, Maik; Kokocinski, Felix; Abdelhamid, Rehab F.; Alioto, Tyler; Antoshechkin, Igor; Baer, Michael T.; Bar, Nadav S.; Batut, Philippe; Bell, Kimberly; Bell, Ian; Chakrabortty, Sudipto; Chen, Xian; Chrast, Jacqueline; Curado, Joao; Derrien, Thomas; Drenkow, Jorg; Dumais, Erica; Dumais, Jacqueline; Duttagupta, Radha; Falconnet, Emilie; Fastuca, Meagan; Fejes-Toth, Kata; Ferreira, Pedro; Foissac, Sylvain; Fullwood, Melissa J.; Gao, Hui; Gonzalez, David; Gordon, Assaf; Gunawardena, Harsha; Howald, Cedric; Jha, Sonali; Johnson, Rory; Kapranov, Philipp; King, Brandon; Kingswood, Colin; Luo, Oscar J.; Park, Eddie; Persaud, Kimberly; Preall, Jonathan B.; Ribeca, Paolo; Risk, Brian; Robyr, Daniel; Sammeth, Michael; Schaffer, Lorian; See, Lei-Hoon; Shahab, Atif; Skancke, Jorgen; Suzuki, Ana Maria; Takahashi, Hazuki; Tilgner, Hagen; Trout, Diane; Walters, Nathalie; Wang, Huaien; Wrobel, John; Yu, Yanbao; Ruan, Xiaoan; Hayashizaki, Yoshihide; Harrow, Jennifer; Gerstein, Mark; Hubbard, Tim; Reymond, Alexandre; Antonarakis, Stylianos E.; Hannon, Gregory; Giddings, Morgan C.; Ruan, Yijun; Wold, Barbara; Carninci, Piero; Guigo, Roderic; Gingeras, Thomas R.			Landscape of transcription in human cells	NATURE			English	Article							RNA; GENOME; IDENTIFICATION; ENHANCERS; MAPS	Eukaryotic cells make many types of primary and processed RNAs that are found either in specific subcellular compartments or throughout the cells. A complete catalogue of these RNAs is not yet available and their characteristic subcellular localizations are also poorly understood. Because RNA represents the direct output of the genetic information encoded by genomes and a significant proportion of a cell's regulatory capabilities are focused on its synthesis, processing, transport, modification and translation, the generation of such a catalogue is crucial for understanding genome function. Here we report evidence that three-quarters of the human genome is capable of being transcribed, as well as observations about the range and levels of expression, localization, processing fates, regulatory regions and modifications of almost all currently annotated and thousands of previously unannotated RNAs. These observations, taken together, prompt a redefinition of the concept of a gene.	[Djebali, Sarah; Merkel, Angelika; Tanzer, Andrea; Lagarde, Julien; Roeder, Maik; Alioto, Tyler; Curado, Joao; Derrien, Thomas; Ferreira, Pedro; Gonzalez, David; Johnson, Rory; King, Brandon; Kingswood, Colin; Ribeca, Paolo; Sammeth, Michael; Skancke, Jorgen; Tilgner, Hagen; Guigo, Roderic] Ctr Gen Regulat, Barcelona 08003, Catalonia, Spain; [Djebali, Sarah; Merkel, Angelika; Tanzer, Andrea; Lagarde, Julien; Roeder, Maik; Alioto, Tyler; Curado, Joao; Derrien, Thomas; Ferreira, Pedro; Gonzalez, David; Johnson, Rory; King, Brandon; Kingswood, Colin; Ribeca, Paolo; Sammeth, Michael; Skancke, Jorgen; Tilgner, Hagen; Guigo, Roderic] UPF, Barcelona 08003, Catalonia, Spain; [Davis, Carrie A.; Dobin, Alex; Lin, Wei; Schlesinger, Felix; Xue, Chenghai; Zaleski, Chris; Baer, Michael T.; Batut, Philippe; Bell, Kimberly; Chakrabortty, Sudipto; Drenkow, Jorg; Fastuca, Meagan; Fejes-Toth, Kata; Gordon, Assaf; Jha, Sonali; Persaud, Kimberly; Preall, Jonathan B.; See, Lei-Hoon; Wang, Huaien; Hannon, Gregory; Gingeras, Thomas R.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11742 USA; [Lassmann, Timo; Abdelhamid, Rehab F.; Suzuki, Ana Maria; Takahashi, Hazuki; Hayashizaki, Yoshihide; Carninci, Piero] RIKEN Omics Sci Ctr, RIKEN Yokohama Inst, Tsurumi ku, Yokohama, Kanagawa 2300045, Japan; [Mortazavi, Ali; Marinov, Georgi K.; Williams, Brian A.; Antoshechkin, Igor; King, Brandon; Schaffer, Lorian; Trout, Diane; Wold, Barbara] CALTECH, Beckman Inst 2, Div Biol, Pasadena, CA 91125 USA; [Mortazavi, Ali; Park, Eddie] Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92697 USA; [Khatun, Jainab; Risk, Brian; Wrobel, John] Boise State Univ, Coll Arts & Sci, Boise, ID 83725 USA; [Rozowsky, Joel; Gerstein, Mark] Yale Univ, Program Computat Biol & Bioinformat, New Haven, CT 06520 USA; [Rozowsky, Joel; Gerstein, Mark] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Kokocinski, Felix; Harrow, Jennifer; Hubbard, Tim] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Alioto, Tyler; Kingswood, Colin; Ribeca, Paolo; Sammeth, Michael] CNAG, Barcelona 08028, Catalonia, Spain; [Bar, Nadav S.; Skancke, Jorgen] Norwegian Univ Sci & Technol, Dept Chem Engn, NO-7491 Trondheim, Norway; [Bell, Ian; Dumais, Erica; Dumais, Jacqueline; Duttagupta, Radha; Foissac, Sylvain; Gao, Hui; Kapranov, Philipp; Gingeras, Thomas R.] Affymetrix Inc, Santa Clara, CA 95051 USA; [Chen, Xian; Gunawardena, Harsha; Yu, Yanbao; Giddings, Morgan C.] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Chrast, Jacqueline; Howald, Cedric; Walters, Nathalie; Reymond, Alexandre] Univ Lausanne, Ctr Integrat Gen, CH-1015 Lausanne, Switzerland; [Falconnet, Emilie; Robyr, Daniel; Antonarakis, Stylianos E.] Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland; [Falconnet, Emilie; Robyr, Daniel; Antonarakis, Stylianos E.] IGE3 Inst Genet & Genom Geneva, CH-1211 Geneva, Switzerland; [Fullwood, Melissa J.; Luo, Oscar J.; Shahab, Atif; Ruan, Xiaoan; Ruan, Yijun] Genome Inst Singapore, Singapore 138672, Singapore; [Kapranov, Philipp] St Laurent Inst, Cambridge, MA 02141 USA; [Gerstein, Mark] Yale Univ, Dept Comp Sci, New Haven, CT 06520 USA; [Guigo, Roderic] Univ Pompeu Fabra, Dept Ciencies Expt & Salut, Barcelona, Catalonia, Spain	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University; Cold Spring Harbor Laboratory; RIKEN; California Institute of Technology; University of California System; University of California Irvine; Idaho; Boise State University; Yale University; Yale University; Wellcome Trust Sanger Institute; Norwegian University of Science & Technology (NTNU); Affymetrix; University of North Carolina; University of North Carolina Chapel Hill; University of Lausanne; University of Geneva; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Yale University; Pompeu Fabra University	Guigo, R (corresponding author), Ctr Gen Regulat, Doctor Aiguader 88, Barcelona 08003, Catalonia, Spain.	roderic.guigo@crg.eu; gingeras@cshl.edu	Hubbard, Tim J/C-2567-2008; Djebali, Sarah/O-9817-2014; Hannon, Gregory/AAB-3568-2019; Kutalik, Zoltan/HHZ-5697-2022; Johnson, Rory/H-2961-2015; Johnson, Rory/ABE-2503-2021; Luo, Junhong/N-8583-2019; Yu, Yanbao/G-3035-2010; Derrien, Thomas/ABD-6197-2020; Guigo, Roderic/D-1303-2010; Alioto, Tyler/AAF-6342-2020; Lassmann, Timo/HCH-4313-2022; Lagarde, Julien/AAI-1686-2020; Antonarakis, Stylianos E/N-8866-2014; Takahashi, Hazuki/F-9007-2017; Ferreira, Pedro/HDO-1346-2022; Hubbard, Tim J.P./AAT-4571-2020; Fullwood, Melissa/G-5713-2011; Tanzer, Andrea/AAY-5431-2021; Alioto, Tyler/K-7267-2015; Lassmann, Timo/A-8271-2008; Ferreira, Pedro G/J-6379-2013; Lin, Wei/AAH-9924-2019; Tanzer, Andrea/L-3147-2015; Sammeth, Michael/C-1157-2014; Luo, Oscar Junhong/G-3293-2018; Gao, Hui/AAF-9770-2019; Carninci, Piero/K-1568-2014	Hubbard, Tim J/0000-0002-1767-9318; Djebali, Sarah/0000-0002-0599-1267; Kutalik, Zoltan/0000-0001-8285-7523; Johnson, Rory/0000-0003-4607-2782; Johnson, Rory/0000-0003-4607-2782; Yu, Yanbao/0000-0003-2994-1974; Guigo, Roderic/0000-0002-5738-4477; Alioto, Tyler/0000-0002-2960-5420; Lassmann, Timo/0000-0002-0138-2691; Lagarde, Julien/0000-0002-0290-7445; Antonarakis, Stylianos E/0000-0001-8907-5823; Takahashi, Hazuki/0000-0001-7315-7349; Hubbard, Tim J.P./0000-0002-1767-9318; Fullwood, Melissa/0000-0003-0321-7865; Tanzer, Andrea/0000-0003-2873-4236; Alioto, Tyler/0000-0002-2960-5420; Lassmann, Timo/0000-0002-0138-2691; Ferreira, Pedro G/0000-0003-3838-8664; Lin, Wei/0000-0002-7506-3466; Tanzer, Andrea/0000-0003-2873-4236; Sammeth, Michael/0000-0002-6528-9883; Carninci, Piero/0000-0001-7202-7243; Marinov, Georgi/0000-0003-1822-7273; Merkel, Angelika/0000-0001-5164-6803; Luo, Oscar Junhong/0000-0002-1266-3069; Kapranov, Philipp/0000-0003-2647-4856; Gingeras, Thomas/0000-0001-9106-3573; Dobin, Alexander/0000-0002-4115-9128; park, eddie/0000-0001-5651-1481; Kokocinski, Felix/0000-0002-8472-9207; Reymond, Alexandre/0000-0003-1030-8327; Batut, Philippe/0000-0003-4250-0663; Derrien, Thomas/0000-0002-8211-5789; Bell, Kimberly/0000-0003-2204-8569; Harrow, Jennifer/0000-0003-0338-3070; Foissac, Sylvain/0000-0002-2631-5356; Rozowsky, Joel/0000-0002-3565-0762; Curado, Joao/0000-0003-3916-0936	National Human Genome Research Institute (NHGRI) [U54HG004557, U54HG004555, U54HG004576, U54HG004558]; NHGRI pilot grant [R01HG003700]; NHGRI ARRA stimulus grant [1RC2HG005591]; National Science Foundation (SNF) [127375]; European Research Council (ERC) [249968]; Japanese Ministry of Education, Culture, Sports, Science and Technology; INB GNV-1 from the Spanish Ministry of Science;  [BIO2011-26205];  [CSD2007-00050]; NATIONAL CANCER INSTITUTE [P30CA045508] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG003147, U54HG004555, U54HG007004, R01HG003700, RC2HG005591, U54HG004557, U54HG004576, U54HG004558] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM062534] Funding Source: NIH RePORTER	National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI pilot grant; NHGRI ARRA stimulus grant; National Science Foundation (SNF); European Research Council (ERC)(European Research Council (ERC)); Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); INB GNV-1 from the Spanish Ministry of Science; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Human Genome Research Institute (NHGRI) production grants U54HG004557, U54HG004555, U54HG004576 and U54HG004558, and by the NHGRI pilot grant R01HG003700. It was also supported by the NHGRI ARRA stimulus grant 1RC2HG005591, the National Science Foundation (SNF) grant 127375, the European Research Council (ERC) grant 249968, a research grant for the RIKEN Omics Science Center from the Japanese Ministry of Education, Culture, Sports, Science and Technology, and grants BIO2011-26205, CSD2007-00050 and INB GNV-1 from the Spanish Ministry of Science. We would also like to thank C. Gunter and W. Spitzer for editorial assistance with the manuscript.	Ameur A, 2011, NAT STRUCT MOL BIOL, V18, P1435, DOI 10.1038/nsmb.2143; Arvey A., GENOME RES IN PRESS; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Cheng J, 2005, SCIENCE, V308, P1149, DOI 10.1126/science.1108625; Coffey AJ, 2011, EUR J HUM GENET, V19, P827, DOI 10.1038/ejhg.2011.28; Cole C, 2009, RNA, V15, P2147, DOI 10.1261/rna.1738409; Faulkner GJ, 2009, NAT GENET, V41, P563, DOI 10.1038/ng.368; Feingold EA, 2004, SCIENCE, V306, P636, DOI 10.1126/science.1105136; Fejes-Toth K, 2009, NATURE, V457, P1028, DOI 10.1038/nature07759; Fu YG, 2011, GENOME RES, V21, P741, DOI 10.1101/gr.115295.110; Harrow J., GENOME RES IN PRESS; Harrow J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s4; Hoffman M., GENOME RES IN PRESS; Kapranov P, 2007, NAT REV GENET, V8, P413, DOI 10.1038/nrg2083; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; KATINAKIS PK, 1980, FEBS LETT, V116, P1, DOI 10.1016/0014-5793(80)80515-1; Kawaji H, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-157; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Kodzius R, 2006, NAT METHODS, V3, P211, DOI 10.1038/nmeth0306-211; Kundaje A., GENOME RES IN PRESS; Lee YS, 2009, GENE DEV, V23, P2639, DOI 10.1101/gad.1837609; Li MY, 2011, SCIENCE, V333, P53, DOI 10.1126/science.1207018; Li QH, 2011, ANN APPL STAT, V5, P1752, DOI 10.1214/11-AOAS466; Mattick JS, 2011, SEMIN CELL DEV BIOL, V22, P327, DOI 10.1016/j.semcdb.2011.05.002; MILCAREK C, 1974, CELL, V3, P1, DOI 10.1016/0092-8674(74)90030-0; Miller B., GENOME RES IN PRESS; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Ng P, 2005, NAT METHODS, V2, P105, DOI 10.1038/NMETH733; Park E., 1943, GENOME RES IN PRESS; Ren B, 2010, NATURE, V465, P173, DOI 10.1038/465173a; Rozowsky J, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.54; SALDITTGEORGIEFF M, 1981, MOL CELL BIOL, V1, P179, DOI 10.1128/MCB.1.2.179; Tilgner H., GENOME RES IN PRESS; Wang D, 2011, NATURE, V474, P390, DOI 10.1038/nature10006; Wang J., GENOME RES IN PRESS; Yip K. Y., GENOME BIOL IN PRESS	36	3422	3559	6	399	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 6	2012	489	7414					101	108		10.1038/nature11233	http://dx.doi.org/10.1038/nature11233			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999WW	22955620	hybrid, Green Accepted, Green Published			2022-12-28	WOS:000308347000043
J	Cruz-Ramirez, A; Diaz-Trivino, S; Blilou, I; Grieneisen, VA; Sozzani, R; Zamioudis, C; Miskolczi, P; Nieuwland, J; Benjamins, R; Dhonukshe, P; Caballero-Perez, J; Horvath, B; Long, YC; Mahonen, AP; Zhang, HT; Xu, J; Murray, JAH; Benfey, PN; Bako, L; Maree, AFM; Scheres, B				Cruz-Ramirez, Alfredo; Diaz-Trivino, Sara; Blilou, Ikram; Grieneisen, Veronica A.; Sozzani, Rosangela; Zamioudis, Christos; Miskolczi, Pal; Nieuwland, Jeroen; Benjamins, Rene; Dhonukshe, Pankaj; Caballero-Perez, Juan; Horvath, Beatrix; Long, Yuchen; Mahonen, Ari Pekka; Zhang, Hongtao; Xu, Jian; Murray, James A. H.; Benfey, Philip N.; Bako, Laszlo; Maree, Athanasius F. M.; Scheres, Ben			A Bistable Circuit Involving SCARECROW-RETINOBLASTOMA Integrates Cues to Inform Asymmetric Stem Cell Division	CELL			English	Article							PROTEIN-PROTEIN INTERACTIONS; ARABIDOPSIS ROOT-MERISTEM; TUMOR-SUPPRESSOR; SPLIT LUCIFERASE; AUXIN TRANSPORT; CYCLE; GENE; DIFFERENTIATION; PLANTS; GROWTH	In plants, where cells cannot migrate, asymmetric cell divisions (ACDs) must be confined to the appropriate spatial context. We investigate tissue-generating asymmetric divisions in a stem cell daughter within the Arabidopsis root. Spatial restriction of these divisions requires physical binding of the stem cell regulator SCARECROW (SCR) by the RETINOBLASTOM-RELATED (RBR) protein. In the stem cell niche, SCR activity is counteracted by phosphorylation of RBR through a cyclinD6;1-CDK complex. This cyclin is itself under transcriptional control of SCR and its partner SHORT ROOT (SHR), creating a robust bistable circuit with either high or low SHR-SCR complex activity. Auxin biases this circuit by promoting CYCD6;1 transcription. Mathematical modeling shows that ACDs are only switched on after integration of radial and longitudinal information, determined by SHR and auxin distribution, respectively. Coupling of cell-cycle progression to protein degradation resets the circuit, resulting in a "flip flop" that constrains asymmetric cell division to the stem cell region.	[Grieneisen, Veronica A.; Maree, Athanasius F. M.] John Innes Ctr, Dept Computat & Syst Biol, Norwich NR4 7UH, Norfolk, England; [Cruz-Ramirez, Alfredo; Diaz-Trivino, Sara; Blilou, Ikram; Zamioudis, Christos; Benjamins, Rene; Dhonukshe, Pankaj; Horvath, Beatrix; Long, Yuchen; Mahonen, Ari Pekka; Zhang, Hongtao; Xu, Jian; Scheres, Ben] Univ Utrecht, Dept Biol, NL-3584 CH Utrecht, Netherlands; [Grieneisen, Veronica A.] Univ E Anglia, Sch Biol Sci, Dept Cell & Dev Biol, Norwich NR4 7TJ, Norfolk, England; [Sozzani, Rosangela; Benfey, Philip N.] Duke Univ, Dept Biol, Ctr Syst Biol, Durham, NC 27708 USA; [Sozzani, Rosangela; Benfey, Philip N.] Duke Univ, Inst Genome Sci & Policy, Ctr Syst Biol, Durham, NC 27708 USA; [Miskolczi, Pal; Bako, Laszlo] Umea Univ, Dept Plant Physiol, Umea Plant Sci Ctr, S-90187 Umea, Sweden; [Miskolczi, Pal; Bako, Laszlo] Swedish Univ Agr Sci, Dept Forest Genet & Plant Physiol, Umea Plant Sci Ctr, S-90183 Umea, Sweden; [Nieuwland, Jeroen; Murray, James A. H.] Cardiff Sch Biosci, Cardiff CF10 3AX, S Glam, Wales; [Caballero-Perez, Juan] Inst Syst Biol, Seattle, WA 98109 USA	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Utrecht University; University of East Anglia; Duke University; Duke University; Umea University; Swedish University of Agricultural Sciences; Umea University; Cardiff University; Institute for Systems Biology (ISB)	Maree, AFM (corresponding author), John Innes Ctr, Dept Computat & Syst Biol, Norwich Res Pk, Norwich NR4 7UH, Norfolk, England.	stan.maree@jic.ac.uk; b.scheres@uu.nl	Murray, James AH/D-3399-2009; Cruz-Ramirez, Luis Alfredo/B-7588-2009; Long, Yuchen/GZA-6989-2022; Ramírez, Luis Alfredo Cruz/K-2548-2019; Mähönen, Ari Pekka/B-9764-2015; Xu, Jian/I-2921-2012; Zhang, Hongtao/HGU-4141-2022; Zamioudis, Christos/AAO-2325-2021	Murray, James AH/0000-0002-2282-3839; Cruz-Ramirez, Luis Alfredo/0000-0001-9973-5784; Long, Yuchen/0000-0001-5071-4632; Ramírez, Luis Alfredo Cruz/0000-0001-9973-5784; Mähönen, Ari Pekka/0000-0001-6051-866X; Xu, Jian/0000-0001-6194-6316; Blilou, Ikram/0000-0001-8003-3782; Grieneisen, Veronica/0000-0001-6780-8301; Miskolczi, Pal/0000-0003-1036-5831; Maree, Athanasius F. M./0000-0003-2689-2484; Scheres, Ben/0000-0001-5400-9578; Zhang, Hongtao/0000-0002-4903-571X; Sozzani, Rosangela/0000-0003-3316-2367; Caballero Perez, Juan/0000-0002-6160-3644	ERC; ALW-ERAPG [855.50.017]; EMBO-ALTF [1114-2006]; CONACYT [000000000092916]; Ministerio de Educacion y Ciencia, Spain; Marie Curie IEF [IEF-2008-237643]; Dorothy Hodgkin Fellowship; UK Biological and Biotechnology Research Council (BBSRC) [BB/J004553/1]; NWO VIDI grant; NIH [R01-GM043778]; Swedish Research Council; Carl Tryggers Stiftelse grants; BBSRC [BB/G00482X]; ERASysBio+ initiative under the EU FP7 ERA-NET Plus scheme; Biotechnology and Biological Sciences Research Council [BB/G00482X/1, BBS/E/J/000C0646, BBS/E/J/000C0645, BB/J009199/1, BB/E022383/2, BB/E022383/1] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM081883, R01GM043778] Funding Source: NIH RePORTER; BBSRC [BB/E022383/1, BBS/E/J/000C0645, BBS/E/J/000C0646, BB/G00482X/1, BB/E022383/2, BB/J009199/1] Funding Source: UKRI	ERC(European Research Council (ERC)European Commission); ALW-ERAPG; EMBO-ALTF; CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Ministerio de Educacion y Ciencia, Spain(Spanish Government); Marie Curie IEF(European Commission); Dorothy Hodgkin Fellowship; UK Biological and Biotechnology Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NWO VIDI grant(Netherlands Organization for Scientific Research (NWO)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swedish Research Council(Swedish Research CouncilEuropean Commission); Carl Tryggers Stiftelse grants; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); ERASysBio+ initiative under the EU FP7 ERA-NET Plus scheme; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank Dominique Bergmann for critically reviewing this manuscript; Fred Sack, Lieven de Veylder, Naohiro Kato, Dorus Gadella, Joachim Goedhart, Tom Beeckman, and Tom Bennett for materials; and Anahi Perez-Torres, Luis Herrera-Estrella, and Juan Carlos del Pozo for technical advice. B. S. was supported by an ERC Advanced Investigator Fellowship and by ALW-ERAPG grant 855.50.017. A.C.-R. was supported by EMBO-ALTF 1114-2006 and CONACYT 000000000092916 grants. S.D.-T. was funded by Ministerio de Educacion y Ciencia, Spain, and by Marie Curie IEF (IEF-2008-237643). V. A. G. was supported by the Dorothy Hodgkin Fellowship. V. A. G. and A. F. M. M. were supported by the UK Biological and Biotechnology Research Council (BBSRC) via grant BB/J004553/1 to the John Innes Centre. I. B. was sponsored by an NWO VIDI grant. P.N.B. was funded by NIH grant R01-GM043778. L. B. was supported by Swedish Research Council and by Carl Tryggers Stiftelse grants. Work in James A. H. Murray laboratory was supported by the BBSRC grant BB/G00482X and by the ERASysBio+ initiative under the EU FP7 ERA-NET Plus scheme.	Abrash EB, 2009, DEV CELL, V16, P783, DOI 10.1016/j.devcel.2009.05.014; Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Berman SD, 2008, MOL CANCER RES, V6, P1440, DOI 10.1158/1541-7786.MCR-08-0176; Boniotti MB, 2001, PLANT J, V28, P341, DOI 10.1046/j.1365-313X.2001.01160.x; Borghi L, 2010, PLANT CELL, V22, P1792, DOI 10.1105/tpc.110.074591; Boruc J, 2010, PLANT CELL, V22, P1264, DOI 10.1105/tpc.109.073635; Calo E, 2010, NATURE, V466, P1110, DOI 10.1038/nature09264; Chen D, 2007, PLOS BIOL, V5, P1504, DOI 10.1371/journal.pbio.0050179; Chen HM, 2008, PLANT PHYSIOL, V146, P368, DOI 10.1104/pp.107.111740; Chen PL, 1996, GENE DEV, V10, P2794, DOI 10.1101/gad.10.21.2794; Cools T, 2010, PLANT J, V64, P705, DOI 10.1111/j.1365-313X.2010.04361.x; Cui HC, 2007, SCIENCE, V316, P421, DOI 10.1126/science.1139531; Dhonukshe P, 2012, CELL, V149, P383, DOI 10.1016/j.cell.2012.02.051; DiLaurenzio L, 1996, CELL, V86, P423, DOI 10.1016/S0092-8674(00)80115-4; Fujikawa Y, 2007, PLANT J, V52, P185, DOI 10.1111/j.1365-313X.2007.03214.x; Fulop K, 2005, CELL CYCLE, V4, P1084; Genschik P, 1998, PLANT CELL, V10, P2063; Grieneisen VA, 2007, NATURE, V449, P1008, DOI 10.1038/nature06215; Harbour JW, 2000, GENE DEV, V14, P2393, DOI 10.1101/gad.813200; Heidstra R, 2004, GENE DEV, V18, P1964, DOI 10.1101/gad.305504; Helariutta Y, 2000, CELL, V101, P555, DOI 10.1016/S0092-8674(00)80865-X; Horvath BM, 2006, EMBO J, V25, P4909, DOI 10.1038/sj.emboj.7601362; Kosugi S, 2002, PLANT J, V29, P45, DOI 10.1046/j.1365-313x.2002.01196.x; KREK W, 1994, CELL, V78, P161, DOI 10.1016/0092-8674(94)90582-7; Laskowski M, 2008, PLOS BIOL, V6, P2721, DOI 10.1371/journal.pbio.0060307; Lechner E, 2002, J BIOL CHEM, V277, P50069, DOI 10.1074/jbc.M204254200; Lee JO, 1998, NATURE, V391, P859, DOI 10.1038/36038; Lendvai A, 2007, J EXP BOT, V58, P1663, DOI 10.1093/jxb/erm022; Lux A, 2005, ANN BOT-LONDON, V96, P989, DOI 10.1093/aob/mci266; Nakagami H, 2002, PLANT CELL, V14, P1847, DOI 10.1105/tpc.002550; Nalam RL, 2009, MOL ENDOCRINOL, V23, P1900, DOI 10.1210/me.2009-0184; Nieuwland J, 2009, P NATL ACAD SCI USA, V106, P22528, DOI 10.1073/pnas.0906354106; Ozawa T, 2001, ANAL CHEM, V73, P2516, DOI 10.1021/ac0013296; PEACEMAN DW, 1955, J SOC IND APPL MATH, V3, P28, DOI 10.1137/0103003; Perez-Torres CA, 2008, PLANT CELL, V20, P3258, DOI 10.1105/tpc.108.058719; Planchais S, 2004, PLANT J, V38, P616, DOI 10.1111/j.0960-7412.2004.02071.x; Sabatini S, 1999, CELL, V99, P463, DOI 10.1016/S0092-8674(00)81535-4; Sabatini S, 2003, GENE DEV, V17, P354, DOI 10.1101/gad.252503; Sanz L, 2011, PLANT CELL, V23, P641, DOI 10.1105/tpc.110.080002; Sarkar AK, 2007, NATURE, V446, P811, DOI 10.1038/nature05703; Segers G, 1996, PLANT J, V10, P601, DOI 10.1046/j.1365-313X.1996.10040601.x; Sena G, 2004, DEVELOPMENT, V131, P2817, DOI 10.1242/dev.01144; Sozzani R, 2010, NATURE, V466, P128, DOI 10.1038/nature09143; Takahashi I, 2010, PLANT CELL REP, V29, P307, DOI 10.1007/s00299-010-0817-9; TEMPLETON DJ, 1991, P NATL ACAD SCI USA, V88, P3033, DOI 10.1073/pnas.88.8.3033; vandenBerg C, 1997, NATURE, V390, P287, DOI 10.1038/36856; Welch D, 2007, GENE DEV, V21, P2196, DOI 10.1101/gad.440307; Wildwater M, 2005, CELL, V123, P1337, DOI 10.1016/j.cell.2005.09.042; Willemsen V, 1998, DEVELOPMENT, V125, P521; Xu J, 2006, SCIENCE, V311, P385, DOI 10.1126/science.1121790; Yao G, 2008, NAT CELL BIOL, V10, P476, DOI 10.1038/ncb1711; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199	52	203	220	1	120	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 31	2012	150	5					1002	1015		10.1016/j.cell.2012.07.017	http://dx.doi.org/10.1016/j.cell.2012.07.017			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	001ZU	22921914	Green Accepted, Bronze			2022-12-28	WOS:000308500200014
J	van Luenen, HGAM; Farris, C; Jan, S; Genest, PA; Tripathi, P; Velds, A; Kerkhoven, RM; Nieuwland, M; Haydock, A; Ramasamy, G; Vainio, S; Heidebrecht, T; Perrakis, A; Pagie, L; van Steensel, B; Myler, PJ; Borst, P				van Luenen, Henri G. A. M.; Farris, Carol; Jan, Sabrina; Genest, Paul-Andre; Tripathi, Pankaj; Velds, Arno; Kerkhoven, Ron M.; Nieuwland, Marja; Haydock, Andrew; Ramasamy, Gowthaman; Vainio, Saara; Heidebrecht, Tatjana; Perrakis, Anastassis; Pagie, Ludo; van Steensel, Bas; Myler, Peter J.; Borst, Piet			Glucosylated Hydroxymethyluracil, DNA Base J, Prevents Transcriptional Readthrough in Leishmania	CELL			English	Article							PROTOZOAN PARASITE LEISHMANIA; MAJOR FRIEDLIN CHROMOSOME-1; SURFACE GLYCOPROTEIN GENES; J-BINDING PROTEIN; TRYPANOSOMA-BRUCEI; POLYCISTRONIC TRANSCRIPTION; KINETOPLASTID PROTOZOANS; GENOMIC ORGANIZATION; MESSENGER-RNAS; SEQUENCE	Some Ts in nuclear DNA of trypanosomes and Leishmania are hydroxylated and glucosylated to yield base J (beta-D-glucosyl-hydroxymethyluracil). In Leishmania, about 99% of J is located in telomeric repeats. We show here that most of the remaining J is located at chromosome-internal RNA polymerase II termination sites. This internal J and telomeric J can be reduced by a knockout of J-binding protein 2 (JBP2), an enzyme involved in the first step of J biosynthesis. J levels are further reduced by growing Leishmania JBP2 knockout cells in BrdU-containing medium, resulting in cell death. The loss of internal J in JBP2 knockout cells is accompanied by massive readthrough at RNA polymerase II termination sites. The readthrough varies between transcription units but may extend over 100 kb. We conclude that J is required for proper transcription termination and infer that the absence of internal J kills Leishmania by massive readthrough of transcriptional stops.	[van Luenen, Henri G. A. M.; Jan, Sabrina; Genest, Paul-Andre; Tripathi, Pankaj; Vainio, Saara; Borst, Piet] Netherlands Canc Inst, Div Mol Biol, NL-1066 CX Amsterdam, Netherlands; [Velds, Arno; Kerkhoven, Ron M.; Nieuwland, Marja] Netherlands Canc Inst, Microarray & Deep Sequencing Facil, NL-1066 CX Amsterdam, Netherlands; [Heidebrecht, Tatjana; Perrakis, Anastassis] Netherlands Canc Inst, Div Biochem, NL-1066 CX Amsterdam, Netherlands; [Pagie, Ludo; van Steensel, Bas] Netherlands Canc Inst, Div Gene Regulat, NL-1066 CX Amsterdam, Netherlands; [Farris, Carol; Haydock, Andrew; Ramasamy, Gowthaman; Myler, Peter J.] Seattle Biomed Res Inst, Seattle, WA 98109 USA; [Farris, Carol; Myler, Peter J.] Univ Washington, Dept Biomed Informat & Med Educ, Seattle, WA 98195 USA; [Myler, Peter J.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA	Netherlands Cancer Institute; Netherlands Cancer Institute; Netherlands Cancer Institute; Netherlands Cancer Institute; Center for Infectious Disease Research; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Borst, P (corresponding author), Netherlands Canc Inst, Div Mol Biol, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	p.borst@nki.nl	Myler, Peter John/AAR-9535-2021; Perrakis, Anastassis/E-8704-2013	Perrakis, Anastassis/0000-0002-1151-6227; Velds, Arno/0000-0003-4333-8872; Genest, Paul-Andre/0000-0001-6341-900X; van Luenen, Henri/0000-0002-5584-7968; Myler, Peter/0000-0002-0056-0513	PHS from the National Institute of Allergy and Infectious Diseases [R01 AI053667]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI053667] Funding Source: NIH RePORTER	PHS from the National Institute of Allergy and Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank F. Raymond, B. Papadopoulou, M. Olivier, M.J. Tremblay, M. Ouellette, and J. Corbeil at CIHR in Quebec, Canada, for sharing the genomic sequence of L. tarentolae before publication. We thank U. Desselberger, University of Cambridge, UK, for providing purified rotavirus RNA preparations. We thank E. Christodoulou for help with JBP1 production. We are grateful to K. de Visser and F. van Leeuwen for critical reading of the manuscript and discussions. This work was supported by PHS grant R01 AI053667 from the National Institute of Allergy and Infectious Diseases to P.J.M.	AGABIAN N, 1990, CELL, V61, P1157, DOI 10.1016/0092-8674(90)90674-4; Beisel C, 2011, NAT REV GENET, V12, P123, DOI 10.1038/nrg2932; Belli SI, 2003, INT J PARASITOL, V33, P965, DOI 10.1016/S0020-7519(03)00126-7; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; BOOTHROYD JC, 1982, GENE, V20, P281, DOI 10.1016/0378-1119(82)90046-4; BORST P, 1965, P NATL ACAD SCI USA, V54, P982, DOI 10.1073/pnas.54.3.982; Borst P, 2008, ANNU REV MICROBIOL, V62, P235, DOI 10.1146/annurev.micro.62.081307.162750; Cliffe LJ, 2010, NUCLEIC ACIDS RES, V38, P3923, DOI 10.1093/nar/gkq146; Cliffe LJ, 2009, NUCLEIC ACIDS RES, V37, P1452, DOI 10.1093/nar/gkn1067; Cross M, 1999, EMBO J, V18, P6573, DOI 10.1093/emboj/18.22.6573; Cross M, 2002, MOL MICROBIOL, V46, P37, DOI 10.1046/j.1365-2958.2002.03144.x; DELANGE T, 1984, NUCLEIC ACIDS RES, V12, P4431, DOI 10.1093/nar/12.11.4431; DELANGE T, 1983, CELL, V34, P891, DOI 10.1016/0092-8674(83)90546-9; DiPaolo C, 2005, MOL CELL, V17, P441, DOI 10.1016/j.molcel.2004.12.022; Dossin FD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002313; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Ekanayake DK, 2011, MOL CELL BIOL, V31, P1690, DOI 10.1128/MCB.01277-10; El-Sayed NM, 2005, SCIENCE, V309, P404, DOI 10.1126/science.1112181; El-Sayed NM, 2005, SCIENCE, V309, P409, DOI 10.1126/science.1112631; Flusberg BA, 2010, NAT METHODS, V7, P461, DOI [10.1038/NMETH.1459, 10.1038/nmeth.1459]; Fujii M, 2010, MOL GENET GENOMICS, V283, P461, DOI 10.1007/s00438-010-0535-6; Genest PA, 2005, NUCLEIC ACIDS RES, V33, P1699, DOI 10.1093/nar/gki304; Genest PA, 2007, NUCLEIC ACIDS RES, V35, P2116, DOI 10.1093/nar/gkm050; GOMMERSAMPT JH, 1993, CELL, V75, P1129, DOI 10.1016/0092-8674(93)90322-H; Grover RK, 2007, ANGEW CHEM INT EDIT, V46, P2839, DOI 10.1002/anie.200604635; Heidebrecht T, 2011, NUCLEIC ACIDS RES, V39, P5715, DOI 10.1093/nar/gkr125; Ivens AC, 2005, SCIENCE, V309, P436, DOI 10.1126/science.1112680; Iyer LM, 2009, CELL CYCLE, V8, P1698, DOI 10.4161/cc.8.11.8580; Jackson AP, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000658; KOOTER JM, 1984, NUCLEIC ACIDS RES, V12, P9457, DOI 10.1093/nar/12.24.9457; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lye LF, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001161; Martinez-Calvillo S, 2003, MOL CELL, V11, P1291, DOI 10.1016/S1097-2765(03)00143-6; Martinez-Calvillo S, 2004, EUKARYOT CELL, V3, P506, DOI 10.1128/EC.3.2.506-517.2004; Miki K, 2010, FEBS J, V277, P4539, DOI 10.1111/j.1742-4658.2010.07868.x; Monnerat S, 2004, MOL BIOCHEM PARASIT, V134, P233, DOI 10.1016/j.molbiopara.2003.12.004; Myler PJ, 1999, P NATL ACAD SCI USA, V96, P2902, DOI 10.1073/pnas.96.6.2902; Myler PJ, 2000, BIOCHEM SOC T, V28, P527, DOI 10.1042/bst0280527; NELSON RG, 1983, CELL, V34, P901, DOI 10.1016/0092-8674(83)90547-0; Otto TD, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1268; Padilla-Mejia NE, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-232; Raymond F, 2012, NUCLEIC ACIDS RES, V40, P1131, DOI 10.1093/nar/gkr834; Richard P, 2009, GENE DEV, V23, P1247, DOI 10.1101/gad.1792809; Robinson KA, 2003, MOL BIOCHEM PARASIT, V128, P217, DOI 10.1016/S0166-6851(03)00079-3; Sabatini R, 2002, J BIOL CHEM, V277, P958, DOI 10.1074/jbc.M109000200; SCHATZ PJ, 1993, BIO-TECHNOL, V11, P1138, DOI 10.1038/nbt1093-1138; Shearwin KE, 2005, TRENDS GENET, V21, P339, DOI 10.1016/j.tig.2005.04.009; Siegel TN, 2009, GENE DEV, V23, P1063, DOI 10.1101/gad.1790409; Simpson AGB, 2006, TRENDS PARASITOL, V22, P168, DOI 10.1016/j.pt.2006.02.006; Stevens JR, 2008, PARASITE, V15, P226, DOI 10.1051/parasite/2008153226; SUTTON RE, 1986, CELL, V47, P527, DOI 10.1016/0092-8674(86)90617-3; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Thomas S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-152; Toaldo CB, 2005, MOL BIOCHEM PARASIT, V143, P111, DOI 10.1016/j.molbiopara.2005.05.001; ULLU E, 1993, MOL CELL BIOL, V13, P720, DOI 10.1128/MCB.13.1.720; Vainio S, 2009, MOL BIOCHEM PARASIT, V164, P157, DOI 10.1016/j.molbiopara.2008.12.001; van Leeuwen F, 1998, MOL CELL BIOL, V18, P5643, DOI 10.1128/MCB.18.10.5643; van Leeuwen F, 1998, P NATL ACAD SCI USA, V95, P2366, DOI 10.1073/pnas.95.5.2366; van Leeuwen F, 2000, MOL BIOCHEM PARASIT, V109, P133, DOI 10.1016/S0166-6851(00)00247-4; VANDERPLOEG LHT, 1982, NUCLEIC ACIDS RES, V10, P3591, DOI 10.1093/nar/10.12.3591; vanLeeuwen F, 1996, NUCLEIC ACIDS RES, V24, P2476, DOI 10.1093/nar/24.13.2476; vanLeeuwen F, 1997, GENE DEV, V11, P3232, DOI 10.1101/gad.11.23.3232; Yu Z, 2007, NUCLEIC ACIDS RES, V35, P2107, DOI 10.1093/nar/gkm049	63	103	103	0	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 31	2012	150	5					909	921		10.1016/j.cell.2012.07.030	http://dx.doi.org/10.1016/j.cell.2012.07.030			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	001ZU	22939620	Green Accepted, Bronze			2022-12-28	WOS:000308500200007
J	Butterworth, J				Butterworth, Jon			Beyond the Higgs	NATURE			English	Editorial Material									UCL, Dept Phys & Astron, London WC1E 6BT, England	University of London; University College London	Butterworth, J (corresponding author), UCL, Dept Phys & Astron, Mortimer St, London WC1E 6BT, England.	j.butterworth@ucl.ac.uk		Butterworth, Jonathan/0000-0002-5905-5394					0	1	1	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 30	2012	488	7413					581	582		10.1038/488581a	http://dx.doi.org/10.1038/488581a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996NC	22932362	Bronze			2022-12-28	WOS:000308095100024
J	Weng, JK; Li, Y; Mo, HP; Chapple, C				Weng, Jing-Ke; Li, Yi; Mo, Huaping; Chapple, Clint			Assembly of an Evolutionarily New Pathway for alpha-Pyrone Biosynthesis in Arabidopsis	SCIENCE			English	Article							LIGNIN BIOSYNTHESIS; SYRINGYL LIGNIN; PLANTS	Plants possess arrays of functionally diverse specialized metabolites, many of which are distributed taxonomically. Here, we describe the evolution of a class of substituted alpha-pyrone metabolites in Arabidopsis, which we have named arabidopyrones. The biosynthesis of arabidopyrones requires a cytochrome P450 enzyme (CYP84A4) to generate the catechol-substituted substrate for an extradiol ring-cleavage dioxygenase (AtLigB). Unlike other ring-cleavage-derived plant metabolites made from tyrosine, arabidopyrones are instead derived from phenylalanine through the early steps of phenylpropanoid metabolism. Whereas CYP84A4, an Arabidopsis-specific paralog of the lignin-biosynthetic enzyme CYP84A1, has neofunctionalized relative to its ancestor, AtLigB homologs are widespread among land plants and many bacteria. This study exemplifies the rapid evolution of a biochemical pathway formed by the addition of a new biological activity into an existing metabolic infrastructure.	[Weng, Jing-Ke; Li, Yi; Chapple, Clint] Purdue Univ, Dept Biochem, W Lafayette, IN 47907 USA; [Mo, Huaping] Purdue Univ, Dept Med Chem & Mol Pharmacol, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Chapple, C (corresponding author), Purdue Univ, Dept Biochem, W Lafayette, IN 47907 USA.	chapple@purdue.edu	Weng, Jing-Ke/E-7343-2013; Chapple, Clint CS/Q-5456-2017; Weng, Jing-Ke/A-6900-2015; Weng, Jing-Ke/V-5934-2019	Weng, Jing-Ke/0000-0003-1079-3668; Chapple, Clint CS/0000-0002-5195-562X; Weng, Jing-Ke/0000-0003-3059-0075; Weng, Jing-Ke/0000-0003-3059-0075	NSF [MCB-1121925]; Global Climate and Energy Project	NSF(National Science Foundation (NSF)); Global Climate and Energy Project	This work is supported by NSF grant MCB-1121925 and the Global Climate and Energy Project (to C. C.). We thank D. A. Colby for helpful discussions about the chemical synthesis of APs and J. Ralph and H. Kim for providing authentic standards. Supporting data and figures relevant to this paper are presented online in the supplementary materials.	Aharoni A, 2005, NAT GENET, V37, P73, DOI 10.1038/ng1482; CHAPPLE CCS, 1992, PLANT CELL, V4, P1413, DOI 10.1105/tpc.4.11.1413; Christinet L, 2004, PLANT PHYSIOL, V134, P265, DOI 10.1104/pp.103.031914; Eckermann S, 1998, NATURE, V396, P387, DOI 10.1038/24652; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Matsuno M, 2009, SCIENCE, V325, P1688, DOI 10.1126/science.1174095; Meyer K, 1998, P NATL ACAD SCI USA, V95, P6619, DOI 10.1073/pnas.95.12.6619; Pichersky E, 2006, SCIENCE, V311, P808, DOI 10.1126/science.1118510; Pichersky E, 2000, TRENDS PLANT SCI, V5, P439, DOI 10.1016/S1360-1385(00)01741-6; SAITO K, 1976, EUR J BIOCHEM, V68, P237, DOI 10.1111/j.1432-1033.1976.tb10783.x; Vogt T, 2010, MOL PLANT, V3, P2, DOI 10.1093/mp/ssp106; Weng JK, 2008, P NATL ACAD SCI USA, V105, P7887, DOI 10.1073/pnas.0801696105; Weng JK, 2010, NEW PHYTOL, V187, P273, DOI 10.1111/j.1469-8137.2010.03327.x; Weng JK, 2010, PLANT CELL, V22, P1033, DOI 10.1105/tpc.109.073528; Wink M., 2010, BIOCH PLANT SECONDAR, V2nd; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	16	65	68	3	68	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 24	2012	337	6097					960	964		10.1126/science.1221614	http://dx.doi.org/10.1126/science.1221614			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992VI	22923580				2022-12-28	WOS:000307807600044
J	Dolling, D; Sabin, C; Delpech, V; Smit, E; Pozniak, A; Asboe, D; Brown, AL; Churchill, D; Williams, I; Geretti, AM; Phillips, A; Mackie, N; Murphy, G; Castro, H; Pillay, D; Cane, P; Dunn, D; Aitken, C; Asboe, D; Pozniak, A; Booth, C; Cane, P; Castro, H; Crofts, J; Dunn, D; Dolling, D; Fearnhill, E; Porter, K; Chadwick, D; Churchill, D; Clark, D; Collins, S; Delpech, V; Geretti, AM; Goldberg, D; Hale, A; Hue, S; Kaye, S; Kellam, P; Lazarus, L; Leigh-Brown, A; Mackie, N; Orkin, C; Rice, P; Pillay, D; Phillips, A; Sabin, C; Smit, E; Templeton, K; Tilston, P; Tong, W; Williams, I; Zhang, HY; Zuckerman, M				Dolling, David; Sabin, Caroline; Delpech, Valerie; Smit, Erasmus; Pozniak, Anton; Asboe, David; Brown, Andrew Leigh; Churchill, Duncan; Williams, Ian; Geretti, Anna Maria; Phillips, Andrew; Mackie, Nicola; Murphy, Gary; Castro, Hannah; Pillay, Deenan; Cane, Patricia; Dunn, David; Aitken, Celia; Asboe, David; Pozniak, Anton; Booth, Clare; Cane, Patricia; Castro, Hannah; Crofts, Jonathan; Dunn, David; Dolling, David; Fearnhill, Esther; Porter, Kholoud; Chadwick, David; Churchill, Duncan; Clark, Duncan; Collins, Simon; Delpech, Valerie; Geretti, Anna Maria; Goldberg, David; Hale, Antony; Hue, Stephane; Kaye, Steve; Kellam, Paul; Lazarus, Linda; Leigh-Brown, Andrew; Mackie, Nicola; Orkin, Chloe; Rice, Philip; Pillay, Deenan; Phillips, Andrew; Sabin, Caroline; Smit, Erasmus; Templeton, Kate; Tilston, Peter; Tong, William; Williams, Ian; Zhang, Hongyi; Zuckerman, Mark		UK Collaborative Grp HIV Drug Resi	Time trends in drug resistant HIV-1 infections in the United Kingdom up to 2009: multicentre observational study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							TRANSMISSION; MUTATIONS; REVEALS; ADULTS; VIRUS	Objective To evaluate whether the prevalence of HIV-1 transmitted drug resistance has continued to decline in infections probably acquired within the United Kingdom. Design Multicentre observational study. Setting All UK public laboratories conducting tests for genotypic HIV resistance as a part of routine care. Participants 14 584 patients infected with HIV-1 subtype B virus, who were first tested for resistance before receiving antiretroviral therapy between January 2002 and December 2009. Main outcome measure Prevalence of transmitted drug resistance, defined as one or more resistance mutations from the surveillance list recommended by the World Health Organization. Results 1654 (11.3%, 95% confidence interval 10.8% to 11.9%) patients had one or more mutations associated with transmitted HIV-1 drug resistance; prevalence was found to decline from 15.5% in 2002 to 9.6% in 2007, followed by a slight increase to 10.9% in 2009 (P=0.21). This later rise was mainly a result of increases in resistance to nucleos(t)ide reverse transcriptase inhibitors (from 5.4% in 2007 to 6.6% in 2009, P=0.24) and protease inhibitors (1.5% to 2.1%, P=0.12). Thymidine analogue mutations, including T215 revertants, remained the most frequent mutations associated with nucleos(t) ide reverse transcriptase inhibitors, despite a considerable fall in stavudine and zidovudine use between 2002 and 2009 (from 29.4% of drug regimens in 2002 to 0.8% in 2009, from 47.9% to 8.8%, respectively). Conclusions The previously observed decline in the prevalence of transmitted drug resistance in HIV-1 infections probably acquired in the UK seems to have stabilised. The continued high prevalence of thymidine analogue mutations suggests that the source of this resistance may be increasingly from patients who have not undergone antiretroviral therapy and who harbour resistant viruses. Testing of all newly diagnosed HIV-1 positive people should be continued.	[Dolling, David] UK HIV Drug Resistance Database, MRC Clin Trials Unit, London WC2B 6NH, England; [Aitken, Celia] Gartnavel Royal Hosp, Glasgow, Lanark, Scotland; [Asboe, David; Pozniak, Anton] Chelsea & Westminster Hosp, London, England; [Booth, Clare] Royal Free NHS Trust, London, England; [Cane, Patricia] Hlth Protect Agcy, Porton Down, England; [Chadwick, David] S Tees Hosp NHS Trust, Middlesbrough, Cleveland, England; [Churchill, Duncan] Brighton & Sussex Univ Hosp NHS Trust, Brighton, E Sussex, England; [Clark, Duncan] St Bartholomews & London NHS Trust, London, England; [Collins, Simon] HIV I Base, London, England; [Delpech, Valerie] Hlth Protect Agcy, Ctr Infect, London, England; [Geretti, Anna Maria] Univ Liverpool, Liverpool, Merseyside, England; [Goldberg, David] Hlth Protect Scotland, Glasgow, Lanark, Scotland; [Hale, Antony] Leeds Teaching Hosp NHS Trust, Leeds, W Yorkshire, England; [Hue, Stephane] UCL, London WC1E 6BT, England; [Kaye, Steve] Imperial Coll London, London, England; [Kellam, Paul] Wellcome Trust Sanger Inst, Hinxton, England; [Kellam, Paul] UCL Med Sch, London, England; [Lazarus, Linda] Hlth Protect Agcy, London, England; [Leigh-Brown, Andrew] Univ Edinburgh, Edinburgh EH8 9YL, Midlothian, Scotland; [Mackie, Nicola] Imperial NHS Trust, London, England; [Orkin, Chloe] St Bartholomews Hosp, London, England; [Rice, Philip] St Georges Healthcare Trust, London, England; [Pillay, Deenan; Phillips, Andrew; Sabin, Caroline] UCL, Sch Med, London WC1E 6BT, England; [Smit, Erasmus] Birmingham Heartlands Hosp, Hlth Protect Agcy, Birmingham, W Midlands, England; [Templeton, Kate] Royal Infirm Edinburgh NHS Trust, Edinburgh, Midlothian, Scotland; [Tilston, Peter] Manchester Royal Infirm, Manchester, Lancs, England; [Tong, William] Guys & St Thomas NHS Fdn Trust, London, England; [Williams, Ian] Mortimer Market Ctr, London, England; [Zhang, Hongyi] Addenbrookes Hosp, Cambridge, England; [Zuckerman, Mark] Kings Coll Hosp London, London, England	Medical Research Council Clinical Trials Unit; Gartnavel Royal Hospital; Imperial College London; University of London; University College London; Health Protection Agency; Brighton and Sussex University Hospitals NHS Trust; University of Brighton; University of London; Queen Mary University London; Health Protection Agency; University of Liverpool; University of Leeds; University of London; University College London; Imperial College London; Wellcome Trust Sanger Institute; University of London; University College London; Health Protection Agency; University of Edinburgh; University of London; Queen Mary University London; St Georges University London; University of London; University College London; UCL Medical School; Health Protection Agency; Heart of England NHS Foundation Trust; University of Birmingham; Royal Infirmary of Edinburgh; University of Edinburgh; University of Manchester; Guy's & St Thomas' NHS Foundation Trust; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; King's College Hospital NHS Foundation Trust; King's College Hospital	Dolling, D (corresponding author), UK HIV Drug Resistance Database, MRC Clin Trials Unit, London WC2B 6NH, England.		Sabin, Caroline/C-2464-2008; Phillips, Andrew N/B-4427-2008; Collins, Simon/AAB-5123-2022; Leigh Brown, Andrew/F-3802-2010; Churchill, Duncan/AAT-5441-2020; Payne, Brendan/I-1233-2016; Brown, Andrew Leigh/ABF-8269-2020	Sabin, Caroline/0000-0001-5173-2760; Phillips, Andrew N/0000-0003-2384-4807; Leigh Brown, Andrew/0000-0002-5700-3128; Payne, Brendan/0000-0002-3101-3512; Brown, Andrew Leigh/0000-0002-5700-3128; Dunn, David/0000-0003-1836-4446; Castro, Hannah/0000-0001-9086-8687; Geretti, Anna Maria/0000-0002-3670-6588; delpech, valerie/0000-0002-9952-8109; Kellam, Paul/0000-0003-3166-4734; Bibby, David/0000-0002-8458-9662	UK Medical Research Council [G0900274]; European Community under the Collaborative HIV and Anti-HIV Drug Resistance Network (CHAIN) [223131]; European Community; MRC [G0900274, MC_U122886351] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Community under the Collaborative HIV and Anti-HIV Drug Resistance Network (CHAIN); European Community(European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the UK Medical Research Council (grant G0900274) and the European Community's 7th framework programme (FP7/2007-2013) under the Collaborative HIV and Anti-HIV Drug Resistance Network (CHAIN; project 223131).; All authors have completed the Unified Competing Interest form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: support from the UK Medical Research Council and the European Community's 7th framework programme; no financial relationships with any organisations that might have an interest in the submitted work in the previous 3 years; and no other relationships or activities that could appear to have influenced the submitted work.	Bansi L, 2010, HIV MED, V11, P432, DOI 10.1111/j.1468-1293.2009.00809.x; Bartmeyer B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012718; Bennett DE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004724; Brenner BG, 2008, AIDS, V22, P2509, DOI 10.1097/QAD.0b013e3283121c90; Burns S, 2007, AIDS, V21, P1035, DOI 10.1097/QAD.0b013e3280b07761; Cairns G, 2011, UK HIV TREATMENT GUI; Castro H, 2012, BMC MED RES IN PRESS; Chilton DN, 2010, ANTIVIR THER, V15, P985, DOI 10.3851/IMP1658; de Oliveira T, 2005, BIOINFORMATICS, V21, P3797, DOI 10.1093/bioinformatics/bti607; Garcia-Lerma JG, 2001, P NATL ACAD SCI USA, V98, P13907, DOI 10.1073/pnas.241300698; Gazzard BG, 2008, HIV MED, V9, P563, DOI 10.1111/j.1468-1293.2008.00636.x; Grant RM, 2003, J CLIN MICROBIOL, V41, P1586, DOI 10.1128/JCM.41.4.1586-1593.2003; Health Protection Agency, 2012, REC INF TEST ALG RIT; Health Protection Agency (HPA), 2010, HLTH PROT REP, V4, P47; Heijman RLJ, 2011, 18 C RETR OPP INF; Hertogs K, 2000, AIDS, V14, P1203, DOI 10.1097/00002030-200006160-00018; Hirsch MS, 2008, CLIN INFECT DIS, V47, P266, DOI 10.1086/589297; *HLTH PROT AG, 2007, TEST TIM HIV OTH SEX; Hue S, 2005, P NATL ACAD SCI USA, V102, P4425, DOI 10.1073/pnas.0407534102; Hue S, 2009, J VIROL, V83, P2645, DOI 10.1128/JVI.01556-08; Jain V, 2011, J INFECT DIS, V203, P1174, DOI 10.1093/infdis/jiq167; Kulkarni R, 2011, 6 C HIV PATH TREATM; Murphy G, 2008, EUROSURVEILLANCE, V13, P4; Pilcher CD, 2007, AIDS, V21, P1723, DOI 10.1097/QAD.0b013e3281532c82; Pingen M, 2011, J ANTIMICROB CHEMOTH, V66, P1467, DOI 10.1093/jac/dkr157; Presanis AM, 2010, AIDS, V24, P2849, DOI 10.1097/QAD.0b013e32834021ed; Sabin C, 2004, HIV MED, V5, P115; Sax PE, 2005, CLIN INFECT DIS, V41, P1316, DOI 10.1086/496984; Schuurman R, 2002, AIDS RES HUM RETROV, V18, P243, DOI 10.1089/088922202753472801; Vallabhaneni S, 2011, 18 C RETR OPP INF; Vercauteren J, 2009, J INFECT DIS, V200, P1503, DOI 10.1086/644505; Williamson LM, 2008, AIDS, V22, P1063, DOI 10.1097/QAD.0b013e3282f8af9b; Wittkop L, 2011, LANCET INFECT DIS, V11, P363, DOI 10.1016/S1473-3099(11)70032-9	33	40	41	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 21	2012	345								e5253	10.1136/bmj.e5253	http://dx.doi.org/10.1136/bmj.e5253			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	996GP	22915687	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000308073200003
J	Stringhini, S; Tabak, AG; Akbaraly, TN; Sabia, S; Shipley, MJ; Marmot, MG; Brunner, EJ; Batty, GD; Bovet, P; Kivimaki, M				Stringhini, Silvia; Tabak, Adam G.; Akbaraly, Tasnime N.; Sabia, Severine; Shipley, Martin J.; Marmot, Michael G.; Brunner, Eric J.; Batty, G. David; Bovet, Pascal; Kivimaeki, Mika			Contribution of modifiable risk factors to social inequalities in type 2 diabetes: prospective Whitehall II cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CORONARY-HEART-DISEASE; SOCIOECONOMIC POSITION; PHYSICAL-ACTIVITY; LIFE-STYLE; FOLLOW-UP; HEALTH BEHAVIORS; AFRICAN-AMERICAN; NATIONAL-HEALTH; MORTALITY; MELLITUS	Objective To assess the contribution of modifiable risk factors to social inequalities in the incidence of type 2 diabetes when these factors are measured at study baseline or repeatedly over follow-up and when long term exposure is accounted for. Design Prospective cohort study with risk factors (health behaviours (smoking, alcohol consumption, diet, and physical activity), body mass index, and biological risk markers (systolic blood pressure, triglycerides and high density lipoprotein cholesterol)) measured four times and diabetes status assessed seven times between 1991-93 and 2007-09. Setting Civil service departments in London (Whitehall II study). Participants 7237 adults without diabetes (mean age 49.4 years; 2196 women). Main outcome measures Incidence of type 2 diabetes and contribution of risk factors to its association with socioeconomic status. Results Over a mean follow-up of 14.2 years, 818 incident cases of diabetes were identified. Participants in the lowest occupational category had a 1.86-fold (hazard ratio 1.86, 95% confidence interval 1.48 to 2.32) greater risk of developing diabetes relative to those in the highest occupational category. Health behaviours and body mass index explained 33% (-1% to 78%) of this socioeconomic differential when risk factors were assessed at study baseline (attenuation of hazard ratio from 1.86 to 1.51), 36% (22% to 66%) when they were assessed repeatedly over the follow-up (attenuated hazard ratio 1.48), and 45% (28% to 75%) when long term exposure over the follow-up was accounted for (attenuated hazard ratio 1.41). With additional adjustment for biological risk markers, a total of 53% (29% to 88%) of the socioeconomic differential was explained (attenuated hazard ratio 1.35, 1.05 to 1.72). Conclusions Modifiable risk factors such as health behaviours and obesity, when measured repeatedly over time, explain almost half of the social inequalities in incidence of type 2 diabetes. This is more than was seen in previous studies based on single measurement of risk factors.	[Stringhini, Silvia; Bovet, Pascal] Univ Lausanne Hosp, Inst Social & Prevent Med, CH-1010 Lausanne, Switzerland; [Tabak, Adam G.; Akbaraly, Tasnime N.; Sabia, Severine; Shipley, Martin J.; Marmot, Michael G.; Brunner, Eric J.; Batty, G. David; Kivimaeki, Mika] UCL, Dept Epidemiol & Publ Hlth, London, England; [Tabak, Adam G.] Semmelweis Univ, Fac Med, Dept Med 1, H-1085 Budapest, Hungary; [Akbaraly, Tasnime N.] INSERM, U1061, Montpellier, France; [Akbaraly, Tasnime N.] Univ Montpellier I, Montpellier, France; [Batty, G. David] Univ Edinburgh, MRC Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh, Midlothian, Scotland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of London; University College London; Semmelweis University; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; University of Edinburgh	Stringhini, S (corresponding author), Univ Lausanne Hosp, Inst Social & Prevent Med, CH-1010 Lausanne, Switzerland.	silvia.stringhini@chuv.ch	Kivimaki, Mika/B-3607-2012; Brunner, Eric/H-2114-2011; Sabia, Séverine/G-2966-2017; Batty, GD/Y-4401-2018; Bovet, Pascal/F-4477-2011; Stringhini, Silvia/B-4899-2013; AKBARALY, Tasnime/H-1389-2018; Tabak, Adam/A-5007-2012; Marmot, M G/Y-3920-2019	Kivimaki, Mika/0000-0002-4699-5627; Brunner, Eric/0000-0002-0595-4474; Sabia, Séverine/0000-0003-3109-9720; Batty, GD/0000-0003-1822-5753; Bovet, Pascal/0000-0002-0242-4259; AKBARALY, Tasnime/0000-0002-2150-4190; Marmot, M G/0000-0002-2431-6419; Tabak, Adam/0000-0002-6234-3936	Swiss School of Public Health; UK Medical Research Council (MRC); US National Institutes of Health (NIH) [R01HL036310, R01AG034454]; EU New OSH ERA Research Programme; Economic and Social Research Council (ESRC); National Heart, Lung, and Blood Institute [R01HL036310]; National Institute of Aging, NIH [R01AG034454]; British Heart Foundation; MRC; British Health and Safety Executive; British Department of Health; UK research council call for lifelong health and wellbeing; MRC [G0902037] Funding Source: UKRI; British Heart Foundation [RG/07/008/23674] Funding Source: researchfish; Medical Research Council [G0902037, G19/35, G0100222, G8802774] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL036310] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG034454] Funding Source: NIH RePORTER	Swiss School of Public Health; UK Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EU New OSH ERA Research Programme; Economic and Social Research Council (ESRC)(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Aging, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); British Heart Foundation(British Heart Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Health and Safety Executive; British Department of Health; UK research council call for lifelong health and wellbeing; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	SStringhini is supported by a postdoctoral fellowship awarded by the Swiss School of Public Health. MK is supported by the UK Medical Research Council (MRC), the US National Institutes of Health (NIH) (R01HL036310; R01AG034454), the EU New OSH ERA Research Programme, and an Economic and Social Research Council (ESRC) professorship. DB is a Wellcome Trust fellow. TA is supported by the National Heart, Lung, and Blood Institute (R01HL036310). SSabia is supported by a grant from the National Institute of Aging, NIH (R01AG034454). MS is supported by the British Heart Foundation. The Whitehall II study has been supported by grants from the MRC; the British Heart Foundation; the British Health and Safety Executive; the British Department of Health; the National Heart, Lung, and Blood Institute (R01HL036310); and the National Institute on Aging, NIH. The University of Edinburgh Centre for Cognitive Ageing and Cognitive Epidemiology is funded as part of the joint UK research council call for lifelong health and wellbeing. The funding organisations or sponsors had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; or preparation, review, or approval of the manuscript.	Agardh EE, 2004, DIABETES CARE, V27, P716, DOI 10.2337/diacare.27.3.716; Agardh E, 2011, INT J EPIDEMIOL, V40, P804, DOI 10.1093/ije/dyr029; Aim-High I., 2011, NEW ENGL J MED, V365, P2255, DOI DOI 10.1056/NEJM0A1107579; Akbaraly TN, 2011, AM J CLIN NUTR, V94, P247, DOI 10.3945/ajcn.111.013128; Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Am Diabetes Assoc, 1999, CIRCULATION, V100, P1132, DOI 10.1161/01.cir.100.10.1132; Astrup A, 2000, Obes Rev, V1, P57, DOI 10.1046/j.1467-789x.2000.00013.x; Athyros VG, 2010, EXPERT OPIN PHARMACO, V11, P1965, DOI 10.1517/14656566.2010.489553; Barker DJP, 1999, ANN INTERN MED, V130, P322, DOI 10.7326/0003-4819-130-4-199902160-00019; Britton A, 2004, AM J EPIDEMIOL, V160, P240, DOI 10.1093/aje/kwh206; Brown AF, 2004, EPIDEMIOL REV, V26, P63, DOI 10.1093/epirev/mxh002; Carnethon MR, 2003, AM J EPIDEMIOL, V158, P416, DOI 10.1093/aje/kwg172; Chinn DJ, 1999, J EPIDEMIOL COMMUN H, V53, P191, DOI 10.1136/jech.53.3.191; Chobanian AV., 2003, HYPERTENSION, V42, P1206, DOI [10.1161/01.HYP.0000107251, DOI 10.1161/01.HYP.9.2_PT_2.II36, DOI 10.1161/01.HYP.0000107251.49515.C2]; Coughlin SS, 2004, AM J EPIDEMIOL, V159, P1160, DOI 10.1093/aje/kwh161; Danaei G, 2006, LANCET, V368, P1651, DOI 10.1016/S0140-6736(06)69700-6; De Irala-Estevez J, 2000, EUR J CLIN NUTR, V54, P706, DOI 10.1038/sj.ejcn.1601080; De Silva NMG, 2011, DIABETES, V60, P1008, DOI 10.2337/db10-1317; Elovainio M, 2011, AM J EPIDEMIOL, V174, P779, DOI 10.1093/aje/kwr149; Espelt A, 2011, CURR DIABETES REV, V7, P148, DOI 10.2174/157339911795843131; EVERHART JE, 1992, DIABETES, V41, P235, DOI 10.2337/diabetes.41.2.235; Hardoon SL, 2012, EUR HEART J, V33, P478, DOI 10.1093/eurheartj/ehr142; Hu G, 2004, ARCH INTERN MED, V164, P892, DOI 10.1001/archinte.164.8.892; Imkampe AK, 2011, EUR J PUBLIC HEALTH, V21, P484, DOI 10.1093/eurpub/ckq106; International Diabetes Federation, 2006, DIAB ALL; Kivimaki M, 2008, LANCET, V372, P1648, DOI 10.1016/S0140-6736(08)61688-8; Kumari M, 2004, ARCH INTERN MED, V164, P1873, DOI 10.1001/archinte.164.17.1873; Lawlor DA, 2002, BRIT MED J, V325, P805, DOI 10.1136/bmj.325.7368.805; Lawlor DA, 2006, OBESITY, V14, P2294, DOI 10.1038/oby.2006.269; Marmot MG, 2008, DIABETOLOGIA, V51, P1980, DOI 10.1007/s00125-008-1144-3; MARMOT MG, 1991, LANCET, V337, P1387, DOI 10.1016/0140-6736(91)93068-K; Matsushima M, 1996, DIABETOLOGIA, V39, P710; Maty SC, 2005, INT J EPIDEMIOL, V34, P1274, DOI 10.1093/ije/dyi167; McCullough ML, 2002, AM J CLIN NUTR, V76, P1261, DOI 10.1093/ajcn/76.6.1261; McGarry JD, 2002, DIABETES, V51, P7, DOI 10.2337/diabetes.51.1.7; Narayan KMV, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P591; National Cholesterol Education Program, 2002, 3 NAT CHOL ED PROGR; OSLER M, 1993, PUBLIC HEALTH, V107, P251, DOI 10.1016/S0033-3506(05)80504-9; Pan A, 2010, ARCH INTERN MED, V170, P1884, DOI 10.1001/archinternmed.2010.356; PERRY IJ, 1995, BRIT MED J, V310, P560, DOI 10.1136/bmj.310.6979.560; Prince SA, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-56; Robbins JM, 2001, AM J PUBLIC HEALTH, V91, P76, DOI 10.2105/AJPH.91.1.76; Sabia S, 2012, AM J PUBLIC HEALTH, V102, P698, DOI 10.2105/AJPH.2011.300257; Samuel-Hodge CD, 2004, DIABETES CARE, V27, P663, DOI 10.2337/diacare.27.3.663; Shah S, 2001, J HYPERTENS, V19, P1333, DOI 10.1097/00004872-200107000-00020; Sokka T, 2008, CLIN EXP RHEUMATOL, V26, pS35, DOI 10.1161/CIRCULATIONAHA.109.192644; Stringhini S, 2010, JAMA-J AM MED ASSOC, V303, P1159, DOI 10.1001/jama.2010.297; Tabak AG, 2009, LANCET, V373, P2215, DOI 10.1016/S0140-6736(09)60619-X; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Wan Q, 2010, DIABETIC MED, V27, P1312, DOI 10.1111/j.1464-5491.2010.03107.x; WHO, 2011, DIAB; WHO Regional Office for Europe, 2007, CHALLENGE OBESITY WH, DOI [10.1186/1479-5868-4-11, DOI 10.1186/1479-5868-4-11]; Wikstrom K, 2011, EUR J PUBLIC HEALTH, V21, P768, DOI 10.1093/eurpub/ckq164; Willi C, 2007, JAMA-J AM MED ASSOC, V298, P2654, DOI 10.1001/jama.298.22.2654; Williams ED, 2010, DIABETOLOGIA, V53, P2538, DOI 10.1007/s00125-010-1888-4; Wooldridge JM, 2007, J ECONOMETRICS, V141, P1281, DOI 10.1016/j.jeconom.2007.02.002; Zhang P, 2004, ANN INTERN MED, V140, P972, DOI 10.7326/0003-4819-140-11-200406010-00039; Zins M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026531	58	106	107	0	32	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 21	2012	345								e5452	10.1136/bmj.e5452	http://dx.doi.org/10.1136/bmj.e5452			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	996GP	22915665	hybrid, Green Submitted, Green Published			2022-12-28	WOS:000308073200002
J	Babu, M; Vlasblom, J; Pu, SY; Guo, XH; Graham, C; Bean, BDM; Burston, HE; Vizeacoumar, FJ; Snider, J; Phanse, S; Fong, V; Tam, YYC; Davey, M; Hnatshak, O; Bajaj, N; Chandran, S; Punna, T; Christopolous, C; Wong, V; Yu, A; Zhong, GQ; Li, J; Stagljar, I; Conibear, E; Wodak, SJ; Emili, A; Greenblatt, JF				Babu, Mohan; Vlasblom, James; Pu, Shuye; Guo, Xinghua; Graham, Chris; Bean, Bjoern D. M.; Burston, Helen E.; Vizeacoumar, Franco J.; Snider, Jamie; Phanse, Sadhna; Fong, Vincent; Tam, Yuen Yi C.; Davey, Michael; Hnatshak, Olha; Bajaj, Navgeet; Chandran, Shamanta; Punna, Thanuja; Christopolous, Constantine; Wong, Victoria; Yu, Analyn; Zhong, Gouqing; Li, Joyce; Stagljar, Igor; Conibear, Elizabeth; Wodak, Shoshana J.; Emili, Andrew; Greenblatt, Jack F.			Interaction landscape of membrane-protein complexes in Saccharomyces cerevisiae	NATURE			English	Article							PHYSICAL INTERACTOME; ER EXIT; YEAST; MAP; EXPLORATION; SELECTION	Macromolecular assemblies involving membrane proteins (MPs) serve vital biological roles and are prime drug targets in a variety of diseases(1). Large-scale affinity purification studies of soluble-protein complexes have been accomplished for diverse model organisms, but no global characterization of MP-complex membership has been described so far. Here we report a complete survey of 1,590 putative integral, peripheral and lipid-anchored MPs from Saccharomyces cerevisiae, which were affinity purified in the presence of non-denaturing detergents. The identities of the co-purifying proteins were determined by tandem mass spectrometry and subsequently used to derive a high-confidence physical interaction map encompassing 1,726 membrane protein-protein interactions and 501 putative heteromeric complexes associated with the various cellular membrane systems. Our analysis reveals unexpected physical associations underlying the membrane biology of eukaryotes and delineates the global topological landscape of the membrane interactome.	[Bean, Bjoern D. M.; Burston, Helen E.; Tam, Yuen Yi C.; Davey, Michael; Conibear, Elizabeth] Univ British Columbia, Child & Family Res Inst, Ctr Mol Med & Therapeut, Vancouver, BC V5Z 4H4, Canada; [Babu, Mohan; Guo, Xinghua; Graham, Chris; Vizeacoumar, Franco J.; Snider, Jamie; Phanse, Sadhna; Fong, Vincent; Hnatshak, Olha; Bajaj, Navgeet; Chandran, Shamanta; Punna, Thanuja; Christopolous, Constantine; Wong, Victoria; Yu, Analyn; Zhong, Gouqing; Li, Joyce; Stagljar, Igor; Emili, Andrew; Greenblatt, Jack F.] Univ Toronto, Donnelly Ctr, Banting & Best Dept Med Res, Toronto, ON M5S 3E1, Canada; [Babu, Mohan] Univ Regina, Res & Innovat Ctr, Dept Biochem, Regina, SK S4S 0A2, Canada; [Vlasblom, James; Pu, Shuye; Wodak, Shoshana J.] Hosp Sick Children, Toronto, ON M5G 1X8, Canada; [Vlasblom, James; Stagljar, Igor; Wodak, Shoshana J.] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; [Stagljar, Igor; Wodak, Shoshana J.; Emili, Andrew; Greenblatt, Jack F.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada	Child & Family Research Institute; University of British Columbia; University of Toronto; University of Regina; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto	Conibear, E (corresponding author), Univ British Columbia, Child & Family Res Inst, Ctr Mol Med & Therapeut, 950 W 28th Ave, Vancouver, BC V5Z 4H4, Canada.	conibear@cmmt.ubc.ca; shoshana@sickkids.ca; andrew.emili@utoronto.ca; jack.greenblatt@utoronto.ca	Mohan, Babu P./I-7362-2019; Vizeacoumar, Franco/GLS-7161-2022	Conibear, Elizabeth/0000-0001-5129-0499; wodak, shoshana/0000-0002-0701-6545; Davey, Michael/0000-0002-1172-5934; Phanse, Sadhna/0000-0001-6306-0551	Canadian Foundation for Innovation; Canadian Institutes of Health Research (CIHR MOP) [81156, 64394, 82940]; Canadian Cancer Society Research Institute; Heart and Stroke Foundation; Cystic Fibrosis Foundation; Novartis; Ontario Genomics Institute; Genome Canada; SickKids Foundation	Canadian Foundation for Innovation(Canada Foundation for Innovation); Canadian Institutes of Health Research (CIHR MOP)(Canadian Institutes of Health Research (CIHR)); Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS)); Heart and Stroke Foundation(Heart & Stroke Foundation of Canada); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); Novartis(Novartis); Ontario Genomics Institute; Genome Canada(Genome Canada); SickKids Foundation	We thank H. Riezman, K. Sato and A. Nakano for providing strains and reagents, C. Ungermann for Sec18 antisera, A. Pierleoni for assistance with MemPype and R. Zheng for technical assistance. This research was supported by grants from the Canadian Foundation for Innovation, the Canadian Institutes of Health Research (CIHR MOP no. 81156, MOP no. 64394 and MOP no. 82940), the Canadian Cancer Society Research Institute, the Heart and Stroke Foundation, the Cystic Fibrosis Foundation, Novartis, the Ontario Genomics Institute and Genome Canada. E. C. is a CIHR New Investigator. S.J.W. is a Canada Research Chair Tier-I and acknowledges support from the SickKids Foundation.	Aguilar PS, 2010, NAT STRUCT MOL BIOL, V17, P901, DOI 10.1038/nsmb.1829; Babu M, 2009, METHODS MOL BIOL, V548, P187, DOI 10.1007/978-1-59745-540-4_11; Bao LY, 2009, MOL MEMBR BIOL, V26, P127, DOI 10.1080/09687680802637652; Collins SR, 2007, MOL CELL PROTEOMICS, V6, P439, DOI 10.1074/mcp.M600381-MCP200; Collins SR, 2007, NATURE, V446, P806, DOI 10.1038/nature05649; Conibear E, 2002, METHOD ENZYMOL, V351, P408; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; de Godoy LMF, 2008, NATURE, V455, P1251, DOI 10.1038/nature07341; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Flinn RJ, 2010, CELL CYCLE, V9, P1869, DOI 10.4161/cc.9.10.11679; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Gelperin DM, 2005, GENE DEV, V19, P2816, DOI 10.1101/gad.1362105; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; James P, 1996, GENETICS, V144, P1425; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Lam KKY, 2006, J CELL BIOL, V174, P19, DOI 10.1083/jcb.200602049; Li ZJ, 2011, NAT BIOTECHNOL, V29, P361, DOI 10.1038/nbt.1832; Mewes HW, 2006, NUCLEIC ACIDS RES, V34, pD169, DOI 10.1093/nar/gkj148; Miller JP, 2005, P NATL ACAD SCI USA, V102, P12123, DOI 10.1073/pnas.0505482102; Ostlund G, 2010, NUCLEIC ACIDS RES, V38, pD196, DOI 10.1093/nar/gkp931; Page LJ, 1999, J CELL BIOL, V146, P993, DOI 10.1083/jcb.146.5.993; Paumi CM, 2007, MOL CELL, V26, P15, DOI 10.1016/j.molcel.2007.03.011; Pieper U, 2011, NUCLEIC ACIDS RES, V39, pD465, DOI 10.1093/nar/gkq1091; Pu SY, 2007, PROTEOMICS, V7, P944, DOI 10.1002/pmic.200600636; Pu SY, 2009, NUCLEIC ACIDS RES, V37, P825, DOI 10.1093/nar/gkn1005; Reguly Teresa, 2006, J Biol, V5, P11, DOI 10.1186/jbiol36; Renard HF, 2010, TRAFFIC, V11, P931, DOI 10.1111/j.1600-0854.2010.01070.x; Rose MD., 1990, METHODS YEAST GENETI; Sato K, 2002, MOL BIOL CELL, V13, P2518, DOI 10.1091/mbc.E02-01-0027; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; SIDHU RS, 1991, GENE, V107, P111, DOI 10.1016/0378-1119(91)90303-S; Snider J, 2010, NAT PROTOC, V5, P1281, DOI 10.1038/nprot.2010.83; Tarassov K, 2008, SCIENCE, V320, P1465, DOI 10.1126/science.1153878; Turner B, 2010, DATABASE-OXFORD, DOI 10.1093/database/baq023; Valdivia RH, 2003, P NATL ACAD SCI USA, V100, P10287, DOI 10.1073/pnas.1834246100; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684; Zhang B, 2009, BRIT J HAEMATOL, V145, P15, DOI 10.1111/j.1365-2141.2008.07559.x	37	168	170	0	108	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 27	2012	489	7417					585	+		10.1038/nature11354	http://dx.doi.org/10.1038/nature11354			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	046RG	22940862				2022-12-28	WOS:000311781500008
J	Venkatesh, S; Smolle, M; Li, H; Gogol, MM; Saint, M; Kumar, S; Natarajan, K; Workman, JL				Venkatesh, Swaminathan; Smolle, Michaela; Li, Hua; Gogol, Madelaine M.; Saint, Malika; Kumar, Shambhu; Natarajan, Krishnamurthy; Workman, Jerry L.			Set2 methylation of histone H3 lysine 36 suppresses histone exchange on transcribed genes	NATURE			English	Article							RNA-POLYMERASE-II; CHROMATIN; ACETYLATION; REGIONS; COMPLEX; DEACETYLATION; ELONGATION; HISTORIES; RECRUITS; DIRECTS	Set2-mediated methylation of histone H3 at Lys 36 (H3K36me) is a co-transcriptional event that is necessary for the activation of the Rpd3S histone deacetylase complex, thereby maintaining the coding region of genes in a hypoacetylated state(1,2). In the absence of Set2, H3K36 or Rpd3S acetylated histones accumulate on open reading frames (ORFs), leading to transcription initiation from cryptic promoters within ORFs(1,3). Although the co-transcriptional deacetylation pathway is well characterized, the factors responsible for acetylation are as yet unknown. Here we show that, in yeast, co-transcriptional acetylation is achieved in part by histone exchange over ORFs. In addition to its function of targeting and activating the Rpd3S complex, H3K36 methylation suppresses the interaction of H3 with histone chaperones, histone exchange over coding regions and the incorporation of new acetylated histones. Thus, Set2 functions both to suppress the incorporation of acetylated histones and to signal for the deacetylation of these histones in transcribed genes. By suppressing spurious cryptic transcripts from initiating within ORFs, this pathway is essential to maintain the accuracy of transcription by RNA polymerase II.	[Venkatesh, Swaminathan; Smolle, Michaela; Li, Hua; Gogol, Madelaine M.; Workman, Jerry L.] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Saint, Malika; Kumar, Shambhu; Natarajan, Krishnamurthy] Jawarharlal Nehru Univ, Sch Life Sci, New Delhi 110067, India	Stowers Institute for Medical Research; Jawaharlal Nehru University, New Delhi	Workman, JL (corresponding author), Stowers Inst Med Res, 1000 E 50th St, Kansas City, MO 64110 USA.	jlw@stowers.org	Kumar, Shambhu/K-1260-2019	Kumar, Shambhu/0000-0003-1225-1790; Gogol, Madelaine/0000-0002-8738-0995; Smolle, Michaela/0000-0001-8900-1541; Saint, Malika/0000-0001-7509-0619; Venkatesh, Swaminathan/0000-0001-9837-1501	National Institutes of Health [R01GM04867]; Stowers Institute for Medical Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047867] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stowers Institute for Medical Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank F. Winston and O. Rando for providing yeast strains used in this study, members of the Workman laboratory for discussion, and J. Chatfield and G. Dialynas for critical reading of our manuscript. This work was supported by National Institutes of Health grant R01GM04867 to J. L. W. and the Stowers Institute for Medical Research.	Adkins MW, 2006, MOL CELL, V21, P405, DOI 10.1016/j.molcel.2005.12.010; Ahmad K, 2002, MOL CELL, V9, P1191, DOI 10.1016/S1097-2765(02)00542-7; Ai X, 2004, MOL CELL, V14, P195, DOI 10.1016/S1097-2765(04)00184-4; Arnold KM, 2011, BIOCHEMISTRY-US, V50, P727, DOI 10.1021/bi101355a; Burgess RJ, 2010, MOL CELL, V37, P469, DOI 10.1016/j.molcel.2010.01.020; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Cheung V, 2008, PLOS BIOL, V6, P2550, DOI 10.1371/journal.pbio.0060277; Dion MF, 2007, SCIENCE, V315, P1405, DOI 10.1126/science.1134053; Drouin S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001173; Duina AA, 2004, MOL CELL BIOL, V24, P561, DOI 10.1128/MCB.24.2.561-572.2004; Fillingham J, 2008, MOL CELL BIOL, V28, P4342, DOI 10.1128/MCB.00182-08; Govind CK, 2010, MOL CELL, V39, P234, DOI 10.1016/j.molcel.2010.07.003; Hewawasam G, 2010, MOL CELL, V40, P444, DOI 10.1016/j.molcel.2010.10.014; Jamai A, 2009, MOL CELL, V35, P377, DOI 10.1016/j.molcel.2009.07.001; Kaplan T, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000270; Katan-Khaykovich Y, 2011, P NATL ACAD SCI USA, V108, P1296, DOI 10.1073/pnas.1018308108; Kim T, 2009, CELL, V137, P259, DOI 10.1016/j.cell.2009.02.045; Kristjuhan A, 2004, EMBO J, V23, P4243, DOI 10.1038/sj.emboj.7600433; Kuo MH, 1996, NATURE, V383, P269, DOI 10.1038/383269a0; Li B, 2007, GENE DEV, V21, P1422, DOI 10.1101/gad.1539307; Li B, 2007, SCIENCE, V316, P1050, DOI 10.1126/science.1139004; Lin LJ, 2010, MOL CELL BIOL, V30, P1116, DOI 10.1128/MCB.01229-09; Masumoto H, 2005, NATURE, V436, P294, DOI 10.1038/nature03714; Mito Y, 2005, NAT GENET, V37, P1090, DOI 10.1038/ng1637; Mosley AL, 2009, MOL CELL, V34, P168, DOI 10.1016/j.molcel.2009.02.025; Nakanishi S, 2008, NAT STRUCT MOL BIOL, V15, P881, DOI 10.1038/nsmb.1454; Pattenden SG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012927; Rufiange A, 2007, MOL CELL, V27, P393, DOI 10.1016/j.molcel.2007.07.011; Schwabish MA, 2004, MOL CELL BIOL, V24, P10111, DOI 10.1128/MCB.24.23.10111-10117.2004; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; Tagami H, 2004, CELL, V116, P51, DOI 10.1016/S0092-8674(03)01064-X; Tsubota T, 2007, MOL CELL, V25, P703, DOI 10.1016/j.molcel.2007.02.006; Verreault A, 1996, CELL, V87, P95, DOI 10.1016/S0092-8674(00)81326-4; Williams SK, 2008, P NATL ACAD SCI USA, V105, P9000, DOI 10.1073/pnas.0800057105; Workman JL, 2006, GENE DEV, V20, P2009, DOI 10.1101/gad.1435706	35	213	220	0	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 20	2012	489	7416					452	U145		10.1038/nature11326	http://dx.doi.org/10.1038/nature11326			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AK	22914091				2022-12-28	WOS:000308860900050
J	Tremaroli, V; Backhed, F				Tremaroli, Valentina; Backhed, Fredrik			Functional interactions between the gut microbiota and host metabolism	NATURE			English	Review							DIET-INDUCED OBESITY; PROTEIN-COUPLED RECEPTOR; CHAIN FATTY-ACIDS; ADIPOSE-TISSUE; BILE-ACIDS; INDUCED INFLAMMATION; INSULIN-RESISTANCE; ENERGY-METABOLISM; BARIATRIC SURGERY; IMMUNE-SYSTEM	The link between the microbes in the human gut and the development of obesity, cardiovascular disease and metabolic syndromes, such as type 2 diabetes, is becoming clearer. However, because of the complexity of the microbial community, the functional connections are less well understood. Studies in both mice and humans are helping to show what effect the gut microbiota has on host metabolism by improving energy yield from food and modulating dietary or the host-derived compounds that alter host metabolic pathways. Through increased knowledge of the mechanisms involved in the interactions between the microbiota and its host, we will be in a better position to develop treatments for metabolic disease.	[Tremaroli, Valentina; Backhed, Fredrik] Sahlgrens Univ Hosp, Wallenberg Lab Cardiovasc & Metab Res, S-41345 Gothenburg, Sweden; [Tremaroli, Valentina; Backhed, Fredrik] Univ Gothenburg, Dept Mol & Clin Med, S-41345 Gothenburg, Sweden; [Backhed, Fredrik] Univ Copenhagen, Fac Hlth Sci, Novo Nordisk Fdn, Ctr Basic Metab Res, DK-2200 Copenhagen, Denmark	Sahlgrenska University Hospital; University of Gothenburg; Novo Nordisk Foundation; University of Copenhagen	Backhed, F (corresponding author), Sahlgrens Univ Hosp, Wallenberg Lab Cardiovasc & Metab Res, S-41345 Gothenburg, Sweden.	Fredrik.Backhed@wlab.gu.se	Tremaroli, Valentina/AAE-8001-2019; Backhed, Fredrik/ABE-6613-2020	Tremaroli, Valentina/0000-0002-9150-4233; Backhed, Fredrik/0000-0002-4871-8818	Swedish Research Council; Swedish Foundation for Strategic Research; Torsten Soderberg's Foundation; Ragnar Soderberg's foundation; AFA Insurances; Knut and Alice Wallenberg foundation; Swedish heart lung foundation; NovoNordisk foundation; Swedish diabetes foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Torsten Soderberg's Foundation; Ragnar Soderberg's foundation; AFA Insurances; Knut and Alice Wallenberg foundation(Knut & Alice Wallenberg Foundation); Swedish heart lung foundation(Swedish Heart-Lung Foundation); NovoNordisk foundation(Novo Nordisk Foundation); Swedish diabetes foundation	The authors are grateful to A. Hallen for contribution to the artwork and to R. Perkins for reading the manuscript. Work in the authors' laboratory is funded by the Swedish Research Council, the Swedish Foundation for Strategic Research, Torsten Soderberg's Foundation, Ragnar Soderberg's foundation, AFA Insurances, the Knut and Alice Wallenberg foundation, the Swedish heart lung foundation, the NovoNordisk foundation and the Swedish diabetes foundation.	Amar J, 2011, DIABETOLOGIA, V54, P3055, DOI 10.1007/s00125-011-2329-8; Amar J, 2008, AM J CLIN NUTR, V87, P1219, DOI 10.1093/ajcn/87.5.1219; Amar J, 2011, EMBO MOL MED, V3, P559, DOI 10.1002/emmm.201100159; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Backhed F, 2007, P NATL ACAD SCI USA, V104, P979, DOI 10.1073/pnas.0605374104; BERGMAN EN, 1990, PHYSIOL REV, V70, P567, DOI 10.1152/physrev.1990.70.2.567; Caesar R, 2012, GUT; Cani PD, 2007, DIABETOLOGIA, V50, P2374, DOI 10.1007/s00125-007-0791-0; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Creely SJ, 2007, AM J PHYSIOL-ENDOC M, V292, pE740, DOI 10.1152/ajpendo.00302.2006; Davie JR, 2003, J NUTR, V133, p2485S, DOI 10.1093/jn/133.7.2485S; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; Donohoe DR, 2011, CELL METAB, V13, P517, DOI 10.1016/j.cmet.2011.02.018; Dumas ME, 2006, P NATL ACAD SCI USA, V103, P12511, DOI 10.1073/pnas.0601056103; Duncan SH, 2008, INT J OBESITY, V32, P1720, DOI 10.1038/ijo.2008.155; EISEMAN B, 1958, SURGERY, V44, P854; Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022; Erridge C, 2007, AM J CLIN NUTR, V86, P1286, DOI 10.1093/ajcn/86.5.1286; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; Food and Agriculture Organization of the United Nations and World Health Organization, 2002, WORK GROUP REP DRAFT; Furet JP, 2010, DIABETES, V59, P3049, DOI 10.2337/db10-0253; Gaboriau-Routhiau V, 2009, IMMUNITY, V31, P677, DOI 10.1016/j.immuni.2009.08.020; Ghoshal S, 2009, J LIPID RES, V50, P90, DOI 10.1194/jlr.M800156-JLR200; Gummesson A, 2011, OBESITY, V19, P2280, DOI 10.1038/oby.2011.251; GUSTAFSSON BE, 1957, P SOC EXP BIOL MED, V94, P467; Henao-Mejia J, 2012, NATURE, V482, P179, DOI 10.1038/nature10809; Hildebrandt MA, 2009, GASTROENTEROLOGY, V137, P1716, DOI 10.1053/j.gastro.2009.08.042; HOVERSTAD T, 1986, J NUTR, V116, P1772, DOI 10.1093/jn/116.9.1772; Hylemon PB, 2009, J LIPID RES, V50, P1509, DOI 10.1194/jlr.R900007-JLR200; Larsson E, 2012, GUT, V61, P1124, DOI 10.1136/gutjnl-2011-301104; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Liu J, 2009, NAT MED, V15, P940, DOI 10.1038/nm.1994; Martens EC, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001221; Maslowski KM, 2009, NATURE, V461, P1282, DOI 10.1038/nature08530; Membrez M, 2008, FASEB J, V22, P2416, DOI 10.1096/fj.07-102723; Murphy EF, 2012, GUT, V00, P000; Nair S, 2001, AM J GASTROENTEROL, V96, P1200, DOI 10.1111/j.1572-0241.2001.03702.x; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; Osborn O, 2012, NAT MED, V18, P363, DOI 10.1038/nm.2627; Prawitt J, 2011, DIABETES, V60, P1861, DOI 10.2337/db11-0030; PRENTISS PG, 1961, ARCH BIOCHEM BIOPHYS, V94, P424, DOI 10.1016/0003-9861(61)90069-8; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Ramirez-Farias C, 2009, BRIT J NUTR, V101, P541, DOI 10.1017/S0007114508019880; Reinhardt C, 2012, NATURE, V483, P627, DOI 10.1038/nature10893; Roberfroid M, 2010, BRIT J NUTR, V104, pS1, DOI 10.1017/S0007114510003363; Robertson MD, 2005, AM J CLIN NUTR, V82, P559, DOI 10.1093/ajcn/82.3.559; Saberi M, 2009, CELL METAB, V10, P419, DOI 10.1016/j.cmet.2009.09.006; Samuel BS, 2008, P NATL ACAD SCI USA, V105, P16767, DOI 10.1073/pnas.0808567105; Samuel BS, 2006, P NATL ACAD SCI USA, V103, P10011, DOI 10.1073/pnas.0602187103; Schertzer JD, 2011, DIABETES, V60, P2206, DOI 10.2337/db11-0004; Schwiertz A, 2010, OBESITY, V18, P190, DOI 10.1038/oby.2009.167; Sina C, 2009, J IMMUNOL, V183, P7514, DOI 10.4049/jimmunol.0900063; Sinal CJ, 2000, CELL, V102, P731, DOI 10.1016/S0092-8674(00)00062-3; Sjogren K, 2012, J BONE MINER RES, V27, P1357, DOI 10.1002/jbmr.1588; Sjostrom L, 2004, NEW ENGL J MED, V351, P2683, DOI 10.1056/NEJMoa035622; Sjostrom L, 2007, NEW ENGL J MED, V357, P741, DOI 10.1056/NEJMoa066254; Spencer MD, 2011, GASTROENTEROLOGY, V140, P976, DOI 10.1053/j.gastro.2010.11.049; Stappenbeck TS, 2002, P NATL ACAD SCI USA, V99, P15451, DOI 10.1073/pnas.202604299; Strowig T, 2012, NATURE, V481, P278, DOI 10.1038/nature10759; Swann JR, 2011, P NATL ACAD SCI USA, V108, P4523, DOI 10.1073/pnas.1006734107; Thomas C, 2009, CELL METAB, V10, P167, DOI 10.1016/j.cmet.2009.08.001; Tolhurst G, 2012, DIABETES, V61, P364, DOI 10.2337/db11-1019; Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000322; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; van Dijk TH, 2009, J BIOL CHEM, V284, P10315, DOI 10.1074/jbc.M807317200; Vance DE, 2008, CURR OPIN LIPIDOL, V19, P229, DOI 10.1097/MOL.0b013e3282fee935; Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279; Velagapudi VR, 2010, J LIPID RES, V51, P1101, DOI 10.1194/jlr.M002774; Vijay-Kumar M, 2010, SCIENCE, V328, P228, DOI 10.1126/science.1179721; Vrieze A, 2012, GASTROENTEROLOGY; Walker AW, 2011, ISME J, V5, P220, DOI 10.1038/ISMEJ.2010.118; Wang ZN, 2011, NATURE, V472, P57, DOI 10.1038/nature09922; Watanabe M, 2006, NATURE, V439, P484, DOI 10.1038/nature04330; Wei XC, 2012, CELL HOST MICROBE, V11, P140, DOI 10.1016/j.chom.2011.12.006; Winer S, 2009, NAT MED, V15, P921, DOI 10.1038/nm.2001; WOSTMANN BS, 1983, LAB ANIM SCI, V33, P46; WOSTMANN BS, 1973, J NUTR, V103, P982, DOI 10.1093/jn/103.7.982; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Xu J, 2003, SCIENCE, V299, P2074, DOI 10.1126/science.1080029; Zhang HS, 2009, P NATL ACAD SCI USA, V106, P2365, DOI 10.1073/pnas.0812600106	85	2715	2918	77	1567	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 13	2012	489	7415					242	249		10.1038/nature11552	http://dx.doi.org/10.1038/nature11552			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003UC	22972297				2022-12-28	WOS:000308635900032
J	Vakarelski, IU; Patankar, NA; Marston, JO; Chan, DYC; Thoroddsen, ST				Vakarelski, Ivan U.; Patankar, Neelesh A.; Marston, Jeremy O.; Chan, Derek Y. C.; Thoroddsen, Sigurdur T.			Stabilization of Leidenfrost vapour layer by textured superhydrophobic surfaces	NATURE			English	Article							HEAT-TRANSFER; WETTABILITY; SPHERES; WATER; DRAG	In 1756, Leidenfrost(1) observed that water drops skittered on a sufficiently hot skillet, owing to levitation by an evaporative vapour film. Such films are stable only when the hot surface is above a critical temperature, and are a central phenomenon in boiling(2). In this so-called Leidenfrost regime, the low thermal conductivity of the vapour layer inhibits heat transfer between the hot surface and the liquid. When the temperature of the cooling surface drops below the critical temperature, the vapour film collapses and the system enters a nucleate-boiling regime, which can result in vapour explosions that are particularly detrimental in certain contexts, such as in nuclear power plants(3). The presence of these vapour films can also reduce liquid-solid drag(4-6). Here we show how vapour film collapse can be completely suppressed at textured superhydrophobic surfaces. At a smooth hydrophobic surface, the vapour film still collapses on cooling, albeit at a reduced critical temperature, and the system switches explosively to nucleate boiling. In contrast, at textured, superhydrophobic surfaces, the vapour layer gradually relaxes until the surface is completely cooled, without exhibiting a nucleate-boiling phase. This result demonstrates that topological texture on superhydrophobic materials is critical in stabilizing the vapour layer and thus in controlling-by heat transfer-the liquid-gas phase transition at hot surfaces. This concept can potentially be applied to control other phase transitions, such as ice or frost formation(7-9), and to the design of low-drag surfaces at which the vapour phase is stabilized in the grooves of textures without heating(10).	[Vakarelski, Ivan U.; Marston, Jeremy O.; Thoroddsen, Sigurdur T.] King Abdullah Univ Sci & Technol KAUST, Div Phys Sci & Engn, Thuwal 239556900, Saudi Arabia; [Vakarelski, Ivan U.; Thoroddsen, Sigurdur T.] King Abdullah Univ Sci & Technol KAUST, Clean Combust Res Ctr, Thuwal 239556900, Saudi Arabia; [Patankar, Neelesh A.] Northwestern Univ, Dept Mech Engn, Evanston, IL 60208 USA; [Chan, Derek Y. C.] Univ Melbourne, Dept Math & Stat, Parkville, Vic 3010, Australia; [Chan, Derek Y. C.] Swinburne Univ Technol, Fac Life & Social Sci, Hawthorn, Vic 3122, Australia	King Abdullah University of Science & Technology; King Abdullah University of Science & Technology; Northwestern University; University of Melbourne; Swinburne University of Technology	Vakarelski, IU (corresponding author), King Abdullah Univ Sci & Technol KAUST, Div Phys Sci & Engn, Thuwal 239556900, Saudi Arabia.	ivanuriev.vakarelski@kaust.edu.sa; n-patankar@northwestern.edu	Chan, Derek Y C/N-3130-2019; Vakarelski, Ivan/C-3132-2009; Patankar, Neelesh A/B-7603-2009; Marston, Jeremy/P-1121-2016	Chan, Derek Y C/0000-0002-2156-074X; Vakarelski, Ivan/0000-0001-9244-9160; Marston, Jeremy/0000-0001-5903-094X; Thoroddsen, Sigurdur T/0000-0001-6997-4311				Baumeister K.J., 1966, D3226 NASA; Bernardin JD, 1999, J HEAT TRANS-T ASME, V121, P894, DOI 10.1115/1.2826080; Berthoud G, 2000, ANNU REV FLUID MECH, V32, P573, DOI 10.1146/annurev.fluid.32.1.573; Carey V.P., 2008, LIQUID VAPOR PHASE C, P353; Cassie ABD, 1944, T FARADAY SOC, V40, P0546, DOI 10.1039/tf9444000546; Ceccio SL, 2010, ANNU REV FLUID MECH, V42, P183, DOI 10.1146/annurev-fluid-121108-145504; Celestini F, 2012, SOFT MATTER, V8, P5992, DOI 10.1039/c2sm25656h; Chen R, 2009, NANO LETT, V9, P548, DOI 10.1021/nl8026857; Deng X, 2012, SCIENCE, V335, P67, DOI 10.1126/science.1207115; DHIR VK, 1978, NUCL ENG DES, V47, P49, DOI 10.1016/0029-5493(78)90004-3; Flynn MR, 2008, J FLUID MECH, V608, P275, DOI 10.1017/S0022112008002048; Kim H, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3560060; Lagubeau G, 2011, NAT PHYS, V7, P395, DOI 10.1038/NPHYS1925; Larmour IA, 2007, ANGEW CHEM INT EDIT, V46, P1710, DOI 10.1002/anie.200604596; Lee C, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.014502; LEIDENFR.JG, 1966, INT J HEAT MASS TRAN, V9, P1153, DOI 10.1016/0017-9310(66)90111-6; Linke H, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.154502; Liu GM, 2011, LANGMUIR, V27, P2595, DOI 10.1021/la104669k; Liu GM, 2010, FARADAY DISCUSS, V146, P141, DOI 10.1039/b924965f; McHale G, 2010, SOFT MATTER, V6, P714, DOI 10.1039/b917861a; Mishchenko L, 2010, ACS NANO, V4, P7699, DOI 10.1021/nn102557p; Nukiyama S., 1934, J JPN SOC MECH ENG, V37, P367; Patankar NA, 2003, LANGMUIR, V19, P1249, DOI 10.1021/la026612+; Patankar NA, 2010, SOFT MATTER, V6, P1613, DOI 10.1039/b923967g; Quere D, 2008, ANNU REV MATER RES, V38, P71, DOI 10.1146/annurev.matsci.38.060407.132434; Rothstein JP, 2010, ANNU REV FLUID MECH, V42, P89, DOI 10.1146/annurev-fluid-121108-145558; Takata Y., 2005, P 5 INT C ENH COMP U, P300; Vakarelski IU, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.214501; WANG CH, 1993, J HEAT TRANS-T ASME, V115, P659, DOI 10.1115/1.2910737; WITTE LC, 1982, INT J HEAT MASS TRAN, V25, P771, DOI 10.1016/0017-9310(82)90089-8; Wong TS, 2011, NATURE, V477, P443, DOI 10.1038/nature10447; Zvirin Y, 1990, EXP HEAT TRANSFER, V3, P185, DOI 10.1080/08916159008946386	32	402	424	23	632	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 13	2012	489	7415					274	277		10.1038/nature11418	http://dx.doi.org/10.1038/nature11418			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003UC	22972299				2022-12-28	WOS:000308635900037
J	Schadt, E; Chang, R				Schadt, Eric; Chang, Rui			A GPS for Navigating DNA	SCIENCE			English	Editorial Material							EXPRESSION; DISEASE		[Schadt, Eric; Chang, Rui] Mt Sinai Sch Med, Inst Genom & Multiscale Biol, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Schadt, E (corresponding author), Mt Sinai Sch Med, Inst Genom & Multiscale Biol, New York, NY 10029 USA.	eric.schadt@mssm.edu	chang, rui/H-2787-2012					Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Bernstein BE, 2010, NAT BIOTECHNOL, V28, P1045, DOI 10.1038/nbt1010-1045; Califano A, 2012, NAT GENET, V44, P841, DOI 10.1038/ng.2355; Committee on a Framework for Developing a New Taxonomy of Disease, 2011, PREC MED BUILD KNOWL; Degner JF, 2012, NATURE, V482, P390, DOI 10.1038/nature10808; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Schadt EE, 2005, NAT GENET, V37, P710, DOI 10.1038/ng1589; Schadt EE, 2009, NATURE, V461, P218, DOI 10.1038/nature08454; Schadt EE, 2009, NAT REV DRUG DISCOV, V8, P286, DOI 10.1038/nrd2826; Stranger BE, 2011, GENETICS, V187, P367, DOI 10.1534/genetics.110.120907; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Zhu J, 2008, NAT GENET, V40, P854, DOI 10.1038/ng.167; Zhu J, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001301	13	6	6	1	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 7	2012	337	6099					1179	1180		10.1126/science.1227739	http://dx.doi.org/10.1126/science.1227739			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	000UJ	22955822				2022-12-28	WOS:000308414000022
J	Vasa, M; Baudendistel, TE; Ohikhuare, CE; Grace, EM; Yan, WS; Josephson, SA; Tierney, LM				Vasa, Miten; Baudendistel, Thomas E.; Ohikhuare, Christine E.; Grace, Elizabeth M.; Yan, Wilson; Josephson, S. Andrew; Tierney, Lawrence M., Jr.			The Eyes Have It	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BOTULINUM TOXIN; FOODBORNE BOTULISM; UNITED-STATES		[Vasa, Miten] Univ Calif Irvine, Orange, CA 92868 USA; [Vasa, Miten; Yan, Wilson] Univ Calif Irvine, Dept Med, Irvine, CA 92717 USA; [Baudendistel, Thomas E.] Kaiser Permanente, Dept Med, Oakland, CA USA; [Ohikhuare, Christine E.] Kaiser Permanente, Dept Med, Anaheim, CA USA; [Josephson, S. Andrew] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA; [Tierney, Lawrence M., Jr.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Grace, Elizabeth M.] Univ Illinois, Eye & Ear Infirm, Dept Ophthalmol, Chicago, IL USA	University of California System; University of California Irvine; University of California System; University of California Irvine; Kaiser Permanente; Kaiser Permanente; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Vasa, M (corresponding author), Univ Calif Irvine, 333 City Blvd W,City Tower Suite 800, Orange, CA 92868 USA.	miten.vasa@gmail.com						Arnon SS, 2001, JAMA-J AM MED ASSOC, V285, P1059, DOI 10.1001/jama.285.8.1059; Caya JG, 2001, SURV OPHTHALMOL, V46, P25, DOI 10.1016/S0039-6257(01)00227-2; Cherington M, 2004, SEMIN NEUROL, V24, P155, DOI 10.1055/s-2004-830901; Cherington M, 1998, MUSCLE NERVE, V21, P701, DOI 10.1002/(SICI)1097-4598(199806)21:6<701::AID-MUS1>3.0.CO;2-B; Ferreira JL, 2004, J FOOD PROTECT, V67, P203, DOI 10.4315/0362-028X-67.1.203; Friedman DI, 2009, OPHTHALMOLOGY, P1026; Hatheway CL, 1995, CURR TOP MICROBIOL, V195, P55; Horowitz BZ, 2005, CRIT CARE CLIN, V21, P825, DOI 10.1016/j.ccc.2005.06.008; HUGHES JM, 1981, ANN INTERN MED, V95, P442, DOI 10.7326/0003-4819-95-4-442; National Center for Home Food Preservation, USDA COMPL GUID HOM; Shapiro RL, 1998, ANN INTERN MED, V129, P221, DOI 10.7326/0003-4819-129-3-199808010-00011; Sobel J, 2005, CLIN INFECT DIS, V41, P1167, DOI 10.1086/444507; Sobel J, 2004, EMERG INFECT DIS, V10, P1606, DOI 10.3201/eid1009.030745; Villar RG, 2006, INFECT DIS CLIN N AM, V20, P313, DOI 10.1016/j.idc.2006.02.003	14	8	8	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 6	2012	367	10					938	943		10.1056/NEJMcps1105394	http://dx.doi.org/10.1056/NEJMcps1105394			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	999VO	22931263				2022-12-28	WOS:000308343300012
J	Ciraci, C; Hill, RT; Mock, JJ; Urzhumov, Y; Fernandez-Dominguez, AI; Maier, SA; Pendry, JB; Chilkoti, A; Smith, DR				Ciraci, C.; Hill, R. T.; Mock, J. J.; Urzhumov, Y.; Fernandez-Dominguez, A. I.; Maier, S. A.; Pendry, J. B.; Chilkoti, A.; Smith, D. R.			Probing the Ultimate Limits of Plasmonic Enhancement	SCIENCE			English	Article							FIELD ENHANCEMENT; NANOPARTICLES; QUANTUM	Metals support surface plasmons at optical wavelengths and have the ability to localize light to subwavelength regions. The field enhancements that occur in these regions set the ultimate limitations on a wide range of nonlinear and quantum optical phenomena. We found that the dominant limiting factor is not the resistive loss of the metal, but rather the intrinsic nonlocality of its dielectric response. A semiclassical model of the electronic response of a metal places strict bounds on the ultimate field enhancement. To demonstrate the accuracy of this model, we studied optical scattering from gold nanoparticles spaced a few angstroms from a gold film. The bounds derived from the models and experiments impose limitations on all nanophotonic systems.	[Ciraci, C.; Mock, J. J.; Urzhumov, Y.; Smith, D. R.] Duke Univ, Ctr Metamat & Integrated Plasmon, Durham, NC 27708 USA; [Ciraci, C.; Mock, J. J.; Urzhumov, Y.; Smith, D. R.] Duke Univ, Dept Elect & Comp Engn, Durham, NC 27708 USA; [Hill, R. T.; Chilkoti, A.] Duke Univ, Ctr Biol Inspired Mat & Mat Syst, Durham, NC 27708 USA; [Fernandez-Dominguez, A. I.; Maier, S. A.; Pendry, J. B.] Univ London Imperial Coll Sci Technol & Med, Dept Phys, Blackett Lab, London SW7 2AZ, England; [Chilkoti, A.] Duke Univ, Dept Biomed Engn, Durham, NC 27708 USA	Duke University; Duke University; Duke University; Imperial College London; Duke University	Ciraci, C (corresponding author), Duke Univ, Ctr Metamat & Integrated Plasmon, Durham, NC 27708 USA.	cristian.ciraci@duke.edu	Fernandez-Dominguez, Antonio I. I/C-4448-2013; Smith, David R/E-4710-2012; Fernandez-Dominguez, Antonio I./AGR-3767-2022; Maier, Stefan/V-2883-2019; Urzhumov, Yaroslav A/E-8360-2010; Ciracì, Cristian/K-3602-2017	Fernandez-Dominguez, Antonio I. I/0000-0002-8082-395X; Fernandez-Dominguez, Antonio I./0000-0002-8082-395X; Maier, Stefan/0000-0001-9704-7902; Ciracì, Cristian/0000-0003-3349-8389; Pendry, John/0000-0001-5145-5441	Air Force Office of Scientific Research [FA9550-09-1-0562]; Army Research Office through Multidisciplinary University Research Initiative [W911NF-09-1-0539]; Leverhulme Trust; Marie Curie Actions; NIH [R21EB009862, F32EB009299]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [F32EB009299, R21EB009862] Funding Source: NIH RePORTER; Engineering and Physical Sciences Research Council [EP/D063329/1, EP/H000917/2] Funding Source: researchfish; EPSRC [EP/H000917/2, EP/D063329/1] Funding Source: UKRI	Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Army Research Office through Multidisciplinary University Research Initiative; Leverhulme Trust(Leverhulme Trust); Marie Curie Actions(European Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We thank M. Scalora, S. Wolter, and A. Moreau for helpful input and discussion. Supported by Air Force Office of Scientific Research grant FA9550-09-1-0562 and by the Army Research Office through Multidisciplinary University Research Initiative grant W911NF-09-1-0539. Also supported by the Leverhulme Trust and the Marie Curie Actions (J.B.P., S. A. M., and A.I.F.-D.), NIH grant R21EB009862 (A. C.), and NIH F32 award F32EB009299 (R.T.H.).	BAIN CD, 1989, J AM CHEM SOC, V111, P321, DOI 10.1021/ja00183a049; Boardman A. D., 1982, ELECTROMAGNETIC SURF; David C, 2011, J PHYS CHEM C, V115, P19470, DOI 10.1021/jp204261u; Decher G, 1997, SCIENCE, V277, P1232, DOI 10.1126/science.277.5330.1232; Esteban R, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1806; Fernandez-Dominguez AI, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.106802; Fernandez-Dominguez AI, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.266807; FUCHS R, 1987, PHYS REV B, V35, P3722, DOI 10.1103/PhysRevB.35.3722; Gu Y, 2012, NANO LETT, V12, P2488, DOI 10.1021/nl300655n; Hill RT, 2010, NANO LETT, V10, P4150, DOI 10.1021/nl102443p; Marinica DC, 2012, NANO LETT, V12, P1333, DOI 10.1021/nl300269c; Mock JJ, 2012, NANO LETT, V12, P1757, DOI 10.1021/nl204596h; MOSKOVITS M, 1985, REV MOD PHYS, V57, P783, DOI 10.1103/RevModPhys.57.783; Oulton RF, 2009, NATURE, V461, P629, DOI 10.1038/nature08364; Renger J, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.046803; Scalora M, 2010, PHYS REV A, V82, DOI 10.1103/PhysRevA.82.043828; Toscano G, 2012, OPT EXPRESS, V20, P4176, DOI 10.1364/OE.20.004176; Zuloaga J, 2009, NANO LETT, V9, P887, DOI 10.1021/nl803811g	18	860	867	25	653	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 31	2012	337	6098					1072	1074		10.1126/science.1224823	http://dx.doi.org/10.1126/science.1224823			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996WP	22936772	Green Accepted, Green Submitted			2022-12-28	WOS:000308125800040
J	Gerbode, SJ; Puzey, JR; McCormick, AG; Mahadevan, L				Gerbode, Sharon J.; Puzey, Joshua R.; McCormick, Andrew G.; Mahadevan, L.			How the Cucumber Tendril Coils and Overwinds	SCIENCE			English	Article							GELATINOUS FIBERS; CLIMBING PLANTS; CURVATURE; GENERATION; PERVERSION; MECHANISM; HELIX; FORCE; WOOD	The helical coiling of plant tendrils has fascinated scientists for centuries, yet the underlying mechanism remains elusive. Moreover, despite Darwin's widely accepted interpretation of coiled tendrils as soft springs, their mechanical behavior remains unknown. Our experiments on cucumber tendrils demonstrate that tendril coiling occurs via asymmetric contraction of an internal fiber ribbon of specialized cells. Under tension, both extracted fiber ribbons and old tendrils exhibit twistless overwinding rather than unwinding, with an initially soft response followed by strong strain-stiffening at large extensions. We explain this behavior using physical models of prestrained rubber strips, geometric arguments, and mathematical models of elastic filaments. Collectively, our study illuminates the origin of tendril coiling, quantifies Darwin's original proposal, and suggests designs for biomimetic twistless springs with tunable mechanical responses.	[Gerbode, Sharon J.; Mahadevan, L.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Gerbode, Sharon J.; Mahadevan, L.] Harvard Univ, Wyss Inst Biol Inspired Engn, Cambridge, MA 02138 USA; [Gerbode, Sharon J.] Harvey Mudd Coll, Dept Phys, Claremont, CA 91711 USA; [Puzey, Joshua R.; Mahadevan, L.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [McCormick, Andrew G.; Mahadevan, L.] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA	Harvard University; Harvard University; Claremont Colleges; Harvey Mudd College; Harvard University; Harvard University	Mahadevan, L (corresponding author), Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA.	lm@seas.harvard.edu		Puzey, Joshua/0000-0001-8019-9993	MacArthur Foundation; Wyss Institute; Kavli Institute	MacArthur Foundation; Wyss Institute; Kavli Institute	This research was supported by funding from the MacArthur Foundation, the Wyss Institute, and the Kavli Institute. S.J.G., J.R.P., and L. M. designed the study. S.J.G., J.R.P., A. G. M., and L. M. conducted the research. S.J.G. and J.R.P. performed the biological and biophysical experiments. S.J.G., A. G. M., and L. M. handled biophysical theory. S.J.G., J.R.P., A. G. M., and L. M. contributed analytical tools and reagents and analyzed data. S.J.G., J.R.P., and L. M. wrote the paper. Harvard University has filed a patent application relating to a tunable, twistless overwinding spring based on the results of this study.	Armon S, 2011, SCIENCE, V333, P1726, DOI 10.1126/science.1203874; Bowling AJ, 2009, AM J BOT, V96, P719, DOI 10.3732/ajb.0800373; Chen Z, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3530441; Darwin C., 1865, MOVEMENTS HABITS CLI; Dastur RH, 1931, ANN BOT-LONDON, V45, P279; Goriely A, 1998, PHYS REV LETT, V80, P1564, DOI 10.1103/PhysRevLett.80.1564; Goswami L, 2008, PLANT J, V56, P531, DOI 10.1111/j.1365-313X.2008.03617.x; Gray A., 1880, STRUCTURAL BOT ORGAN; Isnard S, 2009, AM J BOT, V96, P1205, DOI 10.3732/ajb.0900045; Isnard S, 2009, P R SOC B, V276, P2643, DOI 10.1098/rspb.2009.0380; JAFFE MJ, 1968, ANN REV PLANT PHYSIO, V19, P417, DOI 10.1146/annurev.pp.19.060168.002221; Keller J.B., 1980, LECT MATH LIFE SCI, V13, P257; Lisk H, 1924, BOT GAZ, V78, P85, DOI 10.1086/333357; Love A.E.H., 1906, TREATISE MATH THEORY; MacDougal DT., 1896, ANN BOT-LONDON, V10, P373; McMillen T, 2002, J NONLINEAR SCI, V12, P241, DOI 10.1007/s00332-002-0493-1; Meloche CG, 2007, PLANTA, V225, P485, DOI 10.1007/s00425-006-0363-4; Nath U, 2003, SCIENCE, V299, P1404, DOI 10.1126/science.1079354; Savin T, 2011, NATURE, V476, P57, DOI 10.1038/nature10277; Scher JL, 2001, PLANTA, V213, P192, DOI 10.1007/s004250000503; SILK WK, 1978, AM J BOT, V65, P310, DOI 10.2307/2442271; Von Mohl H, 1852, PRINCIPLES ANATOMY P; WILSON BF, 1977, ANNU REV PLANT PHYS, V28, P23, DOI 10.1146/annurev.pp.28.060177.000323	23	261	265	25	256	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 31	2012	337	6098					1087	1091		10.1126/science.1223304	http://dx.doi.org/10.1126/science.1223304			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996WP	22936777	Green Published			2022-12-28	WOS:000308125800045
J	Baddour, LM; Cha, YM; Wilson, WR				Baddour, Larry M.; Cha, Yong-Mei; Wilson, Walter R.			Infections of Cardiovascular Implantable Electronic Devices	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CARDIOVERTER-DEFIBRILLATOR INFECTION; STAPHYLOCOCCUS-AUREUS BACTEREMIA; PERMANENT PACEMAKER IMPLANTATION; RISK-FACTORS; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; LEAD EXTRACTION; UNITED-STATES; ANTIBIOTIC-PROPHYLAXIS; MEDICARE BENEFICIARIES; ENDOCARDIAL PACEMAKER	A 75-year-old man presents with localized pain, redness, and swelling of 3 weeks' duration at the pocket site in the left upper shoulder, where an implantable cardioverter-defibrillator was placed 6 months earlier. He has no fever or other systemic symptoms. Physical examination reveals redness and induration at the site of the generator pocket on the left shoulder, with no stigmata of infective endocarditis. Results of blood cultures are negative. How should this case be managed?	[Baddour, Larry M.; Wilson, Walter R.] Mayo Clin, Coll Med, Dept Med, Div Infect Dis, Rochester, MN 55905 USA; [Cha, Yong-Mei] Mayo Clin, Coll Med, Dept Med, Div Cardiovasc Dis, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic	Baddour, LM (corresponding author), Mayo Clin, Coll Med, Dept Med, Div Infect Dis, 200 1st St SW, Rochester, MN 55905 USA.	baddour.larry@mayo.edu			Multidisciplinary Alliance against Device-Related Infections and Alini Health; Medtronic; General Electric	Multidisciplinary Alliance against Device-Related Infections and Alini Health; Medtronic(Medtronic); General Electric(General Electric)	Dr. Baddour reports receiving lecture fees from the Multidisciplinary Alliance against Device-Related Infections and Alini Health. Dr. Cha reports receiving lecture fees from Medtronic and grant funding to her institution from Medtronic and General Electric. No other potential conflict of interest relevant to this article was reported.	Al-Khatib SM, 2005, J AM COLL CARDIOL, V46, P1536, DOI 10.1016/j.jacc.2005.04.063; Baddour LM, 2010, CIRCULATION, V121, P458, DOI 10.1161/CIRCULATIONAHA.109.192665; Bloom H, 2006, PACE, V29, P142, DOI 10.1111/j.1540-8159.2006.00307.x; Borer A, 2004, INFECT CONT HOSP EP, V25, P492, DOI 10.1086/502428; Byrd CL, 2002, PACE, V25, P804, DOI 10.1046/j.1460-9592.2002.t01-1-00804.x; Cabell CH, 2004, AM HEART J, V147, P582, DOI 10.1016/j.ahj.2003.06.005; CAMUS C, 1993, CLIN INFECT DIS, V17, P46, DOI 10.1093/clinids/17.1.46; Cengiz M, 2010, CLIN CARDIOL, V33, P406, DOI 10.1002/clc.20765; Chamis AL, 2001, CIRCULATION, V104, P1029, DOI 10.1161/hc3401.095097; Chirillo F, 1995, Am J Card Imaging, V9, P174; Chiu WS, 1998, CAN J CARDIOL, V14, P87; Chua JD, 2005, PACE, V28, P1276, DOI 10.1111/j.1540-8159.2005.00268.x; Chua JD, 2000, ANN INTERN MED, V133, P604, DOI 10.7326/0003-4819-133-8-200010170-00011; Da Costa A, 1998, CIRCULATION, V97, P1796, DOI 10.1161/01.CIR.97.18.1796; DANIEL WG, 1991, CIRCULATION, V83, P817, DOI 10.1161/01.CIR.83.3.817; de Oliveira JC, 2009, CIRC-ARRHYTHMIA ELEC, V2, P29, DOI 10.1161/CIRCEP.108.795906; Downey BC, 2011, PACE, V34, P679, DOI 10.1111/j.1540-8159.2011.03034.x; Greenspon AJ, 2011, J AM COLL CARDIOL, V58, P1001, DOI 10.1016/j.jacc.2011.04.033; Johansen JB, 2011, EUR HEART J, V32, P991, DOI 10.1093/eurheartj/ehq497; Klug D, 2004, HEART, V90, P882, DOI 10.1136/hrt.2003.010595; Klug D, 1997, CIRCULATION, V95, P2098, DOI 10.1161/01.CIR.95.8.2098; Klug D, 2007, CIRCULATION, V116, P1349, DOI 10.1161/CIRCULATIONAHA.106.678664; Le KY, 2011, HEART RHYTHM, V8, P1678, DOI 10.1016/j.hrthm.2011.05.015; Lekkerkerker JC, 2009, HEART, V95, P715, DOI 10.1136/hrt.2008.151985; Lo Ronald, 2006, J Invasive Cardiol, V18, P599; Love CJ, 2000, PACE, V23, P544; Madhavan M, 2010, CIRC-ARRHYTHMIA ELEC, V3, P639, DOI 10.1161/CIRCEP.110.957514; Mond HG, 2011, PACE, V34, P1013, DOI 10.1111/j.1540-8159.2011.03150.x; Nery PB, 2010, J CARDIOVASC ELECTR, V21, P786, DOI 10.1111/j.1540-8167.2009.01690.x; Pichlmaier M, 2011, J THORAC CARDIOV SUR, V142, P1482, DOI 10.1016/j.jtcvs.2010.11.059; Poole JE, 2010, CIRCULATION, V122, P1553, DOI 10.1161/CIRCULATIONAHA.110.976076; Romeyer-Bouchard C, 2010, EUR HEART J, V31, P203, DOI 10.1093/eurheartj/ehp421; SHAPIRO SM, 1994, CHEST, V105, P377, DOI 10.1378/chest.105.2.377; Silvetti MS, 2006, EUROPACE, V8, P530, DOI 10.1093/europace/eul062; Sohail MR, 2012, AM J CARDIOL; Sohail MR, 2008, MAYO CLIN PROC, V83, P46, DOI 10.4065/83.1.46; Sohail MR, 2007, CLIN INFECT DIS, V45, P166, DOI 10.1086/518889; Sohail MR, 2007, J AM COLL CARDIOL, V49, P1851, DOI 10.1016/j.jacc.2007.01.072; Sohail MR, 2011, J INTERV CARD ELECTR, V31, P171, DOI 10.1007/s10840-010-9537-x; Sopena B, 2010, CLIN MICROBIOL INFEC, V16, P274, DOI 10.1111/j.1469-0691.2009.02787.x; Tarakji KG, 2010, HEART RHYTHM, V7, P1043, DOI 10.1016/j.hrthm.2010.05.016; Uslan DZ, 2008, AM HEART J, V155, P896, DOI 10.1016/j.ahj.2007.12.022; Uslan DZ, 2007, ARCH INTERN MED, V167, P669, DOI 10.1001/archinte.167.7.669; Uslan DZ, 2006, CLIN INFECT DIS, V43, P731, DOI 10.1086/506942; Uslan DZ, 2012, PACE, V35, P81, DOI 10.1111/j.1540-8159.2011.03257.x; Uslan DZ, 2010, PACE, V33, P407, DOI 10.1111/j.1540-8159.2009.02565.x; Voigt A, 2006, J AM COLL CARDIOL, V48, P590, DOI 10.1016/j.jacc.2006.05.016; Voigt A, 2010, PACE, V33, P414, DOI 10.1111/j.1540-8159.2009.02569.x; Wazni O, 2010, J AM COLL CARDIOL, V55, P579, DOI 10.1016/j.jacc.2009.08.070; Wilkoff BL, 2009, HEART RHYTHM, V6, P1085, DOI 10.1016/j.hrthm.2009.05.020	50	90	94	0	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 30	2012	367	9					842	849		10.1056/NEJMcp1107675	http://dx.doi.org/10.1056/NEJMcp1107675			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	996EN	22931318				2022-12-28	WOS:000308067400006
J	Timmons, JA; Baar, K; Davidsen, PK; Atherton, PJ				Timmons, James A.; Baar, Keith; Davidsen, Peter K.; Atherton, Philip J.			Is irisin a human exercise gene?	NATURE			English	Letter							SKELETAL-MUSCLE; RESISTANCE		[Timmons, James A.; Davidsen, Peter K.] Univ London, London NW1 0TU, England; [Baar, Keith] Univ Calif Davis, Davis, CA 95616 USA; [Atherton, Philip J.] Univ Nottingham, Derby Royal Infirm, Derby DE22 3DT, England	University of London; University of California System; University of California Davis; University of Nottingham	Timmons, JA (corresponding author), Univ London, Royal Coll St, London NW1 0TU, England.	Jamie.Timmons@gmail.com	Timmons, James A/J-4698-2014; Timmons, James A/M-6350-2019	Timmons, James A/0000-0002-2255-1220; Timmons, James A/0000-0002-2255-1220; Atherton, Philip/0000-0002-7286-046X; Baar, Keith/0000-0001-9337-6186	Biotechnology and Biological Sciences Research Council [BB/G013128/1] Funding Source: Medline; Medical Research Council [G1100015] Funding Source: Medline; MRC [G1100015] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Babraj JA, 2009, BMC ENDOCR DISORD, V9, DOI 10.1186/1472-6823-9-3; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Boule NG, 2005, DIABETES CARE, V28, P108, DOI 10.2337/diacare.28.1.108; Gallagher IJ, 2010, GENOME MED, V2, DOI 10.1186/gm130; Holten MK, 2004, DIABETES, V53, P294, DOI 10.2337/diabetes.53.2.294; Keller P, 2007, BIOCHEM SOC T, V35, P1306, DOI 10.1042/BST0351306; Keller P, 2011, J APPL PHYSIOL, V110, P46, DOI 10.1152/japplphysiol.00634.2010; Melov S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000465; Petrovic N, 2010, J BIOL CHEM, V285, P7153, DOI 10.1074/jbc.M109.053942; Phillips B, 2012, J APPL PHYSIOL, V112, P347, DOI 10.1152/japplphysiol.01031.2011; Timmons JA, 2005, FASEB J, V19, P750, DOI 10.1096/fj.04-1980com; Timmons JA, 2009, NEW ENGL J MED, V361, P415, DOI 10.1056/NEJMc091009; Vollaard NBJ, 2009, J APPL PHYSIOL, V106, P1479, DOI 10.1152/japplphysiol.91453.2008	13	289	312	4	82	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 30	2012	488	7413					E9	E10		10.1038/nature11364	http://dx.doi.org/10.1038/nature11364			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996NC	22932392				2022-12-28	WOS:000308095100001
J	Ellis, O				Ellis, Oliver			The "exclamation mark" school of patient safety	BRITISH MEDICAL JOURNAL			English	Editorial Material												oli.ellis@googlemail.com							0	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	AUG 23	2012	345								e5731	10.1136/bmj.e5731	http://dx.doi.org/10.1136/bmj.e5731			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	996GY	22918598				2022-12-28	WOS:000308074100004
J	Ahmad, T; Felker, GM				Ahmad, Tariq; Felker, G. Michael			Warfarin and aspirin did not differ for death or stroke in heart failure and sinus rhythm	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Ahmad, Tariq; Felker, G. Michael] Duke Univ, Sch Med, Durham, NC 27708 USA	Duke University	Ahmad, T (corresponding author), Duke Univ, Sch Med, Durham, NC 27708 USA.							Eikelboom JW, 2012, NEW ENGL J MED, V366, P1936, DOI 10.1056/NEJMe1202504; Lip GYH, 2012, EUR J HEART FAIL, V14, P681, DOI 10.1093/eurjhf/hfs073	2	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 21	2012	157	4							JC4-7	10.7326/0003-4819-157-4-201208210-02007	http://dx.doi.org/10.7326/0003-4819-157-4-201208210-02007			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	992XG	22910961				2022-12-28	WOS:000307813200006
J	Palmer, SC; Craig, JC; Navaneethan, SD; Tonelli, M; Pellegrini, F; Strippoli, GFM				Palmer, Suetonia C.; Craig, Jonathan C.; Navaneethan, Sankar D.; Tonelli, Marcello; Pellegrini, Fabio; Strippoli, Giovanni F. M.			Benefits and Harms of Statin Therapy for Persons With Chronic Kidney Disease A Systematic Review and Meta-analysis	ANNALS OF INTERNAL MEDICINE			English	Review							C-REACTIVE PROTEIN; PLACEBO-CONTROLLED TRIAL; ALL-CAUSE MORTALITY; RANDOMIZED CONTROLLED-TRIALS; RENAL-TRANSPLANT RECIPIENTS; ACUTE MYOCARDIAL-INFARCTION; COA REDUCTASE INHIBITOR; CORONARY-HEART-DISEASE; ACID-BINDING PROTEIN; LOW-DOSE SIMVASTATIN	Background: Statins have uncertain benefits in persons with chronic kidney disease (CKD) because individual trials may have insufficient power to determine whether treatment effects differ with severity of CKD. Purpose: To summarize the benefits and harms of statin therapy for adults with CKD and examine whether effects of statins vary by stage of kidney disease. Data Sources: Cochrane and EMBASE databases (inception to February 2012). Study Selection: Randomized trials comparing the effects of statins with placebo, no treatment, or another statin on mortality and cardiovascular outcomes. Data Extraction: Two independent reviewers extracted data and assessed risk of bias. Data Synthesis: Eighty trials comprising 51 099 participants compared statin with placebo or no treatment. Treatment effects varied with stage of CKD. Moderate-to high-quality evidence indicated that statins reduced all-cause mortality (relative risk [RR], 0.81 [95% CI, 0.74 to 0.88]), cardiovascular mortality (RR, 0.78 [CI, 0.68 to 0.89]), and cardiovascular events (RR, 0.76 [CI, 0.73 to 0.80]) in persons not receiving dialysis. Moderate-to high-quality evidence indicated that statins had little or no effect on all-cause mortality (RR, 0.96 [CI, 0.88 to 1.04]), cardiovascular mortality (RR, 0.94 [CI, 0.82 to 1.07]), or cardiovascular events (RR, 0.95 [CI, 0.87 to 1.03]) in persons receiving dialysis. Effects of statins in kidney transplant recipients were uncertain. Statins had little or no effect on cancer, myalgia, liver function, or withdrawal from treatment, although adverse events were evaluated systematically in fewer than half of the trials. Limitation: There was a reliance on post hoc subgroup data for earlier stages of CKD. Conclusion: Statins decrease mortality and cardiovascular events in persons with early stages of CKD, have little or no effect in persons receiving dialysis, and have uncertain effects in kidney transplant recipients.	[Strippoli, Giovanni F. M.] Ist Ric Farmacol Mario Negri, Consorzio Mario Negri Sud, Dept Clin Pharmacol & Epidemiol, I-66030 Santa Maria Imbaro, Italy; Univ Otago, Christchurch, New Zealand; Univ Sydney, Sydney, NSW 2006, Australia; Cleveland Clin, Cleveland, OH 44106 USA; Univ Alberta, Edmonton, AB, Canada	Consorzio Mario Negri Sud; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; University of Otago; University of Sydney; Cleveland Clinic Foundation; University of Alberta	Strippoli, GFM (corresponding author), Ist Ric Farmacol Mario Negri, Consorzio Mario Negri Sud, Dept Clin Pharmacol & Epidemiol, Via Nazl 8-A, I-66030 Santa Maria Imbaro, Italy.	strippoli@negrisud.it	Craig, Jonathan/E-2813-2013; Tonelli, Marcello/B-3028-2009	Craig, Jonathan/0000-0002-2548-4035; Tonelli, Marcello/0000-0002-0846-3187	National Institutes of Health; Genzyme; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024990] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Genzyme(Sanofi-AventisGenzyme Corporation); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Dr. Craig: Membership: SHARP Steering Committee. Dr. Navaneethan: Grants/grants pending: National Institutes of Health, Genzyme. Dr. Tonelli: Board membership: Merck. Disclosures can also be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M11-3102.	Ahmadi FL, 2006, NEPHROL DIAL TRANSPL, V21, P229; Anavekar NS, 2004, NEW ENGL J MED, V351, P1285, DOI 10.1056/NEJMoa041365; Aranda Arcas J L, 1994, An Med Interna, V11, P523; ARNADOTTIR M, 1994, NEPHRON, V68, P57, DOI 10.1159/000188088; Asselbergs FW, 2004, CIRCULATION, V110, P2809, DOI 10.1161/01.CIR.0000146378.65439.7A; Baigent C, 2000, LANCET, V356, P147, DOI 10.1016/S0140-6736(00)02456-9; Baigent C, 2005, AM J KIDNEY DIS, V45, P473, DOI 10.1053/j.ajkd.2004.11.015; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Baigent C, 2011, LANCET, V377, P2181, DOI 10.1016/S0140-6736(11)60739-3; Bianchi S, 2003, AM J KIDNEY DIS, V41, P565, DOI 10.1053/ajkd.2003.50140; Boutron I, 2010, JAMA-J AM MED ASSOC, V303, P2058, DOI 10.1001/jama.2010.651; Briel M, 2006, JAMA-J AM MED ASSOC, V295, P2046, DOI 10.1001/jama.295.17.2046; Buemi M, 2000, CLIN PHARMACOL THER, V67, P427, DOI 10.1067/mcp.2000.105330; Burmeister JE, 2009, J NEPHROL, V22, P83; CASTELAO AM, 1993, TRANSPLANT P, V25, P1043; Celik A, 2000, NEPHRON, V84, P81, DOI 10.1159/000045544; Chan J, 2005, ANN PHARMACOTHER, V39, P1611, DOI 10.1345/aph.1G035; Chang JW, 2002, AM J KIDNEY DIS, V39, P1213, DOI 10.1053/ajkd.2002.33393; Chonchol M, 2007, AM J KIDNEY DIS, V49, P373, DOI 10.1053/j.ajkd.2006.11.043; Cofan F, 2002, TRANSPL P, V34, P389, DOI 10.1016/S0041-1345(01)02814-7; Colhoun HM, 2009, AM J KIDNEY DIS, V54, P810, DOI 10.1053/j.ajkd.2009.03.022; Collins R, 2003, LANCET, V361, P2005; de Jager DJ, 2009, JAMA-J AM MED ASSOC, V302, P1782, DOI 10.1001/jama.2009.1488; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Di Angelantonio E, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4986; Di Lullo L, 2005, ADV THER, V22, P601, DOI 10.1007/BF02849954; Diepeveen SHA, 2005, J INTERN MED, V257, P438, DOI 10.1111/j.1365-2796.2005.01484.x; Dornbrook-Lavender KA, 2005, PHARMACOTHERAPY, V25, P335, DOI 10.1592/phco.25.3.335.61599; Dummer CD, 2008, J NEPHROL, V21, P900; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Fassett RG, 2010, ATHEROSCLEROSIS, V213, P218, DOI 10.1016/j.atherosclerosis.2010.07.053; Fassett RG, 2010, SCAND J UROL NEPHROL, V44, P56, DOI 10.3109/00365590903359908; Fellstrom BC, 2009, NEW ENGL J MED, V360, P1395, DOI 10.1056/NEJMoa0810177; Foley RN, 1998, AM J KIDNEY DIS, V32, pS112, DOI 10.1053/ajkd.1998.v32.pm9820470; Fried LF, 2001, J DIABETES COMPLICAT, V15, P113, DOI 10.1016/S1056-8727(01)00140-4; Gheith OA, 2002, NEPHRON, V91, P612, DOI 10.1159/000065021; Goicoechea M, 2006, J AM SOC NEPHROL, V17, pS231, DOI 10.1681/ASN.2006080938; Green D, 2011, AM J KIDNEY DIS, V57, P921, DOI 10.1053/j.ajkd.2011.02.376; Gupta AK, 2011, J HUM HYPERTENS, V25, P633; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Han SH, 2011, NEPHROL DIAL TRANSPL, V26, P3722, DOI 10.1093/ndt/gfr108; Harbord RM, 2006, STAT MED, V25, P3443, DOI 10.1002/sim.2380; Harris KPG, 2002, KIDNEY INT, V61, P1469, DOI 10.1046/j.1523-1755.2002.00262.x; Hausberg M, 2001, KIDNEY INT, V59, P1473, DOI 10.1046/j.1523-1755.2001.0590041473.x; HERNANDEZ BEM, 1993, NEPHROL DIAL TRANSPL, V8, P637; Herzog CA, 1998, NEW ENGL J MED, V339, P799, DOI 10.1056/NEJM199809173391203; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Holdaas H, 2003, LANCET, V361, P2024, DOI 10.1016/S0140-6736(03)13638-0; Holdaas H, 2001, KIDNEY INT, V60, P1990, DOI 10.1046/j.1523-1755.2001.00010.x; HOMMEL E, 1992, DIABETOLOGIA, V35, P447, DOI 10.1007/BF02342442; Ichihara A, 2002, NEPHROL DIAL TRANSPL, V17, P1513, DOI 10.1093/ndt/17.8.1513; Imai Y, 1999, CLIN EXP HYPERTENS, V21, P1345, DOI 10.3109/10641969909070853; Kasiske BL, 2006, J AM SOC NEPHROL, V17, P900, DOI 10.1681/ASN.2005090984; Kasiske BL, 2001, TRANSPLANTATION, V72, P223, DOI 10.1097/00007890-200107270-00009; Katznelson S, 1996, TRANSPLANTATION, V61, P1469, DOI 10.1097/00007890-199605270-00010; Kendrick J, 2010, AM J KIDNEY DIS, V55, P42, DOI 10.1053/j.ajkd.2009.09.020; Koren MJ, 2009, AM J KIDNEY DIS, V53, P741, DOI 10.1053/j.ajkd.2008.11.025; LAM KSL, 1995, DIABETOLOGIA, V38, P604, DOI 10.1007/s001250050326; Lee TM, 2005, KIDNEY INT, V68, P779, DOI 10.1111/j.1523-1755.2005.00457.x; Lemos PA, 2005, AM J CARDIOL, V95, P445, DOI 10.1016/j.amjcard.2004.10.008; Lepre F, 1999, CLIN TRANSPLANT, V13, P520, DOI 10.1034/j.1399-0012.1999.130613.x; Lins RL, 2004, CLIN NEPHROL, V62, P287; LINTOTT CJ, 1995, AM J CARDIOL, V76, pA97, DOI 10.1016/S0002-9149(05)80027-X; Melchor JL, 1998, TRANSPLANT P, V30, P2054, DOI 10.1016/S0041-1345(98)00538-7; MORI Y, 1992, Journal of the Japan Diabetes Society, V35, P265; Nakamura H, 2009, ATHEROSCLEROSIS, V206, P512, DOI 10.1016/j.atherosclerosis.2009.03.031; Nakamura T, 2006, AM J NEPHROL, V26, P82, DOI 10.1159/000091956; Nakamura T, 2005, DIABETES CARE, V28, P2728, DOI 10.2337/diacare.28.11.2728; Nakamura T, 2002, NEPHROL DIAL TRANSPL, V17, P798, DOI 10.1093/ndt/17.5.798; Navaneethan SD, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005019.pub3; Navaneethan SD, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007784; Navaneethan SD, 2009, COCHRANE DATABASE SY; NIELSEN S, 1993, DIABETOLOGIA, V36, P1079, DOI 10.1007/BF02374502; Paczek L, 1997, Pol Arch Med Wewn, V97, P144; Palmer SC, 2011, JAMA-J AM MED ASSOC, V305, P1119, DOI 10.1001/jama.2011.308; Panichi V, 2006, NEPHROL DIAL TRANSPL, V21, P337, DOI 10.1093/ndt/gfi224; Pedersen TR, 2005, JAMA-J AM MED ASSOC, V294, P2437, DOI 10.1001/jama.294.19.2437; Phrommintikul A, 2007, LANCET, V369, P381, DOI 10.1016/S0140-6736(07)60194-9; Raiola Paolino, 1998, Journal of the American Society of Nephrology, V9, p693A; Rayner BL, 1996, CLIN NEPHROL, V46, P219; Renders L, 2001, NEPHROL DIAL TRANSPL, V16, P141, DOI 10.1093/ndt/16.1.141; Renke M, 2010, ACTA BIOCHIM POL, V57, P547; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Ridker PM, 2010, J AM COLL CARDIOL, V55, P1266, DOI 10.1016/j.jacc.2010.01.020; Ruggenenti P, 2010, CLIN J AM SOC NEPHRO, V5, P1928, DOI 10.2215/CJN.03380410; Rutter MK, 2011, DIABETIC MED, V28, P100, DOI 10.1111/j.1464-5491.2010.03139.x; Sahu KM, 2001, CLIN TRANSPLANT, V15, P173, DOI 10.1034/j.1399-0012.2001.150305.x; Saltissi D, 2002, AM J KIDNEY DIS, V39, P283, DOI 10.1053/ajkd.2002.30547; Samuelsson O, 2002, AM J KIDNEY DIS, V39, P67, DOI 10.1053/ajkd.2002.29883; Santos AF, 2001, TRANSPL P, V33, P1194, DOI 10.1016/S0041-1345(00)02382-4; Sawara Y, 2008, INTERNAL MED, V47, P1505, DOI 10.2169/internalmedicine.47.1159; SCANFERLA F, 1991, AM J HYPERTENS, V4, P868, DOI 10.1093/ajh/4.10.868; Seron D, 2008, TRANSPLANTATION, V86, P82, DOI 10.1097/TP.0b013e318174428d; Sharif A, 2009, AM J TRANSPLANT, V9, P1439, DOI 10.1111/j.1600-6143.2009.02644.x; Shepherd J, 2008, J AM COLL CARDIOL, V51, P1448, DOI 10.1016/j.jacc.2007.11.072; Stegmayr BG, 2005, SCAND J UROL NEPHROL, V39, P489, DOI 10.1080/00365590500329304; Stevens KK, 2011, LANCET, V377, P2153, DOI 10.1016/S0140-6736(11)60822-2; Strippoli GFM, 2004, J AM SOC NEPHROL, V15, P411, DOI 10.1097/01.ASN.0000100125.21491.46; Strippoli GFM, 2008, BMJ-BRIT MED J, V336, P645, DOI 10.1136/bmj.39472.580984.AE; THOMAS ME, 1993, KIDNEY INT, V44, P1124, DOI 10.1038/ki.1993.358; Tokunaga M, 2008, J AM SOC NEPHROL, V19, p307A; Tonelli M, 2004, CIRCULATION, V110, P1557, DOI 10.1161/01.CIR.0000143892.84582.60; Tonolo G, 1997, DIABETES CARE, V20, P1891, DOI 10.2337/diacare.20.12.1891; Trivedi H, 2009, NEPHROL DIAL TRANSPL, V24, P258, DOI 10.1093/ndt/gfn426; Tse KC, 2008, J NEPHROL, V21, P283; Tuncer M, 2000, TRANSPLANT P, V32, P622, DOI 10.1016/S0041-1345(00)00921-0; U.S. Food and Drug Administration, 2011, END MET DRUGS ADV CO; United States Renal Data System, 2010, US REN DAT SYST 2010; US Renal Data System, 2010, US REN DAT SYST 2010; van den Akker JM, 2003, J NEPHROL, V16, P238; van Houwelingen HC, 2002, STAT MED, V21, P589, DOI 10.1002/sim.1040; Vareesangthip K, 2005, J AM SOC NEPHROL, V16, p276A; Velickovic-Radovanovic R., 1997, Nephrology Dialysis Transplantation, V12, pA187; Vergoulas G., 1999, Nephrology Dialysis Transplantation, V14, pA312; Verma A, 2005, AM J CARDIOL, V96, P1290, DOI 10.1016/j.amjcard.2005.06.074; Vernaglione L, 2004, AM J KIDNEY DIS, V43, P471, DOI 10.1053/j.ajkd.2003.11.008; Walker RJ, 1997, NEPHROL DIAL TRANSPL, V12, P87, DOI 10.1093/ndt/12.1.87; Wanner C, 2005, NEW ENGL J MED, V353, P238, DOI 10.1056/NEJMoa043545; Weiner DE, 2006, AM J KIDNEY DIS, V48, P392, DOI 10.1053/j.ajkd.2006.05.021; Wetmore JB, 2009, AM J KIDNEY DIS, V53, P457, DOI 10.1053/j.ajkd.2008.07.037; Yasuda G, 2004, RENAL FAILURE, V26, P411, DOI 10.1081/JDI-120039826; ZHANG A, 1995, DIABETES RES CLIN PR, V29, P189, DOI 10.1016/0168-8227(95)01138-2	122	249	261	1	41	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 21	2012	157	4					263	+		10.7326/0003-4819-157-4-201208210-00007	http://dx.doi.org/10.7326/0003-4819-157-4-201208210-00007			21	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	992XG	22910937	Green Accepted			2022-12-28	WOS:000307813200017
J	Tranquada, JM				Tranquada, John M.			Cuprates Get Orders to Charge	SCIENCE			English	Editorial Material							FERMI-SURFACE		Brookhaven Natl Lab, Condensed Matter Phys & Mat Sci Dept, Upton, NY 11973 USA	United States Department of Energy (DOE); Brookhaven National Laboratory	Tranquada, JM (corresponding author), Brookhaven Natl Lab, Condensed Matter Phys & Mat Sci Dept, Upton, NY 11973 USA.	jtran@bnl.gov	Tranquada, John M./A-9832-2009	Tranquada, John M./0000-0003-4984-8857				CASTELLANI C, 1995, PHYS REV LETT, V75, P4650, DOI 10.1103/PhysRevLett.75.4650; Chakravarty S, 2008, SCIENCE, V319, P735, DOI 10.1126/science.1154320; Doiron-Leyraud N, 2012, PHYSICA C, V481, P161, DOI 10.1016/j.physc.2012.04.040; Ghiringhelli G, 2012, SCIENCE, V337, P821, DOI 10.1126/science.1223532; Haug D, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/10/105006; LeBoeuf D, 2007, NATURE, V450, P533, DOI 10.1038/nature06332; Millis AJ, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.220503; Sebastian SE, 2008, NATURE, V454, P200, DOI 10.1038/nature07095; Wu T, 2011, NATURE, V477, P191, DOI 10.1038/nature10345; Yao H, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.012507; Zaanen J, 2006, NAT PHYS, V2, P138	11	4	4	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 17	2012	337	6096					811	812		10.1126/science.1227082	http://dx.doi.org/10.1126/science.1227082			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	989BQ	22904004				2022-12-28	WOS:000307535600032
J	Sabchareon, A; Wallace, D; Sirivichayakul, C; Limkittikul, K; Chanthavanich, P; Suvannadabba, S; Jiwariyavej, V; Dulyachai, W; Pengsaa, K; Wartel, TA; Moureau, A; Saville, M; Bouckenooghe, A; Viviani, S; Tornieporth, NG; Lang, J				Sabchareon, Arunee; Wallace, Derek; Sirivichayakul, Chukiat; Limkittikul, Kriengsak; Chanthavanich, Pornthep; Suvannadabba, Saravudh; Jiwariyavej, Vithaya; Dulyachai, Wut; Pengsaa, Krisana; Wartel, T. Anh; Moureau, Annick; Saville, Melanie; Bouckenooghe, Alain; Viviani, Simonetta; Tornieporth, Nadia G.; Lang, Jean			Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial	LANCET			English	Article							VIRUS; CHILDREN; INFECTION; NEUTRALIZATION; EPIDEMIOLOGY; ADOLESCENTS; RATCHABURI; PREVENTION; GUIDELINES; ANTIBODIES	Background Roughly half the world's population live in dengue-endemic countries, but no vaccine is licensed. We investigated the efficacy of a recombinant, live, attenuated tetravalent dengue vaccine. Methods In this observer-masked, randomised, controlled, monocentre, phase 2b, proof-of-concept trial, healthy Thai schoolchildren aged 4-11 years were randomly assigned (2: 1) to receive three injections of dengue vaccine or control (rabies vaccine or placebo) at months 0, 6, and 12. Randomisation was by computer-generated permuted blocks of six and participants were assigned with an interactive response system. Participants were actively followed up until month 25. All acute febrile illnesses were investigated. Dengue viraemia was confirmed by serotype-specifi c RT-PCR and non-structural protein 1 ELISA. The primary objective was to assess protective efficacy against virologically confirmed, symptomatic dengue, irrespective of severity or serotype, occurring 1 month or longer after the third injection (per-protocol analysis). This trial is registered at ClinicalTrials.gov, NCT00842530. Findings 4002 participants were assigned to vaccine (n=2669) or control (n=1333). 3673 were included in the primary analysis (2452 vaccine, 1221 control). 134 cases of virologically confirmed dengue occurred during the study. Efficacy was 30.2% (95% CI -13.4 to 56.6), and differed by serotype. Dengue vaccine was well tolerated, with no safety signals after 2 years of follow-up after the first dose. Interpretation These data show for the first time that a safe vaccine against dengue is possible. Ongoing large-scale phase 3 studies in various epidemiological settings will provide pivotal data for the CYD dengue vaccine candidate.	[Wallace, Derek; Bouckenooghe, Alain] Sanofi Pasteur, Asia Pacific Clin Dev, Singapore 048580, Singapore; [Sabchareon, Arunee; Sirivichayakul, Chukiat; Limkittikul, Kriengsak; Chanthavanich, Pornthep; Pengsaa, Krisana] Mahidol Univ, Fac Trop Med, Dept Trop Pediat, Bangkok, Thailand; [Suvannadabba, Saravudh] Minist Publ Hlth, Div Dis Control, Nonthaburi, Thailand; [Jiwariyavej, Vithaya; Dulyachai, Wut] Ratchaburi Hosp, Ratchaburi, Thailand; [Wartel, T. Anh] Sanofi Pasteur, Asia Pacific Clin Dev, Bangkok, Thailand; [Moureau, Annick; Saville, Melanie; Viviani, Simonetta] Sanofi Pasteur, Global Clin R&D Dept, Marcy Letoile, France; [Lang, Jean] Sanofi Pasteur, Res & Dev, Marcy Letoile, France; [Tornieporth, Nadia G.] Sanofi Pasteur, Global Clin R&D Dept, Swiftwater, PA USA	Sanofi-Aventis; Mahidol University; Ministry of Public Health - Thailand; Sanofi-Aventis; Sanofi-Aventis; Sanofi France; Sanofi-Aventis; Sanofi France; Sanofi-Aventis	Wallace, D (corresponding author), Sanofi Pasteur, Asia Pacific Clin Dev, Singapore 048580, Singapore.	derek.wallace@sanofipasteur.com	Viviani, Simonetta/AAE-7966-2019	Viviani, Simonetta/0000-0002-3652-5082	Sanofi Pasteur; Ministry of Public Health	Sanofi Pasteur; Ministry of Public Health	The study was funded by Sanofi Pasteur. We thank Prayura Kunasol and Supamit Chunsuthiwat from the Ministry of Public Health for their help in setting up the Ratchaburi cohort; members of Ratchaburi community who supported the study, especially parents and their children, schoolteachers and headmasters, district and subdistrict administrators (ie, Governors, Muang District Major, Chief Medical Officer of the Ratchaburi Provincial Health Office, Ratchaburi hospital directors, paediatricians, and nurses for their outstanding patient care); Pediatric Dengue Vaccine Initiative for supporting dengue epidemiological study and community sociobehavioural study at the study site resulting in excellent background for the study; Pratap Singhasivanon, Dean of the Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand, for his full support; Sutee Yoksan at the Center for Vaccine Development (Mahidol University); and the IDMC members (Frank von Sonnenburg [chair]), Kim Mulholland [past chair], Jose Cordero, Tran Tinh Hien, Quak Seng Hock, Jukka Jokinen, Siripen Kalayanarooj, Peter Smith, and Raul Isturiz). We thank several colleagues at Sanofi Pasteur for the contributions to this study: Denis Crevat and Laurent Chambonneau for contributions to study design; Christophe Fournier for vaccine production; Nadia Souag, Jerome Zobel, Vincent Canouet, Hazel Dy Tioco, Chayanont Boonchaliew, Pattarat Satthaporn, Edith Langevin, Clarisse Lebrun-Plavosin, Anne Dagot, Jean-Sebastien Persico, Leona Fernandes, Nathalie Chretien, Marie-Ange Grosbois, Anatawan Tawan, Chantal Rotario, Anabelle Monnet, Anna Skipetrova, Franck Gressier, and Tom Papa for their medical, technical, and operational contributions to study implementation; Mark Boaz, Linda Starr-Spires, Seema Garg, Ben McEntee, Branda Hu, Tatyana Timiryasova, Rebecca Zedar, Rod Cameron, Celine Petit, and Kara Grundowski at the Global Clinical Immunology laboratory; Veronique Barban, Nathalie Mantel, Sophie Gervais, Lyn Morgan, Patrice Riou, Dany De Grave, Bruno Guy, Jeffrey Almond, and Marie-Jose Quentin-Millet for helpful discussions; and Grenville Marsh for coordinating the preparation of this report.	Barban V, 2012, VIROLOGY, V429, P91, DOI 10.1016/j.virol.2012.03.007; Beatty ME, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000890; BRESLOW NE, 1987, IARC SCI PUBLICATION, V82; Callahan JD, 2001, J CLIN MICROBIOL, V39, P4119, DOI 10.1128/JCM.39.11.4119-4124.2001; Capeding RZ, 2011, VACCINE, V29, P3863, DOI 10.1016/j.vaccine.2011.03.057; Chuansumrit A, 2008, PEDIATR INFECT DIS J, V27, P43, DOI 10.1097/INF.0b013e318150666d; Coller BAG, 2011, CURR OPIN IMMUNOL, V23, P391, DOI 10.1016/j.coi.2011.03.005; Drumond BP, 2012, ARCH VIROL, V157, P2061, DOI 10.1007/s00705-012-1393-9; Gubler DJ, 2012, AM J TROP MED HYG, V86, P743, DOI 10.4269/ajtmh.2012.12-0157; Guirakhoo F, 2000, J VIROL, V74, P5477, DOI 10.1128/JVI.74.12.5477-5485.2000; Guy B, 2011, VACCINE, V29, P7229, DOI 10.1016/j.vaccine.2011.06.094; Hombach J, 2009, J CLIN VIROL, V46, pS7, DOI 10.1016/S1386-6532(09)70287-2; Lanata CF, 2012, VACCINE, V30, P5935, DOI 10.1016/j.vaccine.2012.07.043; San Martin JL, 2010, AM J TROP MED HYG, V82, P128, DOI 10.4269/ajtmh.2010.09-0346; Nisalak A, 2003, AM J TROP MED HYG, V68, P191, DOI 10.4269/ajtmh.2003.68.191; Poo J, 2011, PEDIATR INFECT DIS J, V30, pE9, DOI 10.1097/INF.0b013e3181fe05af; Roehrig JT, 2008, VIRAL IMMUNOL, V21, P123, DOI 10.1089/vim.2008.0007; RUSSELL PK, 1967, J IMMUNOL, V99, P285; Sabchareon A, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001732; Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265; Sin Leo Y, 2012, HUM VACCIN IMMUNOTHE; Sirivichayakul C, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001520; Thomas SJ, 2011, CURR OPIN INFECT DIS, V24, P442, DOI 10.1097/QCO.0b013e32834a1b0b; Thomas SJ, 2011, HUM VACCINES, V7, P674, DOI 10.4161/hv.7.6.14985; Tran NK, 2011, 14 ANN C VACC RES BA; Vu TTH, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000757; Wartel-Tram A, 2009, 58 ANN M AM SOC TROP; WHO, 1997, DENG HAEM FEV DIAGN; World Health Organization, 2009, DENGUE GUIDELINES DI; World Health Organization, 2012, GLOB STRAT DENG PREV	30	607	633	0	77	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	NOV 3	2012	380	9853					1559	1567		10.1016/S0140-6736(12)61428-7	http://dx.doi.org/10.1016/S0140-6736(12)61428-7			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	030VR	22975340				2022-12-28	WOS:000310598700031
J	Goldberger, ZD; Chan, PS; Berg, RA; Kronick, SL; Cooke, CR; Lu, MR; Banerjee, M; Hayward, RA; Krumholz, HM; Nallamothu, BK				Goldberger, Zachary D.; Chan, Paul S.; Berg, Robert A.; Kronick, Steven L.; Cooke, Colin R.; Lu, Mingrui; Banerjee, Mousumi; Hayward, Rodney A.; Krumholz, Harlan M.; Nallamothu, Brahmajee K.		Amer Heart Assoc Get Guidelines-Re	Duration of resuscitation efforts and survival after in-hospital cardiac arrest: an observational study	LANCET			English	Article							AMERICAN-HEART-ASSOCIATION; CARDIOPULMONARY-RESUSCITATION; CARE; GUIDELINES; OUTCOMES; REGISTRY; COUNCIL; RULE	Background During in-hospital cardiac arrests, how long resuscitation attempts should be continued before termination of efforts is unknown. We investigated whether duration of resuscitation attempts varies between hospitals and whether patients at hospitals that attempt resuscitation for longer have higher survival rates than do those at hospitals with shorter durations of resuscitation efforts. Methods Between 2000 and 2008, we identified 64 339 patients with cardiac arrests at 435 US hospitals within the Get With The Guidelines-Resuscitation registry. For each hospital, we calculated the median duration of resuscitation before termination of efforts in non-survivors as a measure of the hospital's overall tendency for longer attempts. We used multilevel regression models to assess the association between the length of resuscitation attempts and risk-adjusted survival. Our primary endpoints were immediate survival with return of spontaneous circulation during cardiac arrest and survival to hospital discharge. Findings 31 198 of 64 339 (48.5%) patients achieved return of spontaneous circulation and 9912 (15.4%) survived to discharge. For patients achieving return of spontaneous circulation, the median duration of resuscitation was 12 min (IQR 6-21) compared with 20 min (14-30) for non-survivors. Compared with patients at hospitals in the quartile with the shortest median resuscitation attempts in non-survivors (16 min [IQR 15-17]), those at hospitals in the quartile with the longest attempts (25 min [25-28]) had a higher likelihood of return of spontaneous circulation (adjusted risk ratio 1.12, 95% CI 1.06-1.18; p<0.0001) and survival to discharge (1.12, 1.02-1.23; 0.021). Interpretation Duration of resuscitation attempts varies between hospitals. Although we cannot define an optimum duration for resuscitation attempts on the basis of these observational data, our findings suggest that efforts to systematically increase the duration of resuscitation could improve survival in this high-risk population.	[Goldberger, Zachary D.; Lu, Mingrui; Nallamothu, Brahmajee K.] Univ Michigan, Div Cardiovasc Med, Ann Arbor, MI 48109 USA; [Goldberger, Zachary D.; Hayward, Rodney A.] Univ Michigan, Robert Wood Johnson Fdn, Clin Scholars Program, Ann Arbor, MI 48109 USA; [Kronick, Steven L.] Univ Michigan, Dept Emergency Med, Ann Arbor, MI 48109 USA; [Hayward, Rodney A.] Univ Michigan, Div Gen Internal Med, Ann Arbor, MI 48109 USA; [Cooke, Colin R.] Univ Michigan, Div Pulm & Crit Care Med, Ann Arbor, MI 48109 USA; [Banerjee, Mousumi] Univ Michigan, Sch Publ Hlth, Dept Biostat, Ann Arbor, MI 48109 USA; [Cooke, Colin R.; Banerjee, Mousumi; Nallamothu, Brahmajee K.] Univ Michigan, Ctr Healthcare Outcomes & Policy, Ann Arbor, MI 48109 USA; [Hayward, Rodney A.; Nallamothu, Brahmajee K.] Univ Michigan, VA Ann Arbor Ctr Clin Management Res, Ann Arbor, MI 48109 USA; [Chan, Paul S.] St Lukes Mid Amer Heart Inst, Kansas City, MI USA; [Berg, Robert A.] Univ Penn, Sch Med, Childrens Hosp Penn, Dept Anesthesiol & Crit Care Med, Philadelphia, PA 19104 USA; [Berg, Robert A.] Univ Penn, Sch Med, Childrens Hosp Penn, Dept Pediat, Philadelphia, PA 19104 USA; [Krumholz, Harlan M.] Yale Univ, Yale Sch Med, Dept Med, Sect Cardiovasc Med, New Haven, CT USA; [Krumholz, Harlan M.] Yale Univ, Yale Sch Med, Dept Med, Robert Wood Johnson Fdn,Clin Scholars Program, New Haven, CT USA; [Krumholz, Harlan M.] Yale Univ, Yale Sch Publ Hlth, Sect Hlth Policy & Adm, New Haven, CT USA; [Krumholz, Harlan M.] Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, New Haven, CT 06504 USA	University of Michigan System; University of Michigan; Robert Wood Johnson Foundation (RWJF); University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Saint Luke's Mid America Heart Institute; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Yale University; Robert Wood Johnson Foundation (RWJF); Yale University; Yale University; Yale University	Nallamothu, BK (corresponding author), Univ Michigan Hlth Syst, Div Cardiovasc Med, Ann Arbor, MI 48109 USA.	bnallamo@umich.edu	, Harlan/AAI-2875-2020	Cooke, Colin/0000-0001-9713-5371	American Heart Association; Robert Wood Johnson Foundation Clinical Scholars Program; National Institutes of Health; Medtronic through Yale University; National Heart, Lung, and Blood Institute [K23HL102224, U01 HL105270-02]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL102224, U01HL105270] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); Robert Wood Johnson Foundation Clinical Scholars Program(Robert Wood Johnson Foundation (RWJF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medtronic through Yale University; National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	American Heart Association, Robert Wood Johnson Foundation Clinical Scholars Program, and the National Institutes of Health.; HMK is the recipient of a research grant from Medtronic through Yale University and is chair of a cardiac scientific advisory board for UnitedHealth. All other authors declare that they have no conflicts of interest.; The American Heart Association provides operational funding for Get With The Guidelines-Resuscitation. ZDG is a 2010-12 Robert Wood Johnson Foundation clinical scholar. PSC is supported by a career development grant award (K23HL102224) from the National Heart, Lung, and Blood Institute. HMK is supported by grant U01 HL105270-02 (Center for Cardiovascular Outcomes Research at Yale University) from the National Heart, Lung, and Blood Institute.	BALLEW KA, 1994, ARCH INTERN MED, V154, P2426, DOI 10.1001/archinte.154.21.2426; BEDELL SE, 1983, NEW ENGL J MED, V309, P569, DOI 10.1056/NEJM198309083091001; Chan PS, 2008, NEW ENGL J MED, V358, P9, DOI 10.1056/NEJMoa0706467; Chan PS, 2012, JAMA-J AM MED ASSOC, V307, P1917, DOI 10.1001/jama.2012.3504; Chan PS, 2010, JAMA-J AM MED ASSOC, V304, P2129, DOI 10.1001/jama.2010.1576; Eisenberg MS, 2001, NEW ENGL J MED, V344, P1304, DOI 10.1056/NEJM200104263441707; Girotra S, N ENGL J ME IN PRESS; Jacobs I, 2004, CIRCULATION, V110, P3385, DOI 10.1161/01.CIR.0000147236.85306.15; Jain R, 2011, ARCH INTERN MED, V171, P89, DOI 10.1001/archinternmed.2010.475; JENNETT B, 1975, LANCET, V7905, P480; Jones PG, 2008, RESUSCITATION, V76, P369, DOI 10.1016/j.resuscitation.2007.08.021; Larkin GL, 2010, RESUSCITATION, V81, P302, DOI 10.1016/j.resuscitation.2009.11.021; McNutt LA, 2003, AM J EPIDEMIOL, V157, P940, DOI 10.1093/aje/kwg074; Merchant RM, 2011, CRIT CARE MED, V39, P2401, DOI 10.1097/CCM.0b013e3182257459; Morrison LJ, 2006, NEW ENGL J MED, V355, P478, DOI 10.1056/NEJMoa052620; Morrison LJ, 2010, CIRCULATION, V122, pS665, DOI 10.1161/CIRCULATIONAHA.110.970905; Nolan JP, 2010, RESUSCITATION, V81, P1219, DOI 10.1016/j.resuscitation.2010.08.021; Peberdy MA, 2003, RESUSCITATION, V58, P297, DOI 10.1016/S0300-9572(03)00215-6; Sandroni C, 2007, INTENS CARE MED, V33, P237, DOI 10.1007/s00134-006-0326-z; Schnijder T.A.B., 2012, MULTILEVEL ANAL INTR, V2nd ed; Schultz SC, 1996, RESUSCITATION, V33, P13, DOI 10.1016/S0300-9572(96)00986-0; Shih CL, 2007, RESUSCITATION, V72, P394, DOI 10.1016/j.resuscitation.2006.07.020; STEMMLER EJ, 1965, ANN INTERN MED, V63, P613, DOI 10.7326/0003-4819-63-4-613; van Walraven C, 1999, ARCH INTERN MED, V159, P129, DOI 10.1001/archinte.159.2.129; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	25	262	277	1	24	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 27	2012	380	9852					1473	1481		10.1016/S0140-6736(12)60862-9	http://dx.doi.org/10.1016/S0140-6736(12)60862-9			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	026JJ	22958912	Green Accepted			2022-12-28	WOS:000310272000027
J	Graves, JA; Swartz, K				Graves, John A.; Swartz, Katherine			Health Care Reform and the Dynamics of Insurance Coverage - Lessons from Massachusetts	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Graves, John A.] Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA; [Swartz, Katherine] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	Vanderbilt University; Harvard University; Harvard T.H. Chan School of Public Health	Graves, JA (corresponding author), Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA.							Cutler DM, 2009, NEW ENGL J MED, V360, P1740, DOI 10.1056/NEJMsa0804668; Long SK, 2009, AM ECON REV, V99, P508, DOI 10.1257/aer.99.2.508; SWARTZ K, 1993, INQUIRY-J HEALTH CAR, V30, P64	3	7	7	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 27	2012	367	13					1181	1184		10.1056/NEJMp1207217	http://dx.doi.org/10.1056/NEJMp1207217			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	011JO	22950842	Bronze			2022-12-28	WOS:000309161100003
J	Lingwood, D; McTamney, PM; Yassine, HM; Whittle, JRR; Guo, XT; Boyington, JC; Wei, CJ; Nabel, GJ				Lingwood, Daniel; McTamney, Patrick M.; Yassine, Hadi M.; Whittle, James R. R.; Guo, Xiaoti; Boyington, Jeffrey C.; Wei, Chih-Jen; Nabel, Gary J.			Structural and genetic basis for development of broadly neutralizing influenza antibodies	NATURE			English	Article							CELL ANTIGEN RECEPTOR; VIRUS; SPECIFICITY; VACCINATION; ACTIVATION; INDUCTION; LYMPHOMAS; IMMUNITY; DENSITY; HIV-1	Influenza viruses take a yearly toll on human life despite efforts to contain them with seasonal vaccines. These viruses evade human immunity through the evolution of variants that resist neutralization. The identification of antibodies that recognize invariant structures on the influenza haemagglutinin (HA) protein have invigorated efforts to develop universal influenza vaccines. Specifically, antibodies to the highly conserved stem region of HA neutralize diverse viral subtypes. These antibodies largely derive from a specific antibody gene, heavy-chain variable region IGHV1-69, after limited affinity maturation from their germline ancestors(1,2), but how HA stimulates naive B cells to mature and induce protective immunity is unknown. To address this question, we analysed the structural and genetic basis for their engagement and maturation into broadly neutralizing antibodies. Here we show that the germline-encoded precursors of these antibodies act as functional B-cell antigen receptors (BCRs) that initiate subsequent affinity maturation. Neither the germline precursor of a prototypic antibody, CR6261 (ref. 3), nor those of two other natural human IGHV1-69 antibodies, bound HA as soluble immunoglobulin-G(IgG). However, all three IGHV1-69 precursors engaged HA when the antibody was expressed as cell surface IgM. HA triggered BCR-associated tyrosine kinase signalling by germline transmembrane IgM. Recognition and virus neutralization was dependent solely on the heavy chain, and affinity maturation of CR6261 required only seven amino acids in the complementarity-determining region (CDR) H1 and framework region 3 (FR3) to restore full activity. These findings provide insight into the initial events that lead to the generation of broadly neutralizing antibodies to influenza, informing the rational design of vaccines to elicit such antibodies and providing a model relevant to other infectious diseases, including human immunodeficiency virus/AIDS. The data further suggest that selected immunoglobulin genes recognize specific protein structural 'patterns' that provide a substrate for further affinity maturation.	[Lingwood, Daniel; McTamney, Patrick M.; Yassine, Hadi M.; Whittle, James R. R.; Guo, Xiaoti; Boyington, Jeffrey C.; Wei, Chih-Jen; Nabel, Gary J.] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Nabel, GJ (corresponding author), NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	gnabel@nih.gov	YASSINE, HADI M./AAW-6475-2020; Wei, Chih/GVT-5734-2022	YASSINE, HADI M./0000-0001-7592-2788; 	US Department of Energy, Office of Science, Office of Basic Energy Sciences [W-31-109-Eng-38]; Intramural Research Program of the Vaccine Research Center, NIAID, National Institutes of Health	US Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Intramural Research Program of the Vaccine Research Center, NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank N. Longo for help with JOINSOLVER analysis, Z.-Y. Yang for the design of membrane-bound IgM antibody, and X. Chen for technical support. We also thank A. Tislerics for manuscript preparation, B. Hartman and J. Farrar for preparation of figures, members of the G. J. N. laboratory and P. Kwong for advice and discussions. Use of the Advanced Photon Source was supported by the US Department of Energy, Office of Science, Office of Basic Energy Sciences, under contract no. W-31-109-Eng-38. This research was supported by the Intramural Research Program of the Vaccine Research Center, NIAID, National Institutes of Health.	AlLazikani B, 1997, J MOL BIOL, V273, P927, DOI 10.1006/jmbi.1997.1354; BENJAMIN D, 1982, J IMMUNOL, V129, P1336; Chan CH, 2001, BLOOD, V97, P1023, DOI 10.1182/blood.V97.4.1023; Corti D, 2010, J CLIN INVEST, V120, P1663, DOI 10.1172/JCI41902; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; Fahmy TM, 2001, IMMUNITY, V14, P135, DOI 10.1016/S1074-7613(09)00099-5; Gustchina E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001182; Haid S, 2009, J BIOL CHEM, V284, P17657, DOI 10.1074/jbc.M109.014647; Heizmann B, 2010, P NATL ACAD SCI USA, V107, P18563, DOI 10.1073/pnas.1009048107; Huang CC, 2004, P NATL ACAD SCI USA, V101, P2706, DOI 10.1073/pnas.0308527100; Huppa JB, 2010, NATURE, V463, P963, DOI 10.1038/nature08746; Kabat EA, 1991, SEQUENCES PROTEINS I; KLEIN G, 1975, INTERVIROLOGY, V5, P319, DOI 10.1159/000149930; Kong WP, 2006, P NATL ACAD SCI USA, V103, P15987, DOI 10.1073/pnas.0607564103; Ledgerwood JE, 2011, LANCET INFECT DIS, V11, P916, DOI 10.1016/S1473-3099(11)70240-7; Liu WL, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002295; Luftig MA, 2006, NAT STRUCT MOL BIOL, V13, P740, DOI 10.1038/nsmb1127; METZGER H, 1992, J IMMUNOL, V149, P1477; Muller R, 2000, P NATL ACAD SCI USA, V97, P8451, DOI 10.1073/pnas.97.15.8451; Nabel GJ, 2010, NAT MED, V16, P1389, DOI 10.1038/nm1210-1389; Prabakaran P, 2006, J BIOL CHEM, V281, P15829, DOI 10.1074/jbc.M600697200; Souto-Carneiro MM, 2004, J IMMUNOL, V172, P6790, DOI 10.4049/jimmunol.172.11.6790; Sui J, 2011, CLIN INFECT DIS, V52, P1003, DOI 10.1093/cid/cir121; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; Wei CJ, 2008, J VIROL, V82, P6200, DOI 10.1128/JVI.00187-08; Wei CJ, 2010, SCIENCE, V329, P1060, DOI 10.1126/science.1192517; Wienands J, 1996, P NATL ACAD SCI USA, V93, P7865, DOI 10.1073/pnas.93.15.7865; Wrammert J, 2011, J EXP MED, V208, P181, DOI 10.1084/jem.20101352; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Xiao XD, 2009, BIOCHEM BIOPH RES CO, V390, P404, DOI 10.1016/j.bbrc.2009.09.029; Yang ZY, 2007, SCIENCE, V317, P825, DOI 10.1126/science.1135165	31	182	187	1	56	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 27	2012	489	7417					566	+		10.1038/nature11371	http://dx.doi.org/10.1038/nature11371			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	046RG	22932267	Green Published			2022-12-28	WOS:000311781500004
J	Klein, NP; Bartlett, J; Rowhani-Rahbar, A; Fireman, B; Baxter, R				Klein, Nicola P.; Bartlett, Joan; Rowhani-Rahbar, Ali; Fireman, Bruce; Baxter, Roger			Waning Protection after Fifth Dose of Acellular Pertussis Vaccine in Children	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							WHOLE-CELL; UNITED-STATES; INFANTS; ADOLESCENTS; RATES; RISK	Background In the United States, children receive five doses of diphtheria, tetanus, and acellular pertussis (DTaP) vaccine before 7 years of age. The duration of protection after five doses of DTaP is unknown. Methods We assessed the risk of pertussis in children in California relative to the time since the fifth dose of DTaP from 2006 to 2011. This period included a large outbreak in 2010. We conducted a case-control study involving members of Kaiser Permanente Northern California who were vaccinated with DTaP at 47 to 84 months of age. We compared children with pertussis confirmed by a positive polymerase-chain-reaction (PCR) assay with two sets of controls: those who were PCR-negative for pertussis and closely matched controls from the general population of health-plan members. We used logistic regression to examine the risk of pertussis in relation to the duration of time since the fifth DTaP dose. Children who received whole- cell pertussis vaccine during infancy or who received any pertussis-containing vaccine after their fifth dose of DTaP were excluded. Results We compared 277 children, 4 to 12 years of age, who were PCR-positive for pertussis with 3318 PCR-negative controls and 6086 matched controls. PCR-positive children were more likely to have received the fifth DTaP dose earlier than PCR-negative controls (P<0.001) or matched controls (P = 0.005). Comparison with PCR-negative controls yielded an odds ratio of 1.42 (95% confidence interval, 1.21 to 1.66), indicating that after the fifth dose of DTaP, the odds of acquiring pertussis increased by an average of 42% per year. Conclusions Protection against pertussis waned during the 5 years after the fifth dose of DTaP. (Funded by Kaiser Permanente).	[Klein, Nicola P.; Bartlett, Joan; Rowhani-Rahbar, Ali; Fireman, Bruce; Baxter, Roger] Kaiser Permanente, Vaccine Study Ctr, Oakland, CA 94612 USA	Kaiser Permanente	Klein, NP (corresponding author), Kaiser Permanente, Vaccine Study Ctr, 1 Kaiser Plaza,16th Fl, Oakland, CA 94612 USA.	nicola.klein@kp.org		Rowhani-Rahbar, Ali/0000-0002-2705-4485	Kaiser Permanente; Sanofi Pasteur; GlaxoSmithKline; Novartis; Merck; Pfizer	Kaiser Permanente; Sanofi Pasteur; GlaxoSmithKline(GlaxoSmithKline); Novartis(Novartis); Merck(Merck & Company); Pfizer(Pfizer)	Funded by Kaiser Permanente.; Drs. Klein and Baxter report receiving grant support to their institution from Sanofi Pasteur, GlaxoSmithKline, Novartis, Merck, and Pfizer. No other potential conflict of interest relevant to this article was reported.	[Anonymous], 1992, MMWR Recomm Rep, V41, P1; [Anonymous], 2010, MMWR MORB MORTAL WKL, V59, P817; [Anonymous], 2007, MMWR MORB MORTAL WKL, V54, P1; [Anonymous], 2006, PEDIATRICS, V117, P965; Cherry JD, 2010, CLIN INFECT DIS, V51, P663, DOI 10.1086/655826; Cherry JD, 1988, PEDIATRICS S, V81, pS933; CODY CL, 1981, PEDIATRICS, V68, P650; Elliott MN, 2008, HEALTH SERV RES, V43, P1722, DOI 10.1111/j.1475-6773.2008.00854.x; FARIZO KM, 1992, CLIN INFECT DIS, V14, P708, DOI 10.1093/clinids/14.3.708; Guris D, 1999, CLIN INFECT DIS, V28, P1230, DOI 10.1086/514776; Gustafsson L, 2006, PEDIATRICS, V118, P978, DOI 10.1542/peds.2005-2746; Khan FN, 2006, PEDIATR INFECT DIS J, V25, P1132, DOI 10.1097/01.inf.0000245099.01427.93; Lacombe K, 2004, VACCINE, V23, P623, DOI 10.1016/j.vaccine.2004.07.007; Lavine J, 2010, VACCINE, V29, P11, DOI 10.1016/j.vaccine.2010.10.029; Lugauer S, 2002, EUR J PEDIATR, V161, P142, DOI 10.1007/s00431-001-0893-5; Matheson A J, 2000, Paediatr Drugs, V2, P139, DOI 10.2165/00128072-200002020-00007; Moore David M, 2002, Can J Infect Dis, V13, P305; MORTIMER EA, 1979, REV INFECT DIS, V1, P927; Olin P, 2003, VACCINE, V21, P2015, DOI 10.1016/S0264-410X(02)00777-6; Prevention and control of tuberculosis in correctional and detention facilities: recommendations from CDC, 2006, MMWR RECOMM REP, V55, P1; Salmaso S, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.5.e81; Simondon F, 1997, VACCINE, V15, P1606, DOI 10.1016/S0264-410X(97)00100-X; Vickers D, 2006, CAN MED ASSOC J, V175, P1213, DOI 10.1503/cmaj.051637; 2011, MMWR MORB MORTAL WKL, V60, P13	24	389	397	0	29	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 13	2012	367	11					1012	1019		10.1056/NEJMoa1200850	http://dx.doi.org/10.1056/NEJMoa1200850			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	003ZE	22970945				2022-12-28	WOS:000308649100007
J	LeBlanc, PM; Hollinger, KA; Klontz, KC				LeBlanc, Pamela M.; Hollinger, Katherine A.; Klontz, Karl C.			Tattoo Ink-Related Infections - Awareness, Diagnosis, Reporting, and Prevention	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[LeBlanc, Pamela M.; Hollinger, Katherine A.; Klontz, Karl C.] US FDA, Ctr Food Safety & Appl Nutr, College Pk, MD USA	US Food & Drug Administration (FDA)	LeBlanc, PM (corresponding author), US FDA, Ctr Food Safety & Appl Nutr, College Pk, MD USA.							[Anonymous], 2012, ONE 5 US ADULTS NOW; Armstrong ML, 2005, J ENVIRON HEALTH, V67, P38; Drage LA, 2010, J AM ACAD DERMATOL, V62, P501, DOI 10.1016/j.jaad.2009.03.034; Food and Drug Administration, 2010, COSM TATT PERM MAK; Food and Drug Administration, 2012, REP SER PROBL FDA	5	35	35	1	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 13	2012	367	11					985	987		10.1056/NEJMp1206063	http://dx.doi.org/10.1056/NEJMp1206063			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	003ZE	22913662	Bronze			2022-12-28	WOS:000308649100003
J	Petreanu, L; Gutnisky, DA; Huber, D; Xu, NL; O'Connor, DH; Tian, L; Looger, L; Svoboda, K				Petreanu, Leopoldo; Gutnisky, Diego A.; Huber, Daniel; Xu, Ning-long; O'Connor, Dan H.; Tian, Lin; Looger, Loren; Svoboda, Karel			Activity in motor-sensory projections reveals distributed coding in somatosensation	NATURE			English	Article							OBJECT LOCALIZATION; ACTION-POTENTIALS; NEURAL ACTIVITY; LAYER-I; CORTEX; RAT; ORGANIZATION; PLASTICITY; CIRCUITS; DYNAMICS	Cortical-feedback projections to primary sensory areas terminate most heavily in layer 1 (L1) of the neocortex(1,2), where they make synapses with tuft dendrites of pyramidal neurons. L1 input is thought to provide 'contextual' information(3), but the signals transmitted by L1 feedback remain uncharacterized. In the rodent somatosensory system, the spatially diffuse(4) feedback projection from vibrissal motor cortex (vM1) to vibrissal somatosensory cortex (vS1, also known as the barrel cortex) may allow whisker touch to be interpreted in the context of whisker position to compute object location(5,6). When mice palpate objects with their whiskers to localize object features(7,8), whisker touch excites vS1(9) and later vM1 in a somatotopic manner(10-13). Here we use axonal calcium imaging to track activity in vM1 -> vS1 afferents in L1 of the barrel cortex while mice performed whisker-dependent object localization. Spatially intermingled individual axons represent whisker movements, touch and other behavioural features. In a subpopulation of axons, activity depends on object location and persists for seconds after touch. Neurons in the barrel cortex thus have information to integrate movements and touches of multiple whiskers over time, key components of object identification and navigation by active touch.	[Petreanu, Leopoldo; Gutnisky, Diego A.; Huber, Daniel; Xu, Ning-long; O'Connor, Dan H.; Tian, Lin; Looger, Loren; Svoboda, Karel] Howard Hughes Med Inst, Ashburn, VA 20147 USA	Howard Hughes Medical Institute	Svoboda, K (corresponding author), Howard Hughes Med Inst, Janelia Farm Res Campus, Ashburn, VA 20147 USA.	svobodak@janelia.hhmi.org	Gutnisky, Diego/E-3846-2012; Xu, Ning-long/U-8665-2019; Huber, Daniel/C-2932-2013	Gutnisky, Diego/0000-0002-8578-0039; Xu, Ning-long/0000-0002-1651-401X; Tian, Lin/0000-0001-7012-6926; Petreanu, Leopoldo/0000-0003-1434-4691; Huber, Daniel/0000-0002-0744-7679				Anjum F, 2006, P NATL ACAD SCI USA, V103, P16544, DOI 10.1073/pnas.0605573103; Birdwell JA, 2007, J NEUROPHYSIOL, V98, P2439, DOI 10.1152/jn.00707.2006; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Carvell GE, 1996, SOMATOSENS MOT RES, V13, P115, DOI 10.3109/08990229609051399; Cauller L, 1995, BEHAV BRAIN RES, V71, P163, DOI 10.1016/0166-4328(95)00032-1; CAULLER LJ, 1994, J NEUROSCI, V14, P751; Clack NG, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002591; Cox CL, 2000, P NATL ACAD SCI USA, V97, P9724, DOI 10.1073/pnas.170278697; DAVIDSON PW, 1972, J EXP PSYCHOL, V93, P43, DOI 10.1037/h0032632; De Paola V, 2006, NEURON, V49, P861, DOI 10.1016/j.neuron.2006.02.017; DeFelipe J, 1997, CEREB CORTEX, V7, P619, DOI 10.1093/cercor/7.7.619; Duda R O, 2001, PATTERN CLASSIFICATI; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Ferezou I, 2007, NEURON, V56, P907, DOI 10.1016/j.neuron.2007.10.007; Guizar-Sicairos M, 2008, OPT LETT, V33, P156, DOI 10.1364/OL.33.000156; Hastie T., 2009, SPRINGER SERIES STAT, DOI 10.1007/978-0-387-84858-7; Hernandez A, 2010, NEURON, V66, P300, DOI 10.1016/j.neuron.2010.03.031; Hill DN, 2008, J NEUROSCI, V28, P3438, DOI 10.1523/JNEUROSCI.5008-07.2008; Hill DN, 2011, NEURON, V72, P344, DOI 10.1016/j.neuron.2011.09.020; Hooks BM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000572; Huber D, 2012, NATURE, V484, P473, DOI 10.1038/nature11039; Kaneko M, 2008, NAT NEUROSCI, V11, P497, DOI 10.1038/nn2068; Kleinfeld D, 2002, NEURON, V34, P1021, DOI 10.1016/S0896-6273(02)00732-8; Knutsen PM, 2006, J NEUROSCI, V26, P8451, DOI 10.1523/JNEUROSCI.1516-06.2006; Knutsen PM, 2009, TRENDS NEUROSCI, V32, P101, DOI 10.1016/j.tins.2008.10.002; Koester HJ, 2000, J PHYSIOL-LONDON, V529, P625, DOI 10.1111/j.1469-7793.2000.00625.x; Komiyama T, 2010, NATURE, V464, P1182, DOI 10.1038/nature08897; Krupa DJ, 2001, J NEUROSCI, V21, P5752, DOI 10.1523/JNEUROSCI.21-15-05752.2001; Larkum ME, 2004, CEREB CORTEX, V14, P1059, DOI 10.1093/cercor/bhh065; Mao TY, 2011, NEURON, V72, P111, DOI 10.1016/j.neuron.2011.07.029; MASINO SA, 1993, P NATL ACAD SCI USA, V90, P9998, DOI 10.1073/pnas.90.21.9998; O'Connor DH, 2010, NEURON, V67, P1048, DOI 10.1016/j.neuron.2010.08.026; O'Connor DH, 2010, J NEUROSCI, V30, P1947, DOI 10.1523/JNEUROSCI.3762-09.2010; Petreanu L, 2009, NATURE, V457, P1142, DOI 10.1038/nature07709; Pologruto TA, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-13; Suter Benjamin A, 2010, Front Neural Circuits, V4, P100, DOI 10.3389/fncir.2010.00100; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Veinante P, 2003, J COMP NEUROL, V464, P98, DOI 10.1002/cne.10769; Vogelstein JT, 2010, J NEUROPHYSIOL, V104, P3691, DOI 10.1152/jn.01073.2009; Voigts J, 2008, J NEUROPHYSIOL, V100, P504, DOI 10.1152/jn.00012.2008	41	216	216	0	57	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 13	2012	489	7415					299	+		10.1038/nature11321	http://dx.doi.org/10.1038/nature11321			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003UC	22922646	Green Published, Green Accepted			2022-12-28	WOS:000308635900043
J	Bains, W				Bains, William			Comment on "Orthographic Processing in Baboons (Papio papio)"	SCIENCE			English	Editorial Material									Univ Cambridge, SENS Lab, Cambridge CB2 1QT, England	University of Cambridge	Bains, W (corresponding author), Univ Cambridge, SENS Lab, Tennis Court Rd, Cambridge CB2 1QT, England.	wab35@cam.ac.uk						Grainger J, 2012, SCIENCE, V336, P245, DOI 10.1126/science.1218152; Platt ML, 2012, SCIENCE, V336, P168, DOI 10.1126/science.1221402	2	5	5	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 7	2012	337	6099								10.1126/science.1224508	http://dx.doi.org/10.1126/science.1224508			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	000UJ	22955818				2022-12-28	WOS:000308414000016
J	Das, P; Horton, R				Das, Pamela; Horton, Richard			Women Deliver: closing the gap for reproductive and maternal health-call for papers	LANCET			English	Editorial Material									[Das, Pamela; Horton, Richard] The Lancet, London NW1 7BY, England		Das, P (corresponding author), The Lancet, London NW1 7BY, England.							World Health Organization (WHO), 2012, TRENDS MAT MORT 1990	1	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 1	2012	380	9844					789	789		10.1016/S0140-6736(12)61421-4	http://dx.doi.org/10.1016/S0140-6736(12)61421-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	000OP	22939671				2022-12-28	WOS:000308396300008
J	Haeusler, GM; Goeman, E; Cheung, M; Creati, M; Curtis, N				Haeusler, Gabrielle M.; Goeman, Emma; Cheung, Michael; Creati, Mick; Curtis, Nigel			Hip to the heart	LANCET			English	Editorial Material							ABIOTROPHIA-DEFECTIVA; INFECTIVE ENDOCARDITIS; ADIACENS		[Cheung, Michael; Curtis, Nigel] Univ Melbourne, Royal Childrens Hosp Melbourne, Dept Paediat, Parkville, Vic 3052, Australia; [Haeusler, Gabrielle M.; Goeman, Emma; Curtis, Nigel] Univ Melbourne, Royal Childrens Hosp Melbourne, Infect Dis Unit, Dept Gen Med, Parkville, Vic 3052, Australia; [Cheung, Michael] Univ Melbourne, Royal Childrens Hosp Melbourne, Dept Cardiol, Parkville, Vic 3052, Australia; [Cheung, Michael; Curtis, Nigel] Univ Melbourne, Royal Childrens Hosp Melbourne, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; [Creati, Mick] Univ Melbourne, Royal Childrens Hosp Melbourne, Ctr Adolescent Hlth, Parkville, Vic 3052, Australia	Royal Children's Hospital Melbourne; University of Melbourne; Royal Children's Hospital Melbourne; University of Melbourne; Royal Children's Hospital Melbourne; University of Melbourne; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne; Royal Children's Hospital Melbourne; University of Melbourne	Curtis, N (corresponding author), Univ Melbourne, Royal Childrens Hosp Melbourne, Dept Paediat, Parkville, Vic 3052, Australia.	nigel.curtis@rch.org.au	Curtis, Nigel/B-3491-2012	Curtis, Nigel/0000-0003-3446-4594; Goeman, Emma/0000-0002-9173-9585; Haeusler, Gabrielle/0000-0003-0371-8176				Baddour LM, 2005, CIRCULATION, V111, pE394, DOI 10.1161/CIRCULATIONAHA.105.165564; Gonzalez-Juanatey C, 2001, MEDICINE, V80, P9, DOI 10.1097/00005792-200101000-00002; KAWAMURA Y, 1995, INT J SYST BACTERIOL, V45, P798, DOI 10.1099/00207713-45-4-798; Kiernan TJ, 2008, INT J INFECT DIS, V12, P478, DOI 10.1016/j.ijid.2008.01.014; Tuohy MJ, 2000, DIAGN MICR INFEC DIS, V38, P189, DOI 10.1016/S0732-8893(00)00194-2	5	1	1	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 1	2012	380	9844					858	858		10.1016/S0140-6736(12)60573-X	http://dx.doi.org/10.1016/S0140-6736(12)60573-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	000OP	22939686				2022-12-28	WOS:000308396300035
J	Cappa, CD; Onasch, TB; Massoli, P; Worsnop, DR; Bates, TS; Cross, ES; Davidovits, P; Hakala, J; Hayden, KL; Jobson, BT; Kolesar, KR; Lack, DA; Lerner, BM; Li, SM; Mellon, D; Nuaaman, I; Olfert, JS; Petaja, T; Quinn, PK; Song, C; Subramanian, R; Williams, EJ; Zaveri, RA				Cappa, Christopher D.; Onasch, Timothy B.; Massoli, Paola; Worsnop, Douglas R.; Bates, Timothy S.; Cross, Eben S.; Davidovits, Paul; Hakala, Jani; Hayden, Katherine L.; Jobson, B. Tom; Kolesar, Katheryn R.; Lack, Daniel A.; Lerner, Brian M.; Li, Shao-Meng; Mellon, Daniel; Nuaaman, Ibraheem; Olfert, Jason S.; Petaja, Tuukka; Quinn, Patricia K.; Song, Chen; Subramanian, R.; Williams, Eric J.; Zaveri, Rahul A.			Radiative Absorption Enhancements Due to the Mixing State of Atmospheric Black Carbon	SCIENCE			English	Article							CITY METROPOLITAN-AREA; LIGHT-ABSORPTION; CROSS-SECTION; AEROSOL; SOOT; MODELS; IMPACT; BROWN	Atmospheric black carbon (BC) warms Earth's climate, and its reduction has been targeted for near-term climate change mitigation. Models that include forcing by BC assume internal mixing with non-BC aerosol components that enhance BC absorption, often by a factor of similar to 2; such model estimates have yet to be clearly validated through atmospheric observations. Here, direct in situ measurements of BC absorption enhancements (E-abs) and mixing state are reported for two California regions. The observed E-abs is small-6% on average at 532 nm-and increases weakly with photochemical aging. The E-abs is less than predicted from observationally constrained theoretical calculations, suggesting that many climate models may overestimate warming by BC. These ambient observations stand in contrast to laboratory measurements that show substantial E-abs for BC are possible.	[Cappa, Christopher D.; Kolesar, Katheryn R.; Mellon, Daniel] Univ Calif Davis, Dept Civil & Environm Engn, Davis, CA 95616 USA; [Onasch, Timothy B.; Massoli, Paola; Worsnop, Douglas R.] Aerodyne Res, Billerica, MA 01821 USA; [Onasch, Timothy B.; Cross, Eben S.; Davidovits, Paul] Boston Coll, Dept Chem, Boston, MA 02467 USA; [Worsnop, Douglas R.; Hakala, Jani; Petaja, Tuukka] Univ Helsinki, Dept Phys, FI-00014 Helsinki, Finland; [Bates, Timothy S.; Quinn, Patricia K.] NOAA, Pacific Marine Environm Lab, Seattle, WA 98115 USA; [Hayden, Katherine L.; Li, Shao-Meng; Nuaaman, Ibraheem] Environm Canada, Air Qual Res Div, Toronto, ON M3H 5T4, Canada; [Jobson, B. Tom] Washington State Univ, Dept Civil & Environm Engn, Pullman, WA 99164 USA; [Lack, Daniel A.; Lerner, Brian M.; Williams, Eric J.] NOAA, Earth Syst Res Lab, Boulder, CO 80305 USA; [Lack, Daniel A.; Lerner, Brian M.] Univ Colorado, Cooperat Inst Res Environm Sci, Boulder, CO 80309 USA; [Nuaaman, Ibraheem] York Univ, Ctr Atmospher Chem, Toronto, ON M3J 1P3, Canada; [Olfert, Jason S.] Univ Alberta, Dept Mech Engn, Edmonton, AB T6G 2R3, Canada; [Song, Chen; Zaveri, Rahul A.] Pacific NW Natl Lab, Atmospher Sci & Global Change Div, Richland, WA 99354 USA; [Subramanian, R.] RTI Int, Res Triangle Pk, NC 27709 USA	University of California System; University of California Davis; Aerodyne Research; Boston College; University of Helsinki; National Oceanic Atmospheric Admin (NOAA) - USA; Environment & Climate Change Canada; Washington State University; National Oceanic Atmospheric Admin (NOAA) - USA; University of Colorado System; University of Colorado Boulder; York University - Canada; University of Alberta; United States Department of Energy (DOE); Pacific Northwest National Laboratory; Research Triangle Institute	Cappa, CD (corresponding author), Univ Calif Davis, Dept Civil & Environm Engn, Davis, CA 95616 USA.	cdcappa@ucdavis.edu; onasch@aerodyne.com	Bates, Timothy S/L-6080-2016; Onasch, Tim/AAY-4998-2020; Lack, Daniel/I-9053-2012; Lerner, Brian M/H-6556-2013; Quinn, Patricia/R-1493-2016; Worsnop, Douglas R/D-2817-2009; Subramanian, R/A-4913-2013; Petäjä, Tuukka/A-8009-2008; Zaveri, Rahul/G-4076-2014	Onasch, Tim/0000-0001-7796-7840; Lerner, Brian M/0000-0001-8721-8165; Quinn, Patricia/0000-0003-0337-4895; Worsnop, Douglas R/0000-0002-8928-8017; Subramanian, R/0000-0002-5553-5913; Petäjä, Tuukka/0000-0002-1881-9044; Cappa, Christopher/0000-0002-3528-3368; Zaveri, Rahul/0000-0001-9874-8807; Li, Shao-Meng/0000-0002-7628-6581; Olfert, Jason/0000-0002-9681-5428; Jobson, Bertram/0000-0003-1812-9745	American River College; NOAA Climate Program Office [NA09OAR4310124, NA09OAR4310125]; U.S. Environmental Protection Agency [RD834558]; NSF Atmospheric Chemistry; California Air Resources Board; U.S. Department of Energy (DOE) Atmospheric System Research (ASR) program; DOE Atmospheric Radiation Measurement (ARM) Climate Research Facility; Canadian Federal Government (PERD) [C12.007]; Natural Sciences and Engineering Research Council of Canada; Div Atmospheric & Geospace Sciences [0904292] Funding Source: National Science Foundation	American River College; NOAA Climate Program Office(National Oceanic Atmospheric Admin (NOAA) - USA); U.S. Environmental Protection Agency(United States Environmental Protection Agency); NSF Atmospheric Chemistry(National Science Foundation (NSF)); California Air Resources Board; U.S. Department of Energy (DOE) Atmospheric System Research (ASR) program(United States Department of Energy (DOE)); DOE Atmospheric Radiation Measurement (ARM) Climate Research Facility; Canadian Federal Government (PERD); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Div Atmospheric & Geospace Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	The authors thank the crew of the R/V Atlantis, the support at American River College and Cambustion for loan of the centrifugal particle mass analyzer (CPMA). This work was supported by the NOAA Climate Program Office (NA09OAR4310124 and NA09OAR4310125), U.S. Environmental Protection Agency (RD834558), NSF Atmospheric Chemistry, California Air Resources Board, U.S. Department of Energy (DOE) Atmospheric System Research (ASR) program and DOE Atmospheric Radiation Measurement (ARM) Climate Research Facility, the Canadian Federal Government (PERD Project C12.007), and the Natural Sciences and Engineering Research Council of Canada.	Adachi K, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD012868; Andreae MO, 2006, ATMOS CHEM PHYS, V6, P3131, DOI 10.5194/acp-6-3131-2006; Barnard JC, 2008, ATMOS CHEM PHYS, V8, P6665, DOI 10.5194/acp-8-6665-2008; Bond TC, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2006JD007315; Chung SH, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2004JD005441; Cross ES, 2010, AEROSOL SCI TECH, V44, P592, DOI 10.1080/02786826.2010.482113; Dickerson RR, 1997, SCIENCE, V278, P827, DOI 10.1126/science.278.5339.827; Doran C, 2007, ATMOS CHEM PHYS, V7, P2197, DOI 10.5194/acp-7-2197-2007; Ghan SJ, 2007, B AM METEOROL SOC, V88, P1059, DOI 10.1175/BAMS-88-7-1059; Grieshop AP, 2009, NAT GEOSCI, V2, P533, DOI 10.1038/ngeo595; Hansen J, 2007, CLIM DYNAM, V29, P661, DOI 10.1007/s00382-007-0255-8; Jacobson MZ, 1999, J GEOPHYS RES-ATMOS, V104, P3527, DOI 10.1029/1998JD100054; Jacobson MZ, 2001, NATURE, V409, P695, DOI 10.1038/35055518; Johnson KS, 2005, ATMOS CHEM PHYS, V5, P3033, DOI 10.5194/acp-5-3033-2005; Knox A, 2009, AEROSOL SCI TECH, V43, P522, DOI 10.1080/02786820902777207; Koch D, 2009, ATMOS CHEM PHYS, V9, P9001, DOI 10.5194/acp-9-9001-2009; Lack DA, 2010, ATMOS CHEM PHYS, V10, P4207, DOI 10.5194/acp-10-4207-2010; Li J, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002106; Myhre G, 2009, SCIENCE, V325, P187, DOI 10.1126/science.1174461; Onasch TB, 2012, AEROSOL SCI TECH, V46, P804, DOI 10.1080/02786826.2012.663948; Ramanathan V, 2008, NAT GEOSCI, V1, P221, DOI 10.1038/ngeo156; Schnaiter M, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2005JD006046; Shindell D, 2012, SCIENCE, V335, P183, DOI 10.1126/science.1210026; Shindell DT, 2009, SCIENCE, V326, P716, DOI 10.1126/science.1174760; Zaveri RA, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD013616	25	455	472	30	489	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 31	2012	337	6098					1078	1081		10.1126/science.1223447	http://dx.doi.org/10.1126/science.1223447			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996WP	22936774				2022-12-28	WOS:000308125800042
J	Liu, XP; Betzenhauser, MJ; Reiken, S; Meli, AC; Xie, WJ; Chen, BX; Arancio, O; Marks, AR				Liu, Xiaoping; Betzenhauser, Matthew J.; Reiken, Steve; Meli, Albano C.; Xie, Wenjun; Chen, Bi-Xing; Arancio, Ottavio; Marks, Andrew R.			Role of Leaky Neuronal Ryanodine Receptors in Stress-Induced Cognitive Dysfunction	CELL			English	Article							INTRACELLULAR CALCIUM LEAK; SKELETAL-MUSCLE; HEART-FAILURE; PKA PHOSPHORYLATION; REPEATED IMMOBILIZATION; NUCLEAR TRANSLOCATION; TYROSINE-HYDROXYLASE; DEFECTIVE REGULATION; SYNAPTIC PLASTICITY; ALZHEIMERS-DISEASE	The type 2 ryanodine receptor/calcium release channel (RyR2), required for excitation-contraction coupling in the heart, is abundant in the brain. Chronic stress induces catecholamine biosynthesis and release, stimulating beta-adrenergic receptors and activating cAMP signaling pathways in neurons. In a murine chronic restraint stress model, neuronal RyR2 were phosphorylated by protein kinase A (PKA), oxidized, and nitrosylated, resulting in depletion of the stabilizing subunit calstabin2 (FKBP12.6) from the channel complex and intracellular calcium leak. Stress-induced cognitive dysfunction, including deficits in learning and memory, and reduced long-term potentiation (LTP) at the hippocampal CA3-CA1 connection were rescued by oral administration of S107, a compound developed in our laboratory that stabilizes RyR2-calstabin2 interaction, or by genetic ablation of the RyR2 PKA phosphorylation site at serine 2808. Thus, neuronal RyR2 remodeling contributes to stress-induced cognitive dysfunction. Leaky RyR2 could be a therapeutic target for treatment of stress-induced cognitive dysfunction.	[Liu, Xiaoping; Betzenhauser, Matthew J.; Reiken, Steve; Meli, Albano C.; Xie, Wenjun; Chen, Bi-Xing; Marks, Andrew R.] Columbia Univ Coll Phys & Surg, Clyde & Helen Wu Ctr Mol Cardiol, Dept Physiol & Cellular Biophys, New York, NY 10032 USA; [Arancio, Ottavio] Columbia Univ Coll Phys & Surg, Dept Pathol & Cell Biol, Taub Inst Res Alzheimers Dis & Aging Brain, New York, NY 10032 USA	Columbia University; Columbia University	Marks, AR (corresponding author), Columbia Univ Coll Phys & Surg, Clyde & Helen Wu Ctr Mol Cardiol, Dept Physiol & Cellular Biophys, 630 W 168th St, New York, NY 10032 USA.	arm42@columbia.edu	Xie, Wenjun/O-4637-2019; arancio, ottavio/AAB-7959-2019; Xie, Wenjun/G-3869-2015; Xie, Wenjun/AAD-6881-2021; Meli, Albano C./O-7647-2018	Xie, Wenjun/0000-0003-0493-062X; Xie, Wenjun/0000-0003-0493-062X; Xie, Wenjun/0000-0003-0493-062X; Meli, Albano C./0000-0002-1727-3027; arancio, ottavio/0000-0001-6335-164X	 [RO1-HL56180];  [RO1-NS049442]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL061503, R01HL056180] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR060037] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS049442] Funding Source: NIH RePORTER	; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors thank Drs. Steven Siegelbaum and Michael Shelanski for helpful comments and Shi-Xian Deng for synthesis of S107. This work was supported by RO1-HL56180 and RO1-NS049442. A.R.M. is a consultant for a startup company, ARMGO Pharma, Inc., which is targeting RyR channels for therapeutic purposes.	AGUILERA G, 1994, FRONT NEUROENDOCRIN, V15, P321, DOI 10.1006/frne.1994.1013; Airan RD, 2007, SCIENCE, V317, P819, DOI 10.1126/science.1144400; Andersson DC, 2011, CELL METAB, V14, P196, DOI 10.1016/j.cmet.2011.05.014; Bellinger AM, 2008, P NATL ACAD SCI USA, V105, P2198, DOI 10.1073/pnas.0711074105; Bellinger AM, 2008, J CLIN INVEST, V118, P445, DOI 10.1172/JCI34006; Bellinger AM, 2009, NAT MED, V15, P325, DOI 10.1038/nm.1916; Berridge MJ, 2010, PFLUG ARCH EUR J PHY, V459, P441, DOI 10.1007/s00424-009-0736-1; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Berridge MJ, 1998, NEURON, V21, P13, DOI 10.1016/S0896-6273(00)80510-3; Bickler PE, 2009, NEUROSCIENCE, V160, P51, DOI 10.1016/j.neuroscience.2009.02.013; Brennan AR, 2008, LEARN MEMORY, V15, P93, DOI 10.1101/lm.767408; Carrasco GA, 2003, EUR J PHARMACOL, V463, P235, DOI 10.1016/S0014-2999(03)01285-8; Cavallaro S, 1997, P NATL ACAD SCI USA, V94, P9669, DOI 10.1073/pnas.94.18.9669; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; CHOI DW, 1988, TRENDS NEUROSCI, V11, P465, DOI 10.1016/0166-2236(88)90200-7; COLQUHOUN D, 1982, PHILOS T ROY SOC B, V300, P1, DOI 10.1098/rstb.1982.0156; Copeland BJ, 2005, SYNAPSE, V57, P167, DOI 10.1002/syn.20169; Copello JA, 2001, CELL CALCIUM, V30, P269, DOI 10.1054/ceca.2001.0235; Denny CA, 2012, HIPPOCAMPUS, V22, P1188, DOI 10.1002/hipo.20964; Deshpande LS, 2008, NEUROSCI LETT, V441, P115, DOI 10.1016/j.neulet.2008.05.113; Etgen T, 2009, FORTSCHR NEUROL PSYC, V77, P72, DOI 10.1055/s-0028-1109116; Fitzjohn SM, 2002, CELL CALCIUM, V32, P405, DOI 10.1016/S0143416002001999; Fukui Y, 1997, J NEUROIMMUNOL, V79, P211, DOI 10.1016/S0165-5728(97)00126-4; Galeotti N, 2008, LEARN MEMORY, V15, P315, DOI 10.1101/lm.929008; GHOSH A, 1995, SCIENCE, V268, P239, DOI 10.1126/science.7716515; GIANNINI G, 1995, J CELL BIOL, V128, P893, DOI 10.1083/jcb.128.5.893; Hall CS, 1934, J COMP PSYCHOL, V18, P385, DOI 10.1037/h0071444; HARTLEY DM, 1993, J NEUROSCI, V13, P1993; Impey S, 1998, NEURON, V21, P869, DOI 10.1016/S0896-6273(00)80602-9; JAYARAMAN T, 1992, J BIOL CHEM, V267, P9474; KEEFE KA, 1989, ARCH NEUROL-CHICAGO, V46, P1070, DOI 10.1001/archneur.1989.00520460046012; KHACHATURIAN ZS, 1994, ANN NY ACAD SCI, V747, P1; Kim JJ, 2002, NAT REV NEUROSCI, V3, P453, DOI 10.1038/nrn849; Lehnart SE, 2004, ANN NY ACAD SCI, V1015, P144, DOI 10.1196/annals.1302.012; Lehnart SE, 2008, J CLIN INVEST, V118, P2230, DOI 10.1172/JCI35346; Lehnart SE, 2006, P NATL ACAD SCI USA, V103, P7906, DOI 10.1073/pnas.0602133103; Liu XP, 2008, ANN NY ACAD SCI, V1148, P1, DOI 10.1196/annals.1410.082; Liu XP, 2005, MOL BRAIN RES, V141, P19, DOI 10.1016/j.molbrainres.2005.07.019; Marx SO, 2000, CELL, V101, P365, DOI 10.1016/S0092-8674(00)80847-8; Mattson MP, 2007, AGING CELL, V6, P337, DOI 10.1111/j.1474-9726.2007.00275.x; McEwen BS, 2008, EUR J PHARMACOL, V583, P174, DOI 10.1016/j.ejphar.2007.11.071; McEwen BS, 2007, PHYSIOL REV, V87, P873, DOI 10.1152/physrev.00041.2006; McEwen BS, 2004, ANN NY ACAD SCI, V1032, P1, DOI 10.1196/annals.1314.001; MCEWEN BS, 1995, CURR OPIN NEUROBIOL, V5, P205, DOI 10.1016/0959-4388(95)80028-X; MCMAHON A, 1992, J NEUROCHEM, V58, P2124, DOI 10.1111/j.1471-4159.1992.tb10954.x; Miller MM, 2006, ANN NY ACAD SCI, V1071, P294, DOI 10.1196/annals.1364.023; Mirescu C, 2006, HIPPOCAMPUS, V16, P233, DOI 10.1002/hipo.20155; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Patel S, 2004, ENDOCRINOLOGY, V145, P5431, DOI 10.1210/en.2004-0638; Patterson SL, 2001, NEURON, V32, P123, DOI 10.1016/S0896-6273(01)00443-3; PELLOW S, 1985, J NEUROSCI METH, V14, P149, DOI 10.1016/0165-0270(85)90031-7; Perrotti LI, 2004, J NEUROSCI, V24, P10594, DOI 10.1523/JNEUROSCI.2542-04.2004; Reiken S, 2003, J CELL BIOL, V160, P919, DOI 10.1083/jcb.200211012; Reiken S, 2003, J BIOL CHEM, V278, P444, DOI 10.1074/jbc.M207028200; Sabban EL, 2004, ANN NY ACAD SCI, V1032, P130, DOI 10.1196/annals.1314.010; SCHENK F, 1985, EXP BRAIN RES, V58, P11; Shan J, 2010, J CLIN INVEST, V120, P4375, DOI 10.1172/JCI37649; Shan J, 2010, J CLIN INVEST, V120, P4388, DOI 10.1172/JCI32726; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; Sherin Jonathan E, 2011, Dialogues Clin Neurosci, V13, P263; Son H, 1998, LEARN MEMORY, V5, P231; Southwick SM, 1999, BIOL PSYCHIAT, V46, P1192, DOI 10.1016/S0006-3223(99)00219-X; Svoboda K, 1997, NATURE, V385, P161, DOI 10.1038/385161a0; TSUDA A, 1985, BEHAV NEUROSCI, V99, P802; Ward CW, 2003, FASEB J, V17, P1517, DOI 10.1096/fj.02-1083fje; Wehrens XHT, 2006, P NATL ACAD SCI USA, V103, P511, DOI 10.1073/pnas.0510113103; Wehrens XHT, 2005, P NATL ACAD SCI USA, V102, P9607, DOI 10.1073/pnas.0500353102; Wehrens XHT, 2004, SCIENCE, V304, P292, DOI 10.1126/science.1094301; Yano M, 2003, CIRCULATION, V107, P477, DOI 10.1161/01.CIR.0000044917.74408.BE; Yehuda R, 1998, AM J PSYCHIAT, V155, P841; ZIGMOND RE, 1989, ANNU REV NEUROSCI, V12, P415, DOI 10.1146/annurev.ne.12.030189.002215	71	102	106	0	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 31	2012	150	5					1055	1067		10.1016/j.cell.2012.06.052	http://dx.doi.org/10.1016/j.cell.2012.06.052			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	001ZU	22939628	Green Accepted, Bronze			2022-12-28	WOS:000308500200018
J	Marquez, PV; Farrington, JL				Marquez, Patricio V.; Farrington, Jill L.			No more disease silos for sub-Saharan Africa	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SOUTH EAST-ASIA; NONCOMMUNICABLE DISEASES; SCALE-UP; CARE; PARTNERSHIP; PREGNANCY; LESSONS; RECORDS		[Marquez, Patricio V.] World Bank, Washington, DC 20433 USA; [Farrington, Jill L.] Nuffield Ctr Int Hlth & Dev, Leeds, W Yorkshire, England	The World Bank; University of Leeds	Marquez, PV (corresponding author), World Bank, 1818 H St NW, Washington, DC 20433 USA.	pmarquez@worldbank.org						Agyei-Mensah S, 2010, J URBAN HEALTH, V87, P879, DOI 10.1007/s11524-010-9492-y; Alamo ST, 2012, AIDS BEHAV, V16, P368, DOI 10.1007/s10461-011-9996-9; Allain TJ, 2011, TROP MED INT HEALTH, V16, P1077, DOI 10.1111/j.1365-3156.2011.02808.x; Arnuna P, 2008, P NUTR SOC, V67, P82, DOI 10.1017/S0029665108006058; Baingana FK, 2006, DISEASE AND MORTALITY IN SUB-SAHARAN AFRICA, 2ND EDITION, P1; Bischoff A, 2009, INT J ENV RES PUB HE, V6, P2258, DOI 10.3390/ijerph6082258; Braitstein P, 2009, JAIDS-J ACQ IMM DEF, V52, pS54, DOI 10.1097/QAI.0b013e3181bbcb67; Callaghan M, 2010, HUM RESOUR HEALTH, V8, DOI 10.1186/1478-4491-8-8; Chisholm D, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e586; Delisle H, 2011, BMC INT HEALTH HUM R, V11, DOI 10.1186/1472-698X-11-S2-S10; Dybul M, 2012, POLICY REV, V174; Gangopadhyay R, 2011, INT J GYNECOL OBSTET, V115, pS11, DOI 10.1016/S0020-7292(11)60005-2; GAVI Alliance, 2012, HUM PAP VACC SUPP; Ginsberg GM, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e614; Grepin KA, 2011, JAIDS-J ACQ IMM DEF, V57, pS77, DOI 10.1097/QAI.0b013e31821f6afa; Haazen D, 2012, MAKING HEALTH FINANCING WORK FOR POOR PEOPLE IN TANZANIA, P1, DOI 10.1596/978-0-8213-9473-1; Harding R, 2005, LANCET, V365, P1971, DOI 10.1016/S0140-6736(05)66666-4; Isenhower W, 2011, CHRON CAR DES M TRAN; KOBER K, 2006, EXPERT PATIENTS AIDS; Levitt NS, 2011, AM J CLIN NUTR, V94, p1690S, DOI 10.3945/ajcn.111.019075; Magnussen EB, 2009, OBSTET GYNECOL, V114, P961, DOI 10.1097/AOG.0b013e3181bb0dfc; Mbewu A, 2006, DISEASE AND MORTALITY IN SUB-SAHARAN AFRICA, 2ND EDITION, P305; Narayan KMV, 2011, NEW ENGL J MED, V365, P876, DOI 10.1056/NEJMp1107189; Nolte E, 2008, CARING PEOPLE CHRONI; Organization WH, 2016, GLOBAL STATUS REPORT; Rabkin M, 2011, GLOB PUBLIC HEALTH, V6, P247, DOI 10.1080/17441692.2011.552068; Samb B, 2009, LANCET, V373, P2137, DOI 10.1016/S0140-6736(09)60919-3; Schneider M, 2009, SCAND J PUBLIC HEALT, V37, P176, DOI 10.1177/1403494808100272; Starfield B, 1988, PRIMARY CARE BALANCI; Steyn K, 2006, DISEASE AND MORTALITY IN SUB-SAHARAN AFRICA, 2ND EDITION, P247; Sunley EM, 2009, TAXATION CIGARETTES; Swartz L, 2002, BMJ-BRIT MED J, V325, P914, DOI 10.1136/bmj.325.7370.914; The Joint United Nations Programme on HIV/AIDS (UNAIDS) New York, 2011, CHRON CAR HIV NONC D; Tseng ZH, 2012, J AM COLL CARDIOL, V59, P1891, DOI 10.1016/j.jacc.2012.02.024; Wagner E H, 1998, Eff Clin Pract, V1, P2; WHO, 2008, PHARMAFORUM 0121; WHO Global Forum for Government Chief Nursing and Midwifery Officers, 2012, FOR STAT STRENGTH RO; World Bank, 2011, AFR FUT WORLD BANKS; World Health Organization, 2008, GLOB BURD DIS 2004 U	39	20	20	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 31	2012	345								e5812	10.1136/bmj.e5812	http://dx.doi.org/10.1136/bmj.e5812			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	036SN	22942189				2022-12-28	WOS:000311050900004
J	Rothballer, A; Kutay, U				Rothballer, Andrea; Kutay, Ulrike			SnapShot: The Nuclear Envelope II	CELL			English	Editorial Material							PORE COMPLEX		[Rothballer, Andrea; Kutay, Ulrike] ETH, Inst Biochem, CH-8093 Zurich, Switzerland	ETH Zurich	Rothballer, A (corresponding author), ETH, Inst Biochem, CH-8093 Zurich, Switzerland.							Brachner A, 2011, BIOCHEM SOC T, V39, P1735, DOI 10.1042/BST20110724; Cronshaw JA, 2002, J CELL BIOL, V158, P915, DOI 10.1083/jcb.200206106; Hoelz A, 2011, ANNU REV BIOCHEM, V80, P613, DOI 10.1146/annurev-biochem-060109-151030; Mellad JA, 2011, CURR OPIN CELL BIOL, V23, P47, DOI 10.1016/j.ceb.2010.11.006; Rout MP, 2000, J CELL BIOL, V148, P635, DOI 10.1083/jcb.148.4.635; Starr DA, 2010, ANNU REV CELL DEV BI, V26, P421, DOI 10.1146/annurev-cellbio-100109-104037	6	9	9	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 31	2012	150	5					1084	+		10.1016/j.cell.2012.08.003	http://dx.doi.org/10.1016/j.cell.2012.08.003			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	001ZU	22939630	Bronze			2022-12-28	WOS:000308500200021
J	Barone-Adesi, F; Chapman, RS; Silverman, DT; He, XZ; Hu, W; Vermeulen, R; Ning, BF; Fraumeni, JF; Rothman, N; Lan, Q				Barone-Adesi, Francesco; Chapman, Robert S.; Silverman, Debra T.; He, Xinghzhou; Hu, Wei; Vermeulen, Roel; Ning, Bofu; Fraumeni, Joseph F., Jr.; Rothman, Nathaniel; Lan, Qing			Risk of lung cancer associated with domestic use of coal in Xuanwei, China: retrospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							HOUSEHOLD STOVE IMPROVEMENT; INDOOR AIR-POLLUTION; MORTALITY; MUTATIONS; SMOKING	Objective To estimate the risk of lung cancer associated with the use of different types of coal for household cooking and heating. Setting Xuanwei County, Yunnan Province, China. Design Retrospective cohort study (follow-up 1976-96) comparing mortality from lung cancer between lifelong users of "smoky coal" (bituminous) and "smokeless coal" (anthracite). Participants 27 310 individuals using smoky coal and 9962 individuals using smokeless coal during their entire life. Main outcome measures Primary outcomes were absolute and relative risk of death from lung cancer among users of different types of coal. Unadjusted survival analysis was used to estimate the absolute risk of lung cancer, while Cox regression models compared mortality hazards for lung cancer between smoky and smokeless coal users. Results Lung cancer mortality was substantially higher among users of smoky coal than users of smokeless coal. The absolute risks of lung cancer death before 70 years of age for men and women using smoky coal were 18% and 20%, respectively, compared with less than 0.5% among smokeless coal users of both sexes. Lung cancer alone accounted for about 40% of all deaths before age 60 among individuals using smoky coal. Compared with smokeless coal, use of smoky coal was associated with an increased risk of lung cancer death (for men, hazard ratio 36 (95% confidence interval 20 to 65); for women, 99 (37 to 266)). Conclusions In Xuanwei, the domestic use of smoky coal is associated with a substantial increase in the absolute lifetime risk of developing lung cancer and is likely to represent one of the strongest effects of environmental pollution reported for cancer risk. Use of less carcinogenic types of coal could translate to a substantial reduction of lung cancer risk.	[Barone-Adesi, Francesco; Silverman, Debra T.; Hu, Wei; Fraumeni, Joseph F., Jr.; Rothman, Nathaniel; Lan, Qing] NCI, Div Canc Epidemiol & Genet, NIH, DHHS, Bethesda, MD 20892 USA; [Chapman, Robert S.] Chulalongkorn Univ, Coll Publ Hlth Sci, Bangkok 10330, Thailand; [He, Xinghzhou] Chinese Acad Prevent Med, Inst Environm Hlth & Engn, Beijing 100050, Peoples R China; [Vermeulen, Roel] Univ Utrecht, Div Environm Epidemiol, Inst Risk Assessment Sci, NL-3584 CK Utrecht, Netherlands; [Ning, Bofu] Xuanwei Ctr Dis Control, Qujing 655400, Yunnan, Peoples R China	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Chulalongkorn University; Chinese Center for Disease Control & Prevention; National Institute of Environmental Health, Chinese Center for Disease Control & Prevention; Utrecht University	Barone-Adesi, F (corresponding author), NCI, Div Canc Epidemiol & Genet, NIH, DHHS, 6120 Executive Blv,EPS 8015, Bethesda, MD 20892 USA.	baroneadesif@mail.nih.gov	wei, hu/GXW-2391-2022; Vermeulen, Roel/F-8037-2011; Barone-Adesi, Francesco/ABG-1580-2020	Vermeulen, Roel/0000-0003-4082-8163; Barone-Adesi, Francesco/0000-0003-1550-436X	Chinese Academy of Preventive Medicine, Beijing, China; Yunnan Province Antiepidemic Station, Kunming, China; US Environmental Protection Agency [5D2290NFFX]; Intramural Research Program of the National Cancer Institute, National Institutes of Health; NATIONAL CANCER INSTITUTE [ZIACP010121] Funding Source: NIH RePORTER	Chinese Academy of Preventive Medicine, Beijing, China; Yunnan Province Antiepidemic Station, Kunming, China; US Environmental Protection Agency(United States Environmental Protection Agency); Intramural Research Program of the National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The study was supported by the Chinese Academy of Preventive Medicine, Beijing, China, by the Yunnan Province Antiepidemic Station, Kunming, China, and by contract 5D2290NFFX from the US Environmental Protection Agency. This study was also supported by the Intramural Research Program of the National Cancer Institute, National Institutes of Health. The Xuanwei cohort study has been reviewed by the US Environmental Protection Agency and the National Cancer Institute. The contents do not necessarily reflect the views or policies of these institutions, nor does mention of trade names or commercial products constitute endorsement or recommendation for use. The funding source had no role in design or conduct of the study; collection, management, analysis, or interpretation of the data; preparation, review, or approval of the manuscript.	Chapman RS, 2005, BMJ-BRIT MED J, V331, P1050, DOI 10.1136/bmj.38628.676088.55; Chen J., 2006, MORTALITY BIOCH DIET; Coviello V, 2004, STATA J, V4, P103, DOI 10.1177/1536867X0400400201; Crispo A, 2004, BRIT J CANCER, V91, P1280, DOI 10.1038/sj.bjc.6602078; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Granville CA, 2003, MUTAT RES-FUND MOL M, V525, P77, DOI 10.1016/S0027-5107(02)00314-7; Hosgood HD, 2008, BRIT J CANCER, V99, P1934, DOI 10.1038/sj.bjc.6604744; Hosgood HD, 2011, INT J EPIDEMIOL, V40, P719, DOI 10.1093/ije/dyq259; Hosgood HD, 2010, ENVIRON HEALTH PERSP, V118, P1743, DOI 10.1289/ehp.1002217; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2010, IARC Monogr Eval Carcinog Risks Hum, V95, P1; Keohavong P, 2003, LUNG CANCER-J IASLC, V41, P21, DOI 10.1016/S0169-5002(03)00125-9; Lan Q, 2002, J NATL CANCER I, V94, P826, DOI 10.1093/jnci/94.11.826; Lan Q, 2008, INT J CANCER, V123, P2164, DOI 10.1002/ijc.23748; Lee KM, 2010, BRIT J CANCER, V103, P727, DOI 10.1038/sj.bjc.6605791; LUBIN JH, 1990, CANCER RES, V50, P174; MUMFORD JL, 1987, SCIENCE, V235, P217, DOI 10.1126/science.3798109; PEPE MS, 1993, STAT MED, V12, P737, DOI 10.1002/sim.4780120803; Peto R, 2000, BRIT MED J, V321, P323, DOI 10.1136/bmj.321.7257.323; Royston P, 2007, STATA J, V7, P45, DOI 10.1177/1536867X0700700103; Shen M, 2009, ENVIRON HEALTH PERSP, V117, P261, DOI 10.1289/ehp.11521; Smith KR, 2000, THORAX, V55, P518, DOI 10.1136/thorax.55.6.518; TAYLOR PR, 1989, BRIT J IND MED, V46, P881; World Health Organization, 1977, INT CLASS DIS; Zhang JJ, 2007, ENVIRON HEALTH PERSP, V115, P848, DOI 10.1289/ehp.9479	24	97	104	1	41	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 30	2012	345								e5414	10.1136/bmj.e5414	http://dx.doi.org/10.1136/bmj.e5414			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	036SM	22936785	Green Submitted, Green Accepted, Green Published, hybrid			2022-12-28	WOS:000311050800002
J	Brown, KM; Fialko, Y				Brown, Kevin M.; Fialko, Yuri			'Melt welt' mechanism of extreme weakening of gabbro at seismic slip rates	NATURE			English	Article							FRICTION; FAULT; INSTABILITY	Laboratory studies of frictional properties of rocks at slip velocities approaching the seismic range (similar to 0.1-1 m s(-1)), and at moderate normal stresses (1-10 MPa), have revealed a complex evolution of the dynamic shear strength, with at least two phases of weakening separated by strengthening at the onset of wholesale melting(1-4). The second post-melting weakening phase is governed by viscous properties of the melt layer and is reasonably well understood(5,6). The initial phase of extreme weakening, however, remains a subject of much debate. Here we show that the initial weakening of gabbro is associated with the formation of hotspots and macroscopic streaks of melt ('melt welts'), which partially unload the rest of the slip interface. Melt welts begin to form when the average rate of frictional heating exceeds 0.1-0.4 MW m(-2), while the average temperature of the shear zone is well below the solidus (250-450 degrees C). Similar heterogeneities in stress and temperature are likely to occur on natural fault surfaces during rapid slip, and to be important for earthquake rupture dynamics.	[Brown, Kevin M.; Fialko, Yuri] Univ Calif San Diego, Scripps Inst Oceanog, Inst Geophys & Planetary Phys, La Jolla, CA 92093 USA	University of California System; University of California San Diego; Scripps Institution of Oceanography	Brown, KM (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, Inst Geophys & Planetary Phys, La Jolla, CA 92093 USA.	kmbrown@ucsd.edu; yfialko@ucsd.edu	Fialko, Yuri/B-9567-2012	Fialko, Yuri/0000-0002-6161-8467	NSF [EAR-0838255]; Directorate For Geosciences [0838255] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We thank D. Lockner for comments that improved this manuscript. The SIO Marine Science Development Center provided the lathe used in our experiments. This work was supported by NSF (grant EAR-0838255).	Abaqus/Simulia v.6.11, 2012, AB SIM V6 11; ANDERSON AE, 1990, WEAR, V135, P319, DOI 10.1016/0043-1648(90)90034-8; BOWDEN FP, 1961, PROC R SOC LON SER-A, V260, P433, DOI 10.1098/rspa.1961.0044; BRUNE JN, 1969, J GEOPHYS RES, V74, P3821, DOI 10.1029/JB074i015p03821; BYERLEE J, 1978, PURE APPL GEOPHYS, V116, P615, DOI 10.1007/BF00876528; Chester FM, 1998, TECTONOPHYSICS, V295, P199, DOI 10.1016/S0040-1951(98)00121-8; Di Toro G, 2004, NATURE, V427, P436, DOI 10.1038/nature02249; Di Toro G, 2011, NATURE, V471, P494, DOI 10.1038/nature09838; DOW TA, 1980, WEAR, V59, P31, DOI 10.1016/0043-1648(80)90268-9; Fialko Y, 2005, J GEOPHYS RES-SOL EA, V110, DOI 10.1029/2005JB003869; Fialko Y, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2003JB002497; Goldsby DL, 2011, SCIENCE, V334, P216, DOI 10.1126/science.1207902; Goldsby DL, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015240; Han R, 2007, SCIENCE, V316, P878, DOI 10.1126/science.1139763; Hirose T, 2003, J STRUCT GEOL, V25, P1569, DOI 10.1016/S0191-8141(03)00009-9; Lapusta N, 2000, J GEOPHYS RES-SOL EA, V105, P23765, DOI 10.1029/2000JB900250; LEE K, 1993, J TRIBOL-T ASME, V115, P607, DOI 10.1115/1.2921683; Molinari A, 1999, J TRIBOL-T ASME, V121, P35, DOI 10.1115/1.2833808; Nielsen S, 2008, J GEOPHYS RES-SOL EA, V113, DOI 10.1029/2007JB005122; Reches Z, 2010, NATURE, V467, P452, DOI 10.1038/nature09348; Rice JR, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2005JB004006; Sammis CG, 2011, PURE APPL GEOPHYS, V168, P2325, DOI 10.1007/s00024-011-0324-0; SCHEDIN E, 1993, WEAR, V170, P119, DOI 10.1016/0043-1648(93)90358-S; Tsutsumi A, 1997, GEOPHYS RES LETT, V24, P699, DOI 10.1029/97GL00503	24	48	48	1	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 30	2012	488	7413					638	+		10.1038/nature11370	http://dx.doi.org/10.1038/nature11370			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996NC	22932388				2022-12-28	WOS:000308095100052
J	Treon, SP; Xu, L; Yang, G; Zhou, YS; Liu, X; Cao, Y; Sheehy, P; Manning, RJ; Patterson, CJ; Tripsas, C; Arcaini, L; Pinkus, GS; Rodig, SJ; Sohani, AR; Harris, NL; Laramie, JM; Skifter, DA; Lincoln, SE; Hunter, ZR				Treon, Steven P.; Xu, Lian; Yang, Guang; Zhou, Yangsheng; Liu, Xia; Cao, Yang; Sheehy, Patricia; Manning, Robert J.; Patterson, Christopher J.; Tripsas, Christina; Arcaini, Luca; Pinkus, Geraldine S.; Rodig, Scott J.; Sohani, Aliyah R.; Harris, Nancy Lee; Laramie, Jason M.; Skifter, Donald A.; Lincoln, Stephen E.; Hunter, Zachary R.			MYD88 L265P Somatic Mutation in Waldenstrom's Macroglobulinemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MONOCLONAL GAMMOPATHIES; FREQUENT MUTATION; KAPPA-B; GENOME; ARID1A; BORTEZOMIB; DISORDERS; EVOLUTION; DISCOVERY; COMPLEX	BACKGROUND Waldenstrom's macroglobulinemia is an incurable, IgM-secreting lymphoplasmacytic lymphoma (LPL). The underlying mutation in this disorder has not been delineated. METHODS We performed whole-genome sequencing of bone marrow LPL cells in 30 patients with Waldenstrom's macroglobulinemia, with paired normal-tissue and tumor-tissue sequencing in 10 patients. Sanger sequencing was used to validate the findings in samples from an expanded cohort of patients with LPL, those with other B-cell disorders that have some of the same features as LPL, and healthy donors. RESULTS Among the patients with Waldenstrom's macroglobulinemia, a somatic variant (T -> C) in LPL cells was identified at position 38182641 at 3p22.2 in the samples from all 10 patients with paired tissue samples and in 17 of 20 samples from patients with unpaired samples. This variant predicted an amino acid change (L265P) in MYD88, a mutation that triggers IRAK-mediated NF-kappa B signaling. Sanger sequencing identified MYD88 L265P in tumor samples from 49 of 54 patients with Waldenstrom's macroglobulinemia and in 3 of 3 patients with non-IgM-secreting LPL (91% of all patients with LPL). MYD88 L265P was absent in paired normal tissue samples from patients with Waldenstrom's macroglobulinemia or non-IgM LPL and in B cells from healthy donors and was absent or rarely expressed in samples from patients with multiple myeloma, marginal-zone lymphoma, or IgM monoclonal gammopathy of unknown significance. Inhibition of MYD88 signaling reduced I kappa B alpha and NF-kappa B p65 phosphorylation, as well as NF-kappa B nuclear staining, in Waldenstrom's macroglobulinemia cells expressing MYD88 L265P. Somatic variants in ARID1A in 5 of 30 patients (17%), leading to a premature stop or frameshift, were also identified and were associated with an increased disease burden. In addition, 2 of 3 patients with Waldenstrom's macroglobulinemia who had wild-type MYD88 had somatic variants in MLL2. CONCLUSIONS MYD88 L265P is a commonly recurring mutation in patients with Waldenstrom's macroglobulinemia that can be useful in differentiating Waldenstrom's macroglobulinemia and non-IgM LPL from B-cell disorders that have some of the same features. (Funded by the Peter and Helen Bing Foundation and others.)	[Treon, Steven P.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Bing Ctr Waldenstroms Macroglobulinemia, Boston, MA 02115 USA; [Pinkus, Geraldine S.; Rodig, Scott J.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Boston, MA USA; [Sohani, Aliyah R.; Harris, Nancy Lee] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Boston, MA USA; [Hunter, Zachary R.] Boston Univ, Sch Med, Dept Pathol & Lab Med, Boston, MA 02118 USA; [Arcaini, Luca] Univ Pavia, Sch Med, Dept Hematol Oncol, I-27100 Pavia, Italy; [Arcaini, Luca] Policlin San Matteo, Fdn Ist Ricovero & Cura Carattere Sci IRCCS, I-27100 Pavia, Italy; [Laramie, Jason M.; Skifter, Donald A.; Lincoln, Stephen E.] Complete Genom, Mountain View, CA USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital; Boston University; University of Pavia; IRCCS Fondazione San Matteo	Treon, SP (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Bing Ctr Waldenstroms Macroglobulinemia, M547,450 Brookline Ave, Boston, MA 02115 USA.	steven_treon@dfci.harvard.edu	Rodig, Scott/Y-3889-2019; Hunter, Zachary Richard/H-3018-2013; Arcaini, Luca/P-8913-2015	Hunter, Zachary Richard/0000-0002-1689-1691; Arcaini, Luca/0000-0002-9504-991X; Yang, Guang/0000-0003-3049-4200	Peter and Helen Bing Foundation; International Waldenstrom's Macroglobulinemia Foundation; Coyote Fund for Waldenstrom's Macroglobulinemia; Waldenstrom's Cancer Fund; Bailey Family Fund for Waldenstrom's Macroglobulinemia; D'Amato Family Fund for Genomic Discovery; Edward and Linda Nelson Fund for Waldenstrom's Macroglobulinemia Research; Bauman Family Trust; Tannenhauser Family Foundation	Peter and Helen Bing Foundation; International Waldenstrom's Macroglobulinemia Foundation; Coyote Fund for Waldenstrom's Macroglobulinemia; Waldenstrom's Cancer Fund; Bailey Family Fund for Waldenstrom's Macroglobulinemia; D'Amato Family Fund for Genomic Discovery; Edward and Linda Nelson Fund for Waldenstrom's Macroglobulinemia Research; Bauman Family Trust; Tannenhauser Family Foundation	Funded by the Peter and Helen Bing Foundation and others.; Supported by the Peter and Helen Bing Foundation, the International Waldenstrom's Macroglobulinemia Foundation, the Coyote Fund for Waldenstrom's Macroglobulinemia, the Waldenstrom's Cancer Fund, the Bailey Family Fund for Waldenstrom's Macroglobulinemia, the D'Amato Family Fund for Genomic Discovery, the Edward and Linda Nelson Fund for Waldenstrom's Macroglobulinemia Research, the Bauman Family Trust, and the Tannenhauser Family Foundation.	Arcaini L, 2011, CL LYMPH MYELOM LEUK, V11, P103, DOI 10.3816/CLML.2011.n.020; Baldini L, 2005, J CLIN ONCOL, V23, P4662, DOI 10.1200/JCO.2005.06.147; Carnevali P, 2012, J COMPUT BIOL, V19, P279, DOI 10.1089/cmb.2011.0201; Cohen L, 1998, NATURE, V395, P292, DOI 10.1038/26254; Dimopoulos MA, 2010, CL LYMPH MYELOM LEUK, V10, P110, DOI 10.3816/CLML.2010.n.015; Drmanac R, 2010, SCIENCE, V327, P78, DOI 10.1126/science.1181498; Euskirchen GM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002008; Jones S, 2012, HUM MUTAT, V33, P100, DOI 10.1002/humu.21633; Kawagoe T, 2008, NAT IMMUNOL, V9, P684, DOI 10.1038/ni.1606; Kristinsson SY, 2008, BLOOD, V112, P3052, DOI 10.1182/blood-2008-06-162768; Kyle RA, 2003, BLOOD, V102, P3759, DOI 10.1182/blood-2003-03-0801; Kyrtsonis MC, 2011, CL LYMPH MYELOM LEUK, V11, P99, DOI 10.3816/CLML.2011.n.019; Lee W, 2010, NATURE, V465, P473, DOI 10.1038/nature09004; Leleu X, 2008, BLOOD, V111, P5068, DOI 10.1182/blood-2007-09-115170; Lin SC, 2010, NATURE, V465, P885, DOI 10.1038/nature09121; Lohr JG, 2012, P NATL ACAD SCI USA, V109, P3879, DOI 10.1073/pnas.1121343109; Loiarro M, 2005, J BIOL CHEM, V280, P15809, DOI 10.1074/jbc.C400613200; Loiarro M, 2009, J BIOL CHEM, V284, P28093, DOI 10.1074/jbc.M109.004465; Mamo A, 2012, ONCOGENE, V31, P2090, DOI 10.1038/onc.2011.386; McMaster ML, 2007, CLIN CANCER RES, V13, P5063, DOI 10.1158/1078-0432.CCR-07-0299; Morin RD, 2011, NATURE, V476, P298, DOI 10.1038/nature10351; Morra E, 2004, LEUKEMIA, V18, P1512, DOI 10.1038/sj.leu.2403442; Ngo VN, 2011, NATURE, V470, P115, DOI 10.1038/nature09671; Owen RG, 2003, SEMIN ONCOL, V30, P110, DOI 10.1053/sonc.2003.50082; Pasqualucci L, 2011, NAT GENET, V43, P830, DOI 10.1038/ng.892; Pottier N, 2008, JNCI-J NATL CANCER I, V100, P1792, DOI 10.1093/jnci/djn416; Powers JP, 2006, BIOORG MED CHEM LETT, V16, P2842, DOI 10.1016/j.bmcl.2006.03.020; Puente XS, 2011, NATURE, V475, P101, DOI 10.1038/nature10113; Roach JC, 2010, SCIENCE, V328, P636, DOI 10.1126/science.1186802; Swerdlow SH, 2008, WHO CLASSIFICATION T, P194; Treon SP, 2006, ANN ONCOL, V17, P488, DOI 10.1093/annonc/mdj111; Treon SP, 2007, CLIN CANCER RES, V13, P3320, DOI 10.1158/1078-0432.CCR-06-2511; Treon SP, 2009, BLOOD, V114, P2375, DOI 10.1182/blood-2009-05-174359; Wang K, 2011, NAT GENET, V43, P1219, DOI 10.1038/ng.982; Watters TM, 2007, IMMUNOL CELL BIOL, V85, P411, DOI 10.1038/sj.icb.7100095	35	818	883	3	40	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 30	2012	367	9					826	833		10.1056/NEJMoa1200710	http://dx.doi.org/10.1056/NEJMoa1200710			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	996EN	22931316	Bronze			2022-12-28	WOS:000308067400004
J	Chookajorn, T; Murdoch, HA; Schuh, CA				Chookajorn, Tongjai; Murdoch, Heather A.; Schuh, Christopher A.			Design of Stable Nanocrystalline Alloys	SCIENCE			English	Article							VACANCY FORMATION ENERGIES; REDUCING GRAIN-BOUNDARY; SOLUTE SEGREGATION; MECHANICAL-BEHAVIOR; THERMAL-STABILITY; ROOM-TEMPERATURE; DISLOCATION LINE; W SYSTEM; TUNGSTEN; METALS	Nanostructured metals are generally unstable; their grains grow rapidly even at low temperatures, rendering them difficult to process and often unsuitable for usage. Alloying has been found to improve stability, but only in a few empirically discovered systems. We have developed a theoretical framework with which stable nanostructured alloys can be designed. A nanostructure stability map based on a thermodynamic model is applied to design stable nanostructured tungsten alloys. We identify a candidate alloy, W-Ti, and demonstrate substantially enhanced stability for the high-temperature, long-duration conditions amenable to powder-route production of bulk nanostructured tungsten. This nanostructured alloy adopts a heterogeneous chemical distribution that is anticipated by the present theoretical framework but unexpected on the basis of conventional bulk thermodynamics.	[Chookajorn, Tongjai; Murdoch, Heather A.; Schuh, Christopher A.] MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Schuh, CA (corresponding author), MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA.	schuh@mit.edu	Chookajorn, Tongjai/K-8326-2014	Chookajorn, Tongjai/0000-0001-6844-3594; Murdoch, Heather/0000-0001-7710-0577; Schuh, Christopher/0000-0001-9856-2682	U.S. Army Research Office [W911NF-09-1-0422]	U.S. Army Research Office	This work was supported by the U.S. Army Research Office under grant no. W911NF-09-1-0422. MIT has applied for a patent, application no. PCT/US12/28811, related to the design methods and materials produced in this work. Additional information and data used in this work can be found in the supplementary materials.	Ames M, 2008, ACTA MATER, V56, P4255, DOI 10.1016/j.actamat.2008.04.051; Baram M, 2011, SCIENCE, V332, P206, DOI 10.1126/science.1201596; Choi P, 2005, ACTA MATER, V53, P4473, DOI 10.1016/j.actamat.2005.06.006; Darling KA, 2010, MAT SCI ENG A-STRUCT, V527, P3572, DOI 10.1016/j.msea.2010.02.043; Detor AJ, 2007, J MATER RES, V22, P3233, DOI 10.1557/JMR.2007.0403; Detor AJ, 2007, ACTA MATER, V55, P4221, DOI 10.1016/j.actamat.2007.03.024; GERMAN RM, 1976, METALL TRANS A, V7, P1873, DOI 10.1007/BF02654983; HAYDEN HW, 1963, J ELECTROCHEM SOC, V110, P805, DOI 10.1149/1.2425876; Hentschel T, 2000, ACTA MATER, V48, P933, DOI 10.1016/S1359-6454(99)00371-7; Jonsson S, 1996, Z METALLKD, V87, P784; KAHLWEIT M, 1988, SCIENCE, V240, P617, DOI 10.1126/science.240.4852.617; Kecskes LJ, 2007, MAT SCI ENG A-STRUCT, V467, P33, DOI 10.1016/j.msea.2007.02.099; Kirchheim R, 2002, ACTA MATER, V50, P413, DOI 10.1016/S1359-6454(01)00338-X; Kirchheim R, 2007, ACTA MATER, V55, P5139, DOI 10.1016/j.actamat.2007.05.033; Kirchheim R, 2007, ACTA MATER, V55, P5129, DOI 10.1016/j.actamat.2007.05.047; Koch CC, 2008, J MATER SCI, V43, P7264, DOI 10.1007/s10853-008-2870-0; Krenn CR, 2001, MAT SCI ENG A-STRUCT, V319, P111, DOI 10.1016/S0921-5093(01)00998-4; Krill CE, 2005, Z METALLKD, V96, P1134, DOI 10.3139/146.101152; Liao XZ, 2003, APPL PHYS LETT, V83, P5062, DOI 10.1063/1.1633975; Liu F, 2004, SCRIPTA MATER, V51, P521, DOI 10.1016/j.scriptamat.2004.05.042; Lu K, 2009, SCIENCE, V324, P349, DOI 10.1126/science.1159610; Lu L, 2004, SCIENCE, V304, P422, DOI 10.1126/science.1092905; Lu L, 2000, SCIENCE, V287, P1463, DOI 10.1126/science.287.5457.1463; Luo J, 2011, SCIENCE, V333, P1730, DOI 10.1126/science.1208774; Mayr SG, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.024111; McHenry ME, 1999, PROG MATER SCI, V44, P291, DOI 10.1016/S0079-6425(99)00002-X; Millett PC, 2007, ACTA MATER, V55, P2329, DOI 10.1016/j.actamat.2006.11.028; Poudel B, 2008, SCIENCE, V320, P634, DOI 10.1126/science.1156446; Roundy D, 2001, PHILOS MAG A, V81, P1725, DOI 10.1080/01418610010007902; Trelewicz JR, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.094112; Van Swygenhoven H, 2006, MATER TODAY, V9, P24, DOI 10.1016/S1369-7021(06)71494-8; Wang YM, 2002, NATURE, V419, P912, DOI 10.1038/nature01133; Weertman JR, 1999, MRS BULL, V24, P44, DOI 10.1557/S088376940005154X; Wei Q, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1875754; WEISSMULLER J, 1993, NANOSTRUCT MATER, V3, P261, DOI 10.1016/0965-9773(93)90088-S; Witkin DB, 2006, PROG MATER SCI, V51, P1, DOI 10.1016/j.pmatsci.2005.04.004	36	595	612	35	783	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 24	2012	337	6097					951	954		10.1126/science.1224737	http://dx.doi.org/10.1126/science.1224737			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992VI	22923577	Green Submitted			2022-12-28	WOS:000307807600041
J	Black, ME				Black, Mary E.			An Olympic legacy for couch potatoes?	BRITISH MEDICAL JOURNAL			English	Editorial Material												drmaryblack@gmail.com							0	0	0	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	AUG 20	2012	345								e5578	10.1136/bmj.e5578	http://dx.doi.org/10.1136/bmj.e5578			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	996GL	22906869				2022-12-28	WOS:000308072800004
J	Nolan, JP; Soar, J				Nolan, Jerry P.; Soar, Jasmeet			Duration of in-hospital resuscitation: when to call time?	LANCET			English	Editorial Material							CARDIAC-ARREST; CARDIOPULMONARY-RESUSCITATION; GUIDELINES; ETHICS		[Nolan, Jerry P.] Royal United Hosp NHS Trust, Bath BA1 3NG, Avon, England; [Soar, Jasmeet] N Bristol NHS Trust, Southmead Hosp, Bristol, Avon, England	North Bristol NHS Trust; Southmead Hospital	Nolan, JP (corresponding author), Royal United Hosp NHS Trust, Bath BA1 3NG, Avon, England.	jerry.nolan@nhs.net	Soar, Jasmeet/HGA-2279-2022; Nolan, Jerry P./ABF-2561-2020	Soar, Jasmeet/0000-0001-5970-6073; Nolan, Jerry/0000-0003-3141-3812				Carr BG, 2009, RESUSCITATION, V80, P30, DOI 10.1016/j.resuscitation.2008.09.001; Chen YS, 2008, LANCET, V372, P554, DOI 10.1016/S0140-6736(08)60958-7; Christenson J, 2009, CIRCULATION, V120, P1241, DOI 10.1161/CIRCULATIONAHA.109.852202; Goldberger ZD, 2012, LANCET; Heradstveit BE, 2012, RESUSCITATION, V83, P813, DOI 10.1016/j.resuscitation.2012.02.021; Idris AH, 2012, CIRCULATION, V125, P3004, DOI 10.1161/CIRCULATIONAHA.111.059535; Lippert FK, 2010, RESUSCITATION, V81, P1445, DOI 10.1016/j.resuscitation.2010.08.013; Morrison LJ, 2010, CIRCULATION, V122, pS665, DOI 10.1161/CIRCULATIONAHA.110.970905; Parnia S, 2012, RESUSCITATION, V83, P982, DOI 10.1016/j.resuscitation.2012.01.039; Shih CL, 2007, RESUSCITATION, V72, P394, DOI 10.1016/j.resuscitation.2006.07.020; Stiell IG, 2012, CRIT CARE MED, V40, P1192, DOI 10.1097/CCM.0b013e31823bc8bb; van Walraven C, 2001, JAMA-J AM MED ASSOC, V285, P1602, DOI 10.1001/jama.285.12.1602	12	11	11	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 27	2012	380	9852					1451	1453		10.1016/S0140-6736(12)61182-9	http://dx.doi.org/10.1016/S0140-6736(12)61182-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	026JJ	22958913				2022-12-28	WOS:000310272000006
J	Gorelick, PB				Gorelick, Philip B.			Assessment of stent retrievers in acute ischaemic stroke	LANCET			English	Editorial Material							THERAPY; INTRAARTERIAL		[Gorelick, Philip B.] Hauenstein Neurosci Ctr, Grand Rapids, MI 49503 USA; [Gorelick, Philip B.] Michigan State Univ, Coll Human Med, Grand Rapids, MI 49503 USA	Michigan State University; Michigan State University College of Human Medicine	Gorelick, PB (corresponding author), Hauenstein Neurosci Ctr, Grand Rapids, MI 49503 USA.	pgorelic@trinity-health.org						Albers GW, 2011, STROKE, V42, P2645, DOI 10.1161/STROKEAHA.111.618850; Baker WL, 2011, ANN INTERN MED, V154, P243, DOI 10.7326/0003-4819-154-4-201102150-00306; Balucani C, 2012, NEUROLOGY, V78, P755, DOI 10.1212/WNL.0b013e318248e558; Brinjikji W, 2011, STROKE, V42, P1648, DOI 10.1161/STROKEAHA.110.607952; Gorelick PB, ANN NY ACAD IN PRESS; Guyatt GH, 2012, CHEST, V141, p7S, DOI 10.1378/chest.1412S3; Nogueira R, 2012, LANCET; Parsons M, 2012, NEW ENGL J MED, V366, P1099, DOI 10.1056/NEJMoa1109842; Saver JJR, 2012, LANCET; Schellinger PD, 2012, EXPERT REV NEUROTHER, V12, P169, DOI [10.1586/ERN.11.198, 10.1586/ern.11.198]; Tomsick TA, 2010, NEUROLOGY, V74, P1069, DOI 10.1212/WNL.0b013e3181d76b8f	11	2	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 6	2012	380	9849					1208	1210		10.1016/S0140-6736(12)61302-6	http://dx.doi.org/10.1016/S0140-6736(12)61302-6			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	020NG	22932712				2022-12-28	WOS:000309817500006
J	Arthur, JC; Perez-Chanona, E; Muhlbauer, M; Tomkovich, S; Uronis, JM; Fan, TJ; Campbell, BJ; Abujamel, T; Dogan, B; Rogers, AB; Rhodes, JM; Stintzi, A; Simpson, KW; Hansen, JJ; Keku, TO; Fodor, AA; Jobin, C				Arthur, Janelle C.; Perez-Chanona, Ernesto; Muehlbauer, Marcus; Tomkovich, Sarah; Uronis, Joshua M.; Fan, Ting-Jia; Campbell, Barry J.; Abujamel, Turki; Dogan, Belgin; Rogers, Arlin B.; Rhodes, Jonathan M.; Stintzi, Alain; Simpson, Kenneth W.; Hansen, Jonathan J.; Keku, Temitope O.; Fodor, Anthony A.; Jobin, Christian			Intestinal Inflammation Targets Cancer-Inducing Activity of the Microbiota	SCIENCE			English	Article							ESCHERICHIA-COLI STRAINS; DOUBLE-STRAND BREAKS; COLORECTAL-CANCER; CROHNS-DISEASE; COMMENSAL BACTERIA; BOWEL-DISEASE; IN-VIVO; CELLS; MICE; EXPRESSION	Inflammation alters host physiology to promote cancer, as seen in colitis-associated colorectal cancer (CRC). Here, we identify the intestinal microbiota as a target of inflammation that affects the progression of CRC. High-throughput sequencing revealed that inflammation modifies gut microbial composition in colitis-susceptible interleukin-10-deficient (Il10(-/-)) mice. Monocolonization with the commensal Escherichia coli NC101 promoted invasive carcinoma in azoxymethane (AOM)-treated Il10(-/-) mice. Deletion of the polyketide synthase (pks) genotoxic island from E. coli NC101 decreased tumor multiplicity and invasion in AOM/Il10(-/-) mice, without altering intestinal inflammation. Mucosa-associated pks(+) E. coli were found in a significantly high percentage of inflammatory bowel disease and CRC patients. This suggests that in mice, colitis can promote tumorigenesis by altering microbial composition and inducing the expansion of microorganisms with genotoxic capabilities.	[Arthur, Janelle C.; Perez-Chanona, Ernesto; Muehlbauer, Marcus; Tomkovich, Sarah; Uronis, Joshua M.; Fan, Ting-Jia; Hansen, Jonathan J.; Keku, Temitope O.; Jobin, Christian] Univ N Carolina, Dept Med Pharmacol & Immunol Microbiol, Chapel Hill, NC 27599 USA; [Campbell, Barry J.; Rhodes, Jonathan M.] Univ Liverpool, Dept Gastroenterol, Liverpool L69 3BX, Merseyside, England; [Abujamel, Turki; Stintzi, Alain] Univ Ottawa, Fac Med, Dept Biochem Microbiol & Immunol, Ottawa Inst Syst Biol, Ottawa, ON K1H 8M5, Canada; [Abujamel, Turki] King Abdulaziz Univ, Fac Appl Med Sci, Dept Med Technol, Jeddah 21589, Saudi Arabia; [Dogan, Belgin; Simpson, Kenneth W.] Cornell Univ, Dept Clin Sci, Ithaca, NY 14853 USA; [Rogers, Arlin B.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Pathol & Lab Med, Chapel Hill, NC 27599 USA; [Fodor, Anthony A.] Univ N Carolina, Dept Bioinformat & Genom, Charlotte, NC 28223 USA	University of North Carolina; University of North Carolina Chapel Hill; University of Liverpool; University of Ottawa; King Abdulaziz University; Cornell University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Charlotte	Jobin, C (corresponding author), Univ N Carolina, Dept Med Pharmacol & Immunol Microbiol, Chapel Hill, NC 27599 USA.	job@med.unc.edu	Abujamel, Turki/GRS-5606-2022; Tomkovich, Sarah/ABF-7952-2020	Tomkovich, Sarah/0000-0003-1638-5307; Arthur, Janelle/0000-0002-4796-0207	NIH [T32 DK007737, R01 DK73338, R01 DK47700, R01 CA136887, R01 DK53347-11]; American Institute for Cancer Research; UNC University Cancer Research Fund; New York Presbyterian/Weill Cornell Medical College; Crohn's and Colitis foundation UK; NIH Research Specialist Biomedical Research Center in Microbial Disease; North West Cancer Research Fund UK; Canadian Institutes of Health Research MOP [114872]; King Abdulaziz University, through the Saudi Arabian Cultural Bureau in Canada; NATIONAL CANCER INSTITUTE [R01CA136887, P30CA016086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053347, T32DK007737, P30DK034987, R01DK047700, R01DK073338] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Institute for Cancer Research; UNC University Cancer Research Fund; New York Presbyterian/Weill Cornell Medical College; Crohn's and Colitis foundation UK; NIH Research Specialist Biomedical Research Center in Microbial Disease; North West Cancer Research Fund UK; Canadian Institutes of Health Research MOP(Canadian Institutes of Health Research (CIHR)); King Abdulaziz University, through the Saudi Arabian Cultural Bureau in Canada; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank M. Bower and S. Tonkonogy of the National Gnotobiotic Rodent Resource Center at University of North Carolina (UNC) and North Carolina State University for assistance with gnotobiotic mice (NIH P40 R018603). Histology was performed at the Center for Gastrointestinal Biology and Diseases histology core (P30 DK034987). This work was supported by funding from NIH T32 DK007737 (J.C.A.), R01 DK73338 (C.J.), R01 DK47700 (C.J.), R01 CA136887 (T.O.K.), R01 DK53347-11 (K.W.S./A.B.S.), the American Institute for Cancer Research (C.J.), UNC University Cancer Research Fund (C.J.), New York Presbyterian/Weill Cornell Medical College (K.W.S.), Crohn's and Colitis foundation UK (B.J.C.), the NIH Research Specialist Biomedical Research Center in Microbial Disease (J.M.R.), the North West Cancer Research Fund UK (B.J.C.), and the Canadian Institutes of Health Research MOP#114872 (A.S.). T.A. is supported by a scholarship from King Abdulaziz University, through the Saudi Arabian Cultural Bureau in Canada. J.M.R. is a member of advisory boards for Atlantic, Procter and Gamble, and Falk and has received speaking honoraria from Abbott, Falk, Ferring, GlaxoSmithKline, Procter and Gamble, Schering Plough, Shire, and Wyeth. All data presented in this manuscript are tabulated in the main paper and in the supplementary materials. Illumina sequencing data are deposited in National Center for Biotechnology Information's (NCBI's) sequence read archive (SRA) and are accessible under SRA055272. Inflammation PCR array data are deposited in NCBI's Gene Expression Omnibus (GEO) and are accessible through GEO series accession no. GSE39085. This work is in the memory of Mathieu Jobin, Lyne Gauthier, and Janine Drysdale.	Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Cuevas-Ramos G, 2010, P NATL ACAD SCI USA, V107, P11537, DOI 10.1073/pnas.1001261107; Danese S, 2010, ONCOGENE, V29, P3313, DOI 10.1038/onc.2010.109; Darfeuille-Michaud A, 1998, GASTROENTEROLOGY, V115, P1405, DOI 10.1016/S0016-5085(98)70019-8; Garrett WS, 2010, CELL HOST MICROBE, V8, P292, DOI 10.1016/j.chom.2010.08.004; Homburg S, 2007, FEMS MICROBIOL LETT, V275, P255, DOI 10.1111/j.1574-6968.2007.00889.x; Inaba Y, 2010, INFLAMM BOWEL DIS, V16, P1488, DOI 10.1002/ibd.21253; Kim SC, 2005, GASTROENTEROLOGY, V128, P891, DOI 10.1053/j.gastro.2005.02.009; Lin WW, 2007, J CLIN INVEST, V117, P1175, DOI 10.1172/JCI31537; Luperchio SA, 2001, MICROBES INFECT, V3, P333, DOI 10.1016/S1286-4579(01)01387-9; MARSHALL BJ, 1995, JAMA-J AM MED ASSOC, V274, P1064, DOI 10.1001/jama.274.13.1064; Martin HM, 2004, GASTROENTEROLOGY, V127, P80, DOI 10.1053/j.gastro.2004.03.054; Masseret E, 2001, GUT, V48, P320, DOI 10.1136/gut.48.3.320; Nougayrede JP, 2006, SCIENCE, V313, P848, DOI 10.1126/science.1127059; Putze J, 2009, INFECT IMMUN, V77, P4696, DOI 10.1128/IAI.00522-09; Rhodes JM, 2002, TRENDS MOL MED, V8, P10, DOI 10.1016/S1471-4914(01)02194-3; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Rothkamm K, 2003, P NATL ACAD SCI USA, V100, P5057, DOI 10.1073/pnas.0830918100; Schwerbrock NMJ, 2004, INFLAMM BOWEL DIS, V10, P811, DOI 10.1097/00054725-200411000-00016; Shen XJ, 2010, GUT MICROBES, V1, P138, DOI 10.4161/gmic.1.3.12360; Swidsinski A, 1998, GASTROENTEROLOGY, V115, P281, DOI 10.1016/S0016-5085(98)70194-5; Ullman TA, 2011, GASTROENTEROLOGY, V140, P1807, DOI 10.1053/j.gastro.2011.01.057; Uronis JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006026	24	1310	1380	15	355	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 5	2012	338	6103					120	123		10.1126/science.1224820	http://dx.doi.org/10.1126/science.1224820			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015PC	22903521	Green Accepted, Green Submitted			2022-12-28	WOS:000309457400067
J	Miyoshi, H; Ajima, R; Luo, CT; Yamaguchi, TP; Stappenbeck, TS				Miyoshi, Hiroyuki; Ajima, Rieko; Luo, Christine T.; Yamaguchi, Terry P.; Stappenbeck, Thaddeus S.			Wnt5a Potentiates TGF-beta Signaling to Promote Colonic Crypt Regeneration After Tissue Injury	SCIENCE			English	Article							STEM-CELLS; IN-VITRO; WNT/BETA-CATENIN; SMALL-INTESTINE; PATHWAY; MOUSE; CRE; RECOMBINATION; ELONGATION; EXPRESSION	Reestablishing homeostasis after tissue damage depends on the proper organization of stem cells and their progeny, though the repair mechanisms are unclear. The mammalian intestinal epithelium is well suited to approach this problem, as it is composed of well-delineated units called crypts of Lieberkuhn. We found that Wnt5a, a noncanonical Wnt ligand, was required for crypt regeneration after injury in mice. Unlike controls, Wnt5a-deficient mice maintained an expanded population of proliferative epithelial cells in the wound. We used an in vitro system to enrich for intestinal epithelial stem cells to discover that Wnt5a inhibited proliferation of these cells. Surprisingly, the effects of Wnt5a were mediated by activation of transforming growth factor-beta (TGF-beta) signaling. These findings suggest a Wnt5a-dependent mechanism for forming new crypt units to reestablish homeostasis.	[Ajima, Rieko; Yamaguchi, Terry P.; Stappenbeck, Thaddeus S.] NCI, Canc & Dev Biol Lab, Ctr Canc Res, NIH, Frederick, MD 21702 USA; [Miyoshi, Hiroyuki; Luo, Christine T.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Washington University (WUSTL)	Yamaguchi, TP (corresponding author), NCI, Canc & Dev Biol Lab, Ctr Canc Res, NIH, Frederick, MD 21702 USA.	stappenb@pathology.wustl.edu; yamagute@mail.nih.gov		Miyoshi, Hiroyuki/0000-0001-7400-0714	NIH [DK90251]; Pew Scholars Program in the Biomedical Sciences; Trans-National Institute of Diabetes and Digestive and Kidney Diseases Short-Term Training for Medical Students [5T35DK074375]; Washington Univ. Digestive Disease Research Core (NIH) [P30-DK52574]; NIH, National Cancer Institute, Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC010345] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK052574, T35DK074375, R01DK071619] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pew Scholars Program in the Biomedical Sciences; Trans-National Institute of Diabetes and Digestive and Kidney Diseases Short-Term Training for Medical Students; Washington Univ. Digestive Disease Research Core (NIH); NIH, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank R. Kopan for comments on the manuscript, W. Pu for reagents, and R. Head and C. Storer for the microarray analysis. This work was funded by the NIH (grant DK90251); the Pew Scholars Program in the Biomedical Sciences; grant 5T35DK074375 (Trans-National Institute of Diabetes and Digestive and Kidney Diseases Short-Term Training for Medical Students); the Washington Univ. Digestive Disease Research Core (NIH grant P30-DK52574); and the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research. Microarray data are available on Array Express (accession no. E-MTAB-1175). Materials transfer agreements will be required for the acquisition of the Wnt5a<SUP>f/f</SUP> mice from the National Cancer Institute and the L-WRN cell line from the Washington Univ. Medical School. The data presented in this manuscript are tabulated in the main paper and in the supplementary materials.	Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Cadwell K, 2010, CELL, V141, P1135, DOI 10.1016/j.cell.2010.05.009; Cervantes S, 2009, DEV BIOL, V326, P285, DOI 10.1016/j.ydbio.2008.11.020; CHANG WWL, 1971, AM J ANAT, V131, P101, DOI 10.1002/aja.1001310106; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; Gough Nancy R, 2008, Sci Signal, V1, peg8, DOI 10.1126/scisignal.146eg8; Gregorieff A, 2005, GASTROENTEROLOGY, V129, P626, DOI 10.1053/j.gastro.2005.06.007; Grumolato L, 2010, GENE DEV, V24, P2517, DOI 10.1101/gad.1957710; HANNON GJ, 1994, NATURE, V371, P257, DOI 10.1038/371257a0; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Iavarone A, 1997, NATURE, V387, P417; Ishitani T, 2003, MOL CELL BIOL, V23, P131, DOI 10.1128/MCB.23.1.131-139.2003; Ito M, 2007, NATURE, V447, P316, DOI 10.1038/nature05766; Jung P, 2011, NAT MED, V17, P1225, DOI 10.1038/nm.2470; Lanza R, 2009, ESSENTIALS OF STEM CELL BIOLOGY, 2ND EDITION, pXV, DOI 10.1016/B978-0-12-374729-7.00073-1; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115; MOSES HL, 1990, CELL, V63, P245, DOI 10.1016/0092-8674(90)90155-8; Ootani A, 2009, NAT MED, V15, P1, DOI 10.1038/nm.1951; PARK HS, 1995, AM J PATHOL, V147, P1416; Philipp I, 2009, P NATL ACAD SCI USA, V106, P4290, DOI 10.1073/pnas.0812847106; Pull SL, 2005, P NATL ACAD SCI USA, V102, P99, DOI 10.1073/pnas.0405979102; Ruzankina Y, 2007, CELL STEM CELL, V1, P113, DOI 10.1016/j.stem.2007.03.002; Sato A, 2010, EMBO J, V29, P41, DOI 10.1038/emboj.2009.322; Sato T, 2011, GASTROENTEROLOGY, V141, P1762, DOI 10.1053/j.gastro.2011.07.050; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Seno H, 2009, P NATL ACAD SCI USA, V106, P256, DOI 10.1073/pnas.0803343106; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Stappenbeck TS, 2009, SCIENCE, V324, P1666, DOI 10.1126/science.1172687; Stoick-Cooper CL, 2007, DEVELOPMENT, V134, P479, DOI 10.1242/dev.001123; Topol L, 2003, J CELL BIOL, V162, P899, DOI 10.1083/jcb.200303158; Walker MR, 2009, J PATHOL, V217, P169, DOI 10.1002/path.2474; Wilm B, 2005, DEVELOPMENT, V132, P5317, DOI 10.1242/dev.02141; Yamada M, 2010, DEV DYNAM, V239, P941, DOI 10.1002/dvdy.22212; Yamaguchi TP, 1999, DEVELOPMENT, V126, P1211; Zhou B, 2008, NATURE, V454, P109, DOI 10.1038/nature07060	37	297	300	4	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 5	2012	338	6103					108	113		10.1126/science.1223821	http://dx.doi.org/10.1126/science.1223821			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015PC	22956684	Green Accepted			2022-12-28	WOS:000309457400064
J	Thiele, H; Zeymer, U; Neumann, FJ; Ferenc, M; Olbrich, HG; Hausleiter, J; Richardt, G; Hennersdorf, M; Empen, K; Fuernau, G; Desch, S; Eitel, I; Hambrecht, R; Fuhrmann, J; Bohm, M; Ebelt, H; Schneider, S; Schuler, G; Werdan, K				Thiele, Holger; Zeymer, Uwe; Neumann, Franz-Josef; Ferenc, Miroslaw; Olbrich, Hans-Georg; Hausleiter, Joerg; Richardt, Gert; Hennersdorf, Marcus; Empen, Klaus; Fuernau, Georg; Desch, Steffen; Eitel, Ingo; Hambrecht, Rainer; Fuhrmann, Joerg; Boehm, Michael; Ebelt, Henning; Schneider, Steffen; Schuler, Gerhard; Werdan, Karl		IABP-SHOCK II Trial Investigators	Intraaortic Balloon Support for Myocardial Infarction with Cardiogenic Shock	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ASSIST DEVICE; COUNTERPULSATION; MANAGEMENT; TRENDS; REVASCULARIZATION; TRIAL; PUMP	BACKGROUND In current international guidelines, intraaortic balloon counterpulsation is considered to be a class I treatment for cardiogenic shock complicating acute myocardial infarction. However, evidence is based mainly on registry data, and there is a paucity of randomized clinical trials. METHODS In this randomized, prospective, open-label, multicenter trial, we randomly assigned 600 patients with cardiogenic shock complicating acute myocardial infarction to intraaortic balloon counterpulsation (IABP group, 301 patients) or no intraaortic balloon counterpulsation (control group, 299 patients). All patients were expected to undergo early revascularization (by means of percutaneous coronary intervention or bypass surgery) and to receive the best available medical therapy. The primary efficacy end point was 30-day all-cause mortality. Safety assessments included major bleeding, peripheral ischemic complications, sepsis, and stroke. RESULTS A total of 300 patients in the IABP group and 298 in the control group were included in the analysis of the primary end point. At 30 days, 119 patients in the IABP group (39.7%) and 123 patients in the control group (41.3%) had died (relative risk with IABP, 0.96; 95% confidence interval, 0.79 to 1.17; P = 0.69). There were no significant differences in secondary end points or in process-of-care measures, including the time to hemodynamic stabilization, the length of stay in the intensive care unit, serum lactate levels, the dose and duration of catecholamine therapy, and renal function. The IABP group and the control group did not differ significantly with respect to the rates of major bleeding (3.3% and 4.4%, respectively; P = 0.51), peripheral ischemic complications (4.3% and 3.4%, P = 0.53), sepsis (15.7% and 20.5%, P = 0.15), and stroke (0.7% and 1.7%, P = 0.28). CONCLUSIONS The use of intraaortic balloon counterpulsation did not significantly reduce 30-day mortality in patients with cardiogenic shock complicating acute myocardial infarction for whom an early revascularization strategy was planned. (Funded by the German Research Foundation and others; IABP-SHOCK II ClinicalTrials.gov number, NCT00491036.)	[Thiele, Holger] Univ Leipzig, Ctr Heart, Dept Internal Med Cardiol, D-04289 Leipzig, Germany; [Zeymer, Uwe; Schneider, Steffen] Klinikum Stadt Ludwigshafen, D-6700 Ludwigshafen, Germany; [Zeymer, Uwe; Schneider, Steffen] Inst Herzinfarktforsch, Ludwigshafen, Germany; [Neumann, Franz-Josef; Ferenc, Miroslaw] Heart Ctr Bad Krozingen, Bad Krozingen, Germany; [Olbrich, Hans-Georg] Asklepios Clin Langen Seligenstadt, Langen, Germany; [Hausleiter, Joerg] German Heart Ctr, D-8000 Munich, Germany; [Richardt, Gert] Segeberger Kliniken, Ctr Heart, Bad Segeberg, Germany; [Hennersdorf, Marcus] SLK Kliniken Heilbronn, Heilbronn, Germany; [Empen, Klaus] Ernst Moritz Arndt Univ Greifswald, Greifswald, Germany; [Hambrecht, Rainer] Klinikum Links Weser, Bremen, Germany; [Fuhrmann, Joerg] Zent Klin Bad Berka, Bad Berka, Germany; [Boehm, Michael] Univ Clin Saarland, Homburg, Germany; [Ebelt, Henning; Werdan, Karl] Univ Halle Wittenberg, Halle, Germany	Heart Center Leipzig GMBH; Leipzig University; University of Hamburg; University Medical Center Hamburg-Eppendorf; Ludwigshafen Hospital; Institute Heart Attack Research; German Heart Centre Munich; Segeberger Kliniken Group; University of Hamburg; University Medical Center Hamburg-Eppendorf; Ernst Moritz Arndt Universitat Greifswald; Zentralklinik Bad Berka; Universitatsklinikum des Saarlandes; Martin Luther University Halle Wittenberg	Thiele, H (corresponding author), Univ Leipzig, Ctr Heart, Dept Internal Med Cardiol, Strumpellstr 39, D-04289 Leipzig, Germany.	thielh@medizin.uni-leipzig.de	Braun-Dullaeus, Ruediger C/G-1844-2013; Thiele, Holger/ABE-6792-2020; Böhm, Michael/C-3638-2011; Fuernau, Georg/T-8798-2017; Fuernau, Georg/HCI-4640-2022; Hausleiter, Jörg/V-4206-2019	Braun-Dullaeus, Ruediger C/0000-0003-3888-6532; Thiele, Holger/0000-0002-0169-998X; Fuernau, Georg/0000-0002-3813-8772; Fuernau, Georg/0000-0002-3813-8772; Ferrari, Markus/0000-0003-3986-1943	German Research Foundation	German Research Foundation(German Research Foundation (DFG))	Funded by the German Research Foundation and others	Abdel-Wahab M, 2010, AM J CARDIOL, V105, P967, DOI 10.1016/j.amjcard.2009.11.021; Antman Elliott M, 2004, J Am Coll Cardiol, V44, P671, DOI 10.1016/j.jacc.2004.07.002; Antman EM, 2005, CIRCULATION, V111, P2013; Babaev A, 2005, JAMA-J AM MED ASSOC, V294, P448, DOI 10.1001/jama.294.4.448; Cheng JM, 2009, EUR HEART J, V30, P2102, DOI 10.1093/eurheartj/ehp292; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Fincke R, 2004, J AM COLL CARDIOL, V44, P340, DOI 10.1016/j.jacc.2004.03.060; Goldberg RJ, 2009, CIRCULATION, V119, P1211, DOI 10.1161/CIRCULATIONAHA.108.814947; Hochman JS, 1999, NEW ENGL J MED, V341, P625, DOI 10.1056/NEJM199908263410901; Hochman JS, 2003, CIRCULATION, V107, P2998, DOI 10.1161/01.CIR.0000075927.67673.F2; Hochman JS, 2007, JAMA-J AM MED ASSOC, V297, P1657; Jeger RV, 2008, ANN INTERN MED, V149, P618, DOI 10.7326/0003-4819-149-9-200811040-00005; LEGALL JR, 1994, JAMA-J AM MED ASSOC, V271, P1321; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; Patel MR, 2011, JAMA-J AM MED ASSOC, V306, P1329, DOI 10.1001/jama.2011.1280; Prondzinsky R, 2012, CLIN RES CARDIOL, V101, P375, DOI 10.1007/s00392-011-0403-3; Prondzinsky R, 2012, SHOCK, V37, P378, DOI 10.1097/SHK.0b013e31824a67af; Prondzinsky R, 2010, CRIT CARE MED, V38, P152, DOI 10.1097/CCM.0b013e3181b78671; SCHEIDT S, 1973, NEW ENGL J MED, V288, P979, DOI 10.1056/NEJM197305102881901; Sjauw KD, 2009, EUR HEART J, V30, P459, DOI 10.1093/eurheartj/ehn602; Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS), 2010, Eur Heart J, V31, P2501, DOI 10.1093/eurheartj/ehq277; Thiele H, 2005, EUR HEART J, V26, P1276, DOI 10.1093/eurheartj/ehi161; Thiele H, 2001, CIRCULATION, V104, P2917, DOI 10.1161/hc4901.100361; Thiele H, 2012, AM HEART J, V163, P938, DOI 10.1016/j.ahj.2012.03.012; Thiele H, 2010, EUR HEART J, V31, P1828, DOI 10.1093/eurheartj/ehq220; TOPOL E, 1993, NEW ENGL J MED, V329, P673, DOI 10.1056/nejm199309023291001; Unverzagt S, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007398.pub2; Van de Werf F, 2008, EUR HEART J, V29, P2909, DOI 10.1093/eurheartj/ehn416; Werdan K, 2012, DTSCH ARZTEBL INT, V109, P343, DOI 10.3238/arztebl.2012.0343; Wilson SR, 2009, CIRCULATION, V119, P2225, DOI 10.1161/CIRCULATIONAHA.109.850610	30	1426	1490	4	61	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 4	2012	367	14					1287	1296		10.1056/NEJMoa1208410	http://dx.doi.org/10.1056/NEJMoa1208410			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	014WJ	22920912				2022-12-28	WOS:000309406100005
J	Geoghegan, P; Sexton, DJ; Giblin, L; O'Regan, A				Geoghegan, Pierce; Sexton, Donal J.; Giblin, Louise; O'Regan, Anthony			Taught a lesson by taut skin	BRITISH MEDICAL JOURNAL			English	Editorial Material							SCLERODERMA RENAL CRISIS; PROGRESSIVE SYSTEMIC-SCLEROSIS; RISK-FACTORS; FAILURE; SURVIVAL; HYPERTENSION; MORTALITY; OUTCOMES; COHORT		[Geoghegan, Pierce; Sexton, Donal J.; Giblin, Louise; O'Regan, Anthony] Galway Univ Hosp, Galway, Ireland	Ollscoil na Gaillimhe-University of Galway	Geoghegan, P (corresponding author), Galway Univ Hosp, Galway, Ireland.	geoghep@tcd.ie		Sexton, Donal/0000-0001-8262-632X				Bryan C, 1996, BRIT J RHEUMATOL, V35, P1122; DeMarco PJ, 2002, ARTHRITIS RHEUM-US, V46, P2983, DOI 10.1002/art.10589; DENTON CP, 1994, BRIT J RHEUMATOL, V33, P90; DONOHOE JF, 1992, KIDNEY INT, V41, P462, DOI 10.1038/ki.1992.65; HELFRICH DJ, 1989, ARTHRITIS RHEUM, V32, P1128, DOI 10.1002/anr.1780320911; Hesselstrand R, 2012, SCAND J RHEUMATOL, V41, P39, DOI 10.3109/03009742.2011.610032; Kitiyakara C, 1998, J AM SOC NEPHROL, V9, P133; MEDSGER TA, 1971, ANN INTERN MED, V75, P369, DOI 10.7326/0003-4819-75-3-369; Mouthon L, 2011, CLIN REV ALLERG IMMU, V40, P84, DOI 10.1007/s12016-009-8191-5; Nguyen B, 2011, ARTHRITIS RHEUM-US, V63, P530, DOI 10.1002/art.30111; NISSENSON AR, 1990, Q J MED, V74, P63; Steen VD, 2000, ANN INTERN MED, V133, P600, DOI 10.7326/0003-4819-133-8-200010170-00010; Steen VD, 2003, RHEUM DIS CLIN N AM, V29, P315, DOI 10.1016/S0889-857X(03)00016-4; Steen VD, 1996, RHEUM DIS CLIN N AM, V22, P861, DOI 10.1016/S0889-857X(05)70305-7; Steen VD, 1998, ARTHRITIS RHEUM, V41, P1613, DOI 10.1002/1529-0131(199809)41:9<1613::AID-ART11>3.0.CO;2-O; STEEN VD, 1990, ANN INTERN MED, V113, P352, DOI 10.7326/0003-4819-113-5-352; STEEN VD, 1984, AM J MED, V76, P779, DOI 10.1016/0002-9343(84)90986-0; Teixeira L, 2008, ANN RHEUM DIS, V67, P110, DOI 10.1136/ard.2006.066985; TRAUB YM, 1983, MEDICINE, V62, P335, DOI 10.1097/00005792-198311000-00001; Whittier WL, 2004, CURR OPIN NEPHROL HY, V13, P661, DOI 10.1097/00041552-200411000-00013; Wong TY, 2005, BRIT MED BULL, V73-74, P57, DOI 10.1093/bmb/ldh050	21	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	SEP 13	2012	345								e5971	10.1136/bmj.e5971	http://dx.doi.org/10.1136/bmj.e5971			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	007BS	22977142				2022-12-28	WOS:000308864400002
J	Puig, P; Canals, M; Company, JB; Martin, J; Amblas, D; Lastras, G; Palanques, A; Calafat, AM				Puig, Pere; Canals, Miquel; Company, Joan B.; Martin, Jacobo; Amblas, David; Lastras, Galderic; Palanques, Albert; Calafat, Antoni M.			Ploughing the deep sea floor	NATURE			English	Article							MOBILE-FISHING-GEAR; CONTINENTAL SHELVES; SUBMARINE CANYONS; TRANSPORT; CURRENTS; GEOLOGY; IMPACT; RESUSPENSION; ECOSYSTEMS; SLOPES	Bottom trawling is a non-selective commercial fishing technique whereby heavy nets and gear are pulled along the sea floor. The direct impact of this technique on fish populations(1,2) and benthic communities(3,4) has received much attention, but trawling can also modify the physical properties of seafloor sediments, water-sediment chemical exchanges and sediment fluxes(5,6). Most of the studies addressing the physical disturbances of trawl gear on the seabed have been undertaken in coastal and shelf environments(7,8), however, where the capacity of trawling to modify the seafloor morphology coexists with high-energy natural processes driving sediment erosion, transport and deposition(9). Here we show that on upper continental slopes, the reworking of the deep sea floor by trawling gradually modifies the shape of the submarine landscape over large spatial scales. We found that trawling-induced sediment displacement and removal from fishing grounds causes the morphology of the deep sea floor to become smoother over time, reducing its original complexity as shown by high-resolution seafloor relief maps. Our results suggest that in recent decades, following the industrialization of fishing fleets, bottom trawling has become an important driver of deep seascape evolution. Given the global dimension of this type of fishery, we anticipate that the morphology of the upper continental slope in many parts of the world's oceans could be altered by intensive bottom trawling, producing comparable effects on the deep sea floor to those generated by agricultural ploughing on land.	[Puig, Pere; Company, Joan B.; Martin, Jacobo; Palanques, Albert] CSIC, Inst Marine Sci, E-08003 Barcelona, Spain; [Canals, Miquel; Amblas, David; Lastras, Galderic; Calafat, Antoni M.] Univ Barcelona, CRG Marine Geosci, E-08028 Barcelona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM); University of Barcelona	Puig, P (corresponding author), CSIC, Inst Marine Sci, E-08003 Barcelona, Spain.	ppuig@icm.csic.es	Company, Joan B./K-7274-2014; Martin, Jacobo/F-1388-2011; Calafat, Antoni/J-5848-2017; Canals, Miquel/F-4922-2013; Puig, Pere/E-5422-2013; Palanques, Albert/C-2661-2013; Amblas, David/A-5482-2015; Lastras, Galderic/A-6487-2013	Company, Joan B./0000-0002-5878-7155; Martin, Jacobo/0000-0001-8933-7731; Calafat, Antoni/0000-0001-7927-3105; Canals, Miquel/0000-0001-5267-7601; Puig, Pere/0000-0001-6189-5504; Amblas, David/0000-0002-6248-5512; Lastras, Galderic/0000-0002-8756-3855; Palanques, Albert/0000-0003-2544-2342	HERMIONE [226354, CTM2010-11084-E]; DOS MARES [CTM2010-21810-C03]; OASIS DEL MAR-Obra Social "la Caixa"; GRACCIE-CONSOLIDER [CSD2007-00067]; REDECO [CTM2008-04973-E]; Catalan Government Grups de Recerca Consolidats grants [SGR 899, 1305]; Spanish General Secretariat of Maritime Fishing (SEGEMAR); Consejo Superior de Investigaciones Cientificas; European Social Fund	HERMIONE; DOS MARES; OASIS DEL MAR-Obra Social "la Caixa"; GRACCIE-CONSOLIDER; REDECO; Catalan Government Grups de Recerca Consolidats grants; Spanish General Secretariat of Maritime Fishing (SEGEMAR); Consejo Superior de Investigaciones Cientificas; European Social Fund(European Social Fund (ESF))	This work was supported by various research projects: HERMIONE (226354 and CTM2010-11084-E), DOS MARES (CTM2010-21810-C03), OASIS DEL MAR-Obra Social "la Caixa", GRACCIE-CONSOLIDER (CSD2007-00067) and REDECO (CTM2008-04973-E). We also received support from Catalan Government Grups de Recerca Consolidats grants (2009 SGR 899 and 1305). VMS data and support were provided by the Spanish General Secretariat of Maritime Fishing (SEGEMAR). Assistance at sea by the crews of RV Hesperides, RV Sarmiento de Gamboa and RV Garcia del Cid is also acknowledged. J.M. was funded through a JAE-DOC contract granted by Consejo Superior de Investigaciones Cientificas and co-financed by the European Social Fund. F. Sarda and T. Milligan provided comments on the manuscript. The final document benefited from a review by P. Talling.	[Anonymous], 2003, OFFICIAL J EUR UNI L, VL333, P17; Benn AR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012730; Brown EJ, 2005, CONT SHELF RES, V25, P1281, DOI 10.1016/j.csr.2004.12.005; Cacchione DA, 2002, SCIENCE, V296, P724, DOI 10.1126/science.1069803; Canals M, 2006, NATURE, V444, P354, DOI 10.1038/nature05271; CHURCHILL JH, 1989, CONT SHELF RES, V9, P841, DOI 10.1016/0278-4343(89)90016-2; Crutzen PJ, 2002, NATURE, V415, P23, DOI 10.1038/415023a; Csorba P, 2010, ANTHROPOGENIC GEOMORPHOLOGY: A GUIDE TO MAN-MADE LANDFORMS, P39, DOI 10.1007/978-90-481-3058-0_4; Ferre B, 2008, CONT SHELF RES, V28, P2071, DOI 10.1016/j.csr.2008.02.002; Gordon J. D. M., 2003, Journal of Northwest Atlantic Fishery Science, V31, P137; Guillen J, 2000, SCI MAR, V64, P427, DOI 10.3989/scimar.2000.64n4427; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; HEEZEN BC, 1966, SCIENCE, V152, P502, DOI 10.1126/science.152.3721.502; JONES JB, 1992, NEW ZEAL J MAR FRESH, V26, P59, DOI 10.1080/00288330.1992.9516500; Lastras G, 2011, MAR GEOL, V280, P20, DOI 10.1016/j.margeo.2010.11.005; Levin LA, 2010, MAR ECOL-EVOL PERSP, V31, P1, DOI 10.1111/j.1439-0485.2009.00358.x; Martin J, 2008, MAR GEOL, V252, P150, DOI 10.1016/j.margeo.2008.03.012; Morato T, 2006, FISH FISH, V7, P24, DOI 10.1111/j.1467-2979.2006.00205.x; NITTROUER CA, 1994, REV GEOPHYS, V32, P85, DOI 10.1029/93RG02603; Norse EA, 2012, MAR POLICY, V36, P307, DOI 10.1016/j.marpol.2011.06.008; Palanques A, 2006, DEEP-SEA RES PT I, V53, P201, DOI 10.1016/j.dsr.2005.10.003; Palanques A, 2006, MAR GEOL, V234, P43, DOI 10.1016/j.margeo.2006.09.002; Piper DJW, 2009, J SEDIMENT RES, V79, P347, DOI 10.2110/jsr.2009.046; Pratson LF, 2007, SPEC PUBL INT ASS SE, V37, P339, DOI 10.1002/9781444304398.ch7; Price SJ, 2011, PHILOS T R SOC A, V369, P1056, DOI 10.1098/rsta.2010.0296; Roberts JM, 2006, SCIENCE, V312, P543, DOI 10.1126/science.1119861; Schwinghamer P, 1998, CONSERV BIOL, V12, P1215, DOI 10.1046/j.1523-1739.1998.0120061215.x; Thurstan RH, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1013; Tobar R., 1987, INF T CN INV PESQ, V142, P3; Tyrrell T, 2011, PHILOS T R SOC A, V369, P887, DOI [10.1098/rsta.2010.0334, 10.1098/rsta.2010.0331]; Watling L, 1998, CONSERV BIOL, V12, P1178, DOI 10.1046/j.1523-1739.1998.0120061178.x; Watling L, 1998, CONSERV BIOL, V12, P1180, DOI 10.1046/j.1523-1739.1998.0120061180.x	32	265	268	3	257	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 13	2012	489	7415					286	+		10.1038/nature11410	http://dx.doi.org/10.1038/nature11410			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003UC	22951970	Green Submitted, Green Accepted			2022-12-28	WOS:000308635900040
J	Moynihan, R				Moynihan, Ray			Reasons to be hopeful: streams of renewal in healthcare	BRITISH MEDICAL JOURNAL			English	Editorial Material									Bond Univ, Southport, Qld 4229, Australia	Bond University	Moynihan, R (corresponding author), Bond Univ, Southport, Qld 4229, Australia.	RayMoynihan@bond.edu.au	Moynihan, Ray/ABC-3010-2020					Illich I, 1990, LIMITS MED MED NEMES; Informed Medical Decisions Foundation, 2012, WHAT WILL IT TAK AV; Jackson T., 2009, PROSPERITY GROWTH; Smith A, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e4682; Smith R, 2010, BMJ GROUP BLOG  0901	5	1	1	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	SEP 12	2012	345								e6042	10.1136/bmj.e6042	http://dx.doi.org/10.1136/bmj.e6042			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	007BP	22977107				2022-12-28	WOS:000308864100009
J	Basaria, S; Bhasin, S				Basaria, Shehzad; Bhasin, Shalender			BASIC IMPLICATIONS OF CLINICAL OBSERVATIONS Targeting the Skeletal Muscle-Metabolism Axis in Prostate-Cancer Therapy	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							ANDROGEN-DEPRIVATION THERAPY; MICE; MASS; MEN; FAT		[Basaria, Shehzad; Bhasin, Shalender] Boston Univ, Sch Med, Dept Med, Div Endocrinol & Metab, Boston, MA 02118 USA	Boston University	Basaria, S (corresponding author), Boston Univ, Sch Med, Dept Med, Div Endocrinol & Metab, Boston, MA 02118 USA.			Basaria, Shehzad/0000-0003-1749-8549; Basaria, Shehzad/0000-0002-8533-2383				Basaria S, 2006, CANCER-AM CANCER SOC, V106, P581, DOI 10.1002/cncr.21642; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Febbraio MA, 2004, DIABETES, V53, P1643, DOI 10.2337/diabetes.53.7.1643; Izumiya Y, 2008, CELL METAB, V7, P159, DOI 10.1016/j.cmet.2007.11.003; Keating NL, 2006, J CLIN ONCOL, V24, P4448, DOI 10.1200/JCO.2006.06.2497; Lee SJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000789; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; Saigal CS, 2007, CANCER-AM CANCER SOC, V110, P1493, DOI 10.1002/cncr.22933; Shahani S, 2008, J CLIN ENDOCR METAB, V93, P2042, DOI 10.1210/jc.2007-2595; Tu P, 2009, DIABETES, V58, P1739, DOI 10.2337/db09-0349; Zhang C, 2012, DIABETOLOGIA, V55, P183, DOI 10.1007/s00125-011-2304-4	11	30	30	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 6	2012	367	10					965	967		10.1056/NEJMcibr1203160	http://dx.doi.org/10.1056/NEJMcibr1203160			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	999VO	22931265				2022-12-28	WOS:000308343300018
J	Witt, DM				Witt, Daniel M.			Rivaroxaban and usual care had similar rates of recurrent VTE and bleeding in symptomatic PE	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Kaiser Permanente Colorado, Aurora, CO USA	Kaiser Permanente	Witt, DM (corresponding author), Kaiser Permanente Colorado, Aurora, CO USA.							Bauersachs R, 2010, NEW ENGL J MED, V363, P2499, DOI 10.1056/NEJMoa1007903	1	2	3	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 21	2012	157	4							JC4-6	10.7326/0003-4819-157-4-201208210-02006	http://dx.doi.org/10.7326/0003-4819-157-4-201208210-02006			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	992XG	22910960				2022-12-28	WOS:000307813200005
J	Wang, WC; McCool, G; Kapur, N; Yuan, G; Shan, B; Nguyen, M; Graham, UM; Davis, BH; Jacobs, G; Cho, K; Hao, XH				Wang, Weichao; McCool, Geoffrey; Kapur, Neeti; Yuan, Guang; Shan, Bin; Nguyen, Matt; Graham, Uschi M.; Davis, Burtron H.; Jacobs, Gary; Cho, Kyeongjae; Hao, Xianghong (Kelly)			Mixed-Phase Oxide Catalyst Based on Mn-Mullite (Sm, Gd)Mn2O5 for NO Oxidation in Diesel Exhaust	SCIENCE			English	Article							ADSORPTION; CONVERSION	Oxidation of nitric oxide (NO) for subsequent efficient reduction in selective catalytic reduction or lean NOx trap devices continues to be a challenge in diesel engines because of the low efficiency and high cost of the currently used platinum (Pt)-based catalysts. We show that mixed-phase oxide materials based on Mn-mullite (Sm, Gd)Mn2O5 are an efficient substitute for the current commercial Pt-based catalysts. Under laboratory-simulated diesel exhaust conditions, this mixed-phase oxide material was superior to Pt in terms of cost, thermal durability, and catalytic activity for NO oxidation. This oxide material is active at temperatures as low as 120 degrees C with conversion maxima of similar to 45% higher than that achieved with Pt. Density functional theory and diffuse reflectance infrared Fourier transform spectroscopy provide insights into the NO-to-NO2 reaction mechanism on catalytically active Mn-Mn sites via the intermediate nitrate species.	[Wang, Weichao; McCool, Geoffrey; Kapur, Neeti; Yuan, Guang; Shan, Bin; Nguyen, Matt; Cho, Kyeongjae; Hao, Xianghong (Kelly)] Nanostellar Inc, Redwood City, CA 94063 USA; [Shan, Bin] Huazhong Univ Sci & Technol, State Key Lab Mat Proc & Die & Mould Technol, Wuhan 430074, Hubei, Peoples R China; [Shan, Bin] Huazhong Univ Sci & Technol, Sch Mat Sci & Engn, Wuhan 430074, Hubei, Peoples R China; [Graham, Uschi M.; Davis, Burtron H.; Jacobs, Gary] Univ Kentucky, Ctr Appl Energy Res, Lexington, KY 40511 USA; [Cho, Kyeongjae] Univ Texas Dallas, Dept Mat Sci & Engn, Richardson, TX 75080 USA; [Cho, Kyeongjae] Univ Texas Dallas, Dept Phys, Richardson, TX 75080 USA; [Cho, Kyeongjae] Seoul Natl Univ, Sch Mech & Aerosp Engn, WCU Multiscale Mech Design Div, Seoul 151742, South Korea	Huazhong University of Science & Technology; Huazhong University of Science & Technology; University of Kentucky; University of Texas System; University of Texas Dallas; University of Texas System; University of Texas Dallas; Seoul National University (SNU)	Wang, WC (corresponding author), Nanostellar Inc, 3696 Haven Ave, Redwood City, CA 94063 USA.	wwang@nanostellar.com; kjcho@utdallas.edu; xhao@nanostellar.com	Wang, Weichao/C-7029-2014; Jacobs, Gary/AAP-6135-2021; Shan, Bin/D-1558-2009; Jacobs, Gary/M-5349-2015	Wang, Weichao/0000-0001-5931-212X; Kapur, Neeti/0000-0002-8515-1240; Jacobs, Gary/0000-0003-0691-6717	Nanostellar; NRF of Korea through WCU program [R-31-2009-000-10083-0]	Nanostellar; NRF of Korea through WCU program(National Research Foundation of Korea)	DFT calculations were performed at the Texas Advanced Computer Center (TACC). The authors acknowledge Nanostellar for supporting this work. A provisional patent application for MnCe-7:1 has been filed on Nanostellar's behalf: U.S. Provisional Patent No 61/561,771. K.C. was supported by the NRF of Korea through WCU program (Grant No. R-31-2009-000-10083-0).	Bartholomew CH, 2006, FUNDAMENTALS OF INDUSTRIAL CATALYTIC PROCESSES, 2ND EDITION, P1, DOI 10.1002/9780471730071; Brunauer S, 1938, J AM CHEM SOC, V60, P309, DOI 10.1021/ja01269a023; Fornasiero P, 2001, COLLECT CZECH CHEM C, V66, P1287, DOI 10.1135/cccc20011287; Kim CH, 2010, SCIENCE, V327, P1624, DOI 10.1126/science.1184087; Mulla SS, 2006, J CATAL, V241, P389, DOI 10.1016/j.jcat.2006.05.016; Niessen W, 1998, J PHYS D APPL PHYS, V31, P542, DOI 10.1088/0022-3727/31/5/011; Patnaik P., 2004, DEANS ANAL CHEM HDB; Schmitz PJ, 2002, J PHYS CHEM B, V106, P4172, DOI 10.1021/jp0133992; Skorodumova NV, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.166601; Tang N, 2011, J PHYS CHEM C, V115, P8214, DOI 10.1021/jp200920z; Tas MA, 1997, PLASMA CHEM PLASMA P, V17, P371, DOI 10.1023/A:1021818313047; Tritsaris GA, 2011, CATAL LETT, V141, P909, DOI 10.1007/s10562-011-0637-8; Wen Y, 2007, CATAL TODAY, V126, P400, DOI 10.1016/j.cattod.2007.06.032	13	246	261	22	451	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 17	2012	337	6096					832	835		10.1126/science.1225091	http://dx.doi.org/10.1126/science.1225091			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	989BQ	22904009				2022-12-28	WOS:000307535600040
J	Oliveira, E; Manuel, P; Alexandre, J; Girao, F				Oliveira, Eurico; Manuel, Paula; Alexandre, Joao; Girao, Fernando			Phantom tumour of the lung	LANCET			English	Editorial Material									[Oliveira, Eurico; Manuel, Paula; Alexandre, Joao; Girao, Fernando] St Teotonio Hosp, Dept Internal Med, P-3504509 Viseu, Portugal		Oliveira, E (corresponding author), St Teotonio Hosp, Dept Internal Med, King D Duarte Ave, P-3504509 Viseu, Portugal.	eurico.oliveira@gmail.com							0	4	4	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	DEC 8	2012	380	9858					2028	2028		10.1016/S0140-6736(12)60693-X	http://dx.doi.org/10.1016/S0140-6736(12)60693-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	051KI	22959416				2022-12-28	WOS:000312124900033
J	Byrne, RA; Kastrati, A; Hausleiter, J				Byrne, Robert A.; Kastrati, Adnan; Hausleiter, Joerg			The battle against stent thrombosis-to protect and to serve	LANCET			English	Editorial Material							DRUG-ELUTING STENTS; CORONARY-ARTERY-DISEASE; RANDOMIZED-TRIALS; METAANALYSIS; INTERVENTION; RISK		[Hausleiter, Joerg] Tech Univ Munich, Deutsch Herzzentrum, D-80636 Munich, Germany; Tech Univ Munich, Klinikum Rechts Isar, D-80636 Munich, Germany	German Heart Center Berlin; German Heart Centre Munich; Technical University of Munich; Technical University of Munich	Hausleiter, J (corresponding author), Tech Univ Munich, Deutsch Herzzentrum, D-80636 Munich, Germany.	hausleiter@dhm.mhn.de	Hausleiter, Jörg/V-4206-2019; , Kastrati/Y-2389-2019; Byrne, Robert/C-3902-2016	Byrne, Robert/0000-0001-5224-6393				Byrne RA, 2009, EUR HEART J, V30, P923, DOI 10.1093/eurheartj/ehp044; Camenzind E, 2012, LANCET; Camenzind E, 2007, CIRCULATION, V115, P1440, DOI 10.1161/CIRCULATIONAHA.106.666800; de Waha A, 2012, CLIN RES CARDIOL, V101, P461, DOI 10.1007/s00392-012-0414-8; Fan J, 2012, INT J CARDIOL; Freemantle N, 2001, BRIT MED J, V322, P989, DOI 10.1136/bmj.322.7292.989; Joner M, 2006, J AM COLL CARDIOL, V48, P193, DOI 10.1016/j.jacc.2006.03.042; King SB, 2008, CIRCULATION, V117, P261, DOI 10.1161/CIRCULATIONAHA.107.188208; Krone RJ, 2010, JACC-CARDIOVASC INTE, V3, P902, DOI 10.1016/j.jcin.2010.06.014; McFadden EP, 2004, LANCET, V364, P1519, DOI 10.1016/S0140-6736(04)17275-9; Nakazawa G, 2011, J AM COLL CARDIOL, V57, P390, DOI 10.1016/j.jacc.2010.05.066; Nordmann AJ, 2006, EUR HEART J, V27, P2784, DOI 10.1093/eurheartj/ehl282; Rasmussen K, 2010, LANCET, V375, P1090, DOI 10.1016/S0140-6736(10)60208-5; Schomig A, 2007, J AM COLL CARDIOL, V50, P1373, DOI 10.1016/j.jacc.2007.06.047; Stefanini GG, 2012, EUR HEART J, V33, P1214, DOI 10.1093/eurheartj/ehs086; Stefanini GG, 2011, LANCET, V378, P1940, DOI 10.1016/S0140-6736(11)61672-3; Stone GW, 2011, J AM COLL CARDIOL, V58, P19, DOI 10.1016/j.jacc.2011.02.022; Vranckx P, 2010, EUROINTERVENTION, V5, P871, DOI 10.4244/EIJV5I7A146	18	2	3	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 20	2012	380	9851					1365	1367		10.1016/S0140-6736(12)61385-3	http://dx.doi.org/10.1016/S0140-6736(12)61385-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	025NM	22951083				2022-12-28	WOS:000310196500007
J	Morf, J; Rey, G; Schneider, K; Stratmann, M; Fujita, J; Naef, F; Schibler, U				Morf, Joerg; Rey, Guillaume; Schneider, Kim; Stratmann, Markus; Fujita, Jun; Naef, Felix; Schibler, Ueli			Cold-Inducible RNA-Binding Protein Modulates Circadian Gene Expression Posttranscriptionally	SCIENCE			English	Article							BODY-TEMPERATURE; TRANSCRIPTION; CELLS; ENTRAINMENT; INSIGHTS; RHYTHMS; CLOCK	In mammalian tissues, circadian gene expression can be driven by local oscillators or systemic signals controlled by the master pacemaker in the suprachiasmatic nucleus. We show that simulated body temperature cycles, but not peripheral oscillators, controlled the rhythmic expression of cold-inducible RNA-binding protein (CIRP) in cultured fibroblasts. In turn, loss-of-function experiments indicated that CIRP was required for high-amplitude circadian gene expression. The transcriptome-wide identification of CIRP-bound RNAs by a biotin-streptavidin-based cross-linking and immunoprecipitation (CLIP) procedure revealed several transcripts encoding circadian oscillator proteins, including CLOCK. Moreover, CLOCK accumulation was strongly reduced in CIRP-depleted fibroblasts. Because ectopic expression of CLOCK improved circadian gene expression in these cells, we surmise that CIRP confers robustness to circadian oscillators through regulation of CLOCK expression.	[Morf, Joerg; Schneider, Kim; Stratmann, Markus; Schibler, Ueli] Univ Geneva, Dept Mol Biol, CH-1211 Geneva, Switzerland; [Morf, Joerg; Schneider, Kim; Stratmann, Markus; Schibler, Ueli] Natl Ctr Competence Res, CH-1211 Geneva, Switzerland; [Rey, Guillaume; Naef, Felix] Ecole Polytech Fed Lausanne, Sch Life Sci, Inst Bioengn, CH-1015 Lausanne, Switzerland; [Rey, Guillaume; Naef, Felix] Swiss Inst Bioinformat, CH-1015 Lausanne, Switzerland; [Fujita, Jun] Kyoto Univ, Grad Sch Med, Dept Clin Mol Biol, Sakyo Ku, Kyoto 6058507, Japan	University of Geneva; University of Geneva; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute of Bioinformatics; Kyoto University	Schibler, U (corresponding author), Univ Geneva, Dept Mol Biol, 30 Quai Ernest Ansermet, CH-1211 Geneva, Switzerland.	ueli.schibler@unige.ch	Morf, Jorg/AAH-4825-2020; Rey, Guillaume/F-5303-2012	Morf, Jorg/0000-0002-0485-3380; Rey, Guillaume/0000-0001-7664-7052; Naef, Felix/0000-0001-9786-3037	Swiss National Science Foundation [SNF 31-113565, SNF 31-128656/1]; European Research Council [ERC-2009-AdG 20090506, ERC-2010-StG-260667]; State of Geneva; Louis Jeantet Foundation of Medicine; Smoking Research Foundation of Japan; Swiss National Science Foundation (SNF) [31-130714]; Ecole Polytechnique Federale de Lausanne (EPFL)	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Research Council(European Research Council (ERC)European Commission); State of Geneva; Louis Jeantet Foundation of Medicine; Smoking Research Foundation of Japan; Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF)); Ecole Polytechnique Federale de Lausanne (EPFL)	We thank A. Liani and Y.-A. Poget for constructing the bioluminescence recording device; J. Strouboulis (Vari, Greece) for the IRES-BirA vector plasmid (pTRIP-IRES-EGFP-BirA); P. Gos, F. Fleury-Olela, K. Harshman and the Lausanne Genomic Technologies Facility, as well as P. Descombes and the National Center of Competence in Research (NCCR) Genomics Platform, Geneva, for technical help; and N. Roggli for the artwork. The computations were performed at the Vital-IT (www.vital-it.ch) Center for high-performance computing of the SIB Swiss Institute of Bioinformatics. The work in the laboratory of U.S. was supported by the Swiss National Science Foundation (SNF 31-113565, SNF 31-128656/1 and the NCCR program grant Frontiers in Genetics), the European Research Council (ERC-2009-AdG 20090506), the State of Geneva, and the Louis Jeantet Foundation of Medicine. The work in the laboratory of J. F. was supported by the Smoking Research Foundation of Japan. The work in the laboratory of F. N. was supported by the Swiss National Science Foundation (SNF grant 31-130714), the European Research Council (ERC-2010-StG-260667), and the Ecole Polytechnique Federale de Lausanne (EPFL). CLIP-seq and RNA-seq data have been deposited in the Gene Expression Omnibus database (accession no. GSE37685).	Abraham U, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.92; Artero-Castro A, 2009, MOL CELL BIOL, V29, P1855, DOI 10.1128/MCB.01386-08; Brown SA, 2002, CURR BIOL, V12, P1574, DOI 10.1016/S0960-9822(02)01145-4; Brown SA, 2008, P NATL ACAD SCI USA, V105, P1602, DOI 10.1073/pnas.0707772105; Buhr ED, 2010, SCIENCE, V330, P379, DOI 10.1126/science.1195262; de Boer E, 2003, P NATL ACAD SCI USA, V100, P7480, DOI 10.1073/pnas.1332608100; Guo X, 2010, MOL CARCINOGEN, V49, P130, DOI 10.1002/mc.20582; Kornmann B, 2007, COLD SH Q B, V72, P319; Kornmann B, 2007, PLOS BIOL, V5, P179, DOI 10.1371/journal.pbio.0050034; Licatalosi DD, 2008, NATURE, V456, P464, DOI 10.1038/nature07488; Nishiyama H, 1997, J CELL BIOL, V137, P899, DOI 10.1083/jcb.137.4.899; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Rey G, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000595; Ripperger JA, 2000, GENE DEV, V14, P679; Saini C, 2012, GENE DEV, V26, P567, DOI 10.1101/gad.183251.111; Saito K, 2010, BRAIN RES, V1358, P20, DOI 10.1016/j.brainres.2010.08.048; Stratmann M, 2006, J BIOL RHYTHM, V21, P494, DOI 10.1177/0748730406293889; Tamaru T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024521; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Vitaterna MH, 2006, P NATL ACAD SCI USA, V103, P9327, DOI 10.1073/pnas.0603601103; Yeo GW, 2009, NAT STRUCT MOL BIOL, V16, P130, DOI 10.1038/nsmb.1545	21	176	184	2	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 19	2012	338	6105					379	383		10.1126/science.1217726	http://dx.doi.org/10.1126/science.1217726			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022JS	22923437				2022-12-28	WOS:000309955800040
J	Roe, MT; Armstrong, PW; Fox, KAA; White, HD; Prabhakaran, D; Goodman, SG; Cornel, JH; Bhatt, DL; Clemmensen, P; Martinez, F; Ardissino, D; Nicolau, JC; Boden, WE; Gurbel, PA; Ruzyllo, W; Dalby, AJ; McGuire, DK; Leiva-Pons, JL; Parkhomenko, A; Gottlieb, S; Topacio, GO; Hamm, C; Pavlides, G; Goudev, AR; Oto, A; Tseng, CD; Merkely, B; Gasparovic, V; Corbalan, R; Cinteza, M; McLendon, RC; Winters, KJ; Brown, EB; Lokhnygina, Y; Aylward, PE; Huber, K; Hochman, JS; Ohman, EM				Roe, Matthew T.; Armstrong, Paul W.; Fox, Keith A. A.; White, Harvey D.; Prabhakaran, Dorairaj; Goodman, Shaun G.; Cornel, Jan H.; Bhatt, Deepak L.; Clemmensen, Peter; Martinez, Felipe; Ardissino, Diego; Nicolau, Jose C.; Boden, William E.; Gurbel, Paul A.; Ruzyllo, Witold; Dalby, Anthony J.; McGuire, Darren K.; Leiva-Pons, Jose L.; Parkhomenko, Alexander; Gottlieb, Shmuel; Topacio, Gracita O.; Hamm, Christian; Pavlides, Gregory; Goudev, Assen R.; Oto, Ali; Tseng, Chuen-Den; Merkely, Bela; Gasparovic, Vladimir; Corbalan, Ramon; Cinteza, Mircea; McLendon, R. Craig; Winters, Kenneth J.; Brown, Eileen B.; Lokhnygina, Yuliya; Aylward, Philip E.; Huber, Kurt; Hochman, Judith S.; Ohman, E. Magnus		TRILOGY ACS Investigators	Prasugrel versus Clopidogrel for Acute Coronary Syndromes without Revascularization	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MYOCARDIAL-INFARCTION; MEDICAL-MANAGEMENT; OUTCOMES; PREDICTORS; STRATEGY	Background The effect of intensified platelet inhibition for patients with unstable angina or myocardial infarction without ST-segment elevation who do not undergo revascularization has not been delineated. Methods In this double-blind, randomized trial, in a primary analysis involving 7243 patients under the age of 75 years receiving aspirin, we evaluated up to 30 months of treatment with prasugrel (10 mg daily) versus clopidogrel (75 mg daily). In a secondary analysis involving 2083 patients 75 years of age or older, we evaluated 5 mg of prasugrel versus 75 mg of clopidogrel. Results At a median follow-up of 17 months, the primary end point of death from cardiovascular causes, myocardial infarction, or stroke among patients under the age of 75 years occurred in 13.9% of the prasugrel group and 16.0% of the clopidogrel group (hazard ratio in the prasugrel group, 0.91; 95% confidence interval [CI], 0.79 to 1.05; P = 0.21). Similar results were observed in the overall population. The prespecified analysis of multiple recurrent ischemic events (all components of the primary end point) suggested a lower risk for prasugrel among patients under the age of 75 years (hazard ratio, 0.85; 95% CI, 0.72 to 1.00; P = 0.04). Rates of severe and intracranial bleeding were similar in the two groups in all age groups. There was no significant between-group difference in the frequency of nonhemorrhagic serious adverse events, except for a higher frequency of heart failure in the clopidogrel group. Conclusions Among patients with unstable angina or myocardial infarction without ST- segment elevation, prasugrel did not significantly reduce the frequency of the primary end point, as compared with clopidogrel, and similar risks of bleeding were observed. (Funded by Eli Lilly and Daiichi Sankyo; TRILOGY ACS ClinicalTrials.gov number, NCT00699998.)	[Roe, Matthew T.; McLendon, R. Craig; Lokhnygina, Yuliya; Ohman, E. Magnus] Duke Univ, Med Ctr, Duke Clin Res Inst, Durham, NC 27705 USA; [Roe, Matthew T.; Ohman, E. Magnus] Duke Univ, Med Ctr, Div Cardiol, Dept Med, Durham, NC 27705 USA; [Armstrong, Paul W.] Univ Alberta, Div Cardiol, Edmonton, AB, Canada; [Goodman, Shaun G.] Univ Toronto, St Michaels Hosp, Dept Med, Div Cardiol, Toronto, ON M5B 1W8, Canada; [Fox, Keith A. A.] Univ Edinburgh, Ctr Cardiovasc Sci, Edinburgh, Midlothian, Scotland; [White, Harvey D.] Auckland City Hosp, Green Lane Cardiovasc Serv, Auckland, New Zealand; [Prabhakaran, Dorairaj] Ctr Chron Dis Control, New Delhi, India; [Cornel, Jan H.] Med Ctr Alkmaar, Dept Cardiol, Alkmaar, Netherlands; [Bhatt, Deepak L.] Brigham & Womens Hosp, VA Boston Healthcare Syst, Boston, MA 02115 USA; [Bhatt, Deepak L.] Harvard Univ, Sch Med, Boston, MA USA; [Clemmensen, Peter] Univ Copenhagen, Rigshosp, DK-2100 Copenhagen, Denmark; [Martinez, Felipe] Natl Univ Cordoba, Dept Cardiol, Cordoba, Argentina; [Ardissino, Diego] Azienda Osped Univ Parma, Div Cardiol, Parma, Italy; [Nicolau, Jose C.] Univ Sao Paulo, Sch Med, Heart Inst InCor, Sao Paulo, Brazil; [Boden, William E.] Albany Med Coll, Stratton VA Med Ctr, Dept Med, Albany, NY 12208 USA; [Hochman, Judith S.] NYU, Sch Med, Leon H Charney Div Cardiol, Cardiovasc Clin Res Ctr, New York, NY USA; [Hochman, Judith S.] NYU Langone Med Ctr, New York, NY USA; [Gurbel, Paul A.] Sinai Hosp Baltimore, Sinai Ctr Thrombosis Res, Baltimore, MD USA; [Ruzyllo, Witold] Inst Cardiol, Dept Coronary Artery Dis, Warsaw, Poland; [Dalby, Anthony J.] Milpark Hosp, Johannesburg, South Africa; [McGuire, Darren K.] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA; [Leiva-Pons, Jose L.] Hosp Cent Dr Morones Prieto, Dept Cardiol, San Luis Potosi, Mexico; [Parkhomenko, Alexander] Inst Cardiol, Kiev, Ukraine; [Gottlieb, Shmuel] Bikur Cholim Hosp, Dept Cardiol, Jerusalem, Israel; [Topacio, Gracita O.] Med Ctr Manila, Dept Med, Manila, Philippines; [Hamm, Christian] Kerckhoff Heart Ctr, Bad Nauheim, Germany; [Pavlides, Gregory] Onassis Cardiac Surg Ctr, Div Cardiol, Kallithea, Greece; [Goudev, Assen R.] Queen Giovanna Univ Hosp, Dept Cardiol, Sofia, Bulgaria; [Oto, Ali] Hacettepe Univ, Fac Med, Dept Cardiol, TR-06100 Ankara, Turkey; [Tseng, Chuen-Den] Natl Taiwan Univ, Coll Med, Div Cardiol, Taipei 10764, Taiwan; [Merkely, Bela] Semmelweis Univ, Ctr Heart, H-1085 Budapest, Hungary; [Gasparovic, Vladimir] Clin Hosp Ctr Zagreb, Dept Intens Care Med, Zagreb, Croatia; [Corbalan, Ramon] Pontificia Univ Catolica Chile, Fac Med, Div Cardiovasc, Santiago, Chile; [Cinteza, Mircea] Emergency Univ Hosp Bucharest, Div Cardiol, Bucharest, Romania; [Winters, Kenneth J.; Brown, Eileen B.] Eli Lilly, Indianapolis, IN USA; [Aylward, Philip E.] Flinders Univ S Australia, Med Ctr, S Australian Hlth & Med Res Inst, Adelaide, SA 5001, Australia; [Huber, Kurt] Wilhelminenhospital, Dept Med Cardiol & Emergency Med 3, Vienna, Austria	Duke University; Duke University; University of Alberta; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Edinburgh; Auckland City Hospital; Medical Center Of Alkmaar; Harvard University; Brigham & Women's Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Boston Healthcare System; Harvard University; Harvard Medical School; Rigshospitalet; University of Copenhagen; National University of Cordoba; University of Parma; University Hospital of Parma; Universidade de Sao Paulo; Albany Medical College; New York University; NYU Langone Medical Center; Sinai Center Thrombosis Research; Sinai Hospital of Baltimore; Institute of Cardiology - Poland; University of Texas System; University of Texas Southwestern Medical Center Dallas; Hospital Central Dr. Ignacio Morones Prieto; National Academy of Medical Sciences of Ukraine; National Scientific Center M.D. Strazhesko Institute of Cardiology of the National Academy of Medical Sciences of Ukraine; Kerckhoff Clinic; Onassis Cardiac Surgery Center; Medical University Sofia; Hacettepe University; National Taiwan University; Semmelweis University; University of Zagreb; Pontificia Universidad Catolica de Chile; Eli Lilly; Flinders University South Australia; South Australian Health & Medical Research Institute (SAHMRI); Wilhelminenspital	Roe, MT (corresponding author), Duke Univ, Med Ctr, Duke Clin Res Inst, 2400 Pratt St,Rm 7035, Durham, NC 27705 USA.	matthew.roe@duke.edu	galvani, marcello/AAQ-3210-2020; De+Servi, Stefano/AAT-2631-2021; Neto, Jose R Faria/G-7559-2012; Boldueva, Svetlana/AAH-3862-2019; Manolis, Antonis/F-5003-2014; Prabhakaran, Dorairaj/B-4147-2011; Fox, keith A A/I-3742-2013; Ardissino, Diego/AAC-4041-2022; Janota, Tomas/S-7725-2017; Linhart, Ales/O-2375-2017; Verheugt, F.W.A./H-8105-2014; Hamm, Christian W./I-3155-2017; BUAKHAMSRI, ADISAI/ABD-3971-2020; Ishmurzin, Gennady/W-7549-2019; McGuire, Darren K./AAL-4172-2021; Malynovsky, Yaroslav/T-1898-2017; Ferrari, Emile/R-2917-2016; Arutyunov, Gregory/M-7368-2019; Nicolau, Jose C/E-1487-2012; Ponikowski, Piotr/O-6454-2015; Reda, Ashraf/AAV-8010-2021; Prunier, Fabrice/A-5210-2011; Kaidashev, Igor/L-2606-2019; Chan, Yan Yee Mark/ABE-1929-2021; cornel, jan hein/Y-7065-2019; Ramshev, Konstantin/GYU-1641-2022; Ushakov, Alexei V/P-4465-2015; Zateyshchikov, Dmitry A/D-6575-2012; Gurevich, Victor/AAP-7641-2020; Widimsky, Petr/P-8088-2016; Sergey, Tereshchenko/AAA-9455-2021; Altun, Armagan/ABB-5844-2020; Laine, Marc/L-1270-2019; Gurevich, Victor/H-2935-2013; Neskovic, Aleksandar/P-5204-2015; Gruchala, Marcin/S-8407-2018; Reis, Gilmar/I-4500-2013	galvani, marcello/0000-0001-5897-667X; Neto, Jose R Faria/0000-0002-1397-0634; Boldueva, Svetlana/0000-0002-1898-084X; Manolis, Antonis/0000-0002-0336-4745; Prabhakaran, Dorairaj/0000-0002-3172-834X; Janota, Tomas/0000-0001-5659-3747; Linhart, Ales/0000-0002-3372-7850; Hamm, Christian W./0000-0001-6763-4161; BUAKHAMSRI, ADISAI/0000-0002-1026-1349; Ishmurzin, Gennady/0000-0002-0962-5790; Malynovsky, Yaroslav/0000-0002-9118-1104; Arutyunov, Gregory/0000-0002-6645-2515; Nicolau, Jose C/0000-0002-9680-3689; Ponikowski, Piotr/0000-0002-3391-7064; Reda, Ashraf/0000-0003-4414-2433; Kaidashev, Igor/0000-0002-4708-0859; Chan, Yan Yee Mark/0000-0003-0389-7450; cornel, jan hein/0000-0002-1006-2112; Ramshev, Konstantin/0000-0002-6978-6641; Ushakov, Alexei V/0000-0002-7020-4442; Zateyshchikov, Dmitry A/0000-0001-7065-2045; Gurevich, Victor/0000-0002-6815-444X; Widimsky, Petr/0000-0001-5686-7752; Sergey, Tereshchenko/0000-0001-9234-6129; Altun, Armagan/0000-0002-3233-8263; Laine, Marc/0000-0002-1458-5543; Gurevich, Victor/0000-0002-6815-444X; Marin-Neto, Jose Antonio/0000-0002-8651-8833; Merkely, Bela/0000-0001-6514-0723; Strickler, John/0000-0001-7579-1175; LLERENA NAVARRO, NASSIP/0000-0001-9436-4099; BOBESCU, ELENA/0000-0002-0945-9067; Yuan, Zuyi/0000-0002-4141-0298; Car, Sinisa/0000-0001-6439-123X; Yusof, Zurkurnai/0000-0002-2483-8145; Volpe, Massimo/0000-0002-9642-8380; Armstrong, Paul/0000-0002-0460-3445; Bartus, Stanislaw/0000-0003-4508-3551; Fox, Keith/0000-0002-0140-2752; Zimmermann, Sergio/0000-0002-9444-9209; Mahon, Niall/0000-0002-2872-2297; ELBAZ, Meyer/0000-0002-3520-7883; Hochman, Judith/0000-0002-5889-5981; Neskovic, Aleksandar/0000-0001-8617-966X; Feitosa, Audes/0000-0002-9983-4720; Bohorquez, Ricardo/0000-0002-9297-1060; Shalaev, Sergei/0000-0003-2724-4016; Gruchala, Marcin/0000-0003-4901-2291; Petrov, Ivo/0000-0002-9989-0730; Rha, Seung-Woon/0000-0001-9456-9852; Reis, Gilmar/0000-0002-4847-1034; Cotton, James/0000-0001-6548-2723; Guimaraes, Anthony/0000-0002-9982-2471; Chew, Derek/0000-0003-3593-296X; Zamoryakhin, Dmitry/0000-0001-8632-5890; Albuquerque, Denilson/0000-0003-1883-6546; Jeong, Jin-Ok/0000-0003-0763-4754; Vojacek, Jan F/0000-0001-7724-9734; solinas, emilia/0000-0003-3532-1317; Dalli Peydro, Ernesto/0000-0002-4340-6620; Katz, Amos/0000-0003-0422-934X; giuseppe, ambrosio/0000-0002-9677-980X; URAL, DILEK/0000-0003-0224-1433; Zafar, S. Yousuf/0000-0002-9039-5258; Alexander, John/0000-0002-1444-2462; Seong, In-Whan/0000-0003-4628-0258; Aylward, Philip/0000-0002-5358-8552; Van de Werf, Frans/0000-0001-9479-7767	Eli Lilly; Daiichi Sankyo	Eli Lilly(Eli Lilly); Daiichi Sankyo(Daiichi Sankyo Company Limited)	Funded by Eli Lilly and Daiichi Sankyo	ANDERSEN PK, 1982, ANN STAT, V10, P1100, DOI 10.1214/aos/1176345976; Chan MY, 2008, JACC-CARDIOVASC INTE, V1, P600, DOI 10.1016/j.jcin.2008.03.019; Chan MY, 2008, JACC-CARDIOVASC INTE, V1, P369, DOI 10.1016/j.jcin.2008.03.019; Chin CT, 2010, AM HEART J, V160, P16, DOI 10.1016/j.ahj.2010.04.022; Goto K, 2010, CIRCULATION, V121, P853, DOI 10.1161/CIRCULATIONAHA.109.877944; Gurbel PA, 2003, CIRCULATION, V107, P2908, DOI 10.1161/01.CIR.0000072771.11429.83; Hamm CW, 2011, EUR HEART J, V32, P2999, DOI 10.1093/eurheartj/ehr236; Murphy SA, 2008, EUR HEART J, V29, P2473, DOI 10.1093/eurheartj/ehn362; Riesmeyer JS, 2012, J CLIN PHARMACOL, V52, P789, DOI 10.1177/0091270011406280; Roe MT, 2012, CIRC-CARDIOVASC QUAL, V5, P205, DOI 10.1161/CIRCOUTCOMES.111.962332; Roe MT, 2010, J AM COLL CARDIOL, V56, P254, DOI 10.1016/j.jacc.2010.05.008; Stone GW, 2011, NEW ENGL J MED, V365, P2040; Stone GW, 2011, NEW ENGL J MED, V364, P226, DOI 10.1056/NEJMoa1002358; Tricoci P, 2012, NEW ENGL J MED, V366, P20, DOI 10.1056/NEJMoa1109719; Wallentin L, 2009, NEW ENGL J MED, V361, P1045, DOI 10.1056/NEJMoa0904327; Wiviott SD, 2007, NEW ENGL J MED, V357, P2001, DOI 10.1056/NEJMoa0706482; Wright RS, 2011, J AM COLL CARDIOL, V57, P1960, DOI 10.1016/j.jacc.2011.04.002; Wright RS, 2011, J AM COLL CARDIOL, V57, P1920, DOI 10.1016/j.jacc.2011.02.009	18	633	686	2	120	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 4	2012	367	14					1297	1309		10.1056/NEJMoa1205512	http://dx.doi.org/10.1056/NEJMoa1205512			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	014WJ	22920930	Green Published			2022-12-28	WOS:000309406100006
J	Chen, XF; Cui, DD; Papusha, A; Zhang, XT; Chu, CD; Tang, JW; Chen, KF; Pan, XW; Ira, G				Chen, Xuefeng; Cui, Dandan; Papusha, Alma; Zhang, Xiaotian; Chu, Chia-Dwo; Tang, Jiangwu; Chen, Kaifu; Pan, Xuewen; Ira, Grzegorz			The Fun30 nucleosome remodeller promotes resection of DNA double-strand break ends	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; HOMOLOGOUS RECOMBINATION; CHECKPOINT ACTIVATION; H2A PHOSPHORYLATION; BUDDING YEAST; REPAIR; CHROMATIN; HELICASE; SGS1; MRE11-RAD50-XRS2	Chromosomal double-strand breaks (DSBs) are resected by 5' nucleases to form 3' single-stranded DNA substrates for binding by homologous recombination and DNA damage checkpoint proteins. Two redundant pathways of extensive resection have been described both in cells(1-3) and in vitro(4-6), one relying on Exo1 exonuclease and the other on Sgs1 helicase and Dna2 nuclease. However, it remains unknown how resection proceeds within the context of chromatin, where histones and histone-bound proteins represent barriers for resection enzymes. Here we identify the yeast nucleosome-remodelling enzyme Fun30 as a factor promoting DSB end resection. Fun30 is the major nucleosome remodeller promoting extensive Exo1- and Sgs1-dependent resection of DSBs. The RSC and INO80 chromatin-remodelling complexes and Fun30 have redundant roles in resection adjacent to DSB ends. ATPase and helicase domains of Fun30, which are needed for nucleosome remodelling(7), are also required for resection. Fun30 is robustly recruited to DNA breaks and spreads along the DSB coincident with resection. Fun30 becomes less important for resection in the absence of the histone-bound Rad9 checkpoint adaptor protein known to block 5' strand processing(8) and in the absence of either histone H3 K79 methylation or gamma-H2A, which mediate recruitment of Rad9 (refs 9, 10). Together these data suggest that Fun30 helps to overcome the inhibitory effect of Rad9 on DNA resection.	[Cui, Dandan; Tang, Jiangwu; Chen, Kaifu; Pan, Xuewen] Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Chen, Xuefeng; Papusha, Alma; Zhang, Xiaotian; Chu, Chia-Dwo; Ira, Grzegorz] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine	Pan, XW (corresponding author), Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, 1 Baylor Plaza, Houston, TX 77030 USA.	xuewenp@bcm.edu; gira@bcm.edu	Chen, Xuefeng/C-3410-2013	Zhang, Xiaotian/0000-0002-9533-4761	National Institutes of Health [GM080600, HG004840]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004840] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080600] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank P. Sung, W.-D. Heyer and A. Pellicioli for antibodies; S.-E. Lee, S. Kron and M. Osley for strains; B. Llorente for sharing unpublished data; and J. Tyler, P. Sung and S. E. Lee for comments on the manuscript. This work was supported by the National Institutes of Health grants GM080600 (to G. I.) and HG004840 (to X.P.).	Alexeev A, 2003, NAT STRUCT BIOL, V10, P182, DOI 10.1038/nsb901; Awad S, 2010, J BIOL CHEM, V285, P9477, DOI 10.1074/jbc.M109.082149; Bothmer A, 2011, MOL CELL, V42, P319, DOI 10.1016/j.molcel.2011.03.019; Bunting SF, 2010, CELL, V141, P243, DOI 10.1016/j.cell.2010.03.012; Cejka P, 2010, NATURE, V467, P112, DOI 10.1038/nature09355; Chen CC, 2008, CELL, V134, P231, DOI 10.1016/j.cell.2008.06.035; Chen XF, 2011, NAT STRUCT MOL BIOL, V18, P1015, DOI 10.1038/nsmb.2105; Chung WH, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000948; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; Flaus A, 2006, NUCLEIC ACIDS RES, V34, P2887, DOI 10.1093/nar/gkl295; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Gravel S, 2008, GENE DEV, V22, P2767, DOI 10.1101/gad.503108; Hammet A, 2007, EMBO REP, V8, P851, DOI 10.1038/sj.embor.7401036; Ira G, 2003, CELL, V115, P401, DOI 10.1016/S0092-8674(03)00886-9; Ira G, 2004, NATURE, V431, P1011, DOI 10.1038/nature02964; IVANOV EL, 1994, MOL CELL BIOL, V14, P3414, DOI 10.1128/MCB.14.5.3414; Kalocsay M, 2009, MOL CELL, V33, P335, DOI 10.1016/j.molcel.2009.01.016; Lambert JP, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.104; Lazzaro F, 2008, EMBO J, V27, P1502, DOI 10.1038/emboj.2008.81; LYDALL D, 1995, SCIENCE, V270, P1488, DOI 10.1126/science.270.5241.1488; Mimitou EP, 2008, NATURE, V455, P770, DOI 10.1038/nature07312; Neves-Costa A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008111; Nicolette ML, 2010, NAT STRUCT MOL BIOL, V17, P1478, DOI 10.1038/nsmb.1957; Niu HY, 2010, NATURE, V467, P108, DOI 10.1038/nature09318; Okazaki N, 2008, J MOL BIOL, V382, P257, DOI 10.1016/j.jmb.2008.07.031; Prakash R, 2009, GENE DEV, V23, P67, DOI 10.1101/gad.1737809; Shim EY, 2007, MOL CELL BIOL, V27, P1602, DOI 10.1128/MCB.01956-06; Sugawara N, 2003, MOL CELL, V12, P209, DOI 10.1016/S1097-2765(03)00269-7; Toh GWL, 2006, DNA REPAIR, V5, P693, DOI 10.1016/j.dnarep.2006.03.005; van Attikum H, 2004, CELL, V119, P777, DOI 10.1016/j.cell.2004.11.033; Vaze MB, 2002, MOL CELL, V10, P373, DOI 10.1016/S1097-2765(02)00593-2; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; Yu Q, 2011, J BIOL CHEM, V286, P14659, DOI 10.1074/jbc.M110.183269; Zhu Z, 2008, CELL, V134, P981, DOI 10.1016/j.cell.2008.08.037	34	173	179	0	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 27	2012	489	7417					576	+		10.1038/nature11355	http://dx.doi.org/10.1038/nature11355			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	046RG	22960743	Green Accepted			2022-12-28	WOS:000311781500006
J	Costelloe, T; Louge, R; Tomimatsu, N; Mukherjee, B; Martini, E; Khadaroo, B; Dubois, K; Wiegant, WW; Thierry, A; Burma, S; van Attikum, H; Llorente, B				Costelloe, Thomas; Louge, Raphael; Tomimatsu, Nozomi; Mukherjee, Bipasha; Martini, Emmanuelle; Khadaroo, Basheer; Dubois, Kenny; Wiegant, Wouter W.; Thierry, Agnes; Burma, Sandeep; van Attikum, Haico; Llorente, Bertrand			The yeast Fun30 and human SMARCAD1 chromatin remodellers promote DNA end resection	NATURE			English	Article							DOUBLE-STRAND BREAKS; SACCHAROMYCES-CEREVISIAE; DISTINCT ROLES; DAMAGE; EXO1; REPAIR; RECOMBINATION; MUTANTS; GENES; SGS1	Several homology-dependent pathways can repair potentially lethal DNA double-strand breaks (DSBs). The first step common to all homologous recombination reactions is the 5'-3' degradation of DSB ends that yields the 39 single-stranded DNA required for the loading of checkpoint and recombination proteins. In yeast, the Mre11-Rad50-Xrs2 complex (Xrs2 is known as NBN or NBS1 in humans) and Sae2 (known as RBBP8 or CTIP in humans) initiate end resection, whereas long-range resection depends on the exonuclease Exo1, or the helicase-topoisomerase complex Sgs1-Top3-Rmi1 together with the endonuclease Dna2 (refs 1-6). DSBs occur in the context of chromatin, but how the resection machinery navigates through nucleosomal DNA is a process that is not well understood(7). Here we show that the yeast Saccharomyces cerevisiae Fun30 protein and its human counterpart SMARCAD1 (ref. 8), two poorly characterized ATP-dependent chromatin remodellers of the Snf2 ATPase family, are directly involved in the DSB response. Fun30 physically associates with DSB ends and directly promotes both Exo1- and Sgs1-dependent end resection through a mechanism involving its ATPase activity. The function of Fun30 in resection facilitates the repair of camptothecin-induced DNA lesions, although it becomes dispensable when Exo1 is ectopically overexpressed. Interestingly, SMARCAD1 is also recruited to DSBs, and the kinetics of recruitment is similar to that of EXO1. The loss of SMARCAD1 impairs end resection and recombinational DNA repair, and renders cells hypersensitive to DNA damage resulting from camptothecin or poly(ADP-ribose) polymerase inhibitor treatments. These findings unveil an evolutionarily conserved role for the Fun30 and SMARCAD1 chromatin remodellers in controlling end resection, homologous recombination and genome stability in the context of chromatin.	[Louge, Raphael; Khadaroo, Basheer; Dubois, Kenny; Llorente, Bertrand] Ctr Rech Cancerol Marseille, CNRS, Unite Mixte Rech 7258, F-13009 Marseille, France; [Costelloe, Thomas; Wiegant, Wouter W.; van Attikum, Haico] Leiden Univ, Med Ctr, Dept Toxicogenet, NL-2333 ZC Leiden, Netherlands; [Louge, Raphael; Khadaroo, Basheer; Dubois, Kenny; Llorente, Bertrand] Aix Marseille Univ, Unite Mixte Rech 7258, F-13284 Marseille, France; [Tomimatsu, Nozomi; Mukherjee, Bipasha; Burma, Sandeep] Univ Texas SW Med Ctr Dallas, Dept Radiat Oncol, Div Mol Radiat Biol, Dallas, TX 75390 USA; [Martini, Emmanuelle] CEA DSV Inst Radiobiol Cellulaire & Mol, F-92265 Fontenay Aux Roses, France; [Thierry, Agnes] Inst Pasteur, CNRS, Unite Genet Mol Levures, F-75724 Paris 15, France; [Thierry, Agnes] Univ Paris 06, F-75724 Paris 15, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; UDICE-French Research Universities; Aix-Marseille Universite; University of Texas System; University of Texas Southwestern Medical Center Dallas; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Sorbonne Universite	Llorente, B (corresponding author), Ctr Rech Cancerol Marseille, CNRS, Unite Mixte Rech 7258, F-13009 Marseille, France.	h.van.attikum@lumc.nl; bllorente@ifr88.cnrs-mrs.fr	van Attikum, Haico/A-4596-2010; llorente, bertrand/M-3501-2016	martini, emmanuelle/0000-0003-2005-0796; Van Attikum, Haico/0000-0001-8590-0240; Llorente, Bertrand/0000-0002-6291-5797	National Institutes of Health [RO1 CA149461]; National Aeronautics and Space Administration [NNX10AE08G]; Cancer Prevention and Research Institute of Texas [RP100644]; Netherlands Organization for Scientific Research (NWO-VIDI grant); Human Frontiers Science Program(HFSP-CDA grant); CNRS (ATIP); Agence Nationale de la Recherche [ANR-10-BLAN-1606-03]; NATIONAL CANCER INSTITUTE [R01CA149461] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Aeronautics and Space Administration(National Aeronautics & Space Administration (NASA)); Cancer Prevention and Research Institute of Texas; Netherlands Organization for Scientific Research (NWO-VIDI grant)(Netherlands Organization for Scientific Research (NWO)); Human Frontiers Science Program(HFSP-CDA grant); CNRS (ATIP)(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche(French National Research Agency (ANR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank G. Ira for sharing unpublished data and S. Janicki, R. Greenberg, L. Symington and all the laboratories from the Centre National de la Recherche Scientifique (CNRS) UPR3081 for providing reagents. We thank S. Coulon for help in the analysis of the fun30 repressible allele, I. Lafontaine for support in statistical analyses, C. V. Camacho for generating the V5-EXO1 constructs and A. Guenole, R. Srivas, T. Ideker, K. Vreeken and M. Vermeulen for help in searching for Fun30 interactors. B. L. is grateful to B. Dujon for hosting him and providing the opportunity to perform the BIR screen. S. B. is supported by grants from the National Institutes of Health (RO1 CA149461), National Aeronautics and Space Administration (NNX10AE08G) and the Cancer Prevention and Research Institute of Texas (RP100644). H.v.A. receives funding from the Netherlands Organization for Scientific Research (NWO-VIDI grant) and Human Frontiers Science Program(HFSP-CDA grant). B. L. is supported by grants from the CNRS (ATIP) and the Agence Nationale de la Recherche (ANR-10-BLAN-1606-03).	Awad S, 2010, J BIOL CHEM, V285, P9477, DOI 10.1074/jbc.M109.082149; Bartsch S, 2000, MOL CELL BIOL, V20, P1194, DOI 10.1128/MCB.20.4.1194-1205.2000; Bekker-Jensen S, 2006, J CELL BIOL, V173, P195, DOI 10.1083/jcb.200510130; Beli P, 2012, MOL CELL, V46, P212, DOI 10.1016/j.molcel.2012.01.026; Bolderson E, 2010, NUCLEIC ACIDS RES, V38, P1821, DOI 10.1093/nar/gkp1164; Burke D., 2005, METHODS YEAST GENETI; Cejka P, 2010, NATURE, V467, P112, DOI 10.1038/nature09355; Chen CC, 2008, CELL, V134, P231, DOI 10.1016/j.cell.2008.06.035; Clerici M, 2006, EMBO REP, V7, P212, DOI 10.1038/sj.embor.7400593; Decourty L, 2008, P NATL ACAD SCI USA, V105, P5821, DOI 10.1073/pnas.0710533105; GARVIK B, 1995, MOL CELL BIOL, V15, P6128; Grandin N, 2007, NUCLEIC ACIDS RES, V35, P822, DOI 10.1093/nar/gkl1081; Gravel S, 2008, GENE DEV, V22, P2767, DOI 10.1101/gad.503108; HERSKOWITZ I, 1991, METHOD ENZYMOL, V194, P132; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Marrero VA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001007; Martini EMD, 2002, GENETICS, V160, P1375; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Mimitou EP, 2008, NATURE, V455, P770, DOI 10.1038/nature07312; Moreau S, 2001, GENETICS, V159, P1423; Neves-Costa A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008111; Nicolette ML, 2010, NAT STRUCT MOL BIOL, V17, P1478, DOI 10.1038/nsmb.1957; Niu HY, 2010, NATURE, V467, P108, DOI 10.1038/nature09318; Ooi SL, 2001, SCIENCE, V294, P2552, DOI 10.1126/science.1065672; Ouspenski II, 1999, NUCLEIC ACIDS RES, V27, P3001, DOI 10.1093/nar/27.15.3001; Pardo B, 2006, GENETICS, V172, P2689, DOI 10.1534/genetics.105.053512; Rowbotham SP, 2011, MOL CELL, V42, P285, DOI 10.1016/j.molcel.2011.02.036; Shanbhag NM, 2010, CELL, V141, P970, DOI 10.1016/j.cell.2010.04.038; Shim EY, 2010, EMBO J, V29, P3370, DOI 10.1038/emboj.2010.219; Sinha M, 2009, EPIGENOMICS-UK, V1, P371, DOI 10.2217/epi.09.22; Sporbert A, 2002, MOL CELL, V10, P1355, DOI 10.1016/S1097-2765(02)00729-3; Stralfors A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001334; Tomimatsu N, 2012, DNA REPAIR, V11, P441, DOI 10.1016/j.dnarep.2012.01.006; Tomimatsu N, 2009, EMBO REP, V10, P629, DOI 10.1038/embor.2009.60; van Attikum H, 2007, EMBO J, V26, P4113, DOI 10.1038/sj.emboj.7601835; WHITE CI, 1990, EMBO J, V9, P663, DOI 10.1002/j.1460-2075.1990.tb08158.x; Zhu Z, 2008, CELL, V134, P981, DOI 10.1016/j.cell.2008.08.037; Zubko MK, 2004, GENETICS, V168, P103, DOI 10.1534/genetics.104.027904	38	185	189	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 27	2012	489	7417					581	+		10.1038/nature11353	http://dx.doi.org/10.1038/nature11353			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	046RG	22960744	Green Accepted			2022-12-28	WOS:000311781500007
J	Egala, A; Clamp, PJ; Hajioff, D				Egala, Aisha; Clamp, Philip J.; Hajioff, Daniel			Ear pain and facial palsy	BRITISH MEDICAL JOURNAL			English	Editorial Material							MALIGNANT EXTERNAL OTITIS; GRADING SYSTEMS; FOLLOW-UP; DIAGNOSIS		[Egala, Aisha; Clamp, Philip J.; Hajioff, Daniel] Southmead Hosp, Dept ENT Surg, Bristol BS10 5NB, Avon, England	Southmead Hospital	Egala, A (corresponding author), Southmead Hosp, Dept ENT Surg, Bristol BS10 5NB, Avon, England.	aisha.egala@gmail.com		Clamp, Philip/0000-0002-6156-4278				Bernstein JM, 2007, J LARYNGOL OTOL, V121, P118, DOI 10.1017/S0022215106002775; BURRES S, 1986, ARCH OTOLARYNGOL, V112, P755; GORDON G, 1994, CLIN INFECT DIS, V19, P866, DOI 10.1093/clinids/19.5.866; GRANDIS JR, 1995, RADIOLOGY, V196, P499, DOI 10.1148/radiology.196.2.7617867; HOLDER CD, 1986, LARYNGOSCOPE, V96, P1021; HOUSE JW, 1985, OTOLARYNG HEAD NECK, V93, P146, DOI 10.1177/019459988509300202; Kang TS, 2002, OTOL NEUROTOL, V23, P767, DOI 10.1097/00129492-200209000-00026; Lee V, 2004, EYE, V18, P1225, DOI 10.1038/sj.eye.6701383; LEVIN WJ, 1986, LARYNGOSCOPE, V96, P1193; LUCENTE FE, 1982, OTOLARYNG HEAD NECK, V90, P266, DOI 10.1177/019459988209000223; Narozny W, 2006, EUR ARCH OTO-RHINO-L, V263, P680, DOI 10.1007/s00405-006-0033-y; Okpala NCE, 2005, J LARYNGOL OTOL, V119, P71, DOI 10.1258/0022215053222978; RUBIN J, 1988, AM J MED, V85, P391, DOI 10.1016/0002-9343(88)90592-X; Siddiq MA, 2008, BMJ-BRIT MED J, V336, P276, DOI 10.1136/bmj.39364.643275.47; Soldati D, 1990, EUR ARCH OTO-RHINO-L, V256, P439; Stokkel MPM, 1996, LARYNGOSCOPE, V106, P338, DOI 10.1097/00005537-199603000-00018; STRASHUN AM, 1984, RADIOLOGY, V150, P541, DOI 10.1148/radiology.150.2.6228955; Yanagihara N, 1997, Ear Nose Throat J, V76, P79; Yanagihara N, 1997, ENT-EAR NOSE THROAT, V76, P83	19	1	1	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	SEP 7	2012	345								e6000	10.1136/bmj.e6000	http://dx.doi.org/10.1136/bmj.e6000			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	003TM	22960379				2022-12-28	WOS:000308634200006
J	Asch, DA; Volpp, KG				Asch, David A.; Volpp, Kevin G.			What Business Are We In? The Emergence of Health as the Business of Health Care	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Asch, David A.] Univ Penn, Ctr Hlth Equ Res & Promot, Philadelphia Vet Affairs Med Ctr, Philadelphia, PA 19104 USA; Univ Penn, Penn Med Ctr Innovat, Philadelphia, PA 19104 USA; Univ Penn, Wharton Sch, Philadelphia, PA 19104 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Pennsylvania; Pennsylvania Medicine; Philadelphia Veterans Affairs Medical Center; University of Pennsylvania; University of Pennsylvania	Asch, DA (corresponding author), Univ Penn, Ctr Hlth Equ Res & Promot, Philadelphia Vet Affairs Med Ctr, Philadelphia, PA 19104 USA.			Volpp, Kevin/0000-0003-1423-4599; Asch, David/0000-0002-7970-286X				Asch DA, 2010, PREV CHRONIC DIS, V7; Levitt B, 2004, HARVARD BUS REV, V82, P138; LINK BG, 1995, J HEALTH SOC BEHAV, V35, P80, DOI 10.2307/2626958; MARMOT MG, 1978, J EPIDEMIOL COMMUN H, V32, P244, DOI 10.1136/jech.32.4.244; McGinnis JM, 2002, HEALTH AFFAIR, V21, P78, DOI 10.1377/hlthaff.21.2.78	5	22	22	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 6	2012	367	10					888	889		10.1056/NEJMp1206862	http://dx.doi.org/10.1056/NEJMp1206862			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	999VO	22931228	Green Published			2022-12-28	WOS:000308343300003
J	Dunham, I; Kundaje, A; Aldred, SF; Collins, PJ; Davis, C; Doyle, F; Epstein, CB; Frietze, S; Harrow, J; Kaul, R; Khatun, J; Lajoie, BR; Landt, SG; Lee, BK; Pauli, F; Rosenbloom, KR; Sabo, P; Safi, A; Sanyal, A; Shoresh, N; Simon, JM; Song, L; Trinklein, ND; Altshuler, RC; Birney, E; Brown, JB; Cheng, C; Djebali, S; Dong, XJ; Dunham, I; Ernst, J; Furey, TS; Gerstein, M; Giardine, B; Greven, M; Hardison, RC; Harris, RS; Herrero, J; Hoffman, MM; Iyer, S; Kellis, M; Khatun, J; Kheradpour, P; Kundaje, A; Lassmann, T; Li, QH; Lin, X; Marinov, GK; Merkel, A; Mortazavi, A; Parker, SCJ; Reddy, TE; Rozowsky, J; Schlesinger, F; Thurman, RE; Wang, J; Ward, LD; Whitfield, TW; Wilder, SP; Wu, W; Xi, HLS; Yip, KY; Zhuang, JL; Bernstein, BE; Birney, E; Dunham, I; Green, ED; Gunter, C; Snyder, M; Pazin, MJ; Lowdon, RF; Dillon, LAL; Adams, LB; Kelly, CJ; Zhang, J; Wexler, JR; Green, ED; Good, PJ; Feingold, EA; Bernstein, BE; Birney, E; Crawford, GE; Dekker, J; Elnitski, L; Farnham, PJ; Gerstein, M; Giddings, MC; Gingeras, TR; Green, ED; Guigo, R; Hardison, RC; Hubbard, TJ; Kellis, M; Kent, WJ; Lieb, JD; Margulies, EH; Myers, RM; Snyder, M; Stamatoyannopoulos, JA; Tenenbaum, SA; Weng, ZP; White, KP; Wold, B; Khatun, J; Yu, Y; Wrobel, J; Risk, BA; Gunawardena, HP; Kuiper, HC; Maier, CW; Xie, L; Chen, X; Giddings, MC; Bernstein, BE; Epstein, CB; Shoresh, N; Ernst, J; Kheradpour, P; Mikkelsen, TS; Gillespie, S; Goren, A; Ram, O; Zhang, XL; Wang, L; Issner, R; Coyne, MJ; Durham, T; Ku, M; Truong, T; Ward, LD; Altshuler, RC; Eaton, ML; Kellis, M; Djebali, S; Davis, CA; Merkel, A; Dobin, A; Lassmann, T; Mortazavi, A; Tanzer, A; Lagarde, J; Lin, W; Schlesinger, F; Xue, CH; Marinov, GK; Khatun, J; Williams, BA; Zaleski, C; Rozowsky, J; Roeder, M; Kokocinski, F; Abdelhamid, RF; Alioto, T; Antoshechkin, I; Baer, MT; Batut, P; Bell, I; Bell, K; Chakrabortty, S; Chen, X; Chrast, J; Curado, J; Derrien, T; Drenkow, J; Dumais, E; Dumais, J; Duttagupta, R; Fastuca, M; Fejes-Toth, K; Ferreira, P; Foissac, S; Fullwood, MJ; Gao, H; Gonzalez, D; Gordon, A; Gunawardena, HP; Howald, C; Jha, S; Johnson, R; Kapranov, P; King, B; Kingswood, C; Li, GL; Luo, OJ; Park, E; Preall, JB; Presaud, K; Ribeca, P; Risk, BA; Robyr, D; Ruan, XA; Sammeth, M; Sandhu, KS; Schaeffer, L; See, LH; Shahab, A; Skancke, J; Suzuki, AM; Takahashi, H; Tilgner, H; Trout, D; Walters, N; Wang, HE; Wrobel, J; Yu, YB; Hayashizaki, Y; Harrow, J; Gerstein, M; Hubbard, TJ; Reymond, A; Antonarakis, SE; Hannon, GJ; Giddings, MC; Ruan, YJ; Wold, B; Carninci, P; Guigo, R; Gingeras, TR; Rosenbloom, KR; Sloan, CA; Learned, K; Malladi, VS; Wong, MC; Barber, G; Cline, MS; Dreszer, TR; Heitner, SG; Karolchik, D; Kent, WJ; Kirkup, VM; Meyer, LR; Long, JC; Maddren, M; Raney, BJ; Furey, TS; Song, LY; Grasfeder, LL; Giresi, PG; Lee, BK; Battenhouse, A; Sheffield, NC; Simon, JM; Showers, KA; Safi, A; London, D; Bhinge, AA; Shestak, C; Schaner, MR; Kim, SK; Zhang, ZZZ; Mieczkowski, PA; Mieczkowska, JO; Liu, Z; McDaniell, RM; Ni, YY; Rashid, NU; Kim, MJ; Adar, S; Zhang, ZC; Wang, TY; Winter, D; Keefe, D; Birney, E; Iyer, VR; Lieb, JD; Crawford, GE; Li, GL; Sandhu, KS; Zheng, MZ; Wang, P; Luo, OJ; Shahab, A; Fullwood, MJ; Ruan, XA; Ruan, YJ; Myers, RM; Pauli, F; Williams, BA; Gertz, J; Marinov, GK; Reddy, TE; Vielmetter, J; Partridge, EC; Trout, D; Varley, KE; Gasper, C; Bansal, A; Pepke, S; Jain, P; Amrhein, H; Bowling, KM; Anaya, M; Cross, MK; King, B; Muratet, MA; Antoshechkin, I; Newberry, KM; Mccue, K; Nesmith, AS; Fisher-Aylor, KI; Pusey, B; DeSalvo, G; Parker, SL; Balasubramanian, S; Davis, NS; Meadows, SK; Eggleston, T; Gunter, C; Newberry, JS; Levy, SE; Absher, DM; Mortazavi, A; Wong, WH; Wold, B; Blow, MJ; Visel, A; Pennachio, LA; Elnitski, L; Margulies, EH; Parker, SCJ; Petrykowska, HM; Abyzov, A; Aken, B; Barrell, D; Barson, G; Berry, A; Bignell, A; Boychenko, V; Bussotti, G; Chrast, J; Davidson, C; Derrien, T; Despacio-Reyes, G; Diekhans, M; Ezkurdia, I; Frankish, A; Gilbert, J; Gonzalez, JM; Griffiths, E; Harte, R; Hendrix, DA; Howald, C; Hunt, T; Jungreis, I; Kay, M; Khurana, E; Kokocinski, F; Leng, J; Lin, MF; Loveland, J; Lu, Z; Manthravadi, D; Mariotti, M; Mudge, J; Mukherjee, G; Notredame, C; Pei, BK; Rodriguez, JM; Saunders, G; Sboner, A; Searle, S; Sisu, C; Snow, C; Steward, C; Tanzer, A; Tapanari, E; Tress, ML; van Baren, MJ; Walters, N; Washietl, S; Wilming, L; Zadissa, A; Zhang, ZD; Brent, M; Haussler, D; Kellis, M; Valencia, A; Gerstein, M; Reymond, A; Guigo, R; Harrow, J; Hubbard, TJ; Landt, SG; Frietze, S; Abyzov, A; Addleman, N; Alexander, RP; Auerbach, RK; Balasubramanian, S; Bettinger, K; Bhardwaj, N; Boyle, AP; Cao, AR; Cayting, P; Charos, A; Cheng, Y; Cheng, C; Eastman, C; Euskirchen, G; Fleming, JD; Grubert, F; Habegger, L; Hariharan, M; Harmanci, A; Iyengar, S; Jin, VX; Karczewski, KJ; Kasowski, M; Lacroute, P; Lam, H; Lamarre-Vincent, N; Leng, J; Lian, J; Lindahl-Allen, M; Min, RQ; Miotto, B; Monahan, H; Moqtaderi, Z; Mu, XMJ; O'Geen, H; Ouyang, ZQ; Patacsil, D; Pei, BK; Raha, D; Ramirez, L; Reed, B; Rozowsky, J; Sboner, A; Shi, MY; Sisu, C; Slifer, T; Witt, H; Wu, LF; Xu, XQ; Yan, KK; Yang, XQ; Yip, KY; Zhang, ZD; Struhl, K; Weissman, SM; Gerstein, M; Farnham, PJ; Snyder, M; Tenenbaum, SA; Penalva, LO; Doyle, F; Karmakar, S; Landt, SG; Bhanvadia, RR; Choudhury, A; Domanus, M; Ma, LJ; Moran, J; Patacsil, D; Slifer, T; Victorsen, A; Yang, XQ; Snyder, M; White, KP; Auer, T; Centanin, L; Eichenlaub, M; Gruhl, F; Heermann, S; Hoeckendorf, B; Inoue, D; Kellner, T; Kirchmaier, S; Mueller, C; Reinhardt, R; Schertel, L; Schneider, S; Sinn, R; Wittbrodt, B; Wittbrodt, J; Weng, ZP; Whitfield, TW; Wang, J; Collins, PJ; Aldred, SF; Trinklein, ND; Partridge, EC; Myers, RM; Dekker, J; Jain, G; Lajoie, BR; Sanyal, A; Balasundaram, G; Bates, DL; Byron, R; Canfield, TK; Diegel, MJ; Dunn, D; Ebersol, AK; Frum, T; Garg, K; Gist, E; Hansen, RS; Boatman, L; Haugen, E; Humbert, R; Jain, G; Johnson, AK; Johnson, EM; Kutyavin, TV; Lajoie, BR; Lee, K; Lotakis, D; Maurano, MT; Neph, SJ; Neri, FV; Nguyen, ED; Qu, HZ; Reynolds, AP; Roach, V; Rynes, E; Sabo, P; Sanchez, ME; Sandstrom, RS; Sanyal, A; Shafer, AO; Stergachis, AB; Thomas, S; Thurman, RE; Vernot, B; Vierstra, J; Vong, S; Wang, H; Weaver, MA; Yan, YQ; Zhang, MH; Akey, JM; Bender, M; Dorschner, MO; Groudine, M; MacCoss, MJ; Navas, P; Stamatoyannopoulos, G; Kaul, R; Dekker, J; Stamatoyannopoulos, JA; Dunham, I; Beal, K; Brazma, A; Flicek, P; Herrero, J; Johnson, N; Keefe, D; Lukk, M; Luscombe, NM; Sobral, D; Vaquerizas, JM; Wilder, SP; Batzoglou, S; Sidow, A; Hussami, N; Kyriazopoulou-Panagiotopoulou, S; Libbrecht, MW; Schaub, MA; Kundaje, A; Hardison, RC; Miller, W; Giardine, B; Harris, RS; Wu, W; Bickel, PJ; Banfai, B; Boley, NP; Brown, JB; Huang, HY; Li, QH; Li, JJ; Noble, WS; Bilmes, JA; Buske, OJ; Hoffman, MM; Sahu, AD; Kharchenko, PV; Park, PJ; Baker, D; Taylor, J; Weng, ZP; Iyer, S; Dong, XJ; Greven, M; Lin, XY; Wang, J; Xi, HLS; Zhuang, JL; Gerstein, M; Alexander, RP; Balasubramanian, S; Cheng, C; Harmanci, A; Lochovsky, L; Min, R; Mu, XMJ; Rozowsky, J; Yan, KK; Yip, KY; Birney, E				Dunham, Ian; Kundaje, Anshul; Aldred, Shelley F.; Collins, Patrick J.; Davis, CarrieA.; Doyle, Francis; Epstein, Charles B.; Frietze, Seth; Harrow, Jennifer; Kaul, Rajinder; Khatun, Jainab; Lajoie, Bryan R.; Landt, Stephen G.; Lee, Bum-Kyu; Pauli, Florencia; Rosenbloom, Kate R.; Sabo, Peter; Safi, Alexias; Sanyal, Amartya; Shoresh, Noam; Simon, Jeremy M.; Song, Lingyun; Trinklein, Nathan D.; Altshuler, Robert C.; Birney, Ewan; Brown, James B.; Cheng, Chao; Djebali, Sarah; Dong, Xianjun; Dunham, Ian; Ernst, Jason; Furey, Terrence S.; Gerstein, Mark; Giardine, Belinda; Greven, Melissa; Hardison, Ross C.; Harris, Robert S.; Herrero, Javier; Hoffman, Michael M.; Iyer, Sowmya; Kellis, Manolis; Khatun, Jainab; Kheradpour, Pouya; Kundaje, Anshul; Lassmann, Timo; Li, Qunhua; Lin, Xinying; Marinov, Georgi K.; Merkel, Angelika; Mortazavi, Ali; Parker, Stephen C. J.; Reddy, Timothy E.; Rozowsky, Joel; Schlesinger, Felix; Thurman, Robert E.; Wang, Jie; Ward, Lucas D.; Whitfield, Troy W.; Wilder, Steven P.; Wu, Weisheng; Xi, Hualin S.; Yip, Kevin Y.; Zhuang, Jiali; Bernstein, Bradley E.; Birney, Ewan; Dunham, Ian; Green, Eric D.; Gunter, Chris; Snyder, Michael; Pazin, Michael J.; Lowdon, Rebecca F.; Dillon, Laura A. L.; Adams, Leslie B.; Kelly, Caroline J.; Zhang, Julia; Wexler, Judith R.; Green, Eric D.; Good, Peter J.; Feingold, Elise A.; Bernstein, Bradley E.; Birney, Ewan; Crawford, Gregory E.; Dekker, Job; Elnitski, Laura; Farnham, Peggy J.; Gerstein, Mark; Giddings, Morgan C.; Gingeras, Thomas R.; Green, Eric D.; Guigo, Roderic; Hardison, Ross C.; Hubbard, Timothy J.; Kellis, Manolis; Kent, W. James; Lieb, Jason D.; Margulies, Elliott H.; Myers, Richard M.; Snyder, Michael; Stamatoyannopoulos, John A.; Tenenbaum, Scott A.; Weng, Zhiping; White, Kevin P.; Wold, Barbara; Khatun, Jainab; Yu, Yanbao; Wrobel, John; Risk, Brian A.; Gunawardena, Harsha P.; Kuiper, Heather C.; Maier, Christopher W.; Xie, Ling; Chen, Xian; Giddings, Morgan C.; Bernstein, Bradley E.; Epstein, Charles B.; Shoresh, Noam; Ernst, Jason; Kheradpour, Pouya; Mikkelsen, Tarjei S.; Gillespie, Shawn; Goren, Alon; Ram, Oren; Zhang, Xiaolan; Wang, Li; Issner, Robbyn; Coyne, Michael J.; Durham, Timothy; Ku, Manching; Truong, Thanh; Ward, Lucas D.; Altshuler, Robert C.; Eaton, Matthew L.; Kellis, Manolis; Djebali, Sarah; Davis, Carrie A.; Merkel, Angelika; Dobin, Alex; Lassmann, Timo; Mortazavi, Ali; Tanzer, Andrea; Lagarde, Julien; Lin, Wei; Schlesinger, Felix; Xue, Chenghai; Marinov, Georgi K.; Khatun, Jainab; Williams, Brian A.; Zaleski, Chris; Rozowsky, Joel; Roeder, Maik; Kokocinski, Felix; Abdelhamid, Rehab F.; Alioto, Tyler; Antoshechkin, Igor; Baer, Michael T.; Batut, Philippe; Bell, Ian; Bell, Kimberly; Chakrabortty, Sudipto; Chen, Xian; Chrast, Jacqueline; Curado, Joao; Derrien, Thomas; Drenkow, Jorg; Dumais, Erica; Dumais, Jackie; Duttagupta, Radha; Fastuca, Megan; Fejes-Toth, Kata; Ferreira, Pedro; Foissac, Sylvain; Fullwood, Melissa J.; Gao, Hui; Gonzalez, David; Gordon, Assaf; Gunawardena, Harsha P.; Howald, Cedric; Jha, Sonali; Johnson, Rory; Kapranov, Philipp; King, Brandon; Kingswood, Colin; Li, Guoliang; Luo, Oscar J.; Park, Eddie; Preall, Jonathan B.; Presaud, Kimberly; Ribeca, Paolo; Risk, Brian A.; Robyr, Daniel; Ruan, Xiaoan; Sammeth, Michael; Sandhu, Kuljeet Singh; Schaeffer, Lorain; See, Lei-Hoon; Shahab, Atif; Skancke, Jorgen; Suzuki, Ana Maria; Takahashi, Hazuki; Tilgner, Hagen; Trout, Diane; Walters, Nathalie; Wang, Huaien; Wrobel, John; Yu, Yanbao; Hayashizaki, Yoshihide; Harrow, Jennifer; Gerstein, Mark; Hubbard, Timothy J.; Reymond, Alexandre; Antonarakis, Stylianos E.; Hannon, Gregory J.; Giddings, Morgan C.; Ruan, Yijun; Wold, Barbara; Carninci, Piero; Guigo, Roderic; Gingeras, Thomas R.; Rosenbloom, Kate R.; Sloan, Cricket A.; Learned, Katrina; Malladi, Venkat S.; Wong, Matthew C.; Barber, Galtp.; Cline, Melissa S.; Dreszer, Timothy R.; Heitner, Steven G.; Karolchik, Donna; Kent, W. James; Kirkup, Vanessa M.; Meyer, Laurence R.; Long, Jeffrey C.; Maddren, Morgan; Raney, Brian J.; Furey, Terrence S.; Song, Lingyun; Grasfeder, Linda L.; Giresi, Paul G.; Lee, Bum-Kyu; Battenhouse, Anna; Sheffield, Nathan C.; Simon, Jeremy M.; Showers, Kimberly A.; Safi, Alexias; London, Darin; Bhinge, Akshay A.; Shestak, Christopher; Schaner, Matthew R.; Kim, Seul Ki; Zhang, Zhuzhu Z.; Mieczkowski, Piotr A.; Mieczkowska, Joanna O.; Liu, Zheng; McDaniell, Ryan M.; Ni, Yunyun; Rashid, Naim U.; Kim, Min Jae; Adar, Sheera; Zhang, Zhancheng; Wang, Tianyuan; Winter, Deborah; Keefe, Damian; Birney, Ewan; Iyer, Vishwanath R.; Lieb, Jason D.; Crawford, Gregory E.; Li, Guoliang; Sandhu, Kuljeet Singh; Zheng, Meizhen; Wang, Ping; Luo, Oscar J.; Shahab, Atif; Fullwood, Melissa J.; Ruan, Xiaoan; Ruan, Yijun; Myers, Richard M.; Pauli, Florencia; Williams, Brian A.; Gertz, Jason; Marinov, Georgi K.; Reddy, Timothy E.; Vielmetter, Jost; Partridge, E. Christopher; Trout, Diane; Varley, Katherine E.; Gasper, Clarke; Bansal, Anita; Pepke, Shirley; Jain, Preti; Amrhein, Henry; Bowling, Kevin M.; Anaya, Michael; Cross, Marie K.; King, Brandon; Muratet, Michael A.; Antoshechkin, Igor; Newberry, Kimberly M.; Mccue, Kenneth; Nesmith, Amy S.; Fisher-Aylor, Katherine I.; Pusey, Barbara; DeSalvo, Gilberto; Parker, Stephanie L.; Balasubramanian, Sreeram; Davis, Nicholas S.; Meadows, Sarah K.; Eggleston, Tracy; Gunter, Chris; Newberry, J. Scott; Levy, Shawn E.; Absher, Devin M.; Mortazavi, Ali; Wong, Wing H.; Wold, Barbara; Blow, Matthew J.; Visel, Axel; Pennachio, Len A.; Elnitski, Laura; Margulies, Elliott H.; Parker, Stephen C. J.; Petrykowska, Hanna M.; Abyzov, Alexej; Aken, Bronwen; Barrell, Daniel; Barson, Gemma; Berry, Andrew; Bignell, Alexandra; Boychenko, Veronika; Bussotti, Giovanni; Chrast, Jacqueline; Davidson, Claire; Derrien, Thomas; Despacio-Reyes, Gloria; Diekhans, Mark; Ezkurdia, Iakes; Frankish, Adam; Gilbert, James; Gonzalez, Jose Manuel; Griffiths, Ed; Harte, Rachel; Hendrix, David A.; Howald, Cedric; Hunt, Toby; Jungreis, Irwin; Kay, Mike; Khurana, Ekta; Kokocinski, Felix; Leng, Jing; Lin, Michael F.; Loveland, Jane; Lu, Zhi; Manthravadi, Deepa; Mariotti, Marco; Mudge, Jonathan; Mukherjee, Gaurab; Notredame, Cedric; Pei, Baikang; Rodriguez, Jose Manuel; Saunders, Gary; Sboner, Andrea; Searle, Stephen; Sisu, Cristina; Snow, Catherine; Steward, Charlie; Tanzer, Andrea; Tapanari, Electra; Tress, Michael L.; van Baren, Marijke J.; Walters, Nathalie; Washietl, Stefan; Wilming, Laurens; Zadissa, Amonida; Zhang, Zhengdong; Brent, Michael; Haussler, David; Kellis, Manolis; Valencia, Alfonso; Gerstein, Mark; Reymond, Alexandre; Guigo, Roderic; Harrow, Jennifer; Hubbard, Timothy J.; Landt, Stephen G.; Frietze, Seth; Abyzov, Alexej; Addleman, Nick; Alexander, Roger P.; Auerbach, Raymond K.; Balasubramanian, Suganthi; Bettinger, Keith; Bhardwaj, Nitin; Boyle, Alan P.; Cao, Alina R.; Cayting, Philip; Charos, Alexandra; Cheng, Yong; Cheng, Chao; Eastman, Catharine; Euskirchen, Ghia; Fleming, Joseph D.; Grubert, Fabian; Habegger, Lukas; Hariharan, Manoj; Harmanci, Arif; Iyengar, Sushma; Jin, Victor X.; Karczewski, Konrad J.; Kasowski, Maya; Lacroute, Phil; Lam, Hugo; Lamarre-Vincent, Nathan; Leng, Jing; Lian, Jin; Lindahl-Allen, Marianne; Min, Renqiang; Miotto, Benoit; Monahan, Hannah; Moqtaderi, Zarmik; Mu, Xinmeng J.; O'Geen, Henriette; Ouyang, Zhengqing; Patacsil, Dorrelyn; Pei, Baikang; Raha, Debasish; Ramirez, Lucia; Reed, Brian; Rozowsky, Joel; Sboner, Andrea; Shi, Minyi; Sisu, Cristina; Slifer, Teri; Witt, Heather; Wu, Linfeng; Xu, Xiaoqin; Yan, Koon-Kiu; Yang, Xinqiong; Yip, Kevin Y.; Zhang, Zhengdong; Struhl, Kevin; Weissman, Sherman M.; Gerstein, Mark; Farnham, Peggy J.; Snyder, Michael; Tenenbaum, Scott A.; Penalva, Luiz O.; Doyle, Francis; Karmakar, Subhradip; Landt, Stephen G.; Bhanvadia, Raj R.; Choudhury, Alina; Domanus, Marc; Ma, Lijia; Moran, Jennifer; Patacsil, Dorrelyn; Slifer, Teri; Victorsen, Alec; Yang, Xinqiong; Snyder, Michael; White, Kevin P.; Auer, Thomas; Centanin, Lazaro; Eichenlaub, Michael; Gruhl, Franziska; Heermann, Stephan; Hoeckendorf, Burkhard; Inoue, Daigo; Kellner, Tanja; Kirchmaier, Stephan; Mueller, Claudia; Reinhardt, Robert; Schertel, Lea; Schneider, Stephanie; Sinn, Rebecca; Wittbrodt, Beate; Wittbrodt, Jochen; Weng, Zhiping; Whitfield, Troy W.; Wang, Jie; Collins, Patrick J.; Aldred, Shelley F.; Trinklein, Nathan D.; Partridge, E. Christopher; Myers, Richard M.; Dekker, Job; Jain, Gaurav; Lajoie, Bryan R.; Sanyal, Amartya; Balasundaram, Gayathri; Bates, Daniel L.; Byron, Rachel; Canfield, Theresa K.; Diegel, Morgan J.; Dunn, Douglas; Ebersol, Abigail K.; Frum, Tristan; Garg, Kavita; Gist, Erica; Hansen, R. Scott; Boatman, Lisa; Haugen, Eric; Humbert, Richard; Jain, Gaurav; Johnson, Audra K.; Johnson, Ericka M.; Kutyavin, Tattyana V.; Lajoie, Bryan R.; Lee, Kristen; Lotakis, Dimitra; Maurano, Matthew T.; Neph, Shane J.; Neri, Fiedencio V.; Nguyen, Eric D.; Qu, Hongzhu; Reynolds, Alex P.; Roach, Vaughn; Rynes, Eric; Sabo, Peter; Sanchez, Minerva E.; Sandstrom, Richard S.; Sanyal, Amartya; Shafer, Anthony O.; Stergachis, Andrew B.; Thomas, Sean; Thurman, Robert E.; Vernot, Benjamin; Vierstra, Jeff; Vong, Shinny; Wang, Hao; Weaver, Molly A.; Yan, Yongqi; Zhang, Miaohua; Akey, Joshua M.; Bender, Michael; Dorschner, Michael O.; Groudine, Mark; MacCoss, Michael J.; Navas, Patrick; Stamatoyannopoulos, George; Kaul, Rajinder; Dekker, Job; Stamatoyannopoulos, John A.; Dunham, Ian; Beal, Kathryn; Brazma, Alvis; Flicek, Paul; Herrero, Javier; Johnson, Nathan; Keefe, Damian; Lukk, Margus; Luscombe, Nicholas M.; Sobral, Daniel; Vaquerizas, Juan M.; Wilder, Steven P.; Batzoglou, Serafim; Sidow, Arend; Hussami, Nadine; Kyriazopoulou-Panagiotopoulou, Sofia; Libbrecht, Max W.; Schaub, Marc A.; Kundaje, Anshul; Hardison, Ross C.; Miller, Webb; Giardine, Belinda; Harris, Robert S.; Wu, Weisheng; Bickel, Peter J.; Banfai, Balazs; Boley, Nathan P.; Brown, James B.; Huang, Haiyan; Li, Qunhua; Li, Jingyi Jessica; Noble, William Stafford; Bilmes, Jeffrey A.; Buske, Orion J.; Hoffman, Michael M.; Sahu, Avinash D.; Kharchenko, Peter V.; Park, Peter J.; Baker, Dannon; Taylor, James; Weng, Zhiping; Iyer, Sowmya; Dong, Xianjun; Greven, Melissa; Lin, Xinying; Wang, Jie; Xi, Hualin S.; Zhuang, Jiali; Gerstein, Mark; Alexander, Roger P.; Balasubramanian, Suganthi; Cheng, Chao; Harmanci, Arif; Lochovsky, Lucas; Min, Renqiang; Mu, Xinmeng J.; Rozowsky, Joel; Yan, Koon-Kiu; Yip, Kevin Y.; Birney, Ewan		ENCODE Project Consortium	An integrated encyclopedia of DNA elements in the human genome	NATURE			English	Article							TRANSCRIPTION FACTOR-BINDING; CHROMOSOME CONFORMATION CAPTURE; HUMAN-CELLS; IN-VIVO; CHROMATIN; REGIONS; MOUSE; MAPS; WIDE; DETERMINANTS	The human genome encodes the blueprint of life, but the function of the vast majority of its nearly three billion bases is unknown. The Encyclopedia of DNA Elements (ENCODE) project has systematically mapped regions of transcription, transcription factor association, chromatin structure and histone modification. These data enabled us to assign biochemical functions for 80% of the genome, in particular outside of the well-studied protein-coding regions. Many discovered candidate regulatory elements are physically associated with one another and with expressed genes, providing new insights into the mechanisms of gene regulation. The newly identified elements also show a statistical correspondence to sequence variants linked to human disease, and can thereby guide interpretation of this variation. Overall, the project provides new insights into the organization and regulation of our genes and genome, and is an expansive resource of functional annotations for biomedical research.	[Dunham, Ian; Birney, Ewan; Herrero, Javier; Wilder, Steven P.; Keefe, Damian; Brazma, Alvis; Flicek, Paul; Lukk, Margus; Sobral, Daniel] European Bioinformat Inst EMBL EBI, Vertebrate Genom Grp, Hinxton CB10 1SD, Cambs, England; [Kundaje, Anshul; Batzoglou, Serafim; Sidow, Arend; Hussami, Nadine; Kyriazopoulou-Panagiotopoulou, Sofia; Libbrecht, Max W.; Schaub, Marc A.] Stanford Univ, Dept Comp Sci, Stanford, CA 94305 USA; [Aldred, Shelley F.; Collins, Patrick J.; Trinklein, Nathan D.] SwitchGear Genom, Menlo Pk, CA 94025 USA; [Davis, CarrieA.; Schlesinger, Felix; Gingeras, Thomas R.; Davis, Carrie A.; Dobin, Alex; Lin, Wei; Xue, Chenghai; Zaleski, Chris; Baer, Michael T.; Batut, Philippe; Bell, Kimberly; Chakrabortty, Sudipto; Drenkow, Jorg; Fastuca, Megan; Fejes-Toth, Kata; Gordon, Assaf; Jha, Sonali; Preall, Jonathan B.; Presaud, Kimberly; See, Lei-Hoon; Wang, Huaien; Hannon, Gregory J.; Frankish, Adam; Ebersol, Abigail K.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Doyle, Francis; Bernstein, Bradley E.; Tenenbaum, Scott A.] SUNY Albany, Albany, NY 12203 USA; [Epstein, Charles B.; Shoresh, Noam; Bernstein, Bradley E.; Mikkelsen, Tarjei S.; Zhang, Xiaolan; Wang, Li; Issner, Robbyn; Coyne, Michael J.; Durham, Timothy; Truong, Thanh; Loveland, Jane] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Frietze, Seth; Farnham, Peggy J.; Witt, Heather] USC Norris Comprehens Canc Ctr, Los Angeles, CA 90089 USA; [Harrow, Jennifer; Hubbard, Timothy J.; Kokocinski, Felix; Aken, Bronwen; Barrell, Daniel; Barson, Gemma; Berry, Andrew; Bignell, Alexandra; Boychenko, Veronika; Davidson, Claire; Despacio-Reyes, Gloria; Frankish, Adam; Gilbert, James; Gonzalez, Jose Manuel; Griffiths, Ed; Hunt, Toby; Kay, Mike; Manthravadi, Deepa; Mudge, Jonathan; Mukherjee, Gaurab; Saunders, Gary; Searle, Stephen; Snow, Catherine; Steward, Charlie; Tapanari, Electra; Wilming, Laurens; Zadissa, Amonida] Wellcome Trust Sanger Inst, Hinxton CB10 1SA, Cambs, England; [Kaul, Rajinder] Univ Washington, Dept Med, Div Med Genet, Seattle, WA 98195 USA; [Khatun, Jainab; Giddings, Morgan C.; Wrobel, John; Risk, Brian A.] Boise State Univ, Coll Arts & Sci, Boise, ID 83725 USA; [Lajoie, Bryan R.; Sanyal, Amartya; Dekker, Job; Jain, Gaurav] Univ Massachusetts, Sch Med, Program Syst Biol, Program Gene Funct & Express,Dept Biochem & Mol P, Worcester, MA 01605 USA; [Landt, Stephen G.; Snyder, Michael; Addleman, Nick; Bettinger, Keith; Boyle, Alan P.; Cayting, Philip; Cheng, Yong; Eastman, Catharine; Euskirchen, Ghia; Grubert, Fabian; Hariharan, Manoj; Karczewski, Konrad J.; Kasowski, Maya; Lacroute, Phil; Lam, Hugo; Ouyang, Zhengqing; Patacsil, Dorrelyn; Ramirez, Lucia; Shi, Minyi; Slifer, Teri; Wu, Linfeng; Yang, Xinqiong; Ebersol, Abigail K.] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Lee, Bum-Kyu; Battenhouse, Anna; Bhinge, Akshay A.; Liu, Zheng; McDaniell, Ryan M.; Ni, Yunyun; Adar, Sheera; Zhang, Zhancheng; Wang, Tianyuan; Iyer, Vishwanath R.] Univ Texas Austin, Ctr Syst & Synthet Biol, Inst Cellular & Mol Biol, Sect Mol Genet & Microbiol, Austin, TX 78712 USA; [Pauli, Florencia; Reddy, Timothy E.; Gunter, Chris; Myers, Richard M.; Gertz, Jason; Partridge, E. Christopher; Varley, Katherine E.; Bansal, Anita; Bowling, Kevin M.; Cross, Marie K.; Muratet, Michael A.; Newberry, Kimberly M.; Nesmith, Amy S.; Pusey, Barbara; Parker, Stephanie L.; Davis, Nicholas S.; Meadows, Sarah K.; Eggleston, Tracy; Newberry, J. Scott; Levy, Shawn E.; Absher, Devin M.] HudsonAlpha Inst Biotechnol, Huntsville, AL 35806 USA; [Rosenbloom, Kate R.; Kent, W. James; Sloan, Cricket A.; Learned, Katrina; Malladi, Venkat S.; Wong, Matthew C.; Barber, Galtp.; Cline, Melissa S.; Dreszer, Timothy R.; Heitner, Steven G.; Karolchik, Donna; Kirkup, Vanessa M.; Meyer, Laurence R.; Long, Jeffrey C.; Maddren, Morgan; Raney, Brian J.; Diekhans, Mark; Harte, Rachel] Univ Calif Santa Cruz, Ctr Biomol Sci & Engn, Santa Cruz, CA 95064 USA; [Sabo, Peter; Hoffman, Michael M.; Thurman, Robert E.; Bates, Daniel L.; Canfield, Theresa K.; Diegel, Morgan J.; Dunn, Douglas; Gist, Erica; Haugen, Eric; Humbert, Richard; Johnson, Audra K.; Kutyavin, Tattyana V.; Lee, Kristen; Maurano, Matthew T.; Neph, Shane J.; Neri, Fiedencio V.; Qu, Hongzhu; Reynolds, Alex P.; Roach, Vaughn; Rynes, Eric; Sandstrom, Richard S.; Shafer, Anthony O.; Stergachis, Andrew B.; Thomas, Sean; Vernot, Benjamin; Vierstra, Jeff; Vong, Shinny; Wang, Hao; Weaver, Molly A.; Akey, Joshua M.; MacCoss, Michael J.; Buske, Orion J.; Sahu, Avinash D.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Safi, Alexias; Song, Lingyun; Crawford, Gregory E.; Sheffield, Nathan C.; London, Darin] Duke Univ, Inst Genome Sci & Policy, Durham, NC 27708 USA; [Simon, Jeremy M.; Lieb, Jason D.; Grasfeder, Linda L.; Giresi, Paul G.; Showers, Kimberly A.; Shestak, Christopher; Schaner, Matthew R.; Kim, Seul Ki; Zhang, Zhuzhu Z.; Mieczkowska, Joanna O.; Kim, Min Jae] Univ N Carolina, Dept Biol, Carolina Ctr Genome Sci, Chapel Hill, NC 27599 USA; [Altshuler, Robert C.; Ernst, Jason; Kellis, Manolis; Kheradpour, Pouya; Ward, Lucas D.; Eaton, Matthew L.; Hendrix, David A.; Jungreis, Irwin; Lin, Michael F.; Washietl, Stefan] MIT, Comp Sci & Artificial Intelligence Lab, Broad Inst MIT & Harvard, Cambridge, MA 02139 USA; [Brown, James B.; Li, Qunhua; Bickel, Peter J.; Banfai, Balazs; Boley, Nathan P.; Huang, Haiyan; Li, Jingyi Jessica] Univ Calif Berkeley, Dept Stat, Berkeley, CA 94720 USA; [Cheng, Chao; Gerstein, Mark; Rozowsky, Joel; Yip, Kevin Y.; Abyzov, Alexej; Khurana, Ekta; Leng, Jing; Pei, Baikang; Sisu, Cristina; Alexander, Roger P.; Auerbach, Raymond K.; Balasubramanian, Suganthi; Bhardwaj, Nitin; Harmanci, Arif; Min, Renqiang; Mu, Xinmeng J.; Yan, Koon-Kiu; Lochovsky, Lucas] Yale Univ, Computat Biol & Bioinformat Program, New Haven, CT 06520 USA; [Djebali, Sarah; Merkel, Angelika; Tanzer, Andrea; Lagarde, Julien; Roeder, Maik; Curado, Joao; Derrien, Thomas; Ferreira, Pedro; Gonzalez, David; Johnson, Rory; Kingswood, Colin; Skancke, Jorgen; Tilgner, Hagen; Bussotti, Giovanni; Mariotti, Marco; Notredame, Cedric] Ctr Genom Regulat, Barcelona 08003, Catalonia, Spain; [Dong, Xianjun; Greven, Melissa; Lin, Xinying; Wang, Jie; Whitfield, Troy W.; Zhuang, Jiali; Weng, Zhiping] Univ Massachusetts, Program Bioinformat & Integrat Biol, Sch Med, Worcester, MA 01605 USA; [Furey, Terrence S.] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; [Giardine, Belinda; Hardison, Ross C.; Harris, Robert S.; Wu, Weisheng; Miller, Webb] Penn State Univ, Ctr Comparat Genom & Bioinformat, University Pk, PA 16802 USA; [Hardison, Ross C.; Hardison, Ross C.] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; [Iyer, Sowmya] Boston Univ, Program Bioinformat, Boston, MA 02215 USA; [Lassmann, Timo; Abdelhamid, Rehab F.; Suzuki, Ana Maria; Takahashi, Hazuki; Hayashizaki, Yoshihide; Carninci, Piero] RIKEN Yokohama Inst, RIKEN Omics Sci Ctr, Tsurumi ku, Yokohama, Kanagawa 2300045, Japan; [Marinov, Georgi K.; Williams, Brian A.; Antoshechkin, Igor; King, Brandon; Schaeffer, Lorain; Trout, Diane; Vielmetter, Jost; Amrhein, Henry; Mccue, Kenneth] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Mortazavi, Ali; Park, Eddie] Univ Calif Irvine, Ctr Complex Biol Syst, Irvine, CA 92697 USA; [Margulies, Elliott H.] NHGRI, Genome Technol Branch, Bethesda, MD 20892 USA; [Xi, Hualin S.] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA; [Bernstein, Bradley E.; Bernstein, Bradley E.; Gillespie, Shawn; Goren, Alon; Ram, Oren; Ku, Manching] Massachusetts Gen Hosp, Howard Hughes Med Inst, Boston, MA 02114 USA; [Bernstein, Bradley E.; Bernstein, Bradley E.; Gillespie, Shawn; Goren, Alon; Ram, Oren; Ku, Manching] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Bernstein, Bradley E.; Bernstein, Bradley E.; Gillespie, Shawn; Goren, Alon; Ram, Oren; Ku, Manching] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Green, Eric D.] NHGRI, NIH, Bethesda, MD 20892 USA; [Pazin, Michael J.; Lowdon, Rebecca F.; Dillon, Laura A. L.; Adams, Leslie B.; Kelly, Caroline J.; Zhang, Julia; Wexler, Judith R.; Good, Peter J.; Feingold, Elise A.] NHGRI, NIH, Bethesda, MD 20892 USA; Duke Univ, Dept Pediat, Div Med Genet, Sch Med, Durham, NC 27710 USA; [Elnitski, Laura; Petrykowska, Hanna M.] NHGRI, NIH, Rockville, MD 20892 USA; [Gingeras, Thomas R.; Gingeras, Thomas R.] Affymetrix Inc, Santa Clara, CA 95051 USA; [Guigo, Roderic] Univ Pompeu Fabra, Dept Ciencies Expt Salut, Barcelona 08002, Catalonia, Spain; [Stamatoyannopoulos, John A.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Stamatoyannopoulos, John A.] Univ Washington, Dept Med, Div Oncol, Seattle, WA 98195 USA; [White, Kevin P.; Karmakar, Subhradip; Bhanvadia, Raj R.; Choudhury, Alina; Domanus, Marc; Ma, Lijia; Moran, Jennifer; Victorsen, Alec; Ebersol, Abigail K.] Univ Chicago, Inst Genom & Syst Biol, Chicago, IL 60637 USA; [Wold, Barbara; Gasper, Clarke; Anaya, Michael; Fisher-Aylor, Katherine I.; DeSalvo, Gilberto; Balasubramanian, Sreeram] CALTECH, Beckman Inst, Pasadena, CA 91125 USA; [Yu, Yanbao; Gunawardena, Harsha P.; Kuiper, Heather C.; Maier, Christopher W.; Xie, Ling; Chen, Xian] Univ N Carolina, Sch Med, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Alioto, Tyler; Ribeca, Paolo; Sammeth, Michael] CNAG, Barcelona 08028, Catalonia, Spain; [Bell, Ian; Dumais, Erica; Dumais, Jackie; Duttagupta, Radha; Foissac, Sylvain; Gao, Hui; Kapranov, Philipp; Reymond, Alexandre] Affymetrix Inc, Genom, Santa Clara, CA 95051 USA; [Chrast, Jacqueline; Howald, Cedric; Walters, Nathalie] Univ Lausanne, Ctr Integrat Genom, CH-1015 Lausanne, Switzerland; [Fullwood, Melissa J.; Luo, Oscar J.; Ruan, Xiaoan; Sandhu, Kuljeet Singh; Shahab, Atif; Ruan, Yijun; Zheng, Meizhen; Wang, Ping] Genome Inst Singapore, Singapore 138672, Singapore; [Li, Guoliang; Reymond, Alexandre] Genome Inst Singapore, Singapore 138672, Singapore; [Robyr, Daniel; Antonarakis, Stylianos E.] Univ Geneva, Dept Genet Med & Dev, Sch Med, CH-1211 Geneva 4, Switzerland; [Robyr, Daniel; Antonarakis, Stylianos E.] Univ Hosp Geneva, CH-1211 Geneva 4, Switzerland; [Mieczkowski, Piotr A.] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; [Rashid, Naim U.; Winter, Deborah] Univ N Carolina, Dept Biostat, Gillings Sch Global Publ Hlth, Chapel Hill, NC 27599 USA; [Pepke, Shirley] CALTECH, Ctr Adv Comp Res, Pasadena, CA 91125 USA; [Wong, Wing H.] Stanford Univ, Dept Stat, Stanford, CA 94305 USA; [Blow, Matthew J.] DOE Joint Genome Inst, Walnut Creek, CA USA; [Visel, Axel; Pennachio, Len A.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Genom Div, Berkeley, CA 94720 USA; [Ezkurdia, Iakes; Rodriguez, Jose Manuel; Tress, Michael L.; Valencia, Alfonso] Spanish Natl Canc Res Ctr CNIO, Madrid 28029, Spain; [Lu, Zhi] Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China; [Sboner, Andrea] Weill Cornell Med Coll, Dept Pathol & Lab Med, Inst Computat Biomed, New York, NY 10065 USA; [van Baren, Marijke J.; Brent, Michael] Washington Univ, St Louis, MO 63130 USA; [Zhang, Zhengdong] Albert Einstein Coll Med, Dept Genet, Bronx, NY 10461 USA; [Haussler, David] Univ Calif Santa Cruz, Ctr Biomol Sci & Engn, Howard Hughes Med Inst, Santa Cruz, CA 95064 USA; [Cao, Alina R.; O'Geen, Henriette; Xu, Xiaoqin] Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA; [Charos, Alexandra; Monahan, Hannah; Raha, Debasish; Reed, Brian] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06511 USA; [Fleming, Joseph D.; Lamarre-Vincent, Nathan; Lindahl-Allen, Marianne; Miotto, Benoit; Moqtaderi, Zarmik; Struhl, Kevin] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Iyengar, Sushma] Univ So Calif, Los Angeles, CA 90089 USA; [Jin, Victor X.] Ohio State Univ, Dept Biomed Informat, Columbus, OH 43210 USA; [Lian, Jin; Weissman, Sherman M.] Yale Univ, Dept Genet, Sch Med, New Haven, CT 06510 USA; [Penalva, Luiz O.] Childrens Canc Res Inst UTHSCSA, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA; [Auer, Thomas; Centanin, Lazaro; Eichenlaub, Michael; Gruhl, Franziska; Heermann, Stephan; Hoeckendorf, Burkhard; Inoue, Daigo; Kellner, Tanja; Kirchmaier, Stephan; Mueller, Claudia; Reinhardt, Robert; Schertel, Lea; Schneider, Stephanie; Sinn, Rebecca; Wittbrodt, Beate; Wittbrodt, Jochen] Heidelberg Univ, Ctr Organismal Studies, D-69120 Heidelberg, Germany; [Balasundaram, Gayathri; Byron, Rachel; Zhang, Miaohua; Bender, Michael; Groudine, Mark] Fred Hutchinson Canc Res Ctr, Basic Sci Div, Seattle, WA 98109 USA; [Ebersol, Abigail K.; Frum, Tristan; Hansen, R. Scott; Boatman, Lisa; Johnson, Ericka M.; Lotakis, Dimitra; Nguyen, Eric D.; Sanchez, Minerva E.; Yan, Yongqi; Navas, Patrick; Stamatoyannopoulos, George] Univ Washington, Dept Med, Div Med Genet, Seattle, WA 98195 USA; [Garg, Kavita] Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98109 USA; [Dorschner, Michael O.] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Beal, Kathryn; Johnson, Nathan] European Bioinformat Inst EMBL EBI, Microarray Informat Grp, Hinxton CB10 1SD, Cambs, England; [Keefe, Damian; Luscombe, Nicholas M.; Vaquerizas, Juan M.] European Bioinformat Inst EMBL EBI, Genom & Regulatory Syst Grp, Hinxton CB10 1SD, Cambs, England; [Keefe, Damian] Stanford Univ, Dept Genet, Dept Pathol, Stanford, CA 94305 USA; [Noble, William Stafford] Dept Comp Sci & Engn, Seattle, WA 98195 USA; [Bilmes, Jeffrey A.] Univ Washington, Dept Elect Engn, Seattle, WA 98195 USA; [Kharchenko, Peter V.; Park, Peter J.] Harvard Univ, Ctr Biomed Informat, Sch Med, Boston, MA 02115 USA; [Baker, Dannon; Taylor, James] Emory Univ, Dept Biol, Atlanta, GA 30322 USA; [Baker, Dannon; Taylor, James] Emory Univ, Dept Math & Comp Sci, Atlanta, GA 30322 USA	European Molecular Biology Laboratory (EMBL); Stanford University; Cold Spring Harbor Laboratory; State University of New York (SUNY) System; State University of New York (SUNY) Albany; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Southern California; Wellcome Trust Sanger Institute; University of Washington; University of Washington Seattle; Idaho; Boise State University; University of Massachusetts System; University of Massachusetts Worcester; Stanford University; University of Texas System; University of Texas Austin; HudsonAlpha Institute for Biotechnology; University of California System; University of California Santa Cruz; University of Washington; University of Washington Seattle; Duke University; University of North Carolina; University of North Carolina Chapel Hill; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of California System; University of California Berkeley; Yale University; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); University of Massachusetts System; University of Massachusetts Worcester; University of North Carolina; University of North Carolina Chapel Hill; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Boston University; RIKEN; California Institute of Technology; University of California System; University of California Irvine; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Massachusetts System; University of Massachusetts Worcester; Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Duke University; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Affymetrix; Pompeu Fabra University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Chicago; California Institute of Technology; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Affymetrix; University of Lausanne; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); University of Geneva; University of Geneva; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; California Institute of Technology; Stanford University; United States Department of Energy (DOE); United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Centro Nacional de Investigaciones Oncologicas (CNIO); Tsinghua University; Cornell University; Washington University (WUSTL); Yeshiva University; Albert Einstein College of Medicine; Howard Hughes Medical Institute; University of California System; University of California Santa Cruz; University of California System; University of California Davis; Yale University; Harvard University; Harvard Medical School; University of Southern California; University System of Ohio; Ohio State University; Yale University; University of Texas System; University of Texas Health San Antonio; Ruprecht Karls University Heidelberg; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL); Stanford University; University of Washington; University of Washington Seattle; Harvard University; Harvard Medical School; Emory University; Emory University	Dunham, I (corresponding author), European Bioinformat Inst EMBL EBI, Vertebrate Genom Grp, Hinxton CB10 1SD, Cambs, England.		Abyzov, Alexej/AAT-4615-2020; Herrero, Javier/H-6971-2019; Tanzer, Andrea/L-3147-2015; Kellis, Manolis/ABE-7385-2020; Lassmann, Timo/HCH-4313-2022; Lassmann, Timo/A-8271-2008; Derrien, Thomas/ABD-6197-2020; Alioto, Tyler/K-7267-2015; Luo, Oscar Junhong/G-3293-2018; Johnson, Rory/ABE-2503-2021; Gunter, Chris/AHA-7271-2022; Taylor, James/F-1026-2011; Raney, Brian/ABE-6267-2020; SANYAL, AMARTYA/D-7240-2015; Sisu, Cristina/K-8994-2019; Wittbrodt, Joachim/D-4735-2014; Ferreira, Pedro/HDO-1346-2022; Lagarde, Julien/AAI-1686-2020; Antonarakis, Stylianos E/N-8866-2014; Johnson, Rory/H-2961-2015; Khurana, Ekta/C-4933-2013; Heermann, Stephan/J-8586-2015; Hardison, Ross C/G-1142-2010; Hannon, Gregory/AAB-3568-2019; Lin, Wei/AAH-9924-2019; Djebali, Sarah/O-9817-2014; Hoffman, Michael M./I-1924-2012; Kundaje, Anshul/Y-2739-2019; zhang, zheng/HCH-9684-2022; Alioto, Tyler/AAF-6342-2020; Visel, Axel/A-9398-2009; Miotto, Benoit/I-6040-2018; Li, Jingyi Jessica/K-2037-2012; Brent, Michael/AAK-3702-2020; Mikkelsen, Tarjei S/A-1306-2007; Dong, Xianjun/N-3867-2014; Abyzov, Alexej/M-4284-2013; Vaquerizas, Juan M/F-2676-2011; Yip, Kevin/AAT-4771-2020; Elnitski, Laura/AAD-3595-2021; Vaquerizas, Juan M/AAY-2339-2020; Boyle, Alan/I-1848-2014; Karmakar, Subhradip/AAF-7678-2021; Karmakar, Subhradip/AAP-6043-2020; Li, Guoliang/D-8014-2012; Brown, James/H-2971-2015; Hubbard, Tim J.P./AAT-4571-2020; Tenenbaum, Scott A/H-4744-2019; Ferreira, Pedro G/J-6379-2013; Ganesh, Dunna Sai/AGX-5170-2022; Sheffield, Nathan/ABG-8124-2020; Rodriguez, Jose/AAS-4147-2021; Li, Jingyi Jessica/I-2779-2019; Ezkurdia, Iakes/H-9334-2015; Guigo, Roderic/D-1303-2010; Sboner, Andrea/C-6487-2008; Vernot, Benjamin/ABH-1495-2021; Sobral, Daniel/K-3097-2019; Parker, Stephen/ABF-1063-2021; cheng, yong/I-4270-2012; Mariotti, Marco/AAB-7136-2019; Carninci, Piero/K-1568-2014; Yan, Koon-Kiu/A-5940-2009; Takahashi, Hazuki/F-9007-2017; Gao, Hui/AAF-9770-2019; Kundaje, Anshul/Y-2598-2019; Luo, Junhong/N-8583-2019; Winter, Deborah R./AAQ-9253-2020; wang, baocheng/B-7805-2008; Valencia, Alfonso/I-3127-2015; Tanzer, Andrea/AAY-5431-2021; Sammeth, Michael/C-1157-2014; Fullwood, Melissa/G-5713-2011; Alexander, Roger/A-8643-2008; Hubbard, Tim J/C-2567-2008; Miotto, Benoit/CAF-2937-2022; Adams, Leslie/AAZ-9323-2020; Rodriguez, Jose josemrc/R-4018-2018; Sobral, Daniel/B-4786-2014; Hariharan, Manoj/N-2855-2015; Mu, Xinmeng/P-2562-2016; Yu, Yanbao/G-3035-2010; Blow, Matthew/G-6369-2012; Karczewski, Jakub/L-7326-2018; Bussotti, Giovanni/C-3082-2019; notredame, cedric/G-3868-2010	Herrero, Javier/0000-0001-7313-717X; Tanzer, Andrea/0000-0003-2873-4236; Kellis, Manolis/0000-0001-7113-9630; Lassmann, Timo/0000-0002-0138-2691; Lassmann, Timo/0000-0002-0138-2691; Alioto, Tyler/0000-0002-2960-5420; Johnson, Rory/0000-0003-4607-2782; Taylor, James/0000-0001-5079-840X; SANYAL, AMARTYA/0000-0002-2109-4478; Sisu, Cristina/0000-0001-9371-0797; Wittbrodt, Joachim/0000-0001-8550-7377; Lagarde, Julien/0000-0002-0290-7445; Antonarakis, Stylianos E/0000-0001-8907-5823; Johnson, Rory/0000-0003-4607-2782; Hardison, Ross C/0000-0003-4084-7516; Lin, Wei/0000-0002-7506-3466; Djebali, Sarah/0000-0002-0599-1267; Hoffman, Michael M./0000-0002-4517-1562; Kundaje, Anshul/0000-0003-3084-2287; Alioto, Tyler/0000-0002-2960-5420; Visel, Axel/0000-0002-4130-7784; Miotto, Benoit/0000-0003-2857-2126; Li, Jingyi Jessica/0000-0002-9288-5648; Brent, Michael/0000-0002-8689-0299; Mikkelsen, Tarjei S/0000-0002-8133-3135; Dong, Xianjun/0000-0002-8052-9320; Vaquerizas, Juan M/0000-0002-6583-6541; Yip, Kevin/0000-0001-5516-9944; Vaquerizas, Juan M/0000-0002-6583-6541; Boyle, Alan/0000-0002-2081-1105; Karmakar, Subhradip/0000-0002-4757-8729; Li, Guoliang/0000-0003-1601-6640; Hubbard, Tim J.P./0000-0002-1767-9318; Ferreira, Pedro G/0000-0003-3838-8664; Sheffield, Nathan/0000-0001-5643-4068; Rodriguez, Jose/0000-0002-9948-5073; Li, Jingyi Jessica/0000-0002-9288-5648; Ezkurdia, Iakes/0000-0001-9074-5302; Guigo, Roderic/0000-0002-5738-4477; Sboner, Andrea/0000-0001-6915-3070; Vernot, Benjamin/0000-0002-6820-2181; Sobral, Daniel/0000-0003-3955-0117; Mariotti, Marco/0000-0002-7411-4161; Carninci, Piero/0000-0001-7202-7243; Takahashi, Hazuki/0000-0001-7315-7349; Kundaje, Anshul/0000-0003-3084-2287; Winter, Deborah R./0000-0003-1806-673X; wang, baocheng/0000-0002-8236-8014; Valencia, Alfonso/0000-0002-8937-6789; Tanzer, Andrea/0000-0003-2873-4236; Sammeth, Michael/0000-0002-6528-9883; Fullwood, Melissa/0000-0003-0321-7865; Alexander, Roger/0000-0002-2967-7395; Hubbard, Tim J/0000-0002-1767-9318; Miotto, Benoit/0000-0003-2857-2126; Adams, Leslie/0000-0003-4956-271X; Rodriguez, Jose josemrc/0000-0002-9948-5073; Sobral, Daniel/0000-0003-3955-0117; Hariharan, Manoj/0000-0002-1006-5372; Mu, Xinmeng/0000-0002-8079-0828; Yu, Yanbao/0000-0003-2994-1974; Blow, Matthew/0000-0002-8844-9149; Reymond, Alexandre/0000-0003-1030-8327; Gillespie, Shawn/0000-0003-1913-0860; Karczewski, Konrad/0000-0003-2878-4671; Kirchmaier, Stephan/0000-0002-3870-8624; Whitfield, Troy/0000-0002-2026-4201; Gunter, Chris/0000-0001-9369-7537; Snow, Catherine/0000-0002-1672-3532; Wilder, Steven/0000-0001-8049-2559; Curado, Joao/0000-0003-3916-0936; Barrell, Daniel/0000-0002-0977-0963; Lee, Bum Kyu/0000-0001-7835-419X; Victorsen, Alec/0000-0003-2326-0916; Varley, Katherine/0000-0003-1622-5290; Merkel, Angelika/0000-0001-5164-6803; Haugen, Eric/0000-0001-7444-8981; Farnham, Peggy/0000-0003-4469-7914; Gilbert, James/0000-0001-8079-3159; Aken, Bronwen/0000-0002-3032-4095; park, eddie/0000-0001-5651-1481; Harrow, Jennifer/0000-0003-0338-3070; Johnson, Nathan/0000-0002-2783-9047; Dunham, Ian/0000-0003-2525-5598; Despacio-Reyes, Gloria/0000-0001-5906-8999; Abyzov, Alexej/0000-0001-5405-6729; Moran, Jennifer/0000-0002-5664-4716; Tress, Michael/0000-0001-9046-6370; FRUM, Tristan/0000-0003-3452-8762; zheng, meizhen/0000-0001-5569-1812; Pazin, Michael/0000-0002-7561-3640; Zadissa, Amonida/0000-0001-5310-8830; Dreszer, Timothy/0000-0002-7328-1283; Birney, Ewan/0000-0001-8314-8497; Loveland, Jane/0000-0002-7669-2934; Park, Peter/0000-0001-9378-960X; Auer, Thomas Oliver/0000-0003-3442-0567; Banfai, Balazs/0000-0003-0422-7977; Flicek, Paul/0000-0002-3897-7955; Sahu, Avinash/0000-0002-2193-6276; Mieczkowska, Joanna/0000-0002-6482-336X; Sandstrom, Richard/0000-0002-3356-1547; Mieczkowski, Piotr/0000-0003-2418-0096; Saunders, Gary/0000-0002-7468-0008; Buske, Orion/0000-0002-9064-092X; Tapanari, Electra/0000-0002-9329-0996; Steward, Charles/0000-0001-8829-5349; Centanin, Lazaro/0000-0003-3889-4524; Batut, Philippe/0000-0003-4250-0663; Luo, Oscar Junhong/0000-0002-1266-3069; Kapranov, Philipp/0000-0003-2647-4856; Gonzalez, Jose M/0000-0001-5569-0705; Pauli Behn, Florencia/0000-0002-8984-4044; Penalva, Luiz/0000-0003-4491-6769; Epstein, Charles B./0000-0001-8358-8345; Frankish, Adam/0000-0002-4333-628X; Akey, Joshua/0000-0002-4411-1330; Foissac, Sylvain/0000-0002-2631-5356; Levy, Shawn/0000-0002-1369-5740; Foss, Kimberly/0000-0003-3996-7895; Berry, Andrew/0000-0001-5096-7701; Ward, Lucas/0000-0002-8017-809X; Nguyen, Eric/0000-0002-0516-2434; Hunt, Toby/0000-0001-8377-0841; Karczewski, Jakub/0000-0001-9322-7842; Snyder, Michael/0000-0003-0784-7987; Anaya, Michael/0000-0002-6944-3614; Bignell, alexandra/0000-0002-5926-7020; Dobin, Alexander/0000-0002-4115-9128; Furey, Terry/0000-0001-5546-9672; Mudge, Jonathan/0000-0003-4789-7495; Balasubramanian, Suganthi/0000-0003-2243-5948; Altshuler, Robert/0000-0001-5096-1932; Rozowsky, Joel/0000-0002-3565-0762; Sandhu, Kuljeet/0000-0001-7632-6339; Lukk, Margus/0000-0002-0701-5358; Gertz, Jason/0000-0001-7568-6789; Kokocinski, Felix/0000-0002-8472-9207; Bussotti, Giovanni/0000-0002-4078-7413; Kaul, Rajinder/0000-0002-7895-9284; Derrien, Thomas/0000-0002-8211-5789; Fisher-Aylor, Katherine/0000-0003-3371-2947; Meyer, Laurence/0000-0003-1430-7225; Kay, Mike/0000-0002-3282-0834; Wilming, Laurens/0000-0002-4154-7358; Elnitski, Laura/0000-0003-1065-019X; Collins, Patrick/0000-0002-7141-7503; Bell, Kimberly/0000-0003-2204-8569; Bhinge, Akshay/0000-0003-2939-099X; Davidson, Claire/0000-0002-4910-8202; Marinov, Georgi/0000-0003-1822-7273; Brazma, Alvis/0000-0001-5988-7409; Gingeras, Thomas/0000-0001-9106-3573; notredame, cedric/0000-0003-1461-0988; Vierstra, Jeff/0000-0001-6406-8563	NHGRI [U54HG004570, U01HG004695, U54HG004563, U54HG004557, U54HG004555, U41HG004568, U54HG004576, U54HG004558, U54HG004592]; American Recovery and Reinvestment Act (ARRA) funds from the NHGRI [U54HG004570, U54HG004563, U41HG004568, U54HG004592, R01HG003143, RC2HG005591, U01HG004561, RC2HG005679, R01HG003541, R01HG003988]; Intramural Research Program of the NHGRI [ZIAHG200323, ZIAHG200341]; United States Department of Energy Joint Genome Institute, Department of Energy, University of California [DE-AC02-05CH11231];  [R01HG003700];  [R01HG004456-03];  [U01HG004571]; NATIONAL CANCER INSTITUTE [P30CA045508, P30CA016086] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG004576, RC2HG005591, U01HG004695, U54HG004592, U54HG004557, R01HG003700, RC2HG005573, RC2HG005679, R01HG003541, U54HG004563, K99HG006698, R01HG005085, U54HG004555, ZIAHG200323, U01HG004561, U01HG004571, U54HG004558, ZIAHG200341, R01HG004456, R01HG003143, U54HG004570, R01HG003988, U41HG004568] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054369, R01DK065806, R37DK044746] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007205] Funding Source: NIH RePORTER	NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); American Recovery and Reinvestment Act (ARRA) funds from the NHGRI; Intramural Research Program of the NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); United States Department of Energy Joint Genome Institute, Department of Energy, University of California; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank additional members of our laboratories and institutions who have contributed to the experimental and analytical components of this project. We thank D. Leja for assistance with production of the figures. The Consortium is funded by grants from the NHGRI as follows: production grants: U54HG004570 (B. E. Bernstein); U01HG004695 (E. Birney); U54HG004563 (G. E. Crawford); U54HG004557 (T. R. Gingeras); U54HG004555 (T. J. Hubbard); U41HG004568 (W. J. Kent); U54HG004576 (R. M. Myers); U54HG004558 (M. Snyder); U54HG004592 (J. A. Stamatoyannopoulos). Pilot grants: R01HG003143 (J. Dekker); RC2HG005591 and R01HG003700 (M. C. Giddings); R01HG004456-03 (Y. Ruan); U01HG004571 (S. A. Tenenbaum); U01HG004561 (Z. Weng); RC2HG005679 (K. P. White). This project was supported in part by American Recovery and Reinvestment Act (ARRA) funds from the NHGRI through grants U54HG004570, U54HG004563, U41HG004568, U54HG004592, R01HG003143, RC2HG005591, R01HG003541, U01HG004561, RC2HG005679 and R01HG003988(L. Pennacchio). In addition, work from NHGRI Groups was supported by the Intramural Research Program of the NHGRI (L. Elnitski, ZIAHG200323; E. H. Margulies, ZIAHG200341). Research in the Pennachio laboratory was performed at Lawrence Berkeley National Laboratory and at the United States Department of Energy Joint Genome Institute, Department of Energy Contract DE-AC02-05CH11231, University of California.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Asthana S, 2007, P NATL ACAD SCI USA, V104, P12410, DOI 10.1073/pnas.0705140104; Ball MP, 2009, NAT BIOTECHNOL, V27, P361, DOI 10.1038/nbt.1533; Bickel PJ, 2010, ANN APPL STAT, V4, P1660, DOI 10.1214/10-AOAS363; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Borneman AR, 2007, SCIENCE, V317, P815, DOI 10.1126/science.1140748; Boyle A. P., 2012, GENOME RES; Boyle AP, 2011, GENOME RES, V21, P456, DOI 10.1101/gr.112656.110; Cheng C., 2012, GENOME RES; Chiaromonte F, 2003, COLD SPRING HARB SYM, V68, P245, DOI 10.1101/sqb.2003.68.245; Cooper GM, 2005, GENOME RES, V15, P901, DOI 10.1101/gr.3577405; Dekker J, 2008, SCIENCE, V319, P1793, DOI 10.1126/science.1152850; Derrien T, 2012, GENOME RES; Dong XJ, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r53; Dostie J, 2006, GENOME RES, V16, P1299, DOI 10.1101/gr.5571506; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Feingold EA, 2004, SCIENCE, V306, P636, DOI 10.1126/science.1105136; Frietze S, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r52; Frietze S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015082; Fu YT, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000138; Fullwood MJ, 2009, NATURE, V462, P58, DOI 10.1038/nature08497; GROSS DS, 1988, ANNU REV BIOCHEM, V57, P159, DOI 10.1146/annurev.bi.57.070188.001111; Harismendy O, 2011, NATURE, V470, P264, DOI 10.1038/nature09753; Harrow J, 2012, GENOME RES; Hesselberth JR, 2009, NAT METHODS, V6, P283, DOI [10.1038/NMETH.1313, 10.1038/nmeth.1313]; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hoffman MM, 2012, NAT METHODS, V9, P473, DOI [10.1038/nmeth.1937, 10.1038/NMETH.1937]; Hon G, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000566; Hon GC, 2009, HUM MOL GENET, V18, pR195, DOI 10.1093/hmg/ddp409; Howald C., 2012, GENOME RES; Huff JT, 2010, NAT STRUCT MOL BIOL, V17, P1495, DOI 10.1038/nsmb.1924; Kaplan T, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001290; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; KING MC, 1975, SCIENCE, V188, P107, DOI 10.1126/science.1090005; Koch F, 2011, NAT STRUCT MOL BIOL, V18, P956, DOI 10.1038/nsmb.2085; KORNBERG RD, 1988, NUCLEIC ACIDS RES, V16, P6677, DOI 10.1093/nar/16.14.6677; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kundaje A., 2012, GENOME RES; Lajoie BR, 2009, NAT METHODS, V6, P690, DOI 10.1038/nmeth1009-690; Landt S. G., 2012, GENOME RES; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li GL, 2012, CELL, V148, P84, DOI 10.1016/j.cell.2011.12.014; Li QH, 2011, ANN APPL STAT, V5, P1752, DOI 10.1214/11-AOAS466; Li XY, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r34; Libioulle C, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030058; Lindblad-Toh K, 2011, NATURE, V478, P476, DOI 10.1038/nature10530; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; Odom DT, 2007, NAT GENET, V39, P730, DOI 10.1038/ng2047; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Parker SCJ, 2009, SCIENCE, V324, P389, DOI 10.1126/science.1169050; Pei BK, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r51; Pheasant M, 2007, GENOME RES, V17, P1245, DOI 10.1101/gr.6406307; Pique-Regi R, 2011, GENOME RES, V21, P447, DOI 10.1101/gr.112623.110; Ponting CP, 2011, GENOME RES, V21, P1769, DOI 10.1101/gr.116814.110; Rozowsky J, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.54; Schaub M. A., 2012, GENOME RES; Schmidt D, 2010, SCIENCE, V328, P1036, DOI 10.1126/science.1186176; Schones DE, 2008, CELL, V132, P887, DOI 10.1016/j.cell.2008.02.022; Schultz DC, 2002, GENE DEV, V16, P919, DOI 10.1101/gad.973302; Schuster SC, 2010, NATURE, V463, P943, DOI 10.1038/nature08795; Spivakov M, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r49; Tilgner H., 2012, GENOME RES; Urnov FD, 2003, J CELL BIOCHEM, V88, P684, DOI 10.1002/jcb.10397; Valouev A, 2011, NATURE, V474, P516, DOI 10.1038/nature10002; Vernot B., 2012, GENOME RES; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Whitfield TW, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r50; Yip KY, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r48; Zhang Y, 2009, NUCLEIC ACIDS RES, V37, P7024, DOI 10.1093/nar/gkp747; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhou VW, 2011, NAT REV GENET, V12, P7, DOI 10.1038/nrg2905	75	10147	10382	62	1643	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 6	2012	489	7414					57	74		10.1038/nature11247	http://dx.doi.org/10.1038/nature11247			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999WW	22955616	Green Submitted, Green Published, Green Accepted, hybrid			2022-12-28	WOS:000308347000039
J	Neph, S; Vierstra, J; Stergachis, AB; Reynolds, AP; Haugen, E; Vernot, B; Thurman, RE; John, S; Sandstrom, R; Johnson, AK; Maurano, MT; Humbert, R; Rynes, E; Wang, H; Vong, S; Lee, K; Bates, D; Diegel, M; Roach, V; Dunn, D; Neri, J; Schafer, A; Hansen, RS; Kutyavin, T; Giste, E; Weaver, M; Canfield, T; Sabo, P; Zhang, MH; Balasundaram, G; Byron, R; MacCoss, MJ; Akey, JM; Bender, MA; Groudine, M; Kaul, R; Stamatoyannopoulos, JA				Neph, Shane; Vierstra, Jeff; Stergachis, Andrew B.; Reynolds, Alex P.; Haugen, Eric; Vernot, Benjamin; Thurman, Robert E.; John, Sam; Sandstrom, Richard; Johnson, Audra K.; Maurano, Matthew T.; Humbert, Richard; Rynes, Eric; Wang, Hao; Vong, Shinny; Lee, Kristen; Bates, Daniel; Diegel, Morgan; Roach, Vaughn; Dunn, Douglas; Neri, Jun; Schafer, Anthony; Hansen, R. Scott; Kutyavin, Tanya; Giste, Erika; Weaver, Molly; Canfield, Theresa; Sabo, Peter; Zhang, Miaohua; Balasundaram, Gayathri; Byron, Rachel; MacCoss, Michael J.; Akey, Joshua M.; Bender, M. A.; Groudine, Mark; Kaul, Rajinder; Stamatoyannopoulos, John A.			An expansive human regulatory lexicon encoded in transcription factor footprints	NATURE			English	Article							IN-VIVO; DNA; PROTEIN; GENE; EXPRESSION; CHROMATIN; DIFFERENTIATION; ERYTHROPOIESIS; INDUCTION; REQUIRES	Regulatory factor binding to genomic DNA protects the underlying sequence from cleavage by DNase I, leaving nucleotide-resolution 'footprints'. Using genomic DNase I footprinting across 41 diverse cell and tissue types, we detected 45 million transcription factor occupancy events within regulatory regions, representing differential binding to 8.4 million distinct short sequence elements. Here we show that this small genomic sequence compartment, roughly twice the size of the exome, encodes an expansive repertoire of conserved recognition sequences for DNA-binding proteins that nearly doubles the size of the human cis-regulatory lexicon. We find that genetic variants affecting allelic chromatin states are concentrated in footprints, and that these elements are preferentially sheltered from DNA methylation. High-resolution DNase I cleavage patterns mirror nucleotide-level evolutionary conservation and track the crystallographic topography of protein-DNA interfaces, indicating that transcription factor structure has been evolutionarily imprinted on the human genome sequence. We identify a stereotyped 50-base-pair footprint that precisely defines the site of transcript origination within thousands of human promoters. Finally, we describe a large collection of novel regulatory factor recognition motifs that are highly conserved in both sequence and function, and exhibit cell-selective occupancy patterns that closely parallel major regulators of development, differentiation and pluripotency.	[Neph, Shane; Vierstra, Jeff; Stergachis, Andrew B.; Reynolds, Alex P.; Haugen, Eric; Vernot, Benjamin; Thurman, Robert E.; John, Sam; Sandstrom, Richard; Johnson, Audra K.; Maurano, Matthew T.; Humbert, Richard; Rynes, Eric; Wang, Hao; Vong, Shinny; Lee, Kristen; Bates, Daniel; Diegel, Morgan; Roach, Vaughn; Dunn, Douglas; Neri, Jun; Schafer, Anthony; Hansen, R. Scott; Kutyavin, Tanya; Giste, Erika; Weaver, Molly; Canfield, Theresa; Sabo, Peter; MacCoss, Michael J.; Akey, Joshua M.; Kaul, Rajinder; Stamatoyannopoulos, John A.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Hansen, R. Scott; Kaul, Rajinder] Univ Washington, Dept Med, Div Med Genet, Seattle, WA 98195 USA; [Zhang, Miaohua; Balasundaram, Gayathri; Byron, Rachel; Bender, M. A.; Groudine, Mark] Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA; [Bender, M. A.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Groudine, Mark] Univ Washington, Dept Med, Dept Radiat Oncol, Seattle, WA 98195 USA; [Stamatoyannopoulos, John A.] Univ Washington, Dept Med, Div Oncol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Stamatoyannopoulos, JA (corresponding author), Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.	jstam@uw.edu	Vernot, Benjamin/ABH-1495-2021	Vernot, Benjamin/0000-0002-6820-2181; Kaul, Rajinder/0000-0002-7895-9284; Haugen, Eric/0000-0001-7444-8981; Sandstrom, Richard/0000-0002-3356-1547; Akey, Joshua/0000-0002-4411-1330; Vierstra, Jeff/0000-0001-6406-8563	National Institutes of Health (NIH) [HG004592, RC2HG005654]; National Science Foundation [DGE-071824]; University of Washington Proteomics Resource [UWPR95794]; NATIONAL CANCER INSTITUTE [P30CA015704] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG004592, RC2HG005654] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK044746, F30DK095678] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); University of Washington Proteomics Resource(University of Washington); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health (NIH) grants HG004592 (J.A.S.) and RC2HG005654 (J.A.S. and M. G.). J.V. is supported by a National Science Foundation Graduate Research Fellowship under grant no. DGE-071824. Additional support was provided in part by the University of Washington Proteomics Resource (UWPR95794). We thank F. Urnov for critical reading of the manuscript and many discussions, and S. Thomas for insights.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Badis G, 2009, SCIENCE, V324, P1720, DOI 10.1126/science.1162327; Biddie SC, 2011, MOL CELL, V43, P145, DOI 10.1016/j.molcel.2011.06.016; Boyle AP, 2008, CELL, V132, P311, DOI 10.1016/j.cell.2007.12.014; Bryne JC, 2008, NUCLEIC ACIDS RES, V36, pD102, DOI 10.1093/nar/gkm955; BURATOWSKI S, 1989, CELL, V56, P549, DOI 10.1016/0092-8674(89)90578-3; CHAN JY, 1993, P NATL ACAD SCI USA, V90, P11371, DOI 10.1073/pnas.90.23.11371; Drmanac R, 2010, SCIENCE, V327, P78, DOI 10.1126/science.1181498; DYNAN WS, 1983, CELL, V35, P79, DOI 10.1016/0092-8674(83)90210-6; Fejes-Toth K, 2009, NATURE, V457, P1028, DOI 10.1038/nature07759; FERREDAMARE AR, 1994, EMBO J, V13, P180, DOI 10.1002/j.1460-2075.1994.tb06247.x; GALAS DJ, 1978, NUCLEIC ACIDS RES, V5, P3157, DOI 10.1093/nar/5.9.3157; GILBERT W, 1966, P NATL ACAD SCI USA, V56, P1891, DOI 10.1073/pnas.56.6.1891; GROSS DS, 1988, ANNU REV BIOCHEM, V57, P159, DOI 10.1146/annurev.bi.57.070188.001111; GROSVELD F, 1987, CELL, V51, P975, DOI 10.1016/0092-8674(87)90584-8; Halupa A, 2005, BLOOD, V105, P552, DOI 10.1182/blood-2003-09-3237; Hesselberth JR, 2009, NAT METHODS, V6, P283, DOI [10.1038/NMETH.1313, 10.1038/nmeth.1313]; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; Kim TK, 1997, P NATL ACAD SCI USA, V94, P12268, DOI 10.1073/pnas.94.23.12268; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Mukherjee S, 2004, NAT GENET, V36, P1331, DOI 10.1038/ng1473; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; Newburger DE, 2009, NUCLEIC ACIDS RES, V37, pD77, DOI 10.1093/nar/gkn660; PELLEGRINI L, 1995, NATURE, V376, P490, DOI 10.1038/376490a0; PEVNY L, 1991, NATURE, V349, P257, DOI 10.1038/349257a0; Pollard KS, 2010, GENOME RES, V20, P110, DOI 10.1101/gr.097857.109; PUGH BF, 1991, GENE DEV, V5, P1935, DOI 10.1101/gad.5.11.1935; Rockman MV, 2002, MOL BIOL EVOL, V19, P1991, DOI 10.1093/oxfordjournals.molbev.a004023; Sabo PJ, 2006, NAT METHODS, V3, P511, DOI 10.1038/NMETH890; Sabo PJ, 2004, P NATL ACAD SCI USA, V101, P16837, DOI 10.1073/pnas.0407387101; SCHOENHERR CJ, 1995, SCIENCE, V267, P1360, DOI 10.1126/science.7871435; Socolovsky M, 2001, BLOOD, V98, P3261, DOI 10.1182/blood.V98.12.3261; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; TATE PH, 1993, CURR OPIN GENET DEV, V3, P226, DOI 10.1016/0959-437X(93)90027-M; Thanos D, 1995, CELL, V83, P1091, DOI 10.1016/0092-8674(95)90136-1; Treisman R., 1985, DNA CELL BIOL, V315, P73; TSAI SF, 1989, NATURE, V339, P446, DOI 10.1038/339446a0; Vaquerizas JM, 2009, NAT REV GENET, V10, P252, DOI 10.1038/nrg2538; Wadman IA, 1997, EMBO J, V16, P3145, DOI 10.1093/emboj/16.11.3145; Yun KS, 1996, CURR OPIN CELL BIOL, V8, P877, DOI 10.1016/S0955-0674(96)80091-3; Zhou Z, 2010, J BIOL CHEM, V285, P15894, DOI 10.1074/jbc.M109.098376	42	527	549	0	73	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 6	2012	489	7414					83	90		10.1038/nature11212	http://dx.doi.org/10.1038/nature11212			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999WW	22955618	hybrid, Green Accepted			2022-12-28	WOS:000308347000041
J	Gornall, J				Gornall, Jonathan			Proton beam therapy: more than a leap of faith?	BRITISH MEDICAL JOURNAL			English	Editorial Material							RANDOMIZED CLINICAL-TRIAL; NEUTRON TREATMENT; ADVANCED TUMORS; GAMMA-RAYS; NECK; HEAD; CANCER; RADIOTHERAPY; RADIATION					jgornall@mac.com						Agency for Healthcare Research and Quality, 2012, PROT BEAM RAD US MED; [Anonymous], 2012, BMJ; CATTERALL M, 1975, BMJ-BRIT MED J, V2, P653, DOI 10.1136/bmj.2.5972.653; CATTERALL M, 1977, BRIT MED J, V1, P1642, DOI 10.1136/bmj.1.6077.1642; Chung CS, 2008, INT J RADIAT ONCOL, V72, pS8, DOI 10.1016/j.ijrobp.2008.06.785; De Ruysscher D, 2012, RADIOTHER ONCOL, V103, P5, DOI 10.1016/j.radonc.2012.01.003; Department of Health, 2007, CANC REF STRAT; Emanuel E, 2012, NY TIMES        1121; Epstein K, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e2488; ERRINGTON RD, 1991, BRIT MED J, V302, P1045, DOI 10.1136/bmj.302.6784.1045; Goitein M, 2008, J CLIN ONCOL, V26, P175, DOI 10.1200/JCO.2007.14.4329; Kunkler IH, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e3193; Lundkvist J, 2005, CANCER-AM CANCER SOC, V103, P793, DOI 10.1002/cncr.20844; MACDOUGALL RH, 1990, BRIT MED J, V301, P1241, DOI 10.1136/bmj.301.6763.1241; MAOR MH, 1995, INT J RADIAT ONCOL, V32, P599, DOI 10.1016/0360-3016(94)00595-C; Miralbell R, 2002, INT J RADIAT ONCOL, V54, P824, DOI 10.1016/S0360-3016(02)02982-6; National Radiotherapy Advisory Group, 2007, RAD DEV WORLD CLASS; National Radiotherapy Advisory Group, 2006, PROT TREATM CANC; National Specialised Commissioning Team, 2011, GUID REF PAT ABR NHS; WILSON RR, 1946, RADIOLOGY, V47, P487, DOI 10.1148/47.5.487	20	4	4	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	SEP 5	2012	345								e4917	10.1136/bmj.e4917	http://dx.doi.org/10.1136/bmj.e4917			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	003TK	22951923				2022-12-28	WOS:000308634000001
J	Schelbert, EB; Cao, JJ; Sigurdsson, S; Aspelund, T; Kellman, P; Aletras, AH; Dyke, CK; Thorgeirsson, G; Eiriksdottir, G; Launer, LJ; Gudnason, V; Harris, TB; Arai, AE				Schelbert, Erik B.; Cao, Jie J.; Sigurdsson, Sigurdur; Aspelund, Thor; Kellman, Peter; Aletras, Anthony H.; Dyke, Christopher K.; Thorgeirsson, Gudmundur; Eiriksdottir, Gudny; Launer, Lenore J.; Gudnason, Vilmundur; Harris, Tamara B.; Arai, Andrew E.			Prevalence and Prognosis of Unrecognized Myocardial Infarction Determined by Cardiac Magnetic Resonance in Older Adults	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							Q-WAVE; CONTRAST; ENHANCEMENT; TOMOGRAPHY; MORTALITY; REYKJAVIK; SYMPTOMS; INJURY; MRI; AGE	Context Unrecognized myocardial infarction (MI) is prognostically important. Electrocardiography (ECG) has limited sensitivity for detecting unrecognized MI (UMI). Objective Determine prevalence and mortality risk for UMI detected by cardiac magnetic resonance (CMR) imaging or ECG among older individuals. Design, Setting, and Participants ICELAND MI is a cohort substudy of the Age, Gene/Environment Susceptibility-Reykjavik Study (enrollment January 2004-January 2007) using ECG or CMR to detect UMI. From a community-dwelling cohort of older individuals in Iceland, data for 936 participants aged 67 to 93 years were analyzed, including 670 who were randomly selected and 266 with diabetes. Main Outcome Measures Prevalence and mortality of MI through September 1, 2011. Results reported with 95% confidence limits and net reclassification improvement (NRI). Results Of 936 participants, 91 had recognized MI (RMI) (9.7%; 95% CI, 8% to 12%), and 157 had UMI detected by CMR (17%; 95% CI, 14% to 19%), which was more prevalent than the 46 UMI detected by ECG (5%; 95% CI, 4% to 6%; P < .001). Participants with diabetes (n = 337) had more UMI detected by CMR than by ECG (n = 72; 21%; 95% CI, 17% to 26%, vs n = 15; 4%; 95% CI, 2% to 7%; P < .001). Unrecognized MI by CMR was associated with atherosclerosis risk factors, coronary calcium, coronary revascularization, and peripheral vascular disease. Over a median of 6.4 years, 30 of 91 participants (33%; 95% CI, 23% to 43%) with RMI died, and 44 of 157 participants (28%; 95% CI, 21% to 35%) with UMI died, both higher rates than the 119 of 688 participants (17%; 95% CI, 15% to 20%) with no MI who died. Unrecognized MI by CMR improved risk stratification for mortality over RMI (NRI, 0.34; 95% CI, 0.16 to 0.53). Adjusting for age, sex, diabetes, and RMI, UMI by CMR remained associated with mortality (hazard ratio [HR], 1.45; 95% CI, 1.02 to 2.06, absolute risk increase [ARI], 8%) and significantly improved risk stratification for mortality (NRI, 0.16; 95% CI, 0.01 to 0.31), but UMI by ECG did not (HR, 0.88; 95% CI, 0.45 to 1.73; ARI, -2%; NRI, -0.05; 95% CI, -0.17 to 0.05). Compared with those with RMI, participants with UMI by CMR used cardiac medications such as statins less often (36%; 95% CI, 28% to 43%, or 56/157, vs 73%; 95% CI, 63% to 82%, or 66/91; P < .001). Conclusions In a community-based cohort of older individuals, the prevalence of UMI by CMR was higher than the prevalence of RMI and was associated with increased mortality risk. In contrast, UMI by ECG prevalence was lower than that of RMI and was not associated with increased mortality risk.	[Arai, Andrew E.] NHLBI, Cardiovasc & Pulm Branch, NIH, Bethesda, MD 20892 USA; [Launer, Lenore J.; Harris, Tamara B.] NIA, NIH, Bethesda, MD 20892 USA; [Sigurdsson, Sigurdur; Aspelund, Thor; Eiriksdottir, Gudny; Gudnason, Vilmundur] Iceland Heart Assoc, Kopavogur, Iceland; [Aspelund, Thor; Thorgeirsson, Gudmundur; Gudnason, Vilmundur] Univ Iceland, Reykjavik, Iceland; [Schelbert, Erik B.] Univ Pittsburgh, Med Ctr, Inst Heart & Vasc, Pittsburgh, PA USA; [Cao, Jie J.] SUNY Stony Brook, St Francis Hosp, Roslyn, NY USA; [Dyke, Christopher K.] Alaska Heart Inst, Anchorage, AK USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Icelandic Heart Association; University of Iceland; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Arai, AE (corresponding author), NHLBI, Cardiovasc & Pulm Branch, NIH, 10 Ctr Dr,Bldg 10,Room B1D416,MSC 1061, Bethesda, MD 20892 USA.	araia@nih.gov	Aletras, Anthony/ABE-9967-2020; Aspelund, Thor/K-7022-2019; Aspelund, Thor/C-5983-2008; Gudnason, Vilmundur/AAE-7126-2019; Gudnason, Vilmundur/K-6885-2015	Aletras, Anthony/0000-0002-3786-3817; Aspelund, Thor/0000-0002-7998-5433; Aspelund, Thor/0000-0002-7998-5433; Gudnason, Vilmundur/0000-0001-5696-0084; Gudnason, Vilmundur/0000-0001-5696-0084; Schelbert, Erik/0000-0003-0356-4437; Arai, Andrew/0000-0002-5413-1466	National Heart, Lung, and Blood Institute [Z01 HL004607-08 CE]; National Institute on Aging [N01-AG-12100]; Hjartavernd (the Icelandic Heart Association); Althingi (the Icelandic Parliament); Medstar Research Institute [2003-145]; T. Franklin Williams Scholarship Award; Atlantic Philanthropies; John A. Hartford Foundation; Association of Specialty Professors; American Heart Association [10GRNT4580000]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL004607, Z01HL004607] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG007420, ZIAAG007480, N01AG012100, ZIAAG007380, ZIAAG007270] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Hjartavernd (the Icelandic Heart Association); Althingi (the Icelandic Parliament); Medstar Research Institute; T. Franklin Williams Scholarship Award; Atlantic Philanthropies; John A. Hartford Foundation; Association of Specialty Professors; American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was funded by the National Heart, Lung, and Blood Institute Intramural Research Program (Z01 HL004607-08 CE), the National Institute on Aging Intramural Research Program (N01-AG-12100), Hjartavernd (the Icelandic Heart Association), and the Althingi (the Icelandic Parliament). The study was approved by the Icelandic National Bioethics Committee (VSN: 00-063) and the Medstar Research Institute (project 2003-145). Dr Schelbert is supported by a T. Franklin Williams Scholarship Award, funding for which is provided by Atlantic Philanthropies, the John A. Hartford Foundation, the Association of Specialty Professors, and the American Heart Association. Dr Cao is supported by an American Heart Association Grant-in-Aid (10GRNT4580000).	Barbier CE, 2011, J AM COLL CARDIOL, V58, P1372, DOI 10.1016/j.jacc.2011.06.028; Boland LL, 2002, AM J CARDIOL, V90, P927, DOI 10.1016/S0002-9149(02)02655-3; Burke AP, 2007, MED CLIN N AM, V91, P553, DOI 10.1016/j.mcna.2007.03.005; Burke AP, 2001, CIRCULATION, V103, P934; Burns RJ, 2002, J AM COLL CARDIOL, V39, P30, DOI 10.1016/S0735-1097(01)01711-9; COX CJB, 1967, LANCET, V1, P1194; Genuth S, 2003, DIABETES CARE, V26, P3160; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Harris TB, 2007, AM J EPIDEMIOL, V165, P1076, DOI 10.1093/aje/kwk115; HORAN LG, 1971, CIRCULATION, V43, P428, DOI 10.1161/01.CIR.43.3.428; KANNEL WB, 1984, NEW ENGL J MED, V311, P1144, DOI 10.1056/NEJM198411013111802; Kellman P, 2002, MAGNET RESON MED, V47, P372, DOI 10.1002/mrm.10051; Kennedy KF, SAS MACRO COMPUTE AD; Kim HW, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000057; Kim RJ, 2008, CIRCULATION, V117, P629, DOI 10.1161/CIRCULATIONAHA.107.723262; Kim RJ, 1999, CIRCULATION, V100, P1992, DOI 10.1161/01.CIR.100.19.1992; Kim RJ, 2000, NEW ENGL J MED, V343, P1445, DOI 10.1056/NEJM200011163432003; Klein C, 2002, CIRCULATION, V105, P162, DOI 10.1161/hc0202.102123; Kwong RY, 2008, CIRCULATION, V118, P1011, DOI 10.1161/CIRCULATIONAHA.107.727826; Kwong RY, 2006, CIRCULATION, V113, P2733, DOI 10.1161/CIRCULATIONAHA.105.570648; Mahrholdt H, 2005, EUR HEART J, V26, P1461, DOI 10.1093/eurheartj/ehi258; Pencina MJ, 2011, STAT MED, V30, P11, DOI 10.1002/sim.4085; Rehwald WG, 2002, CIRCULATION, V105, P224, DOI 10.1161/hc0202.102016; Schelbert EB, 2008, HEART, V94, DOI 10.1136/hrt.2006.111674; Schelbert EB, 2010, CIRC-CARDIOVASC IMAG, V3, P743, DOI 10.1161/CIRCIMAGING.108.835793; Sheifer SE, 2000, J AM COLL CARDIOL, V35, P119, DOI 10.1016/S0735-1097(99)00524-0; SIGURDSSON E, 1995, ANN INTERN MED, V122, P96, DOI 10.7326/0003-4819-122-2-199501150-00003; Wagner A, 2003, LANCET, V361, P374, DOI 10.1016/S0140-6736(03)12389-6; Wu E, 2001, LANCET, V357, P21, DOI 10.1016/S0140-6736(00)03567-4	29	201	210	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 5	2012	308	9					890	897		10.1001/2012.jama.11089	http://dx.doi.org/10.1001/2012.jama.11089			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	999ET	22948699	Green Accepted			2022-12-28	WOS:000308292900019
J	Vafabakhsh, R; Ha, T				Vafabakhsh, Reza; Ha, Taekjip			Extreme Bendability of DNA Less than 100 Base Pairs Long Revealed by Single-Molecule Cyclization	SCIENCE			English	Article							DOUBLE HELIX; DYNAMICS SIMULATIONS; IN-VIVO; FLEXIBILITY; ELASTICITY; FRAGMENTS; CLOSURE; LOOPS	The classical view of DNA posits that DNA must be stiff below the persistence length [<150 base pairs (bp)], but recent studies addressing this have yielded contradictory results. We developed a fluorescence-based, protein-free assay for studying the cyclization of single DNA molecules in real time. The assay samples the equilibrium population of a sharply bent, transient species that is entirely suppressed in single-molecule mechanical measurements and is biologically more relevant than the annealed species sampled in the traditional ligase-based assay. The looping rate has a weak length dependence between 67 and 106 bp that cannot be described by the worm-like chain model. Many biologically important protein-DNA interactions that involve looping and bending of DNA below 100 bp likely use this intrinsic bendability of DNA.	[Vafabakhsh, Reza; Ha, Taekjip] Univ Illinois, Dept Phys, Urbana, IL 61801 USA; [Vafabakhsh, Reza; Ha, Taekjip] Univ Illinois, Ctr Phys Living Cells, Urbana, IL 61801 USA; [Ha, Taekjip] Howard Hughes Med Inst, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Howard Hughes Medical Institute	Ha, T (corresponding author), Univ Illinois, Dept Phys, 1110 W Green St, Urbana, IL 61801 USA.	tjha@illinois.edu	Ha, Taekjip/B-9506-2009	Ha, Taekjip/0000-0003-2195-6258	U.S. National Science Foundation [0646550, 0822613]; U.S. National Institutes of Health [GM065367]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065367] Funding Source: NIH RePORTER	U.S. National Science Foundation(National Science Foundation (NSF)); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. Phillips, H. Garcia, K. Rangunathan, R. Zhou, S. Doganay, A. Jain, K. Lee, G. Lee, and S. Arslan for helpful discussions. We are grateful to the late J. Widom for generous comments on an earlier version of this paper. This work was supported by U.S. National Science Foundation grants 0646550 and 0822613 and U.S. National Institutes of Health grant GM065367 to T. H. T. H. is an employee of the Howard Hughes Medical Institute.	Baumann CG, 1997, P NATL ACAD SCI USA, V94, P6185, DOI 10.1073/pnas.94.12.6185; Becker NA, 2005, J MOL BIOL, V349, P716, DOI 10.1016/j.jmb.2005.04.035; Becker NB, 2009, SCIENCE, V325, DOI 10.1126/science.1168786; Blackwood EM, 1998, SCIENCE, V281, P60, DOI 10.1126/science.281.5373.60; BURKHOFF AM, 1988, NATURE, V331, P455, DOI 10.1038/331455a0; Cisse I, 2007, P NATL ACAD SCI USA, V104, P12646, DOI 10.1073/pnas.0610673104; Cloutier TE, 2005, P NATL ACAD SCI USA, V102, P3645, DOI 10.1073/pnas.0409059102; Curuksu J, 2009, NUCLEIC ACIDS RES, V37, P3766, DOI 10.1093/nar/gkp234; Douarche N, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.061902; Du Q, 2005, P NATL ACAD SCI USA, V102, P5397, DOI 10.1073/pnas.0500983102; Ha T, 1996, P NATL ACAD SCI USA, V93, P6264, DOI 10.1073/pnas.93.13.6264; HAGERMAN PJ, 1988, ANNU REV BIOPHYS BIO, V17, P265; Han L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005621; Lankas F, 2006, STRUCTURE, V14, P1527, DOI 10.1016/j.str.2006.08.004; LEE DH, 1989, P NATL ACAD SCI USA, V86, P476, DOI 10.1073/pnas.86.2.476; Lowary PT, 1997, P NATL ACAD SCI USA, V94, P1183, DOI 10.1073/pnas.94.4.1183; Mastroianni AJ, 2009, BIOPHYS J, V97, P1408, DOI 10.1016/j.bpj.2009.06.031; Mathew-Fenn RS, 2009, SCIENCE, V325, P538, DOI 10.1126/science.1168876; Mathew-Fenn RS, 2008, SCIENCE, V322, P446, DOI 10.1126/science.1158881; Peters JP, 2010, Q REV BIOPHYS, V43, P23, DOI 10.1017/S0033583510000077; PORSCHKE D, 1971, J MOL BIOL, V62, P361, DOI 10.1016/0022-2836(71)90433-5; Richmond TJ, 2003, NATURE, V423, P145, DOI 10.1038/nature01595; Roy R, 2008, NAT METHODS, V5, P507, DOI 10.1038/NMETH.1208; SCHLEIF R, 1992, ANNU REV BIOCHEM, V61, P199, DOI 10.1146/annurev.bi.61.070192.001215; Seol Y, 2007, BIOPHYS J, V93, P4360, DOI 10.1529/biophysj.107.112995; SHIMADA J, 1984, MACROMOLECULES, V17, P689, DOI 10.1021/ma00134a028; SHORE D, 1981, P NATL ACAD SCI-BIOL, V78, P4833, DOI 10.1073/pnas.78.8.4833; Towles KB, 2009, PHYS BIOL, V6, DOI 10.1088/1478-3975/6/2/025001; Wiggins PA, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.021909; Wiggins PA, 2006, NAT NANOTECHNOL, V1, P137, DOI 10.1038/nnano.2006.63; Wong OK, 2008, PLOS BIOL, V6, P2028, DOI 10.1371/journal.pbio.0060232; Yan J, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.061905; Yan J, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.108108; Yuan CL, 2007, NUCLEIC ACIDS RES, V35, P5294, DOI 10.1093/nar/gkm582	34	226	227	1	124	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 31	2012	337	6098					1097	1101		10.1126/science.1224139	http://dx.doi.org/10.1126/science.1224139			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996WP	22936778	Green Accepted			2022-12-28	WOS:000308125800048
J	Alexander, RT; Hemmelgarn, BR; Wiebe, N; Bello, A; Morgan, C; Samuel, S; Klarenbach, SW; Curhan, GC; Tonelli, M				Alexander, R. Todd; Hemmelgarn, Brenda R.; Wiebe, Natasha; Bello, Aminu; Morgan, Catherine; Samuel, Susan; Klarenbach, Scott W.; Curhan, Gary C.; Tonelli, Marcello		Alberta Kidney Dis Network	Kidney stones and kidney function loss: a cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							GENETIC-HETEROGENEITY; UNITED-STATES; DISEASE; PREVALENCE; RISK; RECURRENCE	Objective To investigate whether the presence of kidney stones increase the risk of end stage renal disease (ESRD) or other adverse renal outcomes. Design A registry cohort study using validated algorithms based on claims and facility utilisation data. Median follow-up of 11 years. Setting Alberta, Canada, between 1997 and 2009. Participants 3 089 194 adult patients without ESRD at baseline or a history of pyelonephritis. Of these, 1 954 836 had outpatient serum creatinine measurements and were included in analyses of chronic kidney disease and doubling of serum creatinine level. Exposure One or more kidney stones during follow-up. Main outcome measures Incident ESRD, development of stage 3b-5 chronic kidney disease (estimated glomerular filtration rate <45 mL/min/1.73 m(2)), and sustained doubling of serum creatinine concentration from baseline. Results 23 706 (0.8%) patients had at least one kidney stone, 5333 (0.2%) developed ESRD, 68 525 (4%) developed stage 3b-5 chronic kidney disease, and 6581 (0.3%) experienced sustained doubling of serum creatinine. Overall, one or more stone episodes during follow-up was associated with increased risk of ESRD (adjusted hazard ratio 2.16 (95% CI 1.79 to 2.62)), new stage 3b-5 chronic kidney disease (hazard ratio 1.74 (1.61 to 1.88)), and doubling of serum creatinine (hazard ratio 1.94 (1.56 to 2.43)), all compared with those without kidney stones during follow-up. The excess risk of adverse outcomes associated with at least one episode of stones seemed greater in women than in men, and in people aged <50 years than in those aged >= 50. However, the risks of all three adverse outcomes in those with at least one episode of stones were significantly higher than in those without stones in both sexes and age strata. The absolute increase in the rate of adverse renal outcomes associated with stones was small: the unadjusted rate of ESRD was 2.48 per million person days in people with one or more episodes of stones versus 0.52 per million person days in people without stones. Conclusion Even a single kidney stone episode during follow-up was associated with a significant increase in the likelihood of adverse renal outcomes including ESRD. However, the increases were small in absolute terms.	[Alexander, R. Todd; Wiebe, Natasha; Bello, Aminu; Morgan, Catherine; Klarenbach, Scott W.; Tonelli, Marcello] Univ Alberta, Edmonton, AB T6B 2G3, Canada; [Hemmelgarn, Brenda R.; Samuel, Susan] Univ Calgary, Calgary, AB, Canada; [Curhan, Gary C.] Harvard Univ, Channing Lab, Boston, MA 02115 USA	University of Alberta; University of Calgary; Harvard University	Tonelli, M (corresponding author), Univ Alberta, 7-129 Clin Sci Bldg,8440 112 St, Edmonton, AB T6B 2G3, Canada.	mtonelli-admin@med.ualberta.ca	Hemmelgarn, Brenda R./I-6894-2012; Tonelli, Marcello/B-3028-2009; Wiebe, Natasha/V-7803-2019; Klarenbach, Scott/E-7731-2013; Bello, Aminu K/D-2213-2013; Alexander, R. Todd/G-1373-2012	Tonelli, Marcello/0000-0002-0846-3187; Wiebe, Natasha/0000-0002-5613-1582; Klarenbach, Scott/0000-0002-8611-1056; Bello, Aminu K/0000-0002-6905-5937	Alberta Heritage Foundation for Medical Research (AHFMR); Kidney Foundation of Canada; University Hospital Foundation; Canadian Institute of Health Research; KRESCENT New Investigator award; Alberta Innovates Health Solutions Clinical Investigator Award; Canadian Child Health Clinician Scientist Program Career Development award; National Institutes of Health [DK070756]; AHFMR Population Health Scholar award; Government of Canada Research Chair in the optimal care of people with chronic kidney disease; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK070756] Funding Source: NIH RePORTER	Alberta Heritage Foundation for Medical Research (AHFMR)(Alberta Heritage Foundation for Medical Research); Kidney Foundation of Canada; University Hospital Foundation; Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); KRESCENT New Investigator award(Canadian Institutes of Health Research (CIHR)); Alberta Innovates Health Solutions Clinical Investigator Award; Canadian Child Health Clinician Scientist Program Career Development award; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AHFMR Population Health Scholar award; Government of Canada Research Chair in the optimal care of people with chronic kidney disease; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by a team grant to the Interdisciplinary Chronic Disease Collaboration from the Alberta Heritage Foundation for Medical Research (AHFMR), the Kidney Foundation of Canada, and by the University Hospital Foundation. RTA is supported by a Clinician-Scientist award from the Canadian Institute of Health Research, a KRESCENT New Investigator award, and an Alberta Innovates Health Solutions Clinical Investigator Award. SS is supported by a KRESCENT New Investigator award and a Canadian Child Health Clinician Scientist Program Career Development award. GCC is supported by grant DK070756 from the National Institutes of Health. MT is supported by an AHFMR Population Health Scholar award and a Government of Canada Research Chair in the optimal care of people with chronic kidney disease.	Assimos DG, 2002, J UROLOGY, V168, P27, DOI 10.1016/S0022-5347(05)64824-0; Boddana Preetham, 2009, Nephron Clin Pract, V111 Suppl 1, pc269, DOI 10.1159/000210003; Coe FL, 2010, UROL RES, V38, P147, DOI 10.1007/s00240-010-0271-8; Collins AJ, 2010, AM J KIDNEY DIS, V55, pVI, DOI 10.1053/j.ajkd.2009.10.009; Edvardsson V, 2001, AM J KIDNEY DIS, V38, P473, DOI 10.1053/ajkd.2001.26826; Evan AP, 2010, PEDIATR NEPHROL, V25, P831, DOI 10.1007/s00467-009-1116-y; Hemmelgarn BR, 2009, BMC NEPHROL, V10, DOI 10.1186/1471-2369-10-30; Hippisley-Cox J, 2010, BMC FAM PRACT, V11, DOI 10.1186/1471-2296-11-49; James MT, 2010, LANCET, V376, P2096, DOI 10.1016/S0140-6736(10)61271-8; Jungers P, 2004, AM J KIDNEY DIS, V44, P799, DOI 10.1053/j.ajkd.2004.08.014; Levin A, 2008, CAN MED ASSOC J, V179, P1154, DOI 10.1503/cmaj.080351; Lieske JC, 2005, AM J NEPHROL, V25, P290, DOI 10.1159/000086360; Ludwig M, 2006, NEPHROL DIAL TRANSPL, V21, P2708, DOI 10.1093/ndt/gfl346; McCullough PA, 2010, AM J KIDNEY DIS, V55, pS1, DOI 10.1053/j.ajkd.2009.12.017; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Quan HD, 2009, HYPERTENSION, V54, P1423, DOI 10.1161/HYPERTENSIONAHA.109.139279; Rule AD, 2011, CLIN J AM SOC NEPHRO, V6, P2069, DOI 10.2215/CJN.10651110; Rule AD, 2009, CLIN J AM SOC NEPHRO, V4, P804, DOI 10.2215/CJN.05811108; Stamatelou KK, 2003, KIDNEY INT, V63, P1817, DOI 10.1046/j.1523-1755.2003.00917.x; Stankus N, 2007, UROL RES, V35, P83, DOI 10.1007/s00240-007-0079-3; SUTHERLAND JW, 1985, MINER ELECTROL METAB, V11, P267; Tosetto E, 2006, NEPHROL DIAL TRANSPL, V21, P2452, DOI 10.1093/ndt/gfl274; Trinchieri A, 1999, J UROLOGY, V162, P27, DOI 10.1097/00005392-199907000-00007; United States Renal Data System II, 1997, AM J KIDNEY DIS, V30, pS40	24	171	176	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 30	2012	345								e5287	10.1136/bmj.e5287	http://dx.doi.org/10.1136/bmj.e5287			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	036SM	22936784	hybrid, Green Published			2022-12-28	WOS:000311050800001
J	Clayton, J				Clayton, Julie			CLINICAL APPROVAL Trials of an anticancer jab	NATURE			English	Editorial Material							HUMAN-PAPILLOMAVIRUS; VACCINATION PROGRAM; EFFICACY											Australia Dept. Health and Aging, 2011, NAT HPV VACC DAT GIR; Brotherton J. M. L., LANCET INFE IN PRESS; Brotherton JML, 2011, LANCET, V377, P2085, DOI 10.1016/S0140-6736(11)60551-5; Department of Health, ANN HPV VACC COV ENG; Dillner J, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c3493; Donovan B, 2011, LANCET INFECT DIS, V11, P39, DOI 10.1016/S1473-3099(10)70225-5; Dorell Christina, 2011, Morbidity and Mortality Weekly Report, V60, P1117; Garland SM, 2007, NEW ENGL J MED, V356, P1928, DOI 10.1056/NEJMoa061760; Kreimer AR, 2011, LANCET ONCOL, V12, P862, DOI 10.1016/S1470-2045(11)70213-3; Lehtinen M, 2012, LANCET ONCOL, V13, P89, DOI 10.1016/S1470-2045(11)70286-8; Munoz N, 2010, JNCI-J NATL CANCER I, V102, P325, DOI 10.1093/jnci/djp534; Paovonen J, 2009, LANCET, V374, P301, DOI 10.1016/S0140-6736(09)61248-4; Shearer B., 2011, HPV VACCINATION UNDE; Villa LL, 2007, NEW ENGL J MED, V356, P1915, DOI 10.1056/NEJMoa061741; Widgren K, 2011, VACCINE, V29, P9663, DOI 10.1016/j.vaccine.2011.10.021	15	4	4	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 30	2012	488	7413					S4	S6		10.1038/488S4a	http://dx.doi.org/10.1038/488S4a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	996NC	22932438				2022-12-28	WOS:000308095100005
J	McCartney, M				McCartney, Margaret			The V word: selling genital hygiene products to women	BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				ADAMS R, 2010, GUARDIAN; Advertising Standards Bureau, 2012, ADV STAND BOARD DET; Brown L, 2012, CNN             0621; NHS Choices, VAG HLTH; YouTube, 2012, CAR ACT AD 2012 AU	5	1	2	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	AUG 24	2012	345								e5732	10.1136/bmj.e5732	http://dx.doi.org/10.1136/bmj.e5732			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	996HC	22923540				2022-12-28	WOS:000308074500004
J	Shapiro, D				Shapiro, Daniel			Poolside	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Penn State Coll Med, Dept Humanities, Hershey, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Shapiro, D (corresponding author), Penn State Coll Med, Dept Humanities, Hershey, PA USA.	shapiro@psu.edu		Shapiro, Daniel/0000-0002-7166-7705					0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 22	2012	308	8					775	776		10.1001/jama.2012.9425	http://dx.doi.org/10.1001/jama.2012.9425			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	991ML	22910754				2022-12-28	WOS:000307705300020
J	Cassel, CK; Hood, V; Bauer, W				Cassel, Christine K.; Hood, Virginia; Bauer, Werner			A Physician Charter: The 10th Anniversary	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							MEDICAL PROFESSIONALISM		[Cassel, Christine K.] Amer Board Internal Med, Philadelphia, PA 19106 USA; Univ Vermont, Burlington, VT USA; Swiss Inst Med Educ, Bern, Switzerland	American Board of Internal Medicine; University of Vermont	Cassel, CK (corresponding author), Amer Board Internal Med, 510 Walnut St,Suite 1700, Philadelphia, PA 19106 USA.	ccassel@abim.org						American College of Physicians, 2012, ACSP HIGH VAL COST C; Brennan TA, 2003, ANN INTERN MED, V138, P851, DOI 10.7326/0003-4819-138-10-200305200-00018; Campbell EG, 2007, ANN INTERN MED, V147, P795, DOI 10.7326/0003-4819-147-11-200712040-00012; Cohen E., 2011, WHY YOU NEED KNOW HL; Iezzoni LI, 2012, HEALTH AFFAIR, V31, P383, DOI 10.1377/hlthaff.2010.1137; Lesser CS, 2010, JAMA-J AM MED ASSOC, V304, P2732, DOI 10.1001/jama.2010.1864; Mayo Clinic Shared Decision Making National Resource Center, MAYO CLIN PROGR PROF; Perry M, 2011, DEV LANGUAGE MESSAGE; Ross LF, 2006, HASTINGS CENT REP, V36, P17, DOI 10.1353/hcr.2006.0066; Rothman DJ, 2010, JAMA-J AM MED ASSOC, V304, P2294, DOI 10.1001/jama.2010.1714; Saad L., 2011, HEALTHCARE AM TRUST; Smith Wesley J., 1 THINGS; Sox HC, 2002, ANN INTERN MED, V136, P243, DOI 10.7326/0003-4819-136-3-200202050-00012; Swick HM, 2006, PERSPECT BIOL MED, V49, P263, DOI 10.1353/pbm.2006.0026	14	14	14	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 21	2012	157	4					290	+		10.7326/0003-4819-157-4-201208210-00012	http://dx.doi.org/10.7326/0003-4819-157-4-201208210-00012			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	992XG	22910940				2022-12-28	WOS:000307813200020
J	Owen, J				Owen, James			Anybody else for warfarin?	BRITISH MEDICAL JOURNAL			English	Editorial Material												J.O.Drife@leeds.ac.uk							0	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	AUG 20	2012	345								e5543	10.1136/bmj.e5543	http://dx.doi.org/10.1136/bmj.e5543			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	996GL	22906868				2022-12-28	WOS:000308072800002
J	Wang, L; Liu, BB; Li, H; Yang, WG; Ding, Y; Sinogeikin, SV; Meng, Y; Liu, ZX; Zeng, XC; Mao, WL				Wang, Lin; Liu, Bingbing; Li, Hui; Yang, Wenge; Ding, Yang; Sinogeikin, Stanislav V.; Meng, Yue; Liu, Zhenxian; Zeng, Xiao Cheng; Mao, Wendy L.			Long-Range Ordered Carbon Clusters: A Crystalline Material with Amorphous Building Blocks	SCIENCE			English	Article							SOLID-STATE; C-60; PHASE; FULLERENES; THIN	Solid-state materials can be categorized by their structures into crystalline (having periodic translation symmetry), amorphous (no periodic and orientational symmetry), and quasi-crystalline (having orientational but not periodic translation symmetry) phases. Hybridization of crystalline and amorphous structures at the atomic level has not been experimentally observed. We report the discovery of a long-range ordered material constructed from units of amorphous carbon clusters that was synthesized by compressing solvated fullerenes. Using x-ray diffraction, Raman spectroscopy, and quantum molecular dynamics simulation, we observed that, although carbon-60 cages were crushed and became amorphous, the solvent molecules remained intact, playing a crucial role in maintaining the long-range periodicity. Once formed, the high-pressure phase is quenchable back to ambient conditions and is ultra-incompressible, with the ability to indent diamond.	[Wang, Lin; Yang, Wenge] Carnegie Inst Sci, Geophys Lab, High Pressure Synerget Consortium HPSynC, Argonne, IL 60439 USA; [Wang, Lin; Liu, Bingbing] Jilin Univ, State Key Lab Superhard Mat, Changchun 130012, Peoples R China; [Li, Hui; Zeng, Xiao Cheng] Univ Nebraska, Dept Chem, Lincoln, NE 68588 USA; [Ding, Yang] Argonne Natl Lab, Adv Photon Source, Argonne, IL 60439 USA; [Sinogeikin, Stanislav V.; Meng, Yue] Carnegie Inst Sci, Geophys Lab, HPCAT, Argonne, IL 60439 USA; [Liu, Zhenxian] Carnegie Inst Sci, Geophys Lab, Washington, DC 20015 USA; [Mao, Wendy L.] Stanford Univ, Stanford, CA 94305 USA; [Mao, Wendy L.] SLAC Natl Accelerator Lab, Photon Sci & Stanford Inst Mat & Energy Sci, Menlo Pk, CA 94025 USA	Carnegie Institution for Science; Jilin University; University of Nebraska System; University of Nebraska Lincoln; United States Department of Energy (DOE); Argonne National Laboratory; Carnegie Institution for Science; Carnegie Institution for Science; Stanford University; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory	Wang, L (corresponding author), Carnegie Inst Sci, Geophys Lab, High Pressure Synerget Consortium HPSynC, Argonne, IL 60439 USA.	lwang@ciw.edu	Liu, Bingbing/U-8850-2019; Mao, Wendy/D-1885-2009; Yang, Wenge/H-2740-2012; Zeng, Xiao Cheng/C-1590-2013; liu, bb/GXA-2527-2022; Wang, Lin/N-4161-2017; WANG, LIN/G-7884-2012; Ding, Yang/K-1995-2014; Yang, Wenge/ABD-6594-2020	Liu, Bingbing/0000-0003-3989-0891; Zeng, Xiao Cheng/0000-0003-4672-8585; Ding, Yang/0000-0002-8845-4618; Liu, Zhenxian/0000-0003-2617-7077	EFree, an Energy Frontier Research Center; U.S. Department of Energy (DOE), Office of Science [DE-SC0001057]; Carnegie Institute of Washington, Carnegie DOE Alliance Center, University of Nevada at Las Vegas; Lawrence Livermore National Laboratory; DOE National Nuclear Security Administration; DOE Basic Energy Sciences; National Science Foundation (NSF) [DMR-0805056, EAR 06-49658]; Office of Science of the DOE [DE-AC05-00OR22725]; Holland Computing Center at the University of Nebraska; National Natural Science Foundation of China (NSFC) [11004072]; Program for New Century Excellent Talents in University (NCET)	EFree, an Energy Frontier Research Center; U.S. Department of Energy (DOE), Office of Science(United States Department of Energy (DOE)); Carnegie Institute of Washington, Carnegie DOE Alliance Center, University of Nevada at Las Vegas(United States Department of Energy (DOE)); Lawrence Livermore National Laboratory(United States Department of Energy (DOE)); DOE National Nuclear Security Administration(National Nuclear Security AdministrationUnited States Department of Energy (DOE)); DOE Basic Energy Sciences(United States Department of Energy (DOE)); National Science Foundation (NSF)(National Science Foundation (NSF)); Office of Science of the DOE(United States Department of Energy (DOE)); Holland Computing Center at the University of Nebraska; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University (NCET)(Program for New Century Excellent Talents in University (NCET))	We thank H.-k. Mao for valuable comments. We also thank Y. Xiao, G. Shen, S. Yu, V. Prakapenka, A. Kubo, Y. Zhao, W. Cui, R. Liu, and X. Huang for their help. This work was supported as part of EFree, an Energy Frontier Research Center funded by the U.S. Department of Energy (DOE), Office of Science under DE-SC0001057. The use of HPCAT, Advanced Photon Source (APS) is supported by the Carnegie Institute of Washington, Carnegie DOE Alliance Center, University of Nevada at Las Vegas, and Lawrence Livermore National Laboratory through funding from the DOE National Nuclear Security Administration, DOE Basic Energy Sciences, and National Science Foundation (NSF). The use of beamline U2A is supported by NSF (DMR-0805056; EAR 06-49658, Consortium for Materials Properties Research in Earth Sciences (COMPRES)). For the computational research, we used resources from the Oak Ridge Leadership Computing Facility at Oak Ridge National Laboratory, which is supported by the Office of Science of the DOE under contract DE-AC05-00OR22725, and from Holland Computing Center at the University of Nebraska. The synthesis and characterizations of the samples were conducted by the Jilin University group, supported by the National Natural Science Foundation of China (NSFC, 11004072) and Program for New Century Excellent Talents in University (NCET, 2010).	Barrio M, 2003, CHEM MATER, V15, P288, DOI 10.1021/cm021284k; GRAJA A, 1995, SYNTHETIC MET, V70, P1417, DOI 10.1016/0379-6779(94)02903-C; IIJIMA S, 1991, NATURE, V354, P56, DOI 10.1038/354056a0; IWASA Y, 1994, SCIENCE, V264, P1570, DOI 10.1126/science.264.5165.1570; KROTO HW, 1985, NATURE, V318, P162, DOI 10.1038/318162a0; Mao WL, 2003, SCIENCE, V302, P425, DOI 10.1126/science.1089713; Marques L, 1999, SCIENCE, V283, P1720, DOI 10.1126/science.283.5408.1720; Michaud F, 2000, CHEM MATER, V12, P3595, DOI 10.1021/cm0011099; Miller ED, 1997, CHEM MATER, V9, P18, DOI 10.1021/cm960288k; MOSHARY F, 1992, PHYS REV LETT, V69, P466, DOI 10.1103/PhysRevLett.69.466; Novoselov KS, 2004, SCIENCE, V306, P666, DOI 10.1126/science.1102896; NUNEZREGUEIRO M, 1995, PHYS REV LETT, V74, P278, DOI 10.1103/PhysRevLett.74.278; Ramm M, 1996, CRYST RES TECHNOL, V31, P43, DOI 10.1002/crat.2170310111; REGUEIRO MN, 1991, NATURE, V354, P289, DOI 10.1038/354289a0; Sundqvist B, 1999, ADV PHYS, V48, P1, DOI 10.1080/000187399243464; Swietlik R, 1996, CHEM PHYS LETT, V254, P73, DOI 10.1016/0009-2614(96)00308-9; Talyzin A, 2000, J PHYS CHEM B, V104, P5064, DOI 10.1021/jp993658b; Wang L, 2006, CHEM MATER, V18, P4190, DOI 10.1021/cm060997q; Wang L, 2006, ADV MATER, V18, P1883, DOI 10.1002/adma.200502738; Wang L, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2768634; Wang ZW, 2004, P NATL ACAD SCI USA, V101, P13699, DOI 10.1073/pnas.0405877101; Wu MH, 2011, CHEM COMMUN, V47, P4406, DOI 10.1039/c0cc05738j; YOO CS, 1991, SCIENCE, V254, P1489, DOI 10.1126/science.254.5037.1489	23	144	149	11	303	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 17	2012	337	6096					825	828		10.1126/science.1220522	http://dx.doi.org/10.1126/science.1220522			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	989BQ	22904007	Green Submitted			2022-12-28	WOS:000307535600038
J	Camenzind, E; Wijns, W; Mauri, L; Kurowski, V; Parikh, K; Gao, RL; Bode, C; Greenwood, JP; Boersma, E; Vranckx, P; McFadden, E; Serruys, PW; O'Neil, WW; Jorissen, B; Van Leeuwen, F; Steg, PG				Camenzind, Edoardo; Wijns, William; Mauri, Laura; Kurowski, Volkhard; Parikh, Keyur; Gao, Runlin; Bode, Christoph; Greenwood, John P.; Boersma, Eric; Vranckx, Pascal; McFadden, Eugene; Serruys, Patrick W.; O'Neil, William W.; Jorissen, Brenda; Van Leeuwen, Frank; Steg, Ph Gabriel		PROTECT Steering Comm Investigator	Stent thrombosis and major clinical events at 3 years after zotarolimus-eluting or sirolimus-eluting coronary stent implantation: a randomised, multicentre, open-label, controlled trial	LANCET			English	Article							BARE-METAL; MYOCARDIAL-INFARCTION; DOUBLE-BLIND; SAFETY; OUTCOMES; ARTERY; SORT; INTERVENTION; DEFINITIONS; RATIONALE	Background We sought to compare the long-term safety of two devices with different antiproliferative properties: the Endeavor zotarolimus-eluting stent (E-ZES; Medtronic, Inc) and the Cypher sirolimus-eluting stent (C-SES; Cordis, Johnson & Johnson) in a broad group of patients and lesions. Methods Between May 21, 2007 and Dec 22, 2008, we recruited 8791 patients from 36 recruiting countries to participate in this open-label, multicentre, randomised, superiority trial. Eligible patients were those aged 18 years or older undergoing elective, unplanned, or emergency procedures in native coronary arteries. Patients were randomly assigned to either receive E-ZES and C-SES (ratio 1: 1). Randomisation was stratified per centre with varying block sizes of four, six, or eight patients, and concealed with a central telephone-based or web-based allocation service. The primary outcome was definite or probable stent thrombosis at 3 years and was analysed by intention to treat. Patients and investigators were aware of treatment assignment. This trial is registered with ClinicalTrials.gov, number NCT00476957. Findings PROTECT randomised 8791 patients, of whom 8709 provided consent to participate and were eligible: 4357 were allocated to the E-ZES group and 4352 patients to the C-SES group. At 3 years, rates of definite or probable stent thrombosis did not differ between groups (1.4% for E-ZES [predicted: 1.5%] vs 1.8% [predicted: 2.5%] for C-SES; hazard ratio [HR] 0.81, 95% CI 0.58-1.14, p=0.22). Dual antiplatelet therapy was used in 8402 (96%) patients at discharge, 7456 (88%) at 1 year, 3041 (37%) at 2 years, and 2364 (30%) at 3 years. Interpretation No evidence of superiority of E-ZES compared with C-SES in definite or probable stent thrombosis rates was noted at 3 years. Time analysis suggests a difference in definite or probable stent thrombosis between groups is emerging over time, and a longer follow-up is therefore needed given the clinical relevance of stent thrombosis.	[Camenzind, Edoardo] Univ Geneva, CH-1211 Geneva, Switzerland; [Wijns, William] Onze Lieve Vrouw Hosp, Cardiovasc Ctr, Aalst, Belgium; [Mauri, Laura] Brigham & Womens Hosp, Boston, MA 02115 USA; [Kurowski, Volkhard] Univ Klinikum Lubeck, Lubeck, Germany; [Parikh, Keyur] Heart Care Clin, Ahmadabad, Gujarat, India; [Gao, Runlin] Cardiovasc Inst, Beijing, Peoples R China; [Gao, Runlin] Fuwai Hosp, Beijing, Peoples R China; [Bode, Christoph] Univ Hosp Freiburg, Freiburg, Germany; [Greenwood, John P.] Leeds Gen Infirmary, Leeds, W Yorkshire, England; [Boersma, Eric; Vranckx, Pascal; Serruys, Patrick W.] Erasmus MC, Rotterdam, Netherlands; [O'Neil, William W.] Univ Miami, Miller Sch Med, Miami, FL 33136 USA; [McFadden, Eugene] Univ Hosp, Cork, Ireland; [Jorissen, Brenda; Van Leeuwen, Frank] Medtron Bakken Res Ctr, Maastricht, Netherlands; [Steg, Ph Gabriel] Univ Paris Diderot, INSERM, U698, Paris, France; [Steg, Ph Gabriel] Hop Bichat Claude Bernard, AP HP, F-75877 Paris, France	University of Geneva; Cardiovascular Center Aalst; Harvard University; Brigham & Women's Hospital; University of Lubeck; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; University of Freiburg; Leeds General Infirmary; Erasmus University Rotterdam; Erasmus MC; University of Miami; University College Cork; Medtronic Bakken Research Center B.V.; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite	Camenzind, E (corresponding author), Univ Geneva, Rue Michel Servet 1, CH-1211 Geneva, Switzerland.	edoardo@camenzind-cardio.net	Frey, Norbert/A-9695-2010; STEG, Philippe Gabriel/Z-1567-2019; mauri, laura/GPS-4868-2022; Verheugt, F.W.A./H-8105-2014; Walters, Darren/A-7069-2011	TEIGER, emmanuel/0000-0001-7515-4344; Wijns, William/0000-0002-7267-4376; Lopez-Palop, Ramon/0000-0003-4385-7939; Gilard, Martine/0000-0002-2794-7953; STEG, Philippe Gabriel/0000-0001-6896-2941; CARRIE, didier/0000-0003-2479-8144; Trani, Carlo/0000-0001-9777-013X	Medtronic, Inc.; Medtronic; Cordis; Boston Scientific; Abbott; Bristol-Myers Squibb; Dandified-Adventist; Eli Lilly, Daichii; AstraZeneca; Sanofi-Aventis; Boehringer Ingelheim; NYU School of Medicine; Servier	Medtronic, Inc.(Medtronic); Medtronic(Medtronic); Cordis; Boston Scientific(Boston Scientific); Abbott(Abbott Laboratories); Bristol-Myers Squibb(Bristol-Myers Squibb); Dandified-Adventist; Eli Lilly, Daichii; AstraZeneca(AstraZeneca); Sanofi-Aventis(Sanofi-Aventis); Boehringer Ingelheim(Boehringer Ingelheim); NYU School of Medicine; Servier(Servier)	Medtronic, Inc.; LM has been a consultant for Medtronic and Cordis and has received research grants (to institution) from Medtronic, Cordis, Boston Scientific, Abbott, Bristol-Myers Squibb, Dandified-Adventist, Eli Lilly, Daichii. CB has been advisor and speaker for Bayer, AstraZeneca, and Sanofi-Aventis. EMcF has received honoraria from Medtronic, Abbott Vascular, and Cordis for participation in Clinical Events Committees and travel grants from Medtronic, Boston Scientific, AstraZeneca, Sanofi-Aventis, and Boehringer Ingelheim. PGS has received research grants (to institution) from NYU School of Medicine, Sanofi-Aventis, Servier; has been a consultant or in advisory board for Ablynx, Amarin, Astellas, Bayer, Boehringer Ingelheim, BMS, Daiichi Sankyo-Lilly, GlaxoSmithKline, Medtronic, MSD, Novartis, Pfizer, Roche, Sanofi-Aventis, Servier, and The Medicines Company; and has stockholding for Aterovax. All other authors declare that they have no conflicts of interest.	Bavry AA, 2006, AM J MED, V119, P1056, DOI 10.1016/j.amjmed.2006.01.023; Camenzind E, 2007, CIRCULATION, V115, P1440, DOI 10.1161/CIRCULATIONAHA.106.666800; Camenzind E, 2009, AM HEART J, V158, P902, DOI 10.1016/j.ahj.2009.10.002; Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313; Daemen J, 2007, LANCET, V369, P667, DOI 10.1016/S0140-6736(07)60314-6; Fan J, 2012, INT J CARDIOL; Galloe AM, 2008, JAMA-J AM MED ASSOC, V299, P409, DOI 10.1001/jama.299.4.409; Garg P, 2008, J AM COLL CARDIOL, V51, P1844, DOI 10.1016/j.jacc.2008.01.042; Guagliumi G, 2010, JACC-CARDIOVASC INTE, V3, P531, DOI 10.1016/j.jcin.2010.02.008; Hansson L, 1992, Blood Press, V1, P113, DOI 10.3109/08037059209077502; Jensen LO, 2012, CIRCULATION, V125, P1246, DOI 10.1161/CIRCULATIONAHA.111.063644; Joner M, 2008, J AM COLL CARDIOL, V52, P333, DOI 10.1016/j.jacc.2008.04.030; Joner M, 2006, J AM COLL CARDIOL, V48, P193, DOI 10.1016/j.jacc.2006.03.042; Kandzari DE, 2006, J AM COLL CARDIOL, V48, P2440, DOI 10.1016/j.jacc.2006.08.035; Lotan C, 2009, JACC-CARDIOVASC INTE, V2, P1227, DOI 10.1016/j.jcin.2009.10.001; Marroquin OC, 2008, NEW ENGL J MED, V358, P342, DOI 10.1056/NEJMoa0706258; Mauri L, 2007, NEW ENGL J MED, V356, P1020, DOI 10.1056/NEJMoa067731; Mauri L, 2010, JACC-CARDIOVASC INTE, V3, P1240, DOI 10.1016/j.jcin.2010.08.021; Mauri L, 2010, AM HEART J, V160, P1035, DOI 10.1016/j.ahj.2010.07.038; Morice M, 2002, NEW ENGL J MED, V346, P1773, DOI 10.1056/NEJMoa012843; Morice MC, 2007, J AM COLL CARDIOL, V50, P1299, DOI 10.1016/j.jacc.2007.06.029; Moses JW, 2003, NEW ENGL J MED, V349, P1315, DOI 10.1056/NEJMoa035071; Pfisterer M, 2006, J AM COLL CARDIOL, V48, P2584, DOI 10.1016/j.jacc.2006.10.026; RAO AK, 1988, J AM COLL CARDIOL, V11, P1; Rasmussen K, 2010, LANCET, V375, P1090, DOI 10.1016/S0140-6736(10)60208-5; Schofer J, 2003, LANCET, V362, P1093, DOI 10.1016/S0140-6736(03)14462-5; Silber S, 2005, EUR HEART J, V26, P804, DOI 10.1093/eurheartj/ehi138; Spaulding C, 2007, NEW ENGL J MED, V356, P989, DOI 10.1056/NEJMoa066633; Stone GW, 2007, NEW ENGL J MED, V356, P998, DOI 10.1056/NEJMoa067193; Thygesen K, 2007, EUR HEART J, V28, P2525; Urban P, 2006, CIRCULATION, V113, P1434, DOI 10.1161/CIRCULATIONAHA.104.532242; Vranckx P, 2010, EUROINTERVENTION, V5, P871, DOI 10.4244/EIJV5I7A146; Ware JH, 2011, NEW ENGL J MED, V364, P1685, DOI 10.1056/NEJMp1103502; Win HK, 2007, JAMA-J AM MED ASSOC, V297, P2001, DOI 10.1001/jama.297.18.2001; YUSUF S, 1984, STAT MED, V3, P409, DOI 10.1002/sim.4780030421	35	120	121	0	15	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 20	2012	380	9851					1396	1405		10.1016/S0140-6736(12)61336-1	http://dx.doi.org/10.1016/S0140-6736(12)61336-1			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	025NM	22951082				2022-12-28	WOS:000310196500029
J	Hammerman, PS; Lawrence, MS; Voet, D; Jing, R; Cibulskis, K; Sivachenko, A; Stojanov, P; McKenna, A; Lander, ES; Gabriel, S; Getz, G; Sougnez, C; Imielinski, M; Helman, E; Hernandez, B; Pho, NH; Meyerson, M; Chu, A; Chun, HJE; Mungall, AJ; Pleasance, E; Robertson, AG; Sipahimalani, P; Stoll, D; Balasundaram, M; Birol, I; Butterfield, YSN; Chuah, E; Coope, RJN; Corbett, R; Dhalla, N; Guin, R; Hirst, AC; Hirst, M; Holt, RA; Lee, D; Li, HI; Mayo, M; Moore, RA; Mungall, K; Nip, KM; Olshen, A; Schein, JE; Slobodan, JR; Tam, A; Thiessen, N; Varhol, R; Zeng, T; Zhao, Y; Jones, SJM; Marra, MA; Saksena, G; Cherniack, AD; Schumacher, SE; Tabak, B; Carter, SL; Pho, NH; Nguyen, H; Onofrio, RC; Crenshaw, A; Ardlie, K; Beroukhim, R; Winckler, W; Hammerman, PS; Getz, G; Meyerson, M; Protopopov, A; Zhang, JH; Hadjipanayis, A; Lee, S; Xi, RB; Yang, LX; Ren, XJ; Zhang, HL; Shukla, S; Chen, PC; Haseley, P; Lee, E; Chin, L; Park, PJ; Kucherlapati, R; Socci, ND; Liang, YP; Schultz, N; Borsu, L; Lash, AE; Viale, A; Sander, C; Ladanyi, M; Auman, JT; Hoadley, KA; Wilkerson, MD; Shi, Y; Liquori, C; Meng, SW; Li, L; Turman, YJ; Topal, MD; Tan, DH; Waring, S; Buda, E; Walsh, J; Jones, CD; Mieczkowski, PA; Singh, D; Wu, J; Gulabani, A; Dolina, P; Bodenheimer, T; Hoyle, AP; Simons, JV; Soloway, MG; Mose, LE; Jefferys, SR; Balu, S; O'Connor, BD; Prins, JF; Liu, J; Chiang, DY; Hayes, DN; Perou, CM; Cope, L; Danilova, L; Weisenberger, DJ; Maglinte, DT; Pan, F; den Berg, DJ; Triche, T; Herman, JG; Baylin, SB; Laird, PW; Getz, G; Noble, M; Voet, D; Saksena, G; Gehlenborg, N; DiCara, D; Zhang, JH; Zhang, HL; Wu, CJ; Liu, SY; Lawrence, MS; Zou, LH; Sivachenko, A; Lin, P; Stojanov, P; Jing, R; Cho, J; Nazaire, MD; Robinson, J; Thorvaldsdottir, H; Mesirov, J; Park, PJ; Chin, L; Schultz, N; Sinha, R; Ciriello, G; Cerami, E; Gross, B; Jacobsen, A; Gao, J; Aksoy, BA; Weinhold, N; Ramirez, R; Taylor, BS; Antipin, Y; Reva, B; Shen, RL; Mo, Q; Seshan, V; Paik, PK; Ladanyi, M; Sander, C; Akbani, R; Zhang, NX; Broom, BM; Casasent, T; Unruh, A; Wakefield, C; Cason, RC; Baggerly, KA; Weinstein, JN; Haussler, D; Benz, CC; Stuart, JM; Zhu, JC; Szeto, C; Scott, GK; Yau, C; Ng, S; Goldstein, T; Waltman, P; Sokolov, A; Ellrott, K; Collisson, EA; Zerbino, D; Wilks, C; Ma, S; Craft, B; Wilkerson, MD; Auman, JT; Hoadley, KA; Du, Y; Cabanski, C; Walter, V; Singh, D; Wu, JY; Gulabani, A; Bodenheimer, T; Hoyle, AP; Simons, JV; Soloway, MG; Mose, LE; Jefferys, SR; Balu, S; Marron, JS; Liu, Y; Wang, K; Liu, J; Prins, JF; Hayes, DN; Perou, CM; Creighton, CJ; Zhang, YQ; Travis, WD; Rekhtman, N; Yi, J; Aubry, MC; Cheney, R; Dacic, S; Flieder, D; Funkhouser, W; Illei, P; Myers, J; Tsao, MS; Penny, R; Mallery, D; Shelton, T; Hatfield, M; Morris, S; Yena, P; Shelton, C; Sherman, M; Paulauskis, J; Meyerson, M; Baylin, SB; Govindan, R; Akbani, R; Azodo, I; Beer, D; Bose, R; Byers, LA; Carbone, D; Chang, LW; Chiang, D; Chu, A; Chun, E; Collisson, E; Cope, L; Creighton, CJ; Danilova, L; Ding, L; Getz, G; Hammerman, PS; Hayes, DN; Hernandez, B; Herman, JG; Heymach, J; Ida, C; Imielinski, M; Johnson, B; Jurisica, I; Kaufman, J; Kosari, F; Kucherlapati, R; Kwiatkowski, D; Ladanyi, M; Lawrence, MS; Maher, CA; Mungall, A; Ng, S; Pao, W; Peifer, M; Penny, R; Robertson, G; Rusch, V; Sander, C; Schultz, N; Shen, RL; Siegfried, J; Sinha, R; Sivachenko, A; Sougnez, C; Stoll, D; Stuart, J; Thomas, RK; Tomaszek, S; Tsao, MS; Travis, WD; Vaske, C; Weinstein, JN; Weisenberger, D; Wheeler, D; Wigle, DA; Wilkerson, MD; Wilks, C; Yang, P; Zhang, JJ; Jensen, MA; Sfeir, R; Kahn, AB; Chu, AL; Kothiyal, P; Wang, Z; Snyder, EE; Pontius, J; Pihl, TD; Ayala, B; Backus, M; Walton, J; Baboud, J; Berton, DL; Nicholls, MC; Srinivasan, D; Raman, R; Girshik, S; Kigonya, PA; Alonso, S; Sanbhadti, RN; Barletta, SP; Greene, JM; Pot, DA; Tsao, MS; Bandarchi-Chamkhaleh, B; Boyd, J; Weaver, J; Wigle, DA; Azodo, IA; Tomaszek, SC; Aubry, MC; Ida, CM; Yang, P; Kosari, F; Brock, MV; Rogers, K; Rutledge, M; Brown, T; Lee, B; Shin, J; Trusty, D; Dhir, R; Siegfried, JM; Potapova, O; Fedosenko, KV; Nemirovich-Danchenko, E; Rusch, V; Zakowski, M; Iacocca, MV; Brown, J; Rabeno, B; Czerwinski, C; Petrelli, N; Fan, Z; Todaro, N; Eckman, J; Myers, J; Rathmell, WK; Thorne, LB; Huang, M; Boice, L; Hill, A; Penny, R; Mallery, D; Curley, E; Shelton, C; Yena, P; Morrison, C; Gaudioso, C; Bartlett, JS; Kodeeswaran, S; Zanke, B; Sekhon, H; David, K; Juhl, H; Van Le, X; Kohl, B; Thorp, R; Tien, NV; Van Bang, N; Sussman, H; Phu, BD; Hajek, R; PhiHung, N; Khan, KZ; Muley, T; Shaw, KRM; Sheth, M; Yang, L; Buetow, K; Davidsen, T; Demchok, JA; Eley, G; Ferguson, M; Dillon, LAL; Schaefer, C; Guyer, MS; Ozenberger, BA; Palchik, JD; Peterson, J; Sofia, HJ; Thomson, E; Meyerson, M				Hammerman, Peter S.; Lawrence, Michael S.; Voet, Douglas; Jing, Rui; Cibulskis, Kristian; Sivachenko, Andrey; Stojanov, Petar; McKenna, Aaron; Lander, Eric S.; Gabriel, Stacey; Getz, Gad; Sougnez, Carrie; Imielinski, Marcin; Helman, Elena; Hernandez, Bryan; Pho, Nam H.; Meyerson, Matthew; Chu, Andy; Chun, Hye-Jung E.; Mungall, Andrew J.; Pleasance, Erin; Robertson, A. Gordon; Sipahimalani, Payal; Stoll, Dominik; Balasundaram, Miruna; Birol, Inanc; Butterfield, Yaron S. N.; Chuah, Eric; Coope, Robin J. N.; Corbett, Richard; Dhalla, Noreen; Guin, Ranabir; Hirst, Anhe Carrie; Hirst, Martin; Holt, Robert A.; Lee, Darlene; Li, Haiyan I.; Mayo, Michael; Moore, Richard A.; Mungall, Karen; Nip, Ka Ming; Olshen, Adam; Schein, Jacqueline E.; Slobodan, Jared R.; Tam, Angela; Thiessen, Nina; Varhol, Richard; Zeng, Thomas; Zhao, Yongjun; Jones, Steven J. M.; Marra, Marco A.; Saksena, Gordon; Cherniack, Andrew D.; Schumacher, Stephen E.; Tabak, Barbara; Carter, Scott L.; Pho, Nam H.; Nguyen, Huy; Onofrio, Robert C.; Crenshaw, Andrew; Ardlie, Kristin; Beroukhim, Rameen; Winckler, Wendy; Hammerman, Peter S.; Getz, Gad; Meyerson, Matthew; Protopopov, Alexei; Zhang, Jianhua; Hadjipanayis, Angela; Lee, Semin; Xi, Ruibin; Yang, Lixing; Ren, Xiaojia; Zhang, Hailei; Shukla, Sachet; Chen, Peng-Chieh; Haseley, Psalm; Lee, Eunjung; Chin, Lynda; Park, Peter J.; Kucherlapati, Raju; Socci, Nicholas D.; Liang, Yupu; Schultz, Nikolaus; Borsu, Laetitia; Lash, Alex E.; Viale, Agnes; Sander, Chris; Ladanyi, Marc; Auman, J. Todd; Hoadley, Katherine A.; Wilkerson, Matthew D.; Shi, Yan; Liquori, Christina; Meng, Shaowu; Li, Ling; Turman, Yidi J.; Topal, Michael D.; Tan, Donghui; Waring, Scot; Buda, Elizabeth; Walsh, Jesse; Jones, Corbin D.; Mieczkowski, Piotr A.; Singh, Darshan; Wu, Junyuan; Gulabani, Anisha; Dolina, Peter; Bodenheimer, Tom; Hoyle, Alan P.; Simons, Janae V.; Soloway, Matthew G.; Mose, Lisle E.; Jefferys, Stuart R.; Balu, Saianand; O'Connor, Brian D.; Prins, Jan F.; Liu, Jinze; Chiang, Derek Y.; Hayes, D. Neil; Perou, Charles M.; Cope, Leslie; Danilova, Ludmila; Weisenberger, Daniel J.; Maglinte, Dennis T.; Pan, Fei; Van den Berg, David J.; Triche, Timothy; Herman, James G.; Baylin, Stephen B.; Laird, Peter W.; Getz, Gad; Noble, Michael; Voet, Doug; Saksena, Gordon; Gehlenborg, Nils; DiCara, Daniel; Zhang, Jinhua; Zhang, Hailei; Wu, Chang-Jiun; Liu, Spring Yingchun; Lawrence, Michael S.; Zou, Lihua; Sivachenko, Andrey; Lin, Pei; Stojanov, Petar; Jing, Rui; Cho, Juok; Nazaire, Marc-Danie; Robinson, Jim; Thorvaldsdottir, Helga; Mesirov, Jill; Park, Peter J.; Chin, Lynda; Schultz, Nikolaus; Sinha, Rileen; Ciriello, Giovanni; Cerami, Ethan; Gross, Benjamin; Jacobsen, Anders; Gao, Jianjiong; Aksoy, B. Arman; Weinhold, Nils; Ramirez, Ricardo; Taylor, Barry S.; Antipin, Yevgeniy; Reva, Boris; Shen, Ronglai; Mo, Qianxing; Seshan, Venkatraman; Paik, Paul K.; Ladanyi, Marc; Sander, Chris; Akbani, Rehan; Zhang, Nianxiang; Broom, Bradley M.; Casasent, Tod; Unruh, Anna; Wakefield, Chris; Cason, R. Craig; Baggerly, Keith A.; Weinstein, John N.; Haussler, David; Benz, Christopher C.; Stuart, Joshua M.; Zhu, Jingchun; Szeto, Christopher; Scott, Gary K.; Yau, Christina; Ng, Sam; Goldstein, Ted; Waltman, Peter; Sokolov, Artem; Ellrott, Kyle; Collisson, Eric A.; Zerbino, Daniel; Wilks, Christopher; Ma, Singer; Craft, Brian; Wilkerson, Matthew D.; Auman, J. Todd; Hoadley, Katherine A.; Du, Ying; Cabanski, Christopher; Walter, Vonn; Singh, Darshan; Wu, Junyuan; Gulabani, Anisha; Bodenheimer, Tom; Hoyle, Alan P.; Simons, Janae V.; Soloway, Matthew G.; Mose, Lisle E.; Jefferys, Stuart R.; Balu, Saianand; Marron, J. S.; Liu, Yufeng; Wang, Kai; Liu, Jinze; Prins, Jan F.; Hayes, D. Neil; Perou, Charles M.; Creighton, Chad J.; Zhang, Yiqun; Travis, William D.; Rekhtman, Natasha; Yi, Joanne; Aubry, Marie C.; Cheney, Richard; Dacic, Sanja; Flieder, Douglas; Funkhouser, William; Illei, Peter; Myers, Jerome; Tsao, Ming-Sound; Penny, Robert; Mallery, David; Shelton, Troy; Hatfield, Martha; Morris, Scott; Yena, Peggy; Shelton, Candace; Sherman, Mark; Paulauskis, Joseph; Meyerson, Matthew; Baylin, Stephen B.; Govindan, Ramaswamy; Akbani, Rehan; Azodo, Ijeoma; Beer, David; Bose, Ron; Byers, Lauren A.; Carbone, David; Chang, Li-Wei; Chiang, Derek; Chu, Andy; Chun, Elizabeth; Collisson, Eric; Cope, Leslie; Creighton, Chad J.; Danilova, Ludmila; Ding, Li; Getz, Gad; Hammerman, Peter S.; Hayes, D. Neil; Hernandez, Bryan; Herman, James G.; Heymach, John; Ida, Cristiane; Imielinski, Marcin; Johnson, Bruce; Jurisica, Igor; Kaufman, Jacob; Kosari, Farhad; Kucherlapati, Raju; Kwiatkowski, David; Ladanyi, Marc; Lawrence, Michael S.; Maher, Christopher A.; Mungall, Andy; Ng, Sam; Pao, William; Peifer, Martin; Penny, Robert; Robertson, Gordon; Rusch, Valerie; Sander, Chris; Schultz, Nikolaus; Shen, Ronglai; Siegfried, Jill; Sinha, Rileen; Sivachenko, Andrey; Sougnez, Carrie; Stoll, Dominik; Stuart, Joshua; Thomas, Roman K.; Tomaszek, Sandra; Tsao, Ming-Sound; Travis, William D.; Vaske, Charles; Weinstein, John N.; Weisenberger, Daniel; Wheeler, David; Wigle, Dennis A.; Wilkerson, Matthew D.; Wilks, Christopher; Yang, Ping; Zhang, Jianjua John; Jensen, Mark A.; Sfeir, Robert; Kahn, Ari B.; Chu, Anna L.; Kothiyal, Prachi; Wang, Zhining; Snyder, Eric E.; Pontius, Joan; Pihl, Todd D.; Ayala, Brenda; Backus, Mark; Walton, Jessica; Baboud, Julien; Berton, Dominique L.; Nicholls, Matthew C.; Srinivasan, Deepak; Raman, Rohini; Girshik, Stanley; Kigonya, Peter A.; Alonso, Shelley; Sanbhadti, Rashmi N.; Barletta, Sean P.; Greene, John M.; Pot, David A.; Tsao, Ming-Sound; Bandarchi-Chamkhaleh, Bizhan; Boyd, Jeff; Weaver, JoEllen; Wigle, Dennis A.; Azodo, Ijeoma A.; Tomaszek, Sandra C.; Aubry, Marie Christine; Ida, Christiane M.; Yang, Ping; Kosari, Farhad; Brock, Malcolm V.; Rogers, Kristen; Rutledge, Marian; Brown, Travis; Lee, Beverly; Shin, James; Trusty, Dante; Dhir, Rajiv; Siegfried, Jill M.; Potapova, Olga; Fedosenko, Konstantin V.; Nemirovich-Danchenko, Elena; Rusch, Valerie; Zakowski, Maureen; Iacocca, Mary V.; Brown, Jennifer; Rabeno, Brenda; Czerwinski, Christine; Petrelli, Nicholas; Fan, Zhen; Todaro, Nicole; Eckman, John; Myers, Jerome; Rathmell, W. Kimryn; Thorne, Leigh B.; Huang, Mei; Boice, Lori; Hill, Ashley; Penny, Robert; Mallery, David; Curley, Erin; Shelton, Candace; Yena, Peggy; Morrison, Carl; Gaudioso, Carmelo; Bartlett, Johnm. S.; Kodeeswaran, Sugy; Zanke, Brent; Sekhon, Harman; David, Kerstin; Juhl, Hartmut; Van Le, Xuan; Kohl, Bernard; Thorp, Richard; Tien, Nguyen Viet; Van Bang, Nguyen; Sussman, Howard; Phu, Bui Duc; Hajek, Richard; PhiHung, Nguyen; Khan, Khurram Z.; Muley, Thomas; Shaw, Kenna R. Mills; Sheth, Margi; Yang, Liming; Buetow, Ken; Davidsen, Tanja; Demchok, John A.; Eley, Greg; Ferguson, Martin; Dillon, Laura A. L.; Schaefer, Carl; Guyer, Mark S.; Ozenberger, Bradley A.; Palchik, Jacqueline D.; Peterson, Jane; Sofia, Heidi J.; Thomson, Elizabeth; Meyerson, Matthew		Canc Genome Atlas Res Network	Comprehensive genomic characterization of squamous cell lung cancers	NATURE			English	Article							COPY-NUMBER ALTERATION; THERAPEUTIC TARGET; MUTATIONS; GENE; AMPLIFICATION; CARCINOMA; SENSITIVITY; LANDSCAPE; GEFITINIB; ONCOGENE	Lung squamous cell carcinoma is a common type of lung cancer, causing approximately 400,000 deaths per year worldwide. Genomic alterations in squamous cell lung cancers have not been comprehensively characterized, and no molecularly targeted agents have been specifically developed for its treatment. As part of The Cancer Genome Atlas, here we profile 178 lung squamous cell carcinomas to provide a comprehensive landscape of genomic and epigenomic alterations. We show that the tumour type is characterized by complex genomic alterations, with a mean of 360 exonic mutations, 165 genomic rearrangements, and 323 segments of copy number alteration per tumour. We find statistically recurrent mutations in 11 genes, including mutation of TP53 in nearly all specimens. Previously unreported loss-of-function mutations are seen in the HLA-A class I major histocompatibility gene. Significantly altered pathways included NFE2L2 and KEAP1 in 34%, squamous differentiation genes in 44%, phosphatidylinositol-3-OH kinase pathway genes in 47%, and CDKN2A and RB1 in 72% of tumours. We identified a potential therapeutic target in most tumours, offering new avenues of investigation for the treatment of squamous cell lung cancers.	[Sivachenko, Andrey; McKenna, Aaron; Cherniack, Andrew D.; Crenshaw, Andrew; Hadjipanayis, Angela; Chen, Peng-Chieh; Kucherlapati, Raju] MIT, Eli & Edythe L Broad Inst, Cambridge, MA 02142 USA; [Hammerman, Peter S.; Meyerson, Matthew; Beroukhim, Rameen; Hammerman, Peter S.; Meyerson, Matthew; Johnson, Bruce] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; [Lander, Eric S.] MIT, Dept Biol, Cambridge, MA 02142 USA; [Lander, Eric S.; Sougnez, Carrie] Harvard Univ, Dept Syst Biol, Boston, MA 02115 USA; [Gabriel, Stacey; Getz, Gad; Sougnez, Carrie; Onofrio, Robert C.; Ardlie, Kristin] Harvard Univ, Genet Anal Platform, Cambridge, MA 02142 USA; [Imielinski, Marcin; Meyerson, Matthew; Meyerson, Matthew; Imielinski, Marcin] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Chu, Andy; Chun, Hye-Jung E.; Mungall, Andrew J.; Pleasance, Erin; Robertson, A. Gordon; Sipahimalani, Payal; Stoll, Dominik; Balasundaram, Miruna; Birol, Inanc; Chuah, Eric; Guin, Ranabir; Hirst, Anhe Carrie; Hirst, Martin; Lee, Darlene; Li, Haiyan I.; Mayo, Michael; Mungall, Karen; Nip, Ka Ming; Schein, Jacqueline E.; Slobodan, Jared R.; Thiessen, Nina; Marra, Marco A.; Chun, Elizabeth; Mungall, Andy; Robertson, Gordon] BC Canc Agcy, Canadas Michael Smith Genome Sci Ctr, Vancouver, BC V5Z, Canada; [Olshen, Adam] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Olshen, Adam] Dana Farber Canc Inst, Boston, MA 02115 USA; [Protopopov, Alexei; Zhang, Jianhua; Ren, Xiaojia; Zhang, Hailei; Shukla, Sachet; Zhang, Jinhua; Chin, Lynda] Univ Texas MD Anderson Canc Ctr, Inst Appl Canc Sci, Dept Genom Med, Houston, TX 77030 USA; [Hadjipanayis, Angela; Ren, Xiaojia; Chen, Peng-Chieh; Haseley, Psalm; Lee, Eunjung; Park, Peter J.; Kucherlapati, Raju] Brigham & Womens Hosp, Div Genet, Boston, MA 02115 USA; [Lee, Semin; Xi, Ruibin; Yang, Lixing; Haseley, Psalm; Lee, Eunjung; Gehlenborg, Nils] Harvard Univ, Ctr Biomed Informat, Sch Med, Boston, MA 02115 USA; [Park, Peter J.] Childrens Hosp, Informat Program, Boston, MA 02115 USA; [Socci, Nicholas D.; Liang, Yupu; Schultz, Nikolaus; Borsu, Laetitia; Lash, Alex E.; Viale, Agnes; Sander, Chris; Sinha, Rileen; Ciriello, Giovanni; Cerami, Ethan; Gross, Benjamin; Jacobsen, Anders; Gao, Jianjiong; Aksoy, B. Arman; Weinhold, Nils; Ramirez, Ricardo; Taylor, Barry S.; Antipin, Yevgeniy; Reva, Boris] Mem Sloan Kettering Canc Ctr, Computat Biol Ctr, New York, NY 10065 USA; [Ladanyi, Marc; Ladanyi, Marc] Mem Sloan Kettering Canc Ctr, Dept Mol Oncol, New York, NY 10065 USA; [Ladanyi, Marc; Ladanyi, Marc] Mem Sloan Kettering Canc Ctr, Dept Pathol & Human Oncol, New York, NY 10065 USA; [Auman, J. Todd] Univ N Carolina, Eshelman Sch Pharm, Chapel Hill, NC 27599 USA; [Auman, J. Todd; Zerbino, Daniel; Auman, J. Todd] Univ N Carolina, Inst Pharmacogenet & Individualized Therapy, Chapel Hill, NC 27599 USA; [Hoadley, Katherine A.; Mieczkowski, Piotr A.; Chiang, Derek Y.] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; [Hoadley, Katherine A.; Mose, Lisle E.; Jefferys, Stuart R.; Perou, Charles M.] Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC 27599 USA; [Hoadley, Katherine A.; Wilkerson, Matthew D.; Liquori, Christina; Li, Ling; Buda, Elizabeth; Walsh, Jesse; Singh, Darshan; Wu, Junyuan; Gulabani, Anisha; Dolina, Peter; Hoyle, Alan P.; Simons, Janae V.; Soloway, Matthew G.; Collisson, Eric A.; Craft, Brian; Cabanski, Christopher; Prins, Jan F.; Chiang, Derek; Hayes, D. Neil] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Tan, Donghui; Liu, Yufeng] Univ N Carolina, Carolina Ctr Genome Sci, Chapel Hill, NC 27599 USA; [Jones, Corbin D.; Hayes, D. Neil] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; [Balu, Saianand; Prins, Jan F.] Univ N Carolina, Dept Comp Sci, Chapel Hill, NC 27599 USA; [Liu, Jinze] Univ Kentucky, Dept Comp Sci, Lexington, KY 40506 USA; [Hayes, D. Neil] Univ N Carolina, Dept Internal Med, Div Med Oncol, Chapel Hill, NC 27599 USA; [Cope, Leslie; Danilova, Ludmila; Herman, James G.; Baylin, Stephen B.] Johns Hopkins Univ, Canc Biol Div, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21231 USA; [Weisenberger, Daniel J.; Maglinte, Dennis T.; Pan, Fei; Van den Berg, David J.; Triche, Timothy; Laird, Peter W.; Weisenberger, Daniel; Wilks, Christopher] Univ So Calif, Calif Epigenome Ctr, Los Angeles, CA 90033 USA; [Akbani, Rehan; Zhang, Nianxiang; Broom, Bradley M.; Unruh, Anna; Wakefield, Chris; Baggerly, Keith A.; Weinstein, John N.; Weinstein, John N.] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA; [Cason, R. Craig] Univ Texas MD Anderson Canc Ctr, Div Pathol & Lab Med, Houston, TX 77030 USA; [Weinstein, John N.] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA; [Haussler, David; Stuart, Joshua M.; Zhu, Jingchun; Szeto, Christopher; Ng, Sam; Waltman, Peter; Sokolov, Artem; Ellrott, Kyle; Stuart, Joshua; Vaske, Charles] Univ Calif Santa Cruz, Dept Biomol Engn, Santa Cruz, CA 95064 USA; [Haussler, David; Stuart, Joshua M.; Zhu, Jingchun; Szeto, Christopher; Goldstein, Ted; Waltman, Peter; Sokolov, Artem; Ellrott, Kyle; Stuart, Joshua; Vaske, Charles] Univ Calif Santa Cruz, Ctr Biomol Sci & Engn, Santa Cruz, CA 95064 USA; Univ Calif Santa Cruz, Howard Hughes Med Inst, Santa Cruz, CA 95064 USA; [Benz, Christopher C.; Scott, Gary K.; Yau, Christina] Buck Inst Age Res, Novato, CA 94945 USA; [Collisson, Eric] Univ Calif San Francisco, Div Hematol Oncol, San Francisco, CA 94143 USA; [Marron, J. S.] Univ N Carolina, Dept Stat & Operat Res, Chapel Hill, NC 27599 USA; [Creighton, Chad J.; Zhang, Yiqun] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Zhang, Yiqun] Baylor Coll Med, Dan L Duncan Canc Ctr, Div Biostat, Houston, TX 77030 USA; [Travis, William D.; Rekhtman, Natasha] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10065 USA; [Yi, Joanne; Aubry, Marie C.; Ida, Cristiane] Mayo Clin, Dept Pathol, Rochester, MN 55905 USA; [Cheney, Richard; Shelton, Candace; Yena, Peggy; Morrison, Carl; Gaudioso, Carmelo] Roswell Pk Canc Inst, Dept Pathol, Buffalo, NY 14263 USA; [Dacic, Sanja] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA 15213 USA; [Flieder, Douglas; Boyd, Jeff; Weaver, JoEllen] Fox Chase Canc Ctr, Dept Pathol, Philadelphia, PA 19111 USA; [Funkhouser, William] Univ N Carolina, Dept Pathol, Med Ctr, Chapel Hill, NC 27599 USA; [Illei, Peter] Johns Hopkins Univ, Dept Pathol, Sch Med, Baltimore, MD 21287 USA; [Myers, Jerome] Penrose St Francis Hlth Syst, Dept Pathol, Colorado Springs, CO 80907 USA; [Tsao, Ming-Sound; Bandarchi-Chamkhaleh, Bizhan] Ontario Canc Inst, Dept Pathol & Med Biophys, Toronto, ON M5G 2MY, Canada; [Tsao, Ming-Sound; Bandarchi-Chamkhaleh, Bizhan] Princess Margaret Hosp, Toronto, ON M5G 2MY, Canada; [Penny, Robert; Mallery, David; Shelton, Troy; Hatfield, Martha; Morris, Scott; Yena, Peggy; Shelton, Candace; Sherman, Mark; Paulauskis, Joseph; Hill, Ashley; Curley, Erin] Int Genom Consortium, Phoenix, AZ 85004 USA; [Govindan, Ramaswamy; Bose, Ron; Chang, Li-Wei; Ding, Li; Maher, Christopher A.] Washington Univ, Dept Med, Div Oncol, Sch Med, St Louis, MO 63110 USA; [Beer, David] Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA; [Carbone, David; Kaufman, Jacob; Pao, William] Vanderbilt Univ, Dept Hematol, Nashville, TN 37232 USA; [Jurisica, Igor; Brock, Malcolm V.] IBM Life Sci Discovery Ctr, Ontario Canc Inst, Toronto, ON M5G 1L7, Canada; [Peifer, Martin; Thomas, Roman K.] Univ Cologne, Dept Translat Genom, D-50931 Cologne, Germany; [Rusch, Valerie] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10065 USA; [Siegfried, Jill; Siegfried, Jill M.] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Med Ctr, Pittsburgh, PA 15232 USA; [Thomas, Roman K.] Univ Cologne, Dept Translat Canc Genom, Ctr Integrated Oncol, D-50924 Cologne, Germany; [Wheeler, David] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Ida, Christiane M.] Mayo Clin, Dept Lab Med, Rochester, MN 55905 USA; [Yang, Ping] Mayo Clin, Dept Hlth Sci Res, Rochester, MN 55905 USA; [Rogers, Kristen; Brown, Travis] Johns Hopkins Sch Med, Dept Surg, Baltimore, MD 21287 USA; [Rutledge, Marian; Lee, Beverly] Johns Hopkins Sch Med, Dept Oncol, Baltimore, MD 21287 USA; [Shin, James; Trusty, Dante] Johns Hopkins Sch Med, Dept Pathol, Baltimore, MD 21287 USA; [Dhir, Rajiv] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA 15213 USA; [Potapova, Olga; Nemirovich-Danchenko, Elena] Cureline, San Francisco, CA 94080 USA; [Fedosenko, Konstantin V.] City Clin Oncol Dispensary, St Petersburg 197022, Russia; [Zakowski, Maureen] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10065 USA; [Iacocca, Mary V.; Brown, Jennifer; Rabeno, Brenda; Czerwinski, Christine; Petrelli, Nicholas] Helen F Graham Canc Ctr, Newark, DE 19713 USA; [Fan, Zhen; Todaro, Nicole; Huang, Mei] St Joseph Med Ctr, Towson, MD 21204 USA; [Thorne, Leigh B.] UNC Lineberger Canc Ctr, UNC Tissue Procurement Facil, Dept Pathol, Chapel Hill, NC 27599 USA; [Kodeeswaran, Sugy; Zanke, Brent] Ontario Inst Canc Res, Ontario Tumour Bank, Toronto, ON M5G 0A3, Canada; [David, Kerstin] Indivumed GmbH, D-20251 Hamburg, Germany; [Juhl, Hartmut] Indivumed Inc, Kensington, MD 20895 USA; [Van Le, Xuan; Kohl, Bernard; Thorp, Richard] ILSBio LLC, Chestertown, MD 21620 USA; [Tien, Nguyen Viet] Minist Hlth, Hanoi, Vietnam; [Van Bang, Nguyen] Hue Cent Hosp, Hue City, Vietnam; [Sussman, Howard] Stanford Univ, Med Ctr, Stanford, CA 94305 USA; [Hajek, Richard] Univ Texas MD Anderson Canc Ctr, Ctr Minor Hlth Res, Houston, TX 77030 USA; [Phu, Bui Duc; PhiHung, Nguyen] Natl Canc Inst, Hanoi, Vietnam; [Khan, Khurram Z.] ILSBio LLC, Chestertown, MD 21620 USA; [Muley, Thomas] Univ Heidelberg Hosp, ThoraxKlin, D-69126 Heidelberg, Germany; [Shaw, Kenna R. Mills; Sheth, Margi; Yang, Liming; Demchok, John A.; Dillon, Laura A. L.] NCI, Canc Genome Atlas Program Off, Bethesda, MD 20892 USA; [Buetow, Ken; Davidsen, Tanja; Eley, Greg; Schaefer, Carl] NCI, CBIIT, NIH, Rockville, MD 20852 USA; [Guyer, Mark S.; Ozenberger, Bradley A.; Palchik, Jacqueline D.; Peterson, Jane; Sofia, Heidi J.; Thomson, Elizabeth] NHGRI, NIH, Bethesda, MD 20892 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Dana-Farber Cancer Institute; Massachusetts Institute of Technology (MIT); Harvard University; Harvard University; Harvard University; Harvard Medical School; British Columbia Cancer Agency; University of California System; University of California San Francisco; Harvard University; Dana-Farber Cancer Institute; University of Texas System; UTMD Anderson Cancer Center; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Kentucky; University of North Carolina; University of North Carolina Chapel Hill; Johns Hopkins University; Johns Hopkins Medicine; University of Southern California; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz; Howard Hughes Medical Institute; University of California System; University of California Santa Cruz; Buck Institute for Research on Aging; University of California System; University of California San Francisco; University of North Carolina; University of North Carolina Chapel Hill; Baylor College of Medicine; Baylor College of Medicine; Memorial Sloan Kettering Cancer Center; Mayo Clinic; Roswell Park Cancer Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Fox Chase Cancer Center; University of North Carolina; University of North Carolina Chapel Hill; Johns Hopkins University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; International Genomics Consortium; Washington University (WUSTL); University of Michigan System; University of Michigan; Vanderbilt University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Cologne; Memorial Sloan Kettering Cancer Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Cologne; Baylor College of Medicine; Mayo Clinic; Mayo Clinic; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Memorial Sloan Kettering Cancer Center; Helen F. Graham Cancer Center & Research Institute; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; Stanford University; University of Texas System; UTMD Anderson Cancer Center; Ruprecht Karls University Heidelberg; International Genomics Consortium; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Center for Cancer Genomics (CCG); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Meyerson, M (corresponding author), MIT, Eli & Edythe L Broad Inst, Cambridge, MA 02142 USA.	matthew_meyerson@dfci.harvard.edu	, Pathology Services Core/CEZ-2246-2022; Cibulskis, Kristian/AAC-7380-2019; Wheeler, David A/M-9740-2018; Lawrence, Michael/AAC-8202-2020; Reva, Boris A./B-6436-2014; Weisenberger, Daniel/AAA-8314-2020; Chiang, Derek/L-6452-2019; Tsao, Ming-Sound/M-3503-2017; Hirst, Martin/B-7684-2016; Marra, Marco A/B-5987-2008; Stojanov, Petar/GQI-4462-2022; Mungall, Andrew J./U-7067-2018; Jones, Steven J/C-3621-2009; Reva, Boris/AAB-8932-2022; Mesirov, Jill/AGF-7626-2022; Cherniack, Andrew/AAC-5310-2019; Holt, Robert A/C-3303-2009; Perou, Charles M/H-9934-2014; Kucherlapati, Raju/ABC-8807-2021; Gao, JianJiong/B-5673-2016; Heymach, John/AAG-2361-2019; Walter, Vonn/AAI-3450-2021; Cherniack, Andrew D./AAY-8132-2020; Schultz, Nikolaus/ABE-6347-2020; Tsao, Ming Sound/AFQ-7332-2022; Birol, Inanc/G-5440-2011; Lee, Semin/S-2629-2016; Yang, Lixing/A-7073-2013; Schein, Jacquie E/G-3674-2015; Laird, Peter W/G-8683-2012; Zhang, YiQun/HCI-2427-2022; Auman, James/AAY-7748-2020; Schumacher, Steven/E-9821-2013; Skanderup, Anders Jacobsen/K-1081-2013; Ladanyi, Marc/AAG-8585-2019; Muley, Thomas/AAY-9200-2020; Vaske, Charles/D-6018-2013; Van Den Berg, David J/G-8598-2017; Noble, Michelle M/C-4653-2011; Akbani, Rehan/AAG-1490-2019	Wheeler, David A/0000-0002-9056-6299; Reva, Boris A./0000-0002-8805-389X; Weisenberger, Daniel/0000-0001-8303-2603; Marra, Marco A/0000-0001-7146-7175; Stojanov, Petar/0000-0001-7815-776X; Mungall, Andrew J./0000-0002-0905-2742; Jones, Steven J/0000-0003-3394-2208; Holt, Robert A/0000-0002-7259-1247; Perou, Charles M/0000-0001-9827-2247; Gao, JianJiong/0000-0002-5739-1781; Heymach, John/0000-0001-9068-8942; Walter, Vonn/0000-0001-6114-6714; Cherniack, Andrew D./0000-0003-0470-0111; Tsao, Ming Sound/0000-0002-9160-5405; Birol, Inanc/0000-0003-0950-7839; Lee, Semin/0000-0002-9015-6046; Laird, Peter W/0000-0001-9117-3641; Schumacher, Steven/0000-0002-6819-5647; Skanderup, Anders Jacobsen/0000-0001-6847-4980; Vaske, Charles/0000-0001-8151-6612; Van Den Berg, David J/0000-0002-5404-5218; Noble, Michelle M/0000-0001-6820-1034; Ciriello, Giovanni/0000-0003-2021-8683; O'Connor, Brian/0000-0002-7681-6415; Park, Peter/0000-0001-9378-960X; Cibulskis, Kristian/0000-0003-1343-1582; Hayes, D. Neil/0000-0001-6203-7771; Chen, Peng-Chieh ( Jessica )/0000-0002-2060-1765; Stoll, Dominik/0000-0003-0701-4301; Lash, Alex/0000-0003-3787-1590; Triche, Tim/0000-0001-5665-946X; Rusch, Valerie/0000-0003-2345-6900; Xi, Ruibin/0000-0001-7545-7361; Jensen, Mark/0000-0001-5215-101X; Mieczkowski, Piotr/0000-0003-2418-0096; Zerbino, Daniel/0000-0001-5350-3056; Peifer, Martin/0000-0002-5243-5503; Pot, David/0000-0002-1480-9826; Hoadley, Katherine/0000-0002-1216-477X; Gehlenborg, Nils/0000-0003-0327-8297; Sinha, Rileen/0000-0001-5497-5055; Schultz, Nikolaus/0000-0002-0131-4904; Stuart, Joshua/0000-0002-2171-565X; Casasent, Anna/0000-0002-7857-179X; Weinstein, John/0000-0001-9401-6908; Meyerson, Matthew/0000-0002-9133-8108; Auman, James/0000-0002-9328-8829	NIH [U24 CA126561, U24 CA126551, U24 CA126554, U24 CA126543, U24 CA126546, U24 CA126563, U24 CA126544, U24 CA143845, U24 CA143858, U24 CA144025, U24 CA143882, U24 CA143866, U24 CA143867, U24 CA143848, U24 CA143840, U24 CA143835, U24 CA143799, U24 CA143883, U24 CA143843, U54 HG003067, U54 HG003079, U54 HG003273]; NATIONAL CANCER INSTITUTE [U24CA126543, U24CA144025, U24CA126563, R01CA094143, U24CA126551, U24CA143867, U24CA143858, T32CA009172, U24CA143866, U24CA126554, U24CA143882, U24CA143843, U24CA126546, R00CA149182, K08CA137153, U24CA143883, P30CA016086, U24CA143845, U24CA126544, P30CA016672, U24CA143835, U24CA143848, U24CA126561, U24CA143799, R01CA149569, U24CA143840] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003067, U54HG003273, R01HG006272, U54HG003079] Funding Source: NIH RePORTER; Emerging Frontiers [0850237] Funding Source: National Science Foundation	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Emerging Frontiers(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This study was supported by NIH grants U24 CA126561, U24 CA126551, U24 CA126554, U24 CA126543, U24 CA126546, U24 CA126563, U24 CA126544, U24 CA143845, U24 CA143858, U24 CA144025, U24 CA143882, U24 CA143866, U24 CA143867, U24 CA143848, U24 CA143840, U24 CA143835, U24 CA143799, U24 CA143883, U24 CA143843, U54 HG003067, U54 HG003079 and U54 HG003273.	Agrawal N, 2011, SCIENCE, V333, P1154, DOI 10.1126/science.1206923; Aster JC, 2011, J PATHOL, V223, P262, DOI 10.1002/path.2789; Bass AJ, 2011, NAT GENET, V43, P964, DOI 10.1038/ng.936; Bass AJ, 2009, NAT GENET, V41, P1238, DOI 10.1038/ng.465; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Berger MF, 2011, NATURE, V470, P214, DOI 10.1038/nature09744; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bishop JA, 2011, MODERN PATHOL, V24, p405A; Brahmer JR, 2010, J CLIN ONCOL, V28, P3167, DOI 10.1200/JCO.2009.26.7609; Chapman MA, 2011, NATURE, V471, P467, DOI 10.1038/nature09837; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Ciriello G, 2012, GENOME RES, V22, P398, DOI 10.1101/gr.125567.111; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Dutt A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020351; Felip E, 2011, ANN ONCOL, V22, P1507, DOI 10.1093/annonc/mdr150; Govindan R, 2010, J THORAC ONCOL, V5, pS433, DOI 10.1097/JTO.0b013e3181fd6fe1; Hammerman PS, 2011, CANCER DISCOV, V1, P78, DOI 10.1158/2159-8274.CD-11-0005; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Ju YS, 2012, GENOME RES, V22, P436, DOI 10.1101/gr.133645.111; Kan ZY, 2010, NATURE, V466, P869, DOI 10.1038/nature09208; Kancha RK, 2011, J THORAC ONCOL, V6, P387, DOI 10.1097/JTO.0b013e3182021f3e; Kenfield SA, 2008, TOB CONTROL, V17, P198, DOI 10.1136/tc.2007.022582; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Massion PP, 2003, CANCER RES, V63, P7113; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; Morris PG, 2010, J CLIN ONCOL, V28, P3154, DOI 10.1200/JCO.2009.27.5743; Osada H, 2005, CANCER RES, V65, P10680, DOI 10.1158/0008-5472.CAN-05-1404; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Ramos AH, 2009, CANCER BIOL THER, V8, P2042, DOI 10.4161/cbt.8.21.9764; Rekhtman N, 2012, CLIN CANCER RES, V18, P1167, DOI 10.1158/1078-0432.CCR-11-2109; Reva B, 2011, NUCLEIC ACIDS RES, V39, pE118, DOI 10.1093/nar/gkr407; Shen RL, 2009, BIOINFORMATICS, V25, P2906, DOI 10.1093/bioinformatics/btp543; Shibata T, 2008, P NATL ACAD SCI USA, V105, P13568, DOI 10.1073/pnas.0806268105; Singh A, 2006, PLOS MED, V3, P1865, DOI 10.1371/journal.pmed.0030420; Singh A, 2010, ANTIOXID REDOX SIGN, V13, P1627, DOI 10.1089/ars.2010.3219; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Stephens PJ, 2009, NATURE, V462, P1005, DOI 10.1038/nature08645; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; Tonon G, 2005, P NATL ACAD SCI USA, V102, P9625, DOI 10.1073/pnas.0504126102; Vaske CJ, 2010, BIOINFORMATICS, V26, pi237, DOI 10.1093/bioinformatics/btq182; Wang NJ, 2011, P NATL ACAD SCI USA, V108, P17761, DOI 10.1073/pnas.1114669108; Weiss J, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001451; Wikman H, 2006, EXPERT REV ANTICANC, V6, P515, DOI 10.1586/14737140.6.4.515; Wilkerson MD, 2010, CLIN CANCER RES, V16, P4864, DOI 10.1158/1078-0432.CCR-10-0199; World Health Organization, CANCER	46	2595	2639	16	334	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 27	2012	489	7417					519	525		10.1038/nature11404	http://dx.doi.org/10.1038/nature11404			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	011LT	22960745	hybrid, Green Accepted, Green Published, Green Submitted			2022-12-28	WOS:000309167100041
J	Outterson, K				Outterson, Kevin			Punishing Health Care Fraud - Is the GSK Settlement Sufficient?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Boston Univ, Sch Law, Boston, MA 02215 USA	Boston University	Outterson, K (corresponding author), Boston Univ, Sch Law, Boston, MA 02215 USA.			Outterson, Kevin/0000-0003-2513-3216				[Anonymous], 2012, ECONOMIST       1230; Basken P., 2012, CHRONICLE HIGHER ED; Eisenberg CB, 2012, PEPPERDINE J BUSINES, V5, P243; Kelton E, 2012, FORBES          0826; Kesselheim AS, 2010, NEW ENGL J MED, V362, P1832, DOI 10.1056/NEJMsr0912039	5	18	19	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 20	2012	367	12					1082	1085		10.1056/NEJMp1209249	http://dx.doi.org/10.1056/NEJMp1209249			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	007AS	22970920				2022-12-28	WOS:000308861800002
J	Kennedy, BS; Bedard, B; Younge, M; Tuttle, D; Ammerman, E; Ricci, J; Doniger, AS; Escuyer, VE; Mitchell, K; Noble-Wang, JA; O'Connell, HA; Lanier, WA; Katz, LM; Betts, RF; Mercurio, MG; Scott, GA; Lewis, MA; Goldgeier, MH				Kennedy, Byron S.; Bedard, Brenden; Younge, Mary; Tuttle, Deborah; Ammerman, Eric; Ricci, John; Doniger, Andrew S.; Escuyer, Vincent E.; Mitchell, Kara; Noble-Wang, Judith A.; O'Connell, Heather A.; Lanier, William A.; Katz, Linda M.; Betts, Robert F.; Mercurio, Mary Gail; Scott, Glynis A.; Lewis, Matthew A.; Goldgeier, Mark H.			Outbreak of Mycobacterium chelonae Infection Associated with Tattoo Ink	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RAPIDLY GROWING MYCOBACTERIA; ATYPICAL MYCOBACTERIA; SKIN INFECTION; ABSCESSUS; IDENTIFICATION; PATTERNS; VECTOR	Background In January 2012, on the basis of an initial report from a dermatologist, we began to investigate an outbreak of tattoo-associated Mycobacterium chelonae skin and soft-tissue infections in Rochester, New York. The main goals were to identify the extent, cause, and form of transmission of the outbreak and to prevent further cases of infection. Methods We analyzed data from structured interviews with the patients, histopathological testing of skin-biopsy specimens, acid-fast bacilli smears, and microbial cultures and antimicrobial susceptibility testing. We also performed DNA sequencing, pulsed-field gel electrophoresis (PFGE), cultures of the ink and ingredients used in the preparation and packaging of the ink, assessment of source water and faucets at tattoo parlors, and investigation of the ink manufacturer. Results Between October and December 2011, a persistent, raised, erythematous rash in the tattoo area developed in 19 persons (13 men and 6 women) within 3 weeks after they received a tattoo from a single artist who used premixed gray ink; the highest occurrence of tattooing and rash onset was in November (accounting for 15 and 12 patients, respectively). The average age of the patients was 35 years (range, 18 to 48). Skin-biopsy specimens, obtained from 17 patients, showed abnormalities in all 17, with M. chelonae isolated from 14 and confirmed by means of DNA sequencing. PFGE analysis showed indistinguishable patterns in 11 clinical isolates and one of three unopened bottles of premixed ink. Eighteen of the 19 patients were treated with appropriate antibiotics, and their condition improved. Conclusions The premixed ink was the common source of infection in this outbreak. These findings led to a recall by the manufacturer.	[Kennedy, Byron S.; Bedard, Brenden; Younge, Mary; Tuttle, Deborah; Ammerman, Eric; Ricci, John; Doniger, Andrew S.] Monroe Cty Dept Publ Hlth, Rochester, NY 14620 USA; [Escuyer, Vincent E.; Mitchell, Kara] New York State Dept Hlth, Albany, NY USA; [Betts, Robert F.; Mercurio, Mary Gail; Scott, Glynis A.; Lewis, Matthew A.] Univ Rochester, Med Ctr, Rochester, NY 14642 USA; [Goldgeier, Mark H.] Clinton Crossings Dermatol, Rochester, NY USA; [Noble-Wang, Judith A.; O'Connell, Heather A.] Ctr Dis Control & Prevent, Atlanta, GA USA; [Lanier, William A.; Katz, Linda M.] US FDA, College Pk, MD USA	State University of New York (SUNY) System; University of Rochester; Centers for Disease Control & Prevention - USA; US Food & Drug Administration (FDA)	Kennedy, BS (corresponding author), Monroe Cty Dept Publ Hlth, 111 Westfall Rd,Rm 950, Rochester, NY 14620 USA.	bkennedy@monroecounty.gov		Moulton-Meissner, Heather/0000-0002-0728-2552				Adekambi T, 2003, J CLIN MICROBIOL, V41, P5699, DOI 10.1128/JCM.41.12.5699-5708.2003; Bechara C, 2010, DERMATOLOGY, V221, P1, DOI 10.1159/000313974; Binic I, 2011, AM J CLIN DERMATOL, V12, P404, DOI 10.2165/11589500-000000000-00000; Brown-Elliott BA, 2002, CLIN MICROBIOL REV, V15, P716, DOI 10.1128/CMR.15.4.716-746.2002; Drage LA, 2010, J AM ACAD DERMATOL, V62, P501, DOI 10.1016/j.jaad.2009.03.034; Goldman J, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c5483; Hamsch C, 2011, ACTA DERM-VENEREOL, V91, P63, DOI 10.2340/00015555-1015; Hay RJ, 2009, CURR OPIN INFECT DIS, V22, P99, DOI 10.1097/QCO.0b013e328322b440; Hogsberg T, 2011, J EUR ACAD DERMATOL; Kappel S, 2011, J AM ACAD DERMATOL, V64, P998, DOI 10.1016/j.jaad.2009.08.029; Kay MK, 2011, EMERG INFECT DIS, V17, P1734, DOI 10.3201/eid1709.102011; Kluger N, 2008, ARCH DERMATOL, V144, P941, DOI 10.1001/archderm.144.7.941; Martin A, 2007, J MICROBIOL METH, V71, P39, DOI 10.1016/j.mimet.2007.07.008; Meyers H, 2002, CLIN INFECT DIS, V34, P1500, DOI 10.1086/340399; Mitchell Charles B, 2011, J Am Acad Dermatol, V64, pe70, DOI 10.1016/j.jaad.2009.12.037; Preda VA, 2009, MED J AUSTRALIA, V190, P278, DOI 10.5694/j.1326-5377.2009.tb02396.x; Ricciardo B, 2010, AUSTRALAS J DERMATOL, V51, P287, DOI 10.1111/j.1440-0960.2010.00659.x; Rodriguez-Blanco I, 2011, ACTA DERM-VENEREOL, V91, P61, DOI 10.2340/00015555-1034; SAFRANEK TJ, 1987, NEW ENGL J MED, V317, P197, DOI 10.1056/NEJM198707233170403; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Vanitha JD, 2003, APPL ENVIRON MICROB, V69, P4337, DOI 10.1128/AEM.69.7.4337-4341.2003; WALLACE RJ, 1993, J CLIN MICROBIOL, V31, P2697, DOI 10.1128/JCM.31.10.2697-2701.1993; WENGER JD, 1990, JAMA-J AM MED ASSOC, V264, P373, DOI 10.1001/jama.264.3.373; Winthrop KL, 2002, NEW ENGL J MED, V346, P1366, DOI 10.1056/NEJMoa012643; Wolf R, 2003, J AM ACAD DERMATOL, V48, pS73, DOI 10.1067/mjd.2003.166	25	79	84	4	15	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 13	2012	367	11					1020	1024		10.1056/NEJMoa1205114	http://dx.doi.org/10.1056/NEJMoa1205114			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	003ZE	22913660				2022-12-28	WOS:000308649100008
J	Sachs, JD				Sachs, Jeffrey D.			Achieving universal health coverage in low-income settings	LANCET			English	Editorial Material							CARE		Columbia Univ, Earth Inst, Low Lib 314, New York, NY 10027 USA	Columbia University	Sachs, JD (corresponding author), Columbia Univ, Earth Inst, Low Lib 314, 535 W 116th St, New York, NY 10027 USA.	sachs@columbia.edu						ARROW KJ, 1963, AM ECON REV, V53, P941; Bang A, 2011, HIGH LEVEL EXPERT GR; Cohen J., 2007, FREE DISTRIBUTION CO; Demombynes G, 2012, 6057 WORLD BANK; Jones G, 2003, LANCET, V362, P65, DOI 10.1016/S0140-6736(03)13811-1; Moreno-Serra R, 2012, LANCET, V380, P917, DOI 10.1016/S0140-6736(12)61039-3; Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8; Murray CJL, 2011, LANCET, V378, P8, DOI 10.1016/S0140-6736(10)62356-2; Organisation for Economic Co Operation and Development, 2012, DEV AID DEV COUNTR F; Population Division United Nations Department of Economic and Social Affairs, POP IND PER 2010 15; Reid M, 2011, B WORLD HEALTH ORGAN, V89, P706, DOI 10.2471/BLT.11.021011; Sachs J, 2010, LANCET, V376, P950, DOI 10.1016/S0140-6736(10)61440-7; UN Interagency Group for Child Mortality Estimation, LEV TRENDS CHILD MOR; Waldron Hilary, 2007, 108 ORES OFF POL SOC; WHO, 2010, WORLD MALARIA REPORT 2010, P1; WHO, 1946, CONST WHO INT HLTH C; WHO, WORLD HLTH REP 2010; World Health Organization, 2008, GLOB BURD DIS 2004 U; Yates R, 2009, LANCET, V373, P2078, DOI 10.1016/S0140-6736(09)60258-0	19	77	81	1	13	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 8	2012	380	9845					944	947		10.1016/S0140-6736(12)61149-0	http://dx.doi.org/10.1016/S0140-6736(12)61149-0			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	002QL	22959391				2022-12-28	WOS:000308547300038
J	Ioannou, CC; Guttal, V; Couzin, ID				Ioannou, C. C.; Guttal, V.; Couzin, I. D.			Predatory Fish Select for Coordinated Collective Motion in Virtual Prey	SCIENCE			English	Article							INDIVIDUAL-BASED MODEL; ANIMAL GROUPS; SELFISH HERD; BEHAVIOR; DYNAMICS; SPARROWHAWKS; STRATEGIES; CONFUSION; ATTACK	Movement in animal groups is highly varied and ranges from seemingly disordered motion in swarms to coordinated aligned motion in flocks and schools. These social interactions are often thought to reduce risk from predators, despite a lack of direct evidence. We investigated risk-related selection for collective motion by allowing real predators ( bluegill sunfish) to hunt mobile virtual prey. By fusing simulated and real animal behavior, we isolated predator effects while controlling for confounding factors. Prey with a tendency to be attracted toward, and to align direction of travel with, near neighbors tended to form mobile coordinated groups and were rarely attacked. These results demonstrate that collective motion could evolve as a response to predation, without prey being able to detect and respond to predators.	[Ioannou, C. C.; Guttal, V.; Couzin, I. D.] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Ioannou, C. C.] Univ Bristol, Sch Biol Sci, Bristol BS8 1UG, Avon, England; [Guttal, V.] Indian Inst Sci, Ctr Ecol Sci, Bangalore 560012, Karnataka, India	Princeton University; University of Bristol; Indian Institute of Science (IISC) - Bangalore	Ioannou, CC (corresponding author), Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA.	C.C.Ioannou@bristol.ac.uk; icouzin@princeton.edu	Couzin, Iain D./Q-6862-2018; Guttal, Vishwesha/A-3007-2008	Couzin, Iain D./0000-0001-8556-4558; Guttal, Vishwesha/0000-0002-2677-857X; Ioannou, Christos/0000-0002-9739-889X	Office of Naval Research [N00014-09-1-1074]; NSF [PHY-0848755]; Searle Scholar award [08-SPP-201]; Army Research Office [W911NG-11-1-0385]; Defense Advanced Research Projects Agency [HR0011-05-1-0057]; Leverhulme Trust; Department of Biotechnology, Government of India; Division Of Physics [0848755] Funding Source: National Science Foundation	Office of Naval Research(Office of Naval Research); NSF(National Science Foundation (NSF)); Searle Scholar award; Army Research Office; Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Leverhulme Trust(Leverhulme Trust); Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Division Of Physics(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We thank A. Hundal, M. Jiang, and M. Singh for assistance and A. S. I. Wade, the Couzin lab, and three anonymous reviewers for comments on the manuscript. Funded by Office of Naval Research award N00014-09-1-1074, NSF award PHY-0848755, Searle Scholar award 08-SPP-201, and Army Research Office grant W911NG-11-1-0385 (I. D. C.); Defense Advanced Research Projects Agency grant HR0011-05-1-0057 (Princeton University); Leverhulme Trust Early Career Fellowship (C. C. I.); and a Ramalingaswami Fellowship from the Department of Biotechnology, Government of India (V. G.). All experiments were conducted in accordance with federal and state regulations and were approved by the Princeton University Institutional Animal Care and Use Committee. Data and code are freely available at http://icouzin.princeton.edu.	Ballerini M, 2008, P NATL ACAD SCI USA, V105, P1232, DOI 10.1073/pnas.0711437105; Bazazi S, 2008, CURR BIOL, V18, P735, DOI 10.1016/j.cub.2008.04.035; Buhl J, 2006, SCIENCE, V312, P1402, DOI 10.1126/science.1125142; Couzin ID, 2005, NATURE, V433, P513, DOI 10.1038/nature03236; Couzin ID, 2002, J THEOR BIOL, V218, P1, DOI 10.1006/jtbi.2002.3065; Couzin ID, 2003, ADV STUD BEHAV, V32, P1, DOI 10.1016/S0065-3454(03)01001-5; Cresswell W, 2004, OIKOS, V104, P71, DOI 10.1111/j.0030-1299.2004.12814.x; Cresswell W, 1996, IBIS, V138, P684, DOI 10.1111/j.1474-919X.1996.tb04770.x; EHLINGER TJ, 1988, P NATL ACAD SCI USA, V85, P1878, DOI 10.1073/pnas.85.6.1878; Grunbaum D, 1998, EVOL ECOL, V12, P503, DOI 10.1023/A:1006574607845; Guttal V, 2010, P NATL ACAD SCI USA, V107, P16172, DOI 10.1073/pnas.1006874107; HAMILTON WD, 1971, J THEOR BIOL, V31, P295, DOI 10.1016/0022-5193(71)90189-5; Handegard NO, 2012, CURR BIOL, V22, P1213, DOI 10.1016/j.cub.2012.04.050; Ioannou CC, 2008, BEHAV ECOL, V19, P126, DOI 10.1093/beheco/arm109; Jones KA, 2011, BEHAV ECOL, V22, P831, DOI 10.1093/beheco/arr062; Katz Y, 2011, P NATL ACAD SCI USA, V108, P18720, DOI 10.1073/pnas.1107583108; Krause J, 2002, LIVING GROUPS; Lukeman R, 2010, P NATL ACAD SCI USA, V107, P12576, DOI 10.1073/pnas.1001763107; Parrish JK, 1999, SCIENCE, V284, P99, DOI 10.1126/science.284.5411.99; Romey WL, 2008, BEHAV ECOL, V19, P74, DOI 10.1093/beheco/arm105; Ruxton GD, 2007, BEHAV ECOL, V18, P590, DOI 10.1093/beheco/arm009; Sayama H, 2009, IEEE SYMP ART LIFE, P85, DOI 10.1109/ALIFE.2009.4937698; Tosh CR, 2011, J THEOR BIOL, V281, P24, DOI 10.1016/j.jtbi.2011.04.014; TREHERNE JE, 1982, ANIM BEHAV, V30, P536, DOI 10.1016/S0003-3472(82)80066-3; Vabo R, 1997, FISH OCEANOGR, V6, P155, DOI 10.1046/j.1365-2419.1997.00037.x; Wood AJ, 2007, P R SOC B, V274, P1637, DOI 10.1098/rspb.2007.0306	26	203	210	5	191	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 7	2012	337	6099					1212	1215		10.1126/science.1218919	http://dx.doi.org/10.1126/science.1218919			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	000UJ	22903520	Green Submitted			2022-12-28	WOS:000308414000034
J	Woodgett, J				Woodgett, Jim			We must be open about our mistakes	NATURE			English	Editorial Material									Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute	Woodgett, J (corresponding author), Mt Sinai Hosp, Samuel Lunenfeld Res Inst, 600 Univ Ave, Toronto, ON M5G 1X5, Canada.	woodgett@lunenfeld.ca	Woodgett, Jim/F-1087-2010	Woodgett, Jim/0000-0003-3731-5797					0	5	6	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 6	2012	489	7414					7	7		10.1038/489007a	http://dx.doi.org/10.1038/489007a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	999WW	22962696	Bronze			2022-12-28	WOS:000308347000004
J	Yu, DB; Pendergraff, H; Liu, J; Kordasiewicz, HB; Cleveland, DW; Swayze, EE; Lima, WF; Crooke, ST; Prakash, TP; Corey, DR				Yu, Dongbo; Pendergraff, Hannah; Liu, Jing; Kordasiewicz, Holly B.; Cleveland, Don W.; Swayze, Eric E.; Lima, Walt F.; Crooke, Stanley T.; Prakash, Thazha P.; Corey, David R.			Single-Stranded RNAs Use RNAi to Potently and Allele-Selectively Inhibit Mutant Huntingtin Expression	CELL			English	Article							EXPANDED CAG REPEATS; TRINUCLEOTIDE REPEAT; EMBRYONIC LETHALITY; GENE-EXPRESSION; MESSENGER-RNAS; DISEASE GENES; MOUSE MODEL; INTERFERENCE; ANTISENSE; SIRNAS	Mutant huntingtin (HTT) protein causes Huntington disease (HD), an incurable neurological disorder. Silencing mutant HTT using nucleic acids would eliminate the root cause of HD. Developing nucleic acid drugs is challenging, and an ideal clinical approach to gene silencing would combine the simplicity of single-stranded antisense oligonucleotides with the efficiency of RNAi. Here, we describe RNAi by single-stranded siRNAs (ss-siRNAs). ss-siRNAs are potent (>100-fold more than unmodified RNA) and allele-selective (>30-fold) inhibitors of mutant HTT expression in cells derived from HD patients. Strategic placement of mismatched bases mimics micro-RNA recognition and optimizes discrimination between mutant and wild-type alleles. ss-siRNAs require Argonaute protein and function through the RNAi pathway. Intraventricular infusion of ss-siRNA produced selective silencing of the mutant HTT allele throughout the brain in a mouse HD model. These data demonstrate that chemically modified ss-siRNAs function through the RNAi pathway and provide allele-selective compounds for clinical development.	[Yu, Dongbo; Pendergraff, Hannah; Liu, Jing; Corey, David R.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Yu, Dongbo; Pendergraff, Hannah; Liu, Jing; Corey, David R.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Kordasiewicz, Holly B.; Cleveland, Don W.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Kordasiewicz, Holly B.; Swayze, Eric E.; Lima, Walt F.; Crooke, Stanley T.; Prakash, Thazha P.] ISIS Pharmaceut, Carlsbad, CA 92010 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of California System; University of California San Diego; Isis Pharmaceuticals Inc	Corey, DR (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Pharmacol, 6001 Forest Pk Rd, Dallas, TX 75390 USA.	david.corey@utsouthwestern.edu	Cleveland, Don/AAN-9783-2021	Cleveland, Don/0000-0002-1934-3682; Swayze, Eric/0000-0001-6430-6576	US National Institutes of Health [NIGMS 73042]; McKnight Foundation for Neuroscience; CHDI Foundation Inc.; Robert A. Welch Foundation [I-1244]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073042] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); McKnight Foundation for Neuroscience; CHDI Foundation Inc.; Robert A. Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Work in the Corey Laboratory was supported by the US National Institutes of Health (NIGMS 73042), an award from the McKnight Foundation for Neuroscience, CHDI Foundation Inc., and the Robert A. Welch Foundation (I-1244). We thank Dr. Hui Tian and Haoming Liu of Qinghua Liu's Lab for generously providing us with recombinant hAgo2 proteins and the training on Ago2 activity assay and Dr. Keith Gagnon for helpful comments and for assistance setting up the in vitro AGO2 and RNAse H assays. The authors have filed a patent application related to this research.	Boudreau RL, 2009, MOL THER, V17, P1053, DOI 10.1038/mt.2009.17; Braasch DA, 2003, BIOCHEMISTRY-US, V42, P7967, DOI 10.1021/bi0343774; Broderick JA, 2011, RNA, V17, P1858, DOI 10.1261/rna.2778911; Carroll JB, 2011, MOL THER, V19, P2178, DOI 10.1038/mt.2011.201; Davidson BL, 2011, NAT REV GENET, V12, P329, DOI 10.1038/nrg2968; de Mezer M, 2011, NUCLEIC ACIDS RES, V39, P3852, DOI 10.1093/nar/gkq1323; DiFiglia M, 2007, P NATL ACAD SCI USA, V104, P17204, DOI 10.1073/pnas.0708285104; Drouet V, 2009, ANN NEUROL, V65, P276, DOI 10.1002/ana.21569; DUYAO M, 1993, NAT GENET, V4, P387, DOI 10.1038/ng0893-387; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Finkbeiner S, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a007476; Fiszer A, 2011, NUCLEIC ACIDS RES, V39, P5578, DOI 10.1093/nar/gkr156; Gagnon KT, 2011, J AM CHEM SOC, V133, P8404, DOI 10.1021/ja200312y; Gagnon KT, 2010, BIOCHEMISTRY-US, V49, P10166, DOI 10.1021/bi101208k; Godin JD, 2010, NEURON, V67, P392, DOI 10.1016/j.neuron.2010.06.027; Hall AHS, 2006, NUCLEIC ACIDS RES, V34, P2773, DOI 10.1093/nar/gkl339; Haringsma HJ, 2012, NUCLEIC ACIDS RES, V40, P4125, DOI 10.1093/nar/gkr1301; Harper SQ, 2005, P NATL ACAD SCI USA, V102, P5820, DOI 10.1073/pnas.0501507102; Holen T, 2003, NUCLEIC ACIDS RES, V31, P2401, DOI 10.1093/nar/gkg338; Hu JX, 2011, BIOL CHEM, V392, P315, DOI 10.1515/BC.2011.045; Hu JX, 2010, CHEM BIOL, V17, P1183, DOI 10.1016/j.chembiol.2010.10.013; Hu JX, 2009, NAT BIOTECHNOL, V27, P478, DOI 10.1038/nbt.1539; Huang K, 2011, HUM MOL GENET, V20, P3356, DOI 10.1093/hmg/ddr242; Kordasiewicz HB, 2012, NEURON, V74, P1031, DOI 10.1016/j.neuron.2012.05.009; Kozlowski P, 2010, NUCLEIC ACIDS RES, V38, P4027, DOI 10.1093/nar/gkq127; KREMER B, 1994, NEW ENGL J MED, V330, P1401, DOI 10.1056/NEJM199405193302001; Krzyzosiak WJ, 2012, NUCLEIC ACIDS RES, V40, P11, DOI 10.1093/nar/gkr729; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lima WF, 2012, CELL, V150, P883, DOI 10.1016/j.cell.2012.08.014; Lin CH, 2001, HUM MOL GENET, V10, P137, DOI 10.1093/hmg/10.2.137; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Lombardi MS, 2009, EXP NEUROL, V217, P312, DOI 10.1016/j.expneurol.2009.03.004; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Martinez J, 2002, CELL, V110, P563, DOI 10.1016/S0092-8674(02)00908-X; Matsui M, 2012, DRUG DISCOV TODAY, V17, P443, DOI 10.1016/j.drudis.2012.01.006; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Michlewski G, 2004, J MOL BIOL, V340, P665, DOI 10.1016/j.jmb.2004.05.021; Miller VM, 2003, P NATL ACAD SCI USA, V100, P7195, DOI 10.1073/pnas.1231012100; NASIR J, 1995, CELL, V81, P811, DOI 10.1016/0092-8674(95)90542-1; Omi K, 2005, BIOCHEM BIOPH RES CO, V338, P1229, DOI 10.1016/j.bbrc.2005.10.061; Orr HT, 2007, ANNU REV NEUROSCI, V30, P575, DOI 10.1146/annurev.neuro.29.051605.113042; Pfister EL, 2009, CURR BIOL, V19, P774, DOI 10.1016/j.cub.2009.03.030; Sah DWY, 2011, J CLIN INVEST, V121, P500, DOI 10.1172/JCI45130; Schwarz DS, 2006, PLOS GENET, V2, P1307, DOI 10.1371/journal.pgen.0020140; Schwarz DS, 2002, MOL CELL, V10, P537, DOI 10.1016/S1097-2765(02)00651-2; van Bilsen PHJ, 2008, HUM GENE THER, V19, P710, DOI 10.1089/hum.2007.116; Walker FO, 2007, LANCET, V369, P218, DOI 10.1016/S0140-6736(07)60111-1; Wang YL, 2008, NATURE, V456, P921, DOI 10.1038/nature07666; Warby SC, 2009, AM J HUM GENET, V84, P351, DOI 10.1016/j.ajhg.2009.02.003; Watts JK, 2012, J PATHOL, V226, P365, DOI 10.1002/path.2993; White JK, 1997, NAT GENET, V17, P404, DOI 10.1038/ng1297-404; ZEITLIN S, 1995, NAT GENET, V11, P155, DOI 10.1038/ng1095-155	52	202	241	0	45	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 31	2012	150	5					895	908		10.1016/j.cell.2012.08.002	http://dx.doi.org/10.1016/j.cell.2012.08.002			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	001ZU	22939619	Green Accepted, Bronze			2022-12-28	WOS:000308500200006
J	Humphries, C				Humphries, Courtney			SCREENING Testing times	NATURE			English	Editorial Material																			0	0	0	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 30	2012	488	7413					S8	S9		10.1038/488S8a	http://dx.doi.org/10.1038/488S8a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	996NC	22932440	Bronze			2022-12-28	WOS:000308095100007
J	Lane, R				Lane, Richard			Profile Jeanette Vega: putting equity and resilience into global health	LANCET			English	Biographical-Item																			0	0	0	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG 25	2012	380	9843					721	721		10.1016/S0140-6736(12)61395-6	http://dx.doi.org/10.1016/S0140-6736(12)61395-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	995IK	22920741	Bronze			2022-12-28	WOS:000308001300013
J	Imai, KS; Daido, Y; Kusakabe, TG; Satou, Y				Imai, Kaoru S.; Daido, Yutaka; Kusakabe, Takehiro G.; Satou, Yutaka			Cis-Acting Transcriptional Repression Establishes a Sharp Boundary in Chordate Embryos	SCIENCE			English	Article							DORSALIZING-MORPHOGENETIC-PROTEIN; ORGANIZER; ADMP; GENE; EXPRESSION	The function of bone morphogenetic protein (BMP) signaling in dorsoventral (DV) patterning of animal embryos is conserved among Bilateria. In vertebrates, the BMP ligand antidorsalizing morphogenetic protein (Admp) is expressed dorsally and moves to the opposite side to specify the ventral fate. Here, we show that Pinhead is an antagonist specific for Admp with a role in establishing the DV axis of the trunk epidermis in embryos of the ascidian Ciona intestinalis. Pinhead and Admp exist in tandem in the genomes of various animals from arthropods to vertebrates. This genomic configuration is important for mutually exclusive expression of these genes, because Pinhead transcription directly disturbs the action of the Admp enhancer. Our data suggest that this dual negative regulatory mechanism is widely conserved in animals.	[Imai, Kaoru S.; Satou, Yutaka] Kyoto Univ, Grad Sch Sci, Dept Zool, Sakyo Ku, Kyoto 6068502, Japan; [Imai, Kaoru S.] Kyoto Univ, Grad Sch Sci, Dept Biodivers, Sakyo Ku, Kyoto 6068502, Japan; [Daido, Yutaka; Kusakabe, Takehiro G.] Konan Univ, Fac Sci & Engn, Dept Biol, Kobe, Hyogo 6588501, Japan	Kyoto University; Kyoto University; Konan University	Satou, Y (corresponding author), Kyoto Univ, Grad Sch Sci, Dept Zool, Sakyo Ku, Kyoto 6068502, Japan.	yutaka@ascidian.zool.kyoto-u.ac.jp	Kusakabe, Takehiro/H-7178-2012; Satou, Yutaka/AAJ-2194-2021; Satou, Yutaka/K-7131-2012	Kusakabe, Takehiro/0000-0002-8325-3665; Satou, Yutaka/0000-0001-5193-0708; Satou, Yutaka/0000-0001-5193-0708; Imai, Kaoru/0000-0001-9113-6074	Ministry of Education, Culture, Sports, Science and Technology; Japan Society for the Promotion of Science (JSPS) [22870018, 22310120, 21671004]; Global Center of Excellence program [A06]; Restart Postdoctoral Fellowship (RPD) from JSPS; Grants-in-Aid for Scientific Research [21671004, 22310120] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Global Center of Excellence program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Restart Postdoctoral Fellowship (RPD) from JSPS; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by grants-in-aid from the Ministry of Education, Culture, Sports, Science and Technology and the Japan Society for the Promotion of Science (JSPS) to K. S. I. (22870018), T. G. K. (22310120), and Y.S. (21671004) and also in part by the Global Center of Excellence program (A06) to Kyoto University. K. S. I. was supported by a Restart Postdoctoral Fellowship (RPD) from JSPS. The cDNA sequences for Admp and Pinhead are available under accession nos. AB210298 and AK113761 in the DDBJ/EMBL/GenBank database. We are grateful to K. Hirayama for her assistance with this research.	Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Dickmeis T, 2001, DEV GENES EVOL, V211, P568, DOI 10.1007/s00427-001-0190-3; Dosch R, 2000, MECH DEVELOP, V90, P195, DOI 10.1016/S0925-4773(99)00245-2; Gavino MA, 2011, CURR BIOL, V21, P294, DOI 10.1016/j.cub.2011.01.017; Imai KS, 2006, SCIENCE, V312, P1183, DOI 10.1126/science.1123404; Imai KS, 2004, DEVELOPMENT, V131, P4047, DOI 10.1242/dev.01270; Joubin K, 1999, CELL, V98, P559, DOI 10.1016/S0092-8674(00)80044-6; Kenwrick S, 2004, DEV DYNAM, V229, P289, DOI 10.1002/dvdy.10440; Lele Z, 2001, DEV DYNAM, V222, P681, DOI 10.1002/dvdy.1222; Lemaire P, 2008, CURR BIOL, V18, pR620, DOI 10.1016/j.cub.2008.05.039; Pasini A, 2006, PLOS BIOL, V4, P1173, DOI 10.1371/journal.pbio.0040225; Reversade B, 2005, CELL, V123, P1147, DOI 10.1016/j.cell.2005.08.047; Satou Y, 2008, DEV GENES EVOL, V218, P715, DOI 10.1007/s00427-008-0219-y; Willot V, 2002, DEV BIOL, V241, P59, DOI 10.1006/dbio.2001.0494	14	20	21	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 24	2012	337	6097					964	967		10.1126/science.1222488	http://dx.doi.org/10.1126/science.1222488			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992VI	22923581				2022-12-28	WOS:000307807600045
J	Kaab, A; Berthier, E; Nuth, C; Gardelle, J; Arnaud, Y				Kaab, Andreas; Berthier, Etienne; Nuth, Christopher; Gardelle, Julie; Arnaud, Yves			Contrasting patterns of early twenty-first-century glacier mass change in the Himalayas	NATURE			English	Article							ELEVATION CHANGES; WESTERN HIMALAYA; NEPAL HIMALAYA; BALANCE; PRECIPITATION; PENETRATION; SIGNALS; SNOW	Glaciers are among the best indicators of terrestrial climate variability, contribute importantly to water resources in many mountainous regions(1,2) and are a major contributor to global sea level rise(3,4). In the Hindu Kush-Karakoram-Himalaya region (HKKH), a paucity of appropriate glacier data has prevented a comprehensive assessment of current regional mass balance(5). There is, however, indirect evidence of a complex pattern of glacial responses(5-8) in reaction to heterogeneous climate change signals(9). Here we use satellite laser altimetry and a global elevation model to show widespread glacier wastage in the eastern, central and southwestern parts of the HKKH during 2003-08. Maximal regional thinning rates were 0.66 +/- 0.09 metres per year in the Jammu-Kashmir region. Conversely, in the Karakoram, glaciers thinned only slightly by a few centimetres per year. Contrary to expectations, regionally averaged thinning rates under debris-mantled ice were similar to those of clean ice despite insulation by debris covers. The 2003-08 specific mass balance for our entire HKKH study region was -0.21 +/- 0.05 m yr(-1) water equivalent, significantly less negative than the estimated global average for glaciers and ice caps(4,10). This difference is mainly an effect of the balanced glacier mass budget in the Karakoram. The HKKH sea level contribution amounts to one per cent of the present-day sea level rise(11). Our 2003-08 mass budget of -12.8 +/- 3.5 gigatonnes (Gt) per year is more negative than recent satellite-gravimetry-based estimates of -5 +/- 3 Gt yr(-1) over 2003-10 (ref. 12). For the mountain catchments of the Indus and Ganges basins(13), the glacier imbalance contributed about 3.5% and about 2.0%, respectively, to the annual average river discharge(13), and up to 10% for the Upper Indus basin(14).	[Kaab, Andreas; Nuth, Christopher] Univ Oslo, Dept Geosci, N-0316 Oslo, Norway; [Berthier, Etienne] Univ Toulouse, CNRS, LEGOS, F-31400 Toulouse, France; [Gardelle, Julie] Univ Grenoble 1, CNRS, LGGE, F-38402 St Martin Dheres, France; [Arnaud, Yves] Univ Grenoble 1, IRD, LTHE LGGE, F-38402 St Martin Dheres, France	University of Oslo; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Laboratoire d'Etudes en Geophysique et oceanographie spatiales; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD)	Kaab, A (corresponding author), Univ Oslo, Dept Geosci, POB 1047, N-0316 Oslo, Norway.	kaeaeb@geo.uio.no	Berthier, Etienne/B-8900-2009; Kääb, Andreas/AAG-8769-2020	Berthier, Etienne/0000-0001-5978-9155; Kääb, Andreas/0000-0002-6017-6564	European Space Agency (ESA) [21088/07/I-EC, 4000101778/10/I-AM]; Centre National d'Etudes Spatiales (CNES) through the TOSCA programme; French National Research Agency [ANR-09-CEP-005-01/PAPRIKA]; PNTS; CNES/CNRS; Centre National d'Etudes Spatiales (CNES) through the ISIS programme	European Space Agency (ESA)(European Space Agency); Centre National d'Etudes Spatiales (CNES) through the TOSCA programme; French National Research Agency(French National Research Agency (ANR)); PNTS; CNES/CNRS(Centre National de la Recherche Scientifique (CNRS)Centre National D'etudes Spatiales); Centre National d'Etudes Spatiales (CNES) through the ISIS programme	We thank G. Cogley and A. Gardner for their exceptionally thorough and constructive comments. This study was supported by the European Space Agency (ESA) through the projects GlobGlacier (21088/07/I-EC) and Glaciers_cci (4000101778/10/I-AM). The study is further a contribution to the Global Land Ice Measurements from Space (GLIMS) initiative and the International Centre for Geohazards (ICG). NASA's ICESat GLAS data were obtained from NSIDC, Landsat data are courtesy of NASA and USGS, and the SRTM elevation model version is courtesy of NASA JPL and was further processed by CGIAR. A number of glacier outlines were provided by GLIMS. E.B. and Y.A. acknowledge support from the Centre National d'Etudes Spatiales (CNES) through the TOSCA and ISIS programmes, from the French National Research Agency through ANR-09-CEP-005-01/PAPRIKA, and from the PNTS. J.G. was funded through CNES/CNRS.	Azam MF, 2012, J GLACIOL, V58, P315, DOI 10.3189/2012JoG11J123; Berthier E, 2007, REMOTE SENS ENVIRON, V108, P327, DOI 10.1016/j.rse.2006.11.017; Bolch T, 2012, SCIENCE, V336, P310, DOI 10.1126/science.1215828; Bolch T, 2011, CRYOSPHERE, V5, P349, DOI 10.5194/tc-5-349-2011; Bookhagen B, 2010, J GEOPHYS RES-EARTH, V115, DOI 10.1029/2009JF001426; Cazenave A, 2009, GLOBAL PLANET CHANGE, V65, P83, DOI 10.1016/j.gloplacha.2008.10.004; Church JA, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL048794; Cogley JG, 2009, ANN GLACIOL, V50, P96, DOI 10.3189/172756409787769744; Fowler HJ, 2006, J CLIMATE, V19, P4276, DOI 10.1175/JCLI3860.1; Fujita K, 2011, P NATL ACAD SCI USA, V108, P14011, DOI 10.1073/pnas.1106242108; Fujita K, 2008, EARTH PLANET SC LETT, V276, P14, DOI 10.1016/j.epsl.2008.08.028; Gardelle J, 2012, J GLACIOL, V58, P419, DOI 10.3189/2012JoG11J175; Gardelle J, 2012, NAT GEOSCI, V5, P322, DOI [10.1038/ngeo1450, 10.1038/NGEO1450]; Gardelle J, 2011, GLOBAL PLANET CHANGE, V75, P47, DOI 10.1016/j.gloplacha.2010.10.003; Hewitt K, 2011, MT RES DEV, V31, P188, DOI 10.1659/MRD-JOURNAL-D-11-00020.1; Immerzeel WW, 2009, REMOTE SENS ENVIRON, V113, P40, DOI 10.1016/j.rse.2008.08.010; Immerzeel WW, 2010, SCIENCE, V328, P1382, DOI 10.1126/science.1183188; Immerzeel WW, 2012, MT RES DEV, V32, P30, DOI 10.1659/MRD-JOURNAL-D-11-00097.1; Jacob T, 2012, NATURE, V482, P514, DOI 10.1038/nature10847; Kaab A, 2005, REMOTE SENS ENVIRON, V94, P463, DOI 10.1016/j.rse.2004.11.003; Kaser G, 2010, P NATL ACAD SCI USA, V107, P20223, DOI 10.1073/pnas.1008162107; MATTSON LE, 1993, IAHS-AISH P, P289; Moholdt G, 2010, REMOTE SENS ENVIRON, V114, P2756, DOI 10.1016/j.rse.2010.06.008; Nuimura T, 2012, J GLACIOL, V58, P648, DOI 10.3189/2012JoG11J061; Quincey DJ, 2007, GLOBAL PLANET CHANGE, V56, P137, DOI 10.1016/j.gloplacha.2006.07.013; Reid TD, 2010, J GLACIOL, V56, P903, DOI 10.3189/002214310794457218; Rignot E, 2001, GEOPHYS RES LETT, V28, P3501, DOI 10.1029/2000GL012484; Rodell M, 2009, NATURE, V460, P999, DOI 10.1038/nature08238; Sakai A, 2000, IAHS-AISH P, P119; Scherler D, 2011, NAT GEOSCI, V4, P156, DOI [10.1038/ngeo1068, 10.1038/NGEO1068]	30	750	783	27	325	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 23	2012	488	7412					495	498		10.1038/nature11324	http://dx.doi.org/10.1038/nature11324			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992FS	22914167				2022-12-28	WOS:000307761600033
J	van Ginneken, E; Swartz, K				van Ginneken, Ewout; Swartz, Katherine			Implementing Insurance Exchanges - Lessons from Europe	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[van Ginneken, Ewout; Swartz, Katherine] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	van Ginneken, E (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA.							Chevreul K., 2010, HLTH SYST TRANSIT, V12, P1, DOI DOI 10.1038/KI.2015.25; ENTHOVEN AC, 1993, HEALTH AFFAIR, V12, P24, DOI 10.1377/hlthaff.12.suppl_1.24; Organisation for Economic Cooperation and Development, 2011, OECD REV HLTH SYST S; Struijs JN, 2011, NEW ENGL J MED, V364, P990, DOI 10.1056/NEJMp1011849	4	9	9	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 23	2012	367	8					691	693		10.1056/NEJMp1205832	http://dx.doi.org/10.1056/NEJMp1205832			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	992CX	22913679				2022-12-28	WOS:000307754200003
J	Pronovost, PJ; Bo-Linn, GW				Pronovost, Peter J.; Bo-Linn, George W.			Preventing Patient Harms Through Systems of Care	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							INTENSIVE-CARE		[Pronovost, Peter J.] Johns Hopkins Univ, Dept Hlth Policy & Management, Armstrong Inst Patient Safety & Qual, Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD 21218 USA; [Pronovost, Peter J.] Johns Hopkins Carey Business Sch, Baltimore, MD 21218 USA; [Bo-Linn, George W.] Gordon & Betty Moore Fdn, Patient Care Program, Palo Alto, CA USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University	Pronovost, PJ (corresponding author), Johns Hopkins Med Inst, Dept Anesthesiol & Crit Care Med, 1909 Thames St,2nd Floor, Baltimore, MD 21231 USA.	ppronovo@jhmi.edu						Classen DC, 2011, HEALTH AFFAIR, V30, P581, DOI 10.1377/hlthaff.2011.0190; Emanuel EJ, 2012, JAMA-J AM MED ASSOC, V307, P39, DOI 10.1001/jama.2011.1927; Grossman C., 2011, ENG LEARNING HEALTHC; Gurses AP, 2008, QUAL SAF HEALTH CARE, V17, P351, DOI 10.1136/qshc.2006.021709; Pronovost P J, 2001, Eff Clin Pract, V4, P199; Pronovost PJ, 2010, AM J RESP CRIT CARE, V182, P1463, DOI 10.1164/rccm.201008-1255ED; US Department of Health and Human Services, PARTN PAT LEARN OUR	7	47	51	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 22	2012	308	8					769	770		10.1001/jama.2012.9537	http://dx.doi.org/10.1001/jama.2012.9537			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	991ML	22910751				2022-12-28	WOS:000307705300017
J	Brun-Buisson, C				Brun-Buisson, Christian			Drotrecogin alfa (activated) did not reduce mortality at 28 or 90 days in patients with septic shock	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							SEVERE SEPSIS		CHU Henri Mondor, AP HP, F-94010 Creteil, France	Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP	Brun-Buisson, C (corresponding author), CHU Henri Mondor, AP HP, F-94010 Creteil, France.							Abraham E, 2005, NEW ENGL J MED, V353, P1332, DOI 10.1056/NEJMoa050935; Bernard GR, 2001, NEW ENGL J MED, V344, P699, DOI 10.1056/NEJM200103083441001; Nadel S, 2007, LANCET, V369, P836, DOI 10.1016/S0140-6736(07)60411-5	3	0	1	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 21	2012	157	4							JC4-11	10.7326/0003-4819-157-4-201208210-02011	http://dx.doi.org/10.7326/0003-4819-157-4-201208210-02011			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	992XG	22910965				2022-12-28	WOS:000307813200010
J	Matouschek, A; Finley, D				Matouschek, Andreas; Finley, Daniel			An Ancient Portal to Proteolysis	SCIENCE			English	Editorial Material							AAA-ATPASE; UBIQUITIN; PROTEASOME; P97; CDC48/P97; PROTEINS; ER		[Matouschek, Andreas] Univ Texas Austin, Dept Chem & Biochem, Austin, TX 78712 USA; [Matouschek, Andreas] Univ Texas Austin, Sect Mol Genet & Microbiol, Austin, TX 78712 USA; [Finley, Daniel] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; Harvard University; Harvard Medical School	Matouschek, A (corresponding author), Univ Texas Austin, Dept Chem & Biochem, Austin, TX 78712 USA.	matouschek@austin.utexas.edu; daniel_finley@hms.harvard.edu	Matouschek, Andreas/L-9379-2013	Matouschek, Andreas/0000-0001-6016-2341	NCI NIH HHS [U54 CA143869] Funding Source: Medline; NIGMS NIH HHS [R37 GM043601] Funding Source: Medline; NATIONAL CANCER INSTITUTE [U54CA143869] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM043601] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alexandru G, 2008, CELL, V134, P804, DOI 10.1016/j.cell.2008.06.048; Barthelme D, 2012, SCIENCE, V337, P843, DOI 10.1126/science.1224352; Beskow A, 2009, J MOL BIOL, V394, P732, DOI 10.1016/j.jmb.2009.09.050; Bohm S, 2011, MOL CELL BIOL, V31, P1528, DOI 10.1128/MCB.00962-10; Burroughs AM, 2012, METHODS MOL BIOL, V832, P15, DOI 10.1007/978-1-61779-474-2_2; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Humbard MA, 2010, NATURE, V463, P54, DOI 10.1038/nature08659; Jarosch E, 2002, NAT CELL BIOL, V4, P134, DOI 10.1038/ncb746; Lander GC, 2012, NATURE, V482, P186, DOI 10.1038/nature10774; Meyer H, 2012, NAT CELL BIOL, V14, P117, DOI 10.1038/ncb2407; Pearce MJ, 2008, SCIENCE, V322, P1104, DOI 10.1126/science.1163885; Richly H, 2005, CELL, V120, P73, DOI 10.1016/j.cell.2004.11.013; Smith DM, 2007, MOL CELL, V27, P731, DOI 10.1016/j.molcel.2007.06.033; Verma R, 2001, MOL CELL, V8, P439, DOI 10.1016/S1097-2765(01)00308-2; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Zhang F, 2009, MOL CELL, V34, P473, DOI 10.1016/j.molcel.2009.04.021; Zhao G, 2007, P NATL ACAD SCI USA, V104, P8785, DOI 10.1073/pnas.0702966104	17	3	3	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 17	2012	337	6096					813	814		10.1126/science.1227301	http://dx.doi.org/10.1126/science.1227301			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	989BQ	22904006	Green Accepted			2022-12-28	WOS:000307535600034
J	Arimoto, T; Sato, Y				Arimoto, Tateo; Sato, Yasushi			Rebuilding Public Trust in Science for Policy-Making	SCIENCE			English	Editorial Material									[Arimoto, Tateo; Sato, Yasushi] Japan Sci & Technol Agcy, Ctr Res & Dev Strategy, Chiyoda Ku, Tokyo 1020076, Japan; [Arimoto, Tateo] Natl Grad Inst Policy Studies, Minato Ku, Tokyo 1068677, Japan	Japan Science & Technology Agency (JST); National Graduate Institute for Policy Studies	Sato, Y (corresponding author), Japan Sci & Technol Agcy, Ctr Res & Dev Strategy, Chiyoda Ku, 7 Gobancho, Tokyo 1020076, Japan.	y11sato@jst.go.jp						[Anonymous], 2011, SCI ENG ETHICS, V17; Berlin-Brandenburgische Akademie der Wissenschaften, 2008, LEITL POL; Commission of the European Communities, 2002, COMM COMM COLL US EX; Government of Japan, 2011, 4 SCI TECHN BAS PLAN; Holdren J. P., 2010, MEMORANDUM HEADS EXE; IAC, 2011, CLIM CHANG ASS REV P; Japan Ministry of Education, 2011, SUMM WHIT PAP SCI TE; JST-CRDS, 2012, EST PRINC REG ROL RE; Lentsch J, 2011, POLITICS SCI ADVICE; UK Department for Business, 2010, PRINC SCI ADV GOV; UK Government Office for Science, 2011, COD PRACT SCI ADV CO; UK Government Office for Science, 2010, GOV CHIEF SCI ADV GU; Weisblai A, 2007, RELATIONSHIP HEADS A	13	27	33	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 7	2012	337	6099					1176	1177		10.1126/science.1224004	http://dx.doi.org/10.1126/science.1224004			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	000UJ	22955820				2022-12-28	WOS:000308414000020
J	Nielsen, SF; Bojesen, SE; Schnohr, P; Nordestgaard, BG				Nielsen, Sune F.; Bojesen, Stig E.; Schnohr, Peter; Nordestgaard, Borge G.			Elevated rheumatoid factor and long term risk of rheumatoid arthritis: a prospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CYCLIC CITRULLINATED PEPTIDE; HEART-DISEASE; FOLLOW-UP; ANTIBODIES; PREDICTS; REMISSION; CLASSIFICATION; AUTOANTIBODIES; DIAGNOSIS; CRITERIA	Objective To test whether elevated concentration of rheumatoid factor is associated with long term development of rheumatoid arthritis. Design A prospective cohort study, the Copenhagen City Heart Study. Blood was drawn in 1981-83, and participants were followed until 10 August 2010. Setting Copenhagen general population. Participants 9712 white Danish individuals from the general population aged 20-100 years without rheumatoid arthritis at study entry. Main outcome measures Rheumatoid arthritis according to baseline plasma IgM rheumatoid factor level categories of 25-50, 50.1-100, and >100, versus <25 IU/mL. Results Rheumatoid factor levels were similar from age 20 to 100 years. During 187 659 person years, 183 individuals developed rheumatoid arthritis. In healthy individuals, a doubling in levels of rheumatoid factor was associated with a 3.3-fold (95% confidence interval 2.7 to 4.0) increased risk of developing rheumatoid arthritis, with a similar trend for most other autoimmune rheumatic diseases. The cumulative incidence of rheumatoid arthritis increased with increasing rheumatoid factor category (P-trend<0.0001). Multivariable adjusted hazard ratios for rheumatoid arthritis were 3.6 (95% confidence interval 1.7 to 7.3) for rheumatoid factor levels of 25-50 IU/mL, 6.0 (3.4 to 10) for 50.1-100 IU/mL, and 26 (15 to 46) for >100 IU/mL, compared with <25 IU/mL (P-trend<0.0001). The highest absolute 10 year risk of rheumatoid arthritis of 32% was observed in 50-69 years old women who smoked with rheumatoid factor levels >100 IU/mL. Conclusion Individuals in the general population with elevated rheumatoid factor have up to 26-fold greater long term risk of rheumatoid arthritis, and up to 32% 10 year absolute risk of rheumatoid arthritis. These novel findings may lead to revision of guidelines for early referral to a rheumatologist and early arthritis clinics based on rheumatoid factor testing.	[Nielsen, Sune F.; Bojesen, Stig E.; Nordestgaard, Borge G.] Copenhagen Univ Hosp, Dept Clin Biochem, Herlev Hosp, DK-2730 Herlev, Denmark; [Nielsen, Sune F.; Bojesen, Stig E.; Nordestgaard, Borge G.] Univ Copenhagen, Fac Hlth Sci, DK-1168 Copenhagen, Denmark; [Bojesen, Stig E.; Schnohr, Peter; Nordestgaard, Borge G.] Copenhagen Univ Hosp, Copenhagen City Heart Study, Bispebjerg Hosp, DK-2730 Herlev, Denmark	University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen; University of Copenhagen; Bispebjerg Hospital	Nordestgaard, BG (corresponding author), Copenhagen Univ Hosp, Dept Clin Biochem, Herlev Hosp, 54M1,Herlev Ringvej 75, DK-2730 Herlev, Denmark.	Boerge.Nordestgaard@regionh.dk	Nordestgaard, Borge Gronne/ABF-1310-2020	Bojesen, Stig/0000-0002-4061-4133; Nordestgaard, Borge/0000-0002-1954-7220	Herlev Hospital, Copenhagen University Hospital; Danish Heart Foundation	Herlev Hospital, Copenhagen University Hospital; Danish Heart Foundation	This study was funded by Herlev Hospital, Copenhagen University Hospital and the Danish Heart Foundation. The sponsors had no role in the design of the study; collection, analysis, and interpretation of data; writing of the report; or decision to submit the article for publication. The views expressed in this paper are those of the authors and not those of any funding body or others whose support is acknowledged.	AHO K, 1991, J RHEUMATOL, V18, P1282; Aletaha D, 2010, ARTHRITIS RHEUM-US, V62, P2569, DOI 10.1002/art.27584; Andersen TF, 1999, DAN MED BULL, V46, P263; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Baka Z, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2751; Balsa A, 2010, RHEUMATOLOGY, V49, P458, DOI 10.1093/rheumatology/kep380; Bas S, 2003, RHEUMATOLOGY, V42, P677, DOI 10.1093/rheumatology/keg184; Boutry N, 2009, EUR J RADIOL, V71, P217, DOI 10.1016/j.ejrad.2009.02.013; Catapano AL, 2011, ATHEROSCLEROSIS, V217, P3, DOI 10.1016/j.atherosclerosis.2011.06.028; Cohen SB, 2010, BEST PRACT RES CL RH, V24, P553, DOI 10.1016/j.berh.2009.11.006; Deane KD, 2010, ARTHRITIS RHEUM-US, V62, P3161, DOI 10.1002/art.27638; Don BR, 2010, CLIN NEPHROL, V73, P431; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; FISCHER KM, 1991, MED HYPOTHESES, V34, P116, DOI 10.1016/0306-9877(91)90177-Z; Gaston J. S. H, 1999, RHEUMATIC DIS IMMUNO; Hutchinson D, 2001, ANN RHEUM DIS, V60, P223, DOI 10.1136/ard.60.3.223; Innala L, 2008, J RHEUMATOL, V35, P1002; Johansson M, 2006, SCAND J RHEUMATOL, V35, P29; Julia A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007556; Kastbom A, 2004, ANN RHEUM DIS, V63, P1085, DOI 10.1136/ard.2003.016808; Kuriya B, 2009, ANN RHEUM DIS, V68, P1482, DOI 10.1136/ard.2008.092676; Machold KP, 2002, J RHEUMATOL, V29, P2278; Neovius M, 2011, ANN RHEUM DIS, V70, P624, DOI 10.1136/ard.2010.133371; Nielen MMJ, 2004, ARTHRITIS RHEUM-US, V50, P380, DOI 10.1002/art.20018; Nishimura K, 2007, ANN INTERN MED, V146, P797, DOI 10.7326/0003-4819-146-11-200706050-00008; Nordestgaard BG, 2007, JAMA-J AM MED ASSOC, V298, P299, DOI 10.1001/jama.298.3.299; Orsted D, 2011, EUR J CANCER, V47, pS504, DOI 10.1016/S0959-8049(11)72015-9; Pedersen CB, 2006, DAN MED BULL, V53, P441; Pedersen M, 2004, EUR J EPIDEMIOL, V19, P1097, DOI 10.1007/s10654-004-1025-0; Rantapaa-Dahlqvist S, 2003, ARTHRITIS RHEUM, V48, P2741, DOI 10.1002/art.11223; Schnohr P, 2002, EUR HEART J, V23, P620, DOI 10.1053/euhj.2001.2842; Song YW, 2010, QJM-INT J MED, V103, P139, DOI 10.1093/qjmed/hcp165; Tamai M, 2010, SCAND J RHEUMATOL, V39, P287, DOI 10.3109/03009741003604534; Turesson C, 2007, ANN RHEUM DIS, V66, P59, DOI 10.1136/ard.2006.054445; Ursum J, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2907; Verschueren P, 2009, SCAND J RHEUMATOL, V38, P166, DOI 10.1080/03009740802484846; Verstappen SMM, 2005, ANN RHEUM DIS, V64, P38, DOI 10.1136/ard.2003.014928; Weischer M, 2007, J CLIN ONCOL, V25, P57, DOI 10.1200/JCO.2005.05.5160	38	85	87	0	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 6	2012	345								e5244	10.1136/bmj.e5244	http://dx.doi.org/10.1136/bmj.e5244			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	003TL	22956589	hybrid, Green Published			2022-12-28	WOS:000308634100001
J	Queiros, L; Falcao-Reis, F				Queiros, Lara; Falcao-Reis, Fernando			Corneal Dendrites	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Queiros, Lara; Falcao-Reis, Fernando] Hosp Sao Joao, Oporto, Portugal	Sao Joao Hospital	Queiros, L (corresponding author), Hosp Sao Joao, Oporto, Portugal.	laraqueirosmendanha@gmail.com		Falcao-Reis, Fernando/0000-0002-5995-9430					0	0	0	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 6	2012	367	10					E14	E14		10.1056/NEJMicm1114392	http://dx.doi.org/10.1056/NEJMicm1114392			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	999VO	22931284				2022-12-28	WOS:000308343300001
J	Sanyal, A; Lajoie, BR; Jain, G; Dekker, J				Sanyal, Amartya; Lajoie, Bryan R.; Jain, Gaurav; Dekker, Job			The long-range interaction landscape of gene promoters	NATURE			English	Article							CHROMOSOMAL INTERACTIONS; CHROMATIN CONFORMATION; ELEMENTS; BINDING; DOMAIN; 5C	The vast non-coding portion of the human genome is full of functional elements and disease-causing regulatory variants. The principles defining the relationships between these elements and distal target genes remain unknown. Promoters and distal elements can engage in looping interactions that have been implicated in gene regulation(1). Here we have applied chromosome conformation capture carbon copy (5C(2)) to interrogate comprehensively interactions between transcription start sites (TSSs) and distal elements in 1% of the human genome representing the ENCODE pilot project regions(3). 5C maps were generated for GM12878, K562 and HeLa-S3 cells and results were integrated with data from the ENCODE consortium(4). In each cell line we discovered >1,000 long-range interactions between promoters and distal sites that include elements resembling enhancers, promoters and CTCF-bound sites. We observed significant correlations between gene expression, promoter-enhancer interactions and the presence of enhancer RNAs. Long-range interactions show marked asymmetry with a bias for interactions with elements located similar to 120 kilobases upstream of the TSS. Long-range interactions are often not blocked by sites bound by CTCF and cohesin, indicating that many of these sites do not demarcate physically insulated gene domains. Furthermore, only similar to 7% of looping interactions are with the nearest gene, indicating that genomic proximity is not a simple predictor for long-range interactions. Finally, promoters and distal elements are engaged in multiple long-range interactions to form complex networks. Our results start to place genes and regulatory elements in three-dimensional context, revealing their functional relationships.	[Sanyal, Amartya; Lajoie, Bryan R.; Jain, Gaurav; Dekker, Job] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Program Syst Biol,Program Gene Funct & Express, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Dekker, J (corresponding author), Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Program Syst Biol,Program Gene Funct & Express, 364 Plantat St, Worcester, MA 01605 USA.	job.dekker@umassmed.edu	SANYAL, AMARTYA/D-7240-2015; Peng, Bo/A-6920-2009	SANYAL, AMARTYA/0000-0002-2109-4478; Peng, Bo/0000-0001-8225-2284	National Institutes of Health, National Human Genome Research Institute [HG003143, HG003143-06S1]; W.M Keck Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003143] Funding Source: NIH RePORTER	National Institutes of Health, National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); W.M Keck Foundation(W.M. Keck Foundation); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank the University of Massachusetts Medical School Deep Sequencing core for sequencing 5C libraries, and R. Thurman and J. Stamatoyannopoulos for discussion and help with peak calling analysis. We thank M. Walhout and members of the Dekker laboratory for discussions. This work was supported by grants from the National Institutes of Health, National Human Genome Research Institute (HG003143 and HG003143-06S1) and a W.M Keck Foundation Distinguished Young scholar in Medical Research award to J.D.	Bau D, 2011, NAT STRUCT MOL BIOL, V18, P107, DOI 10.1038/nsmb.1936; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Dekker J, 2008, SCIENCE, V319, P1793, DOI 10.1126/science.1152850; Dong X., GENOME BIOL IN PRESS; Dostie J, 2007, NAT PROTOC, V2, P988, DOI 10.1038/nprot.2007.116; Dostie J, 2006, GENOME RES, V16, P1299, DOI 10.1101/gr.5571506; Fullwood MJ, 2009, NATURE, V462, P58, DOI 10.1038/nature08497; Gheldof N, 2006, P NATL ACAD SCI USA, V103, P12463, DOI 10.1073/pnas.0605343103; Harrow J, 2012, GENOME RES; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Kurukuti S, 2006, P NATL ACAD SCI USA, V103, P10684, DOI 10.1073/pnas.0600326103; Lajoie BR, 2009, NAT METHODS, V6, P690, DOI 10.1038/nmeth1009-690; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Miele A, 2008, MOL BIOSYST, V4, P1046, DOI 10.1039/b803580f; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; Palstra RJ, 2003, NAT GENET, V35, P190, DOI 10.1038/ng1244; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Simonis M, 2006, NAT GENET, V38, P1348, DOI 10.1038/ng1896; Song LY, 2011, GENOME RES, V21, P1757, DOI 10.1101/gr.121541.111; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; Vavouri T, 2006, TRENDS GENET, V22, P5, DOI 10.1016/j.tig.2005.10.005; Vernimmen D, 2007, EMBO J, V26, P2041, DOI 10.1038/sj.emboj.7601654; Wallace JA, 2007, CURR OPIN GENET DEV, V17, P400, DOI 10.1016/j.gde.2007.08.005; Wendt KS, 2008, NATURE, V451, P796, DOI 10.1038/nature06634; Zhao Z, 2006, NAT GENET, V38, P1341, DOI 10.1038/ng1891	26	986	1023	6	177	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 6	2012	489	7414					109	U127		10.1038/nature11279	http://dx.doi.org/10.1038/nature11279			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999WW	22955621	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000308347000044
J	Nelson, PC				Nelson, Philip C.			Spare the (Elastic) Rod	SCIENCE			English	Editorial Material							DNA; FLEXIBILITY		Univ Penn, Dept Phys & Astron, Philadelphia, PA 19104 USA	University of Pennsylvania	Nelson, PC (corresponding author), Univ Penn, Dept Phys & Astron, 209 S 33rd St, Philadelphia, PA 19104 USA.	nelson@physics.upenn.edu	Nelson, Philip C/I-6251-2015	Nelson, Philip C/0000-0002-1782-3076	Emerging Frontiers [0928048] Funding Source: National Science Foundation	Emerging Frontiers(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))		BUSTAMANTE C, 1994, SCIENCE, V265, P1599, DOI 10.1126/science.8079175; Cloutier TE, 2005, P NATL ACAD SCI USA, V102, P3645, DOI 10.1073/pnas.0409059102; Cloutier TE, 2004, MOL CELL, V14, P355, DOI 10.1016/S1097-2765(04)00210-2; CRICK FHC, 1975, NATURE, V255, P530, DOI 10.1038/255530a0; Han L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005621; HOGAN ME, 1987, NATURE, V328, P554, DOI 10.1038/328554a0; Johnson S, 2012, NUCLEIC ACIDS RES, V40, P7728, DOI 10.1093/nar/gks473; Peters JP, 2010, Q REV BIOPHYS, V43, P23, DOI 10.1017/S0033583510000077; Phillips R, 2011, NATURE, V476, P400, DOI 10.1038/476400a; Richmond TJ, 2003, NATURE, V423, P145, DOI 10.1038/nature01595; Vafabakhsh R, 2012, SCIENCE, V337, P1097, DOI 10.1126/science.1224139; Wiggins PA, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.021909; Wiggins PA, 2006, NAT NANOTECHNOL, V1, P137, DOI 10.1038/nnano.2006.63; Yan J, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.108108	14	15	16	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 31	2012	337	6098					1045	1046		10.1126/science.1227014	http://dx.doi.org/10.1126/science.1227014			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996WP	22936762				2022-12-28	WOS:000308125800029
J	Smith, FG; Davies, R; Lyne, A				Smith, Francis Graham; Davies, Rodney; Lyne, Andrew			Bernard Lovell (1913-2012) OBITUARY	NATURE			English	Biographical-Item									[Smith, Francis Graham; Davies, Rodney; Lyne, Andrew] Univ Manchester, Manchester M13 9PL, Lancs, England	University of Manchester	Smith, FG (corresponding author), Univ Manchester, Manchester M13 9PL, Lancs, England.	fgs@jb.man.ac.uk							0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 30	2012	488	7413					592	592		10.1038/488592a	http://dx.doi.org/10.1038/488592a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996NC	22932377	Bronze			2022-12-28	WOS:000308095100038
J	Gal-Yam, A				Gal-Yam, Avishay			Luminous Supernovae	SCIENCE			English	Review							CORE-COLLAPSE SUPERNOVAE; GAMMA-RAY BURSTS; PAIR-INSTABILITY; IIN SUPERNOVA; OPTICAL TRANSIENT; LOW-METALLICITY; DWARF GALAXIES; SHOCK BREAKOUT; IC SUPERNOVAE; LIGHT CURVES	Supernovae, the luminous explosions of stars, have been observed since antiquity. However, various examples of superluminous supernovae (SLSNe; luminosities >7 x 10(43) ergs per second) have only recently been documented. From the accumulated evidence, SLSNe can be classified as radioactively powered (SLSN-R), hydrogen-rich (SLSN-II), and hydrogen-poor (SLSN-I, the most luminous class). The SLSN-II and SLSN-I classes are more common, whereas the SLSN-R class is better understood. The physical origins of the extreme luminosity emitted by SLSNe are a focus of current research.	Weizmann Inst Sci, Fac Phys, Dept Particle Phys & Astrophys, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Gal-Yam, A (corresponding author), Weizmann Inst Sci, Fac Phys, Dept Particle Phys & Astrophys, IL-76100 Rehovot, Israel.	avishay.gal-yam@weizmann.ac.il		Gal-Yam, Avishay/0000-0002-3653-5598	Israeli Science Foundation; U.S.-Israel Binational Science Foundation; German-Israeli Foundation; Minerva Foundation; Lord Sieff of Brimpton Fund	Israeli Science Foundation(Israel Science Foundation); U.S.-Israel Binational Science Foundation(US-Israel Binational Science Foundation); German-Israeli Foundation(German-Israeli Foundation for Scientific Research and Development); Minerva Foundation; Lord Sieff of Brimpton Fund	I thank O. Yaron; Caltech Core-Collapse Project members E. Enriquez, A. Soderberg, S. B. Cenko, D. Leonard, D. Fox, D. Moon, and D. Sand; M. Phillips and P. Nugent; E. Chatzopoulos; L. Chomiuk and R. Quimby for use of data presented here; E. Nakar, P. Mazzali, D. Xu, R. Waldman, A. Pastorello, I. Arcavi, A. Howell, E. O. Ofek, A. Drake, S. Smartt, C. Wheeler, and A. Miller for useful advice; members of the PTF collaboration, and in particular J. S. Bloom, M. M. Kasliwal, S. R. Kulkami, N. M. Law, and D. Poznanski, for use of unpublished PTF material; and the anonymous reviewers for useful and constructive suggestions and comments. Supported by grants from the Israeli Science Foundation, the U.S.-Israel Binational Science Foundation, the German-Israeli Foundation, the Minerva Foundation, ARCHES (Award for Research Cooperation and High Excellence in Science), and the Lord Sieff of Brimpton Fund. This research has made use of the NASA/IPAC (Infrared Processing and Analysis Center) Extragalactic Database, which is operated by the Jet Propulsion Laboratory, California Institute of Technology, under contract with NASA. All spectra shown are available in digital form from the Weizmann Interactive Supernova Data Repository (WISeREP) (81) at www.weizmann.ac.il/astrophysics/wiserep.	Agnoletto I, 2009, ASTROPHYS J, V691, P1348, DOI 10.1088/0004-637X/691/2/1348; Arcavi I, 2011, ASTROPHYS J LETT, V742, DOI 10.1088/2041-8205/742/2/L18; Arcavi I, 2010, ASTROPHYS J, V721, P777, DOI 10.1088/0004-637X/721/1/777; ARNETT WD, 1982, ASTROPHYS J, V253, P785, DOI 10.1086/159681; Barbary K, 2009, ASTROPHYS J, V690, P1358, DOI 10.1088/0004-637X/690/2/1358; BARKAT Z, 1967, PHYS REV LETT, V18, P379, DOI 10.1103/PhysRevLett.18.379; BOND JR, 1984, ASTROPHYS J, V280, P825, DOI 10.1086/162057; Chatzopoulos E, 2011, ASTROPHYS J, V729, DOI 10.1088/0004-637X/729/2/143; Chevalier RA, 2011, ASTROPHYS J LETT, V729, DOI 10.1088/2041-8205/729/1/L6; Drake AJ, 2011, ASTROPHYS J, V735, DOI 10.1088/0004-637X/735/2/106; Drake AJ, 2010, ASTROPHYS J LETT, V718, pL127, DOI 10.1088/2041-8205/718/2/L127; Drout MR, 2011, ASTROPHYS J, V741, DOI 10.1088/0004-637X/741/2/97; Filippenko A. V., IAU C, V183; Filippenko AV, 1997, ANNU REV ASTRON ASTR, V35, P309, DOI 10.1146/annurev.astro.35.1.309; Gal-Yam A, 2009, NATURE, V462, P624, DOI 10.1038/nature08579; Gal-Yam A, 2009, NATURE, V458, P865, DOI 10.1038/nature07934; Gal-Yam A., 2011, STOCKH EXPL ID MASS; Gal-Yam A, 2007, ASTROPHYS J, V656, P372, DOI 10.1086/510523; Germany LM, 2000, ASTROPHYS J, V533, P320, DOI 10.1086/308639; Gezari S, 2009, ASTROPHYS J, V690, P1313, DOI 10.1088/0004-637X/690/2/1313; Guetta D, 2007, ASTROPHYS J, V657, pL73, DOI 10.1086/511417; Hamuy M, 2003, NATURE, V424, P651, DOI 10.1038/nature01854; HATANO K, 2001, BAAS, V33, P838; Heger A, 2002, ASTROPHYS J, V567, P532, DOI 10.1086/338487; HUMPHREYS RM, 1994, PUBL ASTRON SOC PAC, V106, P1025, DOI 10.1086/133478; Kasen D, 2010, ASTROPHYS J, V717, P245, DOI 10.1088/0004-637X/717/1/245; Kiewe M, 2012, ASTROPHYS J, V744, DOI 10.1088/0004-637X/744/1/10; KNOP R, 1999, 7128 IAU; Kodros J., 2010, CENTRAL BUREAU ELECT, V2461; Langer N, 2007, ASTRON ASTROPHYS, V475, pL19, DOI 10.1051/0004-6361:20078482; Leonard DC, 2002, PUBL ASTRON SOC PAC, V114, P35, DOI 10.1086/324785; MacFadyen AI, 1999, ASTROPHYS J, V524, P262, DOI 10.1086/307790; Mazzali PA, 2007, ASTROPHYS J, V670, P592, DOI 10.1086/521873; Mazzali PA, 2010, MON NOT R ASTRON SOC, V408, P87, DOI 10.1111/j.1365-2966.2010.17133.x; Miller AA, 2009, ASTROPHYS J, V690, P1303, DOI 10.1088/0004-637X/690/2/1303; Moriya T, 2010, ASTROPHYS J LETT, V717, pL83, DOI 10.1088/2041-8205/717/2/L83; Neill JD, 2011, ASTROPHYS J, V727, DOI 10.1088/0004-637X/727/1/15; Nugent P., 1999, 7133 IAU, V7133; Ofek EO, 2007, ASTROPHYS J, V659, pL13, DOI 10.1086/516749; Ofek EO, 2010, ASTROPHYS J, V724, P1396, DOI 10.1088/0004-637X/724/2/1396; Paczynski B., 2001, ASTRONOMICAL SOC, P121; Pastorello A, 2010, ASTROPHYS J LETT, V724, pL16, DOI 10.1088/2041-8205/724/1/L16; Perets HB, 2010, NATURE, V465, P322, DOI 10.1038/nature09056; QUIMBY R, 2006, THESIS U TEXAS; Quimby RM, 2011, NATURE, V474, P487, DOI 10.1038/nature10095; Quimby RM, 2007, ASTROPHYS J, V668, pL99, DOI 10.1086/522862; RAKAVY G, 1967, ASTROPHYS J, V148, P803, DOI 10.1086/149204; Rest A, 2011, ASTROPHYS J, V729, DOI 10.1088/0004-637X/729/2/88; Sauer DN, 2006, MON NOT R ASTRON SOC, V369, P1939, DOI 10.1111/j.1365-2966.2006.10438.x; Scannapieco E, 2005, ASTROPHYS J, V633, P1031, DOI 10.1086/444450; Smartt S., 2011, STOCKH EXPL ID MASS; Smith N, 2008, ASTROPHYS J, V686, P467, DOI 10.1086/591021; Smith N, 2007, ASTROPHYS J, V666, P1116, DOI 10.1086/519949; Smith N, 2010, ASTROPHYS J, V709, P856, DOI 10.1088/0004-637X/709/2/856; Stoll R, 2011, ASTROPHYS J, V730, DOI 10.1088/0004-637X/730/1/34; Umeda H, 2008, ASTROPHYS J, V673, P1014, DOI 10.1086/524767; Vinko J., 2010, CENTRAL BUREAU ELECT, V2476; Waldman R, 2008, ASTROPHYS J, V685, P1103, DOI 10.1086/591267; Woosley SE, 2007, NATURE, V450, P390, DOI 10.1038/nature06333; Woosley SE, 2010, ASTROPHYS J LETT, V719, pL204, DOI 10.1088/2041-8205/719/2/L204; Yoshida T, 2011, MON NOT R ASTRON SOC, V412, pL78, DOI 10.1111/j.1745-3933.2011.01008.x; Young DR, 2008, ASTRON ASTROPHYS, V489, P359, DOI 10.1051/0004-6361:20078662; Young DR, 2010, ASTRON ASTROPHYS, V512, DOI 10.1051/0004-6361/200913004; Young TR, 2005, ASTROPHYS J, V625, pL87, DOI 10.1086/431279	66	411	412	0	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 24	2012	337	6097					927	932		10.1126/science.1203601	http://dx.doi.org/10.1126/science.1203601			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992VI	22923572	Green Submitted			2022-12-28	WOS:000307807600035
J	Kong, A; Frigge, ML; Masson, G; Besenbacher, S; Sulem, P; Magnusson, G; Gudjonsson, SA; Sigurdsson, A; Jonasdottir, A; Jonasdottir, A; Wong, WSW; Sigurdsson, G; Walters, GB; Steinberg, S; Helgason, H; Thorleifsson, G; Gudbjartsson, DF; Helgason, A; Magnusson, OT; Thorsteinsdottir, U; Stefansson, K				Kong, Augustine; Frigge, Michael L.; Masson, Gisli; Besenbacher, Soren; Sulem, Patrick; Magnusson, Gisli; Gudjonsson, Sigurjon A.; Sigurdsson, Asgeir; Jonasdottir, Aslaug; Jonasdottir, Adalbjorg; Wong, Wendy S. W.; Sigurdsson, Gunnar; Walters, G. Bragi; Steinberg, Stacy; Helgason, Hannes; Thorleifsson, Gudmar; Gudbjartsson, Daniel F.; Helgason, Agnar; Magnusson, Olafur Th.; Thorsteinsdottir, Unnur; Stefansson, Kari			Rate of de novo mutations and the importance of father's age to disease risk	NATURE			English	Article							AUTISM SPECTRUM DISORDERS; SCHIZOPHRENIA; HUMANS; CONSEQUENCES; NUCLEOTIDE; PATTERNS; NRXN1	Mutations generate sequence diversity and provide a substrate for selection. The rate of de novo mutations is therefore of major importance to evolution. Here we conduct a study of genome-wide mutation rates by sequencing the entire genomes of 78 Icelandic parent-offspring trios at high coverage. We show that in our samples, with an average father's age of 29.7, the average de novo mutation rate is 1.20 x 10(-8) per nucleotide per generation. Most notably, the diversity in mutation rate of single nucleotide polymorphisms is dominated by the age of the father at conception of the child. The effect is an increase of about two mutations per year. An exponential model estimates paternal mutations doubling every 16.5 years. After accounting for random Poisson variation, father's age is estimated to explain nearly all of the remaining variation in the de novo mutation counts. These observations shed light on the importance of the father's age on the risk of diseases such as schizophrenia and autism.	[Kong, Augustine; Frigge, Michael L.; Masson, Gisli; Besenbacher, Soren; Sulem, Patrick; Magnusson, Gisli; Gudjonsson, Sigurjon A.; Sigurdsson, Asgeir; Jonasdottir, Aslaug; Jonasdottir, Adalbjorg; Sigurdsson, Gunnar; Walters, G. Bragi; Steinberg, Stacy; Helgason, Hannes; Thorleifsson, Gudmar; Gudbjartsson, Daniel F.; Helgason, Agnar; Magnusson, Olafur Th.; Thorsteinsdottir, Unnur; Stefansson, Kari] deCODE Genet, IS-101 Reykjavik, Iceland; [Besenbacher, Soren] Aarhus Univ, Bioinformat Res Ctr, DK-8000 Aarhus, Denmark; [Wong, Wendy S. W.] Illumina Cambridge Ltd, Saffron Walden CB10 1XL, Essex, England; [Thorsteinsdottir, Unnur; Stefansson, Kari] Univ Iceland, Fac Med, IS-101 Reykjavik, Iceland	Aarhus University; Illumina; University of Iceland	Kong, A (corresponding author), deCODE Genet, Sturlugata 8, IS-101 Reykjavik, Iceland.	kong@decode.is; kari.stefansson@decode.is	Walters, G. Bragi/L-4215-2013; Stefansson, Kari/AAE-7187-2019; Helgason, Agnar/K-1522-2015	Walters, G. Bragi/0000-0002-5415-6487; Helgason, Agnar/0000-0002-8545-3767; Gudjonsson, Sigurjon A./0000-0001-9314-7412; Besenbacher, Soren/0000-0003-1455-1738; Kong, Augustine/0000-0001-8193-5438; Gudbjartsson, Daniel/0000-0002-5222-9857	National Institutes of Health [MH071425]; European Community [HEALTH-F2-2009-223423, IAPP-MC-251592]; European Community IMI grant EU-AIMS [115300]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH071425] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Community(European Commission); European Community IMI grant EU-AIMS; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was partly funded by The National Institutes of Health grant MH071425 (K.S.); the European Community's Seventh Framework Programme, PsychCNVs project, grant agreement HEALTH-F2-2009-223423, and NextGene project, grant agreement IAPP-MC-251592; The European Community IMI grant EU-AIMS, grant agreement 115300.	Boyden LM, 2012, NATURE, V482, P98, DOI 10.1038/nature10814; Conrad DF, 2011, NAT GENET, V43, P712, DOI 10.1038/ng.862; COULONDRE C, 1978, NATURE, V274, P775, DOI 10.1038/274775a0; Croen LA, 2007, ARCH PEDIAT ADOL MED, V161, P334, DOI 10.1001/archpedi.161.4.334; Crow JF, 2000, NAT REV GENET, V1, P40, DOI 10.1038/35049558; Duong L, 2012, AM J MED GENET B, V159B, P354, DOI 10.1002/ajmg.b.32036; Gauthier J, 2011, HUM GENET, V130, P563, DOI 10.1007/s00439-011-0975-z; Holm H, 2011, NAT GENET, V43, P316, DOI 10.1038/ng.781; Keightley PD, 2012, GENETICS, V190, P295, DOI 10.1534/genetics.111.134668; Keightley PD, 2009, GENOME RES, V19, P1195, DOI 10.1101/gr.091231.109; Kirov G, 2008, HUM MOL GENET, V17, P458, DOI 10.1093/hmg/ddm323; Kondrashov AS, 2003, HUM MUTAT, V21, P12, DOI 10.1002/humu.10147; Kong A, 2004, NAT GENET, V36, P1203, DOI 10.1038/ng1445; Levinson DF, 2011, AM J PSYCHIAT, V168, P302, DOI 10.1176/appi.ajp.2010.10060876; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lynch M, 2010, P NATL ACAD SCI USA, V107, P961, DOI 10.1073/pnas.0912629107; Malaspina D, 2001, SCHIZOPHRENIA BULL, V27, P379, DOI 10.1093/oxfordjournals.schbul.a006882; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Nachman MW, 2000, GENETICS, V156, P297; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; Rafnar T, 2011, NAT GENET, V43, P1104, DOI 10.1038/ng.955; Roach JC, 2010, SCIENCE, V328, P636, DOI 10.1126/science.1186802; Rujescu D, 2009, HUM MOL GENET, V18, P988, DOI 10.1093/hmg/ddn351; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Sulem P, 2011, NAT GENET, V43, P1127, DOI 10.1038/ng.972; Xue YL, 2009, CURR BIOL, V19, P1453, DOI 10.1016/j.cub.2009.07.032	27	1252	1282	5	361	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 23	2012	488	7412					471	475		10.1038/nature11396	http://dx.doi.org/10.1038/nature11396			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992FS	22914163	Green Accepted			2022-12-28	WOS:000307761600028
J	Lee, D; Lin, BJ; Lee, AK				Lee, Doyun; Lin, Bei-Jung; Lee, Albert K.			Hippocampal Place Fields Emerge upon Single-Cell Manipulation of Excitability During Behavior	SCIENCE			English	Article							SPATIAL MAP; GRID CELLS; INPUT; CA1; DENDRITES; DYNAMICS; NEURONS; REPRESENTATION; INHIBITION; RECORDINGS	The origin of the spatial receptive fields of hippocampal place cells has not been established. A hippocampal CA1 pyramidal cell receives thousands of synaptic inputs, mostly from other spatially tuned neurons; however, how the postsynaptic neuron's cellular properties determine the response to these inputs during behavior is unknown. We discovered that, contrary to expectations from basic models of place cells and neuronal integration, a small, spatially uniform depolarization of the spatially untuned somatic membrane potential of a silent cell leads to the sudden and reversible emergence of a spatially tuned subthreshold response and place-field spiking. Such gating of inputs by postsynaptic neuronal excitability reveals a cellular mechanism for receptive field origin and may be critical for the formation of hippocampal memory representations.	[Lee, Doyun; Lin, Bei-Jung; Lee, Albert K.] Howard Hughes Med Inst, Ashburn, VA 20147 USA	Howard Hughes Medical Institute	Lee, D (corresponding author), Howard Hughes Med Inst, Janelia Farm Res Campus, Ashburn, VA 20147 USA.	leed@janelia.hhmi.org; leea@janelia.hhmi.org	Lee, Doyun/AAK-5369-2020	Lee, Doyun/0000-0002-9968-9113; Lin, Bei-Jung/0000-0002-1755-1664	Howard Hughes Medical Institute	Howard Hughes Medical Institute(Howard Hughes Medical Institute)	We would like to thank G. Shtengel, J. Osborne, L. Ramasamy, D. Cabaniss, S. Bassin, C. Werner, B. Shields, A. Hu, M. J. Kim, H.-P. Liaw, G. Crosby, and D. Culley for technical advice and assistance and J. Dudman, N. Spruston, G. Murphy, J. Magee, K. Svoboda, J. Cohen, and D. Rich for valuable discussions about the manuscript. This work was supported by the Howard Hughes Medical Institute.	Brun VH, 2008, NEURON, V57, P290, DOI 10.1016/j.neuron.2007.11.034; Brun VH, 2002, SCIENCE, V296, P2243, DOI 10.1126/science.1071089; Burgess N, 1996, HIPPOCAMPUS, V6, P749; Chevaleyre V, 2010, NEURON, V66, P560, DOI 10.1016/j.neuron.2010.04.013; Crochet S, 2011, NEURON, V69, P1160, DOI 10.1016/j.neuron.2011.02.022; de Almeida L, 2009, J NEUROSCI, V29, P7504, DOI 10.1523/JNEUROSCI.6048-08.2009; Epsztein J, 2011, NEURON, V70, P109, DOI 10.1016/j.neuron.2011.03.006; Frank LM, 2004, J NEUROSCI, V24, P7681, DOI 10.1523/JNEUROSCI.1958-04.2004; Golding NL, 1998, NEURON, V21, P1189, DOI 10.1016/S0896-6273(00)80635-2; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Harvey CD, 2009, NATURE, V461, P941, DOI 10.1038/nature08499; Hausser M, 2000, SCIENCE, V290, P739, DOI 10.1126/science.290.5492.739; Jarsky T, 2005, NAT NEUROSCI, V8, P1667, DOI 10.1038/nn1599; Jia HB, 2010, NATURE, V464, P1307, DOI 10.1038/nature08947; Johnston D, 2008, TRENDS NEUROSCI, V31, P309, DOI 10.1016/j.tins.2008.03.004; Lee A. K., 2008, SOC NEUR ABSTR, V2008, P69022; Lee AK, 2006, NEURON, V51, P399, DOI 10.1016/j.neuron.2006.07.004; Lee AK, 2009, NAT PROTOC, V4, P385, DOI 10.1038/nprot.2009.5; Losonczy A, 2008, NATURE, V452, P436, DOI 10.1038/nature06725; Major G, 2008, J NEUROPHYSIOL, V99, P2584, DOI 10.1152/jn.00011.2008; Nakashiba T, 2008, SCIENCE, V319, P1260, DOI 10.1126/science.1151120; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; Priebe NJ, 2008, NEURON, V57, P482, DOI 10.1016/j.neuron.2008.02.005; Quiroga RQ, 2005, NATURE, V435, P1102, DOI 10.1038/nature03687; Samsonovich A, 1997, J NEUROSCI, V17, P5900; Solstad T, 2006, HIPPOCAMPUS, V16, P1026, DOI 10.1002/hipo.20244; THOMPSON LT, 1989, J NEUROSCI, V9, P2382; Tsodyks M, 1995, INTERNATIONAL JOURNAL OF NEURAL SYSTEMS, SUPPLEMENTARY ISSUE, 1995, P81; Wei DS, 2001, SCIENCE, V293, P2272, DOI 10.1126/science.1061198; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520; Zhou Y, 2009, NAT NEUROSCI, V12, P1438, DOI 10.1038/nn.2405	32	159	160	0	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 17	2012	337	6096					849	853		10.1126/science.1221489	http://dx.doi.org/10.1126/science.1221489			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	989BQ	22904011				2022-12-28	WOS:000307535600045
J	Sander, PM				Sander, P. Martin			Reproduction in Early Amniotes	SCIENCE			English	Editorial Material							LIFE-HISTORY; REPTILIA		Univ Bonn, Div Paleontol, Steinmann Inst Geol Mineral & Paleontol, D-53115 Bonn, Germany	University of Bonn	Sander, PM (corresponding author), Univ Bonn, Div Paleontol, Steinmann Inst Geol Mineral & Paleontol, Nussallee 8, D-53115 Bonn, Germany.	martin.sander@uni-bonn.de						BURGIN T, 1989, SCI AM, V260, P74; Caldwell MW, 2001, P ROY SOC B-BIOL SCI, V268, P2397, DOI 10.1098/rspb.2001.1796; Cheng YN, 2009, J VERTEBR PALEONTOL, V29, P401, DOI 10.1671/039.029.0230; Hou LH, 2010, P ROY SOC B-BIOL SCI, V277, P1235, DOI 10.1098/rspb.2009.2035; Houssaye A, 2009, INTEGR ZOOL, V4, P325, DOI 10.1111/j.1749-4877.2009.00146.x; Koenigswald Wighart V., 2004, Palaeontologische Zeitschrift, V78, P417; Modesto SP, 2010, J VERTEBR PALEONTOL, V30, P1378, DOI 10.1080/02724634.2010.501443; O'Keefe FR, 2011, SCIENCE, V333, P870, DOI 10.1126/science.1205689; Pineiro G, 2012, HIST BIOL, V24, P620, DOI 10.1080/08912963.2012.662230; Reisz RR, 2012, P NATL ACAD SCI USA, V109, P2428, DOI 10.1073/pnas.1109385109; Reisz RR, 2004, TRENDS GENET, V20, P237, DOI 10.1016/j.tig.2004.03.007; SANDER PM, 1988, SCIENCE, V239, P780, DOI 10.1126/science.3340859; Sumida S. S., 1997, AMNIOTE ORIGINS COMP; Wilkinson M, 2002, J NAT HIST, V36, P2185, DOI 10.1080/00222930110071714	14	35	35	0	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 17	2012	337	6096					806	808		10.1126/science.1224301	http://dx.doi.org/10.1126/science.1224301			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	989BQ	22904001				2022-12-28	WOS:000307535600029
J	Koretz, RL				Koretz, Ronald L.			Review: Proton-pump inhibitors are associated with increased risk for Clostridium difficile infection	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							CLOPIDOGREL		Olive View UCLA Med Ctr, Sylmar, CA 91342 USA	University of California System; University of California Los Angeles	Koretz, RL (corresponding author), Olive View UCLA Med Ctr, 14445 Olive View Dr, Sylmar, CA 91342 USA.							Bhatt DL, 2010, NEW ENGL J MED, V363, P1909, DOI 10.1056/NEJMoa1007964; Ho PM, 2009, JAMA-J AM MED ASSOC, V301, P937, DOI 10.1001/jama.2009.261	2	1	2	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 21	2012	157	4							JC4-13	10.7326/0003-4819-157-4-201208210-02013	http://dx.doi.org/10.7326/0003-4819-157-4-201208210-02013			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	992XG	22910967				2022-12-28	WOS:000307813200012
J	Ford, AC; Talley, NJ				Ford, Alexander C.; Talley, Nicholas J.			Irritable bowel syndrome	BMJ-BRITISH MEDICAL JOURNAL			English	Review							PLACEBO-CONTROLLED TRIAL; DOUBLE-BLIND; CELIAC-DISEASE; SYMPTOMS; EFFICACY; PREVALENCE; THERAPIES		[Ford, Alexander C.] St James Univ Hosp, Leeds Gastroenterol Inst, Leeds LS9 7TF, W Yorkshire, England; [Ford, Alexander C.] Univ Leeds, Leeds Inst Mol Med, Leeds, W Yorkshire, England; [Talley, Nicholas J.] Univ Newcastle, Fac Hlth, Callaghan, NSW 2308, Australia	Saint James's University Hospital; University of Leeds; University of Newcastle	Ford, AC (corresponding author), St James Univ Hosp, Leeds Gastroenterol Inst, Leeds LS9 7TF, W Yorkshire, England.	alexf12399@yahoo.com	Ford, Alexander/K-5491-2012; Talley, Nicholas J/D-5399-2013	Ford, Alexander/0000-0001-6371-4359; Talley, Nicholas J/0000-0003-2537-3092	Shire pharmaceuticals; Abbott; Focus Medical; Accreddit Ed; Astra Zeneca; Salix; Ironwood; Falk; Forest; Janssen; Takeda	Shire pharmaceuticals; Abbott(Abbott Laboratories); Focus Medical; Accreddit Ed; Astra Zeneca(AstraZeneca); Salix; Ironwood; Falk; Forest; Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Takeda(Takeda Pharmaceutical Company Ltd)	All authors have completed the Unified Competing Interest form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: no support from any organisation for the submitted work; ACF has received speakers fees from Shire pharmaceuticals; NJT has consulted for ARYx, Astellenas Pharma, Boehringer Ingelheim, ConCERT Pharma, Forest, Ironwood Pharma, Janssen, Johnson & Johnson, Pfizer, Proctor and Gamble, Prometheus, Salix Pharma, Sanofi-Adventis, Theravance, Doyen, Care Capital, Edusa Pharma, Falk, Meritage Pharma, NicOx, Novaritis, Shire, Tranzyme, UptoDate, XenoPort, and Zeria; NJT has received speakers fees from Abbott, Focus Medical, Accreddit Ed, Astra Zeneca, Salix, and Ironwood; NJT has patents with Prometheus and separately for biomarkers, and has received research support from Falk, Forest, Janssen, and Takeda.	Atkinson W, 2004, GUT, V53, P1459, DOI 10.1136/gut.2003.037697; Biesiekierski JR, 2011, AM J GASTROENTEROL, V106, P508, DOI 10.1038/ajg.2010.487; Bijkerk CJ, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3154; Chey WD, 2011, GASTROENTEROLOGY, V140, pS135; Drossman DA, 2009, ALIMENT PHARM THER, V29, P329, DOI 10.1111/j.1365-2036.2008.03881.x; Ford AC, 2010, ALIMENT PHARM THER, V32, P144, DOI 10.1111/j.1365-2036.2010.04328.x; Ford AC, 2009, GUT, V58, P367, DOI 10.1136/gut.2008.163162; Ford AC, 2008, BMJ-BRIT MED J, V337, P1388; Ford AC, 2008, JAMA-J AM MED ASSOC, V300, P1793, DOI 10.1001/jama.300.15.1793; Ford AC, 2011, GUT, V60, P209, DOI 10.1136/gut.2010.227132; Ford AC, 2009, AM J GASTROENTEROL, V104, P1831, DOI 10.1038/ajg.2009.223; Ford AC, 2009, ARCH INTERN MED, V169, P651, DOI 10.1001/archinternmed.2009.22; Gaylord SA, 2011, AM J GASTROENTEROL, V106, P1678, DOI 10.1038/ajg.2011.184; Johannesson E, 2011, AM J GASTROENTEROL, V106, P915, DOI 10.1038/ajg.2010.480; Kaptchuk TJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015591; Lindfors P, 2012, AM J GASTROENTEROL, V107, P276, DOI 10.1038/ajg.2011.340; Lovell RM, 2012, AM J GASTROENTEROL, V107, P991, DOI 10.1038/ajg.2012.131; Lovell RM, 2012, CLIN GASTROENTEROL H, V10, P712, DOI 10.1016/j.cgh.2012.02.029; Lu WZ, 2005, ALIMENT PHARM THER, V22, P927, DOI 10.1111/j.1365-2036.2005.02673.x; Madisch A, 2004, ALIMENT PHARM THER, V19, P271, DOI 10.1111/j.1365-2036.2004.01859.x; Manheimer E, 2012, AM J GASTROENTEROL, V107, P835, DOI 10.1038/ajg.2012.66; Moayyedi P, 2010, GUT, V59, P325, DOI 10.1136/gut.2008.167270; Money ME, 2011, FRONTLINE GASTROENTE, V2, P48, DOI 10.1136/fg.2010.002253; Odunsi-Shiyanbade ST, 2010, CLIN GASTROENTEROL H, V8, P159, DOI 10.1016/j.cgh.2009.10.020; Ong DK, 2010, J GASTROEN HEPATOL, V25, P1366, DOI 10.1111/j.1440-1746.2010.06370.x; Pimentel M, 2011, NEW ENGL J MED, V364, P22, DOI 10.1056/NEJMoa1004409; Ruepert L, 2011, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD003460.pub3, 10.1002/14651858.CD003460]; Saito YA, 2004, CLIN GASTROENTEROL H, V2, P576, DOI 10.1016/S1542-3565(04)00241-1; Saito YA, 2010, AM J GASTROENTEROL, V105, P170, DOI 10.1038/ajg.2009.577; Zijdenbos IL, 2009, COCHRANE DB SYST REV, V21	30	51	51	0	21	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 4	2012	345								e5836	10.1136/bmj.e5836	http://dx.doi.org/10.1136/bmj.e5836			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	003TI	22296841				2022-12-28	WOS:000308633800003
J	Koretz, RL				Koretz, Ronald L.			Invitation to screening with colonoscopy had lower participation but similar yield as CT colonography	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							COLORECTAL-CANCER		Olive View UCLA Med Ctr, Sylmar, CA 91342 USA	University of California System; University of California Los Angeles	Koretz, RL (corresponding author), Olive View UCLA Med Ctr, 14445 Olive View Dr, Sylmar, CA 91342 USA.							Atkin WS, 2010, LANCET, V375, P1624, DOI 10.1016/S0140-6736(10)60551-X; Baxter NN, 2009, ANN INTERN MED, V150, P1, DOI 10.7326/0003-4819-150-1-200901060-00306; Brenner H, 2011, ANN INTERN MED, V154, P22, DOI 10.7326/0003-4819-154-1-201101040-00004; Hewitson P, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001216.pub2; Quintero E, 2012, NEW ENGL J MED, V366, P697, DOI [10.1056/NEJMoa1108895, 10.1056/NEJMx150040]	5	1	2	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 17	2012	157	2							JC2-5	10.7326/0003-4819-157-2-201207170-02005	http://dx.doi.org/10.7326/0003-4819-157-2-201207170-02005			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	992ON	22910967				2022-12-28	WOS:000307787900004
